PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Crossman, DJ; Ruygrok, PR; Soeller, C; Cannell, MB				Crossman, David J.; Ruygrok, Peter R.; Soeller, Christian; Cannell, Mark B.			Changes in the Organization of Excitation-Contraction Coupling Structures in Failing Human Heart	PLOS ONE			English	Article							TRANSVERSE TUBULAR SYSTEM; HUMAN CARDIAC MYOCYTES; T-TUBULES; VENTRICULAR MYOCYTES; REDUCED SYNCHRONY; CA2+ RELEASE; RYANODINE RECEPTORS; HUMAN MYOCARDIUM; RAT MYOCYTES; FAILURE	Background: The cardiac myocyte t-tubular system ensures rapid, uniform cell activation and several experimental lines of evidence suggest changes in the t-tubular system and associated excitation-contraction coupling proteins may occur in heart failure. Methods and Results: The organization of t-tubules, L-type calcium channels (DHPRs), ryanodine receptors (RyRs) and contractile machinery were examined in fixed ventricular tissue samples from both normal and failing hearts (idiopathic (non-ischemic) dilated cardiomyopathy) using high resolution fluorescent imaging. Wheat germ agglutinin (WGA), Na-Ca exchanger, DHPR and caveolin-3 labels revealed a shift from a predominantly transverse orientation to oblique and axial directions in failing myocytes. In failure, dilation of peripheral t-tubules occurred and a change in the extent of protein glycosylation was evident. There was no change in the fractional area occupied by myofilaments (labeled with phalloidin) but there was a small reduction in the number of RyR clusters per unit area. The general relationship between DHPRs and RyR was not changed and RyR labeling overlapped with 51 +/- 3% of DHPR labeling in normal hearts. In longitudinal (but not transverse) sections there was an similar to 30% reduction in the degree of colocalization between DHPRs and RyRs as measured by Pearson's correlation coefficient in failing hearts. Conclusions: The results show that extensive remodelling of the t-tubular network and associated excitation-contraction coupling proteins occurs in failing human heart. These changes may contribute to abnormal calcium handling in heart failure. The general organization of the t-system and changes observed in failure samples have subtle differences to some animal models although the general direction of changes are generally similar.	[Crossman, David J.; Ruygrok, Peter R.; Soeller, Christian; Cannell, Mark B.] Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand; [Ruygrok, Peter R.] Auckland City Hosp, Auckland, New Zealand	University of Auckland; Auckland City Hospital	Crossman, DJ (corresponding author), Univ Auckland, Dept Physiol, Fac Med & Hlth Sci, Auckland, New Zealand.	m.cannell@auckland.ac.nz	Soeller, Christian/G-5525-2011	Soeller, Christian/0000-0002-9302-2203; Crossman, David/0000-0003-3811-5455	Health Research Council of New Zealand [05/049]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Health Research Council of New Zealand (05/049) http://hrc.govt.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquila LA, 2004, J HEART LUNG TRANSPL, V23, P954, DOI 10.1016/j.healun.2004.05.018; Balijepalli RC, 2003, CARDIOVASC RES, V59, P67, DOI 10.1016/S0008-6363(03)00325-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Cannell MB, 2006, J MUSCLE RES CELL M, V27, P297, DOI 10.1007/s10974-006-9089-y; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; Cannell MB, 1998, TRENDS PHARMACOL SCI, V19, P16, DOI 10.1016/S0165-6147(97)01149-8; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; CHENG H, 1994, PFLUG ARCH EUR J PHY, V428, P415, DOI 10.1007/BF00724526; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; FAWCETT DW, 1969, J CELL BIOL, V42, P1, DOI 10.1083/jcb.42.1.1; FORBES MS, 1988, ANAT RECORD, V222, P362, DOI 10.1002/ar.1092220409; FORSSMAN.WG, 1970, J CELL BIOL, V44, P1, DOI 10.1083/jcb.44.1.1; Franzini-Armstrong C, 2004, BIOL RES, V37, P507; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; He JQ, 2001, CARDIOVASC RES, V49, P298, DOI 10.1016/S0008-6363(00)00256-X; Heinzel FR, 2008, CIRC RES, V102, P338, DOI 10.1161/CIRCRESAHA.107.160085; Heling A, 2000, CIRC RES, V86, P846, DOI 10.1161/01.RES.86.8.846; Jayasinghe ID, 2009, BIOPHYS J, V97, P2664, DOI 10.1016/j.bpj.2009.08.036; Kaprielian RR, 2000, CIRCULATION, V101, P2586, DOI 10.1161/01.CIR.101.22.2586; Kostin S, 1998, CELL TISSUE RES, V294, P449, DOI 10.1007/s004410051196; Kostin S, 2000, Heart Fail Rev, V5, P271; Lindner M, 2002, CELL CALCIUM, V31, P175, DOI 10.1054/ceca.2002.0272; Louch WE, 2004, CARDIOVASC RES, V62, P63, DOI 10.1016/j.cardiores.2003.12.031; Louch WE, 2006, J PHYSIOL-LONDON, V574, P519, DOI 10.1113/jphysiol.2006.107227; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Ohler A, 2009, CARDIOL RES PRACT, V2009, DOI 10.4061/2009/802373; PAGE E, 1979, CIRC RES, V45, P260, DOI 10.1161/01.RES.45.2.260; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Savio-Galimberti E, 2008, BIOPHYS J, V95, P2053, DOI 10.1529/biophysj.108.130617; Scriven DRL, 2002, ANN NY ACAD SCI, V976, P488; Soeller C, 1999, CIRC RES, V84, P266, DOI 10.1161/01.RES.84.3.266; Soeller C, 2007, P NATL ACAD SCI USA, V104, P14958, DOI 10.1073/pnas.0703016104; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Vatta M, 2002, LANCET, V359, P936, DOI 10.1016/S0140-6736(02)08026-1; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	38	114	114	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17901	10.1371/journal.pone.0017901	http://dx.doi.org/10.1371/journal.pone.0017901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408028	gold, Green Published			2022-12-27	WOS:000288170900054
J	Lundbye-Jensen, J; Petersen, TH; Rothwell, JC; Nielsen, JB				Lundbye-Jensen, Jesper; Petersen, Tue Hvass; Rothwell, John C.; Nielsen, Jens Bo			Interference in Ballistic Motor Learning: Specificity and Role of Sensory Error Signals	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; CORTEX EXCITABILITY; BRAILLE READERS; READING HAND; CONSOLIDATION; MEMORY; ADAPTATION; SKILL; MODULATION	Humans are capable of learning numerous motor skills, but newly acquired skills may be abolished by subsequent learning. Here we ask what factors determine whether interference occurs in motor learning. We speculated that interference requires competing processes of synaptic plasticity in overlapping circuits and predicted specificity. To test this, subjects learned a ballistic motor task. Interference was observed following subsequent learning of an accuracy-tracking task, but only if the competing task involved the same muscles and movement direction. Interference was not observed from a non-learning task suggesting that interference requires competing learning. Subsequent learning of the competing task 4 h after initial learning did not cause interference suggesting disruption of early motor memory consolidation as one possible mechanism underlying interference. Repeated transcranial magnetic stimulation (rTMS) of corticospinal motor output at intensities below movement threshold did not cause interference, whereas suprathreshold rTMS evoking motor responses and (re) afferent activation did. Finally, the experiments revealed that suprathreshold repetitive electrical stimulation of the agonist (but not antagonist) peripheral nerve caused interference. The present study is, to our knowledge, the first to demonstrate that peripheral nerve stimulation may cause interference. The finding underscores the importance of sensory feedback as error signals in motor learning. We conclude that interference requires competing plasticity in overlapping circuits. Interference is remarkably specific for circuits involved in a specific movement and it may relate to sensory error signals.	[Lundbye-Jensen, Jesper; Petersen, Tue Hvass; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Lundbye-Jensen, Jesper; Petersen, Tue Hvass; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Rothwell, John C.] UCL, Sobell Dept Motor Neurosci & Movement Disorders, Inst Neurol, London, England	University of Copenhagen; University of Copenhagen; University of London; University College London	Lundbye-Jensen, J (corresponding author), Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	jljensen@ifi.ku.dk	Nielsen, Jens Bo/C-7632-2015; Lundbye-Jensen, Jesper/ABH-4025-2020	Nielsen, Jens Bo/0000-0001-5568-2916; Lundbye-Jensen, Jesper/0000-0003-3144-861X; Rothwell, John/0000-0003-1367-6467	Ludvig and Sara Elsass Foundation	Ludvig and Sara Elsass Foundation	The study was supported by Ludvig and Sara Elsass Foundation (www.elsassfonden.dk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraduc P, 2004, CURR BIOL, V14, P252, DOI 10.1016/j.cub.2004.01.033; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Chen HY, 2006, CEREB CORTEX, V16, P1462, DOI 10.1093/bhj087; Chen R, 2001, NEUROLOGY, V57, P379, DOI 10.1212/WNL.57.3.379; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Cothros N, 2006, J COGNITIVE NEUROSCI, V18, P2167, DOI 10.1162/jocn.2006.18.12.2167; Cothros N, 2009, J NEUROPHYSIOL, V102, P2112, DOI 10.1152/jn.00493.2009; Di Lazzaro V, 1998, EXP BRAIN RES, V119, P265; Di Lazzaro V, 2008, BRAIN STIMUL, V1, P345, DOI 10.1016/j.brs.2008.07.004; Fitzgerald PB, 2006, CLIN NEUROPHYSIOL, V117, P2584, DOI 10.1016/j.clinph.2006.06.712; Goedert KM, 2002, LEARN MEMORY, V9, P279, DOI 10.1101/lm.50102; Hadipour-Niktarash A, 2007, J NEUROSCI, V27, P13413, DOI 10.1523/JNEUROSCI.2570-07.2007; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, NATURE, V377, P155; Krakauer JW, 2009, ADV EXP MED BIOL, V629, P405, DOI 10.1007/978-0-387-77064-2_21; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Krakauer JW, 2005, J NEUROSCI, V25, P473, DOI 10.1523/JNEUROSCI.4218-04.2005; Lang N, 2006, CLIN NEUROPHYSIOL, V117, P2292, DOI 10.1016/j.clinph.2006.05.030; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Luft AR, 2005, CEREBELLUM, V4, P90, DOI 10.1080/14734220410019084; MARSDEN CD, 1983, J PHYSIOL-LONDON, V335, P1; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; PascualLeone A, 1995, ANN NEUROL, V38, P910, DOI 10.1002/ana.410380611; PASCUALLEONE A, 1993, ANN NEUROL, V34, P33, DOI 10.1002/ana.410340108; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8	35	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17451	10.1371/journal.pone.0017451	http://dx.doi.org/10.1371/journal.pone.0017451			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408054	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900017
J	Sendina-Nadal, I; Ofran, Y; Almendral, JA; Buldu, JM; Leyva, I; Li, DQ; Havlin, S; Boccaletti, S				Sendina-Nadal, Irene; Ofran, Yanay; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada; Li, Daqing; Havlin, Shlomo; Boccaletti, Stefano			Unveiling Protein Functions through the Dynamics of the Interaction Network	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; PREDICTION; DISCOVERY; COMPLEXES	Protein interaction networks have become a tool to study biological processes, either for predicting molecular functions or for designing proper new drugs to regulate the main biological interactions. Furthermore, such networks are known to be organized in sub-networks of proteins contributing to the same cellular function. However, the protein function prediction is not accurate and each protein has traditionally been assigned to only one function by the network formalism. By considering the network of the physical interactions between proteins of the yeast together with a manual and single functional classification scheme, we introduce a method able to reveal important information on protein function, at both micro-and macro-scale. In particular, the inspection of the properties of oscillatory dynamics on top of the protein interaction network leads to the identification of misclassification problems in protein function assignments, as well as to unveil correct identification of protein functions. We also demonstrate that our approach can give a network representation of the meta-organization of biological processes by unraveling the interactions between different functional classes.	[Sendina-Nadal, Irene; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Sendina-Nadal, Irene; Almendral, Juan A.; Buldu, Javier M.; Leyva, Inmaculada] Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain; [Ofran, Yanay] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Li, Daqing; Havlin, Shlomo] Bar Ilan Univ, Dept Phys, Minerva Ctr, Ramat Gan, Israel; [Boccaletti, Stefano] CNR, Ist Sistemi Complessi, Sesto Fiorentino, Italy	Universidad Rey Juan Carlos; Bar Ilan University; Bar Ilan University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Sendina-Nadal, I (corresponding author), Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain.	irene.sendina@urjc.es	Buldu, Javier Martin/R-8167-2018; Almendral, Juan/ABC-8025-2021; Leyva, I./M-1820-2013; Sendiña-Nadal, Irene/M-3083-2013; Havlin, Shlomo/ABF-1527-2020; Buldu, Javier/N-5422-2014; Boccaletti, Stefano/U-7603-2019	Almendral, Juan/0000-0003-1100-7446; Leyva, I./0000-0001-9634-5385; Sendiña-Nadal, Irene/0000-0003-0432-235X; Buldu, Javier/0000-0002-9345-599X; Boccaletti, Stefano/0000-0002-5758-7012	EU [043309 GABA]; Spanish Ministry of ST [FIS2009-07072]; Community of Madrid [MODELICO-CM/S2009ESP-1691]	EU(European Commission); Spanish Ministry of ST; Community of Madrid(Comunidad de Madrid)	Work partly supported by EU contract 043309 GABA, the Spanish Ministry of S&T under Project n. FIS2009-07072, and the Community of Madrid under the R&D Program of activities MODELICO-CM/S2009ESP-1691. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendral JA, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.016115; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bu DB, 2003, NUCLEIC ACIDS RES, V31, P2443, DOI 10.1093/nar/gkg340; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hu PZ, 2007, NAT REV CANCER, V7, P23, DOI 10.1038/nrc2036; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Karaoz U, 2004, P NATL ACAD SCI USA, V101, P2888, DOI 10.1073/pnas.0307326101; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Punta M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000160; Rost B, 2003, CELL MOL LIFE SCI, V60, P2637, DOI 10.1007/s00018-003-3114-8; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yeang CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r62; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	30	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17679	10.1371/journal.pone.0017679	http://dx.doi.org/10.1371/journal.pone.0017679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408013	gold, Green Accepted, Green Published			2022-12-27	WOS:000288170900040
J	Walther, T; Dietrich, N; Langhammer, M; Kucia, M; Hammon, H; Renne, U; Siems, WE; Metges, CC				Walther, Thomas; Dietrich, Nils; Langhammer, Martina; Kucia, Marzena; Hammon, Harald; Renne, Ulla; Siems, Wolf-Eberhard; Metges, Cornelia C.			High-Protein Diet in Lactation Leads to a Sudden Infant Death-Like Syndrome in Mice	PLOS ONE			English	Article							MATERNAL NUTRITION; LATE PREGNANCY; EXPRESSION; WEIGHT; STRAIN; GROWTH; BIRTH; RISK; LIFE	Background: It is well accepted that reduced foetal growth and development resulting from maternal malnutrition are associated with a number of chronic conditions in later life. On the other hand such generation-transcending effects of overnutrition and of high-protein consumption in pregnancy and lactation, a proven fact in all developed societies, are widely unknown. Thus, we intended to describe the generation-transcending effects of a high-protein diet, covering most relevant topics of human life like embryonic mortality, infant death, and physical health in later life. Methods: Female mice received control food (21% protein) or were fed a high protein diet (42% protein) during mating. After fertilisation, females stayed on their respective diet until weaning. At birth, pups were put to foster mothers who were fed with standard food or with HP diet. After weaning, control diet was fed to all mice. All offspring were monitored up to 360 days after birth. We determined glucose-tolerance and measured cardiovascular parameters using a tip-catheter. Finally, abdominal fat amount was measured. Results and Conclusions: We identified a worried impact of high-protein diet during pregnancy on dams' body weight gain, body weight of newborns, number of offspring, and also survival in later life. Even more important is the discovery that high-protein diet during lactation caused a more than eight-fold increase in offspring mortality. The observed higher newborn mortality during lactation is a hitherto non-described, unique link to the still incompletely understood human sudden infant death syndrome (SIDS). Thus, although offspring of lactating mothers on high-protein diet might have the advantage of lower abdominal fat within the second half of life, this benefit seems not to compensate the immense risk of an early sudden death during lactation. Our data may implicate that both pregnant women and lactating mothers should not follow classical high-protein diets.	[Walther, Thomas] Univ Giessen, Dept Expt Cardiol, Giessen, Germany; [Walther, Thomas] Univ Hull, Ctr Biomed Res, Hull York Med Sch, Kingston Upon Hull HU6 7RX, N Humberside, England; [Dietrich, Nils; Langhammer, Martina; Kucia, Marzena; Hammon, Harald; Renne, Ulla; Metges, Cornelia C.] Leibniz Inst Farm Anim Biol FBN, Res Unit Nutr Physiol, Dummerstorf, Germany; [Dietrich, Nils] Free Univ Berlin, D-1000 Berlin, Germany; [Siems, Wolf-Eberhard] Leibniz Inst Mol Pharmakol FMP, Berlin, Germany	Justus Liebig University Giessen; University of Hull; University of York - UK; Forschungsinstitut fur Nutztierbiologie (FBN); Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Walther, T (corresponding author), Univ Giessen, Dept Expt Cardiol, Giessen, Germany.	thomas.walther@hyms.ac.uk	Hammon, Harald/AAD-9990-2020		Commission of the European Community [5.4.3.1, Food-CT-2005-007036]; Deutsche Forschungsgemeinschaft (DFG) [WA1441/18, SI483/8]	Commission of the European Community(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Commission of the European Community, within the FP 6 priority 5.4.3.1, Food quality and safety (EARNEST, Food-CT-2005-007036); and by the Deutsche Forschungsgemeinschaft (DFG): WA1441/18 and SI483/8. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasyan K, 2007, EUR J CLIN NUTR, V61, P498, DOI 10.1038/sj.ejcn.1602552; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Barker DJP, 1997, NUTRITION, V13, P807, DOI 10.1016/S0899-9007(97)00193-7; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Dietl G, 2004, ARCH TIERZUCHT, V47, P595, DOI 10.5194/aab-47-595-2004; Gors S, 2009, J DAIRY SCI, V92, P632, DOI 10.3168/jds.2008-1563; Golding J, 1997, EARLY HUM DEV, V49, pS1, DOI 10.1016/S0378-3782(97)00050-9; Greco A M, 1983, Arch Sci Med (Torino), V140, P139; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Martorell R, 2001, J NUTR, V131, p874S, DOI 10.1093/jn/131.3.874S; McCowen KC, 2005, CURR OPIN GASTROEN, V21, P207, DOI 10.1097/01.mog.0000153361.90653.cb; McVea K L, 2000, J Hum Lact, V16, P13, DOI 10.1177/089033440001600104; Mitchell EA, 2009, ACTA PAEDIATR, V98, P1712, DOI 10.1111/j.1651-2227.2009.01503.x; Mitchell M, 2009, BIOL REPROD, V80, P295, DOI 10.1095/biolreprod.108.069864; Ostfeld BM, 2010, PEDIATRICS, V125, P447, DOI 10.1542/peds.2009-0038; Prandota Joseph, 2004, Am J Ther, V11, P517, DOI 10.1097/01.mjt.0000140648.30948.bd; Raiten DJ, 2007, AM J CLIN NUTR, V85, p577S, DOI 10.1093/ajcn/85.2.577S; Reynolds RM, 2007, J CLIN ENDOCR METAB, V92, P2208, DOI 10.1210/jc.2007-0071; Sullivan FM, 2001, PAEDIATR PERINAT EP, V15, P144; Thone-Reineke C, 2006, AM J PHYSIOL-REG I, V291, pR1025, DOI 10.1152/ajpregu.00898.2005; Timtchenko D, 1999, INT J OBESITY, V23, P586, DOI 10.1038/sj.ijo.0800872; Wang Y, 2007, EUR J HEART FAIL, V9, P548, DOI 10.1016/j.ejheart.2007.02.006	23	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17443	10.1371/journal.pone.0017443	http://dx.doi.org/10.1371/journal.pone.0017443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408058	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900016
J	Smeenk, L; van Heeringen, SJ; Koeppel, M; Gilbert, B; Janssen-Megens, E; Stunnenberg, HG; Lohrum, M				Smeenk, Leonie; van Heeringen, Simon J.; Koeppel, Max; Gilbert, Bianca; Janssen-Megens, Eva; Stunnenberg, Hendrik G.; Lohrum, Marion			Role of p53 Serine 46 in p53 Target Gene Regulation	PLOS ONE			English	Article							CELL-CYCLE ARREST; INTERACTING PROTEIN KINASE-2; DNA-DAMAGE; TUMOR-SUPPRESSOR; POSTTRANSLATIONAL MODIFICATION; APOPTOTIC RESPONSE; PHOSPHORYLATES P53; BINDING-SITES; STRESS; CHROMATIN	The tumor suppressor p53 plays a crucial role in cellular growth control inducing a plethora of different response pathways. The molecular mechanisms that discriminate between the distinct p53-responses have remained largely elusive. Here, we have analyzed the p53-regulated pathways induced by Actinomycin D and Etoposide treatment resulting in more growth arrested versus apoptotic cells respectively. We found that the genome-wide p53 DNA-binding patterns are almost identical upon both treatments notwithstanding transcriptional differences that we observed in global transcriptome analysis. To assess the role of post-translational modifications in target gene choice and activation we investigated the genome-wide level of phosphorylation of Serine 46 of p53 bound to DNA ( p53-pS46) and of Serine 15 (p53-pS15). Interestingly, the extent of S46 phosphorylation of p53 bound to DNA is considerably higher in cells directed towards apoptosis while the degree of phosphorylation at S15 remains highly similar. Moreover, our data suggest that following different chemotherapeutical treatments, the amount of chromatin-associated p53 phosphorylated at S46 but not at pS15 is higher on certain apoptosis related target genes. Our data provide evidence that cell fate decisions are not made primarily on the level of general p53 DNA-binding and that post-translationally modified p53 can have distinct DNA-binding characteristics.	[Smeenk, Leonie; van Heeringen, Simon J.; Koeppel, Max; Janssen-Megens, Eva; Stunnenberg, Hendrik G.; Lohrum, Marion] Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Gilbert, Bianca; Lohrum, Marion] Georg Speyer Haus, Frankfurt, Germany	Radboud University Nijmegen	Smeenk, L (corresponding author), Radboud Univ Nijmegen, Fac Sci, Nijmegen Ctr Mol Life Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands.	Lohrum@em.uni-frankfurt.de	Stunnenberg, Hendrik G./D-6875-2012; van Heeringen, Simon/Q-8530-2017	Stunnenberg, Hendrik G./0000-0002-0066-1576; van Heeringen, Simon/0000-0002-0411-3219; Smeenk, Leonie/0000-0001-7025-8515	Dutch Cancer Foundation (KWF) [KUN 2003-2926, KUN 2005-3347]; Netherlands Organisation for Scientific Research (NWO) [Vidi 846.05.002]	Dutch Cancer Foundation (KWF)(KWF Kankerbestrijding); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	Funding for this work was provided by Dutch Cancer Foundation (KWF) (KUN 2003-2926 to LS and MK, KUN 2005-3347 to LS) and by the Netherlands Organisation for Scientific Research (NWO) (Vidi 846.05.002 to SJH and ML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Braastad CD, 2003, J BIOL CHEM, V278, P8261, DOI 10.1074/jbc.M204256200; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Coutts AS, 2005, BIOCHEM BIOPH RES CO, V331, P778, DOI 10.1016/j.bbrc.2005.03.150; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Georges SA, 2009, CELL CYCLE, V8, P680; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Hussain SP, 1999, MUTAT RES-FUND MOL M, V428, P23, DOI 10.1016/S1383-5742(99)00028-9; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kodama M, 2010, MOL CELL BIOL, V30, P1620, DOI 10.1128/MCB.00810-09; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Mayo LD, 2005, J BIOL CHEM, V280, P25953, DOI 10.1074/jbc.M503026200; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Perfettini JL, 2005, J EXP MED, V201, P279, DOI 10.1084/jem.20041502; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shaked H, 2008, CANCER RES, V68, P9671, DOI 10.1158/0008-5472.CAN-08-0865; Shmueli A, 2007, MOL CELL, V25, P794, DOI 10.1016/j.molcel.2007.03.006; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Smeenk L, 2010, INT J ONCOL, V37, P1061, DOI 10.3892/ijo_00000757; Sullivan A, 2007, BRIT J CANCER, V96, P196, DOI 10.1038/sj.bjc.6603525; Taira N, 2007, MOL CELL, V25, P725, DOI 10.1016/j.molcel.2007.02.007; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Vrba L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-486; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zacchi P, 2002, NATURE, V419, P853, DOI 10.1038/nature01120; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	51	120	122	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17574	10.1371/journal.pone.0017574	http://dx.doi.org/10.1371/journal.pone.0017574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394211	Green Submitted, gold, Green Published			2022-12-27	WOS:000288025500017
J	Schulz, EC; Bergfeld, AK; Ficner, R; Muhlenhoff, M				Schulz, Eike C.; Bergfeld, Anne K.; Ficner, Ralf; Muehlenhoff, Martina			Crystal Structure Analysis of the Polysialic Acid Specific O-Acetyltransferase NeuO	PLOS ONE			English	Article							ESCHERICHIA-COLI; SEROGROUP-C; POLYSACCHARIDE ANTIGENS; CAPSULAR POLYSACCHARIDE; FORM VARIATION; BETA-HELIX; GROUP-B; GENE; ACETYLATION; BACTEREMIA	The major virulence factor of the neuroinvasive pathogen Escherichia coli K1 is the K1 capsule composed of alpha 2,8-linked polysialic acid (polySia). K1 strains harboring the CUS-3 prophage modify their capsular polysaccharide by phase-variable O-acetlyation, a step that is associated with increased virulence. Here we present the crystal structure of the prophage-encoded polysialate O-acetyltransferase NeuO. The homotrimeric enzyme belongs to the left-handed beta-helix (L beta H) family of acyltransferases and is characterized by an unusual funnel-shaped outline. Comparison with other members of the L beta H family allowed the identification of active site residues and proposal of a catalytic mechanism and highlighted structural characteristics of polySia specific O-acetyltransferases. As a unique feature of NeuO, the enzymatic activity linearly increases with the length of the N-terminal poly-psi-domain which is composed of a variable number of tandem copies of an RLKTQDS heptad. Since the poly-psi-domain was not resolved in the crystal structure it is assumed to be unfolded in the apo-enyzme.	[Schulz, Eike C.; Ficner, Ralf] Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, Gottingen, Germany; [Bergfeld, Anne K.; Muehlenhoff, Martina] Hannover Med Sch, Inst Zellulare Chem, D-30623 Hannover, Germany	University of Gottingen; Hannover Medical School	Schulz, EC (corresponding author), Univ Gottingen, Abt Mol Strukturbiol, Inst Mikrobiol & Genet, Gottingen, Germany.	rficner@gwdg.de; muehlenhoff.martina@mh-hannover.de			Deutsche Forschungsgemeinschaft [MU1774/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant number MU1774/2 to M.M.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Claus H, 2004, MOL MICROBIOL, V51, P227, DOI 10.1046/j.1365-2958.2003.03819.x; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FINNE J, 1987, J IMMUNOL, V138, P4402; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; HIGA HH, 1988, J BIOL CHEM, V263, P8872; Imai YN, 2007, J MED CHEM, V50, P1189, DOI 10.1021/jm061038a; Iwaoka M, 2002, J AM CHEM SOC, V124, P10613, DOI 10.1021/ja026472q; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Johnson CM, 2005, ARCH BIOCHEM BIOPHYS, V433, P85, DOI 10.1016/j.abb.2004.08.014; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; King MR, 2007, J BACTERIOL, V189, P6447, DOI 10.1128/JB.00657-07; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Lee HJ, 2009, J BIOL CHEM, V284, P24501, DOI 10.1074/jbc.M109.006049; LEWENDON A, 1995, J BIOL CHEM, V270, P26326, DOI 10.1074/jbc.270.44.26326; LEYING H, 1990, INFECT IMMUN, V58, P222, DOI 10.1128/IAI.58.1.222-227.1990; Lo Leggio L, 2003, BIOCHEMISTRY-US, V42, P5225, DOI 10.1021/bi0271446; Mordhorst IL, 2009, ENVIRON MICROBIOL, V11, P3154, DOI 10.1111/j.1462-2920.2009.02019.x; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; ROHR TE, 1980, J BIOL CHEM, V255, P2332; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Stein DM, 2006, VACCINE, V24, P221, DOI 10.1016/j.vaccine.2005.07.084; Stummeyer K, 2006, MOL MICROBIOL, V60, P1123, DOI 10.1111/j.1365-2958.2006.05173.x; Sugantino M, 2002, BIOCHEMISTRY-US, V41, P2209, DOI 10.1021/bi011991b; Taylor G, 1996, CURR OPIN STRUC BIOL, V6, P830, DOI 10.1016/S0959-440X(96)80014-5; VAARA M, 1992, FEMS MICROBIOL LETT, V97, P249, DOI 10.1016/0378-1097(92)90344-N; Wang XG, 2002, STRUCTURE, V10, P581, DOI 10.1016/S0969-2126(02)00741-4; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Xie Y, 2004, FEMS IMMUNOL MED MIC, V42, P271, DOI 10.1016/j.femsim.2004.09.001	45	9	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17403	10.1371/journal.pone.0017403	http://dx.doi.org/10.1371/journal.pone.0017403			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390252	Green Published, gold			2022-12-27	WOS:000287932100015
J	Bailey, RI; Innocenti, P; Morrow, EH; Friberg, U; Qvarnstrom, A				Bailey, Richard I.; Innocenti, Paolo; Morrow, Edward H.; Friberg, Urban; Qvarnstrom, Anna			Female Drosophila melanogaster Gene Expression and Mate Choice: The X Chromosome Harbours Candidate Genes Underlying Sexual Isolation	PLOS ONE			English	Article							INCIPIENT SPECIATION; EVOLUTION; POPULATIONS; SELECTION; REINFORCEMENT; INCOMPATIBILITIES; BUTTERFLIES; ADAPTATION; RESPONSES; AFRICAN	Background: The evolution of female choice mechanisms favouring males of their own kind is considered a crucial step during the early stages of speciation. However, although the genomics of mate choice may influence both the likelihood and speed of speciation, the identity and location of genes underlying assortative mating remain largely unknown. Methods and Findings: We used mate choice experiments and gene expression analysis of female Drosophila melanogaster to examine three key components influencing speciation. We show that the 1,498 genes in Zimbabwean female D. melanogaster whose expression levels differ when mating with more (Zimbabwean) versus less (Cosmopolitan strain) preferred males include many with high expression in the central nervous system and ovaries, are disproportionately X-linked and form a number of clusters with low recombination distance. Significant involvement of the brain and ovaries is consistent with the action of a combination of pre- and postcopulatory female choice mechanisms, while sex linkage and clustering of genes lead to high potential evolutionary rate and sheltering against the homogenizing effects of gene exchange between populations. Conclusion: Taken together our results imply favourable genomic conditions for the evolution of reproductive isolation through mate choice in Zimbabwean D. melanogaster and suggest that mate choice may, in general, act as an even more important engine of speciation than previously realized.	[Bailey, Richard I.; Innocenti, Paolo; Morrow, Edward H.; Friberg, Urban; Qvarnstrom, Anna] Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden	Uppsala University	Bailey, RI (corresponding author), Uppsala Univ, Dept Ecol & Genet, EBC, Uppsala, Sweden.	anna.qvarnstrom@ebc.uu.se	Friberg, Urban/C-9412-2015; Morrow, Edward/C-2358-2011; Morrow, Edward H/Q-6730-2019; Friberg, Urban/H-4569-2011; Bailey, Richard/HHM-4964-2022	Friberg, Urban/0000-0001-6112-9586; Morrow, Edward/0000-0002-1853-7469; Morrow, Edward H/0000-0002-1853-7469; Bailey, Richard/0000-0001-9870-410X; Qvarnstrom, Anna/0000-0002-1178-4053; Innocenti, Paolo/0000-0003-2082-0586	Wenner-Gren foundation; European Young Investigator Award; Swedish Research Council	Wenner-Gren foundation; European Young Investigator Award; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financed by the Wenner-Gren foundation (AQ), a European Young Investigator Award (AQ), and the Swedish Research Council (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipaz JA, 2001, P ROY SOC B-BIOL SCI, V268, P789, DOI 10.1098/rspb.2000.1420; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Bailey RI, 2004, J EVOLUTION BIOL, V17, P108, DOI 10.1046/j.1420-9101.2003.00648.x; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; Chintapalli V., 2007, FLYATLAS DROSOPHILA; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Coyne JA, 2006, EVOLUTION, V60, P279; Cummings ME, 2008, P ROY SOC B-BIOL SCI, V275, P393, DOI 10.1098/rspb.2007.1454; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Davies N, 1997, P ROY SOC B-BIOL SCI, V264, P845, DOI 10.1098/rspb.1997.0118; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRULA JW, 1980, EVOLUTION, V34, P688, DOI 10.1111/j.1558-5646.1980.tb04007.x; Hall DW, 2006, EVOLUTION, V60, P908; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Hollocher H, 1997, GENETICS, V147, P1191; Innocenti P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000335; Kauer M, 2003, MOL BIOL EVOL, V20, P1329, DOI 10.1093/molbev/msg148; Keller A, 2007, CURR BIOL, V17, pR77, DOI 10.1016/j.cub.2006.12.031; Kirkpatrick M, 2004, EVOLUTION, V58, P683; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kulathinal RJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000550; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; Michalak P, 2007, MOL ECOL, V16, P1179, DOI 10.1111/j.1365-294X.2007.03201.x; Orr HA, 2001, GENETICS, V157, P875; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; R Core Team, 2020, R LANG ENV STAT COMP; Rice WR, 2005, P NATL ACAD SCI USA, V102, P6527, DOI 10.1073/pnas.0501889102; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; Schlotterer C, 2002, MOL ECOL, V11, P947, DOI 10.1046/j.1365-294X.2002.01491.x; Servedio MR, 2001, EVOLUTION, V55, P1909, DOI 10.1111/j.0014-3820.2001.tb01309.x; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Voolstra C, 2007, GENOME RES, V17, P42, DOI 10.1101/gr.5683806	38	16	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17358	10.1371/journal.pone.0017358	http://dx.doi.org/10.1371/journal.pone.0017358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386982	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287931400061
J	Purser, J; Radford, AN				Purser, Julia; Radford, Andrew N.			Acoustic Noise Induces Attention Shifts and Reduces Foraging Performance in Three-Spined Sticklebacks (Gasterosteus aculeatus)	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; INDUCED HEARING-LOSS; FRESH-WATER FISHES; LIMITED ATTENTION; ANTHROPOGENIC NOISE; PREDATION RISK; LOUD NOISE; STRESS; CONSEQUENCES; HYPOTHESIS	Acoustic noise is known to have a variety of detrimental effects on many animals, including humans, but surprisingly little is known about its impacts on foraging behaviour, despite the obvious potential consequences for survival and reproductive success. We therefore exposed captive three-spined sticklebacks (Gasterosteus aculeatus) to brief and prolonged noise to investigate how foraging performance is affected by the addition of acoustic noise to an otherwise quiet environment. The addition of noise induced only mild fear-related behaviours - there was an increase in startle responses, but no change in the time spent freezing or hiding compared to a silent control - and thus had no significant impact on the total amount of food eaten. However, there was strong evidence that the addition of noise increased food-handling errors and reduced discrimination between food and non-food items, results that are consistent with a shift in attention. Consequently, noise resulted in decreased foraging efficiency, with more attacks needed to consume the same number of prey items. Our results suggest that acoustic noise has the potential to influence a whole host of everyday activities through effects on attention, and that even very brief noise exposure can cause functionally significant impacts, emphasising the threat posed by ever-increasing levels of anthropogenic noise in the environment.	[Purser, Julia; Radford, Andrew N.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of Bristol	Purser, J (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	julia.purser@bristol.ac.uk	Purser, Julia/C-2538-2013	Purser, Julia/0000-0003-0303-9966; Radford, Andrew N/0000-0001-5470-3463	University of Bristol; BBSRC	University of Bristol; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by University of Bristol start up funds to Andrew N. Radford. A BBSRC David Phillips Research Fellowship supported Andrew N. Radford during this period. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoser S, 2003, J ACOUST SOC AM, V113, P2170, DOI 10.1121/1.1557212; Amoser S, 2004, J ACOUST SOC AM, V116, P3789, DOI 10.1121/1.1808219; Barber JR, 2010, TRENDS ECOL EVOL, V25, P180, DOI 10.1016/j.tree.2009.08.002; Bateson M., 2007, INT J COMP PSYCHOL, V20, P169; Bee MA, 2007, ANIM BEHAV, V74, P1765, DOI 10.1016/j.anbehav.2007.03.019; Bejder L, 2009, MAR ECOL PROG SER, V395, P177, DOI 10.3354/meps07979; Bernier NJ, 2006, GEN COMP ENDOCR, V146, P45, DOI 10.1016/j.ygcen.2005.11.016; Bernier NJ, 2004, GEN COMP ENDOCR, V135, P230, DOI 10.1016/j.ygcen.2003.09.016; BLAXTER JHS, 1981, J MAR BIOL ASSOC UK, V61, P851, DOI 10.1017/S0025315400023006; Broom D.M., 2019, STRESS ANIMAL WELFAR, V2nd ed., P99; Chan AAYH, 2010, BIOL LETTERS, V6, P458, DOI 10.1098/rsbl.2009.1081; CLARK WW, 1991, J ACOUST SOC AM, V90, P155, DOI 10.1121/1.401309; Dai B., 2008, IME4 LINEAR MIXED EF; Dukas R, 2000, BEHAV ECOL, V11, P502, DOI 10.1093/beheco/11.5.502; Dukas R, 2004, BRAIN BEHAV EVOLUT, V63, P197, DOI 10.1159/000076781; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Dukas R, 2001, BEHAV ECOL, V12, P192, DOI 10.1093/beheco/12.2.192; European Union, 2008, OFF J EUR UNION L, VL164, P19; Gill JA, 2001, BIOL CONSERV, V97, P265, DOI 10.1016/S0006-3207(00)00002-1; Harrison RV, 2008, PAED CHILD HEALT-CAN, V13, P377, DOI 10.1093/pch/13.5.377; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; HOCKEY GRJ, 1970, Q J EXP PSYCHOL, V22, P28, DOI 10.1080/14640747008401898; Huntingford FA, 2009, J FISH BIOL, V75, P1943, DOI 10.1111/j.1095-8649.2009.02420.x; IBRAHIM AA, 1989, ETHOLOGY, V81, P265; Kastelein RA, 2008, MAR ENVIRON RES, V65, P369, DOI 10.1016/j.marenvres.2008.01.001; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mann DA, 2007, J FISH BIOL, V70, P109, DOI 10.1111/j.1095-8649.2006.01279.x; Masini CV, 2008, BEHAV NEUROSCI, V122, P210, DOI 10.1037/0735-7044.122.1.210; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; METCALFE NB, 1987, ANIM BEHAV, V35, P931, DOI 10.1016/S0003-3472(87)80134-3; METCALFE NB, 1987, ANIM BEHAV, V35, P901, DOI 10.1016/S0003-3472(87)80125-2; Nemeth E, 2010, AM NAT, V176, P465, DOI 10.1086/656275; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; POPPER AN, 2010, HEAR RES IN PRESS; R Core Team, 2018, R LANG ENV STAT COMP; Schaub A, 2008, J EXP BIOL, V211, P3174, DOI 10.1242/jeb.022863; Shettleworth S. J., 2009, COGNITION EVOLUTION; Siemers BM, 2007, INT J PRIMATOL, V28, P291, DOI 10.1007/s10764-007-9135-7; Skals N, 2005, J EXP BIOL, V208, P595, DOI 10.1242/jeb.01400; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; SMITH AP, 1991, BRIT J PSYCHOL, V82, P313, DOI 10.1111/j.2044-8295.1991.tb02402.x; Smith ME, 2004, J EXP BIOL, V207, P427, DOI 10.1242/jeb.00755; Smith ME, 2004, J EXP BIOL, V207, P3591, DOI 10.1242/jeb.01188; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; Wright A.J., 2007, INT J COMP PSYCHOL, V20, P250; Wysocki LE, 2006, BIOL CONSERV, V128, P501, DOI 10.1016/j.biocon.2005.10.020; Wysocki LE, 2007, J ACOUST SOC AM, V121, P2559, DOI 10.1121/1.2713661	50	151	152	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17478	10.1371/journal.pone.0017478	http://dx.doi.org/10.1371/journal.pone.0017478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386909	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400081
J	Wang, QL; Liang, B; Shirwany, NA; Zou, MH				Wang, Qilong; Liang, Bin; Shirwany, Najeeb A.; Zou, Ming-Hui			2-Deoxy-D-Glucose Treatment of Endothelial Cells Induces Autophagy by Reactive Oxygen Species-Mediated Activation of the AMP-Activated Protein Kinase	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUCOSE DEPRIVATION; CANCER-CELLS; MITOCHONDRIAL DYSFUNCTION; MAMMALIAN TARGET; SKELETAL-MUSCLE; IN-VIVO; APOPTOSIS; ROS; DISEASE	Autophagy is a cellular self-digestion process activated in response to stresses such as energy deprivation and oxidative stress. However, the mechanisms by which energy deprivation and oxidative stress trigger autophagy remain undefined. Here, we report that activation of AMP-activated protein kinase (AMPK) by mitochondria-derived reactive oxygen species (ROS) is required for autophagy in cultured endothelial cells. AMPK activity, ROS levels, and the markers of autophagy were monitored in confluent bovine aortic endothelial cells (BAEC) treated with the glycolysis blocker 2-deoxy-D-glucose (2-DG). Treatment of BAEC with 2-DG (5 mM) for 24 hours or with low concentrations of H2O2 (100 mu M) induced autophagy, including increased conversion of microtubule-associated protein light chain 3 (LC3)-I to LC3-II, accumulation of GFP-tagged LC3 positive intracellular vacuoles, and increased fusion of autophagosomes with lysosomes. 2-DG-treatment also induced AMPK phosphorylation, which was blocked by either co-administration of two potent anti-oxidants (Tempol and N-Acetyl-L-cysteine) or overexpression of superoxide dismutase 1 or catalase in BAEC. Further, 2-DG-induced autophagy in BAEC was blocked by overexpressing catalase or siRNA-mediated knockdown of AMPK. Finally, pretreatment of BAEC with 2-DG increased endothelial cell viability after exposure to hypoxic stress. Thus, AMPK is required for ROS-triggered autophagy in endothelial cells, which increases endothelial cell survival in response to cell stress.	[Wang, Qilong; Liang, Bin; Shirwany, Najeeb A.; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Dept Med,Sect Mol Med, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Wang, QL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Dept Med,Sect Mol Med, Oklahoma City, OK 73190 USA.	ming-hui-zou@ouhsc.edu	wang, qinghong/M-7969-2017; wang, qilong/O-1962-2013	wang, qilong/0000-0002-4375-991X	NIH [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157]; American Diabetes Association; Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110488, R01HL080499, R01HL079584, R01HL089920, R01HL105157, R01HL096032, R01HL074399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants (HL079584, HL080499, HL074399, HL089920, HL096032, and HL105157), a research award from the American Diabetes Association, and the funds from Paul H. Doris Eaton Travis Chair in Endocrinology from the University of Oklahoma Health Sciences Center. Dr. Zou is a recipient of the National Established Investigator Award of American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2008, HEPATOLOGY, V47, P677, DOI 10.1002/hep.21991; An ZB, 2007, J BIOL CHEM, V282, P26793, DOI 10.1074/jbc.M703701200; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Cai Y, 2007, FREE RADICAL BIO MED, V42, P64, DOI 10.1016/j.freeradbiomed.2006.09.018; Caruso R, 2004, ANAL BIOCHEM, V330, P43, DOI 10.1016/j.ab.2004.03.063; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; CHAMBERS MA, 2009, J PHYSL; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Dixit M, 2008, CARDIOVASC RES, V77, P160, DOI 10.1093/cvr/cvm017; Dworakowski R, 2008, PHARMACOL REP, V60, P21; ESSICK EE, OXID MED CELL LONGEV, V3, P168; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Gurusamy N, 2009, ANTIOXID REDOX SIGN, V11, P1975, DOI [10.1089/ars.2009.2524, 10.1089/ARS.2009.2524]; Gusarova GA, 2009, MOL CELL BIOL, V29, P3455, DOI 10.1128/MCB.00054-09; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hayashi S, 2009, ARTERIOSCL THROM VAS, V29, P1909, DOI 10.1161/ATVBAHA.109.188516; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hwang JT, 2008, GENES NUTR, V2, P323, DOI 10.1007/s12263-007-0069-7; Jiang WQ, 2008, MOL CARCINOGEN, V47, P616, DOI 10.1002/mc.20425; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; Kim WH, 2007, CELL SIGNAL, V19, P791, DOI 10.1016/j.cellsig.2006.10.004; Klimova TA, 2009, FASEB J, V23, P783, DOI 10.1096/fj.08-114256; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Kwon YN, 2009, DRUG METAB DISPOS, V37, P1187, DOI 10.1124/dmd.108.025908; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; MARAMBIO P, BIOCH BIOPHYS ACTA; Marsh J, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-33; Martinet W, 2008, CURR ATHEROSCLER REP, V10, P216, DOI 10.1007/s11883-008-0034-y; Matsuda F, 2009, AUTOPHAGY, V5, P484, DOI 10.4161/auto.5.4.7760; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; MAZURE NM, 2009, CURR OPIN CELL BIOL; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Sandstrom ME, 2006, J PHYSIOL-LONDON, V575, P251, DOI 10.1113/jphysiol.2006.110601; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; SHIRWANY NA, ACTA PHARM SIN, V31, P1075; SOLS A, 1954, J BIOL CHEM, V206, P925; Tannous P, 2007, CIRCULATION, V116, P255; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yin L, 2009, INT J ONCOL, V34, P1691, DOI 10.3892/ijo_00000300; Yoo BH, 2009, AUTOPHAGY, V5, P1166, DOI 10.4161/auto.5.8.10167; Yu ZF, 1999, J NEUROSCI RES, V57, P830, DOI 10.1002/(SICI)1097-4547(19990915)57:6&lt;830::AID-JNR8&gt;3.0.CO;2-2; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	60	149	156	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17234	10.1371/journal.pone.0017234	http://dx.doi.org/10.1371/journal.pone.0017234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386904	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400039
J	Du, HD; Vimaleswaran, KS; Angquist, L; Hansen, RD; van der A, DL; Holst, C; Tjonneland, A; Overvad, K; Jakobsen, MU; Boeing, H; Meidtner, K; Palli, D; Masala, G; Bouatia-Naji, N; Saris, WHM; Feskens, EJM; Wareham, NJ; Sorensen, TIA; Loos, RJF				Du, Huaidong; Vimaleswaran, Karani S.; Angquist, Lars; Hansen, Rikke D.; van der A, Daphne L.; Holst, Claus; Tjonneland, Anne; Overvad, Kim; Jakobsen, Marianne Uhre; Boeing, Heiner; Meidtner, Karina; Palli, Domenico; Masala, Giovanna; Bouatia-Naji, Nabila; Saris, Wim H. M.; Feskens, Edith J. M.; Wareham, Nicolas J.; Sorensen, Thorkild I. A.; Loos, Ruth J. F.			Genetic Polymorphisms in the Hypothalamic Pathway in Relation to Subsequent Weight Change - The DiOGenes Study	PLOS ONE			English	Article							DIETARY GLYCEMIC INDEX; NEUROMEDIN-B GENE; BODY-WEIGHT; FOOD-INTAKE; ENERGY HOMEOSTASIS; ADIPOSE-TISSUE; OBESITY GENE; MC4R GENE; FAT MASS; PROTEIN	Background: Single nucleotide polymorphisms (SNPs) in genes encoding the components involved in the hypothalamic pathway may influence weight gain and dietary factors may modify their effects. \ Aim: We conducted a case-cohort study to investigate the associations of SNPs in candidate genes with weight change during an average of 6.8 years of follow-up and to examine the potential effect modification by glycemic index (GI) and protein intake. Methods and Findings: Participants, aged 20-60 years at baseline, came from five European countries. Cases ('weight gainers') were selected from the total eligible cohort (n = 50,293) as those with the greatest unexplained annual weight gain (n = 5,584). A random subcohort (n = 6,566) was drawn with the intention to obtain an equal number of cases and noncases (n = 5,507). We genotyped 134 SNPs that captured all common genetic variation across the 15 candidate genes; 123 met the quality control criteria. Each SNP was tested for association with the risk of being a 'weight gainer' (logistic regression models) in the case-noncase data and with weight gain (linear regression models) in the random subcohort data. After accounting for multiple testing, none of the SNPs was significantly associated with weight change. Furthermore, we observed no significant effect modification by dietary factors, except for SNP rs7180849 in the neuromedin beta gene (NMB). Carriers of the minor allele had a more pronounced weight gain at a higher GI (P = 2x10(-7)). Conclusions: We found no evidence of association between SNPs in the studied hypothalamic genes with weight change. The interaction between GI and NMB SNP rs7180849 needs further confirmation.	[Du, Huaidong; van der A, Daphne L.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Du, Huaidong; Saris, Wim H. M.] Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Human Biol, Maastricht, Netherlands; [Vimaleswaran, Karani S.; Bouatia-Naji, Nabila; Wareham, Nicolas J.; Loos, Ruth J. F.] Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Angquist, Lars; Holst, Claus; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Hansen, Rikke D.; Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Overvad, Kim; Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Aalborg Hosp, Dept Cardiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Boeing, Heiner; Meidtner, Karina] German Inst Human Nutr, Dept Epidemiol, Potsdam, Germany; [Palli, Domenico; Masala, Giovanna] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Bouatia-Naji, Nabila] Univ Lille Nord France, Lille, France; [Bouatia-Naji, Nabila] Inst Pasteur, CNRS, UMR 8199, Lille, France; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Netherlands National Institute for Public Health & the Environment; Maastricht University; University of Cambridge; University of Copenhagen; Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Wageningen University & Research	Du, HD (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	huaidong.du@ctsu.ox.ac.uk	Bouatia-Naji, Nabila/AGF-1400-2022; Feskens, Edith/ABI-1446-2020; BOUATIA-NAJI, NABILA/D-5863-2013; Masala, Giovanna/AAC-5474-2022; Feskens, Edith JM/A-3757-2012; Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Jakobsen, Marianne Uhre/I-8550-2018	Bouatia-Naji, Nabila/0000-0001-5424-2134; Feskens, Edith/0000-0001-5819-2488; Masala, Giovanna/0000-0002-5758-9069; Loos, Ruth J F/0000-0002-8532-5087; Jakobsen, Marianne Uhre/0000-0001-6518-4136; Tjonneland, Anne/0000-0003-4385-2097; PALLI, Domenico/0000-0002-5558-2437; tumino, rosario/0000-0003-2666-414X; Du, Huaidong/0000-0002-9814-0049; Meidtner, Karina/0000-0001-5810-4062; Karani, Vimal/0000-0002-8485-8930; Overvad, Kim/0000-0001-6429-7921; Angquist, Lars/0000-0002-9516-4424	European Community [FOOD-CT-2005-513946]; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106179471, MC_U106188470] Funding Source: researchfish	European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DIOGENES is the acronym of the project "Diet, Obesity and Genes" supported by the European Community (Contract no. FOOD-CT-2005-513946). The parties of the project are listed on the website of the project (http://www.diogenes-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson N, 2010, INT J OBESITY, V34, P1011, DOI 10.1038/ijo.2010.27; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Blom WAM, 2006, AM J CLIN NUTR, V83, P211; Bornet FRJ, 2007, APPETITE, V49, P535, DOI 10.1016/j.appet.2007.04.006; Bouchard L, 2004, AM J CLIN NUTR, V80, P1478, DOI 10.1093/ajcn/80.6.1478; Coll AP, 2009, MOL CELL ENDOCRINOL, V300, P147, DOI 10.1016/j.mce.2008.09.007; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2006, ACTA CARDIOL, V61, P383, DOI 10.2143/AC.61.4.2017298; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Fetissov SO, 2010, APPETITE, V54, P346, DOI 10.1016/j.appet.2009.12.015; Friedman JM, 1998, NUTR REV, V56, pS38; Gauderman WJ, 2006, COMPUTER PROGRAM POW; HALKJAER J, 2010, INT J OBES IN PRESS; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoggard N, 2007, J MOL ENDOCRINOL, V39, P199, DOI 10.1677/JME-07-0071; Huda MSB, 2006, OBES REV, V7, P163, DOI 10.1111/j.1467-789X.2006.00245.x; Jeor STS, 2001, CIRCULATION, V104, P1869, DOI 10.1161/hc4001.096152; Lenard NR, 2008, OBESITY, V16, pS11, DOI 10.1038/oby.2008.511; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nonogaki K, 2008, BIOCHEM BIOPH RES CO, V372, P186, DOI 10.1016/j.bbrc.2008.05.010; Oeffner F, 2000, ACTA DIABETOL, V37, P93, DOI 10.1007/s005920070026; Pigeyre M, 2010, INT J OBESITY, V34, P478, DOI 10.1038/ijo.2009.260; Qi L, 2008, HUM MOL GENET, V17, P3502, DOI 10.1093/hmg/ddn242; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Reynolds RC, 2009, EUR J CLIN NUTR, V63, P872, DOI 10.1038/ejcn.2008.52; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rinaldi S, 2006, INT J CANCER, V118, P2832, DOI 10.1002/ijc.21730; Rushing PA, 1996, PHYSIOL BEHAV, V60, P1501, DOI 10.1016/S0031-9384(96)00324-1; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Small CJ, 2004, CNS NEUROL DISORD-DR, V3, P379, DOI 10.2174/1568007043336950; Spalova J, 2008, PHYSIOL RES, V57, pS39, DOI 10.33549/physiolres.931488; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Swartz TD, 2010, BRAIN RES, V1308, P79, DOI 10.1016/j.brainres.2009.10.045; Veldhorst M, 2008, PHYSIOL BEHAV, V94, P300, DOI 10.1016/j.physbeh.2008.01.003; Westerterp-Plantenga MS, 2003, CURR OPIN CLIN NUTR, V6, P635, DOI 10.1097/00075197-200311000-00005; Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609	48	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17436	10.1371/journal.pone.0017436	http://dx.doi.org/10.1371/journal.pone.0017436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390334	Green Accepted, Green Published, gold			2022-12-27	WOS:000287761700056
J	Li, G; Zhang, JJ; Tong, XM; Liu, WJ; Ye, X				Li, Gang; Zhang, Junjie; Tong, Xiaomei; Liu, Wenjun; Ye, Xin			Heat Shock Protein 70 Inhibits the Activity of Influenza A Virus Ribonucleoprotein and Blocks the Replication of Virus In Vitro and In Vivo	PLOS ONE			English	Article							CELL-CYCLE ARREST; RNA-POLYMERASE; PA SUBUNIT; VIRAL-RNA; PROSTAGLANDIN-A; NUCLEAR IMPORT; CAP-BINDING; PROTEIN; IDENTIFICATION; ENDONUCLEASE	Background: Heat shock protein 70 (Hsp70) was identified as a cellular interaction partner of the influenza virus ribonucleoprotein (RNP) complex. The biological significance of the interaction between Hsp70 and RNP has not been fully investigated. Principal Findings: Here we demonstrated that Hsp70 was involved in the regulation of influenza A viral transcription and replication. It was found that Hsp70 was associated with viral RNP by directly interacting with the PB1 and PB2 subunits, and the ATPase domain of Hsp70 was required for the association. Immunofluorescence analysis showed that Hsp70 was translocated from the cytoplasm into the nucleus in infected cells. Then we found that Hsp70 negatively regulated the expression of viral proteins in infected cells. Real-time PCR analysis revealed that the transcription and replication of all eight viral segments were significantly reduced in Hsp70 overexpressed cells and greatly increased as Hsp70 was knocked down by RNA interference. Luciferase assay showed that overexpression of Hsp70 could inhibit the viral RNP activity on both vRNA and cRNA promoters. Biochemical analysis demonstrated that Hsp70 interfered with the integrity of RNP. Furthermore, delivered Hsp70 could inhibit the replication of influenza A virus in mice. Significance: Our study indicated that Hsp70 interacted with PB1 and PB2 of RNP and could interfere with the integrity of RNP and block the virus replication in vitro and in vivo possibly through disrupting the binding of viral polymerase with viral RNA.	[Li, Gang; Zhang, Junjie; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Liu, Wenjun] Chinese Acad Sci, Ctr Mol Virol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China; [Li, Gang; Zhang, Junjie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, G (corresponding author), Chinese Acad Sci, Ctr Mol Immunol, CAS Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing, Peoples R China.	yex@im.ac.cn		Zhang, Junjie/0000-0003-3812-3850	Ministry of Science and Technology of China [2007DFC30240, 2004BA519A64, 2009ZX10004-101, 2008ZX10002-009, 2011CB504705]; Chinese Academy of Sciences [KSCX2-YW-N-054, KSCX2-YW-R-198]; Innovative Research Group of the National Natural Science Foundation of China (NSFC) [81021003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovative Research Group of the National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The Ministry of Science and Technology of China (2007DFC30240, 2004BA519A64, 2009ZX10004-101, 2008ZX10002-009, 2011CB504705) and Chinese Academy of Sciences Innovation projects (KSCX2-YW-N-054, KSCX2-YW-R-198). Xin Ye is a principal investigator of the Innovative Research Group of the National Natural Science Foundation of China (NSFC, Grant No. 81021003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMICI C, 1991, J GEN VIROL, V72, P1877, DOI 10.1099/0022-1317-72-8-1877; AMICI C, 1992, P NATL ACAD SCI USA, V89, P6227, DOI 10.1073/pnas.89.14.6227; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Carrello A, 2004, CELL STRESS CHAPERON, V9, P167, DOI 10.1379/CSC-26R.1; Chan W, 2008, VIROLOGY, V380, P304, DOI 10.1016/j.virol.2008.07.027; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DIGARD P, 1989, VIROLOGY, V171, P162, DOI 10.1016/0042-6822(89)90523-0; Doeppner TR, 2009, J CEREBR BLOOD F MET, V29, P1187, DOI 10.1038/jcbfm.2009.44; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Glotzer JB, 2000, NATURE, V407, P207, DOI 10.1038/35025102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1999, J VIROL, V73, P631; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Honda A, 2007, GENES CELLS, V12, P133, DOI 10.1111/j.1365-2443.2007.01047.x; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Ivanovic T, 2007, J BIOL CHEM, V282, P12210, DOI 10.1074/jbc.M610258200; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Judd AK, 1997, ANTIMICROB AGENTS CH, V41, P687, DOI 10.1128/AAC.41.3.687; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; KOESTLER TP, 1984, P NATL ACAD SCI-BIOL, V81, P4505, DOI 10.1073/pnas.81.14.4505; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; MARK GE, 1979, J VIROL, V29, P744, DOI 10.1128/JVI.29.2.744-752.1979; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Michels AA, 1999, J BIOL CHEM, V274, P36757, DOI 10.1074/jbc.274.51.36757; MILARSKI KL, 1986, P NATL ACAD SCI USA, V83, P9517, DOI 10.1073/pnas.83.24.9517; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Nagata K, 2008, REV MED VIROL, V18, P247, DOI 10.1002/rmv.575; Nagel F, 2008, J NEUROSCI METH, V171, P226, DOI 10.1016/j.jneumeth.2008.03.008; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; POCH O, 1989, EMBO J, V8, P3867, DOI 10.1002/j.1460-2075.1989.tb08565.x; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; SANTORO MG, 1988, ARCH VIROL, V99, P89, DOI 10.1007/BF01311026; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Vidya Priyadarsini R, 2010, Eur J Pharmacol, V649, P84, DOI 10.1016/j.ejphar.2010.09.020; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Watanabe K, 2006, FEBS LETT, V580, P5785, DOI 10.1016/j.febslet.2006.09.040; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	62	54	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16546	10.1371/journal.pone.0016546	http://dx.doi.org/10.1371/journal.pone.0016546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390211	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700010
J	Pai, VP; Horseman, ND				Pai, Vaibhav P.; Horseman, Nelson D.			Multiple Cellular Responses to Serotonin Contribute to Epithelial Homeostasis	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; STEM-CELLS; TIGHT JUNCTIONS; APOPTOSIS; TURNOVER; CANCER; MECHANISMS; LACTATION; PROSTATE; RELEASE	Epithelial homeostasis incorporates the paradoxical concept of internal change (epithelial turnover) enabling the maintenance of anatomical status quo. Epithelial cell differentiation and cell loss (cell shedding and apoptosis) form important components of epithelial turnover. Although the mechanisms of cell loss are being uncovered the crucial triggers that modulate epithelial turnover through regulation of cell loss remain undetermined. Serotonin is emerging as a common autocrine-paracine regulator in epithelia of multiple organs, including the breast. Here we address whether serotonin affects epithelial turnover. Specifically, serotonin's roles in regulating cell shedding, apoptosis and barrier function of the epithelium. Using in vivo studies in mouse and a robust model of differentiated human mammary duct epithelium (MCF10A), we show that serotonin induces mammary epithelial cell shedding and disrupts tight junctions in a reversible manner. However, upon sustained exposure, serotonin induces apoptosis in the replenishing cell population, causing irreversible changes to the epithelial membrane. The staggered nature of these events induced by serotonin slowly shifts the balance in the epithelium from reversible to irreversible. These finding have very important implications towards our ability to control epithelial regeneration and thus address pathologies of aberrant epithelial turnover, which range from degenerative disorders (e.g.; pancreatitis and thyrioditis) to proliferative disorders (e. g.; mastitis, ductal ectasia, cholangiopathies and epithelial cancers).	[Pai, Vaibhav P.; Horseman, Nelson D.] Univ Cincinnati, Dept Mol & Cellular Physiol, Cincinnati, OH USA	University System of Ohio; University of Cincinnati	Pai, VP (corresponding author), Tufts Univ, Dept Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	nelson.horseman@uc.edu			National Institutes of Health [DK52134]; Department of the Army [BC052576]; USDA Cooperative State Research, Education and Extension Service [2007-35206-17898]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of the Army; USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work reported here was supported by grants from the National Institutes of Health (DK52134) and Department of the Army (BC052576) (NDH). This project was supported by National Research Initiative Competitive Grant no: 2007-35206-17898 from the USDA Cooperative State Research, Education and Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bement WM, 2002, CURR BIOL, V12, pR12, DOI 10.1016/S0960-9822(01)00639-X; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Bussard KM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2754; Conder R, 2009, CELL, V137, P1185, DOI 10.1016/j.cell.2009.06.006; Corfe BM, 2000, CELL DEATH DIFFER, V7, P234, DOI 10.1038/sj.cdd.4400634; GKONOS PJ, 1995, UROL RES, V23, P81, DOI 10.1007/BF00307937; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; HALL PA, 1994, J CELL SCI, V107, P3569; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hetts SW, 1998, JAMA-J AM MED ASSOC, V279, P300, DOI 10.1001/jama.279.4.300; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jones BA, 1997, AM J PHYSIOL-GASTR L, V273, pG1174, DOI 10.1152/ajpgi.1997.273.6.G1174; LEBLOND C. P., 1964, NAT CANCER INST MONOGR, V14, P119; Lopez JI, 2008, ONCOGENE, V27, P6981, DOI 10.1038/onc.2008.348; MADARA JL, 1990, J MEMBRANE BIOL, V116, P177, DOI 10.1007/BF01868675; MARSHALL AM, 2008, CELL TISSUE RES; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Marzioni M, 2005, GASTROENTEROLOGY, V128, P121, DOI 10.1053/j.gastro.2004.10.002; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Medh RD, 2000, CELL TISSUE RES, V301, P101, DOI 10.1007/s004419900159; Mohammad-Zadeh LF, 2008, J VET PHARMACOL THER, V31, P187, DOI 10.1111/j.1365-2885.2008.00944.x; Molyneux G, 2007, CELL MOL LIFE SCI, V64, P3248, DOI 10.1007/s00018-007-7391-5; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Norgaard JV, 2008, J DAIRY SCI, V91, P2319, DOI 10.3168/jds.2007-0767; Pai VP, 2008, J BIOL CHEM, V283, P30901, DOI 10.1074/jbc.M802476200; Pai VP, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2448; Pan J, 2006, AM J PHYSIOL-LUNG C, V290, pL185, DOI 10.1152/ajplung.00167.2005; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park M, 2008, BIOSCI BIOTECH BIOCH, V72, P2456, DOI 10.1271/bbb.80220; PELC SR, 1964, J CELL BIOL, V22, P21, DOI 10.1083/jcb.22.1.21; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; Reinhardt TA, 2009, BIOCHEM BIOPH RES CO, V378, P99, DOI 10.1016/j.bbrc.2008.11.004; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Schulte-Hermann R, 1995, Prog Liver Dis, V13, P1; Smith GH, 2001, MICROSC RES TECHNIQ, V52, P190, DOI 10.1002/1097-0029(20010115)52:2<190::AID-JEMT1005>3.0.CO;2-O; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Suzuki A, 2001, J CLIN INVEST, V108, P749, DOI 10.1172/JCI200112312; Turner JT, 1996, J DENT RES, V75, P935, DOI 10.1177/00220345960750031101; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yu PL, 2001, AM J PHYSIOL-GASTR L, V280, pG1099, DOI 10.1152/ajpgi.2001.280.6.G1099; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061	44	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17028	10.1371/journal.pone.0017028	http://dx.doi.org/10.1371/journal.pone.0017028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390323	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700026
J	Dunstan, AJ; Ward, PD; Marshall, NJ				Dunstan, Andrew J.; Ward, Peter D.; Marshall, N. Justin			Vertical Distribution and Migration Patterns of Nautilus pompilius	PLOS ONE			English	Article							LIVING NAUTILUS; PALAU; ISLANDS; BELAUENSIS; IMPLOSION; BEHAVIOR; MOVEMENT; BIOLOGY; FIJI	Vertical depth migrations into shallower waters at night by the chambered cephalopod Nautilus were first hypothesized early in the early 20(th) Century. Subsequent studies have supported the hypothesis that Nautilus spend daytime hours at depth and only ascend to around 200 m at night. Here we challenge this idea of a universal Nautilus behavior. Ultrasonic telemetry techniques were employed to track eleven specimens of Nautilus pompilius for variable times ranging from one to 78 days at Osprey Reef, Coral Sea, Australia. To supplement these observations, six remotely operated vehicle (ROV) dives were conducted at the same location to provide 29 hours of observations from 100 to 800 meter depths which sighted an additional 48 individuals, including five juveniles, all deeper than 489 m. The resulting data suggest virtually continuous, nightly movement between depths of 130 to 700 m, with daytime behavior split between either virtual stasis in the relatively shallow 160-225 m depths or active foraging in depths between 489 to 700 m. The findings also extend the known habitable depth range of Nautilus to 700 m, demonstrate juvenile distribution within the same habitat as adults and document daytime feeding behavior. These data support a hypothesis that, contrary to previously observed diurnal patterns of shallower at night than day, more complex vertical movement patterns may exist in at least this, and perhaps all other Nautilus populations. These are most likely dictated by optimal feeding substrate, avoidance of daytime visual predators, requirements for resting periods at 200 m to regain neutral buoyancy, upper temperature limits of around 25 degrees C and implosion depths of 800 m. The slope, terrain and biological community of the various geographically separated Nautilus populations may provide different permutations and combinations of the above factors resulting in preferred vertical movement strategies most suited for each population.	[Dunstan, Andrew J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Ward, Peter D.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Washington; University of Washington Seattle; University of Queensland	Dunstan, AJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	andy.dunstan@gmail.com		Marshall, Justin/0000-0001-9006-6713	Undersea Explorer; University of Queensland; University of Washington; Andrew Dunstan; Australian Research Council [LP0775179]	Undersea Explorer; University of Queensland(University of Queensland); University of Washington(University of Washington); Andrew Dunstan; Australian Research Council(Australian Research Council)	Funding for this work was provided by Undersea Explorer, University of Queensland, University of Washington, Andrew Dunstan and Australian Research Council Linkage Projects: Project ID: LP0775179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutilier RG, 1996, NATURE, V382, P534, DOI 10.1038/382534a0; CARLSON BA, 1984, PAC SCI, V38, P183; CARLSON BA, 1979, PAC SCI, V33, P118; DUNSTAN A, 2010, FISHERIES R IN PRESS; DUNSTAN A, 2010, PLOS ONE IN PRESS; HAVEN N, 1977, MAR BIOL, V42, P177, DOI 10.1007/BF00391570; KANIE Y, 1980, PALEOBIOLOGY, V6, P44, DOI 10.1017/S0094837300012483; ODOR RK, 1993, NATURE, V362, P626, DOI 10.1038/362626a0; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1979, SCIENCE, V204, P1199, DOI 10.1126/science.204.4398.1199; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; Tanabe K., 1985, KAGOSHIMA U RES CTR, V4, P38; WARD P, 1980, LETHAIA, V13, P182, DOI 10.1111/j.1502-3931.1980.tb01050.x; WARD P, 1984, NATURE, V309, P248, DOI 10.1038/309248a0; WARD P, 1978, J EXP ZOOL, V205, P5, DOI 10.1002/jez.1402050103; WARD P, 1977, PALEOBIOLOGY, V3, P377, DOI 10.1017/S0094837300005534; Ward P. D., 1987, NATURAL HIST NAUTILU; WELLS MJ, 1992, J MAR BIOL ASSOC UK, V72, P313, DOI 10.1017/S0025315400037723; ZANN LP, 1984, VELIGER, V27, P19	19	42	44	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16311	10.1371/journal.pone.0016311	http://dx.doi.org/10.1371/journal.pone.0016311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364981	Green Published, gold			2022-12-27	WOS:000287656600005
J	El-Sayed, AM; Tracy, M; Scarborough, P; Galea, S				El-Sayed, Abdulrahman M.; Tracy, Melissa; Scarborough, Peter; Galea, Sandro			Suicide among Arab-Americans	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; NEIGHBORHOOD CONTEXT; SMALL-AREA; DISCRIMINATION; ACCULTURATION; DEPRESSION; PARADOX; HEALTH; STATES; RATES	Background: Arab-American (AA) populations in the US are exposed to discrimination and acculturative stress-two factors that have been associated with higher suicide risk. However, prior work suggests that socially oriented norms and behaviors, which characterize recent immigrant ethnic groups, may be protective against suicide risk. Here we explored suicide rates and their determinants among AAs in Michigan, the state with the largest proportion of AAs in the US. Methodology/Principal Findings: ICD-9/10 underlying cause of death codes were used to identify suicide deaths from among all deaths in Michigan between 1990 and 2007. Data from the 2000 U. S. Census were collected for population denominators. Age-adjusted suicide rates among AAs and non-ethnic whites were calculated by gender using the direct method of standardization. We also stratified by residence inside or outside of Wayne County (WC), the county with the largest AA population in the state. Suicide rates were 25.10 per 100,000 per year among men and 6.40 per 100,000 per year among women in Michigan from 1990 to 2007. AA men had a 51% lower suicide rate and AA women had a 33% lower rate than non-ethnic white men and women, respectively. The suicide rate among AA men in WC was 29% lower than in all other counties, while the rate among AA women in WC was 20% lower than in all other counties. Among non-ethnic whites, the suicide rate in WC was higher compared to all other counties among both men (12%) and women (16%). Conclusions/Significance: Suicide rates were higher among non-ethnic white men and women compared to AA men and women in both contexts. Arab ethnicity may protect against suicide in both sexes, but more so among men. Additionally, ethnic density may protect against suicide among Arab-Americans.	[El-Sayed, Abdulrahman M.; Tracy, Melissa; Galea, Sandro] Columbia Univ, Dept Epidemiol, New York, NY 10027 USA; [El-Sayed, Abdulrahman M.; Scarborough, Peter] Univ Oxford, Dept Publ Hlth, Oxford, England; [El-Sayed, Abdulrahman M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Tracy, Melissa] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ctr Social Epidemiol & Populat Hlth, Ann Arbor, MI 48109 USA	Columbia University; University of Oxford; Columbia University; University of Michigan System; University of Michigan	El-Sayed, AM (corresponding author), Columbia Univ, Dept Epidemiol, New York, NY 10027 USA.	ame2145@columbia.edu	El-Sayed, Abdulrahman/F-7427-2013; Scarborough, Peter/ABD-6111-2021; Galea, Sandro/GLR-6066-2022	El-Sayed, Abdulrahman/0000-0002-4809-5630; Scarborough, Peter/0000-0002-2378-2944; Galea, Sandro/0000-0002-7534-0945	NIH [GM07863, DA022720, DA017642]; British Heart Foundation; Rhodes Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017642, R01DA022720] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Rhodes Trust; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work was funded in part by NIH Grants GM07863, DA022720 and DA017642, the British Heart Foundation, and the Rhodes Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Laban Baha, 1989, ARAB AM CONTINUITY C; ABUDABBEH N, 1996, ETHNICITY FAMILY THE, P333; Ajrouch KJ, 2007, J CROSS-CULT GERONTO, V22, P167, DOI 10.1007/s10823-006-9033-z; Amer Mona M, 2007, J Immigr Minor Health, V9, P335, DOI 10.1007/s10903-007-9045-y; *AR AM ANT COMM RE, 2001, REP HAT CRIM DISCR A; *AR AM I FDN, 2008, AR AM DEM; *AR AM I FDN, 2003, STAT PROF MICH; *AR AM I POLL RES, AR AM AR STRONG ADV; Cagney KA, 2007, AM J PUBLIC HEALTH, V97, P919, DOI 10.2105/AJPH.2005.071472; Cobas JA, 1996, AM J PUBLIC HEALTH, V86, P394, DOI 10.2105/AJPH.86.3.394; de la Rosa Ivan A., 2002, Ethnicity & Disease, V12, P480; El-Sayed AM, 2010, J EPIDEMIOL COMMUN H, V64, P155, DOI 10.1136/jech.2008.084491; El-Sayed AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-272; Eschbach K, 2004, AM J PUBLIC HEALTH, V94, P1807, DOI 10.2105/AJPH.94.10.1807; Guendelman S, 2001, SOC SCI MED, V52, P1805, DOI 10.1016/S0277-9536(00)00296-3; Joe S, 2001, SUICIDE LIFE-THREAT, V31, P106, DOI 10.1521/suli.31.1.5.106.24223; Leong FT, 2008, SER DEATH DYING, P1; Leong FTL, 2008, SER DEATH DYING, P117; Logan JR, 2002, AM SOCIOL REV, V67, P299, DOI 10.2307/3088897; MEEHAN PJ, 1991, AM J PUBLIC HEALTH, V81, P1198, DOI 10.2105/AJPH.81.9.1198; Moradi B, 2004, J COUNS PSYCHOL, V51, P418, DOI 10.1037/0022-0167.51.4.418; NAFF A, 1985, DEV ARAB AM IDENTITY; *NAT CTR HLTH STAT, 2001, ICD10ICD9 NAT CTR HL; Neeleman J, 2001, J EPIDEMIOL COMMUN H, V55, P85, DOI 10.1136/jech.55.2.85; Neeleman J, 1999, PSYCHOL MED, V29, P429, DOI 10.1017/S003329179800806X; Oquendo MA, 2001, AM J PSYCHIAT, V158, P1652, DOI 10.1176/appi.ajp.158.10.1652; Ostir GV, 2003, J EPIDEMIOL COMMUN H, V57, P987, DOI 10.1136/jech.57.12.987; Padela AI, 2010, AM J PUBLIC HEALTH, V100, P284, DOI 10.2105/AJPH.2009.164954; PEAK G, 2002, J IMMIGR MINOR HEALT, V4, P125; Pridmore S., 2004, AUSTR PSYCHIAT, V12, P380, DOI [DOI 10.1111/J.1440-1665.2004.02131.X, DOI 10.1080/J.1440-1665.2004.02131.X]; Rockett IRH, 2006, SOC SCI MED, V63, P2165, DOI 10.1016/j.socscimed.2006.05.017; Ruggles S, 2009, INTEGRATED PUBLIC US; Sarfraz A, 2002, AUSTRALAS PSYCHIATRY, V10, P48, DOI DOI 10.1046/J.1440-1665.2002.00392.X; SCRIBNER R, 1989, AM J PUBLIC HEALTH, V79, P1263, DOI 10.2105/AJPH.79.9.1263; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; *US BUR CENS, WAYN COUNT QUICKFACT; Wrobel NH, 2009, J CROSS-CULT GERONTO, V24, P273, DOI 10.1007/s10823-009-9096-8	37	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14704	10.1371/journal.pone.0014704	http://dx.doi.org/10.1371/journal.pone.0014704			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21379577	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300007
J	Geiger, TR; Song, JY; Rosado, A; Peeper, DS				Geiger, Thomas R.; Song, Ji-Ying; Rosado, Aranzazu; Peeper, Daniel S.			Functional Characterization of Human Cancer-Derived TRKB Mutations	PLOS ONE			English	Article							NEUROTROPHIC RECEPTOR TRKB; HER2-POSITIVE BREAST-CANCER; ETV6-NTRK3 GENE FUSION; TYROSINE KINASE; CELL-LINES; ADJUVANT CHEMOTHERAPY; ANOIKIS RESISTANCE; COLORECTAL CANCERS; SOMATIC MUTATIONS; LUNG-CANCER	Cancer originates from cells that have acquired mutations in genes critical for controlling cell proliferation, survival and differentiation. Often, tumors continue to depend on these so-called driver mutations, providing the rationale for targeted anticancer therapies. To date, large-scale sequencing analyses have revealed hundreds of mutations in human tumors. However, without their functional validation it remains unclear which mutations correspond to driver, or rather bystander, mutations and, therefore, whether the mutated gene represents a target for therapeutic intervention. In human colorectal tumors, the neurotrophic receptor TRKB has been found mutated on two different sites in its kinase domain (TRKB(T695I) and TRKB(D751N)). Another site, in the extracellular part of TRKB, is mutated in a human lung adenocarcinoma cell line (TRKB(L138F)). Lastly, our own analysis has identified one additional TRKB point mutation proximal to the kinase domain (TRKB(P507L)) in a human melanoma cell line. The functional consequences of all these point mutations, however, have so far remained elusive. Previously, we have shown that TRKB is a potent suppressor of anoikis and that TRKB-expressing cells form highly invasive and metastatic tumors in nude mice. To assess the functional consequences of these four TRKB mutations, we determined their potential to suppress anoikis and to form tumors in nude mice. Unexpectedly, both colon cancer-derived mutants, TRKB(T695I) and TRKB(D751N), displayed reduced activity compared to that of wild-type TRKB. Consistently, upon stimulation with the TRKB ligand BDNF, these mutants were impaired in activating TRKB and its downstream effectors AKT and ERK. The two mutants derived from human tumor cell lines (TRKB(L138F) and TRKB(P507L)) were functionally indistinguishable from wild-type TRKB in both in-vitro and in-vivo assays. In conclusion, we fail to detect any gain-of-function of four cancer-derived TRKB point mutations.	[Geiger, Thomas R.; Rosado, Aranzazu; Peeper, Daniel S.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Song, Ji-Ying] Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Geiger, TR (corresponding author), NCI, Lab Canc Biol & Genet, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	Rosado Diez, Aranzazu/0000-0002-3362-2450	European Union	European Union(European Commission)	This work was supported by a European Union FP6 grant to T. R. G., A. R. and D. S. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; BLAY J, 1984, CELL BIOL INT REP, V8, P551, DOI 10.1016/0309-1651(84)90054-7; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BONGARZONE I, 1989, ONCOGENE, V4, P1457; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Eide FF, 1996, J NEUROSCI, V16, P3123; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Geiger TR, 2005, CANCER RES, V65, P7033, DOI 10.1158/0008-5472.CAN-05-0709; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lacroix M, 2008, INT J CANCER, V122, P1, DOI 10.1002/ijc.23233; Li ZK, 2009, CANCER RES, V69, P7851, DOI 10.1158/0008-5472.CAN-08-4002; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marchetti A, 2008, HUM MUTAT, V29, P609, DOI 10.1002/humu.20707; Ninkina N, 1997, J BIOL CHEM, V272, P13019, DOI 10.1074/jbc.272.20.13019; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Ruggeri BA, 1999, CURR MED CHEM, V6, P845; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smit MA, 2009, MOL CELL BIOL, V29, P3722, DOI 10.1128/MCB.01164-08; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tognon C, 2002, CANCER CELL, V2, P367, DOI 10.1016/S1535-6108(02)00180-0; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Weinstein IB, 1997, CLIN CANCER RES, V3, P2696; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035	50	36	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16871	10.1371/journal.pone.0016871	http://dx.doi.org/10.1371/journal.pone.0016871			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379385	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482300023
J	Soto-De Leon, S; Camargo, M; Sanchez, R; Munoz, M; Perez-Prados, A; Purroy, A; Patarroyo, ME; Patarroyo, MA				Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Munoz, Marina; Perez-Prados, Antonio; Purroy, Antonio; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			Distribution Patterns of Infection with Multiple Types of Human Papillomaviruses and Their Association with Risk Factors	PLOS ONE			English	Article							CERVICAL-CANCER; GENETIC SUSCEPTIBILITY; AFRICAN-AMERICAN; HPV INFECTION; PCR DETECTION; PRIMER SETS; WOMEN; EPIDEMIOLOGY; PREVALENCE; HLA-DQB1	Background: Infection with multiple types of human papillomavirus (HPV) is one of the main risk factors associated with the development of cervical lesions. In this study, cervical samples collected from 1,810 women with diverse sociocultural backgrounds, who attended to their cervical screening program in different geographical regions of Colombia, were examined for the presence of cervical lesions and HPV by Papanicolau testing and DNA PCR detection, respectively. Principal Findings: The negative binomial distribution model used in this study showed differences between the observed and expected values within some risk factor categories analyzed. Particularly in the case of single infection and coinfection with more than 4 HPV types, observed frequencies were smaller than expected, while the number of women infected with 2 to 4 viral types were higher than expected. Data analysis according to a negative binomial regression showed an increase in the risk of acquiring more HPV types in women who were of indigenous ethnicity (+37.8%), while this risk decreased in women who had given birth more than 4 times (-31.1%), or were of mestizo (-24.6%) or black (-40.9%) ethnicity. Conclusions: According to a theoretical probability distribution, the observed number of women having either a single infection or more than 4 viral types was smaller than expected, while for those infected with 2-4 HPV types it was larger than expected. Taking into account that this study showed a higher HPV coinfection rate in the indigenous ethnicity, the role of underlying factors should be assessed in detail in future studies.	[Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Munoz, Marina; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia, Dept Mol Biol, Bogota, Colombia; [Soto-De Leon, Sara; Camargo, Milena; Munoz, Marina; Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia; [Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Perez-Prados, Antonio; Purroy, Antonio] Univ Publ Navarra, Dept Math, Navarra, Spain	Universidad del Rosario; Universidad Nacional de Colombia; Universidad Publica de Navarra	Soto-De Leon, S (corresponding author), Fdn Inst Inmunol Colombia, Dept Mol Biol, Bogota, Colombia.	mapatarr.fidic@gmail.com	Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Patarroyo, Manuel A/I-8046-2016; De León, Sara Cecilia Soto/AAF-6301-2021; Leon, Sara Cecilia Soto-De/ABD-3186-2020; Sanchez, Ricardo/K-8254-2015	Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Patarroyo, Manuel A/0000-0002-4751-2500; De León, Sara Cecilia Soto/0000-0003-4515-6749; Perez Prados, Antonio/0000-0002-6496-4242; Camargo, Milena/0000-0003-0246-0716; Sanchez, Ricardo/0000-0002-7540-4734	Asociacion Investigacion Solidaria SADAR; Caja Navarra (Navarra, Spain); Spanish Agency for International Development Cooperation (AECID) [08-CAP2-0609]	Asociacion Investigacion Solidaria SADAR; Caja Navarra (Navarra, Spain); Spanish Agency for International Development Cooperation (AECID)	This project was funded by Asociacion Investigacion Solidaria SADAR, Caja Navarra (Navarra, Spain) and the Spanish Agency for International Development Cooperation (AECID) (Project 08-CAP2-0609). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008; Au WW, 2004, TOXICOLOGY, V198, P117, DOI 10.1016/j.tox.2004.01.022; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Baseman JG, 2005, J CLIN VIROL, V32, pS16, DOI 10.1016/j.jcv.2004.12.008; CAMARGO M, 2010, ANN EPIDEMI IN PRESS; Castellsague X, 2002, VIRUS RES, V89, P191, DOI 10.1016/S0168-1702(02)00188-0; Cervantes Jorge, 2003, Rev. Inst. Med. trop. S. Paulo, V45, P131, DOI 10.1590/S0036-46652003000300003; Chang DY, 1997, J MED MICROBIOL, V46, P54, DOI 10.1099/00222615-46-1-54; Chaturvedi AK, 2005, CANCER EPIDEM BIOMAR, V14, P2439, DOI 10.1158/1055-9965.EPI-05-0465; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Dal Bello B, 2009, J MED VIROL, V81, P703, DOI 10.1002/jmv.21429; Dao DD, 2005, GYNECOL ONCOL, V96, P349, DOI 10.1016/j.ygyno.2004.10.002; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Depuydt CE, 2007, J CELL MOL MED, V11, P881, DOI 10.1111/j.1582-4934.2007.00073.x; Franco EL, 1999, J INFECT DIS, V180, P1415, DOI 10.1086/315086; Franco EL, 2003, CANCER J, V9, P348, DOI 10.1097/00130404-200309000-00004; Goncalves MAG, 2008, EUR J OBSTET GYN R B, V141, P70, DOI 10.1016/j.ejogrb.2008.06.010; Gauthier A, 2008, EUR J PUBLIC HEALTH, V18, P674, DOI 10.1093/eurpub/ckn064; GREGOIRE L, 1994, INT J CANCER, V57, P504, DOI 10.1002/ijc.2910570411; Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007; Herrero R, 2008, VACCINE, V26, P4795, DOI 10.1016/j.vaccine.2008.07.002; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iftner Thomas, 2003, J Natl Cancer Inst Monogr, P80; Javanbakht M, 2010, SEX TRANSM DIS, V37, P68, DOI 10.1097/OLQ.0b013e3181bcd3e7; Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996; Kenney JW, 1996, J ADV NURS, V23, P1221, DOI 10.1046/j.1365-2648.1996.11721.x; Kim H, 2009, OCCUP ENVIRON MED, V66, P733, DOI 10.1136/oem.2008.042887; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Lee Yuan-Ming, 2001, Journal of Microbiology Immunology and Infection, V34, P87; Leon SCSD, 2009, CLIN MICROBIOL INFEC, V15, P100, DOI 10.1111/j.1469-0691.2008.02120.x; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Mahmud SM, 2007, J INFECT DIS, V196, P82, DOI 10.1086/518612; McLaughlin-Drubin ME, 2003, VIROLOGY, V312, P1, DOI 10.1016/S0042-6822(03)00312-X; Mejlhede N, 2010, APMIS, V118, P346, DOI 10.1111/j.1600-0463.2010.02602.x; Mejlhede N, 2009, APMIS, V117, P108, DOI 10.1111/j.1600-0463.2008.00019.x; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Moscicki AB, 2005, J ADOLESCENT HEALTH, V37, pS3, DOI 10.1016/j.jadohealth.2005.09.011; Napoles-Springer A, 1996, J Med Syst, V20, P277, DOI 10.1007/BF02257041; Nelson JH, 2000, J CLIN MICROBIOL, V38, P688, DOI 10.1128/JCM.38.2.688-695.2000; Orjuela K, 2007, DIAGN MICR INFEC DIS, V59, P101, DOI 10.1016/j.diagmicrobio.2007.04.003; Parkin DM, 2008, VACCINE, V26, pM1, DOI 10.1016/j.vaccine.2008.05.010; PISTA A, 2010, CLIN MICROB IN PRESS; Qu WM, 1997, J CLIN MICROBIOL, V35, P1304, DOI 10.1128/JCM.35.6.1304-1310.1997; Ragin Camille C, 2009, Infect Agent Cancer, V4 Suppl 1, pS9, DOI 10.1186/1750-9378-4-S1-S9; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Rousseau MC, 2003, CANCER EPIDEM BIOMAR, V12, P1029; Rousseau MC, 2001, J INFECT DIS, V184, P1508, DOI 10.1086/324579; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Souza PSD, 2003, MUTAT RES-REV MUTAT, V544, P375, DOI 10.1016/j.mrrev.2003.06.013; Tabora N, 2009, CANCER CAUSE CONTROL, V20, P1663, DOI 10.1007/s10552-009-9414-z; Tate JE, 1996, MOL CELL PROBE, V10, P347, DOI 10.1006/mcpr.1996.0047; Tonon SA, 2004, INT J INFECT DIS, V8, P13, DOI 10.1016/j.ijid.2003.03.001; Tortolero-Luna G, 1998, Cad Saude Publica, V14 Suppl 3, P149, DOI 10.1590/S0102-311X1998000700015; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Villa LL, 1997, ADV CANCER RES, V71, P321, DOI 10.1016/S0065-230X(08)60102-5; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO/ICO Information Centre on HPV and Cervical Cancer, 2007, Vaccine, V25 Suppl 3, pC1; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064	60	32	34	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14705	10.1371/journal.pone.0014705	http://dx.doi.org/10.1371/journal.pone.0014705			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379574	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000287482300008
J	Vogne, C; Bisht, H; Arias, S; Fraile, S; Lal, R; van der Meer, JR				Vogne, Christelle; Bisht, Hansi; Arias, Sagrario; Fraile, Sofia; Lal, Rup; van der Meer, Jan Roelof			Characterisation of the Putative Effector Interaction Site of the Regulatory HbpR Protein from Pseudomonas azelaica by Site-Directed Mutagenesis	PLOS ONE			English	Article							SP STRAIN CF600; TRANSCRIPTIONAL REGULATORS; 2-HYDROXYBIPHENYL DEGRADATION; AROMATIC-COMPOUNDS; GENETIC-EVIDENCE; SWISS-MODEL; TOL PLASMID; NTRC FAMILY; B-LINKER; BINDING	Bacterial transcription activators of the XylR/DmpR subfamily exert their expression control via sigma(54)-dependent RNA polymerase upon stimulation by a chemical effector, typically an aromatic compound. Where the chemical effector interacts with the transcription regulator protein to achieve activation is still largely unknown. Here we focus on the HbpR protein from Pseudomonas azelaica, which is a member of the XylR/DmpR subfamily and responds to biaromatic effectors such as 2-hydroxybiphenyl. We use protein structure modeling to predict folding of the effector recognition domain of HbpR and molecular docking to identify the region where 2-hydroxybiphenyl may interact with HbpR. A large number of site-directed HbpR mutants of residues in-and outside the predicted interaction area was created and their potential to induce reporter gene expression in Escherichia coli from the cognate P(C) promoter upon activation with 2-hydroxybiphenyl was studied. Mutant proteins were purified to study their conformation. Critical residues for effector stimulation indeed grouped near the predicted area, some of which are conserved among XylR/DmpR subfamily members in spite of displaying different effector specificities. This suggests that they are important for the process of effector activation, but not necessarily for effector specificity recognition.	[Vogne, Christelle; Arias, Sagrario; van der Meer, Jan Roelof] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Bisht, Hansi; Lal, Rup] Univ Delhi, Dept Zool, Delhi 110007, India; [Fraile, Sofia] CSIC, Natl Biotechnol Ctr, Madrid, Spain	University of Lausanne; University of Delhi; Consejo Superior de Investigaciones Cientificas (CSIC)	Vogne, C (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.	janroelof.vandermeer@unil.ch	van der Meer, Jan Roelof/G-6610-2012; Lal, Rup/AFP-1009-2022; Arias Rivas, Sagrario/G-8082-2012	van der Meer, Jan Roelof/0000-0003-1485-3082; 	Indo-Swiss Joint Research Program [LS04 TRAROMAT]; Spanish government	Indo-Swiss Joint Research Program; Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by a grant under the Indo-Swiss Joint Research Program (http://indo-swiss.epfl.ch/, grant number: LS04 TRAROMAT). S. A. acknowledges support from the Spanish government for a travel grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenghi FLG, 2001, EMBO REP, V2, P409, DOI 10.1093/embo-reports/kve092; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beggah S, 2008, MICROB BIOTECHNOL, V1, P68, DOI 10.1111/j.1751-7915.2007.00008.x; DELGADO A, 1994, J BIOL CHEM, V269, P8059; Devos D, 2002, ENVIRON MICROBIOL, V4, P29, DOI 10.1046/j.1462-2920.2002.00265.x; FERNANDEZ S, 1995, MOL MICROBIOL, V16, P205, DOI 10.1111/j.1365-2958.1995.tb02293.x; Fraile S, 2001, J BACTERIOL, V183, P5571, DOI 10.1128/JB.183.19.5571-5579.2001; Galvao TC, 2007, MOL MICROBIOL, V65, P907, DOI 10.1111/j.1365-2958.2007.05832.x; Garmendia J, 2000, MOL MICROBIOL, V38, P401, DOI 10.1046/j.1365-2958.2000.02139.x; Garmendia J, 2000, MICROBIOL-SGM, V146, P2555, DOI 10.1099/00221287-146-10-2555; Garmendia J, 2001, MOL MICROBIOL, V42, P47, DOI 10.1046/j.1365-2958.2001.02633.x; Jaspers MCM, 2000, J BACTERIOL, V182, P405, DOI 10.1128/JB.182.2.405-417.2000; Jaspers MCM, 2001, MICROBIOL-SGM, V147, P2183, DOI 10.1099/00221287-147-8-2183; Jaspers MCM, 2001, J BACTERIOL, V183, P270, DOI 10.1128/JB.183-1.270-279.2001; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Leahy JG, 1997, APPL ENVIRON MICROB, V63, P3736, DOI 10.1128/AEM.63.9.3736-3739.1997; Neuwald AF, 1999, GENOME RES, V9, P27; Ng LC, 1996, J BIOL CHEM, V271, P17281, DOI 10.1074/jbc.271.29.17281; O'Neill E, 1998, MOL MICROBIOL, V28, P131, DOI 10.1046/j.1365-2958.1998.00780.x; O'Neill E, 2001, EMBO J, V20, P819, DOI 10.1093/emboj/20.4.819; PAVEL H, 1994, J BACTERIOL, V176, P7550, DOI 10.1128/JB.176.24.7550-7557.1994; PerezMartin J, 1996, CELL, V86, P331, DOI 10.1016/S0092-8674(00)80104-X; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Salto R, 1998, J BACTERIOL, V180, P600, DOI 10.1128/JB.180.3.600-604.1998; Sambrook J, 2001, MOL CLONING LAB MANU; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shingler V, 1996, MOL MICROBIOL, V19, P409, DOI 10.1046/j.1365-2958.1996.388920.x; SHINGLER V, 1994, J BACTERIOL, V176, P1555, DOI 10.1128/jb.176.6.1555-1560.1994; Skarfstad E, 2000, J BACTERIOL, V182, P3008, DOI 10.1128/JB.182.11.3008-3016.2000; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Tropel D, 2005, FEBS J, V272, P1756, DOI 10.1111/j.1742-4658.2005.04607.x; Tropel D, 2004, ENVIRON MICROBIOL, V6, P1186, DOI 10.1111/j.1462-2920.2004.00645.x; Tropel D, 2002, J BACTERIOL, V184, P2914, DOI 10.1128/JB.184.11.2914-2924.2002; Van Dien SJ, 2003, J THEOR BIOL, V224, P437, DOI 10.1016/S0022-5193(03)00191-7; ZAFRA O, 2010, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462-2920.2010.02401.X	36	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16539	10.1371/journal.pone.0016539	http://dx.doi.org/10.1371/journal.pone.0016539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379585	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300017
J	Greenup, AG; Sasani, S; Oliver, SN; Walford, SA; Millar, AA; Trevaskis, B				Greenup, Aaron G.; Sasani, Sharyar; Oliver, Sandra N.; Walford, Sally A.; Millar, Anthony A.; Trevaskis, Ben			Transcriptome Analysis of the Vernalization Response in Barley (Hordeum vulgare) Seedlings	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; TRITICUM-AESTIVUM L.; NEAR-ISOGENIC LINES; FREEZING TOLERANCE; COLD-ACCLIMATION; GENE-EXPRESSION; FROST TOLERANCE; LOCUS FR-A(M)2; CBF GENES; WHEAT	Temperate cereals, such as wheat (Triticum spp.) and barley (Hordeum vulgare), respond to prolonged cold by becoming more tolerant of freezing (cold acclimation) and by becoming competent to flower (vernalization). These responses occur concomitantly during winter, but vernalization continues to influence development during spring. Previous studies identified VERNALIZATION1 (VRN1) as a master regulator of the vernalization response in cereals. The extent to which other genes contribute to this process is unclear. In this study the Barley1 Affymetrix chip was used to assay gene expression in barley seedlings during short or prolonged cold treatment. Gene expression was also assayed in the leaves of plants after prolonged cold treatment, in order to identify genes that show lasting responses to prolonged cold, which might contribute to vernalization-induced flowering. Many genes showed altered expression in response to short or prolonged cold treatment, but these responses differed markedly. A limited number of genes showed lasting responses to prolonged cold treatment. These include genes known to be regulated by vernalization, such as VRN1 and ODDSOC2, and also contigs encoding a calcium binding protein, 23-KD jasmonate induced proteins, an RNase S-like protein, a PR17d secretory protein and a serine acetyltransferase. Some contigs that were up-regulated by short term cold also showed lasting changes in expression after prolonged cold treatment. These include COLD REGULATED 14B (COR14B) and the barley homologue of WHEAT COLD SPECIFIC 19 (WSC19), which were expressed at elevated levels after prolonged cold. Conversely, two C-REPEAT BINDING FACTOR (CBF) genes showed reduced expression after prolonged cold. Overall, these data show that a limited number of barley genes exhibit lasting changes in expression after prolonged cold treatment, highlighting the central role of VRN1 in the vernalization response in cereals.	[Greenup, Aaron G.; Oliver, Sandra N.; Walford, Sally A.; Trevaskis, Ben] CSIRO, Div Plant Ind, Canberra, ACT, Australia; [Greenup, Aaron G.; Millar, Anthony A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Sasani, Sharyar] Seed & Plant Improvement Inst, Dept Cereals Res, Tehran, Iran	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University	Greenup, AG (corresponding author), CSIRO, Div Plant Ind, Canberra, ACT, Australia.	Ben.Trevaskis@csiro.au	Walford, Sally/B-5488-2011; sasani, shahryar/U-7757-2019; Millar, Anthony A/C-9323-2009; Trevaskis, Ben/B-5350-2011	sasani, shahryar/0000-0001-9077-3274; Trevaskis, Ben/0000-0001-7277-4994; Millar, Anthony/0000-0002-6668-1326	Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry; CSIRO Office of the Chief Executive (OCE); Australian National University College of Science	Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); CSIRO Office of the Chief Executive (OCE); Australian National University College of Science	This research was supported by the Commonwealth Scientific and Industrial Research Organization (CSIRO) Division of Plant Industry and the CSIRO Office of the Chief Executive (OCE). Aaron Greenup was supported by a scholarship from the Australian National University College of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; CHOUARD P, 1960, ANNU REV PLANT PHYS, V11, P191, DOI 10.1146/annurev.pp.11.060160.001203; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Crosatti C, 1999, PLANT PHYSIOL, V119, P671, DOI 10.1104/pp.119.2.671; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Distelfeld A, 2009, CURR OPIN PLANT BIOL, V12, P178, DOI 10.1016/j.pbi.2008.12.010; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; ENTZ MH, 1991, AGRON J, V83, P527, DOI 10.2134/agronj1991.00021962008300030002x; Fowler DB, 1996, THEOR APPL GENET, V93, P554, DOI 10.1007/BF00417947; Francia E, 2004, THEOR APPL GENET, V108, P670, DOI 10.1007/s00122-003-1468-9; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Garcion C, 2006, TRENDS PLANT SCI, V11, P320, DOI 10.1016/j.tplants.2006.05.009; Gassner G, 1918, Z BOT, V10, P27, DOI DOI 10.1007/BF00709593; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GOTT MB, 1955, ANN BOT, V21, P87; Gray GR, 1997, PLANT PHYSIOL, V114, P467, DOI 10.1104/pp.114.2.467; Greenup AG, 2010, PLANT PHYSIOL, V153, P1062, DOI 10.1104/pp.109.152488; HAYES PM, 1993, GENOME, V36, P66, DOI 10.1139/g93-009; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hemming MN, 2009, MOL GENET GENOMICS, V282, P107, DOI 10.1007/s00438-009-0449-3; King RW, 2009, FUNCT PLANT BIOL, V36, P1027, DOI 10.1071/FP09170; Knight H, 1996, PLANT CELL, V8, P489, DOI 10.1105/tpc.8.3.489; Knox AK, 2008, PLANT MOL BIOL, V67, P257, DOI 10.1007/s11103-008-9316-6; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Koemel JE, 2004, THEOR APPL GENET, V109, P839, DOI 10.1007/s00122-004-1686-9; Kwon CS, 2009, PLANT J, V60, P112, DOI 10.1111/j.1365-313X.2009.03938.x; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Monroy AF, 2007, PLANT MOL BIOL, V64, P409, DOI 10.1007/s11103-007-9161-z; Murai K, 2003, PLANT CELL PHYSIOL, V44, P1255, DOI 10.1093/pcp/pcg171; Nilan RA, 1971, P388; Oikawa A, 2009, BREEDING SCI, V59, P664, DOI 10.1270/jsbbs.59.664; Oliver SN, 2009, P NATL ACAD SCI USA, V106, P8386, DOI 10.1073/pnas.0903566106; Purvis ON, 1934, ANN BOT-LONDON, V48, P919, DOI 10.1093/oxfordjournals.aob.a090485; ROBERTS DWA, 1990, GENOME, V33, P247, DOI 10.1139/g90-039; SAEED AI, 2006, 9 TM4 MICROARRAY SOF, P134; Sasani S, 2009, J EXP BOT, V60, P2169, DOI 10.1093/jxb/erp098; Shitsukawa N, 2007, GENES GENET SYST, V82, P167, DOI 10.1266/ggs.82.167; Skinner J, 2006, THEOR APPL GENET, V112, P832, DOI 10.1007/s00122-005-0185-y; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stockinger EJ, 2007, PLANT J, V51, P308, DOI 10.1111/j.1365-313X.2007.0141.x; SUTKA J, 1989, EUPHYTICA, V42, P41, DOI 10.1007/BF00042613; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tommasini L, 2008, FUNCT INTEGR GENOMIC, V8, P387, DOI 10.1007/s10142-008-0081-z; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Trevaskis B, 2003, P NATL ACAD SCI USA, V100, P13099, DOI 10.1073/pnas.1635053100; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Trevaskis B, 2010, FUNCT PLANT BIOL, V37, P479, DOI 10.1071/FP10056; Vagujfalvi A, 2000, MOL GEN GENET, V263, P194, DOI 10.1007/s004380051160; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; Winfield MO, 2010, PLANT BIOTECHNOL J, V8, P749, DOI 10.1111/j.1467-7652.2010.00536.x; Winfield MO, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-55; WISE R. P., 2008, PLANT BIOINFORMATICS, P347; Wit E, 2004, STAT MICROARRAYS DES; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100	61	45	46	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17900	10.1371/journal.pone.0017900	http://dx.doi.org/10.1371/journal.pone.0017900			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408015	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900053
J	Miller, N; Saada, R; Fishman, S; Hurwitz, I; Susswein, AJ				Miller, Nimrod; Saada, Ravit; Fishman, Shlomi; Hurwitz, Itay; Susswein, Abraham J.			Neurons Controlling Aplysia Feeding Inhibit Themselves by Continuous NO Production	PLOS ONE			English	Article							IDENTIFIED HISTAMINERGIC NEURON; BUCCAL MOTOR PROGRAMS; NITRIC-OXIDE SYNTHASE; ORTHOGRADE COTRANSMITTER; PROTRACTION PHASE; BEHAVIORAL STATE; CYCLIC-GMP; IN-VITRO; C-PR; FOOD	Background: Neural activity can be affected by nitric oxide (NO) produced by spiking neurons. Can neural activity also be affected by NO produced in neurons in the absence of spiking? Methodology/Principal Findings: Applying an NO scavenger to quiescent Aplysia buccal ganglia initiated fictive feeding, indicating that NO production at rest inhibits feeding. The inhibition is in part via effects on neurons B31/B32, neurons initiating food consumption. Applying NO scavengers or nitric oxide synthase (NOS) blockers to B31/B32 neurons cultured in isolation caused inactive neurons to depolarize and fire, indicating that B31/B32 produce NO tonically without action potentials, and tonic NO production contributes to the B31/B32 resting potentials. Guanylyl cyclase blockers also caused depolarization and firing, indicating that the cGMP second messenger cascade, presumably activated by the tonic presence of NO, contributes to the B31/B32 resting potential. Blocking NO while voltage-clamping revealed an inward leak current, indicating that NO prevents this current from depolarizing the neuron. Blocking nitrergic transmission had no effect on a number of other cultured, isolated neurons. However, treatment with NO blockers did excite cerebral ganglion neuron C-PR, a command-like neuron initiating food-finding behavior, both in situ, and when the neuron was cultured in isolation, indicating that this neuron also inhibits itself by producing NO at rest. Conclusion/Significance: Self-inhibitory, tonic NO production is a novel mechanism for the modulation of neural activity. Localization of this mechanism to critical neurons in different ganglia controlling different aspects of a behavior provides a mechanism by which a humeral signal affecting background NO production, such as the NO precursor L-arginine, could control multiple aspects of the behavior.	[Miller, Nimrod] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University; Bar Ilan University	Miller, N (corresponding author), Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel.	avy@mail.biu.ac.il		Madar, Ravit/0000-0002-2025-8178; Susswein, Abraham J./0000-0001-6107-5901; Miller, Nimrod/0000-0002-2221-139X	Israel Science Foundation [420/06]	Israel Science Foundation(Israel Science Foundation)	The research was supported by grant 420/06 from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov I, 2007, J NEUROSCI, V27, P10993, DOI 10.1523/JNEUROSCI.2357-07.2007; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Bon CLM, 2003, J NEUROSCI, V23, P1941; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; CHIEL HJ, 1986, J NEUROSCI, V6, P2427; Dembrow NC, 2004, J NEUROSCI, V24, P5230, DOI 10.1523/JNEUROSCI.5649-03.2004; Douglas SJ, 2005, TRENDS NEUROSCI, V28, P644, DOI 10.1016/j.tins.2005.09.006; Elliott CJH, 2002, J EXP BIOL, V205, P877; ELPHICK MR, 1995, J NEUROSCI, V15, P7653; FESENKO EE, 1985, NATURE, V313, P310, DOI 10.1038/313310a0; Fossier P, 1999, NEUROSCIENCE, V93, P597, DOI 10.1016/S0306-4522(99)00165-7; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Garthwaite G, 2006, J NEUROSCI, V26, P7730, DOI 10.1523/JNEUROSCI.1528-06.2006; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Hopper RA, 2006, J NEUROSCI, V26, P11513, DOI 10.1523/JNEUROSCI.2259-06.2006; Hurwitz I, 2003, J NEUROPHYSIOL, V89, P2120, DOI 10.1152/jn.00497.2002; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1309, DOI 10.1152/jn.1996.75.4.1309; HURWITZ I, 1994, J NEUROPHYSIOL, V71, P1514, DOI 10.1152/jn.1994.71.4.1514; Hurwitz I, 1996, J NEUROPHYSIOL, V75, P1327, DOI 10.1152/jn.1996.75.4.1327; Hurwitz I, 1997, J NEUROPHYSIOL, V78, P1305, DOI 10.1152/jn.1997.78.3.1305; Hurwitz I, 1999, J NEUROPHYSIOL, V81, P521, DOI 10.1152/jn.1999.81.2.521; Hurwitz I, 2008, J NEUROPHYSIOL, V99, P814, DOI 10.1152/jn.00972.2007; JACKLET JW, 1995, J NEUROPHYSIOL, V74, P891, DOI 10.1152/jn.1995.74.2.891; Jacklet JW, 2004, J NEUROPHYSIOL, V91, P656, DOI 10.1152/jn.00409.2003; Jacklet JW, 2001, AM ZOOL, V41, P282, DOI 10.1668/0003-1569(2001)041[0282:NOAAOC]2.0.CO;2; Katzoff A, 2002, J NEUROSCI, V22, P9581; Katzoff A, 2006, J NEUROPHYSIOL, V96, P1247, DOI 10.1152/jn.00056.2006; Katzoff A, 2010, LEARN MEMORY, V17, P839, DOI 10.1101/lm.1624610; Kaun KR, 2009, GENOME, V52, P1, DOI 10.1139/G08-090; Kobayashi S, 2000, NEUROSCI LETT, V285, P209, DOI 10.1016/S0304-3940(00)01079-X; Kobayashi S, 2000, NEUROSCI RES, V38, P27, DOI 10.1016/S0168-0102(00)00136-X; Kupferman I., 1968, Commns Behav Biol, V2A, P13; KUPFERMANN I, 1974, BEHAV BIOL, V10, P89, DOI 10.1016/S0091-6773(74)91694-0; KUPFERMANN I, 1991, BIOL BULL, V180, P262, DOI 10.2307/1542396; KUPFERMANN I, 1974, BEHAV BIOL, V10, P1, DOI 10.1016/S0091-6773(74)91644-7; Kyriakatos A, 2009, J NEUROSCI, V29, P13283, DOI 10.1523/JNEUROSCI.3069-09.2009; Lewin MR, 1999, NAT NEUROSCI, V2, P18, DOI 10.1038/4520; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; LU TZ, 2009, 2009 NEUR M PLANN; Lucas C, 2010, ARCH INSECT BIOCHEM, V74, P52, DOI 10.1002/arch.20363; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Mahadevan A, 2004, J NEUROSCI, V24, P2813, DOI 10.1523/JNEUROSCI.3779-03.2004; MCCAMAN RE, 1985, J NEUROPHYSIOL, V53, P1016, DOI 10.1152/jn.1985.53.4.1016; McLean DL, 2000, J EXP BIOL, V203, P705; McLean DL, 2002, J NEUROSCI, V22, P4175, DOI 10.1523/JNEUROSCI.22-10-04175.2002; MILLER N, 2011, J NEUROPHYS IN PRESS; Miller N, 2008, J EXP BIOL, V211, P2388, DOI 10.1242/jeb.015040; Morgan PT, 2002, J NEUROPHYSIOL, V87, P49, DOI 10.1152/jn.00438.2001; Moroz LL, 1996, J NEUROCHEM, V66, P873; Moroz LL, 2006, J COMP NEUROL, V495, P10, DOI 10.1002/cne.20842; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; NAGAHAMA T, 1993, J NEUROPHYSIOL, V70, P1231, DOI 10.1152/jn.1993.70.3.1231; Nargeot R, 1999, J NEUROSCI, V19, P2261; RAYPORT SG, 1986, J NEUROSCI, V6, P759; ROSEN SC, 1991, J NEUROSCI, V11, P3630; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sasaki K, 2007, J NEUROPHYSIOL, V98, P3796, DOI 10.1152/jn.00965.2007; Schacher S, 1999, J NEUROSCI, V19, P6338; Scholz NL, 2001, J NEUROSCI, V21, P1610, DOI 10.1523/JNEUROSCI.21-05-01610.2001; SCHWARZ M, 1988, BEHAV NEUROSCI, V102, P124, DOI 10.1037/0735-7044.102.1.124; Staras K, 2003, CURR BIOL, V13, P116, DOI 10.1016/S0960-9822(02)01435-5; Straub VA, 2007, J NEUROPHYSIOL, V97, P1088, DOI 10.1152/jn.01048.2006; STUART DK, 1980, J NEUROPHYSIOL, V43, P499, DOI 10.1152/jn.1980.43.2.499; SUSSWEIN AJ, 1988, J NEUROSCI, V8, P2049; TEYKE T, 1990, SCIENCE, V247, P85, DOI 10.1126/science.2294596; WEISS KR, 1986, J NEUROSCI, V6, P2393; Ye XY, 2010, ACS CHEM NEUROSCI, V1, P182, DOI 10.1021/cn900016z	68	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17779	10.1371/journal.pone.0017779	http://dx.doi.org/10.1371/journal.pone.0017779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408021	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170900046
J	Dao, KK; Pey, AL; Gjerde, AU; Teigen, K; Byeon, IJL; Doskeland, SO; Gronenborn, AM; Martinez, A				Dao, Khanh K.; Pey, Angel L.; Gjerde, Anja Underhaug; Teigen, Knut; Byeon, In-Ja L.; Doskeland, Stein O.; Gronenborn, Angela M.; Martinez, Aurora			The Regulatory Subunit of PKA-I Remains Partially Structured and Undergoes beta-Aggregation upon Thermal Denaturation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; DIFFERENTIAL SCANNING CALORIMETRY; CIRCULAR-DICHROISM SPECTRA; AMYLOID FIBRIL; STRUCTURE REVEALS; ESCHERICHIA-COLI; BINDING-SITES; FORCE-FIELD; CAMP; STABILITY	Background: The regulatory subunit (R) of cAMP-dependent protein kinase (PKA) is a modular flexible protein that responds with large conformational changes to the binding of the effector cAMP. Considering its highly dynamic nature, the protein is rather stable. We studied the thermal denaturation of full-length RI alpha and a truncated RIa(92-381) that contains the tandem cyclic nucleotide binding (CNB) domains A and B. Methodology/Principal Findings: As revealed by circular dichroism (CD) and differential scanning calorimetry, both RIa proteins contain significant residual structure in the heat-denatured state. As evidenced by CD, the predominantly alpha-helical spectrum at 25 degrees C with double negative peaks at 209 and 222 nm changes to a spectrum with a single negative peak at 212-216 nm, characteristic of beta-structure. A similar alpha ->beta transition occurs at higher temperature in the presence of cAMP. Thioflavin T fluorescence and atomic force microscopy studies support the notion that the structural transition is associated with cross-beta-intermolecular aggregation and formation of non-fibrillar oligomers. Conclusions/Significance: Thermal denaturation of RIa leads to partial loss of native packing with exposure of aggregation-prone motifs, such as the B' helices in the phosphate-binding cassettes of both CNB domains. The topology of the beta-sandwiches in these domains favors inter-molecular beta-aggregation, which is suppressed in the ligand-bound states of RI alpha under physiological conditions. Moreover, our results reveal that the CNB domains persist as structural cores through heat-denaturation.	[Dao, Khanh K.; Gjerde, Anja Underhaug; Teigen, Knut; Doskeland, Stein O.; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway; [Pey, Angel L.] Univ Granada, Fac Ciencias, Dept Quim Fis, Granada, Spain; [Byeon, In-Ja L.; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA USA	University of Bergen; University of Granada; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dao, KK (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	aurora.martinez@biomed.uib.no	Teigen, Knut/K-3934-2012; Martinez, Aurora/M-3088-2019	Teigen, Knut/0000-0002-7031-9215; Martinez, Aurora/0000-0003-1643-6506; Pey, Angel Luis/0000-0001-7706-3243; Gronenborn, Angela M/0000-0001-9072-3525; Doskeland, Stein Ove/0000-0002-4009-4756	Research Council of Norway; Norwegian Cancer Society; Spanish Ministry of Sciences and Innovation (MICINN)	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Spanish Ministry of Sciences and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was financed in part with grants from The Research Council of Norway and the Norwegian Cancer Society (to AM and SOD). ALP is supported by a Ramon y Cajal research contract from the Spanish Ministry of Sciences and Innovation (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar MS, 2002, BIOCHEMISTRY-US, V41, P3819, DOI 10.1021/bi0116700; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aoki R, 2009, J AGR FOOD CHEM, V57, P4995, DOI 10.1021/jf900168y; Arutyunyan AM, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1378, DOI 10.1023/A:1013337930104; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Byeon IJL, 2010, J BIOL CHEM, V285, P14062, DOI 10.1074/jbc.M110.106666; Canaves JM, 2000, BIOCHEMISTRY-US, V39, P15022, DOI 10.1021/bi001563q; CARNEY JA, 1995, DERMATOL CLIN, V13, P19, DOI 10.1016/S0733-8635(18)30102-5; Carrell RW, 2005, TRENDS CELL BIOL, V15, P574, DOI 10.1016/j.tcb.2005.09.005; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiti F, 1999, P NATL ACAD SCI USA, V96, P3590, DOI 10.1073/pnas.96.7.3590; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Day R, 2002, J MOL BIOL, V322, P189, DOI 10.1016/S0022-2836(02)00672-1; del Pino IMP, 2000, PROTEINS, V40, P58, DOI 10.1002/(SICI)1097-0134(20000701)40:1<58::AID-PROT80>3.0.CO;2-M; Deu E, 2007, BIOCHEMISTRY-US, V46, P5810, DOI 10.1021/bi602621t; DOSKELAND SO, 1984, J BIOL CHEM, V259, P2291; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fandrich M, 2002, EMBO J, V21, P5682, DOI 10.1093/emboj/cdf573; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Ferguson N, 2005, J MOL BIOL, V347, P855, DOI 10.1016/j.jmb.2004.12.061; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Greene EL, 2008, HUM MUTAT, V29, P633, DOI 10.1002/humu.20688; Hamada D, 2002, PROTEIN SCI, V11, P2417, DOI 10.1110/ps.0217702; HAYNIE DT, 1993, PROTEINS, V16, P115, DOI 10.1002/prot.340160202; Hilser VJ, 1996, PROTEINS, V26, P123, DOI 10.1002/(SICI)1097-0134(199610)26:2<123::AID-PROT2>3.0.CO;2-H; HOLM L, 1994, PROTEIN ENG, V7, P1449, DOI 10.1093/protein/7.12.1449; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; Kannan N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r264; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kopperud R, 2002, J BIOL CHEM, V277, P13443, DOI 10.1074/jbc.M109869200; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; LEON DA, 1991, BIOCHEMISTRY-US, V30, P3035, DOI 10.1021/bi00226a008; Leon DA, 2000, BIOCHEMISTRY-US, V39, P5662, DOI 10.1021/bi992819z; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Louis JM, 2005, J MOL BIOL, V348, P687, DOI 10.1016/j.jmb.2005.02.071; Luque I, 1998, PROTEINS, V30, P74, DOI 10.1002/(SICI)1097-0134(199801)30:1<74::AID-PROT7>3.3.CO;2-G; Manno M, 2006, BIOPHYS J, V90, P4585, DOI 10.1529/biophysj.105.077636; Mauro M, 2007, J MOL BIOL, V366, P258, DOI 10.1016/j.jmb.2006.11.008; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; PoteetSmith CE, 1997, J BIOL CHEM, V272, P379; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Sancho J, 2006, CELL MOL LIFE SCI, V63, P855, DOI 10.1007/s00018-005-5514-4; Shrivastava R, 2007, INT J BIOL MACROMOL, V41, P154, DOI 10.1016/j.ijbiomac.2007.01.010; Soldi G, 2008, J AM CHEM SOC, V130, P4295, DOI 10.1021/ja076628s; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Tang KES, 1998, J BIOMOL STRUCT DYN, V16, P397, DOI 10.1080/07391102.1998.10508256; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Vetri V, 2007, BIOPHYS CHEM, V125, P184, DOI 10.1016/j.bpc.2006.07.012; Vigil D, 2006, PROTEIN SCI, V15, P113, DOI 10.1110/ps.051723606; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055	68	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17602	10.1371/journal.pone.0017602	http://dx.doi.org/10.1371/journal.pone.0017602			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394209	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000288025500018
J	Neeb, L; Hellen, P; Boehnke, C; Hoffmann, J; Schuh-Hofer, S; Dirnagl, U; Reuter, U				Neeb, Lars; Hellen, Peter; Boehnke, Carsten; Hoffmann, Jan; Schuh-Hofer, Sigrid; Dirnagl, Ulrich; Reuter, Uwe			IL-1 beta Stimulates COX-2 Dependent PGE(2) Synthesis and CGRP Release in Rat Trigeminal Ganglia Cells	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; NECROSIS-FACTOR-ALPHA; PRIMARY AFFERENT NEURONS; NITRIC-OXIDE SYNTHASE; MESSENGER-RNA LEVELS; DORSAL-ROOT GANGLIA; SUBSTANCE-P RELEASE; PROINFLAMMATORY CYTOKINES; PROSTAGLANDIN E-2; MIGRAINE PATIENTS	Objective: Pro-inflammatory cytokines like Interleukin-1 beta (IL-1 beta) have been implicated in the pathophysiology of migraine and inflammatory pain. The trigeminal ganglion and calcitonin gene-related peptide (CGRP) are crucial components in the pathophysiology of primary headaches. 5-HT1B/D receptor agonists, which reduce CGRP release, and cyclooxygenase (COX) inhibitors can abort trigeminally mediated pain. However, the cellular source of COX and the interplay between COX and CGRP within the trigeminal ganglion have not been clearly identified. Methods and Results: 1. We used primary cultured rat trigeminal ganglia cells to assess whether IL-1 beta can induce the expression of COX-2 and which cells express COX-2. Stimulation with IL-1 beta caused a dose and time dependent induction of COX-2 but not COX-1 mRNA. Immunohistochemistry revealed expression of COX-2 protein in neuronal and glial cells. 2. Functional significance was demonstrated by prostaglandin E2 (PGE(2)) release 4 hours after stimulation with IL-1 beta, which could be aborted by a selective COX-2 (parecoxib) and a non-selective COX-inhibitor (indomethacin). 3. Induction of CGRP release, indicating functional neuronal activation, was seen 1 hour after PGE(2) and 24 hours after IL-1 beta stimulation. Immunohistochemistry showed trigeminal neurons as the source of CGRP. IL-1 beta induced CGRP release was blocked by parecoxib and indomethacin, but the 5-HT1B/D receptor agonist sumatriptan had no effect. Conclusion: We identified a COX-2 dependent pathway of cytokine induced CGRP release in trigeminal ganglia neurons that is not affected by 5-HT1B/D receptor activation. Activation of neuronal and glial cells in the trigeminal ganglion by IL-beta leads to an elevated expression of COX-2 in these cells. Newly synthesized PGE(2) (by COX-2) in turn activates trigeminal neurons to release CGRP. These findings support a glia-neuron interaction in the trigeminal ganglion and demonstrate a sequential link between COX-2 and CGRP. The results could help to explain the mechanism of action of COX-2 inhibitors in migraine.	[Neeb, Lars; Hellen, Peter; Boehnke, Carsten; Hoffmann, Jan; Dirnagl, Ulrich; Reuter, Uwe] Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany; [Schuh-Hofer, Sigrid] Univ Klinikum Tubingen, Dept Neurol, Tubingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Neeb, L (corresponding author), Charite, Dept Neurol & Expt Neurol, D-13353 Berlin, Germany.	uwe.reuter@charite.de	Neeb, Lars/ABG-6683-2021; Hoffmann, Jan/AAP-8376-2020	Reuter, Uwe/0000-0002-8527-0725; Dirnagl, Ulrich/0000-0003-0755-6119	Bundesministerium fur Bildung und Forschung [BMBF 01EM 0515]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF 01EM 0515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACCAGLINI PI, 1983, P NATL ACAD SCI-BIOL, V80, P594, DOI 10.1073/pnas.80.2.594; Benarroch EE, 2005, MAYO CLIN PROC, V80, P1326, DOI 10.4065/80.10.1326; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Bruno PP, 2007, EUR REV MED PHARMACO, V11, P245; Capuano A, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-43; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; CUNHA FQ, 1992, BRIT J PHARMACOL, V107, P660, DOI 10.1111/j.1476-5381.1992.tb14503.x; Cunha JM, 2000, BRIT J PHARMACOL, V130, P1418, DOI 10.1038/sj.bjp.0703434; Damodaram S, 2009, HEADACHE, V49, P5, DOI 10.1111/j.1526-4610.2008.01262.x; Durham PL, 2006, HEADACHE, V46, P1291, DOI 10.1111/j.1526-4610.2006.00538.x; Durham PL, 1999, J NEUROSCI, V19, P3423; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Durham PL, 2004, HEADACHE, V44, P35, DOI 10.1111/j.1526-4610.2004.04007.x; Eberhardt M, 2009, NEUROPEPTIDES, V43, P483, DOI 10.1016/j.npep.2009.09.002; Ebersberger A, 1999, NEUROSCIENCE, V89, P901, DOI 10.1016/S0306-4522(98)00366-2; EDVINSSON L, 1989, J CEREBR BLOOD F MET, V9, P212, DOI 10.1038/jcbfm.1989.31; Eftekhari S, 2010, NEUROSCIENCE, V169, P683, DOI 10.1016/j.neuroscience.2010.05.016; Fanciullacci Marcello, 1995, Pain, V60, P119, DOI 10.1016/0304-3959(94)00097-X; Fehrenbacher JC, 2005, PAIN, V113, P113, DOI 10.1016/j.pain.2004.09.031; GOEBEL H, 2003, AKTUELLE NEUROLOG S1, P776; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Ho TW, 2008, LANCET, V372, P2115, DOI 10.1016/S0140-6736(08)61626-8; Hou LF, 2003, J NEUROSCI RES, V73, P188, DOI 10.1002/jnr.10651; Igwe OJ, 2001, NEUROSCIENCE, V105, P971, DOI 10.1016/S0306-4522(01)00253-6; Inoue A, 1999, J NEUROCHEM, V73, P2206; Ivanov AI, 2002, AM J PHYSIOL-REG I, V283, pR1104, DOI 10.1152/ajpregu.00347.2002; Jansen-Olesen I, 2005, BASIC CLIN PHARMACOL, V97, P355, DOI 10.1111/j.1742-7843.2005.pto_195.x; Jenkins DW, 2004, NEUROSCI LETT, V366, P241, DOI 10.1016/j.neulet.2004.05.067; Jenkins DW, 2001, BRIT J PHARMACOL, V134, P1296, DOI 10.1038/sj.bjp.0704357; Juhasz G, 2003, PAIN, V106, P461, DOI 10.1016/j.pain.2003.09.008; Kocer A, 2009, PAIN PRACT, V9, P375, DOI 10.1111/j.1533-2500.2009.00301.x; Kuris A, 2007, BRAIN RES, V1173, P6, DOI 10.1016/j.brainres.2007.07.073; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Li J, 2008, BRAIN RES, V1196, P22, DOI 10.1016/j.brainres.2007.12.028; Matsushita K, 2000, J NEUROSCI, V20, P6879, DOI 10.1523/JNEUROSCI.20-18-06879.2000; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Morioka N, 2002, NEUROPHARMACOLOGY, V43, P868, DOI 10.1016/S0028-3908(02)00143-0; OCONNOR TP, 1988, J NEUROSCI, V8, P2468; OKA T, 1995, BRAIN RES, V692, P123, DOI 10.1016/0006-8993(95)00691-I; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Perini F, 2005, HEADACHE, V45, P926, DOI 10.1111/j.1526-4610.2005.05135.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen M K, 2001, Curr Med Res Opin, V17 Suppl 1, ps26, DOI 10.1185/0300799039117012; Reuter U, 2001, BRAIN, V124, P2490, DOI 10.1093/brain/124.12.2490; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; SAFIEHGARABEDIAN B, 1995, BRIT J PHARMACOL, V115, P1265, DOI 10.1111/j.1476-5381.1995.tb15035.x; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Sarchielli P, 2006, HEADACHE, V46, P200, DOI 10.1111/j.1526-4610.2006.00337.x; Silberstein S, 2004, NEUROLOGY, V62, P1552, DOI 10.1212/01.WNL.0000123260.61631.C4; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Sommer C, 2004, NEUROSCI LETT, V361, P184, DOI 10.1016/j.neulet.2003.12.007; Storer RJ, 2004, BRIT J PHARMACOL, V142, P1171, DOI 10.1038/sj.bjp.0705807; Takeda M, 2007, PAIN, V129, P155, DOI 10.1016/j.pain.2006.10.007; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; UDDMAN R, 1985, NEUROSCI LETT, V62, P131, DOI 10.1016/0304-3940(85)90296-4; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007; Zimmermann K, 2003, PAIN, V103, P313, DOI 10.1016/S0304-3959(02)00459-1	59	97	106	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17360	10.1371/journal.pone.0017360	http://dx.doi.org/10.1371/journal.pone.0017360			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394197	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500011
J	Adekar, SP; Segan, AT; Chen, C; Bermudez, R; Elias, MD; Selling, BH; Kapadnis, BP; Simpson, LL; Simon, PM; Dessain, SK				Adekar, Sharad P.; Segan, Andrew T.; Chen, Cindy; Bermudez, Rodney; Elias, M. D.; Selling, Bernard H.; Kapadnis, B. P.; Simpson, Lance L.; Simon, Paul M.; Dessain, Scott K.			Enhanced Neutralization Potency of Botulinum Neurotoxin Antibodies Using a Red Blood Cell-Targeting Fusion Protein	PLOS ONE			English	Article							CLEARANCE; BINDING; TOXIN; RECEPTOR; SEROTYPE; IDENTIFICATION; STREPTAVIDIN; COMPLEMENT; MECHANISMS; VACCINE	Botulinum neurotoxin (BoNT) potently inhibits cholinergic signaling at the neuromuscular junction. The ideal countermeasures for BoNT exposure are monoclonal antibodies or BoNT antisera, which form BoNT-containing immune complexes that are rapidly cleared from the general circulation. Clearance of opsonized toxins may involve complement receptor-mediated immunoadherence to red blood cells (RBC) in primates or to platelets in rodents. Methods of enhancing immunoadherence of BoNT-specific antibodies may increase their potency in vivo. We designed a novel fusion protein (FP) to link biotinylated molecules to glycophorin A (GPA) on the RBC surface. The FP consists of an scFv specific for murine GPA fused to streptavidin. FP: mAb: BoNT complexes bound specifically to the RBC surface in vitro. In a mouse model of BoNT neutralization, the FP increased the potency of single and double antibody combinations in BoNT neutralization. A combination of two antibodies with the FP gave complete neutralization of 5,000 LD50 BoNT in mice. Neutralization in vivo was dependent on biotinylation of both antibodies and correlated with a reduction of plasma BoNT levels. In a post-exposure model of intoxication, FP: mAb complexes gave complete protection from a lethal BoNT/A1 dose when administered within 2 hours of toxin exposure. In a pre-exposure prophylaxis model, mice were fully protected for 72 hours following administration of the FP: mAb complex. These results demonstrate that RBC-targeted immunoadherence through the FP is a potent enhancer of BoNT neutralization by antibodies in vivo.	[Adekar, Sharad P.; Segan, Andrew T.; Chen, Cindy; Dessain, Scott K.] Lankenau Inst Med Res, Wynnewood, PA USA; [Adekar, Sharad P.; Bermudez, Rodney] Immunome Inc, Wynnewood, PA USA; [Elias, M. D.; Simpson, Lance L.] Thomas Jefferson Univ, Div Infect Dis & Environm Med, Philadelphia, PA 19107 USA; [Selling, Bernard H.] Impact Biol Inc, Wallingford, PA USA; [Kapadnis, B. P.] Univ Pune, Dept Microbiol, Pune, Maharashtra, India; [Adekar, Sharad P.; Simon, Paul M.] Augmenta Biol LLC, Wynnewood, PA USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; Savitribai Phule Pune University	Adekar, SP (corresponding author), Lankenau Inst Med Res, Wynnewood, PA USA.	simonpm@augmentabio.com; scott.dessain@gmail.com		Chen, Cindy/0000-0001-8796-7983	National Institutes of Health, NIAID [R01 AI065967]; Augmenta, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065967] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Augmenta, LLC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the National Institutes of Health, NIAID R01 AI065967 to S. K. D. and institutional support from the Lankenau Institute for Medical Research. Augmenta, LLC, provided support for PMS and contracted Impact Biologicals, Inc. for production of the FP. PMS, as a corresponding author, participated in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, HYBRIDOMA, V27, P11, DOI 10.1089/hyb.2007.0536; Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; Al-Saleem FH, 2008, J PHARMACOL EXP THER, V326, P856, DOI 10.1124/jpet.108.136242; Alexander JJ, 2001, J BIOL CHEM, V276, P32129, DOI 10.1074/jbc.M101299200; Arnon SS, 2006, NEW ENGL J MED, V354, P462, DOI 10.1056/NEJMoa051926; *CA DEP HLTH, 2009, SUMM BAS APPR BOT IM; CHASIS JA, 1992, BLOOD, V80, P1869; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; DAVIES KA, 1990, J IMMUNOL, V144, P4613; DAVIES KA, 1992, J CLIN INVEST, V90, P2075, DOI 10.1172/JCI116090; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Eubanks LM, 2007, P NATL ACAD SCI USA, V104, P2602, DOI 10.1073/pnas.0611213104; Lindorfer MA, 2001, IMMUNOL REV, V183, P10, DOI 10.1034/j.1600-065x.2001.1830102.x; Mazuet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012416; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; PAHLER A, 1987, J BIOL CHEM, V262, P13933; Pier CL, 2008, INFECT IMMUN, V76, P437, DOI 10.1128/IAI.00843-07; Ravichandran E, 2007, INFECT IMMUN, V75, P3043, DOI 10.1128/IAI.01893-06; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Rummel A, 2004, MOL MICROBIOL, V51, P631, DOI 10.1046/j.1365-2958.2003.03872.x; SANO T, 1990, J BIOL CHEM, V265, P3369; Sepulveda J, 2010, INFECT IMMUN, V78, P756, DOI 10.1128/IAI.01084-09; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Spitzer D, 2004, MOL IMMUNOL, V40, P911, DOI 10.1016/j.molimm.2003.10.017; Takahashi T, 2009, VACCINE, V27, P2616, DOI 10.1016/j.vaccine.2009.02.051; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Taylor RP, 1997, CANCER IMMUNOL IMMUN, V45, P152, DOI 10.1007/s002620050420	31	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17491	10.1371/journal.pone.0017491	http://dx.doi.org/10.1371/journal.pone.0017491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399689	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300027
J	Deng, M; Yu, CL; Liang, QA; He, RL; Yau, SST				Deng, Mo; Yu, Chenglong; Liang, Qian; He, Rong L.; Yau, Stephen S. -T.			A Novel Method of Characterizing Genetic Sequences: Genome Space with Biological Distance and Applications	PLOS ONE			English	Article							DNA-SEQUENCES; EVOLUTION; HUMANS; EMERGENCE; VIRUSES; H1	Background: Most existing methods for phylogenetic analysis involve developing an evolutionary model and then using some type of computational algorithm to perform multiple sequence alignment. There are two problems with this approach: (1) different evolutionary models can lead to different results, and (2) the computation time required for multiple alignments makes it impossible to analyse the phylogeny of a whole genome. This motivates us to create a new approach to characterize genetic sequences. Methodology: To each DNA sequence, we associate a natural vector based on the distributions of nucleotides. This produces a one-to-one correspondence between the DNA sequence and its natural vector. We define the distance between two DNA sequences to be the distance between their associated natural vectors. This creates a genome space with a biological distance which makes global comparison of genomes with same topology possible. We use our proposed method to analyze the genomes of the new influenza A (H1N1) virus, human rhinoviruses (HRV) and mammalian mitochondrial. The result shows that a triple-reassortant swine virus circulating in North America and the Eurasian swine virus belong to the lineage of the influenza A (H1N1) virus. For the HRV and mammalian mitochondrial genomes, the results coincide with biologists' analyses. Conclusions: Our approach provides a powerful new tool for analyzing and annotating genomes and their phylogenetic relationships. Whole or partial genomes can be handled more easily and more quickly than using multiple alignment methods. Once a genome space has been constructed, it can be stored in a database. There is no need to reconstruct the genome space for subsequent applications, whereas in multiple alignment methods, realignment is needed to add new sequences. Furthermore, one can make a global comparison of all genomes simultaneously, which no other existing method can achieve.	[Deng, Mo; Liang, Qian; Yau, Stephen S. -T.] Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA; [Yu, Chenglong] Chinese Univ Hong Kong, Inst Math Sci, Shatin, Hong Kong, Peoples R China; [He, Rong L.] Chicago State Univ, Dept Biol Sci, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chinese University of Hong Kong; Chicago State University	Deng, M (corresponding author), Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60680 USA.	yau@uic.edu		Yu, Chenglong/0000-0002-0546-2779	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM098180] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1120824] Funding Source: National Science Foundation; NIGMS NIH HHS [SC3 GM098180] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe T, 2003, GENOME RES, V13, P693, DOI 10.1101/gr.634603; AMANO K, 2003, GENOME INFORM, V14, P575; Belshe RB, 2009, NEW ENGL J MED, V360, P2667, DOI 10.1056/NEJMe0903995; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Carr K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009550; Chuzhanova NA, 1998, BIOINFORMATICS, V14, P139, DOI 10.1093/bioinformatics/14.2.139; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EMRICH SJ, 2006, HDB COMPUTATIONAL MO; FitzGerald PC, 2004, GENOME RES, V14, P1562, DOI 10.1101/gr.1953904; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kamimura T., 2003, GENOME INFORM, V14, P350, DOI [10.11234/gi1990.14.350., DOI 10.11234/GI1990.14.350]; KARLIN S, 1994, P NATL ACAD SCI USA, V91, P12832, DOI 10.1073/pnas.91.26.12832; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kingsford C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006402; Kou Z, 2009, CHINESE SCI BULL, V54, P2159, DOI 10.1007/s11434-009-0412-z; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu FGR, 2001, SCIENCE, V291, P1786, DOI 10.1126/science.1056346; Liu LB, 2006, MOL PHYLOGENET EVOL, V41, P64, DOI 10.1016/j.ympev.2006.05.019; Ma W, 2009, J MOL GENET MED, V3, P158; Murtagh F., 1985, COMPSTAT LECT, V4; Musto H, 1997, MEM I OSWALDO CRUZ, V92, P835, DOI 10.1590/S0074-02761997000600020; Nakashima H, 1998, DNA Res, V5, P251, DOI 10.1093/dnares/5.5.251; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Raina SZ, 2005, GENOME RES, V15, P665, DOI 10.1101/gr.3128605; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Wang L., 1994, J COMPUT BIOL, V13, P1323; Waterman S. M, 1995, INTRO COMPUTATIONAL; Yau SST, 2003, NUCLEIC ACIDS RES, V31, P3078, DOI 10.1093/nar/gkg432; Yau SST, 2008, DNA CELL BIOL, V27, P241, DOI 10.1089/dna.2007.0676; Yu CL, 2010, DNA RES, V17, P155, DOI 10.1093/dnares/dsq008	35	86	86	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17293	10.1371/journal.pone.0017293	http://dx.doi.org/10.1371/journal.pone.0017293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399690	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300015
J	Kyba, CCM; Ruhtz, T; Fischer, J; Holker, F				Kyba, Christopher C. M.; Ruhtz, Thomas; Fischer, Juergen; Hoelker, Franz			Cloud Coverage Acts as an Amplifier for Ecological Light Pollution in Urban Ecosystems	PLOS ONE			English	Article							NIGHT-SKY BRIGHTNESS; BREAST-CANCER; AT-NIGHT; BEHAVIOR; ZOOPLANKTON; MOONLIGHT; FLAGSTAFF; ARIZONA; FISH	The diurnal cycle of light and dark is one of the strongest environmental factors for life on Earth. Many species in both terrestrial and aquatic ecosystems use the level of ambient light to regulate their metabolism, growth, and behavior. The sky glow caused by artificial lighting from urban areas disrupts this natural cycle, and has been shown to impact the behavior of organisms, even many kilometers away from the light sources. It could be hypothesized that factors that increase the luminance of the sky amplify the degree of this "ecological light pollution''. We show that cloud coverage dramatically amplifies the sky luminance, by a factor of 10.1 for one location inside of Berlin and by a factor of 2.8 at 32 km from the city center. We also show that inside of the city overcast nights are brighter than clear rural moonlit nights, by a factor of 4.1. These results have important implications for choronobiological and chronoecological studies in urban areas, where this amplification effect has previously not been considered.	[Kyba, Christopher C. M.; Ruhtz, Thomas; Fischer, Juergen] Free Univ Berlin, Inst Space Sci, D-1000 Berlin, Germany; [Kyba, Christopher C. M.; Hoelker, Franz] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany	Free University of Berlin; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Kyba, CCM (corresponding author), Free Univ Berlin, Inst Space Sci, D-1000 Berlin, Germany.	christopher.kyba@wew.fu-berlin.de	Hölker, Franz/A-5683-2009; Kyba, Christopher CM/I-2014-2012; Ruhtz, Thomas/Z-5496-2019	Hölker, Franz/0000-0001-5932-266X; Kyba, Christopher CM/0000-0001-7014-1843; Ruhtz, Thomas/0000-0003-4646-3791	Federal Ministry of Education and Research, Germany [BMBF-033L038A]; MILIEU (FU Berlin)	Federal Ministry of Education and Research, Germany(Federal Ministry of Education & Research (BMBF)); MILIEU (FU Berlin)	This work was supported by the project Verlust der Nacht (funded by the Federal Ministry of Education and Research, Germany, BMBF-033L038A) and by MILIEU (FU Berlin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aube M., 2007, P STARL 2007 C PALM; Bender DJ, 1996, AM MIDL NAT, V136, P413, DOI 10.2307/2426745; Bergen F, 1997, J ORNITHOL, V138, P451, DOI 10.1007/BF01651380; Boscarino BT, 2009, AQUAT BIOL, V5, P263, DOI 10.3354/ab00161; Bramm ME, 2009, FRESHWATER BIOL, V54, P1093, DOI 10.1111/j.1365-2427.2008.02156.x; BUCHANAN BW, 1993, ANIM BEHAV, V45, P893, DOI 10.1006/anbe.1993.1109; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cinzano P., 2000, Memorie della Societa Astronomica Italiana, V71, P231; Cinzano P., 2005, 9 ISTIL; CLARKE JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P205, DOI 10.1007/BF00299924; Duriscoe DM, 2007, PUBL ASTRON SOC PAC, V119, P192, DOI 10.1086/512069; Eisenbeis Gerhard, 2001, Schriftenreihe fuer Landschaftspflege und Naturschutz, V67, P75; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Gannon MR, 1997, BIOTROPICA, V29, P525, DOI 10.1111/j.1744-7429.1997.tb00048.x; GARSTANG RH, 1989, PUBL ASTRON SOC PAC, V101, P306, DOI 10.1086/132436; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; Holker F, 2010, ECOL SOC, V15; Holker F, 2010, TRENDS ECOL EVOL, V25, P681, DOI 10.1016/j.tree.2010.09.007; Kantermann T, 2009, CHRONOBIOL INT, V26, P1069, DOI 10.1080/07420520903223984; Kloog I, 2008, CHRONOBIOL INT, V25, P65, DOI 10.1080/07420520801921572; Kocifaj M, 2010, MON NOT R ASTRON SOC, V403, P2105, DOI 10.1111/j.1365-2966.2010.16241.x; Kocifaj M, 2007, APPL OPTICS, V46, P3013, DOI 10.1364/AO.46.003013; Kokhanovsky A. A., 2005, LIGHT SCATTERING MED; Kokhanovsky AA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD001543; Kollath Z, 2010, J PHYS CONF SER, V218, DOI 10.1088/1742-6596/218/1/012001; Longcore T, 2004, FRONT ECOL ENVIRON, V2, P191, DOI 10.2307/3868314; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P185, DOI 10.1086/597625; Luginbuhl CB, 2009, PUBL ASTRON SOC PAC, V121, P204, DOI 10.1086/597626; Meeus JH., 1991, ASTRONOMICAL ALGORIT; Moore Marianne V., 2006, P365; Moore MV, 2000, VERH INT VER LIMNOL, V27, P779, DOI DOI 10.1080/03680770.1998.11901341; Moser JC, 2004, J ZOOL, V264, P69, DOI 10.1017/S0952836904005527; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; Petty G. W., 2006, 1 COURSE ATMOSPHERIC, V2; Reiter R.J., 2011, J EXP INTEGR MED, V1, P13, DOI DOI 10.5455/JEIM.101210.IR.001; Rich C., 2006, ECOLOGICAL CONSEQUEN; Salmon M, 1995, J HERPETOL, V29, P568, DOI 10.2307/1564740; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; SO CW, 2010, THESIS U HONG KONG; STEVENS RG, 1987, AM J EPIDEMIOL, V125, P556, DOI 10.1093/oxfordjournals.aje.a114569; Stevens RG, 2009, INT J EPIDEMIOL, V38, P963, DOI 10.1093/ije/dyp178; *UN, 2009, SKY QUAL MET LENS ET; Woods CP, 2008, WILSON J ORNITHOL, V120, P505, DOI 10.1676/06-067.1; Yela JL, 1997, ENVIRON ENTOMOL, V26, P1283, DOI 10.1093/ee/26.6.1283	45	182	183	4	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17307	10.1371/journal.pone.0017307	http://dx.doi.org/10.1371/journal.pone.0017307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399694	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300016
J	Wong, PG; Winter, SL; Zaika, E; Cao, TV; Oguz, U; Koomen, JM; Hamlin, JL; Alexandrow, MG				Wong, Philip G.; Winter, Sherry L.; Zaika, Elena; Cao, Thinh V.; Oguz, Umut; Koomen, John M.; Hamlin, Joyce L.; Alexandrow, Mark G.			Cdc45 Limits Replicon Usage from a Low Density of preRCs in Mammalian Cells	PLOS ONE			English	Article							ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACTS; MINICHROMOSOME MAINTENANCE PROTEINS; EUKARYOTIC DNA-REPLICATION; DIHYDROFOLATE-REDUCTASE ORIGIN; MCM PROTEINS; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; BUDDING YEAST	Little is known about mammalian preRC stoichiometry, the number of preRCs on chromosomes, and how this relates to replicon size and usage. We show here that, on average, each 100-kb of the mammalian genome contains a preRC composed of approximately one ORC hexamer, 4-5 MCM hexamers, and 2 Cdc6. Relative to these subunits, similar to 0.35 total molecules of the pre-Initiation Complex factor Cdc45 are present. Thus, based on ORC availability, somatic cells contain similar to 70,000 preRCs of this average total stoichiometry, although subunits may not be juxtaposed with each other. Except for ORC, the chromatin-bound complement of preRC subunits is even lower. Cdc45 is present at very low levels relative to the preRC subunits, but is highly stable, and the same limited number of stable Cdc45 molecules are present from the beginning of S-phase to its completion. Efforts to artificially increase Cdc45 levels through ectopic expression block cell growth. However, microinjection of excess purified Cdc45 into S-phase nuclei activates additional replication foci by threefold, indicating that Cdc45 functions to activate dormant preRCs and is rate-limiting for somatic replicon usage. Paradoxically, although Cdc45 colocalizes in vivo with some MCM sites and is rate-limiting for DNA replication to occur, neither Cdc45 nor MCMs colocalize with active replication sites. Embryonic metazoan chromatin consists of small replicons that are used efficiently via an excess of preRC subunits. In contrast, somatic mammalian cells contain a low density of preRCs, each containing only a few MCMs that compete for limiting amounts of Cdc45. This provides a molecular explanation why, relative to embryonic replicon dynamics, somatic replicons are, on average, larger and origin efficiency tends to be lower. The stable, continuous, and rate-limiting nature of Cdc45 suggests that Cdc45 contributes to the staggering of replicon usage throughout S-phase, and that replicon activation requires reutilization of existing Cdc45 during S-phase.	[Wong, Philip G.; Winter, Sherry L.; Cao, Thinh V.; Koomen, John M.; Alexandrow, Mark G.] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Oguz, Umut; Koomen, John M.] H Lee Moffitt Canc Ctr & Res Inst, Prote Facil, Tampa, FL USA; [Zaika, Elena; Hamlin, Joyce L.] Univ Virginia, Charlottesville, VA USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Virginia	Wong, PG (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA.	Mark.Alexandrow@Moffitt.org	Koomen, John/D-1844-2013		Bankhead-Coley; Florida Department of Health [06BS-02-9614]; Analytic Microscopy Facility at Moffitt; NIH [GM26108]; Florida Department of Health; James and Esther King Foundation [06-NIR-01]; NCI [CA130865]; NATIONAL CANCER INSTITUTE [R01CA130865, P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026108] Funding Source: NIH RePORTER	Bankhead-Coley; Florida Department of Health; Analytic Microscopy Facility at Moffitt; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; James and Esther King Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Proteomics Facility is supported by the National Functional Genomics Center (DAMD17-02-2-0051), the NCI (P30-CA076292), and the Moffitt Foundation. The triple quadrupole mass spectrometer was purchased with funds from Bankhead-Coley and the Florida Department of Health (06BS-02-9614). This work was supported in part by the Analytic Microscopy Facility at Moffitt. Additional funding was provided by the NIH (to J. L. Hamlin; GM26108), the Florida Department of Health and James and Esther King Foundation (to M. G. Alexandrow; 06-NIR-01), and the NCI (to M. G. Alexandrow; CA130865). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrow MG, 2005, J CELL BIOL, V168, P875, DOI 10.1083/jcb.200409055; Alexandrow MG, 2004, MOL CELL BIOL, V24, P1614, DOI 10.1128/MCB.24.4.1614-1627.2004; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, GENE DEV, V16, P659, DOI 10.1101/gad.969602; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; BLOW JJ, 1989, J CELL SCI, P183; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Blow JJ, 2001, EMBO J, V20, P3293, DOI 10.1093/emboj/20.13.3293; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; BURKHART R, 1995, EUR J BIOCHEM, V228, P431; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Dhar SK, 2001, CELL, V106, P287, DOI 10.1016/S0092-8674(01)00458-5; DIJKWEL PA, 1994, NUCLEIC ACIDS RES, V22, P4989, DOI 10.1093/nar/22.23.4989; Dijkwel PA, 2000, EXP CELL RES, V256, P150, DOI 10.1006/excr.2000.4809; DIJKWEL PA, 1995, MOL CELL BIOL, V15, P3023; Dijkwel PA, 2002, MOL CELL BIOL, V22, P3053, DOI 10.1128/MCB.22.9.3053-3065.2002; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Groth A, 2007, SCIENCE, V318, P1928, DOI 10.1126/science.1148992; Harlow E., 1988, ANTIBODIES LAB MANUA; Harvey KJ, 2003, MOL CELL BIOL, V23, P6769, DOI 10.1128/MCB.23.19.6769-6779.2003; Hiraiwa A, 1997, INT J CANCER, V74, P180, DOI 10.1002/(SICI)1097-0215(19970422)74:2<180::AID-IJC7>3.3.CO;2-E; Hua XQH, 1998, J CELL BIOL, V140, P271, DOI 10.1083/jcb.140.2.271; HUBERMAN JA, 1966, P NATL ACAD SCI USA, V55, P599, DOI 10.1073/pnas.55.3.599; HUBERMAN JA, 1995, CELL, V82, P535, DOI 10.1016/0092-8674(95)90025-X; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1996, J BIOL CHEM, V271, P24115, DOI 10.1074/jbc.271.39.24115; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Krude T, 1996, J CELL SCI, V109, P309; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Labib K, 1999, NAT CELL BIOL, V1, P415, DOI 10.1038/15649; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Lee C, 2010, MOL CELL BIOL, V30, P423, DOI 10.1128/MCB.01240-09; Lei M, 1996, MOL CELL BIOL, V16, P5081; MADINE MA, 1995, CURR BIOL, V5, P1270, DOI 10.1016/S0960-9822(95)00253-3; MAHBUBANI HM, 1992, NUCLEIC ACIDS RES, V20, P1457, DOI 10.1093/nar/20.7.1457; Mahbubani HM, 1997, J CELL BIOL, V136, P125, DOI 10.1083/jcb.136.1.125; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mesner LD, 2006, MOL CELL, V21, P719, DOI 10.1016/j.molcel.2006.01.015; Nguyen VQ, 2000, CURR BIOL, V10, P195, DOI 10.1016/S0960-9822(00)00337-7; Norio P, 2005, MOL CELL, V20, P575, DOI 10.1016/j.molcel.2005.10.029; Oehlmann M, 2004, J CELL BIOL, V165, P181, DOI 10.1083/jcb.200311044; Okuno Y, 2001, EMBO J, V20, P4263, DOI 10.1093/emboj/20.15.4263; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Pollok S, 2007, FEBS J, V274, P3669, DOI 10.1111/j.1742-4658.2007.05900.x; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ritzi M, 1998, J BIOL CHEM, V273, P24543, DOI 10.1074/jbc.273.38.24543; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Santocanale C, 1996, EMBO J, V15, P6671, DOI 10.1002/j.1460-2075.1996.tb01057.x; Schulte D, 1996, EUR J BIOCHEM, V235, P144, DOI 10.1111/j.1432-1033.1996.00144.x; Sun W, 2000, J CELL SCI, V113, P683; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Todovov IT, 1998, LAB INVEST, V78, P73; Trivedi A, 1998, DNA CELL BIOL, V17, P885, DOI 10.1089/dna.1998.17.885; Vashee S, 2003, GENE DEV, V17, P1894, DOI 10.1101/gad.1084203; VAUGHN JP, 1990, CELL, V61, P1075, DOI 10.1016/0092-8674(90)90071-L; Waiter J, 1997, SCIENCE, V275, P993, DOI 10.1126/science.275.5302.993; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Winter Sherry L., 2009, V523, P27, DOI 10.1007/978-1-59745-190-1_3; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; You ZY, 1999, MOL CELL BIOL, V19, P8003; ZIMM S, 1985, CANCER RES, V45, P4156	81	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17533	10.1371/journal.pone.0017533	http://dx.doi.org/10.1371/journal.pone.0017533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390258	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100022
J	Yu, FY; Chen, QA; Yu, XJ; Li, QQ; Ding, BX; Yang, LH; Chen, C; Qin, ZQ; Parsons, C; Zhang, XQ; Huang, JW; Luo, Y; Wang, LX; Pan, JY				Yu, Fangyou; Chen, Qiang; Yu, Xiaojun; Li, Qiaoqiao; Ding, Baixing; Yang, Lehe; Chen, Cong; Qin, Zhiqiang; Parsons, Chris; Zhang, Xueqing; Huang, Jinwei; Luo, Yun; Wang, Liangxing; Pan, Jingye			High Prevalence of Extended-Spectrum Beta Lactamases among Salmonella enterica Typhimurium Isolates from Pediatric Patients with Diarrhea in China	PLOS ONE			English	Article							GENOTYPE DISTRIBUTION; SEROVAR ENTERITIDIS; ESCHERICHIA-COLI; RESISTANCE; EMERGENCE; GENES; CTX-M-15; OUTBREAK	We investigated the extended-spectrum beta lactamases among 62 Salmonella enterica Typhimurium isolates recovered from children with diarrhea in a Chinese pediatric hospital. A large proportion of S. enterica Typhimurium isolates were resistant to multiple antimicrobial agents, including ampicillin (90.3%), tetracycline (80.6%), trimethoprim/sulfamethoxazole (74.2%), chloramphenicol (66.1%), cefotaxime (27.4%). Forty-nine (79.0%) of S. enterica Typhimurium isolates were positive for bla(TEM-1b) and resistant to ampicillin. Thirteen S. enterica Typhimurium isolates (21.0%) were positive for bla(CTX-M-1-group) and bla(CTX-M-9-group), and all isolates harboring bla(CTX-M) genes were positive for ISEcp1. Two main clones (PFGE type A and D) accounted for nearly 70% of S. enterica Typhimurium isolates, and 7 CTX-M-producing isolates belonged to PFGE type D. Collectively, our data reveal multi-drug resistance and a high prevalence of extended spectrum beta lactamases among S. enterica Typhimurium isolates from children in China. In addition, we report the first identification of bla(CTX-M-55) within Salmonella spp. Our data also suggest that clonal spread is responsible for the dissemination of S. enterica Typhimurium isolates.	[Yu, Fangyou; Zhang, Xueqing] Wenzhou Med Coll, Dept Lab Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Chen, Qiang; Yu, Xiaojun] Jiangxi Prov Children Hosp, Dept Lab Med, Nanchang, Peoples R China; [Li, Qiaoqiao; Yang, Lehe; Wang, Liangxing] Wenzhou Med Coll, Dept Resp Med, Affiliated Hosp 1, Wenzhou, Peoples R China; [Ding, Baixing; Chen, Cong; Pan, Jingye] Wenzhou Med Coll, Dept Intens Care Unit, Affiliated Hosp 1, Wenzhou, Peoples R China; [Qin, Zhiqiang; Parsons, Chris] Med Univ S Carolina, Dept Med, Div Infect Dis, Charleston, SC 29425 USA; [Huang, Jinwei] Lishui Ctr Hosp, Dept Lab Med, Lishui, Peoples R China; [Luo, Yun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Microbiol, Hangzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Medical University of South Carolina; Zhejiang Provincial Center for Disease Control & Prevention	Yu, FY (corresponding author), Wenzhou Med Coll, Dept Lab Med, Affiliated Hosp 1, Wenzhou, Peoples R China.	wzyxywlx@163.com; 081101072@fudan.edu.cn	Chen, Qiang/AAC-3689-2019; chen, qiang/GWZ-7308-2022; Chen, Qiang/GRJ-2224-2022; chen, qiang/HGU-5418-2022	Chen, Qiang/0000-0001-8714-6819; 	Medical Science Fund of Jiangxi Province, China [20094009, 20091256]	Medical Science Fund of Jiangxi Province, China	This work was supported by Medical Science Fund of Jiangxi Province, China (20094009; 20091256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelGhani SMM, 2010, J INFECT DEV COUNTR, V4, P58, DOI 10.3855/jidc.386; Archambault M, 2006, MICROB DRUG RESIST, V12, P192, DOI 10.1089/mdr.2006.12.192; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bouallegue-Godet O, 2005, J CLIN MICROBIOL, V43, P1037, DOI 10.1128/JCM.43.3.1037-1044.2005; Cheung TKM, 2005, J ANTIMICROB CHEMOTH, V56, P586, DOI 10.1093/jac/dki250; Chyou S C, 1988, Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi, V29, P213; *CLSI, 2008, PERF STAND ANT SUSC; Cui SH, 2009, J ANTIMICROB CHEMOTH, V63, P87, DOI 10.1093/jac/dkn452; Gonzalez-Sanz R, 2009, J ANTIMICROB CHEMOTH, V64, P1181, DOI 10.1093/jac/dkp361; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hamidian M, 2009, JPN J INFECT DIS, V62, P368; Izumiya H, 2005, ANTIMICROB AGENTS CH, V49, P2568, DOI 10.1128/AAC.49.6.2568-2570.2005; Jiang XF, 2005, J CLIN MICROBIOL, V43, P826, DOI 10.1128/JCM.43.2.826-831.2005; Kiratisin P, 2007, DIAGN MICR INFEC DIS, V58, P349, DOI 10.1016/j.diagmicrobio.2007.02.005; Li WC, 2005, J CLIN MICROBIOL, V43, P3237, DOI 10.1128/JCM.43.7.3237-3243.2005; Liu WE, 2009, J ANTIMICROB CHEMOTH, V63, P895, DOI 10.1093/jac/dkp068; Rotimi VO, 2008, J MED MICROBIOL, V57, P881, DOI 10.1099/jmm.0.47509-0; Shi WF, 2009, CHINESE MED J-PEKING, V122, P1092, DOI 10.3760/cma.j.issn.0366-6999.2009.09.015; SUN Y, 2009, CLIN MICROBIOL INFEC; Touati A, 2008, PEDIATR INFECT DIS J, V27, P479, DOI 10.1097/INF.0b013e31816a35bd; Usha G, 2008, DIAGN MICR INFEC DIS, V62, P86, DOI 10.1016/j.diagmicrobio.2008.04.014; Verdet C, 2000, ANTIMICROB AGENTS CH, V44, P222, DOI 10.1128/AAC.44.1.222-225.2000; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Xia SL, 2009, J CLIN MICROBIOL, V47, P401, DOI 10.1128/JCM.01099-08; Yin J, 2009, J MED MICROBIOL, V58, P811, DOI 10.1099/jmm.0.006007-0; Yu YS, 2007, J INFECTION, V54, P53, DOI 10.1016/j.jinf.2006.01.014	27	26	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16801	10.1371/journal.pone.0016801	http://dx.doi.org/10.1371/journal.pone.0016801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390297	Green Published, Green Submitted, gold			2022-12-27	WOS:000287932100004
J	Isella, L; Romano, M; Barrat, A; Cattuto, C; Colizza, V; Van den Broeck, W; Gesualdo, F; Pandolfi, E; Rava, L; Rizzo, C; Tozzi, AE				Isella, Lorenzo; Romano, Mariateresa; Barrat, Alain; Cattuto, Ciro; Colizza, Vittoria; Van den Broeck, Wouter; Gesualdo, Francesco; Pandolfi, Elisabetta; Rava, Lucilla; Rizzo, Caterina; Tozzi, Alberto Eugenio			Close Encounters in a Pediatric Ward: Measuring Face-to-Face Proximity and Mixing Patterns with Wearable Sensors	PLOS ONE			English	Article							NOSOCOMIAL INFECTIONS; PANDEMIC INFLUENZA; SOCIAL CONTACTS; TRANSMISSION; SPREAD; MODELS	Background: Nosocomial infections place a substantial burden on health care systems and represent one of the major issues in current public health, requiring notable efforts for its prevention. Understanding the dynamics of infection transmission in a hospital setting is essential for tailoring interventions and predicting the spread among individuals. Mathematical models need to be informed with accurate data on contacts among individuals. Methods and Findings: We used wearable active Radio-Frequency Identification Devices (RFID) to detect face-to-face contacts among individuals with a spatial resolution of about 1.5 meters, and a time resolution of 20 seconds. The study was conducted in a general pediatrics hospital ward, during a one-week period, and included 119 participants, with 51 health care workers, 37 patients, and 31 caregivers. Nearly 16,000 contacts were recorded during the study period, with a median of approximately 20 contacts per participants per day. Overall, 25% of the contacts involved a ward assistant, 23% a nurse, 22% a patient, 22% a caregiver, and 8% a physician. The majority of contacts were of brief duration, but long and frequent contacts especially between patients and caregivers were also found. In the setting under study, caregivers do not represent a significant potential for infection spread to a large number of individuals, as their interactions mainly involve the corresponding patient. Nurses would deserve priority in prevention strategies due to their central role in the potential propagation paths of infections. Conclusions: Our study shows the feasibility of accurate and reproducible measures of the pattern of contacts in a hospital setting. The obtained results are particularly useful for the study of the spread of respiratory infections, for monitoring critical patterns, and for setting up tailored prevention strategies. Proximity-sensing technology should be considered as a valuable tool for measuring such patterns and evaluating nosocomial prevention strategies in specific settings.	[Isella, Lorenzo; Barrat, Alain; Cattuto, Ciro; Colizza, Vittoria; Van den Broeck, Wouter] Inst Sci Interchange Fdn, Complex Networks & Syst Grp, Turin, Italy; [Romano, Mariateresa; Gesualdo, Francesco; Pandolfi, Elisabetta; Rava, Lucilla; Tozzi, Alberto Eugenio] Bambino Gesu Pediat Hosp, Epidemiol Unit, Rome, Italy; [Barrat, Alain] CNRS, UMR 6207, Ctr Phys Theor Marseille, Marseille, France; [Rizzo, Caterina] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, I-00161 Rome, Italy	IRCCS Bambino Gesu; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Istituto Superiore di Sanita (ISS)	Isella, L (corresponding author), Inst Sci Interchange Fdn, Complex Networks & Syst Grp, Turin, Italy.	alberto.tozzi@gmail.com	Tozzi, Alberto Eugenio/F-9494-2012; Rizzo, Caterina/H-4092-2012; Gesualdo, Francesco/H-9221-2012; Romano, Mariateresa/AAA-6160-2020; Pandolfi, Elisabetta/K-5173-2016	Tozzi, Alberto Eugenio/0000-0002-6884-984X; Rizzo, Caterina/0000-0002-5583-7508; Gesualdo, Francesco/0000-0002-9087-4398; Colizza, Vittoria/0000-0002-2113-2374; Isella, Lorenzo/0000-0001-9525-4123; Pandolfi, Elisabetta/0000-0003-2424-2736	Italian Ministry of Health [1M22]; EC [233847]; ERC [ERC-2007-Stg204863]	Italian Ministry of Health(Ministry of Health, Italy); EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission)	This work has been partially supported by the Italian Ministry of Health (Grant n. 1M22) to C. R., A. T. and C. C.; by the EC FET-Open project DYNANETS (contract number 233847) to L. I. and V. C.; and by the ERC Ideas grant EpiFor (contract no. ERC-2007-Stg204863) to V. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alani H, 2009, LECT NOTES COMPUT SC, V5823, P698, DOI 10.1007/978-3-642-04930-9_44; ANDERSON R M, 1991; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Bernard H, 2009, EMERG INFECT DIS, V15, P1438, DOI 10.3201/eid1509.081475; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Cavalcante SS, 2006, PEDIATR INFECT DIS J, V25, P438, DOI 10.1097/01.inf.0000217377.54597.92; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Donker T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000715; Edmunds WJ, 2006, EMERG THEMES EPIDEMI, V3, DOI 10.1186/1742-7622-3-10; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Halloran ME, 2006, AM J EPIDEMIOL, V164, P945, DOI 10.1093/aje/kwj318; *IT HLTH MIN, 2009, NUOV INFL A H1N1; Kazandjieva M., 2010, ACM WORKSH HOT TOP E; Kretzschmar M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005931; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Muller MP, 2006, CURR OPIN CRIT CARE, V12, P37, DOI 10.1097/01.ccx.0000198056.58083.a1; Ogunjimi B, 2009, MATH BIOSCI, V218, P80, DOI 10.1016/j.mbs.2008.12.009; OLGUIN O, 2009, 3 INT C PERV COMP TE; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; *SOCIOPATTERNS, SOCIOPATTERN PROJ; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; *WHO, 2002, WHOCDSCSREPH200212; Zagheni E, 2008, AM J EPIDEMIOL, V168, P1082, DOI 10.1093/aje/kwn220	35	140	144	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17144	10.1371/journal.pone.0017144	http://dx.doi.org/10.1371/journal.pone.0017144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386902	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400032
J	McGowan, PO; Suderman, M; Sasaki, A; Huang, TCT; Hallett, M; Meaney, MJ; Szyf, M				McGowan, Patrick O.; Suderman, Matthew; Sasaki, Aya; Huang, Tony C. T.; Hallett, Michael; Meaney, Michael J.; Szyf, Moshe			Broad Epigenetic Signature of Maternal Care in the Brain of Adult Rats	PLOS ONE			English	Article							RECEPTOR SUBUNIT EXPRESSION; LONG-TERM POTENTIATION; DE-NOVO METHYLATION; PROTOCADHERIN-ALPHA; DNA METHYLATION; ENVIRONMENTAL ENRICHMENT; GLUCOCORTICOID-RECEPTOR; STRESS RESPONSES; MESSENGER-RNA; BREAST-CANCER	Background: Maternal care is associated with long-term effects on behavior and epigenetic programming of the NR3C1 (GLUCOCORTICOID RECEPTOR) gene in the hippocampus of both rats and humans. In the rat, these effects are reversed by cross-fostering, demonstrating that they are defined by epigenetic rather than genetic processes. However, epigenetic changes at a single gene promoter are unlikely to account for the range of outcomes and the persistent change in expression of hundreds of additional genes in adult rats in response to differences in maternal care. Methodology/Principal Findings: We examine here using high-density oligonucleotide array the state of DNA methylation, histone acetylation and gene expression in a 7 million base pair region of chromosome 18 containing the NR3C1 gene in the hippocampus of adult rats. Natural variations in maternal care are associated with coordinate epigenetic changes spanning over a hundred kilobase pairs. The adult offspring of high compared to low maternal care mothers show epigenetic changes in promoters, exons, and gene ends associated with higher transcriptional activity across many genes within the locus examined. Other genes in this region remain unchanged, indicating a clustered yet specific and patterned response. Interestingly, the chromosomal region containing the protocadherin-alpha, -beta, and -gamma (Pcdh) gene families implicated in synaptogenesis show the highest differential response to maternal care. Conclusions/Significance: The results suggest for the first time that the epigenetic response to maternal care is coordinated in clusters across broad genomic areas. The data indicate that the epigenetic response to maternal care involves not only single candidate gene promoters but includes transcriptional and intragenic sequences, as well as those residing distantly from transcription start sites. These epigenetic and transcriptional profiles constitute the first tiling microarray data set exploring the relationship between epigenetic modifications and RNA expression in both protein coding and non-coding regions across a chromosomal locus in the mammalian brain.	[McGowan, Patrick O.; Sasaki, Aya; Meaney, Michael J.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [McGowan, Patrick O.; Suderman, Matthew; Sasaki, Aya; Meaney, Michael J.; Szyf, Moshe] McGill Univ, Sackler Program Epigenet & Dev Psychobiol, Montreal, PQ, Canada; [McGowan, Patrick O.; Sasaki, Aya] Univ Toronto, Ctr Neurobiol Stress, Toronto, ON, Canada; [Suderman, Matthew; Huang, Tony C. T.; Szyf, Moshe] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Suderman, Matthew; Hallett, Michael] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ, Canada; [Meaney, Michael J.] Singapore Inst Clin Sci, Singapore, Singapore; [Meaney, Michael J.; Szyf, Moshe] Canadian Inst Adv Res, Experience Based Brain & Biol Dev Program, Toronto, ON, Canada	McGill University; University of Toronto; McGill University; McGill University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); Canadian Institute for Advanced Research (CIFAR)	McGowan, PO (corresponding author), Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	patrick.mcgowan@utoronto.ca; moshe.szyf@mcgill.ca	Meaney, Michael/N-5931-2019	Suderman, Matthew/0000-0002-2715-9930; Hallett, Michael/0000-0001-6738-6786	Canadian Institutes of Mental Health (CIHR); Sackler Foundation	Canadian Institutes of Mental Health (CIHR)(Canadian Institutes of Health Research (CIHR)); Sackler Foundation	This study was supported by grants from the Canadian Institutes of Mental Health (CIHR) and the Sackler Foundation to MJM and MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bredy TW, 2004, EUR J NEUROSCI, V20, P1355, DOI 10.1111/j.1460-9568.2004.03599.x; Bredy TW, 2003, NEUROSCIENCE, V118, P571, DOI 10.1016/S0306-4522(02)00918-1; Bredy TW, 2003, EUR J NEUROSCI, V18, P2903, DOI 10.1111/j.1460-9568.2003.02965.x; Brown SE, 2008, CELL CYCLE, V7, P382, DOI 10.4161/cc.7.3.5283; Caldji C, 2003, NEUROPSYCHOPHARMACOL, V28, P1950, DOI 10.1038/sj.npp.1300237; Champagne DL, 2008, J NEUROSCI, V28, P6037, DOI 10.1523/JNEUROSCI.0526-08.2008; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Coldwell J, 2006, J CHILD PSYCHOL PSYC, V47, P1116, DOI 10.1111/j.1469-7610.2006.01655.x; COOLEN MW, NAT CELL BIOL, V12, P235; Crane-Robinson C, 1999, METHOD ENZYMOL, V304, P533; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Flanagan JM, 2009, HUM MOL GENET, V18, P1332, DOI 10.1093/hmg/ddp033; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Katori S, 2009, J NEUROSCI, V29, P9137, DOI 10.1523/JNEUROSCI.5478-08.2009; Kawaguchi M, 2008, J BIOL CHEM, V283, P12064, DOI 10.1074/jbc.M709648200; Kendler KS, 2002, AM J PSYCHIAT, V159, P1133, DOI 10.1176/appi.ajp.159.7.1133; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; KOROSI A, DEV PSYCHOBIOL, V52, P661; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; McCormick JA, 2000, MOL ENDOCRINOL, V14, P506, DOI 10.1210/me.14.4.506; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Menard JL, 2007, BEHAV BRAIN RES, V176, P302, DOI 10.1016/j.bbr.2006.10.014; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Nemeroff CB Charles B, 2004, Psychopharmacol Bull, V38, P14; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Ovtscharoff W, 2006, BRAIN RES, V1116, P58, DOI 10.1016/j.brainres.2006.07.106; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Poeggel G, 2003, P NATL ACAD SCI USA, V100, P16137, DOI 10.1073/pnas.2434663100; R Development Core Team, 2007, R LANG ENV STAT COMP; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; RIDEOUT WM, 1994, MOL CELL BIOL, V14, P6143, DOI 10.1128/MCB.14.9.6143; Sadikovic B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002834; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Smith DT, 2009, GENET RES, V91, P237, DOI 10.1017/S0016672309000226; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tang AC, 2002, HIPPOCAMPUS, V12, P398, DOI 10.1002/hipo.10017; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Toki S, 2007, EUR J NEUROSCI, V25, P815, DOI 10.1111/j.1460-9568.2007.05288.x; WAKSHLAK A, 1990, PHYSIOL BEHAV, V48, P289, DOI 10.1016/0031-9384(90)90315-U; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WILSON DA, 1986, BEHAV BRAIN RES, V21, P223, DOI 10.1016/0166-4328(86)90240-8; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Yagi T, 2008, DEV GROWTH DIFFER, V50, pS131, DOI 10.1111/j.1440-169X.2008.00991.x; Zou C, 2007, NEUROSCIENCE, V144, P579, DOI 10.1016/j.neuroscience.2006.10.011	57	283	286	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14739	10.1371/journal.pone.0014739	http://dx.doi.org/10.1371/journal.pone.0014739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386994	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400004
J	Zhang, HF; Liu, KY; Zhang, X; Tang, W; Wang, JS; Guo, M; Zhao, QA; Zheng, XB; Wang, P; Zhang, ZG				Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Wang, Ping; Zhang, Zhengguang			Two Phosphodiesterase Genes, PDEL and PDEH, Regulate Development and Pathogenicity by Modulating Intracellular Cyclic AMP Levels in Magnaporthe oryzae	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; RICE BLAST FUNGUS; AFFINITY CAMP-PHOSPHODIESTERASE; SACCHAROMYCES-CEREVISIAE MUTANT; CELL-WALL INTEGRITY; OXIDATIVE STRESS; NUCLEOTIDE PHOSPHODIESTERASE; CATALYTIC SUBUNIT; HYDROPHOBIN GENE; APPRESSORIUM FORMATION	Cyclic AMP (cAMP) signaling plays an important role in regulating multiple cellular responses, such as growth, morphogenesis, and/or pathogenicity of eukaryotic organisms such as fungi. As a second messenger, cAMP is important in the activation of downstream effector molecules. The balance of intracellular cAMP levels depends on biosynthesis by adenylyl cyclases (ACs) and hydrolysis by cAMP phosphodiesterases (PDEases). The rice blast fungus Magnaporthe oryzae contains a high-affinity (PdeH/Pde2) and a low-affinity (PdeL/Pde1) PDEases, and a previous study showed that PdeH has a major role in asexual differentiation and pathogenicity. Here, we show that PdeL is required for asexual development and conidial morphology, and it also plays a minor role in regulating cAMP signaling. This is in contrast to PdeH whose mutation resulted in major defects in conidial morphology, cell wall integrity, and surface hydrophobicity, as well as a significant reduction in pathogenicity. Consistent with both PdeH and PdeL functioning in cAMP signaling, disruption of PDEH only partially rescued the mutant phenotype of Delta magB and Delta pka1. Further studies suggest that PdeH might function through a feedback mechanism to regulate the expression of pathogenicity factor Mpg1 during surface hydrophobicity and pathogenic development. Moreover, microarray data revealed new insights into the underlying cAMP regulatory mechanisms that may help to identify potential pathogenicity factors for the development of new disease management strategies.	[Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China; [Zhang, Haifeng; Liu, Kaiyue; Zhang, Xing; Tang, Wei; Wang, Jiansheng; Guo, Min; Zhao, Qian; Zheng, Xiaobo; Zhang, Zhengguang] Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Hlth Sci Ctr, Res Inst Children, New Orleans, LA USA	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Dept Plant Pathol, Nanjing, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-scientific Research in the Public Interest [200803008]; Natural Science Foundations of China [30771394, 30971890]; Ministry of Education of China [NCET-07-0442]; US NIH/NIAID [AI054958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054958] Funding Source: NIH RePORTER	Special Fund for Agro-scientific Research in the Public Interest; Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (200803008 to ZG Zhang), the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng), and the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang). Research in Ping Wang lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Adachi K, 1998, PLANT CELL, V10, P1361, DOI 10.1105/tpc.10.8.1361; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Banno S, 2005, GENES GENET SYST, V80, P25, DOI 10.1266/ggs.80.25; BARNUN N, 1988, PHYTOCHEMISTRY, V27, P2505, DOI 10.1016/0031-9422(88)87018-3; BELLPEDERSEN D, 1992, GENE DEV, V6, P2382, DOI 10.1101/gad.6.12a.2382; Bencina M, 1997, MICROBIOL-SGM, V143, P1211, DOI 10.1099/00221287-143-4-1211; BRADLEY DJ, 1992, CELL, V70, P21, DOI 10.1016/0092-8674(92)90530-P; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Cabib E, 2001, J BIOL CHEM, V276, P19679, DOI 10.1074/jbc.R000031200; CHARBONNEAU H, 1986, P NATL ACAD SCI USA, V83, P9308, DOI 10.1073/pnas.83.24.9308; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; D'Angelo MA, 2004, BIOCHEM J, V378, P63, DOI 10.1042/BJ20031147; Daniel PB, 1998, ANNU REV NUTR, V18, P353, DOI 10.1146/annurev.nutr.18.1.353; Davey J, 1998, YEAST, V14, P1529, DOI 10.1002/(SICI)1097-0061(199812)14:16<1529::AID-YEA357>3.0.CO;2-0; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Dou XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016439; DUNLAP PV, 1993, J BACTERIOL, V175, P4615, DOI 10.1128/JB.175.15.4615-4624.1993; Durrenberger F, 1998, P NATL ACAD SCI USA, V95, P5684, DOI 10.1073/pnas.95.10.5684; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Fang EGC, 2000, MOL PLANT MICROBE IN, V13, P1214, DOI 10.1094/MPMI.2000.13.11.1214; Gold SE, 1997, PLANT CELL, V9, P1585, DOI 10.1105/tpc.9.9.1585; Grosse C, 2008, APPL ENVIRON MICROB, V74, P4923, DOI 10.1128/AEM.00470-08; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; HOYER LL, 1994, MICROBIOL-UK, V140, P1533, DOI 10.1099/13500872-140-7-1533; Ivey FD, 2002, EUKARYOT CELL, V1, P634, DOI 10.1128/EC.1.4.634-642.2002; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jones DL, 2004, COMP FUNCT GENOM, V5, P419, DOI 10.1002/cfg.415; Jones DL, 2003, PHYSIOL GENOMICS, V16, P107, DOI 10.1152/physiolgenomics.00139.2003; Jung WH, 2005, YEAST, V22, P285, DOI 10.1002/yea.1199; Kays AM, 2004, GENETICS, V166, P1229, DOI 10.1534/genetics.166.3.1229; Kays AM, 2000, MOL CELL BIOL, V20, P7693, DOI 10.1128/MCB.20.20.7693-7705.2000; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kunz S, 2004, EUR J BIOCHEM, V271, P637, DOI 10.1111/j.1432-1033.2003.03967.x; LACOMBE ML, 1986, J BIOL CHEM, V261, P6811; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Larraya LM, 2005, EUKARYOT CELL, V4, P2029, DOI 10.1128/EC.4.12.2029-2043.2005; Lauge R, 1997, MOL PLANT MICROBE IN, V10, P725, DOI 10.1094/MPMI.1997.10.6.725; LAUTER FR, 1992, GENE DEV, V6, P2373, DOI 10.1101/gad.6.12a.2373; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; LEE YH, 1993, PLANT CELL, V5, P693, DOI 10.1105/tpc.5.6.693; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liebmann B, 2003, MOL GENET GENOMICS, V269, P420, DOI 10.1007/s00438-003-0852-0; Lin CH, 2009, MOL PLANT MICROBE IN, V22, P942, DOI 10.1094/MPMI-22-8-0942; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Liu SH, 1997, MOL PLANT MICROBE IN, V10, P1075, DOI 10.1094/MPMI.1997.10.9.1075; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; Mei CS, 2006, MOL PLANT MICROBE IN, V19, P1127, DOI 10.1094/MPMI-19-1127; Meima ME, 2003, J BIOL CHEM, V278, P14356, DOI 10.1074/jbc.M209648200; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Oh Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r85; Pan XW, 1999, MOL CELL BIOL, V19, P4874; Park JI, 2005, BIOCHEM BIOPH RES CO, V327, P311, DOI 10.1016/j.bbrc.2004.12.019; PIETERSE CMJ, 1993, PHYSIOL MOL PLANT P, V43, P69, DOI 10.1006/pmpp.1993.1041; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Rascon A, 2000, MOL BIOCHEM PARASIT, V106, P283, DOI 10.1016/S0166-6851(99)00224-8; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Schneper L, 2004, EUKARYOT CELL, V3, P108, DOI 10.1128/EC.3.1.108-120.2004; Song WW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013193; Spanu P, 1998, PHYSIOL MOL PLANT P, V52, P323, DOI 10.1006/pmpp.1998.0157; Staudohar M, 2002, MICROBIOL-SGM, V148, P2635, DOI 10.1099/00221287-148-8-2635; Stephenson SA, 2000, MOL PLANT MICROBE IN, V13, P929, DOI 10.1094/MPMI.2000.13.9.929; STRINGER MA, 1991, GENE DEV, V5, P1161, DOI 10.1101/gad.5.7.1161; STRINGER MA, 1995, MOL MICROBIOL, V16, P33, DOI 10.1111/j.1365-2958.1995.tb02389.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; Toone WM, 1999, CURR OPIN GENET DEV, V9, P55, DOI 10.1016/S0959-437X(99)80008-2; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; vanWetter MA, 1996, FEMS MICROBIOL LETT, V140, P265, DOI 10.1016/0378-1097(96)00192-9; Wilson D, 2007, MOL MICROBIOL, V65, P841, DOI 10.1111/j.1365-2958.2007.05788.x; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yamamoto M, 1996, TRENDS BIOCHEM SCI, V21, P18, DOI 10.1016/0968-0004(96)80880-2; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	99	77	86	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17241	10.1371/journal.pone.0017241	http://dx.doi.org/10.1371/journal.pone.0017241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386978	gold, Green Published			2022-12-27	WOS:000287931400041
J	Hartling, L; Bond, K; Vandermeer, B; Seida, J; Dryden, DM; Rowe, BH				Hartling, Lisa; Bond, Kenneth; Vandermeer, Ben; Seida, Jennifer; Dryden, Donna M.; Rowe, Brian H.			Applying the Risk of Bias Tool in a Systematic Review of Combination Long-Acting Beta-Agonists and Inhaled Corticosteroids for Persistent Asthma	PLOS ONE			English	Article							QUALITY; TRIALS	Background: The Risk of Bias (RoB) tool is used to assess internal validity of randomized controlled trials (RCTs). Our objectives were to: 1) evaluate inter-rater agreement of the RoB tool; 2) determine the time to access supplemental study information; 3) compare the RoB tool with the Jadad scale and Schulz allocation concealment (AC); and 4) examine the relationship between RoB and effect estimates. Methods: We conducted a systematic review of long-acting beta agonists (LABA) combined with inhaled corticosteroids (ICS) for adults with persistent asthma. Two reviewers independently assessed 107 trials using RoB, Jadad, and AC. One reviewer searched for study protocols. We assessed inter-rater agreement using weighted Kappa (kappa) and the correlation between tools using Kendall's Tau (tau). Mean differences in effect sizes for RCTs with different RoB were calculated using inverse variance method and random effects model. Results: Trials had good Jadad scores (median 4, IQR 3-4); however, 85% had unclear AC and 87% high RoB. The factor that most influenced RoB was the potential inappropriate influence of study sponsors (95% industry funded). Agreement on RoB domains was fair (kappa = 0.40) to almost perfect (kappa = 0.86), and moderate for overall RoB (kappa = 0.41). Median time to complete RoB assessments was 21 minutes (IQR 14-27) and 12 minutes (IQR 9-16) to search for protocols. Protocols were identified for 5/42 studies (12%); in 3 cases the assessment of selective outcome reporting changed. There was low correlation between overall RoB vs. Jadad (tau=0.04, p = 0.3) and AC (tau = -0.02, p = 0.7). Analyses comparing effect estimates and risk showed no important patterns. Conclusions: Inter-rater agreement on RoB assessments was better than previously reported suggesting that review-specific guidelines are important. The correlation between RoB and Jadad was low suggesting measurement of different constructs (risk of bias vs. quality of reporting). The extensive involvement of the pharmaceutical industry in this LABA/ICS research should raise concerns about potential overestimates of treatment effects.	[Hartling, Lisa; Bond, Kenneth; Vandermeer, Ben; Seida, Jennifer; Dryden, Donna M.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	hartling@ualberta.ca			Canadian Agency for Drugs in Technologies in Health (CADTH)	Canadian Agency for Drugs in Technologies in Health (CADTH)	The original systematic review which formed the basis for this project was funded by the Canadian Agency for Drugs in Technologies in Health (CADTH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond K, 2009, 122 CAN AG DRUGS TEC; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Laine C, 2007, JAMA-J AM MED ASSOC, V298, P93, DOI 10.1001/jama.298.1.jed70037; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moher D, 1999, Health Technol Assess, V3, pi; Olivo SA, 2008, PHYS THER, V88, P156, DOI 10.2522/ptj.20070147; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sismondo S, 2008, CONTEMP CLIN TRIALS, V29, P109, DOI 10.1016/j.cct.2007.08.001	14	44	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17242	10.1371/journal.pone.0017242	http://dx.doi.org/10.1371/journal.pone.0017242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390219	Green Published, gold			2022-12-27	WOS:000287761700040
J	Jedelsky, PL; Dolezal, P; Rada, P; Pyrih, J; Smid, O; Hrdy, I; Sedinova, M; Marcincikova, M; Voleman, L; Perry, AJ; Beltran, NC; Lithgow, T; Tachezy, J				Jedelsky, Petr L.; Dolezal, Pavel; Rada, Petr; Pyrih, Jan; Smid, Ondrej; Hrdy, Ivan; Sedinova, Miroslava; Marcincikova, Michaela; Voleman, Lubomir; Perry, Andrew J.; Beltran, Neritza Campo; Lithgow, Trevor; Tachezy, Jan			The Minimal Proteome in the Reduced Mitochondrion of the Parasitic Protist Giardia intestinalis	PLOS ONE			English	Article							GENOME SEQUENCE; CRYPTOSPORIDIUM-PARVUM; TOM COMPLEX; MEMBRANE; IMPORT; TRANSPORTER; ORGANELLE; EVOLUTION; PROTEINS; REMNANT	The mitosomes of Giardia intestinalis are thought to be mitochondria highly-reduced in response to the oxygen-poor niche. We performed a quantitative proteomic assessment of Giardia mitosomes to increase understanding of the function and evolutionary origin of these enigmatic organelles. Mitosome-enriched fractions were obtained from cell homogenate using Optiprep gradient centrifugation. To distinguish mitosomal proteins from contamination, we used a quantitative shot-gun strategy based on isobaric tagging of peptides with iTRAQ and tandem mass spectrometry. Altogether, 638 proteins were identified in mitosome-enriched fractions. Of these, 139 proteins had iTRAQ ratio similar to that of the six known mitosomal markers. Proteins were selected for expression in Giardia to verify their cellular localizations and the mitosomal localization of 20 proteins was confirmed. These proteins include nine components of the FeS cluster assembly machinery, a novel diflavo-protein with NADPH reductase activity, a novel VAMP-associated protein, and a key component of the outer membrane protein translocase. None of the novel mitosomal proteins was predicted by previous genome analyses. The small proteome of the Giardia mitosome reflects the reduction in mitochondrial metabolism, which is limited to the FeS cluster assembly pathway, and a simplicity in the protein import pathway required for organelle biogenesis.	[Jedelsky, Petr L.; Dolezal, Pavel; Rada, Petr; Pyrih, Jan; Smid, Ondrej; Hrdy, Ivan; Sedinova, Miroslava; Marcincikova, Michaela; Voleman, Lubomir; Beltran, Neritza Campo; Tachezy, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Jedelsky, Petr L.] Charles Univ Prague, Lab Mass Spectrometry, Fac Sci, Prague, Czech Republic; [Perry, Andrew J.; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	Charles University Prague; Charles University Prague; Monash University	Jedelsky, PL (corresponding author), Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic.	tachezy@gmail.com	Šmíd, Ondřej/M-7545-2017; Lithgow, Trevor J/H-5925-2017; Perry, Andrew/E-5607-2010; Dolezal, Pavel/V-1907-2017; Tachezy, Jan/R-4945-2017; Jedelsky, Petr/C-5879-2009; Rada, Petr/M-5289-2017; Voleman, Luboš/M-8076-2017; Hrdý, Ivan/K-8931-2017	Šmíd, Ondřej/0000-0001-9260-6509; Lithgow, Trevor J/0000-0002-0102-7884; Perry, Andrew/0000-0001-9256-6068; Dolezal, Pavel/0000-0003-1285-9026; Tachezy, Jan/0000-0001-6976-8446; Jedelsky, Petr/0000-0003-3813-2343; Rada, Petr/0000-0001-6241-969X; Voleman, Luboš/0000-0003-0589-240X; Hrdý, Ivan/0000-0002-5595-9177; Pyrih, Jan/0000-0003-0715-2448	Czech Ministry of Education [MSM0021620858, LC07032]; Czech Science Foundation [204/05/H023, 204/06/0947]; Australian Research Council	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Australian Research Council(Australian Research Council)	This work was supported by the Czech Ministry of Education (MSM0021620858, LC07032) and the Czech Science Foundation grants 204/05/H023 (P.J.) and 204/06/0947 (J.T.) and the Australian Research Council (T.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Alcock F, 2010, SCIENCE, V327, P649, DOI 10.1126/science.1182129; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Billington D, 1998, ANAL BIOCHEM, V258, P251, DOI 10.1006/abio.1998.2561; Bych K, 2008, EMBO J, V27, P1736, DOI 10.1038/emboj.2008.98; Cavalier-Smith T, 2010, BIOL LETTERS, V6, P342, DOI 10.1098/rsbl.2009.0948; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P17, DOI 10.1111/j.1749-6632.1987.tb40596.x; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan KW, 2005, CURR BIOL, V15, P737, DOI 10.1016/j.cub.2005.02.068; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Dagley MJ, 2009, MOL BIOL EVOL, V26, P1941, DOI 10.1093/molbev/msp117; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dolezal P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000812; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Elsner S, 2009, INT J MOL SCI, V10, P2041, DOI 10.3390/ijms10052041; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Gabaldon T, 2004, BBA-BIOENERGETICS, V1659, P212, DOI 10.1016/j.bbabio.2004.07.011; Gabaldon T, 2007, PLOS COMPUT BIOL, V3, P2209, DOI 10.1371/journal.pcbi.0030219; Gatsos X, 2008, FEMS MICROBIOL REV, V32, P995, DOI 10.1111/j.1574-6976.2008.00130.x; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Goldberg AV, 2008, NATURE, V452, P624, DOI 10.1038/nature06606; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Horwich AL, 2007, ANNU REV CELL DEV BI, V23, P115, DOI 10.1146/annurev.cellbio.23.090506.123555; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; HRDY I, 2008, MICROBIOL MONOGR, V9, P113, DOI DOI 10.1007/7171_2007_110; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kmita H, 2000, BBA-BIOMEMBRANES, V1509, P86, DOI 10.1016/S0005-2736(00)00284-4; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Likic VA, 2010, METHODS MOL BIOL, V619, P271, DOI 10.1007/978-1-60327-412-8_16; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Mi-ichi F, 2009, P NATL ACAD SCI USA, V106, P21731, DOI 10.1073/pnas.0907106106; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Muhlenhoff U, 2002, J BIOL CHEM, V277, P29810, DOI 10.1074/jbc.M204675200; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Putignani L, 2004, PARASITOLOGY, V129, P1, DOI 10.1017/S003118200400527X; Rada P, 2009, EUKARYOT CELL, V8, P1584, DOI 10.1128/EC.00181-09; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Riordan CE, 1999, J EUKARYOT MICROBIOL, V46, p52S; Sanderson SJ, 2008, PROTEOMICS, V8, P1398, DOI 10.1002/pmic.200700804; Schneider A, 2008, TRENDS CELL BIOL, V18, P12, DOI 10.1016/j.tcb.2007.09.009; Sheftel AD, 2009, MOL CELL BIOL, V29, P6059, DOI 10.1128/MCB.00817-09; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Smid O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000243; Song DS, 2009, J BIOL CHEM, V284, P35297, DOI 10.1074/jbc.M109.040014; Sun CH, 1998, MOL BIOCHEM PARASIT, V92, P123, DOI 10.1016/S0166-6851(97)00239-9; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; TACHEZY J, 2008, MICROBIOL MONOGR, V9, P201, DOI DOI 10.1007/7171_2007_113; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vernis L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004376; Vinella D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000497; Waller RF, 2009, EUKARYOT CELL, V8, P19, DOI 10.1128/EC.00313-08; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	73	89	89	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17285	10.1371/journal.pone.0017285	http://dx.doi.org/10.1371/journal.pone.0017285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390322	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700043
J	Li, YY; Tollefsbol, TO				Li, Yuanyuan; Tollefsbol, Trygve O.			p16(INK4a) Suppression by Glucose Restriction Contributes to Human Cellular Lifespan Extension through SIRT1-Mediated Epigenetic and Genetic Mechanisms	PLOS ONE			English	Article							CALORIC RESTRICTION; CYCLE PROGRESSION; RAPAMYCIN TOR; GROWTH; SIR2; METHYLATION; EXPRESSION; P53; SENESCENCE; NUTRITION	Although caloric restriction (CR) has been shown to increase lifespan in various animal models, the mechanisms underlying this phenomenon have not yet been revealed. We developed an in vitro system to mimic CR by reducing glucose concentration in cell growth medium which excludes metabolic factors and allows assessment of the effects of CR at the cellular and molecular level. We monitored cellular proliferation of normal WI-38, IMR-90 and MRC-5 human lung fibroblasts and found that glucose restriction (GR) can inhibit cellular senescence and significantly extend cellular lifespan compared with cells receiving normal glucose (NG) in the culture medium. Moreover, GR decreased expression of p16(INK4a) (p16), a well-known senescence-related gene, in all of the tested cell lines. Over-expressed p16 resulted in early replicative senescence in glucose-restricted cells suggesting a crucial role of p16 regulation in GR-induced cellular lifespan extension. The decreased expression of p16 was partly due to GR-induced chromatin remodeling through effects on histone acetylation and methylation of the p16 promoter. GR resulted in an increased expression of SIRT1, a NAD-dependent histone deacetylase, which has positive correlation with CR-induced longevity. The elevated SIRT1 was accompanied by enhanced activation of the Akt/p70S6K1 signaling pathway in response to GR. Furthermore, knockdown of SIRT1 abolished GR-induced p16 repression as well as Akt/p70S6K1 activation implying that SIRT1 may affect p16 repression through direct deacetylation effects and indirect regulation of Akt/p70S6K1 signaling. Collectively, these results provide new insights into interactions between epigenetic and genetic mechanisms on CR-induced longevity that may contribute to anti-aging approaches and also provide a general molecular model for studying CR in vitro in mammalian systems.	[Li, Yuanyuan; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Li, YY (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	trygve@uab.edu		Tollefsbol, Trygve/0000-0002-0284-1511	Glenn Foundation for Medical Research; National Cancer Institute [R01 CA 129415]; American Institute for Cancer Research (AICR); NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	Glenn Foundation for Medical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Institute for Cancer Research (AICR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Glenn Foundation for Medical Research, the National Cancer Institute (R01 CA 129415), Susan G. Komen for the Cure, and a Postdoctoral Award (PDA) sponsored by the American Institute for Cancer Research (AICR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaszadegan MR, 2005, J GASTROINTEST CANC, V36, P47, DOI 10.1385/IJGC:36:1:047; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cooper TM, 2004, FASEB J, V18, P1591, DOI 10.1096/fj.03-1464fje; Dennis PB, 1999, CURR OPIN GENET DEV, V9, P49, DOI 10.1016/S0959-437X(99)80007-0; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Forster MJ, 2003, FASEB J, V17, P690, DOI 10.1096/fj.02-0533fje; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Greenwood SK, 2004, ENVIRON MOL MUTAGEN, V43, P36, DOI 10.1002/em.10207; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001710; Jarmalaite S, 2003, INT J CANCER, V106, P913, DOI 10.1002/ijc.11322; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Li YY, 2010, FASEB J, V24, P1442, DOI 10.1096/fj.09-149328; Li YY, 2010, EPIGENETICS OF AGING, P407, DOI 10.1007/978-1-4419-0639-7_22; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Martin B, 2010, P NATL ACAD SCI USA, V107, P6127, DOI 10.1073/pnas.0912955107; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MCCAY CM, 1989, NUTRITION, V5, P155; Melk A, 2004, KIDNEY INT, V65, P510, DOI 10.1111/j.1523-1755.2004.00438.x; Merry BJ, 2002, INT J BIOCHEM CELL B, V34, P1340, DOI 10.1016/S1357-2725(02)00038-9; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Romanelli A, 2002, J BIOL CHEM, V277, P40281, DOI 10.1074/jbc.M205168200; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Weindruch R., 1988, RETARDATION AGING DI	41	45	52	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17421	10.1371/journal.pone.0017421	http://dx.doi.org/10.1371/journal.pone.0017421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390332	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700054
J	Sancier, F; Dumont, A; Sirvent, A; de Plater, LP; Edmonds, T; David, G; Jan, M; de Montrion, C; Coge, F; Leonce, S; Burbridge, M; Bruno, A; Boutin, JA; Lockhart, B; Roche, S; Cruzalegui, F				Sancier, Florence; Dumont, Aurelie; Sirvent, Audrey; de Plater, Ludmilla Paquay; Edmonds, Thomas; David, Geraldine; Jan, Michel; de Montrion, Catherine; Coge, Francis; Leonce, Stephane; Burbridge, Michael; Bruno, Alain; Boutin, Jean A.; Lockhart, Brian; Roche, Serge; Cruzalegui, Francisco			Specific Oncogenic Activity of the Src-Family Tyrosine Kinase c-Yes in Colon Carcinoma Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CANCER-CELLS; DISTINCT POOLS; DNA-SYNTHESIS; BETA-CATENIN; METASTASIS; ACTIVATION; EXPRESSION; CADHERIN; PP2	c-Yes, a member of the Src tyrosine kinase family, is found highly activated in colon carcinoma but its importance relative to c-Src has remained unclear. Here we show that, in HT29 colon carcinoma cells, silencing of c-Yes, but not of c-Src, selectively leads to an increase of cell clustering associated with a localisation of beta-catenin at cell membranes and a reduction of expression of beta-catenin target genes. c-Yes silencing induced an increase in apoptosis, inhibition of growth in soft-agar and in mouse xenografts, inhibition of cell migration and loss of the capacity to generate liver metastases in mice. Reintroduction of c-Yes, but not c-Src, restores transforming properties of c-Yes depleted cells. Moreover, we found that c-Yes kinase activity is required for its role in beta-catenin localisation and growth in soft agar, whereas kinase activity is dispensable for its role in cell migration. We conclude that c-Yes regulates specific oncogenic signalling pathways important for colon cancer progression that is not shared with c-Src.	[Sancier, Florence; Dumont, Aurelie; de Plater, Ludmilla Paquay; Edmonds, Thomas; David, Geraldine; Jan, Michel; de Montrion, Catherine; Coge, Francis; Leonce, Stephane; Burbridge, Michael; Bruno, Alain; Boutin, Jean A.; Lockhart, Brian; Cruzalegui, Francisco] Inst Rech Servier, Croissy Sur Seine, France; [Sirvent, Audrey; Roche, Serge] UMR5237 Ctr Natl Rech Sci, Ctr Rech Biochim Macromol, Equipe Iabellisee LA LIGUE 2009, Montpellier, France	Servier; Institut de Recherches Internationales Servier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Sancier, F (corresponding author), Inst Rech Servier, Croissy Sur Seine, France.	serge.roche@crbm.cnrs.fr; francisco.cruzalegui@fr.netgrs.com	Boutin, Jean Albert/W-9103-2019	Boutin, Jean Albert/0000-0003-0068-7204; roche, serge/0000-0003-3413-3859	Servier laboratories; CNRS; University of Montpellier I and II; charity "la Ligue National Contre le Cancer"; INCa institute (Institut national du cancer)	Servier laboratories; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Montpellier I and II; charity "la Ligue National Contre le Cancer"; INCa institute (Institut national du cancer)(Institut National du Cancer (INCA) France)	This work was supported by Servier laboratories (http://www.servier.fr), the CNRS (http://www.cnrs.fr), the University of Montpellier I and II and the charity "la Ligue National Contre le Cancer" (http://www.ligue-cancer.net). SR is a research fellow of the INSERM institute (http://www.inserm.fr) and AS was supported by the INCa institute (Institut national du cancer; http://www.e-cancer.fr). The Institut de Recherches Servier employed some authors of this study and so have played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Calcagno AM, 2005, MOL PHARMACEUT, V2, P170, DOI 10.1021/mp0499003; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Clump DA, 2005, GROWTH FACTORS, V23, P263, DOI 10.1080/08977190500199360; Coluccia AML, 2006, CANCER RES, V66, P2279, DOI 10.1158/0008-5472.CAN-05-2057; Easwaran V, 2003, CANCER RES, V63, P3145; Han NM, 1996, CLIN CANCER RES, V2, P1397; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Luton F, 1999, MOL CELL, V4, P627, DOI 10.1016/S1097-2765(00)80213-0; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Oneyama C, 2009, MOL CELL BIOL, V29, P6462, DOI 10.1128/MCB.00941-09; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; PENA SV, 1995, GASTROENTEROLOGY, V108, P117, DOI 10.1016/0016-5085(95)90015-2; ROCHE S, 1995, SCIENCE, V269, P1567, DOI 10.1126/science.7545311; ROCHE S, 1997, ONCOGENIC CYTOPLASMI, pP87; Sirvent A, 2007, ONCOGENE, V26, P7313, DOI 10.1038/sj.onc.1210543; SIRVENT A, ONCOGENE, V29, P1303; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Veracini L, 2005, BIOCHEM SOC T, V33, P1313, DOI 10.1042/BST0331313; Veracini L, 2006, J CELL SCI, V119, P2921, DOI 10.1242/jcs.03015; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130	27	34	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17237	10.1371/journal.pone.0017237	http://dx.doi.org/10.1371/journal.pone.0017237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390316	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700038
J	Santorelli, CJ; Schaffner, CM; Campbell, CJ; Notman, H; Pavelka, MS; Weghorst, JA; Aureli, F				Santorelli, Claire J.; Schaffner, Colleen M.; Campbell, Christina J.; Notman, Hugh; Pavelka, Mary S.; Weghorst, Jennifer A.; Aureli, Filippo			Traditions in Spider Monkeys Are Biased towards the Social Domain	PLOS ONE			English	Article							ATELES-GEOFFROYI; TOOL USE; CULTURAL TRANSMISSION; CAPUCHIN MONKEYS; EVOLUTION; BEHAVIOR; PRIMATES; PREFERENCES; AGGRESSION; DIFFUSION	Cross-site comparison studies of behavioral variation can provide evidence for traditions in wild species once ecological and genetic factors are excluded as causes for cross-site differences. These studies ensure behavior variants are considered within the context of a species' ecology and evolutionary adaptations. We examined wide-scale geographic variation in the behavior of spider monkeys (Ateles geoffroyi) across five long-term field sites in Central America using a well established ethnographic cross-site survey method. Spider monkeys possess a relatively rare social system with a high degree of fission-fusion dynamics, also typical of chimpanzees (Pan troglodytes) and humans (Homo sapiens). From the initial 62 behaviors surveyed 65% failed to meet the necessary criteria for traditions. The remaining 22 behaviors showed cross-site variation in occurrence ranging from absent through to customary, representing to our knowledge, the first documented cases of traditions in this taxon and only the second case of multiple traditions in a New World monkey species. Of the 22 behavioral variants recorded across all sites, on average 57% occurred in the social domain, 19% in food-related domains and 24% in other domains. This social bias contrasts with the food-related bias reported in great ape cross-site comparison studies and has implications for the evolution of human culture. No pattern of geographical radiation was found in relation to distance across sites. Our findings promote A. geoffroyi as a model species to investigate traditions with field and captive based experiments and emphasize the importance of the social domain for the study of animal traditions.	[Santorelli, Claire J.; Schaffner, Colleen M.] Univ Chester, Dept Psychol, Chester, Cheshire, England; [Campbell, Christina J.] Calif State Univ Northridge, Dept Anthropol, Northridge, CA 91330 USA; [Notman, Hugh] Athabasca Univ, Ctr Work & Community Studies, Athabasca, AB, Canada; [Pavelka, Mary S.] Univ Calgary, Dept Anthropol, Calgary, AB, Canada; [Weghorst, Jennifer A.] Univ Kansas, Museum Nat Hist, Lawrence, KS 66045 USA; [Weghorst, Jennifer A.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Aureli, Filippo] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Sch Nat Sci & Psychol, Liverpool L3 5UX, Merseyside, England	University of Chester; California State University System; California State University Northridge; Athabasca University; University of Calgary; University of Kansas; University of Kansas; Liverpool John Moores University	Santorelli, CJ (corresponding author), Univ Chester, Dept Psychol, Chester, Cheshire, England.	c.santorelli@chester.ac.uk		Aureli, Filippo/0000-0002-0671-013X	National Science Foundation [SBR-9711161]; Leakey Foundation; Department of Anthropology, University of California, Berkeley; Smithsonian Tropical Research Institute; NSF [0233248, BSR 8315399]; Wenner-Gren Foundation; American Society of Primatologists; Washington University in St. Louis; WWF grant; Mellon Foundation through the Institute of Latin American Studies at UT Austin; British Academy; North of England Zoological Society; University of Chester; Santander University; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Leakey Foundation; Department of Anthropology, University of California, Berkeley(University of California System); Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); NSF(National Science Foundation (NSF)); Wenner-Gren Foundation; American Society of Primatologists; Washington University in St. Louis; WWF grant; Mellon Foundation through the Institute of Latin American Studies at UT Austin; British Academy; North of England Zoological Society; University of Chester; Santander University; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Research at Barro Colorado Island was supported by grants from the National Science Foundation (SBR-9711161), the Leakey Foundation, the Department of Anthropology, University of California, Berkeley (www.berkeley.edu) and a Short-term Fellowship from the Smithsonian Tropical Research Institute (www.stri.org). Research at Corcovado National Park's Sirena Biological Station was supported by NSF award 0233248 (with R. Sussman), the Wenner-Gren Foundation, the Leakey Foundation, the American Society of Primatologists (www.asp.org), and Washington University in St. Louis (www.wustl.edu). Funds for Sirena's field lab facility were provided to L. E. Gilbert (Univ. of Texas at Austin) by NSF BSR 8315399 and a matching WWF grant, and funds for updating Sirena's trail system and installation of spatial reference system were provided by the Mellon Foundation through the Institute of Latin American Studies at UT Austin. Research at Santa Rosa and Punta Laguna was supported by The British Academy (www.britac.ac.uk), the Wenner-Gren Foundation (www.wennergren.org), the Leakey Foundation (www.leakeyfoundation.org) and the North of England Zoological Society (www.chesterzoo.org). CJS was supported by a Gladstone bursary from the University of Chester (www.chester.ac.uk) and by the Santander University Scheme (www.santander.co.uk). Research at Runaway Creek was supported by the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asensio N, 2009, BEHAV ECOL SOCIOBIOL, V63, P649, DOI 10.1007/s00265-008-0699-9; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Aureli F, 2006, AM J PHYS ANTHROPOL, V131, P486, DOI 10.1002/ajpa.20451; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; AZIZ MA, 1986, PRIMATES, V27, P293, DOI 10.1007/BF02382073; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Borenstein E, 2008, EVOLUTION, V62, P586, DOI 10.1111/j.1558-5646.2007.00313.x; Boughman JW, 1998, ANIM BEHAV, V55, P1717, DOI 10.1006/anbe.1997.0721; Brosnan SF, 2004, J COMP PSYCHOL, V118, P133, DOI 10.1037/0735-7036.118.2.133; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Campbell CJ, 2005, INT J PRIMATOL, V26, P1039, DOI 10.1007/s10764-005-6457-1; Campbell CJ, 2003, INT J PRIMATOL, V24, P223, DOI 10.1023/A:1023036830192; Campbell CJ, 2000, AM J PRIMATOL, V51, P205, DOI 10.1002/1098-2345(200007)51:3<205::AID-AJP5>3.0.CO;2-L; CHAPMAN C, 1987, FOLIA PRIMATOL, V49, P90, DOI 10.1159/000156311; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; CHAPMAN CA, 1991, FOLIA PRIMATOL, V56, P162, DOI 10.1159/000156542; Collins AC, 2008, CAM S BIO EVOL ANTHR, V55, P50; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Datta S, 2002, SIGNAL PROCESS, V82, P251, DOI 10.1016/S0165-1684(01)00184-0; de Waal F., 2001, APE SUSHI MASTER CUL; Di Fiore A, 2008, CAM S BIO EVOL ANTHR, V55, P81; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Efferson C, 2008, EVOL HUM BEHAV, V29, P56, DOI 10.1016/j.evolhumbehav.2007.08.003; ERIKSON G. E., 1963, SYMP ZOOL SOC LONDON, V10, P135; ESTRADA A, 1988, AM J PRIMATOL, V14, P315, DOI 10.1002/ajp.1350140402; Fragaszy DM., 2003, BIOL TRADITIONS MODE, P1, DOI DOI 10.1017/CBO9780511584022.002; Galef BG, 2004, LEARN BEHAV, V32, P53; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Heyes CM., 1996, SOCIAL LEARNING ANIM; Heymann EW, 2006, AM J PRIMATOL, V68, P650, DOI 10.1002/ajp.20258; Horner V, 2006, P NATL ACAD SCI USA, V103, P13878, DOI 10.1073/pnas.0606015103; Humle T, 2008, ANIM BEHAV, V75, P267, DOI 10.1016/j.anbehav.2007.05.021; Humle Tatyana, 2010, P116; Klein L. L., 1972, THESIS U CALIFORNIA; Krutzen M, 2007, TRENDS ECOL EVOL, V22, P6, DOI 10.1016/j.tree.2006.10.011; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lachlan RF, 1998, ANIM BEHAV, V56, P181, DOI 10.1006/anbe.1998.0760; Laland K., 2002, INT ENCY SOCIAL BEHA, P3164; Laland KN, 2008, CURR BIOL, V18, pR366, DOI 10.1016/j.cub.2008.02.049; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Laska M, 2007, PRIMATES, V48, P160, DOI 10.1007/s10329-006-0019-9; Leca JB, 2008, AM J PRIMATOL, V70, P803, DOI 10.1002/ajp.20551; Lindshield SM, 2009, PRIMATES, V50, P269, DOI 10.1007/s10329-009-0144-3; Link Andres, 2003, Neotropical Primates, V11, P104; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; McGrew WC, 1998, ANNU REV ANTHROPOL, V27, P301, DOI 10.1146/annurev.anthro.27.1.301; McGrew William, 2004, CULTURED CHIMPANZEE; Milton K, 2006, DEV PRIMATOL-PROG PR, P417, DOI 10.1007/0-387-25872-8_21; Milton K, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P375; Milton K., 2006, FEEDING ECOLOGY APES, P381; Nishida T., 1987, P165; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; POZO RWE, 2004, ANUAR INVESTIGACION, V2, P77; RAMOSFERNA N, 2003, NEOTROPICAL PRIMATES, V11, P115; RAMOSFERNA N, 2002, PRIMATES FRAGMENTS E, P191; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Richerson PJ., 2005, NOT GENES ALONE CULT; Rocha OJ, 2001, AM J BOT, V88, P1607, DOI 10.2307/3558405; RODSETH L, 1991, CURR ANTHROPOL, V32, P221, DOI 10.1086/203952; Rosenberger AL, 2008, CAM S BIO EVOL ANTHR, V55, P19; SADER SA, 2001, STLOUIS MISS ASPRS 2; Schaffner CM, 2005, INT J PRIMATOL, V26, P1093, DOI 10.1007/s10764-005-6460-6; Shimooka Y, 2008, CAM S BIO EVOL ANTHR, V55, P329; Thornton A, 2008, ANIM BEHAV, V76, P1411, DOI 10.1016/j.anbehav.2008.07.007; van de Waal E, 2010, P ROY SOC B-BIOL SCI, V277, P2105, DOI 10.1098/rspb.2009.2260; van der Post DJ, 2009, ANIM BEHAV, V78, P155, DOI 10.1016/j.anbehav.2009.04.009; van Roosmalen M.G.M., 1988, P455; van Schaik C. P., 2009, QUESTION ANIMAL CULT, P70; Van Schaik Carel P., 2003, P297, DOI 10.1017/CBO9780511584022.012; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; van Schaik CP, 2002, INT J PRIMATOL, V23, P527, DOI 10.1023/A:1014965516127; Vick LG, 2008, CAM S BIO EVOL ANTHR, V55, P288; Watson CFI, 2009, INT J PRIMATOL, V30, P143, DOI 10.1007/s10764-009-9334-5; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WHITEN A, 2006, SOCIAL INFORM TRANSM, P119; Whiten A, 2008, PHILOS T R SOC B, V363, P3477, DOI 10.1098/rstb.2008.0134; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031	84	35	35	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16863	10.1371/journal.pone.0016863	http://dx.doi.org/10.1371/journal.pone.0016863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373196	Green Published, gold			2022-12-27	WOS:000287657500020
J	Cortes-Bratti, X; Basseres, E; Herrera-Rodriguez, F; Botero-Kleiven, S; Coppotelli, G; Andersen, JB; Masucci, MG; Holmgren, A; Chaves-Olarte, E; Frisan, T; Avila-Carino, J				Cortes-Bratti, Ximena; Basseres, Eugenie; Herrera-Rodriguez, Fabiola; Botero-Kleiven, Silvia; Coppotelli, Giuseppe; Andersen, Jens B.; Masucci, Maria G.; Holmgren, Arne; Chaves-Olarte, Esteban; Frisan, Teresa; Avila-Carino, Javier			Thioredoxin 80-Activated-Monocytes (TAMs) Inhibit the Replication of Intracellular Pathogens	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; CYTOTOXICITY-ENHANCING FACTOR; LISTERIA-MONOCYTOGENES; TRUNCATED THIOREDOXIN; MITOGENIC CYTOKINE; EXPRESSION; MONOCYTES; INFECTION; TRX80; BRUCELLA	Background: Thioredoxin 80 (Trx80) is an 80 amino acid natural cleavage product of Trx, produced primarily by monocytes. Trx80 induces differentiation of human monocytes into a novel cell type, named Trx80-activated-monocytes (TAMs). Principal Findings: In this investigation we present evidence for a role of TAMs in the control of intracellular bacterial infections. As model pathogens we have chosen Listeria monocytogenes and Brucella abortus which replicate in the cytosol and the endoplasmic reticulum respectively. Our data indicate that TAMs efficiently inhibit intracellular growth of both L. monocytogenes and B. abortus. Further analysis shows that Trx80 activation prevents the escape of GFP-tagged L. monocytogenes into the cytosol, and induces accumulation of the bacteria within the lysosomes. Inhibition of the lysosomal activity by chloroquine treatment resulted in higher replication of bacteria in TAMs compared to that observed in control cells 24 h post-infection, indicating that TAMs kill bacteria by preventing their escape from the endosomal compartments, which progress into a highly degradative phagolysosome. Significance: Our results show that Trx80 potentiates the bactericidal activities of professional phagocytes, and contributes to the first line of defense against intracellular bacteria.	[Cortes-Bratti, Ximena; Basseres, Eugenie; Coppotelli, Giuseppe; Masucci, Maria G.; Frisan, Teresa; Avila-Carino, Javier] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Herrera-Rodriguez, Fabiola; Chaves-Olarte, Esteban] Univ Costa Rica, Fac Microbiol, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Botero-Kleiven, Silvia] Swedish Inst Infect Dis Control, Solna, Sweden; [Andersen, Jens B.] Natl Food Inst, Dept Microbiol & Risk Assessment, Soborg, Denmark; [Holmgren, Arne] Karolinska Inst, Dept Biochem & Biophys, Stockholm, Sweden	Karolinska Institutet; Universidad Costa Rica; Swedish Institute for Infectious Disease Control; Technical University of Denmark; Karolinska Institutet	Cortes-Bratti, X (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	teresa.frisan@ki.se; javier.avila-carino@ki.se	Masucci, Maria/AAC-6666-2019; Andersen, Jens B/J-4256-2017; Frisan, Teresa/H-8444-2019	Masucci, Maria/0000-0002-5541-2809; Andersen, Jens B/0000-0003-1720-1581; Frisan, Teresa/0000-0002-1209-0942	Cancer and Allergy Foundation; Swedish Research Council; Swedish Cancer Society; Magnus Bergvall Foundation; Karolinska Institutet; Association for International Cancer Research; Edinburgh UK; European Community [LSHC-CT-2005-018683]	Cancer and Allergy Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Magnus Bergvall Foundation; Karolinska Institutet(Karolinska Institutet); Association for International Cancer Research; Edinburgh UK; European Community(European Commission)	Funding: This work was supported by the Cancer and Allergy Foundation (http://www.cancerochallergifonden.se/) to JAC; the Swedish Research Council (http://www.vr.se/inenglish. 4.12fff4451215cbd83e4800015152.html), the Swedish Cancer Society (http://www.cancerfonden.se/sv/Information-in-English/), the Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu/), and the Karolinska Institutet (http://ki.se/ki/jsp/polopoly.jsp?l = en&d = 20152) to JAC and TF; and the Association for International Cancer Research (http://www.aicr.org.uk/research.stm), Edinburgh UK and the European Community Network of Excellence RUBICON (http://www.rubicon-net.org/) Project No. LSHC-CT-2005-018683 to MGM. XCB is a NETROPICA (http://www.netropica.org/portal/) fellow. TF is supported by the Swedish Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-86; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Bernal-Bayard J, 2009, J BIOL CHEM, V284, P27587, DOI 10.1074/jbc.M109.010363; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bizzarri C, 2005, ANTIOXID REDOX SIGN, V7, P1189, DOI 10.1089/ars.2005.7.1189; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; DESSEIN AJ, 1984, CELL IMMUNOL, V85, P100, DOI 10.1016/0008-8749(84)90282-X; Diacovich L, 2010, NAT REV MICROBIOL, V8, P117, DOI 10.1038/nrmicro2295; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Freitag NE, 1999, INFECT IMMUN, V67, P1844; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; JENG MF, 1994, STRUCTURE, V2, P853, DOI 10.1016/S0969-2126(94)00086-7; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Lemarechal H, 2007, CLIN SCI, V113, P149, DOI 10.1042/CS20070067; LENZI HL, 1985, CELL IMMUNOL, V94, P333, DOI 10.1016/0008-8749(85)90257-6; NEWMAN GW, 1994, J EXP MED, V180, P359, DOI 10.1084/jem.180.1.359; Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pekkari K, 2005, BLOOD, V105, P1598, DOI 10.1182/blood-2004-04-1577; Pekkari K, 2003, FEBS LETT, V539, P143, DOI 10.1016/S0014-5793(03)00214-X; Pekkari K, 2001, BLOOD, V97, P3184, DOI 10.1182/blood.V97.10.3184; Pekkari K, 2000, J BIOL CHEM, V275, P37474, DOI 10.1074/jbc.M001012200; Sahaf B, 1997, EXP CELL RES, V236, P181, DOI 10.1006/excr.1997.3699; Sahaf B, 2000, ANTIOXID REDOX SIGN, V2, P717, DOI 10.1089/ars.2000.2.4-717; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SILBERSTEIN DS, 1989, J IMMUNOL, V143, P979; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16960	10.1371/journal.pone.0016960	http://dx.doi.org/10.1371/journal.pone.0016960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365006	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800023
J	Kikusui, T; Nakanishi, K; Nakagawa, R; Nagasawa, M; Mogi, K; Okanoya, K				Kikusui, Takefumi; Nakanishi, Kaori; Nakagawa, Ryoko; Nagasawa, Miho; Mogi, Kazutaka; Okanoya, Kazuo			Cross Fostering Experiments Suggest That Mice Songs Are Innate	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; POSTPARTUM ESTRUS; MUS-MUSCULUS; NORWAY RATS; BEHAVIOR; FOXP2; SPEECH; COMMUNICATION; EVOLUTION; LANGUAGE	Background: Vocal learning is a central functional constituent of human speech, and recent studies showing that adult male mice emit ultrasonic sound sequences characterized as "songs'' have suggested that the ultrasonic courtship sounds of mice provide a mammalian model of vocal learning. Objectives: We tested whether mouse songs are learned, by examining the relative role of rearing environment in a cross-fostering experiment. Methods and Findings: We found that C57BL/6 and BALB/c males emit a clearly different pattern of songs with different frequency and syllable compositions; C57BL/6 males showed a higher peak frequency of syllables, shorter intervals between syllables, and more upward frequency modulations with jumps, whereas BALB/c males produced more "chevron'' and "harmonics'' syllables. To establish the degree of environmental influences in mouse song development, sons of these two strains were cross-fostered to another strain of parents. Songs were recorded when these cross-fostered pups were fully developed and their songs were compared with those of male mice reared by the genetic parents. The cross-fostered animals sang songs with acoustic characteristics - including syllable interval, peak frequency, and modulation patterns - similar to those of their genetic parents. In addition their song elements retained sequential characteristics similar to those of their genetic parents' songs. Conclusion: These results do not support the hypothesis that mouse "song'' is learned; we found no evidence for vocal learning of any sort under the conditions of this experiment. Our observation that the strain-specific character of the song profile persisted even after changing the developmental auditory environment suggests that the structure of these courtship sound sequences is under strong genetic control. Thus, the usefulness of mouse "song'' as a model of mammalian vocal learning is limited, but mouse song has the potential to be an indispensable model to study genetic mechanisms for vocal patterning and behavioral sequences.	[Kikusui, Takefumi; Nakanishi, Kaori; Nagasawa, Miho; Mogi, Kazutaka] Azabu Univ, Sch Vet Med, Kanagawa, Japan; [Nakagawa, Ryoko; Okanoya, Kazuo] RIKEN, Lab Biolinguist Mind & Intelligence Res Core, Brain Sci Inst BSI, Wako, Saitama, Japan; [Okanoya, Kazuo] Japan Sci & Technol Corp, Okanoya Emot Informat Project, ERATO, Wako, Saitama, Japan	Azabu University; RIKEN; Japan Science & Technology Agency (JST)	Kikusui, T (corresponding author), Azabu Univ, Sch Vet Med, Kanagawa, Japan.	okanoya@brain.riken.jp		Mogi, Kazutaka/0000-0002-0689-9761	Japan Society for the Promotion of Science; Promotion and Mutual Aid Corporation for Private Schools of Japan; Japan Science and Technology Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Promotion and Mutual Aid Corporation for Private Schools of Japan(Promotion and Mutual Aid Corporation for Private Schools of Japan); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST))	This research was supported by Japan Society for the Promotion of Science (T.K. and R.N.), the Promotion and Mutual Aid Corporation for Private Schools of Japan, Grant-in-Aid for Matching Fund Subsidy for Private Universities (T.K.), RIKEN Brain Science Institute (K.O.), and by "Exploratory Research for Advanced Technology, Okanoya Emotional Information Project'' (K.O.) from Japan Science and Technology Corporation. Funders paid for experimental supplies and personnel cost for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRIAGA G, 2009, INT ETH CONF ABSTR; ARRIAGA G, 2008, ACC COMM AN ABSTR, P7; Bernstein S. E., 1966, BIOL LAB MOUSE; Catchpole Clive K, 2003, BIRD SONG BIOL THEME; CLAYTON NS, 1989, BEHAVIOUR, V109, P163, DOI 10.1163/156853989X00204; CONNOR JR, 1980, BIOL REPROD, V23, P994, DOI 10.1095/biolreprod23.5.994; CONNOR JR, 1980, BIOL REPROD, V23, P1000, DOI 10.1095/biolreprod23.5.1000; Crowcroft P., 1966, MICE ALL; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Feng AS, 2006, NATURE, V440, P333, DOI 10.1038/nature04416; Fitch WT, 2006, COGNITION, V100, P173, DOI 10.1016/j.cognition.2005.11.009; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Jarvis E., 2004, NATURES MUSIC SCI BI, P239; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; Marler P, 1997, J NEUROBIOL, V33, P501; Marler P., 1977, ANIMALS COMMUNICATE, P965; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; Musolf K, 2010, ANIM BEHAV, V79, P757, DOI 10.1016/j.anbehav.2009.12.034; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; NUNEZ AA, 1978, HORM BEHAV, V11, P264, DOI 10.1016/0018-506X(78)90030-2; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; POMERANTZ SM, 1983, PHYSIOL BEHAV, V31, P91, DOI 10.1016/0031-9384(83)90101-4; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SEWELL GD, 1970, NATURE, V227, P410, DOI 10.1038/227410a0; Shnerson A, 1983, AUDITORY PSYCHOBIOLO, P395; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Uematsu A, 2007, BRAIN RES, V1163, P91, DOI 10.1016/j.brainres.2007.05.056; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; WILD JM, 1994, BRAIN BEHAV EVOLUT, V44, P192, DOI 10.1159/000113577	39	102	103	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17721	10.1371/journal.pone.0017721	http://dx.doi.org/10.1371/journal.pone.0017721			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408017	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170900042
J	Nehme, NT; Quintin, J; Cho, JH; Lee, J; Lafarge, MC; Kocks, C; Ferrandon, D				Nehme, Nadine T.; Quintin, Jessica; Cho, Ju Hyun; Lee, Janice; Lafarge, Marie-Celine; Kocks, Christine; Ferrandon, Dominique			Relative Roles of the Cellular and Humoral Responses in the Drosophila Host Defense against Three Gram-Positive Bacterial Infections	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTOR; IMMUNE-RESPONSE; TOLL-PATHWAY; ANTIMICROBIAL PEPTIDES; IMD PATHWAYS; PGRP-SD; PHAGOCYTOSIS; PROTEIN; RESISTANCE; ACTIVATION	Background: Two NF-kappaB signaling pathways, Toll and immune deficiency (imd), are required for survival to bacterial infections in Drosophila. In response to septic injury, these pathways mediate rapid transcriptional activation of distinct sets of effector molecules, including antimicrobial peptides, which are important components of a humoral defense response. However, it is less clear to what extent macrophage-like hemocytes contribute to host defense. Methodology/Principal Findings: In order to dissect the relative importance of humoral and cellular defenses after septic injury with three different Gram-positive bacteria (Micrococcus luteus, Enterococcus faecalis, Staphylococcus aureus), we used latex bead pre-injection to ablate macrophage function in flies wildtype or mutant for various Toll and imd pathway components. We found that in all three infection models a compromised phagocytic system impaired fly survival independently of concomitant Toll or imd pathway activation. Our data failed to confirm a role of the PGRP-SA and GNBP1 Pattern Recognition Receptors for phagocytosis of S. aureus. The Drosophila scavenger receptor Eater mediates the phagocytosis by hemocytes or S2 cells of E. faecalis and S. aureus, but not of M. luteus. In the case of M. luteus and E. faecalis, but not S. aureus, decreased survival due to defective phagocytosis could be compensated for by genetically enhancing the humoral immune response. Conclusions/Significance: Our results underscore the fundamental importance of both cellular and humoral mechanisms in Drosophila immunity and shed light on the balance between these two arms of host defense depending on the invading pathogen.	[Nehme, Nadine T.; Quintin, Jessica; Cho, Ju Hyun; Lee, Janice; Lafarge, Marie-Celine; Kocks, Christine; Ferrandon, Dominique] Univ Strasbourg, CNRS, Inst Biol Mol & Cellulaire, Equipe Fdn Rech Med,UPR 9022, Strasbourg, France; [Cho, Ju Hyun; Lee, Janice; Kocks, Christine] Harvard Univ, Sch Med, Dept Pediat, Massachusetts Gen Hosp, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School; Massachusetts General Hospital	Nehme, NT (corresponding author), Hop Necker Enfants Malad, INSERM, U768, Paris, France.	D.Ferrandon@ibmc.u-strasbg.fr		FERRANDON, Dominique/0000-0001-7680-7773	Conseil National de la Recherche Scientifique du Liban; CNRS; NIH [PO1 AI44220]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	Conseil National de la Recherche Scientifique du Liban; CNRS(Centre National de la Recherche Scientifique (CNRS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	N.N. was partially supported by a fellowship from the Conseil National de la Recherche Scientifique du Liban. This work was supported financially by the CNRS, a NIH Program grant PO1 AI44220, and a DROSELEGANS grant from the Agence Nationale de la Recherche. The Strasbourg team is an "Equipe FRM", a label awarded by the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Avet-Rochex A, 2005, CELL MICROBIOL, V7, P799, DOI 10.1111/j.1462-5822.2005.00512.x; Avet-Rochex A, 2007, GENES CELLS, V12, P1193, DOI 10.1111/j.1365-2443.2007.01121.x; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Chang CI, 2004, PLOS BIOL, V2, P1293, DOI 10.1371/journal.pbio.0020277; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; DiAngelo JR, 2009, P NATL ACAD SCI USA, V106, P20853, DOI 10.1073/pnas.0906749106; DIMARCQ JL, 1994, EUR J BIOCHEM, V221, P201, DOI 10.1111/j.1432-1033.1994.tb18730.x; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hashimoto Y, 2009, J IMMUNOL, V183, P7451, DOI 10.4049/jimmunol.0901032; HOFFMANN D, 1976, CR ACAD SCI D NAT, V282, P1021; HOFFMANN JA, 1992, IMMUNOL TODAY, V13, P411, DOI 10.1016/0167-5699(92)90092-L; Imler Jean-Luc, 2005, V86, P1, DOI 10.1159/000086648; Jung AC, 2001, BIOTECHNIQUES, V30, P594, DOI 10.2144/01303rr04; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; Matova N, 2006, P NATL ACAD SCI USA, V103, P16424, DOI 10.1073/pnas.0605721103; Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pluddemann Annette, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000159; POWELL DA, 1975, BIOCHEM J, V151, P387, DOI 10.1042/bj1510387; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Stuart LM, 2008, NAT REV IMMUNOL, V8, P131, DOI 10.1038/nri2240; Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Wang L, 2008, P NATL ACAD SCI USA, V105, P11881, DOI 10.1073/pnas.0710092105; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861	58	71	73	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14743	10.1371/journal.pone.0014743	http://dx.doi.org/10.1371/journal.pone.0014743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390224	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200003
J	Yuan, SH; Martin, J; Elia, J; Flippin, J; Paramban, RI; Hefferan, MP; Vidal, JG; Mu, YL; Killian, RL; Israel, MA; Emre, N; Marsala, S; Marsala, M; Gage, FH; Goldstein, LSB; Carson, CT				Yuan, Shauna H.; Martin, Jody; Elia, Jeanne; Flippin, Jessica; Paramban, Rosanto I.; Hefferan, Mike P.; Vidal, Jason G.; Mu, Yangling; Killian, Rhiannon L.; Israel, Mason A.; Emre, Nil; Marsala, Silvia; Marsala, Martin; Gage, Fred H.; Goldstein, Lawrence S. B.; Carson, Christian T.			Cell-Surface Marker Signatures for the Isolation of Neural Stem Cells, Glia and Neurons Derived from Human Pluripotent Stem Cells	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; PROGENITOR CELLS; SPINAL-CORD; DOPAMINERGIC-NEURONS; NERVOUS-SYSTEM; HUMAN ES; HUMAN BLASTOCYSTS; SELF-RENEWAL; DIFFERENTIATION; FETAL	Background: Neural induction of human pluripotent stem cells often yields heterogeneous cell populations that can hamper quantitative and comparative analyses. There is a need for improved differentiation and enrichment procedures that generate highly pure populations of neural stem cells (NSC), glia and neurons. One way to address this problem is to identify cell-surface signatures that enable the isolation of these cell types from heterogeneous cell populations by fluorescence activated cell sorting (FACS). Methodology/Principal Findings: We performed an unbiased FACS- and image-based immunophenotyping analysis using 190 antibodies to cell surface markers on naive human embryonic stem cells (hESC) and cell derivatives from neural differentiation cultures. From this analysis we identified prospective cell surface signatures for the isolation of NSC, glia and neurons. We isolated a population of NSC that was CD184(+)/CD271(-)/CD44(-)/CD24(+) from neural induction cultures of hESC and human induced pluripotent stem cells (hiPSC). Sorted NSC could be propagated for many passages and could differentiate to mixed cultures of neurons and glia in vitro and in vivo. A population of neurons that was CD184(-)/CD44(-)/CD15(LOW)/CD24(+) and a population of glia that was CD184(+)/CD44(+) were subsequently purified from cultures of differentiating NSC. Purified neurons were viable, expressed mature and subtype-specific neuronal markers, and could fire action potentials. Purified glia were mitotic and could mature to GFAP-expressing astrocytes in vitro and in vivo. Conclusions/Significance: These findings illustrate the utility of immunophenotyping screens for the identification of cell surface signatures of neural cells derived from human pluripotent stem cells. These signatures can be used for isolating highly pure populations of viable NSC, glia and neurons by FACS. The methods described here will enable downstream studies that require consistent and defined neural cell populations.	[Yuan, Shauna H.; Flippin, Jessica; Killian, Rhiannon L.; Israel, Mason A.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Yuan, Shauna H.; Flippin, Jessica; Killian, Rhiannon L.; Israel, Mason A.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Yuan, Shauna H.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Martin, Jody; Elia, Jeanne; Paramban, Rosanto I.; Vidal, Jason G.; Emre, Nil; Carson, Christian T.] BD Biosci, La Jolla, CA USA; [Hefferan, Mike P.; Marsala, Silvia; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Anesthesiol Res Lab, La Jolla, CA 92093 USA; [Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Killian, Rhiannon L.; Israel, Mason A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Slovak Academy of Sciences	Yuan, SH (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	christian_carson@bd.com		Israel, Mason/0000-0003-0867-0626; Yuan, Shauna/0000-0003-4058-4146	UCSD [T1-00003]; CIRM [RC1-00116-1, RC1-00131-1]; HHMI; Becton Dickinson Biosciences	UCSD; CIRM(California Institute for Regenerative Medicine); HHMI(Howard Hughes Medical Institute); Becton Dickinson Biosciences	SHY, RLN and MAI were partially supported by the CIRM Interdisciplinary Stem Cell Training Program at UCSD (grant T1-00003 Larry Goldstein, PD). LSBG is a Howard Hughes Investigator. This work was partially supported by a grant from CIRM to LSBG (RC1-00116-1) and to MM (RC1-00131-1) and HHMI. CTC, NE, RP, JM, JE and JGV were supported by Becton Dickinson Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DK, 1995, BRAIN PATHOL, V5, P451, DOI 10.1111/j.1750-3639.1995.tb00624.x; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Bucay N, 2009, STEM CELLS, V27, P68, DOI 10.1634/stemcells.2007-1018; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carson CT, 2006, NAT MED, V12, P1237, DOI 10.1038/nm1106-1237; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cizkova D, 2007, NEUROSCIENCE, V147, P546, DOI 10.1016/j.neuroscience.2007.02.065; Corti S, 2005, FASEB J, V19, P1860, DOI 10.1096/fj.05-4170fje; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; GERDES J, 1984, J IMMUNOL, V133, P1710; Giovanini MA, 1997, EXP NEUROL, V148, P523, DOI 10.1006/exnr.1997.6703; Golebiewska A, 2009, STEM CELLS, V27, P1298, DOI 10.1002/stem.59; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Kakinohana O, 2004, EXP NEUROL, V190, P122, DOI 10.1016/j.expneurol.2004.07.014; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Keyoung HM, 2001, NAT BIOTECHNOL, V19, P843, DOI 10.1038/nbt0901-843; Koch P, 2009, P NATL ACAD SCI USA, V106, P3225, DOI 10.1073/pnas.0808387106; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; Liu Y, 2004, DEV BIOL, V276, P31, DOI 10.1016/j.ydbio.2004.08.018; Luo YQ, 2002, J NEUROCHEM, V83, P1481, DOI 10.1046/j.1471-4159.2002.01260.x; Maric D, 2003, J NEUROSCI, V23, P240; Marsala M, 2004, EUR J NEUROSCI, V20, P2401, DOI 10.1111/j.1460-9568.2004.03702.x; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Nelson TJ, 2008, STEM CELLS, V26, P1464, DOI 10.1634/stemcells.2007-0808; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Peh GSL, 2009, STEM CELLS DEV, V18, P269, DOI 10.1089/scd.2008.0124; Peng H, 2007, J NEUROIMMUNE PHARM, V2, P251, DOI 10.1007/s11481-007-9081-3; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; PRUSZAK J, 2009, STEM CELLS; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Roy NS, 2000, NAT MED, V6, P271; Schwartz PH, 2003, J NEUROSCI RES, V74, P838, DOI 10.1002/jnr.10854; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Taira Y, 1996, STROKE, V27, P1850, DOI 10.1161/01.STR.27.10.1850; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; USVALD D, 2010, CELL TRANSPLANT; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	56	258	276	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17540	10.1371/journal.pone.0017540	http://dx.doi.org/10.1371/journal.pone.0017540			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407814	Green Submitted, gold, Green Published			2022-12-27	WOS:000287933300032
J	Ristic, N; Zukurov, J; Alkmim, W; Diaz, RS; Janini, LM; Chin, MPS				Ristic, Natalia; Zukurov, Jean; Alkmim, Wagner; Diaz, Ricardo Sobhie; Janini, Luiz Mario; Chin, Mario P. S.			Analysis of the Origin and Evolutionary History of HIV-1 CRF28_BF and CRF29_BF Reveals a Decreasing Prevalence in the AIDS Epidemic of Brazil	PLOS ONE			English	Article							INTERSUBTYPE RECOMBINANT VIRUSES; RIO-DE-JANEIRO; SUBTYPE-B; BLOOD-DONORS; SAO-PAULO; TYPE-1; IDENTIFICATION; INDIVIDUALS; INFECTIONS; ARGENTINA	Background: HIV-1 subtype B and subtype F are prevalent in the AIDS epidemic of Brazil. Recombinations between these subtypes have generated at least four BF circulating recombinant forms (CRFs). CRF28_BF and CRF29_BF are among the first two BF recombinants being identified in Brazil and they contributed significantly to the epidemic. However, the evolution and demographic histories of the CRFs are unclear. Methodology/Principal Findings: A collection of gag and pol sequences sampled within Brazil was screened for CRF28_BF-like and CRF29_BF-like recombination patterns. A Bayesian coalescent framework was employed to delineate the phylogenetic, divergence time and population dynamics of the virus having CRF28_BF-like and CRF29_BF-like genotype. These recombinants were phylogenetically related to each other and formed a well-supported monophyletic clade dated to 1988-1989. The effective number of infections by these recombinants grew exponentially over a five-year period after their emergence, but then decreased toward the present following a logistic model of population growth. The demographic pattern of both recombinants closely resembles those previously reported for CRF31_BC. Conclusions: We revealed that HIV-1 recombinants of the CRF28_BF/CRF29_BF clade are still circulating in the Brazilian population. These recombinants did not exhibit a strong founder effect and showed a decreasing prevalence in the AIDS epidemic of Brazil. Our data suggested that multiple URFs may also play a role in shaping the epidemic of recombinant BF HIV-1 in the region.	[Ristic, Natalia; Chin, Mario P. S.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Zukurov, Jean; Diaz, Ricardo Sobhie] Univ Fed Sao Paulo, Dept Med, Sao Paulo, Brazil; [Alkmim, Wagner; Janini, Luiz Mario] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil	Rockefeller University; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Ristic, N (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA.	mchin@adarc.org	Diaz, Ricardo/K-3978-2012; Janini, Luiz Mario R/E-9700-2012	Janini, Luiz Mario/0000-0002-6186-6284	Aaron Diamond AIDS Research Center; National Institutes of Health [DA026293]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA026293, K99DA026293] Funding Source: NIH RePORTER	Aaron Diamond AIDS Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by internal funds of Aaron Diamond AIDS Research Center and National Institutes of Health grant DA026293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulicino PC, 2007, AIDS RES HUM RETROV, V23, P1176, DOI 10.1089/aid.2007.0038; AULICINO PC, 2010, INFECT GENET EVOL; Bello G, 2006, AIDS, V20, P763, DOI 10.1097/01.aids.0000216377.84313.52; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bello G, 2007, INFECT GENET EVOL, V7, P263, DOI 10.1016/j.meegid.2006.11.002; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Bello G, 2009, AIDS RES HUM RETROV, V25, P1065, DOI 10.1089/aid.2009.0106; Passaes CPB, 2009, INFECT GENET EVOL, V9, P474, DOI 10.1016/j.meegid.2009.01.008; *BRAZ MIN HLTH, 2009, AIDS EP B; Brennan CA, 2007, AIDS RES HUM RETROV, V23, P1434, DOI 10.1089/aid.2007.0121; Brigido LFM, 2005, AIDS RES HUM RETROV, V21, P673, DOI 10.1089/aid.2005.21.673; Carr JK, 2001, AIDS, V15, pF41, DOI 10.1097/00002030-200110190-00002; Chin MPS, 2007, VIROLOGY, V363, P437, DOI 10.1016/j.virol.2007.01.034; Chin MPS, 2005, P NATL ACAD SCI USA, V102, P9002, DOI 10.1073/pnas.0502522102; De Sa DJ, 2005, AIDS RES HUM RETROV, V21, P145, DOI 10.1089/aid.2005.21.145; De Sa DJ, 2006, AIDS RES HUM RETROV, V22, P1; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FELSENSTEIN J, 1973, AM J HUM GENET, V25, P471; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Guimaraes ML, 2008, AIDS, V22, P433, DOI 10.1097/QAD.0b013e3282f47ad0; Guiniaraes ML, 2002, AIDS RES HUM RETROV, V18, P1261, DOI 10.1089/088922202320886307; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Leal E, 2008, RETROVIROLOGY RES TR, V1, P1; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Moore Michael D., 2009, V485, P87, DOI 10.1007/978-1-59745-170-3_7; MORGADO MG, 1994, AIDS RES HUM RETROV, V10, P569, DOI 10.1089/aid.1994.10.569; Ramos A, 1999, EMERG INFECT DIS, V5, P65, DOI 10.3201/eid0501.990108; Rhodes T, 2003, J VIROL, V77, P11193, DOI 10.1128/JVI.77.20.11193-11200.2003; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Sa D, 2007, AIDS RES HUM RETROV, V23, P1087, DOI 10.1089/aid.2006.0173; SABINO EC, 1994, J VIROL, V68, P6340, DOI 10.1128/JVI.68.10.6340-6346.1994; Sanabani S, 2006, INFECT GENET EVOL, V6, P368, DOI 10.1016/j.meegid.2006.01.003; Sanabani SS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-74; Schierup MH, 2000, GENETICS, V156, P879; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Tanuri A, 1999, J ACQ IMMUN DEF SYND, V20, P60, DOI 10.1097/00042560-199901010-00009; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thomson MM, 2000, AIDS, V14, P897, DOI 10.1097/00002030-200005050-00020; Thomson MM, 2004, AIDS RES HUM RETROV, V20, P1126, DOI 10.1089/aid.2004.20.1126; Thomson MM, 2002, J GEN VIROL, V83, P107, DOI 10.1099/0022-1317-83-1-107; Walker Polly R., 2005, Infection Genetics and Evolution, V5, P199, DOI 10.1016/j.meegid.2004.06.011; Worobey M, 2001, MOL BIOL EVOL, V18, P1425, DOI 10.1093/oxfordjournals.molbev.a003928	50	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17485	10.1371/journal.pone.0017485	http://dx.doi.org/10.1371/journal.pone.0017485			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390250	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100020
J	Dong, GY; Luo, J; Zhang, H; Wang, CM; Duan, MX; Deliberto, TJ; Nolte, DL; Ji, GJ; He, HX				Dong, Guoying; Luo, Jing; Zhang, Hong; Wang, Chengmin; Duan, Mingxing; Deliberto, Thomas Jude; Nolte, Dale Louis; Ji, Guangju; He, Hongxuan			Phylogenetic Diversity and Genotypical Complexity of H9N2 Influenza A Viruses Revealed by Genomic Sequence Analysis	PLOS ONE			English	Article							AVIAN INFLUENZA; SOUTHERN CHINA; MOLECULAR EPIDEMIOLOGY; HUMAN INFECTION; EVOLUTION; POULTRY; HEMAGGLUTININ; GENES; TRANSMISSION; ECOLOGY	H9N2 influenza A viruses have become established worldwide in terrestrial poultry and wild birds, and are occasionally transmitted to mammals including humans and pigs. To comprehensively elucidate the genetic and evolutionary characteristics of H9N2 influenza viruses, we performed a large-scale sequence analysis of 571 viral genomes from the NCBI Influenza Virus Resource Database, representing the spectrum of H9N2 influenza viruses isolated from 1966 to 2009. Our study provides a panoramic framework for better understanding the genesis and evolution of H9N2 influenza viruses, and for describing the history of H9N2 viruses circulating in diverse hosts. Panorama phylogenetic analysis of the eight viral gene segments revealed the complexity and diversity of H9N2 influenza viruses. The 571 H9N2 viral genomes were classified into 74 separate lineages, which had marked host and geographical differences in phylogeny. Panorama genotypical analysis also revealed that H9N2 viruses include at least 98 genotypes, which were further divided according to their HA lineages into seven series (A-G). Phylogenetic analysis of the internal genes showed that H9N2 viruses are closely related to H3, H4, H5, H7, H10, and H14 subtype influenza viruses. Our results indicate that H9N2 viruses have undergone extensive reassortments to generate multiple reassortants and genotypes, suggesting that the continued circulation of multiple genotypical H9N2 viruses throughout the world in diverse hosts has the potential to cause future influenza outbreaks in poultry and epidemics in humans. We propose a nomenclature system for identifying and unifying all lineages and genotypes of H9N2 influenza viruses in order to facilitate international communication on the evolution, ecology and epidemiology of H9N2 influenza viruses.	[Dong, Guoying; Luo, Jing; Zhang, Hong; Wang, Chengmin; He, Hongxuan] Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Dong, Guoying; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100080, Peoples R China; [Duan, Mingxing] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Deliberto, Thomas Jude; Nolte, Dale Louis] US Anim & Plant Hlth Inspect Serv, Natl Wildlife Dis Program, Wildlife Serv, USDA, Ft Collins, CO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; United States Department of Agriculture (USDA)	Dong, GY (corresponding author), Chinese Acad Sci, Inst Zool, Natl Res Ctr Wildlife Born Dis, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	gj28@ibp.ac.cn; hehx@ioz.ac.cn		Ji, Guangju/0000-0001-8626-3490	Science & Technology Support Project of the eleventh-five-year plan of China [2009BAI83B01]; National Key Basic Research and Development Program of China [2007BC109103]; National Department of Science and Technology [2009ZX10004-109]; NWDP USDA-IOZ CAS joint project [0760621234]	Science & Technology Support Project of the eleventh-five-year plan of China; National Key Basic Research and Development Program of China(National Basic Research Program of China); National Department of Science and Technology; NWDP USDA-IOZ CAS joint project	This work was supported by grants from the Science & Technology Support Project of the eleventh-five-year plan of China (2009BAI83B01), the National Key Basic Research and Development Program of China (Grant No. 2007BC109103), the Special Major Project of the National Department of Science and Technology (2009ZX10004-109) and NWDP USDA-IOZ CAS joint project (0760621234). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir UB, 2007, VIROLOGY, V361, P45, DOI 10.1016/j.virol.2006.10.037; Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Banks J, 2000, AVIAN PATHOL, V29, P353, DOI 10.1080/03079450050118485; Brown IH, 1997, J GEN VIROL, V78, P553, DOI 10.1099/0022-1317-78-3-553; Brown IH, 2006, DEV BIOLOGICALS, V124, P45; Cameron KR, 2000, VIROLOGY, V278, P36, DOI 10.1006/viro.2000.0585; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; HOMME P J, 1970, Avian Diseases, V14, P66, DOI 10.2307/1588557; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Kawaoka Y, 1998, VIRUS RES, V55, P143, DOI 10.1016/S0168-1702(98)00038-0; Lee CW, 2000, AVIAN DIS, V44, P527, DOI 10.2307/1593091; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Lin YP, 2000, P NATL ACAD SCI USA, V97, P9654, DOI 10.1073/pnas.160270697; Liu JH, 2003, VIRUS GENES, V27, P291, DOI 10.1023/A:1026304117797; Liu S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005022; Lu JH, 2005, VIRUS GENES, V31, P163, DOI 10.1007/s11262-005-1790-1; Macken CA, 2006, J GEN VIROL, V87, P2803, DOI 10.1099/vir.0.81454-0; MUNIR I, 2009, PLOS ONE, V4, pE5788; Naeem K, 1999, VET REC, V145, P560, DOI 10.1136/vr.145.19.560; Nili H, 2002, AVIAN PATHOL, V31, P247, DOI 10.1080/03079450220136567; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perk S, 2006, DEV BIOLOGICALS, V124, P201; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P10389, DOI 10.1128/JVI.00979-07; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	36	62	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17212	10.1371/journal.pone.0017212	http://dx.doi.org/10.1371/journal.pone.0017212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386964	gold, Green Published			2022-12-27	WOS:000287931400037
J	McHugh, PC; Wright, JA; Brown, DR				McHugh, Patrick C.; Wright, Josephine A.; Brown, David R.			Transcriptional Regulation of the Beta-Synuclein 5 '-Promoter Metal Response Element by Metal Transcription Factor-1	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; MESSENGER-RNA; PROTEASOMAL FUNCTION; ALZHEIMERS-DISEASE; GAMMA-SYNUCLEIN; GENE-EXPRESSION; FACTOR MTF-1; LEWY BODY; PROTEIN	The progression of many human neurodegenerative disorders is associated with an accumulation of alpha-synuclein. Alpha-synuclein belongs to the homologous synuclein family, which includes beta-synuclein. It has been proposed that beta-synuclein may be a natural regulator of alpha-synuclein. Therefore controlling beta-synuclein expression may control the accumulation of alpha-synuclein and ultimately prevent disease progression. The regulation of synucleins is poorly understood. We investigated the transcriptional regulation of beta-synuclein, with the aim of identifying molecules that differentially control beta-synuclein expression levels. To investigate transcriptional regulation of beta-synuclein, we used reporter gene assays and bioinformatics. We identified a region -1.1/-0.6 kb upstream of the beta-synuclein translational start site to be a key regulatory region of beta-synuclein 5'-promoter activity in human dopaminergic cells (SH-SY5Y). Within this key promoter region we identified a metal response element pertaining to a putative Metal Transcription Factor-1 (MTF1) binding site. We demonstrated that MTF-1 binds to this 5'-promoter region using EMSA analysis. Moreover, we showed that MTF-1 differentially regulates beta-synuclein promoter binding site, as well as beta-synuclein mRNA and protein expression. This effect of MTF-1 on expression was found to be specific to beta-synuclein when compared to alpha-synuclein. Understanding the regulation of synucleins and how they interact may point to molecular targets that could be manipulated for therapeutic benefit. In this study we showed that MTF-1 differentially controls the expression of beta-synuclein when compared to its homolog alpha-synuclein. This could potentially provide a novel targets or pathways for therapeutic intervention and/or treatment of synucleinopathies.	[McHugh, Patrick C.; Wright, Josephine A.; Brown, David R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	McHugh, PC (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Wright, Josephine/0000-0003-4588-8827; McHugh, Patrick/0000-0003-0661-919X	Alzheimer's Research Trust [PG2007/1]; Alzheimers Research UK [ART-PG2007-1] Funding Source: researchfish	Alzheimer's Research Trust; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by Alzheimer's Research Trust/PG2007/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Bahadorani S, 2010, NEUROBIOL AGING, V31, P1215, DOI 10.1016/j.neurobiolaging.2008.08.001; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Binolfi A, 2008, J AM CHEM SOC, V130, P11801, DOI 10.1021/ja803494v; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Brown DR, 2004, NEUROBIOL DIS, V15, P534, DOI 10.1016/j.nbd.2003.11.009; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; DAVIES P, 2010, BIOCHEMISTRY-US, DOI DOI 10.1021/BI101582; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Fan Y, 2006, HUM MOL GENET, V15, P3002, DOI 10.1093/hmg/ddl242; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Galvin JE, 1999, P NATL ACAD SCI USA, V96, P13450, DOI 10.1073/pnas.96.23.13450; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; HEUCHEL R, 1994, EMBO J, V13, P2870, DOI 10.1002/j.1460-2075.1994.tb06581.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kruger R, 1999, ANN NEUROL, V45, P611, DOI 10.1002/1531-8249(199905)45:5<611::AID-ANA9>3.0.CO;2-X; LaRochelle O, 2008, J BIOL CHEM, V283, P8190, DOI 10.1074/jbc.M800640200; Lavedan C, 1998, GENOMICS, V54, P173, DOI 10.1006/geno.1998.5556; Lee JC, 2008, J AM CHEM SOC, V130, P6898, DOI 10.1021/ja711415b; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Lichtlen P, 2001, SWISS MED WKLY, V131, P647; McHugh PC, 2008, J NEUROSCI RES, V86, P306, DOI 10.1002/jnr.21482; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Mori F, 2003, NEUROREPORT, V14, P1783, DOI 10.1097/00001756-200310060-00005; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Ohtake H, 2004, NEUROLOGY, V63, P805, DOI 10.1212/01.WNL.0000139870.14385.3C; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pradet-Balade B, 2001, BIOTECHNIQUES, V30, P1352, DOI 10.2144/01306rr03; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Roth S, 2010, J TRACE ELEM MED BIO, V24, P130, DOI 10.1016/j.jtemb.2010.01.007; Saini N, 2010, BIOL CHEM, V391, P513, DOI 10.1515/BC.2010.052; Saydam N, 2001, J BIOL CHEM, V276, P25487, DOI 10.1074/jbc.M009154200; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; SERFLING E, 1985, EMBO J, V4, P3851, DOI 10.1002/j.1460-2075.1985.tb04157.x; SHEN Q, 2006, NAT NEUROSCI; Shinyashiki M, 2000, P NATL ACAD SCI USA, V97, P2491, DOI 10.1073/pnas.050586597; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Tabner BJ, 2002, FREE RADICAL BIO MED, V32, P1076, DOI 10.1016/S0891-5849(02)00801-8; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Wang XY, 2010, J NEUROCHEM, V113, P704, DOI 10.1111/j.1471-4159.2010.06638.x; West AB, 2001, EUR J HUM GENET, V9, P659, DOI 10.1038/sj.ejhg.5200698; Wright JA, 2009, CELL MOL LIFE SCI, V66, P3809, DOI 10.1007/s00018-009-0154-8; Wright JA, 2009, FASEB J, V23, P2384, DOI 10.1096/fj.09-130039; Xia Z, 1996, J Biochem Toxicol, V11, P203, DOI 10.1002/(SICI)1522-7146(1996)11:4<203::AID-JBT6>3.3.CO;2-F; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021	50	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17354	10.1371/journal.pone.0017354	http://dx.doi.org/10.1371/journal.pone.0017354			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386983	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287931400060
J	Masucci, AP; Kalampokis, A; Eguiluz, VM; Hernandez-Garcia, E				Paolo Masucci, Adolfo; Kalampokis, Alkiviadis; Martinez Eguiluz, Victor; Hernandez-Garcia, Emilio			Wikipedia Information Flow Analysis Reveals the Scale-Free Architecture of the Semantic Space	PLOS ONE			English	Article							NETWORKS; LANGUAGE; WEB; DYNAMICS; MODEL	In this paper we extract the topology of the semantic space in its encyclopedic acception, measuring the semantic flow between the different entries of the largest modern encyclopedia, Wikipedia, and thus creating a directed complex network of semantic flows. Notably at the percolation threshold the semantic space is characterised by scale-free behaviour at different levels of complexity and this relates the semantic space to a wide range of biological, social and linguistics phenomena. In particular we find that the cluster size distribution, representing the size of different semantic areas, is scale-free. Moreover the topology of the resulting semantic space is scale-free in the connectivity distribution and displays small-world properties. However its statistical properties do not allow a classical interpretation via a generative model based on a simple multiplicative process. After giving a detailed description and interpretation of the topological properties of the semantic space, we introduce a stochastic model of content-based network, based on a copy and mutation algorithm and on the Heaps' law, that is able to capture the main statistical properties of the analysed semantic space, including the Zipf's law for the word frequency distribution.	[Paolo Masucci, Adolfo; Martinez Eguiluz, Victor; Hernandez-Garcia, Emilio] Univ Illes Balears, CSIC, Inst Fis Interdisciplinar & Sistemas Complejos, Palma de Mallorca, Spain; [Kalampokis, Alkiviadis] Univ Aegean, Dept Marine Sci, Mitilini, Lesvos, Greece	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); University of Aegean	Masucci, AP (corresponding author), Univ Illes Balears, CSIC, Inst Fis Interdisciplinar & Sistemas Complejos, Palma de Mallorca, Spain.	paolo@ifisc.uib.es	Eguíluz, Víctor M./B-9655-2008; Hernandez-Garcia, Emilio/B-1271-2008	Eguíluz, Víctor M./0000-0003-1133-1289; Hernandez-Garcia, Emilio/0000-0002-9568-8287; Kalampokis, Alkiviadis/0000-0001-5619-5407	Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional [FIS2007-60327]	Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Supported by Ministerio de Ciencia e Innovacion and Fondo Europeo de Desarrollo Regional through project FISICOS (FIS2007-60327). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Serrano MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005372; Balcan D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000501; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Bastian M., 2009, INT AAAI C WEBL SOC, P361; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Berko Gleason J., PSYCHOLINGUISTICS; Bizer C, 2009, J WEB SEMANT, V7, P154, DOI 10.1016/j.websem.2009.07.002; Borge-Holthoefer J, 2010, EUR PHYS J B, V74, P265, DOI 10.1140/epjb/e2010-00058-9; CANCHO RFI, 2001, J QUANT LINGUIST, V8, P165, DOI DOI 10.1076/JQUL.8.3.165.4101; Capocci A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036116; Csardi G., 2006, INT J COMPLEX SYST, P1695; Deleuze G., 1976, RHIZOME; Deleuze Gilles, 2004, 1000 PLATEAUS CAPITA; DERRIDA J, 1972, MARGINS PHILOS; Dorogovtsev SN, 2001, P ROY SOC B-BIOL SCI, V268, P2603, DOI 10.1098/rspb.2001.1824; DOROGOVTSEV SN, 2003, EVOLUTION NETWORKS F; Eco Umberto, 1984, SEMIOTICS PHILOS LAN; Fitch WT, 2007, NATURE, V449, P665, DOI 10.1038/449665a; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; Holanda AD, 2004, PHYSICA A, V344, P530, DOI 10.1016/j.physa.2004.06.025; Hopper P.J., 1993, GRAMMATICALIZATION; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; LIN JH, 1991, IEEE T INFORM THEORY, V37, P145, DOI 10.1109/18.61115; Macdonald PJ, 2005, EUROPHYS LETT, V72, P308, DOI 10.1209/epl/i2005-10232-x; Masucci AP, 2007, PHYSICA A, V386, P557, DOI 10.1016/j.physa.2007.07.021; Masucci AP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026102; Masucci AP, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.026103; Menczer F, 2002, P NATL ACAD SCI USA, V99, P14014, DOI 10.1073/pnas.212348399; Montemurro MA, 2010, ADV COMPLEX SYST, V13, P135, DOI 10.1142/S0219525910002530; Muchnik L, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016106; Mungan M, 2005, J PHYS A-MATH GEN, V38, P9599, DOI 10.1088/0305-4470/38/44/001; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Ramasco JJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036122; Samsonovic AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010921; Sigman M, 2002, P NATL ACAD SCI USA, V99, P1742, DOI 10.1073/pnas.022341799; SIMON HA, 1955, BIOMETRIKA, V42, P425; Sinatra R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.178702; Skyrms B., 2010, SIGNALS EVOLUTION LE, DOI [DOI 10.1093/ACPROF:OSO/9780199580828.001.0001, 10.1093/acprof:oso/9780199580828.001.0001]; STAUFFER D, 1994, INTRO PERCOLATION TH; Steyvers M, 2005, COGNITIVE SCI, V29, P41, DOI 10.1207/s15516709cog2901_3; van Leijenhorst DC, 2005, INFORM SCIENCES, V170, P263, DOI 10.1016/j.ins.2004.03.006; VIOLI P, 1997, MEANING EXPERIENCE; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ZANETTE DH, 2005, J QUANT LINGUIST, V12, P29, DOI DOI 10.1080/09296170500055293; Zipf G. K., 1972, HUMAN BEHAV PRINCIPL	47	40	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17333	10.1371/journal.pone.0017333	http://dx.doi.org/10.1371/journal.pone.0017333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21407801	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400057
J	Ren, LP; McLean, JR; Hazbun, TR; Fields, S; Kooi, CV; Ohi, MD; Gould, KL				Ren, Liping; McLean, Janel R.; Hazbun, Tony R.; Fields, Stanley; Kooi, Craig Vander; Ohi, Melanie D.; Gould, Kathleen L.			Systematic Two-Hybrid and Comparative Proteomic Analyses Reveal Novel Yeast Pre-mRNA Splicing Factors Connected to Prp19	PLOS ONE			English	Article							PROTEIN-INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; U-BOX; PRP19P-ASSOCIATED COMPLEX; SPLICEOSOME ACTIVATION; PEPTIDE IDENTIFICATION; CATALYTIC ACTIVATION; HETEROLOGOUS MODULES	Prp19 is the founding member of the NineTeen Complex, or NTC, which is a spliceosomal subcomplex essential for spliceosome activation. To define Prp19 connectivity and dynamic protein interactions within the spliceosome, we systematically queried the Saccharomyces cerevisiae proteome for Prp19 WD40 domain interaction partners by two-hybrid analysis. We report that in addition to S. cerevisiae Cwc2, the splicing factor Prp17 binds directly to the Prp19 WD40 domain in a 1: 1 ratio. Prp17 binds simultaneously with Cwc2 indicating that it is part of the core NTC complex. We also find that the previously uncharacterized protein Urn1 (Dre4 in Schizosaccharomyces pombe) directly interacts with Prp19, and that Dre4 is conditionally required for pre-mRNA splicing in S. pombe. S. pombe Dre4 and S. cerevisiae Urn1 co-purify U2, U5, and U6 snRNAs and multiple splicing factors, and dre4 Delta and urn1 Delta strains display numerous negative genetic interactions with known splicing mutants. The S. pombe Prp19-containing Dre4 complex co-purifies three previously uncharacterized proteins that participate in pre-mRNA splicing, likely before spliceosome activation. Our multi-faceted approach has revealed new low abundance splicing factors connected to NTC function, provides evidence for distinct Prp19 containing complexes, and underscores the role of the Prp19 WD40 domain as a splicing scaffold.	[Ren, Liping; McLean, Janel R.; Hazbun, Tony R.; Fields, Stanley; Gould, Kathleen L.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Ren, Liping; McLean, Janel R.; Ohi, Melanie D.; Gould, Kathleen L.] Univ Washington, Sch Med, Vanderbilt Univ, Dept Cell & Dev Biol, Seattle, WA 98195 USA; [Hazbun, Tony R.; Fields, Stanley] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Hazbun, Tony R.; Fields, Stanley] Univ Washington, Dept Med, Seattle, WA USA; [Kooi, Craig Vander] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY USA; [Kooi, Craig Vander] Univ Kentucky, Struct Biol Ctr, Lexington, KY USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Kentucky; University of Kentucky	Ren, LP (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	kathy.gould@vanderbilt.edu	Hazbun, Tony/K-2597-2019	Hazbun, Tony/0000-0003-0675-8093; Gould, Kathleen/0000-0002-3810-4070	NCI [T32CA119925]; National Institutes of Health [P41 RR11823, 1DP2OD004483, P20RR020171]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA119925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171, P41RR011823] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004483] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.R.M. was supported by NCI T32CA119925. This work was supported by National Institutes of Health grant P41 RR11823 (S. F.), NIH operating grant 1DP2OD004483 (M.D.O.), P20RR020171 (C. W. V. K.) and the Howard Hughes Medical Institute (http://www.hhmi.org/), of which S. F. and K. L. G. are investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DS, 2008, J BIOL CHEM, V283, P31256, DOI 10.1074/jbc.M803512200; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Ben Yehuda S, 1998, RNA, V4, P1304; Bonet R, 2008, PROTEINS, V73, P1001, DOI 10.1002/prot.22127; Burns C G, 1999, Front Horm Res, V25, P59; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen HR, 1998, MOL CELL BIOL, V18, P2196, DOI 10.1128/MCB.18.4.2196; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; COLLART M, 1993, CURRENT PROTOCOLS MO; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Craggs G, 2001, J BIOL CHEM, V276, P30552, DOI 10.1074/jbc.M103142200; DASILVA KVCL, 1995, CURR GENET, V27, P207, DOI 10.1007/BF00326150; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gomez EB, 2005, GENETICS, V169, P77, DOI 10.1534/genetics.104.034231; Gotzmann J, 2000, EXP CELL RES, V261, P166, DOI 10.1006/excr.2000.5025; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; GUTHRIE C, GUIDE YEAST GENETICS; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HENRIQUES JAP, 1989, MUTAT RES, V218, P111, DOI 10.1016/0921-8777(89)90017-7; James P, 1996, GENETICS, V144, P1425; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kawashima T, 2009, RNA, V15, P2236, DOI 10.1261/rna.1736809; KEENEY JB, 1994, GENETICS, V136, P849; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; Liakopoulos D, 1998, EMBO J, V17, P2208, DOI 10.1093/emboj/17.8.2208; Lindsey LA, 1998, J BIOL CHEM, V273, P32771, DOI 10.1074/jbc.273.49.32771; Lindsey-Boltz LA, 2000, RNA, V6, P1289, DOI 10.1017/S1355838200000327; Liu WG, 1997, HUM GENET, V99, P578, DOI 10.1007/s004390050409; Llorian M, 2004, BIOCHEM J, V378, P229, DOI 10.1042/BJ20030950; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; McDonald WH, 1999, MOL CELL BIOL, V19, P5352; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; MEIRA LB, 1992, MOL GEN GENET, V235, P311, DOI 10.1007/BF00279375; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Ohi MD, 2005, MOL CELL BIOL, V25, P451, DOI 10.1128/MCB.25.1.451-460.2005; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Ohi MD, 2007, P NATL ACAD SCI USA, V104, P3195, DOI 10.1073/pnas.0611591104; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Roberts-Galbraith RH, 2009, J CELL BIOL, V184, P113, DOI 10.1083/jcb.200806044; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Sapra AK, 2004, J BIOL CHEM, V279, P52437, DOI 10.1074/jbc.M408815200; Sapra AK, 2008, BIOCHEM J, V416, P365, DOI 10.1042/BJ20081195; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Seshadri V, 1996, GENETICS, V143, P45; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054; TARN WY, 1993, P NATL ACAD SCI USA, V90, P10821, DOI 10.1073/pnas.90.22.10821; TARN WY, 1993, MOL CELL BIOL, V13, P1883, DOI 10.1128/MCB.13.3.1883; TARN WY, 1994, EMBO J, V13, P2421, DOI 10.1002/j.1460-2075.1994.tb06527.x; Tasto JJ, 2001, YEAST, V18, P657, DOI 10.1002/yea.713; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vander Kooi CW, 2010, STRUCTURE, V18, P584, DOI 10.1016/j.str.2010.02.015; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; YEH H, 1994, GENOMICS, V23, P443, DOI 10.1006/geno.1994.1521; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zhang B, 2007, J PROTEOME RES, V6, P3549, DOI 10.1021/pr070230d	76	43	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16719	10.1371/journal.pone.0016719	http://dx.doi.org/10.1371/journal.pone.0016719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386897	gold, Green Published			2022-12-27	WOS:000287931400010
J	Varshney, A; Rehan, M; Subbarao, N; Rabbani, G; Khan, RH				Varshney, Ankita; Rehan, Mohd; Subbarao, Naidu; Rabbani, Gulam; Khan, Rizwan Hasan			Elimination of Endogenous Toxin, Creatinine from Blood Plasma Depends on Albumin Conformation: Site Specific Uremic Toxicity & Impaired Drug Binding	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; RENAL-FAILURE; HEMODIALYSIS-PATIENTS; GUANIDINO COMPOUNDS; MOLECULAR DOCKING; HYPERTENSION; MICROALBUMINURIA; POPULATION; MORTALITY; REMOVAL	Uremic syndrome results from malfunctioning of various organ systems due to the retention of uremic toxins which, under normal conditions, would be excreted into the urine and/or metabolized by the kidneys. The aim of this study was to elucidate the mechanisms underlying the renal elimination of uremic toxin creatinine that accumulate in chronic renal failure. Quantitative investigation of the plausible correlations was performed by spectroscopy, calorimetry, molecular docking and accessibility of surface area. Alkalinization of normal plasma from pH 7.0 to 9.0 modifies the distribution of toxin in the body and therefore may affect both the accumulation and the rate of toxin elimination. The ligand loading of HSA with uremic toxin predicts several key side chain interactions of site I that presumably have the potential to impact the specificity and impaired drug binding. These findings provide useful information for elucidating the complicated mechanism of toxin disposition in renal disease state.	[Varshney, Ankita; Rabbani, Gulam; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India; [Rehan, Mohd; Subbarao, Naidu] Jawaharlal Nehru Univ, Sch Informat Technol, Ctr Computat Biol & Bioinformat, New Delhi 110067, India	Aligarh Muslim University; Jawaharlal Nehru University, New Delhi	Varshney, A (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Subbarao, Prof Naidu/AAZ-1832-2020; Rehan, Mohd/H-9835-2012; Khan, Rizwan Hasan/F-8276-2014; Khan, Rizwan/GXZ-5789-2022; Rabbani, Gulam/AAE-5629-2022	Subbarao, Prof Naidu/0000-0002-1720-2165; Khan, Rizwan Hasan/0000-0002-9965-8982; Rabbani, Gulam/0000-0002-5293-8231; Rehan, Mohd/0000-0003-4898-6043	Council of Scientific and Industrial Research, New Delhi [37/1278/06 EMR-II]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Council of Scientific and Industrial Research, New Delhi [37/1278/06 EMR-II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad B, 2005, ARCH BIOCHEM BIOPHYS, V437, P159, DOI 10.1016/j.abb.2005.03.013; Berge-Lefranc D, 2009, MICROPOR MESOPOR MAT, V119, P186, DOI 10.1016/j.micromeso.2008.10.016; Brantsma AH, 2006, J AM SOC NEPHROL, V17, P331, DOI 10.1681/ASN.2005111153; Celej MS, 2005, BBA-PROTEINS PROTEOM, V1750, P122, DOI 10.1016/j.bbapap.2005.05.003; Cheema MA, 2007, BIOMACROMOLECULES, V8, P2576, DOI 10.1021/bm070354j; De Deyn PP, 2009, SEMIN DIALYSIS, V22, P340, DOI 10.1111/j.1525-139X.2009.00577.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Forman JP, 2006, KIDNEY INT, V69, P22, DOI 10.1038/sj.ki.5000056; Gao HW, 2008, BIOPHYS J, V94, P906, DOI 10.1529/biophysj.107.120865; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Ghosh KS, 2009, BIOPOLYMERS, V91, P737, DOI 10.1002/bip.21220; Glorieux GL, 2004, KIDNEY INT, V65, P2184, DOI 10.1111/j.1523-1755.2004.00631.x; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Ivanov AI, 2002, ARCH BIOCHEM BIOPHYS, V408, P69, DOI 10.1016/S0003-9861(02)00533-7; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kang J, 2004, BBA-GEN SUBJECTS, V1674, P205, DOI 10.1016/j.bbagen.2004.06.021; Kestenbaum B, 2008, ANN INTERN MED, V148, P501, DOI 10.7326/0003-4819-148-7-200804010-00006; Kosa T, 2007, J PHARM SCI-US, V96, P3117, DOI 10.1002/jps.20887; Mattix HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341034; Mingrone G, 1997, CLIN CHIM ACTA, V260, P27, DOI 10.1016/S0009-8981(96)06504-7; Perna AF, 2004, J AM SOC NEPHROL, V15, P2747, DOI 10.1097/01.ASN.0000141041.71717.11; PETERSON JC, 1995, ANN INTERN MED, V123, P754, DOI 10.7326/0003-4819-123-10-199511150-00003; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sarnatskaya VV, 2007, ARTIF CELL BLOOD SUB, V35, P287, DOI 10.1080/10731190701378618; Sarnatskaya VV, 2002, BIOCHEM PHARMACOL, V63, P1287, DOI 10.1016/S0006-2952(02)00869-9; Sarnatskaya VV, 1998, ARTIF ORGANS, V22, P107; Sun H, 2006, PHARMACOL THERAPEUT, V109, P1, DOI 10.1016/j.pharmthera.2005.05.010; Taes YEC, 2008, NEPHROL DIAL TRANSPL, V23, P1330, DOI 10.1093/ndt/gfm793; Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y; Vaidya VS, 2009, KIDNEY INT, V76, P108, DOI 10.1038/ki.2009.96; Van Biesen W, 2007, EUR HEART J, V28, P478, DOI 10.1093/eurheartj/ehl455; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Vanholder R, 2003, ARTIF ORGANS, V27, P218, DOI 10.1046/j.1525-1594.2003.07212.x; VANHOLDER R, 1994, SEMIN NEPHROL, V14, P205; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Vanholder R, 2001, INT J ARTIF ORGANS, V24, P695, DOI 10.1177/039139880102401004; Varshney A, 2008, INT J BIOL MACROMOL, V42, P483, DOI 10.1016/j.ijbiomac.2008.03.004; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; YANG M, 1998, J BEIJING MED U, V30, P97	43	83	83	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17230	10.1371/journal.pone.0017230	http://dx.doi.org/10.1371/journal.pone.0017230			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386972	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400038
J	Di Meglio, P; Di Cesare, A; Laggner, U; Chu, CC; Napolitano, L; Villanova, F; Tosi, I; Capon, F; Trembath, RC; Peris, K; Nestle, FO				Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Capon, Francesca; Trembath, Richard C.; Peris, Ketty; Nestle, Frank O.			The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR-BETA; GENOME-WIDE ASSOCIATION; T-HELPER-CELLS; INTESTINAL INFLAMMATION; AUTOIMMUNE INFLAMMATION; CROHNS-DISEASE; PSORIASIS-VULGARIS; IL-23; INTERLEUKIN-23	IL-23 and Th17 cells are key players in tissue immunosurveillance and are implicated in human immune-mediated diseases. Genome-wide association studies have shown that the IL23R R381Q gene variant protects against psoriasis, Crohn's disease and ankylosing spondylitis. We investigated the immunological consequences of the protective IL23R R381Q gene variant in healthy donors. The IL23R R381Q gene variant had no major effect on Th17 cell differentiation as the frequency of circulating Th17 cells was similar in carriers of the IL23R protective (A) and common (G) allele. Accordingly, Th17 cells generated from (and G donors produced similar amounts of Th17 cytokines. However, IL-23-mediated Th17 cell effector function was impaired, as Th17 cells from (allele carriers had significantly reduced IL-23-induced IL-17(production and STAT3 phosphorylation compared to G allele carriers. Our functional analysis of (human disease-associated gene variant demonstrates that IL23R R381Q exerts its protective effects through selective attenuation of IL-23-induced Th17 cell effector function without interfering with Th17 differentiation, and highlights its importance in the protection against IL-23-induced tissue pathologies.	[Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Nestle, Frank O.] Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England; [Di Meglio, Paola; Di Cesare, Antonella; Laggner, Ute; Chu, Chung-Ching; Napolitano, Luca; Villanova, Federica; Tosi, Isabella; Capon, Francesca; Trembath, Richard C.; Nestle, Frank O.] NIHR Biomed Res Ctr, London, England; [Capon, Francesca; Trembath, Richard C.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Di Cesare, Antonella; Peris, Ketty] Univ Aquila, Dept Dermatol, I-67100 Laquila, Italy	University of London; King's College London; University of London; King's College London; University of L'Aquila	Di Meglio, P (corresponding author), Kings Coll London, St Johns Inst Dermatol, London WC2R 2LS, England.	frank.nestle@kcl.ac.uk	Capon, Francesca/F-4763-2011	Capon, Francesca/0000-0003-2432-5793; Peris, Ketty/0000-0002-5237-0463; Trembath, Richard/0000-0003-0550-3400; Di Meglio, Paola/0000-0002-2066-7780	Wellcome Trust [GR078173MA]; National Institutes of Health [RO1AR040065]; NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK [G0601387]; Dunhill Medical Trust; SIDeMaST; Wyeth Advances in Psoriasis Research; MRC [G0601387] Funding Source: UKRI; Medical Research Council [G0600698B, G0601387] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040065] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR Comprehensive Biomedical Research Centre Guy's; St. Thomas' Hospital and King's College London; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); SIDeMaST; Wyeth Advances in Psoriasis Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We acknowledge support by the following grant funding bodies: Wellcome Trust Programme GR078173MA, National Institutes of Health RO1AR040065, NIHR Comprehensive Biomedical Research Centre Guy's and St. Thomas' Hospital and King's College London, Medical Research Council UK Programme G0601387 and fellowships,Dunhill Medical Trust. A.D.C. was supported by a SIDeMaST fellowship award. L.N. was supported by an unrestricted Wyeth Advances in Psoriasis Research Grant Programme Award. The funders had no role in study design, data collection and analysis, decision to publish, or p[reparation of the manuscript.	Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Boniface K, 2010, J IMMUNOL, V185, P679, DOI 10.4049/jimmunol.1000366; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chen Y, 2006, J CLIN INVEST, V116, P1317, DOI 10.1172/JCI25308; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; de Paus RA, 2008, MOL IMMUNOL, V45, P3889, DOI 10.1016/j.molimm.2008.06.029; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duffin KC, 2009, J INVEST DERMATOL, V129, P827, DOI 10.1038/jid.2008.308; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt C, 2005, INFLAMM BOWEL DIS, V11, P16, DOI 10.1097/00054725-200501000-00003; Tonel G, 2010, J IMMUNOL, V185, P5688, DOI 10.4049/jimmunol.1001538; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	41	196	200	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17160	10.1371/journal.pone.0017160	http://dx.doi.org/10.1371/journal.pone.0017160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364948	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600033
J	Pandit, B; Gartel, AL				Pandit, Bulbul; Gartel, Andrei L.			Thiazole Antibiotic Thiostrepton Synergize with Bortezomib to Induce Apoptosis in Cancer Cells	PLOS ONE			English	Article							ANTICANCER; COMBINATION; INHIBITORS; CURCUMIN	Thiazole antibiotic, thiostrepton was recently identified as proteasome inhibitor. We investigated the therapeutic potential of the combination of thiostrepton and proteasome inhibitor bortezomib (Velcade) on various human tumor cell lines. Combination of sub-lethal concentrations of thiostrepton and bortezomib induced potent apoptosis and inhibition of long-term colony formation in a wide variety of human cancer cell lines. The synergistic relationship between thiostrepton and bortezomib combination was also quantitatively demonstrated by calculating their combination index values that were much lower than 1 in all studied cell lines. The synergy between these drugs was based on their proteasome inhibitory activities, because thiostrepton modification, thiostrepton methyl ester, which did not have intact quinaldic acid ring and did not inhibit proteasome activity failed to demonstrate any synergy in combination with bortezomib.	[Pandit, Bulbul; Gartel, Andrei L.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Gartel, Andrei L.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL USA; [Gartel, Andrei L.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Pandit, B (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	agartel@uic.edu			National Institutes of Health [1RO1CA1294414, 1R21CA134615]; NATIONAL CANCER INSTITUTE [R21CA134615] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by National Institutes of Health grants 1RO1CA1294414 and 1R21CA134615 (A. L. Gartel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BK, 2004, BIOORGAN MED CHEM, V12, P3871, DOI 10.1016/j.bmc.2004.05.006; Bhat UG, 2008, CELL CYCLE, V7, P1851, DOI 10.4161/cc.7.12.6032; Bhat UG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005592; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Pandit B, 2011, CANCER BIOL THER, V11, P43, DOI 10.4161/cbt.11.1.13854; Pandit B, 2010, PROSTATE, V70, P825, DOI 10.1002/pros.21116; Park J, 2008, MOL ONCOL, V2, P317, DOI 10.1016/j.molonc.2008.09.006; Schoof S, 2010, ANGEW CHEM INT EDIT, V49, P3317, DOI 10.1002/anie.200906988; Shirley RB, 2005, NEOPLASIA, V7, P1104, DOI 10.1593/neo.05520	9	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17110	10.1371/journal.pone.0017110	http://dx.doi.org/10.1371/journal.pone.0017110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365012	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800026
J	Van Cutsem, G; Ford, N; Hildebrand, K; Goemaere, E; Mathee, S; Abrahams, M; Coetzee, D; Boulle, A				Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Goemaere, Eric; Mathee, Shaheed; Abrahams, Musaed; Coetzee, David; Boulle, Andrew			Correcting for Mortality Among Patients Lost to Follow Up on Antiretroviral Therapy in South Africa: A Cohort Analysis	PLOS ONE			English	Article							OUTCOMES; CARE; KHAYELITSHA; EXPERIENCE; PROGRAMS; RETENTION; ADHERENCE; INCOME	Background: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) programmes, since it encompasses patients alive but lost to programme and deaths misclassified as LTF. We describe LTF before and after correction for mortality in a primary care ART programme with linkages to the national vital registration system. Methods and Findings: We included 6411 patients enrolled on ART between March 2001 and June 2007. Patients LTF with available civil identification numbers were matched with the national vital registration system to ascertain vital status. Corrected mortality and true LTF were determined by weighting these patients to represent all patients LTF. We used Kaplan-Meier estimates and Cox regression to describe LTF, mortality among those LTF, and true LTF. Of 627 patients LTF, 85 (28.8%) had died within 3 months after their last clinic visits. Respective estimates of LTF before and after correction for mortality were 6.9% (95% confidence interval [ CI] 6.2-7.6) and 4.3% (95% CI 3.5-5.3) at one year on ART, and 23.9% (95% CI 21.0-27.2) and 19.7% (95% CI 16.1-23.7) at 5 years. After correction for mortality, the hazard of LTF was reversed from decreasing to increasing with time on ART. Younger age, higher baseline CD4 count, pregnancy and increasing calendar year were associated with higher true LTF. Mortality of patients LTF at 1, 12 and 24 months after their last visits was respectively 23.1%, 30.9% and 43.8%; 78.0% of deaths occurred during the first 3 months after last visit and 45.0% in patients on ART for 0 to 3 months. Conclusions: Mortality of patients LTF was high and occurred early after last clinic visit, especially in patients recently started on ART. Correction for these misclassified deaths revealed that the risk of true LTF increased over time. Research targeting groups at higher risk of LTF (youth, pregnant women and patients with higher CD4 counts) is needed.	[Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Goemaere, Eric; Abrahams, Musaed] Med Sans Frontieres, Cape Town, South Africa; [Van Cutsem, Gilles; Ford, Nathan; Hildebrand, Katherine; Coetzee, David; Boulle, Andrew] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Mathee, Shaheed] Prov Govt Western Cape, Dept Hlth, Cape Town, South Africa	University of Cape Town	Van Cutsem, G (corresponding author), Med Sans Frontieres, Cape Town, South Africa.	gillesvancutsem@gmail.com	Boulle, Andrew/C-1413-2008; Van Cutsem, Gilles/ABB-1171-2021	Boulle, Andrew/0000-0002-7713-8062; Van Cutsem, Gilles/0000-0002-8972-4480	M�decins Sans Fronti�res [09_NAT_ERB_013] Funding Source: researchfish	M�decins Sans Fronti�res		Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; CHI B, 2010, 18 INT AIDS C; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Coetzee D, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406003-00006; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Deribe K, 2008, TROP MED INT HEALTH, V13, P328, DOI 10.1111/j.1365-3156.2008.02006.x; Ford N, 2010, AIDS, V24, P2645, DOI 10.1097/QAD.0b013e32833ec5b2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Fox MP, 2010, TROP MED INT HEALTH, V15, P405, DOI 10.1111/j.1365-3156.2010.02473.x; Fox RC, 2006, CAMB Q HEALTHC ETHIC, V15, P302; GENG EH, J ACQUIR IMMUNE DEFI, V53, P405; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Losina E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000173; Maskew M, 2007, SAMJ S AFR MED J, V97, P853; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Nachega JB, 2010, CURR OPIN HIV AIDS, V5, P70, DOI 10.1097/COH.0b013e328333ad61; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *STAT S AFR, 2009, MOR CAUS DEATH S AFR; World Health Organization, 2009, RAP ADV ANT THER HIV; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739; Zachariah R, 2008, T ROY SOC TROP MED H, V102, P288, DOI 10.1016/j.trstmh.2007.12.007	30	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14684	10.1371/journal.pone.0014684	http://dx.doi.org/10.1371/journal.pone.0014684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379378	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300003
J	Razanajatovo, NH; Richard, V; Hoffmann, J; Reynes, JM; Razafitrimo, GM; Randremanana, RV; Heraud, JM				Razanajatovo, Norosoa Harline; Richard, Vincent; Hoffmann, Jonathan; Reynes, Jean-Marc; Razafitrimo, Girard Marcellin; Randremanana, Rindra Vatosoa; Heraud, Jean-Michel			Viral Etiology of Influenza-Like Illnesses in Antananarivo, Madagascar, July 2008 to June 2009	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; REAL-TIME PCR; HOSPITALIZED CHILDREN; HUMAN METAPNEUMOVIRUS; SEASONAL INFLUENZA; TRACT INFECTIONS; CORONAVIRUS; DIAGNOSIS; DISEASE; ASSAY	Background: In Madagascar, despite an influenza surveillance established since 1978, little is known about the etiology and prevalence of viruses other than influenza causing influenza-like illnesses (ILIs). Methodology/Principal Findings: From July 2008 to June 2009, we collected respiratory specimens from patients who presented ILIs symptoms in public and private clinics in Antananarivo (the capital city of Madagascar). ILIs were defined as body temperature >= 38 degrees C and cough and at least two of the following symptoms: sore throat, rhinorrhea, headache and muscular pain, for a maximum duration of 3 days. We screened these specimens using five multiplex real time Reverse Transcription and/or Polymerase Chain Reaction assays for detection of 14 respiratory viruses. We detected respiratory viruses in 235/313 (75.1%) samples. Overall influenza virus A (27.3%) was the most common virus followed by rhinovirus (24.8%), RSV (21.2%), adenovirus (6.1%), coronavirus OC43 (6.1%), influenza virus B (3.9%), parainfluenza virus-3 (2.9%), and parainfluenza virus-1 (2.3%). Co-infections occurred in 29.4% (69/235) of infected patients and rhinovirus was the most detected virus (27.5%). Children under 5 years were more likely to have one or more detectable virus associated with their ILI. In this age group, compared to those >= 5 years, the risk of detecting more than one virus was higher (OR = 1.9), as was the risk of detecting of RSV (OR = 10.1) and adenovirus (OR = 4.7). While rhinovirus and adenovirus infections occurred year round, RSV, influenza virus A and coronavirus OC43 had defined period of circulation. Conclusions: In our study, we found that respiratory viruses play an important role in ILIs in the Malagasy community, particularly in children under 5 years old. These data provide a better understanding of the viral etiology of outpatients with ILI and describe for the first time importance of these viruses in different age group and their period of circulation.	[Razanajatovo, Norosoa Harline; Hoffmann, Jonathan; Reynes, Jean-Marc; Razafitrimo, Girard Marcellin; Heraud, Jean-Michel] Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar; [Richard, Vincent; Randremanana, Rindra Vatosoa] IPM, Epidemiol Unit, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Heraud, JM (corresponding author), Inst Pasteur Madagascar, Virol Unit, Natl Influenza Ctr, Antananarivo, Madagascar.	jmheraud@pasteur.mg	Reynes, Jean-Marc/M-6108-2014; Heraud, Jean-Michel/O-1464-2013	Heraud, Jean-Michel/0000-0003-1107-0859; Reynes, Jean-Marc/0000-0002-3712-941X; Vincent, RICHARD/0000-0002-6961-1753; HOFFMANN, JONATHAN/0000-0002-2400-8862	WHO Geneva [OD/AP-08-02451]; Sanofi-Pasteur; French Ministry of Health; US Centers for Disease Control and Prevention [U51/IP000327-01]; US Department of Health and Human Service via the International Network of Pasteur Institutes [6 IDSEP060001-01-01]; National Center for Immunization and Respiratory Diseases (NCIRD) [U51IP000327] Funding Source: NIH RePORTER	WHO Geneva(World Health Organization); Sanofi-Pasteur; French Ministry of Health; US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); US Department of Health and Human Service via the International Network of Pasteur Institutes; National Center for Immunization and Respiratory Diseases (NCIRD)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by WHO Geneva (APW/Ref. OD/AP-08-02451), Sanofi-Pasteur, the French Ministry of Health, the US Centers for Disease Control and Prevention (Cooperative Agreement Number: U51/IP000327-01) and the US Department of Health and Human Service (Grant Number 6 IDSEP060001-01-01) via the International Network of Pasteur Institutes. The authors are therefore grateful to Wenqing Zhang from WHO Geneva, Beatrice Barret and Myriam Beigeaud from Sanofi Pasteur and Kathleen Victoir and Marc Jouan from the International Network of Pasteur Institutes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chan PKS, 2009, J MED VIROL, V81, P1797, DOI 10.1002/jmv.21551; Chen HL, 2004, J TROP PEDIATRICS, V50, P279, DOI 10.1093/tropej/50.5.279; Di Carlo P, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-11; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; El-Hajje MJ, 2008, PRESSE MED, V37, P37, DOI 10.1016/j.lpm.2007.06.023; Hindiyeh M, 2001, AM J CLIN PATHOL, V116, P218; Jartti T, 2004, J MED VIROL, V72, P695, DOI 10.1002/jmv.20027; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Mathisen M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-35; Matthew J, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-16; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Pabbaraju K, 2007, J CLIN VIROL, V40, P186, DOI 10.1016/j.jcv.2007.08.004; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Puzelli S, 2009, J MED VIROL, V81, P2066, DOI 10.1002/jmv.21610; Rabarijaona L. P., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P20; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Raobijaona H., 1999, Archives de l'Institut Pasteur de Madagascar, V65, P107; Rasamoelisoa J. M., 1999, Archives de l'Institut Pasteur de Madagascar, V65, P127; RAVAOARINORO M, 1986, Archives de l'Institut Pasteur de Madagascar, V52, P147; Sapin G, 2001, B SOC PATHOL EXOT, V94, P3; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; Soares J. L., 2003, Archives de l'Institut Pasteur de Madagascar, V69, P12; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Williams JV, 2006, J INFECT DIS, V193, P387, DOI 10.1086/499274; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2010, AC RESP INF CHILDR; World Health Organization, 1999, WHOCDSCSRISR992	35	60	62	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17579	10.1371/journal.pone.0017579	http://dx.doi.org/10.1371/journal.pone.0017579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390235	Green Published, gold			2022-12-27	WOS:000287965200029
J	Granadeiro, JP; Phillips, RA; Brickle, P; Catry, P				Granadeiro, Jose P.; Phillips, Richard A.; Brickle, Paul; Catry, Paulo			Albatrosses Following Fishing Vessels: How Badly Hooked Are They on an Easy Meal?	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERY; BLACK-BROWED ALBATROSS; DIOMEDEA-EXULANS; FALKLAND ISLANDS; GPS TRACKING; SEABIRDS; PETRELS; RESPONSES; TRAWLERS; RATES	Fisheries have major impacts on seabirds, both by changing food availability and by causing direct mortality of birds during trawling and longline setting. However, little is known about the nature and the spatial-temporal extent of the interactions between individual birds and vessels. By studying a system in which we had fine-scale data on bird movements and activity, and near real-time information on vessel distribution, we provide new insights on the association of a threatened albatross with fisheries. During early chick-rearing, black-browed albatrosses Thalassarche melanophris from two different colonies (separated by only 75 km) showed significant differences in the degree of association with fisheries, despite being nearly equidistant to the Falklands fishing fleet. Most foraging trips from either colony did not bring tracked individuals close to vessels, and proportionally little time and foraging effort was spent near ships. Nevertheless, a few individuals repeatedly visited fishing vessels, which may indicate they specialise on fisheries-linked food sources and so are potentially more vulnerable to bycatch. The evidence suggests that this population has little reliance on fisheries discards at a critical stage of its nesting cycle, and hence measures to limit fisheries waste on the Patagonian shelf that also reduce vessel attractiveness and the risk of incidental mortality, would be of high overall conservation benefit.	[Granadeiro, Jose P.] Univ Lisbon, Museu Nacl Hist Nat, CESAM, Lisbon, Portugal; [Phillips, Richard A.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Catry, Paulo] ISPA, Ecoethol Res Unit, Lisbon, Portugal	Universidade de Lisboa; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Instituto Superior Psicologia Aplicada (ISPA)	Granadeiro, JP (corresponding author), Univ Lisbon, Museu Nacl Hist Nat, CESAM, Lisbon, Portugal.	jpgranadeiro@fc.ul.pt	Granadeiro, José Pedro/E-8060-2011; Catry, Paulo/I-5408-2013	Granadeiro, José Pedro/0000-0002-7207-3474; Catry, Paulo/0000-0003-3000-0522; Brickle, Paul/0000-0002-9870-3518	Fundacao para a Ciencia e Tecnologia [PTDC/MAR/099366/2008]; Programa Plurianual [UID 331/94]; Falkland Islands Government; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Plurianual; Falkland Islands Government; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by Fundacao para a Ciencia e Tecnologia (www.fct.mctes.pt, Portugal) through Project PTDC/MAR/099366/2008 and as part of the Programa Plurianual (UI&D 331/94) and by the Falkland Islands Government (http://www.falklands.gov.fk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACAP, 2009, ACAP SPEC ASS BLACK; Arata J, 2003, POLAR BIOL, V26, P638, DOI 10.1007/s00300-003-0530-z; Bartumeus F, 2010, CURR BIOL, V20, P215, DOI 10.1016/j.cub.2009.11.073; Batschelet E, 1981, CIRCULAR STAT BIOL; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Brothers NP, 1999, FAO FISHERIES CIRCUL; Bugoni Leandro, 2008, Endangered Species Research, V5, P137, DOI 10.3354/esr00115; Bugoni L, 2010, J EXP MAR BIOL ECOL, V391, P190, DOI 10.1016/j.jembe.2010.06.027; Catry P, 2006, ANIM BEHAV, V72, P383, DOI 10.1016/j.anbehav.2005.10.030; Cuthbert R, 2005, BIOL CONSERV, V121, P345, DOI 10.1016/j.biocon.2004.05.007; FAVERO M, 2010, ANIM CONSER IN PRESS; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Furness RW, 2003, SCI MAR, V67, P33, DOI 10.3989/scimar.2003.67s233; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Huin N, 2002, AQUAT CONSERV, V12, P89, DOI 10.1002/aqc.479; Hyrenbach KD, 2003, BIOL CONSERV, V112, P391, DOI 10.1016/S0006-3207(02)00337-3; Jimenez S, 2010, AQUAT LIVING RESOUR, V23, P49, DOI 10.1051/alr/2010002; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Montevecchi William A., 2002, P527; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; Otley H, 2007, POLAR BIOL, V30, P359, DOI 10.1007/s00300-006-0192-8; Petersen Samantha L., 2008, Endangered Species Research, V5, P117, DOI 10.3354/esr00132; Phalan B, 2007, MAR ECOL PROG SER, V340, P271, DOI 10.3354/meps340271; Phillips RA, 2006, BIOL CONSERV, V129, P336, DOI 10.1016/j.biocon.2005.10.046; Pierre JP, 2010, BIOL CONSERV, V143, P2779, DOI 10.1016/j.biocon.2010.07.026; Skov H, 2001, MAR ECOL PROG SER, V214, P289, DOI 10.3354/meps214289; Sullivan BJ, 2006, BIOL CONSERV, V131, P495, DOI 10.1016/j.biocon.2006.02.007; THOMPSON KR, 1995, IBIS, V137, P198, DOI 10.1111/j.1474-919X.1995.tb03240.x; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Witt MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001111; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	34	51	53	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17467	10.1371/journal.pone.0017467	http://dx.doi.org/10.1371/journal.pone.0017467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399696	Green Submitted, gold, Green Published			2022-12-27	WOS:000287933300025
J	Muhly, TB; Semeniuk, C; Massolo, A; Hickman, L; Musiani, M				Muhly, Tyler B.; Semeniuk, Christina; Massolo, Alessandro; Hickman, Laura; Musiani, Marco			Human Activity Helps Prey Win the Predator-Prey Space Race	PLOS ONE			English	Article							PHOTOGRAPHIC RATES; ESTIMATE DENSITIES; HABITAT SELECTION; TROPHIC CASCADES; CRYPTIC MAMMALS; NATIONAL-PARK; CAMERA TRAPS; WOLVES; RISK; ELK	Predator-prey interactions, including between large mammalian wildlife species, can be represented as a "space race'', where prey try to minimize and predators maximize spatial overlap. Human activity can also influence the distribution of wildlife species. In particular, high-human disturbance can displace large carnivore predators, a trait-mediated direct effect. Predator displacement by humans could then indirectly benefit prey species by reducing predation risk, a trait-mediated indirect effect of humans that spatially decouples predators from prey. The purpose of this research was to test the hypothesis that high-human activity was displacing predators and thus indirectly creating spatial refuge for prey species, helping prey win the "space race''. We measured the occurrence of eleven large mammal species (including humans and cattle) at 43 camera traps deployed on roads and trails in southwest Alberta, Canada. We tested species co-occurrence at camera sites using hierarchical cluster and nonmetric multidimensional scaling (NMS) analyses; and tested whether human activity, food and/or habitat influenced predator and prey species counts at camera sites using regression tree analysis. Cluster and NMS analysis indicated that at camera sites humans co-occurred with prey species more than predator species and predator species had relatively low co-occurrence with prey species. Regression tree analysis indicated that prey species were three times more abundant on roads and trails with > 32 humans/day. However, predators were less abundant on roads and trails that exceeded 18 humans/day. Our results support the hypothesis that high-human activity displaced predators but not prey species, creating spatial refuge from predation. High-human activity on roads and trails (i.e., > 18 humans/day) has the potential to interfere with predator-prey interactions via trait-mediated direct and indirect effects. We urge scientist and managers to carefully consider and quantify the trait-mediated indirect effects of humans, in addition to direct effects, when assessing human impacts on wildlife and ecosystems.	[Muhly, Tyler B.; Hickman, Laura; Musiani, Marco] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Semeniuk, Christina] Univ Calgary, Dept Geomat Engn, Calgary, AB, Canada; [Massolo, Alessandro] Univ Calgary, Fac Vet Med, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Muhly, TB (corresponding author), Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada.	tmuhly@ucalgary.ca	Massolo, Alessandro/AAO-5344-2021; Massolo, Alessandro/I-3437-2012; Musiani, Marco/ABB-9387-2021	Massolo, Alessandro/0000-0002-6333-4281; Musiani, Marco/0000-0002-6097-5841	Natural Science and Engineering Research Council of Canada; Royal Dutch Shell; Montane Elk Project; Institute for Sustainable Energy, Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Faculty of Environmental Design, University of Calgary	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Dutch Shell(Royal Dutch Shell); Montane Elk Project; Institute for Sustainable Energy, Environment and Economy; Canadian Wildlife Federation; Glaholt Scholarship; Alberta Tourism; Parks and Recreation; Alberta Sustainable Resource Development; Faculty of Environmental Design, University of Calgary	The Natural Science and Engineering Research Council of Canada, Royal Dutch Shell, the Montane Elk Project, the Institute for Sustainable Energy, Environment and Economy, the Canadian Wildlife Federation, the Glaholt Scholarship, Alberta Tourism, Parks and Recreation, Alberta Sustainable Resource Development, and the Faculty of Environmental Design, University of Calgary funded this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberta Beef Producers, 2010, ALB CATTL IND STAT; *ASRD, 2002, SO FOOTH MOUNT ELK S; *ASRD, 2010, ASRD WILDLIFE STATUS, V37, P1; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Breiman L., 1984, CLASSIFICATION REGRE; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Carbone C, 2002, ANIM CONSERV, V5, P121, DOI 10.1017/S1367943002002172; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Flaxman SM, 2009, J THEOR BIOL, V256, P187, DOI 10.1016/j.jtbi.2008.09.024; Frid A, 2002, CONSERV ECOL, V6; Gaudard M., 2006, INTERACTIVE DATA MIN; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2008, J APPL ECOL, V45, P834, DOI 10.1111/j.1365-2664.2008.01466.x; Hegel TA, 2009, J ENVIRON MANAGE, V90, P222, DOI 10.1016/j.jenvman.2007.09.005; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Jennelle CS, 2002, ANIM CONSERV, V5, P119, DOI 10.1017/S1367943002002160; Kays R.W., 2009, MAMMALS N AM, V2nd; Kays Roland W., 2008, P110; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kunkel K, 2001, J WILDLIFE MANAGE, V65, P520, DOI 10.2307/3803105; Laporte I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011954; Leighton PA, 2010, BIOL CONSERV, V143, P2156, DOI 10.1016/j.biocon.2010.05.028; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Long RA, 2011, LANDSCAPE ECOL, V26, P327, DOI 10.1007/s10980-010-9547-1; MacKay Paula, 2008, P1; MATHER PM, 1976, COMPUTATIONAL METHOD, P532; McCune B., 2006, PC ORD MULTIVARIATE; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; Mech L.D., 2002, CRITIQUE WILDLIFE RA; MINCHIN PR, 1987, VEGETATIO, V69, P89, DOI 10.1007/BF00038690; Muhly TB, 2010, THESIS U CALGARY CAL; Muhly TB, 2010, OIKOS, V119, P1243, DOI 10.1111/j.1600-0706.2009.18350.x; Nevin OT, 2005, BIOL CONSERV, V123, P453, DOI 10.1016/j.biocon.2005.01.007; NORTHRUP JM, J WILDLIFE IN PRESS; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2001, BIOL CONSERV, V102, P227, DOI 10.1016/S0006-3207(01)00107-0; Roth TC, 2007, AM NAT, V169, P264, DOI 10.1086/510605; Rovero F, 2009, J APPL ECOL, V46, P1011, DOI 10.1111/j.1365-2664.2009.01705.x; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Salomon AK, 2010, CONSERV BIOL, V24, P382, DOI 10.1111/j.1523-1739.2009.01436.x; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; SIH A, 1984, AM NAT, V123, P143, DOI 10.1086/284193; Sih Andrew, 2005, P240; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Treves A, 2010, BIOL CONSERV, V143, P521, DOI 10.1016/j.biocon.2009.11.025; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Young F.W., 1987, MULTIDIMENSIONAL SCA	64	168	172	5	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17050	10.1371/journal.pone.0017050	http://dx.doi.org/10.1371/journal.pone.0017050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399682	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300009
J	Rigamonti, A; Brennand, K; Lau, F; Cowan, CA				Rigamonti, Alessandra; Brennand, Kristen; Lau, Frank; Cowan, Chad A.			Rapid Cellular Turnover in Adipose Tissue	PLOS ONE			English	Article							CHILDHOOD OBESITY; PROGENITOR CELLS; PPAR-GAMMA; LONG-TERM; IN-VIVO; OB GENE; EXPRESSION; PROLIFERATION; MOUSE; FAT	It was recently shown that cellular turnover occurs within the human adipocyte population. Through three independent experimental approaches - dilution of an inducible histone 2B-green fluorescent protein (H2BGFP), labeling with the cell cycle marker Ki67 and incorporation of BrdU - we characterized the degree of cellular turnover in murine adipose tissue. We observed rapid turnover of the adipocyte population, finding that 4.8% of preadipocytes are replicating at any time and that between 1-5% of adipocytes are replaced each day. In light of these findings, we suggest that adipose tissue turnover represents a possible new avenue of therapeutic intervention against obesity.	[Rigamonti, Alessandra; Lau, Frank; Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Rigamonti, Alessandra] Univ Milan, Milan, Italy; [Brennand, Kristen] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Harvard University; University of Milan; Salk Institute	Rigamonti, A (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Boston, MA 02115 USA.	ccowan1@partners.org	Brennand, Kristen J/U-5470-2019; Brennand, Kristen J/J-8704-2012	Brennand, Kristen J/0000-0003-0993-5956	Stowers Medical Institute	Stowers Medical Institute	This work was funded by the Stowers Medical Institute and departmental resources from the Massachusetts General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; BJORNTORP P, 1975, AM J CLIN NUTR, V28, P445; BJORNTORP P, 1971, ACTA MED SCAND, V190, P363; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hutley LJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE1037, DOI 10.1152/ajpendo.2001.281.5.E1037; LALOR PA, 1987, RHEUMATOL INT, V7, P183, DOI 10.1007/BF00541375; Leroy P, 1996, J BIOL CHEM, V271, P2365, DOI 10.1074/jbc.271.5.2365; LLOYD JK, 1961, BRIT MED J, V2, P145, DOI 10.1136/bmj.2.5245.145; Maumus M, 2008, J CLIN ENDOCR METAB, V93, P4098, DOI 10.1210/jc.2008-0044; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; MILLER WH, 1984, J LIPID RES, V25, P336; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 2000, GENE DEV, V14, P1293; SASAKI K, 1988, CANCER, V62, P989, DOI 10.1002/1097-0142(19880901)62:5<989::AID-CNCR2820620525>3.0.CO;2-U; SASAKI K, 1987, J CELL PHYSIOL, V133, P579, DOI 10.1002/jcp.1041330321; SJOSTROM L, 1974, ACTA MED SCAND, V195, P201; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STASZKIEWICZ J, 2008, BIOCH BIOPHYS RES CO; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; TANG W, 2008, SCIENCE; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhang HH, 2000, J ENDOCRINOL, V164, P119, DOI 10.1677/joe.0.1640119	38	92	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17637	10.1371/journal.pone.0017637	http://dx.doi.org/10.1371/journal.pone.0017637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407813	Green Submitted, Green Published, gold			2022-12-27	WOS:000287933300039
J	Hewitt, KJ; Shamis, Y; Hayman, RB; Margvelashvili, M; Dong, SM; Carlson, MW; Garlick, JA				Hewitt, Kyle J.; Shamis, Yulia; Hayman, Ryan B.; Margvelashvili, Mariam; Dong, Shumin; Carlson, Mark W.; Garlick, Jonathan A.			Epigenetic and Phenotypic Profile of Fibroblasts Derived from Induced Pluripotent Stem Cells	PLOS ONE			English	Article							FUNCTIONAL-PROPERTIES; TISSUE; DIFFERENTIATION; METHYLATION; BIOLOGY	Human induced pluripotent stem (hiPS) cells offer a novel source of patient-specific cells for regenerative medicine. However, the biological potential of iPS-derived cells and their similarities to cells differentiated from human embryonic stem (hES) cells remain unclear. We derived fibroblast-like cells from two hiPS cell lines and show that their phenotypic properties and patterns of DNA methylation were similar to that of mature fibroblasts and to fibroblasts derived from hES cells. iPS-derived fibroblasts (iPDK) and their hES-derived counterparts (EDK) showed similar cell morphology throughout differentiation, and patterns of gene expression and cell surface markers were characteristic of mature fibroblasts. Array-based methylation analysis was performed for EDK, iPDK and their parental hES and iPS cell lines, and hierarchical clustering revealed that EDK and iPDK had closely-related methylation profiles. DNA methylation analysis of promoter regions associated with extracellular matrix (ECM)-production (COL1A1) by iPS- and hESC-derived fibroblasts and fibroblast lineage commitment (PDGFR beta), revealed promoter demethylation linked to their expression, and patterns of transcription and methylation of genes related to the functional properties of mature stromal cells were seen in both hiPS- and hES-derived fibroblasts. iPDK cells also showed functional properties analogous to those of hES-derived and mature fibroblasts, as seen by their capacity to direct the morphogenesis of engineered human skin equivalents. Characterization of the functional behavior of ES- and iPS-derived fibroblasts in engineered 3D tissues demonstrates the utility of this tissue platform to predict the capacity of iPS-derived cells before their therapeutic application.	[Hewitt, Kyle J.; Shamis, Yulia; Garlick, Jonathan A.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Hayman, Ryan B.] Tufts Univ, Dept Chem, Medford, MA 02155 USA; [Margvelashvili, Mariam; Dong, Shumin; Carlson, Mark W.; Garlick, Jonathan A.] Tufts Univ, Dept Oral & Maxillofacial Pathol, Boston, MA 02111 USA; [Margvelashvili, Mariam] Univ Siena, Sch Dent, Dept Dent Mat, I-53100 Siena, Italy	Tufts University; Tufts University; Tufts University; University of Siena	Hewitt, KJ (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	jonathan.garlick@tufts.edu	Hewitt, Kyle/S-6512-2019		National Institutes of Health [R01 DE017413-01A1]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grant number R01 DE017413-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Andriani F, 2003, J INVEST DERMATOL, V120, P923, DOI 10.1046/j.1523-1747.2003.12235.x; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hewitt KJ, 2009, TISSUE ENG PT A, V15, P3417, DOI [10.1089/ten.tea.2009.0060, 10.1089/ten.TEA.2009.0060]; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang K, 2010, REGEN MED, V5, P531, DOI [10.2217/rme.10.35, 10.2217/RME.10.35]; Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272; Jahoda CAB, 1996, DERMATOL CLIN, V14, P573, DOI 10.1016/S0733-8635(05)70385-5; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Lin N, 2010, CELL PROLIFERAT, V43, P427, DOI 10.1111/j.1365-2184.2010.00692.x; Liu YP, 2009, J CEREBR BLOOD F MET, V29, P780, DOI 10.1038/jcbfm.2009.1; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Margulis A, 2004, METH MOL B, V289, P61; Metallo CM, 2008, J CELL MOL MED, V12, P709, DOI 10.1111/j.1582-4934.2008.00228.x; Miles GB, 2004, J NEUROSCI, V24, P7848, DOI 10.1523/JNEUROSCI.1972-04.2004; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	39	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17128	10.1371/journal.pone.0017128	http://dx.doi.org/10.1371/journal.pone.0017128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386890	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400031
J	Mazza, V; Caramazza, A				Mazza, Veronica; Caramazza, Alfonso			Temporal Brain Dynamics of Multiple Object Processing: The Flexibility of Individuation	PLOS ONE			English	Article							SHORT-TERM-MEMORY; SPATIAL ATTENTION; N2PC COMPONENT; TRACKING; SELECTION; NUMBER; REPRESENTATIONS; PERCEPTION; MECHANISMS; NUMEROSITY	The ability to process concurrently multiple visual objects is fundamental for a coherent perception of the world. A core component of this ability is the simultaneous individuation of multiple objects. Many studies have addressed the mechanism of object individuation but it remains unknown whether the visual system mandatorily individuates all relevant elements in the visual field, or whether object indexing depends on task demands. We used a neural measure of visual selection, the N2pc component, to evaluate the flexibility of multiple object individuation. In three ERP experiments, participants saw a variable number of target elements among homogenous distracters and performed either an enumeration task (Experiment 1) or a detection task, reporting whether at least one (Experiment 2) or a specified number of target elements (Experiment 3) was present. While in the enumeration task the N2pc response increased as a function of the number of targets, no such modulation was found in Experiment 2, indicating that individuation of multiple targets is not mandatory. However, a modulation of the N2pc similar to the enumeration task was visible in Experiment 3, further highlighting that object individuation is a flexible mechanism that binds indexes to object properties and locations as needed for further object processing.	[Mazza, Veronica; Caramazza, Alfonso] Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy; [Mazza, Veronica] Univ Trento, Dept Cognit Sci & Educ, Trento, Italy; [Caramazza, Alfonso] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	University of Trento; University of Trento; Harvard University	Mazza, V (corresponding author), Univ Trento, Ctr Mind Brain Sci CIMeC, Trento, Italy.	veronica.mazza@unitn.it		Mazza, Veronica/0000-0002-8898-4651	Fondazione Cassa di Risparmio di Trento e Rovereto (Italy)	Fondazione Cassa di Risparmio di Trento e Rovereto (Italy)	This research was supported by a grant from the Fondazione Cassa di Risparmio di Trento e Rovereto (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Castelli F, 2006, P NATL ACAD SCI USA, V103, P4693, DOI 10.1073/pnas.0600444103; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; DAVIS H, 1988, BEHAV BRAIN SCI, V11, P561, DOI 10.1017/S0140525X00053437; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Eimer M, 2008, J COGNITIVE NEUROSCI, V20, P1423, DOI 10.1162/jocn.2008.20099; Fuggetta G, 2006, J NEUROPHYSIOL, V95, P3277, DOI 10.1152/jn.01273.2005; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Halberda J, 2006, PSYCHOL SCI, V17, P572, DOI 10.1111/j.1467-9280.2006.01746.x; Hopf JM, 2002, COGNITIVE BRAIN RES, V15, P17, DOI 10.1016/S0926-6410(02)00213-6; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Hyun JS, 2009, VIS COGN, V17, P10, DOI 10.1080/13506280802113894; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Izard V, 2008, PLOS BIOL, V6, P275, DOI 10.1371/journal.pbio.0060011; Jolicoeur P, 2008, BRAIN RES, V1215, P160, DOI 10.1016/j.brainres.2008.03.059; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Leblanc E, 2008, J COGNITIVE NEUROSCI, V20, P657, DOI 10.1162/jocn.2008.20051; Leslie AM, 1998, TRENDS COGN SCI, V2, P10, DOI 10.1016/S1364-6613(97)01113-3; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Mazza V, 2007, EXP BRAIN RES, V181, P531, DOI 10.1007/s00221-007-1002-4; Mazza V, 2009, PSYCHOPHYSIOLOGY, V46, P771, DOI 10.1111/j.1469-8986.2009.00814.x; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Perron R, 2009, PSYCHOL RES-PSYCH FO, V73, P222, DOI 10.1007/s00426-008-0214-y; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2009, NEUROSCIENTIST, V15, P261, DOI 10.1177/1073858409333073; PYLYSHYN Z, 1989, COGNITION, V32, P65, DOI 10.1016/0010-0277(89)90014-0; PYLYSHYN Z, 1994, COGNITION, V50, P363, DOI 10.1016/0010-0277(94)90036-1; Pylyshyn ZW, 2006, SPATIAL VISION, V19, P485, DOI 10.1163/156856806779194017; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Robitaille N, 2006, CAN J EXP PSYCHOL, V60, P101, DOI 10.1037/cjep2006011; Scholl BJ, 2001, COGNITION, V80, P1, DOI 10.1016/S0010-0277(00)00152-9; TRICK LM, 1993, J EXP PSYCHOL HUMAN, V19, P331, DOI 10.1037/0096-1523.19.2.331; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Woodman GF, 2009, BRAIN RES, V1297, P101, DOI 10.1016/j.brainres.2009.08.011; Woodman GF, 2003, PSYCHOL SCI, V14, P605, DOI 10.1046/j.0956-7976.2003.psci_1472.x; Xu YD, 2007, P NATL ACAD SCI USA, V104, P18766, DOI 10.1073/pnas.0705618104; Xu YD, 2009, TRENDS COGN SCI, V13, P167, DOI 10.1016/j.tics.2009.01.008; Xu YD, 2009, J COGNITIVE NEUROSCI, V21, P511, DOI 10.1162/jocn.2008.21024; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262	48	76	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17453	10.1371/journal.pone.0017453	http://dx.doi.org/10.1371/journal.pone.0017453			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729EM	21387002	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400077
J	Santini, SM; Lapenta, C; Donati, S; Spadaro, F; Belardelli, F; Ferrantini, M				Santini, Stefano M.; Lapenta, Caterina; Donati, Simona; Spadaro, Francesca; Belardelli, Filippo; Ferrantini, Maria			Interferon-alpha-Conditioned Human Monocytes Combine a Th1-Orienting Attitude with the Induction of Autologous Th17 Responses: Role of IL-23 and IL-12	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN T-CELLS; DENDRITIC CELLS; I INTERFERON; IFN-ALPHA; CROHNS-DISEASE; CUTTING EDGE; DIFFERENTIATION; AUTOIMMUNITY; CYTOKINES	IFN-alpha exerts multiple effects leading to immune protection against pathogens and cancer as well to autoimmune reactions by acting on monocytes and dendritic cells. We analyzed the versatility of human monocytes conditioned by IFN-alpha towards dendritic cell differentiation (IFN-DC) in shaping the autologous T-helper response. Priming of naive CD4 T cells with autologous IFN-DC in the presence of either SEA or anti-CD3, resulted, in addition to a prominent expansion of CXCR3+ IFN-gamma-producing CD4 Th1 cells, in the emergence of two distinct subsets of IL-17-producing CD4 T cells: i) a predominant Th17 population selectively producing IL-17 and expressing CCR6; ii) a minor Th1/Th17 population, producing both IL-17 and IFN-gamma. After phagocytosis of apoptotic cells, IFN-DC induced Th17 cell expansion and IL-17 release. Notably, the use of neutralizing antibodies revealed that IL-23 was an essential cytokine in mediating Th17 cell development by IFN-DC. The demonstration of the IFN-DC-induced expansion of both Th1 and Th17 cell populations reveals the intrinsic plasticity of these DC in orienting the immune response and provides a mechanistic link between IFN-alpha and the onset of autoimmune phenomena, which have been correlated with both IL-17 production and exposure to IFN-alpha.	[Santini, Stefano M.; Lapenta, Caterina; Donati, Simona; Spadaro, Francesca; Belardelli, Filippo; Ferrantini, Maria] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Santini, SM (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	maria.ferrantini@iss.it	Lapenta, Caterina cu/K-6009-2016; Santini, Stefano Maria/K-5907-2016; Spadaro, Francesca/M-7512-2017; Donati, Simona/M-7936-2017	Lapenta, Caterina cu/0000-0002-2771-6813; Santini, Stefano Maria/0000-0002-7580-5589; Spadaro, Francesca/0000-0002-6610-350X; Donati, Simona/0000-0001-5214-9913; Belardelli, Filippo/0000-0002-3082-3169; Ferrantini, Maria/0000-0002-6979-0149	Italian Ministry of Health [7OAF1/4, ACC2-WP2.2]; Italian Association for Research against Cancer	Italian Ministry of Health(Ministry of Health, Italy); Italian Association for Research against Cancer(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Italian Ministry of Health (www.salute.gov.it) ["Progetto Integrato Oncologia" (7OAF1/4), "Progetto ISS per ACC" (ACC2-WP2.2)] and from the Italian Association for Research against Cancer (www.airc.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Amadi-Obi A, 2007, NAT MED, V13, P711, DOI 10.1038/nm1585; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Annunziato F, 2009, BLOOD, V114, P2213, DOI 10.1182/blood-2009-03-209189; Baccala R, 2007, NAT MED, V13, P543, DOI 10.1038/nm1590; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; Benwell RK, 2010, CLIN IMMUNOL, V134, P178, DOI 10.1016/j.clim.2009.09.013; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Ferrantini M, 2008, CYTOKINE GROWTH F R, V19, P93, DOI 10.1016/j.cytogfr.2007.10.003; Gerosa F, 2008, J EXP MED, V205, P1447, DOI 10.1084/jem.20071450; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Koon H, 2006, NEW ENGL J MED, V354, P758, DOI 10.1056/NEJMe058307; Kryczek I, 2008, J IMMUNOL, V181, P5842, DOI 10.4049/jimmunol.181.9.5842; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Lapenta C, 2006, EUR J IMMUNOL, V36, P2046, DOI 10.1002/eji.200535579; Le Bon A, 2006, J IMMUNOL, V176, P2074, DOI 10.4049/jimmunol.176.4.2074; Lebre MC, 2008, AM J PATHOL, V172, P940, DOI 10.2353/ajpath.2008.070703; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468; Salim SY, 2009, AM J PATHOL, V174, P82, DOI 10.2353/ajpath.2009.080273; Sallusto F, 2009, MICROBES INFECT, V11, P620, DOI 10.1016/j.micinf.2009.04.004; Santini SM, 2000, J EXP MED, V191, P1777, DOI 10.1084/jem.191.10.1777; Santini Stefano Maria, 2009, Handb Exp Pharmacol, P295, DOI 10.1007/978-3-540-71029-5_14; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613	41	44	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17364	10.1371/journal.pone.0017364	http://dx.doi.org/10.1371/journal.pone.0017364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387004	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400063
J	Vivodtzev, I; Gagnon, P; Pepin, V; Saey, D; Laviolette, L; Brouillard, C; Maltais, F				Vivodtzev, Isabelle; Gagnon, Philippe; Pepin, Veronique; Saey, Didier; Laviolette, Louis; Brouillard, Cynthia; Maltais, Francois			Physiological Correlates of Endurance Time Variability during Constant-Workrate Cycling Exercise in Patients with COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MUSCLE STRENGTH; WALKING TEST; CAPACITY; HYPERINFLATION; IMPROVEMENTS; TIOTROPIUM; MORTALITY	Rationale: The endurance time (T-end) during constant-workrate cycling exercise (CET) is highly variable in COPD. We investigated pulmonary and physiological variables that may contribute to these variations in T-end. Methods: Ninety-two patients with COPD completed a CET performed at 80% of peak workrate capacity (W-peak). Patients were divided into tertiles of T-end [Group 1: < 4 min; Group 2: 4-6 min; Group 3: > 6 min]. Disease severity (FEV1), aerobic fitness (W-peak, peak oxygen consumption [(V) over dotO(2peak)], ventilatory threshold [(V) over dotO(2VT)]), quadriceps strength (MVC), symptom scores at the end of CET and exercise intensity during CET (heart rate at the end of CET to heart rate at peak incremental exercise ratio [HRCET/HRpeak]) were analyzed as potential variables influencing T-end. Results: W-peak, (V) over dotO(2peak), (V) over dotO(2VT), MVC, leg fatigue at end of CET, and HRCET/HRpeak were lower in group 1 than in group 2 or 3 (p <= 0.05). (V) over dotO(2VT) and leg fatigue at end of CET independently predicted T-end in multiple regression analysis (r = 0.50, p = 0.001). Conclusion: T-end was independently related to the aerobic fitness and to tolerance to leg fatigue at the end of exercise. A large fraction of the variability in T-end was not explained by the physiological parameters assessed in the present study. Individualization of exercise intensity during CET should help in reducing variations in T-end among patients with COPD.	[Vivodtzev, Isabelle; Gagnon, Philippe; Saey, Didier; Laviolette, Louis; Brouillard, Cynthia; Maltais, Francois] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Vivodtzev, Isabelle] CHU Grenoble, INSERM, ERI17, REx S Lab HP2, F-38043 Grenoble, France; [Pepin, Veronique] Concordia Univ, Ctr Rech, Hop Sacre Coeur, Montreal, PQ, Canada; [Pepin, Veronique] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Laviolette, Louis] Grp Hosp Pitie Salpetriere, Ctr Rech, F-75634 Paris, France	Laval University; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Concordia University - Canada; Universite de Montreal; Concordia University - Canada; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Vivodtzev, I (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Francois.Maltais@fmed.ulaval.ca	Saey, Didier/F-7963-2014; Vivodtzev, Isabelle/M-7368-2014	Vivodtzev, Isabelle/0000-0002-5201-8603	Fonds de la Recherche en Sante du Quebec	Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by local research funds. Financial support of the authors: I. Vivodtzev and P. Gagnon are recipients of a research training award from Fonds de la Recherche en Sante du Quebec. V. Pepin is a research scholar of the Fonds de la Recherche en Sante du Quebec. F. Maltais holds a GSK/CIHR Research Chair on COPD at Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brouillard C, 2008, EUR RESPIR J, V31, P579, DOI 10.1183/09031936.00119007; Casaburi Richard, 2005, COPD, V2, P131; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; CLARK TJH, 1969, CLIN SCI, V36, P307; GUYATT GH, 1984, THORAX, V39, P818, DOI 10.1136/thx.39.11.818; HAMILTON AL, 1995, AM J RESP CRIT CARE, V152, P2021, DOI 10.1164/ajrccm.152.6.8520771; ISSEKUTZ B, 1961, J APPL PHYSIOL, V16, P606, DOI 10.1152/jappl.1961.16.4.606; Laviolette L, 2008, THORAX, V63, P115, DOI 10.1136/thx.2006.076844; Mador MJ, 2004, CHEST, V125, P2036, DOI 10.1378/chest.125.6.2036; Mador MJ, 2003, AM J RESP CRIT CARE, V168, P102, DOI 10.1164/rccm.200202-080OC; Maltais F, 2005, CHEST, V128, P1168, DOI 10.1378/chest.128.3.1168; Martinez FJ, 2006, AM J RESP CRIT CARE, V173, P1326, DOI 10.1164/rccm.200510-1677OC; Neder JA, 2000, AM J RESP CRIT CARE, V162, P497, DOI 10.1164/ajrccm.162.2.9907122; O'Donnell DE, 2004, EUR RESPIR J, V23, P832, DOI 10.1183/09031936.04.00116004; O'Donnell DE, 2001, MED SCI SPORT EXER, V33, pS647, DOI 10.1097/00005768-200107001-00002; O'Donnell DE, 1998, AM J RESP CRIT CARE, V157, P1489, DOI 10.1164/ajrccm.157.5.9708010; Oga T, 2003, AM J RESP CRIT CARE, V167, P544, DOI 10.1164/rccm.200206-583OC; Ong Kian-Chung, 2004, Respir Care, V49, P1498; Pepin V, 2005, AM J RESP CRIT CARE, V172, P1517, DOI 10.1164/rccm.200507-1037OC; Porszasz J, 2005, CHEST, V128, P2025, DOI 10.1378/chest.128.4.2025; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Saey D, 2003, AM J RESP CRIT CARE, V168, P425, DOI 10.1164/rccm.200208-856OC; Whipp BJ, 2009, EUR RESPIR J, V33, P1254, DOI 10.1183/09031936.00110108	26	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17007	10.1371/journal.pone.0017007	http://dx.doi.org/10.1371/journal.pone.0017007			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386991	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000287931400020
J	Carriconde, F; Gilgado, F; Arthur, I; Ellis, D; Malik, R; van de Wiele, N; Robert, V; Currie, BJ; Meyer, W				Carriconde, Fabian; Gilgado, Felix; Arthur, Ian; Ellis, David; Malik, Richard; van de Wiele, Nathalie; Robert, Vincent; Currie, Bart J.; Meyer, Wieland			Clonality and alpha-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia	PLOS ONE			English	Article							NEOFORMANS VAR. GATTII; VANCOUVER-ISLAND; NORTHERN AUSTRALIA; STATISTICAL TESTS; BRITISH-COLUMBIA; NATURAL HABITAT; MATING-TYPE; EPIDEMIOLOGY; DISPERSAL; INFECTION	Background: Cryptococcus gattii is a basidiomycetous yeast that causes life-threatening disease in humans and animals. Within C. gattii, four molecular types are recognized (VGI to VGIV). The Australian VGII population has been in the spotlight since 2005, when it was suggested as the possible origin for the ongoing outbreak at Vancouver Island (British Columbia, Canada), with same-sex mating being suggested as the driving force behind the emergence of this outbreak, and is nowadays hypothesized as a widespread phenomenon in C. gattii. However, an in-depth characterization of the Australian VGII population is still lacking. The present work aimed to define the genetic variability within the Australian VGII population and determine processes shaping its population structure. Methodology/Principal Findings: A total of 54 clinical, veterinary and environmental VGII isolates from different parts of the Australian continent were studied. To place the Australian population in a global context, 17 isolates from North America, Europe, Asia and South America were included. Genetic variability was assessed using the newly adopted international consensus multi-locus sequence typing (MLST) scheme, including seven genetic loci: CAP59, GPD1, LAC1, PLB1, SOD1, URA5 and IGS1. Despite the overall clonality observed, the presence of MATa VGII isolates in Australia was demonstrated for the first time in association with recombination in MAT alpha-MATa populations. Our results also support the hypothesis of a "smouldering" outbreak throughout the Australian continent, involving a limited number of VGII genotypes, which is possibly caused by a founder effect followed by a clonal expansion. Conclusions/Significance: The detection of sexual recombination in MAT alpha-MATa population in Australia is in accordance with the natural life cycle of C. gattii involving opposite mating types and presents an alternative to the same-sex mating strategy suggested elsewhere. The potential for an Australian wide outbreak highlights the crucial issue to develop active surveillance procedures.	[Carriconde, Fabian; Gilgado, Felix; van de Wiele, Nathalie; Meyer, Wieland] Univ Sydney, Mol Mycol Res Lab, Sydney Med Sch,Westmead Millennium Inst, Westmead Hosp,Ctr Infect Dis & Microbiol,Sydney E, Sydney, NSW 2006, Australia; [Arthur, Ian] QEII Med Ctr, PathW Lab Med WA, Nedlands, WA, Australia; [Ellis, David] Womens & Childrens Hosp, SA Pathol, Adelaide, SA, Australia; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW 2006, Australia; [van de Wiele, Nathalie] Hogesch, Leiden, Netherlands; [Robert, Vincent] CBS Fungal Biodivers Ctr, Utrecht, Netherlands; [Currie, Bart J.] Royal Darwin Hosp, Trop & Emerging Infect Dis Div, Menzies Sch Hlth Res, No Terr Clin Sch, Casuarina, NT, Australia; [Currie, Bart J.] Royal Darwin Hosp, Dept Infect Dis, Casuarina, NT, Australia	University of Sydney; Westmead Institute for Medical Research; University of Western Australia; SA Pathology; Womens & Childrens Hospital Australia; University of Sydney; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW); Charles Darwin University; Menzies School of Health Research; Northern Territory Government	Carriconde, F (corresponding author), Univ Sydney, Mol Mycol Res Lab, Sydney Med Sch,Westmead Millennium Inst, Westmead Hosp,Ctr Infect Dis & Microbiol,Sydney E, Sydney, NSW 2006, Australia.	w.meyer@usyd.edu.au	Meyer, Wieland/G-1204-2015; Malik, Richard/I-2009-2019	Meyer, Wieland/0000-0001-9933-8340; 	Valentine Charlton Bequest; University of Sydney [100124681]	Valentine Charlton Bequest; University of Sydney(University of Sydney)	Richard Malik is supported by the Valentine Charlton Bequest administered by the Centre for Veterinary Education of the University of Sydney. This work was supported by a University of Sydney Bridging grant #100124681 to WM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Brown JKM, 2002, SCIENCE, V297, P537, DOI 10.1126/science.1072678; BURNETT J, 2003, FUNGAL POPULATION SP, P47; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Byrnes EJ, 2009, J INFECT DIS, V199, P1081, DOI 10.1086/597306; Callejas A, 1998, MED MYCOL, V36, P341, DOI 10.1080/02681219880000531; Campbell LT, 2006, FEMS YEAST RES, V6, P588, DOI 10.1111/j.1567-1364.2006.00087.x; Campbell LT, 2005, EUKARYOT CELL, V4, P1403, DOI 10.1128/EC.4.8.1403-1409.2005; CARTER D, 2007, SEX FUNGI MOL DETERM; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 1997, T ROY SOC TROP MED H, V91, P547, DOI 10.1016/S0035-9203(97)90021-3; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; FISHER D, 1993, AUST NZ J MED, V23, P678, DOI 10.1111/j.1445-5994.1993.tb04726.x; Fisher MC, 2005, PLOS PATHOG, V1, P159, DOI 10.1371/journal.ppat.0010020; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Georgi A, 2009, INFECTION, V37, P370, DOI 10.1007/s15010-008-8211-z; Goddard MR, 2005, NATURE, V434, P636, DOI 10.1038/nature03405; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Halliday CL, 1999, J CLIN MICROBIOL, V37, P2920, DOI 10.1128/JCM.37.9.2920-2926.1999; Hiremath SS, 2008, MICROBIOL-SGM, V154, P1513, DOI 10.1099/mic.0.2007/015594-0; Jenney A, 2004, J CLIN MICROBIOL, V42, P3865, DOI 10.1128/JCM.42.8.3865-3868.2004; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Krockenberger MB, 2002, MED MYCOL, V40, P263, DOI 10.1080/mmy.40.3.263.272; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; Lazera MS, 1998, MED MYCOL, V36, P119, DOI 10.1080/02681219880000191; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin XR, 2005, NATURE, V434, P1017, DOI 10.1038/nature03448; Lindberg J, 2007, EMERG INFECT DIS, V13, P178, DOI 10.3201/eid1301.060945; McGill S, 2009, MED MYCOL, V47, P625, DOI 10.1080/13693780802512519; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; NAGARAJAN S, 1990, ANNU REV PHYTOPATHOL, V28, P139, DOI 10.1146/annurev.py.28.090190.001035; NGAMSKULRUNGROJ P, 2010, CLIN MICROBIOL INFEC, DOI DOI 10.1111/J.1469-0691.2010.03222.X; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rees JR, 1998, CLIN INFECT DIS, V27, P1138, DOI 10.1093/clinids/27.5.1138; RILEY CB, 1992, AUST VET J, V69, P135, DOI 10.1111/j.1751-0813.1992.tb07482.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Saul N, 2008, EUKARYOT CELL, V7, P727, DOI 10.1128/EC.00020-08; Schneider S, 1999, GENETICS, V152, P1079; SLATKIN M, 1991, GENETICS, V129, P555; Sorrell Tania C., 1997, Revista Iberoamericana de Micologia, V14, P42; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1261, DOI 10.1128/JCM.34.5.1261-1263.1996; SPEED BR, 2002, MICRO AUST, V23, P5; Stern H, 2000, AUST METEOROL MAG, V49, P87; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x	60	61	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16936	10.1371/journal.pone.0016936	http://dx.doi.org/10.1371/journal.pone.0016936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383989	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700019
J	Shuval, K; Harker, K; Roudsari, B; Groce, NE; Mills, B; Siddiqi, Z; Shachak, A				Shuval, Kerem; Harker, Karen; Roudsari, Bahman; Groce, Nora E.; Mills, Britain; Siddiqi, Zoveen; Shachak, Aviv			Is Qualitative Research Second Class Science? A Quantitative Longitudinal Examination of Qualitative Research in Medical Journals	PLOS ONE			English	Article							HEALTH-CARE; HELP	Background: Qualitative research appears to be gaining acceptability in medical journals. Yet, little is actually known about the proportion of qualitative research and factors affecting its publication. This study describes the proportion of qualitative research over a 10 year period and correlates associated with its publication. Design: A quantitative longitudinal examination of the proportion of original qualitative research in 67 journals of general medicine during a 10 year period (1998-2007). The proportion of qualitative research was determined by dividing original qualitative studies published (numerator) by all original research articles published (denominator). We used a generalized estimating equations approach to assess the longitudinal association between the proportion of qualitative studies and independent variables (i.e. journals' country of publication and impact factor; editorial/methodological papers discussing qualitative research; and specific journal guidelines pertaining to qualitative research). Findings: A 2.9% absolute increase and 3.4-fold relative increase in qualitative research publications occurred over a 10 year period (1.2% in 1998 vs. 4.1% in 2007). The proportion of original qualitative research was independently and significantly associated with the publication of editorial/methodological papers in the journal (b = 3.688, P = 0.012); and with qualitative research specifically mentioned in guidelines for authors (b = 6.847, P < 0.001). Additionally, a higher proportion of qualitative research was associated only with journals published in the UK in comparison to other countries, yet with borderline statistical significance (b = 1.776, P = 0.075). The journals' impact factor was not associated with the publication of qualitative research. Conclusions: Despite an increase in the proportion of qualitative research in medical journals over a 10 year period, the proportion remains low. Journals' policies pertaining to qualitative research, as expressed by the appearance of specific guidelines and editorials/methodological papers on the subject, are independently associated with the publication of original qualitative research; irrespective of the journals' impact factor.	[Shuval, Kerem; Harker, Karen; Roudsari, Bahman; Mills, Britain; Siddiqi, Zoveen] Univ Texas Dallas, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Dallas, TX 75230 USA; [Harker, Karen] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Groce, Nora E.] UCL, Leonard Cheshire Disabil & Inclus Dev Ctr, Dept Epidemiol & Publ Hlth, London, England; [Shachak, Aviv] Univ Toronto, Fac Informat, Toronto, ON, Canada; [Shachak, Aviv] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; University College London; University of Toronto; University of Toronto	Shuval, K (corresponding author), Univ Texas Dallas, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Dallas, TX 75230 USA.	kerem.shuval@UTSouthwestern.edu	Mills, Britain/B-1225-2012	Groce, Nora/0000-0002-7885-7042; Shachak, Aviv/0000-0002-1166-609X				Bailie R, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-129; BENGTSSON L, 1997, SCAND J MANAG, V13, P473; Britten N, 2005, MED EDUC, V39, P5, DOI 10.1111/j.1365-2929.2004.02024.x; Creswell J. W.., 2018, SAGE PUBLICATIONS; Ebell MH, 2004, J AM BOARD FAM PRACT, V17, P59, DOI 10.3122/jabfm.17.1.59; Finkelstein A, 2005, J FAM PRACTICE, V54, P1032; Gault I, 2009, HEALTH SOC CARE COMM, V17, P504, DOI 10.1111/j.1365-2524.2009.00847.x; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478; Green J, 1998, BMJ-BRIT MED J, V316, P1230, DOI 10.1136/bmj.316.7139.1230; Greenhalgh T, 1997, BMJ-BRIT MED J, V315, P740, DOI 10.1136/bmj.315.7110.740; Grypdonck MHE, 2006, QUAL HEALTH RES, V16, P1371, DOI 10.1177/1049732306294089; Hardin JW, 2012, GEN ESTIMATING EQUAT; JONES R, 1995, BRIT MED J, V311, P2, DOI 10.1136/bmj.311.6996.2; Kuper A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a288; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lewin S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3496; Lyytinen K, 2007, EUR J INFORM SYST, V16, P317, DOI 10.1057/palgrave.ejis.3000695; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; McKibbon Kathleen Ann, 2004, BMC Med Inform Decis Mak, V4, P11, DOI 10.1186/1472-6947-4-11; Morse JM, 2003, QUAL HEALTH RES, V13, P739, DOI 10.1177/1049732303013006001; Petticrew M, 2008, J EPIDEMIOL COMMUN H, V62, P552, DOI 10.1136/jech.2006.059394; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pope C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3425; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1020; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a949; SANDELOWSKI M, 2003, SAGE ENCY SOCIAL SCI; Shachak A, 2009, J GEN INTERN MED, V24, P341, DOI 10.1007/s11606-008-0892-6; Shuval K, 2007, J GEN INTERN MED, V22, P327, DOI 10.1007/s11606-006-0055-6; *THOMS REUT, SCOP NOT SCI CIT IND; Yamazaki H, 2009, BIOSCI TRENDS, V3, P202	31	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16937	10.1371/journal.pone.0016937	http://dx.doi.org/10.1371/journal.pone.0016937			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21383987	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700020
J	Sallam, HM; Seiffert, ER; Simons, EL				Sallam, Hesham M.; Seiffert, Erik R.; Simons, Elwyn L.			Craniodental Morphology and Systematics of a New Family of Hystricognathous Rodents (Gaudeamuridae) from the Late Eocene and Early Oligocene of Egypt	PLOS ONE			English	Article							FAYUM DEPRESSION; AGE; DISCOVERY; PHYLOGENY; PALEOGENE; MAMMALIA	Background: Gaudeamus is an enigmatic hystricognathous rodent that was, until recently, known solely from fragmentary material from early Oligocene sites in Egypt, Oman, and Libya. Gaudeamus' molars are similar to those of the extant cane rat Thryonomys, and multiple authorities have aligned Gaudeamus with Thryonomys to the exclusion of other living and extinct African hystricognaths; recent phylogenetic analyses have, however, also suggested affinities with South American caviomorphs or Old World porcupines (Hystricidae). Methodology/Principal Findings: Here we describe the oldest known remains of Gaudeamus, including largely complete but crushed crania and complete upper and lower dentitions. Unlike younger Gaudeamus species, the primitive species described here have relatively complex occlusal patterns, and retain a number of plesiomorphic features. Unconstrained parsimony analysis nests Gaudeamus and Hystrix within the South American caviomorph radiation, implying what we consider to be an implausible back-dispersal across the Atlantic Ocean to account for Gaudeamus' presence in the late Eocene of Africa. An analysis that was constrained to recover the biogeographically more plausible hypothesis of caviomorph monophyly does not place Gaudeamus as a stem caviomorph, but rather as a sister taxon of hystricids. Conclusions/Significance: We place Gaudeamus species in a new family, Gaudeamuridae, and consider it likely that the group originated, diversified, and then went extinct over a geologically brief period of time during the latest Eocene and early Oligocene in Afro-Arabia. Gaudeamurids are the only known crown hystricognaths from Afro-Arabia that are likely to be aligned with non-phiomorph members of that clade, and as such provide additional support for an Afro-Arabian origin of advanced stem and basal crown members of Hystricognathi.	[Sallam, Hesham M.] Mansoura Univ, Fac Sci, Dept Geol, Mansoura 35516, Egypt; [Seiffert, Erik R.] SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA; [Simons, Elwyn L.] Duke Lemur Ctr, Div Fossil Primates, Durham, NC USA	Egyptian Knowledge Bank (EKB); Mansoura University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sallam, HM (corresponding author), Mansoura Univ, Fac Sci, Dept Geol, Mansoura 35516, Egypt.	sallam@mans.edu.eg	Sallam, Hesham/T-6534-2018	Sallam, Hesham/0000-0001-6584-6312	U.S. National Science Foundation; Leakey Foundation; Smithsonian Foreign Currency Program; Oxford University; Division Of Behavioral and Cognitive Sci [0819186] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Leakey Foundation; Smithsonian Foreign Currency Program; Oxford University; Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research has been funded by a series of grants from the U.S. National Science Foundation as well as The Leakey Foundation, Gordon and Ann Getty, Margot Marsh, Verna Simons, the Smithsonian Foreign Currency Program, and the Boise Fund of Oxford University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS CW, DESCRIPTIVE CATALOGU; Antonanzas RL, 2004, ZOOL J LINN SOC-LOND, V142, P423; BEADNELL HJL, 2005, TOPOGRAPHY GEOLOGY F; Bown T.M., 1988, US GEOL SURV PROF PA, V1452, P1; Bryant J. Daniel, 1995, American Museum Novitates, V3156, P1; COSTER P, NATURWISSEN IN PRESS; De Blieux DD, 2002, J VERTEBR PALEONTOL, V22, P122, DOI 10.1671/0272-4634(2002)022[0122:CADAOA]2.0.CO;2; Flynn JJ, 2003, PALAEOGEOGR PALAEOCL, V195, P229, DOI 10.1016/S0031-0182(03)00360-2; Flynn Lawrence J., 1994, Historical Biology, V9, P223; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Hautier L, 2009, J ANAT, V215, P401, DOI 10.1111/j.1469-7580.2009.01130.x; HOFFSTETTER R, 1972, CR ACAD SCI D NAT, V274, P2867; Holroyd P. A., 1994, EXAMINATION DISPERSA; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; KAPPELMAN J, 1992, J GEOL, V100, P647, DOI 10.1086/629619; Lavocat R., 1978, P69; Lavocat R., 1973, RONGEURS MIOCENE AFR; Lewis Patrick J., 2007, Palaeontologia Africana, V42, P37; Manthi Fredrick Kyalo, 2007, Kirtlandia, V56, P92; Marivaux L, 2004, ZOOL J LINN SOC-LOND, V142, P105, DOI 10.1111/j.1096-3642.2004.00131.x; Mein P, 2010, HIST BIOL, V22, P224, DOI 10.1080/08912961003644104; Patterson B., 1982, Bulletin of the Museum of Comparative Zoology, V149, P371; Pickford M., 2008, MEM GEOL SURV NAMIBI, V20, P465; Rasmussen D.T., 1991, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V182, P187; Robaszynski F., 1984, Revue de Micropaleontologie, V26, P145; SALLAM H, 2009, P NATL ACAD SCI US; Schlosser M., 1911, Beitreage zur Palaeontologie u Geologie Oesterreich-Ungarns u des Orients Wien u Leipzig, V24; Seiffert ER, 2006, P NATL ACAD SCI USA, V103, P5000, DOI 10.1073/pnas.0600689103; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; Simons E. L., 1990, GEOLOGY EGYPT, P627; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; Simons EL, 1997, P NATL ACAD SCI USA, V94, P14970, DOI 10.1073/pnas.94.26.14970; SIMONS EL, 1968, PEABODY MUS NAT HIST, V28, P1; STEHLIN HG, 1951, SCHWEIZ PALEONT ABH, V67, P1; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; THOMAS H, 1989, GEOBIOS-LYON, V22, P101, DOI 10.1016/S0016-6995(89)80091-9; van der Merwe M, 2000, J ZOOL, V251, P541, DOI 10.1111/j.1469-7998.2000.tb00811.x; WINKLER AJ, 2010, CENOZOIC MAMMALS AFR; Wood A.E., 1968, PEABODY MUSEUM B, V28, P23; WOOD ALBERT E., 1959, BULL MUS COMP ZOOL HARVARD UNIV, V120, P279	41	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16525	10.1371/journal.pone.0016525	http://dx.doi.org/10.1371/journal.pone.0016525			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364934	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600008
J	Urcuqui-Inchima, S; Patino, C; Zapata, X; Garcia, MP; Arteaga, J; Chamot, C; Kumar, A; Hernandez-Verdun, D				Urcuqui-Inchima, Silvio; Patino, Claudia; Zapata, Ximena; Patricia Garcia, Maria; Arteaga, Jose; Chamot, Christophe; Kumar, Ajit; Hernandez-Verdun, Daniele			Production of HIV Particles Is Regulated by Altering Sub-Cellular Localization and Dynamics of Rev Induced by Double-Strand RNA Binding Protein	PLOS ONE			English	Article							NUCLEAR EXPORT ELEMENTS; MESSENGER-RNA; GENE-EXPRESSION; VIRUS; NF90; PHOSPHORYLATION; REPLICATION; TRAFFICKING; TRANSLATION; LOCATION	Human immunodeficiency virus (HIV)-1 encoded Rev is essential for export from the nucleus to the cytoplasm, of unspliced and singly spliced transcripts coding for structural and nonstructural viral proteins. This process is spatially and temporally coordinated resulting from the interactions between cellular and viral proteins. Here we examined the effects of the subcellular localization and dynamics of Rev on the efficiency of nucleocytoplasmic transport of HIV-1 Gag transcripts and virus particle production. Using confocal microscopy and fluorescence recovery after bleaching (FRAP), we report that NF90ctv, a cellular protein involved in Rev function, alters both the sub-cellular localization and dynamics of Rev in vivo, which drastically affects the accumulation of the viral protein p24. The CRM1-dependent nuclear export of Gag mRNA linked to the Rev Response Element (RRE) is dependent on specific domains of the NF90ctv protein. Taken together, our results demonstrate that the appropriate intracellular localization and dynamics of Rev could regulate Gag assembly and HIV-1 replication.	[Urcuqui-Inchima, Silvio; Patino, Claudia; Zapata, Ximena; Patricia Garcia, Maria] Univ Antioquia, Sede Invest Univ, Grp Inmunoviol, Medellin, Colombia; [Arteaga, Jose] Univ Ind Santander, Bucaramanga, Colombia; [Chamot, Christophe; Hernandez-Verdun, Daniele] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, Paris, France; [Kumar, Ajit] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC USA	Universidad de Antioquia; Universidad Industrial de Santander; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; George Washington University	Urcuqui-Inchima, S (corresponding author), Univ Antioquia, Sede Invest Univ, Grp Inmunoviol, Medellin, Colombia.	silviourcuqui@gmail.com		Arteaga, H Jose/0000-0002-5270-9017; Urcuqui-Inchima, Silvio/0000-0002-2865-3041	Colciencias [111534319145]; Universidad de Antioquia; Fundacion para la Promocion de la Investigacion y la Tecnologia [2211]; CNRS [UMR 7592]; University Paris 7 (France)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia; Fundacion para la Promocion de la Investigacion y la Tecnologia; CNRS(Centre National de la Recherche Scientifique (CNRS)); University Paris 7 (France)	This study was supported by Colciencias, grant 111534319145 and Universidad de Antioquia, and by Fundacion para la Promocion de la Investigacion y la Tecnologia, grant 2211; CNRS funding to "Nuclear and cell cycle" group and Imagery platform of Institut Jacques Monod UMR 7592, University Paris 7 (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbottah ET, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-41; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Bieniasz PD, 2000, J VIROL, V74, P9868, DOI 10.1128/JVI.74.21.9868-9877.2000; Boris-Lawrie K, 2001, LIFE SCI, V69, P2697, DOI 10.1016/S0024-3205(01)01360-1; Chatel-Chaix L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-41; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Cullen BR, 2003, J CELL SCI, V116, P587, DOI 10.1242/jcs.00268; Daelemans D, 2005, MOL CELL BIOL, V25, P728, DOI 10.1128/MCB.25.2.728-739.2005; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; DUNDR M, 1995, J CELL SCI, V108, P2811; FISCHER U, 1994, EMBO J, V13, P4105, DOI 10.1002/j.1460-2075.1994.tb06728.x; Fontoura BMA, 2005, IUBMB LIFE, V57, P65, DOI 10.1080/15216540500078608; Gwizdek C, 2004, J BIOL CHEM, V279, P884, DOI 10.1074/jbc.M306808200; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Jin J, 2007, J VIROL, V81, P11226, DOI 10.1128/JVI.00431-07; Jin J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006551; Krasnoselskaya-Riz I, 2002, AIDS RES HUM RETROV, V18, P591, DOI 10.1089/088922202753747941; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Lechertier T, 2009, EXP CELL RES, V315, P928, DOI 10.1016/j.yexcr.2009.01.016; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; Parker LM, 2001, J BIOL CHEM, V276, P32522, DOI 10.1074/jbc.M104408200; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; RUGGIERI A, 2007, GASTROENTEROLOGY, V12, P7; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2001, GENOMICS, V71, P256, DOI 10.1006/geno.2000.6423; Sherer NM, 2009, J VIROL, V83, P8525, DOI 10.1128/JVI.00699-09; Shin HJ, 2002, ARCH VIROL, V147, P471, DOI 10.1007/s007050200001; STAUBER R, 1995, VIROLOGY, V213, P439, DOI 10.1006/viro.1995.0016; Swanson CM, 2004, EMBO J, V23, P2632, DOI 10.1038/sj.emboj.7600270; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; Wang P, 2009, J VIROL, V83, P7850, DOI 10.1128/JVI.00735-09; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Zheng YH, 2003, NAT CELL BIOL, V5, P611, DOI 10.1038/ncb1000	42	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16686	10.1371/journal.pone.0016686	http://dx.doi.org/10.1371/journal.pone.0016686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364984	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600013
J	Mathew, SS; Hablitz, JJ				Mathew, Seena S.; Hablitz, John J.			Presynaptic NMDA Receptors Mediate IPSC Potentiation at GABAergic Synapses in Developing Rat Neocortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-ASPARTATE RECEPTORS; SYNAPTIC-TRANSMISSION; TONIC FACILITATION; GLUTAMATE RELEASE; GABA; ACTIVATION; INHIBITION; MATURATION; PLASTICITY	Background: NMDA receptors are traditionally viewed as being located postsynaptically, at both synaptic and extrasynaptic locations. However, both anatomical and physiological studies have indicated the presence of NMDA receptors located presynaptically. Physiological studies of presynaptic NMDA receptors on neocortical GABAergic terminals and their possible role in synaptic plasticity are lacking. Methodology/Principal Findings: We report here that presynaptic NMDA receptors are present on GABAergic terminals in developing (postnatal day (PND) 12-15) but not older (PND21-25) rat frontal cortex. Using MK-801 in the recording pipette to block postsynaptic NMDA receptors, evoked and miniature IPSCs were recorded in layer II/III pyramidal cells in the presence of AMPA/KA receptor antagonists. Bath application of NMDA or NMDA receptor antagonists produced increases and decreases in mIPSC frequency, respectively. Physiologically patterned stimulation (10 bursts of 10 stimuli at 25 Hz delivered at 1.25 Hz) induced potentiation at inhibitory synapses in PND12-15 animals. This consisted of an initial rapid, large increase in IPSC amplitude followed by a significant but smaller persistent increase. Similar changes were not observed in PND21-25 animals. When 20 mM BAPTA was included in the recording pipette, potentiation was still observed in the PND12-15 group indicating that postsynaptic increases in calcium were not required. Potentiation was not observed when patterned stimulation was given in the presence of D-APV or the NR2B subunit antagonist Ro25-6981. Conclusions/Significance: The present results indicate that presynaptic NMDA receptors modulate GABA release onto neocortical pyramidal cells. Presynaptic NR2B subunit containing NMDA receptors are also involved in potentiation at developing GABAergic synapses in rat frontal cortex. Modulation of inhibitory GABAergic synapses by presynaptic NMDA receptors may be important for proper functioning of local cortical networks during development.	[Mathew, Seena S.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Mathew, SS (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	jhablitz@uab.edu			National Institutes of Health [NS22373, NS63342, P30-NS47466, P30-HD38985, P30-NS57098]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD038985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047466, P30NS057098, R01NS022373, R21NS063342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health research grants NS22373 and NS63342, and core facilities grants, P30-NS47466, P30-HD38985 and P30-NS57098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Bandrowski AE, 2003, J NEUROPHYSIOL, V89, P1308, DOI 10.1152/jn.00644.2002; Berretta N, 1996, NEUROSCIENCE, V75, P339, DOI 10.1016/0306-4522(96)00301-6; BURGARD EC, 1994, DEV BRAIN RES, V80, P275, DOI 10.1016/0165-3806(94)90113-9; BUSTOS G, 1992, BRAIN RES, V585, P105, DOI 10.1016/0006-8993(92)91195-K; Campbell SL, 2004, NEUROSCIENCE, V127, P625, DOI 10.1016/j.neuroscience.2004.05.030; Campbell SL, 2007, NEUROPHARMACOLOGY, V53, P37, DOI 10.1016/j.neuropharm.2007.04.008; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Charton JP, 1999, BRAIN RES, V816, P609, DOI 10.1016/S0006-8993(98)01243-8; Christie JM, 2008, NEURON, V60, P298, DOI 10.1016/j.neuron.2008.08.028; Christie JM, 2009, J NEUROSCI, V29, P11441, DOI 10.1523/JNEUROSCI.2387-09.2009; Corlew R, 2007, J NEUROSCI, V27, P9835, DOI 10.1523/JNEUROSCI.5494-06.2007; Corlew R, 2008, NEUROSCIENTIST, V14, P609, DOI 10.1177/1073858408322675; DeBiasi S, 1996, NEUROREPORT, V7, P2773, DOI 10.1097/00001756-199611040-00073; DEISZ RA, 1989, J PHYSIOL-LONDON, V412, P513, DOI 10.1113/jphysiol.1989.sp017629; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Featherstone DE, 2008, NEUROSCIENTIST, V14, P171, DOI 10.1177/1073858407308518; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Glitsch M, 1999, J NEUROSCI, V19, P511; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Liu SJ, 2006, J NEUROSCI, V26, P9332, DOI 10.1523/JNEUROSCI.2929-06.2006; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Manent JB, 2007, NEUROSCIENTIST, V13, P268, DOI 10.1177/1073858406298918; MARTIN D, 1991, J NEUROCHEM, V56, P1647, DOI 10.1111/j.1471-4159.1991.tb02063.x; Mathew SS, 2008, NEUROPHARMACOLOGY, V55, P106, DOI 10.1016/j.neuropharm.2008.05.005; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; MORISHITA W, 1991, NEUROREPORT, V2, P533; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Paquet M, 2000, J COMP NEUROL, V423, P330, DOI 10.1002/1096-9861(20000724)423:2<330::AID-CNE10>3.0.CO;2-9; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Roberts AC, 2009, NEURON, V63, P342, DOI 10.1016/j.neuron.2009.06.016; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Stell BM, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0003.2002; Tovar KR, 1999, J NEUROSCI, V19, P4180; TROMMER BL, 1995, EXP NEUROL, V131, P83, DOI 10.1016/0014-4886(95)90010-1; Varela JA, 1999, J NEUROSCI, V19, P4293; Wang DD, 2008, J NEUROSCI, V28, P5547, DOI 10.1523/JNEUROSCI.5599-07.2008; Woodhall G, 2001, J NEUROPHYSIOL, V86, P1644, DOI 10.1152/jn.2001.86.4.1644; XIE Z, 1991, NEUROREPORT, V2, P389, DOI 10.1097/00001756-199107000-00009; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006	56	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17311	10.1371/journal.pone.0017311	http://dx.doi.org/10.1371/journal.pone.0017311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365001	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800046
J	Ravva, SV; Sarreal, CZ; Mandrell, RE				Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.			Bacterial Communities in Aerosols and Manure Samples from Two Different Dairies in Central and Sonoma Valleys of California	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; AVIUM SUBSP PARATUBERCULOSIS; FECAL POLLUTION; GENETIC-MARKERS; WASTE; IDENTIFICATION; ENVIRONMENT; SURVIVAL; 16S; TRANSMISSION	Aerosols have been suspected to transport food pathogens and contaminate fruits and vegetables grown in close proximity to concentrated animal feeding operations, but studies are lacking that substantiate such transport. To monitor the potential transport of bacteria originated from fresh or dry manure through aerosols on a dairy, we identified by 16S rRNA sequencing, bacteria in aerosols collected within 2 to 3 meters from dairy cows at two dairies. Gram-positive Firmicutes were predominant in aerosols from a dairy in Sonoma, California, and surrounded by vineyards, in contrast to sequences of Gram-negative Proteobacteria predominant in aerosols from a dairy in Modesto, California, also surrounded by other dairies. Although Firmicutes represented approximately 50% of the 10 most abundant sequences, aerosols from the Sonoma dairy also contained sequences of Bacteriodetes and Actinobacteria, identified previously with animal feces. While none of the top 10 sequences from fresh or dry manure from Modesto dairy were detected in aerosols, two of the sequences from the phylum Bacteriodetes and one from class Clostridia from fresh manure were detected in aerosols from Sonoma. Interestingly, none of the sequences from dry manure were in the top 10 sequences in aerosols from both dairies. The 10 most abundant sequences in aerosols from the Modesto dairy were all from Proteobacteria and nearly half of them were from genus Massilia, which have been isolated previously from immune-compromised people and aerosols. We conclude that the predominant bacteria in aerosols are diverse among locations and that they do not reflect the predominant species of bacteria present in cow feces and/or in close proximity to cows. These results suggest that the aerosol sequences did not originate from manure. Large volumes of aerosols would be required to determine if bacterial sequences from aerosols could be used to track bacteria in manure to crops grown in proximity.	[Ravva, Subbarao V.; Sarreal, Chester Z.; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA)	Ravva, SV (corresponding author), ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA.	subbarao.ravva@ars.usda.gov	Mandrell, Robert E/O-9814-2018		U.S. Department of Agriculture, Agricultural Research Service [5325-42000-044]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The work was funded by the U.S. Department of Agriculture, Agricultural Research Service under CRIS project 5325-42000-044. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baertsch C, 2007, APPL ENVIRON MICROB, V73, P4522, DOI 10.1128/AEM.02387-06; Bergman W, 2005, J AEROSOL SCI, V36, P619, DOI 10.1016/j.jaerosci.2004.12.010; Bernhard AE, 2000, APPL ENVIRON MICROB, V66, P1587, DOI 10.1128/AEM.66.4.1587-1594.2000; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brooks JP, 2010, SCI TOTAL ENVIRON, V408, P4770, DOI 10.1016/j.scitotenv.2010.06.038; Cole DJ, 1999, OCCUP MED-STATE ART, V14, P423; Cooley M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001159; Cornick NA, 2008, APPL ENVIRON MICROB, V74, P2488, DOI 10.1128/AEM.02897-07; DURSO LM, 2011, FOODBORNE P IN PRESS; Harbaugh E, 2006, POULTRY SCI, V85, P1693, DOI 10.1093/ps/85.10.1693; Hernlem BJ, 2007, J ENVIRON MONITOR, V9, P1317, DOI 10.1039/b710512f; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Hutchison ML, 2008, J APPL MICROBIOL, V105, P848, DOI 10.1111/j.1365-2672.2008.03811.x; Ibekwe AM, 2004, FEMS MICROBIOL ECOL, V48, P239, DOI 10.1016/j.femsec.2004.01.012; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; La Scola B, 1998, J CLIN MICROBIOL, V36, P2847, DOI 10.1128/JCM.36.10.2847-2852.1998; Le Goff O, 2010, J APPL MICROBIOL, V108, P325, DOI 10.1111/j.1365-2672.2009.04427.x; Leclerc MC, 2000, RES MICROBIOL, V151, P629, DOI 10.1016/S0923-2508(00)90129-3; McBride MT, 2003, ANAL CHEM, V75, P5293, DOI 10.1021/ac034722v; McGarvey JA, 2004, APPL ENVIRON MICROB, V70, P4267, DOI 10.1128/AEM.70.7.4267-4275.2004; McGarvey JA, 2007, APPL ENVIRON MICROB, V73, P193, DOI 10.1128/AEM.01422-06; McGarvey JA, 2010, APPL MICROBIOL BIOT, V85, P1947, DOI 10.1007/s00253-009-2229-8; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Patton TG, 2009, VET MICROBIOL, V136, P285, DOI 10.1016/j.vetmic.2008.10.032; Pillai SD, 2002, CAN J MICROBIOL, V48, P681, DOI [10.1139/w02-070, 10.1139/W02-070]; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Raizman EA, 2004, J DAIRY SCI, V87, P2959, DOI 10.3168/jds.S0022-0302(04)73427-X; Ravva SV, 2006, J APPL MICROBIOL, V101, P891, DOI 10.1111/j.1365-2672.2006.02956.x; Ravva SV, 2005, J MICROBIOL METH, V63, P305, DOI 10.1016/j.mimet.2005.04.004; Savichtcheva O, 2006, WATER RES, V40, P2463, DOI 10.1016/j.watres.2006.04.040; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whittington RJ, 2004, APPL ENVIRON MICROB, V70, P2989, DOI 10.1128/AEM.70.5.2989-3004.2004; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285	33	25	25	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17281	10.1371/journal.pone.0017281	http://dx.doi.org/10.1371/journal.pone.0017281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364996	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800045
J	Ojha, J; Karmegam, RV; Masilamoni, JG; Terry, AV; Cashikar, AG				Ojha, Juhi; Karmegam, Rajalakshmi V.; Masilamoni, J. Gunasingh; Terry, Alvin V., Jr.; Cashikar, Anil G.			Behavioral Defects in Chaperone-Deficient Alzheimer's Disease Model Mice	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; DESMIN-RELATED MYOPATHY; AMYLOID-BETA PROTEIN; ALEXANDERS-DISEASE; MISSENSE MUTATION; MOUSE MODEL; EXPRESSION; GENE; BRAINS	Molecular chaperones protect cells from the deleterious effects of protein misfolding and aggregation. Neurotoxicity of amyloid-beta (A beta) aggregates and their deposition in senile plaques are hallmarks of Alzheimer's disease (AD). We observed that the overall content of alpha B-crystallin, a small heat shock protein molecular chaperone, decreased in AD model mice in an age-dependent manner. We hypothesized that alpha B-crystallin protects cells against A beta toxicity. To test this, we crossed alpha B-crystallin/HspB2 deficient (CRYAB(-/-) HSPB2(-/-)) mice with AD model transgenic mice expressing mutant human amyloid precursor protein. Transgenic and non-transgenic mice in chaperone-sufficient or deficient backgrounds were examined for representative behavioral paradigms for locomotion and memory network functions: (i) spatial orientation and locomotion was monitored by open field test; (ii) sequential organization and associative learning was monitored by fear conditioning; and (iii) evoked behavioral response was tested by hot plate method. Interestingly, alpha B-crystallin/HspB2 deficient transgenic mice were severely impaired in locomotion compared to each genetic model separately. Our results highlight a synergistic effect of combining chaperone deficiency in a transgenic mouse model for AD underscoring an important role for chaperones in protein misfolding diseases.	[Ojha, Juhi; Karmegam, Rajalakshmi V.; Masilamoni, J. Gunasingh; Cashikar, Anil G.] Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA; [Terry, Alvin V., Jr.] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Ojha, J (corresponding author), Med Coll Georgia, Ctr Mol Chaperones & Radiobiol, Augusta, GA 30912 USA.	acashikar@mcg.edu	Cashikar, Anil G/F-5968-2011	Cashikar, Anil/0000-0002-3671-684X; Terry, Alvin/0000-0003-2071-4767	Medical College of Georgia	Medical College of Georgia	This work was funded by the Medical College of Georgia faculty startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony SG, 2003, J ALZHEIMERS DIS, V5, P171, DOI 10.3233/JAD-2003-5301; ARRIGO AP, 1994, BIOL HEAT SHOCK PROT; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; Dabir DV, 2004, AM J PATHOL, V164, P155, DOI 10.1016/S0002-9440(10)63106-9; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Fonte V, 2002, P NATL ACAD SCI USA, V99, P9439, DOI 10.1073/pnas.152313999; Franck E, 2004, J MOL EVOL, V59, P792, DOI 10.1007/s00239-004-0013-z; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Haslbeck M, 2002, CELL MOL LIFE SCI, V59, P1649, DOI 10.1007/PL00012492; Head MW, 2000, NEUROPATH APPL NEURO, V26, P304, DOI 10.1046/j.1365-2990.2000.00269.x; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iwaki A, 1997, GENOMICS, V45, P386, DOI 10.1006/geno.1997.4956; IWAKI T, 1989, CELL, V57, P71, DOI 10.1016/0092-8674(89)90173-6; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Litt M, 1998, HUM MOL GENET, V7, P471, DOI 10.1093/hmg/7.3.471; LOWE J, 1992, J PATHOL, V166, P61, DOI 10.1002/path.1711660110; MacRae TH, 2000, CELL MOL LIFE SCI, V57, P899, DOI 10.1007/PL00000733; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; RENKAWEK K, 1992, ACTA NEUROPATHOL, V83, P324, DOI 10.1007/BF00296796; Renkawek K, 1999, NEUROREPORT, V10, P2273, DOI 10.1097/00001756-199908020-00009; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Rudy JW, 1999, BEHAV NEUROSCI, V113, P867, DOI 10.1037/0735-7044.113.5.867; Rustay NR, 2010, BRAIN RES, V1311, P136, DOI 10.1016/j.brainres.2009.11.040; Sanders MJ, 2003, EUR J PHARMACOL, V463, P217, DOI 10.1016/S0014-2999(03)01283-4; SHINOHARA H, 1993, J NEUROL SCI, V119, P203, DOI 10.1016/0022-510X(93)90135-L; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; van Rijk AF, 2000, OPHTHALMOLOGICA, V214, P7, DOI 10.1159/000027468; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wilhelmus MMM, 2006, NEUROPATH APPL NEURO, V32, P119, DOI 10.1111/j.1365-2990.2006.00689.x; WILSON RC, 1976, BEHAV BIOL, V17, P495, DOI 10.1016/S0091-6773(76)90901-9; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	47	33	33	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16550	10.1371/journal.pone.0016550	http://dx.doi.org/10.1371/journal.pone.0016550			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379584	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300018
J	Simanek, AM; Dowd, JB; Pawelec, G; Melzer, D; Dutta, A; Aiello, AE				Simanek, Amanda M.; Dowd, Jennifer Beam; Pawelec, Graham; Melzer, David; Dutta, Ambarish; Aiello, Allison E.			Seropositivity to Cytomegalovirus, Inflammation, All-Cause and Cardiovascular Disease-Related Mortality in the United States	PLOS ONE			English	Article							C-REACTIVE PROTEIN; IMMUNE RISK PHENOTYPE; HERPES-SIMPLEX-VIRUS; SMOOTH-MUSCLE-CELLS; SOCIOECONOMIC POSITION; HIGH PREVALENCE; ARTERIAL-WALLS; LATE-LIFE; T-CELLS; INFECTION	Background: Studies have suggested that CMV infection may influence cardiovascular disease (CVD) risk and mortality. However, there have been no large-scale examinations of these relationships among demographically diverse populations. The inflammatory marker C-reactive protein (CRP) is also linked with CVD outcomes and mortality and may play an important role in the pathway between CMV and mortality. We utilized a U. S. nationally representative study to examine whether CMV infection is associated with all-cause and CVD-related mortality. We also assessed whether CRP level mediated or modified these relationships. Methodology/Principal Findings: Data come from subjects >= 25 years of age who were tested for CMV and CRP level and were eligible for mortality follow-up on December 31(st), 2006 (N = 14153) in the National Health and Nutrition Examination Survey (NHANES) III (1988-1994). Cox proportional hazard models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for all-cause and CVD-related mortality by CMV serostatus. After adjusting for multiple confounders, CMV seropositivity remained statistically significantly associated with all-cause mortality (HR 1.19, 95% CI: 1.01, 1.41). The association between CMV and CVD-related mortality did not achieve statistical significance after confounder adjustment. CRP did not mediate these associations. However, CMV seropositive individuals with high CRP levels showed a 30.1% higher risk for all-cause mortality and 29.5% higher risk for CVD-related mortality compared to CMV seropositive individuals with low CRP levels. Conclusions/Significance: CMV was associated with a significant increased risk for all-cause mortality and CMV seropositive subjects who also had high CRP levels were at substantially higher risk for both for all-cause and CVD-related mortality than subjects with low CRP levels. Future work should target the mechanisms by which CMV infection and low-level inflammation interact to yield significant impact on mortality.	[Simanek, Amanda M.; Aiello, Allison E.] Univ Michigan, Sch Publ Hlth, Ctr Social Epidemiol & Populat Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Dowd, Jennifer Beam] CUNY, CUNY Inst Demog Res, Hunter Coll, Sch Publ Hlth, New York, NY 10021 USA; [Pawelec, Graham] Univ Tubingen, Sch Med, ZMF, Med Res Ctr,Dept Internal Med 2, Tubingen, Germany; [Melzer, David; Dutta, Ambarish] Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter, Devon, England	University of Michigan System; University of Michigan; City University of New York (CUNY) System; Hunter College (CUNY); Eberhard Karls University of Tubingen; University of Exeter	Simanek, AM (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Social Epidemiol & Populat Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	aielloa@umich.edu	Dowd, Jennifer B/C-1127-2012; Pawelec, Graham/H-2713-2019; Simanek, Amanda/AAC-1426-2019	Dowd, Jennifer B/0000-0003-2006-5656; Pawelec, Graham/0000-0002-3600-0163; Dutta, Ambarish/0000-0002-4019-7472	Rackham Graduate School, University of Michigan; National Institutes of Health [R21 NR011181]; Stanley Medical Research Institute; European Commission [EU-LSHG-CT-2007-036894]; NATIONAL INSTITUTE OF NURSING RESEARCH [R21NR011181] Funding Source: NIH RePORTER	Rackham Graduate School, University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	AMS was supported by Rackham Graduate School Predoctoral Fellowship, University of Michigan. JBD and AEA were funded by National Institutes of Health grant (R21 NR011181). AEA was funded by the Stanley Medical Research Institute. GP was supported by the European Commission (EU-LSHG-CT-2007-036894 "LifeSpan"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J GERONTOL A-BIOL, V63, P610, DOI 10.1093/gerona/63.6.610; Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Albert LJ, 1999, NEW ENGL J MED, V341, P2068, DOI 10.1056/NEJM199912303412707; ALMEIDA GD, 1994, BLOOD, V83, P370; Arcavi L, 2004, ARCH INTERN MED, V164, P2206, DOI 10.1001/archinte.164.20.2206; Bajpai A, 2010, CLIN CARDIOL, V33, P190, DOI 10.1002/clc.20681; Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Berencsi K, 1998, CELL ADHES COMMUN, V5, P39, DOI 10.3109/15419069809005597; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Blankenberg S, 2001, CIRCULATION, V103, P2915, DOI 10.1161/01.CIR.103.24.2915; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Chan D, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-34; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71; Costalonga EC, 2009, CLIN TRANSPLANT, V23, P710, DOI 10.1111/j.1399-0012.2009.01030.x; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Epstein SE, 2000, ARTERIOSCL THROM VAS, V20, P1417, DOI 10.1161/01.ATV.20.6.1417; Epstein SE, 2002, CIRC RES, V90, P2, DOI 10.1161/res.90.1.2; Epstein SE, 2009, CIRCULATION, V119, P3133, DOI 10.1161/CIRCULATIONAHA.109.849455; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guetta E, 1997, CIRC RES, V81, P8, DOI 10.1161/01.RES.81.1.8; Gunter EW, 1996, LAB PROCEDURES USED; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hansen SG, 2010, SCIENCE, V328, P102, DOI 10.1126/science.1185350; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; He LP, 2010, HEART, V96, P339, DOI 10.1136/hrt.2009.174912; HENDRIX MGR, 1990, AM J PATHOL, V136, P23; Hsich E, 2001, ATHEROSCLEROSIS, V156, P23, DOI 10.1016/S0021-9150(00)00608-0; Knosel T, 2004, CANCER LETT, V211, P243, DOI 10.1016/j.canlet.2004.02.011; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Lee TA, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.03.003; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Lunardi C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000473; MELNICK JL, 1983, LANCET, V2, P644; MELNICK JL, 1994, J MED VIROL, V42, P170, DOI 10.1002/jmv.1890420213; Mendall MA, 2000, EUR HEART J, V21, P1584, DOI 10.1053/euhj.1999.1982; Mocarski ES, 2006, CYTOMEGALOVIRUSES: MOLECULAR BIOLOGY AND IMMUNOLOGY, P465; Muhlestein JB, 2000, CIRCULATION, V102, P1917, DOI 10.1161/01.CIR.102.16.1917; National Center for Health Statistics, 1998, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2010, COMP AN NHANES 3 PUB; National Center for Health Statistics. Centers for Disease Control and Prevention, 2010, NAT HLTH NUTR EX SUR; National Center for Health Statistics. Office of Analysis and Epidemiology, 2009, 3 NAT HLTH NUTR EX S; Nieto FJ, 1996, CIRCULATION, V94, P922, DOI 10.1161/01.CIR.94.5.922; Olsson J, 2000, MECH AGEING DEV, V121, P187; OONEY RJ, 1999, CLIN IMMUNOL, V90, P213; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Prasad K, 2006, CARDIOVASC DRUG REV, V24, P33, DOI 10.1111/j.1527-3466.2006.00033.x; Rask K, 2009, J PUBLIC HEALTH-UK, V31, P231, DOI 10.1093/pubmed/fdp015; Reinhardt B, 2005, CARDIOVASC RES, V67, P151, DOI 10.1016/j.cardiores.2005.03.012; *RES TRIANGL I, 2008, SUDAAN LANG MAN REL; Ridker PM, 2003, CIRCULATION, V108, pE81, DOI 10.1161/01.CIR.0000093381.57779.67; Ridker PM, 1998, CIRCULATION, V98, P2796, DOI 10.1161/01.CIR.98.25.2796; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Rothman K., 1998, MODERN EPIDEMIOLOGY; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schmaltz HN, 2005, J AM GERIATR SOC, V53, P747, DOI 10.1111/j.1532-5415.2005.53250.x; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Simanek AM, 2009, INT J EPIDEMIOL, V38, P775, DOI 10.1093/ije/dyn273; Singh GK, 2006, INT J EPIDEMIOL, V35, P903, DOI 10.1093/ije/dyl089; Smieja M, 2003, CIRCULATION, V107, P251, DOI 10.1161/01.CIR.0000044940.65226.1F; SMITH PD, 1992, J CLIN INVEST, V90, P1642, DOI 10.1172/JCI116035; Sorlie PD, 2000, ARCH INTERN MED, V160, P2027, DOI 10.1001/archinte.160.13.2027; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stassen FR, 2006, J CLIN VIROL, V35, P349, DOI 10.1016/j.jcv.2005.11.007; Stassen FR, 2008, PHARMACOL REP, V60, P85; Strandberg TE, 2009, JAMA-J AM MED ASSOC, V301, P380, DOI 10.1001/jama.2009.4; Tice JA, 2003, AM J MED, V114, P199, DOI 10.1016/S0002-9343(02)01497-3; United States National Center for Health Statistics, 2005, NAT HLTH NUTR EX SUR; VANDAMMIERAS MCE, 1992, THROMB HAEMOSTASIS, V68, P364; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; WIKBY A, 1994, EXP GERONTOL, V29, P531, DOI 10.1016/0531-5565(94)90036-1; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; Zhu JH, 1999, J AM COLL CARDIOL, V34, P1738, DOI 10.1016/S0735-1097(99)00410-6	80	268	271	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16103	10.1371/journal.pone.0016103	http://dx.doi.org/10.1371/journal.pone.0016103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379581	Green Published, gold			2022-12-27	WOS:000287482300014
J	Moller, AP; Bonisoli-Alquati, A; Rudolfsen, G; Mousseau, TA				Moller, Anders Pape; Bonisoli-Alquati, Andea; Rudolfsen, Geir; Mousseau, Timothy A.			Chernobyl Birds Have Smaller Brains	PLOS ONE			English	Article							BARN SWALLOWS; OXIDATIVE STRESS; EYE SIZE; RADIATION; MALFORMATIONS; ANTIOXIDANTS; GLUTATHIONE; DISPERSAL; DISASTER	Background: Animals living in areas contaminated by radioactive material from Chernobyl suffer from increased oxidative stress and low levels of antioxidants. Therefore, normal development of the nervous system is jeopardized as reflected by high frequencies of developmental errors, reduced brain size and impaired cognitive abilities in humans. Alternatively, associations between psychological effects and radiation have been attributed to post-traumatic stress in humans. Methodology/Principal Finding: Here we used an extensive sample of 550 birds belonging to 48 species to test the prediction that even in the absence of post-traumatic stress, there is a negative association between relative brain size and level of background radiation. We found a negative association between brain size as reflected by external head volume and level of background radiation, independent of structural body size and body mass. The observed reduction in brain size in relation to background radiation amounted to 5% across the range of almost a factor 5,000 in radiation level. Species differed significantly in reduction in brain size with increasing background radiation, and brain size was the only morphological character that showed a negative relationship with radiation. Brain size was significantly smaller in yearlings than in older individuals. Conclusions/Significance: Low dose radiation can have significant effects on normal brain development as reflected by brain size and therefore potentially cognitive ability. The fact that brain size was smaller in yearlings than in older individuals implies that there was significant directional selection on brain size with individuals with larger brains experiencing a viability advantage.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andea; Mousseau, Timothy A.] NRPA, Dept Environm Radioact, Polar Environm Ctr, Tromso, Norway; [Rudolfsen, Geir] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France.	anders.moller@u-psud.fr	Mousseau, Timothy A/A-1253-2011; Alquati, Andrea Bonisoli/S-2082-2017; Moller, Anders/O-6665-2016; Bonisoli Alquati, Andrea/A-6409-2008; Rudolfsen, Geir/ABD-7777-2020	Alquati, Andrea Bonisoli/0000-0002-9255-7556; Moller, Anders/0000-0003-3739-4675; Rudolfsen, Geir/0000-0001-7984-8458; Mousseau, Timothy/0000-0002-2235-4868	University of South Carolina School of the Environment; Bill Murray and the Samuel Freeman Charitable Trust; National Science Foundation; NATO; Fulbright Program; CRDF; National Geographic Society	University of South Carolina School of the Environment; Bill Murray and the Samuel Freeman Charitable Trust; National Science Foundation(National Science Foundation (NSF)); NATO(NATO (North Atlantic Treaty Organisation)); Fulbright Program; CRDF; National Geographic Society(National Geographic Society)	The authors received funding from the University of South Carolina School of the Environment, Bill Murray and the Samuel Freeman Charitable Trust, the National Science Foundation, NATO, the Fulbright Program, CRDF and the National Geographic Society to conduct their research. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOND D, 2007, NATL BUREAU EC RES, V1334, P1; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Battley PF, 2000, P ROY SOC B-BIOL SCI, V267, P191, DOI 10.1098/rspb.2000.0986; Bazhan K V, 1998, Lik Sprava, P47; Ben-Amotz A, 1998, RADIAT ENVIRON BIOPH, V37, P187, DOI 10.1007/s004110050116; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Burnham KP, 2001, MODEL SELECTION MULT; Chaialo P P, 1991, Med Radiol (Mosk), V36, P20; CHUPRYKOV AP, 1992, MENTAL DISORDERS RAD; Cohen J., 1988, STAT POWER ANAL BEHA; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; DZYKOVICH IB, 1996, MED BIOL ASPECTS CHE, V1, P16; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Havenaar JM, 1997, AM J PSYCHIAT, V154, P1605, DOI 10.1176/ajp.154.11.1605; Heiervang KS, 2010, SCAND J PSYCHOL, V51, P210, DOI 10.1111/j.1467-9450.2010.00814.x; Hoffman DJ, 1998, ENVIRON TOXICOL CHEM, V17, P161, DOI 10.1002/etc.5620170204; Hoffmann W, 2001, ARCH ENVIRON HEALTH, V56, P478, DOI 10.1080/00039890109602895; Ivanyuta L. I., 1998, Ukrainskii Biokhimicheskii Zhurnal, V70, P132; Iwaniuk AN, 2004, P ROY SOC B-BIOL SCI, V271, pS148, DOI 10.1098/rsbl.2003.0127; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; Kimler BF, 1998, INT J RADIAT BIOL, V73, P423, DOI 10.1080/095530098142266; Kumerova AO, 2000, BIOL TRACE ELEM RES, V77, P1, DOI 10.1385/BTER:77:1:1; Lykholat E. A., 1999, Ukrainskii Biokhimicheskii Zhurnal, V71, P82; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2007, P ROY SOC B-BIOL SCI, V274, P1443, DOI 10.1098/rspb.2007.0005; Moller AP, 2006, ECOL APPL, V16, P1696, DOI 10.1890/1051-0761(2006)016[1696:CAAPSF]2.0.CO;2; Moller AP, 2010, J EVOLUTION BIOL, V23, P625, DOI 10.1111/j.1420-9101.2009.01928.x; Moller AP, 2010, ETHOLOGY, V116, P458, DOI 10.1111/j.1439-0310.2010.01754.x; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2005, J EVOLUTION BIOL, V18, P223, DOI 10.1111/j.1420-9101.2004.00805.x; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; MOLLER AP, 2010, ECOL INDICA IN PRESS; Moller AP., 1994, SEXUAL SELECTION BAR; MOLLER AP, 2007, BIOL LETT, V5, P356; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Neyfakh EA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1138; Neyfakh EA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P977; Nyagu AI, 1998, INT J PSYCHOPHYSIOL, V30, P303, DOI 10.1016/S0167-8760(98)00022-1; NYAGU AI, 2003, HLTH PHYS, V89; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Rosenthal R, 1991, METAANALYTIC PROCEDU; *SAS I INC, 2000, JMP VERS 7; Sewalk CJ, 2000, J TOXICOL ENV HEAL A, V62, P33, DOI 10.1080/00984100050201659; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; Svensson L.A., 2006, IDENTIFICATION GUIDE; Timmermans S, 2000, BRAIN BEHAV EVOLUT, V56, P196, DOI 10.1159/000047204; Wertelecki W, 2010, PEDIATRICS, V125, pE836, DOI 10.1542/peds.2009-2219; YABLOKOV A. V., 2009, CHERNOBYL CONSEQUENC; Zhavoronkova L A, 2002, Dokl Biol Sci, V386, P410, DOI 10.1023/A:1020702015207	51	41	42	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 4	2011	6	2							e16862	10.1371/journal.pone.0016862	http://dx.doi.org/10.1371/journal.pone.0016862			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	717IN	21390202	gold, Green Submitted, Green Published			2022-12-27	WOS:000287037000028
J	Bao, B; Ali, S; Kong, DJ; Sarkar, SH; Wang, ZW; Banerjee, S; Aboukameel, A; Padhye, S; Philip, PA; Sarkar, FH				Bao, Bin; Ali, Shadan; Kong, Dejuan; Sarkar, Sanila H.; Wang, Zhiwei; Banerjee, Sanjeev; Aboukameel, Amro; Padhye, Subhash; Philip, Philip A.; Sarkar, Fazlul H.			Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer	PLOS ONE			English	Article							NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; DRUG-RESISTANCE; STEM-CELLS; CURCUMIN; MICRORNA-21; EXPRESSION; ADHESION; INVASION; TARGET	Background: The existence of cancer stem cells (CSCs) or cancer stem-like cells in a tumor mass is believed to be responsible for tumor recurrence because of their intrinsic and extrinsic drug-resistance characteristics. Therefore, targeted killing of CSCs would be a newer strategy for the prevention of tumor recurrence and/or treatment by overcoming drug-resistance. We have developed a novel synthetic compound-CDF, which showed greater bioavailability in animal tissues such as pancreas, and also induced cell growth inhibition and apoptosis, which was mediated by inactivation of NF-kappa B, COX-2, and VEGF in pancreatic cancer (PC) cells. Methodology/Principal Findings: In the current study we showed, for the first time, that CDF could significantly inhibit the sphere-forming ability (pancreatospheres) of PC cells consistent with increased disintegration of pancreatospheres, which was associated with attenuation of CSC markers (CD44 and EpCAM), especially in gemcitabine-resistant (MIAPaCa-2) PC cells containing high proportion of CSCs consistent with increased miR-21 and decreased miR-200. In a xenograft mouse model of human PC, CDF treatment significantly inhibited tumor growth, which was associated with decreased NF-kappa B DNA binding activity, COX-2, and miR-21 expression, and increased PTEN and miR-200 expression in tumor remnants. Conclusions/Significance: These results strongly suggest that the anti-tumor activity of CDF is associated with inhibition of CSC function via down-regulation of CSC-associated signaling pathways. Therefore, CDF could be useful for the prevention of tumor recurrence and/or treatment of PC with better treatment outcome in the future.	[Bao, Bin; Kong, Dejuan; Sarkar, Sanila H.; Wang, Zhiwei; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA; [Ali, Shadan; Aboukameel, Amro; Philip, Philip A.] Wayne State Univ, Karmanos Canc Inst, Div Hematol Oncol, Detroit, MI USA; [Padhye, Subhash] Dr DY Patil Univ, Pune, Maharashtra, India	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Dr DY Patil Vidyapeeth Pune	Bao, B (corresponding author), Wayne State Univ, Dept Pathol, Detroit, MI 48202 USA.	fsarkar@med.wayne.edu			National Cancer Institute, NIH [5R01CA131151, 3R01CA131151-02S1, 5R01CA132794]; Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE [R01CA154321, R01CA131151, R01CA132794] Funding Source: NIH RePORTER	National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Puschelberg and Guido foundations; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute, NIH grants 5R01CA131151, 3R01CA131151-02S1, and 5R01CA132794 (F. H. Sarkar). We thank Puschelberg and Guido foundations for their generous financial contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abas F, 2005, J NAT PROD, V68, P1090, DOI 10.1021/np0500171; Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Arlt A, 2003, ONCOGENE, V22, P3243, DOI 10.1038/sj.onc.1206390; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Creighton CJ, 2010, J MAMMARY GLAND BIOL, V15, P253, DOI 10.1007/s10911-010-9173-1; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; El-Rayes BF, 2004, MOL CANCER THER, V3, P1421; Gaviraghi M, 2010, BIOSCI REP; Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Ischenko I, 2010, LANGENBECK ARCH SURG, V395, P1, DOI 10.1007/s00423-009-0502-z; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kong DJ, 2009, STEM CELLS, V27, P1712, DOI 10.1002/stem.101; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li YW, 2010, CANCER RES, V70, P1486, DOI 10.1158/0008-5472.CAN-09-2792; Li YW, 2010, PHARM RES-DORDR, V27, P1027, DOI 10.1007/s11095-010-0105-y; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mueller Maria-Theresa, 2010, Front Biosci (Elite Ed), V2, P602, DOI 10.2741/e117; Narayan S, 2004, J MOL HISTOL, V35, P301, DOI 10.1023/B:HIJO.0000032361.98815.bb; Padhye S, 2009, PHARM RES-DORDR, V26, P2438, DOI 10.1007/s11095-009-9955-6; Padhye S, 2009, PHARM RES-DORDR, V26, P1874, DOI 10.1007/s11095-009-9900-8; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; Sebens S., 2008, V177, P151; Shimosegawa T, 2009, CLIN GASTROENTEROL H, V7, pS23, DOI 10.1016/j.cgh.2009.07.042; VandenBoom TG, 2008, CURR GENOMICS, V9, P97, DOI 10.2174/138920208784139555; Wang ZW, 2010, PHARM RES-DORDR, V27, P1159, DOI 10.1007/s11095-010-0106-x; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang ZQ, 2006, INT J ONCOL, V29, P185	34	158	169	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17850	10.1371/journal.pone.0017850	http://dx.doi.org/10.1371/journal.pone.0017850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408027	Green Published, gold			2022-12-27	WOS:000288170900051
J	Ataera, H; Hyde, E; Price, KM; Stoitzner, P; Ronchese, F				Ataera, Haley; Hyde, Evelyn; Price, Kylie M.; Stoitzner, Patrizia; Ronchese, Franca			Murine Melanoma-Infiltrating Dendritic Cells Are Defective in Antigen Presenting Function Regardless of the Presence of CD4(+)CD25(+) Regulatory T Cells	PLOS ONE			English	Article							TUMOR-DERIVED ANTIGEN; IN-VIVO; TGF-BETA; PROGNOSTIC VALUE; II PRESENTATION; CUTTING EDGE; LYMPH-NODES; EFFECTOR; ACTIVATION; IMMUNITY	Tumor-infiltrating dendritic cells are often ineffective at presenting tumor-derived antigen in vivo, a defect usually ascribed to the suppressive tumor environment. We investigated the effects of depleting CD4(+)CD25(+) "natural" regulatory T cells (Treg) on the frequency, phenotype and function of total dendritic cell populations in B16.OVA tumors and in tumor-draining lymph nodes. Intraperitoneal injection of the anti-CD25 monoclonal antibody PC61 reduced Treg frequency in blood and tumors, but did not affect the frequency of tumor-infiltrating dendritic cells, or their expression of CD40, CD86 and MHCII. Tumor-infiltrating dendritic cells from PC61-treated or untreated mice induced the proliferation of allogeneic T cells in vitro, but could not induce proliferation of OVA-specific OTI and OTIIT cells unless specific peptide antigen was added in culture. Some proliferation of naive, OVA-specific OTI T cells, but not OTII T cells, was observed in the tumor-draining LN of mice carrying B16.OVA tumors, however, this was not improved by PC61 treatment. Experiments using RAG1(-/-) hosts adoptively transferred with OTI and CD25-depleted OTII cells also failed to show improved OTI and OTII T cell proliferation in vivo compared to C57BL/6 hosts. We conclude that the defective presentation of B16.OVA tumor antigen by tumor-infiltrating dendritic cells and in the tumor-draining lymph node is not due to the presence of "natural" CD4(+)CD25(+) Treg.	[Ataera, Haley; Hyde, Evelyn; Price, Kylie M.; Stoitzner, Patrizia; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington	Ataera, H (corresponding author), Baylor Coll Med, Ctr Gene Therapy, Houston, TX 77030 USA.	fronchese@malaghan.org.nz	Price, Kylie/AAO-4061-2020; Ronchese, Franca/M-9618-2019	Price, Kylie/0000-0002-1446-6958; Ronchese, Franca/0000-0001-5835-8230; stoitzner, patrizia/0000-0002-8488-6704	Health Research Council of NZ; Cancer Society of NZ [HRC 04/249]; Austrian Science Fund [FWF-J2479]	Health Research Council of NZ(Health Research Council of New Zealand); Cancer Society of NZ; Austrian Science Fund(Austrian Science Fund (FWF))	This work was funded by a research grant from the Health Research Council of NZ and Cancer Society of NZ to FR (HRC 04/249). HA was funded by a PhD scholarship from the Health Research Council of NZ and by the Wellington division of the Cancer Society. PS was supported by the Erwin Schroedinger Auslandsstipendium from the Austrian Science Fund (FWF-J2479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Billiard F, 2006, J IMMUNOL, V177, P2167, DOI 10.4049/jimmunol.177.4.2167; Biollaz G, 2009, EUR J IMMUNOL, V39, P1323, DOI 10.1002/eji.200838921; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bui JD, 2006, CANCER RES, V66, P7301, DOI 10.1158/0008-5472.CAN-06-0556; Carbone FR, 2004, TRENDS IMMUNOL, V25, P655, DOI 10.1016/j.it.2004.09.013; Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X; Chaux P, 1997, INT J CANCER, V72, P619, DOI 10.1002/(SICI)1097-0215(19970807)72:4<619::AID-IJC12>3.3.CO;2-Y; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; ENGLEMAN EG, 2004, SCI STKE, pPE28; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gerner MY, 2008, J IMMUNOL, V181, P155, DOI 10.4049/jimmunol.181.1.155; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Grauer OM, 2007, INT J CANCER, V121, P95, DOI 10.1002/ijc.22607; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Kieper WC, 1999, P NATL ACAD SCI USA, V96, P13306, DOI 10.1073/pnas.96.23.13306; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Marincola FM, 2003, TRENDS IMMUNOL, V24, P335, DOI 10.1016/S1471-4906(03)00116-9; Matsushita N, 2008, J IMMUNOL METHODS, V333, P167, DOI 10.1016/j.jim.2008.01.012; McDonnell AM, 2010, EUR J IMMUNOL, V40, P1617, DOI 10.1002/eji.200940153; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Norian LA, 2009, CANCER RES, V69, P3086, DOI 10.1158/0008-5472.CAN-08-2826; Oberle N, 2007, J IMMUNOL, V179, P3578, DOI 10.4049/jimmunol.179.6.3578; Pinzon-Charry A, 2005, IMMUNOL CELL BIOL, V83, P451, DOI 10.1111/j.1440-1711.2005.01371.x; Prasad SJ, 2005, J IMMUNOL, V174, P90, DOI 10.4049/jimmunol.174.1.90; Preynat-Seauve O, 2006, J IMMUNOL, V176, P61, DOI 10.4049/jimmunol.176.1.61; Qin FXF, 2009, CELL MOL IMMUNOL, V6, P3, DOI 10.1038/cmi.2009.2; Sandel MH, 2005, CLIN CANCER RES, V11, P2576, DOI 10.1158/1078-0432.CCR-04-1448; Scheinecker C, 2002, J EXP MED, V196, P1079, DOI 10.1084/jem.20020991; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Shimizu J, 1999, J IMMUNOL, V163, P5211; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Stoitzner P, 2008, CANCER IMMUNOL IMMUN, V57, P1665, DOI 10.1007/s00262-008-0487-4; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thompson ED, 2010, J EXP MED, V207, P1791, DOI 10.1084/jem.20092454; van Mierlo GJD, 2008, J IMMUNOL, V180, P2747, DOI 10.4049/jimmunol.180.5.2747; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Vicari AP, 2002, SEMIN CANCER BIOL, V12, P33, DOI 10.1006/scbi.2001.0400; Yang ZZ, 2006, CANCER RES, V66, P10145, DOI 10.1158/0008-5472.CAN-06-1822	55	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17515	10.1371/journal.pone.0017515	http://dx.doi.org/10.1371/journal.pone.0017515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390236	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200019
J	Hensel, M; Steurer, R; Fichtl, J; Elger, C; Wedekind, F; Petzold, A; Schlothauer, T; Molhoj, M; Reusch, D; Bulau, P				Hensel, Miriam; Steurer, Rebecca; Fichtl, Juergen; Elger, Carsten; Wedekind, Frank; Petzold, Andreas; Schlothauer, Tilman; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick			Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS	PLOS ONE			English	Article							METHIONINE OXIDATION; MONOCLONAL-ANTIBODY; HUMAN IGG1; PROTEIN; BINDING; FC; PHARMACEUTICALS; DEGRADATION; MECHANISMS	Amino acid oxidation is known to affect the structure, activity, and rate of degradation of proteins. Methionine oxidation is one of the several chemical degradation pathways for recombinant antibodies. In this study, we have identified for the first time a solvent accessible tryptophan residue (Trp-32) in the complementary-determining region (CDR) of a recombinant IgG1 antibody susceptible to oxidation under real-time storage and elevated temperature conditions. The degree of light chain Trp-32 oxidation was found to be higher than the oxidation level of the conserved heavy chain Met-429 and the heavy chain Met-107 of the recombinant IgG1 antibody HER2, which have already been identified as being solvent accessible and sensitive to chemical oxidation. In order to reduce the time for simultaneous identification and functional evaluation of potential methionine and tryptophan oxidation sites, a test system employing tert-butylhydroperoxide (TBHP) and quantitative LC-MS was developed. The optimized oxidizing conditions allowed us to specifically oxidize the solvent accessible methionine and tryptophan residues that displayed significant oxidation in the real-time stability and elevated temperature study. The achieved degree of tryptophan oxidation was adequate to identify the functional consequence of the tryptophan oxidation by binding studies. In summary, the here presented approach of employing TBHP as oxidizing reagent combined with quantitative LC-MS and binding studies greatly facilitates the efficient identification and functional evaluation of methionine and tryptophan oxidation sites in the CDR of recombinant antibodies.	[Hensel, Miriam; Steurer, Rebecca; Fichtl, Juergen; Elger, Carsten; Wedekind, Frank; Molhoj, Michael; Reusch, Dietmar; Bulau, Patrick] Roche Diagnost GmbH, Pharma Dev Penzberg, Penzberg, Germany; [Petzold, Andreas; Schlothauer, Tilman] Roche Diagnost GmbH, Pharma Res Penzberg, Penzberg, Germany	Roche Holding; Roche Holding	Bulau, P (corresponding author), Roche Diagnost GmbH, Pharma Dev Penzberg, Penzberg, Germany.	patrick.bulau@roche.com		Bulau, Patrick/0000-0002-7121-2954				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertolotti-Ciarlet A, 2009, MOL IMMUNOL, V46, P1878, DOI 10.1016/j.molimm.2009.02.002; Churnsae C, 2007, J CHROMATOGR B, V850, P285, DOI 10.1016/j.jchromb.2006.11.050; DAVIES KJA, 1987, J BIOL CHEM, V262, P9902; Houde D, 2006, J CHROMATOGR A, V1123, P189, DOI 10.1016/j.chroma.2006.04.046; Hovorka SW, 2001, J PHARM SCI-US, V90, P253, DOI 10.1002/1520-6017(200103)90:3<253::AID-JPS1>3.0.CO;2-W; Ji JA, 2009, J PHARM SCI-US, V98, P4485, DOI 10.1002/jps.21746; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; LI SH, 1995, BIOTECHNOL BIOENG, V48, P490, DOI 10.1002/bit.260480511; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; Liu HC, 2008, MOL IMMUNOL, V45, P701, DOI 10.1016/j.molimm.2007.07.012; NGUYEN TH, 1993, PHARMACEUT RES, V10, P1563, DOI 10.1023/A:1018908316698; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Shen FJ., 1996, TECHNIQUES PROTEIN C, V7, P275; Timm V, 2010, J CHROMATOGR B, V878, P777, DOI 10.1016/j.jchromb.2010.01.036; UCHIDA K, 1989, AGR BIOL CHEM TOKYO, V53, P3285, DOI 10.1080/00021369.1989.10869852; Wei ZP, 2007, ANAL CHEM, V79, P2797, DOI 10.1021/ac062311j; Yang J, 2007, J CHROMATOGR A, V1156, P174, DOI 10.1016/j.chroma.2007.01.140	19	43	43	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17708	10.1371/journal.pone.0017708	http://dx.doi.org/10.1371/journal.pone.0017708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390239	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200038
J	Kawasaki, H; Kosugi, I; Arai, Y; Iwashita, T; Tsutsui, Y				Kawasaki, Hideya; Kosugi, Isao; Arai, Yoshifumi; Iwashita, Toshihide; Tsutsui, Yoshihiro			Mouse Embryonic Stem Cells Inhibit Murine Cytomegalovirus Infection through a Multi-Step Process	PLOS ONE			English	Article							IMMEDIATE-EARLY PROMOTER; HUMAN TERATOCARCINOMA CELLS; GROWTH-FACTOR RECEPTOR; TRANSGENIC MICE; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; RETINOIC ACID; IN-VITRO; PROTEIN EXPRESSION; EPITHELIAL-CELLS	In humans, cytomegalovirus (CMV) is the most significant infectious cause of intrauterine infections that cause congenital anomalies of the central nervous system. Currently, it is not known how this process is affected by the timing of infection and the susceptibility of early-gestational-period cells. Embryonic stem (ES) cells are more resistant to CMV than most other cell types, although the mechanism responsible for this resistance is not well understood. Using a plaque assay and evaluation of immediate-early 1 mRNA and protein expression, we found that mouse ES cells were resistant to murine CMV (MCMV) at the point of transcription. In ES cells infected with MCMV, treatment with forskolin and trichostatin A did not confer full permissiveness to MCMV. In ES cultures infected with elongation factor-1 alpha (EF-1 alpha) promoter-green fluorescent protein (GFP) recombinant MCMV at a multiplicity of infection of 10, less than 5% of cells were GFP-positive, despite the fact that ES cells have relatively high EF-1 alpha promoter activity. Quantitative PCR analysis of the MCMV genome showed that ES cells allow approximately 20-fold less MCMV DNA to enter the nucleus than mouse embryonic fibroblasts (MEFs) do, and that this inhibition occurs in a multi-step manner. In situ hybridization revealed that ES cell nuclei have significantly less MCMV DNA than MEF nuclei. This appears to be facilitated by the fact that ES cells express less heparan sulfate, beta 1 integrin, and vimentin, and have fewer nuclear pores, than MEF. This may reduce the ability of MCMV to attach to and enter through the cellular membrane, translocate to the nucleus, and cross the nuclear membrane in pluripotent stem cells (ES/induced pluripotent stem cells). The results presented here provide perspective on the relationship between CMV susceptibility and cell differentiation.	[Kawasaki, Hideya; Kosugi, Isao; Arai, Yoshifumi; Iwashita, Toshihide] Hamamatsu Univ Sch Med, Dept Pathol 2, Hamamatsu, Shizuoka 4313192, Japan; [Tsutsui, Yoshihiro] Hamamatsu Univ, Fac Hlth Sci, Hamamatsu, Shizuoka 4312102, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Kawasaki, H (corresponding author), Hamamatsu Univ Sch Med, Dept Pathol 2, Hamamatsu, Shizuoka 4313192, Japan.	gloria@hama-med.ac.jp			Ministry of Education, Science and Culture, Japan [20790301]; Hamamatsu University School of Medicine	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hamamatsu University School of Medicine	This work has been supported by a grant (#20790301) from the Ministry of Education, Science and Culture, Japan and through funding from Hamamatsu University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba-Masago S, 1999, AM J PATHOL, V154, P735, DOI 10.1016/S0002-9440(10)65320-5; Bouhon IA, 2006, STEM CELLS, V24, P1908, DOI 10.1634/stemcells.2006-0031; CARDIN RD, 1995, VIROLOGY, V209, P236, DOI 10.1006/viro.1995.1249; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; COONEN E, 1993, HISTOCHEMISTRY, V99, P141, DOI 10.1007/BF00571875; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; EBIHARA K, 1984, J VIROL, V51, P117, DOI 10.1128/JVI.51.1.117-122.1984; Feire AL, 2004, P NATL ACAD SCI USA, V101, P15470, DOI 10.1073/pnas.0406821101; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; GHAZAL P, 1992, P NATL ACAD SCI USA, V89, P7630, DOI 10.1073/pnas.89.16.7630; GONCZOL E, 1985, J GEN VIROL, V66, P509, DOI 10.1099/0022-1317-66-3-509; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; Harel A, 2001, NAT CELL BIOL, V3, pE267, DOI 10.1038/ncb1201-e267; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Huber MT, 2002, J VIROL, V76, P5748, DOI 10.1128/JVI.76.11.5748-5758.2002; Isaacson MK, 2007, J VIROL, V81, P6241, DOI 10.1128/JVI.00169-07; Ishiguro K, 2004, EUR J BIOCHEM, V271, P2379, DOI 10.1111/j.1432-1033.2004.04157.x; Ivaska J, 2005, EMBO J, V24, P3834, DOI 10.1038/sj.emboj.7600847; Jurak I, 2006, EMBO J, V25, P2634, DOI 10.1038/sj.emboj.7601133; KASHIWAI A, 1992, ARCH VIROL, V127, P37, DOI 10.1007/BF01309573; Kawabata K, 2005, MOL THER, V12, P547, DOI 10.1016/j.ymthe.2005.04.015; Kawasaki H, 2002, LAB INVEST, V82, P1347, DOI 10.1097/01.LAB.0000032376.58688.D4; Kawasaki H, 2007, J VIROL, V81, P9013, DOI 10.1128/JVI.00261-07; Keller MJ, 2007, J VIROL, V81, P6669, DOI 10.1128/JVI.01524-06; Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088; Kosugi I, 2000, LAB INVEST, V80, P1373, DOI 10.1038/labinvest.3780145; Krmpotic A, 2003, MICROBES INFECT, V5, P1263, DOI 10.1016/j.micinf.2003.09.007; LAFEMINA R, 1986, J VIROL, V58, P434, DOI 10.1128/JVI.58.2.434-440.1986; Lentz BR, 1999, MOL MEMBR BIOL, V16, P279, DOI 10.1080/096876899294508; Li RY, 2001, GLIA, V35, P41, DOI 10.1002/glia.1069; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; Matsukage S, 2006, BIRTH DEFECTS RES A, V76, P115, DOI 10.1002/bdra.20233; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; Meier JL, 1997, J VIROL, V71, P1246, DOI 10.1128/JVI.71.2.1246-1255.1997; Meier JL, 2001, J VIROL, V75, P1581, DOI 10.1128/JVI.75.4.1581-1593.2001; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; Miller MS, 2009, J VIROL, V83, P7015, DOI 10.1128/JVI.00398-09; MILLER N, 1992, J VIROL, V66, P3409, DOI 10.1128/JVI.66.6.3409-3414.1992; Mocarski E.S, 2007, FIELDS VIROLOGY, P2702; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; NELSON JA, 1986, MOL CELL BIOL, V6, P452, DOI 10.1128/MCB.6.2.452; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Odeberg J, 2006, J VIROL, V80, P8929, DOI 10.1128/JVI.00676-06; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Perez-Terzic Carmen, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS68, DOI 10.1038/ncpcardio0763; RAUB TJ, 1990, J CELL PHYSIOL, V144, P52, DOI 10.1002/jcp.1041440108; Reeves MB, 2005, J GEN VIROL, V86, P2949, DOI 10.1099/vir.0.81161-0; Schleiss MR, 2002, J CLIN VIROL, V25, pS37; Scrivano L, 2010, J VIROL, V84, P4469, DOI 10.1128/JVI.02441-09; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shinmura Y, 1997, AM J PATHOL, V151, P1331; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Simon CO, 2005, J VIROL, V79, P326, DOI 10.1128/JVI.79.1.326-340.2005; Sinzger C, 2008, J CLIN VIROL, V41, P174, DOI 10.1016/j.jcv.2007.12.002; Slobbe-van Drunen MEP, 1998, VIRUS RES, V56, P149, DOI 10.1016/S0168-1702(98)00064-1; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Soroceanu L, 2008, NATURE, V455, P391, DOI 10.1038/nature07209; STENBERG RM, 1990, J VIROL, V64, P1556, DOI 10.1128/JVI.64.4.1556-1565.1990; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang QY, 2006, J VIROL, V80, P7510, DOI 10.1128/JVI.00684-06; Tang QY, 2000, J VIROL, V74, P9694, DOI 10.1128/JVI.74.20.9694-9700.2000; TSUTSUI Y, 1995, PATHOL INT, V45, P91, DOI 10.1111/j.1440-1827.1995.tb03428.x; Tsutsui Y, 2005, REV MED VIROL, V15, P327, DOI 10.1002/rmv.475; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; van den Pol AN, 1999, J NEUROSCI, V19, P10948, DOI 10.1523/JNEUROSCI.19-24-10948.1999; Vanarsdall AL, 2008, J VIROL, V82, P11837, DOI 10.1128/JVI.01623-08; Wang D, 2007, P NATL ACAD SCI USA, V104, P20037, DOI 10.1073/pnas.0709704104; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Wang X, 2005, NAT MED, V11, P515, DOI 10.1038/nm1236; Wang X, 2003, NATURE, V424, P456, DOI 10.1038/nature01818; Wang XQ, 2003, J VIROL, V77, P7182, DOI 10.1128/JVI.77.13.7182-7192.2003; Wang YM, 2006, METHODS, V39, P356, DOI 10.1016/j.ymeth.2006.06.010; WENTHWOR.BB, 1970, P SOC EXP BIOL MED, V135, P253, DOI 10.3181/00379727-135-35031; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; 1991, CONGENITAL PERINATAL, P205	81	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17492	10.1371/journal.pone.0017492	http://dx.doi.org/10.1371/journal.pone.0017492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407806	Green Submitted, gold, Green Published			2022-12-27	WOS:000287933300028
J	Rutledge, RG				Rutledge, Robert G.			A Java Program for LRE-Based Real-Time qPCR that Enables Large-Scale Absolute Quantification	PLOS ONE			English	Article							PCR; STANDARD	Background: Linear regression of efficiency (LRE) introduced a new paradigm for real-time qPCR that enables large-scale absolute quantification by eliminating the need for standard curves. Developed through the application of sigmoidal mathematics to SYBR Green I-based assays, target quantity is derived directly from fluorescence readings within the central region of an amplification profile. However, a major challenge of implementing LRE quantification is the labor intensive nature of the analysis. Findings: Utilizing the extensive resources that are available for developing Java-based software, the LRE Analyzer was written using the NetBeans IDE, and is built on top of the modular architecture and windowing system provided by the NetBeans Platform. This fully featured desktop application determines the number of target molecules within a sample with little or no intervention by the user, in addition to providing extensive database capabilities. MS Excel is used to import data, allowing LRE quantification to be conducted with any real-time PCR instrument that provides access to the raw fluorescence readings. An extensive help set also provides an in-depth introduction to LRE, in addition to guidelines on how to implement LRE quantification. Conclusions: The LRE Analyzer provides the automated analysis and data storage capabilities required by large-scale qPCR projects wanting to exploit the many advantages of absolute quantification. Foremost is the universal perspective afforded by absolute quantification, which among other attributes, provides the ability to directly compare quantitative data produced by different assays and/or instruments. Furthermore, absolute quantification has important implications for gene expression profiling in that it provides the foundation for comparing transcript quantities produced by any gene with any other gene, within and between samples.	Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada	Natural Resources Canada; Canadian Forest Service	Rutledge, RG (corresponding author), Nat Resources Canada, Canadian Forest Serv, Quebec City, PQ, Canada.	Bob.Rutledge@NRCan.gc.ca			Canadian Biotechnology Strategy	Canadian Biotechnology Strategy	The research was supported in part by a grant to RGR from the Canadian Biotechnology Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding were received for this study.	Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Murphy J, 2009, EXPERT REV MOL DIAGN, V9, P187, DOI 10.1586/14737159.9.2.187; Pfaffl MW, 2010, METHODS, V50, P215, DOI 10.1016/j.ymeth.2010.02.005; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Vermeulen J, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp721	11	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17636	10.1371/journal.pone.0017636	http://dx.doi.org/10.1371/journal.pone.0017636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407812	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300038
J	Jurat-Fuentes, JL; Karumbaiah, L; Jakka, SRK; Ning, CM; Liu, CX; Wu, KM; Jackson, J; Gould, F; Blanco, C; Portilla, M; Perera, O; Adang, M				Jurat-Fuentes, Juan Luis; Karumbaiah, Lohitash; Jakka, Siva Rama Krishna; Ning, Changming; Liu, Chenxi; Wu, Kongming; Jackson, Jerreme; Gould, Fred; Blanco, Carlos; Portilla, Maribel; Perera, Omaththage; Adang, Michael			Reduced Levels of Membrane-Bound Alkaline Phosphatase Are Common to Lepidopteran Strains Resistant to Cry Toxins from Bacillus thuringiensis	PLOS ONE			English	Article							HELIOTHIS-VIRESCENS LEPIDOPTERA; ARMIGERA HUBNER LEPIDOPTERA; P38 MAP KINASE; DELTA-ENDOTOXIN; MANDUCA-SEXTA; BINDING-PROTEINS; BT COTTON; CONFERRING RESISTANCE; INSECT RESISTANCE; TRANSGENIC COTTON	Development of insect resistance is one of the main concerns with the use of transgenic crops expressing Cry toxins from the bacterium Bacillus thuringiensis. Identification of biomarkers would assist in the development of sensitive DNA-based methods to monitor evolution of resistance to Bt toxins in natural populations. We report on the proteomic and genomic detection of reduced levels of midgut membrane-bound alkaline phosphatase (mALP) as a common feature in strains of Cry-resistant Heliothis virescens, Helicoverpa armigera and Spodoptera frugiperda when compared to susceptible larvae. Reduced levels of H. virescens mALP protein (HvmALP) were detected by two dimensional differential in-gel electrophoresis (2D-DIGE) analysis in Cry-resistant compared to susceptible larvae, further supported by alkaline phosphatase activity assays and Western blotting. Through quantitative real-time polymerase chain reaction (qRT-PCR) we demonstrate that the reduction in HvmALP protein levels in resistant larvae are the result of reduced transcript amounts. Similar reductions in ALP activity and mALP transcript levels were also detected for a Cry1Ac-resistant strain of H. armigera and field-derived strains of S. frugiperda resistant to Cry1Fa. Considering the unique resistance and cross-resistance phenotypes of the insect strains used in this work, our data suggest that reduced mALP expression should be targeted for development of effective biomarkers for resistance to Cry toxins in lepidopteran pests.	[Jurat-Fuentes, Juan Luis; Jakka, Siva Rama Krishna] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Karumbaiah, Lohitash; Adang, Michael] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Ning, Changming; Liu, Chenxi; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Plant Dis & Insect Pests, Inst Plant Protect, Beijing, Peoples R China; [Jackson, Jerreme] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37901 USA; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Blanco, Carlos] US Anim & Plant Hlth Inspect Serv, Biotechnol Regulatory Serv, USDA, Riverdale, MD USA; [Portilla, Maribel; Perera, Omaththage] ARS, So Insect Management Res Unit, USDA, Stoneville, MS USA; [Adang, Michael] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Georgia; University of Georgia; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University System of Georgia; University of Georgia	Jurat-Fuentes, JL (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	jurat@utk.edu	Jurat-Fuentes, Juan Luis/A-5104-2014; Portilla, Maribel/AAJ-9247-2020; Blanco, Carlos/AAE-9032-2022	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Karumbaiah, Lohitash/0000-0001-7969-417X	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture [2004-35607-14936, 2008-39211-19577]	Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This material is based upon work supported by Cooperative State Research, Education, and Extension Service, U.S. Department of Agriculture, under National Research Initiative Award No. 2004-35607-14936 to M.J.A. and J.L.J.-F., and Biotechnology Risk Assessment Grant Award No. 2008-39211-19577 to J.L.J.-F. and O.P.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture.	Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Baxter SW, 2005, INSECT MOL BIOL, V14, P327, DOI 10.1111/j.1365-2583.2005.00563.x; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Blanco CA, 2010, SOUTHWEST ENTOMOL, V35, P409, DOI 10.3958/059.035.0325; Blanco CA, 2009, J ECON ENTOMOL, V102, P381, DOI 10.1603/029.102.0149; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Cancino-Rodezno A, 2010, INSECT BIOCHEM MOLEC, V40, P58, DOI 10.1016/j.ibmb.2009.12.010; Ding QM, 2001, BIOCHEM BIOPH RES CO, V284, P282, DOI 10.1006/bbrc.2001.4969; EGUCHI M, 1995, COMP BIOCHEM PHYS B, V111, P151, DOI 10.1016/0305-0491(94)00248-S; ENGLISH LH, 1989, INSECT BIOCHEM, V19, P145, DOI 10.1016/0020-1790(89)90085-1; Fernandez LE, 2006, BIOCHEM J, V394, P77, DOI 10.1042/BJ20051517; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Forcada C, 1999, ARCH INSECT BIOCHEM, V42, P51, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;51::AID-ARCH6&gt;3.0.CO;2-6; Gahan LJ, 2007, J ECON ENTOMOL, V100, P187, DOI 10.1603/0022-0493(2007)100[187:APCRSO]2.0.CO;2; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2005, J ECON ENTOMOL, V98, P1357, DOI 10.1603/0022-0493-98.4.1357; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GOULD F, 1995, J ECON ENTOMOL, V88, P1545, DOI 10.1093/jee/88.6.1545; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Hua G, 2009, BIOCHEMISTRY-US, V48, P9785, DOI 10.1021/bi9014538; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2003, APPL ENVIRON MICROB, V69, P5898, DOI 10.1128/AEM.69.10.5898-5906.2003; Jurat-Fuentes JL, 2002, APPL ENVIRON MICROB, V68, P5711, DOI 10.1128/AEM.68.11.5711-5717.2002; Jurat-Fuentes JL, 2001, APPL ENVIRON MICROB, V67, P323, DOI 10.1128/AEM.67.1.323-329.2001; Jurat-Fuentes JL, 2007, J INVERTEBR PATHOL, V95, P187, DOI 10.1016/j.jip.2007.01.008; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Karumbaiah L, 2007, COMP BIOCHEM PHYS B, V146, P139, DOI 10.1016/j.cbpb.2006.10.104; Kaur M, 2009, J ENVIRON BIOL, V30, P1019; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; KUCERA M, 1974, ACTA ENTOMOL BOHEMOS, V71, P289; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu MG, 2004, PEST MANAG SCI, V60, P887, DOI 10.1002/ps.882; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Martinez-Ramirez AC, 1999, BIOCONTROL SCI TECHN, V9, P239, DOI 10.1080/09583159929811; Martins ES, 2010, INSECT BIOCHEM MOLEC, V40, P138, DOI 10.1016/j.ibmb.2010.01.005; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Meng FX, 2004, PEST MANAG SCI, V60, P167, DOI 10.1002/ps.806; Miao YG, 2002, J APPL ENTOMOL, V126, P138, DOI 10.1046/j.1439-0418.2002.00625.x; Morin S, 2004, INSECT BIOCHEM MOLEC, V34, P1225, DOI 10.1016/j.ibmb.2004.08.003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Rahman MM, 2004, P NATL ACAD SCI USA, V101, P2696, DOI 10.1073/pnas.0306669101; Raymond B, 2010, TRENDS MICROBIOL, V18, P189, DOI 10.1016/j.tim.2010.02.006; SANGADALA S, 1994, J BIOL CHEM, V269, P10088; Hernandez-Rodriguez CS, 2008, APPL ENVIRON MICROB, V74, P7654, DOI 10.1128/AEM.01373-08; Sarkar A, 2009, J PROTEOME RES, V8, P1838, DOI 10.1021/pr8006528; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; Suzuki A, 1999, ENDOCRINOLOGY, V140, P3177, DOI 10.1210/en.140.7.3177; Suzuki A, 2002, BONE, V30, P91, DOI 10.1016/S8756-3282(01)00660-3; Tabashnik BE, 2005, J ECON ENTOMOL, V98, P635, DOI 10.1603/0022-0493-98.3.635; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P2125, DOI 10.1603/0022-0493-99.6.2125; Tabashnik BE, 2006, J ECON ENTOMOL, V99, P1525, DOI 10.1603/0022-0493-99.5.1525; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Xu ZP, 2009, PEST MANAG SCI, V65, P391, DOI 10.1002/ps.1703; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103; Zhao J, 2010, INSECT BIOCHEM MOLEC, V40, P113, DOI 10.1016/j.ibmb.2010.01.001; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	69	119	134	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17606	10.1371/journal.pone.0017606	http://dx.doi.org/10.1371/journal.pone.0017606			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390253	Green Submitted, Green Published, gold			2022-12-27	WOS:000287932100025
J	Gomila, RC; Martin, GW; Gehrke, L				Gomila, Raul C.; Martin, Glover W., III; Gehrke, Lee			NF90 Binds the Dengue Virus RNA 3 ' Terminus and Is a Positive Regulator of Dengue Virus Replication	PLOS ONE			English	Article							3'-TERMINAL STEM-LOOP; 3'-UNTRANSLATED REGION; MESSENGER-RNA; GENOMIC RNA; SECONDARY STRUCTURE; CYCLIZATION SEQUENCES; BREAST-CANCER; DC-SIGN; PROTEIN; TRANSLATION	Background: Viral RNA translation and replication are regulated by sequence and structural elements in the 5' and 3' untranslated regions (UTR) and by host cell and/or viral proteins that bind them. Dengue virus has a single-stranded RNA genome with positive polarity, a 5' m7GpppG cap, and a conserved 3'-terminal stem loop (SL) that is linked to proposed functions in viral RNA transcription and translation. Mechanisms explaining the contributions of host proteins to viral RNA translation and replication are poorly defined, yet understanding host protein-viral RNA interactions may identify new targets for therapeutic intervention. This study was directed at identifying functionally significant host proteins that bind the conserved dengue virus RNA 3' terminus. Methodology/Principal Findings: Proteins eluted from a dengue 3' SL RNA affinity column at increasing ionic strength included two with double-strand RNA binding motifs (NF90/DRBP76 and DEAH box polypeptide 9/RNA helicase A (RHA)), in addition to NF45, which forms a heterodimer with NF90. Although detectable NF90 and RHA proteins localized to the nucleus of uninfected cells, immunofluorescence revealed cytoplasmic NF90 in dengue virus-infected cells, leading us to hypothesize that NF90 has a functional role(s) in dengue infections. Cells depleted of NF90 were used to quantify viral RNA transcript levels and production of infectious dengue virus. NF90 depletion was accompanied by a 50%-70% decrease in dengue RNA levels and in production of infectious viral progeny. Conclusions/Significance: The results indicate that NF90 interacts with the 3' SL structure of the dengue RNA and is a positive regulator of dengue virus replication. NF90 depletion diminished the production of infectious dengue virus by more than 50%, which may have important significance for identifying therapeutic targets to limit a virus that threatens more than a billion people worldwide.	Harvard Univ, Sch Med, Div Hlth Sci, Boston, MA USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gomila, RC (corresponding author), Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA.	lee_gehrke@hms.harvard.edu			Ruth L. Kirschstein National Research Service Award; NIH-NRSA [GM64985]; UNCF-Merck; NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID); Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042504, F31GM064985] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck(Merck & Company); NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship, NIH-NRSA GM64985, to RCG; a UNCF-Merck Postdoctoral Fellowship and NIAID New England Regional Center for Excellence in Biodefense and Emerging Infectious Disease (NERCE-BEID) Career Development Fellowship to GWM; and an award to LG from the Ellison Medical Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J PATHOL, V164, P1683, DOI 10.1016/S0002-9440(10)63727-3; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; BAKER PR, CLAUSER KR MS FIT; Balliet JW, 1999, J VIROL, V73, P3054, DOI 10.1128/JVI.73.4.3054-3061.1999; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BLACKWELL JL, 1995, J VIROL, V69, P5650, DOI 10.1128/JVI.69.9.5650-5658.1995; BRAY M, 1991, P NATL ACAD SCI USA, V88, P10342, DOI 10.1073/pnas.88.22.10342; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997; Copeland PR, 2002, METHOD ENZYMOL, V347, P40; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; DENG RT, 1993, NUCLEIC ACIDS RES, V21, P1949, DOI 10.1093/nar/21.8.1949; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; GRANGE T, 1985, FEBS LETT, V188, P159, DOI 10.1016/0014-5793(85)80895-4; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Heukelbach J, 2001, TROP MED INT HEALTH, V6, P635, DOI 10.1046/j.1365-3156.2001.00762.x; Holden KL, 2006, VIROLOGY, V344, P439, DOI 10.1016/j.virol.2005.08.034; Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004; HOUSERSCOTT F, 1994, J VIROL, V68, P2194, DOI 10.1128/JVI.68.4.2194-2205.1994; Isken O, 2003, EMBO J, V22, P5655, DOI 10.1093/emboj/cdg562; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997; JOBLING SA, 1988, NUCLEIC ACIDS RES, V16, P4483, DOI 10.1093/nar/16.10.4483; Kaminski A, 1995, RNA, V1, P924; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Lawrence P, 2009, J VIROL, V83, P11356, DOI 10.1128/JVI.02677-08; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Merrill MK, 2006, J VIROL, V80, P3147, DOI 10.1128/JVI.80.7.3147-3156.2006; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfeifer I, 2008, P NATL ACAD SCI USA, V105, P4173, DOI 10.1073/pnas.0711222105; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Zeng LL, 1998, J VIROL, V72, P7510, DOI 10.1128/JVI.72.9.7510-7522.1998	56	71	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16687	10.1371/journal.pone.0016687	http://dx.doi.org/10.1371/journal.pone.0016687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386893	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400009
J	Narbonne-Reveau, K; Charroux, B; Royet, J				Narbonne-Reveau, Karine; Charroux, Bernard; Royet, Julien			Lack of an Antibacterial Response Defect in Drosophila Toll-9 Mutant	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; ANTIMICROBIAL PEPTIDE GENES; DORSAL-VENTRAL POLARITY; GENOME-WIDE ANALYSIS; IMMUNE-RESPONSE; HOST-DEFENSE; NEGATIVE REGULATOR; EXPRESSION; INDUCTION	Toll and Toll-like receptors represent families of receptors involved in mediating innate immunity response in insects and mammals. Although Drosophila proteome contains multiple Toll paralogs, Toll-1 is, so far, the only receptor to which an immune role has been attributed. In contrast, every single mammalian TLR is a key membrane receptor upstream of the vertebrate immune signaling cascades. The prevailing view is that TLR-mediated immunity is ancient. Structural analysis reveals that Drosophila Toll-9 is the most closely related to vertebrate TLRs and utilizes similar signaling components as Toll-1. This suggests that Toll-9 could be an ancestor of TLR-like receptors and could have immune function. Consistently, it has been reported that over-expression of Toll-9 in immune tissues is sufficient to induce the expression of some antimicrobial peptides in flies. These results have led to the idea that Toll-9 could be a constitutively active receptor that maintain significant levels of antimicrobial molecules and therefore provide constant basal protection against micro-organisms. To test theses hypotheses, we generated and analyzed phenotypes associated with a complete loss-of-function allele of Toll-9. Our results suggest that Toll-9 is neither required to maintain a basal anti-microbial response nor to mount an efficient immune response to bacterial infection.	[Narbonne-Reveau, Karine; Charroux, Bernard; Royet, Julien] Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Narbonne-Reveau, K (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, Campus Luminy, F-13284 Marseille 07, France.	royet@ibdml.univmed.fr		Narbonne-Reveau, Karine/0000-0002-4650-4576	Centre National de la Recherche Scientifique, Agence Nationale de la Recherche; Fondation pour la Recherche Medicale	Centre National de la Recherche Scientifique, Agence Nationale de la Recherche(French National Research Agency (ANR)Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by Centre National de la Recherche Scientifique, Agence Nationale de la Recherche and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KV, 1985, CELL, V42, P791, DOI 10.1016/0092-8674(85)90275-2; Armant MA, 2002, GENOME BIOL, V3; Bergmann A, 1996, MECH DEVELOP, V60, P109, DOI 10.1016/S0925-4773(96)00607-7; Bettencourt R, 2004, J ENDOTOXIN RES, V10, P261, DOI 10.1179/096805104225004897; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bilak H, 2003, BIOCHEM SOC T, V31, P648, DOI 10.1042/bst0310648; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Cameron JS, 2007, J NEUROSCI, V27, P13033, DOI 10.1523/JNEUROSCI.4290-06.2007; Charroux B, 2010, FLY, V4, P40, DOI 10.4161/fly.4.1.10810; Charroux B, 2009, P NATL ACAD SCI USA, V106, P9797, DOI 10.1073/pnas.0903971106; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Defaye A, 2009, J INNATE IMMUN, V1, P322, DOI 10.1159/000210264; DEV A, 2010, CURR TOP MICROBIOL I; Du X, 2000, EUR CYTOKINE NETW, V11, P362; ELDON E, 1994, DEVELOPMENT, V120, P885; Fernandez NQ, 2001, DEVELOPMENT, V128, P2963; Gangloff M, 2008, J BIOL CHEM, V283, P14629, DOI 10.1074/jbc.M800112200; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; HALFON MS, 1995, DEV BIOL, V169, P151, DOI 10.1006/dbio.1995.1134; HASHIMOTO C, 1988, CELL, V52, P269, DOI 10.1016/0092-8674(88)90516-8; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hoshino K, 1999, J IMMUNOL, V162, P3749; Imler JL, 2004, J LEUKOCYTE BIOL, V75, P18, DOI 10.1189/jlb.0403160; Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998; Kambris Zakaria, 2002, Gene Expression Patterns, V2, P311, DOI 10.1016/S1567-133X(02)00020-0; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim S, 2006, GENESIS, V44, P541, DOI 10.1002/dvg.20245; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Luo CH, 2000, IMMUNOGENETICS, V51, P92, DOI 10.1007/s002510050017; Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107; Ooi JY, 2002, EMBO REP, V3, P82, DOI 10.1093/embo-reports/kvf004; Pal S, 2009, ADV EXP MED BIOL, V653, P162; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Rose D, 1997, DEVELOPMENT, V124, P1561; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Seppo A, 2003, DEVELOPMENT, V130, P1439, DOI 10.1242/dev.00347; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Sun HY, 2004, EMBO J, V23, P100, DOI 10.1038/sj.emboj.7600033; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202; Wu S, 2010, DEV COMP IMMUNOL, V34, P93, DOI 10.1016/j.dci.2009.08.010; Yagi Y, 2010, DEV GROWTH DIFFER, V52, P771, DOI 10.1111/j.1440-169X.2010.01213.x	71	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17470	10.1371/journal.pone.0017470	http://dx.doi.org/10.1371/journal.pone.0017470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386906	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400080
J	Arsenault, D; Julien, C; Tremblay, C; Calon, F				Arsenault, Dany; Julien, Carl; Tremblay, Cyntia; Calon, Frederic			DHA Improves Cognition and Prevents Dysfunction of Entorhinal Cortex Neurons in 3xTg-AD Mice	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY DOCOSAHEXAENOIC ACID; BETA-AMYLOID ACCUMULATION; TRIPLE-TRANSGENIC MODEL; ALZHEIMERS-DISEASE; SYNAPTIC NOISE; MOUSE MODEL; MEMBRANE CAPACITANCE; RECOGNITION MEMORY; PREFRONTAL CORTEX	Defects in neuronal activity of the entorhinal cortex (EC) are suspected to underlie the symptoms of Alzheimer's disease (AD). Whereas neuroprotective effects of docosahexaenoic acid (DHA) have been described, the effects of DHA on the physiology of EC neurons remain unexplored in animal models of AD. Here, we show that DHA consumption improved object recognition (up arrow 12%), preventing deficits observed in old 3xTg-AD mice (down arrow 12%). Moreover, 3xTg-AD mice displayed seizure-like akinetic episodes, not detected in NonTg littermates and partly prevented by DHA (down arrow 50%). Patch-clamp recording revealed that 3xTg-AD EC neurons displayed (i) loss of cell capacitance (CC), suggesting reduced membrane surface area; (ii) increase of firing rate versus injected current (F-I) curve associated with modified action potentials, and (iii) overactivation of glutamatergic synapses, without changes in synaptophysin levels. DHA consumption increased CC (up arrow 12%) and decreased F-I slopes (down arrow 21%), thereby preventing the opposite alterations observed in 3xTg-AD mice. Our results indicate that cognitive performance and basic physiology of EC neurons depend on DHA intake in a mouse model of AD.	[Arsenault, Dany; Julien, Carl; Calon, Frederic] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Arsenault, Dany; Julien, Carl; Tremblay, Cyntia; Calon, Frederic] CHUL CHUQ Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University	Arsenault, D (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	Frederic.Calon@crchul.ulaval.ca	Calon, Frederic/AAF-4390-2020; Julien, Carl/AAU-5309-2021	Calon, Frederic/0000-0002-4203-0887	Canadian Institutes of Health Research (CIHR) [FC - MOP74443]; Alzheimer Society Canada [FC - ASC 0516]; Canada Foundation for Innovation [10307]; "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University; "Fonds de la recherche en sante du Quebec (FRSQ)"; Clinical Research Initiative; CIHR Institute of Aging [CAN-76833]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University; "Fonds de la recherche en sante du Quebec (FRSQ)"(Fonds de la Recherche en Sante du Quebec); Clinical Research Initiative; CIHR Institute of Aging(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR) (FC - MOP74443), the Alzheimer Society Canada (FC - ASC 0516) and the Canada Foundation for Innovation (10307). D. Arsenault held studentships from the CIHR and "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University. C. Julien is supported by the Alzheimer Society Canada, "Fonds de la recherche en sante du Quebec (FRSQ)" and the "Fonds d'Enseignement and de Recherche" from the faculty of pharmacy of Laval University. The work of F. Calon was supported by a New Investigator Award from the Clinical Research Initiative and the CIHR Institute of Aging (CAN-76833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akirav I, 2006, CEREB CORTEX, V16, P1759, DOI 10.1093/cercor/bhj114; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Arsenault D, 2006, J PHYSIOL-LONDON, V573, P121, DOI 10.1113/jphysiol.2006.106542; Balderas I, 2008, LEARN MEMORY, V15, P618, DOI 10.1101/lm.1028008; Boston PF, 2004, PROSTAG LEUKOTR ESS, V71, P341, DOI 10.1016/j.plefa.2004.07.001; Boudrault C, 2009, J NUTR BIOCHEM, V20, P1, DOI 10.1016/j.jnutbio.2008.05.016; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Brunel N, 2001, PHYS REV LETT, V86, P2186, DOI 10.1103/PhysRevLett.86.2186; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calon F, 2005, EUR J NEUROSCI, V22, P617, DOI 10.1111/j.1460-9568.2005.04253.x; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Calon F, 2007, PROSTAG LEUKOTR ESS, V77, P287, DOI 10.1016/j.plefa.2007.10.019; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Chang YM, 2005, CEREB CORTEX, V15, P409, DOI 10.1093/cercor/bhh144; Chen CT, 2009, PROSTAG LEUKOTR ESS, V80, P157, DOI 10.1016/j.plefa.2009.01.005; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Clinton LK, 2007, NEUROBIOL DIS, V28, P76, DOI 10.1016/j.nbd.2007.06.013; Counts SE, 2006, J NEUROPATH EXP NEUR, V65, P592, DOI 10.1097/00005072-200606000-00007; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; de Lima MN, 2006, NEUROSCI LETT, V405, P142, DOI 10.1016/j.neulet.2006.06.044; Devore EE, 2009, AM J CLIN NUTR, V90, P170, DOI 10.3945/ajcn.2008.27037; Diau GY, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-11; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Dullemeijer C, 2008, BRIT J NUTR, V100, P794, DOI 10.1017/S0007114508943737; Duyckaerts C, 2004, NEUROBIOL AGING, V25, P735, DOI 10.1016/neurobiolaging.2003.12.014; Faumont S, 2006, J NEUROPHYSIOL, V95, P3665, DOI 10.1152/jn.00052.2006; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fotuhi M, 2009, NAT CLIN PRACT NEURO, V5, P140, DOI 10.1038/ncpneuro1044; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Golowasch J, 2009, J NEUROPHYSIOL, V102, P2161, DOI 10.1152/jn.00160.2009; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; Hamilton JA, 2002, MOL CELL BIOCHEM, V239, P17, DOI 10.1023/A:1020542220599; Hamilton JA, 2007, J MOL NEUROSCI, V33, P12, DOI 10.1007/s12031-007-0050-3; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Heude B, 2003, AM J CLIN NUTR, V77, P803, DOI 10.1093/ajcn/77.4.803; Hogan SA, 2003, J MICROENCAPSUL, V20, P675, DOI 10.1080/0265204031000151974; Hooijmans CR, 2009, NEUROBIOL DIS, V33, P482, DOI 10.1016/j.nbd.2008.12.002; Hsieh AT, 2009, PROSTAG LEUKOTR ESS, V81, P105, DOI 10.1016/j.plefa.2009.05.012; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Hunt CA, 1996, J NEUROSCI, V16, P1380; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; JONES RSG, 1993, TRENDS NEUROSCI, V16, P58, DOI 10.1016/0166-2236(93)90018-H; Julien C, 2010, NEUROBIOL AGING, V31, P1516, DOI 10.1016/j.neurobiolaging.2008.08.022; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; King DL, 2002, BRAIN RES, V926, P58, DOI 10.1016/S0006-8993(01)03294-2; Kohn AF, 1998, BIOSYSTEMS, V48, P113; Kolanowski W, 2004, INT J FOOD SCI NUTR, V55, P333, DOI 10.1080/09637480410001725157; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Kroger E, 2009, AM J CLIN NUTR, V90, P184, DOI 10.3945/ajcn.2008.26987; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lipton P. A., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/258467; Martin RE, 2000, NEUROCHEM RES, V25, P715, DOI 10.1023/A:1007575406896; Martinez-Coria H, 2010, AM J PATHOL, V176, P870, DOI 10.2353/ajpath.2010.090452; Masood A, 2005, J LIPID RES, V46, P2299, DOI 10.1194/jlr.D500022-JLR200; Matthews EA, 2008, P NATL ACAD SCI USA, V105, P15154, DOI 10.1073/pnas.0805855105; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mitchell JH, 2001, CLIN SCI, V100, P613, DOI 10.1042/CS20000212; MIZUSHIMA Y, 1984, EXPERIENTIA, V40, P359, DOI 10.1007/BF01952551; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Nejak-Bowen KN, 2009, J BIOL CHEM, V284, P28115, DOI 10.1074/jbc.M109.047258; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Prescott SA, 2003, P NATL ACAD SCI USA, V100, P2076, DOI 10.1073/pnas.0337591100; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; ROBSON LG, 2008, NEUROBIOL AGING; Sah P, 2002, PROG NEUROBIOL, V66, P345, DOI 10.1016/S0301-0082(02)00004-7; Sah P, 2000, CLIN EXP PHARMACOL P, V27, P657, DOI 10.1046/j.1440-1681.2000.03317.x; Sakamoto T, 2007, BRAIN RES, V1182, P50, DOI 10.1016/j.brainres.2007.08.089; SALEM N, 1989, OMEGA 3 FATTY ACIDS, P109; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Scheff SW, 2006, J ALZHEIMERS DIS, V9, P101; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; SERTH J, 1991, EMBO J, V10, P1325, DOI 10.1002/j.1460-2075.1991.tb07651.x; Sewards TV, 2003, BRAIN RES REV, V42, P243, DOI 10.1016/S0165-0173(03)00175-9; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Stacey WC, 2009, J NEUROPHYSIOL, V102, P2342, DOI 10.1152/jn.00397.2009; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; TAHA AY, 2010, EPILEPSIA; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thid D, 2007, LANGMUIR, V23, P5878, DOI 10.1021/la700523x; VANDERHEYDEN MJ, 1994, BIOL CYBERN, V72, P133, DOI 10.1007/BF00205977; Voskuyl RA, 1998, EUR J PHARMACOL, V341, P145, DOI 10.1016/S0014-2999(97)01467-2; Wang HB, 2005, P NATL ACAD SCI USA, V102, P9960, DOI 10.1073/pnas.0501632102; Whelan J, 2006, ANNU REV NUTR, V26, P75, DOI 10.1146/annurev.nutr.25.050304.092605; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Woodhall GL, 2005, HIPPOCAMPUS, V15, P232, DOI 10.1002/hipo.20047; Wurtman RJ, 2009, J NUTR HEALTH AGING, V13, P189, DOI 10.1007/s12603-009-0056-3; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6; Young C, 2000, SYNAPSE, V37, P90, DOI 10.1002/1098-2396(200008)37:2&lt;90::AID-SYN2&gt;3.0.CO;2-Z; Yuen AWC, 2005, EPILEPSY BEHAV, V7, P253, DOI 10.1016/j.yebeh.2005.04.014; Yurko-Mauro K, 2010, ALZHEIMERS DEMENT; Zhang ZW, 2005, J PHYSIOL-LONDON, V566, P379, DOI 10.1113/jphysiol.2005.086066; Zhou FM, 1996, J NEUROPHYSIOL, V76, P651, DOI 10.1152/jn.1996.76.2.651	119	123	126	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17397	10.1371/journal.pone.0017397	http://dx.doi.org/10.1371/journal.pone.0017397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383850	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500054
J	Maier, E; Nord, H; von Hofsten, J; Gunhaga, L				Maier, Esther; Nord, Hanna; von Hofsten, Jonas; Gunhaga, Lena			A Balance of BMP and Notch Activity Regulates Neurogenesis and Olfactory Nerve Formation	PLOS ONE			English	Article							CHICK-EMBRYO; STEM-CELLS; ENDOTHELIAL-CELLS; NEURON LINEAGE; SPINAL-CORD; EXPRESSION; DIFFERENTIATION; EPITHELIUM; PLACODE; SPECIFICATION	Although the function of the adult olfactory system has been thoroughly studied, the molecular mechanisms regulating the initial formation of the olfactory nerve, the first cranial nerve, remain poorly defined. Here, we provide evidence that both modulated Notch and bone morphogenetic protein (BMP) signaling affect the generation of neurons in the olfactory epithelium and reduce the number of migratory neurons, so called epithelioid cells. We show that this reduction of epithelial and migratory neurons is followed by a subsequent failure or complete absence of olfactory nerve formation. These data provide new insights into the early generation of neurons in the olfactory epithelium and the initial formation of the olfactory nerve tract. Our results present a novel mechanism in which BMP signals negatively affect Notch activity in a dominant manner in the olfactory epithelium, thereby regulating neurogenesis and explain why a balance of BMP and Notch activity is critical for the generation of neurons and proper development of the olfactory nerve.	[Maier, Esther; Nord, Hanna; von Hofsten, Jonas; Gunhaga, Lena] Umea Univ, Umea Ctr Mol Med, Umea, Sweden	Umea University	Maier, E (corresponding author), Umea Univ, Umea Ctr Mol Med, Umea, Sweden.	lena.gunhaga@ucmm.umu.se	Maier, Esther/AAR-6123-2020	von Hofsten, Jonas/0000-0003-3730-1790	Magnus Bergvalls Foundation; Umea University, Sweden; O.E. and Edla Johanssons Foundation; Ake Wibergs Foundation	Magnus Bergvalls Foundation; Umea University, Sweden; O.E. and Edla Johanssons Foundation; Ake Wibergs Foundation	J.v.H. is supported by Magnus Bergvalls Foundation, and L. G. is supported by Umea University, Sweden, O.E. and Edla Johanssons Foundation, and Ake Wibergs Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akai J, 2005, GENE DEV, V19, P2877, DOI 10.1101/gad.357705; Alanentalo T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3000430; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 2002, DEVELOPMENT, V129, P1871; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; CROUCHER SJ, 1989, DEVELOPMENT, V106, P493; Drapkin PT, 1999, DEV DYNAM, V214, P349, DOI 10.1002/(SICI)1097-0177(199904)214:4<349::AID-AJA7>3.3.CO;2-5; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fornaro M, 2003, NEUROSCIENCE, V122, P123, DOI 10.1016/j.neuroscience.2003.07.004; Fornaro M, 2001, NEUROSCIENCE, V107, P191, DOI 10.1016/S0306-4522(01)00334-7; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; Haddon C, 1998, DEVELOPMENT, V125, P359; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh F, 2004, EMBO J, V23, P541, DOI 10.1038/sj.emboj.7600065; James RG, 2005, DEV BIOL, V288, P113, DOI 10.1016/j.ydbio.2005.09.025; Kee Y, 2001, MECH DEVELOP, V109, P337, DOI 10.1016/S0925-4773(01)00575-5; Lassiter RNT, 2010, DEV BIOL, V344, P836, DOI 10.1016/j.ydbio.2010.05.514; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Le Roux I, 2003, INT J DEV BIOL, V47, P263; Machold RP, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-5; Maier E, 2010, DEVELOPMENT, V137, P1601, DOI 10.1242/dev.051219; Maier E, 2009, DEV DYNAM, V238, P1617, DOI 10.1002/dvdy.21966; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; MENDOZA AS, 1982, J EMBRYOL EXP MORPH, V69, P47; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Orita Y, 2006, ACTA OTO-LARYNGOL, V126, P498, DOI 10.1080/00016480500437419; Perez SE, 1999, DEVELOPMENT, V126, P1715; Schwarting GA, 2007, J MOL HISTOL, V38, P543, DOI 10.1007/s10735-007-9110-9; Shou J, 1999, NAT NEUROSCI, V2, P339, DOI 10.1038/7251; Shou JY, 2000, DEVELOPMENT, V127, P5403; Sjodal M, 2007, DEV CELL, V13, P141, DOI 10.1016/j.devcel.2007.04.020; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Timmer JR, 2002, DEVELOPMENT, V129, P2459; Tsarovina K, 2008, MOL CELL NEUROSCI, V37, P20, DOI 10.1016/j.mcn.2007.08.010; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; VALVERDE F, 1992, NEUROSCIENCE, V49, P255, DOI 10.1016/0306-4522(92)90094-I; Vargesson N, 1998, MECH DEVELOP, V77, P197, DOI 10.1016/S0925-4773(98)00138-5; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475	45	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17379	10.1371/journal.pone.0017379	http://dx.doi.org/10.1371/journal.pone.0017379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383851	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500052
J	Peinemann, F; Kroger, N; Bartel, C; Grouven, U; Pittler, M; Erttmann, R; Kulig, M				Peinemann, Frank; Kroeger, Nicolaus; Bartel, Carmen; Grouven, Ulrich; Pittler, Max; Erttmann, Rudolf; Kulig, Michael			High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation for Metastatic Rhabdomyosarcoma-A Systematic Review	PLOS ONE			English	Review							BONE-MARROW-TRANSPLANTATION; SOFT-TISSUE SARCOMA; RISK SOLID TUMORS; SMALL ROUND-CELL; INTENSIVE CHEMOTHERAPY; ALVEOLAR RHABDOMYOSARCOMA; MULTIAGENT CHEMOTHERAPY; COMPLETE REMISSION; PEDIATRIC BONE; EWINGS-SARCOMA	Introduction: Patients with metastatic rhabdomyosarcoma (RMS) have a poor prognosis. The aim of this systematic review is to investigate whether high-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) in patients with metastatic RMS has additional benefit or harm compared to standard chemotherapy. Methods: Systematic literature searches were performed in MEDLINE, EMBASE, and The Cochrane Library. All databases were searched from inception to February 2010. PubMed was searched in June 2010 for a last update. In addition to randomized and non-randomized controlled trials, case series and case reports were included to complement results from scant data. The primary outcome was overall survival. A meta-analysis was performed using the hazard ratio as primary effect measure, which was estimated from Cox proportional hazard models or from summary statistics of Kaplan Meier product-limit estimations. Results: A total of 40 studies with 287 transplant patients with metastatic RMS (age range 0 to 32 years) were included in the assessment. We identified 3 non-randomized controlled trials. The 3-year overall survival ranged from 22% to 53% in the transplant groups vs. 18% to 55% in the control groups. Meta-analysis on overall survival in controlled trials showed no difference between treatments. Result of meta-analysis of pooled individual survival data of case series and case reports, and results from uncontrolled studies with aggregate data were in the range of those from controlled data. The risk of bias was high in all studies due to methodological flaws. Conclusions: HDCT followed by autologous HSCT in patients with RMS remains an experimental treatment. At present, it does not appear justifiable to use this treatment except in appropriately designed controlled trials.	[Peinemann, Frank; Bartel, Carmen; Grouven, Ulrich; Kulig, Michael] Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany; [Kroeger, Nicolaus] Univ Hosp Hamburg Eppendorf, Interdisciplinary Clin Stem Cell Transplantat, Hamburg, Germany; [Grouven, Ulrich] Hannover Med Sch, D-3000 Hannover, Germany; [Pittler, Max] Univ Freiburg, German Cochrane Ctr, Freiburg, Germany; [Erttmann, Rudolf] Univ Hosp Hamburg Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Kulig, Michael] German Hlth Care Syst G BA, Fed Joint Comm, Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf	Peinemann, F (corresponding author), Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany.	frank.peinemann@iqwig.de	Peinemann, Frank/H-2800-2019	Peinemann, Frank/0000-0002-4727-1313				ADMIRAAL R, 2007, COCHRANE DB SYST REV; BADER JL, 1989, RADIOTHER ONCOL, V16, P189, DOI 10.1016/0167-8140(89)90019-4; BAGNULO S, 1985, EUR PAEDIATR HAEMAT, V2, P129, DOI 10.3109/08880018509141221; Banna Giuseppe Luigi, 2007, Curr Stem Cell Res Ther, V2, P65; Bernbeck B, 2007, KLIN PADIATR, V219, P318, DOI 10.1055/s-2007-985896; BIEN E, 2007, CHILDS NERVOUS SYS, P1147; Bisogno G, 2009, EUR J CANCER, V45, P3035, DOI 10.1016/j.ejca.2009.08.019; Blay JY, 2000, J CLIN ONCOL, V18, P3643, DOI 10.1200/JCO.2000.18.21.3643; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Carli M, 2004, J CLIN ONCOL, V22, P4787, DOI 10.1200/JCO.2004.04.083; Carli M, 1999, J CLIN ONCOL, V17, P2796, DOI 10.1200/JCO.1999.17.9.2796; Carvajal R, 2005, HEMATOL ONCOL CLIN N, V19, P501, DOI 10.1016/j.hoc.2005.03.004; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; CHAN KW, 1991, BONE MARROW TRANSPL, V7, P171; Cochrane Collaboration, 2005, GLOSS TERMS COCHR CO; *CTEP, 2009, COMM TERM CRIT ADV E; Deeks J J, 2003, Health Technol Assess, V7, piii; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DUMONTET C, 1992, BONE MARROW TRANSPL, V10, P405; *EBMT, 2010, ONG STUD STWP SOL TU; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ek ETH, 2006, EXPERT REV ANTICANC, V6, P225, DOI 10.1586/14737140.6.2.225; EKERT H, 1984, AUST PAEDIATR J, V20, P195; Elias AD, 1998, SEMIN ONCOL, V25, P19; EMMINGER W, 1991, BONE MARROW TRANSPL, V8, P119; Endo M, 1996, ONCOL REP, V3, P519; Engelhardt M, 2007, J CANCER RES CLIN, V133, P1, DOI 10.1007/s00432-006-0137-1; FEKRAT S, 1993, ARCH OPHTHALMOL-CHIC, V111, P1662, DOI 10.1001/archopht.1993.01090120084026; Fraser CJ, 2006, BONE MARROW TRANSPL, V37, P175, DOI 10.1038/sj.bmt.1705224; Galandi Daniel, 2006, BMC Med Res Methodol, V6, P30, DOI 10.1186/1471-2288-6-30; Goodenough JB, 2001, STRUCT BOND, V98, P1; Gratwohl A, 2007, BONE MARROW TRANSPL, V39, P71, DOI 10.1038/sj.bmt.1705555; GURNEY JG, 1999, NIH PUB, P111; Hale GA, 2005, EXPERT REV ANTICANC, V5, P835, DOI 10.1586/14737140.5.5.835; Hara J, 1998, BONE MARROW TRANSPL, V22, P7, DOI 10.1038/sj.bmt.1701283; Hawkins DS, 2002, CANCER, V95, P1354, DOI 10.1002/cncr.10801; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hosoi H, 2007, INT J CLIN ONCOL, V12, P137, DOI 10.1007/s10147-006-0638-6; Juni P, 2002, INT J EPIDEMIOL, V31, P115, DOI 10.1093/ije/31.1.115; KAIZER H, 1979, EXP HEMATOL, V7, P309; KANABAR DJ, 1995, PEDIATR HEMAT ONCOL, V12, P29, DOI 10.3109/08880019509029525; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasper B, 2004, BONE MARROW TRANSPL, V34, P37, DOI 10.1038/sj.bmt.1704520; Kasper B, 2010, BONE MARROW TRANSPL, V45, P1234, DOI 10.1038/bmt.2009.333; Kasper B, 2007, ONCOLOGY-BASEL, V73, P58, DOI 10.1159/000120629; KAVAN P, 1997, KLIN ONKOLOGIE, V10, P148; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Klingebiel T, 2008, PEDIATR BLOOD CANCER, V50, P739, DOI 10.1002/pbc.21494; Korfel A, 2001, BONE MARROW TRANSPL, V28, P787, DOI 10.1038/sj.bmt.1703212; Koscielniak E, 1997, BONE MARROW TRANSPL, V19, P227, DOI 10.1038/sj.bmt.1700628; Kuroiwa Minoru, 2009, J Pediatr Surg, V44, pe31, DOI 10.1016/j.jpedsurg.2008.12.010; Kwan WH, 1996, PEDIATR HEMAT ONCOL, V13, P277, DOI 10.3109/08880019609030828; Kwon SY, 2010, PEDIATR HEMAT ONCOL, V27, P1, DOI 10.3109/14992020903352226; Ladenstein Ruth, 1997, Current Opinion in Pediatrics, V9, P55, DOI 10.1097/00008480-199702000-00013; Lafay-Cousin L, 2000, BONE MARROW TRANSPL, V26, P627, DOI 10.1038/sj.bmt.1702573; Lashkari A, 2009, ANTICANCER RES, V29, P3281; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lucidarme N, 1998, BONE MARROW TRANSPL, V22, P535, DOI 10.1038/sj.bmt.1701395; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mackall CL, 2001, J PEDIAT HEMATOL ONC, V23, P266, DOI 10.1097/00043426-200106000-00005; Matsubara H, 2003, PEDIATR HEMAT ONCOL, V20, P201, DOI 10.1080/08880010390158829; McDowell HP, 2010, EUR J CANCER, V46, P1588, DOI 10.1016/j.ejca.2010.02.051; Meyers PA, 2004, CURR OPIN ONCOL, V16, P120, DOI 10.1097/00001622-200403000-00006; Michon J, 1999, BEST PRACT RES CL HA, V12, P247, DOI 10.1053/beha.1999.0021; MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W; MITCHELL PLR, 1994, ARCH DIS CHILD, V70, P237, DOI 10.1136/adc.70.3.237; Moher D, 2003, Health Technol Assess, V7, P1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; MUNOZ LL, 1983, INT J RADIAT ONCOL, V9, P1951, DOI 10.1016/0360-3016(83)90367-X; *NAT LIB MED, 2006, MESH TREE NUMB CHANG; Navid F, 2006, CANCER-AM CANCER SOC, V106, P1846, DOI 10.1002/cncr.21810; *NCI, 2010, CLIN TRIALS PHYS DAT; *NIHR, 2010, UK CLIN RES NETW UKC; Oue T, 2003, J PEDIATR SURG, V38, P130, DOI 10.1053/jpsu.2003.50026; Parham DM, 2006, ARCH PATHOL LAB MED, V130, P1454; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pedrazzoli P, 2006, ANN ONCOL, V17, P1479, DOI 10.1093/annonc/mdl044; Perentesis JP, 1999, BONE MARROW TRANSPL, V24, P609, DOI 10.1038/sj.bmt.1701950; PINKERTON R, 1986, CLIN HAEMATOL, V15, P187, DOI 10.1016/S0308-2261(86)80011-X; Reichardt P, 2002, CRIT REV ONCOL HEMAT, V41, P157, DOI 10.1016/S1040-8428(01)00153-6; Ritchie DS, 2004, INTERN MED J, V34, P431, DOI 10.1111/j.1444-0903.2004.00630.x; Rossbach HC, 1999, J PEDIAT HEMATOL ONC, V21, P528, DOI 10.1097/00043426-199911000-00016; Rosti G, 2002, CRIT REV ONCOL HEMAT, V41, P129, DOI 10.1016/S1040-8428(01)00150-0; Saikawa Y, 2006, J CLIN ONCOL, V24, P5783, DOI 10.1200/JCO.2006.08.4673; Sakayama K, 2008, ANTICANCER RES, V28, P2361; Sanchez-Garcia I, 2007, BIOESSAYS, V29, P1269, DOI 10.1002/bies.20679; Sanz N, 1997, PEDIATR SURG INT, V12, P200, DOI 10.1007/BF01350002; Schlemmer M, 2006, ONCOLOGY-BASEL, V71, P32, DOI 10.1159/000100447; SEEGER RC, 1991, PEDIATR CLIN N AM, V38, P393; Shaw PJ, 1996, BONE MARROW TRANSPL, V18, P1043; Sobin LH., 2009, TNM CLASSIFICATION M, V7th edition; Song, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI DOI 10.3310/HTA4100; Stiff PJ, 2010, BIOL BLOOD MARROW TR, V16, P525, DOI 10.1016/j.bbmt.2009.11.020; Suita S, 2005, EUR J PEDIATR SURG, V15, P409, DOI 10.1055/s-2005-872927; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; TYBAERT S, 2007, NLM TECH B, pE6; Verma S, 2008, CANCER-AM CANCER SOC, V112, P1197, DOI 10.1002/cncr.23302; Walterhouse DO, 1999, MED PEDIATR ONCOL, V32, P88, DOI 10.1002/(SICI)1096-911X(199902)32:2<88::AID-MPO3>3.0.CO;2-N; Weigel BJ, 2001, J PEDIAT HEMATOL ONC, V23, P272, DOI 10.1097/00043426-200106000-00007; Williams BA, 2004, J PEDIAT HEMATOL ONC, V26, P243, DOI 10.1097/00043426-200404000-00006; WOODS WG, 1999, CANC RES THERAPY CON, V9, P95; Yamada K, 2007, BONE MARROW TRANSPL, V39, P471, DOI 10.1038/sj.bmt.1705625	103	12	12	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17127	10.1371/journal.pone.0017127	http://dx.doi.org/10.1371/journal.pone.0017127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373200	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500034
J	Schutzer, SE; Angel, TE; Liu, T; Schepmoes, AA; Clauss, TR; Adkins, JN; Camp, DG; Holland, BK; Bergquist, J; Coyle, PK; Smith, RD; Fallon, BA; Natelson, BH				Schutzer, Steven E.; Angel, Thomas E.; Liu, Tao; Schepmoes, Athena A.; Clauss, Therese R.; Adkins, Joshua N.; Camp, David G., II; Holland, Bart K.; Bergquist, Jonas; Coyle, Patricia K.; Smith, Richard D.; Fallon, Brian A.; Natelson, Benjamin H.			Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; NEUROLOGIC MANIFESTATIONS; PROTEIN IDENTIFICATIONS; ACCURATE MASS; VALIDATION; STRATEGY; PEPTIDE; BRAIN; MODEL; TOOL	Background: Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS) are syndromes of unknown etiology. They share features of fatigue and cognitive dysfunction, making it difficult to differentiate them. Unresolved is whether nPTLS is a subset of CFS. Methods and Principal Findings: Pooled cerebrospinal fluid (CSF) samples from nPTLS patients, CFS patients, and healthy volunteers were comprehensively analyzed using high-resolution mass spectrometry (MS), coupled with immunoaffinity depletion methods to reduce protein-masking by abundant proteins. Individual patient and healthy control CSF samples were analyzed directly employing a MS-based label-free quantitative proteomics approach. We found that both groups, and individuals within the groups, could be distinguished from each other and normals based on their specific CSF proteins (p<0.01). CFS (n = 43) had 2,783 non-redundant proteins, nPTLS (n = 25) contained 2,768 proteins, and healthy normals had 2,630 proteins. Preliminary pathway analysis demonstrated that the data could be useful for hypothesis generation on the pathogenetic mechanisms underlying these two related syndromes. Conclusions: nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions.	[Schutzer, Steven E.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA; [Natelson, Benjamin H.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Neurol, Newark, NJ 07103 USA; [Holland, Bart K.] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Biostat & Epidemiol, Newark, NJ 07103 USA; [Angel, Thomas E.; Liu, Tao; Schepmoes, Athena A.; Clauss, Therese R.; Adkins, Joshua N.; Camp, David G., II; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Bergquist, Jonas] Uppsala Univ, Dept Phys & Analyt Chem, Uppsala, Sweden; [Coyle, Patricia K.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Fallon, Brian A.] Columbia Univ, Dept Psychiat, Med Ctr, New York, NY USA; [Natelson, Benjamin H.] Albert Einstein Coll Med, Dept Pain Med & Palliat Care, Bronx, NY USA; [Natelson, Benjamin H.] Albert Einstein Coll Med, Beth Israel Med Ctr, Bronx, NY USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Uppsala University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Columbia University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Yeshiva University; Albert Einstein College of Medicine	Schutzer, SE (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA.	schutzer@umdnj.edu	Liu, Tao/A-9020-2013; Smith, Richard D/J-3664-2012; Adkins, Joshua/B-9881-2013; Tuluc, Petronel/C-2527-2011; Bergquist, Jonas/C-5894-2015	Liu, Tao/0000-0001-9529-6550; Smith, Richard D/0000-0002-2381-2349; Adkins, Joshua/0000-0003-0399-0700; Bergquist, Jonas/0000-0002-4597-041X	National Institutes of Health, through NIAID [AI088765]; NIDA [DA021071]; NINDS [NS38636]; National Center for Research Resources [RR018522]; Swedish Research Council [621-2008-3592]; Uppsala Berzelii Technology Center for Neurodiagnostics; SciLifeLab-Uppsala; Time for Lyme; Lyme Disease Association; Tami Fund; Department of Energy (DOE); NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645, P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021071] Funding Source: NIH RePORTER	National Institutes of Health, through NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Center for Neurodiagnostics; SciLifeLab-Uppsala; Time for Lyme; Lyme Disease Association; Tami Fund; Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health, through NIAID (grant AI088765), NIDA (grant DA021071), NINDS (grant NS38636), the National Center for Research Resources (RR018522), the Swedish Research Council (621-2008-3592), Uppsala Berzelii Technology Center for Neurodiagnostics, SciLifeLab-Uppsala, Time for Lyme, Lyme Disease Association, and the Tami Fund for support of portions of the research. Pacific Northwest National Laboratory units are located in the Environmental Molecular Sciences Laboratory, a national scientific user facility, sponsored by the Department of Energy (DOE), operated by Battelle Memorial Institute for the DOE under Contract DE-AC05-76RL0 1830. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Aebersold R, 2009, NAT METHODS, V6, P411, DOI [10.1038/NMETH.F.255, 10.1038/nmeth.f.255]; Budowle B, 2008, APPL ENVIRON MICROB, V74, P5599, DOI 10.1128/AEM.00966-08; CDC, 1997, PREVENTION, V46, P1; COYLE PK, 1992, SEMIN NEUROL, V12, P200, DOI 10.1055/s-2008-1041176; Domon B, 2010, NAT BIOTECHNOL, V28, P710, DOI 10.1038/nbt.1661; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Fallon BA, 2008, NEUROLOGY, V70, P992, DOI 10.1212/01.WNL.0000284604.61160.2d; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gaudino EA, 1997, ARCH NEUROL-CHICAGO, V54, P1372, DOI 10.1001/archneur.1997.00550230045015; HOSSAIN M, 2010, MOL CELL PROTEOMICS; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102; Logigian EL, 1999, J INFECT DIS, V180, P377, DOI 10.1086/314860; Mayampurath AM, 2008, BIOINFORMATICS, V24, P1021, DOI 10.1093/bioinformatics/btn063; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mitchell P, 2010, NAT BIOTECHNOL, V28, P665, DOI 10.1038/nbt0710-665; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Natelson BH, 2005, CLIN DIAGN LAB IMMUN, V12, P52, DOI 10.1128/CDLI.12.1.52-55.2005; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47; Pan S, 2009, J PROTEOME RES, V8, P787, DOI 10.1021/pr800538n; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Petyuk VA, 2007, GENOME RES, V17, P328, DOI 10.1101/gr.5799207; Polpitiya AD, 2008, BIOINFORMATICS, V24, P1556, DOI 10.1093/bioinformatics/btn217; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Ransohoff RM, 2009, NATURE, V457, P155, DOI 10.1038/457155a; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Schmidt A, 2009, CURR OPIN CHEM BIOL, V13, P510, DOI 10.1016/j.cbpa.2009.08.016; Schutzer SE, 1999, NEUROLOGY, V53, P1340, DOI 10.1212/WNL.53.6.1340; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Schutzer SE, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000372; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Zimmer JSD, 2006, MASS SPECTROM REV, V25, P450, DOI 10.1002/mas.20071	40	72	75	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17287	10.1371/journal.pone.0017287	http://dx.doi.org/10.1371/journal.pone.0017287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383843	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500048
J	Chemello, F; Bean, C; Cancellara, P; Laveder, P; Reggiani, C; Lanfranchi, G				Chemello, Francesco; Bean, Camilla; Cancellara, Pasqua; Laveder, Paolo; Reggiani, Carlo; Lanfranchi, Gerolamo			Microgenomic Analysis in Skeletal Muscle: Expression Signatures of Individual Fast and Slow Myofibers	PLOS ONE			English	Article							TIME RT-PCR; GENE-EXPRESSION; SIGNALING PATHWAYS; TWITCH MUSCLE; FIBER TYPES; IN-VIVO; CELL; DIVERSITY; EXERCISE; PLASTICITY	Background: Skeletal muscle is a complex, versatile tissue composed of a variety of functionally diverse fiber types. Although the biochemical, structural and functional properties of myofibers have been the subject of intense investigation for the last decades, understanding molecular processes regulating fiber type diversity is still complicated by the heterogeneity of cell types present in the whole muscle organ. Methodology/Principal Findings: We have produced a first catalogue of genes expressed in mouse slow-oxidative (type 1) and fast-glycolytic (type 2B) fibers through transcriptome analysis at the single fiber level (microgenomics). Individual fibers were obtained from murine soleus and EDL muscles and initially classified by myosin heavy chain isoform content. Gene expression profiling on high density DNA oligonucleotide microarrays showed that both qualitative and quantitative improvements were achieved, compared to results with standard muscle homogenate. First, myofiber profiles were virtually free from non-muscle transcriptional activity. Second, thousands of muscle-specific genes were identified, leading to a better definition of gene signatures in the two fiber types as well as the detection of metabolic and signaling pathways that are differentially activated in specific fiber types. Several regulatory proteins showed preferential expression in slow myofibers. Discriminant analysis revealed novel genes that could be useful for fiber type functional classification. Conclusions/Significance: As gene expression analyses at the single fiber level significantly increased the resolution power, this innovative approach would allow a better understanding of the adaptive transcriptomic transitions occurring in myofibers under physiological and pathological conditions.	[Chemello, Francesco; Bean, Camilla; Laveder, Paolo; Lanfranchi, Gerolamo] Univ Padua, Dept Biol, Padua, Italy; [Chemello, Francesco; Bean, Camilla; Laveder, Paolo; Lanfranchi, Gerolamo] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Cancellara, Pasqua; Reggiani, Carlo] Univ Padua, Dept Anat & Physiol, Padua, Italy	University of Padua; University of Padua; University of Padua	Chemello, F (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	gerolamo.lanfranchi@unipd.it	Chemello, Francesco/ABB-3801-2020	Chemello, Francesco/0000-0002-3877-527X; Bean, Camilla/0000-0001-6491-7211	Italian Ministry of University and Research; University of Padova [CPDA099940]; Fondazione CARIPARO	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova; Fondazione CARIPARO(Fondazione Cariparo)	This work was supported by the Italian Ministry of University and Research (http://prin.miur.it, PRIN 2008), University of Padova (http://www.unipd.it, CPDA099940) and Fondazione CARIPARO (http://www.fondazionecariparo.it, Progetti Eccellenza 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin KM, 2002, AM J PHYS MED REHAB, V81, pS40, DOI 10.1097/00002060-200211001-00006; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Bontoux N, 2008, LAB CHIP, V8, P443, DOI 10.1039/b716543a; Boutin C, 2010, P NATL ACAD SCI USA, V107, P1201, DOI 10.1073/pnas.0909015107; Brandt SP, 2005, J EXP BOT, V56, P495, DOI 10.1093/jxb/eri066; Bruusgaard JC, 2003, J PHYSIOL-LONDON, V551, P467, DOI 10.1113/jphysiol.2003.045328; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Calderon JC, 2010, J PHYSIOL-LONDON, V588, P267, DOI 10.1113/jphysiol.2009.180893; Campbell WG, 2001, AM J PHYSIOL-CELL PH, V280, pC763, DOI 10.1152/ajpcell.2001.280.4.C763; Canepari M, 2010, ACTA PHYSIOL, V199, P465, DOI 10.1111/j.1748-1716.2010.02118.x; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; Dodd LE, 2004, BIOINFORMATICS, V20, P2685, DOI 10.1093/bioinformatics/bth309; Feltrin E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-6; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Habets PEMH, 1999, J HISTOCHEM CYTOCHEM, V47, P995, DOI 10.1177/002215549904700803; Hampson R, 2001, GENOME BIOL, V2; Haslett JN, 2002, INT J DEV NEUROSCI, V20, P359, DOI 10.1016/S0736-5748(02)00041-2; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemiolo B, 2004, BIOCHEM BIOPH RES CO, V320, P1043, DOI 10.1016/j.bbrc.2004.05.223; Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007; Levsky JM, 2003, TRENDS CELL BIOL, V13, P4, DOI 10.1016/S0962-8924(02)00002-8; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lovering RC, 2009, ATHEROSCLEROSIS, V205, P9, DOI 10.1016/j.atherosclerosis.2008.10.014; Luther PK, 2009, J MUSCLE RES CELL M, V30, P171, DOI 10.1007/s10974-009-9189-6; Marino JH, 2003, J IMMUNOL METHODS, V283, P291, DOI 10.1016/S0022-1759(03)00103-0; Moriscot AS, 2010, J STRUCT BIOL, V170, P344, DOI 10.1016/j.jsb.2010.02.001; NERVI C, 1995, CELL GROWTH DIFFER, V6, P81; Nygaard V, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-147; Nygaard V, 2006, NUCLEIC ACIDS RES, V34, P996, DOI 10.1093/nar/gkj499; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Pette D, 1999, ACTA PHYSIOL SCAND, V166, P261; PETTE D, 2006, SKELETAL MUSCLE PLAS; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raffaello A, 2006, PHYSIOL GENOMICS, V25, P60, DOI 10.1152/physiolgenomics.00051.2005; Ravenscroft G, 2007, CELL MOTIL CYTOSKEL, V64, P727, DOI 10.1002/cm.20223; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; Reggiani C, 2006, J MUSCLE RES CELL M, V27, P327, DOI 10.1007/s10974-006-9076-3; Romualdi C, 2005, NUCLEIC ACIDS RES, V33, pW644, DOI 10.1093/nar/gki497; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sotgia F, 2003, AM J PATHOL, V163, P2619, DOI 10.1016/S0002-9440(10)63616-4; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Totsuka Y, 2003, J APPL PHYSIOL, V95, P720, DOI 10.1152/japplphysiol.00946.2002; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; VOYTIK SL, 1993, DEV DYNAM, V198, P214, DOI 10.1002/aja.1001980307; Wacker MJ, 2008, J APPL PHYSIOL, V105, P308, DOI 10.1152/japplphysiol.00897.2007; Wang DJ, 2010, TRENDS BIOTECHNOL, V28, P281, DOI 10.1016/j.tibtech.2010.03.002; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200; Wu H, 2003, J MUSCLE RES CELL M, V24, P587, DOI 10.1023/B:JURE.0000009968.60331.86; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	65	65	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16807	10.1371/journal.pone.0016807	http://dx.doi.org/10.1371/journal.pone.0016807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364935	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600021
J	Diao, YP; Qi, YM; Ma, YJ; Xia, A; Sharakhov, I; Chen, XG; Biedler, J; Ling, E; Tu, ZJ				Diao, Yupu; Qi, Yumin; Ma, Yajun; Xia, Ai; Sharakhov, Igor; Chen, Xiaoguang; Biedler, Jim; Ling, Erjun; Tu, Zhijian Jake			Next-Generation Sequencing Reveals Recent Horizontal Transfer of a DNA Transposon between Divergent Mosquitoes	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; AEDES-AEGYPTI; GENE-TRANSFER; ELEMENT; EVOLUTION	Horizontal transfer of genetic material between complex organisms often involves transposable elements (TEs). For example, a DNA transposon mariner has been shown to undergo horizontal transfer between different orders of insects and between different phyla of animals. Here we report the discovery and characterization of an ITmD37D transposon, MJ1, in Anopheles sinensis. We show that some MJ1 elements in Aedes aegypti and An. sinensis contain intact open reading frames and share nearly 99% nucleotide identity over the entire transposon, which is unexpectedly high given that these two genera had diverged 145-200 million years ago. Chromosomal hybridization and TE-display showed that MJ1 copy number is low in An. sinensis. Among 24 mosquito species surveyed, MJ1 is only found in Ae. aegypti and the hyrcanus group of anopheline mosquitoes to which An. sinensis belongs. Phylogenetic analysis is consistent with horizontal transfer and provides the basis for inference of its timing and direction. Although report of horizontal transfer of DNA transposons between higher eukaryotes is accumulating, our analysis is one of a small number of cases in which horizontal transfer of nearly identical TEs among highly divergent species has been thoroughly investigated and strongly supported. Horizontal transfer involving mosquitoes is of particular interest because there are ongoing investigations of the possibility of spreading pathogen-resistant genes into mosquito populations to control malaria and other infectious diseases. The initial indication of horizontal transfer of MJ1 came from comparisons between a 0.4x coverage An. sinensis 454 sequence database and available TEs in mosquito genomes. Therefore we have shown that it is feasible to use low coverage sequencing to systematically uncover horizontal transfer events. Expanding such efforts across a wide range of species will generate novel insights into the relative frequency of horizontal transfer of different TEs and provide the evolutionary context of these lateral transfer events.	[Diao, Yupu; Ling, Erjun] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Qi, Yumin; Biedler, Jim; Tu, Zhijian Jake] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Ma, Yajun] Second Mil Med Univ, Dept Etiol Biol, Shanghai, Peoples R China; [Xia, Ai; Sharakhov, Igor] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Chen, Xiaoguang] So Med Univ, Dept Parasitol, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Virginia Polytechnic Institute & State University; Naval Medical University; Virginia Polytechnic Institute & State University; Southern Medical University - China	Diao, YP (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	jaketu@vt.edu	Sharakhov, Igor/B-1972-2008	Sharakhov, Igor/0000-0003-0752-3747	National Basic Research Program of China [2007CB513107]; US National Institutes of Health [AI042121]; NIH [R21AI081023]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042121, R29AI042121, R21AI081023] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Basic Research Program of China (Grant 2007CB513107 to EL) and the US National Institutes of Health (NIH grant AI042121 to ZT). AX and IS are supported by NIH grant R21AI081023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolome C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r22; Biedler J, 2003, INSECT MOL BIOL, V12, P211, DOI 10.1046/j.1365-2583.2003.00403.x; Biedler JK, 2007, GENETICS, V177, P2553, DOI 10.1534/genetics.107.081109; Coy MR, 2007, INSECT MOL BIOL, V16, P411, DOI 10.1111/j.1365-2583.2007.00735.x; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Handler AM, 2008, INSECT MOL BIOL, V17, P387, DOI 10.1111/j.1365-2583.2008.00813.x; HEINKOFF S, 1992, NEW BIOL, V4, P382; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2007, PARASITOL RES, V101, P885, DOI 10.1007/s00436-007-0553-4; JACOBSON JW, 1986, P NATL ACAD SCI USA, V83, P8684, DOI 10.1073/pnas.83.22.8684; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Joshi D, 2009, AM J TROP MED HYG, V81, P1020, DOI 10.4269/ajtmh.2009.09-0123; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KIMURA M, 1981, P NATL ACAD SCI-BIOL, V78, P454, DOI 10.1073/pnas.78.1.454; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Lisch D, 2008, P NATL ACAD SCI USA, V105, P16827, DOI 10.1073/pnas.0809525105; Loreto ELS, 2008, HEREDITY, V100, P545, DOI 10.1038/sj.hdy.6801094; Ma YJ, 2005, J MED ENTOMOL, V42, P610, DOI 10.1603/0022-2585(2005)042[0610:THGOAA]2.0.CO;2; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; ROBERTSON HM, 1993, NATURE, V362, P241, DOI 10.1038/362241a0; Robertson HM, 1997, J HERED, V88, P195, DOI 10.1093/oxfordjournals.jhered.a023088; Shao HG, 2001, GENETICS, V159, P1103; Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57; Ye Binghui, 1983, Acta Genetica Sinica, V10, P489	30	8	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 10	2011	6	2							e16743	10.1371/journal.pone.0016743	http://dx.doi.org/10.1371/journal.pone.0016743			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NZ	21379317	Green Submitted, Green Published, gold			2022-12-27	WOS:000287363000015
J	Chiew, KS; Braver, TS				Chiew, Kimberly S.; Braver, Todd S.			Neural Circuitry of Emotional and Cognitive Conflict Revealed through Facial Expressions	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EVENT-RELATED FMRI; PREFRONTAL CORTEX; SIGNIFICANT ACTIVATION; RELEVANCE DETECTION; WORKING-MEMORY; HUMAN AMYGDALA; VALENCE; REGIONS; SCHIZOPHRENIA	Background: Neural systems underlying conflict processing have been well studied in the cognitive realm, but the extent to which these overlap with those underlying emotional conflict processing remains unclear. A novel adaptation of the AX Continuous Performance Task (AX-CPT), a stimulus-response incompatibility paradigm, was examined that permits close comparison of emotional and cognitive conflict conditions, through the use of affectively-valenced facial expressions as the response modality. Methodology/Principal Findings: Brain activity was monitored with functional magnetic resonance imaging (fMRI) during performance of the emotional AX-CPT. Emotional conflict was manipulated on a trial-by-trial basis, by requiring contextually pre-cued facial expressions to emotional probe stimuli (IAPS images) that were either affectively compatible (low-conflict) or incompatible (high-conflict). The emotion condition was contrasted against a matched cognitive condition that was identical in all respects, except that probe stimuli were emotionally neutral. Components of the brain cognitive control network, including dorsal anterior cingulate cortex (ACC) and lateral prefrontal cortex (PFC), showed conflict-related activation increases in both conditions, but with higher activity during emotion conditions. In contrast, emotion conflict effects were not found in regions associated with affective processing, such as rostral ACC. Conclusions/Significance: These activation patterns provide evidence for a domain-general neural system that is active for both emotional and cognitive conflict processing. In line with previous behavioural evidence, greatest activity in these brain regions occurred when both emotional and cognitive influences additively combined to produce increased interference.	[Chiew, Kimberly S.; Braver, Todd S.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Washington University (WUSTL)	Chiew, KS (corresponding author), Washington Univ, Dept Psychol, St Louis, MO 63130 USA.	kschiew@wustl.edu		Chiew, Kimberly/0000-0003-3049-4059; Braver, Todd/0000-0002-2631-3393	National Institutes of Health [RO1 MH66078]; Natural Sciences and Engineering Research Council of Canada; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grant RO1 MH66078 from the National Institutes of Health to T. S. B. and a Natural Sciences and Engineering Research Council of Canada Postgraduate Scholarship to K. S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS., 2002, PRINCIPLES FRONTAL L, P428, DOI [10.1093/acprof:oso/9780195134971.003.0027, DOI 10.1093/ACPROF:OSO/9780195134971.003.0027]; BRAVER TS, 2007, NEUROSCIENCE RULE GU, P255; Buhle J., 2010, SELF CONTROL SOC MIN, P93, DOI DOI 10.1093/ACPROF:OSO/9780195391381.003.0006; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chiew KS, 2010, EMOTION, V10, P842, DOI 10.1037/a0019704; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; Cole MW, 2007, NEUROIMAGE, V37, P343, DOI 10.1016/j.neuroimage.2007.03.071; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Egner T, 2008, CEREB CORTEX, V18, P1475, DOI 10.1093/cercor/bhm179; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Haas BW, 2006, COGN AFFECT BEHAV NE, V6, P152, DOI 10.3758/CABN.6.2.152; Holland PC, 2006, J NEUROSCI, V26, P3791, DOI 10.1523/JNEUROSCI.0390-06.2006; Holland PC, 1999, TRENDS COGN SCI, V3, P65, DOI 10.1016/S1364-6613(98)01271-6; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Krug MK, 2010, COGN AFFECT BEHAV NE, V10, P357, DOI 10.3758/CABN.10.3.357; Lang P. J., 1999, INT AFFECTIVE PICTUR; Larsen RJ, 2006, EMOTION, V6, P62, DOI 10.1037/1528-3542.6.1.62; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; MacDonald AW, 2003, J ABNORM PSYCHOL, V112, P689, DOI 10.1037/0021-843X.112.4.689; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; McAvoy MP, 2001, NEUROIMAGE, V13, pS198; Nitschke JB, 2006, NAT NEUROSCI, V9, P435, DOI 10.1038/nn1645; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; OCHSNER KN, 2008, J COGN NEUROSCI; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ousdal OT, 2008, NEUROSCIENCE, V156, P450, DOI 10.1016/j.neuroscience.2008.07.066; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Paxton JL, 2008, CEREB CORTEX, V18, P1010, DOI 10.1093/cercor/bhm135; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Sohn MH, 2007, P NATL ACAD SCI USA, V104, P10330, DOI 10.1073/pnas.0703225104; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TALAIRAICH J, 1988, COPLANAR STEREOTAXIC; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Wager TD, 2003, COGN AFFECT BEHAV NE, V3, P255, DOI 10.3758/CABN.3.4.255; Ward D.B., 2000, SIMULTANEOUS INFEREN; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Wittfoth M, 2010, CEREB CORTEX, V20, P383, DOI 10.1093/cercor/bhp106	61	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17635	10.1371/journal.pone.0017635	http://dx.doi.org/10.1371/journal.pone.0017635			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408006	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900033
J	Ras, RT; Zock, PL; Draijer, R				Ras, Rouyanne T.; Zock, Peter L.; Draijer, Richard			Tea Consumption Enhances Endothelial-Dependent Vasodilation; a Meta-Analysis	PLOS ONE			English	Article							FLOW-MEDIATED VASODILATION; PERIPHERAL ARTERIAL-DISEASE; NITRIC-OXIDE SYNTHASE; BLACK TEA; BRACHIAL-ARTERY; GREEN TEA; CARDIOVASCULAR EVENTS; PREDICTIVE-VALUE; VASCULAR FUNCTION; CLINICAL-TRIALS	Background: Tea consumption is associated with a lower risk of cardiovascular disease including stroke. Direct effects of tea components on the vasculature, particularly the endothelium, may partly explain this association. Objective: We performed a meta-analysis of controlled human intervention studies on the effect of tea on flow-mediated dilation (FMD) of the brachial artery, a measurement of endothelial function, which is suggested to be associated with cardiovascular risk. Methods: Human intervention studies were identified by systematic search of the databases Medline, Embase, Chemical Abstracts and Biosis through March 2009 and by hand-searching related articles. Studies were selected based on predefined criteria: intervention with tea as the sole experimental variable, placebo-controlled design, and no missing data on FMD outcome or its variability. A random effects model was used to calculate the pooled overall effect on FMD due to the intake of tea. The impact of various subject and treatment characteristics was investigated in the presence of heterogeneity. Results: In total, 9 studies from different research groups were included with 15 relevant study arms. The overall absolute increase in FMD of tea vs. placebo was 2.6% of the arterial diameter (95% CI: 1.8-3.3%; P-value < 0.001) for a median daily dose of 500 mL of tea (2-3 cups). This is a relative increase of approximately 40% compared to the average FMD of 6.3% measured under placebo or baseline conditions. There was significant heterogeneity between studies (P-value < 0.001) that might partly be explained by the cuff position either distal or proximal to the area of FMD measurement. No indication for publication bias was found. Conclusion: Moderate consumption of tea substantially enhances endothelial-dependent vasodilation. This may provide a mechanistic explanation for the reduced risk of cardiovascular events and stroke observed among tea drinkers.	[Ras, Rouyanne T.; Zock, Peter L.; Draijer, Richard] Unilever Res Labs, Nutr & Hlth Dept, Vlaardingen, Netherlands	Unilever	Ras, RT (corresponding author), Unilever Res Labs, Nutr & Hlth Dept, Vlaardingen, Netherlands.	Rouyanne.Ras@unilever.com		Zock, Peter/0000-0002-0322-0565	Unilever RD Vlaardingen	Unilever RD Vlaardingen(Unilever)	Unilever R&D Vlaardingen is the funder of this review as all authors are employed by this company. All authors were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. No external funding was involved.	Alexopoulos N, 2008, EUR J CARDIOV PREV R, V15, P300, DOI 10.1097/HJR.0b013e3282f4832f; Anter E, 2004, J BIOL CHEM, V279, P46637, DOI 10.1074/jbc.M405547200; ARAB L, 2009, STROKE; Ardalan MR, 2007, TRANSPL P, V39, P1139, DOI 10.1016/j.transproceed.2007.04.010; Astill C, 2001, J AGR FOOD CHEM, V49, P5340, DOI 10.1021/jf010759+; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Chan SY, 2003, J AM COLL CARDIOL, V42, P1037, DOI 10.1016/S0735-1097(03)00927-6; Chow HHS, 2005, CLIN CANCER RES, V11, P4627, DOI 10.1158/1078-0432.CCR-04-2549; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; de Bree A, 2007, AM J CLIN NUTR, V86, P610, DOI 10.1093/ajcn/86.3.610; De Roos NM, 2003, ULTRASOUND MED BIOL, V29, P401, DOI 10.1016/S0301-5629(02)00709-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Doshi SN, 2001, CLIN SCI, V101, P629, DOI 10.1042/CS20010033; Duffy SJ, 2001, CIRCULATION, V104, P151, DOI 10.1161/01.CIR.104.2.151; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fathi R, 2004, J AM COLL CARDIOL, V43, P616, DOI 10.1016/j.jacc.2003.09.042; FITZPATRICK DF, 1995, J CARDIOVASC PHARM, V26, P90, DOI 10.1097/00005344-199507000-00015; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Frick M, 2005, J AM COLL CARDIOL, V46, P1006, DOI 10.1016/j.jacc.2005.05.070; Gokce N, 2003, J AM COLL CARDIOL, V41, P1769, DOI 10.1016/S0735-1097(03)00333-4; Grassi D, 2008, J NUTR, V138, P1554; Grassi D, 2009, J HYPERTENS, V27, P774, DOI 10.1097/HJH.0b013e328326066c; Herrington DM, 2001, J CARDIOVASC RISK, V8, P319, DOI 10.1097/00043798-200110000-00012; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirata K, 2004, AM J CARDIOL, V93, P1384, DOI 10.1016/j.amjcard.2004.02.035; Hodgson JM, 2005, J HYPERTENS, V23, P47, DOI 10.1097/00004872-200501000-00012; Hodgson JM, 2002, CLIN SCI, V102, P195, DOI 10.1042/CS20010120; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Huang AL, 2007, ARTERIOSCL THROM VAS, V27, P2113, DOI 10.1161/ATVBAHA.107.147322; Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992; Karatzis EN, 2006, AM J CARDIOL, V98, P1424, DOI 10.1016/j.amjcard.2006.06.043; Kim W, 2006, CIRC J, V70, P1052, DOI 10.1253/circj.70.1052; Kitta Y, 2009, J AM COLL CARDIOL, V53, P323, DOI 10.1016/j.jacc.2008.08.074; Lakenbrink C, 2000, J AGR FOOD CHEM, V48, P2848, DOI 10.1021/jf9908042; Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018; Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200; Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442; Modena MG, 2002, J AM COLL CARDIOL, V40, P505, DOI 10.1016/S0735-1097(02)01976-9; Papamichael CM, 2005, CLIN SCI, V109, P55, DOI 10.1042/CS20040358; Park CS, 2010, INT J CARDIOL, V145, P261, DOI 10.1016/j.ijcard.2009.09.471; Persson IAL, 2006, J PHARM PHARMACOL, V58, P1139, DOI 10.1211/jpp.58.8.0016; Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495; PYKE, 2005, J PHYSL, V568, P357; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schewe T, 2008, ARCH BIOCHEM BIOPHYS, V476, P102, DOI 10.1016/j.abb.2008.03.004; Shechter M, 2009, INT J CARDIOL, V134, P52, DOI 10.1016/j.ijcard.2008.01.021; Shimbo D, 2007, ATHEROSCLEROSIS, V192, P197, DOI 10.1016/j.atherosclerosis.2006.05.005; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Vita JA, 2003, J NUTR, V133, p3293S, DOI 10.1093/jn/133.10.3293S; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Widlansky ME, 2007, J AM COLL NUTR, V26, P95, DOI 10.1080/07315724.2007.10719590; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Yeboah J, 2009, CIRCULATION, V120, P502, DOI 10.1161/CIRCULATIONAHA.109.864801	62	112	116	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e16974	10.1371/journal.pone.0016974	http://dx.doi.org/10.1371/journal.pone.0016974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394199	gold, Green Published, Green Submitted			2022-12-27	WOS:000288025500004
J	Creekmore, AL; Silkworth, WT; Cimini, D; Jensen, RV; Roberts, PC; Schmelz, EM				Creekmore, Amy L.; Silkworth, William T.; Cimini, Daniela; Jensen, Roderick V.; Roberts, Paul C.; Schmelz, Eva M.			Changes in Gene Expression and Cellular Architecture in an Ovarian Cancer Progression Model	PLOS ONE			English	Article							PROTEIN-KINASE-C; FOCAL ADHESION KINASE; EPITHELIAL-CELLS; MEMBRANE ASSOCIATION; RECYCLING ENDOSOMES; ACTIN CYTOSKELETON; TUMOR-SUPPRESSOR; ONTO-TOOLS; BETA-II; APC	Background: Ovarian cancer is the fifth leading cause of cancer deaths among women. Early stage disease often remains undetected due the lack of symptoms and reliable biomarkers. The identification of early genetic changes could provide insights into novel signaling pathways that may be exploited for early detection and treatment. Methodology/Principal Findings: Mouse ovarian surface epithelial (MOSE) cells were used to identify stage-dependent changes in gene expression levels and signal transduction pathways by mouse whole genome microarray analyses and gene ontology. These cells have undergone spontaneous transformation in cell culture and transitioned from non-tumorigenic to intermediate and aggressive, malignant phenotypes. Significantly changed genes were overrepresented in a number of pathways, most notably the cytoskeleton functional category. Concurrent with gene expression changes, the cytoskeletal architecture became progressively disorganized, resulting in aberrant expression or subcellular distribution of key cytoskeletal regulatory proteins (focal adhesion kinase, alpha-actinin, and vinculin). The cytoskeletal disorganization was accompanied by altered patterns of serine and tyrosine phosphorylation as well as changed expression and subcellular localization of integral signaling intermediates APC and PKC beta II. Conclusions/Significance: Our studies have identified genes that are aberrantly expressed during MOSE cell neoplastic progression. We show that early stage dysregulation of actin microfilaments is followed by progressive disorganization of microtubules and intermediate filaments at later stages. These stage-specific, step-wise changes provide further insights into the time and spatial sequence of events that lead to the fully transformed state since these changes are also observed in aggressive human ovarian cancer cell lines independent of their histological type. Moreover, our studies support a link between aberrant cytoskeleton organization and regulation of important downstream signaling events that may be involved in cancer progression. Thus, our MOSE-derived cell model represents a unique model for in depth mechanistic studies of ovarian cancer progression.	[Roberts, Paul C.] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA; [Creekmore, Amy L.; Schmelz, Eva M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Silkworth, William T.; Cimini, Daniela; Jensen, Roderick V.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Roberts, PC (corresponding author), Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA.	pcroberts@vt.edu; eschmelz@vt.edu	Schmelz, Eva M/E-6579-2012; Cimini, Daniela/A-3039-2016	Cimini, Daniela/0000-0002-4082-4894; Creekmore, Amy/0000-0002-7092-823X	NIH [R01 CA118846]; AICR [04B071]; NATIONAL CANCER INSTITUTE [R01CA118846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AICR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The studies were supported by NIH R01 CA118846 (to EMS, PCR) and AICR grant 04B071 (EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Alvi F, 2007, CELL MOL LIFE SCI, V64, P263, DOI 10.1007/s00018-006-6363-5; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Basu R, 2007, CURR OPIN CELL BIOL, V19, P88, DOI 10.1016/j.ceb.2006.12.012; Becker KP, 2003, J BIOL CHEM, V278, P52747, DOI 10.1074/jbc.M305228200; Bevington P. R, 2003, DATA REDUCTION ERROR, pxi; Bijman MNA, 2008, BIOCHEM PHARMACOL, V76, P707, DOI 10.1016/j.bcp.2008.06.014; Blobe GC, 1996, J BIOL CHEM, V271, P15823, DOI 10.1074/jbc.271.26.15823; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Brautigam K, 2009, TRANSL ONCOL, V2, P164, DOI 10.1593/tlo.09121; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; BURRIDGE K, 1981, NATURE, V294, P691, DOI 10.1038/294691a0; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Dikovskaya D, 2010, J CELL SCI, V123, P736, DOI 10.1242/jcs.060806; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; DwyerNield LD, 1996, AM J PHYSIOL-LUNG C, V270, pL526, DOI 10.1152/ajplung.1996.270.4.L526; Earley S, 2008, BIOCHEM BIOPH RES CO, V366, P476, DOI 10.1016/j.bbrc.2007.11.181; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Gagne JP, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-16; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Goicoechea SM, 2009, ONCOGENE, V28, P587, DOI 10.1038/onc.2008.408; GOODNIGHT J, 1995, J BIOL CHEM, V270, P9991, DOI 10.1074/jbc.270.17.9991; Halder J, 2007, CANCER RES, V67, P10976, DOI 10.1158/0008-5472.CAN-07-2667; Halder J, 2006, CLIN CANCER RES, V12, P4916, DOI 10.1158/1078-0432.CCR-06-0021; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Honore S, 2005, CELL MOL LIFE SCI, V62, P3039, DOI 10.1007/s00018-005-5330-x; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Iorio E, CANC RES, V70, P2126; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Keller A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-290; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; Koivunen J, 2006, CANCER LETT, V235, P1, DOI 10.1016/j.canlet.2005.03.033; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kurman RJ, 2008, INT J GYNECOL PATHOL, V27, P151, DOI 10.1097/PGP.0b013e318161e4f5; Lee Y, 2007, J PATHOL, V211, P26, DOI 10.1002/path.2091; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; Menendez L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-10; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nagaraja AK, 2010, MOL ENDOCRINOL, V24, P447, DOI 10.1210/me.2009-0295; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Neufeld KL, 2009, ADV EXP MED BIOL, V656, P13, DOI 10.1007/978-1-4419-1145-2_2; Ogura T, 2006, CLIN CANCER RES, V12, P5216, DOI 10.1158/1078-0432.CCR-06-0674; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Pascale A, 2004, GLIA, V46, P169, DOI 10.1002/glia.10354; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Raul U, 2004, INT J CANCER, V111, P662, DOI 10.1002/ijc.20349; Roberts PC, 2005, NEOPLASIA, V7, P944, DOI 10.1593/neo.05358; Rosin-Arbesfeld R, 2001, EMBO J, V20, P5929, DOI 10.1093/emboj/20.21.5929; Sakamoto M, 2001, Hum Cell, V14, P305; Sarrio D, 2006, HUM PATHOL, V37, P1042, DOI 10.1016/j.humpath.2006.03.003; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schwartz DR, 2002, CANCER RES, V62, P4722; Sjoblom B, 2008, CELL MOL LIFE SCI, V65, P2688, DOI 10.1007/s00018-008-8080-8; Sodek KL, 2008, MOL BIOSYST, V4, P762, DOI 10.1039/b717542f; Taniguchi S, 2005, CANCER SCI, V96, P738, DOI 10.1111/j.1349-7006.2005.00118.x; Verhey KJ, 2009, NAT REV MOL CELL BIO, V10, P765, DOI 10.1038/nrm2782; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Xu R, 2009, CANCER METAST REV, V28, P167, DOI 10.1007/s10555-008-9178-z; Zhao Y, 2009, EXPERT OPIN THER PAT, V19, P607, DOI 10.1517/13543770902775713	74	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17676	10.1371/journal.pone.0017676	http://dx.doi.org/10.1371/journal.pone.0017676			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390237	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200035
J	Lopez-Lopez, P; Ferrer, M; Madero, A; Casado, E; McGrady, M				Lopez-Lopez, Pascual; Ferrer, Miguel; Madero, Agustin; Casado, Eva; McGrady, Michael			Solving Man-Induced Large-Scale Conservation Problems: The Spanish Imperial Eagle and Power Lines	PLOS ONE			English	Article							AQUILA-ADALBERTI; RAPTOR ELECTROCUTION; HIERAAETUS-FASCIATUS; MORTALITY; SPAIN; COLLISION; STOCHASTICITY; POPULATIONS; MANAGEMENT; RECOVERY	Background: Man-induced mortality of birds caused by electrocution with poorly-designed pylons and power lines has been reported to be an important mortality factor that could become a major cause of population decline of one of the world rarest raptors, the Spanish imperial eagle (Aquila adalberti). Consequently it has resulted in an increasing awareness of this problem amongst land managers and the public at large, as well as increased research into the distribution of electrocution events and likely mitigation measures. Methodology/Principal Findings: We provide information of how mitigation measures implemented on a regional level under the conservation program of the Spanish imperial eagle have resulted in a positive shift of demographic trends in Spain. A 35 years temporal data set (1974-2009) on mortality of Spanish imperial eagle was recorded, including population censuses, and data on electrocution and non-electrocution of birds. Additional information was obtained from 32 radio-tracked young eagles and specific field surveys. Data were divided into two periods, before and after the approval of a regional regulation of power line design in 1990 which established mandatory rules aimed at minimizing or eliminating the negative impacts of power lines facilities on avian populations. Our results show how population size and the average annual percentage of population change have increased between the two periods, whereas the number of electrocuted birds has been reduced in spite of the continuous growing of the wiring network. Conclusions: Our results demonstrate that solving bird electrocution is an affordable problem if political interest is shown and financial investment is made. The combination of an adequate spatial planning with a sustainable development of human infrastructures will contribute positively to the conservation of the Spanish imperial eagle and may underpin population growth and range expansion, with positive side effects on other endangered species.	[Lopez-Lopez, Pascual] Univ Valencia, Terr Vertebrates Grp, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Lopez-Lopez, Pascual; Ferrer, Miguel] Spanish Natl Res Council, Donana Biol Stn, Biodivers Conservat Grp, Seville, Spain; [Madero, Agustin] Junta de Andalucia, Consejeria Medio Ambiente, Seville, Spain; [Casado, Eva] Fdn Migres, Seville, Spain; [McGrady, Michael] Nat Res Ltd, Krems, Austria	University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lopez-Lopez, P (corresponding author), Univ Valencia, Terr Vertebrates Grp, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	Pascual.Lopez@uv.es	López-López, Pascual/C-1039-2011; Ferrer, Miguel/AFU-8286-2022; Casado, Eva/F-8211-2016; Ferrer, Miguel/G-3519-2015	López-López, Pascual/0000-0001-5269-652X; Ferrer, Miguel/0000-0003-0092-8450	Spanish Ministerio de Educacion [AP2005-0874]; Spanish Ministry of Education; Natural Research Ltd.; Junta de Andalucia	Spanish Ministerio de Educacion(Spanish Government); Spanish Ministry of Education(Spanish Government); Natural Research Ltd.; Junta de Andalucia(Junta de Andalucia)	P. Lopez-Lopez was supported by FPU grant of the Spanish Ministerio de Educacion (reference AP2005-0874) and wrote this paper during a pre-doctoral stay at Donana Biological Station (CSIC) in Sevilla, Spain. The funders of this study (Spanish Ministry of Education, Natural Research Ltd. and Junta de Andalucia) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson PC., 1981, THESIS B YOUNG U PRO; Bevanger K, 1998, BIOL CONSERV, V86, P67, DOI 10.1016/S0006-3207(97)00176-6; BEVANGER K, 1994, IBIS, V136, P412, DOI 10.1111/j.1474-919X.1994.tb01116.x; *BIRDLIFE INT, 2010, SPEC FACTSH AQ AD; Boeker EL, 1975, WILDLIFE SOC B, V3, P79; CLAVE AT, 1992, IBERDROLA CONSEJO SU, P50; FERRER M, 1991, WILDLIFE SOC B, V19, P436; FERRER M, 1991, J FIELD ORNITHOL, V62, P181; FERRER M, 1990, BIOL CONSERV, V51, P151, DOI 10.1016/0006-3207(90)90109-3; FERRER M, 1992, BIOL CONSERV, V60, P57, DOI 10.1016/0006-3207(92)90799-S; FERRER M, 1987, RICH BIOL SELVAG, V12, P97; FERRER M, 2001, SPANISH IMPERIAL EAG; FERRER M, 1999, BIRDS POWER LINES CO, P145; Ferrer M, 2008, J APPL ECOL, V45, P1453, DOI 10.1111/j.1365-2664.2008.01497.x; Ferrer M, 2009, CONSERV BIOL, V23, P1017, DOI 10.1111/j.1523-1739.2009.01215.x; GONZALEZ LM, 2004, LIBRO ROJO AVES ESPA, P145; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Janss G.F.E., 1999, BIRDS POWER LINES CO, p145e159; Janss GFE, 1999, WILDLIFE SOC B, V27, P263; Janss GFE, 1999, J RAPTOR RES, V33, P154; Janss GFE, 1998, J FIELD ORNITHOL, V69, P8; Janss GFE, 2001, BIRD CONSERV INT, V11, P3, DOI 10.1017/S0959270901001022; JANSS GFE, 2001, THESIS UTRECHT U, P175; Katzner TE, 2006, BIOL CONSERV, V132, P322, DOI 10.1016/j.biocon.2006.04.024; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; MESTEL R, 1993, NEW SCI, V1901, P4; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Penteriani V, 2005, OIKOS, V108, P523, DOI 10.1111/j.0030-1299.2005.13514.x; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Rollan A, 2010, BIRD CONSERV INT, V20, P279, DOI 10.1017/S0959270910000250; Schaub M, 2010, BIOL CONSERV, V143, P1911, DOI 10.1016/j.biocon.2010.04.047; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Soutullo A, 2008, BIOL CONSERV, V141, P1013, DOI 10.1016/j.biocon.2008.01.011; *STATSOFT INC, 2004, STATISTICA DAT AN SO; *UNESA, 2005, SECT EL TRAV UNESA 1; Zar JH, 1999, BIOSTATISTICAL ANAL	36	58	60	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17196	10.1371/journal.pone.0017196	http://dx.doi.org/10.1371/journal.pone.0017196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399692	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300013
J	Holderness, J; Schepetkin, IA; Freedman, B; Kirpotina, LN; Quinn, MT; Hedges, JF; Jutila, MA				Holderness, Jeff; Schepetkin, Igor A.; Freedman, Brett; Kirpotina, Liliya N.; Quinn, Mark T.; Hedges, Jodi F.; Jutila, Mark A.			Polysaccharides Isolated from Acai Fruit Induce Innate Immune Responses	PLOS ONE			English	Article							DELTA-T-CELLS; EUTERPE-OLERACEA MART.; MACROPHAGE IMMUNOMODULATORY ACTIVITY; ANION-EXCHANGE CHROMATOGRAPHY; IN-VITRO; INTRACELLULAR BACTERIUM; CARBOHYDRATE ANALYSIS; ANTIOXIDANT CAPACITY; GANODERMA-LUCIDUM; GAMMA	The Acai (Acai) fruit is a popular nutritional supplement that purportedly enhances immune system function. These anecdotal claims are supported by limited studies describing immune responses to the Acai polyphenol fraction. Previously, we characterized gamma delta T cell responses to both polyphenol and polysaccharide fractions from several plant-derived nutritional supplements. Similar polyphenol and polysaccharide fractions are found in Acai fruit. Thus, we hypothesized that one or both of these fractions could activate gamma delta T cells. Contrary to previous reports, we did not identify agonist activity in the polyphenol fraction; however, the Acai polysaccharide fraction induced robust gamma delta T cell stimulatory activity in human, mouse, and bovine PBMC cultures. To characterize the immune response to Acai polysaccharides, we fractionated the crude polysaccharide preparation and tested these fractions for activity in human PBMC cultures. The largest Acai polysaccharides were the most active in vitro as indicated by activation of myeloid and gamma delta T cells. When delivered in vivo, Acai polysaccharide induced myeloid cell recruitment and IL-12 production. These results define innate immune responses induced by the polysaccharide component of Acai and have implications for the treatment of asthma and infectious disease.	[Holderness, Jeff; Schepetkin, Igor A.; Freedman, Brett; Kirpotina, Liliya N.; Quinn, Mark T.; Hedges, Jodi F.; Jutila, Mark A.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Holderness, J (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	uvsmj@montana.edu		Quinn, Mark/0000-0001-8114-5073; Holderness, Jeff/0000-0002-4290-162X	National Institutes of Health (NIH) [NCCAM AT0004986-01]; National Institute of Allergy and Infectious Diseases Contract [HHSN26620040009C/N01-AI-40009]; NIH Centers of Biomedical Research Excellence; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases Contract(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Centers of Biomedical Research Excellence; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This study was supported by funding from the National Institutes of Health (NIH) (NCCAM AT0004986-01), National Institute of Allergy and Infectious Diseases Contract (HHSN26620040009C/N01-AI-40009), NIH Centers of Biomedical Research Excellence (http://www.ncrr.nih.gov/), The M. J. Murdock Charitable Trust (www.murdock-trust.org) and The Montana State University Agricultural Experimental Station (http://ag.montana.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Araki A, 2005, J GASTROENTEROL, V40, P16, DOI 10.1007/s00535-004-1492-9; BAND H, 1987, SCIENCE, V238, P682, DOI 10.1126/science.3672118; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Born W, 1999, Adv Immunol, V71, P77; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Casetti R, 2005, J IMMUNOL, V175, P1593, DOI 10.4049/jimmunol.175.3.1593; CICCONE E, 1988, J EXP MED, V167, P1517, DOI 10.1084/jem.167.4.1517; Collins RA, 1998, J LEUKOCYTE BIOL, V63, P707, DOI 10.1002/jlb.63.6.707; Daiber A, 2004, FREE RADICAL RES, V38, P259, DOI 10.1080/10715760410001659773; Dalton JE, 2006, GASTROENTEROLOGY, V131, P818, DOI 10.1053/j.gastro.2006.06.003; Davis WC, 1996, VET IMMUNOL IMMUNOP, V52, P301, DOI 10.1016/0165-2427(96)05581-X; Dellacasagrande J, 2002, J IMMUNOL, V169, P6309, DOI 10.4049/jimmunol.169.11.6309; DERUITER GA, 1992, ANAL BIOCHEM, V207, P176, DOI 10.1016/0003-2697(92)90520-H; Diallo D, 2001, J ETHNOPHARMACOL, V74, P159, DOI 10.1016/S0378-8741(00)00361-5; Dieli F, 2003, BLOOD, V102, P2310, DOI 10.1182/blood-2003-05-1655; Dong Q, 2001, CARBOHYD RES, V332, P109, DOI 10.1016/S0008-6215(01)00073-8; Egan CE, 2005, J IMMUNOL, V175, P8191, DOI 10.4049/jimmunol.175.12.8191; Egan PJ, 2000, J EXP MED, V191, P2145, DOI 10.1084/jem.191.12.2145; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; FERRICK DA, 1995, NATURE, V373, P255, DOI 10.1038/373255a0; Fischer S, 1996, IMMUNOL LETT, V52, P69, DOI 10.1016/0165-2478(96)02584-9; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; GANE AM, 1995, CARBOHYD RES, V277, P67, DOI 10.1016/0008-6215(95)00197-2; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; Graff JC, 2009, INT IMMUNOPHARMACOL, V9, P1313, DOI 10.1016/j.intimp.2009.07.015; GRANICHER F, 1994, PHYTOCHEM ANALYSIS, V5, P297, DOI 10.1002/pca.2800050605; Guo L, 2009, INT IMMUNOPHARMACOL, V9, P1175, DOI 10.1016/j.intimp.2009.06.005; Hamzaoui A, 2002, MEDIAT INFLAMM, V11, P113, DOI 10.1080/09629350220131971; HARDY MR, 1994, METHOD ENZYMOL, V230, P208; Harnack U, 2009, INT IMMUNOPHARMACOL, V9, P1298, DOI 10.1016/j.intimp.2009.07.013; Hassimotto NMA, 2005, J AGR FOOD CHEM, V53, P2928, DOI 10.1021/jf047894h; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hedges JF, 2003, J LEUKOCYTE BIOL, V73, P306, DOI 10.1189/jlb.0902453; Hedges JF, 2005, J IMMUNOL, V174, P6045, DOI 10.4049/jimmunol.174.10.6045; HESTDAL K, 1991, J IMMUNOL, V147, P22; HIRANO M, 1994, PLANTA MED, V60, P248, DOI 10.1055/s-2006-959469; Holderness J, 2007, J IMMUNOL, V179, P6468, DOI 10.4049/jimmunol.179.10.6468; Holderness J, 2008, CRIT REV IMMUNOL, V28, P377, DOI 10.1615/CritRevImmunol.v28.i5.20; Imada I, 1999, ANAL BIOCHEM, V271, P53, DOI 10.1006/abio.1999.4107; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jin N, 2005, J IMMUNOL, V174, P2671, DOI 10.4049/jimmunol.174.5.2671; Kamath AB, 2003, P NATL ACAD SCI USA, V100, P6009, DOI 10.1073/pnas.1035603100; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Krug N, 2001, AM J RESP CELL MOL, V25, P125, DOI 10.1165/ajrcmb.25.1.4194; KUPCHAN SM, 1973, J ORG CHEM, V38, P178, DOI 10.1021/jo00941a049; KURAMOCHIMOTEGI A, 1992, BIOCHEM PHARMACOL, V44, P1961; Lichtenthaler R, 2005, INT J FOOD SCI NUTR, V56, P53, DOI 10.1080/09637480500082082; Mak TW, 1998, NAT MED, V4, P764, DOI 10.1038/nm0798-764; Martino A, 2005, J CLIN IMMUNOL, V25, P230, DOI 10.1007/s10875-005-4080-8; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mertens-Talcott SU, 2008, J AGR FOOD CHEM, V56, P7796, DOI 10.1021/jf8007037; Nakasone C, 2007, MICROBES INFECT, V9, P251, DOI 10.1016/j.micinf.2006.11.015; Nantz MP, 2006, J NUTR, V136, P2606, DOI 10.1093/jn/136.10.2606; O'Brien RL, 2000, J IMMUNOL, V165, P6472, DOI 10.4049/jimmunol.165.11.6472; Okuda T, 2005, PHYTOCHEMISTRY, V66, P2012, DOI 10.1016/j.phytochem.2005.04.023; Pacheco-Palencia LA, 2008, J AGR FOOD CHEM, V56, P3593, DOI 10.1021/jf8001608; Pang X, 2007, J FOOD SCI, V72, pS435, DOI 10.1111/j.1750-3841.2007.00431.x; Percival SS, 2008, J NUTR, V138, P1; Percival SS, 2009, J NUTR, V139, p1801S, DOI 10.3945/jn.109.108324; Polle AY, 2002, CARBOHYD POLYM, V49, P337, DOI 10.1016/S0144-8617(01)00346-0; Pozo-Insfran D. del, 2006, Journal of Agricultural and Food Chemistry, V54, P1222, DOI 10.1021/jf052132n; Pugh ND, 2008, INT IMMUNOPHARMACOL, V8, P1023, DOI 10.1016/j.intimp.2008.03.007; RIVAS A, 1989, J IMMUNOL, V142, P1840; Rodrigues RB, 2006, J AGR FOOD CHEM, V54, P4162, DOI 10.1021/jf058169p; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Schepetkin IA, 2005, INT IMMUNOPHARMACOL, V5, P1783, DOI 10.1016/j.intimp.2005.05.009; Schepetkin IA, 2006, INT IMMUNOPHARMACOL, V6, P317, DOI 10.1016/j.intimp.2005.10.005; Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003; Schepetkin IA, 2009, J IMMUNOL, V183, P6754, DOI 10.4049/jimmunol.0901827; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Stein GM, 1999, ANTICANCER RES, V19, P3907; Tamta H, 2008, J AGR FOOD CHEM, V56, P10552, DOI 10.1021/jf8023722; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Venkatesan N, 2000, INT J PHARM, V203, P169, DOI 10.1016/S0378-5173(00)00442-7; Volman JJ, 2010, NUTR RES, V30, P40, DOI 10.1016/j.nutres.2009.10.023; Waddell SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009753; Wang LS, 2001, J CLIN INVEST, V108, P1349, DOI 10.1172/JCI13584; Wilson E, 1998, IMMUNOL LETT, V64, P39, DOI 10.1016/S0165-2478(98)00077-7; Xie G, 2008, PHYTOCHEMISTRY, V69, P1359, DOI 10.1016/j.phytochem.2008.01.009; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x; Zuany-Amorim C, 1998, SCIENCE, V280, P1265, DOI 10.1126/science.280.5367.1265	84	54	57	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17301	10.1371/journal.pone.0017301	http://dx.doi.org/10.1371/journal.pone.0017301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386979	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400053
J	Sanghvi, VR; Steel, LF				Sanghvi, Viraj R.; Steel, Laura F.			A Re-Examination of Global Suppression of RNA Interference by HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIVIRAL IMMUNITY; CELLULAR MICRORNA; MAMMALIAN-CELLS; BINDING PROTEIN; SILENCING PATHWAY; NONCODING RNA; EXPRESSION; DICER; TRBP	The nature of the interaction between replicating HIV-1 and the cellular RNAi pathway has been controversial, but it is clear that it can be complex and multifaceted. It has been proposed that the interaction is bi-directional, whereby cellular silencing pathways can restrict HIV-1 replication, and in turn, HIV-1 can suppress silencing pathways. Overall suppression of RNAi has been suggested to occur via direct binding and inhibition of Dicer by the HIV-1 Tat protein or through sequestration of TRBP, a Dicer co-factor, by the structured TAR element of HIV-1 transcripts. The role of Tat as an inhibitor of Dicer has been questioned and our results support and extend the conclusion that Tat does not inhibit RNAi that is mediated by either exogenous or endogenous miRNAs. Similarly, we find no suppression of silencing pathways in cells with replicating virus, suggesting that viral products such as the TAR RNA elements also do not reduce the efficacy of cellular RNA silencing. However, knockdown of Dicer does allow increased viral replication and this occurs at a post-transcriptional level. These results support the idea that although individual miRNAs can act to restrict HIV-1 replication, the virus does not counter these effects through a global suppression of RNAi synthesis or processing.	[Sanghvi, Viraj R.; Steel, Laura F.] Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA	Drexel University	Sanghvi, VR (corresponding author), Drexel Univ, Coll Med, Inst Mol Med & Infect Dis, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA.	laura.steel@drexelmed.edu		Sanghvi, Viraj/0000-0001-6526-7820	Commonwealth of Pennsylvania Department of Health	Commonwealth of Pennsylvania Department of Health	This work was supported by a grant to LFS from the Commonwealth of Pennsylvania Department of Health, Tobacco Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Bennasser Y, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-95; Bennasser Y, 2006, J BIOL CHEM, V281, P27674, DOI 10.1074/jbc.C600072200; Berkhou B, 2009, FUTURE MICROBIOL, V4, P151, DOI 10.2217/17460913.4.2.151; Berkhout B, 2009, EXPERT OPIN BIOL TH, V9, P161, DOI [10.1517/14712590802653619 , 10.1517/14712590802653619]; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Chable-Bessia C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-26; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Das AT, 2007, J VIROL, V81, P7742, DOI 10.1128/JVI.00392-07; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eletto D, 2008, J CELL PHYSIOL, V216, P764, DOI 10.1002/jcp.21452; Gatignol A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-65; GATIGNOL A, 1991, SCIENCE, V251, P1597, DOI 10.1126/science.2011739; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; Houzet L, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-118; HOWCROFT TK, 1995, IMMUNITY, V3, P127; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Kok KH, 2007, J BIOL CHEM, V282, P17649, DOI 10.1074/jbc.M611768200; Kok KH, 2006, J GEN VIROL, V87, P2639, DOI 10.1099/vir.0.81764-0; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lantermann M, 2007, VIRUS RES, V126, P1, DOI 10.1016/j.virusres.2007.01.009; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Matskevich AA, 2007, J GEN VIROL, V88, P2627, DOI 10.1099/vir.0.83103-0; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Persson H, 2009, NAT CELL BIOL, V11, P1268, DOI 10.1038/ncb1972; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Scherer L, 2007, GENE THER, V14, P1057, DOI 10.1038/sj.gt.3302977; Snyder LL, 2008, ANTIVIR RES, V80, P36, DOI 10.1016/j.antiviral.2008.04.001; Snyder LL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp657; Sullivan CS, 2005, J VIROL, V79, P7371, DOI 10.1128/JVI.79.12.7371-7379.2005; SUNE C, 1995, J VIROL, V69, P3098; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wang F, 2009, BMB REP, V42, P725, DOI 10.5483/BMBRep.2009.42.11.725; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Yeung ML, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-81; ZHANG GL, 2010, ANTIVIRAL RES	60	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17246	10.1371/journal.pone.0017246	http://dx.doi.org/10.1371/journal.pone.0017246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386885	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400042
J	Stoks, R; De Block, M				Stoks, Robby; De Block, Marjan			Rapid Growth Reduces Cold Resistance: Evidence from Latitudinal Variation in Growth Rate, Cold Resistance and Stress Proteins	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; COMPENSATORY GROWTH; TIME CONSTRAINTS; PHOSPHOGLUCOSE ISOMERASE; DROSOPHILA-MELANOGASTER; PHYSIOLOGICAL COSTS; GENETIC-VARIATION; OXIDATIVE STRESS; TRADE-OFF; EXPRESSION	Background: Physiological costs of rapid growth may contribute to the observation that organisms typically grow at submaximal rates. Although, it has been hypothesized that faster growing individuals would do worse in dealing with suboptimal temperatures, this type of cost has never been explored empirically. Furthermore, the mechanistic basis of the physiological costs of rapid growth is largely unexplored. Methodology/Principal Finding: Larvae of the damselfly Ischnura elegans from two univoltine northern and two multivoltine southern populations were reared at three temperatures and after emergence given a cold shock. Cold resistance, measured by chill coma recovery times in the adult stage, was lower in the southern populations. The faster larval growth rates in the southern populations contributed to this latitudinal pattern in cold resistance. In accordance with their assumed role in cold resistance, Hsp70 levels were lower in the southern populations, and faster growing larvae had lower Hsp70 levels. Yet, individual variation in Hsp70 levels did not explain variation in cold resistance. Conclusions/Significance: We provide evidence for a novel cost of rapid growth: reduced cold resistance. Our results indicate that the reduced cold resistance in southern populations of animals that change voltinism along the latitudinal gradient may not entirely be explained by thermal selection per se but also by the costs of time constraint-induced higher growth rates. This also illustrates that stressors imposed in the larval stage may carry over and shape fitness in the adult stage and highlights the importance of physiological costs in the evolution of life-histories at macro-scales.	[Stoks, Robby; De Block, Marjan] Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium	KU Leuven	Stoks, R (corresponding author), Katholieke Univ Leuven, Lab Aquat Ecol & Evolutionary Biol, Louvain, Belgium.	robby.stoks@bio.kuleuven.be	Stoks, Robby/AAK-1227-2020	Stoks, Robby/0000-0003-4130-0459	Fund for Scientific Research - Flanders [G.0419.08]; KULeuven Research Fund [GOA/2008/06, PF/10/007]	Fund for Scientific Research - Flanders(FWO); KULeuven Research Fund(KU Leuven)	This research was supported by a research grant of the Fund for Scientific Research - Flanders (G.0419.08) and research grants from the KULeuven Research Fund (GOA/2008/06 and PF/10/007). M. De Block is postdoctoral researcher of the Fund for Scientific Research - Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; Altermatt F, 2010, P ROY SOC B-BIOL SCI, V277, P1281, DOI 10.1098/rspb.2009.1910; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; AYRES MP, 1994, ECOL MONOGR, V64, P465, DOI 10.2307/2937146; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Clowers KJ, 2010, GENET RES, V92, P103, DOI 10.1017/S0016672310000108; Colinet H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010925; Colinet H, 2010, FEBS J, V277, P174, DOI 10.1111/j.1742-4658.2009.07470.x; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; Dahlhoff EP, 2000, P NATL ACAD SCI USA, V97, P10056, DOI 10.1073/pnas.160277697; De Block M, 2004, OECOLOGIA, V140, P68, DOI 10.1007/s00442-004-1575-6; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; De Block M, 2008, ECOL ENTOMOL, V33, P796, DOI 10.1111/j.1365-2311.2008.01024.x; De Block M, 2008, P ROY SOC B-BIOL SCI, V275, P781, DOI 10.1098/rspb.2007.1515; Dijkstra K.-D.B., 2006, FIELD GUIDE DRAGONFL; Fischer K, 2004, EVOL ECOL, V18, P343, DOI 10.1007/s10682-004-2004-3; Gaston KJ, 2009, AM NAT, V174, P595, DOI 10.1086/605982; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Gotthard K, 2001, EXPTL BIOL REV, P287; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Hall ME, 2010, FUNCT ECOL, V24, P365, DOI 10.1111/j.1365-2435.2009.01635.x; Hoffmann AA, 2005, FUNCT ECOL, V19, P222, DOI 10.1111/j.1365-2435.2005.00959.x; Hoffmann AA, 2002, ECOL LETT, V5, P614, DOI 10.1046/j.1461-0248.2002.00367.x; Johansson F, 1999, ECOLOGY, V80, P1242, DOI 10.2307/177071; Johansson F, 2001, ECOLOGY, V82, P1857, DOI 10.1890/0012-9658(2001)082[1857:LHPIAD]2.0.CO;2; Karl I, 2008, FUNCT ECOL, V22, P887, DOI 10.1111/j.1365-2435.2008.01438.x; Karl I, 2009, J EVOLUTION BIOL, V22, P172, DOI 10.1111/j.1420-9101.2008.01630.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kostal V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004546; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Ragland GJ, 2007, J EVOLUTION BIOL, V20, P2144, DOI 10.1111/j.1420-9101.2007.01428.x; Ragland GJ, 2008, EVOLUTION, V62, P1345, DOI 10.1111/j.1558-5646.2008.00367.x; Richter-Boix A, 2010, MOL ECOL, V19, P716, DOI 10.1111/j.1365-294X.2009.04502.x; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Roff Derek A., 1992; Rolff J, 2004, AM NAT, V164, P559, DOI 10.1086/423715; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Sonoda S, 2006, ARCH INSECT BIOCHEM, V63, P36, DOI 10.1002/arch.20138; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Stearns S.C., 1992, pi; Stoks R, 2005, J ANIM ECOL, V74, P708, DOI 10.1111/j.1365-2656.2005.00969.x; Stoks R, 2006, ECOLOGY, V87, P1566, DOI 10.1890/0012-9658(2006)87[1566:PCOCGI]2.0.CO;2; Tammaru T, 2004, OIKOS, V107, P352, DOI 10.1111/j.0030-1299.2004.13363.x; Turnbull LA, 2008, ECOLOGY, V89, P1352, DOI 10.1890/07-1531.1; Van Doorslaer W, 2005, OIKOS, V111, P599, DOI 10.1111/j.1600-0706.2005.14335.x	51	64	66	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16935	10.1371/journal.pone.0016935	http://dx.doi.org/10.1371/journal.pone.0016935			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390210	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700018
J	Katz, I; Komatsu, R; Low-Beer, D; Atun, R				Katz, Itamar; Komatsu, Ryuichi; Low-Beer, Daniel; Atun, Rifat			Scaling Up Towards International Targets for AIDS, Tuberculosis, and Malaria: Contribution of Global Fund-Supported Programs in 2011-2015	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; AFRICA; COVERAGE; THERAPY; BURDEN; IMPACT	Objective: The paper projects the contribution to 2011-2015 international targets of three major pandemics by programs in 140 countries funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, the largest external financier of tuberculosis and malaria programs and a major external funder of HIV programs in low and middle income countries. Design: Estimates, using past trends, for the period 2011-2015 of the number of persons receiving antiretroviral (ARV) treatment, tuberculosis case detection using the internationally approved DOTS strategy, and insecticide-treated nets (ITNs) to be delivered by programs in low and middle income countries supported by the Global Fund compared to international targets established by UNAIDS, Stop TB Partnership, Roll Back Malaria Partnership and the World Health Organisation. Results: Global Fund-supported programs are projected to provide ARV treatment to 5.5-5.8 million people, providing 30%-31% of the 2015 international target. Investments in tuberculosis and malaria control will enable reaching in 2015 60%-63% of the international target for tuberculosis case detection and 30%-35% of the ITN distribution target in sub-Saharan Africa. Conclusion: Global Fund investments will substantially contribute to the achievement by 2015 of international targets for HIV, TB and malaria. However, additional large scale international and domestic financing is needed if these targets are to be reached by 2015.	[Katz, Itamar; Komatsu, Ryuichi; Low-Beer, Daniel; Atun, Rifat] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Atun, Rifat] Univ London Imperial Coll Sci Technol & Med, Sch Business, London, England	Imperial College London	Katz, I (corresponding author), Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland.	katz@cantab.net	Abrams, William R/A-5782-2008; Katz, Itamar/A-8771-2008; Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Katz, Itamar/0000-0001-8266-1360				Alnwick D., 2007, BRINGING HIV PREVENT; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], AIDS EP UPD 2009; Asamoah-Odei E, 2004, LANCET, V364, P35, DOI 10.1016/S0140-6736(04)16587-2; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Boerma JT, 2006, B WORLD HEALTH ORGAN, V84, P145, DOI 10.2471/BLT.05.025189; Enserink M, 2007, SCIENCE, V318, P560, DOI 10.1126/science.318.5850.560; Feachem RGA, 2007, JAMA-J AM MED ASSOC, V297, P2281, DOI 10.1001/jama.297.20.2281; Hayden EC, 2008, NATURE, V454, P812, DOI 10.1038/454812a; Katz I, 2010, INT J TUBERC LUNG D, V14, P1097; Katz I, 2008, SEX TRANSM DIS, V35, P837, DOI 10.1097/OLQ.0b013e31817c0be5; Komatsu R, 2007, B WORLD HEALTH ORGAN, V85, P805, DOI 10.2471/BLT.06.038315; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; LAXMINARAYAN R, 2007, 4295 WORLD BANK; Lengeler C., 2004, INSECTICIDE TREATED; Low-Beer D, 2007, PLOS MED, V4, P1308, DOI 10.1371/journal.pmed.0040219; Low-Beer Daniel, 2004, Afr J AIDS Res, V3, P1, DOI 10.2989/16085900409490313; LOWBEER D, 2009, SCALING IMPACT GLOBA; Miller JM, 2007, JAMA-J AM MED ASSOC, V297, P2241, DOI 10.1001/jama.297.20.2241; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; Nahlen BL, 2007, AM J TROP MED HYG, V77, P321, DOI 10.4269/ajtmh.2007.77.321; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Shelton JD, 2006, LANCET, V367, P1120, DOI 10.1016/S0140-6736(06)68436-5; *UN, 2005, PAR DECL AID EFF; *UN WHO, 2006, GLOB PLAN STOP TB 20; UN-United Nations, 2005, 2005 WORLD SUMM OUTC; UNAIDS, 2007, UN GEN ASS SPEC SESS; UNAIDS, 2007, FIN RES REQ ACH UN A; *UNAIDS WHO, 2007, AIDS EP UPD; United Nations, 2009, MILL DEV GOALS REP 2; *WHO, 2009, GLOB TUB CONTR SHORT; *WHO UNAIDS, 2006, GLOB FUND FIGHT AIDS; [World Health Organization (WHO) UNAIDS UNICEF], 2010, UN ACC SCAL PRIOR HI; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	34	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17166	10.1371/journal.pone.0017166	http://dx.doi.org/10.1371/journal.pone.0017166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383839	gold, Green Published, Green Submitted			2022-12-27	WOS:000287657500037
J	Liu, MX; Wang, L; Shi, ZBA; Zhang, Z; Zhang, K; Shen, JH				Liu, Mingxin; Wang, Li; Shi, Zhanbiao; Zhang, Zhen; Zhang, Kan; Shen, Jianhua			Mental Health Problems among Children One-Year after Sichuan Earthquake in China: A Follow-up Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DEPRESSIVE REACTIONS; EXPOSURE; ADOLESCENTS; SURVIVORS; RISK; PREVALENCE; SYMPTOMS; VIOLENCE; AGE	Background: On May 12, 2008, a destructive earthquake registering 8.0 on the Richter scale struck Sichuan Province, southwest China. Beichuan County was the epicenter which was one of the areas nearly completely destroyed by the earthquake. In Beichuan, about 15000 people died and 3000 people were missing. Specially, the earthquake took 1587 students' and 214 teachers' lives from the elementary and middle schools there. The main purpose of the study was to provide a better understanding of mental health problems and associated risk factors among children after earthquake. Method: Three hundred and thirty grades 3-5 children completed the questionnaire of disaster - related experience and the Trauma Symptom Checklist for Children-Alternate Version (TSCC-A). The first survey was carried out six months after the earthquake, and the second one was carried out six months later. The measurements and methodology applied in the two sessions were identical. Results: The prevalence rates of the problems at two time-points were 23.3% and 22.7% for anxiety, 14.5% and 16.1% for depression, and 11.2% and 13.4% for PTSD, respectively. Among demographic variables, no significant age difference existed, while it was found that 6 months after the earthquake, symptoms of anxiety, depression and PTSD were significantly more common among students in grades 4 and 5 than those in grade 3, Initial exposure to death, bereavement and extreme fear were significant predictive factors for the occurrence of anxiety, depression and PTSD. Conclusions: Findings of this study suggest that posttraumatic mental health problems after natural disaster in children may have reached epidemic proportions and remain high for a long period. Psychologist and social workers should pay more attention to children who experienced more traumatic stresses and provide appropriate mental health interventions. Implications and limitations of these findings were discussed.	[Liu, Mingxin; Wang, Li; Shi, Zhanbiao; Zhang, Zhen] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Zhang, Kan] Chinese Acad Sci, Inst Psychol, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Shen, Jianhua] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; University of Toronto	Liu, MX (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangli1@psych.ac.cn		wang, li/0000-0002-1459-3412	National Foundation of Natural Science [30900402, 31040001]; China Postdoctoral Science Foundation [200902143, 20100470595]; Institute of Psychology, Chinese Academy of Sciences [O9CX143014]; Chinese Academy of Sciences	National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by the National Foundation of Natural Science (No. 30900402 and No. 31040001), http://www.nsfc.gov.cn, China Postdoctoral Science Foundation (No. 200902143 and No. 20100470595), http://www.chinapostdoctor.org.cn/, and a grant for science development from Institute of Psychology, Chinese Academy of Sciences (No. O9CX143014), www.psych.ac.cn, and the Knowledge Innovation Project of the Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briere J, 2000, J TRAUMA STRESS, V13, P661, DOI 10.1023/A:1007814301369; Briere J., 1996, TRAUMA SYMPTOM CHECK; Bulut S, 2005, SCHOOL PSYCHOL INT, V26, P55, DOI 10.1177/0143034305050893; CAHAN S, 1989, CHILD DEV, V60, P1239, DOI 10.2307/1130797; Chou FHC, 2007, PSYCHIAT CLIN NEUROS, V61, P370, DOI 10.1111/j.1440-1819.2007.01688.x; Cook A, 2008, J ENVIRON MONITOR, V10, P167, DOI 10.1039/b713256p; Crone DA, 1999, J EDUC PSYCHOL, V91, P604, DOI 10.1037/0022-0663.91.4.604; Elhai JD, 2005, J TRAUMA STRESS, V18, P541, DOI 10.1002/jts.20062; Garbarino J, 1996, CHILD DEV, V67, P33, DOI 10.1111/j.1467-8624.1996.tb01717.x; Goenjian AK, 2001, AM J PSYCHIAT, V158, P788, DOI 10.1176/appi.ajp.158.5.788; Ho J, 2008, J INTERPERS VIOLENCE, V23, P136, DOI 10.1177/0886260507307653; Lai TJ, 2004, J PSYCHIATR RES, V38, P313, DOI 10.1016/j.jpsychires.2003.08.005; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; PYNOOS RS, 1993, BRIT J PSYCHIAT, V163, P239, DOI 10.1192/bjp.163.2.239; Roussos A, 2005, AM J PSYCHIAT, V162, P530, DOI 10.1176/appi.ajp.162.3.530; Rustemli A, 1996, J SOC BEHAV PERS, V11, P767; Thienkrua W, 2006, JAMA-J AM MED ASSOC, V296, P549, DOI 10.1001/jama.296.5.549; Udwin O, 2000, J CHILD PSYCHOL PSYC, V41, P969, DOI 10.1111/1469-7610.00685; UDWIN O, 1993, J CHILD PSYCHOL PSYC, V34, P115, DOI 10.1111/j.1469-7610.1993.tb00974.x; Wang L, 2009, J TRAUMA STRESS, V22, P444, DOI 10.1002/jts.20439; Wickrama KAS, 2007, SOC SCI MED, V64, P713, DOI 10.1016/j.socscimed.2006.09.031	21	115	123	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14706	10.1371/journal.pone.0014706	http://dx.doi.org/10.1371/journal.pone.0014706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373188	Green Published, gold			2022-12-27	WOS:000287657500002
J	Nourein, AB; Abass, MA; Nugud, AHD; El Hassan, I; Snow, RW; Noor, AM				Nourein, Amal B.; Abass, Mohammed A.; Nugud, Abdel Hameed D.; El Hassan, Ibrahim; Snow, Robert W.; Noor, Abdisalan M.			Identifying Residual Foci of Plasmodium falciparum Infections for Malaria Elimination: The Urban Context of Khartoum, Sudan	PLOS ONE			English	Article							RISK; CLUSTERS; VIVAX; COAST	Background: Identifying the location and size of residual foci of infections is critical where malaria elimination is the primary goal. Here the spatial heterogeneity of Plasmodium falciparum infections within the urban extent of Khartoum state in Sudan is investigated using data from cross-sectional surveys undertaken from 1999 to 2008 to inform the Khartoum Malaria Free Initiative (KMFI). Methods: From 1999-2008 the KMFI undertook cross-sectional surveys of 256 clusters across 203 random samples of residential blocks in the urban Khartoum state in September of each year. Within sampled blocks, at least five persons, including at least one child under the age of five years, were selected from each household. Blood smears were collected from the sampled individuals to examine the presence of P. falciparum parasites. Residential blocks were mapped. Data were analysed for spatial clustering using the Bernoulli model and the significance of clusters were tested using the Kulldorff scan statistic. Results: A total of 128,510 malaria slide examinations were undertaken during the study period. In 1999, overall prevalence was 2.5%, rising to 3.2% in 2000 and consistently staying below 1% in subsequent years. From 2006, over 90% of all surveyed clusters reported no infections. Spatial clustering of infections was present in each year but not statistically significant in the years 2001, 2002, 2004 and 2008. Spatial clusters of high infection were often located at the junction of the Blue and White Niles. Conclusion: Persisting foci of malaria infection in Khartoum are likely to distort wide area assessments and disproportionately affect future transmission within the city limits. Improved investments in surveillance that combines both passive and active case detection linked to a geographic information system and a more detailed analysis of the location and stability of foci should be undertaken to facilitate and track malaria elimination in the state of Khartoum.	[Nourein, Amal B.; El Hassan, Ibrahim] Univ Khartoum, Dept Parasitol, Inst Endem Dis, Khartoum, Sudan; [Abass, Mohammed A.] Khartoum State Malaria Control Programme, Khartoum Malaria Free Initiat, Khartoum, Sudan; [Nugud, Abdel Hameed D.] Minist Hlth Sudan, Natl Hlth Lab, Khartoum, Sudan; [El Hassan, Ibrahim] Univ Jazan, Fac Med, Jazan, Saudi Arabia; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Malaria Publ Hlth & Epidemiol Grp, Ctr Geog Med, KEMRI,Wellcome Trust Res Programme, Nairobi, Kenya; [Snow, Robert W.; Noor, Abdisalan M.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England	University of Khartoum; Jazan University; University of Oxford	Nourein, AB (corresponding author), Univ Khartoum, Dept Parasitol, Inst Endem Dis, Khartoum, Sudan.	anoor@nairobi.kemri-wellcome.org	Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088	Khartoum State Malaria Control Programme; World Health Organization; Japanese government; Global Fund; Wellcome Trust [079080, 081829]; ABM; Wellcome Trust, UK; Kenya Medical Research Institute; Novartis in Africa; Pfizer	Khartoum State Malaria Control Programme; World Health Organization(World Health Organization); Japanese government; Global Fund; Wellcome Trust(Wellcome TrustEuropean Commission); ABM; Wellcome Trust, UK(Wellcome Trust); Kenya Medical Research Institute; Novartis in Africa; Pfizer(Pfizer)	The study received funding from the Khartoum State Malaria Control Programme with support from the World Health Organization, the Japanese government and the Global Fund to Fight AIDS, Tuberculosis and Malaria. RWS is supported by the Wellcome Trust through a Principal Research Fellowship (#079080) which also supported ABM during her internship to complete this work. VAA is supported by a grant to Professor Snow from the Wellcome Trust. AMN is supported by the Wellcome Trust as a Research Training Fellow (#081829). This work forms part of the output of the Malaria Atlas Project ( MAP, http://www.map.ox.ac.uk), principally funded by the Wellcome Trust, UK. RWS and AMN also acknowledge the support from the Kenya Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RWS has received funding from Novartis for chairing meetings of national control programmes in Africa and has received a research grant from Pfizer. All other authors have no conflicts of interest.	Baird JK, 2009, ANN TROP PAEDIATR, V29, P251, DOI 10.1179/027249309X12547917868808; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; BALFOUR A, 2004, 1 WELL TROP RES LAB; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; *CBS, 2009, CBS YB; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; *FED MIN HLTH, 2010, NAT MAL IND SURV NO; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Hernandez-Avila JE, 2006, SALUD PUBLICA MEXICO, V48, P405, DOI 10.1590/S0036-36342006000500007; IHOUSE ME, 1997, P NATL ACAD SCI USA, V94, P338; KHALIFA SM, 2008, E MEDTR MED J, V14, P206; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Kulldorff M, 1997, AM J EPIDEMIOL, V146, P161; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Macauley C, 2005, SOC SCI MED, V60, P563, DOI 10.1016/j.socscimed.2004.05.025; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; MOONEN B, 2010, LANCET, DOI DOI 10.1016/S0140-6736(10)61269X; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Osorio L, 2007, TROP MED INT HEALTH, V12, P331, DOI 10.1111/j.1365-3156.2006.01791.x; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; PULL JH, 1972, AM J TROP MED HYG, V21, P651, DOI 10.4269/ajtmh.1972.21.651; Schellenberg JA, 1998, INT J EPIDEMIOL, V27, P323, DOI 10.1093/ije/27.2.323; Shanks GD, 2005, T ROY SOC TROP MED H, V99, P71, DOI 10.1016/j.trstmh.2004.04.001; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; SNOW RW, 1993, T ROY SOC TROP MED H, V87, P386, DOI 10.1016/0035-9203(93)90007-D; *STATSCAN, SOFTW SPAT TEMP SPAC; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005	34	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16948	10.1371/journal.pone.0016948	http://dx.doi.org/10.1371/journal.pone.0016948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373202	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500025
J	Fode, P; Jespersgaard, C; Hardwick, RJ; Bogle, H; Theisen, M; Dodoo, D; Lenicek, M; Vitek, L; Vieira, A; Freitas, J; Andersen, PS; Hollox, EJ				Fode, Peder; Jespersgaard, Cathrine; Hardwick, Robert J.; Bogle, Helen; Theisen, Michael; Dodoo, Daniel; Lenicek, Martin; Vitek, Libor; Vieira, Ana; Freitas, Joao; Andersen, Paal Skytt; Hollox, Edward J.			Determination of Beta-Defensin Genomic Copy Number in Different Populations: A Comparison of Three Methods	PLOS ONE			English	Article							STRUCTURAL VARIATION; ANTIMICROBIAL PEPTIDES; ALPHA-DEFENSIN; RISK-FACTOR; POLYMORPHISM; GENES; SUSCEPTIBILITY; PREDISPOSES; PSORIASIS; VARIANTS	Background: There have been conflicting reports in the literature on association of gene copy number with disease, including CCL3L1 and HIV susceptibility, and beta-defensins and Crohn's disease. Quantification of precise gene copy numbers is important in order to define any association of gene copy number with disease. At present, real-time quantitative PCR (QPCR) is the most commonly used method to determine gene copy number, however the Paralogue Ratio Test (PRT) is being used in more and more laboratories. Findings: In this study we compare a Pyrosequencing-based Paralogue Ratio Test (PPRT) for determining beta-defensin gene copy number with two currently used methods for gene copy number determination, QPCR and triplex PRT by typing five different cohorts (UK, Danish, Portuguese, Ghanaian and Czech) of DNA from a total of 576 healthy individuals. We found a systematic measurement bias between DNA cohorts revealed by QPCR, but not by the PRT-based methods. Using PRT, copy number ranged from 2 to 9 copies, with a modal copy number of 4 in all populations. Conclusions: QPCR is very sensitive to quality of the template DNA, generating systematic biases that could produce false-positive or negative disease associations. Both triplex PRT and PPRT do not show this systematic bias, and type copy number within the correct range, although triplex PRT appears to be a more precise and accurate method to type beta-defensin copy number.	[Fode, Peder; Andersen, Paal Skytt] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Jespersgaard, Cathrine; Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Hardwick, Robert J.; Bogle, Helen; Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Dodoo, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Lenicek, Martin; Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Clin Biochem & Lab Diagnost, Prague, Czech Republic; [Lenicek, Martin; Vitek, Libor] Charles Univ Prague, Fac Med 1, Dept Internal Med 4, Prague, Czech Republic; [Vieira, Ana; Freitas, Joao] Hosp Garcia Orta, Dept Gastroenterol, Almada, Portugal	Statens Serum Institut; Statens Serum Institut; University of Leicester; University of Ghana; Charles University Prague; Charles University Prague; Hospital Garcia de Orta	Fode, P (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	ejh33@le.ac.uk	Vitek, Libor/A-2645-2008; Andersen, Paal S/H-2087-2015; Lenicek, Martin/A-5495-2009	Vitek, Libor/0000-0002-5318-0151; Andersen, Paal S/0000-0001-5656-0427; Hollox, Edward/0000-0002-0115-2298; Lenicek, Martin/0000-0001-6242-3488; Theisen, Michael/0000-0003-4412-1392	Idella Foundation; Danish Crohn and Colitis Association; Augustinus Foundation; Medical Research Council (UK) [GO801123]; Wellcome Trust (UK) [087663]; Medical Research Council [G0801123] Funding Source: researchfish	Idella Foundation; Danish Crohn and Colitis Association; Augustinus Foundation; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust (UK)(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the Idella Foundation, the Danish Crohn and Colitis Association, the Augustinus Foundation, the Medical Research Council (UK) New Investigator award GO801123, and Wellcome Trust (UK) grant 087663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Abu Bakar S, 2009, P NATL ACAD SCI USA, V106, P853, DOI 10.1073/pnas.0809073106; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aldhous MC, 2010, HUM MOL GENET, V19, P4930, DOI 10.1093/hmg/ddq411; Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bentley RW, 2010, AM J GASTROENTEROL, V105, P354, DOI 10.1038/ajg.2009.582; Boniotto M, 2006, ANTIMICROB AGENTS CH, V50, P1433, DOI 10.1128/AAC.50.4.1433-1441.2006; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cukier HN, 2009, ANAL BIOCHEM, V386, P288, DOI 10.1016/j.ab.2008.11.040; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Field SF, 2009, NAT MED, V15, P1115, DOI 10.1038/nm1009-1115; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; GROTH M, 2010, GENES IMMUN, P1158; Groth M, 2008, HUM MUTAT, V29, P1247, DOI 10.1002/humu.20751; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Hollox EJ, 2008, CYTOGENET GENOME RES, V123, P148, DOI 10.1159/000184702; Hollox EJ, 2008, GENOME RES, V18, P1686, DOI 10.1101/gr.080945.108; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9; Hollox EJ, 2010, AM J GASTROENTEROL, V105, P360, DOI 10.1038/ajg.2009.573; Hollox EJ, 2009, HUM MUTAT, V30, P477, DOI 10.1002/humu.20911; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Huffmeier U, 2010, J INVEST DERMATOL, V130, P979, DOI 10.1038/jid.2009.385; Husea K, 2008, TUMOR BIOL, V29, P83, DOI 10.1159/000135688; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jin G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010993; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Linzmeier R, 1999, GENE, V233, P205, DOI 10.1016/S0378-1119(99)00136-5; Linzmeier RM, 2005, GENOMICS, V86, P423, DOI 10.1016/j.ygeno.2005.06.003; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Perne A, 2009, BIOTECHNIQUES, V47, P1023, DOI 10.2144/000113300; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ronaghi M, 1996, ANAL BIOCHEM, V242, P84, DOI 10.1006/abio.1996.0432; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Semple F, 2010, EUR J IMMUNOL, V40, P1073, DOI 10.1002/eji.200940041; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weterman MAJ, 2010, EUR J HUM GENET, V18, P421, DOI 10.1038/ejhg.2009.186; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001	55	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16768	10.1371/journal.pone.0016768	http://dx.doi.org/10.1371/journal.pone.0016768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364933	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600019
J	von Figura, G; Wagner, M; Nalapareddy, K; Hartmann, D; Kleger, A; Guachalla, LM; Rolyan, H; Adler, G; Rudolph, KL				von Figura, Guido; Wagner, Martin; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Adler, Guido; Rudolph, Karl Lenhard			Regeneration of the Exocrine Pancreas Is Delayed in Telomere-Dysfunctional Mice	PLOS ONE			English	Article							TUBULAR COMPLEXES; LIVER-CIRRHOSIS; SENESCENCE; CELLS; GENE; DISEASE; CANCER; RATS	Introduction: Telomere shortening is a cell-intrinsic mechanism that limits cell proliferation by induction of DNA damage responses resulting either in apoptosis or cellular senescence. Shortening of telomeres has been shown to occur during human aging and in chronic diseases that accelerate cell turnover, such as chronic hepatitis. Telomere shortening can limit organ homeostasis and regeneration in response to injury. Whether the same holds true for pancreas regeneration in response to injury is not known. Methods: In the present study, pancreatic regeneration after acute cerulein-induced pancreatitis was studied in late generation telomerase knockout mice with short telomeres compared to telomerase wild-type mice with long telomeres. Results: Late generation telomerase knockout mice exhibited impaired exocrine pancreatic regeneration after acute pancreatitis as seen by persistence of metaplastic acinar cells and markedly reduced proliferation. The expression levels of p53 and p21 were not significantly increased in regenerating pancreas of late generation telomerase knockout mice compared to wild-type mice. Conclusion: Our results indicate that pancreatic regeneration is limited in the context of telomere dysfunction without evidence for p53 checkpoint activation.	[von Figura, Guido; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Inst Mol Med, Ulm, Germany; [von Figura, Guido; Nalapareddy, Kodandaramireddy; Hartmann, Daniel; Kleger, Alexander; Guachalla, Luis Miguel; Rolyan, Harshvardhan; Rudolph, Karl Lenhard] Univ Ulm, Max Planck Res Grp Stem Cell Aging, Ulm, Germany; [von Figura, Guido; Wagner, Martin; Kleger, Alexander; Adler, Guido] Univ Ulm, Dept Internal Med, D-7900 Ulm, Germany; [Hartmann, Daniel] Tech Univ Munich, Dept Surg, Munich, Germany	Ulm University; Max Planck Society; Ulm University; Ulm University; Technical University of Munich	von Figura, G (corresponding author), Univ Ulm, Inst Mol Med, Ulm, Germany.	lenhard.rudolph@uni-ulm.de	; Rolyan, Harshvardhan/G-2461-2017	Kleger, Alexander/0000-0003-0592-5232; Nalapareddy, Kodandaramireddy/0000-0003-3290-5114; Guachalla, Luis Miguel/0000-0003-1152-9930; Hartmann, Daniel/0000-0003-4366-8986; Rudolph, Karl Lenhard/0000-0002-4839-2862; Rolyan, Harshvardhan/0000-0001-8967-9627	Deutsche Forschungsgemeinschaft [SFB518]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft (SFB518). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; BOCKMAN DE, 1982, AM J SURG, V144, P243, DOI 10.1016/0002-9610(82)90518-9; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937; DELISLE RC, 1990, PANCREAS, V5, P381, DOI 10.1097/00006676-199007000-00002; Elsasser H P, 1986, Pancreas, V1, P421, DOI 10.1097/00006676-198609000-00006; Gardner TB, 2008, PANCREATOLOGY, V8, P265, DOI 10.1159/000134274; Ishii A, 2006, EXP GERONTOL, V41, P882, DOI 10.1016/j.exger.2006.06.036; Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0; Lechel A, 2007, GASTROENTEROLOGY, V132, P1465, DOI 10.1053/j.gastro.2007.01.045; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Poon SSS, 1999, CYTOMETRY, V36, P267, DOI 10.1002/(SICI)1097-0320(19990801)36:4<267::AID-CYTO1>3.0.CO;2-O; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Satyanarayana A, 2004, CELL CYCLE, V3, P1405, DOI 10.4161/cc.3.11.1212; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com; WILLEMER S, 1992, EUR SURG RES, V24, P29, DOI 10.1159/000129237; WILLEMER S, 1987, PANCREAS, V2, P669, DOI 10.1097/00006676-198711000-00008; Witt H, 2007, GASTROENTEROLOGY, V132, P1557, DOI 10.1053/j.gastro.2007.03.001; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	25	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17122	10.1371/journal.pone.0017122	http://dx.doi.org/10.1371/journal.pone.0017122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364961	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600031
J	Clegg, NJ; Couto, SS; Wongvipat, J; Hieronymus, H; Carver, BS; Taylor, BS; Ellwood-Yen, K; Gerald, WL; Sander, C; Sawyers, CL				Clegg, Nicola J.; Couto, Suzana S.; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Taylor, Barry S.; Ellwood-Yen, Katharine; Gerald, William L.; Sander, Chris; Sawyers, Charles L.			MYC Cooperates with AKT in Prostate Tumorigenesis and Alters Sensitivity to mTOR Inhibitors	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; CANCER PROGRESSION; MAMMALIAN TARGET; RAPAMYCIN; ACTIVATION; PATHWAYS; PTEN; CARCINOGENESIS; EIF4E; CELLS	MYC and phosphoinositide 3-kinase (PI3K)-pathway deregulation are common in human prostate cancer. Through examination of 194 human prostate tumors, we observed statistically significant co-occurrence of MYC amplification and PI3K-pathway alteration, raising the possibility that these two lesions cooperate in prostate cancer progression. To investigate this, we generated bigenic mice in which both activated human AKT1 and human MYC are expressed in the prostate (MPAKT/Hi-MYC model). In contrast to mice expressing AKT1 alone (MPAKT model) or MYC alone (Hi-MYC model), the bigenic phenotype demonstrates accelerated progression of mouse prostate intraepithelial neoplasia (mPIN) to microinvasive disease with disruption of basement membrane, significant stromal remodeling and infiltration of macrophages, B- and T-lymphocytes, similar to inflammation observed in human prostate tumors. In contrast to the reversibility of mPIN lesions in young MPAKT mice after treatment with mTOR inhibitors, Hi-MYC and bigenic MPAKT/HiMYC mice were resistant. Additionally, older MPAKT mice showed reduced sensitivity to mTOR inhibition, suggesting that additional genetic events may dampen mTOR dependence. Since increased MYC expression is an early feature of many human prostate cancers, these data have implications for treatment of human prostate cancers with PI3K-pathway alterations using mTOR inhibitors.	[Clegg, Nicola J.; Wongvipat, John; Hieronymus, Haley; Carver, Brett S.; Gerald, William L.; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Couto, Suzana S.] Mem Sloan Kettering Canc Ctr, Lab Comparat Pathol, New York, NY 10021 USA; [Wongvipat, John; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; [Carver, Brett S.] Mem Sloan Kettering Canc Ctr, Urol Serv, New York, NY 10021 USA; [Carver, Brett S.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Taylor, Barry S.; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Ellwood-Yen, Katharine] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Clegg, NJ (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org	Sander, Chris/H-1452-2011; Sawyers, Charles/G-5327-2016	Sander, Chris/0000-0001-6059-6270; 	Charles H. Revson Senior Fellowship in Life Sciences; David H. Koch Fellowship in Cancer Genomics; Howard Hughes Medical Institute; NCI [5P01CA089021]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA089021] Funding Source: NIH RePORTER	Charles H. Revson Senior Fellowship in Life Sciences; David H. Koch Fellowship in Cancer Genomics; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Charles H. Revson Senior Fellowship in Life Sciences (www. revsonfoundation. org) (NJC); David H. Koch Fellowship in Cancer Genomics (www.kochfamilyfoundations.org/FoundationsDHK.asp) (BST); Howard Hughes Medical Institute (www.hhmi.org) (CLS); NCI 5P01CA089021 (www.cancer.gov) (CLS); and the Prostate Cancer Foundation (www.pcf.org) (CLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Amato RJ, 2008, CLIN GENITOURIN CANC, V6, P97, DOI 10.3816/CGC.2008.n.015; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Balakumaran BS, 2009, CANCER RES, V69, P7803, DOI 10.1158/0008-5472.CAN-09-0910; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chen Y, 2009, LANCET ONCOL, V10, P981, DOI 10.1016/S1470-2045(09)70229-3; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; DeNardo D, 2010, CANCER METAST REV, V29, P309, DOI 10.1007/s10555-010-9223-6; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Jenkins RB, 1997, CANCER RES, V57, P524; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; Kuczyk M, 1998, BRIT J UROL, V81, P406; Kumar-Sinha C, 2008, NAT REV CANCER, V8, P497, DOI 10.1038/nrc2402; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Majumder PK, 2003, P NATL ACAD SCI USA, V100, P7841, DOI 10.1073/pnas.1232229100; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; She QB, 2010, CANCER CELL, V18, P39, DOI 10.1016/j.ccr.2010.05.023; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wu LC, 2005, CANCER RES, V65, P2825, DOI 10.1158/0008-5472.CAN-04-3137; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7	47	66	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17449	10.1371/journal.pone.0017449	http://dx.doi.org/10.1371/journal.pone.0017449			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394210	gold, Green Published, Green Submitted			2022-12-27	WOS:000288025500014
J	Das, S; Dutta, K; Kumawat, KL; Ghoshal, A; Adhya, D; Basu, A				Das, Sulagna; Dutta, Kallol; Kumawat, Kanhaiya Lal; Ghoshal, Ayan; Adhya, Dwaipayan; Basu, Anirban			Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; NECROSIS-FACTOR-ALPHA; SUBVENTRICULAR ZONE NEUROGENESIS; ADULT HIPPOCAMPAL NEUROGENESIS; FOCAL CEREBRAL-ISCHEMIA; BLOOD-BRAIN-BARRIER; NITRIC-OXIDE; PROGENITOR CELLS; NEURONAL DEATH	Background: Japanese encephalitis virus (JEV) induces neuroinflammation with typical features of viral encephalitis, including inflammatory cell infiltration, activation of microglia, and neuronal degeneration. The detrimental effects of inflammation on neurogenesis have been reported in various models of acute and chronic inflammation. We investigated whether JEV-induced inflammation has similar adverse effects on neurogenesis and whether those effects can be reversed using an anti-inflammatory compound minocycline. Methodology/Principal Findings: Here, using in vitro studies and mouse models, we observed that an acute inflammatory milieu is created in the subventricular neurogenic niche following Japanese encephalitis ( JE) and a resultant impairment in neurogenesis occurs, which can be reversed with minocycline treatment. Immunohistological studies showed that proliferating cells were replenished and the population of migrating neuroblasts was restored in the niche following minocycline treatment. In vitro, we checked for the efficacy of minocycline as an anti-inflammatory compound and cytokine bead array showed that production of cyto/chemokines decreased in JEV-activated BV2 cells. Furthermore, mouse neurospheres grown in the conditioned media from JEV-activated microglia exhibit arrest in both proliferation and differentiation of the spheres compared to conditioned media from control microglia. These effects were completely reversed when conditioned media from JEV-activated and minocycline treated microglia was used. Conclusion/Significance: This study provides conclusive evidence that JEV-activated microglia and the resultant inflammatory molecules are anti-proliferative and anti-neurogenic for NSPCs growth and development, and therefore contribute to the viral neuropathogenesis. The role of minocycline in restoring neurogenesis may implicate enhanced neuronal repair and attenuation of the neuropsychiatric sequelae in JE survivors.	[Das, Sulagna; Dutta, Kallol; Kumawat, Kanhaiya Lal; Ghoshal, Ayan; Adhya, Dwaipayan; Basu, Anirban] Natl Brain Res Ctr, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Das, S (corresponding author), Natl Brain Res Ctr, Manesar, Haryana, India.	anirban@nbrc.ac.in	Dutta, Kallol/J-5827-2019	Dutta, Kallol/0000-0001-6402-1300; Basu, Anirban/0000-0002-5200-2054; Das, Sulagna/0000-0002-8495-3153	Department of Biotechnology, Government of India [BT/PR8682/Med/14/1273/2007]; Council of Scientific and Industrial Research [27(0173)/07/EMR-II]; University Grants Commission, Government of India; Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, Government of India(University Grants Commission, India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is funded by grants to A. B. from the Department of Biotechnology, Government of India (BT/PR8682/Med/14/1273/2007), and the Council of Scientific and Industrial Research (27(0173)/07/EMR-II); S.D. is the recipient of a Senior Research Fellowship from the University Grants Commission, Government of India; K.D. is a recipient of a Research Associateship in Biotechnology and Life Sciences from the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Ben-Hur T, 2003, MOL CELL NEUROSCI, V24, P623, DOI 10.1016/S1044-7431(03)00218-5; Bernardino L, 2008, STEM CELLS, V26, P2361, DOI 10.1634/stemcells.2007-0914; Buckner CM, 2006, J NEUROIMMUNE PHARM, V1, P160, DOI 10.1007/s11481-006-9017-3; Cacci E, 2005, J NEUROSCI RES, V80, P789, DOI 10.1002/jnr.20531; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; CHATURVEDI UC, 1979, CLIN EXP IMMUNOL, V38, P492; Covacu R, 2006, STEM CELLS, V24, P2792, DOI 10.1634/stemcells.2005-0640; Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Das S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008134; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Heldmann U, 2005, EXP NEUROL, V196, P204, DOI 10.1016/j.expneurol.2005.07.024; Hoehn BD, 2005, STROKE, V36, P2718, DOI 10.1161/01.STR.0000190020.30282.cc; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Krathwohl MD, 2004, STEM CELLS, V22, P109, DOI 10.1634/stemcells.22-1-109; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Lazarini F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007017; Liu YP, 2005, BRAIN RES, V1054, P152, DOI 10.1016/j.brainres.2005.06.085; Liu ZY, 2007, STROKE, V38, P146, DOI 10.1161/01.STR.0000251791.64910.cd; Ma DK, 2009, CELL RES, V19, P672, DOI 10.1038/cr.2009.56; Marchetti B, 2005, TRENDS PHARMACOL SCI, V26, P517, DOI 10.1016/j.tips.2005.08.007; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Matarredona ER, 2005, BRAIN RES REV, V49, P355, DOI 10.1016/j.brainresrev.2005.01.001; MATHUR A, 1992, INT J EXP PATHOL, V73, P603; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Mishra MK, 2007, NEUROCHEM INT, V50, P764, DOI 10.1016/j.neuint.2007.01.014; Mishra MK, 2009, NEUROCHEM INT, V55, P717, DOI 10.1016/j.neuint.2009.07.006; MISRA UK, PROG NEUROBIOL, V91, P108; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Monnet FP, 2003, EUR PSYCHIAT, V18, P269, DOI 10.1016/j.eurpsy.2003.09.001; MORI K, NEUROSCI LETT; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Peng H, 2008, GLIA, V56, P903, DOI 10.1002/glia.20665; Pluchino S, 2008, BRAIN, V131, P2564, DOI 10.1093/brain/awn198; Poluektova L, 2005, GLIA, V52, P344, DOI 10.1002/glia.20253; Reyes TM, 1998, AM J PHYSIOL-REG I, V274, pR139, DOI 10.1152/ajpregu.1998.274.1.R139; RICHTER RW, 1961, NEUROLOGY, V11, P553, DOI 10.1212/WNL.11.7.553; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Romero-Grimaldi C, 2006, EUR J NEUROSCI, V24, P2461, DOI 10.1111/j.1460-9568.2006.05127.x; Strassburger M, 2008, EUR J PHARMACOL, V592, P55, DOI 10.1016/j.ejphar.2008.06.099; Swarup V, 2008, NEUROCHEM INT, V52, P1310, DOI 10.1016/j.neuint.2008.01.014; Swarup V, 2007, J NEUROCHEM, V103, P771, DOI 10.1111/j.1471-4159.2007.04790.x; Tanapat P, 1998, INT J DEV NEUROSCI, V16, P235, DOI 10.1016/S0736-5748(98)00029-X; Tewari R, 2008, J NEUROCHEM, V107, P616, DOI 10.1111/j.1471-4159.2008.05625.x; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Torroglosa A, 2007, STEM CELLS, V25, P88, DOI 10.1634/stemcells.2006-0131; Tran PB, 2005, NEUROTOX RES, V8, P149, DOI 10.1007/BF03033826; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Widera D, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-64; Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Zink MC, 2005, JAMA-J AM MED ASSOC, V293, P2003, DOI 10.1001/jama.293.16.2003; Ziv Y, 2008, BRAIN BEHAV IMMUN, V22, P167, DOI 10.1016/j.bbi.2007.08.006; Ziv Y, 2008, TRENDS MOL MED, V14, P471, DOI 10.1016/j.molmed.2008.09.004	65	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17225	10.1371/journal.pone.0017225	http://dx.doi.org/10.1371/journal.pone.0017225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390230	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200012
J	Liu, SJ; Madiai, F; Hackshaw, KV; Allen, CE; Carl, J; Huschart, E; Karanfilov, C; Litsky, A; Hickey, CJ; Marcucci, G; Huja, S; Agarwal, S; Yu, JH; Caligiuri, MA; Wu, LC				Liu, Shujun; Madiai, Francesca; Hackshaw, Kevin V.; Allen, Carl E.; Carl, Joseph; Huschart, Emily; Karanfilov, Chris; Litsky, Alan; Hickey, Christopher J.; Marcucci, Guido; Huja, Sarandeep; Agarwal, Sudha; Yu, Jianhua; Caligiuri, Michael A.; Wu, Lai-Chu			The Large Zinc Finger Protein ZAS3 Is a Critical Modulator of Osteoclastogenesis	PLOS ONE			English	Article							NF-KAPPA-B; BINDING-PROTEIN; C-JUN; V(D)J RECOMBINATION; SIGNALING PATHWAY; MYELOID-LEUKEMIA; DNA-BINDING; T-CELLS; TRANSCRIPTION; RECEPTOR	Background: Mice deficient in the large zinc finger protein, ZAS3, show postnatal increase in bone mass suggesting that ZAS3 is critical in the regulation of bone homeostasis. Although ZAS3 has been shown to inhibit osteoblast differentiation, its role on osteoclastogenesis has not been determined. In this report we demonstrated the role of ZAS3 in bone resorption by examining the signaling mechanisms involved in osteoclastogenesis. Methodology/Principal Findings: Comparison of adult wild-type and ZAS3 knockout (ZAS32/2) mice showed that ZAS3 deficiency led to thicker bones that are more resistant to mechanical fracture. Additionally, ZAS32/2 bones showed fewer osteoclasts and inefficient M-CSF/sRANKL-mediated osteoclastogenesis ex vivo. Utilizing RAW 264.7 pre-osteoclasts, we demonstrated that overexpression of ZAS3 promoted osteoclastogenesis and the expression of crucial osteoclastic molecules, including phospho-p38, c-Jun, NFATc1, TRAP and CTSK. Contrarily, ZAS3 silencing by siRNA inhibited osteoclastogenesis. Co-immunoprecipitation experiments demonstrated that ZAS3 associated with TRAF6, the major receptor associated molecule in RANK signaling. Furthermore, EMSA suggested that nuclear ZAS3 could regulate transcription by binding to gene regulatory elements. Conclusion/Significance: Collectively, the data suggested a novel role of ZAS3 as a positive regulator of osteoclast differentiation. ZAS3 deficiency caused increased bone mass, at least in part due to decreased osteoclast formation and bone resorption. These functions of ZAS3 were mediated via activation of multiple intracellular targets. In the cytoplasmic compartment, ZAS3 associated with TRAF6 to control NF-kB and MAP kinase signaling cascades. Nuclear ZAS3 acted as a transcriptional regulator for osteoclast-associated genes. Additionally, ZAS3 activated NFATc1 required for the integration of RANK signaling in the terminal differentiation of osteoclasts. Thus, ZAS3 was a crucial molecule in osteoclast differentiation, which might potentially serve as a target in the design of therapeutic interventions for the treatment of bone diseases related to increased osteoclast activity such as postmenopausal osteoporosis, Paget's disease, and rheumatoid arthritis.	[Liu, Shujun; Madiai, Francesca; Hackshaw, Kevin V.; Marcucci, Guido; Wu, Lai-Chu] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Liu, Shujun; Hickey, Christopher J.; Marcucci, Guido; Yu, Jianhua; Caligiuri, Michael A.; Wu, Lai-Chu] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Allen, Carl E.; Hickey, Christopher J.; Wu, Lai-Chu] Ohio State Univ, Mol & Cellular Dev Biol Grad Program, Columbus, OH 43210 USA; [Carl, Joseph; Huschart, Emily; Wu, Lai-Chu] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Karanfilov, Chris] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Litsky, Alan] Ohio State Univ, Dept Orthopaed, Columbus, OH 43210 USA; [Litsky, Alan] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Huja, Sarandeep] Ohio State Univ, Div Orthodont, Columbus, OH 43210 USA; [Agarwal, Sudha] Ohio State Univ, Div Oral Biol, Biomech & Tissue Engn Lab, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liu, SJ (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	laichu.wu@osumc.edu	Litsky, Alan S/E-3523-2011; Wu, Lai-Chu/E-4328-2011; Huja, Sarandeep/I-6234-2016	Wu, Lai-Chu/0000-0002-1348-269X; Huja, Sarandeep/0000-0002-4617-5055	National Cancer Institute [P30 CA16058]; Columbus Medical Research Foundation; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Columbus Medical Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a grant P30 CA16058 from the National Cancer Institute and by grants from the Columbus Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CE, 2007, GENE EXPRESSION, V14, P83, DOI 10.3727/105221607783417574; ALLEN CE, 2004, ZINC FINGER PROTEINS, P233; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Baldridge D, 2010, ANNU REV GENOM HUM G, V11, P189, DOI 10.1146/annurev-genom-082908-150158; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Dorflinger U, 1999, MOL CELL BIOL, V19, P3736; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hjelmsoe I, 2000, J BIOL CHEM, V275, P913, DOI 10.1074/jbc.275.2.913; Hong JW, 2003, P NATL ACAD SCI USA, V100, P12301, DOI 10.1073/pnas.2133048100; Hu R, 2007, MOL CELL BIOL, V27, P4018, DOI 10.1128/MCB.01839-06; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Liang J, 2003, DEVELOPMENT, V130, P6453, DOI 10.1242/dev.00863; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; MAKINO R, 1994, NUCLEIC ACIDS RES, V22, P5679, DOI 10.1093/nar/22.25.5679; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; Nakabayashi Y, 1994, J Arthroplasty, V9, P307, DOI 10.1016/0883-5403(94)90086-8; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Oukka M, 2004, J EXP MED, V199, P15, DOI 10.1084/jem.20030421; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Wu LC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-4; Wu LC, 2002, GENE EXPRESSION, V10, P137, DOI 10.3727/000000002783992479; WU LC, 1993, NUCLEIC ACIDS RES, V21, P5067, DOI 10.1093/nar/21.22.5067; Yakovich AJ, 2011, CELL SIGNAL, V23, P105, DOI 10.1016/j.cellsig.2010.08.009; Yang X, 2005, J BIOL CHEM, V280, P18710, DOI 10.1074/jbc.M500859200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	36	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17161	10.1371/journal.pone.0017161	http://dx.doi.org/10.1371/journal.pone.0017161			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390242	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200010
J	Stankiewicz, E; Prowse, DM; Ng, M; Cuzick, J; Mesher, D; Hiscock, F; Lu, YJ; Watkin, N; Corbishley, C; Lam, W; Berney, DM				Stankiewicz, Elzbieta; Prowse, David M.; Ng, Mansum; Cuzick, Jack; Mesher, David; Hiscock, Frances; Lu, Yong-Jie; Watkin, Nicholas; Corbishley, Catherine; Lam, Wayne; Berney, Daniel M.			Alternative HER/PTEN/Akt Pathway Activation in HPV Positive and Negative Penile Carcinomas	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMAS; HUMAN-PAPILLOMAVIRUS; RECEPTOR FAMILY; CANCER PATIENTS; IN-SITU; EXPRESSION; EGFR; CARCINOGENESIS; THERAPY	Background: The pathogenesis of penile squamous cell carcinoma (PSCC) is not well understood, though risk factors include human papillomavirus (HPV). Disruption of HER/PTEN/Akt pathway is present in many cancers; however there is little information on its function in PSCC. We investigated HER family receptors and phosphatase and tension homolog (PTEN) in HPV-positive and negative PSCC and its impact on Akt activation using immunohistochemistry and fluorescent in situ hybridisation (FISH). Methodology/Principal Findings: 148 PSCCs were microarrayed and immunostained for phosphorylated EGFR (pEGFR), HER2, HER3, HER4, phosphorylated Akt (pAkt), Akt1 and PTEN proteins. EGFR and PTEN gene status were also evaluated using FISH. HPV presence was assessed by PCR. pEGFR expression was detected significantly less frequently in HPV-positive than HPV-negative tumours (p = 0.0143). Conversely, HER3 expression was significantly more common in HPV-positive cases (p = 0.0128). HER4, pAkt, Akt and PTEN protein expression were not related to HPV. HER3 (p = 0.0054) and HER4 (p = 0.0002) receptors significantly correlated with cytoplasmic Akt1 immunostaining. All three proteins positively correlated with tumour grade (HER3, p = 0.0029; HER4, p = 0.0118; Akt1, p = 0.0001). pEGFR expression correlated with pAkt but not with tumour grade or stage. There was no EGFR gene amplification. HER2 was not detected. PTEN protein expression was reduced or absent in 62% of tumours but PTEN gene copy loss was present only in 4% of PSCCs. Conclusions/Significance: EGFR, HER3 and HER4 but not HER2 are associated with penile carcinogenesis. HPV-negative tumours tend to express significantly more pEGFR than HPV-positive cancers and this expression correlates with pAkt protein, indicating EGFR as an upstream regulator of Akt signalling in PSCC. Conversely, HER3 expression is significantly more common in HPV-positive cases and positively correlates with cytoplasmic Akt1 expression. HER4 and PTEN protein expression are not related to HPV infection. Our results suggest that PSCC patients could benefit from therapies developed to target HER receptors.	[Stankiewicz, Elzbieta; Prowse, David M.; Ng, Mansum; Hiscock, Frances; Lu, Yong-Jie; Berney, Daniel M.] Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England; [Cuzick, Jack; Mesher, David] Queen Mary Univ London, Canc Res UK Ctr Epidemiol Math & Stat, Wolfson Inst Prevent Med, Barts & London Sch Med & Dent, London, England; [Watkin, Nicholas] St George Hosp, Dept Urol, London, England; [Corbishley, Catherine; Lam, Wayne] St George Hosp, Dept Cellular Pathol, London, England	University of London; Queen Mary University London; Cancer Research UK; University of London; Queen Mary University London; St Georges University London; St Georges University London	Stankiewicz, E (corresponding author), Queen Mary Univ London, Ctr Mol Oncol & Imaging, Inst Canc, Barts & London Sch Med & Dent, London, England.	e.stankiewicz@qmul.ac.uk		Stankiewicz, Elzbieta/0000-0003-0812-4086; Berney, Daniel/0000-0001-5474-8696; Lu, Yong-Jie/0000-0001-6174-6621; Mesher, David/0000-0001-9163-6757	Jean Shanks Foundation; Orchid Cancer Appeal	Jean Shanks Foundation; Orchid Cancer Appeal	This work was funded by a grant from the Jean Shanks Foundation, http://www.jeanshanksfoundation.org and Orchid Cancer Appeal, http://www.orchid-cancer.org.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2008, J UROLOGY, V179, P2030, DOI 10.1016/j.juro.2007.12.040; Arteaga CL, 2003, CLIN CANCER RES, V9, P1579; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Borgermann C, 2009, UROLOGE, V48, P1483, DOI 10.1007/s00120-009-2101-6; Bose S, 2002, HUM PATHOL, V33, P405, DOI 10.1053/hupa.2002.124721; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Chow NH, 2001, CLIN CANCER RES, V7, P1957; CUBILLA LC, 2004, STERNBERGS DIAGNOSTI, P2233; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; Earp H Shelton 3rd, 2003, Trans Am Clin Climatol Assoc, V114, P315; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Hirsch FR, 2008, J CLIN ONCOL, V26, P3351, DOI 10.1200/JCO.2007.14.0111; Hsieh AC, 2007, BRIT J CANCER, V97, P453, DOI 10.1038/sj.bjc.6603910; Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x; Kong CS, 2009, INT J RADIAT ONCOL, V74, P553, DOI 10.1016/j.ijrobp.2009.02.015; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kountourakis P, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-46; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Lavens N, 2010, CURR ONCOL, V17, P8; Le Page C, 2006, BRIT J CANCER, V94, P1906, DOI 10.1038/sj.bjc.6603184; Lee CM, 2005, GYNECOL ONCOL, V99, P415, DOI 10.1016/j.ygyno.2005.05.045; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Mayer TJ, 2000, IN VITRO CELL DEV-AN, V36, P667; Ming M, 2009, J INVEST DERMATOL, V129, P2109, DOI 10.1038/jid.2009.79; NARAYANA AS, 1982, CANCER, V49, P2185, DOI 10.1002/1097-0142(19820515)49:10<2185::AID-CNCR2820491034>3.0.CO;2-M; Narisawa-Saito M, 2007, ONCOGENE, V26, P2988, DOI 10.1038/sj.onc.1210118; Planchon SM, 2008, J CELL SCI, V121, P249, DOI 10.1242/jcs.022459; Prowse DM, 2008, BRIT J DERMATOL, V158, P261, DOI 10.1111/j.1365-2133.2007.08305.x; QUINN AG, 1994, CANCER RES, V54, P4756; Razis E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-234; Reimers N, 2007, INT J CANCER, V120, P1731, DOI 10.1002/ijc.22355; Robinson D, 2009, BRIT J CANCER, V100, P527, DOI 10.1038/sj.bjc.6604871; Rubin MA, 2001, AM J PATHOL, V159, P1211, DOI 10.1016/S0002-9440(10)62506-0; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; Sobin, 2009, UICC TNM CLASSIFICAT; STANKIEWICZ E, 2010, HISTOPATHOLOGY; Stankiewicz E, 2009, MODERN PATHOL, V22, P1160, DOI 10.1038/modpathol.2009.77; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Webster KA, 2004, CIRC RES, V94, P856, DOI 10.1161/01.RES.0000126699.49835.5D; Zhang BY, 2005, ONCOGENE, V24, P2585, DOI 10.1038/sj.onc.1208453	44	63	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17517	10.1371/journal.pone.0017517	http://dx.doi.org/10.1371/journal.pone.0017517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407808	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300031
J	Lara-Ramirez, EE; Segura-Cabrera, A; Guo, XW; Yu, GX; Garcia-Perez, CA; Rodriguez-Perez, MA				Eduardo Lara-Ramirez, Edgar; Segura-Cabrera, Aldo; Guo, Xianwu; Yu, Gongxin; Armando Garcia-Perez, Carlos; Rodriguez-Perez, Mario A.			New Implications on Genomic Adaptation Derived from the Helicobacter pylori Genome Comparison	PLOS ONE			English	Article							RICH PROTEIN-A; FRUITING BODY MORPHOGENESIS; PHASE VARIATION; REPLICATION ORIENTATION; SEQUENCE ALIGNMENT; C-SIGNAL; GENE; LIPOPOLYSACCHARIDE; RECOMBINATION; INFECTION	Background: Helicobacter pylori has a reduced genome and lives in a tough environment for long-term persistence. It evolved with its particular characteristics for biological adaptation. Because several H. pylori genome sequences are available, comparative analysis could help to better understand genomic adaptation of this particular bacterium. Principal Findings: We analyzed nine H. pylori genomes with emphasis on microevolution from a different perspective. Inversion was an important factor to shape the genome structure. Illegitimate recombination not only led to genomic inversion but also inverted fragment duplication, both of which contributed to the creation of new genes and gene family, and further, homological recombination contributed to events of inversion. Based on the information of genomic rearrangement, the first genome scaffold structure of H. pylori last common ancestor was produced. The core genome consists of 1186 genes, of which 22 genes could particularly adapt to human stomach niche. H. pylori contains high proportion of pseudogenes whose genesis was principally caused by homopolynucleotide (HPN) mutations. Such mutations are reversible and facilitate the control of gene expression through the change of DNA structure. The reversible mutations and a quasi-panmictic feature could allow such genes or gene fragments frequently transferred within or between populations. Hence, pseudogenes could be a reservoir of adaptation materials and the HPN mutations could be favorable to H. pylori adaptation, leading to HPN accumulation on the genomes, which corresponds to a special feature of Helicobacter species: extremely high HPN composition of genome. Conclusion: Our research demonstrated that both genome content and structure of H. pylori have been highly adapted to its particular life style.	[Eduardo Lara-Ramirez, Edgar; Segura-Cabrera, Aldo; Guo, Xianwu; Rodriguez-Perez, Mario A.] Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa, Mexico; [Yu, Gongxin] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Armando Garcia-Perez, Carlos] Univ Salamanca, Fac Ciencias, Dept Informat & Automat, E-37008 Salamanca, Spain	Instituto Politecnico Nacional - Mexico; Idaho; Boise State University; University of Salamanca	Lara-Ramirez, EE (corresponding author), Inst Politecn Nacl, Ctr Biotecnol Genom, Reynosa, Mexico.	gxianwu@yahoo.com	Guo, Xianwu/D-6709-2018; Perez, Mario A. Rodriguez/AAH-3572-2020; Rodriguez-Perez, Mario A./P-8814-2014	Perez, Mario A. Rodriguez/0000-0002-0905-6073; Rodriguez-Perez, Mario A./0000-0002-0905-6073; Segura-Cabrera, Aldo/0000-0003-3044-8028; Lara-Ramirez, Edgar E./0000-0001-7112-3233	Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional, Mexico [20080390, 20091288]; Consejo Nacional de Ciencia y Tecnologia-Mexico [87935]; Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional	Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional, Mexico; Consejo Nacional de Ciencia y Tecnologia-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional	This work was supported by Secretaria de Investigacion y Posgrado del Instituto Politecnico Nacional, Mexico (http://www.sip.ipn.mx/WPS/WCM/CONNECT/SIP/SIP/INICIO/INDEX.HTM) (Grant numbers: 20080390 and 20091288) and by the Consejo Nacional de Ciencia y Tecnologia-Mexico (http://www.conacyt.gob.mx/convocatorias/Paginas/default.aspx) (Fondo Sectorial de Investigacion en Salud y Seguridad Social SSA/IMSS/ISSSTE with grant number: 87935). There are no current external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Mrs. Marisa Rodriguez Padilla, Mrs. Angeles Moreno, and Mrs. Rosa M. Ocampo for helping in information collection. Alfredo Eduardo Velez Aguirre for computer technique help. Xianwu Guo and Mario A. Rodriguez-Perez hold a scholarship from Comision de Operacion y Fomento de Actividades Academicas/Instituto Politecnico Nacional.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Appelmelk BJ, 1999, INFECT IMMUN, V67, P5361, DOI 10.1128/IAI.67.10.5361-5366.1999; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Aras RA, 2003, P NATL ACAD SCI USA, V100, P13579, DOI 10.1073/pnas.1735481100; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Bourque G, 2002, GENOME RES, V12, P26; CRIVELLONE MD, 1994, J BIOL CHEM, V269, P21284; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Devi SM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-184; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; DUBOIS A, 1995, J CLIN MICROBIOL, V33, P1492, DOI 10.1128/JCM.33.6.1492-1495.1995; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; EATON KA, 1991, INFECT IMMUN, V59, P2470, DOI 10.1128/IAI.59.7.2470-2475.1991; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisen JA, 2000, GENOME BIOL, V1; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Farnbacher M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-335; FISCHER W, 2010, NUCL ACIDS RES; Flores M, 2007, P NATL ACAD SCI USA, V104, P6099, DOI 10.1073/pnas.0701631104; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Guo XW, 2003, GENOME RES, V13, P1810, DOI 10.1101/gr.1260903; Hofreuter D, 2003, INT J MED MICROBIOL, V293, P153, DOI 10.1078/1438-4221-00258; Hofreuter D, 1998, MOL MICROBIOL, V28, P1027, DOI 10.1046/j.1365-2958.1998.00879.x; Jelsbak L, 1999, P NATL ACAD SCI USA, V96, P5031, DOI 10.1073/pnas.96.9.5031; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kruse T, 2001, MOL MICROBIOL, V40, P156, DOI 10.1046/j.1365-2958.2001.02365.x; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Langdon R, 2005, J MED MICROBIOL, V54, P697, DOI 10.1099/jmm.0.45842-0; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lin LF, 2001, P NATL ACAD SCI USA, V98, P2740, DOI 10.1073/pnas.051612298; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; McClain MS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-3; Mittl PRE, 2003, CLIN DIAGN LAB IMMUN, V10, P542, DOI 10.1128/CDLI.10.4.542-545.2003; Mittl PRE, 2000, J BIOL CHEM, V275, P17693, DOI 10.1074/jbc.M001869200; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Oleastro M, 2010, J BACTERIOL, V192, P3961, DOI 10.1128/JB.00395-10; Persson B, 1999, ADV EXP MED BIOL, V463, P373; PETES TD, 1988, ANNU REV GENET, V22, P147, DOI 10.1146/annurev.ge.22.120188.001051; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Salaun L, 2004, MICROBIOL-SGM, V150, P817, DOI 10.1099/mic.0.26993-0; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schlieben NH, 2005, J MOL BIOL, V349, P801, DOI 10.1016/j.jmb.2005.04.029; Schreiber S, 2005, INFECT IMMUN, V73, P1584, DOI 10.1128/IAI.73.3.1584-1589.2005; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; Solnick JV, 2003, J CLIN MICROBIOL, V41, P5511, DOI 10.1128/JCM.41.12.5511-5516.2003; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tannaes T, 2001, INFECT IMMUN, V69, P7334, DOI 10.1128/IAI.69.12.7334-7340.2001; Thiberge JM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-368; Tillier ERM, 2000, J MOL EVOL, V51, P459, DOI 10.1007/s002390010108; Tillier ERM, 2000, J MOL EVOL, V50, P249, DOI 10.1007/s002399910029; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Yamaoka Y, 2002, FEBS LETT, V517, P180, DOI 10.1016/S0014-5793(02)02617-0; Yu GX, 2007, NUCLEIC ACIDS RES, V35, P3953, DOI 10.1093/nar/gkm377	64	15	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17300	10.1371/journal.pone.0017300	http://dx.doi.org/10.1371/journal.pone.0017300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387011	Green Published, gold			2022-12-27	WOS:000287931400052
J	Vilares, I; Dam, G; Kording, K				Vilares, Iris; Dam, Gregory; Kording, Konrad			Trust and Reciprocity: Are Effort and Money Equivalent?	PLOS ONE			English	Article							INTERPERSONAL-TRUST; EXCHANGE; GAME; COOPERATION; PERFORMANCE; REPUTATION; FAIRNESS; BEHAVIOR; RISK	Trust and reciprocity facilitate cooperation and are relevant to virtually all human interactions. They are typically studied using trust games: one subject gives (entrusts) money to another subject, which may return some of the proceeds (reciprocate). Currently, however, it is unclear whether trust and reciprocity in monetary transactions are similar in other settings, such as physical effort. Trust and reciprocity of physical effort are important as many everyday decisions imply an exchange of physical effort, and such exchange is central to labor relations. Here we studied a trust game based on physical effort and compared the results with those of a computationally equivalent monetary trust game. We found no significant difference between effort and money conditions in both the amount trusted and the quantity reciprocated. Moreover, there is a high positive correlation in subjects' behavior across conditions. This suggests that trust and reciprocity may be character traits: subjects that are trustful/trustworthy in monetary settings behave similarly during exchanges of physical effort. Our results validate the use of trust games to study exchanges in physical effort and to characterize inter-subject differences in trust and reciprocity, and also suggest a new behavioral paradigm to study these differences.	[Vilares, Iris; Dam, Gregory; Kording, Konrad] Northwestern Univ, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Vilares, Iris; Dam, Gregory; Kording, Konrad] Northwestern Univ, Rehabil Inst Chicago, Dept Physiol, Chicago, IL 60611 USA; [Vilares, Iris; Dam, Gregory; Kording, Konrad] Northwestern Univ, Rehabil Inst Chicago, Dept Appl Math, Chicago, IL 60611 USA; [Vilares, Iris] Inst Gulbenkian Ciencias, Int Neurosci Doctoral Programme, Champalimaud Neurosci Programme, Oeiras, Portugal	Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab; Northwestern University; Shirley Ryan AbilityLab; Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Vilares, I (corresponding author), Northwestern Univ, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA.	iris-vilares@northwestern.edu	Kording, Konrad P/A-1233-2007	Kording, Konrad P/0000-0001-8408-4499; Dam, Gregory/0000-0002-8370-1632; Vilares, Iris/0000-0003-1500-3864	Fundacao Calouste Gulbenkian; Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia [SFRH/BD/33272/2007]; National Institutes of Health (NIH) [R01NS057814, K12GM088020, 1R01NS063399]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399, R01NS057814] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian(European Commission); Fundacao Champalimaud; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors wish to thank the International Neuroscience Doctoral Program, Portugal (sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud and Fundacao para a Ciencia e Tecnologia; SFRH/BD/33272/2007), and the National Institutes of Health (NIH) grants R01NS057814, K12GM088020 and 1R01NS063399 for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Burks SV, 2003, J ECON BEHAV ORGAN, V51, P195, DOI 10.1016/S0167-2681(02)00093-8; Camerer C, 2002, MEASURING SOCIAL NOR; Camerer CF, 2003, TRENDS COGN SCI, V7, P225, DOI 10.1016/S1364-6613(03)00094-9; Cesarini D, 2008, P NATL ACAD SCI USA, V105, P3721, DOI 10.1073/pnas.0710069105; Dirks KT, 2001, ORGAN SCI, V12, P450, DOI 10.1287/orsc.12.4.450.10640; Dirks KT, 1999, J APPL PSYCHOL, V84, P445, DOI 10.1037/0021-9010.84.3.445; Evans AM, 2008, J RES PERS, V42, P1585, DOI 10.1016/j.jrp.2008.07.011; Fahr R, 2000, ECON LETT, V66, P275, DOI 10.1016/S0165-1765(99)00236-0; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 1997, ECONOMETRICA, V65, P833, DOI 10.2307/2171941; Fehr E., 2003, NATION WIDE LAB EXAM; Fehr E, 2004, J EUR ECON ASSOC, V2, DOI 10.1162/1542476042782297; FREY BS, 1993, ECON INQ, V31, P663, DOI 10.1111/j.1465-7295.1993.tb00897.x; Gachter S, 2002, SCAND J ECON, V104, P1, DOI 10.1111/1467-9442.00269; Gambetta D, 2000, TRUST MAKING BREAKIN; GLAESER EL, 1999, WHAT IS SOCIAL CAPIT; Guseva A, 2001, AM SOCIOL REV, V66, P623, DOI 10.2307/3088951; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; KLIMOSKI RJ, 1976, J APPL PSYCHOL, V61, P630, DOI 10.1037/0021-9010.61.5.630; Knack S, 1997, Q J ECON, V112, P1251, DOI 10.1162/003355300555475; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Krueger D. W., 1986, LAST TABOO MONEY SYM, P3, DOI DOI 10.1176/PS.38.1.84; Krueger F, 2007, P NATL ACAD SCI USA, V104, P20084, DOI 10.1073/pnas.0710103104; Maloney L.T., 2007, INTEGRATED MODELS CO, P297, DOI [10.1093/acprof:oso/9780195189193.003.0021, DOI 10.1093/ACPROF:OSO/9780195189193.003.0021, https://doi.org/10.1093/acprof:oso/9780195189193.003.0021]; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Meyerson D., 1996, TRUST ORG FRONTIERS, P166, DOI [10.4135/9781452243610.n9, DOI 10.4135/9781452243610.N9]; Miller G, 2005, SCIENCE, V308, P36; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; van Dijk F, 2001, EUR ECON REV, V45, P187, DOI 10.1016/S0014-2921(00)00056-8; WILLIAMS KD, 1991, J PERS SOC PSYCHOL, V61, P570, DOI 10.1037/0022-3514.61.4.570; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	37	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17113	10.1371/journal.pone.0017113	http://dx.doi.org/10.1371/journal.pone.0017113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726YS	21364931	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100028
J	Srougi, MC; Burridge, K				Srougi, Melissa C.; Burridge, Keith			The Nuclear Guanine Nucleotide Exchange Factors Ect2 and Net1 Regulate RhoB-Mediated Cell Death after DNA Damage	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; HUMAN-BREAST-CANCER; GTPASE RHOB; INDUCED APOPTOSIS; EXPRESSION; PROTEINS; ACTIVATION; ONCOGENE; AKT; BIM	Commonly used antitumor treatments, including radiation and chemotherapy, function by damaging the DNA of rapidly proliferating cells. However, resistance to these agents is a predominant clinical problem. A member of the Rho family of small GTPases, RhoB has been shown to be integral in mediating cell death after ionizing radiation (IR) or other DNA damaging agents in Ras-transformed cell lines. In addition, RhoB protein expression increases after genotoxic stress, and loss of RhoB expression causes radio-and chemotherapeutic resistance. However, the signaling pathways that govern RhoB-induced cell death after DNA damage remain enigmatic. Here, we show that RhoB activity increases in human breast and cervical cancer cell lines after treatment with DNA damaging agents. Furthermore, RhoB activity is necessary for DNA damage-induced cell death, as the stable loss of RhoB protein expression using shRNA partially protects cells and prevents the phosphorylation of c-Jun N-terminal kinases (JNKs) and the induction of the pro-apoptotic protein Bim after IR. The increase in RhoB activity after genotoxic stress is associated with increased activity of the nuclear guanine nucleotide exchange factors (GEFs), Ect2 and Net1, but not the cytoplasmic GEFs p115 RhoGEF or Vav2. Importantly, loss of Ect2 and Net1 via siRNA-mediated protein knock-down inhibited IR-induced increases in RhoB activity, reduced apoptotic signaling events, and protected cells from IR-induced cell death. Collectively, these data suggest a mechanism involving the nuclear GEFs Ect2 and Net1 for activating RhoB after genotoxic stress, thereby facilitating cell death after treatment with DNA damaging agents.	[Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Srougi, MC (corresponding author), Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	melissa_srougi@med.unc.edu		Srougi, Melissa/0000-0003-2183-0233	National Institutes of Health [GM029860]; American Cancer Society [PF-09-048-01-GMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health Grant GM029860 (to K.B.). M.C.S. is supported by the American Cancer Society Postdoctoral Fellowship PF-09-048-01-GMC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, CLIN CANCER RES, V8, P2225; Aghajanian A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008045; Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bentle MS, 2007, CANCER RES, V67, P6936, DOI 10.1158/0008-5472.CAN-07-0935; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; CARMICHAEL J, 1989, EUR J CANCER CLIN ON, V25, P527, DOI 10.1016/0277-5379(89)90266-6; Chan AML, 1996, ONCOGENE, V12, P1259; DECREMOUX P, 1994, INT J CANCER, V59, P408, DOI 10.1002/ijc.2910590320; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Ellerbroek SM, 2004, MOL BIOL CELL, V15, P3309, DOI 10.1091/mbc.E04-02-0146; Engel ME, 1998, J BIOL CHEM, V273, P9921, DOI 10.1074/jbc.273.16.9921; Forget MA, 2002, CLIN EXP METASTAS, V19, P9, DOI 10.1023/A:1013884426692; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fritz G, 2001, J BIOL CHEM, V276, P3115, DOI 10.1074/jbc.M005058200; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 2002, BIOCHEM J, V366, P393, DOI 10.1042/BJ20020844; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Garcia-Mata R, 2007, MOL CELL BIOL, V27, P8683, DOI 10.1128/MCB.00157-07; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kim CH, 2010, BIOCHEM BIOPH RES CO, V391, P1182, DOI 10.1016/j.bbrc.2009.12.012; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kong JY, 2005, BIOCHEM CELL BIOL, V83, P608, DOI 10.1139/o05-066; Lee JJ, 2010, ONCOGENE, V29, P561, DOI 10.1038/onc.2009.355; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2000, MOL CELL BIOL, V20, P6105, DOI 10.1128/MCB.20.16.6105-6113.2000; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; ROCHLITZ CF, 1989, CANCER RES, V49, P357; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; Scoumanne A, 2006, CANCER RES, V66, P6271, DOI 10.1158/0008-5472.CAN-06-0121; Sunters A, 2006, CANCER RES, V66, P212, DOI 10.1158/0008-5472.CAN-05-1997; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Teramoto H, 1996, J BIOL CHEM, V271, P25731, DOI 10.1074/jbc.271.42.25731; Trapp T, 2001, MOL CELL NEUROSCI, V17, P883, DOI 10.1006/mcne.2001.0971; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Yang JY, 2006, INT J ONCOL, V29, P643	53	41	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17108	10.1371/journal.pone.0017108	http://dx.doi.org/10.1371/journal.pone.0017108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373644	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500033
J	Wang, QH; Li, FG; Zhang, X; Zhang, YG; Hou, YX; Zhang, SR; Wu, ZX				Wang, Qinghua; Li, Fuguang; Zhang, Xue; Zhang, Yongan; Hou, Yuxia; Zhang, Shengrui; Wu, Zhixia			Purification and Characterization of a CkTLP Protein from Cynanchum komarovii Seeds that Confers Antifungal Activity	PLOS ONE			English	Article							THAUMATIN-LIKE PROTEIN; PATHOGENESIS-RELATED PROTEINS; TRANSGENIC TOBACCO; VERTICILLIUM-DAHLIAE; MOLECULAR CHARACTERIZATION; ARABIDOPSIS-THALIANA; ENHANCES RESISTANCE; GENE-EXPRESSION; SALT STRESS; PLANTS	Background: Cynanchum komarovii Al Iljinski is a desert plant that has been used as analgesic, anthelminthic and antidiarrheal, but also as a herbal medicine to treat cholecystitis in people. We have found that the protein extractions from C. komarovii seeds have strong antifungal activity. There is strong interest to develop protein medication and antifungal pesticides from C. komarovii for pharmacological or other uses. Methodology/Principal Findings: An antifungal protein with sequence homology to thaumatin-like proteins (TLPs) was isolated from C. komarovii seeds and named CkTLP. The three-dimensional structure prediction of CkTLP indicated the protein has an acid cleft and a hydrophobic patch. The protein showed antifungal activity against fungal growth of Verticillium dahliae, Fusarium oxysporum, Rhizoctonia solani, Botrytis cinerea and Valsa mali. The full-length cDNA was cloned by RT-PCR and RACE-PCR according to the partial protein sequences obtained by nanoESI-MS/MS. The real-time PCR showed the transcription level of CkTLP had a significant increase under the stress of abscisic acid (ABA), salicylic acid (SA), methyl jasmonate (MeJA), NaCl and drought, which indicates that CkTLP may play an important role in response to abiotic stresses. Histochemical staining showed GUS activity in almost the whole plant, especially in cotyledons, trichomes and vascular tissues of primary root and inflorescences. The CkTLP protein was located in the extracellular space/cell wall by CkTLP:: GFP fusion protein in transgenic Arabidopsis. Furthermore, over-expression of CkTLP significantly enhanced the resistance of Arabidopsis against V. dahliae. Conclusions/Significance: The results suggest that the CkTLP is a good candidate protein or gene for contributing to the development of disease-resistant crops.	[Wang, Qinghua; Zhang, Xue; Zhang, Yongan; Hou, Yuxia; Zhang, Shengrui] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China; [Li, Fuguang; Wu, Zhixia] Chinese Acad Agr Sci, Cotton Res Inst, Anyang, Henan, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Wang, QH (corresponding author), China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.	lifug@cricaas.com.cn; houyuxia@cau.edu.cn	Wang, Qinghua/GVT-3252-2022		Genetically Modified Organism Breeding Major Project [2008ZX08005-002]; National Nature Science Foundation of China [31071751]; Ministry of Science and Technology, P.R. China [2008AA10Z127]	Genetically Modified Organism Breeding Major Project; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology, P.R. China(Ministry of Science and Technology, China)	This work was supported by the Genetically Modified Organism Breeding Major Project (grant no. 2008ZX08005-002), the Program of National Nature Science Foundation of China (grant no. 31071751) and State 863 Project funded by Ministry of Science and Technology (grant no. 2008AA10Z127) P.R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthakur S, 2001, J PLANT BIOCHEM BIOT, V10, P31, DOI 10.1007/BF03263103; Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; Campos MA, 2002, PHYSIOL MOL PLANT P, V61, P205, DOI 10.1006/pmpp.2002.0430; CARCIACASADO G, 2000, PHYSIOL PLANTARUM, V110, P172; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Chu KT, 2003, BIOCHEM BIOPH RES CO, V301, P364, DOI 10.1016/S0006-291X(02)02998-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fierens E, 2007, BIOCHEM J, V403, P583, DOI 10.1042/BJ20061291; Fierens E, 2009, J ENZYM INHIB MED CH, V24, P646, DOI 10.1080/14756360802321831; Futamura N, 2006, TREE PHYSIOL, V26, P51, DOI 10.1093/treephys/26.1.51; Grenier J, 1999, PLANT J, V19, P473, DOI 10.1046/j.1365-313X.1999.00551.x; Ho VSM, 2007, PEPTIDES, V28, P760, DOI 10.1016/j.peptides.2007.01.005; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Hu X, 1997, PLANT MOL BIOL, V34, P949, DOI 10.1023/A:1005893119263; Husaini AM, 2008, PLANT SCI, V174, P446, DOI 10.1016/j.plantsci.2008.01.007; Jayaraj J, 2004, BIOL PLANTARUM, V48, P425, DOI 10.1023/B:BIOP.0000041097.03177.2d; Jayasankar S, 2003, FUNCT PLANT BIOL, V30, P1105, DOI 10.1071/FP03066; Jung YC, 2005, PLANT CELL REP, V24, P366, DOI 10.1007/s00299-005-0944-x; Kombrink E., 1997, PLANT RELATIONSHIPS, DOI [10.1007/978-3-662-10370-8_7, DOI 10.1007/978-3-662-10370-8_7]; KUMAR V, 1992, PLANT MOL BIOL, V18, P621, DOI 10.1007/BF00040683; Kuwabara C, 2002, PHYSIOL PLANTARUM, V115, P101, DOI 10.1034/j.1399-3054.2002.1150112.x; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; LI YM, 2007, INNER MONGOLIA AGR S, V5, P94; Liu JJ, 2010, PLANT CELL REP, V29, P419, DOI 10.1007/s00299-010-0826-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackintosh CA, 2007, PLANT CELL REP, V26, P479, DOI 10.1007/s00299-006-0265-8; Munis MFH, 2010, BIOCHEM BIOPH RES CO, V393, P38, DOI 10.1016/j.bbrc.2010.01.069; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Parkhi V, 2009, MOL BREEDING, V23, P625, DOI 10.1007/s11032-009-9261-3; Pressey R, 1997, PHYTOCHEMISTRY, V44, P1241, DOI 10.1016/S0031-9422(96)00667-X; Rajam MV, 2007, BIOL PLANTARUM, V51, P135, DOI 10.1007/s10535-007-0026-8; ROBERTS WK, 1990, J GEN MICROBIOL, V136, P1771, DOI 10.1099/00221287-136-9-1771; Sassa H, 2002, PLANT MOL BIOL, V50, P371, DOI 10.1023/A:1019866029629; Schestibratov KA, 2005, SCI HORTIC-AMSTERDAM, V106, P177, DOI 10.1016/j.scienta.2005.03.016; Skadsen RW, 2000, PLANT SCI, V156, P11, DOI 10.1016/S0168-9452(00)00226-0; Tachi H, 2009, PLANT PHYSIOL BIOCH, V47, P73, DOI 10.1016/j.plaphy.2008.09.012; Tjamos SE, 2005, MOL PLANT MICROBE IN, V18, P555, DOI 10.1094/MPMI-18-0555; Van Damme EJM, 2002, PLANTA, V214, P853, DOI 10.1007/s00425-001-0713-1; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; VANDERWEL H, 1972, EUR J BIOCHEM, V31, P221; Wang HX, 2002, PHYTOCHEMISTRY, V61, P1, DOI 10.1016/S0031-9422(02)00144-9; Ye XY, 1999, BIOCHEM BIOPH RES CO, V263, P1002; Zhu L, 2007, J PLANT PATHOL, V89, P41	43	28	37	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16930	10.1371/journal.pone.0016930	http://dx.doi.org/10.1371/journal.pone.0016930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364945	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600026
J	Murdolo, G; Nowotny, B; Celi, F; Donati, M; Bini, V; Papi, F; Gornitzka, G; Castellani, S; Roden, M; Falorni, A; Herder, C; Falorni, A				Murdolo, Giuseppe; Nowotny, Bettina; Celi, Federica; Donati, Miranda; Bini, Vittorio; Papi, Francesco; Gornitzka, Gabi; Castellani, Serena; Roden, Michael; Falorni, Adriano; Herder, Christian; Falorni, Alberto			Inflammatory Adipokines, High Molecular Weight Adiponectin, and Insulin Resistance: A Population-Based Survey in Prepubertal Schoolchildren	PLOS ONE			English	Article							BODY-MASS INDEX; COOPERATIVE HEALTH RESEARCH; METABOLIC SYNDROME; OBESE CHILDREN; PLASMA LEPTIN; MONICA/KORA AUGSBURG; GENDER-DIFFERENCES; SCHOOL-CHILDREN; ADIPOSE-TISSUE; 3 PROVINCES	Background: The aim of this study was to investigate sex differences and associations of high molecular weight (HMW) adiponectin, leptin and proinflammatory adipokines, individually or in combinations, with adiposity and insulin resistance (IR) measures in prepubertal childhood. Methodology: We studied 305 prepubertal children (boys/girls: 144/161; Tanner stage 1; age: 5-13 yr), included in a cohort of 44,231 adolescents who participated in an extensive Italian school-based survey. According to Cole's criteria, 105 individuals were lean (L; boys/girls: 59/46), 60 overweight (OW; boys/girls: 32/28) and 140 obese (OB; boys/girls: 70/70). Measurements comprised total and HMW adiponectin, leptin, as well as a panel of proinflammatory adipokines/chemokines associated with diabetes risk. Principal Findings: Leptin-, and the leptin-to-HMW adiponectin ratio (L/HMW)-, increased progressively (p<0.0001) from L to OW to OB boys and girls. When compared with L peers, OW and OB girls exhibited lower (p<0.001) HMW adiponectin levels, while in boys the HMW multimers did not differ significantly across the BMI-stratified groups. OB girls displayed higher (p, 0.05) IL-8, IL-18, monocyte chemoattractant protein-1 (MCP-1) and soluble intercellular adhesion molecule-1 levels (sICAM-1) than L girls, whereas increased macrophage migration inhibitory factor (MIF) concentrations in OB vs OW boys were seen. HMW adiponectin (negatively), leptin or inflammatory markers (positively) correlated with adiposity and IR measures. In multivariate models, leptin represented a strong and independent determinant of HOMA-IR (R-2 0.378; p<0.01). Adjustment for age, BMIz-score, lipids and inflammatory mediators abolished the association between leptin and HOMA-IR in boys, while in girls leptin remained still a significant predictor of IR (R-2 0.513; p<0.01). Finally, in both sexes, the joint effect of the L/HMW did not improve the prediction of basal IR as compared with leptin levels alone, which were mainly explained by the BMIz-score. Conclusions: In prepubertal children, leptin emerges as a sex-independent discrimination marker of adiposity degree and as a useful, sex-associated predictor of the systemic insulin resistance.	[Murdolo, Giuseppe; Donati, Miranda; Bini, Vittorio; Falorni, Alberto] Univ Perugia, Dept Internal Med, Sect Internal Med Endocrine & Metab Sci, I-06100 Perugia, Italy; [Nowotny, Bettina; Gornitzka, Gabi; Roden, Michael; Herder, Christian] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Celi, Federica; Papi, Francesco; Castellani, Serena; Falorni, Adriano] Univ Perugia, Dept Surg Sci & Publ Hlth, Sect Pediat, I-06100 Perugia, Italy; [Roden, Michael] Univ Dusseldorf, Dept Metab Dis, Univ Clin, Dusseldorf, Germany	University of Perugia; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Perugia; Heinrich Heine University Dusseldorf	Murdolo, G (corresponding author), Univ Perugia, Dept Internal Med, Sect Internal Med Endocrine & Metab Sci, I-06100 Perugia, Italy.	gmurdolo@tiscalinet.it	Roden, Michael/AAD-3843-2019; Bini, Vittorio/AAA-1104-2019; Murdolo, Giuseppe/I-1812-2012; FALORNI, Alberto/E-5747-2011; Bini, Vittorio/F-5134-2010	Bini, Vittorio/0000-0001-8404-2918; FALORNI, Alberto/0000-0003-4532-3519; Bini, Vittorio/0000-0001-8404-2918; Nowotny, Bettina/0000-0002-0671-9644; Murdolo, Giuseppe/0000-0001-5654-1760	Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany)	Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany)	This work was partly supported by the Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science, Research and Technology of the state North Rhine-Westphalia (Dusseldorf, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Andersen KK, 2007, J CLIN ENDOCR METAB, V92, P1857, DOI 10.1210/jc.2006-2310; [Anonymous], 2004, PEDIATRICS, V114, P555; Araki S, 2006, J CLIN ENDOCR METAB, V91, P5113, DOI 10.1210/jc.2006-1051; Aygun AD, 2005, MEDIAT INFLAMM, P180, DOI 10.1155/MI.2005.180; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Celi F, 2003, EUR J CLIN NUTR, V57, P1045, DOI 10.1038/sj.ejcn.1601640; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Di Stefano G, 2000, INT J OBESITY, V24, P1586, DOI 10.1038/sj.ijo.0801448; Falorni A, 1998, INT J OBESITY, V22, P1197, DOI 10.1038/sj/ijo/0800746; Falorni A, 1997, INT J OBESITY, V21, P881, DOI 10.1038/sj.ijo.0800485; Finucane FM, 2009, DIABETOLOGIA, V52, P2345, DOI 10.1007/s00125-009-1508-3; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Herder C, 2006, DIABETOLOGIA, V49, P921, DOI 10.1007/s00125-006-0190-y; Herder C, 2006, EUR J ENDOCRINOL, V154, P311, DOI 10.1530/eje.1.02090; Herder C, 2006, DIABETES CARE, V29, P368, DOI 10.2337/diacare.29.02.06.dc05-1474; Herder C, 2005, GESUNDHEITSWESEN, V67, pS115, DOI 10.1055/s-2005-858252; Herder C, 2007, J CLIN ENDOCR METAB, V92, P4569, DOI 10.1210/jc.2007-0955; Herder C, 2006, DIABETES CARE, V29, P1626, DOI 10.2337/dc05-1900; Hung YJ, 2006, INT J CLIN PRACT, V60, P1582, DOI 10.1111/j.1742-1241.2006.00909.x; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Karakas M, 2009, ATHEROSCLEROSIS; Lee MJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE858, DOI 10.1152/ajpendo.00439.2006; Ley SH, 2008, DIABETES CARE, V31, P1410, DOI 10.2337/dc08-0036; Mangge H, 2008, OBESITY, V16, P2578, DOI 10.1038/oby.2008.439; MARTOSMORENO G, 2010, OBESITY; McNeely MJ, 1999, DIABETES CARE, V22, P65, DOI 10.2337/diacare.22.1.65; MURDOLO G, 2009, J CLIN ENDOCRINOL ME; Ong KK, 2006, DIABETES, V55, P1337, DOI 10.2337/db05-1272; Punthakee Z, 2006, J CLIN ENDOCR METAB, V91, P2119, DOI 10.1210/jc.2005-2346; Sabin MA, 2006, J CLIN ENDOCR METAB, V91, P332, DOI 10.1210/jc.2005-1571; Satoh N, 2004, DIABETES CARE, V27, P2488, DOI 10.2337/diacare.27.10.2488; Sbarbati A, 2006, PEDIATRICS, V117, P220, DOI 10.1542/peds.2004-2854; Thorand B, 2007, DIABETES CARE, V30, P854, DOI 10.2337/dc06-1693; Tsou PL, 2004, DIABETES CARE, V27, P308, DOI 10.2337/diacare.27.2.308; Valle M, 2005, DIABETES METAB, V31, P55, DOI 10.1016/S1262-3636(07)70167-2; Valle M, 2003, INT J OBESITY, V27, P13, DOI 10.1038/sj.ijo.0802154; Wallace AM, 2001, CIRCULATION, V104, P3052, DOI 10.1161/hc5001.101061; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Xie LL, 2008, BBA-MOL BASIS DIS, V1782, P99, DOI 10.1016/j.bbadis.2007.12.003	43	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17264	10.1371/journal.pone.0017264	http://dx.doi.org/10.1371/journal.pone.0017264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365005	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800041
J	Crawford, AD; Liekens, S; Kamuhabwa, AR; Maes, J; Munck, S; Busson, R; Rozenski, J; Esguerra, CV; de Witte, PAM				Crawford, Alexander D.; Liekens, Sandra; Kamuhabwa, Appolinary R.; Maes, Jan; Munck, Sebastian; Busson, Roger; Rozenski, Jef; Esguerra, Camila V.; de Witte, Peter A. M.			Zebrafish Bioassay-Guided Natural Product Discovery: Isolation of Angiogenesis Inhibitors from East African Medicinal Plants	PLOS ONE			English	Article							PROTEIN-KINASE CK2; IN-VIVO; TRANSGENIC ZEBRAFISH; VASCULAR DEVELOPMENT; GENETIC APPROACH; DRUG DISCOVERY; EMODIN; NEOVASCULARIZATION; GROWTH; CELLS	Natural products represent a significant reservoir of unexplored chemical diversity for early-stage drug discovery. The identification of lead compounds of natural origin would benefit from therapeutically relevant bioassays capable of facilitating the isolation of bioactive molecules from multi-constituent extracts. Towards this end, we developed an in vivo bioassay-guided isolation approach for natural product discovery that combines bioactivity screening in zebrafish embryos with rapid fractionation by analytical thin-layer chromatography (TLC) and initial structural elucidation by high-resolution electrospray mass spectrometry (HRESIMS). Bioactivity screening of East African medicinal plant extracts using fli-1: EGFP transgenic zebrafish embryos identified Oxygonum sinuatum and Plectranthus barbatus as inhibiting vascular development. Zebrafish bioassay-guided fractionation identified the active components of these plants as emodin, an inhibitor of the protein kinase CK2, and coleon A lactone, a rare abietane diterpenoid with no previously described bioactivity. Both emodin and coleon A lactone inhibited mammalian endothelial cell proliferation, migration, and tube formation in vitro, as well as angiogenesis in the chick chorioallantoic membrane (CAM) assay. These results suggest that the combination of zebrafish bioassays with analytical chromatography methods is an effective strategy for the rapid identification of bioactive natural products.	[Crawford, Alexander D.; Maes, Jan; Busson, Roger; Rozenski, Jef; Esguerra, Camila V.; de Witte, Peter A. M.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Leuven, Belgium; [Liekens, Sandra; Busson, Roger; Rozenski, Jef] Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Liekens, Sandra] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Kamuhabwa, Appolinary R.] Muhimbili Univ Hlth & Allied Sci, Dept Pharmacognosy, Dar Es Salaam, Tanzania; [Munck, Sebastian] Univ Leuven, Flanders Interuniv Inst Biotechnol, Dept Human Genet, Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven; Muhimbili University of Health & Allied Sciences; KU Leuven	Crawford, AD (corresponding author), Katholieke Univ Leuven, Dept Pharmaceut Sci, Leuven, Belgium.	alexander.crawford@pharm.kuleuven.be; peter.dewitte@pharm.kuleuven.be	Esguerra, Camila/N-6159-2015; Esguerra, Camila/D-7657-2014	Esguerra, Camila/0000-0002-2271-8094; Esguerra, Camila/0000-0001-7891-1427; Munck, Sebastian/0000-0002-5182-5358; Rozenski, Jef/0000-0001-9624-5536; de Witte, Peter/0000-0002-9989-9567	Industrieel Onderzoeksfonds [IOF-HB/06/018]; Centers of Excellence of the K. U. Leuven [EF-05/15]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [G. 0486.08]	Industrieel Onderzoeksfonds; Centers of Excellence of the K. U. Leuven; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	This work was funded in part by the Industrieel Onderzoeksfonds (IOF-HB/06/018) of K. U. Leuven, the Centers of Excellence of the K. U. Leuven (EF-05/15) and the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (G. 0486.08). Sandra Liekens is a postdoctoral researcher of the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMON HPT, 1985, PLANTA MED, V51, P473, DOI 10.1055/s-2007-969566; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Arbiser JL, 2007, BLOOD, V109, P560, DOI 10.1182/blood-2006-06-029934; Berger J, 2007, CURR MED CHEM, V14, P2413, DOI 10.2174/092986707781745532; Breyer-Brandwijk M.G., 1962, MED POISONOUS PLANTS, V2nd; Cao YH, 2009, SEMIN CANCER BIOL, V19, P338, DOI 10.1016/j.semcancer.2009.05.001; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cha Young Ryun, 2007, Birth Defects Research, V81, P286, DOI 10.1002/bdrc.20103; Chan J, 2002, CANCER CELL, V1, P257, DOI 10.1016/S1535-6108(02)00042-9; Choueiri TK, 2010, J CLIN ONCOL, V28, P2280, DOI 10.1200/JCO.2009.27.2757; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; del Valle-Perez B, 2004, FEBS LETT, V569, P105, DOI 10.1016/j.febslet.2004.05.058; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Driever W, 1996, DEVELOPMENT, V123, P37; Eimon PM, 2009, EXPERT OPIN DRUG MET, V5, P393, DOI [10.1517/17425250902882128 , 10.1517/17425250902882128]; Fong TAT, 1999, CANCER RES, V59, P99; Haffter P, 1996, DEVELOPMENT, V123, P1; He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033; He ZH, 2009, J ETHNOPHARMACOL, V121, P313, DOI 10.1016/j.jep.2008.11.008; Ivy SP, 2009, NAT REV CLIN ONCOL, V6, P569, DOI 10.1038/nrclinonc.2009.130; JAYASURIYA H, 1992, J NAT PROD, V55, P696, DOI 10.1021/np50083a026; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; JONES ROY W., 1957, TRANS AMER MICROSC SOC, V76, P177, DOI 10.2307/3223629; JONES RW, 1964, CANCER CHEMOTH REP, P19; Kidd KR, 2003, BRIT J PHARMACOL, V140, P585, DOI 10.1038/sj.bjp.0705496; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; KUNZLE JM, 1987, HELV CHIM ACTA, V70, P1911, DOI 10.1002/hlca.19870700726; Kwak HJ, 2006, INT J CANCER, V118, P2711, DOI 10.1002/ijc.21641; Lam HW, 2008, J CELL BIOCHEM, V103, P195, DOI 10.1002/jcb.21403; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liekens S, 2004, J BIOL CHEM, V279, P29598, DOI 10.1074/jbc.M402602200; Ljubimov AV, 2004, INVEST OPHTH VIS SCI, V45, P4583, DOI 10.1167/iovs.04-0686; Luesch H, 2006, NAT CHEM BIOL, V2, P158, DOI 10.1038/nchembio769; Lukhoba CW, 2006, J ETHNOPHARMACOL, V103, P1, DOI 10.1016/j.jep.2005.09.011; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nicoli S, 2007, CANCER RES, V67, P2927, DOI 10.1158/0008-5472.CAN-06-4268; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Patton EE, 2001, NAT REV GENET, V2, P956, DOI 10.1038/35103567; Peterson RT, 2004, NAT BIOTECHNOL, V22, P595, DOI 10.1038/nbt963; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Pueyo ME, 1998, EXP CELL RES, V238, P354, DOI 10.1006/excr.1997.3864; Rapisarda A, 2009, DRUG RESIST UPDATE, V12, P74, DOI 10.1016/j.drup.2009.03.002; Sachidanandan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001947; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Serbedzija G N, 1999, Angiogenesis, V3, P353, DOI 10.1023/A:1026598300052; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; TSOPANOGLOU NE, 1994, J VASC RES, V31, P195, DOI 10.1159/000159044; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang Xin-hua, 2004, Yaoxue Xuebao, V39, P254; Wennberg T, 2004, J LIQ CHROMATOGR R T, V27, P2573, DOI 10.1081/JLC-200028419; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; WIESINGE.D, 1974, EXPERIENTIA, V30, P135, DOI 10.1007/BF01927691; Wolfender JL, 2005, MAGN RESON CHEM, V43, P697, DOI 10.1002/mrc.1631; Yim H, 1999, PLANTA MED, V65, P9, DOI 10.1055/s-1999-13953; ZHANG LS, 1995, CANCER RES, V55, P3890; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	61	62	63	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14694	10.1371/journal.pone.0014694	http://dx.doi.org/10.1371/journal.pone.0014694			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379387	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300005
J	Zavada, A; Buckley, CL; Martinez, D; Rospars, JP; Nowotny, T				Zavada, Andrei; Buckley, Christopher L.; Martinez, Dominique; Rospars, Jean-Pierre; Nowotny, Thomas			Competition-Based Model of Pheromone Component Ratio Detection in the Moth	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS LEPIDOPTERA; LOCUST ANTENNAL LOBE; MANDUCA-SEXTA; SPHINX MOTH; CHEMICAL COMMUNICATION; HELIOTHIS-VIRESCENS; ODOR DISCRIMINATION; PROJECTION NEURONS; NEURAL ASSEMBLIES; AGROTIS-SEGETUM	For some moth species, especially those closely interrelated and sympatric, recognizing a specific pheromone component concentration ratio is essential for males to successfully locate conspecific females. We propose and determine the properties of a minimalist competition-based feed-forward neuronal model capable of detecting a certain ratio of pheromone components independently of overall concentration. This model represents an elementary recognition unit for the ratio of binary mixtures which we propose is entirely contained in the macroglomerular complex (MGC) of the male moth. A set of such units, along with projection neurons (PNs), can provide the input to higher brain centres. We found that (1) accuracy is mainly achieved by maintaining a certain ratio of connection strengths between olfactory receptor neurons (ORN) and local neurons (LN), much less by properties of the interconnections between the competing LNs proper. An exception to this rule is that it is beneficial if connections between generalist LNs (i.e. excited by either pheromone component) and specialist LNs (i.e. excited by one component only) have the same strength as the reciprocal specialist to generalist connections. (2) successful ratio recognition is achieved using latency-to-first-spike in the LN populations which, in contrast to expectations with a population rate code, leads to a broadening of responses for higher overall concentrations consistent with experimental observations. (3) when longer durations of the competition between LNs were observed it did not lead to higher recognition accuracy.	[Zavada, Andrei; Buckley, Christopher L.; Nowotny, Thomas] Univ Sussex, Brighton, E Sussex, England; [Martinez, Dominique] LORIA, CORTEX Team, Vandoeuvre Les Nancy, France; [Rospars, Jean-Pierre] INRA, Unite Phytopharm & Mediateurs Chim, F-78026 Versailles, France	University of Sussex; Universite de Lorraine; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Zavada, A (corresponding author), Univ Sussex, Brighton, E Sussex, England.	a.zavada@sussex.ac.uk	Nowotny, Thomas/C-3883-2012	Nowotny, Thomas/0000-0002-4451-915X; Buckley, Christopher L/0000-0002-8551-9121	Biotechnology and Biological Sciences Research Council [BB/F005113/1]; French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative; BBSRC [BB/F005113/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500315/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative(French National Research Agency (ANR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (grant number BB/F005113/1) within the French-British ANR BBSRC SysBio 006 01 "Pherosys'' initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTON S, 1994, J COMP NEUROL, V350, P199, DOI 10.1002/cne.903500205; AVRON E, 1995, BIOSYSTEMS, V36, P101, DOI 10.1016/0303-2647(95)01531-O; AvRon E, 1996, BIOSYSTEMS, V39, P241, DOI 10.1016/0303-2647(96)01620-6; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; CHRISTENSEN TA, 1989, CHEM SENSES, V14, P463, DOI 10.1093/chemse/14.3.463; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Christensen Thomas A., 1994, Progress in Zoology, V39, P37; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; Ditzen M, 2003, CHEM SENSES, V28, P781, DOI 10.1093/chemse/bjg070; Getz WM, 1999, CHEM SENSES, V24, P351, DOI 10.1093/chemse/24.4.351; HANSSON BS, 1995, J COMP PHYSIOL A, V177, P535, DOI 10.1007/BF00207183; Hansson BS, 2000, ANNU REV ENTOMOL, V45, P203, DOI 10.1146/annurev.ento.45.1.203; Heinbockel T, 1998, J COMP PHYSIOL A, V182, P703, DOI 10.1007/s003590050215; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Husch A, 2008, J NEUROPHYSIOL, V99, P320, DOI 10.1152/jn.00719.2007; Husch A, 2009, J NEUROPHYSIOL, V102, P2834, DOI 10.1152/jn.00627.2009; Husch A, 2009, J NEUROSCI, V29, P716, DOI 10.1523/JNEUROSCI.3677-08.2009; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; Kwok YC, 2007, THESIS U LEICESTER; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Linster C, 1994, J Comput Neurosci, V1, P231, DOI 10.1007/BF00961735; Linster C, 1996, CHEM SENSES, V21, P19, DOI 10.1093/chemse/21.1.19; LINSTER C, 1993, NEURAL COMPUT, V5, P228, DOI 10.1162/neco.1993.5.2.228; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; MATSUMOTO SG, 1981, PROC R SOC SER B-BIO, V213, P249, DOI 10.1098/rspb.1981.0066; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; PRESS WH, 1992, NUMERICAL RECIPES C, pCH15; Rabinovich M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.068102; SANES JR, 1976, DEV BIOL, V51, P282, DOI 10.1016/0012-1606(76)90144-5; SCHAFER S, 1986, J COMP NEUROL, V246, P287, DOI 10.1002/cne.902460302; Schneider D, 1970, NEUROSCIENCES 2ND ST, P511; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Todd Julie L., 1999, P67; TOTH M, 1992, J CHEM ECOL, V18, P1337, DOI 10.1007/BF00994360; Traub R.D., 1991, NEURONAL NETWORKS HI; TUMLINSON JH, 1989, ARCH INSECT BIOCHEM, V10, P255, DOI 10.1002/arch.940100402; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VICKERS NJ, 1991, J COMP PHYSIOL A, V169, P275; WALDROP B, 1987, J COMP PHYSIOL A, V161, P23, DOI 10.1007/BF00609452; Wu WQ, 1996, P NATL ACAD SCI USA, V93, P8022, DOI 10.1073/pnas.93.15.8022	47	15	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16308	10.1371/journal.pone.0016308	http://dx.doi.org/10.1371/journal.pone.0016308			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21373177	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700016
J	Morrison, WE; Hay, ME				Morrison, Wendy E.; Hay, Mark E.			Herbivore Preference for Native vs. Exotic Plants: Generalist Herbivores from Multiple Continents Prefer Exotic Plants That Are Evolutionarily Naive	PLOS ONE			English	Article							FRESH-WATER MACROPHYTES; ENEMY RELEASE; BIOTIC RESISTANCE; NATURAL ENEMIES; CHEMICAL DEFENSES; INVASIONS; INVASIVENESS; METAANALYSIS	Enemy release and biotic resistance are competing, but not mutually exclusive, hypotheses addressing the success or failure of non-native plants entering a new region. Enemy release predicts that exotic plants become invasive by escaping their co-adapted herbivores and by being unrecognized or unpalatable to native herbivores that have not been selected to consume them. In contrast, biotic resistance predicts that native generalist herbivores will suppress exotic plants that will not have been selected to deter these herbivores. We tested these hypotheses using five generalist herbivores from North or South America and nine confamilial pairs of native and exotic aquatic plants. Four of five herbivores showed 2.4-17.3 fold preferences for exotic over native plants. Three species of South American apple snails (Pomacea sp.) preferred North American over South American macrophytes, while a North American crayfish Procambarus spiculifer preferred South American, Asian, and Australian macrophytes over North American relatives. Apple snails have their center of diversity in South America, but a single species (Pomacea paludosa) occurs in North America. This species, with a South American lineage but a North American distribution, did not differentiate between South American and North American plants. Its preferences correlated with preferences of its South American relatives rather than with preferences of the North American crayfish, consistent with evolutionary inertia due to its South American lineage. Tests of plant traits indicated that the crayfish responded primarily to plant structure, the apple snails primarily to plant chemistry, and that plant protein concentration played no detectable role. Generalist herbivores preferred non-native plants, suggesting that intact guilds of native, generalist herbivores may provide biotic resistance to plant invasions. Past invasions may have been facilitated by removal of native herbivores, introduction of non-native herbivores (which commonly prefer native plants), or both.	[Morrison, Wendy E.; Hay, Mark E.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Morrison, WE (corresponding author), Natl Marine Fisheries Serv, Natl Ocean & Atmospher Adm NOAA, Silver Spring, MD 20910 USA.	mark.hay@biology.gatech.edu	Morrison, Wendy/G-1322-2012; Hay, Mark E/D-9752-2011	Hay, Mark E/0000-0002-6130-9349	National Science Foundation; Harry and Linda Teasley endowment	National Science Foundation(National Science Foundation (NSF)); Harry and Linda Teasley endowment	Support provided via the National Science Foundation (Integrative Graduate Education and Research Traineeship Program) and the Harry and Linda Teasley endowment to Georgia Tech. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Best RJ, 2009, OECOLOGIA, V159, P139, DOI 10.1007/s00442-008-1172-1; Bolser RC, 1998, OECOLOGIA, V116, P143, DOI 10.1007/s004420050573; Bolser RC, 1998, J CHEM ECOL, V24, P1639, DOI 10.1023/A:1020816511924; Byrnes JE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000295; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Cappuccino N, 2005, BIOL LETTERS, V1, P435, DOI 10.1098/rsbl.2005.0341; Cappuccino N, 2006, BIOL LETTERS, V2, P189, DOI 10.1098/rsbl.2005.0433; Carlsson NOL, 2004, ECOLOGY, V85, P1575, DOI 10.1890/03-3146; Carpenter D, 2005, J ECOL, V93, P315, DOI 10.1111/j.1365-2745.2005.00973.x; *CMNH, 2009, GERMPLASM RESOURCE I; *CMNH, 2009, CARN MUS NAT HIST GL; Crawley M.J., 1989, P45; Cronin G, 2002, J CRUSTACEAN BIOL, V22, P708, DOI 10.1651/0278-0372(2002)022[0708:CFPFFM]2.0.CO;2; Dawson W, 2009, DIVERS DISTRIB, V15, P141, DOI 10.1111/j.1472-4642.2008.00527.x; Eschtruth AK, 2009, ECOL MONOGR, V79, P265, DOI 10.1890/08-0221.1; HAY M. E., 1998, METHODS CHEM ECOLOGY, V2, P39; Hay Mark E., 1992, P371; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KR, 2008, BIOL INVASIONS, V10, P483, DOI 10.1007/s10530-007-9146-5; Hill SB, 2009, OECOLOGIA, V161, P581, DOI 10.1007/s00442-009-1403-0; HOKKANEN HMT, 1989, CAN ENTOMOL, V121, P829, DOI 10.4039/Ent121829-10; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Landry SM, 2008, ATLAS FLORIDA VASCUL; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lind EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010429; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lodge DM, 1998, ECOL STU AN, V131, P149; Lowe S., 2000, ENCY BIOL INVASIONS; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Parker IM, 2007, ECOLOGY, V88, P1210, DOI 10.1890/06-1377; Parker JD, 2005, ECOL LETT, V8, P959, DOI 10.1111/j.1461-0248.2005.00799.x; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Prusak AC, 2005, J CHEM ECOL, V31, P1145, DOI 10.1007/s10886-005-4253-1; Rawlings TA, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-97; Ricciardi A, 2006, SCIENCE, V313, DOI 10.1126/science.1128946; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; Rosenthal SK, 2006, CAN J FISH AQUAT SCI, V63, P1276, DOI 10.1139/F06-037; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Stachowicz JJ, 1996, OECOLOGIA, V105, P377, DOI 10.1007/BF00328741; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Verhoeven KJF, 2009, ECOL LETT, V12, P107, DOI 10.1111/j.1461-0248.2008.01248.x; Xiong W, 2008, FRESHWATER BIOL, V53, P2256, DOI 10.1111/j.1365-2427.2008.02058.x	49	102	105	3	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17227	10.1371/journal.pone.0017227	http://dx.doi.org/10.1371/journal.pone.0017227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394202	Green Published, gold			2022-12-27	WOS:000288025500006
J	Tonnesen, J; Parish, CL; Sorensen, AT; Andersson, A; Lundberg, C; Deisseroth, K; Arenas, E; Lindvall, O; Kokaia, M				Tonnesen, Jan; Parish, Clare L.; Sorensen, Andreas T.; Andersson, Angelica; Lundberg, Cecilia; Deisseroth, Karl; Arenas, Ernest; Lindvall, Olle; Kokaia, Merab			Functional Integration of Grafted Neural Stem Cell-Derived Dopaminergic Neurons Monitored by Optogenetics in an In Vitro Parkinson Model	PLOS ONE			English	Article							OPTICAL CONTROL; MIDBRAIN; RECEPTORS; COMPACTA; DISEASE; CULTURE; REPAIR; BRAIN; GABA; MICE	Intrastriatal grafts of stem cell-derived dopamine (DA) neurons induce behavioral recovery in animal models of Parkinson's disease (PD), but how they functionally integrate in host neural circuitries is poorly understood. Here, Wnt5a-overexpressing neural stem cells derived from embryonic ventral mesencephalon of tyrosine hydroxylase-GFP transgenic mice were expanded as neurospheres and transplanted into organotypic cultures of wild type mouse striatum. Differentiated GFP-labeled DA neurons in the grafts exhibited mature neuronal properties, including spontaneous firing of action potentials, presence of post-synaptic currents, and functional expression of DA D-2 autoreceptors. These properties resembled those recorded from identical cells in acute slices of intrastriatal grafts in the 6-hydroxy-DA-induced mouse PD model and from DA neurons in intact substantia nigra. Optogenetic activation or inhibition of grafted cells and host neurons using channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR), respectively, revealed complex, bi-directional synaptic interactions between grafted cells and host neurons and extensive synaptic connectivity within the graft. Our data demonstrate for the first time using optogenetics that ectopically grafted stem cell-derived DA neurons become functionally integrated in the DA-denervated striatum. Further optogenetic dissection of the synaptic wiring between grafted and host neurons will be crucial to clarify the cellular and synaptic mechanisms underlying behavioral recovery as well as adverse effects following stem cell-based DA cell replacement strategies in PD.	[Tonnesen, Jan; Sorensen, Andreas T.; Andersson, Angelica; Kokaia, Merab] Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Epilepsy Grp, S-22185 Lund, Sweden; [Parish, Clare L.; Arenas, Ernest] Ctr Dev Biol & Regenerat Med, Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Lab, Stockholm, Sweden; [Lundberg, Cecilia] Univ Lund Hosp, Wallenberg Neurosci Ctr, CNS Gene Therapy Unit, S-22185 Lund, Sweden; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Lindvall, Olle] Univ Lund Hosp, Wallenberg Neurosci Ctr, Lab Neurogenesis & Cell Therapy, S-22185 Lund, Sweden	Lund University; Skane University Hospital; Karolinska Institutet; Lund University; Skane University Hospital; Stanford University; Lund University; Skane University Hospital	Tonnesen, J (corresponding author), Univ Lund Hosp, Wallenberg Neurosci Ctr, Expt Epilepsy Grp, S-22185 Lund, Sweden.	Merab.Kokaia@med.lu.se	Tonnesen, Jan/C-7464-2011; Parish, Clare/A-3380-2014; Sørensen, Andreas Toft/P-4745-2018; Arenas, Ernest/AAO-5231-2020	Tonnesen, Jan/0000-0003-3663-8463; Sørensen, Andreas Toft/0000-0001-5887-9247; Arenas, Ernest/0000-0003-0197-6577; Lundberg, Cecilia/0000-0002-6959-2564; Parish, Clare/0000-0001-8212-9884	European Community [22943]; Excell [214706]; Swedish Research Council; Royal Physiographic Society; Lars Hierta's Memorial and Kock Foundations; National Health & Medical Research Council	European Community(European Commission); Excell; Swedish Research Council(Swedish Research CouncilEuropean Commission); Royal Physiographic Society; Lars Hierta's Memorial and Kock Foundations; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by grants from the European Community's Seventh Framework Programme through NeuroStemcell (nr. 22943) and Excell (nr. 214706), The Swedish Research Council, The Royal Physiographic Society, and Lars Hierta's Memorial and Kock Foundations. CLP is supported by a National Health & Medical Research Council Career Development Award Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenius H, 2009, J NEUROSCI, V29, P4408, DOI 10.1523/JNEUROSCI.6003-08.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Fasano C., 2008, CURR PROTOC NEUROSCI, DOI DOI 10.1002/0471142301.NS0321S44; FISHER LJ, 1991, NEUROSCIENCE, V40, P109, DOI 10.1016/0306-4522(91)90178-Q; Friling S, 2009, P NATL ACAD SCI USA, V106, P7613, DOI 10.1073/pnas.0902396106; GRACE AA, 1989, J NEUROSCI, V9, P3463; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Iversen L. L., 2010, DOPAMINE HDB; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Joyce MP, 2000, NEUROSCIENCE, V99, P445, DOI 10.1016/S0306-4522(00)00219-0; Kearns SM, 2006, J NEUROSCI METH, V157, P1, DOI 10.1016/j.jneumeth.2006.03.020; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; LACEY MG, 1989, J NEUROSCI, V9, P1233; Leinekugel X, 1999, Adv Neurol, V79, P189; Lindvall O, 2006, NATURE, V441, P1094, DOI 10.1038/nature04960; Lindvall Olle, 2004, NeuroRx, V1, P382; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; MERCURI NB, 1992, LIFE SCI, V51, P711, DOI 10.1016/0024-3205(92)90479-9; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; NISENBAUM ES, 1992, J NEUROPHYSIOL, V67, P477, DOI 10.1152/jn.1992.67.2.477; NISENBAUM ES, 1993, SYNAPSE, V14, P221, DOI 10.1002/syn.890140306; Parish CL, 2008, J CLIN INVEST, V118, P149, DOI 10.1172/JCI32273; Piccini P, 2000, ANN NEUROL, V48, P689, DOI 10.1002/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N; Plenz D, 1996, NEUROSCIENCE, V70, P893, DOI 10.1016/0306-4522(95)00405-X; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Sarkis C, 2000, P NATL ACAD SCI USA, V97, P14638, DOI 10.1073/pnas.260472897; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Sorensen AT, 2005, EUR J NEUROSCI, V21, P2793, DOI 10.1111/j.1460-9568.2005.04116.x; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tecuapetla F, 2010, J NEUROSCI, V30, P7105, DOI 10.1523/JNEUROSCI.0265-10.2010; Tepper JM, 2007, PROG BRAIN RES, V160, P189, DOI 10.1016/S0079-6123(06)60011-3; Tonnesen J, 2009, P NATL ACAD SCI USA, V106, P12162, DOI 10.1073/pnas.0901915106; Uchida K, 2005, NEUROSCI RES, V52, P276, DOI 10.1016/j.neures.2005.03.015; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	38	77	79	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17560	10.1371/journal.pone.0017560	http://dx.doi.org/10.1371/journal.pone.0017560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394212	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500016
J	Purushothaman, S; Annamalai, K; Tyagi, AK; Surolia, A				Purushothaman, Sudha; Annamalai, Karthikeyan; Tyagi, Anil K.; Surolia, Avadhesha			Diversity in Functional Organization of Class I and Class II Biotin Protein Ligase	PLOS ONE			English	Article							ESCHERICHIA-COLI REPRESSOR; CARBOXYL CARRIER SUBUNIT; AQUIFEX-AEOLICUS; COA CARBOXYLASE; TERMINAL DOMAIN; CELL-WALL; BIOSYNTHESIS; BIOTINYLATION; TUBERCULOSIS; APO	The cell envelope of Mycobacterium tuberculosis (M. tuberculosis) is composed of a variety of lipids including mycolic acids, sulpholipids, lipoarabinomannans, etc., which impart rigidity crucial for its survival and pathogenesis. Acyl CoA carboxylase (ACC) provides malonyl-CoA and methylmalonyl-CoA, committed precursors for fatty acid and essential for mycolic acid synthesis respectively. Biotin Protein Ligase (BPL/BirA) activates apo-biotin carboxyl carrier protein (BCCP) by biotinylating it to an active holo-BCCP. A minimal peptide (Schatz), an efficient substrate for Escherichia coli BirA, failed to serve as substrate for M. tuberculosis Biotin Protein Ligase (MtBPL). MtBPL specifically biotinylates homologous BCCP domain, MtBCCP87, but not EcBCCP87. This is a unique feature of MtBPL as EcBirA lacks such a stringent substrate specificity. This feature is also reflected in the lack of self/promiscuous biotinylation by MtBPL. The N-terminus/HTH domain of EcBirA has the selfbiotinable lysine residue that is inhibited in the presence of Schatz peptide, a peptide designed to act as a universal acceptor for EcBirA. This suggests that when biotin is limiting, EcBirA preferentially catalyzes, biotinylation of BCCP over selfbiotinylation. R118G mutant of EcBirA showed enhanced self and promiscuous biotinylation but its homologue, R69A MtBPL did not exhibit these properties. The catalytic domain of MtBPL was characterized further by limited proteolysis. Holo-MtBPL is protected from proteolysis by biotinyl-59 AMP, an intermediate of MtBPL catalyzed reaction. In contrast, apo-MtBPL is completely digested by trypsin within 20 min of co-incubation. Substrate selectivity and inability to promote self biotinylation are exquisite features of MtBPL and are a consequence of the unique molecular mechanism of an enzyme adapted for the high turnover of fatty acid biosynthesis.	[Purushothaman, Sudha; Annamalai, Karthikeyan; Surolia, Avadhesha] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Surolia, Avadhesha] Natl Inst Immunol, New Delhi 110067, India; [Tyagi, Anil K.] Univ Delhi, Dept Biochem, New Delhi, India	Indian Institute of Science (IISC) - Bangalore; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Delhi	Purushothaman, S (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in			Department of Biotechnology (DBT), Government of India; Department of Science & Technology (DST), Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Department of Science & Technology (DST), Government of India(Department of Science & Technology (India))	This work was supported by Centre of Excellence grant from the Department of Biotechnology (DBT), Government of India to A. S. and by another Department of Science & Technology (DST), Government of India grant to A.S. A.S. is also a J.C. Bose Fellow of the Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT J, 1993, BIOCHEMISTRY-US, V32, P9649, DOI 10.1021/bi00088a017; Athappilly FK, 1995, STRUCTURE, V3, P1407, DOI 10.1016/S0969-2126(01)00277-5; Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Beckett D, 2009, J NUTR, V139, P167, DOI 10.3945/jn.108.095760; BLOOM BR, 1992, SCIENCE, V257, P1055, DOI 10.1126/science.257.5073.1055; Brennan PJ, 2009, TUBERCULOSIS, V89, P329, DOI 10.1016/j.tube.2009.08.003; Chapman-Smith A, 1999, TRENDS BIOCHEM SCI, V24, P359, DOI 10.1016/S0968-0004(99)01438-3; Chapman-Smith A, 1999, J NUTR, V129, p477S, DOI 10.1093/jn/129.2.477S; ChapmanSmith A, 1997, J BIOL CHEM, V272, P26017, DOI 10.1074/jbc.272.41.26017; Chatterjee D, 1997, CURR OPIN CHEM BIOL, V1, P579, DOI 10.1016/S1367-5931(97)80055-5; Choi-Rhee E, 2004, PROTEIN SCI, V13, P3043, DOI 10.1110/ps.04911804; Clarke DJ, 2003, EUR J BIOCHEM, V270, P1277, DOI 10.1046/j.1432-1033.2003.03493.x; Cole ST, 2007, BIOCHEM SOC T, V35, P1321, DOI 10.1042/BST0351321; Cronan JE, 2001, J BIOL CHEM, V276, P37355, DOI 10.1074/jbc.M106353200; DOLIN PJ, 1994, B WORLD HEALTH ORGAN, V72, P213; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Goude R, 2008, FUTURE MICROBIOL, V3, P299, DOI 10.2217/17460913.3.3.299; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Li YQ, 2006, FEBS LETT, V580, P1536, DOI 10.1016/j.febslet.2006.01.083; Oh TJ, 2006, J BIOL CHEM, V281, P3899, DOI 10.1074/jbc.M511761200; Orme IM, 2001, TRENDS MICROBIOL, V9, P115, DOI 10.1016/S0966-842X(00)01949-1; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; Purushothaman S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002320; Reyda MR, 2008, ARCH BIOCHEM BIOPHYS, V471, P32, DOI 10.1016/j.abb.2007.12.001; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; Streaker ED, 2006, BIOCHEMISTRY-US, V45, P6417, DOI 10.1021/bi052599r; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Sueda S, 2006, BIOCHEM BIOPH RES CO, V344, P155, DOI 10.1016/j.bbrc.2006.03.118; Tron CM, 2009, J MOL BIOL, V387, P129, DOI 10.1016/j.jmb.2008.12.086; Wagenfuhr K, 2007, J MOL BIOL, V366, P93, DOI 10.1016/j.jmb.2006.10.087; Xu Y, 1995, BIOCHEMISTRY-US, V34, P16624, DOI 10.1021/bi00051a010; Xu Y, 1996, BIOCHEMISTRY-US, V35, P1783, DOI 10.1021/bi952269e; Yao X, 1997, BIOCHEMISTRY-US, V36, P15089, DOI 10.1021/bi971485f; Yao X, 1999, PROTEIN SCI, V8, P307	37	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16850	10.1371/journal.pone.0016850	http://dx.doi.org/10.1371/journal.pone.0016850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390227	gold, Green Published, Green Accepted			2022-12-27	WOS:000287965200006
J	Eulalio, A; Frohlich, KS; Mano, M; Giacca, M; Vogel, J				Eulalio, Ana; Froehlich, Kathrin S.; Mano, Miguel; Giacca, Mauro; Vogel, Joerg			A Candidate Approach Implicates the Secreted Salmonella Effector Protein SpvB in P-Body Disassembly	PLOS ONE			English	Article							STRESS GRANULE FORMATION; RNA-DECAPPING FACTORS; GW/P BODIES; VIRULENCE PLASMID; EUKARYOTIC CELLS; INFECTED-CELLS; IN-VIVO; TRANSLATION; ENTERICA; DEADENYLATION	P-bodies are dynamic aggregates of RNA and proteins involved in several post-transcriptional regulation processes. P-bodies have been shown to play important roles in regulating viral infection, whereas their interplay with bacterial pathogens, specifically intracellular bacteria that extensively manipulate host cell pathways, remains unknown. Here, we report that Salmonella infection induces P-body disassembly in a cell type-specific manner, and independently of previously characterized pathways such as inhibition of host cell RNA synthesis or microRNA-mediated gene silencing. We show that the Salmonella-induced P-body disassembly depends on the activation of the SPI-2 encoded type 3 secretion system, and that the secreted effector protein SpvB plays a major role in this process. P-body disruption is also induced by the related pathogen, Shigella flexneri, arguing that this might be a new mechanism by which intracellular bacterial pathogens subvert host cell function.	[Eulalio, Ana; Vogel, Joerg] Max Planck Inst Infect Biol, RNA Biol Grp, Berlin, Germany; [Froehlich, Kathrin S.; Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Eulalio, Ana; Mano, Miguel; Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy	Max Planck Society; University of Wurzburg; International Center for Genetic Engineering & Biotechnology (ICGEB)	Eulalio, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Lab, Padriciano 99, I-34012 Trieste, Italy.	ana.eulalio@icgeb.org; joerg.vogel@uni-wuerzburg.de	Giacca, Mauro/J-9287-2016; Eulalio, Ana/D-3083-2013; Vogel, Jörg/D-5574-2011; Mano, Miguel/A-4462-2013	Giacca, Mauro/0000-0003-2927-7225; Eulalio, Ana/0000-0002-7355-0674; Vogel, Jörg/0000-0003-2220-1404; Mano, Miguel/0000-0003-1922-4824; Frohlich, Kathrin/0000-0003-2352-9751	NGFN; European Commission; Region Friuli Venezia Giulia; Region Friuli Venezia Giulia, Italy; German Research Foundation (DFG)	NGFN; European Commission(European CommissionEuropean Commission Joint Research Centre); Region Friuli Venezia Giulia(Regione Friuli Venezia Giulia); Region Friuli Venezia Giulia, Italy; German Research Foundation (DFG)(German Research Foundation (DFG))	Work in the Vogel lab is supported by NGFN and by the Sixth Framework Programme of the European Commission through the SIROCCO Integrated Project. M.M. was supported by Project "SeND - Search for New Drugs," funded by Region Friuli Venezia Giulia and III supplementary contract of Framework Programme on Scientific Research in Region Friuli Venezia Giulia, Italy. This publication was funded by the German Research Foundation (DFG) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Balagopal V, 2009, CURR OPIN CELL BIOL, V21, P403, DOI 10.1016/j.ceb.2009.03.005; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Bhanji RA, 2007, CLIN IMMUNOL, V125, P247, DOI 10.1016/j.clim.2007.07.016; BLOBEL G, 1971, P NATL ACAD SCI USA, V68, P390, DOI 10.1073/pnas.68.2.390; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Browne SH, 2002, INFECT IMMUN, V70, P7126, DOI 10.1128/IAI.70.12.7126-7135.2002; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; DOUGHERTY JD, J VIROL; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; FIERER J, 1993, INFECT IMMUN, V61, P5231, DOI 10.1128/IAI.61.12.5231-5236.1993; Galan JE, 2009, CELL HOST MICROBE, V5, P571, DOI 10.1016/j.chom.2009.04.008; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kurita A, 2003, MICROB PATHOGENESIS, V35, P43, DOI 10.1016/S0882-4010(03)00066-4; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174; Mas A, 2006, J VIROL, V80, P246, DOI 10.1128/JVI.80.1.246-251.2006; Mastroeni P, 2009, NAT REV MICROBIOL, V7, P73, DOI 10.1038/nrmicro2034; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Noueiry AO, 2003, MOL CELL BIOL, V23, P4094, DOI 10.1128/MCB.23.12.4094-4106.2003; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Otto H, 2000, MOL MICROBIOL, V37, P1106, DOI 10.1046/j.1365-2958.2000.02064.x; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Pauley KM, 2010, IMMUNOL CELL BIOL, V88, P205, DOI 10.1038/icb.2009.84; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Tezcan-Merdol D, 2001, MOL MICROBIOL, V39, P606, DOI 10.1046/j.1365-2958.2001.02258.x; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yu XJ, 2010, SCIENCE, V328, P1040, DOI 10.1126/science.1189000; Yu XJ, 2004, MOL MICROBIOL, V54, P604, DOI 10.1111/j.1365-2958.2004.04297.x; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196	53	18	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17296	10.1371/journal.pone.0017296	http://dx.doi.org/10.1371/journal.pone.0017296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390246	Green Submitted, Green Published, gold			2022-12-27	WOS:000287932100011
J	Gaunt, ER; Jansen, RR; Poovorawan, Y; Templeton, KE; Toms, GL; Simmonds, P				Gaunt, Eleanor R.; Jansen, Rogier R.; Poovorawan, Yong; Templeton, Kate E.; Toms, Geoffrey L.; Simmonds, Peter			Molecular Epidemiology and Evolution of Human Respiratory Syncytial Virus and Human Metapneumovirus	PLOS ONE			English	Article							ATTACHMENT G PROTEIN; G-GLYCOPROTEIN; SUBGROUP-A; GENETIC DIVERSITY; CLINICAL-MANIFESTATIONS; STRAIN VARIATION; NEUTRALIZING EPITOPES; ANTIGENIC RELATEDNESS; CIRCULATION PATTERNS; NUCLEOTIDE-SEQUENCE	Human respiratory syncytial virus (HRSV) and human metapneumovirus (HMPV) are ubiquitous respiratory pathogens of the Pneumovirinae subfamily of the Paramyxoviridae. Two major surface antigens are expressed by both viruses; the highly conserved fusion (F) protein, and the extremely diverse attachment (G) glycoprotein. Both viruses comprise two genetic groups, A and B. Circulation frequencies of the two genetic groups fluctuate for both viruses, giving rise to frequently observed switching of the predominantly circulating group. Nucleotide sequence data for the F and G gene regions of HRSV and HMPV variants from the UK, the Netherlands, Bangkok and data available from Genbank were used to identify clades of both viruses. Several contemporary circulating clades of HRSV and HMPV were identified by phylogenetic reconstructions. The molecular epidemiology and evolutionary dynamics of clades were modelled in parallel. Times of origin were determined and positively selected sites were identified. Sustained circulation of contemporary clades of both viruses for decades and their global dissemination demonstrated that switching of the predominant genetic group did not arise through the emergence of novel lineages each respiratory season, but through the fluctuating circulation frequencies of pre-existing lineages which undergo proliferative and eclipse phases. An abundance of sites were identified as positively selected within the G protein but not the F protein of both viruses. For HRSV, these were discordant with previously identified residues under selection, suggesting the virus can evade immune responses by generating diversity at multiple sites within linear epitopes. For both viruses, different sites were identified as positively selected between genetic groups.	[Gaunt, Eleanor R.; Simmonds, Peter] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland; [Jansen, Rogier R.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Poovorawan, Yong] Chulalongkorn Univ, Ctr Excellence Clin Virol, Bangkok, Thailand; [Toms, Geoffrey L.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Templeton, Kate E.] Royal Infirm Edinburgh NHS Trust, Specialist Virol Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Amsterdam; Academic Medical Center Amsterdam; Chulalongkorn University; Newcastle University - UK; Royal Infirmary of Edinburgh; University of Edinburgh	Gaunt, ER (corresponding author), Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland.	e.gaunt@sms.ed.ac.uk	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	Templeton, Kate/0000-0001-7414-1277; Poovorawan, Yong/0000-0002-2337-6807; Simmonds, Peter/0000-0002-7964-4700	BBSRC; Thailand Research Fund; Commission on Higher Education, King Chulalongkorn Memorial Hospital; Center of Excellence in Clinical Virology; Chulalongkorn University	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Thailand Research Fund(Thailand Research Fund (TRF)); Commission on Higher Education, King Chulalongkorn Memorial Hospital(Office of Higher Education Commission (OHEC)); Center of Excellence in Clinical Virology; Chulalongkorn University(Chulalongkorn University)	This research was supported by a studentship awarded to E.G. by the BBSRC, the Thailand Research Fund, the Commission on Higher Education, King Chulalongkorn Memorial Hospital, the Center of Excellence in Clinical Virology and CU Centenary Academic Development Project, Chulalongkorn University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapov E, 2006, J INFECT DIS, V193, P396, DOI 10.1086/499310; AKERLIND B, 1986, J MED VIROL, V19, P241, DOI 10.1002/jmv.1890190306; ANDERSON LJ, 1985, J INFECT DIS, V151, P626, DOI 10.1093/infdis/151.4.626; Bastien N, 2003, J CLIN MICROBIOL, V41, P4642, DOI 10.1128/JCM.41.10.4642-4646.2003; Biacchesi S, 2003, VIROLOGY, V315, P1, DOI 10.1016/S0042-6822(03)00528-2; Boivin G, 2004, EMERG INFECT DIS, V10, P1154, DOI 10.3201/eid1006.031097; Boivin G, 2002, J INFECT DIS, V186, P1330, DOI 10.1086/344319; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; BUKREYEV A, 2008, J VIROL; CANE PA, 1995, J VIROL, V69, P2918, DOI 10.1128/JVI.69.5.2918-2925.1995; Cane PA, 1997, J MED VIROL, V51, P297, DOI 10.1002/(SICI)1096-9071(199704)51:4<297::AID-JMV7>3.0.CO;2-0; CANE PA, 1994, J CLIN MICROBIOL, V32, P1; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chieochansin T, 2008, J INFECTION, V56, P137, DOI 10.1016/j.jinf.2007.11.006; de Graaf M, 2008, J GEN VIROL, V89, P2933, DOI 10.1099/vir.0.2008/006957-0; Deng Jie, 2006, Zhonghua Er Ke Za Zhi, V44, P924; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Endo R, 2008, J GEN VIROL, V89, P1970, DOI 10.1099/vir.0.83679-0; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Falsey AR, 2003, J INFECT DIS, V187, P785, DOI 10.1086/367901; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; FREYMUTH F, 1991, J CLIN MICROBIOL, V29, P653, DOI 10.1128/JCM.29.3.653-655.1991; GARCIA O, 1994, J VIROL, V68, P5448; GARCIABARRENO B, 1990, EMBO J, V9, P4181, DOI 10.1002/j.1460-2075.1990.tb07642.x; Gaunt E, 2009, J CLIN VIROL, V46, P318, DOI 10.1016/j.jcv.2009.09.016; Gorman JJ, 2001, J BIOL CHEM, V276, P38988, DOI 10.1074/jbc.M106288200; HENDRY RM, 1988, J INFECT DIS, V157, P640, DOI 10.1093/infdis/157.4.640; HENDRY RM, 1989, J INFECT DIS, V160, P185, DOI 10.1093/infdis/160.2.185; Herd KA, 2006, J VIROL, V80, P2034, DOI 10.1128/JVI.80.4.2034-2044.2006; Herfst S, 2007, J GEN VIROL, V88, P2702, DOI 10.1099/vir.0.83084-0; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Ishiguro N, 2004, J CLIN MICROBIOL, V42, P3406, DOI 10.1128/JCM.42.8.3406-3414.2004; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Langedijk JPM, 1996, J GEN VIROL, V77, P1249, DOI 10.1099/0022-1317-77-6-1249; LEITCH ECM, 2010, J VIROL; LERCH RA, 1990, J VIROL, V64, P5559, DOI 10.1128/JVI.64.11.5559-5569.1990; LOPEZ JA, 1993, J GEN VIROL, V74, P2567, DOI 10.1099/0022-1317-74-12-2567; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Martinez I, 1997, J GEN VIROL, V78, P2419, DOI 10.1099/0022-1317-78-10-2419; Martinez I, 1999, J GEN VIROL, V80, P125, DOI 10.1099/0022-1317-80-1-125; Matsuzaki Y, 2008, J MED VIROL, V80, P1084, DOI 10.1002/jmv.21194; McGill A, 2004, J MED VIROL, V74, P492, DOI 10.1002/jmv.20203; Melero JA, 1997, J GEN VIROL, V78, P2411, DOI 10.1099/0022-1317-78-10-2411; MONTO AS, 1990, J INFECT DIS, V161, P781, DOI 10.1093/infdis/161.4.781; MORGAN LA, 1987, J GEN VIROL, V68, P2781, DOI 10.1099/0022-1317-68-11-2781; MUFSON MA, 1988, J INFECT DIS, V157, P143, DOI 10.1093/infdis/157.1.143; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murata Y, 2010, CLIN VACCINE IMMUNOL, V17, P695, DOI 10.1128/CVI.00432-09; OLMSTED RA, 1989, J VIROL, V63, P411, DOI 10.1128/JVI.63.1.411-420.1989; OLMSTED RA, 1986, P NATL ACAD SCI USA, V83, P7462, DOI 10.1073/pnas.83.19.7462; Padhi A, 2008, VIRUS RES, V131, P121, DOI 10.1016/j.virusres.2007.08.014; Palomo C, 2000, J MED VIROL, V60, P468, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;468::AID-JMV16&gt;3.0.CO;2-E; Peret TCT, 2004, J GEN VIROL, V85, P679, DOI 10.1099/vir.0.19504-0; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; RUEDA P, 1995, VIRAL IMMUNOL, V8, P37, DOI 10.1089/vim.1995.8.37; Santibanez S, 2002, J GEN VIROL, V83, P2699, DOI 10.1099/0022-1317-83-11-2699; Scott PD, 2006, J INFECT DIS, V193, P59, DOI 10.1086/498246; Skiadopoulos MH, 2004, J VIROL, V78, P6927, DOI 10.1128/JVI.78.13.6927-6937.2004; Stockton J, 2002, EMERG INFECT DIS, V8, P897, DOI 10.3201/eid0809.020084; Sullender WM, 1998, J INFECT DIS, V178, P925, DOI 10.1086/515697; SULLENDER WM, 1991, J VIROL, V65, P5425, DOI 10.1128/JVI.65.10.5425-5434.1991; TAYLOR CE, 1989, LANCET, V1, P777; Tripp RA, 2001, NAT IMMUNOL, V2, P732, DOI 10.1038/90675; van den Hoogen BG, 2007, J GEN VIROL, V88, P1251, DOI 10.1099/vir.0.82663-0; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Vicente D, 2006, CLIN INFECT DIS, V42, pE111, DOI 10.1086/504378; Walsh EE, 1998, J GEN VIROL, V79, P479, DOI 10.1099/0022-1317-79-3-479; WERTZ GW, 1985, P NATL ACAD SCI USA, V82, P4075, DOI 10.1073/pnas.82.12.4075; White LJ, 2005, EPIDEMIOL INFECT, V133, P279, DOI 10.1017/S0950268804003450; Woelk CH, 2001, J MOL EVOL, V52, P182, DOI 10.1007/s002390010147; Yang CF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-138; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005; Zlateva KT, 2004, J VIROL, V78, P4675, DOI 10.1128/JVI.78.9.4675-4683.2004; ZLATEVA KT, 2007, J CLIN MICROBIOL	79	42	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17427	10.1371/journal.pone.0017427	http://dx.doi.org/10.1371/journal.pone.0017427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390255	Green Submitted, Green Published, gold			2022-12-27	WOS:000287932100016
J	Cheng, D; Jenner, AM; Shui, GH; Cheong, WF; Mitchell, TW; Nealon, JR; Kim, WS; McCann, H; Wenk, MR; Halliday, GM; Garner, B				Cheng, Danni; Jenner, Andrew M.; Shui, Guanghou; Cheong, Wei Fun; Mitchell, Todd W.; Nealon, Jessica R.; Kim, Woojin S.; McCann, Heather; Wenk, Markus R.; Halliday, Glenda M.; Garner, Brett			Lipid Pathway Alterations in Parkinson's Disease Primary Visual Cortex	PLOS ONE			English	Article							LEWY BODY DISEASE; APOLIPOPROTEIN-D EXPRESSION; TANDEM MASS-SPECTROMETRY; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; LIVER X RECEPTORS; ALPHA-SYNUCLEIN; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA	Background: We present a lipidomics analysis of human Parkinson's disease tissues. We have focused on the primary visual cortex, a region that is devoid of pathological changes and Lewy bodies; and two additional regions, the amygdala and anterior cingulate cortex which contain Lewy bodies at different disease stages but do not have as severe degeneration as the substantia nigra. Methodology/Principal Findings: Using liquid chromatography mass spectrometry lipidomics techniques for an initial screen of 200 lipid species, significant changes in 79 sphingolipid, glycerophospholipid and cholesterol species were detected in the visual cortex of Parkinson's disease patients (n = 10) compared to controls (n = 10) as assessed by two-sided unpaired t-test (p-value <0.05). False discovery rate analysis confirmed that 73 of these 79 lipid species were significantly changed in the visual cortex (q-value < 0.05). By contrast, changes in 17 and 12 lipid species were identified in the Parkinson's disease amygdala and anterior cingulate cortex, respectively, compared to controls; none of which remained significant after false discovery rate analysis. Using gas chromatography mass spectrometry techniques, 6 out of 7 oxysterols analysed from both non-enzymatic and enzymatic pathways were also selectively increased in the Parkinson's disease visual cortex. Many of these changes in visual cortex lipids were correlated with relevant changes in the expression of genes involved in lipid metabolism and an oxidative stress response as determined by quantitative polymerase chain reaction techniques. Conclusions/Significance: The data indicate that changes in lipid metabolism occur in the Parkinson's disease visual cortex in the absence of obvious pathology. This suggests that normalization of lipid metabolism and/or oxidative stress status in the visual cortex may represent a novel route for treatment of non-motor symptoms, such as visual hallucinations, that are experienced by a majority of Parkinson's disease patients.	[Cheng, Danni; Kim, Woojin S.; McCann, Heather; Halliday, Glenda M.; Garner, Brett] Neurosci Res Australia, Sydney, NSW, Australia; [Jenner, Andrew M.; Shui, Guanghou; Cheong, Wei Fun; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Shui, Guanghou] Natl Univ Singapore, Inst Life Sci, Singapore 117548, Singapore; [Mitchell, Todd W.] Univ Wollongong, Sch Hlth Sci, Wollongong, NSW, Australia; [Mitchell, Todd W.; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Nealon, Jessica R.] Univ Wollongong, Sch Chem, Wollongong, NSW, Australia; [Kim, Woojin S.; Halliday, Glenda M.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Wenk, Markus R.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia	Neuroscience Research Australia; National University of Singapore; National University of Singapore; University of Wollongong; University of Wollongong; University of Wollongong; University of New South Wales Sydney; National University of Singapore; University of Wollongong	Cheng, D (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	brettg@uow.edu.au	Halliday, Glenda M/E-8555-2011; jenner, andrew M/H-4791-2016; jenner, andrew/AGZ-2767-2022; Wenk, Markus Rene/D-1441-2014; McCann, Heather/I-3815-2012; Mitchell, Todd/G-7044-2012	Halliday, Glenda M/0000-0003-0422-8398; jenner, andrew M/0000-0003-1767-2033; jenner, andrew/0000-0003-1767-2033; McCann, Heather/0000-0002-8474-8969; Mitchell, Todd/0000-0002-1372-9963; Shui, Guanghou/0000-0002-1621-9643	Australian Brain Foundation; Australian Research Council; Singapore National Research Foundation [2007-04]; Biomedical Research Council of Singapore [R-183-000-211-305]; National Medical Research Council [R-183-000-224-213]; SystemsX.ch RTD project LipidX; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia (NHMRC); University of Sydney; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism	Australian Brain Foundation; Australian Research Council(Australian Research Council); Singapore National Research Foundation(National Research Foundation, Singapore); Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); SystemsX.ch RTD project LipidX; Neuroscience Research Australia; University of New South Wales; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney(University of Sydney); Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	DC is supported by a PhD scholarship from the Australian Brain Foundation. GH and BG are Fellows of the NHMRC. BG holds an Australian Research Council Future Fellowship. Work at the NUS lipidomics laboratory (MRW) is supported by grants from the Singapore National Research Foundation under CRP Award No. 2007-04, the Biomedical Research Council of Singapore (R-183-000-211-305), the National Medical Research Council (R-183-000-224-213) and the SystemsX.ch RTD project LipidX. The Sydney Brain Bank is supported by Neuroscience Research Australia, the University of New South Wales and the National Health and Medical Research Council of Australia (NHMRC). The NSW Tissue Resource Centre is supported by the University of Sydney, the NHMRC, the Schizophrenia Research Institute and the National Institute of Alcohol Abuse and Alcoholism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On P, 2008, J NEUROCHEM, V105, P1656, DOI 10.1111/j.1471-4159.2008.05254.x; Barcelo-Coblijn G, 2007, J NEUROCHEM, V101, P132, DOI 10.1111/j.1471-4159.2006.04348.x; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bosco DA, 2006, NAT CHEM BIOL, V2, P249, DOI 10.1038/nchembio782; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burke RE, 2008, ANN NEUROL, V64, P485, DOI 10.1002/ana.21541; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cartagena CM, 2010, BRAIN RES, V1319, P1, DOI 10.1016/j.brainres.2009.12.080; Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08; Cheng D, 2008, NEUROREPORT, V19, P1685, DOI 10.1097/WNR.0b013e32831578b2; DAMIER P, 1993, NEUROSCIENCE, V52, P1, DOI 10.1016/0306-4522(93)90175-F; De Haan EH, 2007, NEUROREPORT, V18, P1177, DOI 10.1097/WNR.0b013e32820049d3; Deeley JM, 2008, BBA-MOL CELL BIOL L, V1781, P288, DOI 10.1016/j.bbalip.2008.04.002; DEXTER DT, 1994, MOVEMENT DISORD, V9, P92, DOI 10.1002/mds.870090115; Dickson DW, 2009, PARKINSONISM RELAT D, V15, pS1, DOI 10.1016/S1353-8020(09)70769-2; Diederich NJ, 2009, NAT REV NEUROL, V5, P331, DOI 10.1038/nrneurol.2009.62; EBERLING JL, 1994, NEUROBIOL AGING, V15, P329, DOI 10.1016/0197-4580(94)90028-0; Elliott DA, 2011, NEUROBIOL AGING, V32, P257, DOI 10.1016/j.neurobiolaging.2009.02.006; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Fasano C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000612; Fedorow H, 2005, J NEUROCHEM, V92, P990, DOI 10.1111/j.1471-4159.2004.02975.x; Forsaa EB, 2010, ARCH NEUROL-CHICAGO, V67, P996, DOI 10.1001/archneurol.2010.166; Gai WP, 2000, EXP NEUROL, V166, P324, DOI 10.1006/exnr.2000.7527; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Guerrera IC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007735; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; Halliday G, 2002, ACTA NEUROPATHOL, V104, P72, DOI 10.1007/s00401-002-0529-5; Halliday GM, 2010, ANN NY ACAD SCI, V1184, P188, DOI 10.1111/j.1749-6632.2009.05118.x; Halliday GM, 2005, BRAIN, V128, P2654, DOI 10.1093/brain/awh584; Han XL, 2010, BBA-MOL CELL BIOL L, V1801, P774, DOI 10.1016/j.bbalip.2010.01.010; Han XL, 2002, ANAL BIOCHEM, V302, P199, DOI 10.1006/abio.2001.5536; Harding AJ, 2002, BRAIN, V125, P2431, DOI 10.1093/brain/awf251; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Heverin M, 2004, J LIPID RES, V45, P186, DOI 10.1194/jlr.M300320-JLR200; Holroyd S, 2006, J NEUROPSYCH CLIN N, V18, P402, DOI 10.1176/appi.neuropsych.18.3.402; Hu CX, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0013318, 10.1371/journal.pone.0015542]; Huang Q, 2006, CANCER RES, V66, P5807, DOI 10.1158/0008-5472.CAN-06-0077; Ibarretxe-Bilbao N, 2009, MOVEMENT DISORD, V24, pS748, DOI 10.1002/mds.22670; Jellinger KA, 2008, ACTA NEUROPATHOL, V116, P1, DOI 10.1007/s00401-008-0406-y; JENNER P, 1992, ANN NEUROL, V32, pS82, DOI 10.1002/ana.410320714; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Kolsch H, 1999, BRAIN RES, V818, P171, DOI 10.1016/S0006-8993(98)01274-8; Kolsch H, 2000, NEUROCHEM INT, V36, P507, DOI 10.1016/S0197-0186(99)00157-6; Le Lay S, 2009, J LIPID RES, V50, P1609, DOI 10.1194/jlr.M800601-JLR200; Lee CYJ, 2009, ANTIOXID REDOX SIGN, V11, P407, DOI [10.1089/ars.2008.2179, 10.1089/ARS.2008.2179]; Lwin A, 2004, MOL GENET METAB, V81, P70, DOI 10.1016/j.ymgme.2003.11.004; Meppelink AM, 2009, BRAIN, V132, P2980, DOI 10.1093/brain/awp223; Mosconi L, 2008, ANN NY ACAD SCI, V1147, P180, DOI 10.1196/annals.1427.007; Neumann J, 2009, BRAIN, V132, P1783, DOI 10.1093/brain/awp044; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Ordonez C, 2006, HISTOL HISTOPATHOL, V21, P361, DOI 10.14670/HH-21.361; Owen AD, 1996, ANN NY ACAD SCI, V786, P217, DOI 10.1111/j.1749-6632.1996.tb39064.x; Power JHT, 2009, ACTA NEUROPATHOL, V117, P63, DOI 10.1007/s00401-008-0438-3; Prabhakara JPR, 2008, J NEUROCHEM, V107, P1722, DOI 10.1111/j.1471-4159.2008.05736.x; Ramirez-Ruiz B, 2007, EUR J NEUROL, V14, P750, DOI 10.1111/j.1468-1331.2007.01768.x; Ramirez-Ruiz B, 2008, MOVEMENT DISORD, V23, P2335, DOI 10.1002/mds.22258; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; RUIPEREZ V, 2010, PROG LIPID RES; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Sanchez-Castaneda C, 2010, MOVEMENT DISORD, V25, P615, DOI 10.1002/mds.22873; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Scholpp J, 2004, J NEUROTRAUM, V21, P667, DOI 10.1089/0897715041269632; Schwab U, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002630; Seet RCS, 2010, FREE RADICAL BIO MED, V48, P560, DOI 10.1016/j.freeradbiomed.2009.11.026; Shui G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011956; Shui GH, 2010, MOL BIOSYST, V6, P1008, DOI 10.1039/b913353d; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STALLBER.S, 1965, J LIPID RES, V6, P146; STOMMEL A, 1989, MECH AGEING DEV, V48, P1, DOI 10.1016/0047-6374(89)90021-3; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; Tong JC, 2010, BRAIN, V133, P172, DOI 10.1093/brain/awp282; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Williams DR, 2008, J NEUROL NEUROSUR PS, V79, P652, DOI 10.1136/jnnp.2007.124677; Williams DR, 2005, LANCET NEUROL, V4, P605, DOI 10.1016/S1474-4422(05)70146-0; Wilson RS, 2000, J NEUROL NEUROSUR PS, V69, P172, DOI 10.1136/jnnp.69.2.172; Zhang Qingchen, 2003, Curr Psychiatry Rep, V5, P197, DOI 10.1007/s11920-003-0042-0	88	106	106	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17299	10.1371/journal.pone.0017299	http://dx.doi.org/10.1371/journal.pone.0017299			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387008	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000287931400051
J	Lage, GM; Malloy-Diniz, LF; Matos, LO; Bastos, MAR; Abrantes, SSC; Correa, H				Lage, Guilherme M.; Malloy-Diniz, Leandro F.; Matos, Lorena O.; Bastos, Marisa A. R.; Abrantes, Suzana S. C.; Correa, Humberto			Impulsivity and the 5-HTTLPR Polymorphism in a Non-Clinical Sample	PLOS ONE			English	Article							SEROTONIN TRANSPORTER POLYMORPHISM; TRYPTOPHAN DEPLETION; PERSONALITY-TRAITS; DECISION-MAKING; BEHAVIOR; ASSOCIATION	Background: Impulsivity has been associated with serotonergic system functions. However, few researchers have investigated the relationship between a polymorphism in the promoter of the serotonin transporter gene (5-HTTLPR) and the different components of impulsivity in a non-clinical population. The aim of this study was to investigate the relationship between a polymorphism in the promoter region of the serotonin transporter gene (5-HTTLPR) and the different components of impulsivity in a non-clinical population. Methodology/Principal Findings: We administered two neuropsychological tests, the Continuous Performance Task and the Iowa Gambling Task, to 127 healthy participants to measure their levels of motor, attentional and non-planning impulsivity. Then, these participants were grouped by genotype and gender, and their scores on impulsivity measures were compared. There were no significant differences between group scores on attentional, motor and non-planning impulsivity. Conclusions/Significance: Our results suggest that 5-HTTLPR genotype is not significantly associated with subsets of impulsive behavior in a non-clinical sample when measured by neuropsychological tests. These findings are discussed in terms of the sensitivity of neuropsychological tests to detect impulsivity in a non-clinical population and the role of gender and race in the relationship between the 5-HTTLPR and impulsivity.	[Lage, Guilherme M.; Matos, Lorena O.; Bastos, Marisa A. R.; Abrantes, Suzana S. C.] FUMEC Univ, Coll Human Social & Hlth Sci, Belo Horizonte, MG, Brazil; [Lage, Guilherme M.] Univ Fed Minas Gerais, Inst Biol Sci, Grad Program Neurosci, Belo Horizonte, MG, Brazil; [Malloy-Diniz, Leandro F.] Univ Fed Minas Gerais, Dept Psychol, Coll Philosophy & Human Sci, Belo Horizonte, MG, Brazil; [Correa, Humberto] Univ Fed Minas Gerais, Dept Mental Hlth, Coll Med, Belo Horizonte, MG, Brazil; [Correa, Humberto] Univ Paris Decartes, St Anne Hosp, Paris, Ile De France, France	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; GHU PARIS Psychiatrie Neurosciences; UDICE-French Research Universities; Universite Paris Cite	Lage, GM (corresponding author), FUMEC Univ, Coll Human Social & Hlth Sci, Belo Horizonte, MG, Brazil.	menezeslage@gmail.com	Malloy-Diniz, Leandro/D-7829-2013; Correa, Humberto/B-6497-2009; Lage, Guilherme/F-4355-2011; Malloy-Diniz, Leandro Fernandes/AAR-4025-2021	Malloy-Diniz, Leandro/0000-0002-6606-1354; Correa, Humberto/0000-0003-4327-6413; Lage, Guilherme/0000-0001-8296-3676; Malloy-Diniz, Leandro Fernandes/0000-0002-6606-1354	Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG); CNPq [473674/2009-2]; FAPEMIG [PPM 00141-10]	Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by Instituto Nacional de Ciencia e Tecnologia de Medicina Molecular (INCT/CNPq/MCT, FAPEMIG; http://www.medicina.ufmg.br/molecular/), CNPq grant #473674/2009-2 (http://www.cnpq.br/) and FAPEMIG Project PPM 00141-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Booij L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011255; Clark L, 2005, PSYCHOPHARMACOLOGY, V182, P570, DOI 10.1007/s00213-005-0104-6; Correa H, 2004, ACTA PSYCHIAT SCAND, V110, P459, DOI 10.1111/j.1600-0447.2004.00340.x; Enticott PG, 2006, PERS INDIV DIFFER, V41, P285, DOI 10.1016/j.paid.2006.01.011; Hu XZ, 2006, AM J HUM GENET, V78, P815, DOI 10.1086/503850; Hu XZ, 2004, BIOL PSYCHIAT, V55, p191S; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; Malloy-Diniz LF, 2008, REV BRAS PSIQUIATR, V30, P144, DOI 10.1590/S1516-44462008005000009; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Paaver M, 2007, PSYCHOPHARMACOLOGY, V194, P545, DOI 10.1007/s00213-007-0867-z; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Roiser JP, 2007, INT J NEUROPSYCHOPH, V10, P449, DOI 10.1017/S146114570600705X; Sakado K, 2003, AM J MED GENET B, V121B, P71, DOI 10.1002/ajmg.b.20063; Salgado JV, 2009, REV BRAS PSIQUIATR, V31, P4, DOI 10.1590/S1516-44462009000100003; Swann AC, 2002, BIOL PSYCHIAT, V51, P988, DOI 10.1016/S0006-3223(01)01357-9; Umekage T, 2003, NEUROSCI LETT, V337, P13, DOI 10.1016/S0304-3940(02)01291-0; Walderhaug E, 2008, J CLIN EXP NEUROPSYC, V30, P204, DOI 10.1080/13803390701346311; Walderhaug E, 2007, BIOL PSYCHIAT, V62, P593, DOI 10.1016/j.biopsych.2007.02.012; Walderhaug E, 2010, NEUROSCI LETT, V473, P208, DOI 10.1016/j.neulet.2010.02.048	23	27	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16927	10.1371/journal.pone.0016927	http://dx.doi.org/10.1371/journal.pone.0016927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386887	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400014
J	Muturi, CN; Ouma, JO; Malele, II; Ngure, RM; Rutto, JJ; Mithofer, KM; Enyaru, J; Masiga, DK				Muturi, Catherine N.; Ouma, Johnson O.; Malele, Imna I.; Ngure, Raphael M.; Rutto, Jane J.; Mithoefer, Klaus M.; Enyaru, John; Masiga, Daniel K.			Tracking the Feeding Patterns of Tsetse Flies (Glossina Genus) by Analysis of Bloodmeals Using Mitochondrial Cytochromes Genes	PLOS ONE			English	Article							G-LONGIPENNIS DIPTERA; SPECIES IDENTIFICATION; PALLIDIPES; NGURUMAN; MEALS	Tsetse flies are notoriously difficult to observe in nature, particularly when populations densities are low. It is therefore difficult to observe them on their hosts in nature; hence their vertebrate species can very often only be determined indirectly by analysis of their gut contents. This knowledge is a critical component of the information on which control tactics can be developed. The objective of this study was to determine the sources of tsetse bloodmeals, hence investigate their feeding preferences. We used mitochondrial cytochrome c oxidase 1 (COI) and cytochrome b (cytb) gene sequences for identification of tsetse fly blood meals, in order to provide a foundation for rational decisions to guide control of trypanosomiasis, and their vectors. Glossina swynnertoni were sampled from Serengeti (Tanzania) and G. pallidipes from Kenya (Nguruman and Busia), and Uganda. Sequences were used to query public databases, and the percentage identities obtained used to identify hosts. An initial assay showed that the feeds were from single sources. Hosts identified from blood fed flies collected in Serengeti ecosystem, included buffaloes (25/40), giraffes (8/40), warthogs (3/40), elephants (3/40) and one spotted hyena. In Nguruman, where G. pallidipes flies were analyzed, the feeds were from elephants (6/13) and warthogs (5/13), while buffaloes and baboons accounted for one bloodmeal each. Only cattle blood was detected in flies caught in Busia and Uganda. Out of four flies tested in Mbita Point, Suba District in western Kenya, one had fed on cattle, the other three on the Nile monitor lizard. These results demonstrate that cattle will form an integral part of a control strategy for trypanosomiasis in Busia and Uganda, while different approaches are required for Serengeti and Nguruman ecosystems, where wildlife abound and are the major component of the tsetse fly food source.	[Muturi, Catherine N.; Mithoefer, Klaus M.; Masiga, Daniel K.] Int Ctr Insect Physiol & Ecol, Mol Biol & Biotechnol Dept, Nairobi, Kenya; [Ouma, Johnson O.; Rutto, Jane J.] Trypanosomiasis Res Ctr, Kenya Agr Res Inst, Kikuyu, Kenya; [Malele, Imna I.] Tsetse & Trypanosomiasis Res Inst, Tanga, Tanzania; [Ngure, Raphael M.] Egerton Univ, Dept Biochem & Mol Biol, Egerton, Kenya; [Enyaru, John] Makerere Univ, Dept Biochem, Kampala, Uganda	International Centre of Insect Physiology & Ecology (ICIPE); Egerton University; Makerere University	Muturi, CN (corresponding author), Int Ctr Insect Physiol & Ecol, Mol Biol & Biotechnol Dept, POB 30772, Nairobi, Kenya.	dmasiga@icipe.org	Ouma, Johnson/AAS-5044-2020	Masiga, Daniel/0000-0001-7513-0887; Malele, Imna/0000-0002-9343-7150	Bill & Melinda Gates Foundation [49042.01]; International Atomic Energy Agency [15617]; Biosciences East and Central Africa Network, BecANET [BecA 2/2007]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); International Atomic Energy Agency(International Atomic Energy Agency); Biosciences East and Central Africa Network, BecANET	This study was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org) Grant Number 49042.01; the International Atomic Energy Agency (www.iaea.org) Research Contract Number 15617; and Biosciences East and Central Africa Network, BecANET (hub.africabiosciences.org), Grant Number BecA 2/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAYLIS M, 1993, B ENTOMOL RES, V83, P145, DOI 10.1017/S0007485300034635; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brightwell R, 1997, B ENTOMOL RES, V87, P349, DOI 10.1017/S0007485300037378; Burkett-Cadena ND, 2008, AM J TROP MED HYG, V79, P809, DOI 10.4269/ajtmh.2008.79.809; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Clare EL, 2009, MOL ECOL, V18, P2532, DOI 10.1111/j.1365-294X.2009.04184.x; Clausen PH, 1998, MED VET ENTOMOL, V12, P169, DOI 10.1046/j.1365-2915.1998.00097.x; DRANSFIELD RD, 1992, TSETSE CONTROL TRAIN, V4; Drummond A.J, 2010, GENEIOUS, V5, P3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; JORDAN AM, 1995, J AM MOSQUITO CONTR, V11, P249; KAARE TM, 2007, TRAVEL MED INFECT DI, V5, P117; Kgori PM, 2006, ACTA TROP, V99, P184, DOI 10.1016/j.actatropica.2006.07.007; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Lindh JM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000474; Ng'ayo Musa O, 2005, Kinetoplastid Biol Dis, V4, P5, DOI 10.1186/1475-9292-4-5; Njiokou F, 2004, ACTA TROP, V91, P117, DOI 10.1016/j.actatropica.2004.03.006; Omolo MO, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000435; Ouma JO, 2006, MED VET ENTOMOL, V20, P138, DOI 10.1111/j.1365-2915.2006.00609.x; Pepin J, 2001, ADV PARASIT, V49, P71, DOI 10.1016/S0065-308X(01)49038-5; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rayaisse JB, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000632; REINHARDT E, 2002, TRAVAILLER ENSEMBLE; ROGERS D, 1973, Acta Tropica, V30, P24; RURANGIRWA FR, 1986, ACTA TROP, V43, P379; Sambrook J., 2001, MOL CLONING LAB MANU; SASAKI H, 1995, J MED ENTOMOL, V32, P390, DOI 10.1093/jmedent/32.3.390; Schofield CJ, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-24; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; STAAK C, 1986, TROP MED PARASITOL, V37, P59; Steuber S, 2005, PARASITOL RES, V97, P247, DOI 10.1007/s00436-005-1410-y; Tarimo-Nesbitt RA, 1999, VET PARASITOL, V81, P107, DOI 10.1016/S0304-4017(98)00194-0; TEMPELIS CH, 1975, J MED ENTOMOL, V11, P635, DOI 10.1093/jmedent/11.6.635; TORBJORN E, 2007, MOL PHYLOGENET EVOL, V43, P530; Wamwiri FN, 2007, ANN TROP MED PARASIT, V101, P225, DOI 10.1179/136485907X156979; WEITZ B, 1963, B WORLD HEALTH ORGAN, V28, P711; WILLEMSE LPM, 1994, J MED ENTOMOL, V31, P775, DOI 10.1093/jmedent/31.6.775	42	48	51	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17284	10.1371/journal.pone.0017284	http://dx.doi.org/10.1371/journal.pone.0017284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386971	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400048
J	Vinnik, E; Itskov, PM; Balaban, E				Vinnik, Ekaterina; Itskov, Pavel M.; Balaban, Evan			Individual Differences in Sound-in-Noise Perception Are Related to the Strength of Short-Latency Neural Responses to Noise	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; HEARING ILLUSORY SOUNDS; INFORMATIONAL MASKING; CONTINUITY; CORTEX; TRANSFORMATIONS; INTELLIGIBILITY; ORGANIZATION; COHERENCE; MULTIPLE	Important sounds can be easily missed or misidentified in the presence of extraneous noise. We describe an auditory illusion in which a continuous ongoing tone becomes inaudible during a brief, non-masking noise burst more than one octave away, which is unexpected given the frequency resolution of human hearing. Participants strongly susceptible to this illusory discontinuity did not perceive illusory auditory continuity (in which a sound subjectively continues during a burst of masking noise) when the noises were short, yet did so at longer noise durations. Participants who were not prone to illusory discontinuity showed robust early electroencephalographic responses at 40-66 ms after noise burst onset, whereas those prone to the illusion lacked these early responses. These data suggest that short-latency neural responses to auditory scene components reflect subsequent individual differences in the parsing of auditory scenes.	[Vinnik, Ekaterina; Balaban, Evan] SISSA, Cognit Neurosci Sector, I-34014 Trieste, Italy; [Itskov, Pavel M.; Balaban, Evan] McGill Univ, Behav Neurosci Program, Montreal, PQ, Canada	International School for Advanced Studies (SISSA); McGill University	Vinnik, E (corresponding author), SISSA, Cognit Neurosci Sector, I-34014 Trieste, Italy.	vinnik.ekaterina@gmail.com	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433; Vinnik, Ekaterina/0000-0001-6853-1156; Itskov, Pavel/0000-0002-2191-7083	SISSA Cognitive Neuroscience Sector	SISSA Cognitive Neuroscience Sector	The research was funded by SISSA Cognitive Neuroscience Sector PHD program (http://www.sissa.it/main/?p=SECTOR_CNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binder JR, 2004, NAT NEUROSCI, V7, P295, DOI 10.1038/nn1198; Bregman A.S., 1990, AUDITORY SCENE ANAL; CHERRY C, 1967, NATURE, V214, P1164, DOI 10.1038/2141164a0; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Godey B, 2001, CLIN NEUROPHYSIOL, V112, P1850, DOI 10.1016/S1388-2457(01)00636-8; GRIER JB, 1971, PSYCHOL BULL, V75, P424, DOI 10.1037/h0031246; Grossberg S, 2004, NEURAL NETWORKS, V17, P511, DOI 10.1016/j.neunet.2003.10.002; Gutschalk A, 2005, J NEUROSCI, V25, P5382, DOI 10.1523/JNEUROSCI.0347-05.2005; Heinrich A, 2008, J COGNITIVE NEUROSCI, V20, P1737, DOI 10.1162/jocn.2008.20069; Heinrich A, 2011, J COGNITIVE NEUROSCI, V23, P2675, DOI 10.1162/jocn.2011.21627; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Huang MX, 2003, CLIN NEUROPHYSIOL, V114, P835, DOI 10.1016/S1388-2457(03)00041-5; Kidd G, 2003, J ACOUST SOC AM, V114, P2835, DOI 10.1121/1.1621864; Kropotov J, 2008, QUANTITATIVE EEG EVE; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Lutfi RA, 2003, PERCEPT PSYCHOPHYS, V65, P396, DOI 10.3758/BF03194571; Micheyl C, 2007, HEARING RES, V229, P116, DOI 10.1016/j.heares.2007.01.007; MILLER GA, 1950, J ACOUST SOC AM, V22, P167, DOI 10.1121/1.1906584; NEFF DL, 1995, J ACOUST SOC AM, V98, P125, DOI 10.1121/1.413748; NEFF DL, 1993, J ACOUST SOC AM, V94, P3112, DOI 10.1121/1.407217; Oh EL, 2001, J ACOUST SOC AM, V109, P2888, DOI 10.1121/1.1371764; Oxenham AJ, 2003, J ACOUST SOC AM, V114, P1543, DOI 10.1121/1.1598197; Patterson JV, 2008, PSYCHIAT RES, V158, P226, DOI 10.1016/j.psychres.2007.02.009; Petkov CI, 2007, NEURON, V54, P153, DOI 10.1016/j.neuron.2007.02.031; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; POWERS GL, 1977, J ACOUST SOC AM, V61, P195, DOI 10.1121/1.381255; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; REITE M, 1988, ELECTROEN CLIN NEURO, V70, P490, DOI 10.1016/0013-4694(88)90147-2; Riecke L, 2008, PERCEPT PSYCHOPHYS, V70, P1, DOI 10.3758/PP.70.1.1; Riecke L, 2007, J NEUROSCI, V27, P12684, DOI 10.1523/JNEUROSCI.2713-07.2007; Riecke L, 2011, J NEUROSCI, V31, P1479, DOI 10.1523/JNEUROSCI.3450-10.2011; Riecke L, 2009, NEURON, V64, P550, DOI 10.1016/j.neuron.2009.10.016; Rosburg T, 2004, NEUROSCI LETT, V372, P245, DOI 10.1016/j.neulet.2004.09.047; Shahin AJ, 2009, NEUROIMAGE, V44, P1133, DOI 10.1016/j.neuroimage.2008.09.045; Shinn-Cunningham BG, 2008, J ACOUST SOC AM, V123, P295, DOI 10.1121/1.2804701; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Snyder JS, 2007, PSYCHOL BULL, V133, P780, DOI 10.1037/0033-2909.133.5.780; Steinschneider M, 1999, J NEUROPHYSIOL, V82, P2346, DOI 10.1152/jn.1999.82.5.2346; TOUGAS Y, 1990, PERCEPT PSYCHOPHYS, V47, P121, DOI 10.3758/BF03205976; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; Warren R. M., 1999, AUDITORY PERCEPTION; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; WOOD CC, 1982, ELECTROEN CLIN NEURO, V54, P25, DOI 10.1016/0013-4694(82)90228-0; [No title captured]; [No title captured]; [No title captured]	48	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17266	10.1371/journal.pone.0017266	http://dx.doi.org/10.1371/journal.pone.0017266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387016	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400046
J	Yao, S; Sucheston, LE; Millen, AE; Johnson, CS; Trump, DL; Nesline, MK; Davis, W; Hong, CC; McCann, SE; Hwang, H; Kulkarni, S; Edge, SB; O'Connor, TL; Ambrosone, CB				Yao, Song; Sucheston, Lara E.; Millen, Amy E.; Johnson, Candace S.; Trump, Donald L.; Nesline, Mary K.; Davis, Warren; Hong, Chi-Chen; McCann, Susan E.; Hwang, Helena; Kulkarni, Swati; Edge, Stephen B.; O'Connor, Tracey L.; Ambrosone, Christine B.			Pretreatment Serum Concentrations of 25-Hydroxyvitamin D and Breast Cancer Prognostic Characteristics: A Case-Control and a Case-Series Study	PLOS ONE			English	Article							DIETARY VITAMIN-D; RISK; EXPRESSION; CELLS; CALCIUM; WOMEN; PREVENTION; PHENOTYPE; PATHWAYS; SUBTYPES	Background: Results from epidemiologic studies on the relationship between vitamin D and breast cancer risk are inconclusive. It is possible that vitamin D may be effective in reducing risk only of specific subtypes due to disease heterogeneity. Methods and Findings: In case-control and case-series analyses, we examined serum concentrations of 25-hydroxyvitamin D (25OHD) in relation to breast cancer prognostic characteristics, including histologic grade, estrogen receptor (ER), and molecular subtypes defined by ER, progesterone receptor (PR) and HER2, among 579 women with incident breast cancer and 574 controls matched on age and time of blood draw enrolled in the Roswell Park Cancer Institute from 2003 to 2008. We found that breast cancer cases had significantly lower 25OHD concentrations than controls (adjusted mean, 22.8 versus 26.2 ng/mL, p < 0.001). Among premenopausal women, 25OHD concentrations were lower in those with high-versus low-grade tumors, and ER negative versus ER positive tumors (p <= 0.03). Levels were lowest among women with triple-negative cancer (17.5 ng/mL), significantly different from those with luminal A cancer (24.5 ng/mL, p = 0.002). In case-control analyses, premenopausal women with 25OHD concentrations above the median had significantly lower odds of having triple-negative cancer (OR = 0.21, 95% CI = 0.08-0.53) than those with levels below the median; and every 10 ng/mL increase in serum 25OHD concentrations was associated with a 64% lower odds of having triple-negative cancer (OR = 0.36, 95% CI = 0.22-0.56). The differential associations by tumor subtypes among premenopausal women were confirmed in case-series analyses. Conclusion: In our analyses, higher serum levels of 25OHD were associated with reduced risk of breast cancer, with associations strongest for high grade, ER negative or triple negative cancers in premenopausal women. With further confirmation in large prospective studies, these findings could warrant vitamin D supplementation for reducing breast cancer risk, particularly those with poor prognostic characteristics among premenopausal women.	[Yao, Song; Sucheston, Lara E.; Nesline, Mary K.; Davis, Warren; Hong, Chi-Chen; McCann, Susan E.; Ambrosone, Christine B.] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Millen, Amy E.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Johnson, Candace S.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Trump, Donald L.; O'Connor, Tracey L.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Hwang, Helena] Roswell Pk Canc Inst, Dept Pathol, Buffalo, NY 14263 USA; [Kulkarni, Swati; Edge, Stephen B.] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Yao, S (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	song.yao@roswellpark.org	Yao, Song/A-2534-2012	Yao, Song/0000-0001-9442-1313	Breast Cancer Research Foundation; Department of Defense [W81XWH-08-1-0223]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the Breast Cancer Research Foundation (C. B. A.), and a fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-08-1-0223) (S.Y.). The Roswell Park Cancer Institute DataBank and Biorepository is a CCSG Shared Resource (NIH P30 CA016056-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Abbas S, 2008, CARCINOGENESIS, V29, P93, DOI 10.1093/carcin/bgm240; Abbas S, 2007, NUTR CANCER, V59, P54, DOI 10.1080/01635580701390223; Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Ambrosone CB, 2006, CANCER EPIDEM BIOMAR, V15, P1575, DOI 10.1158/1055-9965.EPI-06-0628; Artaza JN, 2009, J ENDOCRINOL, V200, P207, DOI 10.1677/JOE-08-0241; Banwell CM, 2006, CLIN CANCER RES, V12, P2004, DOI 10.1158/1078-0432.CCR-05-1218; Bertone-Johnson ER, 2009, ANN EPIDEMIOL, V19, P462, DOI 10.1016/j.annepidem.2009.01.003; Bertone-Johnson ER, 2005, CANCER EPIDEM BIOMAR, V14, P1991, DOI 10.1158/1055-9965.EPI-04-0722; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Gandini S., 2010, INT J CANC; Giovannucci E, 2010, J STEROID BIOCHEM, V121, P349, DOI 10.1016/j.jsbmb.2010.03.085; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; IARC, 2008, VIT D CANC; Knight JA, 2010, CANCER CAUSE CONTROL, V21, P479, DOI 10.1007/s10552-009-9466-0; Kuper H, 2009, CANCER EPIDEM BIOMAR, V18, P2558, DOI 10.1158/1055-9965.EPI-09-0449; Kwan ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2261; Li HJ, 2007, PLOS MED, V4, P562, DOI 10.1371/journal.pmed.0040103; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Ma HY, 2010, CANCER RES, V70, P575, DOI 10.1158/0008-5472.CAN-09-3460; Matthews D, 2010, J STEROID BIOCHEM, V121, P362, DOI 10.1016/j.jsbmb.2010.03.061; McCullough ML, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2356; McCullough ML, 2005, CANCER EPIDEM BIOMAR, V14, P2898, DOI 10.1158/1055-9965.EPI-05-0611; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Neuhouser ML, 2008, AM J CLIN NUTR, V88, P133, DOI 10.1093/ajcn/88.1.133; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Palmieri C, 2006, J CLIN PATHOL, V59, P1334, DOI 10.1136/jcp.2006.042747; Pendas-Franco N, 2007, DIFFERENTIATION, V75, P193, DOI 10.1111/j.1432-0436.2006.00131.x; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rainville Christa, 2009, Cases J, V2, P8390, DOI 10.4076/1757-1626-2-8390; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Swami S, 2000, CLIN CANCER RES, V6, P3371; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Welsh J, 2004, AM J CLIN NUTR, V80, p1721S, DOI 10.1093/ajcn/80.6.1721S; Welsh J, 2007, ACTA PHARMACOL SIN, V28, P1373, DOI 10.1111/j.1745-7254.2007.00700.x; Yin L, 2010, EUR J CANCER, V46, P2196, DOI 10.1016/j.ejca.2010.03.037; Zinser GM, 2005, J STEROID BIOCHEM, V97, P153, DOI 10.1016/j.jsbmb.2005.06.024	41	78	78	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17251	10.1371/journal.pone.0017251	http://dx.doi.org/10.1371/journal.pone.0017251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386992	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400044
J	Fan, B; Onteru, SK; Du, ZQ; Garrick, DJ; Stalder, KJ; Rothschild, MF				Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.			Genome-Wide Association Study Identifies Loci for Body Composition and Structural Soundness Traits in Pigs	PLOS ONE			English	Article							DIVERGENT SELECTION; GENETIC VALUE; MUSCLE; GROWTH; PREDICTION; FATNESS; BONE; EXPRESSION; SKELETAL; SEQUENCE	Background: The recent completion of the swine genome sequencing project and development of a high density porcine SNP array has made genome-wide association (GWA) studies feasible in pigs. Methodology/Principal Findings: Using Illumina's PorcineSNP60 BeadChip, we performed a pilot GWA study in 820 commercial female pigs phenotyped for backfat, loin muscle area, body conformation in addition to feet and leg (FL) structural soundness traits. A total of 51,385 SNPs were jointly fitted using Bayesian techniques as random effects in a mixture model that assumed a known large proportion (99.5%) of SNPs had zero effect. SNP annotations were implemented through the Sus scrofa Build 9 available from pig Ensembl. We discovered a number of candidate chromosomal regions, and some of them corresponded to QTL regions previously reported. We not only have identified some well-known candidate genes for the traits of interest, such as MC4R (for backfat) and IGF2 (for loin muscle area), but also obtained novel promising genes, including CHCHD3 (for backfat), BMP2 (for loin muscle area, body size and several FL structure traits), and some HOXA family genes (for overall leg action). The candidate regions responsible for body conformation and FL structure soundness did not overlap greatly which implied that these traits were controlled by different genes. Functional clustering analyses classified the genes into categories related to bone and cartilage development, muscle growth and development or the insulin pathway suggesting the traits are regulated by common pathways or gene networks that exert roles at different spatial and temporal stages. Conclusions/Significance: This study is one of the earliest GWA reports on important quantitative traits in pigs, and the findings will contribute to the further biological function analysis of the identified candidate genes and potential utilization of them in marker assisted selection.	[Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Fan, Bin; Onteru, Suneel K.; Du, Zhi-Qiang; Garrick, Dorian J.; Stalder, Kenneth J.; Rothschild, Max F.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA; [Fan, Bin] Huazhong Agr Univ, Minist Educ, Key Lab Agr Anim Genet Breeding & Reprod, Wuhan, Peoples R China; [Fan, Bin] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan, Peoples R China	Iowa State University; Iowa State University; Huazhong Agricultural University; Huazhong Agricultural University	Fan, B (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Garrick, Dorian/Q-3239-2019; Garrick, Dorian/P-9628-2019; STALDER, Kenneth/I-3781-2019	Garrick, Dorian/0000-0001-8640-5372; STALDER, Kenneth/0000-0001-9540-681X	National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch	National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch	This work was supported in part by the National Pork Board and Newsham Choice Genetics, State of Iowa and Hatch funding, and The College of Agriculture and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S2-S2; ALBARELLA U, 2007, PIGS HUMAN 10 000 YE; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; ANDERSSON L, 1994, SCIENCE, V263, P1771, DOI 10.1126/science.8134840; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berg F, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-17; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Dayton W R, 2008, J Anim Sci, V86, pE217, DOI 10.2527/jas.2007-0456; DRAPER DD, 1992, GENET SEL EVOL, V24, P363, DOI 10.1051/gse:19920406; DRAPER DD, 1991, AM J VET RES, V52, P164; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fan B, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-14; Favier B, 1997, MOL HUM REPROD, V3, P115, DOI 10.1093/molehr/3.2.115; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Fernando RL, 2008, GENSEL USER MANUAL P; Feugang JM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-176; Gianola D, 2006, GENETICS, V173, P1761, DOI 10.1534/genetics.105.049510; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006676; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ibanez-Escriche N, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-12; Jeon JT, 1999, NAT GENET, V21, P157, DOI 10.1038/5938; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kim CH, 2005, MOL CELL BIOL, V25, P5329, DOI 10.1128/MCB.25.13.5329-5338.2005; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Kirk RK, 2005, J VET MED A, V52, P423, DOI 10.1111/j.1439-0442.2005.00747.x; Kizilkaya K, 2010, J ANIM SCI, V88, P544, DOI 10.2527/jas.2009-2064; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meshkani R, 2007, CLIN CHEM, V53, P1585, DOI 10.1373/clinchem.2007.088146; Meuwissen THE, 2001, GENETICS, V157, P1819; Nakanishi T, 2001, BIOCHEM BIOPH RES CO, V281, P678, DOI 10.1006/bbrc.2001.4379; NIKKILA M, 2008, HERITABILITIES GENET; Park HB, 2002, ANIM GENET, V33, P155, DOI 10.1046/j.1365-2052.2002.00824.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian J, 1999, BIOCHEM J, V341, P315, DOI 10.1042/0264-6021:3410315; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rothschild MF, 2007, INT J BIOL SCI, V3, P192; Settles M, 2009, ANIM GENET, V40, P655, DOI 10.1111/j.1365-2052.2009.01896.x; Snelling WM, 2010, J ANIM SCI, V88, P837, DOI 10.2527/jas.2009-2257; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Stalder K. J., 2004, Pig News and Information, V25, p53N; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SUN X, 2010, BMC P IN PRESS; Toosi A, 2010, J ANIM SCI, V88, P32, DOI 10.2527/jas.2009-1975; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; VERHAEGHE J, 2002, PRINCIPLES BONE BIOL, P549; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wood SH, 2009, IMMUNOGENETICS, V61, P765, DOI 10.1007/s00251-009-0402-y	54	149	164	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14726	10.1371/journal.pone.0014726	http://dx.doi.org/10.1371/journal.pone.0014726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383979	gold, Green Published, Green Submitted			2022-12-27	WOS:000287761700004
J	Vijgen, GHEJ; Bouvy, ND; Teule, GJJ; Brans, B; Schrauwen, P; Lichtenbelt, WDV				Vijgen, Guy H. E. J.; Bouvy, Nicole D.; Teule, G. J. Jaap; Brans, Boudewijn; Schrauwen, Patrick; Lichtenbelt, Wouter D. van Marken			Brown Adipose Tissue in Morbidly Obese Subjects	PLOS ONE			English	Article							THERMOGENESIS; ADIPOCYTES; WHITE	Background: Cold-stimulated adaptive thermogenesis in brown adipose tissue (BAT) to increase energy expenditure is suggested as a possible therapeutic target for the treatment of obesity. We have recently shown high prevalence of BAT in adult humans, which was inversely related to body mass index (BMI) and body fat percentage (BF%), suggesting that obesity is associated with lower BAT activity. Here, we examined BAT activity in morbidly obese subjects and its role in cold-induced thermogenesis (CIT) after applying a personalized cooling protocol. We hypothesize that morbidly obese subjects show reduced BAT activity upon cold exposure. Methods and Findings: After applying a personalized cooling protocol for maximal non-shivering conditions, BAT activity was determined using positron-emission tomography and computed tomography (PET-CT). Cold-induced BAT activity was detected in three out of 15 morbidly obese subjects. Combined with results from lean to morbidly obese subjects (n = 39) from previous study, the collective data show a highly significant correlation between BAT activity and body composition (P<0.001), respectively explaining 64% and 60% of the variance in BMI (r = 0.8; P<0.001) and BF% (r = 0.75; P<0.001). Obese individuals demonstrate a blunted CIT combined with low BAT activity. Only in BAT-positive subjects (n = 26) mean energy expenditure was increased significantly upon cold exposure (51.5 +/- 6.7 J/s versus 44.0 +/- 5.1 J/s, P = 0.001), and the increase was significantly higher compared to BAT-negative subjects (+15.5 +/- 8.9% versus +3.6 +/- 8.9%, P = 0.001), indicating a role for BAT in CIT in humans. Conclusions: This study shows that in an extremely large range of body compositions, BAT activity is highly correlated with BMI and BF%. BAT-positive subjects showed higher CIT, indicating that BAT is also in humans involved in adaptive thermogenesis. Increasing BAT activity could be a therapeutic target in (morbid) obesity.	[Vijgen, Guy H. E. J.; Schrauwen, Patrick; Lichtenbelt, Wouter D. van Marken] Maastricht Univ, Dept Human Biol, Sch Nutr & Toxicol & Metab NUTRIM, Maastricht, Netherlands; [Vijgen, Guy H. E. J.; Bouvy, Nicole D.] Maastricht Univ, Med Ctr, Dept Gen Surg, Maastricht, Netherlands; [Teule, G. J. Jaap; Brans, Boudewijn] Maastricht Univ, Med Ctr, Dept Nucl Med, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Vijgen, GHEJ (corresponding author), Maastricht Univ, Dept Human Biol, Sch Nutr & Toxicol & Metab NUTRIM, Maastricht, Netherlands.	markenlichtenbelt@maastrichtuniversity.nl	Bouvy, Nicole/AAD-2844-2021	Vijgen, Guy/0000-0002-6011-753X; schrauwen, patrick/0000-0002-0973-847X	Netherlands Science Foundation ZonMw [TOP 91209037]	Netherlands Science Foundation ZonMw	The authors acknowledge support for this study from Netherlands Science Foundation ZonMw TOP 91209037 (to W. D. van Marken Lichtenbelt, www.zonmw.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BOUCHARD C, 1990, NEW ENGL J MED, V322, P1477, DOI 10.1056/NEJM199005243222101; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Ghorbani M, 1997, INT J OBESITY, V21, P465, DOI 10.1038/sj.ijo.0800432; HEATON JM, 1972, J ANAT, V112, P35; Himms-Hagen J, 2001, Rev Endocr Metab Disord, V2, P395, DOI 10.1023/A:1011856617047; HUTTUNEN P, 1981, EUR J APPL PHYSIOL O, V46, P339, DOI 10.1007/BF00422121; Ishibashi J, 2010, SCIENCE, V328, P1113, DOI 10.1126/science.1190816; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lidell ME, 2010, NAT REV ENDOCRINOL, V6, P319, DOI 10.1038/nrendo.2010.64; Oberkofler H, 1997, J LIPID RES, V38, P2125; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; van Ooijen AMJ, 2004, PHYSIOL BEHAV, V82, P545, DOI 10.1016/j.physbeh.2004.05.001; van Ooijen AMJ, 2005, BRIT J NUTR, V93, P387, DOI 10.1079/BJN20041362; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wijers SLJ, 2010, OBESITY, V18, P1092, DOI 10.1038/oby.2010.74; YONESHIRO T, 2010, OBESITY         0506; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	27	273	279	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17247	10.1371/journal.pone.0017247	http://dx.doi.org/10.1371/journal.pone.0017247			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390318	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700041
J	Sabri, M; Ai, JL; Marsden, PA; Macdonald, RL				Sabri, Mohammed; Ai, Jinglu; Marsden, Philip A.; Macdonald, R. Loch			Simvastatin Re-Couples Dysfunctional Endothelial Nitric Oxide Synthase in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							COA-REDUCTASE INHIBITOR; ATTENUATES CEREBRAL VASOSPASM; STATIN USE; COLLAGEN CONTENT; IN-VITRO; METALLOPROTEINASES; STABILIZATION; PEROXYNITRITE; CHOLESTEROL; SUPEROXIDE	Reduced endothelial nitric oxide synthase (eNOS) function has been linked to secondary complications of subarachnoid hemorrhage (SAH). We previously found that there is increased eNOS function after SAH but that it is uncoupled, leading to secondary complications such as vasospasm, microthromboembolism and neuronal apoptosis. Here we test the hypothesis that recoupling eNOS with simvastatin can prevent these complications. SAH was created in mice that were treated with vehicle or simvastatin starting 2 weeks before or 30 minutes after SAH. SAH increased phosphorylated eNOS which was prevented by pre- or post-treatment with simvastatin. Simvastatin pre-treatment also prevented the increase in eNOS monomer formation that was associated with SAH, decreased superoxide anion radical production and increased NO. These changes were associated with decreased vasospasm, microthromboemboli and neuronal injury. The data suggest that simvastatin re-couples eNOS after SAH, leading to decreased secondary complications such as vasospasm, microthromboemboli and neuronal injury.	[Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] St Michaels Hosp, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Sabri, Mohammed; Ai, Jinglu; Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Marsden, Philip A.] St Michaels Hosp, Div Renal, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Marsden, Philip A.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Sabri, M (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	Macdonaldlo@smh.ca	Marsden, Philip A/B-1441-2012	AI, JINGLU/0000-0001-7414-0207	Physician's Services Incorporated Foundation [07-039]; Brain Aneurysm Foundation	Physician's Services Incorporated Foundation; Brain Aneurysm Foundation	This work was supported by Physician's Services Incorporated Foundation (http://www.psifoundation.org, grant # 07-039) and the Brain Aneurysm Foundation (http://www.bafound.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2001, CIRCULATION, V103, P276; Aoki T, 2008, STROKE, V39, P1276, DOI 10.1161/STROKEAHA.107.503086; Berra L V, 2007, J Neurosurg Sci, V51, P1; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Clark JF, 2008, FRONT BIOSCI-LANDMRK, V13, P1806, DOI 10.2741/2801; Crisby M, 2001, CIRCULATION, V103, P926, DOI 10.1161/01.cir.103.7.926; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Espey MG, 2002, P NATL ACAD SCI USA, V99, P11127, DOI 10.1073/pnas.152157599; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Fukumoto Y, 2001, CIRCULATION, V103, P993; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Huhle G, 1999, THROMB RES, V95, P229, DOI 10.1016/S0049-3848(99)00037-7; KERZ T, 2008, NEUROL RES; Kramer AH, 2008, NEUROSURGERY, V62, P422, DOI 10.1227/01.neu.0000316009.19012.e3; Leber A, 1999, J BIOL CHEM, V274, P37658, DOI 10.1074/jbc.274.53.37658; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lynch JR, 2005, STROKE, V36, P2024, DOI 10.1161/01.STR.0000177879.11607.10; Macdonald RL, 2007, NAT CLIN PRACT NEURO, V3, P256, DOI 10.1038/ncpneuro0490; MACDONALD RL, 1994, FREE RADICAL BIO MED, V16, P633; McGirt MJ, 2006, J NEUROSURG, V105, P671, DOI 10.3171/jns.2006.105.5.671; McGirt MJ, 2006, NEUROSURGERY, V58, P945, DOI 10.1227/01.NEU.0000210262.67628.7E; McGirt MJ, 2002, STROKE, V33, P2317, DOI 10.1161/01.STR.0000027207.67639.1E; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; ODriscoll G, 1997, CIRCULATION, V95, P1126, DOI 10.1161/01.cir.95.5.1126; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Parra A, 2005, NEUROSURGERY, V56, P476, DOI 10.1227/01.NEU.0000153925.96889.8A; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Pluta RM, 2006, NEUROL RES, V28, P730, DOI 10.1179/016164106X152052; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Rikitake Y, 2001, ATHEROSCLEROSIS, V154, P87, DOI 10.1016/S0021-9150(00)00468-8; SABRI M, 2010, J CEREB BLOOD FLOW M; Sabri M, 2009, BRAIN RES, V1295, P179, DOI 10.1016/j.brainres.2009.08.021; Samdani AF, 1997, STROKE, V28, P1283, DOI 10.1161/01.STR.28.6.1283; Singhal AB, 2005, NEUROLOGY, V64, P1008, DOI 10.1212/01.WNL.0000154523.21633.0E; Stein SC, 2006, NEUROSURGERY, V59, P781, DOI 10.1227/01.NEU.0000227519.27569.45; Sugawara T, 2008, ACTA NEUROCHIR SUPPL, V102, P391, DOI 10.1007/978-3-211-85578-2_76; Sugawara T, 2008, J NEUROSCI RES, V86, P3635, DOI 10.1002/jnr.21807; Sydow K, 2003, ATHEROSCLEROSIS SUPP, V4, P41, DOI 10.1016/S1567-5688(03)00033-3; Takata K, 2009, J NEUROSURG ANESTH, V21, P326, DOI 10.1097/ANA.0b013e3181acfde7; Teichert AM, 2000, AM J PHYSIOL-HEART C, V278, pH1352, DOI 10.1152/ajpheart.2000.278.4.H1352; van der Most PJ, 2009, PROG NEUROBIOL, V88, P64, DOI 10.1016/j.pneurobio.2009.02.002; van Faassen EE, 2009, MED RES REV, V29, P683, DOI 10.1002/med.20151; Vergouwen MDI, 2010, STROKE, V41, pE47, DOI 10.1161/STROKEAHA.109.556332; Wang Q, 2005, BRIT J PHARMACOL, V144, P933, DOI 10.1038/sj.bjp.0706106; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wiesbauer F, 2002, BRIT J PHARMACOL, V135, P284, DOI 10.1038/sj.bjp.0704454; Zou MH, 2002, J CLIN INVEST, V109, P817, DOI 10.1172/JCI200214442	47	35	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17062	10.1371/journal.pone.0017062	http://dx.doi.org/10.1371/journal.pone.0017062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373645	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500030
J	Depinay, N; Franetich, JF; Gruner, AC; Mauduit, M; Chavatte, JM; Luty, AJF; van Gemert, GJ; Sauerwein, RW; Siksik, JM; Hannoun, L; Mazier, D; Snounou, G; Renia, L				Depinay, Nadya; Franetich, Jean Francois; Gruener, Anne Charlotte; Mauduit, Marjorie; Chavatte, Jean-Marc; Luty, Adrian J. F.; van Gemert, Geert-Jan; Sauerwein, Robert W.; Siksik, Jean-Michel; Hannoun, Laurent; Mazier, Dominique; Snounou, Georges; Renia, Laurent			Inhibitory Effect of TNF-alpha on Malaria Pre-Erythrocytic Stage Development: Influence of Host Hepatocyte/Parasite Combinations	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PLASMODIUM CIRCUMSPOROZOITE PROTEIN; RECOMBINANT INTERFERON-GAMMA; IN-VITRO; PLASMA-PROTEINS; FACTOR RECEPTOR; HEPATIC PHASE; LIVER STAGES; SERUM-LEVELS; CRUCIAL ROLE	Background: The liver stages of malaria parasites are inhibited by cytokines such as interferon-gamma or Interleukin (IL)-6. Binding of these cytokines to their receptors at the surface of the infected hepatocytes leads to the production of nitric oxide (NO) and radical oxygen intermediates (ROI), which kill hepatic parasites. However, conflicting results were obtained with TNF-alpha possibly because of differences in the models used. We have reassessed the role of TNF-alpha in the different cellular systems used to study the Plasmodium pre-erythrocytic stages. Methods and Findings: Human or mouse TNF-alpha were tested against human and rodent malaria parasites grown in vitro in human or rodent primary hepatocytes, or in hepatoma cell lines. Our data demonstrated that TNF-alpha treatment prevents the development of malaria pre-erythrocytic stages. This inhibitory effect however varies with the infecting parasite species and with the nature and origin of the cytokine and hepatocytes. Inhibition was only observed for all parasite species tested when hepatocytes were pre-incubated 24 or 48 hrs before infection and activity was directed only against early hepatic parasite. We further showed that TNF-alpha a inhibition was mediated by a soluble factor present in the supernatant of TNF-alpha stimulated hepatocytes but it was not related to NO or ROI. Treatment TNF-alpha prevents the development of human and rodent malaria pre-erythrocytic stages through the activity of a mediator that remains to be identified. Conclusions: Treatment TNF-alpha prevents the development of human and rodent malaria pre-erythrocytic stages through the activity of a mediator that remains to be identified. However, the nature of the cytokine-host cell-parasite combination must be carefully considered for extrapolation to the human infection.	[Depinay, Nadya; Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] Univ Paris 05, CNRS, Inst Cochin, Dept Immunol,UMR 8104, Paris, France; [Depinay, Nadya; Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] INSERM, U567, Paris, France; [Franetich, Jean Francois; Mazier, Dominique; Snounou, Georges] INSERM, UMRS 945, Paris, France; [Franetich, Jean Francois; Mazier, Dominique; Snounou, Georges] Univ Paris 06, Fac Med Pitie Salpetriere, Paris, France; [Gruener, Anne Charlotte; Mauduit, Marjorie; Renia, Laurent] Biopolis, Singapore Immunol Network, Agcy Sci Technol & Res A STAR, Singapore, Singapore; [Chavatte, Jean-Marc; Snounou, Georges] Museum Natl Hist Nat, CNRS, Equipe Parasitol Comparee & Modeles Expt USM0307, IFR101, Paris, France; [Luty, Adrian J. F.; van Gemert, Geert-Jan; Sauerwein, Robert W.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Siksik, Jean-Michel; Hannoun, Laurent] Univ Pitie Salpetriere, AP HP, Ctr Hosp, Serv Chirurg Digest,Hepatobilio Pancreat & Transp, Paris, France; [Mazier, Dominique; Snounou, Georges] Univ Pitie Salpetriere, AP HP, Ctr Hosp, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Radboud University Nijmegen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Depinay, N (corresponding author), Univ Paris 05, CNRS, Inst Cochin, Dept Immunol,UMR 8104, Paris, France.	renia_laurent@immunol.a-star.edu.sg	Luty, Adrian/CAH-2547-2022; Snounou, Georges/F-3352-2011; Franetich, Jean-François/GZA-9674-2022; Renia, Laurent/E-2117-2011; Gruner, Anne Charlotte/C-1841-2012; Sauerwein, Robert/C-8519-2013	Snounou, Georges/0000-0002-6133-6398; Renia, Laurent/0000-0003-0349-1557; Luty, Adrian John Frederick/0000-0001-8830-3425; Chavatte, Jean-Marc/0000-0002-0003-541X	Agency for Science, Technology and Research (A*STAR); Institut National de la Sante et de la Recherche Medicale (INSERM); European community [LSH-CT-2005-01299]	Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); European community(European Commission)	This work was supported by intramural grants from the Agency for Science, Technology and Research (A*STAR) and Institut National de la Sante et de la Recherche Medicale (INSERM), and by a grant from the European community (MALINV contract number LSH-CT-2005-01299) (L.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; BAUMANN H, 1987, J IMMUNOL, V139, P4122; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; CALVOCALLE JM, 1994, EXP PARASITOL, V79, P362, DOI 10.1006/expr.1994.1098; CASTELL JV, 1989, FEBS LETT, V242, P237, DOI 10.1016/0014-5793(89)80476-4; CLARK IA, 1987, J IMMUNOL, V139, P3493; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Cotgreave I A, 1997, Adv Pharmacol, V38, P205; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fey G H, 1990, Prog Liver Dis, V9, P89; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gego A, 2006, ANTIMICROB AGENTS CH, V50, P1586, DOI 10.1128/AAC.50.4.1586-1589.2006; GHEZZI P, 1988, LYMPHOKINE RES, V7, P157; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hernandez-Valladares M, 2006, EXP PARASITOL, V114, P271, DOI 10.1016/j.exppara.2006.04.003; HOLLINGDALE MR, 1983, AM J TROP MED HYG, V32, P682, DOI 10.4269/ajtmh.1983.32.682; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Lee HJ, 2007, J MOL BIOL, V369, P967, DOI 10.1016/j.jmb.2007.03.072; MAGIELSKAZERO D, 1988, BIOCHEM INT, V17, P17; Marussig M, 1997, INT IMMUNOL, V9, P1817, DOI 10.1093/intimm/9.12.1817; MAZIER D, 1990, IMMUNOL LETT, V25, P65, DOI 10.1016/0165-2478(90)90093-6; MAZIER D, 1990, B WORLD HEALTH ORGAN, V68, P126; Mordmuller BG, 1997, EUR CYTOKINE NETW, V8, P29; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mota MM, 2000, EXP PARASITOL, V96, P257, DOI 10.1006/expr.2000.4570; NUDELMAN S, 1989, J IMMUNOL, V143, P996; NUSSLER A, 1991, INT IMMUNOL, V3, P317, DOI 10.1093/intimm/3.4.317; NUSSLER A, 1991, EUR J IMMUNOL, V21, P227, DOI 10.1002/eji.1830210134; NUSSLER A, 1991, EXP PARASITOL, V72, P1, DOI 10.1016/0014-4894(91)90114-C; PIED S, 1989, INFECT IMMUN, V57, P278, DOI 10.1128/IAI.57.1.278-282.1989; PIED S, 1991, PARASITE IMMUNOL, V13, P211, DOI 10.1111/j.1365-3024.1991.tb00276.x; PIED S, 1995, PARASITE, V2, P263, DOI 10.1051/parasite/1995023263; PONNUDURAI T, 1983, PARASITOLOGY, V87, P439, DOI 10.1017/S0031182000082962; RENIA L, 1990, EUR J IMMUNOL, V20, P1445, DOI 10.1002/eji.1830200706; SCHOFIELD L, 1988, 10TH M SCI WORK GROU, P17; Silvie O, 2004, J BIOL CHEM, V279, P9490, DOI 10.1074/jbc.M311331200; Silvie O, 2006, CELL MICROBIOL, V8, P1134, DOI 10.1111/j.1462-5822.2006.00697.x; Singh AP, 2007, CELL, V131, P492, DOI 10.1016/j.cell.2007.09.013; SOUTHAN GJ, 1995, BRIT J PHARMACOL, V114, P510, DOI 10.1111/j.1476-5381.1995.tb13256.x; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; Yamada Y, 1998, HEPATOLOGY, V28, P959, DOI 10.1002/hep.510280410; YAP SH, 1991, BIOCHIM BIOPHYS ACTA, V1091, P405, DOI 10.1016/0167-4889(91)90207-E	49	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17464	10.1371/journal.pone.0017464	http://dx.doi.org/10.1371/journal.pone.0017464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394207	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500015
J	Chan, JYH; Tsai, CY; Wu, CHY; Li, FCH; Dai, KY; Sun, EYH; Chan, SHH; Chang, AYW				Chan, Julie Y. H.; Tsai, Ching-Yi; Wu, Carol H. Y.; Li, Faith C. H.; Dai, Kuang-Yu; Sun, Enya Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.			Sumoylation of Hypoxia-Inducible Factor-1 alpha Ameliorates Failure of Brain Stem Cardiovascular Regulation in Experimental Brain Death	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYSTEMIC ARTERIAL-PRESSURE; NITRIC-OXIDE SYNTHASE; ACUTE MEVINPHOS INTOXICATION; HEART-RATE SIGNALS; FACTOR-I; VASOMOTOR COMPONENT; SPECTRAL-ANALYSIS; SUMO CONJUGATION; GENE-EXPRESSION	Background: One aspect of brain death is cardiovascular deregulation because asystole invariably occurs shortly after its diagnosis. A suitable neural substrate for mechanistic delineation of this aspect of brain death resides in the rostral ventrolateral medulla (RVLM). RVLM is the origin of a life-and-death signal that our laboratory detected from blood pressure of comatose patients that disappears before brain death ensues. At the same time, transcriptional upregulation of heme oxygenase-1 in RVLM by hypoxia-inducible factor-1 alpha (HIF-1a) plays a pro-life role in experimental brain death, and HIF-1a is subject to sumoylation activated by transient cerebral ischemia. It follows that sumoylation of HIF-1a in RVLM in response to hypoxia may play a modulatory role on brain stem cardiovascular regulation during experimental brain death. Methodology/Principal Findings: A clinically relevant animal model that employed mevinphos as the experimental insult in Sprague-Dawley rat was used. Biochemical changes in RVLM during distinct phenotypes in systemic arterial pressure spectrum that reflect maintained or defunct brain stem cardiovascular regulation were studied. Western blot analysis, EMSA, ELISA, confocal microscopy and immunoprecipitation demonstrated that drastic tissue hypoxia, elevated levels of proteins conjugated by small ubiquitin-related modifier-1 (SUMO-1), Ubc9 (the only known conjugating enzyme for the sumoylation pathway) or HIF-1 alpha, augmented sumoylation of HIF-1 alpha, nucleus-bound translocation and enhanced transcriptional activity of HIF-1 alpha in RVLM neurons took place preferentially during the pro-life phase of experimental brain death. Furthermore, loss-of-function manipulations by immunoneutralization of SUMO-1, Ubc9 or HIF-1 alpha in RVLM blunted the upregulated nitric oxide synthase I/protein kinase G signaling cascade, which sustains the brain stem cardiovascular regulatory machinery during the pro-life phase. Conclusions/Significance: We conclude that sumoylation of HIF-1 alpha in RVLM ameliorates brain stem cardiovascular regulatory failure during experimental brain death via upregulation of nitric oxide synthase I/protein kinase G signaling. This information should offer new therapeutic initiatives against this fatal eventuality.	[Chan, Julie Y. H.] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Chan, Julie Y. H.; Tsai, Ching-Yi; Wu, Carol H. Y.; Li, Faith C. H.; Dai, Kuang-Yu; Sun, Enya Y. H.; Chan, Samuel H. H.; Chang, Alice Y. W.] Chang Gung Mem Hosp, Kaohsiung Med Ctr, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital; Chang Gung Memorial Hospital	Chan, JYH (corresponding author), Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan.	shhchan@adm.cgmh.org.tw; cgmf.kmc@gmail.com	Chan, Julie/X-5253-2019; Tsai, CY/AAV-9723-2021	Tsai, CY/0000-0002-9548-9851	National Science Council, Taiwan, Republic of China [NSC98-2321-B075-B-001, NSC97-2320-B-182A-007-MY3, NSC97-2321-B-182A-006, NSC98-2321-B-182A-003, NSC99-2321-B-182A-006]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Taiwan, Republic of China (NSC98-2321-B075-B-001 to J.Y.H.C.; NSC97-2320-B-182A-007-MY3 to S.H.H.C.; and NSC97-2321-B-182A-006, NSC98-2321-B-182A-003 and NSC99-2321-B-182A-006 (A.Y.W.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Beetz N, 2009, J CLIN INVEST, V119, P3597, DOI 10.1172/JCI38433; Bernhardt WM, 2007, METHOD ENZYMOL, V435, P221, DOI 10.1016/S0076-6879(07)35012-X; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Chan JYH, 2007, J PHYSIOL-LONDON, V581, P1293, DOI 10.1113/jphysiol.2007.130872; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; Chan JYH, 2005, NEUROPHARMACOLOGY, V48, P161, DOI 10.1016/j.neuropharm.2004.08.012; Chan JYH, 2004, NEUROPHARMACOLOGY, V46, P1184, DOI 10.1016/j.neuropharm.2004.01.017; Chang AYW, 2009, SHOCK, V32, P651, DOI 10.1097/SHK.0b013e3181a71027; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Cheng JK, 2006, NEOPLASIA, V8, P667, DOI 10.1593/neo.06445; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Dai KY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-72; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; GILL G, 2009, GENE DEV, V18, P2046; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hellwig-Burgel T, 2005, J INTERF CYTOK RES, V25, P297, DOI 10.1089/jir.2005.25.297; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Louapre P, 2005, CELL STRESS CHAPERON, V10, P17, DOI 10.1379/CSC-74R.1; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; McLaren AT, 2007, AM J PHYSIOL-REG I, V292, pR403, DOI 10.1152/ajpregu.00403.2006; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Natarajan R, 2005, BIOCHEM CELL BIOL, V83, P597, DOI 10.1139/o05-047; Pallis CA, 1983, ABC BRAIN STEM DEATH; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; Pouyssegur J, 2006, BIOL CHEM, V387, P1337, DOI 10.1515/BC.2006.167; Rapino C, 2005, AGING CELL, V4, P177, DOI 10.1111/j.1474-9726.2005.00161.x; Rosenberger C, 2005, KIDNEY INT, V67, P531, DOI 10.1111/j.1523-1755.2005.67110.x; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yen DHT, 2005, SHOCK, V23, P353, DOI 10.1097/01.shk.0000156673.44063.e8; Yen DHT, 2001, SHOCK, V15, P35, DOI 10.1097/00024382-200115010-00006; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; Yin JH, 2000, BIOCHEM BIOPH RES CO, V279, P30, DOI 10.1006/bbrc.2000.3896	54	22	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17375	10.1371/journal.pone.0017375	http://dx.doi.org/10.1371/journal.pone.0017375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390240	Green Submitted, gold, Green Published			2022-12-27	WOS:000287965200015
J	Martins, R; Silva, B; Proenca, D; Faustino, P				Martins, Rute; Silva, Bruno; Proenca, Daniela; Faustino, Paula			Differential HFE Gene Expression Is Regulated by Alternative Splicing in Human Tissues	PLOS ONE			English	Article							HEMOCHROMATOSIS PROTEIN HFE; TRANSFERRIN RECEPTOR 2; HEREDITARY HEMOCHROMATOSIS; MESSENGER-RNA; HLA-H; HEPCIDIN; LOCALIZATION; VARIANTS; CELLS	Background: The pathophysiology of HFE-derived Hereditary Hemochromatosis and the function of HFE protein in iron homeostasis remain uncertain. Also, the role of alternative splicing in HFE gene expression regulation and the possible function of the corresponding protein isoforms are still unknown. The aim of this study was to gain insights into the physiological significance of these alternative HFE variants. Methodology/Principal Findings: Alternatively spliced HFE transcripts in diverse human tissues were identified by RT-PCR, cloning and sequencing. Total HFE transcripts, as well as two alternative splicing transcripts were quantified using a realtime PCR methodology. Intracellular localization, trafficking and protein association of GFP-tagged HFE protein variants were analysed in transiently transfected HepG2 cells by immunoprecipitation and immunofluorescence assays. Alternatively spliced HFE transcripts present both level-and tissue-specificity. Concerning the exon 2 skipping and intron 4 inclusion transcripts, the liver presents the lowest relative level, while duodenum presents one of the highest amounts. The protein resulting from exon 2 skipping transcript is unable to associate with b2M and TfR1 and reveals an ER retention. Conversely, the intron 4 inclusion transcript gives rise to a truncated, soluble protein (sHFE) that is mostly secreted by cells to the medium in association with beta 2M. Conclusions/Significance: HFE gene post-transcriptional regulation is clearly affected by a tissue-dependent alternative splicing mechanism. Among the corresponding proteins, a sHFE isoform stands out, which upon being secreted into the bloodstream, may act in remote tissues. It could be either an agonist or antagonist of the full length HFE, through hepcidin expression regulation in the liver or by controlling dietary iron absorption in the duodenum.	[Martins, Rute; Silva, Bruno; Proenca, Daniela; Faustino, Paula] Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal	Instituto Nacional de Saude Dr. Ricardo Jorge	Martins, R (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Dept Genet, Lisbon, Portugal.	paula.faustino@insa.min-saude.pt	Faustino, Paula/E-4546-2010	Faustino, Paula/0000-0002-6269-4867; Silva, Bruno/0000-0002-1452-9779	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU/GMG/64494/2006, SFRH/BD/21340/2005, SFRH/BD/60718/2009]; Programa de Financiamento Plurianual do CIGMH	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa de Financiamento Plurianual do CIGMH	This work was partially supported by Fundacao para a Ciencia e a Tecnologia (FCT; grant PTDC/SAU/GMG/64494/2006) and Programa de Financiamento Plurianual do CIGMH. RM and BS were supported by FCT fellowships (SFRH/BD/21340/2005 and SFRH/BD/60718/2009). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastin JM, 1998, BRIT J HAEMATOL, V103, P931, DOI 10.1046/j.1365-2141.1998.01102.x; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; CARTWRIGHT GE, 1979, NEW ENGL J MED, V301, P175, DOI 10.1056/NEJM197907263010402; Chen JX, 2007, J BIOL CHEM, V282, P36862, DOI 10.1074/jbc.M706720200; Chen JX, 2009, TRAFFIC, V10, P1488, DOI 10.1111/j.1600-0854.2009.00961.x; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Fleming RE, 2006, AM J PHYSIOL-GASTR L, V290, pG590, DOI 10.1152/ajpgi.00486.2005; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Griffiths WJH, 2000, QJM-MON J ASSOC PHYS, V93, P575, DOI 10.1093/qjmed/93.9.575; Gross CN, 1998, J BIOL CHEM, V273, P22068, DOI 10.1074/jbc.273.34.22068; Hviid TVF, 2006, HUM REPROD UPDATE, V12, P209, DOI 10.1093/humupd/dmi048; Jeffrey GP, 1999, BLOOD CELL MOL DIS, V25, P61, DOI 10.1006/bcmd.1999.0227; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Laham N, 2004, J CELL BIOCHEM, V91, P1130, DOI 10.1002/jcb.20015; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Parkkila S, 1997, P NATL ACAD SCI USA, V94, P2534, DOI 10.1073/pnas.94.6.2534; Parkkila S, 2000, HAEMATOLOGICA, V85, P340; Ramalingam TS, 2000, NAT CELL BIOL, V2, P953, DOI 10.1038/35046611; Rhodes DA, 1999, IMMUNOGENETICS, V49, P357, DOI 10.1007/s002510050505; Sanchez M, 2001, BLOOD CELL MOL DIS, V27, P35, DOI 10.1006/bcmd.2000.0346; Sangrouber D, 2007, J IMMUNOL METHODS, V326, P54, DOI 10.1016/j.jim.2007.07.001; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Spasic MV, 2007, BLOOD, V109, P4511, DOI 10.1182/blood-2006-07-036186; Thenie A, 2000, BLOOD CELL MOL DIS, V26, P155, DOI 10.1006/bcmd.2000.0291; Wallace DF, 2009, HEPATOLOGY, V50, P1992, DOI 10.1002/hep.23198; Walton HS, 2007, J NEUROSCI METH, V160, P294, DOI 10.1016/j.jneumeth.2006.09.022	29	16	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17542	10.1371/journal.pone.0017542	http://dx.doi.org/10.1371/journal.pone.0017542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407826	gold, Green Submitted, Green Published			2022-12-27	WOS:000287965200022
J	Gu, YQ; Rospars, JP				Gu, Yuqiao; Rospars, Jean-Pierre			Dynamical Modeling of the Moth Pheromone-Sensitive Olfactory Receptor Neuron within Its Sensillar Environment	PLOS ONE			English	Article							PHOSPHOLIPASE-C-BETA; ELECTRICAL CIRCUITRY; ODOR TRANSDUCTION; ANTHERAEA-PERNYI; BOMBYX-MORI; ACTIVATION; IDENTIFICATION; MOLECULES; ANTENNAE; CURRENTS	In insects, olfactory receptor neurons (ORNs), surrounded with auxiliary cells and protected by a cuticular wall, form small discrete sensory organs - the sensilla. The moth pheromone-sensitive sensillum is a well studied example of hair-like sensillum that is favorable to both experimental and modeling investigations. The model presented takes into account both the molecular processes of ORNs, i.e. the biochemical reactions and ionic currents giving rise to the receptor potential, and the cellular organization and compartmentalization of the organ represented by an electrical circuit. The number of isopotential compartments needed to describe the long dendrite bearing pheromone receptors was determined. The transduction parameters that must be modified when the number of compartments is increased were identified. This model reproduces the amplitude and time course of the experimentally recorded receptor potential. A first complete version of the model was analyzed in response to pheromone pulses of various strengths. It provided a quantitative description of the spatial and temporal evolution of the pheromone-dependent conductances, currents and potentials along the outer dendrite and served to determine the contribution of the various steps in the cascade to its global sensitivity. A second simplified version of the model, utilizing a single depolarizing conductance and leak conductances for repolarizing the ORN, was derived from the first version. It served to analyze the effects on the sensory properties of varying the electrical parameters and the size of the main sensillum parts. The consequences of the results obtained on the still uncertain mechanisms of olfactory transduction in moth ORNs - involvement or not of G-proteins, role of chloride and potassium currents - are discussed as well as the optimality of the sensillum organization, the dependence of biochemical parameters on the neuron spatial extension and the respective contributions of the biochemical and electrical parameters to the overall neuron response.	[Gu, Yuqiao; Rospars, Jean-Pierre] INRA, UMR 1272, F-78026 Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Gu, YQ (corresponding author), INRA, UMR 1272, F-78026 Versailles, France.	rospars@versailles.inra.fr			French-British ANR BBSRC SysBio [006 01]; European FP7-ICT	French-British ANR BBSRC SysBio(French National Research Agency (ANR)); European FP7-ICT	This work was supported by French-British ANR BBSRC SysBio 006 01 "Pherosys'' (http://www.informatics.sussex.ac.uk/research/projects/PheroSys/index.php/Main_Page) and European FP7-ICT 2007 STREP Bio-ICT convergence "Neurochem'' (http://www.neurochem-project.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altner H., 1980, International Review of Cytology, V67, P69, DOI 10.1016/S0074-7696(08)62427-4; BOEKHOFF I, 1990, CELL SIGNAL, V2, P49, DOI 10.1016/0898-6568(90)90032-6; BOEKHOFF I, 1990, J COMP PHYSIOL B, V160, P99, DOI 10.1007/BF00258768; BOEKHOFF I, 1993, INSECT BIOCHEM MOLEC, V23, P757, DOI 10.1016/0965-1748(93)90063-X; BREER H, 1990, NATURE, V345, P65, DOI 10.1038/345065a0; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chouquet B, 2010, CHEM SENSES, V35, P363, DOI 10.1093/chemse/bjq024; Cole K. S., 1972, MEMBRANE IONS IMPULS; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; DEKRAMER JJ, 1985, J NEUROSCI, V5, P2484; DEKRAMER JJ, 1984, CHEM SENSES, V8, P289, DOI 10.1093/chemse/8.3.289; DEKRAMER JJ, 1982, REGENSBURG; Fabre J-H., 1882, NOUVEAUX SOUVENIRS E; FUTRELLE RP, 1984, TRENDS NEUROSCI, V7, P116, DOI 10.1016/S0166-2236(84)80238-6; GNATZY W, 1984, CELL TISSUE RES, V235, P35; Gu YQ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000321; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Jacquin-Joly E., 2005, CURR TOP NEUROCHEM, V4, P75; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; Kaissling K.-E., 1971, Handbook of sensory physiology, Vol. IV, P351; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; Kaissling KE, 2009, J COMP PHYSIOL A, V195, P895, DOI 10.1007/s00359-009-0461-4; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kaissling KE, 2004, CHEM SENSES, V29, P529, DOI 10.1093/chemse/bjh057; Kaissling KE, 1998, CHEM SENSES, V23, P99, DOI 10.1093/chemse/23.1.99; Kaissling KE, 1998, CHEM SENSES, V23, P385, DOI 10.1093/chemse/23.4.385; Kaissling KE, 2004, ANIR, V6, P73, DOI DOI 10.1371/journal.pone.0152147; Kalidas S, 2002, NEURON, V33, P177, DOI 10.1016/S0896-6273(02)00560-3; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Keil T.A., 1984, P477; KEIL TA, 1984, ZOOMORPHOLOGY, V104, P147, DOI 10.1007/BF00312133; Keil Thomas A., 1999, P5; Kleene SJ, 2008, CHEM SENSES, V33, P839, DOI 10.1093/chemse/bjn048; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Laue M, 1997, CELL TISSUE RES, V288, P149, DOI 10.1007/s004410050802; Laue M, 1997, INT J INSECT MORPHOL, V26, P217, DOI 10.1016/S0020-7322(97)00023-8; Lucas P, 2002, CHEM SENSES, V27, P599, DOI 10.1093/chemse/27.7.599; Maida R, 2000, NEUROREPORT, V11, P1773, DOI 10.1097/00001756-200006050-00035; Minor AV, 2003, J COMP PHYSIOL A, V189, P221, DOI 10.1007/s00359-003-0394-2; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; PAIN J, 1961, ANN ABEILLE, V4, P1; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Pezier A, 2010, J NEUROSCI, V30, P6323, DOI 10.1523/JNEUROSCI.0261-10.2010; Pophof B, 2002, CHEM SENSES, V27, P435, DOI 10.1093/chemse/27.5.435; Rospars JP, 2007, BIOSYSTEMS, V89, P101, DOI 10.1016/j.biosystems.2006.05.015; Rospars JP, 2010, CHINESE J PHYSIOL, V53, P364, DOI 10.4077/CJP.2010.AMM038; Rospars JP, 2003, CHEM SENSES, V28, P509, DOI 10.1093/chemse/28.6.509; Rospars JP, 1996, J COMPUT NEUROSCI, V3, P51, DOI 10.1007/BF00158337; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; SCHNEIDER D, 1968, NATURWISSENSCHAFTEN, V55, P395, DOI 10.1007/BF00593307; Silbering AF, 2010, EMBO REP, V11, P173, DOI 10.1038/embor.2010.8; STENGL M, 1994, J COMP PHYSIOL A, V174, P187; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; Thurm U., 1980, P735; Tuckwell H. C, 1988, INTRO THEORETICAL NE, V1; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V2; Tuckwell HC, 1996, J THEOR BIOL, V181, P25, DOI 10.1006/jtbi.1996.0111; Vermeulen A, 1996, B MATH BIOL, V58, P493, DOI 10.1007/BF02460594; Vermeulen A, 2004, EUR BIOPHYS J BIOPHY, V33, P633, DOI 10.1007/s00249-004-0405-4; Vermeulen A, 2001, NEUROCOMPUTING, V38, P1011, DOI 10.1016/S0925-2312(01)00368-X; Vermeulen A, 2001, EUR BIOPHYS J BIOPHY, V29, P587, DOI 10.1007/s002490000116; Vermeulen A, 1998, J COMPUT NEUROSCI, V5, P243, DOI 10.1023/A:1008826827728; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yao CA, 2010, J NEUROSCI, V30, P4562, DOI 10.1523/JNEUROSCI.6357-09.2010; ZACK C, 1979, THESIS LUDWIGMAXIMIL; ZUFALL F, 1991, J NEUROSCI, V11, P956; ZUFALL F, 1991, P NATL ACAD SCI USA, V88, P8520, DOI 10.1073/pnas.88.19.8520	70	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17422	10.1371/journal.pone.0017422	http://dx.doi.org/10.1371/journal.pone.0017422			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399691	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300023
J	Fischer, H; Scherz, J; Szabo, S; Mildner, M; Benarafa, C; Torriglia, A; Tschachler, E; Eckhart, L				Fischer, Heinz; Scherz, Jennifer; Szabo, Sandra; Mildner, Michael; Benarafa, Charaf; Torriglia, Alicia; Tschachler, Erwin; Eckhart, Leopold			DNase 2 Is the Main DNA-Degrading Enzyme of the Stratum Corneum	PLOS ONE			English	Article							DEOXYRIBONUCLEASE-II; PSEUDOMONAS-AERUGINOSA; SALINE EXTRACTS; HUMAN EPIDERMIS; INHIBITOR; DEGRADATION; APOPTOSIS; SKIN; CASPASE-14; DIFFERENTIATION	The cornified layer, the stratum corneum, of the epidermis is an efficient barrier to the passage of genetic material, i.e. nucleic acids. It contains enzymes that degrade RNA and DNA which originate from either the living part of the epidermis or from infectious agents of the environment. However, the molecular identities of these nucleases are only incompletely known at present. Here we performed biochemical and genetic experiments to determine the main DNase activity of the stratum corneum. DNA degradation assays and zymographic analyses identified the acid endonucleases L-DNase II, which is derived from serpinB1, and DNase 2 as candidate DNases of the cornified layer of the epidermis. siRNA-mediated knockdown of serpinB1 in human in vitro skin models and the investigation of mice deficient in serpinB1a demonstrated that serpinB1-derived L-DNase II is dispensable for epidermal DNase activity. By contrast, knockdown of DNase 2, also known as DNase 2a, reduced DNase activity in human in vitro skin models. Moreover, the genetic ablation of DNase 2a in the mouse was associated with the lack of acid DNase activity in the stratum corneum in vivo. The degradation of endogenous DNA in the course of cornification of keratinocytes was not impaired by the absence of DNase 2. Taken together, these data identify DNase 2 as the predominant DNase on the mammalian skin surface and indicate that its activity is primarily targeted to exogenous DNA.	[Fischer, Heinz; Scherz, Jennifer; Szabo, Sandra; Mildner, Michael; Tschachler, Erwin; Eckhart, Leopold] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Benarafa, Charaf] Univ Bern, Theodor Kocher Inst, Bern, Switzerland; [Torriglia, Alicia] Ctr Rech Cordeliers, INSERM, UMR 872, Paris, France; [Tschachler, Erwin] Ctr Rech & Invest Epiderm & Sensorielle, Neuilly Sur Seine, France	Medical University of Vienna; University of Bern; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Fischer, H (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	leopold.eckhart@meduniwien.ac.at	Torriglia, Alicia/L-6957-2017; Torriglia, Alicia/Q-3509-2019; Fischer, Heinz/AAD-9950-2020	Torriglia, Alicia/0000-0003-1181-6710; Eckhart, Leopold/0000-0002-5645-2036; Fischer, Heinz/0000-0003-1280-0200; Tschachler, Erwin/0000-0002-0248-1798; Mildner, Michael/0000-0002-6892-925X; Benarafa, Charaf/0000-0002-2049-7769	Austrian Science Fund (FWF) [P20043, P21312]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants to LE (Austrian Science Fund (FWF): P20043 and P21312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtin A, 2009, J INVEST DERMATOL, V129, P2193, DOI 10.1038/jid.2009.35; Altairac S, 2003, CELL DEATH DIFFER, V10, P548, DOI 10.1038/sj.cdd.4401195; Benarafa C, 2002, J BIOL CHEM, V277, P42028, DOI 10.1074/jbc.M207080200; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; DIKSTEIN S, 1994, ACTA DERM-VENEREOL, P18; Eckhart L, 2007, BRIT J DERMATOL, V156, P1342, DOI 10.1111/j.1365-2133.2007.07886.x; Eckhart L, 1999, J BIOL CHEM, V274, P2613, DOI 10.1074/jbc.274.5.2613; Elias PM, 2005, J INVEST DERMATOL, V125, P183, DOI 10.1111/j.0022-202X.2005.23668.x; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fischer H, 2004, FEBS LETT, V577, P446, DOI 10.1016/j.febslet.2004.10.046; Fischer H, 2007, J INVEST DERMATOL, V127, P24, DOI 10.1038/sj.jid.5700503; Fischer H, 2011, J INVEST DERMATOL, V131, P1208, DOI 10.1038/jid.2011.13; FORSTER FJ, 1975, ARCH DERMATOL FORSCH, V253, P213, DOI 10.1007/BF00561146; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Howell DPG, 2003, MOL THER, V8, P957, DOI 10.1016/j.ymthe.2003.09.011; Jager K, 2007, DIFFERENTIATION, V75, P939; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Krieser RJ, 2002, CELL DEATH DIFFER, V9, P956, DOI 10.1038/sj.cdd.4401056; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mildner M, 2006, BIOCHEM BIOPH RES CO, V348, P76, DOI 10.1016/j.bbrc.2006.07.035; Nagata S, 2005, ANNU REV IMMUNOL, V23, P853, DOI 10.1146/annurev.immunol.23.021704.115811; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; OHMAN H, 1994, ACTA DERM-VENEREOL, V74, P375; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Pandey S, 1997, BIOCHEMISTRY-US, V36, P711, DOI 10.1021/bi962387h; Parra D, 2009, CANCER RES, V69, P6676, DOI 10.1158/0008-5472.CAN-09-1208; PARRISH JE, 1995, HUM MOL GENET, V4, P1557, DOI 10.1093/hmg/4.9.1557; Raymond AA, 2008, MOL CELL PROTEOMICS, V7, P2151, DOI 10.1074/mcp.M700334-MCP200; Rees DD, 1999, AM J RESP CELL MOL, V20, P69, DOI 10.1165/ajrcmb.20.1.3306; Rendl M, 2002, J INVEST DERMATOL, V119, P1150, DOI 10.1046/j.1523-1747.2002.19532.x; Rossol M, 2009, ANN RHEUM DIS, V68, P1498, DOI 10.1136/ard.2008.092239; SANTOIANNI P, 1961, J INVEST DERMATOL, V37, P489, DOI 10.1038/jid.1961.149; Shiokawa D, 2001, BIOCHEMISTRY-US, V40, P143, DOI 10.1021/bi001041a; TABACHNICK J, 1961, NATURE, V190, P921, DOI 10.1038/190921a0; TABACHNICK J, 1964, J INVEST DERMATOL, V42, P471, DOI 10.1038/jid.1964.100; Torriglia A, 1998, MOL CELL BIOL, V18, P3612, DOI 10.1128/MCB.18.6.3612; Torriglia A, 2009, FRONT BIOSCI-LANDMRK, V14, P4836, DOI 10.2741/3572; Torriglia A, 2008, BIOCHEM PHARMACOL, V76, P1490, DOI 10.1016/j.bcp.2008.07.039; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Yasuda T, 2000, FEBS LETT, V467, P231, DOI 10.1016/S0014-5793(00)01162-5; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146	48	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17581	10.1371/journal.pone.0017581	http://dx.doi.org/10.1371/journal.pone.0017581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390259	Green Published, Green Submitted, gold			2022-12-27	WOS:000287932100024
J	Talbot, K; Louneva, N; Cohen, JW; Kazi, H; Blake, DJ; Arnold, SE				Talbot, Konrad; Louneva, Natalia; Cohen, Julia W.; Kazi, Hala; Blake, Derek J.; Arnold, Steven E.			Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; DORSOLATERAL PREFRONTAL CORTEX; HIPPOCAMPAL-FORMATION; SUSCEPTIBILITY GENE; AUDITORY-CORTEX; NEGATIVE SYMPTOMS; EPISODIC MEMORY; MOOD DISORDERS; MESSENGER-RNA; SPINE DENSITY	Background: An increasing number of studies report associations between variation in DTNBP1, a top candidate gene in schizophrenia, and both the clinical symptoms of the disorder and its cognitive deficits. DTNBP1 encodes dysbindin-1, reduced levels of which have been found in synaptic fields of schizophrenia cases. This study determined whether such synaptic reductions are isoform-specific. Methodology/Principal Findings: Using Western blotting of tissue fractions, we first determined the synaptic localization of the three major dysbindin-1 isoforms (A, B, and C). All three were concentrated in synaptosomes of multiple brain areas, including auditory association cortices in the posterior half of the superior temporal gyrus (pSTG) and the hippocampal formation (HF). Tests on the subsynaptic tissue fractions revealed that each isoform is predominantly, if not exclusively, associated with synaptic vesicles (dysbindin-1B) or with postsynaptic densities (dysbindin-1A and -1C). Using Western blotting on pSTG (n = 15) and HF (n = 15) synaptosomal fractions from schizophrenia cases and their matched controls, we discovered that synaptic dysbindin-1 is reduced in an isoform-specific manner in schizophrenia without changes in levels of synaptophysin or PSD-95. In pSTG, about 92% of the schizophrenia cases displayed synaptic dysbindin-1A reductions averaging 48% (p = 0.0007) without alterations in other dysbindin-1 isoforms. In the HF, by contrast, schizophrenia cases displayed normal levels of synaptic dysbindin-1A, but 67% showed synaptic reductions in dysbindin-1B averaging 33% (p = 0.0256), while 80% showed synaptic reductions in dysbindin-1C averaging 35% (p = 0.0171). Conclusions/Significance: Given the distinctive subsynaptic localization of dysbindin-1A, -1B, and -1C across brain regions, the observed pSTG reductions in dysbindin-1A are postsynaptic and may promote dendritic spine loss with consequent disruption of auditory information processing, while the noted HF reductions in dysbindin-1B and -1C are both presynaptic and postsynaptic and could promote deficits in spatial working memory.	[Talbot, Konrad; Louneva, Natalia; Cohen, Julia W.; Kazi, Hala; Arnold, Steven E.] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Blake, Derek J.] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Blake, Derek J.] Cardiff Univ, Dept Psychol Med & Neurol, Cardiff, S Glam, Wales	University of Pennsylvania; Pennsylvania Medicine; Cardiff University; Cardiff University	Talbot, K (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	talbotk2@mail.med.upenn.edu	Arnold, Steven E/J-7546-2012	Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health [RO1 MH072880, P50 MH064045]; MRC [G0800509] Funding Source: UKRI; Medical Research Council [G0800509, G0801418B] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072880, P50MH064045] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health grants RO1 MH072880 and P50 MH064045 (SEA). The funders had no role in the study design, data collection, data analysis, the decision to publish, or preparation of the manuscript.	Albert KA, 2002, ARCH GEN PSYCHIAT, V59, P705, DOI 10.1001/archpsyc.59.8.705; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; ARNOLD SE, 1995, AM J PSYCHIAT, V152, P731; Barch DM, 2005, ANNU REV CLIN PSYCHO, V1, P321, DOI 10.1146/annurev.clinpsy.1.102803.143959; Bhardwaj SK, 2009, BEHAV BRAIN RES, V197, P435, DOI 10.1016/j.bbr.2008.10.011; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; Burdick KE, 2007, SCHIZOPHR RES, V89, P169, DOI 10.1016/j.schres.2006.09.008; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chance SA, 2008, BRAIN, V131, P3178, DOI 10.1093/brain/awn211; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chiba S, 2006, J NEURAL TRANSM, V113, P1337, DOI 10.1007/s00702-005-0414-1; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Deng C, 2005, J NEUROSCI RES, V81, P883, DOI 10.1002/jnr.20600; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; Diagnostic A, 1994, DIAGN STAT MAN MENT, P886; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Donohoe G, 2007, NEUROPSYCHOLOGIA, V45, P454, DOI 10.1016/j.neuropsychologia.2006.06.016; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Falcon-Perez JM, 2002, PIGM CELL RES, V15, P82, DOI 10.1034/j.1600-0749.2002.1r082.x; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fountoulakis M, 2001, EXP NEUROL, V167, P86, DOI 10.1006/exnr.2000.7529; Garcia-Marti G, 2008, PROG NEURO-PSYCHOPH, V32, P72, DOI 10.1016/j.pnpbp.2007.07.014; Hahn CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005251; Hanlon FM, 2006, SCHIZOPHR RES, V87, P67, DOI 10.1016/j.schres.2006.05.021; Hashimoto T, 2008, MOL PSYCHIATR, V13, P147, DOI 10.1038/sj.mp.4002011; HECKERS S, 2009, HDB NEUROCHEMISTRY M, V27, P315; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Aguilar EJ, 2008, EUR J RADIOL, V67, P434, DOI 10.1016/j.ejrad.2008.02.046; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Kasai K, 2003, AM J PSYCHIAT, V160, P156, DOI 10.1176/appi.ajp.160.1.156; Konopaske GT, 2006, NEUROSCIENCE, V138, P189, DOI 10.1016/j.neuroscience.2005.10.070; Kraus MS, 2007, BRIT J PSYCHIAT, V191, pS46, DOI 10.1192/bjp.191.50.s46; Law AJ, 2004, AM J PSYCHIAT, V161, P1848, DOI 10.1176/appi.ajp.161.10.1848; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; LOUNEVA N, 2009, SOC NEUR ANN M CHIC; Louneva N, 2008, AM J PATHOL, V173, P1488, DOI 10.2353/ajpath.2008.080434; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nazarian R, 2006, BIOCHEM J, V395, P587, DOI 10.1042/BJ20051965; Neckelmann G, 2006, INT J NEUROSCI, V116, P9, DOI 10.1080/00207450690962244; Nestor PG, 2007, PSYCHIAT RES-NEUROIM, V155, P21, DOI 10.1016/j.pscychresns.2006.12.020; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Pae CU, 2008, NEUROSCI LETT, V440, P150, DOI 10.1016/j.neulet.2008.05.069; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Phillips GR, 2005, J NEUROSCI RES, V81, P762, DOI 10.1002/jnr.20614; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Reichenberg A, 2007, PSYCHOL BULL, V133, P833, DOI 10.1037/0033-2909.133.5.833; Rethelyi JM, 2010, AM J MED GENET B, V153B, P792, DOI 10.1002/ajmg.b.31049; Riley B, 2009, SCHIZOPHR RES, V115, P245, DOI 10.1016/j.schres.2009.09.008; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Ryder PV, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293pe66; SMILEY JF, 2009, HDB NEUROCHEMISTRY M, V27, P353; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Stephan KE, 2009, SCHIZOPHRENIA BULL, V35, P509, DOI 10.1093/schbul/sbn176; Sumich A, 2005, BIOL PSYCHIAT, V57, P947, DOI 10.1016/j.biopsych.2004.12.041; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Sun JH, 2009, BRAIN RES REV, V61, P14, DOI 10.1016/j.brainresrev.2009.03.004; Sweet RA, 2005, J COMP NEUROL, V491, P270, DOI 10.1002/cne.20702; Sweet RA, 2004, BIOL PSYCHIAT, V55, P1128, DOI 10.1016/j.biopsych.2004.03.002; Sweet RA, 2007, BIOL PSYCHIAT, V61, P854, DOI 10.1016/j.biopsych.2006.07.033; Sweet RA, 2009, NEUROPSYCHOPHARMACOL, V34, P374, DOI 10.1038/npp.2008.67; Szeszko PR, 2002, AM J PSYCHIAT, V159, P217, DOI 10.1176/appi.ajp.159.2.217; Takahashi T, 2006, SCHIZOPHR RES, V83, P131, DOI 10.1016/j.schres.2006.01.016; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; TALBOT K, 2009, HDB NEUROCHEMISTRY M, V27, P107; Talbot K, 2006, HUM MOL GENET, V15, P3041, DOI 10.1093/hmg/ddl246; Talbot K, 2009, PROG BRAIN RES, V179, P87, DOI 10.1016/S0079-6123(09)17910-4; Tang JX, 2009, HUM MOL GENET, V18, P3851, DOI 10.1093/hmg/ddp329; Thoma RJ, 2009, J INT NEUROPSYCH SOC, V15, P182, DOI 10.1017/S1355617709090225; Toulopoulou T, 2004, BIOL PSYCHIAT, V56, P447, DOI 10.1016/j.biopsych.2004.06.026; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; Velakoulis D, 2006, ARCH GEN PSYCHIAT, V63, P139, DOI 10.1001/archpsyc.63.2.139; Weickert CS, 2008, SCHIZOPHR RES, V98, P105, DOI 10.1016/j.schres.2007.05.041; Wessman J, 2009, BIOL PSYCHIAT, V66, P990, DOI 10.1016/j.biopsych.2009.05.034; Wirgenes KV, 2009, NEUROPSYCHOBIOLOGY, V60, P31, DOI 10.1159/000235799; Zinkstok JR, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-19; Zuo LJ, 2009, PSYCHIAT GENET, V19, P292, DOI 10.1097/YPG.0b013e32832a50bc	85	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16886	10.1371/journal.pone.0016886	http://dx.doi.org/10.1371/journal.pone.0016886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390302	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287932100006
J	Hoffmann, S; Falkenstein, M				Hoffmann, Sven; Falkenstein, Michael			Aging and Error Processing: Age Related Increase in the Variability of the Error-Negativity Is Not Accompanied by Increase in Response Variability	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; WORD RECOGNITION; NEURAL SYSTEM; PERFORMANCE; OLDER; YOUNGER; LOCALIZATION; DOPAMINE; DYNAMICS; REFLECT	Background: Several studies report an amplitude reduction of the error negativity (Ne or ERN), an event-related potential occurring after erroneous responses, in older participants. In earlier studies it was shown that the Ne can be explained by a single independent component. In the present study we aimed to investigate whether the Ne reduction usually found in older subjects is due to an altered component structure, i.e., a true alteration in response monitoring in older subjects. Methodology/Principal Findings: Two age groups conducted two tasks with different stimulus response mappings and task difficulty. Both groups received fully balanced speed or accuracy instructions and an individually adapted deadline in both tasks. Event-related potentials, Independent Component analysis of EEG-data and between trial variability of the Ne were combined with analysis of error rates, coefficients of variation of RT-data and ex-Gaussian fittings to reaction times. The Ne was examined by means of ICA and PCA, yielding a prominent independent component on error trials, the Ne-IC. The Ne-IC was smaller in the older than the younger subjects for both speed and accuracy instructions. Also, the Ne-IC contributed to a much lesser extent to the Ne in older than in younger subjects. RT distribution parameters were not related to Ne/ERP-variability. Conclusions/Significance: The results show a genuine reduction as well as a different component structure of the Ne in older compared to young subjects. This reduction is not reflected in behaviour, apart from a general slowing of older participants. Also, the Ne decline in the elderly is not due to speed accuracy trade-off. Hence, the results indicate that older subjects can compensate the reduction in control reflected in the reduced Ne, at least in simple tasks that induce reaction slips.	[Hoffmann, Sven; Falkenstein, Michael] Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Hoffmann, S (corresponding author), Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	shoffmann@ifado.de	Falkenstein, Michael/ABA-7497-2020	Hoffmann, Sven/0000-0002-4521-8332	German Research Foundation [FA 211/23-1]	German Research Foundation(German Research Foundation (DFG))	The study was funded by a grant of the German Research Foundation (FA 211/23-1) to M. Falkenstein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Balota DA, 1999, J EXP PSYCHOL GEN, V128, P32, DOI 10.1037/0096-3445.128.1.32; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Carbonnell L, 2006, BRAIN RES, V1095, P124, DOI 10.1016/j.brainres.2006.04.004; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI, V5, P303, DOI 10.1111/j.1467-9280.1994.tb00630.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Dywan J, 2008, PSYCHOPHYSIOLOGY, V45, P389, DOI 10.1111/j.1469-8986.2007.00637.x; Eppinger B, 2008, NEUROPSYCHOLOGIA, V46, P521, DOI 10.1016/j.neuropsychologia.2007.09.001; Falkenstein M, 2006, INT J PSYCHOPHYSIOL, V59, P22, DOI 10.1016/j.ijpsycho.2005.08.004; Falkenstein M, 2001, EXP BRAIN RES, V138, P258, DOI 10.1007/s002210100712; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Falkenstein M., 1990, PSYCHOPHYSIOLOGICAL, P192; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; KAVANAGH RN, 1978, IEEE T BIO-MED ENG, V25, P421, DOI 10.1109/TBME.1978.326339; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Lee TW, 1999, NEURAL COMPUT, V11, P417, DOI 10.1162/089976699300016719; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Maier M, 2008, J COGNITIVE NEUROSCI, V20, P2263, DOI 10.1162/jocn.2008.20159; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; Masaki H, 2007, PSYCHOPHYSIOLOGY, V44, P579, DOI 10.1111/j.1469-8986.2007.00522.x; Mathalon DH, 2003, NEUROBIOL AGING, V24, P675, DOI 10.1016/S0197-4580(02)00154-9; Mathewson KJ, 2005, BIOL PSYCHOL, V70, P88, DOI 10.1016/j.biopsycho.2004.12.005; McAuley T, 2006, DEV NEUROPSYCHOL, V29, P447, DOI 10.1207/s15326942dn2903_4; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; Myerson J, 2007, J EXP ANAL BEHAV, V88, P319, DOI 10.1901/jeab.2007.88-319; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Pietschmann M, 2008, PSYCHOPHYSIOLOGY, V45, P559, DOI 10.1111/j.1469-8986.2008.00651.x; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; SCHERG M, 1990, Brain Topography, V3, P268; Spieler DH, 1996, J EXP PSYCHOL HUMAN, V22, P461, DOI 10.1037/0096-1523.22.2.461; Spieler DH, 2000, J EXP PSYCHOL HUMAN, V26, P506, DOI 10.1037//0096-1523.26.2.506; Tewes U., 1994, HAMBURG WECHSLER INT; Wascher E, 1999, J COGNITIVE NEUROSCI, V11, P214, DOI 10.1162/089892999563346; West R, 2002, BRAIN COGNITION, V49, P402, DOI 10.1006/brcg.2001.1507; Willemssen R, 2004, PSYCHOPHYSIOLOGY, V41, P762, DOI 10.1111/j.1469-8986.2004.00201.x; [No title captured]; [No title captured]; [No title captured]	49	38	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17482	10.1371/journal.pone.0017482	http://dx.doi.org/10.1371/journal.pone.0017482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729EM	21386986	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400082
J	Kramer, P; Di Bono, MG; Zorzi, M				Kramer, Peter; Di Bono, Maria Grazia; Zorzi, Marco			Numerosity Estimation in Visual Stimuli in the Absence of Luminance-Based Cues	PLOS ONE			English	Article							LARGE-NUMBER DISCRIMINATION; TEXTURE DENSITY ADAPTATION; PERCEIVED NUMEROSITY; REPRESENTATION; JUDGMENT; MAGNITUDE; QUANTITY; MONKEYS	Background: Numerosity estimation is a basic preverbal ability that humans share with many animal species and that is believed to be foundational of numeracy skills. It is notoriously difficult, however, to establish whether numerosity estimation is based on numerosity itself, or on one or more non-numerical cues like-in visual stimuli-spatial extent and density. Frequently, different non-numerical cues are held constant on different trials. This strategy, however, still allows numerosity estimation to be based on a combination of non-numerical cues rather than on any particular one by itself. Methodology/Principal Findings: Here we introduce a novel method, based on second-order ( contrast-based) visual motion, to create stimuli that exclude all first-order ( luminance-based) cues to numerosity. We show that numerosities can be estimated almost as well in second-order motion as in first-order motion. Conclusions/Significance: The results show that numerosity estimation need not be based on first-order spatial filtering, first-order density perception, or any other processing of luminance-based cues to numerosity. Our method can be used as an effective tool to control non-numerical variables in studies of numerosity estimation.	[Kramer, Peter; Di Bono, Maria Grazia; Zorzi, Marco] Univ Padua, Dipartimento Psicol Gen, Padua, Italy	University of Padua	Kramer, P (corresponding author), Univ Padua, Dipartimento Psicol Gen, Padua, Italy.	peter.kramer@unipd.it	Kramer, Peter/O-6633-2015; Zorzi, Marco/B-7863-2008	Kramer, Peter/0000-0003-4807-7077; Zorzi, Marco/0000-0002-4651-6390	Cariparo Foundation; Italian Ministry of Education and Scientific Research	Cariparo Foundation(Fondazione Cariparo); Italian Ministry of Education and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study was in part supported by grants from the Cariparo Foundation (Progetti di Eccellenza 2007) and the Italian Ministry of Education and Scientific Research (PRIN 2008) to MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; ALLIK J, 1991, PERCEPT PSYCHOPHYS, V49, P303, DOI 10.3758/BF03205986; Alvarez GA, 2008, PSYCHOL SCI, V19, P392, DOI 10.1111/j.1467-9280.2008.02098.x; Alvarez GA, 2009, P NATL ACAD SCI USA, V106, P7345, DOI 10.1073/pnas.0808981106; Ariely D, 2001, PSYCHOL SCI, V12, P157, DOI 10.1111/1467-9280.00327; Armstrong V, 2009, VISION RES, V49, P2774, DOI 10.1016/j.visres.2009.08.016; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2006, Q J EXP PSYCHOL, V59, P2065, DOI 10.1080/17470210600701171; BEVAN W, 1963, AM J PSYCHOL, V76, P464, DOI 10.2307/1419789; BEVAN W, 1964, J EXPT PSYCHOL HUMAN, V102, P537; Burr D, 2008, CURR BIOL, V18, pR857, DOI 10.1016/j.cub.2008.07.052; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Chong SC, 2003, VISION RES, V43, P393, DOI 10.1016/S0042-6989(02)00596-5; CHURCH RM, 1990, COGNITION, V37, P55, DOI 10.1016/0010-0277(90)90018-F; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; DURGIN FH, 1995, J EXP PSYCHOL HUMAN, V21, P149, DOI 10.1037/0096-1523.21.1.149; Durgin FH, 2008, CURR BIOL, V18, pR855, DOI 10.1016/j.cub.2008.07.053; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Franconeri SL, 2009, COGNITION, V113, P1, DOI 10.1016/j.cognition.2009.07.002; FRITH CD, 1972, PERCEPT PSYCHOPHYS, V11, P409, DOI 10.3758/BF03206279; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GINSBURG N, 1988, PERCEPT MOTOR SKILL, V67, P656, DOI 10.2466/pms.1988.67.2.656; GINSBURG N, 1978, AM J PSYCHOL, V91, P267, DOI 10.2307/1421536; GINSBURG N, 1987, AM J PSYCHOL, V100, P193, DOI 10.2307/1422403; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; He LX, 2009, PSYCHON B REV, V16, P509, DOI 10.3758/PBR.16.3.509; Henderson JM, 2003, PSYCHOL SCI, V14, P493, DOI 10.1111/1467-9280.02459; HOLLINGSWORTH WH, 1991, B PSYCHONOMIC SOC, V29, P448; Hsu LC, 2006, VISION RES, V46, P1973, DOI 10.1016/j.visres.2005.11.004; INDOW T, 1977, PERCEPT PSYCHOPHYS, V22, P265, DOI 10.3758/BF03199689; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Izard V, 2008, COGNITION, V106, P1221, DOI 10.1016/j.cognition.2007.06.004; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; Jordan KE, 2008, COGNITION, V108, P617, DOI 10.1016/j.cognition.2008.05.006; Kovas Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004587; KRUEGER LE, 1982, PERCEPT PSYCHOPHYS, V31, P175, DOI 10.3758/BF03206218; KRUEGER LE, 1972, PERCEPT PSYCHOPHYS, V11, P5, DOI 10.3758/BF03212674; KRUEGER LE, 1984, PERCEPT PSYCHOPHYS, V35, P536, DOI 10.3758/BF03205949; Landy M., 2004, VISUAL NEUROSCIENCES, P1106; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; MASIN SC, 1983, PERCEPT MOTOR SKILL, V56, P851, DOI 10.2466/pms.1983.56.3.851; MILLER AI, 1968, AM J PSYCHOL, V81, P83, DOI 10.2307/1420810; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Pansky A, 2002, J EXP PSYCHOL LEARN, V28, P259, DOI 10.1037//0278-7393.28.2.259; Philippi TG, 2008, BRAIN RES, V1242, P116, DOI 10.1016/j.brainres.2008.05.056; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Shuman M., 2007, THESIS HARVARD U CAM; Sophian C, 2008, COGNITION, V107, P460, DOI 10.1016/j.cognition.2007.10.009; Sophian C, 2007, LECT NOTES ARTIF INT, V4565, P157; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; VOS PG, 1988, PSYCHOL RES-PSYCH FO, V50, P148, DOI 10.1007/BF00310175; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	61	16	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17378	10.1371/journal.pone.0017378	http://dx.doi.org/10.1371/journal.pone.0017378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729EM	21387017	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400066
J	Roghmann, MC; Johnson, JK; Stine, OC; Lydecker, AD; Ryan, KA; Mitchell, BD; Shuldiner, AR				Roghmann, Mary-Claire; Johnson, J. Kristie; Stine, O. Colin; Lydecker, Alison D.; Ryan, Kathleen A.; Mitchell, Braxton D.; Shuldiner, Alan R.			Persistent Staphylococcus aureus Colonization Is Not a Strongly Heritable Trait in Amish Families	PLOS ONE			English	Article							SOFT-TISSUE INFECTIONS; OLD-ORDER AMISH; NASAL CARRIAGE; RECEPTOR GENE; UNITED-STATES; POLYMORPHISMS; POPULATION; PREVALENCE; HOSPITALS; SAMPLES	About 20% of adults are persistently colonized with S. aureus in the anterior nares. Host genetic factors could contribute susceptibility to this phenotype. The objective of this study was to determine whether the phenotype of persistent S. aureus colonization aggregates in family members who live in different households. Healthy adults and their eligible same sex siblings who lived in different households were recruited from the Old Order Amish of Lancaster, Pennsylvania. All participants had two cultures of the anterior nares to determine if they were persistently colonized with S. aureus. Three hundred and ninety eight participants finished the study, of whom 166 were index cases and 232 were siblings of index cases. Eighteen per cent (71/398) of all participants and 17% (29/166) of index cases were persistently colonized with S. aureus. Twenty two per cent (8/36) of siblings of persistently colonized index cases were persistently colonized with S. aureus compared to 17% (34/196) of siblings of non-persistently colonized index cases, yielding a prevalence rate ratio of 1.28 (95% CI: 0.65-2.54, p = 0.64) and sibling relative risk of 1.25 (95% CI: 0.65-2.38, p = 0.51). The heritability of persistent colonization was 0.19 +/- 0.21 (p = 0.31). Persistent S. aureus colonization does not strongly aggregate in Amish family members in different households and heritability is low, suggesting that environmental factors or acquired host factors are more important than host genetic factors in determining persistent S. aureus colonization in this community.	[Roghmann, Mary-Claire; Johnson, J. Kristie; Stine, O. Colin; Lydecker, Alison D.; Ryan, Kathleen A.; Mitchell, Braxton D.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Roghmann, Mary-Claire; Shuldiner, Alan R.] VA Maryland Hlth Care Syst, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore	Roghmann, MC (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.	mroghman@epi.umaryland.edu	Mitchell, Braxton/CAF-0876-2022	Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305; Roghmann, Mary-Claire/0000-0003-1063-9257	National Center for Research Resources at the National Institutes of Health [1K12RR023250]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250] Funding Source: NIH RePORTER	National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	M-C. R., J.K.J., and A. R. S. were supported by grant 1K12RR023250 from the National Center for Research Resources at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; ALY R, 1977, INFECT IMMUN, V17, P546, DOI 10.1128/IAI.17.3.546-549.1977; ALY R, 1974, AM J DIS CHILD, V127, P486, DOI 10.1001/archpedi.1974.02110230032004; Bancroft EA, 2007, JAMA-J AM MED ASSOC, V298, P1803, DOI 10.1001/jama.298.15.1803; Blangero J, 2001, ADV GENET, V42, P151, DOI 10.1016/S0065-2660(01)42021-9; Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Claassen M, 2005, FEMS IMMUNOL MED MIC, V43, P173, DOI 10.1016/j.femsim.2004.08.002; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Emonts M, 2008, J INFECT DIS, V197, P1244, DOI 10.1086/533501; Emonts M, 2007, FEMS IMMUNOL MED MIC, V50, P330, DOI 10.1111/j.1574-695X.2007.00250.x; Eveillard M, 2004, INFECT CONT HOSP EP, V25, P114, DOI 10.1086/502360; Graham PL, 2006, ANN INTERN MED, V144, P318, DOI 10.7326/0003-4819-144-5-200603070-00006; HOEKSMA A, 1963, Acta Leiden, V32, P123; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Lautenbach E, 2009, INFECT CONT HOSP EP, V30, P380, DOI 10.1086/596045; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Morrison MA, 2006, J HOSP INFECT, V62, P241, DOI 10.1016/j.jhin.2005.07.011; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; NOBLE WC, 1967, J HYG-CAMB, V65, P567, DOI 10.1017/S002217240004609X; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; Pallin DJ, 2008, ANN EMERG MED, V51, P291, DOI 10.1016/j.annemergmed.2007.12.004; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Pollin TI, 2008, HUM HERED, V65, P91, DOI 10.1159/000108941; van Belkum A, 2007, MICROBES INFECT, V9, P1471, DOI 10.1016/j.micinf.2007.08.003; van den Akker ELT, 2006, J INFECT DIS, V194, P814, DOI 10.1086/506367; Van Hout CV, 2010, GENET EPIDEMIOL, V34, P146, DOI 10.1002/gepi.20444; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4	32	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17368	10.1371/journal.pone.0017368	http://dx.doi.org/10.1371/journal.pone.0017368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386985	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400065
J	Loset, GA; Bogen, B; Sandlie, I				Loset, Geir Age; Bogen, Bjarne; Sandlie, Inger			Expanding the Versatility of Phage Display I: Efficient Display of Peptide-Tags on Protein VII of the Filamentous Phage	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; COAT PROTEIN; SYSTEM; SELECTION; LIBRARIES; GENES; RESPONSES; LIGANDS; COMPLEX; FORMAT	Background: Phage display is a platform for selection of specific binding molecules and this is a clear-cut motivation for increasing its performance. Polypeptides are normally displayed as fusions to the major coat protein VIII (pVIII), or the minor coat protein III (pIII). Display on other coat proteins such as pVII allows for display of heterologous peptide sequences on the virions in addition to those displayed on pIII and pVIII. In addition, pVII display is an alternative to pIII or pVIII display. Methodology/Principal Findings: Here we demonstrate how standard pIII or pVIII display phagemids are complemented with a helper phage which supports production of virions that are tagged with octa FLAG, HIS(6) or AviTag on pVII. The periplasmic signal sequence required for pIII and pVIII display, and which has been added to pVII in earlier studies, is omitted altogether. Conclusions/Significance: Tagging on pVII is an important and very useful add-on feature to standard pIII and pVII display. Any phagemid bearing a protein of interest on either pIII or pVIII can be tagged with any of the tags depending simply on choice of helper phage. We show in this paper how such tags may be utilized for immobilization and separation as well as purification and detection of monoclonal and polyclonal phage populations.	[Loset, Geir Age; Bogen, Bjarne; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Loset, Geir Age; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Loset, GA (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	g.a.loset@imbv.uio.no; inger.sandlie@imbv.uio.no	Løset, Geir/I-6413-2015	Løset, Geir/0000-0002-5257-8571	Research Council of Norway [174796]	Research Council of Norway(Research Council of Norway)	GAL was supported by the Research Council of Norway (grant no. 174796). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balass M, 1996, ANAL BIOCHEM, V243, P264, DOI 10.1006/abio.1996.0515; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bar H, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-37; BOGEN B, 1990, EUR J IMMUNOL, V20, P2359, DOI 10.1002/eji.1830201030; BOWLEY DR, 2009, P NATL ACAD SCI US; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; Chen LM, 2004, CHEM BIOL, V11, P1081, DOI 10.1016/j.chembiol.2004.05.019; CRAMERI R, 1994, EUR J BIOCHEM, V226, P53, DOI 10.1111/j.1432-1033.1994.tb20025.x; De Berardinis P, 2000, NAT BIOTECHNOL, V18, P873, DOI 10.1038/78490; ENDEMANN H, 1995, J MOL BIOL, V250, P496, DOI 10.1006/jmbi.1995.0393; Gao CS, 1999, P NATL ACAD SCI USA, V96, P6025, DOI 10.1073/pnas.96.11.6025; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hufton SE, 1999, J IMMUNOL METHODS, V231, P39, DOI 10.1016/S0022-1759(99)00139-8; IVEYHOYLE M, 1989, J MOL BIOL, V208, P233, DOI 10.1016/0022-2836(89)90385-9; Khalil AS, 2007, P NATL ACAD SCI USA, V104, P4892, DOI 10.1073/pnas.0605727104; Kwasnikowski P, 2005, J IMMUNOL METHODS, V307, P135, DOI 10.1016/j.jim.2005.10.002; Lauvrak V, 2004, SCAND J IMMUNOL, V59, P373, DOI 10.1111/j.1365-3083.2004.01400.x; Lee YJ, 2009, SCIENCE, V324, P1051, DOI [10.1126/science.1171541, 10.1126/science.1169041]; Loset GA, 2007, PROTEIN ENG DES SEL, V20, P461, DOI 10.1093/protein/gzm044; Loset GA, 2008, BIOTECHNIQUES, V44, P551, DOI 10.2144/000112724; Malik P, 1998, FEBS LETT, V436, P263, DOI 10.1016/S0014-5793(98)01140-5; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Petrenko V.A., 2005, PHAGE DISPLAY BIOTEC, P63; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sambrook J, 2001, MOL CLONING LAB MANU; Sartorius R, 2008, J IMMUNOL, V180, P3719, DOI 10.4049/jimmunol.180.6.3719; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SIMONS GFM, 1981, P NATL ACAD SCI-BIOL, V78, P4194, DOI 10.1073/pnas.78.7.4194; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902	32	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14702	10.1371/journal.pone.0014702	http://dx.doi.org/10.1371/journal.pone.0014702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390217	Green Submitted, gold, Green Published			2022-12-27	WOS:000287761700002
J	Baguelin, M; Hoschler, K; Stanford, E; Waight, P; Hardelid, P; Andrews, N; Miller, E				Baguelin, Marc; Hoschler, Katja; Stanford, Elaine; Waight, Pauline; Hardelid, Pia; Andrews, Nick; Miller, Elizabeth			Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation	PLOS ONE			English	Article								Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1-4, 5-14, 15-24, 25-44 years). The highest cumulative incidence was in 5-14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1-4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.	[Baguelin, Marc; Waight, Pauline; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Baguelin, Marc] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England; [Hoschler, Katja] Hlth Protect Agcy, Resp Virus Unit, Virus Reference Dept, London, England; [Stanford, Elaine] Hlth Protect Agcy, Vaccine Evaluat Seroepidemiol Unit, Manchester, Lancs, England; [Hardelid, Pia; Andrews, Nick] Hlth Protect Agcy, Stat Unit, London, England	Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Health Protection Agency; Health Protection Agency	Baguelin, M (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	marc.baguelin@hpa.org.uk	Hardelid, Pia/K-3353-2013	Hardelid, Pia/0000-0002-0154-1306	National Institute for Health Research; Novartis; Sanofi Pasteur; Baxter; CSL Australia	National Institute for Health Research(National Institute for Health Research (NIHR)); Novartis(Novartis); Sanofi Pasteur; Baxter; CSL Australia	The testing of the serological samples was supported by the National Institute for Health Research Health Technology Assessment Programme (http://www.hta.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; KH: In 2006 Sanofi Pasteur paid conference fees and accommodations for an international meeting at which he presented data for a Sanofi vaccine study. ES has received support to attend a scientific meeting from Wyeth Vaccines in 2006. The RVU lab (KH) has received funding for influenza vaccine work from Novartis, Sanofi Pasteur, Baxter and CSL Australia. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors (MB, PW, PH, NA, EM) have declared that no competing interests exist.	Baguelin M, 2010, VACCINE, V28, P2370, DOI 10.1016/j.vaccine.2010.01.002; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Donaldson LJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c612; Ellis J, 2009, EUROSURVEILLANCE, V14; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Gilks WR, 2005, MARKOV CHAIN MONTE C; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; VANHOEK AJ, RESPONSE GUEST EDITO; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740; [No title captured]	15	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17074	10.1371/journal.pone.0017074	http://dx.doi.org/10.1371/journal.pone.0017074			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373639	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500031
J	Haldar, B; Burda, S; Williams, C; Heyndrickx, L; Vanham, G; Gorny, MK; Nyambi, P				Haldar, Bijayesh; Burda, Sherri; Williams, Constance; Heyndrickx, Leo; Vanham, Guido; Gorny, Miroslaw K.; Nyambi, Phillipe			Longitudinal Study of Primary HIV-1 Isolates in Drug-Naive Individuals Reveals the Emergence of Variants Sensitive to Anti-HIV-1 Monoclonal Antibodies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; V3 LOOP; TYPE-1 HIV-1; EPITOPE; GP120; GENERATION; INFECTION; ENVELOPE; ESCAPE	To study how virus evolution affects neutralization sensitivity and to determine changes that occur in and around epitopes, we tested the ability of 13 anti-HIV-1 gp120 (anti-V2, anti-V3, anti-CD4bd and anti-carbohydrate) human monoclonal antibodies (mAbs) to neutralize sequential viruses obtained from five HIV-1 chronically infected drug naive individuals. Overall, primary viruses collected from patients at first visit were resistant to neutralization by all anti-HIV-1 mAbs with the exception of one virus sensitive to IgG1b12. Four of the five patients' viruses evolved increased sensitivity to neutralization by anti-V3 mAbs. Virus collected from a patient obtained 31 months later, evolved increased sensitivity to anti-V2, anti-V3, and anti-CD4bd mAbs. Furthermore, the anti-V2 and anti-CD4bd mAbs also exhibited increased neutralization capacities against virus collected from a patient 29 months later. Of the seven anti-V3 mAbs, five showed increased potency to neutralize the evolved virus from a patient collected after 11 months, and three exhibited increased potency against viruses from two patients collected 29 and 36 months later. Anti-V3 mAbs exhibited the most breadth and potency in neutralizing the evolving viruses. Sequence analysis of the envelope regions revealed amino acid conservation within the V3 loop, while most of the changes identified occurred outside the core epitopes and in particular within the C3 region; these may account for increased neutralization sensitivity. These studies demonstrate that in vivo, HIV-1 can evolve increased neutralization sensitivity to mAbs and that the spectrum of neutralization capacities by mAbs can be broader when studied in longitudinal analysis.	[Haldar, Bijayesh; Burda, Sherri; Williams, Constance; Gorny, Miroslaw K.; Nyambi, Phillipe] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Nyambi, Phillipe] Vet Affairs New York Harbor Healthcare Syst, New York, NY USA; [Heyndrickx, Leo; Vanham, Guido] Inst Trop Med, Dept Microbiol, B-2000 Antwerp, Belgium; [Vanham, Guido] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium	New York University; Institute of Tropical Medicine (ITM); University of Antwerp	Haldar, B (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	Phillipe.Nyambi@nyumc.org		Gorny, Miroslaw/0000-0002-2714-8780	National Institute of Allergy and Infectious Diseases (NIAID) [AI47053]; National Institutes of Health (NIH); Fogarty International Center [TW001409]; Center for AIDS Research; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047053, P30AI027742] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Center for AIDS Research; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant number AI47053 from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Fogarty International Center (TW001409), Center for AIDS Research (AI027742-17), and funds from the Department of Veterans Affairs (Merit Review Award and the Research Enhancement Award Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Geffin R, 2003, VIROLOGY, V310, P207, DOI 10.1016/S0042-6822(03)00137-5; Gigler A, 1999, J VIROL, V73, P1974, DOI 10.1128/JVI.73.3.1974-1979.1999; Gorny MK, 2000, J VIROL, V74, P6186, DOI 10.1128/JVI.74.13.6186-6192.2000; GORNY MK, 1992, J VIROL, V66, P7538, DOI 10.1128/JVI.66.12.7538-7542.1992; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Gorny MK, 2004, J VIROL, V78, P2394, DOI 10.1128/JVI.78.5.2394-2404.2004; GORNY MK, 1993, J IMMUNOL, V150, P635; Gorny MK, 1997, J IMMUNOL, V159, P5114; GORNY MK, 1989, P NATL ACAD SCI USA, V86, P1624, DOI 10.1073/pnas.86.5.1624; GORNY MK, 1994, J VIROL, V68, P8312, DOI 10.1128/JVI.68.12.8312-8320.1994; Gorny MK, 2002, J VIROL, V76, P9035, DOI 10.1128/JVI.76.18.9035-9045.2002; GRAM GJ, 1994, ARCH VIROL, V139, P253, DOI 10.1007/BF01310789; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; KARWOWSKA S, 1992, AIDS RES HUM RETROV, V8, P1099, DOI 10.1089/aid.1992.8.1099; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Nyambi P, 2008, AIDS RES HUM RETROV, V24, P1507, DOI 10.1089/aid.2008.0154; NYAMBI PN, 1995, J INFECT DIS, V172, P1228, DOI 10.1093/infdis/172.5.1228; Nyambi PN, 1998, J VIROL, V72, P9384, DOI 10.1128/JVI.72.11.9384-9391.1998; Nyambi PN, 2001, J IMMUNOL METHODS, V253, P253, DOI 10.1016/S0022-1759(01)00384-2; Pincus SH, 2003, J IMMUNOL, V170, P2236, DOI 10.4049/jimmunol.170.4.2236; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; SPIRA AI, 1995, J VIROL, V69, P422, DOI 10.1128/JVI.69.1.422-429.1995; Staden R, 2000, Methods Mol Biol, V132, P115; TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; TSANG ML, 1994, J INFECT DIS, V170, P1141, DOI 10.1093/infdis/170.5.1141; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILLIAMS LM, 1991, VIROLOGY, V184, P723, DOI 10.1016/0042-6822(91)90442-E; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zolla-Pazner S, 2008, VIROLOGY, V372, P233, DOI 10.1016/j.virol.2007.09.024	43	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17253	10.1371/journal.pone.0017253	http://dx.doi.org/10.1371/journal.pone.0017253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383841	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500045
J	Kessler, TM; Bachmann, LM; Minder, C; Lohrer, D; Umbehr, M; Schunemann, HJ; Kessels, AGH				Kessler, Thomas M.; Bachmann, Lucas M.; Minder, Christoph; Loehrer, David; Umbehr, Martin; Schuenemann, Holger J.; Kessels, Alfons G. H.			Adverse Event Assessment of Antimuscarinics for Treating Overactive Bladder: A Network Meta-Analytic Approach	PLOS ONE			English	Article							SELECTIVE RECEPTOR ANTAGONIST; CONTROLLED-RELEASE OXYBUTYNIN; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; DETRUSOR INSTABILITY; EXTENDED-RELEASE; TROSPIUM CHLORIDE; URGE INCONTINENCE; URINARY-INCONTINENCE; CLINICAL-EFFICACY	Background: Overactive bladder (OAB) affects the lives of millions of people worldwide and antimuscarinics are the pharmacological treatment of choice. Meta-analyses of all currently used antimuscarinics for treating OAB found similar efficacy, making the choice dependent on their adverse event profiles. However, conventional meta-analyses often fail to quantify and compare adverse events across different drugs, dosages, formulations, and routes of administration. In addition, the assessment of the broad variety of adverse events is dissatisfying. Our aim was to compare adverse events of antimuscarinics using a network meta-analytic approach that overcomes shortcomings of conventional analyses. Methods: Cochrane Incontinence Group Specialized Trials Register, previous systematic reviews, conference abstracts, book chapters, and reference lists of relevant articles were searched. Eligible studies included randomized controlled trials comparing at least one antimuscarinic for treating OAB with placebo or with another antimuscarinic, and adverse events as outcome measures. Two authors independently extracted data. A network meta-analytic approach was applied allowing for joint assessment of all adverse events of all currently used antimuscarinics while fully maintaining randomization. Results: 69 trials enrolling 26'229 patients were included. Similar overall adverse event profiles were found for darifenacin, fesoterodine, transdermal oxybutynin, propiverine, solifenacin, tolterodine, and trospium chloride but not for oxybutynin orally administered when currently used starting dosages were compared. Conclusions: The proposed generally applicable transparent network meta-analytic approach summarizes adverse events in an easy to grasp way allowing straightforward benchmarking of antimuscarinics for treating OAB in clinical practice. Most currently used antimuscarinics seem to be equivalent first choice drugs to start the treatment of OAB except for oral oxybutynin dosages of >10 mg/d which may have more unfavorable adverse event profiles.	[Kessler, Thomas M.; Bachmann, Lucas M.; Minder, Christoph; Loehrer, David; Umbehr, Martin; Kessels, Alfons G. H.] Univ Zurich, Horten Ctr Patient Oriented Res, Zurich, Switzerland; [Kessler, Thomas M.] Balgrist Univ Hosp, Spinal Cord Injury Ctr, Zurich, Switzerland; [Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Kessels, Alfons G. H.] Maastricht Univ Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands	University of Zurich; University of Zurich; McMaster University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kessler, TM (corresponding author), Univ Zurich, Horten Ctr Patient Oriented Res, Zurich, Switzerland.	lucas.bachmann@usz.ch	Bachmann, Lucas M/C-9686-2011	, Lucas/0000-0002-9868-154X; Schunemann, Holger/0000-0003-3211-8479	Swiss National Science Foundation [PBBEB-121068, 3233B0-103182, 3200B0-103183]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Dr. Kessler (grant no. PBBEB-121068) and Dr. Bachmann (grants no. 3233B0-103182 and 3200B0-103183) have been supported by grants of the Swiss National Science Foundation. However, the Swiss National Science Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 1998, BRIT J UROL, V81, P801; Abrams P, 2006, J UROLOGY, V175, P999, DOI 10.1016/S0022-5347(05)00483-0; Abrams P, 2005, NEUROUROL URODYNAM, V24, P495; Abrams P, 2000, AM J MANAG CARE, V6, pS580; Abrams P, 1996, P INT CONT SOC 26 AN, P276; ABRAMS P, 2005, EUR UROL SUPPL, V3, P62; Abrams P, 2006, INT J UROL, V13, P692, DOI 10.1111/j.1442-2042.2006.01387.x; Alloussi S, 1998, J CLIN RES, V1, P439; Altan-Yaycioglu R, 2005, BRIT J CLIN PHARMACO, V59, P588, DOI 10.1111/j.1365-2125.2005.02356.x; Anderson RU, 1999, J UROLOGY, V161, P1809, DOI 10.1016/S0022-5347(05)68810-6; [Anonymous], **NON-TRADITIONAL**; Appell RA, 2001, MAYO CLIN PROC, V76, P358; Barkin J, 2004, CLIN THER, V26, P1026, DOI 10.1016/S0149-2918(04)90174-9; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Birns J, 2000, BJU INT, V85, P793, DOI 10.1046/j.1464-410x.2000.00623.x; Bono AV, 1982, UROLOGIA, V49, P764; Brown JS, 2000, J AM GERIATR SOC, V48, P721, DOI 10.1111/j.1532-5415.2000.tb04744.x; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; CALLAWAY E, 1992, BIOL PSYCHOL, V33, P1, DOI 10.1016/0301-0511(92)90002-C; Cardozo L, 2004, J UROLOGY, V172, P1919, DOI 10.1097/01.ju.0000140729.07840.16; Cardozo L, 2005, J UROLOGY, V173, P1214, DOI 10.1097/01.ju.0000155798.78911.57; Cardozo L, 2000, BJU INT, V85, P659, DOI 10.1046/j.1464-410x.2000.00575.x; Chapple C, 2007, CURR MED RES OPIN, V23, P2347, DOI 10.1185/03007X226294; Chapple C, 2005, EUR UROL, V48, P5, DOI 10.1016/j.eururo.2005.02.024; Chapple C, 2007, EUR UROL, V52, P1204, DOI 10.1016/j.eururo.2007.07.009; Chapple CR, 2008, EUR UROL, V54, P543, DOI 10.1016/j.eururo.2008.06.047; Chapple CR, 2007, EUR UROL, V52, P1195, DOI 10.1016/j.eururo.2007.05.027; Chapple CR, 2004, BJU INT, V93, P303, DOI 10.1111/j.1464-410X.2004.04606.x; Chapple CR, 2004, BJU INT, V93, P71, DOI 10.1111/j.1464-410X.2004.04561.x; Corcos J, 2006, BJU INT, V97, P520, DOI 10.1111/j.1464-410X.2005.06031.x; Coyne KS, 2007, J SEX MED, V4, P656, DOI 10.1111/j.1743-6109.2007.00493.x; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Davila GW, 2001, J UROLOGY, V166, P140, DOI 10.1016/S0022-5347(05)66095-8; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Diokno AC, 2003, MAYO CLIN PROC, V78, P687, DOI 10.4065/78.6.687; Dmochowski RR, 2003, UROLOGY, V62, P237, DOI 10.1016/S0090-4295(03)00356-X; Dmochowski RR, 2002, J UROLOGY, V168, P580, DOI 10.1016/S0022-5347(05)64684-8; Dorschner W, 2000, EUR UROL, V37, P702, DOI 10.1159/000020221; Drutz H P, 1999, Int Urogynecol J Pelvic Floor Dysfunct, V10, P283, DOI 10.1007/s001929970003; Giannitsas K, 2004, EUR UROL, V46, P776, DOI 10.1016/j.eururo.2004.07.021; GITTELMAN M, 2003, 17 INT FED GYN OBST; Haab F, 2004, EUR UROL, V45, P420, DOI 10.1016/j.eururo.2004.01.008; Halaska M., 2003, World Journal of Urology, V20, P392; Hasselblad V, 1998, MED DECIS MAKING, V18, P37, DOI 10.1177/0272989X9801800110; Hay-Smith J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005429; Herbison P, 2003, BMJ-BRIT MED J, V326, P841, DOI 10.1136/bmj.326.7394.841; Hill S, 2006, INT UROGYNECOL J, V17, P239, DOI 10.1007/s00192-005-1340-3; Homma Y, 2003, BJU INT, V92, P741, DOI 10.1046/j.1464-410X.2003.04468.x; Jacquetin B, 2001, EUR J OBSTET GYN R B, V98, P97, DOI 10.1016/S0301-2115(00)00561-3; Jonas U, 1997, WORLD J UROL, V15, P144, DOI 10.1007/BF02201987; Junemann KP, 2006, UROL INT, V77, P334, DOI 10.1159/000096338; Junemann KP, 2005, EUR UROL, V48, P478, DOI 10.1016/j.eururo.2005.04.023; Junemann KP, 1999, NEUROUROL URODYNAM, V18, P375; Kaplan SA, 2006, JAMA-J AM MED ASSOC, V296, P2319, DOI 10.1001/jama.296.19.2319; Kelleher CJ, 1997, BRIT J OBSTET GYNAEC, V104, P988, DOI 10.1111/j.1471-0528.1997.tb12054.x; Kessler TM, 2002, J UROLOGY, V167, P2507, DOI 10.1016/S0022-5347(05)65015-X; Khullar V, 2004, UROLOGY, V64, P269, DOI 10.1016/j.urology.2004.02.029; Khullar V, 2006, UROLOGY, V68, P38, DOI 10.1016/j.urology.2006.05.043; Klotz T, 2007, EUR UROL, V51, P1654, DOI 10.1016/j.eururo.2006.11.040; Lee JG, 2002, INT J UROL, V9, P247, DOI 10.1046/j.1442-2042.2002.00460.x; Madersbacher H, 1999, BJU INT, V84, P646; Malone-Lee J, 2001, J UROLOGY, V165, P1452, DOI 10.1016/S0022-5347(05)66326-4; Malone-Lee JG, 2001, J AM GERIATR SOC, V49, P700, DOI 10.1046/j.1532-5415.2001.49144.x; MAZUR D, 1995, SCAND J UROL NEPHROL, V29, P289, DOI 10.3109/00365599509180578; Millard R, 1999, J UROLOGY, V161, P1551, DOI 10.1016/S0022-5347(05)68951-3; Milsom I, 2001, BJU INT, V87, P760, DOI 10.1046/j.1464-410x.2001.02228.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; MOISEY CU, 1980, BRIT J UROL, V52, P472, DOI 10.1111/j.1464-410X.1980.tb03093.x; MOORE KH, 1990, BRIT J UROL, V66, P479, DOI 10.1111/j.1464-410X.1990.tb14992.x; MURRAY KHA, 1984, P 14 ANN M INT CONT; Nabi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003781.pub2; *NAT CANC I COMM T, NAT CANC I COMM TERM; Nilsson CG, 1997, NEUROUROL URODYNAM, V16, P533, DOI 10.1002/(SICI)1520-6777(1997)16:6<533::AID-NAU3>3.0.CO;2-F; NITTI V, 2005, P 35 ANN INT CONT SO; Nitti VW, 2007, J UROLOGY, V178, P2488, DOI 10.1016/j.juro.2007.08.033; Novara G, 2008, EUR UROL, V54, P740, DOI 10.1016/j.eururo.2008.06.080; Perry EK, 2003, ANN NEUROL, V54, P235, DOI 10.1002/ana.10639; Rackley R, 2006, UROLOGY, V67, P731, DOI 10.1016/j.urology.2005.10.061; Rentzhog L, 1998, BRIT J UROL, V81, P42; Riva D, 1984, Clin Exp Obstet Gynecol, V11, P37; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Romanzi LJ, 2005, OBSTET GYNECOL, V105, p88S; Rudy D, 2006, BJU INT, V97, P540, DOI 10.1111/j.1464-410X.2006.06035.x; Scheepe J, 2000, NEUROUROL URODYNAM, V19, P714; Serrano Brambila EA, 2000, GINECOL OBSTET MEX, V68, P174; Staskin D, 2007, J UROLOGY, V178, P978, DOI 10.1016/j.juro.2007.05.058; Steers W, 2005, BJU INT, V95, P580, DOI 10.1111/j.1464-410X.2005.05343.x; Stewart WF, 2002, WORLD J UROL, V20, P327, DOI 10.1007/s00345-002-0301-4; Stohrer M, 1999, SPINAL CORD, V37, P196, DOI 10.1038/sj.sc.3100750; STOHRER M, 1991, UROL INT, V47, P138; SZONYI G, 1995, AGE AGEING, V24, P287, DOI 10.1093/ageing/24.4.287; Takayasu H, 1990, IGAKU NO AYUMI, V153, P459; TAPP AJS, 1990, BRIT J OBSTET GYNAEC, V97, P521, DOI 10.1111/j.1471-0528.1990.tb02523.x; THUROFF JW, 1991, J UROLOGY, V145, P813, DOI 10.1016/S0022-5347(17)38459-8; Ulshofer B, 2001, CLIN DRUG INVEST, V21, P563, DOI 10.2165/00044011-200121080-00005; Van Kerrebroeck P, 2001, UROLOGY, V57, P414, DOI 10.1016/S0090-4295(00)01113-4; Van Kerrebroeck P. E. V., 1997, Neurourology and Urodynamics, V16, P478; Van Kerrebroeck PEVA, 1998, NEUROUROL URODYNAM, V17, P499, DOI 10.1002/(SICI)1520-6777(1998)17:5<499::AID-NAU6>3.0.CO;2-8; Versi E, 2000, OBSTET GYNECOL, V95, P718, DOI 10.1016/S0029-7844(99)00661-4; WEHNERT J, 1992, AKTUEL UROL, V23, P7, DOI 10.1055/s-2008-1060401; Yamaguchi O, 2007, BJU INT, V100, P579, DOI 10.1111/j.1464-410X.2007.07031.x; ZEEGERS AGM, 1987, WORLD J UROL, V5, P57, DOI 10.1007/BF00326777; Zinner N, 2006, INT J CLIN PRACT, V60, P119, DOI 10.1111/j.1368-5031.2005.00770.x; Zinner N, 2004, J UROLOGY, V171, P2311, DOI 10.1097/01.ju.0000127742.73136.0c; Zinner N, 2005, WORLD J UROL, V23, P248, DOI 10.1007/s00345-005-0507-3; Zinner NR, 2002, J AM GERIATR SOC, V50, P799, DOI 10.1046/j.1532-5415.2002.50203.x; ZORZITTO ML, 1989, AGE AGEING, V18, P195, DOI 10.1093/ageing/18.3.195	107	89	90	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16718	10.1371/journal.pone.0016718	http://dx.doi.org/10.1371/journal.pone.0016718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373193	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000287657500015
J	Kondylis, V; Tang, Y; Fuchs, F; Boutros, M; Rabouille, C				Kondylis, Vangelis; Tang, Yang; Fuchs, Florian; Boutros, Michael; Rabouille, Catherine			Identification of ER Proteins Involved in the Functional Organisation of the Early Secretory Pathway in Drosophila Cells by a Targeted RNAi Screen	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GOLGI ORGANIZATION; TRANSITIONAL ER; CYTOCHROME B561; KIN RECOGNITION; LIPID DROPLETS; FAMILY-MEMBERS; CASPASE DRONC; EXIT SITES; HELA-CELLS	Background: In Drosophila, the early secretory apparatus comprises discrete paired Golgi stacks in close proximity to exit sites from the endoplasmic reticulum (tER sites), thus forming tER-Golgi units. Although many components involved in secretion have been identified, the structural components sustaining its organisation are less known. Here we set out to identify novel ER resident proteins involved in the of tER-Golgi unit organisation. Results: To do so, we designed a novel screening strategy combining a bioinformatics pre-selection with an RNAi screen. We first selected 156 proteins exhibiting known or related ER retention/retrieval signals from a list of proteins predicted to have a signal sequence. We then performed a microscopy-based primary and confirmation RNAi screen in Drosophila S2 cells directly scoring the organisation of the tER-Golgi units. We identified 49 hits, most of which leading to an increased number of smaller tER-Golgi units (MG for "more and smaller Golgi'') upon depletion. 16 of them were validated and characterised, showing that this phenotype was not due to an inhibition in secretion, a block in G2, or ER stress. Interestingly, the MG phenotype was often accompanied by an increase in the cell volume. Out of 6 proteins, 4 were localised to the ER. Conclusions: This work has identified novel proteins involved in the organisation of the Drosophila early secretory pathway. It contributes to the effort of assigning protein functions to gene annotation in the secretory pathway, and analysis of the MG hits revealed an enrichment of ER proteins. These results suggest a link between ER localisation, aspects of cell metabolism and tER-Golgi structural organisation.	[Kondylis, Vangelis; Tang, Yang; Rabouille, Catherine] UMC, Cell Microscopy Ctr, Dept Cell Biol, Utrecht, Netherlands; [Fuchs, Florian; Boutros, Michael] German Canc Res Ctr, Heidelberg, Germany; [Fuchs, Florian; Boutros, Michael] Heidelberg Univ, Div Signaling & Funct Genom, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Kondylis, V (corresponding author), Univ Cologne, Inst Genet, Mouse Genet & Inflammat Lab, Weyertal 121, D-5000 Cologne, Germany.	e.kondylis@uni-koeln.de; c.rabouille@hubrecht.eu	Boutros, Michael/C-3566-2008; Kondylis, Vangelis/S-6276-2019	Boutros, Michael/0000-0002-9458-817X; Kondylis, Vangelis/0000-0002-6970-8731	EMBO fellowship; National Regie-Orgaan Genomics [050-71-029]; Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO) [816.02.004]; German Research Council; Helmholtz Alliance for Systems Biology	EMBO fellowship(European Molecular Biology Organization (EMBO)); National Regie-Orgaan Genomics; Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); German Research Council(German Research Foundation (DFG)); Helmholtz Alliance for Systems Biology	This work was funded by a short term EMBO fellowship, the Horizon Programme from National Regie-Orgaan Genomics (050-71-029), an Aard en Levenswetenschappen grant from the Nederlandse Organisatie voor Wetenschappelijke Onderzoek (NWO, 816.02.004), an Emmy-Nother Grant from the German Research Council, and the Helmholtz Alliance for Systems Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bartscherer K, 2008, EMBO REP, V9, P977, DOI 10.1038/embor.2008.167; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707; Bostrom P, 2009, BIOCHEM SOC T, V37, P981, DOI 10.1042/BST0370981; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; de Vries HI, 2005, J CELL SCI, V118, P1833, DOI 10.1242/jcs.02309; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Farhan H, 2010, J CELL BIOL, V189, P997, DOI 10.1083/jcb.200912082; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Friggi-Grelin F, 2006, EUR J CELL BIOL, V85, P1155, DOI 10.1016/j.ejcb.2006.07.001; Gilsdorf M, 2010, NUCLEIC ACIDS RES, V38, pD448, DOI 10.1093/nar/gkp1038; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Horn T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r61; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes H, 2009, J CELL SCI, V122, P2924, DOI 10.1242/jcs.044032; Iliadi KG, 2008, P NATL ACAD SCI USA, V105, P19986, DOI 10.1073/pnas.0810698105; Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jones D, 2009, NAT REV DRUG DISCOV, V8, P525, DOI 10.1038/nrd2940; Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136; Kondylis V, 2001, MOL BIOL CELL, V12, P2308, DOI 10.1091/mbc.12.8.2308; Kondylis V, 2007, DEV CELL, V12, P901, DOI 10.1016/j.devcel.2007.03.008; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005; Liu F, 2006, PEPTIDES, V27, P3137, DOI 10.1016/j.peptides.2006.08.021; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Miron M, 2003, MOL CELL BIOL, V23, P9117, DOI 10.1128/MCB.23.24.9117-9126.2003; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Neumann FR, 2007, J CELL BIOL, V179, P593, DOI 10.1083/jcb.200708054; NILSSON T, 1994, EMBO J, V13, P562, DOI 10.1002/j.1460-2075.1994.tb06294.x; Nilsson T, 1996, J CELL SCI, V109, P1975; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Plongthongkum N, 2007, BIOCHEM BIOPH RES CO, V354, P789, DOI 10.1016/j.bbrc.2007.01.056; Rabouille C, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-213; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Sardiello M, 2005, TRENDS GENET, V21, P12, DOI 10.1016/j.tig.2004.11.009; Simpson JC, 2007, J BIOTECHNOL, V129, P352, DOI 10.1016/j.jbiotec.2006.12.027; Simpson JC, 2009, SEMIN CELL DEV BIOL, V20, P903, DOI 10.1016/j.semcdb.2009.07.005; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tsubaki M, 2005, BBA-PROTEINS PROTEOM, V1753, P174, DOI 10.1016/j.bbapap.2005.08.015; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; Wendler F, 2010, EMBO J, V29, P304, DOI 10.1038/emboj.2009.350; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zheng Y, 2008, HEMOGLOBIN, V32, P135, DOI 10.1080/03630260701727077	68	23	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17173	10.1371/journal.pone.0017173	http://dx.doi.org/10.1371/journal.pone.0017173			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383842	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500038
J	Yang, HJ; Choi, MJ; Wen, H; Kwon, HN; Jung, KH; Hong, SW; Kim, JM; Hong, SS; Park, S				Yang, Hye-ji; Choi, Myung-Joo; Wen, He; Kwon, Hyuk Nam; Jung, Kyung Hee; Hong, Sang-Won; Kim, Joon Mee; Hong, Soon-Sun; Park, Sunghyouk			An Effective Assessment of Simvastatin-Induced Toxicity with NMR-Based Metabonomics Approach	PLOS ONE			English	Article							INDUCED HEPATOTOXICITY; LIQUID-CHROMATOGRAPHY; REDUCTASE INHIBITORS; OXIDATIVE STRESS; DRUG TOXICITY; METABOLOMICS; UBIQUINOL-10; ANTIOXIDANT; PRAVASTATIN; METABOLISM	Background: Simvastatin, which is used to control elevated cholesterol levels, is one of the most widely prescribed drugs. However, a daily excessive dose can induce drug-toxicity, especially in muscle and liver. Current markers for toxicity reflect mostly the late stages of tissue damage; thus, more efficient methods of toxicity evaluation are desired. Methodology/Principal Findings: As a new way to evaluate toxicity, we performed NMR-based metabonomics analysis of urine samples. Compared to conventional markers, such as AST, ALT, and CK, the urine metabolic profile provided clearer distinction between the pre- and post-treatment groups treated with toxic levels of simvastatin. Through multivariate statistical analysis, we identified marker metabolites associated with the toxicity. Importantly, we observed that the treatment group could be further categorized into two subgroups based on the NMR profiles: weak toxicity (WT) and high toxicity (HT). The distinction between these two groups was confirmed by the enzyme values and histopathological exams. Time-dependent studies showed that the toxicity at 10 days could be reliably predicted from the metabolic profiles at 6 days. Conclusions/Significance: This metabonomics approach may provide a non-invasive and effective way to evaluate the simvastatin-induced toxicity in a manner that can complement current measures. The approach is expected to find broader application in other drug-induced toxicity assessments.	[Yang, Hye-ji; Wen, He; Kwon, Hyuk Nam; Park, Sunghyouk] Inha Univ, Inha Univ Hosp, Dept Biochem, Inchon, South Korea; [Yang, Hye-ji; Choi, Myung-Joo; Wen, He; Kwon, Hyuk Nam; Jung, Kyung Hee; Hong, Sang-Won; Kim, Joon Mee; Hong, Soon-Sun; Park, Sunghyouk] Inha Univ, Coll Med, Project BK21, Ctr Adv Med Educ, Inchon, South Korea; [Choi, Myung-Joo; Jung, Kyung Hee; Hong, Sang-Won; Hong, Soon-Sun] Inha Univ, Inha Univ Hosp, Dept Biomed Sci, Inchon, South Korea; [Kim, Joon Mee] Inha Univ, Inha Univ Hosp, Dept Pathol, Inchon, South Korea	Inha University; Inha University Hospital; Inha University; Inha University; Inha University Hospital; Inha University; Inha University Hospital	Yang, HJ (corresponding author), Inha Univ, Inha Univ Hosp, Dept Biochem, Inchon, South Korea.	hongs@inha.ac.kr; spark@inha.ac.kr	Kwon, Hyuk Nam/V-2301-2018; Wen, He/GZL-8825-2022	Kwon, Hyuk Nam/0000-0003-4096-4712; 	Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084338]; Korean gvernment [2010-0076692]	Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean gvernment	This work was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A084338). This work was also supported by a National Research Foundation of Korea grant, funded by the Korean gvernment (2010-0076692). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beger RD, 2010, TOXICOL APPL PHARM, V243, P154, DOI 10.1016/j.taap.2009.11.019; Bollard ME, 2005, TOXICOL APPL PHARM, V204, P135, DOI 10.1016/j.taap.2004.06.031; Borgert CJ, 2007, TOXICOL APPL PHARM, V223, P114, DOI 10.1016/j.taap.2007.01.002; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Clarke AT, 2006, DIGEST LIVER DIS, V38, P772, DOI 10.1016/j.dld.2006.04.013; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Coen M, 2008, CHEM RES TOXICOL, V21, P9, DOI 10.1021/tx700335d; Collins R, 2003, LANCET, V361, P2005; Corsini A, 1996, CARDIOLOGY, V87, P458, DOI 10.1159/000177139; Davidson MH, 2002, AM J CARDIOL, V90, p1K; Farmer JA, 2000, DRUG SAFETY, V23, P197, DOI 10.2165/00002018-200023030-00003; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; Henke AC, 2002, ADV ANAT PATHOL, V9, P301, DOI 10.1097/00125480-200209000-00004; Idborg H, 2005, J CHROMATOGR B, V828, P9, DOI 10.1016/j.jchromb.2005.07.031; Kand'ar R, 2006, CLIN CHIM ACTA, V365, P249, DOI 10.1016/j.cca.2005.09.002; Kang J, 2008, ARCH PHARM RES, V31, P330, DOI 10.1007/s12272-001-1160-2; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Kettawan A, 2007, J CLIN BIOCHEM NUTR, V40, P194, DOI 10.3164/jcbn.40.194; Kolker S, 2001, J NEUROSCI RES, V66, P666, DOI 10.1002/jnr.10012; Krishnan N, 2006, J BACTERIOL, V188, P1227, DOI 10.1128/JB.188.4.1227-1235.2006; Kumar BS, 2010, ANAL CHIM ACTA, V661, P47, DOI 10.1016/j.aca.2009.11.063; Lindon JC, 2006, PHARM RES, V23, P1075, DOI 10.1007/s11095-006-0025-z; Mortishire-Smith RJ, 2004, CHEM RES TOXICOL, V17, P165, DOI 10.1021/tx034123j; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; OLSSON AG, 2009, LAKARTIDNINGEN, V106, P2784; Olsson Anders G, 2009, Lakartidningen, V106, P2783; PARKER N, 1991, AUST NZ J PSYCHIAT, V25, P371, DOI 10.3109/00048679109062638; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Reo NV, 2002, DRUG CHEM TOXICOL, V25, P375, DOI 10.1081/DCT-120014789; Rosenson RS, 2004, AM J MED, V116, P408, DOI 10.1016/j.amjmed.2003.10.033; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Schnackenberg LK, 2008, TOXICOL MECH METHOD, V18, P301, DOI 10.1080/15376510701623193; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646; Tavintharan S, 2007, TOXICOL APPL PHARM, V223, P173, DOI 10.1016/j.taap.2007.05.013; Weljie AM, 2007, J PROTEOME RES, V6, P3456, DOI 10.1021/pr070123j; Wen H, 2010, PHYTOCHEM ANALYSIS, V21, P73, DOI 10.1002/pca.1166	39	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16641	10.1371/journal.pone.0016641	http://dx.doi.org/10.1371/journal.pone.0016641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364936	gold, Green Submitted, Green Published			2022-12-27	WOS:000287656600010
J	Chambon, V; Domenech, P; Pacherie, E; Koechlin, E; Baraduc, P; Farrer, C				Chambon, Valerian; Domenech, Philippe; Pacherie, Elisabeth; Koechlin, Etienne; Baraduc, Pierre; Farrer, Chloee			What Are They Up To? The Role of Sensory Evidence and Prior Knowledge in Action Understanding	PLOS ONE			English	Article							SOCIAL COGNITION; PSYCHOMETRIC FUNCTION; SIMULATION; MIND; REPRESENTATION; ARGUMENT; SYSTEM; BRAIN; MODEL; SELF	Explaining or predicting the behaviour of our conspecifics requires the ability to infer the intentions that motivate it. Such inferences are assumed to rely on two types of information: (1) the sensory information conveyed by movement kinematics and (2) the observer's prior expectations - acquired from past experience or derived from prior knowledge. However, the respective contribution of these two sources of information is still controversial. This controversy stems in part from the fact that "intention" is an umbrella term that may embrace various sub-types each being assigned different scopes and targets. We hypothesized that variations in the scope and target of intentions may account for variations in the contribution of visual kinematics and prior knowledge to the intention inference process. To test this hypothesis, we conducted four behavioural experiments in which participants were instructed to identify different types of intention: basic intentions (i.e. simple goal of a motor act), superordinate intentions (i.e. general goal of a sequence of motor acts), or social intentions (i.e. intentions accomplished in a context of reciprocal interaction). For each of the above-mentioned intentions, we varied (1) the amount of visual information available from the action scene and (2) participant's prior expectations concerning the intention that was more likely to be accomplished. First, we showed that intentional judgments depend on a consistent interaction between visual information and participant's prior expectations. Moreover, we demonstrated that this interaction varied according to the type of intention to be inferred, with participant's priors rather than perceptual evidence exerting a greater effect on the inference of social and superordinate intentions. The results are discussed by appealing to the specific properties of each type of intention considered and further interpreted in the light of a hierarchical model of action representation.	[Chambon, Valerian; Domenech, Philippe; Baraduc, Pierre] Univ Lyon, CNRS, Ctr Neurosci Cognit, Bron, France; [Pacherie, Elisabeth] CNRS, Inst Jean Nicod, EHESS, DEC ENS, Paris, France; [Koechlin, Etienne] Univ Paris 06, INSERM, Ecole Normale Super, Paris, France; [Farrer, Chloee] Univ Toulouse, UPS CNRS, Ctr Rech Cerveau & Cognit, Toulouse, France; [Farrer, Chloee] Fac Med Rangueil, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Chambon, V (corresponding author), Univ Lyon, CNRS, Ctr Neurosci Cognit, Bron, France.	valerian.chambon@isc.cnrs.fr	Chambon, Valerian/AAF-5482-2019; Koechlin, Etienne/E-5061-2016; Farrer-Pujol, Chloe/G-5125-2011; Koechlin, Etienne/AAF-5717-2021; Domenech, Philippe/AHB-1727-2022; Pacherie, Elisabeth/E-2951-2019	Chambon, Valerian/0000-0002-2401-1906; Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311; Domenech, Philippe/0000-0003-0122-7349; Pacherie, Elisabeth/0000-0003-2337-581X	Agence Nationale de la Recherche [ANR-ZR81]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by a grant of the Agence Nationale de la Recherche obtained by C. F. (ANR-ZR81). V. C. and P. D. were supported by scholarships from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Andre JB, 2007, J THEOR BIOL, V247, P11, DOI 10.1016/j.jtbi.2007.02.007; Axelrod R., 1997, COMPLEXITY COOPERATI, DOI [10.1515/9781400822300, DOI 10.1515/9781400822300]; Baker C.L., 2006, ADV NEURAL INFORM PR, V18, P99; BAKER CL, 2007, P 29 ANN C COGN SCI, P779; Blakemore SJ, 2004, NEUROREPORT, V15, P119, DOI 10.1097/00001756-200401190-00024; Brass M, 2007, CURR BIOL, V17, P2117, DOI 10.1016/j.cub.2007.11.057; Bratman M., 1987, INTENTION PLANS; Carey S., 1985, CONCEPTUAL CHANGE CH; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Ciaramidaro A, 2007, NEUROPSYCHOLOGIA, V45, P3105, DOI 10.1016/j.neuropsychologia.2007.05.011; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Frith CD, 2007, CURR BIOL, V17, pR724, DOI 10.1016/j.cub.2007.05.068; Fu GY, 2007, DEVELOPMENTAL SCI, V10, P255, DOI 10.1111/j.1467-7687.2007.00583.x; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Gold JI, 2002, NEURON, V36, P299, DOI 10.1016/S0896-6273(02)00971-6; Goldman AI, 2005, TRENDS COGN SCI, V9, P320, DOI 10.1016/j.tics.2005.05.008; GOPNIK A, 1994, MAPPING MIND DOMAIN; Grafton ST, 2007, HUM MOVEMENT SCI, V26, P590, DOI 10.1016/j.humov.2007.05.009; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jacob P, 2009, CONSCIOUS COGN, V18, P229, DOI 10.1016/j.concog.2008.05.002; Jeannerod M, 2004, MIND LANG, V19, P113, DOI 10.1111/j.1468-0017.2004.00251.x; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2007, NEUROREPORT, V18, P619, DOI 10.1097/WNR.0b013e3281139ed0; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kourtis D, 2010, BIOL LETTERS, V6, P758, DOI 10.1098/rsbl.2010.0478; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; Mamassian P, 2001, COGNITION, V81, pB1, DOI 10.1016/S0010-0277(01)00116-0; Mele AR., 1992, SPRINGS ACTION UNDER; Mitchell JP, 2005, TRENDS COGN SCI, V9, P363, DOI 10.1016/j.tics.2005.06.010; NACHMIAS J, 1981, VISION RES, V21, P215, DOI 10.1016/0042-6989(81)90115-2; Nichols Shaun, 2003, MINDREADING INTEGRAT; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Pacherie E, 2000, MIND LANG, V15, P400; Pacherie E, 2008, COGNITION, V107, P179, DOI 10.1016/j.cognition.2007.09.003; RAPOPORT A, 1967, PSYCHOL REV, V74, P136, DOI 10.1037/h0024282; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Searle J, 1995, CONSTRUCTION SOCIAL; Searle John, 1983, INTENTIONALITY; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Sebanz N, 2009, PSYCHON B REV, V16, P170, DOI 10.3758/PBR.16.1.170; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; Wellman H. M., 1992, MIND LANG, V7, P145, DOI DOI 10.1111/J.1468-0017.1992.TB00202.X; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Ybarra O, 2002, PSYCHOL BULL, V128, P421, DOI 10.1037//0033-2909.128.3.421	59	41	42	6	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17133	10.1371/journal.pone.0017133	http://dx.doi.org/10.1371/journal.pone.0017133			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723CC	21364992	gold, Green Published			2022-12-27	WOS:000287482800027
J	Suzuki, H; Osaki, K; Sano, K; Alam, AHMK; Nakamura, Y; Ishigaki, Y; Kawahara, K; Tsukahara, T				Suzuki, Hitoshi; Osaki, Ken; Sano, Kaori; Alam, A. H. M. Khurshid; Nakamura, Yuichiro; Ishigaki, Yasuhito; Kawahara, Kozo; Tsukahara, Toshifumi			Comprehensive Analysis of Alternative Splicing and Functionality in Neuronal Differentiation of P19 Cells	PLOS ONE			English	Article							EMBRYONAL CARCINOMA-CELLS; GENOME; TRANSCRIPTION; INSIGHTS; MEMORY; FOX-2; MEF2C	Background: Alternative splicing, which produces multiple mRNAs from a single gene, occurs in most human genes and contributes to protein diversity. Many alternative isoforms are expressed in a spatio-temporal manner, and function in diverse processes, including in the neural system. Methodology/Principal Findings: The purpose of the present study was to comprehensively investigate neural-splicing using P19 cells. GeneChip Exon Array analysis was performed using total RNAs purified from cells during neuronal cell differentiation. To efficiently and readily extract the alternative exon candidates, 9 filtering conditions were prepared, yielding 262 candidate exons (236 genes). Semiquantitative RT-PCR results in 30 randomly selected candidates suggested that 87% of the candidates were differentially alternatively spliced in neuronal cells compared to undifferentiated cells. Gene ontology and pathway analyses suggested that many of the candidate genes were associated with neural events. Together with 66 genes whose functions in neural cells or organs were reported previously, 47 candidate genes were found to be linked to 189 events in the gene-level profile of neural differentiation. By text-mining for the alternative isoform, distinct functions of the isoforms of 9 candidate genes indicated by the result of Exon Array were confirmed. Conclusions/Significance: Alternative exons were successfully extracted. Results from the informatics analyses suggested that neural events were primarily governed by genes whose expression was increased and whose transcripts were differentially alternatively spliced in the neuronal cells. In addition to known functions in neural cells or organs, the uninvestigated alternative splicing events of 11 genes among 47 candidate genes suggested that cell cycle events are also potentially important. These genes may help researchers to differentiate the roles of alternative splicing in cell differentiation and cell proliferation.	[Suzuki, Hitoshi; Tsukahara, Toshifumi] Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa, Japan; [Osaki, Ken; Nakamura, Yuichiro; Kawahara, Kozo] World Fus Co Ltd, Chuo Ku, Tokyo, Japan; [Sano, Kaori; Alam, A. H. M. Khurshid] Japan Adv Inst Sci & Technol, Grad Sch Mat Sci, Nomi, Ishikawa, Japan; [Ishigaki, Yasuhito] Kanazawa Med Univ, Med Res Inst, Kanazawa, Ishikawa, Japan	Japan Advanced Institute of Science & Technology (JAIST); Japan Advanced Institute of Science & Technology (JAIST); Kanazawa Medical University	Suzuki, H (corresponding author), Japan Adv Inst Sci & Technol, Ctr Nano Mat & Technol, Nomi, Ishikawa, Japan.	suzuki-h@jaist.ac.jp		Alam, AHM Khurshid/0000-0003-2690-6559	JAIST Foundation; JSPS; HLW; World Fusion Co. Ltd.	JAIST Foundation; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); HLW; World Fusion Co. Ltd.	Funding: This work was supported by Grants-in-Aid from the JAIST Foundation and in part by JSPS, HLW, and World Fusion Co. Ltd. KO and YN are World Fusion Co. Ltd. employees and KK is an executive. They performed data analyses in this study. The other funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ab Hakim NH, 2010, GENES CELLS, V15, P255, DOI 10.1111/j.1365-2443.2009.01378.x; *AFF INC, 2006, ID VAL ALT SPL EV, P1; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Dhingra A, 2002, J NEUROSCI, V22, P4878, DOI 10.1523/JNEUROSCI.22-12-04878.2002; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Grove M, 2004, MOL CELL BIOL, V24, P10905, DOI 10.1128/MCB.24.24.10905-10922.2004; Ha KCH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-519; Hallegger M, 2010, FEBS J, V277, P856, DOI 10.1111/j.1742-4658.2009.07521.x; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; Moller-Levet CS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000571; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Novichkova S, 2003, BIOINFORMATICS, V19, P1699, DOI 10.1093/bioinformatics/btg207; Roberts GC, 2002, CURR OPIN CHEM BIOL, V6, P375, DOI 10.1016/S1367-5931(02)00320-4; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Skerjanc IS, 1999, TRENDS CARDIOVAS MED, V9, P139, DOI 10.1016/S1050-1738(99)00017-1; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2006, MOL CELL, V23, P61, DOI 10.1016/j.molcel.2006.05.018; Xing Y, 2008, RNA, V14, P1470, DOI 10.1261/rna.1070208; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16880	10.1371/journal.pone.0016880	http://dx.doi.org/10.1371/journal.pone.0016880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365003	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800019
J	Li, XS; Wu, XP; Camacho, R; Schwartz, GJ; LeRoith, D				Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.; LeRoith, Derek			Intracerebroventricular Leptin Infusion Improves Glucose Homeostasis in Lean Type 2 Diabetic MKR Mice via Hepatic Vagal and Non-Vagal Mechanisms	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; INSULIN-RESISTANCE; THERAPY; RATS; MUSCLE	MKR mice, lacking insulin-like growth factor 1 receptor (IGF-1R) signaling in skeletal muscle, are lean yet hyperlipidemic, hyperinsulinemic, and hyperglycemic, with severe insulin resistance and elevated hepatic and skeletal muscle levels of triglycerides. We have previously shown that chronic peripheral administration of the adipokine leptin improves hepatic insulin sensitivity in these mice independently of its effects on food intake. As central leptin signaling has been implicated in the control of peripheral glucose homeostasis, here we examined the ability of central intracerebroventricular leptin administration to affect energy balance and peripheral glucose homeostasis in non-obese diabetic male MKR mice. Central leptin significantly reduced food intake, body weight gain and adiposity, as well as serum glucose, insulin, leptin, free fatty acid and triglyceride levels relative to ACSF treated controls. These reductions were accompanied by increased fat oxidation as measured by indirect calorimetry, as well as increased oxygen consumption. Central leptin also improved glucose tolerance and hepatic insulin sensitivity determined using the euglycemic-hyperinsulinemic clamps relative to pair fed vehicle treated controls, as well as increasing the rate of glucose disappearance. Hepatic vagotomy only partially reversed the ability of central leptin to improve glucose tolerance. These results demonstrate that central leptin dramatically improves insulin sensitivity independently of its effects on food intake, in a lean mouse model of type 2 diabetes. The findings also suggest that: 1) both hepatic vagal and non-vagal pathways contribute to this improvement, and 2) central leptin alters glucose disposal in skeletal muscle in this model.	[Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Li, Xiaosong; Wu, Xhiping; Camacho, Raul; Schwartz, Gary J.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA; [LeRoith, Derek] Mt Sinai Sch Med, Dept Med, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Li, XS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	derek.leroith@mssm.edu			American Diabetes Association [7-08-MN-33]; National Institutes of Health, New York Obesity Center [NIH-DK-26687]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); National Institutes of Health, New York Obesity Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by an American Diabetes Association Mentor grant (7-08-MN-33) awarded to DLR and by the National Institutes of Health grant NIH-DK-26687, New York Obesity Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babic T, 2010, BRAIN RES, V1345, P146, DOI 10.1016/j.brainres.2010.05.042; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; German J, 2009, ENDOCRINOLOGY, V150, P4502, DOI 10.1210/en.2009-0445; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; Kim H, 2006, AM J PHYSIOL-ENDOC M, V290, pE1227, DOI 10.1152/ajpendo.00344.2005; Liu LS, 1998, J BIOL CHEM, V273, P31160, DOI 10.1074/jbc.273.47.31160; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Minokoshi Y, 2003, BIOCHEM SOC T, V31, P196, DOI 10.1042/bst0310196; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Morton GJ, 2003, ENDOCRINOLOGY, V144, P2016, DOI 10.1210/en.2002-0115; Pocai A, 2005, DIABETES, V54, P3182, DOI 10.2337/diabetes.54.11.3182; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Roman EAFR, 2010, MOL CELL ENDOCRINOL, V314, P62, DOI 10.1016/j.mce.2009.08.007; Shen J, 2007, NEUROSCI LETT, V416, P193, DOI 10.1016/j.neulet.2007.02.003; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Toyoshima Y, 2005, ENDOCRINOLOGY, V146, P4024, DOI 10.1210/en.2005-0087; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11	20	7	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17058	10.1371/journal.pone.0017058	http://dx.doi.org/10.1371/journal.pone.0017058			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379576	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300027
J	Ibey, BL; Roth, CC; Pakhomov, AG; Bernhard, JA; Wilmink, GJ; Pakhomova, ON				Ibey, Bennett L.; Roth, Caleb C.; Pakhomov, Andrei G.; Bernhard, Joshua A.; Wilmink, Gerald J.; Pakhomova, Olga N.			Dose-Dependent Thresholds of 10-ns Electric Pulse Induced Plasma Membrane Disruption and Cytotoxicity in Multiple Cell Lines	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; IRREVERSIBLE ELECTROPORATION; HIGH-INTENSITY; PHOSPHOLIPID TRANSLOCATION; FIELD NSPEF; IN-VITRO; NANOSECOND; APOPTOSIS; ELECTROPERMEABILIZATION; ELECTROCHEMOTHERAPY	In this study, we determined the LD50 (50% lethal dose) for cell death, and the ED50 (50% of cell population staining positive) for propidium (Pr) iodide uptake, and phosphatidylserine (PS) externalization for several commonly studied cell lines (HeLa, Jurkat, U937, CHO-K1, and GH3) exposed to 10-ns electric pulses (EP). We found that the LD50 varied substantially across the cell lines studied, increasing from 51 J/g for Jurkat to 1861 J/g for HeLa. PS externalized at doses equal or lower than that required for death in all cell lines ranging from 51 J/g in Jurkat, to 199 J/g in CHO-K1. Pr uptake occurred at doses lower than required for death in three of the cell lines: 656 J/g for CHO-K1, 634 J/g for HeLa, and 142 J/g for GH3. Both Jurkat and U937 had a LD50 lower than the ED50 for Pr uptake at 780 J/g and 1274 J/g, respectively. The mechanism responsible for these differences was explored by evaluating cell size, calcium concentration in the exposure medium, and effect of trypsin treatment prior to exposure. None of the studied parameters correlated with the observed results suggesting that cellular susceptibility to injury and death by 10-ns EP was largely determined by cell physiology. In contrast to previous studies, our findings suggest that permeabilization of internal membranes may not necessarily be responsible for cell death by 10-ns EP. Additionally, a mixture of Jurkat and HeLa cells was exposed to 10-ns EP at a dose of 280 J/g. Death was observed only in Jurkat cells suggesting that 10-ns EP may selectively kill cells within a heterogeneous tissue.	[Ibey, Bennett L.; Bernhard, Joshua A.; Wilmink, Gerald J.] USAF, Radio Frequency Radiat Branch, Res Lab, Brooks City Base, San Antonio, TX USA; [Pakhomov, Andrei G.; Pakhomova, Olga N.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA	United States Department of Defense; United States Air Force; Old Dominion University	Ibey, BL (corresponding author), USAF, Radio Frequency Radiat Branch, Res Lab, Brooks City Base, 711th Human Performance Wing, San Antonio, TX USA.	Bennett.Ibey@brooks.af.mil	Roth, Caleb/Y-1487-2019	Roth, Caleb/0000-0001-8962-1097; Pakhomov, Andrei/0000-0003-3816-3860	Air Force Office of Scientific Research; Air Force Surgeon General Clinical Investigation Program; National Cancer Institute [R01CA125482]; National Institute of General Medical Sciences [R01GM088303]; NATIONAL CANCER INSTITUTE [R01CA125482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088303] Funding Source: NIH RePORTER	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force Surgeon General Clinical Investigation Program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported in part by the Air Force Office of Scientific Research, by Air Force Surgeon General Clinical Investigation Program, by the National Cancer Institute R01CA125482, and by the National Institute of General Medical Sciences R01GM088303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2007, ANAL CHEM, V79, P3589, DOI 10.1021/ac062049e; Al-Sakere B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001135; Beebe SJ, 2003, FASEB J, V17, P1493, DOI 10.1096/fj.02-0859fje; Beebe SJ, 2002, IEEE T PLASMA SCI, V30, P286, DOI 10.1109/TPS.2002.1003872; Cemazar M, 1998, ELECTRO MAGNETOBIOL, V17, P263; Cemazar M, 2003, DNA CELL BIOL, V22, P765, DOI 10.1089/104454903322624975; Chang D.C., 1992, GUIDE ELECTROPORATIO; CHEN G, 2007, 15 INT S HIGH VOLT E; [程先忠 Chen Xianzhong], 2008, [分析仪器, Analytical Instrumentation], P28; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Deng JD, 2003, BIOPHYS J, V84, P2709, DOI 10.1016/S0006-3495(03)75076-0; Garon EB, 2007, INT J CANCER, V121, P675, DOI 10.1002/ijc.22723; GROSSE C, 1992, BIOPHYS J, V63, P1632, DOI 10.1016/S0006-3495(92)81740-X; Hall EH, 2005, DNA CELL BIOL, V24, P283, DOI 10.1089/dna.2005.24.283; Hall EH, 2007, APOPTOSIS, V12, P1721, DOI 10.1007/s10495-007-0083-7; Hampton MB, 1996, FEBS LETT, V399, P277, DOI 10.1016/S0014-5793(96)01341-5; Heller R, 1998, CANCER-AM CANCER SOC, V83, P148, DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W; Ibey BL, 2010, BBA-GEN SUBJECTS, V1800, P1210, DOI 10.1016/j.bbagen.2010.07.008; Ibey BL, 2010, BIOELECTROCHEMISTRY, V79, P114, DOI 10.1016/j.bioelechem.2010.01.001; Ibey BL, 2009, BIOELECTROMAGNETICS, V30, P92, DOI 10.1002/bem.20451; Kennedy SM, 2008, BIOPHYS J, V94, P5018, DOI 10.1529/biophysj.106.103218; Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185; Kotnik T, 2006, BIOPHYS J, V90, P480, DOI 10.1529/biophysj.105.070771; Landstrom FJ, 2010, DERMATOL SURG, V36, P1245, DOI 10.1111/j.1524-4725.2010.01617.x; LORENZ A, 1988, J VIROL, V62, P3050, DOI 10.1128/JVI.62.8.3050-3052.1988; Miller L, 2005, TECHNOL CANCER RES T, V4, P699, DOI 10.1177/153303460500400615; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; Neal RE, 2009, ANN BIOMED ENG, V37, P2615, DOI 10.1007/s10439-009-9796-9; Neumann E., 1989, ELECTROPORATION ELEC; Nuccitelli R, 2006, BIOCHEM BIOPH RES CO, V343, P351, DOI 10.1016/j.bbrc.2006.02.181; Nuccitelli R, 2009, INT J CANCER, V125, P438, DOI 10.1002/ijc.24345; Pakhomov AG, 2004, IEEE T PLASMA SCI, V32, P1579, DOI 10.1109/TPS.2004.831773; Pakhomov AG, 2007, BIOELECTROMAGNETICS, V28, P655, DOI 10.1002/bem.20354; Pakhomov AG, 2007, ARCH BIOCHEM BIOPHYS, V465, P109, DOI 10.1016/j.abb.2007.05.003; Pakhomov AG, 2009, BIOCHEM BIOPH RES CO, V385, P181, DOI 10.1016/j.bbrc.2009.05.035; Rubinsky B, 2010, SER BIOMED ENG, P1, DOI 10.1007/978-3-642-05420-4; Rubinsky J, 2008, J UROLOGY, V180, P2668, DOI 10.1016/j.juro.2008.08.003; Saulis G, 1999, Biomed Sci Instrum, V35, P409; Saulis G, 1997, BIOPHYS J, V73, P1299, DOI 10.1016/S0006-3495(97)78163-3; Schoenbach KH, 2007, IEEE T DIELECT EL IN, V14, P1088, DOI 10.1109/TDEI.2007.4339468; Schoenbach KH, 2008, IEEE INT POWER MODUL, P60, DOI 10.1109/IPMC.2008.4743576; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Stacey M, 2003, MUTAT RES-GEN TOX EN, V542, P65, DOI 10.1016/j.mrgentox.2003.08.006; Teissie J, 1999, ADV DRUG DELIVER REV, V35, P3, DOI 10.1016/S0169-409X(98)00060-X; Vasilkoski Z, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021904; Vernier PT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-37; Vernier PT, 2005, P ANN INT IEEE EMBS, P5850, DOI 10.1109/IEMBS.2005.1615820; Vernier PT, 2006, J AM CHEM SOC, V128, P6288, DOI 10.1021/ja0588306; Vernier PT, 2004, BIOPHYS J, V86, P4040, DOI 10.1529/biophysj.103.037945; Vernier PT, 2003, IEEE T DIELECT EL IN, V10, P795, DOI 10.1109/TDEI.2003.1237329; Weaver JC, 2003, IEEE T DIELECT EL IN, V10, P754, DOI 10.1109/TDEI.2003.1237325; WINTERBOURNE DJ, 1998, BIOCHEM J, V251, P427; XIAO S, 2007, PULS POW C 2007 16 I, V1, P744; Xiao S, 2010, IEEE ANTENN WIREL PR, V9, P12, DOI 10.1109/LAWP.2010.2041027	55	66	68	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15642	10.1371/journal.pone.0015642	http://dx.doi.org/10.1371/journal.pone.0015642			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	21390200	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800010
J	Jardri, R; Pins, D; Lafargue, G; Very, E; Ameller, A; Delmaire, C; Thomas, P				Jardri, Renaud; Pins, Delphine; Lafargue, Gilles; Very, Etienne; Ameller, Aurely; Delmaire, Christine; Thomas, Pierre			Increased Overlap between the Brain Areas Involved in Self-Other Distinction in Schizophrenia	PLOS ONE			English	Article							MIRROR NEURONS; PARIETAL; AGENCY; HALLUCINATIONS; SYMPTOMS; REPRESENTATIONS; SYSTEM; BODY; PET; RECOGNITION	Self-awareness impairments are frequently mentioned as being responsible for the positive symptoms of schizophrenia spectrum disorders. However, the neural correlates of self-other distinction in this pathology are still poorly understood. In the present study, we developed an fMRI procedure in order to examine self-other distinction during speech exchange situations. Fifteen subjects with schizophrenia were compared to 15 matched controls. The results revealed an increased overlap between the self and non-self cortical maps in schizophrenia, in the medial frontal and medial parietal cortices, as well as in the right middle temporal cortex and the right inferior parietal lobule. Moreover, these neural structures showed less BOLD amplitude differences between the self and non-self conditions in the patients. These activation patterns were judged to be independent of mirror-like properties, familiarity or body-ownership processing. Significantly, the increase in the right IPL signal was found to correlate positively with the severity of first-rank symptoms, and thus could be considered a "state-marker" of schizophrenia, whereas temporal and medial parieto-frontal differences appear to be "trait-markers" of the disease. Such an increased overlap between self and non-self cortical maps might be considered a neuro-physiological signature of the well established self-awareness impairment in people suffering from schizophrenia.	[Jardri, Renaud; Pins, Delphine; Lafargue, Gilles; Delmaire, Christine; Thomas, Pierre] Univ Lille Nord de France, Lab Neurosci Fonct & Pathol, EA 4559, Lille, France; [Jardri, Renaud] CHRU Lille, Hop Fontan, Serv Psychiat Infanto Juvenile, Lille, France; [Pins, Delphine] CNRS, Paris, France; [Very, Etienne] Hop Purpan, Serv Urgences Psychiat Univ, Toulouse, France; [Ameller, Aurely; Thomas, Pierre] CHRU Lille, Hop Fontan, Psychiat Serv, Lille, France; [Delmaire, Christine] CHRU Lille, Hop Salengro, Serv Neuroradiol, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Jardri, R (corresponding author), Univ Lille Nord de France, Lab Neurosci Fonct & Pathol, EA 4559, Lille, France.	renaud.jardri@chru-lille.fr	Jardri, Renaud/J-9202-2012; Jardri, Renaud/ABE-5841-2021	Jardri, Renaud/0000-0003-4596-1502; Pins, Delphine/0000-0001-9158-8425				Agnew Z, 2008, J NEUROSCI, V28, P12268, DOI 10.1523/JNEUROSCI.2836-08.2008; Allen PP, 2004, SCHIZOPHR RES, V69, P277, DOI 10.1016/j.schres.2003.09.008; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Buccino G, 2008, CURR OPIN PSYCHIATR, V21, P281, DOI 10.1097/YCO.0b013e3282fbcd32; Bulot V, 2007, EXP BRAIN RES, V183, P115, DOI 10.1007/s00221-007-1027-8; Charney DS, 2002, RESEARCH AGENDA FOR DSM-V, P31; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Crow TJ, 1998, BRIT J PSYCHIAT, V173, P303, DOI 10.1192/bjp.173.4.303; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Farrer C, 2004, PSYCHIAT RES-NEUROIM, V131, P31, DOI 10.1016/j.pscychresns.2004.02.004; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; FEINBERG I, 1978, SCHIZOPHRENIA BULL, V4, P636, DOI 10.1093/schbul/4.4.636; Franck N, 2001, AM J PSYCHIAT, V158, P454, DOI 10.1176/appi.ajp.158.3.454; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; FRITH CD, 1989, PSYCHOL MED, V19, P359, DOI 10.1017/S003329170001240X; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Georgieff N, 1998, CONSCIOUS COGN, V7, P465, DOI 10.1006/ccog.1998.0367; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jardri R, 2007, NEUROIMAGE, V35, P1645, DOI 10.1016/j.neuroimage.2007.02.002; Jardri R, 2009, NEUROPSYCHOLOGIA, V47, P132, DOI 10.1016/j.neuropsychologia.2008.08.006; Jeannerod M, 2009, EXP BRAIN RES, V192, P527, DOI 10.1007/s00221-008-1533-3; Johns LC, 2001, PSYCHOL MED, V31, P705, DOI 10.1017/S0033291701003774; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kiebel S., 2003, HUMAN BRAIN FUNCTION, P725; Lafargue G, 2009, CONSCIOUS COGN, V18, P277, DOI 10.1016/j.concog.2008.05.004; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Maruff P, 2005, PSYCHOL MED, V35, P783, DOI 10.1017/S0033291704003113; MELLOR CS, 1970, BRIT J PSYCHIAT, V117, P15, DOI 10.1192/S0007125000192116; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plaze M, 2011, SCHIZOPHRENIA BULL, V37, P212, DOI 10.1093/schbul/sbp081; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; SCHNEIDER K, 1955, KLIN PSYCHOPATHOLOGI; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; Talairach I., 1988, COPLANAR STEREOTACTI; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; van den Bos E, 2002, COGNITION, V85, P177, DOI 10.1016/S0010-0277(02)00100-2; Waters FAV, 2010, SCHIZOPHRENIA BULL, V36, P510, DOI 10.1093/schbul/sbn112; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; Wilke M, 2001, NEUROIMAGE, V13, P814, DOI 10.1006/nimg.2001.0751	51	45	46	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17500	10.1371/journal.pone.0017500	http://dx.doi.org/10.1371/journal.pone.0017500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408008	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900023
J	Cheng, LA; Wang, J; Li, XZ; Xing, QA; Du, PS; Su, LS; Wang, SD				Cheng, Liang; Wang, Jun; Li, Xiaozhu; Xing, Qiao; Du, Peishuang; Su, Lishan; Wang, Shengdian			Interleukin-6 Induces Gr-1+CD11b+Myeloid Cells to Suppress CD8+T Cell-Mediated Liver Injury in Mice	PLOS ONE			English	Article							VIRUS-TRANSGENIC MICE; T-CELL; HEPATOCELLULAR-CARCINOMA; HEPATITIS-B; INDUCED ARTHRITIS; IN-VIVO; IL-6; ACTIVATION; INFLAMMATION; PATHOGENESIS	Background: Agonist antibodies against CD137 (4-1BB) on T lymphocytes are used to increase host anti-tumor immunity, but often leading to severe liver injury in treated mice or in patients during clinical trials. Interleukin-6 (IL-6) has been reported to protect hepatocyte death, but the role of IL-6 in protecting chronic T cell-induced liver diseases is not clearly defined due to lack of relevant animal models. We aimed to define the role of IL-6 in CD8+ T cell-mediated liver injury induced by a CD137 agonistic mAb (clone 2A) in mice. Methods/Principal Findings: We expressed IL-6 in the liver by hydrodynamic gene delivery in mice treated with 2A or control mAb and studied how IL-6 treatment affected host immunity and T cell-mediated liver injury. We found that ectopic IL-6 expression in the liver elevated intrahepatic leukocyte infiltration but prevented CD8+ T cell-mediated liver injury. In IL-6 treated mice, CD8+ T cells proliferation and IFN-gamma expression were inhibited in the liver. We discovered that IL-6 increased accumulation of Gr-1+CD11b+ myeloid derived suppressor cells (MDSCs) in the liver and spleen. These MDSCs had the ability to inhibit T cells proliferation and activation. Finally, we showed that the MDSCs were sufficient and essential for IL-6-mediated protection of anti-CD137 mAb-induced liver injury. Conclusions/Significance: We concluded that IL-6 induced Gr-1+CD11b+ MDSCs in the liver to inhibit T cell-mediated liver injury. The findings have defined a novel mechanism of IL-6 in protecting liver from CD8+ T cell-mediated injury.	[Cheng, Liang; Wang, Jun; Li, Xiaozhu; Xing, Qiao; Du, Peishuang; Su, Lishan; Wang, Shengdian] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Cheng, Liang; Wang, Jun] Grad Univ, Chinese Acad Sci, Beijing, Peoples R China; [Su, Lishan] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Cheng, LA (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	lsu@med.unc.edu; sdwang@moon.ibp.ac.cn	Wang, Jun/G-8361-2011	Wang, Jun/0000-0002-6346-2929	Ministry of Science and Technology of China [2006AA02A410]; National Key Technologies Research and Development Program of China [2008ZX10002-006, 2009ZX10004-309, 2008ZX10002-001]; Chinese Academy of Sciences [KSCX1-YW-10-02]; National Institutes of Health of USA [AA018372, AI076142, AA018009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018009, R21AA018372] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Key Technologies Research and Development Program of China(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences); National Institutes of Health of USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The project was supported in part by grants from the Ministry of Science and Technology of China's 863 programs (2006AA02A410 to S.W.), the National Key Technologies Research and Development Program of China (2008ZX10002-006, 2009ZX10004-309, 2008ZX10002-001 and 2009ZX10004-309 to S. W.), the Innovative Program of Chinese Academy of Sciences (KSCX1-YW-10-02 to S.W.) and from National Institutes of Health of USA (AA018372, AI076142 and AA018009 to L.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Chen YY, 2007, HEPATOLOGY, V46, P706, DOI 10.1002/hep.21872; *CLINICALTRIALS GO, 2011, PHAS 2 2 LIN MEL RAN; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Croft M, 2003, NAT REV IMMUNOL, V3, P609, DOI 10.1038/nri1148; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1223, DOI 10.1007/s00262-010-0846-9; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Halstead ES, 2002, NAT IMMUNOL, V3, P536, DOI 10.1038/ni798; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; HWU WJ, 2010, TARGETED THERAPY MET; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Masubachi Y, 2003, BIOCHEM BIOPH RES CO, V304, P207, DOI 10.1016/S0006-291X(03)00572-2; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Mizuhara H, 1996, HEPATOLOGY, V23, P1608, DOI 10.1002/hep.510230643; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Myers LM, 2005, TRENDS IMMUNOL, V26, P440, DOI 10.1016/j.it.2005.06.003; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Streetz KL, 2003, HEPATOLOGY, V38, P218, DOI 10.1053/jhep.2003.50268; Sun R, 2004, J IMMUNOL, V172, P5648, DOI 10.4049/jimmunol.172.9.5648; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Wang J, 2010, J IMMUNOL, V185, P7654, DOI 10.4049/jimmunol.1000927; Wilcox RA, 2002, J CLIN INVEST, V109, P651, DOI 10.1172/JCI200214184; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878; Zhu YW, 2007, BLOOD, V109, P4882, DOI 10.1182/blood-2006-10-043463	40	39	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17631	10.1371/journal.pone.0017631	http://dx.doi.org/10.1371/journal.pone.0017631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394214	Green Published, gold, Green Submitted			2022-12-27	WOS:000288025500019
J	Kwakman, PHS; Velde, AAT; de Boer, L; Vandenbroucke-Grauls, CMJE; Zaat, SAJ				Kwakman, Paulus H. S.; Velde, Anje A. Te; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.			Two Major Medicinal Honeys Have Different Mechanisms of Bactericidal Activity	PLOS ONE			English	Article							LEPTOSPERMUM-SCOPARIUM HONEY; ZEALAND MANUKA HONEY; HYDROGEN-PEROXIDE; ANTIBACTERIAL ACTIVITY; FOODBORNE PATHOGENS; POLYACRYLAMIDE-GEL; GROWTH-INHIBITION; IDENTIFICATION; METHYLGLYOXAL; ORIGIN	Honey is increasingly valued for its antibacterial activity, but knowledge regarding the mechanism of action is still incomplete. We assessed the bactericidal activity and mechanism of action of Revamil (R) source (RS) honey and manuka honey, the sources of two major medical-grade honeys. RS honey killed Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa within 2 hours, whereas manuka honey had such rapid activity only against B. subtilis. After 24 hours of incubation, both honeys killed all tested bacteria, including methicillin-resistant Staphylococcus aureus, but manuka honey retained activity up to higher dilutions than RS honey. Bee defensin-1 and H(2)O(2) were the major factors involved in rapid bactericidal activity of RS honey. These factors were absent in manuka honey, but this honey contained 44-fold higher concentrations of methylglyoxal than RS honey. Methylglyoxal was a major bactericidal factor in manuka honey, but after neutralization of this compound manuka honey retained bactericidal activity due to several unknown factors. RS and manuka honey have highly distinct compositions of bactericidal factors, resulting in large differences in bactericidal activity.	[Kwakman, Paulus H. S.; de Boer, Leonie; Vandenbroucke-Grauls, Christina M. J. E.; Zaat, Sebastian A. J.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Velde, Anje A. Te] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Kwakman, PHS (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.a.zaat@amc.uva.nl	Vandenbroucke-Grauls, Christina/AAO-7953-2020	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597				Adams CJ, 2008, CARBOHYD RES, V343, P651, DOI 10.1016/j.carres.2007.12.011; Adams CJ, 2009, CARBOHYD RES, V344, P1050, DOI 10.1016/j.carres.2009.03.020; ALLEN KL, 1991, J PHARM PHARMACOL, V43, P817, DOI 10.1111/j.2042-7158.1991.tb03186.x; Bachanova K, 2002, APIDOLOGIE, V33, P259, DOI 10.1051/apido:2002015; Bang LM, 2003, J ALTERN COMPLEM MED, V9, P267, DOI 10.1089/10755530360623383; Bogdanov S, 1997, FOOD SCI TECHNOL-LEB, V30, P748, DOI 10.1006/fstl.1997.0259; Carattoli A, 2008, CLIN MICROBIOL INFEC, V14, P117, DOI 10.1111/j.1469-0691.2007.01851.x; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; EFEM SEE, 1988, BRIT J SURG, V75, P679, DOI 10.1002/bjs.1800750718; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Kalapos MP, 2008, CHEM-BIOL INTERACT, V171, P251, DOI 10.1016/j.cbi.2007.11.009; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Krushna NSA, 2007, INDIAN J EXP BIOL, V45, P459; Kwakman PHS, 2008, CLIN INFECT DIS, V46, P1677, DOI 10.1086/587892; Kwakman PHS, 2010, FASEB J, V24, P2576, DOI 10.1096/fj.09-150789; LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198; LENSKY Y, 1983, COMP BIOCHEM PHYS B, V75, P607, DOI 10.1016/0305-0491(83)90104-9; Majno G., 1975, MAN WOUND ANCIENT WO; Majtan J, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq013; Mavric E, 2008, MOL NUTR FOOD RES, V52, P483, DOI 10.1002/mnfr.200700282; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; MOLAN PC, 1992, BEE WORLD, V73, P59, DOI 10.1080/0005772X.1992.11099118; Mundo MA, 2004, INT J FOOD MICROBIOL, V97, P1, DOI 10.1016/j.ijfoodmicro.2004.03.025; RACKER E, 1951, J BIOL CHEM, V190, P685; RUSSELL KM, 1990, J AGR FOOD CHEM, V38, P10, DOI 10.1021/jf00091a002; SCHEPARTZ A I, 1966, Journal of Apicultural Research, V5, P167; Taormina PJ, 2001, INT J FOOD MICROBIOL, V69, P217, DOI 10.1016/S0168-1605(01)00505-0; Walsh C., 2003, ANTIBIOTICS ACTIONS; Weigel KU, 2004, EUR FOOD RES TECHNOL, V218, P147, DOI 10.1007/s00217-003-0814-0; Weston RJ, 2000, FOOD CHEM, V70, P427, DOI 10.1016/S0308-8146(00)00127-8; Weston RJ, 1999, FOOD CHEM, V64, P295, DOI 10.1016/S0308-8146(98)00100-9; White J. W., 1963, J APICULT RES, V2, P93, DOI [10.1080/00218839.1963.11100066, DOI 10.1080/00218839.1963.11100066]; WHITE JONATHAN W., 1964, J APICULT RES, V3, P45; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; WHITE JW, 1964, J FOOD SCI, V29, P819, DOI 10.1111/j.1365-2621.1964.tb00455.x; ZUMLA A, 1989, J ROY SOC MED, V82, P384, DOI 10.1177/014107688908200704	38	151	167	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17709	10.1371/journal.pone.0017709	http://dx.doi.org/10.1371/journal.pone.0017709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394213	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500021
J	Chaturvedi, S; Rajkumar, SS; Li, X; Hurteau, GJ; Shtutman, M; Chaturvedi, V				Chaturvedi, Sudha; Rajkumar, Sunanda S.; Li, Xiaojiang; Hurteau, Gregory J.; Shtutman, Michael; Chaturvedi, Vishnu			Antifungal Testing and High-Throughput Screening of Compound Library against Geomyces destructans, the Etiologic Agent of Geomycosis (WNS) in Bats	PLOS ONE			English	Article							ASPERGILLUS; 5-FLUOROCYTOSINE; 5-FLUOROURACIL; ITRACONAZOLE; ETEST; MODE; CAVE	Bats in the northeastern U.S. are affected by geomycosis caused by the fungus Geomyces destructans (Gd). This infection is commonly referred to as White Nose Syndrome (WNS). Over a million hibernating bats have died since the fungus was first discovered in 2006 in a cave near Albany, New York. A population viability analysis conducted on little brown bats (Myotis lucifugus), one of six bat species infected with Gd, suggests regional extinction of this species within 20 years. The fungus Gd is a psychrophile ("cold loving''), but nothing is known about how it thrives at low temperatures and what pathogenic attributes allow it to infect bats. This study aimed to determine if currently available antifungal drugs and biocides are effective against Gd. We tested five Gd strains for their susceptibility to antifungal drugs and high-throughput screened (HTS) one representative strain with SpectrumPlus compound library containing 1,920 compounds. The results indicated that Gd is susceptible to a number of antifungal drugs at concentrations similar to the susceptibility range of human pathogenic fungi. Strains of Gd were susceptible to amphotericin B, fluconazole, itraconazole, ketoconazole and voriconazole. In contrast, very high MICs (minimum inhibitory concentrations) of flucytosine and echinocandins were needed for growth inhibition, which were suggestive of fungal resistance to these drugs. Of the1,920 compounds in the library, a few caused 50% - to greater than 90% inhibition of Gd growth. A number of azole antifungals, a fungicide, and some biocides caused prominent growth inhibition. Our results could provide a theoretical basis for future strategies aimed at the rehabilitation of most affected bat species and for decontamination of Gd in the cave environment.	[Chaturvedi, Sudha; Rajkumar, Sunanda S.; Li, Xiaojiang; Chaturvedi, Vishnu] New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA; [Chaturvedi, Sudha; Chaturvedi, Vishnu] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA; [Shtutman, Michael] Ordway Res Inst, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Ordway Research Institute	Chaturvedi, S (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mycol Lab, Albany, NY 12237 USA.	vishnu@wadsworth.org	Shtutman, Michael/AAB-8391-2020	Shtutman, Michael/0000-0002-2458-3226; Chaturvedi, Vishnu/0000-0002-3922-9676				Arikan S, 2001, ANTIMICROB AGENTS CH, V45, P327, DOI 10.1128/AAC.45.1.327-330.2001; Bastian F, 2009, NATURWISSENSCHAFTEN, V96, P863, DOI 10.1007/s00114-009-0540-y; Bending GD, 2007, CHEMOSPHERE, V69, P82, DOI 10.1016/j.chemosphere.2007.04.042; Berger L, 2009, RES VET SCI, V87, P106, DOI 10.1016/j.rvsc.2008.11.005; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; CLSI, 2008, M38A2 CLSI, V28; CLSI, 2008, M27A3 CLSI, V28; CUNNINGHAM KI, 1995, ENVIRON GEOL, V25, P2, DOI 10.1007/BF01061824; Espinel-Ingroff Ana, 2003, Revista Iberoamericana de Micologia, V20, P121; *EUCAST, 2008, CLIN MICROBIOL INFEC, P982; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Garner TWJ, 2009, DIS AQUAT ORGAN, V83, P257, DOI 10.3354/dao02008; Hoskins J, 2007, YEAST, V24, P861, DOI 10.1002/yea.1516; Katiyar SK, 2009, ANTIMICROB AGENTS CH, V53, P1772, DOI 10.1128/AAC.00020-09; Li H, 2008, J LIPID RES, V49, P230, DOI 10.1194/jlr.D700015-JLR200; Maltby L, 2009, ENVIRON SCI TECHNOL, V43, P7556, DOI 10.1021/es901461c; Marchetti V, 2006, VET RES COMMUN, V30, P255, DOI 10.1007/s11259-006-3199-2; Martel A, 2011, MED MYCOL, V49, P143, DOI 10.3109/13693786.2010.508185; Martin-Mazuelos E, 2003, J ANTIMICROB CHEMOTH, V52, P365, DOI 10.1093/jac/dkg384; Martos AI, 2010, MED MYCOL, V48, P858, DOI 10.3109/13693781003586943; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; POLAK A, 1983, SABOURAUDIA, V21, P15; Shapiro J, 2010, AM MIDL NAT, V163, P76, DOI 10.1674/0003-0031-163.1.76; Tamukai K, 2010, J VET MED SCI; TOSH FE, 1966, AM J EPIDEMIOL, V83, P262, DOI 10.1093/oxfordjournals.aje.a120582; Urzi C, 2010, MICROB ECOL, V60, P116, DOI 10.1007/s00248-010-9710-x; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; WAGNER GE, 1979, CHEMOTHERAPY, V25, P61, DOI 10.1159/000237824; Zhang LX, 2007, P NATL ACAD SCI USA, V104, P4606, DOI 10.1073/pnas.0609370104	30	25	26	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17032	10.1371/journal.pone.0017032	http://dx.doi.org/10.1371/journal.pone.0017032			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399675	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300008
J	Mutch, WAC; Fransoo, RR; Campbell, BI; Chateau, DG; Sirski, M; Warrian, RK				Mutch, W. Alan C.; Fransoo, Randall R.; Campbell, Barry I.; Chateau, Dan G.; Sirski, Monica; Warrian, R. Keith			Dementia and Depression with Ischemic Heart Disease: A Population-Based Longitudinal Study Comparing Interventional Approaches to Medical Management	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; COGNITIVE DECLINE; ALZHEIMERS-DISEASE; GRAFT-SURGERY; CEREBROVASCULAR-DISEASE; CARDIOPULMONARY BYPASS; RISK-FACTOR; OUTCOMES; IMPAIRMENT; BRAIN	Background: We compared the proportion of ischemic heart disease (IHD) patients newly diagnosed with dementia and depression across three treatment groups: percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical management alone (IHD-medical). Methods and Findings: De-identified, individual-level administrative records of health service use for the population of Manitoba, Canada (approximately 1.1 million) were examined. From April 1, 1993 to March 31, 1998, patients were identified with a diagnosis of IHD (ICD-9-CM codes). Index events of CABG or PCI were identified from April 1, 1998 to March 31, 2003. Outcomes were depression or dementia after the index event. Patients were followed forward to March 31, 2006 or until censored. Proportional hazards regression analysis was undertaken. Independent variables examined were age, sex, diabetes, hypertension and income quintile, medical management alone for IHD, or intervention by PCI or CABG. Age, sex, diabetes, and presence of hypertension were all strongly associated with the diagnosis of depression and dementia. There was no association with income quintile. Dementia was less frequent with PCI compared to medical management; (HR = 0.65; p = 0.017). CABG did not provide the same protective effect compared to medical management (HR = 0.90; p = 0.372). New diagnosis depression was more frequent with interventional approaches: PCI (n = 626; hazard ratio = 1.25; p = 0.028) and CABG (n = 1124, HR = 1.32; p = 0.0001) than non-interventional patients (n = 34,508). Subsequent CABG was nearly 16-fold higher (p, 0.0001) and subsequent PCI was 22-fold higher (p, 0.0001) for PCI-managed than CABG-managed patients. Conclusions: Patients managed with PCI had the lowest likelihood of dementia-only 65% of the risk for medical management alone. Both interventional approaches were associated with a higher risk of new diagnosed depression compared to medical management. Long-term myocardial revascularization was superior with CABG. These findings suggest that PCI may confer a long-term protective effect from dementia. The mechanism(s) of dementia protection requires elucidation.	[Mutch, W. Alan C.] Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada; [Fransoo, Randall R.; Chateau, Dan G.; Sirski, Monica] Univ Manitoba, Manitoba Ctr Hlth Policy, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Campbell, Barry I.] Univ Manitoba, St Boniface Gen Hosp, Dept Psychiat, Winnipeg, MB, Canada; [Warrian, R. Keith] Univ Manitoba, St Boniface Gen Hosp, Dept Surg, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Mutch, WAC (corresponding author), Univ Manitoba, Hlth Sci Ctr, Dept Anesthesia & Perioperat Med, Winnipeg, MB, Canada.	amutch@cc.umanitoba.ca		Fransoo, Randall/0000-0002-8375-972X; chateau, Dan/0000-0002-2215-820X; Mutch, W. Alan/0000-0001-7174-7839	Academic Oversight Committee (AOC) of the Department of Anesthesia at the University of Manitoba; Population Health Research Data Repository [HIPC 2007/08-05]	Academic Oversight Committee (AOC) of the Department of Anesthesia at the University of Manitoba; Population Health Research Data Repository	This study was supported through the Academic Oversight Committee (AOC) of the Department of Anesthesia at the University of Manitoba by a grant awarded to Dr. W.A.C. Mutch. The AOC had no input into the design, data collection, data analysis, data interpretation or writing of the report. Dr. Mutch as corresponding author had full access to all data in the study and had final responsibility to submit for publication.; None of the authors has a conflict of interest to declare. The authors acknowledge the Manitoba Centre for Health Policy for use of the data contained in the Population Health Research Data Repository under project number HIPC 2007/08-05. The results and conclusions are those of the authors and no official endorsement by the Manitoba Centre for Health Policy, Manitoba Health or other data providers is intended or should be inferred.	Ahto M, 1999, GERONTOLOGY, V45, P87, DOI 10.1159/000022069; Arrowsmith JE, 1999, J CARDIOTHOR VASC AN, V13, P736, DOI 10.1016/S1053-0770(99)90132-5; Beeri MS, 2006, NEUROLOGY, V66, P1399, DOI 10.1212/01.wnl.0000210447.19748.0b; Borowicz LM, 1996, J CARDIOTHOR VASC AN, V10, P105, DOI 10.1016/S1053-0770(96)80185-6; Bounhoure JP, 2006, B ACAD NAT MED PARIS, V190, P1723, DOI 10.1016/S0001-4079(19)33171-1; Bursi F, 2006, AM J EPIDEMIOL, V163, P135, DOI 10.1093/aje/kwj025; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; Cacciatore F, 1998, J AM GERIATR SOC, V46, P1343, DOI 10.1111/j.1532-5415.1998.tb05999.x; CROUGHWELL ND, 1994, ANN THORAC SURG, V58, P1702, DOI 10.1016/0003-4975(94)91666-7; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; de la Torre JC, 2010, NEURODEGENER DIS, V7, P116, DOI 10.1159/000285520; DeCarli C, 2003, NEUROLOGIST, V9, P123, DOI 10.1097/00127893-200305000-00001; Diller GP, 2008, EUR J CARDIO-THORAC, V34, P995, DOI 10.1016/j.ejcts.2008.08.008; Dudas RB, 2005, AM J GERIAT PSYCHIAT, V13, P218, DOI 10.1176/appi.ajgp.13.3.218; Grubb NR, 2000, AM HEART J, V140, pE1; Hannan EL, 2008, NEW ENGL J MED, V358, P331, DOI 10.1056/NEJMoa071804; Hawkes AL, 2006, VASC HEALTH RISK MAN, V2, P477, DOI 10.2147/vhrm.2006.2.4.477; Jefferson AL, 2010, CIRCULATION, V122, P690, DOI 10.1161/CIRCULATIONAHA.109.905091; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jensen BO, 2006, CIRCULATION, V113, P2790, DOI 10.1161/CIRCULATIONAHA.105.587931; Joshi SB, 2010, CARDIOVASC REVASCULA, V11, P98, DOI 10.1016/j.carrev.2009.04.002; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Kirschbaum SW, 2010, JACC-CARDIOVASC INTE, V3, P392, DOI 10.1016/j.jcin.2010.01.011; Lee TA, 2005, J ALZHEIMERS DIS, V7, P319; Lee TH, 2009, NEW ENGL J MED, V360, pE5, DOI 10.1056/NEJMp0810969; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Lix L, 2006, DEFINING VALIDATING; MARTEN PJ, 2004, PATTERNS REGIONAL ME; Martens PJ, 2007, CAN J PSYCHIAT, V52, P581, DOI 10.1177/070674370705200906; McKenzie LH, 2010, PSYCHOL HEALTH MED, V15, P74, DOI 10.1080/13548500903483486; McKhann GM, 1997, ANN THORAC SURG, V63, P510; Muller M, 2007, ATHEROSCLEROSIS, V190, P143, DOI 10.1016/j.atherosclerosis.2006.01.005; MURKIN JM, 1995, ANN THORAC SURG, V59, P1308, DOI 10.1016/0003-4975(95)00107-V; MUTCH WAC, 1994, J CEREBR BLOOD F MET, V14, P510, DOI 10.1038/jcbfm.1994.63; Mutch WAC, 1997, ANN THORAC SURG, V64, P695, DOI 10.1016/S0003-4975(97)00634-6; Nardi P, 2009, ANN THORAC SURG, V87, P1401, DOI 10.1016/j.athoracsur.2009.02.062; NEWMAN MF, 1995, ANN THORAC SURG, V59, P1326, DOI 10.1016/0003-4975(95)00076-W; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Nyenhuis David L, 2007, Curr Atheroscler Rep, V9, P326, DOI 10.1007/s11883-007-0040-5; Qiu CX, 2010, J ALZHEIMERS DIS, V20, P293, DOI 10.3233/JAD-2010-1361; Raja PV, 2004, CNS SPECTRUMS, V9, P763, DOI 10.1017/S1092852900022409; Reichenberg Abraham, 2007, Dialogues Clin Neurosci, V9, P85; Roos LL, 2005, CAN J AGING, V24, P153, DOI 10.1353/cja.2005.0055; Roose SP, 2005, PSYCHOSOM MED, V67, pS54, DOI 10.1097/01.psy.0000163455.43226.bf; Roose SP, 2003, BIOL PSYCHIAT, V54, P262, DOI 10.1016/S0006-3223(03)00320-2; Rosengart TK, 2005, ANN THORAC SURG, V80, P1327, DOI 10.1016/j.athoracsur.2005.06.052; Royter V, 2005, J NEUROL SCI, V229, P65, DOI 10.1016/j.jns.2004.11.003; Runge TM, 2004, CLIN CARDIOL, V27, P594, DOI 10.1002/clc.4960271103; Selnes OA, 2010, J INT NEUROPSYCH SOC, V16, P221, DOI 10.1017/S1355617709991196; Selnes OA, 2009, ANN THORAC SURG, V88, P445, DOI 10.1016/j.athoracsur.2009.04.061; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Singh-Manoux A, 2008, EUR HEART J, V29, P2100, DOI 10.1093/eurheartj/ehn298; Sweet JJ, 2008, ANN THORAC SURG, V85, P1571, DOI 10.1016/j.athoracsur.2008.01.090; Symes E, 2000, AUST NZ J PSYCHIAT, V34, P770, DOI 10.1046/j.1440-1614.2000.00808.x; Tully PJ, 2008, J BEHAV MED, V31, P281, DOI 10.1007/s10865-008-9153-8; van Dijk Diederik, 2009, Ann Thorac Surg, V88, P454, DOI 10.1016/j.athoracsur.2009.05.034; Wellenius GA, 2008, CIRCULATION, V117, P2313, DOI 10.1161/CIRCULATIONAHA.107.741058	57	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17457	10.1371/journal.pone.0017457	http://dx.doi.org/10.1371/journal.pone.0017457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729EM	21387018	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400078
J	Ramirez-Villegas, JF; Lam-Espinosa, E; Ramirez-Moreno, DF; Calvo-Echeverry, PC; Agredo-Rodriguez, W				Ramirez-Villegas, Juan F.; Lam-Espinosa, Eric; Ramirez-Moreno, David F.; Calvo-Echeverry, Paulo C.; Agredo-Rodriguez, Wilfredo			Heart Rate Variability Dynamics for the Prognosis of Cardiovascular Risk	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; MYOCARDIAL-INFARCTION; WAVELET TRANSFORM; SPECTRAL-ANALYSIS; CHAOS THEORY; HRV INDEXES; INDIVIDUALS; COMPLEXITY; PARAMETERS; FEATURES	Statistical, spectral, multi-resolution and non-linear methods were applied to heart rate variability (HRV) series linked with classification schemes for the prognosis of cardiovascular risk. A total of 90 HRV records were analyzed: 45 from healthy subjects and 45 from cardiovascular risk patients. A total of 52 features from all the analysis methods were evaluated using standard two-sample Kolmogorov-Smirnov test (KS-test). The results of the statistical procedure provided input to multilayer perceptron (MLP) neural networks, radial basis function (RBF) neural networks and support vector machines (SVM) for data classification. These schemes showed high performances with both training and test sets and many combinations of features (with a maximum accuracy of 96.67%). Additionally, there was a strong consideration for breathing frequency as a relevant feature in the HRV analysis.	[Ramirez-Villegas, Juan F.; Ramirez-Moreno, David F.] Univ Autonoma Occidente, Dept Phys, Cali, Colombia; [Lam-Espinosa, Eric; Calvo-Echeverry, Paulo C.; Agredo-Rodriguez, Wilfredo] Univ Autonoma Occidente, Dept Automat & Elect, Fac Engn, Cali, Colombia	Universidad Autonoma de Occidente; Universidad Autonoma de Occidente	Ramirez-Villegas, JF (corresponding author), Univ Autonoma Occidente, Dept Phys, Cali, Colombia.	juanfelipe.rv@gmail.com			Universidad Autonoma de Occidente, Cali, Colombia; Occupational Health Office (Universidad Autonoma de Occidente)	Universidad Autonoma de Occidente, Cali, Colombia; Occupational Health Office (Universidad Autonoma de Occidente)	All the financial resources to carry out this research were provided by Universidad Autonoma de Occidente, Cali, Colombia. They provided the necessary medical equipment for the data recording and analysis. The funders had no role in the preparation of the manuscript.; We acknowledge the support of the Occupational Health Office (Universidad Autonoma de Occidente), the Coomeva IPS S. A. experts and the patients which formed part of this study. We also acknowledge the special reviewing collaboration of Dr. Odelia Schwartz (Albert Einstein College of Medicine, NY, USA). Finally, we are grateful for the important suggestions given by anonymous reviewers.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Asl BM, 2008, ARTIF INTELL MED, V44, P51, DOI 10.1016/j.artmed.2008.04.007; AXELROD S, 1987, NEPHRON, V45, P202, DOI 10.1159/000184117; Belova NY, 2007, AUTON NEUROSCI-BASIC, V131, P107, DOI 10.1016/j.autneu.2006.07.006; BELTRANBOHORQUE.JR, 2010, REV COLOMB CARDIOL, V17, P111; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Bezerianos A, 1999, ARTIF INTELL MED, V15, P215, DOI 10.1016/S0933-3657(98)00055-4; Bilgin S, 2008, DIGIT SIGNAL PROCESS, V18, P892, DOI 10.1016/j.dsp.2008.04.007; Blanco S, 1998, PHYS REV E, V57, P932, DOI 10.1103/PhysRevE.57.932; Boardman A, 2002, PHYSIOL MEAS, V23, P325, DOI 10.1088/0967-3334/23/2/308; Brennan M, 2002, AM J PHYSIOL-HEART C, V283, pH1873, DOI 10.1152/ajpheart.00405.2000; Brennan M, 2001, IEEE T BIO-MED ENG, V48, P1342, DOI 10.1109/10.959330; Camm AJ, 1996, CIRCULATION, V93, P1043; Chattipakorn N, 2007, INT J CARDIOL, V120, P289, DOI 10.1016/j.ijcard.2006.11.221; Chesnokov YV, 2008, ARTIF INTELL MED, V43, P151, DOI 10.1016/j.artmed.2008.03.009; D'Addio G, 1999, COMPUT CARDIOL, V26, P611, DOI 10.1109/CIC.1999.826045; D'Addio G, 1998, COMPUT CARDIOL, V25, P381, DOI 10.1109/CIC.1998.731819; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fukuda O, 2001, P ANN INT IEEE EMBS, V23, P1769, DOI 10.1109/IEMBS.2001.1020562; Gallagher D, 1992, Clin Auton Res, V2, P383, DOI 10.1007/BF01831395; GARCIAGONZALEZ MA, 1998, THESIS U POLITECNICA; Goldberger AL, 1996, LANCET, V347, P1312, DOI 10.1016/S0140-6736(96)90948-4; Gutierrez A, 2005, COMPUT SIST, V8, P293; Haykin S, 1999, P842; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Hnatkova K, 1995, J ELECTROCARDIOL, V28, P74, DOI 10.1016/S0022-0736(95)80020-4; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; KATONA PG, 1975, J APPL PHYSIOL, V39, P801, DOI 10.1152/jappl.1975.39.5.801; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Koorpelainen JT, 1999, STROKE, V30, P1008, DOI 10.1161/01.STR.30.5.1008; Kuss O, 2008, J ELECTROCARDIOL, V41, P287, DOI 10.1016/j.jelectrocard.2008.02.014; Lerma C, 2003, CLIN PHYSIOL FUNCT I, V23, P72; Liao DP, 2002, DIABETES, V51, P3524, DOI 10.2337/diabetes.51.12.3524; LIPPMAN N, 1994, AM J PHYSIOL, V267, pH411, DOI 10.1152/ajpheart.1994.267.1.H411; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lombardi F, 2000, CIRCULATION, V101, P8, DOI 10.1161/01.CIR.101.1.8; Lopes P, 2006, PHYSL ASSESSMENT HUM, P39; MALIK M, 1989, EUR HEART J, V10, P1060, DOI 10.1093/oxfordjournals.eurheartj.a059428; Marciano F, 1994, COMPUT CARDIOL, P557, DOI DOI 10.1109/CIC.1994.470126; Meiss J.D., 2007, DIFFERENTIAL DYNAMIC; MONTANO N, 2008, NEUROSCIENC IN PRESS; Motivala SJ, 1999, INT J BEHAV MED, V6, P78, DOI 10.1207/s15327558ijbm0601_6; NISKANEN JP, 2002, COMPUTER ME IN PRESS; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Pal GK, 2009, MED HYPOTHESES, V72, P183, DOI 10.1016/j.mehy.2008.07.060; PENAZ J, 1968, SPECTRAL ANAL SOME S, P223; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; Piepoli M, 1997, CIRCULATION, V95, P1813; Pincus SM, 2001, ANN NY ACAD SCI, V954, P245; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; RAMIREZVILLEGAS JF, 2009, THESIS U AUTONOMA OC; RAVICHANDRAN IT, 2003, ESTIMATION POWER SPE, P223; Rencher AC, 2002, METHODS MULTIVARIATE; ROSNER B, 1983, TECHNOMETRICS, V25, P165, DOI 10.2307/1268549; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; RUEDA OL, 2007, MED SANITAS 22; SANO M, 1985, PHYS REV LETT, V55, P1082, DOI 10.1103/PhysRevLett.55.1082; Singh D, 2005, 2005 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSING AND INFORMATION PROCESSING, PROCEEDINGS, P430, DOI 10.1109/ICISIP.2005.1529493; Thong T, 2007, P ANN INT IEEE EMBS, P4641, DOI 10.1109/IEMBS.2007.4353374; Urbanowicz K, 2007, PHYSICA A, V384, P439, DOI 10.1016/j.physa.2007.05.052; Wang LP, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, VOLS 1 AND 2, P666; Williams JS, 2009, NEW ENGL J MED, V360, pE6, DOI 10.1056/NEJMvcm0800157; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; WOLF MM, 1978, MED J AUSTRALIA, V2, P52, DOI 10.5694/j.1326-5377.1978.tb131339.x; WOO MA, 1992, AM HEART J, V123, P704, DOI 10.1016/0002-8703(92)90510-3	66	33	35	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17060	10.1371/journal.pone.0017060	http://dx.doi.org/10.1371/journal.pone.0017060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386966	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400027
J	Stax, MJ; Naarding, MA; Tanck, MWT; Lindquist, S; Hernell, O; Lyle, R; Brandtzaeg, P; Eggesbo, M; Pollakis, G; Paxton, WA				Stax, Martijn J.; Naarding, Marloes A.; Tanck, Michael W. T.; Lindquist, Susanne; Hernell, Olle; Lyle, Robert; Brandtzaeg, Per; Eggesbo, Merete; Pollakis, Georgios; Paxton, William A.			Binding of Human Milk to Pathogen Receptor DC-SIGN Varies with Bile Salt-Stimulated Lipase (BSSL) Gene Polymorphism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-LYMPHOCYTES; DENDRITIC CELLS; LIGAND-BINDING; IMMUNE-SYSTEM; MAMMARY-GLAND; HIV-1; TRANSMISSION; INFECTION; NONINTEGRIN	Objective: Dendritic cells bind an array of antigens and DC-SIGN has been postulated to act as a receptor for mucosal pathogen transmission. Bile salt-stimulated lipase (BSSL) from human milk potently binds DC-SIGN and blocks DC-SIGN mediated trans-infection of CD4+ T-lymphocytes with HIV-1. Objective was to study variation in DC-SIGN binding properties and the relation between DC-SIGN binding capacity of milk and BSSL gene polymorphisms. Study Design: ELISA and PCR were used to study DC-SIGN binding properties and BSSL exon 11 size variation for human milk derived from 269 different mothers distributed over 4 geographical regions. Results: DC-SIGN binding properties were highly variable for milks derived from different mothers and between samplings from different geographical regions. Differences in DC-SIGN binding were correlated with a genetic polymorphism in BSSL which is related to the number of 11 amino acid repeats at the C-terminus of the protein. Conclusion: The observed variation in DC-SIGN binding properties among milk samples may have implications for the risk of mucosal transmission of pathogens during breastfeeding.	[Stax, Martijn J.; Naarding, Marloes A.; Pollakis, Georgios; Paxton, William A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, NL-1105 AZ Amsterdam, Netherlands; [Tanck, Michael W. T.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Lindquist, Susanne; Hernell, Olle] Umea Univ, Dept Clin Sci, Pediat Unit, Umea, Sweden; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Brandtzaeg, Per] Univ Oslo, Ctr Immune Regulat, LIIPAT, Oslo, Norway; [Brandtzaeg, Per] Natl Hosp Norway, Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Eggesbo, Merete] Norwegian Inst Publ Hlth, Dept Genes & Environm, Div Epidemiol, Oslo, Norway	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Umea University; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH)	Stax, MJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Dept Med Microbiol,Lab Expt Virol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.a.paxton@amc.uva.nl	paxton, william/R-9747-2019; Georgios, Pollakis/Y-2341-2019	Paxton, William/0000-0001-5200-0801; Eggesbo, Merete/0000-0002-0006-5336; Pollakis, Georgios/0000-0002-9659-5461; Tanck, Michael/0000-0001-9828-4459; Paxton, William/0000-0002-2654-5186	Dutch AIDS fund grant [2005024]	Dutch AIDS fund grant	This work was funded by a Dutch AIDS fund grant (2005024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; BLACKBERG L, 1981, EUR J BIOCHEM, V116, P221, DOI 10.1111/j.1432-1033.1981.tb05322.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brandtzaeg P, 2010, J PEDIATR-US, V156, pS8, DOI 10.1016/j.jpeds.2009.11.014; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Coovadia H, 2008, CURR OPIN INFECT DIS, V21, P11, DOI 10.1097/QCO.0b013e3282f40689; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; de Witte L, 2006, J VIROL, V80, P3477, DOI 10.1128/JVI.80.7.3477-3486.2006; Fumagalli M, 2009, GENOME RES, V19, P199, DOI 10.1101/gr.082768.108; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; HERNELL O, 1994, J PEDIATR-US, V125, pS56, DOI 10.1016/S0022-3476(06)80737-7; Jendrysik MA, 2005, J INFECT DIS, V192, P630, DOI 10.1086/432071; Kannius-Janson M, 1998, BIOCHEM J, V336, P577, DOI 10.1042/bj3360577; Kannius-Janson M, 2002, J BIOL CHEM, V277, P17589, DOI 10.1074/jbc.M105979200; Landberg E, 2000, ARCH BIOCHEM BIOPHYS, V377, P246, DOI 10.1006/abbi.2000.1778; Li F, 1997, J BIOL CHEM, V272, P28666, DOI 10.1074/jbc.272.45.28666; LIDBERG U, 1992, GENOMICS, V13, P630, DOI 10.1016/0888-7543(92)90134-E; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; McKillop AM, 1998, PEDIATR RES, V43, P101, DOI 10.1203/00006450-199801000-00015; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Naarding MA, 2006, ANTIMICROB AGENTS CH, V50, P3367, DOI 10.1128/AAC.00593-06; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; NISHIHARA S, 1994, J BIOL CHEM, V269, P29271; Pasqualini E, 1998, J BIOL CHEM, V273, P28208, DOI 10.1074/jbc.273.43.28208; Ruvoen-Clouet N, 2006, BIOCHEM J, V393, P627, DOI 10.1042/BJ20050898; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039	35	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17316	10.1371/journal.pone.0017316	http://dx.doi.org/10.1371/journal.pone.0017316			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386960	gold, Green Submitted, Green Published			2022-12-27	WOS:000287931400054
J	El-Said, WA; Kim, TH; Kim, H; Choi, JW				El-Said, Waleed Ahmed; Kim, Tae-Hyung; Kim, Hyuncheol; Choi, Jeong-Woo			Analysis of Intracellular State Based on Controlled 3D Nanostructures Mediated Surface Enhanced Raman Scattering	PLOS ONE			English	Article							CANCER-CELLS; SPECTROSCOPY; NANOPARTICLES; MOLECULES; SUBSTRATE; DIAGNOSIS; SITE; SERS; DNA	Near-infrared surface-enhanced Raman spectroscopy (SERS) is a powerful technique for analyzing the chemical composition within a single living cell at unprecedented resolution. However, current SERS methods employing uncontrollable colloidal metal particles or non-uniformly distributed metal particles on a substrate as SERS-active sites show relatively low reliability and reproducibility. Here, we report a highly-ordered SERS-active surface that is provided by a gold nano-dots array based on thermal evaporation of gold onto an ITO surface through a nanoporous alumina mask. This new combined technique showed a broader distribution of hot spots and a higher signal-to-noise ratio than current SERS techniques due to the highly reproducible and uniform geometrical structures over a large area. This SERS-active surface was applied as cell culture system to study living cells in situ within their culture environment without any external preparation processes. We applied this newly developed method to cell-based research to differentiate cell lines, cells at different cell cycle stages, and live/dead cells. The enhanced Raman signals achieved from each cell, which represent the changes in biochemical compositions, enabled differentiation of each state and the conditions of the cells. This SERS technique employing a tightly controlled nanostructure array can potentially be applied to single cell analysis, early cancer diagnosis and cell physiology research.	[El-Said, Waleed Ahmed; Kim, Hyuncheol; Choi, Jeong-Woo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea; [Kim, Tae-Hyung; Kim, Hyuncheol; Choi, Jeong-Woo] Sogang Univ, Dept Chem & Biomol Engn, Seoul, South Korea	Sogang University; Sogang University	El-Said, WA (corresponding author), Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul, South Korea.	jwchoi@sogang.ac.kr	El-Said, Waleed/X-9913-2018; El-Said, Waleed/A-5749-2013	El-Said, Waleed/0000-0002-7052-7612; El-Said, Waleed/0000-0002-7052-7612	Korea government (MEST) [2010-0000845]; Ministry of Education, Science, and Technology (MEST) [M10536090001-05N3609-00110]; Ministry of the Environment of the Republic of Korea	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of the Environment of the Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2010-0000845), the Nano/Bio Science & Technology Program (M10536090001-05N3609-00110) of the Ministry of Education, Science, and Technology (MEST), and the Ministry of the Environment of the Republic of Korea as The Eco-technopia 21 project (http://www.nrf.go.kr) (http://www.keiti.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroca R., 2006, SURFACE ENHANCED VIB, P73, DOI DOI 10.1002/9780470035641.CH3; Choi JW, 2005, BIOSENS BIOELECTRON, V20, P2300, DOI 10.1016/j.bios.2004.11.019; CORREA P, 1988, CANCER RES, V48, P3554; El-Said WA, 2010, BIOSENS BIOELECTRON, V26, P1486, DOI 10.1016/j.bios.2010.07.089; El-Said WA, 2009, BIOSENS BIOELECTRON, V24, P1259, DOI 10.1016/j.bios.2008.07.037; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Fang Y, 2008, SCIENCE, V321, P388, DOI 10.1126/science.1159499; FOGGIA MD, 2009, J MOL STRUCT, V924, P120; Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015; Gremlich H.-U., 2001, INFRARED RAMAN SPECT; Huang XH, 2007, NANO LETT, V7, P1591, DOI 10.1021/nl070472c; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Kafi MA, 2010, BIOSENS BIOELECTRON, V26, P1359, DOI 10.1016/j.bios.2010.07.049; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Krishna CM, 2005, VIB SPECTROSC, V38, P95, DOI 10.1016/j.vibspec.2005.02.018; Li MD, 2008, ANAL CHEM, V80, P5118, DOI 10.1021/ac8003083; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Michaels AM, 2000, J PHYS CHEM B, V104, P11965, DOI 10.1021/jp0025476; MORJANI H, 1993, CANCER RES, V53, P4784; Mourant JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1928050; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Notingher I, 2003, BIOPOLYMERS, V72, P230, DOI 10.1002/bip.10378; Pancrazio JJ, 1999, ANN BIOMED ENG, V27, P697, DOI 10.1114/1.225; Prasad S, 2006, BIOSENS BIOELECTRON, V21, P1219, DOI 10.1016/j.bios.2005.05.005; Sankar DG, 2003, ASIAN J CHEM, V15, P1856; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037; Teh SK, 2008, BRIT J CANCER, V98, P457, DOI 10.1038/sj.bjc.6604176; Tkachenko AG, 2003, J AM CHEM SOC, V125, P4700, DOI 10.1021/ja0296935; Wen R, 2005, J COLLOID INTERF SCI, V292, P469, DOI 10.1016/j.jcis.2005.05.091	31	44	44	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e15836	10.1371/journal.pone.0015836	http://dx.doi.org/10.1371/journal.pone.0015836			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390213	gold, Green Submitted, Green Published			2022-12-27	WOS:000287761700008
J	Montoro, AG; Ramirez, SC; Quiroga, R; Taubas, JV				Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Quiroga, Rodrigo; Valdez Taubas, Javier			Specificity of Transmembrane Protein Palmitoylation in Yeast	PLOS ONE			English	Article							CYSTEINE-RICH DOMAIN; DHHC; IDENTIFICATION; PALMITOYLTRANSFERASES; ACYLTRANSFERASE; UBIQUITINATION; MECHANISM; ALIGNMENT; RESIDUES; REVEALS	Many proteins are modified after their synthesis, by the addition of a lipid molecule to one or more cysteine residues, through a thioester bond. This modification is called S-acylation, and more commonly palmitoylation. This reaction is carried out by a family of enzymes, called palmitoyltransferases (PATs), characterized by the presence of a conserved 50-aminoacids domain called LAsp-His-His-Cys-Cysteine Rich Domain" (DHHC-CRD). There are 7 members of this family in the yeast Saccharomyces cerevisiae, and each of these proteins is thought to be responsible for the palmitoylation of a subset of substrates. Substrate specificity of PATs, however, is not yet fully understood. Several yeast PATs seem to have overlapping specificity, and it has been proposed that the machinery responsible for palmitoylating peripheral membrane proteins in mammalian cells, lacks specificity altogether. Here we investigate the specificity of transmembrane protein palmitoylation in S. cerevisiae, which is carried out predominantly by two PATs, Swf1 and Pfa4. We show that palmitoylation of transmembrane substrates requires dedicated PATs, since other yeast PATs are mostly unable to perform Swf1 or Pfa4 functions, even when overexpressed. Furthermore, we find that Swf1 is highly specific for its substrates, as it is unable to substitute for other PATs. To identify where Swf1 specificity lies, we carried out a bioinformatics survey to identify amino acids responsible for the determination of specificity or Specificity Determination Positions (SDPs) and showed experimentally, that mutation of the two best SDP candidates, A145 and K148, results in complete and partial loss of function, respectively. These residues are located within the conserved catalytic DHHC domain suggesting that it could also be involved in the determination of specificity. Finally, we show that modifying the position of the cysteines in Tlg1, a Swf1 substrate, results in lack of palmitoylation, as expected for a highly specific enzymatic reaction.	[Gonzalez Montoro, Ayelen; Chumpen Ramirez, Sabrina; Quiroga, Rodrigo; Valdez Taubas, Javier] Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Montoro, AG (corresponding author), Univ Nacl Cordoba, Ctr Invest Quim Biol Cordoba, CIQUIBIC UNC CONICET, Dept Quim Biol,Fac Ciencias Quim, RA-5000 Cordoba, Argentina.	jvaldezt@dqb.fcq.unc.edu.ar	Quiroga, Rodrigo/GLT-7145-2022	Quiroga, Rodrigo/0000-0001-5015-0531; Gonzalez Montoro, Ayelen/0000-0002-6978-8284; Valdez Taubas, Javier/0000-0002-2806-9419	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC) [RES214/10]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT) [PICT 2006 1239, PICT 2005 32937]; CONICET	Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT)(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Secretaria de Ciencia y Tecnologia, Universidad Nacional de Cordoba (Secyt UNC 2007 and 2010 to JVT RES214/10; http://www.secyt.unc.edu.ar/nuevo/) and Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina (ANPCyT) (PICT 2006 1239 to Hugo Maccioni and JVT, and PICT 2005 32937 to JVT; http://www.agencia.mincyt.gov.ar/). JVT is a Career Investigator of CONICET (Argentina). AGM and SC have fellowships from CONICET. RQ is a FONCyT fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COUVE A, 1995, P NATL ACAD SCI USA, V92, P5987, DOI 10.1073/pnas.92.13.5987; DeMar JC, 1997, J BIOL CHEM, V272, P31362, DOI 10.1074/jbc.272.50.31362; Dighe SA, 2008, MOL BIOL CELL, V19, P4454, DOI 10.1091/mbc.E08-03-0252; Ducker CE, 2004, ONCOGENE, V23, P9230, DOI 10.1038/sj.onc.1208171; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; Harlow L, 1988, ANTIBODIES LAB MANUA; HE Y, 2008, J LIPID RES; Hettema EH, 2004, EMBO J, V23, P1279, DOI 10.1038/sj.emboj.7600137; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lam KKY, 2006, J CELL BIOL, V174, P19, DOI 10.1083/jcb.200602049; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Mitchell DA, 2006, J LIPID RES, V47, P1118, DOI 10.1194/jlr.R600007-JLR200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Nadolski MJ, 2009, J BIOL CHEM, V284, P17720, DOI 10.1074/jbc.M109.005447; PRESCOTT GR, 2009, J NEUROCHEM; Putilina T, 1999, MOL CELL BIOCHEM, V195, P219, DOI 10.1023/A:1006932522197; Rausell A, 2010, P NATL ACAD SCI USA, V107, P1995, DOI 10.1073/pnas.0908044107; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Smotrys JE, 2005, J CELL BIOL, V170, P1091, DOI 10.1083/jcb.200507048; Valdez-Taubas J, 2005, EMBO J, V24, P2524, DOI 10.1038/sj.emboj.7600724; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Washbourne P, 2004, NEURON, V44, P901, DOI 10.1016/S0896-6273(04)00799-8; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yik JHN, 2002, J BIOL CHEM, V277, P47305, DOI 10.1074/jbc.M208751200	46	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16969	10.1371/journal.pone.0016969	http://dx.doi.org/10.1371/journal.pone.0016969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383992	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700022
J	Nader, IW; Pietschnig, J; Niederkrotenthaler, T; Kapusta, ND; Sonneck, G; Voracek, M				Nader, Ingo W.; Pietschnig, Jakob; Niederkrotenthaler, Thomas; Kapusta, Nestor D.; Sonneck, Gernot; Voracek, Martin			Suicide Seasonality: Complex Demodulation as a Novel Approach in Epidemiologic Analysis	PLOS ONE			English	Article							RATES; FINLAND; EXPERIENCE; AUSTRALIA; AMPLITUDE; SLOVENIA; TIME; SEX	Background: Seasonality of suicides is well-known and nearly ubiquitous, but recent evidence showed inconsistent patterns of decreasing or increasing seasonality in different countries. Furthermore, strength of seasonality was hypothesized to be associated with suicide prevalence. This study aimed at pointing out methodological difficulties in examining changes in suicide seasonality. Methododology/Principal Findings: The present study examines the hypothesis of decreasing seasonality with a superior method that allows continuous modeling of seasonality. Suicides in Austria (1970-2008, N = 67,741) were analyzed with complex demodulation, a local (point-in-time specific) version of harmonic analysis. This avoids the need to arbitrarily split the time series, as is common practice in the field of suicide seasonality research, and facilitates incorporating the association with suicide prevalence. Regression models were used to assess time trends and association of amplitude and absolute suicide numbers. Results showed that strength of seasonality was associated with absolute suicide numbers, and that strength of seasonality was stable during the study period when this association was taken into account. Conclusion/Significance: Continuous modeling of suicide seasonality with complex demodulation avoids spurious findings that can result when time series are segmented and analyzed piecewise or when the association with suicide prevalence is disregarded.	[Nader, Ingo W.; Pietschnig, Jakob; Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria; [Niederkrotenthaler, Thomas] Med Univ Vienna, Ctr Publ Hlth, Dept Gen Practice & Family Med, Vienna, Austria; [Niederkrotenthaler, Thomas; Sonneck, Gernot] Med Univ Vienna, Ctr Publ Hlth, Dept Med Psychol, Vienna, Austria; [Kapusta, Nestor D.] Med Univ Vienna, Dept Psychoanal & Psychotherapy, Vienna, Austria; [Sonneck, Gernot] Ludwig Boltzmann Inst Social Psychiat, Vienna, Austria	University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Ludwig Boltzmann Institute	Nader, IW (corresponding author), Univ Vienna, Sch Psychol, Dept Basic Psychol Res, Vienna, Austria.	ingo.nader@univie.ac.at	Voracek, Martin/S-5865-2016; Pietschnig, Jakob/AAE-8913-2020; Kapusta, Nestor D/C-9368-2009	Voracek, Martin/0000-0001-6109-6155; Pietschnig, Jakob/0000-0003-0222-9557; Kapusta, Nestor D/0000-0002-0970-4341; Nader, Ingo/0000-0002-9673-0360; Niederkrotenthaler, Thomas/0000-0001-9550-628X				Ajdacic-Gross V, 2005, J EPIDEMIOL COMMUN H, V59, P967, DOI 10.1136/jech.2004.030981; Ajdacic-Gross V, 2003, SOC SCI MED, V57, P1173, DOI 10.1016/S0277-9536(02)00493-8; Ajdacic-Gross V, 2007, AM J EPIDEMIOL, V165, P561, DOI 10.1093/aje/kwk034; Bloomfield P., 2000, FOURIER ANAL TIME SE, P261; Bridges FS, 2005, PERCEPT MOTOR SKILL, V100, P920, DOI 10.2466/pms.100.3c.920-924; CHEW KSY, 1995, SOC SCI MED, V40, P223, DOI 10.1016/0277-9536(94)E0070-9; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Fisher RA, 1929, P R SOC LOND A-CONTA, V125, P54, DOI 10.1098/rspa.1929.0151; Hakko H, 1998, J AFFECT DISORDERS, V50, P49, DOI 10.1016/S0165-0327(98)00031-7; Hakko H, 2002, SUICIDE LIFE-THREAT, V32, P191, DOI 10.1521/suli.32.2.191.24403; Jessen G, 1998, ARCH SUICIDE RES, V4, P263, DOI 10.1080/13811119808258301; Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x; KEVAN SM, 1980, SOC SCI MED-MED GEOG, V14, P369, DOI 10.1016/0160-8002(80)90005-2; MEARES R, 1981, BRIT J PSYCHIAT, V138, P321, DOI 10.1192/bjp.138.4.321; NAYHA S, 1983, ACTA PSYCHIAT SCAND, V67, P32, DOI 10.1111/j.1600-0447.1983.tb00328.x; NAYHA S, 1982, BRIT J PSYCHIAT, V141, P512, DOI 10.1192/bjp.141.5.512; NEWEY WK, 1987, ECONOMETRICA, V55, P703, DOI 10.2307/1913610; Oravecz R, 2007, J AFFECT DISORDERS, V104, P211, DOI 10.1016/j.jad.2007.03.009; Oravecz R, 2006, J AFFECT DISORDERS, V95, P135, DOI 10.1016/j.jad.2006.04.027; Preti A, 2002, ACTA NEUROPSYCHIATR, V14, P17, DOI 10.1034/j.1601-5215.2002.140103.x; Preti A, 2000, Crisis, V21, P59, DOI 10.1027//0227-5910.21.2.59; R Development Core Team, 2010, LANG ENV STAT COMP V; Rihmer Z, 1998, PSYCHIAT RES, V81, P233, DOI 10.1016/S0165-1781(98)00106-1; Rocchi MBL, 2007, NEUROPSYCHOBIOLOGY, V56, P86, DOI 10.1159/000111538; Rocchi MBL, 2007, J AFFECT DISORDERS, V100, P129, DOI 10.1016/j.jad.2006.10.003; Rock D, 2003, PSYCHIAT RES, V120, P43, DOI 10.1016/S0165-1781(03)00165-3; RUSSELL RJH, 1985, BRIT J MATH STAT PSY, V38, P116, DOI 10.1111/j.2044-8317.1985.tb00820.x; Voracek M, 2004, PERCEPT MOTOR SKILL, V99, P17, DOI 10.2466/pms.99.1.17-18; Warner R.M., 1998, SPECTRAL ANAL TIME S; Yip PSF, 2006, J AFFECT DISORDERS, V96, P117, DOI 10.1016/j.jad.2006.05.012; Yip PSF, 2000, BRIT J PSYCHIAT, V177, P366, DOI 10.1192/bjp.177.4.366; Yip PSF, 1998, J AFFECT DISORDERS, V47, P141, DOI 10.1016/S0165-0327(97)00135-3; Zeileis A., 2004, J STAT SOFTW, V11, P1, DOI [10.18637/jss.v011.i10, DOI 10.18637/JSS.V011.I10]; [No title captured]	34	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17413	10.1371/journal.pone.0017413	http://dx.doi.org/10.1371/journal.pone.0017413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390315	Green Submitted, gold, Green Published			2022-12-27	WOS:000287761700052
J	Thomson, JM; Hansen, R; Berry, SH; Hope, ME; Murray, GI; Mukhopadhya, I; McLean, MH; Shen, ZL; Fox, JG; El-Omar, E; Hold, GL				Thomson, John M.; Hansen, Richard; Berry, Susan H.; Hope, Mairi E.; Murray, Graeme I.; Mukhopadhya, Indrani; McLean, Mairi H.; Shen, Zeli; Fox, James G.; El-Omar, Emad; Hold, Georgina L.			Enterohepatic Helicobacter in Ulcerative Colitis: Potential Pathogenic Entities?	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; SP-NOV; BOWEL; IDENTIFICATION; PYLORI; GASTROENTERITIS; PHENOTYPE; PULLORUM; BACTERIA; DISEASE	Background: Changes in bacterial populations termed "dysbiosis'' are thought central to ulcerative colitis (UC) pathogenesis. In particular, the possibility that novel Helicobacter organisms play a role in human UC has been debated but not comprehensively investigated. The aim of this study was to develop a molecular approach to investigate the presence of Helicobacter organisms in adults with and without UC. Methodology/Principal Findings: A dual molecular approach to detect Helicobacter was developed. Oligonucleotide probes against the genus Helicobacter were designed and optimised alongside a validation of published H. pylori probes. A comprehensive evaluation of Helicobacter genus and H. pylori PCR primers was also undertaken. The combined approach was then assessed in a range of gastrointestinal samples prior to assessment of a UC cohort. Archival colonic samples were available from 106 individuals for FISH analysis (57 with UC and 49 non-IBD controls). A further 118 individuals were collected prospectively for dual FISH and PCR analysis (86 UC and 32 non-IBD controls). An additional 27 non-IBD controls were available for PCR analysis. All Helicobacter PCR-positive samples were sequenced. The association between Helicobacter and each study group was statistically analysed using the Pearson Chi Squared 2 tailed test. Helicobacter genus PCR positivity was significantly higher in UC than controls (32 of 77 versus 11 of 59, p = 0.004). Sequence analysis indicated enterohepatic Helicobacter species prevalence was significantly higher in the UC group compared to the control group (30 of 77 versus 2 of 59, p<0.0001). PCR and FISH results were concordant in 74 (67.9%) of subjects. The majority of discordant results were attributable to a higher positivity rate with FISH than PCR. Conclusions/Significance: Helicobacter organisms warrant consideration as potential pathogenic entities in UC. Isolation of these organisms from colonic tissue is needed to enable interrogation of pathogenicity against established criteria.	[Thomson, John M.; Hansen, Richard; Berry, Susan H.; Hope, Mairi E.; Mukhopadhya, Indrani; McLean, Mairi H.; El-Omar, Emad; Hold, Georgina L.] Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Aberdeen, Scotland; [Hansen, Richard] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Murray, Graeme I.] Univ Aberdeen, Dept Pathol, Aberdeen, Scotland; [Shen, Zeli; Fox, James G.] MIT, Div Comparat Med, Cambridge, MA 02139 USA	University of Aberdeen; University of Aberdeen; University of Aberdeen; Massachusetts Institute of Technology (MIT)	Thomson, JM (corresponding author), Univ Aberdeen, Gastrointestinal Res Grp, Div Appl Med, Aberdeen, Scotland.	g.l.hold@abdn.ac.uk	Hold, Georgina Louise/AAG-9923-2020; Mukhopadhya, Indrani/K-1113-2019; El-Omar, Emad/AAT-7780-2021; Hansen, Richard/G-3871-2011	Hold, Georgina Louise/0000-0001-7573-3397; Mukhopadhya, Indrani/0000-0003-2577-518X; El-Omar, Emad/0000-0002-0011-3924; Hansen, Richard/0000-0002-3944-6646; McLean, Mairi/0000-0002-7443-2653	Broad Medical Research Program [IBD-0178]; GI Research Unit, Aberdeen Royal Infirmary; Chief Scientist Office [CAF/08/01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	Broad Medical Research Program; GI Research Unit, Aberdeen Royal Infirmary; Chief Scientist Office; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the Broad Medical Research Program (Grant number IBD-0178). JMT was supported by grants from the GI Research Unit, Aberdeen Royal Infirmary; RH was supported by a Clinical Academic Training Fellowship, from the Chief Scientist Office (CAF/08/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bell SJ, 2003, ALIMENT PHARM THER, V18, P481, DOI 10.1046/j.1365-2036.2003.01703.x; Bohr URM, 2004, J CLIN MICROBIOL, V42, P2766, DOI 10.1128/JCM.42.6.2766-2768.2004; BURNENS AP, 1994, LANCET, V344, P1569, DOI 10.1016/S0140-6736(94)90376-X; BURNENS AP, 1993, J CLIN MICROBIOL, V31, P1916, DOI 10.1128/JCM.31.7.1916-1917.1993; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Fox JG, 1998, GASTROENTEROLOGY, V114, P755, DOI 10.1016/S0016-5085(98)70589-X; Fox JG, 2000, J CLIN MICROBIOL, V38, P2546, DOI 10.1128/JCM.38.7.2546-2549.2000; FOX JG, 1990, GASTROENTEROLOGY, V99, P352, DOI 10.1016/0016-5085(90)91016-Y; Grehan M, 2004, J CLIN MICROBIOL, V42, P874, DOI 10.1128/JCM.42.2.874-876.2004; Grehan M, 2002, APPL ENVIRON MICROB, V68, P5164, DOI 10.1128/AEM.68.10.5164-5166.2002; Hansen R, 2011, FEMS IMMUNOL MED MIC, V61, P1, DOI 10.1111/j.1574-695X.2010.00744.x; Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x; Jergens AE, 2007, GUT, V56, P934, DOI 10.1136/gut.2006.099242; KOCH R, 1884, MITT KAISER GESUNDH, V2, P1, DOI DOI 10.1016/S0174-3031(82)80099-1; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Laharie D, 2009, ALIMENT PHARM THER, V30, P283, DOI 10.1111/j.1365-2036.2009.04034.x; Lastovica AJ, 2000, J CLIN MICROBIOL, V38, P2798; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Melito PL, 2001, J CLIN MICROBIOL, V39, P2412, DOI 10.1128/JCM.39.7.2412-2417.2001; Miyazaki K, 1997, ANAEROBE, V3, P373, DOI 10.1006/anae.1997.0125; Moreno Y, 2003, WATER RES, V37, P2251, DOI 10.1016/S0043-1354(02)00624-3; MOROTOMI M, 1989, J CLIN MICROBIOL, V27, P2652, DOI 10.1128/JCM.27.12.2652-2655.1989; ROMERO S, 1988, J CLIN MICROBIOL, V26, P142, DOI 10.1128/JCM.26.1.142-143.1988; Schwiertz A, 2000, APPL ENVIRON MICROB, V66, P375, DOI 10.1128/AEM.66.1.375-382.2000; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; STANLEY J, 1994, MICROBIOL-UK, V140, P3441, DOI 10.1099/13500872-140-12-3441; STANLEY J, 1993, J GEN MICROBIOL, V139, P2495, DOI 10.1099/00221287-139-10-2495; Steinbrueckner B, 1997, SCAND J INFECT DIS, V29, P315, DOI 10.3109/00365549709019053; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEE W, 1987, J CLIN MICROBIOL, V25, P1248, DOI 10.1128/JCM.25.7.1248-1252.1987; Trebesius K, 2000, GUT, V46, P608, DOI 10.1136/gut.46.5.608; VANDAMME P, 1990, J CLIN MICROBIOL, V28, P1016, DOI 10.1128/JCM.28.5.1016-1020.1990; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; WHARY MT, 2004, COMPARATIVE MED, V36, P139; Zhang L, 2006, J CLIN MICROBIOL, V44, P2276, DOI 10.1128/JCM.02017-05	41	67	68	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17184	10.1371/journal.pone.0017184	http://dx.doi.org/10.1371/journal.pone.0017184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383845	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000287657500040
J	Xue, JM; Gochuico, BR; Alawad, AS; Feghali-Bostwick, CA; Noth, I; Nathan, SD; Rosen, GD; Rosas, IO; Dacic, S; Ocak, I; Fuhrman, CR; Cuenco, KT; Smith, MA; Jacobs, SS; Zeevi, A; Morel, PA; Pilewski, JM; Valentine, VG; Gibson, KF; Kaminski, N; Sciurba, FC; Zhang, YZ; Duncan, SR				Xue, Jianmin; Gochuico, Bernadette R.; Alawad, Ahmad Samer; Feghali-Bostwick, Carol A.; Noth, Imre; Nathan, Steven D.; Rosen, Glenn D.; Rosas, Ivan O.; Dacic, Sanja; Ocak, Iclal; Fuhrman, Carl R.; Cuenco, Karen T.; Smith, Mary A.; Jacobs, Susan S.; Zeevi, Adriana; Morel, Penelope A.; Pilewski, Joseph M.; Valentine, Vincent G.; Gibson, Kevin F.; Kaminski, Naftali; Sciurba, Frank C.; Zhang, Yingze; Duncan, Steven R.			The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							HIGH-RESOLUTION; T-CELLS; HAPLOTYPE; DISEASE; ASSOCIATION; IMPAIRMENT; PREVALENCE; SCLEROSIS; ANTIGENS; COMPLEX	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and medically refractory lung disease with a grim prognosis. Although the etiology of IPF remains perplexing, abnormal adaptive immune responses are evident in many afflicted patients. We hypothesized that perturbations of human leukocyte antigen (HLA) allele frequencies, which are often seen among patients with immunologic diseases, may also be present in IPF patients. Methods/Principal Findings: HLA alleles were determined in subpopulations of IPF and normal subjects using molecular typing methods. HLA-DRB1*15 was over-represented in a discovery cohort of 79 Caucasian IPF subjects who had lung transplantations at the University of Pittsburgh (36.7%) compared to normal reference populations. These findings were prospectively replicated in a validation cohort of 196 additional IPF subjects from four other U. S. medical centers that included both ambulatory patients and lung transplantation recipients. High-resolution typing was used to further define specific HLA-DRB1*15 alleles. DRB1*1501 prevalence in IPF subjects was similar among the 143 ambulatory patients and 132 transplant recipients (31.5% and 34.8%, respectively, p = 0.55). The aggregate prevalence of DRB1*1501 in IPF patients was significantly greater than among 285 healthy controls (33.1% vs. 20.0%, respectively, OR 2.0; 95% CI 1.3-2.9, p = 0.0004). IPF patients with DRB1*1501 (n = 91) tended to have decreased diffusing capacities for carbon monoxide (DLCO) compared to the 184 disease subjects who lacked this allele (37.8 +/- 1.7% vs. 42.8 +/- 1.4%, p = 0.036). Conclusions/Significance: DRB1*1501 is more prevalent among IPF patients than normal subjects, and may be associated with greater impairment of gas exchange. These data are novel evidence that immunogenetic processes can play a role in the susceptibility to and/or manifestations of IPF. Findings here of a disease association at the HLA-DR locus have broad pathogenic implications, illustrate a specific chromosomal area for incremental, targeted genomic study, and may identify a distinct clinical phenotype among patients with this enigmatic, morbid lung disease.	[Xue, Jianmin; Alawad, Ahmad Samer; Feghali-Bostwick, Carol A.; Pilewski, Joseph M.; Gibson, Kevin F.; Kaminski, Naftali; Sciurba, Frank C.; Zhang, Yingze; Duncan, Steven R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Gochuico, Bernadette R.] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Noth, Imre] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA; [Nathan, Steven D.; Smith, Mary A.] Inova Fairfax Hosp, Adv Lung Dis Program, Falls Church, VA USA; [Rosen, Glenn D.; Jacobs, Susan S.] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Rosas, Ivan O.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Dacic, Sanja; Zeevi, Adriana] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Ocak, Iclal; Fuhrman, Carl R.] Univ Pittsburgh, Dept Radiol, Pittsburgh, PA 15260 USA; [Cuenco, Karen T.] Univ Pittsburgh, Dept Oral Biol Dent Med & Human Genet, Pittsburgh, PA USA; [Morel, Penelope A.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Valentine, Vincent G.] Univ Texas Med Branch, Dept Med, Galveston, TX USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago; University of Chicago Medical Center; Inova Fairfax Hospital; Stanford University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Medical Branch Galveston	Xue, JM (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	duncsr@upmc.edu	Pilewski, Joseph/AAF-5149-2021; Morel, Penelope Anne/AAI-6239-2020; Sciurba, Frank/AAZ-9339-2021	Morel, Penelope Anne/0000-0002-1743-3676; sciurba, frank/0000-0001-7468-2225; Kaminski, Naftali/0000-0001-5917-4601	United States National Institutes of Health [1RO1HL073241, 1P50 HL084932, 1 P50 HL084948, 5T32 HL007563]; National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084948, R01HL073241, P50HL084932, T32HL007563] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by the United States National Institutes of Health grants 1RO1HL073241, 1P50 HL084932, 1 P50 HL084948, 5T32 HL007563, and the Intramural Research Program of the National Human Genome Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; Collard HR, 2004, AM J RESP CRIT CARE, V169, P1076; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Dobashi N, 2000, LUNG, V178, P171, DOI 10.1007/s004080000020; EVANS CC, 1976, THORAX, V31, P483; Falfan-Valencia R, 2005, HUM GENET, V118, P235, DOI 10.1007/s00439-005-0035-7; Falkner D, 2000, J RHEUMATOL, V27, P1196; Feghali-Bostwick CA, 2007, J IMMUNOL, V179, P2592, DOI 10.4049/jimmunol.179.4.2592; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; FULMER JD, 1978, AM REV RESPIR DIS, V118, P141; Gilani SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008959; Grutters JC, 2005, EUR RESPIR J, V25, P915, DOI 10.1183/09031936.05.00133404; Hall F, 1996, HLA MHC GENES MOL FU, P353; Homolka J, 2003, RESPIRATION, V70, P262, DOI 10.1159/000072007; Katzenstein ALA, 1998, AM J RESP CRIT CARE, V157, P1301, DOI 10.1164/ajrccm.157.4.9707039; Klitz W, 2003, TISSUE ANTIGENS, V62, P296, DOI 10.1034/j.1399-0039.2003.00103.x; Kotsianidis I, 2009, AM J RESP CRIT CARE, V179, P1121, DOI 10.1164/rccm.200812-1936OC; Kreider Maryl, 2009, Proc Am Thorac Soc, V6, P20, DOI 10.1513/pats.200808-097GO; Kurosu K, 2008, J IMMUNOL, V181, P756, DOI 10.4049/jimmunol.181.1.756; Lawson William E, 2006, Proc Am Thorac Soc, V3, P345, DOI 10.1513/pats.200512-137TK; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; LIBBY DM, 1983, AM REV RESPIR DIS, V127, P618, DOI 10.1164/arrd.1983.127.5.618; Magro CM, 2006, HUM IMMUNOL, V67, P284, DOI 10.1016/j.humimm.2006.02.026; Marchal-Somme J, 2006, J IMMUNOL, V176, P5735, DOI 10.4049/jimmunol.176.10.5735; *NAT BON MARR DON, HAPL FREQ; Ogushi Fumitaka, 2001, Journal of Medical Investigation, V48, P181; Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1; Papiris Spyros A, 2007, J Inflamm (Lond), V4, P14, DOI 10.1186/1476-9255-4-14; Ren P, 2007, AM J RESP CRIT CARE, V175, P1151, DOI 10.1164/rccm.200607-958OC; Rosas IO, 2007, AM J RESP CRIT CARE, V176, P698, DOI 10.1164/rccm.200702-254OC; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmidt H, 2007, AM J EPIDEMIOL, V165, P1097, DOI 10.1093/aje/kwk118; Selman MS, 2004, DRUGS, V64, P405, DOI 10.2165/00003495-200464040-00005; Shimizudani N, 2002, CLIN EXP IMMUNOL, V129, P140, DOI 10.1046/j.1365-2249.2002.01871.x; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; STRIMLAN CV, 1977, AM REV RESPIR DIS, V116, P1120; Studer SM, 2008, AM J RESP CRIT CARE, V178, P765, DOI 10.1164/rccm.200701-013OC; TAILLE C, 2010, AM J RESP CRIT  1008; Takahashi T, 2007, RESPIROLOGY, V12, P642, DOI 10.1111/j.1440-1843.2007.01140.x; Takeuchi F, 2005, INT J IMMUNOGENET, V32, P173, DOI 10.1111/j.1744-313X.2005.00504.x; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; TURTON CWG, 1978, LANCET, V1, P507; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; Vanderlugt CL, 2002, NAT REV IMMUNOL, V2, P85, DOI 10.1038/nri724; VARPELA E, 1979, TISSUE ANTIGENS, V14, P68; Voorter CEM, 2005, HUM IMMUNOL, V66, P826, DOI 10.1016/j.humimm.2005.04.003; WARRENS A, 1999, HLA HLTH DIS	48	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14715	10.1371/journal.pone.0014715	http://dx.doi.org/10.1371/journal.pone.0014715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373184	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000287657500003
J	Mpindi, JP; Sara, H; Haapa-Paananen, S; Kilpinen, S; Pisto, T; Bucher, E; Ojala, K; Iljin, K; Vainio, P; Bjorkman, M; Gupta, S; Kohonen, P; Nees, M; Kallioniemi, O				Mpindi, John Patrick; Sara, Henri; Haapa-Paananen, Saija; Kilpinen, Sami; Pisto, Tommi; Bucher, Elmar; Ojala, Kalle; Iljin, Kristiina; Vainio, Paula; Bjorkman, Mari; Gupta, Santosh; Kohonen, Pekka; Nees, Matthias; Kallioniemi, Olli			GTI: A Novel Algorithm for Identifying Outlier Gene Expression Profiles from Integrated Microarray Datasets	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II; CANCER; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; GEMCITABINE; GENERATIONS; REGRESSION; ARRAYS; MAP	Background: Meta-analysis of gene expression microarray datasets presents significant challenges for statistical analysis. We developed and validated a new bioinformatic method for the identification of genes upregulated in subsets of samples of a given tumour type ('outlier genes'), a hallmark of potential oncogenes. Methodology: A new statistical method (the gene tissue index, GTI) was developed by modifying and adapting algorithms originally developed for statistical problems in economics. We compared the potential of the GTI to detect outlier genes in meta-datasets with four previously defined statistical methods, COPA, the OS statistic, the t-test and ORT, using simulated data. We demonstrated that the GTI performed equally well to existing methods in a single study simulation. Next, we evaluated the performance of the GTI in the analysis of combined Affymetrix gene expression data from several published studies covering 392 normal samples of tissue from the central nervous system, 74 astrocytomas, and 353 glioblastomas. According to the results, the GTI was better able than most of the previous methods to identify known oncogenic outlier genes. In addition, the GTI identified 29 novel outlier genes in glioblastomas, including TYMS and CDKN2A. The overexpression of these genes was validated in vivo by immunohistochemical staining data from clinical glioblastoma samples. Immunohistochemical data were available for 65% (19 of 29) of these genes, and 17 of these 19 genes (90%) showed a typical outlier staining pattern. Furthermore, raltitrexed, a specific inhibitor of TYMS used in the therapy of tumour types other than glioblastoma, also effectively blocked cell proliferation in glioblastoma cell lines, thus highlighting this outlier gene candidate as a potential therapeutic target. Conclusions/Significance: Taken together, these results support the GTI as a novel approach to identify potential oncogene outliers and drug targets. The algorithm is implemented in an R package (Text S1).	[Mpindi, John Patrick; Kilpinen, Sami; Kallioniemi, Olli] Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland; [Sara, Henri; Vainio, Paula; Bjorkman, Mari; Gupta, Santosh] Univ Turku, Dept Pharmacol Drug Dev & Therapeut, Turku, Finland; [Haapa-Paananen, Saija; Pisto, Tommi; Bucher, Elmar; Ojala, Kalle; Iljin, Kristiina; Kohonen, Pekka; Nees, Matthias] VTT Tech Res Ctr, Turku, Finland	University of Helsinki; University of Turku; VTT Technical Research Center Finland	Mpindi, JP (corresponding author), Univ Helsinki, FIMM Inst Mol Med Finland, Helsinki, Finland.	john.mpindi@helsinki.fi	Nees, Matthias/AAT-5577-2020; Nees, Matthias/W-6596-2018; Haapa-Paananen, Saija/D-3075-2012; Kohonen, Pekka/F-9596-2011; Kallioniemi, Olli P/H-5111-2011	Nees, Matthias/0000-0002-9034-301X; Kohonen, Pekka/0000-0002-7845-3611; Kallioniemi, Olli P/0000-0002-3231-0332; Kilpinen, Sami/0000-0003-3444-2539; Iljin, Kristiina/0000-0002-5161-0584; bucher, elmar/0000-0002-2929-2460	FIMM-HBGS graduate school; Institute for Molecular Medicine Finland; Academy of Finland (Centre of Excellence); Finnish Cancer Society; Sigrid Juselius Foundation; EU	FIMM-HBGS graduate school; Institute for Molecular Medicine Finland; Academy of Finland (Centre of Excellence)(Academy of Finland); Finnish Cancer Society; Sigrid Juselius Foundation(Sigrid Juselius Foundation); EU(European Commission)	The work of JPM was supported by the FIMM-HBGS graduate school and the Institute for Molecular Medicine Finland. This research was funded by the Academy of Finland (Centre of Excellence), as well as the Finnish Cancer Society and the Sigrid Juselius Foundation, EU Marie Curie project Canceromics, EU-FP7 Epitron and Genica projects. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARROW KJ, 1999, SCANDINAVIAN J EC, P163; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bhattacharya S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni159; Callow MJ, 2000, GENOME RES, V10, P2022, DOI 10.1101/gr.10.12.2022; DEARMOND SJ, 1980, PATHOL RES PRACT, V168, P374, DOI 10.1016/S0344-0338(80)80273-1; Dudoit S, 2002, STAT SINICA, V12, P111; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; ENG LF, 1978, J HISTOCHEM CYTOCHEM, V26, P513, DOI 10.1177/26.7.357640; Friddle CJ, 2000, P NATL ACAD SCI USA, V97, P6745, DOI 10.1073/pnas.100127897; Gertler SZ, 2000, ANN ONCOL, V11, P315, DOI 10.1023/A:1008336607135; Hober S, 2008, CURR OPIN BIOTECH, V19, P30, DOI 10.1016/j.copbio.2007.11.006; HOBERA S, 2008, HPA              JUL; Hu JH, 2007, BIOMETRICS, V63, P41, DOI 10.1111/j.1541-0420.2006.00675.x; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li L, 2007, PHYSIOL GENOMICS, V32, P154, DOI 10.1152/physiolgenomics.00259.2006; LIAN H, 2007, BIOSTATISTICS; Liu F, 2007, COMPUT BIOL CHEM, V31, P65, DOI 10.1016/j.compbiolchem.2007.02.004; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; MacDonald JW, 2006, BIOINFORMATICS, V22, P2950, DOI 10.1093/bioinformatics/btl433; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Swartling FJ, 2008, UPSALA J MED SCI, V113, P1; Tibshirani R, 2007, BIOSTATISTICS, V8, P2, DOI 10.1093/biostatistics/kxl005; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Weller M, 2001, CANCER, V91, P423, DOI 10.1002/1097-0142(20010115)91:2<423::AID-CNCR1017>3.0.CO;2-H; Wick W, 2002, J NEURO-ONCOL, V59, P151, DOI 10.1023/A:1019641314661; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Wu BL, 2007, BIOSTATISTICS, V8, P566, DOI 10.1093/biostatistics/kxl029	30	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17259	10.1371/journal.pone.0017259	http://dx.doi.org/10.1371/journal.pone.0017259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365010	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800039
J	Alter, MD; Kharkar, R; Ramsey, KE; Craig, DW; Melmed, RD; Grebe, TA; Bay, RC; Ober-Reynolds, S; Kirwan, J; Jones, JJ; Turner, JB; Hen, R; Stephan, DA				Alter, Mark D.; Kharkar, Rutwik; Ramsey, Keri E.; Craig, David W.; Melmed, Raun D.; Grebe, Theresa A.; Bay, R. Curtis; Ober-Reynolds, Sharman; Kirwan, Janet; Jones, Josh J.; Turner, J. Blake; Hen, Rene; Stephan, Dietrich A.			Autism and Increased Paternal Age Related Changes in Global Levels of Gene Expression Regulation	PLOS ONE			English	Article							DE-NOVO MUTATIONS; SPECTRUM DISORDERS; SYNAPTIC PLASTICITY; VALPROIC ACID; ANIMAL-MODEL; MOUSE MODEL; CHILDREN; MEMORY; SCHIZOPHRENIA; RESPONSES	A causal role of mutations in multiple general transcription factors in neurodevelopmental disorders including autism suggested that alterations in global levels of gene expression regulation might also relate to disease risk in sporadic cases of autism. This premise can be tested by evaluating for changes in the overall distribution of gene expression levels. For instance, in mice, variability in hippocampal-dependent behaviors was associated with variability in the pattern of the overall distribution of gene expression levels, as assessed by variance in the distribution of gene expression levels in the hippocampus. We hypothesized that a similar change in variance might be found in children with autism. Gene expression microarrays covering greater than 47,000 unique RNA transcripts were done on RNA from peripheral blood lymphocytes (PBL) of children with autism (n = 82) and controls (n = 64). Variance in the distribution of gene expression levels from each microarray was compared between groups of children. Also tested was whether a risk factor for autism, increased paternal age, was associated with variance. A decrease in the variance in the distribution of gene expression levels in PBL was associated with the diagnosis of autism and a risk factor for autism, increased paternal age. Traditional approaches to microarray analysis of gene expression suggested a possible mechanism for decreased variance in gene expression. Gene expression pathways involved in transcriptional regulation were down-regulated in the blood of children with autism and children of older fathers. Thus, results from global and gene specific approaches to studying microarray data were complimentary and supported the hypothesis that alterations at the global level of gene expression regulation are related to autism and increased paternal age. Global regulation of transcription, thus, represents a possible point of convergence for multiple etiologies of autism and other neurodevelopmental disorders.	[Alter, Mark D.; Kharkar, Rutwik] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Ramsey, Keri E.; Craig, David W.; Stephan, Dietrich A.] Translat Gen Res Inst, Neurogen Div, Phoenix, AZ USA; [Melmed, Raun D.; Grebe, Theresa A.; Bay, R. Curtis; Ober-Reynolds, Sharman; Kirwan, Janet; Jones, Josh J.] SW Autism Res & Resource Ctr, Phoenix, AZ USA; [Turner, J. Blake] Columbia Univ, Dept Psychiat, Div Child & Adolescent Psychiat, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY USA; [Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; Translational Genomics Research Institute; Columbia University; Columbia University; Columbia University	Alter, MD (corresponding author), Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA.	markalter1968@gmail.com	Craig, David Wesley/K-6961-2019	Craig, David Wesley/0000-0003-2040-1955	NARSAD; state of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH080228] Funding Source: NIH RePORTER	NARSAD(NARSAD); state of Arizona; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Research support: Dr. Alter's salary was paid in part through a NARSAD Young Investigator Award (http://www.narsad.org/?q = node/124/apply_for_grants/124); sample collection and processing, microarrays, and salary support provided through a grant from the state of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo AM, 2010, BIOFACTORS, V36, P117, DOI 10.1002/biof.91; AIMO L, 2010, J NUTR BIOCH; Alter MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003344; ALTER MD, 2009, BIOL PSYCHIAT; Ashwood Paul, 2004, Clin Dev Immunol, V11, P165, DOI 10.1080/10446670410001722096; Aso T, 1996, J CLIN INVEST, V97, P1561, DOI 10.1172/JCI118580; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; Cantor RM, 2007, MOL PSYCHIATR, V12, P419, DOI 10.1038/sj.mp.4001966; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DREXHAGE RC, EXPERT REV NEUROTHER, V10, P59; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Faber S, 2009, BIOMARKERS, V14, P171, DOI 10.1080/13547500902783747; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jyonouchi H, 2001, J NEUROIMMUNOL, V120, P170, DOI 10.1016/S0165-5728(01)00421-0; Kimura M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040037; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levenson JM, 2006, CELL MOL LIFE SCI, V63, P1009, DOI 10.1007/s00018-006-6026-6; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mackenzie GG, 2007, IUBMB LIFE, V59, P299, DOI 10.1080/15216540701225966; Malaspina D, 2005, PSYCHIAT GENET, V15, P117, DOI 10.1097/00041444-200506000-00008; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Malaspina D, 2002, AM J MED GENET, V114, P299, DOI 10.1002/ajmg.1701; Malaspina D, 2001, SCHIZOPHRENIA BULL, V27, P379, DOI 10.1093/oxfordjournals.schbul.a006882; MILLER MC, 2006, HARV MENT HLTH LETT, V23, P8; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Ornoy A, 2009, REPROD TOXICOL, V28, P1, DOI 10.1016/j.reprotox.2009.02.014; Puleo CM, 2008, MOL PSYCHIATR, V13, P243, DOI 10.1038/sj.mp.4002102; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Saha S, 2009, SCHIZOPHR RES, V115, P130, DOI 10.1016/j.schres.2009.09.012; Saha S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000040; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Schneider T, 2007, PSYCHOPHARMACOLOGY, V193, P547, DOI 10.1007/s00213-007-0795-y; Stephan DA, 2008, AM J HUM GENET, V82, P7, DOI 10.1016/j.ajhg.2007.12.003; Sykes Nuala H., 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000452; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsuchiya KJ, 2008, BRIT J PSYCHIAT, V193, P316, DOI 10.1192/bjp.bp.107.045120; Unryn BM, 2005, AGING CELL, V4, P97, DOI 10.1111/j.1474-9728.2005.00144.x; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wagner GC, 2006, J AUTISM DEV DISORD, V36, P779, DOI 10.1007/s10803-006-0117-y; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang Z, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-9; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wiegert JS, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-124; Williams G, 2001, DEV MED CHILD NEUROL, V43, P202, DOI 10.1017/S001216220100038X; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	53	72	72	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16715	10.1371/journal.pone.0016715	http://dx.doi.org/10.1371/journal.pone.0016715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379579	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300020
J	Smalley, JW; Byrne, DP; Birss, AJ; Wojtowicz, H; Sroka, A; Potempa, J; Olczak, T				Smalley, John W.; Byrne, Dominic P.; Birss, Andrew J.; Wojtowicz, Halina; Sroka, Aneta; Potempa, Jan; Olczak, Teresa			HmuY Haemophore and Gingipain Proteases Constitute a Unique Syntrophic System of Haem Acquisition by Porphyromonas gingivalis	PLOS ONE			English	Article							LYSINE-SPECIFIC GINGIPAIN; CONTAINING PIGMENT; PROTOPORPHYRIN-IX; CREVICULAR FLUID; ISOLATED CHAINS; GLOBIN LINKAGE; HEMOGLOBIN; MECHANISM; OXYHEMOGLOBIN; PROTEINS	Haem (iron protoporphyrin IX) is both an essential growth factor and virulence regulator for the periodontal pathogen Porphyromonas gingivalis, which acquires it mainly from haemoglobin via the sequential actions of the R-and K-specific gingipain proteases. The haem-binding lipoprotein haemophore HmuY and its cognate receptor HmuR of P. gingivalis, are responsible for capture and internalisation of haem. This study examined the role of the HmuY in acquisition of haem from haemoglobin and the cooperation between HmuY and gingipain proteases in this process. Using UV-visible spectroscopy and polyacrylamide gel electrophoresis, HmuY was demonstrated to wrest haem from immobilised methaemoglobin and deoxyhaemoglobin. Haem extraction from oxyhaemoglobin was facilitated after oxidation to methaemoglobin by pretreatment with the P. gingivalis R-gingipain A (HRgpA). HmuY was also capable of scavenging haem from oxyhaemoglobin pre-treated with the K-gingipain (Kgp). This is the first demonstration of a haemophore working in conjunction with proteases to acquire haem from haemoglobin. In addition, HmuY was able to extract haem from methaemalbumin, and could bind haem, either free in solution or from methaemoglobin, even in the presence of serum albumin.	[Smalley, John W.; Byrne, Dominic P.; Birss, Andrew J.] Univ Liverpool, Sch Dent Sci, Liverpool L69 3BX, Merseyside, England; [Wojtowicz, Halina; Olczak, Teresa] Univ Wroclaw, Biochem Lab, Fac Biotechnol, PL-50138 Wroclaw, Poland; [Sroka, Aneta; Potempa, Jan] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Hlth & Rehabil, Louisville, KY 40292 USA	University of Liverpool; University of Wroclaw; Jagiellonian University; University of Louisville	Smalley, JW (corresponding author), Univ Liverpool, Sch Dent Sci, Liverpool L69 3BX, Merseyside, England.	josmall@liv.ac.uk	Potempa, Jan/AAA-6850-2021	Sroka, Aneta/0000-0002-3386-5364; Potempa, Jan/0000-0002-3600-7461	Ministry of Science and Higher Education, Poland [N N303 406136, 1642/B/P01/2008/35]; Jagiellonian University [DS/9/WBBiB]; National Institutes of Health [DE 09761]; Foundation for Polish Science [Team/2009-4/8]; European Union [POIG.02.01.00-12-064/08]; School of Dental Science, University of Liverpool; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Jagiellonian University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union(European Commission); School of Dental Science, University of Liverpool; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in parts by the Ministry of Science and Higher Education, Poland (grant No. N N303 406136 and 1642/B/P01/2008/35 to T.O. and J.P.,respectively), the Jagiellonian University (statutory funds DS/9/WBBIB), the National Institutes of Health (Grant DE 09761) and the Foundation for Polish Science (Team/2009-4/8). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficiary of the structural funds from the European Union (grant No. POIG.02.01.00-12-064/08 -" Molecular biotechnology for health"). J.W.S. is grateful to the School of Dental Science, University of Liverpool, for financial support for D. P. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS PA, 1980, BIOCHEM J, V191, P95, DOI 10.1042/bj1910095; BENESCH RE, 1990, J BIOL CHEM, V265, P14881; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; BUNN HF, 1968, J BIOL CHEM, V243, P465; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; CURTIS MA, 1988, J CLIN PERIODONTOL, V15, P628, DOI 10.1111/j.1600-051X.1988.tb02263.x; EGGERT FM, 1991, ARCH ORAL BIOL, V36, P233, DOI 10.1016/0003-9969(91)90091-8; Gattoni M, 1996, J BIOL CHEM, V271, P10130, DOI 10.1074/jbc.271.17.10130; Holt SC, 2005, PERIODONTOL 2000, V38, P72, DOI 10.1111/j.1600-0757.2005.00113.x; HRKAL Z, 1974, EUR J BIOCHEM, V43, P73, DOI 10.1111/j.1432-1033.1974.tb03386.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; MARSH PD, 1994, MICROBIOL-UK, V140, P861, DOI 10.1099/00221287-140-4-861; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; MONZANI E, BIOCH BIOPHYS ACTA, V1547, P302; Olczak T, 2001, J BACTERIOL, V183, P5599, DOI 10.1128/JB.183.19.5599-5608.2001; Olczak T, 2005, FEMS MICROBIOL REV, V29, P119, DOI 10.1016/j.femsre.2004.09.001; Olczak T, 2008, ARCH MICROBIOL, V189, P197, DOI 10.1007/s00203-007-0309-7; Olczak T, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-134; PIKE R, 1994, J BIOL CHEM, V269, P406; Potempa J, 1998, J BIOL CHEM, V273, P21648, DOI 10.1074/jbc.273.34.21648; Smalley JW, 2006, MICROBIOL-SGM, V152, P1839, DOI 10.1099/mic.0.28835-0; Smalley JW, 2008, BIOL CHEM, V389, P1235, DOI 10.1515/BC.2008.140; Smalley JW, 2007, ARCH BIOCHEM BIOPHYS, V465, P44, DOI 10.1016/j.abb.2007.05.011; SMALLEY JW, 1993, J GEN MICROBIOL, V139, P2145, DOI 10.1099/00221287-139-9-2145; SMALLEY JW, 1991, FEMS MICROBIOL LETT, V90, P63, DOI 10.1016/0378-1097(91)90647-S; Smalley JW, 1998, BIOCHEM J, V331, P681, DOI 10.1042/bj3310681; Smalley JW, 2004, BIOCHEM J, V379, P833, DOI 10.1042/BJ20031221; Smalley JW, 2002, BIOCHEM J, V362, P239, DOI 10.1042/0264-6021:3620239; Tsuruga M, 1998, J BIOL CHEM, V273, P8607, DOI 10.1074/jbc.273.15.8607; Wojtowicz H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000419; Wojtowicz H, 2009, BIOCHEM BIOPH RES CO, V383, P178, DOI 10.1016/j.bbrc.2009.03.148	34	60	62	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17182	10.1371/journal.pone.0017182	http://dx.doi.org/10.1371/journal.pone.0017182			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21390208	gold, Green Published			2022-12-27	WOS:000287482300035
J	Sandoval, CJ; Martinez-Claros, M; Bello-Medina, PC; Perez, O; Ramirez-Amaya, V				Jimena Sandoval, C.; Martinez-Claros, Marisela; Bello-Medina, Paola C.; Perez, Oswaldo; Ramirez-Amaya, Victor			When Are New Hippocampal Neurons, Born in the Adult Brain, Integrated into the Network That Processes Spatial Information?	PLOS ONE			English	Article							GENERATED GRANULE CELLS; DENTATE GYRUS; SYNAPTIC PLASTICITY; PROTEIN EXPRESSION; CRITICAL PERIOD; RAT; NEUROGENESIS; MATURATION; DIFFERENTIATION; SURVIVAL	Adult-born neurons in the dentate gyrus (DG) functionally integrate into the behaviorally relevant hippocampal networks, showing a specific Arc-expression response to spatial exploration when mature. However, it is not clear when, during the 4- to 6-week interval that is critical for survival and maturation of these neurons, this specific response develops. Therefore, we characterized Arc expression after spatial exploration or cage control conditions in adult-born neurons from rats that were injected with BrdU on one day and were sacrificed 1, 7, 15, 30, and 45 days post-BrdU injection (PBI). Triple immunostaining for NeuN, Arc, and BrdU was analyzed through the different DG layers. Arc protein expression in BrdU-positive cells was observed from day 1 to day 15 PBI but was not related to behavioral stimulation. The specific Arc-expression response to spatial exploration was observed from day 30 and 45 in about 5% of the BrdU-positive cell population. Most of the BrdU-positive neurons expressing Arc in response to spatial exploration(similar to 90%) were located in DG layer 1, and no Arc expression was observed in cells located in the subgranular zone (SGZ). Using the current data and that obtained previously, we propose a mathematical model suggesting that new neurons are unlikely to respond to exploration by expressing Arc after they are 301 days old, and also that in a 7-month-old rat the majority (60%) of the neurons that respond to exploration must have been born during adulthood; thus, suggesting that adult neurogenesis in the DG is highly relevant for spatial information processing.	[Jimena Sandoval, C.; Martinez-Claros, Marisela; Bello-Medina, Paola C.; Ramirez-Amaya, Victor] Univ Nacl Autonoma Mexico, Lab Redes Neuronales Plast, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro Qro, Mexico; [Perez, Oswaldo] Univ Nacl Autonoma Mexico, Lab Neurofisiol Percepc, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Queretaro Qro, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Sandoval, CJ (corresponding author), Univ Nacl Autonoma Mexico, Lab Redes Neuronales Plast, Dept Neurobiol Conductual & Cognit, Inst Neurobiol, Campus Juriquilla, Queretaro Qro, Mexico.	vramirez@unam.mx	Bello-Medina, Paola C./AAS-2330-2021	Bello-Medina, Paola C./0000-0003-3815-4956; Perez, Oswaldo/0000-0002-1888-7434	CONACyT [51028]; PAPIIT [IN213907, IN216510-21]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This work was funded by CONACyT 51028 and PAPIIT IN213907 and IN216510-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; ADAMS N, 1983, J COMP PSYCHOL, V97, P24, DOI 10.1037/0735-7036.97.1.24; Alme CB, 2010, HIPPOCAMPUS, V20, P1109, DOI 10.1002/hipo.20810; Ambrogini P, 2000, NEUROSCI LETT, V286, P21, DOI 10.1016/S0304-3940(00)01074-0; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Babu H, 2009, FRONT NEUROSCI-SWITZ, V3, DOI 10.3389/neuro.22.001.2009; Bischofberger J, 2007, NAT NEUROSCI, V10, P273, DOI 10.1038/nn0307-273; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; DRICKAMER L C, 1977, Laboratory Animals (London), V11, P159, DOI 10.1258/002367777780936639; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jessberger S, 2003, EUR J NEUROSCI, V18, P2707, DOI 10.1111/j.1460-9568.2003.02986.x; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Karten YJG, 2006, HIPPOCAMPUS, V16, P312, DOI 10.1002/hipo.20165; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuipers SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004885; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P2326, DOI 10.1523/JNEUROSCI.4111-05.2006; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Ramirez-Amaya V, 2006, J NEUROSCI, V26, P12237, DOI 10.1523/JNEUROSCI.2195-06.2006; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rapp PR, 1996, P NATL ACAD SCI USA, V93, P9926, DOI 10.1073/pnas.93.18.9926; RIHN LL, 1990, DEV BRAIN RES, V54, P115, DOI 10.1016/0165-3806(90)90071-6; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SNYDER JS, 2009, ADULT BORN HIPPOCAMP; STONE SSD, 2010, FUNCTIONAL CONVERGEN; Tashiro A, 2007, J NEUROSCI, V27, P3252, DOI 10.1523/JNEUROSCI.4941-06.2007; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	49	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17689	10.1371/journal.pone.0017689	http://dx.doi.org/10.1371/journal.pone.0017689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408012	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900041
J	Poza, DJ; Santos, JI; Galan, JM; Lopez-Paredes, A				Poza, David J.; Santos, Jose I.; Galan, Jose M.; Lopez-Paredes, Adolfo			Mesoscopic Effects in an Agent-Based Bargaining Model in Regular Lattices	PLOS ONE			English	Article							COMMUNITY STRUCTURE; EVOLUTIONARY GAMES; PRISONERS-DILEMMA; COOPERATION; NETWORK; DYNAMICS	The effect of spatial structure has been proved very relevant in repeated games. In this work we propose an agent based model where a fixed finite population of tagged agents play iteratively the Nash demand game in a regular lattice. The model extends the multiagent bargaining model by Axtell, Epstein and Young [1] modifying the assumption of global interaction. Each agent is endowed with a memory and plays the best reply against the opponent's most frequent demand. We focus our analysis on the transient dynamics of the system, studying by computer simulation the set of states in which the system spends a considerable fraction of the time. The results show that all the possible persistent regimes in the global interaction model can also be observed in this spatial version. We also find that the mesoscopic properties of the interaction networks that the spatial distribution induces in the model have a significant impact on the diffusion of strategies, and can lead to new persistent regimes different from those found in previous research. In particular, community structure in the intratype interaction networks may cause that communities reach different persistent regimes as a consequence of the hindering diffusion effect of fluctuating agents at their borders.	[Poza, David J.; Lopez-Paredes, Adolfo] Social Syst Engn Ctr INSISOC, Valladolid, Spain; [Santos, Jose I.; Galan, Jose M.] Univ Burgos, Dept Ingn Civil, Area Org Empresas, Burgos, Spain	Universidad de Burgos	Poza, DJ (corresponding author), Social Syst Engn Ctr INSISOC, Valladolid, Spain.	djpoza@gmail.com	Poza, David/AFF-8145-2022; Santos, José I/K-5924-2014; lopez-paredes, adolfo/B-9900-2009; Poza, David/D-5529-2016; Galán, José Manuel/B-9782-2009	Santos, José I/0000-0002-6653-043X; Poza, David/0000-0002-9878-221X; Galán, José Manuel/0000-0003-3360-7602; lopez-paredes, adolfo/0000-0001-5748-8308	Spanish Ministry of Science and Innovation [TIN2008-06464-C03-02, CSD2010-00034]; Junta de Castilla y Leon [VA006A009, BU034A08, GREX251-2009]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work stems from the participation of the authors in research projects funded by the Spanish Ministry of Science and Innovation, references TIN2008-06464-C03-02 and CSD2010-00034 (CONSOLIDER-INGENIO 2010), and by the Junta de Castilla y Leon, references VA006A009, BU034A08 and GREX251-2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 1999, J PHILOS, V96, P588, DOI 10.2307/2564625; Axtell RL, 2001, SOCIAL DYNAMICS, P191; Castello X, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/66006; Charness G, 2007, J ECON THEORY, V136, P28, DOI 10.1016/j.jet.2005.06.009; Chen JL, 2009, PHYSICA A, V388, P945, DOI 10.1016/j.physa.2008.11.039; Coleman J., 1990, FDN SOCIAL THEORY; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Floria LM, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026106; Fort H, 2005, JASSS-J ARTIF SOC S, V8; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu F, 2007, EUR PHYS J B, V56, P367, DOI 10.1140/epjb/e2007-00124-5; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.026117; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleiser PM, 2003, ADV COMPLEX SYST, V6, P565, DOI 10.1142/S0219525903001067; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Guimera R, 2006, J ECON BEHAV ORGAN, V61, P653, DOI 10.1016/j.jebo.2004.07.021; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Izquierdo LR, 2009, JASSS-J ARTIF SOC S, V12; Izquierdo SS, 2010, J THEOR BIOL, V267, P76, DOI 10.1016/j.jtbi.2010.07.039; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Kirley M, 2006, PHYSICA A, V365, P521, DOI 10.1016/j.physa.2005.10.002; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Lozano S, 2008, J ECON INTERACT COOR, V3, P183, DOI 10.1007/s11403-008-0041-7; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Nash JF, 1950, ECONOMETRICA, V18, P155, DOI 10.2307/1907266; Newman MEJ, 2004, EUR PHYS J B, V38, P321, DOI 10.1140/epjb/e2004-00124-y; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ohtsuki H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108106; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Porter MA., 2009, NOT AM MATH SOC, V56, P1082, DOI DOI 10.1103/PHYSREVE.69.066133; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; Poza DJ, 2011, DISCRETE DYN NAT SOC, V2011, DOI 10.1155/2011/915279; Roca CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015210; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Skyrms B, 2014, EVOLUTION SOCIAL CON, DOI 10.1017/CBO9781139924825; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Toivonen R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016109; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Tomassini M, 2010, INT J MOD PHYS C, V21, P1277, DOI 10.1142/S012918311001583X; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Yamashita T, 2005, LECT NOTES COMPUT SC, V3415, P185; YAMASHITA T, 2004, LNCS LNAI, V3012, P137, DOI DOI 10.1007/978-3-540-24666-4_9; Yang HX, 2008, CHINESE PHYS B, V17, P2759, DOI 10.1088/1674-1056/17/8/002; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252; YOUNG HP, 1993, J ECON THEORY, V59, P145, DOI 10.1006/jeth.1993.1009	63	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17661	10.1371/journal.pone.0017661	http://dx.doi.org/10.1371/journal.pone.0017661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408019	Green Published, gold			2022-12-27	WOS:000288170900037
J	Toth, KG; Mckay, BR; De Lisio, M; Little, JP; Tarnopolsky, MA; Parise, G				Toth, Kyle G.; Mckay, Bryon R.; De Lisio, Michael; Little, Jonathon P.; Tarnopolsky, Mark A.; Parise, Gianni			IL-6 Induced STAT3 Signalling Is Associated with the Proliferation of Human Muscle Satellite Cells Following Acute Muscle Damage	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ACUTE RESISTANCE EXERCISE; LENGTHENING CONTRACTIONS; MYONUCLEAR ADDITION; ECCENTRIC EXERCISE; STEM-CELLS; OLDER MEN; INTERLEUKIN-6; GROWTH; HYPERTROPHY	Background: Although the satellite cell (SC) is a key regulator of muscle growth during development and muscle adaptation following exercise, the regulation of human muscle SC function remains largely unexplored. STAT3 signalling mediated via interleukin-6 (IL-6) has recently come to the forefront as a potential regulator of SC proliferation. The early response of the SC population in human muscle to muscle-lengthening contractions (MLC) as mediated by STAT3 has not been studied. Methodology/Principal Findings: Twelve male subjects (21 +/- 2 y; 83 +/- 12 kg) performed 300 maximal MLC of the quadriceps femoris at 180 degrees.s(-1) over a 55 degrees range of motion with muscle samples (vastus lateralis) and blood samples (antecubital vein) taken prior to exercise (PRE), 1 hour (T1), 3 hours (T3) and 24 hours (T24) post-exercise. Cytoplasmic and nuclear fractions of muscle biopsies were purified and analyzed for total and phosphorylated STAT3 (p-STAT3) by western blot. p-STAT3 was detected in cytoplasmic fractions across the time course peaking at T24 (p<0.01 vs. PRE). Nuclear total and p-STAT3 were not detected at appreciable levels. However, immunohistochemical analysis revealed a progressive increase in the proportion of SCs expressing p-STAT3 with similar to 60% of all SCs positive for p-STAT3 at T24 (p<0.001 vs. PRE). Additionally, cMyc, a STAT3 downstream gene, was significantly up-regulated in SCs at T24 versus PRE (p<0.05). Whole muscle mRNA analysis revealed induction of the STAT3 target genes IL-6, SOCS3, cMyc (peaking at T3, p<0.05), IL-6Ra and GP130 (peaking at T24, p<0.05). In addition, Myf5 mRNA was up-regulated at T24 (p<0.05) with no appreciable change in MRF4 mRNA. Conclusions/Significant Findings: We demonstrate that IL-6 induction of STAT3 signaling occurred exclusively in the nuclei of SCs in response to MLC. An increase in the number of cMyc+ SCs indicated that human SCs were induced to proliferate under the control of STAT3 signaling.	[Toth, Kyle G.; Mckay, Bryon R.; De Lisio, Michael; Little, Jonathon P.; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada	McMaster University; McMaster University	Toth, KG (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	pariseg@mcmaster.ca	Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008	CIHR [86830]; NSERC [327073]	CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this study was provided by CIHR (86830:www.cihr.ca) and NSERC (327073:www.nserc.ca) grants awarded to G. P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2002, BBA-MOL CELL RES, V1542, P66, DOI 10.1016/S0167-4889(01)00167-7; Beaton LJ, 2002, MED SCI SPORT EXER, V34, P798, DOI 10.1097/00005768-200205000-00012; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; Bourgeois JM, 2004, MITOCHONDRION, V4, P441, DOI 10.1016/j.mito.2004.07.036; Carlson ME, 2009, EMBO MOL MED, V1, P381, DOI 10.1002/emmm.200900045; Carlson ME, 2009, AGING CELL, V8, P676, DOI 10.1111/j.1474-9726.2009.00517.x; Charifi N, 2003, MUSCLE NERVE, V28, P87, DOI 10.1002/mus.10394; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Crameri RM, 2007, J PHYSIOL-LONDON, V583, P365, DOI 10.1113/jphysiol.2007.128827; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dreyer HC, 2006, MUSCLE NERVE, V33, P242, DOI 10.1002/mus.20461; Fischer CP, 2006, EXERC IMMUNOL REV, V12, P6; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Fukada T, 1998, EMBO J, V17, P6670, DOI 10.1093/emboj/17.22.6670; GAO SP, 2006, SCI STKE, pPE30; GIBALA MJ, 1995, J APPL PHYSIOL, V78, P702, DOI 10.1152/jappl.1995.78.2.702; Gibala MJ, 2000, CAN J PHYSIOL PHARM, V78, P656, DOI 10.1139/cjpp-78-8-656; Hennessey JV, 1997, J APPL PHYSIOL, V82, P1739, DOI 10.1152/jappl.1997.82.6.1739; Hiscock N., 2004, FASEB J; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Keller P, 2005, FASEB J, V19, P1181, DOI 10.1096/fj.04-3278fje; Keller P, 2003, BIOCHEM BIOPH RES CO, V310, P550, DOI 10.1016/j.bbrc.2003.09.048; Kimura A, 2010, AM J PATHOL, V176, P40, DOI 10.2353/ajpath.2010.090146; Kiuchi N, 1999, J EXP MED, V189, P63, DOI 10.1084/jem.189.1.63; Korzus E, 1997, J BIOL CHEM, V272, P1188, DOI 10.1074/jbc.272.2.1188; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Machida S, 2004, P NUTR SOC, V63, P337, DOI 10.1079/PNS2004354; Mackey AL, 2007, SCAND J MED SCI SPOR, V17, P34, DOI 10.1111/j.1600-0838.2006.00534.x; Masuda M, 2002, CANCER RES, V62, P3351; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; MCKAY BR, 2010, J PHYSL; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; McKay BR, 2008, J PHYSIOL-LONDON, V586, P5549, DOI 10.1113/jphysiol.2008.160176; NABATA T, 1990, BIOCHEM INT, V20, P445; Naka T, 1999, TRENDS BIOCHEM SCI, V24, P394, DOI 10.1016/S0968-0004(99)01454-1; O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146; Olmedillas H, 2010, EUR J APPL PHYSIOL, V108, P749, DOI 10.1007/s00421-009-1281-5; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Petrella JK, 2008, J APPL PHYSIOL, V104, P1736, DOI 10.1152/japplphysiol.01215.2007; Petrella JK, 2006, AM J PHYSIOL-ENDOC M, V291, pE937, DOI 10.1152/ajpendo.00190.2006; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Reich NC, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.290pe61; ROSENBLATT JD, 1994, MUSCLE NERVE, V17, P608, DOI 10.1002/mus.880170607; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHULTZ E, 1989, MED SCI SPORT EXER, V21, pS181; SENFT C, 2010, J NEUROONCOL; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Spangenburg EE, 2002, AM J PHYSIOL-CELL PH, V283, pC204, DOI 10.1152/ajpcell.00574.2001; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Tamaki T, 2002, J HISTOCHEM CYTOCHEM, V50, P1097, DOI 10.1177/002215540205000812; Trenerry MK, 2007, J APPL PHYSIOL, V102, P1483, DOI 10.1152/japplphysiol.01147.2006; Walker SR, 2010, MOL PHARM; Walsh FS, 2005, BIOCHEM SOC T, V33, P1513, DOI 10.1042/BST0331513; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yue H, 2010, CARDIOVASC RES, V85, P90, DOI 10.1093/cvr/cvp285	59	104	108	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17392	10.1371/journal.pone.0017392	http://dx.doi.org/10.1371/journal.pone.0017392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408055	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900014
J	van den Berg, FE; Swinnen, SP; Wenderoth, N				van den Berg, Femke E.; Swinnen, Stephan P.; Wenderoth, Nicole			Excitability of the Motor Cortex Ipsilateral to the Moving Body Side Depends on Spatio-Temporal Task Complexity and Hemispheric Specialization	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTRACORTICAL INHIBITION; FINGER MOVEMENTS; CORTICOSPINAL PROJECTIONS; FUNCTIONAL CONNECTIVITY; INTERLIMB COORDINATION; VOLUNTARY CONTRACTION; DORSAL PREMOTOR; HAND MOVEMENTS; UPPER LIMBS	Unilateral movements are mainly controlled by the contralateral hemisphere, even though the primary motor cortex ipsilateral (M1(ipsi)) to the moving body side can undergo task-related changes of activity as well. Here we used transcranial magnetic stimulation (TMS) to investigate whether representations of the wrist flexor (FCR) and extensor (ECR) in M1(ipsi) would be modulated when unilateral rhythmical wrist movements were executed in isolation or in the context of a simple or difficult hand-foot coordination pattern, and whether this modulation would differ for the left versus right hemisphere. We found that M1(ipsi) facilitation of the resting ECR and FCR mirrored the activation of the moving wrist such that facilitation was higher when the homologous muscle was activated during the cyclical movement. We showed that this ipsilateral facilitation increased significantly when the wrist movements were performed in the context of demanding hand-foot coordination tasks whereas foot movements alone influenced the hand representation of M1(ipsi) only slightly. Our data revealed a clear hemispheric asymmetry such that MEP responses were significantly larger when elicited in the left M1(ipsi) than in the right. In experiment 2, we tested whether the modulations of M1(ipsi) facilitation, caused by performing different coordination tasks with the left versus right body sides, could be explained by changes in short intracortical inhibition (SICI). We found that SICI was increasingly reduced for a complex coordination pattern as compared to rest, but only in the right M1(ipsi). We argue that our results might reflect the stronger involvement of the left versus right hemisphere in performing demanding motor tasks.	[van den Berg, Femke E.; Swinnen, Stephan P.; Wenderoth, Nicole] Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Motor Control & Neuroplast, Motor Control Lab,Grp Biomed Sci, Leuven, Belgium	KU Leuven	van den Berg, FE (corresponding author), Katholieke Univ Leuven, Dept Biomed Kinesiol, Res Ctr Motor Control & Neuroplast, Motor Control Lab,Grp Biomed Sci, Leuven, Belgium.	nici.wenderoth@faber.kuleuven.be	Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386	Flanders Fund for Scientific Research [G.0758.10]	Flanders Fund for Scientific Research(FWO)	Support for this study was provided through a grant from the Flanders Fund for Scientific Research (Project G.0758.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzino L, 2008, EUR J NEUROSCI, V27, P1285, DOI 10.1111/j.1460-9568.2008.06086.x; Aymard C, 2000, BRAIN, V123, P1688, DOI 10.1093/brain/123.8.1688; Baumer T, 2007, EXP BRAIN RES, V180, P195, DOI 10.1007/s00221-007-0866-7; BALDISSERA F, 1982, NEUROSCI LETT, V34, P95, DOI 10.1016/0304-3940(82)90098-2; Baldissera F, 2002, J PHYSIOL-LONDON, V539, P903, DOI 10.1113/jphysiol.2001.013282; Baldissera F, 2000, EXP BRAIN RES, V133, P165, DOI 10.1007/s002210000368; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Bohlhalter S, 2009, CEREB CORTEX, V19, P1256, DOI 10.1093/cercor/bhn168; Byblow WD, 2007, J NEUROPHYSIOL, V98, P414, DOI 10.1152/jn.00325.2007; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; CALLAERT DV, 2010, HUM BRAIN MAPP; Carson RG, 2005, BRAIN RES REV, V49, P641, DOI 10.1016/j.brainresrev.2005.03.005; Carson RG, 2004, J PHYSIOL-LONDON, V560, P929, DOI 10.1113/jphysiol.2004.069088; Chen R, 1997, ANN NEUROL, V41, P247, DOI 10.1002/ana.410410216; Cincotta M, 2008, CLIN NEUROPHYSIOL, V119, P744, DOI 10.1016/j.clinph.2007.11.047; Davare M, 2007, CEREB CORTEX, V17, P353, DOI 10.1093/cercor/bhj152; De Gennaro L, 2004, NEUROSCI RES, V48, P129, DOI 10.1016/j.neures.2003.10.004; Debaere F, 2001, NEUROIMAGE, V14, P947, DOI 10.1006/nimg.2001.0892; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Haaland KY, 2006, CLIN NEUROPSYCHOL, V20, P609, DOI 10.1080/13854040590967577; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; HESS CW, 1986, NEUROSCI LETT, V71, P235, DOI 10.1016/0304-3940(86)90565-3; Heuninckx S, 2005, J NEUROSCI, V25, P6787, DOI 10.1523/JNEUROSCI.1263-05.2005; Hortobagyi T, 2003, J NEUROPHYSIOL, V90, P2451, DOI 10.1152/jn.01001.2002; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Kobayashi M, 2003, NEUROIMAGE, V20, P2259, DOI 10.1016/S1053-8119(03)00220-9; Koch G, 2006, J NEUROSCI, V26, P7452, DOI 10.1523/JNEUROSCI.1158-06.2006; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Liepert J, 2001, CLIN NEUROPHYSIOL, V112, P114, DOI 10.1016/S1388-2457(00)00503-4; Moes PE, 2007, NEUROPSYCHOLOGIA, V45, P2626, DOI 10.1016/j.neuropsychologia.2007.03.017; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; NETZ J, 1995, EXP BRAIN RES, V104, P527; Netz J, 1999, EEG CL N SU, P137; O'Shea J, 2007, NEURON, V54, P479, DOI 10.1016/j.neuron.2007.04.021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perez MA, 2008, J NEUROSCI, V28, P5631, DOI 10.1523/JNEUROSCI.0093-08.2008; Perez MA, 2009, CORTEX, V45, P1065, DOI 10.1016/j.cortex.2008.12.006; Rijntjes M, 1999, J NEUROSCI, V19, P8043; Rosenkranz K, 2003, J PHYSIOL-LONDON, V551, P649, DOI 10.1113/jphysiol.2003.043752; Rosenkranz K, 2005, BRAIN, V128, P918, DOI 10.1093/brain/awh402; Roshan L, 2003, EXP BRAIN RES, V151, P330, DOI 10.1007/s00221-003-1502-9; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROUILLER EM, 1994, EXP BRAIN RES, V102, P227; Salerno A, 1996, ELECTROMYOGR MOTOR C, V101, P395, DOI 10.1016/0924-980X(96)95680-5; SCHIEBER MH, 1990, TRENDS NEUROSCI, V13, P440, DOI 10.1016/0166-2236(90)90093-P; Serrien DJ, 2006, NAT REV NEUROSCI, V7, P160, DOI 10.1038/nrn1849; Sohn YH, 2003, EXP BRAIN RES, V148, P176, DOI 10.1007/s00221-002-1292-5; Stedman A, 1998, MUSCLE NERVE, V21, P1033, DOI 10.1002/(SICI)1097-4598(199808)21:8<1033::AID-MUS7>3.0.CO;2-9; Stinear CM, 2004, MOVEMENT DISORD, V19, P1312, DOI 10.1002/mds.20160; Stinear CM, 2001, EXP BRAIN RES, V139, P101, DOI 10.1007/s002210100758; Swinnen SP, 2010, NEUROIMAGE, V49, P2570, DOI 10.1016/j.neuroimage.2009.10.052; SWINNEN SP, 1995, EXP BRAIN RES, V105, P439; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Tinazzi M, 1998, NEUROSCI LETT, V244, P121, DOI 10.1016/S0304-3940(98)00150-5; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; Ziemann U, 2001, CLIN NEUROPHYSIOL, V112, P107, DOI 10.1016/S1388-2457(00)00502-2	59	33	33	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17742	10.1371/journal.pone.0017742	http://dx.doi.org/10.1371/journal.pone.0017742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408031	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900045
J	Li, XT; Wang, QJ; Pan, N; Lee, S; Zhao, YM; Chait, BT; Yue, ZY				Li, Xianting; Wang, Qing Jun; Pan, Nina; Lee, Sangkyu; Zhao, Yingming; Chait, Brian T.; Yue, Zhenyu			Phosphorylation-Dependent 14-3-3 Binding to LRRK2 Is Impaired by Common Mutations of Familial Parkinson's Disease	PLOS ONE			English	Article							PROTEIN-KINASE-A; LEUCINE-RICH-REPEAT-KINASE-2 LRRK2; IN-VIVO; RECEPTOR; GTPASE; GENE; NEUROTRANSMISSION; 14-3-3-PROTEINS; RIM1-ALPHA; PLASTICITY	Background: Recent studies show that mutations in Leucine Rich Repeat Kinase 2 (LRRK2) are the cause of the most common inherited and some sporadic forms of Parkinson's disease (PD). The molecular mechanism underlying the pathogenic role of LRRK2 mutations in PD remains unknown. Methodology/Principal Findings: Using affinity purification and mass spectrometric analysis, we investigated phosphorylation sites and binding proteins of LRRK2 purified from mouse brain. We identified multiple phosphorylation sites at N-terminus of LRRK2 including S910, S912, S935 and S973. Focusing on the high stoichiometry S935 phosphorylation site, we developed an anti-pS935 specific antibody and showed that LRRK2 is constitutively phosphorylated at S935 in various tissues (including brain) and at different ages in mice. We find that 14-3-3 proteins (especially isoforms gamma and eta) bind LRRK2 and this binding depends on phosphorylation of S935. The binding of 14-3-3, with little effect on dimer formation of LRRK2, confers protection of the phosphorylation status of S935. Furthermore, we show that protein kinase A (PKA), but not LRRK2 kinase itself, can cause the phosphorylation of LRRK2 at S935 in vitro and in cell culture, suggesting that PKA is a potential upstream kinase that regulates LRRK2 function. Finally, our study indicates that the common PD-related mutations of LRRK2, R1441G, Y1699C and G2019S, decrease homeostatic phosphorylation levels of S935 and impair 14-3-3 binding of LRRK2. Conclusions/Significance: LRRK2 is extensively phosphorylated in vivo, and the phosphorylation of specific sites (e.g. S935) determines 14-3-3 binding of LRRK2. We propose that 14-3-3 is an important regulator of LRRK2-mediated cellular functions. Our study suggests that PKA, a cAMP-dependent kinase involved in regulating dopamine physiology, is a potential upstream kinase that phosphorylates LRRK2 at S935. Furthermore, the reduction of phosphorylation/14-3-3 binding of LRRK2 due to the common familial PD-related mutations provides novel insight into the pathogenic mechanism of LRRK2-linked PD.	[Li, Xianting; Pan, Nina; Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA; [Wang, Qing Jun; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA; [Lee, Sangkyu; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Icahn School of Medicine at Mount Sinai; Rockefeller University; University of Chicago	Li, XT (corresponding author), Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA.	zhenyu.yue@mssm.edu		Wang, Qingjun/0000-0002-1959-4107; Li, Xianting/0000-0002-3153-0931	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [NS061152, NS060809, RNS055683A]; Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P20RR020171, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS061152, R01NS060809, R21NS055683] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the US National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) NS061152 (Z.Y.), NS060809 (Z.Y.), RNS055683A (Z.Y.), Michael J. Fox Foundation (Z.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Craparo A, 1997, J BIOL CHEM, V272, P11663; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Darling DL, 2005, CURR TOP DEV BIOL, V68, P281, DOI 10.1016/S0070-2153(05)68010-6; Deng JP, 2008, P NATL ACAD SCI USA, V105, P1499, DOI 10.1073/pnas.0709098105; Dubois T, 1997, J BIOL CHEM, V272, P28882, DOI 10.1074/jbc.272.46.28882; DZAMKO N, BIOCH J, V430, P405; Feng LP, 2004, FEBS LETT, V557, P275, DOI 10.1016/S0014-5793(03)01507-2; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; LEE BD, NAT MED, V16, P998; LI X, J NEUROSCI, V30, P1788; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Meller N, 1996, MOL CELL BIOL, V16, P5782; MELROSE HL, NEUROBIOL DIS, V40, P503; NICHOLS RJ, BIOCH J, V430, P393; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Sen S, 2009, J BIOL CHEM, V284, P36346, DOI 10.1074/jbc.M109.025437; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thomas D, 2005, CURR TOP DEV BIOL, V67, P285, DOI 10.1016/S0070-2153(05)67009-3; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Wang HN, 1998, J BIOL CHEM, V273, P16297, DOI 10.1074/jbc.273.26.16297; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wolf ME, 2003, ANN NY ACAD SCI, V1003, P241, DOI 10.1196/annals.1300.015; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	45	119	121	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17153	10.1371/journal.pone.0017153	http://dx.doi.org/10.1371/journal.pone.0017153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390248	Green Submitted, gold, Green Published			2022-12-27	WOS:000287932100010
J	Grillon, E; Farion, R; Fablet, K; De Waard, M; Tse, CM; Donowitz, M; Remy, C; Coles, JA				Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Tse, Chung Ming; Donowitz, Mark; Remy, Chantal; Coles, Jonathan A.			The Spatial Organization of Proton and Lactate Transport in a Rat Brain Tumor	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; IN-VIVO; NA+/H+ EXCHANGER; EXTRACELLULAR PH; INTRACELLULAR PH; MONOCARBOXYLATE TRANSPORTERS; MATRIX METALLOPROTEINASES; ANTIPORT ACTIVITY; CELL-MIGRATION; ACIDIC PH	Tumors create a heterogeneous acidic microenvironment which assists their growth and which must be taken into account in the design of drugs and their delivery. In addition, the acidic extracellular pH (pHe) is itself exploited in several experimental techniques for drug delivery. The way the acidity is created is not clear. We report here the spatial organization of key proton-handling proteins in C6 gliomas in rat brain. The mean profiles across the tumor rim of the Na+/H+ exchanger NHE1, and the lactate-H+ cotransporter MCT1, both showed peaks. NHE1, which is important for extension and migration of cells in vitro, showed a peak 1.55 times higher than in extratumoural tissue at 0.33 mm from the edge. MCT1 had a broader peak, further into the tumor (maximum 1.76 fold at 1.0 mm from the edge). In contrast, MCT4 and the carbonic anhydrase CAIX, which are associated with hypoxia, were not significantly upregulated in the rim. The spatial distribution of MCT4 was highly correlated with that of CAIX, suggesting that their expression is regulated by the same factors. Since protons extruded by NHE1 diffuse away through extracellular clefts, NHE1 requires a continuous source of intracellular protons. From the stoichiometries of metabolic pathways that produce or consume H+, and the greater availability of glucose compared to oxygen in most parts of a tumor, we support the classic view that most of the net proton efflux from C6 gliomas originates in glycolytic formation of lactate and H+ inside the tumor, but add that some lactate is taken up into cells in the rim on MCT1, and some lactate diffuses away, leaving its associated protons available to re-enter cells for extrusion on NHE1. Therapeutic inhibition of NHE1, MCT1 or CAIX is predicted to affect different parts of a tumor.	[Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Remy, Chantal; Coles, Jonathan A.] INSERM, U836, La Tronche, Isere, France; [Grillon, Emmanuelle; Farion, Regine; Fablet, Katell; De Waard, Michel; Remy, Chantal; Coles, Jonathan A.] Univ Grenoble 1, Grenoble Inst Neurosci, Grenoble, France; [Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Div Gastroenterol, Baltimore, MD 21205 USA; [Tse, Chung Ming; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA; [Coles, Jonathan A.] Univ Strathclyde, Ctr Biophoton, Glasgow, Lanark, Scotland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Johns Hopkins University; Johns Hopkins University; University of Strathclyde	Grillon, E (corresponding author), INSERM, U836, La Tronche, Isere, France.	Jonathan.Coles@glasgow.ac.uk	De Waard, Michel/G-7406-2014; Remy, Chantal/L-9459-2014	De Waard, Michel/0000-0002-2782-9615; 	INSERM [U836]; NIDDK [R01 DK26523, DK61765]; Hopkins Basic Research Digestive Diseases Development Core Center [R24 DK 64388]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064388, R01DK061765, R01DK026523] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hopkins Basic Research Digestive Diseases Development Core Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by program grant U836 of INSERM and Action Concertee Incitative 2008-2009 INCa (C.R.), NIDDK R01 DK26523 and DK61765 and Hopkins Basic Research Digestive Diseases Development Core Center R24 DK 64388 (M.D.). Some imaging and expenses of JAC were supported by the Sir David Anderson Bequest from the University of Strathclyde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; BENDA P, 1971, J NEUROSURG, V34, P310, DOI 10.3171/jns.1971.34.3.0310; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bergersen LH, 2007, NEUROSCIENCE, V145, P11, DOI 10.1016/j.neuroscience.2006.11.062; Bolanos JP, 2010, TRENDS BIOCHEM SCI, V35, P145, DOI 10.1016/j.tibs.2009.10.006; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Busco G, 2010, FASEB J; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Chiang YH, 2008, J CELL PHYSIOL, V214, P810, DOI 10.1002/jcp.21277; Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470; De Milito A, 2010, INT J CANCER, V127, P207, DOI 10.1002/ijc.25009; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; ENGASSER JM, 1974, PHYSIOL CHEM PHYS M, V6, P541; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Froberg MK, 2001, NEUROREPORT, V12, P761, DOI 10.1097/00001756-200103260-00030; Gallagher FA, 2008, NATURE, V453, P940, DOI 10.1038/nature07017; Garcia-Martin ML, 2001, CANCER RES, V61, P6524; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024; Gerweck LE, 1996, CANCER RES, V56, P1194; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; GILLIES RJ, 1994, AM J PHYSIOL, V267, pC195, DOI 10.1152/ajpcell.1994.267.1.C195; GIOIA M, 2010, J BIOL INORG CHEM, V12; Haapasalo JA, 2006, CLIN CANCER RES, V12, P473, DOI 10.1158/1078-0432.CCR-05-0848; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLM E, 1995, CANCER RES, V55, P1373; Hunter T, 2010, CURR OPIN GENET DEV, V20, P1, DOI 10.1016/j.gde.2010.01.001; Julien C, 2004, BRIT J CANCER, V91, P374, DOI 10.1038/sj.bjc.6601908; Kallio H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-22; Kersh AE, 2009, AM J PHYSIOL-REG I, V297, pR1409, DOI 10.1152/ajpregu.91038.2008; Korkolopoulou P, 2007, HUM PATHOL, V38, P629, DOI 10.1016/j.humpath.2006.07.020; LAGARDE AE, 1988, J CELL BIOCHEM, V36, P249, DOI 10.1002/jcb.240360306; Lane AN, 2009, METABOLOMICS, V5, P163, DOI 10.1007/s11306-008-0142-2; Lee GH, 2010, ONCOGENE, V29, P2130, DOI 10.1038/onc.2009.491; Loncaster JA, 2001, CANCER RES, V61, P6394; MAJUMDAR D, 2010, NEUROSCIENCE; Mathupala SP, 2004, NEUROSURGERY, V55, P1410, DOI 10.1227/01.NEU.0000143034.62913.59; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; Min KH, 2010, J CONTROL RELEASE, V144, P259, DOI 10.1016/j.jconrel.2010.02.024; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Moulin P, 2007, J MOL ENDOCRINOL, V38, P409, DOI 10.1677/jme.1.02164; Musa-Aziz R, 2009, P NATL ACAD SCI USA, V106, P5406, DOI 10.1073/pnas.0813231106; Ojugo ASE, 1999, NMR BIOMED, V12, P495, DOI 10.1002/(SICI)1099-1492(199912)12:8<495::AID-NBM594>3.0.CO;2-K; Olson ES, 2010, P NATL ACAD SCI USA, V107, P4311, DOI 10.1073/pnas.0910283107; Ord JJ, 2005, BRIT J CANCER, V93, P346, DOI 10.1038/sj.bjc.6602666; Parkkila S, 2000, J HISTOCHEM CYTOCHEM, V48, P1601, DOI 10.1177/002215540004801203; Pinheiro C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/427694; POUYSSEGUR J, 1984, P NATL ACAD SCI-BIOL, V81, P4833, DOI 10.1073/pnas.81.15.4833; Proescholdt MA, 2005, NEURO-ONCOLOGY, V7, P465, DOI 10.1215/S1152851705000025; Provent P, 2007, CANCER RES, V67, P7638, DOI 10.1158/0008-5472.CAN-06-3459; Raghunand N, 2001, NEOPLASIA, V3, P227, DOI 10.1038/sj.neo.7900151; ROTIN D, 1989, CANCER RES, V49, P205; Segala J, 2009, INT J MOL SCI, V10, P3478, DOI 10.3390/ijms10083478; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sier CFM, 1996, BRIT J CANCER, V74, P413, DOI 10.1038/bjc.1996.374; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stock C, 2008, EUR J CELL BIOL, V87, P591, DOI 10.1016/j.ejcb.2008.01.007; Stock C, 2009, PFLUG ARCH EUR J PHY, V458, P981, DOI 10.1007/s00424-009-0677-8; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; SWIETACH P, 2010, NEW INSIGHTS PHYSIOL; Swietach P, 2009, J BIOL CHEM, V284, P20299, DOI 10.1074/jbc.M109.006478; THOMAS RC, 1984, J PHYSIOL-LONDON, V354, pP3; Ullah MS, 2006, J BIOL CHEM, V281, P9030, DOI 10.1074/jbc.M511397200; Voegtlin C, 1933, SCIENCE, V77, P567, DOI 10.1126/science.77.2006.567; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Webb S.D., 2001, NOVART FDN SYMP, V240, P181; WIKEHOOLEY JL, 1984, RADIOTHER ONCOL, V2, P343, DOI 10.1016/S0167-8140(84)80077-8; Zhang XM, 2010, J NUCL MED, V51, P1167, DOI 10.2967/jnumed.109.068981; Zoula S, 2003, BRIT J CANCER, V88, P1439, DOI 10.1038/sj.bjc.6600837	77	34	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17416	10.1371/journal.pone.0017416	http://dx.doi.org/10.1371/journal.pone.0017416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390324	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000287761700053
J	Iwata, A; de Claro, RA; Morgan-Stevenson, VL; Tupper, JC; Schwartz, BR; Liu, L; Zhu, XD; Jordan, KC; Winn, RK; Harlan, JM				Iwata, Akiko; de Claro, R. Angelo; Morgan-Stevenson, Vicki L.; Tupper, Joan C.; Schwartz, Barbara R.; Liu, Li; Zhu, Xiaodong; Jordan, Katherine C.; Winn, Robert K.; Harlan, John M.			Extracellular Administration of BCL2 Protein Reduces Apoptosis and Improves Survival in a Murine Model of Sepsis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INNATE IMMUNE-RESPONSES; CELL-DEATH; SEPTIC MICE; RECEPTOR; HMGB1; EXPRESSION; INJURY; DANGER; PLASMA	Background: Severe sepsis and septic shock are major causes of morbidity and mortality worldwide. In experimental sepsis there is prominent apoptosis of various cell types, and genetic manipulation of death and survival pathways has been shown to modulate organ injury and survival. Methodology/Principal Findings: We investigated the effect of extracellular administration of two anti-apoptotic members of the BCL2 (B-cell lymphoma 2) family of intracellular regulators of cell death in a murine model of sepsis induced by cecal ligation and puncture (CLP). We show that intraperitoneal injection of picomole range doses of recombinant human (rh) BCL2 or rhBCL2A1 protein markedly improved survival as assessed by surrogate markers of death. Treatment with rhBCL2 or rhBCL2A1 protein significantly reduced the number of apoptotic cells in the intestine and heart following CLP, and this was accompanied by increased expression of endogenous mouse BCL2 protein. Further, mice treated with rhBCL2A1 protein showed an increase in the total number of neutrophils in the peritoneum following CLP with reduced neutrophil apoptosis. Finally, although neither BCL2 nor BCL2A1 are a direct TLR2 ligand, TLR2-null mice were not protected by rhBCL2A1 protein, indicating that TLR2 signaling was required for the protective activity of extracellularly adminsitered BCL2A1 protein in vivo. Conclusions/Significance: Treatment with rhBCL2A1 or rhBCL2 protein protects mice from sepsis by reducing apoptosis in multiple target tissues, demonstrating an unexpected, potent activity of extracellularly administered BCL2 BH4-domain proteins.	[Iwata, Akiko; Morgan-Stevenson, Vicki L.; Winn, Robert K.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [de Claro, R. Angelo; Tupper, Joan C.; Schwartz, Barbara R.; Liu, Li; Zhu, Xiaodong; Jordan, Katherine C.; Harlan, John M.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Iwata, A (corresponding author), Univ Washington, Dept Surg, Seattle, WA 98195 USA.	jharlan@uw.edu			National Institutes of Health [GM042686, GM071398]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042686, R01GM071398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health grants GM042686 (RKW, JMH) and GM071398 (JMH) supported this work. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahn T, 2010, CELL CALCIUM, V47, P387, DOI 10.1016/j.ceca.2010.02.003; Akanda N, 2008, CELL CYCLE, V7, P3225, DOI 10.4161/cc.7.20.6831; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; Baier PK, 2006, HEPATO-GASTROENTEROL, V53, P747; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Buerke U, 2008, SHOCK, V29, P497, DOI 10.1097/SHK.0b013e318142c434; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Clark RSB, 2000, J PEDIATR-US, V137, P197, DOI 10.1067/mpd.2000.106903; Coopersmith CM, 2002, CRIT CARE MED, V30, P195, DOI 10.1097/00003246-200201000-00028; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; Fathi NA, 2006, CLIN EXP IMMUNOL, V146, P339, DOI 10.1111/j.1365-2249.2006.03219.x; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Hagiwara S, 2008, INTENS CARE MED, V34, P1812, DOI 10.1007/s00134-008-1161-1; Hajishengallis G, 2008, P NATL ACAD SCI USA, V105, P13532, DOI 10.1073/pnas.0803852105; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Hotchkiss RS, 2005, J IMMUNOL, V174, P5110, DOI 10.4049/jimmunol.174.8.5110; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hotchkiss RS, 2002, CRIT CARE MED, V30, pS225, DOI 10.1097/00003246-200205001-00009; Houston G, 2009, CLIN MICROBIOL INFEC, V15, P319, DOI 10.1111/j.1469-0691.2009.02751.x; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Iwata A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009103; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; McCarthy BA, 2008, MOL MED, V14, P618, DOI 10.2119/2008.00061.McCarthy; MORTON DB, 1985, VET REC, V116, P431, DOI 10.1136/vr.116.16.431; Mzayek F, 2008, CRIT CARE MED, V36, P2690, DOI 10.1097/CCM.0b013e3181833c6f; Oberholzer C, 2001, P NATL ACAD SCI USA, V98, P11503, DOI 10.1073/pnas.181338198; Osman H G, 2007, Indian J Med Microbiol, V25, P323; Protopsaltis J, 2007, MED PRIN PRACT, V16, P222, DOI 10.1159/000100394; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Reed JC, 2008, BLOOD, V111, P3322, DOI 10.1182/blood-2007-09-078162; Reimers K, 2007, INT J BIOL SCI, V3, P471; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Rong YP, 2009, P NATL ACAD SCI USA, V106, P14397, DOI 10.1073/pnas.0907555106; Rouhiainen A, 2007, J LEUKOCYTE BIOL, V81, P49, DOI 10.1189/jlb.0306200; Sakai T, 1999, J INTERF CYTOK RES, V19, P999, DOI 10.1089/107999099313208; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Sunden-Cullberg J, 2005, CRIT CARE MED, V33, P564, DOI [10.1097/01.CCM.0000155991.88802.4D, 10.1097/01.ccm.0000155991.88802.4D]; Vyas D, 2007, HISTOL HISTOPATHOL, V22, P623, DOI 10.14670/HH-22.623; Walsh M, 2002, BLOOD, V99, P3439, DOI 10.1182/blood.V99.9.3439; Wesche DE, 2005, J LEUKOCYTE BIOL, V78, P325, DOI 10.1189/jlb.0105017; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	51	23	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14729	10.1371/journal.pone.0014729	http://dx.doi.org/10.1371/journal.pone.0014729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390214	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700007
J	Sala, E; Guasch, L; Iwaszkiewicz, J; Mulero, M; Salvado, MJ; Pinent, M; Zoete, V; Grosdidier, A; Garcia-Vallve, S; Michielin, O; Pujadas, G				Sala, Esther; Guasch, Laura; Iwaszkiewicz, Justyna; Mulero, Miquel; Salvado, Maria-Josepa; Pinent, Montserrat; Zoete, Vincent; Grosdidier, Aurelien; Garcia-Vallve, Santiago; Michielin, Olivier; Pujadas, Gerard			Identification of Human IKK-2 Inhibitors of Natural Origin (Part I): Modeling of the IKK-2 Kinase Domain, Virtual Screening and Activity Assays	PLOS ONE			English	Article							KAPPA-B-KINASE; HIT-TO-LEAD; BETA INHIBITORS; DRUG DISCOVERY; POTENT; DERIVATIVES; MECHANISM; DATABASE; PRODUCTS; DESIGN	Background: Their large scaffold diversity and properties, such as structural complexity and drug similarity, form the basis of claims that natural products are ideal starting points for drug design and development. Consequently, there has been great interest in determining whether such molecules show biological activity toward protein targets of pharmacological relevance. One target of particular interest is hIKK-2, a serine-threonine protein kinase belonging to the IKK complex that is the primary component responsible for activating NF-kappa B in response to various inflammatory stimuli. Indeed, this has led to the development of synthetic ATP-competitive inhibitors for hIKK-2. Therefore, the main goals of this study were (a) to use virtual screening to identify potential hIKK-2 inhibitors of natural origin that compete with ATP and (b) to evaluate the reliability of our virtual-screening protocol by experimentally testing the in vitro activity of selected natural-product hits. Methodology/Principal Findings: We thus predicted that 1,061 out of the 89,425 natural products present in the studied database would inhibit hIKK-2 with good ADMET properties. Notably, when these 1,061 molecules were merged with the 98 synthetic hIKK-2 inhibitors used in this study and the resulting set was classified into ten clusters according to chemical similarity, there were three clusters that contained only natural products. Five molecules from these three clusters (for which no anti-inflammatory activity has been previously described) were then selected for in vitro activity testing, in which three out of the five molecules were shown to inhibit hIKK-2. Conclusions/Significance: We demonstrated that our virtual-screening protocol was successful in identifying lead compounds for developing new inhibitors for hIKK-2, a target of great interest in medicinal chemistry. Additionally, all the tools developed during the current study (i.e., the homology model for the hIKK-2 kinase domain and the pharmacophore) will be made available to interested readers upon request.	[Sala, Esther; Guasch, Laura; Mulero, Miquel; Salvado, Maria-Josepa; Pinent, Montserrat; Garcia-Vallve, Santiago; Pujadas, Gerard] Univ Rovira & Virgili, Grp Recerca Nutrigenom, Dept Bioquim & Biotecnol, Tarragona, Catalonia, Spain; [Garcia-Vallve, Santiago; Pujadas, Gerard] Ctr Tecnol Nutr & Salut, Reus, Catalonia, Spain; [Iwaszkiewicz, Justyna; Zoete, Vincent; Grosdidier, Aurelien; Michielin, Olivier] Quartier UNIL Sorge, Swiss Inst Bioinformat, Mol Modeling Grp, Lausanne, Switzerland	Universitat Rovira i Virgili; Swiss Institute of Bioinformatics	Sala, E (corresponding author), Univ Rovira & Virgili, Grp Recerca Nutrigenom, Dept Bioquim & Biotecnol, Campus Sescelades, Tarragona, Catalonia, Spain.	gerard.pujadas@urv.cat	PUJADAS, GERARD/W-9348-2019; Michielin, Olivier/ABE-7924-2020; Sala, Esther/AAB-4997-2022; Garcia-Vallve, Santi/A-4226-2008; Mulero, Miquel/L-4672-2014; Pinent, Montserrat/ABE-6178-2021; Pujadas, Gerard/B-1457-2010; Salvado, M. Josepa/B-6062-2015; Pinent, Montserrat/C-7109-2011	PUJADAS, GERARD/0000-0003-2598-8089; Garcia-Vallve, Santi/0000-0002-0348-7497; Mulero, Miquel/0000-0003-2545-2065; Pinent, Montserrat/0000-0003-3550-5378; Pujadas, Gerard/0000-0003-2598-8089; Salvado, M. Josepa/0000-0003-3883-3326; Pinent, Montserrat/0000-0003-3550-5378; Iwaszkiewicz, Justyna/0000-0003-3494-589X; Grosdidier, Aurelien/0000-0001-9873-3461; Sala, Esther/0000-0002-5149-1992; Guasch, Laura/0000-0003-4990-7765	Ministerio de Educacion y Ciencia of the Spanish Government [AGL2008-00387/ALI]; EMBO [ASTF 61-2009]; Generalitat de Catalunya [TECCT10-1-0008]	Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government); EMBO(European Molecular Biology Organization (EMBO)); Generalitat de Catalunya(Generalitat de Catalunya)	This study was supported by Grant Number AGL2008-00387/ALI from the Ministerio de Educacion y Ciencia of the Spanish Government, Grant Number ASTF 61-2009 from the EMBO Short-Term Fellowship program and the ACC1O (TECCT10-1-0008) program (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila CM, 2009, BIOORG MED CHEM LETT, V19, P6907, DOI 10.1016/j.bmcl.2009.10.076; Baxter A, 2004, BIOORG MED CHEM LETT, V14, P2817, DOI 10.1016/j.bmcl.2004.03.058; Beaulieu F, 2007, BIOORG MED CHEM LETT, V17, P1233, DOI 10.1016/j.bmcl.2006.12.017; Belema M, 2007, BIOORG MED CHEM LETT, V17, P4284, DOI 10.1016/j.bmcl.2007.05.031; Bencharit S, 2003, CHEM BIOL, V10, P341, DOI 10.1016/S1074-5521(03)00071-1; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bhagwat SS, 2009, PURINERG SIGNAL, V5, P107, DOI 10.1007/s11302-008-9117-z; Bhattarai BR, 2010, BIOORG MED CHEM LETT, V20, P1075, DOI 10.1016/j.bmcl.2009.12.033; Bingham AH, 2004, BIOORG MED CHEM LETT, V14, P409, DOI 10.1016/j.bmcl.2003.10.047; Bingham AH, 2008, BIOORG MED CHEM LETT, V18, P3622, DOI 10.1016/j.bmcl.2008.04.062; Bonafoux D, 2005, BIOORG MED CHEM LETT, V15, P2870, DOI 10.1016/j.bmcl.2005.03.090; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Castro AC, 2003, BIOORG MED CHEM LETT, V13, P2419, DOI 10.1016/S0960-894X(03)00408-6; Christopher JA, 2007, BIOORG MED CHEM LETT, V17, P3972, DOI 10.1016/j.bmcl.2007.04.088; Christopher JA, 2009, J MED CHEM, V52, P3098, DOI 10.1021/jm9000117; Cragg GM, 2009, PHYTOCHEM REV, V8, P313, DOI 10.1007/s11101-009-9123-y; Crombie AL, 2010, BIOORG MED CHEM LETT, V20, P3821, DOI 10.1016/j.bmcl.2010.04.022; De Silva D, 2010, BRIT J PHARMACOL, V160, P1808, DOI 10.1111/j.1476-5381.2010.00839.x; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Eglen RM, 2009, ASSAY DRUG DEV TECHN, V7, P22, DOI 10.1089/adt.2008.164; Engh RA, 2002, PHARMACOL THERAPEUT, V93, P99, DOI 10.1016/S0163-7258(02)00180-8; Ghose AK, 2008, J MED CHEM, V51, P5149, DOI 10.1021/jm800475y; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kumar K, 2009, ANGEW CHEM INT EDIT, V48, P3224, DOI 10.1002/anie.200803437; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lauria A, 2010, J MOL GRAPH MODEL, V29, P72, DOI 10.1016/j.jmgm.2010.04.008; Liddle J, 2009, BIOORG MED CHEM LETT, V19, P2504, DOI 10.1016/j.bmcl.2009.03.034; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mbalaviele G, 2009, J PHARMACOL EXP THER, V329, P14, DOI 10.1124/jpet.108.143800; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Mills N, 2006, J AM CHEM SOC, V128, P13649, DOI 10.1021/ja0697875; Morwick T, 2006, J MED CHEM, V49, P2898, DOI 10.1021/jm0510979; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4019, DOI 10.1016/j.bmcl.2004.05.041; Murata T, 2004, BIOORG MED CHEM LETT, V14, P4013, DOI 10.1016/j.bmcl.2004.05.040; Murata T, 2003, BIOORG MED CHEM LETT, V13, P913, DOI 10.1016/S0960-894X(02)01046-6; Nagarajan S, 2011, J MOL MODEL, V17, P209, DOI 10.1007/s00894-010-0714-8; Nagarajan S, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S7-S15, 10.1186/1471-2105-11-S7-515]; Nagarajan S, 2010, BIOORGAN MED CHEM, V18, P3951, DOI 10.1016/j.bmc.2010.04.030; Nagarajan S, 2009, BIOORGAN MED CHEM, V17, P2759, DOI 10.1016/j.bmc.2009.02.041; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Noha SM, 2011, BIOORG MED CHEM LETT, V21, P577, DOI 10.1016/j.bmcl.2010.10.051; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rollinger JM, 2006, PLANTA MED, V72, P671, DOI 10.1055/s-2006-941506; Rollinger JM, 2006, CURR MED CHEM, V13, P1491, DOI 10.2174/092986706777442075; Rollinger Judith M., 2008, V65; Rudolph MI, 1997, J PHARMACOL EXP THER, V282, P256; Rudolph MI, 1997, GEN PHARMACOL-VASC S, V28, P381, DOI 10.1016/S0306-3623(96)00288-1; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sala E, 2009, QSAR COMB SCI, V28, P678, DOI 10.1002/qsar.200860167; Schmid JA, 2008, CYTOKINE GROWTH F R, V19, P157, DOI 10.1016/j.cytogfr.2008.01.006; Shimizu H, 2010, BIOORG MED CHEM LETT, V20, P5113, DOI 10.1016/j.bmcl.2010.07.026; Sommers CD, 2009, J PHARMACOL EXP THER, V330, P377, DOI 10.1124/jpet.108.147538; Sowadski JM, 1999, PHARMACOL THERAPEUT, V82, P157, DOI 10.1016/S0163-7258(98)00054-0; Stealey S. A., 2005, PCT Int. Appl., Patent No. [2005037797, WO 2005/037797]; Sugiyama H, 2007, CHEM PHARM BULL, V55, P613, DOI 10.1248/cpb.55.613; Waelchli R, 2006, BIOORG MED CHEM LETT, V16, P108, DOI 10.1016/j.bmcl.2005.09.035; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Williams PG, 2009, TRENDS BIOTECHNOL, V27, P45, DOI 10.1016/j.tibtech.2008.10.005; Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e; Zhou XW, 2009, J PHARM PHARMACOL, V61, P279, DOI [10.1211/jpp/61.03.0002, 10.1211/jpp.61.03.0002]; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176; Zsoldos Z, 2006, CURR PROTEIN PEPT SC, V7, P421, DOI 10.2174/138920306778559412	74	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16903	10.1371/journal.pone.0016903	http://dx.doi.org/10.1371/journal.pone.0016903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390216	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700017
J	Tanabe, Y; Watanabe, MM				Tanabe, Yuuhiko; Watanabe, Makoto M.			Local Expansion of a Panmictic Lineage of Water Bloom-Forming Cyanobacterium Microcystis aeruginosa	PLOS ONE			English	Article							NATURAL-POPULATIONS; GENETIC EXCHANGE; TOXIC CYANOBACTERIA; DNA POLYMORPHISM; RECOMBINATION; DIVERSITY; SPECIATION; BACTERIA	In previous studies, we have demonstrated that the population structure of the bloom-forming cyanobacterium Microcystis aeruginosa is clonal. Expanded multilocus sequence typing analysis of M. aeruginosa using 412 isolates identified five intraspecific lineages suggested to be panmictic while maintaining overall clonal structure probably due to a reduced recombination rate between lineages. Interestingly, since 2005 most strains belonging to one of these panmictic clusters (group G) have been found in a particular locality (Lake Kasumigaura Basin) in Japan. In this locality, multiple, similar but distinct genotypes of this lineage predominated in the bloom, a pattern that is unprecedented for M. aeruginosa. The population structure underlying blooms associated with this lineage is comparable to epidemics of pathogens. Our results may reveal an expansion of the possible adaptive lineage in a localized aquatic environment, providing us with a unique opportunity to investigate its ecological and biogeographical consequences.	[Tanabe, Yuuhiko; Watanabe, Makoto M.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba	Tanabe, Y (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	y_tanabe@sakura.cc.tsukuba.ac.jp		Tanabe, Yuuhiko/0000-0003-0841-4569	Institute for Fermentation, Osaka (IFO); Ministry of the Environment, Japan [D-0905]	Institute for Fermentation, Osaka (IFO)(Institute for Fermentation (IFO)); Ministry of the Environment, Japan(Ministry of the Environment, Japan)	This work was supported by a grant of the Institute for Fermentation, Osaka (IFO) (http://www.ifo.or.jp/) to YT, and by the Global Environment Research Fund (D-0905) (http://www.env.go.jp/earth/suishinhi/english/index.html) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baas Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN; Barker GLA, 2000, MICROBIOL-UK, V146, P2865, DOI 10.1099/00221287-146-11-2865; BEASLEY VR, 1989, VET CLIN N AM-FOOD A, V5, P345, DOI 10.1016/S0749-0720(15)30980-4; Carmichael WW, 1996, TOXIC MICROCYSTIS, P1; Cohan FM, 2002, ANNU REV MICROBIOL, V56, P457, DOI 10.1146/annurev.micro.56.012302.160634; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; den Bakker HC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-277; Deng L, 2008, FRESHWATER BIOL, V53, P1240, DOI 10.1111/j.1365-2427.2007.01947.x; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fewer DP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-183; Frangeul L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-274; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Fraser C, 2009, SCIENCE, V323, P741, DOI 10.1126/science.1159388; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Goss EM, 2005, GENETICS, V169, P21, DOI 10.1534/genetics.104.031351; Hanage WP, 2006, PHILOS T R SOC B, V361, P2039, DOI 10.1098/rstb.2006.1926; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Ionescu D, 2010, FEMS MICROBIOL ECOL, V72, P103, DOI 10.1111/j.1574-6941.2010.00835.x; Janse I, 2004, APPL ENVIRON MICROB, V70, P3979, DOI 10.1128/AEM.70.7.3979-3987.2004; Jing HM, 2005, EXTREMOPHILES, V9, P325, DOI 10.1007/s00792-005-0456-1; Jochimsen EM, 1998, NEW ENGL J MED, V338, P873, DOI 10.1056/NEJM199803263381304; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kasai F, 2004, NIES COLLECTION LIST, V7; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Kurmayer R, 2005, MICROBIOL-SGM, V151, P1525, DOI 10.1099/mic.0.27779-0; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Lodders N, 2005, ENVIRON MICROBIOL, V7, P434, DOI 10.1111/j.1462-2920.2005.00730.x; Majewski J, 2000, J BACTERIOL, V182, P1016, DOI 10.1128/JB.182.4.1016-1023.2000; Nei M., 1987, MOL EVOLUTIONARY GEN; Papke RT, 2003, ENVIRON MICROBIOL, V5, P650, DOI 10.1046/j.1462-2920.2003.00460.x; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; SOUZA V, 1992, P NATL ACAD SCI USA, V89, P8389, DOI 10.1073/pnas.89.17.8389; Spratt BG, 2001, CURR OPIN MICROBIOL, V4, P602, DOI 10.1016/S1369-5274(00)00257-5; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanabe Y, 2004, J MOL EVOL, V58, P633, DOI 10.1007/s00239-004-2583-1; Tanabe Y, 2007, MICROBIOL-SGM, V153, P3695, DOI 10.1099/mic.0.2007/010645-0; Tanabe Y, 2009, ENV MICROBIOL REP, V1, P575, DOI 10.1111/j.1758-2229.2009.00088.x; Tanabe Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-115; Vulic M, 1997, P NATL ACAD SCI USA, V94, P9763, DOI 10.1073/pnas.94.18.9763	45	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17085	10.1371/journal.pone.0017085	http://dx.doi.org/10.1371/journal.pone.0017085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390221	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700028
J	Tarasuik, JC; Galligan, R; Kaufman, J				Tarasuik, Joanne Catherine; Galligan, Roslyn; Kaufman, Jordy			Almost Being There: Video Communication with Young Children	PLOS ONE			English	Article							TELEVISION; ATTACHMENT; SPOUSES	Background: Video communication is increasingly used to connect people around the world. This includes connecting young children with their parents and other relatives during times of separation. An important issue is the extent to which video communication with children can approximate a physical presence such that familial relationships can be truly maintained by this means. Methodology/Principal Findings: The current study employed an adaptation of the Separation and Reunion Paradigm with children (17 months to 5 years) to investigate the potential for video communication with a parent to afford a sense of proximity and security to children. The protocol involved a free-play session with the parent, followed by two separation-reunion episodes. During one of the separation episodes the parent was 'virtually available' to the child via a video link. Our results revealed three important differences. First, children left alone played longer in a strange room when their parent was virtually available to them compared to when the children were left alone with neither physical nor video contact with their parent. Second, younger participants sought physical contact with their parent less at the end of the video separation episode compared to when they were left entirely alone. Finally, the comparison between free play with video and free play with parent, revealed that the children exhibit a similar level of interactivity with their parent by video as they did in person. Conclusions/Significance: For young children a video connection can have many of the same effects as a physical presence. This is a significant finding as it is the first such empirical demonstration and indicates considerable promise in video communication as a tool to maintain family relationships when physical presence is not possible.	[Tarasuik, Joanne Catherine; Galligan, Roslyn; Kaufman, Jordy] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Melbourne, Vic, Australia	Swinburne University of Technology	Tarasuik, JC (corresponding author), Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Melbourne, Vic, Australia.	Jkaufman@swin.edu.au	Kaufman, Jordy/A-5742-2008	Kaufman, Jordy/0000-0001-9881-371X	Eric Ormond Baker Charitable Fund	Eric Ormond Baker Charitable Fund	This research was supported by the Eric Ormond Baker Charitable Fund (http://www.eqt.com.au/not-for-profit-organisations/grants/trust-list/trustdetail.aspx?ID=24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth M.D.S., 1971, ORIGINS HUMAN SOCIAL, P17; AINSWORTH MDS, 1979, AM PSYCHOL, V34, P932, DOI 10.1037/0003-066X.34.10.932; American Association of Retired People, 2002, GRANDP STUD 2002 REP; Australian Bureau of Statistics, 2008, FAM CHAR TRANS AUSTR; Ballagas R., 2009, P 8 INT C INTERACTIO, P321, DOI [10.1145/1551788.1551874, DOI 10.1145/1551788.1551874]; BIEDERMAN M, 1999, NY TIMES        1212; Borenstein, 2002, HDB PARENTING, P141; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Chamber of Minerals and Energy of Western Australia, 2005, FLY FLY OUT SUST PER; De Bruycker T, 2008, J FAM ISSUES, V29, P1448, DOI 10.1177/0192513X08318154; Dennison BA, 2002, PEDIATRICS, V109, P1028, DOI 10.1542/peds.109.6.1028; *EBAY, EB PAYPAL SKYP FIN H; Farrell M. A., 1998, WOMEN CRIMINAL JUSTI, V9, P47, DOI DOI 10.1300/J012V09N04_02; HARMON A, 2008, NY TIMES        1128; Lester P, 2010, J AM ACAD CHILD PSY, V49, P310, DOI 10.1016/j.jaac.2010.01.003; Linebarger DL, 2005, AM BEHAV SCI, V48, P624, DOI 10.1177/0002764204271505; Myers B.J., 1999, J CHILD FAM STUD, V8, P15, DOI [10.1023/A:1022990410036, DOI 10.1023/A:1022990410036]; *QUAK UN OFF, 2009, CHILDR NEED DADS TOO; TAUB EA, 2009, NY TIMES        1029; Troseth GL, 2006, CHILD DEV, V77, P786, DOI 10.1111/j.1467-8624.2006.00903.x; *US BUR CENS, 2008, NAT SEC VET AFF; *US BUR CENS, 2009, CUST MOTH FATH THEIR; van Ijzendoorn MH, 2004, CHILD DEV, V75, P1188, DOI 10.1111/j.1467-8624.2004.00733.x; Vetere F, 2009, INT J HUM-COMPUT ST, V67, P165, DOI 10.1016/j.ijhcs.2008.09.004; Westman M, 2009, STRESS QUAL WORK LIF, P19; [No title captured]	26	29	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17129	10.1371/journal.pone.0017129	http://dx.doi.org/10.1371/journal.pone.0017129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390330	Green Published, gold			2022-12-27	WOS:000287761700030
J	Francis, SM; Chakrabarti, S; Dick, FA				Francis, Sarah M.; Chakrabarti, Subrata; Dick, Frederick A.			A Context-Specific Role for Retinoblastoma Protein-Dependent Negative Growth Control in Suppressing Mammary Tumorigenesis	PLOS ONE			English	Article							MEDIATED G(1) ARREST; CELL-CYCLE CONTROL; BREAST-CANCER; GLAND DEVELOPMENT; MICE LACKING; NEU PROTOONCOGENE; EPITHELIAL-CELLS; TRANSGENIC MICE; FACTOR-BETA; TGF-BETA	Background: The ability to respond to anti-growth signals is critical to maintain tissue homeostasis and loss of this negative growth control safeguard is considered a hallmark of cancer. Negative growth regulation generally occurs during the G0/G1 phase of the cell cycle, yet the redundancy and complexity among components of this regulatory network has made it difficult to discern how negative growth cues protect cells from aberrant proliferation. Methodology/Principal Findings: The retinoblastoma protein (pRB) acts as the final barrier to prevent cells from entering into the cell cycle. By introducing subtle changes in the endogenous mouse Rb1 gene (Rb1(Delta L)), we have previously shown that interactions at the LXCXE binding cleft are necessary for the proper response to anti-growth signals such as DNA damage and TGF-beta, with minimal effects on overall development. This disrupts the balance of pro-and anti-growth signals in mammary epithelium of Rb1(Delta L/Delta L) mice. Here we show that Rb1(Delta L/Delta L) mice are more prone to mammary tumors in the Wapp53(R172H) transgenic background indicating that negative growth regulation is important for tumor suppression in these mice. In contrast, the same defect in anti-growth control has no impact on Neu-induced mammary tumorigenesis. Conclusions/Significance: Our work demonstrates that negative growth control by pRB acts as a crucial barrier against oncogenic transformation. Strikingly, our data also reveals that this tumor suppressive effect is context-dependent.	[Francis, Sarah M.; Dick, Frederick A.] London Reg Canc Program, London, ON, Canada; [Francis, Sarah M.; Dick, Frederick A.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Dick, Frederick A.] Childrens Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Francis, SM (corresponding author), London Reg Canc Program, London, ON, Canada.	fdick@uwo.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Cancer Research Society; Canadian Institutes of Health Research [MOP-64253]	Cancer Research Society; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by research grants from the Cancer Research Society and the Canadian Institutes of Health Research (MOP-64253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BORG A, 1992, CANCER RES, V52, P2991; Bosco EE, 2007, CELL CYCLE, V6, P667, DOI 10.4161/cc.6.6.3988; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Coschi CH, 2010, GENE DEV, V24, P1351, DOI 10.1101/gad.1917610; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Ewan KBR, 2005, AM J PATHOL, V167, P409, DOI 10.1016/S0002-9440(10)62985-9; Fernandez PL, 1998, J CLIN PATHOL-MOL PA, V51, P305, DOI 10.1136/mp.51.6.305; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Florenes VA, 1996, ONCOGENE, V13, P2447; Francis SM, 2009, MOL CELL BIOL, V29, P4455, DOI 10.1128/MCB.00473-09; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hojilla CV, 2007, J CELL SCI, V120, P1050, DOI 10.1242/jcs.003335; Iavarone A, 1997, NATURE, V387, P417; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Nielsen NH, 1997, ONCOGENE, V14, P295, DOI 10.1038/sj.onc.1200833; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PIETILAINEN T, 1995, EUR J CANCER, V31A, P329, DOI 10.1016/0959-8049(94)00463-F; Robinson GW, 2001, ONCOGENE, V20, P7115, DOI 10.1038/sj.onc.1204888; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Talluri S, 2010, MOL CELL BIOL, V30, P948, DOI 10.1128/MCB.01168-09; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16434	10.1371/journal.pone.0016434	http://dx.doi.org/10.1371/journal.pone.0016434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364977	Green Submitted, gold, Green Published			2022-12-27	WOS:000287656600007
J	Quintana, AM; Zhou, YE; Pena, JJ; O'Rourke, JP; Ness, SA				Quintana, Anita M.; Zhou, Ye E.; Pena, Janeth J.; O'Rourke, John P.; Ness, Scott A.			Dramatic Repositioning of c-Myb to Different Promoters during the Cell Cycle Observed by Combining Cell Sorting with Chromatin Immunoprecipitation	PLOS ONE			English	Article							HUMAN HEMATOPOIETIC-CELLS; FORMALDEHYDE CROSS-LINKING; V-MYB; SANT DOMAIN; NF-Y; CANCER-CELLS; TRANSCRIPTION; EXPRESSION; GENE; LEUKEMIA	The c-Myb transcription factor is a critical regulator of proliferation and stem cell differentiation, and mutated alleles of c-Myb are oncogenic, but little is known about changes in c-Myb activity during the cell cycle. To map the association of c-Myb with specific target genes during the cell cycle, we developed a novel Fix-Sort-ChIP approach, in which asynchronously growing cells were fixed with formaldehyde, stained with Hoechst 33342 and separated into different cell cycle fractions by flow sorting, then processed for chromatin immunoprecipitation (ChIP) assays. We found that c-Myb actively repositions, binding to some genes only in specific cell cycle phases. In addition, the specificity of c-Myb is dramatically different in small subpopulations of cells, for example cells in the G2/M phase of the cell cycle, than in the bulk population. The repositioning of c-Myb during the cell cycle is not due to changes in its expression and also occurs with ectopically expressed, epitope-tagged versions of c-Myb. The repositioning occurs in established cell lines, in primary human CD34+ hematopoietic progenitors and in primary human acute myeloid leukemia cells. The combination of fixation, sorting and ChIP analysis sheds new light on the dynamic nature of gene regulation during the cell cycle and provides a new type of tool for the analysis of gene regulation in small subsets of cells, such as cells in a specific phase of the cell cycle.	[Quintana, Anita M.; Zhou, Ye E.; Pena, Janeth J.; O'Rourke, John P.; Ness, Scott A.] Univ New Mexico, Hlth Sci Ctr, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Quintana, AM (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	ness@unm.edu	Ness, Scott/AAV-4009-2020	Ness, Scott/0000-0001-6965-8909; Quintana, Anita/0000-0002-3596-1587	NIH [5R01CA058443, 5R01CA105257]; NIDDK Core Center of Excellence in Hematology [DK56465];  [5F31HL090024-03]; NATIONAL CANCER INSTITUTE [P30CA118100, R01CA058443, R01CA105257] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL090024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Core Center of Excellence in Hematology; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants 5R01CA058443 and 5R01CA105257 (to SAN). AMQ was partially supported by grant 5F31HL090024-03. Purified CD34+ cells were provided by the Fred Hutchinson Cancer Research Center Large-Scale Cell Processing Core, supported by NIDDK Core Center of Excellence in Hematology grant DK56465. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Bies J, 2000, ONCOGENE, V19, P2846, DOI 10.1038/sj.onc.1203613; Bies J, 2001, BLOOD CELL MOL DIS, V27, P422, DOI 10.1006/bcmd.2001.0400; Boyer LA, 2004, NAT REV MOL CELL BIO, V5, P158, DOI 10.1038/nrm1314; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Clappier E, 2007, BLOOD, V110, P1251, DOI 10.1182/blood-2006-12-064683; Donati G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002066; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Frampton J, 1996, GENE DEV, V10, P2720, DOI 10.1101/gad.10.21.2720; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; Gatta R, 2008, NUCLEIC ACIDS RES, V36, P6592, DOI 10.1093/nar/gkn699; GEWIRTZ AM, 1988, SCIENCE, V242, P1303, DOI 10.1126/science.2461588; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Juan G, 2002, CYTOMETRY, V49, P170, DOI 10.1002/cyto.10173; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Lei WL, 2005, BLOOD, V105, P3855, DOI 10.1182/blood-2004-08-3342; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Nakata Y, 2007, MOL CELL BIOL, V27, P2048, DOI 10.1128/MCB.01100-06; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; Ness SA, 1996, BBA-REV CANCER, V1288, pF123, DOI 10.1016/S0304-419X(96)00027-3; Ness SA, 2003, BLOOD CELL MOL DIS, V31, P192, DOI 10.1016/S1079-9796(03)00151-7; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; O'Rourke JP, 2008, MOL CELL BIOL, V28, P2091, DOI 10.1128/MCB.01870-07; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Panzenbock B, 1998, BLOOD, V92, P3658, DOI 10.1182/blood.V92.10.3658.422k18_3658_3668; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Ratajczak MZ, 1998, BLOOD, V91, P1934, DOI 10.1182/blood.V91.6.1934.1934_1934_1946; Rombouts EJC, 2004, BLOOD, V104, P550, DOI 10.1182/blood-2004-02-0566; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Salsi V, 2003, J BIOL CHEM, V278, P6642, DOI 10.1074/jbc.M210065200; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Vandenbark GR, 1996, CELL GROWTH DIFFER, V7, P1383; Vegiopoulos A, 2006, BLOOD, V107, P4703, DOI 10.1182/blood-2005-07-2968; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhao HW, 2009, BLOOD, V113, P505, DOI 10.1182/blood-2008-01-136218	49	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17362	10.1371/journal.pone.0017362	http://dx.doi.org/10.1371/journal.pone.0017362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364958	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600045
J	Danielsson, A; Dzojic, H; Rashkova, V; Cheng, WS; Essand, M				Danielsson, Angelika; Dzojic, Helena; Rashkova, Victoria; Cheng, Wing-Shing; Essand, Magnus			The HDAC Inhibitor FK228 Enhances Adenoviral Transgene Expression by a Transduction-Independent Mechanism but Does Not Increase Adenovirus Replication	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; REFRACTORY PROSTATE-CANCER; GENE-THERAPY; ONCOLYTIC ADENOVIRUS; SEROTYPE-35 TROPISM; DEPSIPEPTIDE FK228; MALIGNANT-CELLS; VALPROIC ACID; T-CELLS; PROMOTER	The histone deacetylase inhibitor FK228 has previously been shown to enhance adenoviral transgene expression when cells are pre-incubated with the drug. Upregulation of the coxsackie adenovirus receptor (CAR), leading to increased viral transduction, has been proposed as the main mechanism. In the present study, we found that the highest increase in transgene expression was achieved when non-toxic concentrations of FK228 were added immediately after transduction, demonstrating that the main effect by which FK228 enhances transgene expression is transduction-independent. FK228 had positive effects both on Ad5 and Ad5/f35 vectors with a variety of transgenes and promoters, indicating that FK228 works mainly by increasing transgene expression at the transcriptional level. In some cases, the effects were dramatic, as demonstrated by an increase in CD40L expression by FK228 from 0.3% to 62% when the murine prostate cancer cell line TRAMP-C2 was transduced with Ad[ CD40L]. One unexpected finding was that FK228 decreased the transgene expression of an adenoviral vector with the prostate cell-specific PPT promoter in the human prostate adenocarcinoma cell lines LNCaP and PC-346C. This is probably a consequence of alteration of the adenocarcinoma cell lines towards a neuroendocrine differentiation after FK228 treatment. The observations in this study indicate that FK228 enhances adenoviral therapy by a transduction-independent mechanism. Furthermore, since histone deacetylase inhibitors may affect the differentiation of cells, it is important to keep in mind that the activity and specificity of tissue-and tumor-specific promoters may also be affected.	[Danielsson, Angelika; Dzojic, Helena; Rashkova, Victoria; Cheng, Wing-Shing; Essand, Magnus] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University	Danielsson, A (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	angelika.danielsson@igp.uu.se			Swedish Cancer Society [CAN 2007/885, CAN 2009/55]; Swedish Research Council [K2008-68X-15270-04-3]; Gunnar Nilsson's Cancer Foundation [65/09]; European Community [LSHB-CT-2004-512087]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gunnar Nilsson's Cancer Foundation; European Community(European Commission)	This work was supported by funding from The Swedish Cancer Society (Grant CAN 2007/885 and CAN 2009/55), the Swedish Research Council (Grant K2008-68X-15270-04-3), Gunnar Nilsson's Cancer Foundation (Grant 65/09) and the European Community on behalf of GIANT (Grant LSHB-CT-2004-512087). ME is a recipient of the Swedish Cancer Society Senior Investigator Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrd JC, 2005, BLOOD, V105, P959, DOI 10.1182/blood-2004-05-1693; Carlsson B, 2003, BRIT J HAEMATOL, V121, P428, DOI 10.1046/j.1365-2141.2003.04300.x; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Cheng WS, 2006, CANCER GENE THER, V13, P13, DOI 10.1038/sj.cgt.7700881; Cheng WS, 2004, MOL THER, V10, P355, DOI 10.1016/j.ymthe.2004.05.022; Crabb SJ, 2008, BIOCHEM PHARMACOL, V76, P463, DOI 10.1016/j.bcp.2008.06.004; DANIELL E, 1981, MOL CELL BIOL, V1, P1094, DOI 10.1128/MCB.1.12.1094; Danielsson A, 2008, CANCER GENE THER, V15, P203, DOI 10.1038/sj.cgt.7701117; Doi S, 2004, MOL CANCER THER, V3, P1397; Dzojic H, 2006, PROSTATE, V66, P831, DOI 10.1002/pros.20344; Forsberg O, 2008, BRIT J HAEMATOL, V141, P188, DOI 10.1111/j.1365-2141.2008.07026.x; Frigo DE, 2008, MOL CANCER THER, V7, P659, DOI 10.1158/1535-7163.MCT-07-0480; Fukuda Hiroki, 2006, Briefings in Functional Genomics & Proteomics, V5, P190, DOI 10.1093/bfgp/ell032; Goldsmith ME, 2003, CLIN CANCER RES, V9, P5394; Goldsmith ME, 2007, MOL CANCER THER, V6, P496, DOI 10.1158/1535-7163.MCT-06-0431; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hoshino I, 2007, ONCOL REP, V18, P585; Hoti N, 2006, MOL THER, V14, P768, DOI 10.1016/j.ymthe.2006.07.009; Kanzaki M, 2007, ONCOL REP, V17, P761; Kitazono M, 2001, CANCER RES, V61, P6328; Ko D, 2005, ONCOGENE, V24, P7763, DOI 10.1038/sj.onc.1209048; KOMATSU T, 2010, NUCL ACIDS RES; Konstantinopoulos PA, 2006, CANCER CHEMOTH PHARM, V58, P711, DOI 10.1007/s00280-005-0182-5; Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532; Loskog A, 2004, J IMMUNOL, V172, P7200, DOI 10.4049/jimmunol.172.11.7200; Loskog Angelica, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P23; Malmstrom PU, 2010, CLIN CANCER RES, V16, P3279, DOI 10.1158/1078-0432.CCR-10-0385; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Nilsson M, 2004, MOL THER, V9, P377, DOI 10.1016/j.ymthe.2003.12.014; Okegawa T, 2004, ACTA BIOCHIM POL, V51, P445; Pong RC, 2003, CANCER RES, V63, P8680; Pong RC, 2006, CANCER RES, V66, P8822, DOI 10.1158/0008-5472.CAN-05-4672; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Sasaki Y, 2008, MOL CANCER THER, V7, P779, DOI 10.1158/1535-7163.MCT-07-0395; Saukkonen K, 2004, EXPERT OPIN BIOL TH, V4, P683, DOI 10.1517/eobt.4.5.683.31060; SERGEANT A, 1979, J VIROL, V29, P888, DOI 10.1128/JVI.29.3.888-898.1979; Sowa Y, 1999, ANN NY ACAD SCI, V886, P195, DOI 10.1111/j.1749-6632.1999.tb09415.x; TATE VE, 1979, NUCLEIC ACIDS RES, V6, P2769, DOI 10.1093/nar/6.8.2769; Taura K, 2004, J GENE MED, V6, P526, DOI 10.1002/jgm.546; Valentini A, 2007, DRUG METAB DISPOS, V35, P968, DOI 10.1124/dmd.107.014662; Watanabe K, 2005, CELL DEATH DIFFER, V12, P10, DOI 10.1038/sj.cdd.4401507; Watanabe T, 2006, EXP CELL RES, V312, P256, DOI 10.1016/j.yexcr.2005.10.026; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Zhang ZW, 2007, UROLOGY, V70, P396, DOI 10.1016/j.urology.2007.03.052	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14700	10.1371/journal.pone.0014700	http://dx.doi.org/10.1371/journal.pone.0014700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379379	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300006
J	Sharathchandra, RG; Stander, C; Jacobson, D; Ndimba, B; Vivier, MA				Sharathchandra, Ramaschandra G.; Stander, Charmaine; Jacobson, Dan; Ndimba, Bongani; Vivier, Melane A.			Proteomic Analysis of Grape Berry Cell Cultures Reveals that Developmentally Regulated Ripening Related Processes Can Be Studied Using Cultured Cells	PLOS ONE			English	Article							LIQUID-PHASE IEF; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; PROTEIN; OXIDOREDUCTASE; ARABIDOPSIS; ISOFORMS; NITROGEN; BINDING; PLANTS	Background: This work describes a proteomics profiling method, optimized and applied to berry cell suspensions to organ-specific cultures as a platform to study grape berry ripening. Variations in berry ripening within a cluster(s) a vine and in a vineyard are a major impediment towards complete understanding of the functional processes that ripening, specifically when a characterized and homogenous sample is required. Berry cell suspensions could some of these problems, but their suitability as a model system for berry development and ripening needs to be first. Methodology/Principal Findings: In this study we report on the proteomic evaluation of the cytosolic proteins obtained synchronized cell suspension cultures that were established from callus lines originating from green, veraison and ripe vinifera berry explants. The proteins were separated using liquid phase IEF in a Microrotofor cell and SDS PAGE. This proved superior to gel-based 2DE. Principal component analysis confirmed that biological and technical repeats tightly and importantly, showed that the proteomes of berry cultures originating from the different growth/stages were distinct. A total of twenty six common bands were selected after band matching between different stages and twenty two of these bands were positively identified. Thirty two % of the identified proteins are currently as hypothetical. The differential expression profile of the identified proteins, when compared with published on grape berry ripening, suggested common trends in terms of relative abundance in the different developmental between real berries and cell suspensions. Conclusions: The advantages of having suspension cultures that accurately mimic specific developmental stages are and could significantly contribute to the study of the intricate regulatory and signaling networks responsible for development and ripening.	[Sharathchandra, Ramaschandra G.; Stander, Charmaine; Jacobson, Dan; Vivier, Melane A.] Univ Stellenbosch, Inst Wine Biotechnol, Dept Viticulture & Oenol, ZA-7600 Stellenbosch, South Africa; [Ndimba, Bongani] Univ Western Cape, Dept Biotechnol, Prote Res Lab, ZA-7535 Bellville, South Africa	Stellenbosch University; University of the Western Cape	Sharathchandra, RG (corresponding author), Univ Stellenbosch, Inst Wine Biotechnol, Dept Viticulture & Oenol, ZA-7600 Stellenbosch, South Africa.	mav@sun.ac.za		Ramasandra Govind, Sharathchandra/0000-0002-1156-9986; Jacobson, Daniel/0000-0002-9822-8251	Wine Industry Network of Expertise and Technology (Winetech); Table Grape Industry (SATI); National Research Foundation of South Africa; South African Technology and Human Resources for Industry Programme (THRIP); Claude Leon Foundation	Wine Industry Network of Expertise and Technology (Winetech); Table Grape Industry (SATI); National Research Foundation of South Africa(National Research Foundation - South Africa); South African Technology and Human Resources for Industry Programme (THRIP); Claude Leon Foundation	The work was financially supported by the Wine Industry Network of Expertise and Technology (Winetech) and the Table Grape Industry (SATI), the National Research Foundation of South Africa, the South African Technology and Human Resources for Industry Programme (THRIP) and the Claude Leon Foundation. Winetech and SATI are the official overarching coordinators of all research funding of the Wine Industry and Table Grape Industry respectively. None of the funders had any role in the study design, data collection and analysis, or the decision to publish, or the preparation of the manuscript.	Agasse A, 2009, GRAPEVINE MOL PHYSL, P105; Brobey RKB, 2007, PROTEOMICS, V7, P116, DOI 10.1002/pmic.200600587; Buchner P, 2002, PLANT MOL BIOL, V49, P171, DOI 10.1023/A:1014910900312; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; CALDERON AA, 1994, PLANT CELL TISS ORG, V37, P121, DOI 10.1007/BF00043605; Conde C, 2006, PLANT PHYSIOL, V141, P1563, DOI 10.1104/pp.106.080804; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; COOMBE BG, 1992, AM J ENOL VITICULT, V43, P101; Davies C, 2000, PLANT PHYSIOL, V122, P803, DOI 10.1104/pp.122.3.803; Deluc LG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-429; Deytieux C, 2007, J EXP BOT, V58, P1851, DOI 10.1093/jxb/erm049; Faurie B, 2009, J PLANT PHYSIOL, V166, P1863, DOI 10.1016/j.jplph.2009.05.015; Ferri M, 2009, PROTEOMICS, V9, P610, DOI 10.1002/pmic.200800386; Garavaglia BS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-51; Garavaglia BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008950; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gazzana G, 2007, J PROTEOME RES, V6, P3143, DOI 10.1021/pr070097p; GHISI R, 1984, VITIS, V23, P257; Giribaldi M, 2007, PROTEOMICS, V7, P3154, DOI 10.1002/pmic.200600974; Grimplet J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-187; Gummadova JO, 2007, J EXP BOT, V58, P3971, DOI 10.1093/jxb/erm252; Hanke GT, 2005, PLANT CELL ENVIRON, V28, P1146, DOI 10.1111/j.1365-3040.2005.01352.x; HAWKER J S, 1973, Hortscience, V8, P398; Hey Julie, 2008, V424, P225, DOI 10.1007/978-1-60327-064-9_19; Hiratsuka S, 2001, SCI HORTIC-AMSTERDAM, V90, P121, DOI 10.1016/S0304-4238(00)00264-8; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Lashbrooke JG, 2010, AUST J GRAPE WINE R, V16, P349, DOI 10.1111/j.1755-0238.2010.00097.x; Lintala M, 2009, PLANT J, V57, P1103, DOI 10.1111/j.1365-313X.2008.03753.x; Lucker J, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-50; Lund ST, 2008, PLANT MOL BIOL, V68, P301, DOI 10.1007/s11103-008-9371-z; Martinez-Esteso MJ, 2009, J PROTEOMICS, V73, P331, DOI 10.1016/j.jprot.2009.10.001; Mechin V, 2004, PHYTOCHEMISTRY, V65, P1609, DOI 10.1016/j.phytochem.2004.04.035; METZGER GH, 2000, PATHOGENESIS RELATED, P48; Miller RNG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-15; Monteiro S, 2007, PHYTOCHEMISTRY, V68, P416, DOI 10.1016/j.phytochem.2006.11.014; Moser C., 2005, Functional & Integrative Genomics, V5, P208, DOI 10.1007/s10142-005-0143-4; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Rao SR, 2002, BIOTECHNOL ADV, V20, P101, DOI 10.1016/S0734-9750(02)00007-1; Robinson S. P., 2000, Australian Journal of Grape and Wine Research, V6, P175, DOI 10.1111/j.1755-0238.2000.tb00177.x; Rogalski M, 2008, PLANT CELL, V20, P2221, DOI 10.1105/tpc.108.060392; Sarry JE, 2004, PROTEOMICS, V4, P201, DOI 10.1002/pmic.200300499; Seshi B, 2007, PROTEOMICS, V7, P1984, DOI 10.1002/pmic.200600868; Sormo CG, 2006, PHYTOCHEMISTRY, V67, P2332, DOI 10.1016/j.phytochem.2006.08.011; Sweetman C, 2009, PHYTOCHEMISTRY, V70, P1329, DOI 10.1016/j.phytochem.2009.08.006; Takabayashi A, 2005, P NATL ACAD SCI USA, V102, P16898, DOI 10.1073/pnas.0507095102; TAUREILLESSAUREL C, 1995, AM J ENOL VITICULT, V46, P29; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; Thelen JJ, 2007, PLANT CELL, V19, P3339, DOI 10.1105/tpc.107.053991; Vincent D, 2006, ELECTROPHORESIS, V27, P1853, DOI 10.1002/elps.200500698; Vincent D, 2009, ELECTROPHORESIS, V30, P4118, DOI 10.1002/elps.200900415; Vitrac X, 2000, PHYTOCHEMISTRY, V53, P659, DOI 10.1016/S0031-9422(99)00620-2; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang W, 2009, ACTA PHYSIOL PLANT, V31, P597, DOI 10.1007/s11738-008-0269-9; Yuksel B, 2008, J EXP BOT, V59, P3831, DOI 10.1093/jxb/ern223; Zhang JW, 2008, J EXP BOT, V59, P2979, DOI 10.1093/jxb/ern156; Zuo X, 2000, ANAL BIOCHEM, V284, P266, DOI 10.1006/abio.2000.4714	57	19	19	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14708	10.1371/journal.pone.0014708	http://dx.doi.org/10.1371/journal.pone.0014708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379583	Green Published, gold			2022-12-27	WOS:000287482300009
J	Konyukh, M; Delorme, R; Chaste, P; Leblond, C; Lemiere, N; Nygren, G; Anckarsater, H; Rastam, M; Stahlberg, O; Amsellem, F; Gillberg, C; Mouren-Simeoni, MC; Herbrecht, E; Fauchereau, F; Toro, R; Gillberg, C; Leboyer, M; Bourgeron, T				Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Nygren, Gudrun; Anckarsater, Henrik; Rastam, Maria; Stahlberg, Ola; Amsellem, Frederique; Gillberg, Carina; Mouren-Simeoni, Marie Christine; Herbrecht, Evelyn; Fauchereau, Fabien; Toro, Roberto; Gillberg, Christopher; Leboyer, Marion; Bourgeron, Thomas			Variations of the Candidate SEZ6L2 Gene on Chromosome 16p11.2 in Patients with Autism Spectrum Disorders and in Human Populations	PLOS ONE			English	Article							MICRODELETION; MUTATIONS	Background: Autism spectrum disorders (ASD) are a group of severe childhood neurodevelopmental disorders with still unknown etiology. One of the most frequently reported associations is the presence of recurrent de novo or inherited microdeletions and microduplications on chromosome 16p11.2. The analysis of rare variations of 8 candidate genes among the 27 genes located in this region suggested SEZ6L2 as a compelling candidate. Methodology/Principal Findings: We further explored the role of SEZ6L2 variations by screening its coding part in a group of 452 individuals, including 170 patients with ASD and 282 individuals from different ethnic backgrounds of the Human Genome Diversity Panel (HGDP), complementing the previously reported screening. We detected 7 previously unidentified non-synonymous variations of SEZ6L2 in ASD patients. We also identified 6 non-synonymous variations present only in HGDP. When we merged our results with the previously published, no enrichment of non-synonymous variation in SEZ6L2 was observed in the ASD group compared with controls. Conclusions/Significance: Our results provide an extensive ascertainment of the genetic variability of SEZ6L2 in human populations and do not support a major role for SEZ6L2 sequence variations in the susceptibility to ASD.	[Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Fauchereau, Fabien; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, Paris, France; [Konyukh, Marina; Delorme, Richard; Chaste, Pauline; Leblond, Claire; Lemiere, Nathalie; Fauchereau, Fabien; Toro, Roberto; Bourgeron, Thomas] Inst Pasteur, CNRS, URA 2182, Paris, France; [Delorme, Richard; Chaste, Pauline; Amsellem, Frederique; Mouren-Simeoni, Marie Christine] Hop Robert Debre, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Delorme, Richard; Chaste, Pauline; Amsellem, Frederique; Gillberg, Christopher] INSERM, IMRB, Dept Med Genom, Psychiat Genet team,U 995, Creteil, France; [Nygren, Gudrun; Anckarsater, Henrik; Stahlberg, Ola; Gillberg, Carina] Univ Gothenburg, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; [Anckarsater, Henrik] Lund Univ, Inst Clin Sci, Malmo, Sweden; [Rastam, Maria] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Herbrecht, Evelyn; Leboyer, Marion] Univ Paris Est Creteil, Fac Med, IFR10, Creteil, France; [Herbrecht, Evelyn; Leboyer, Marion] Henri Mondor Albert Chenevier Hosp, AP HP, Creteil, France; [Herbrecht, Evelyn; Leboyer, Marion; Bourgeron, Thomas] French Natl Sci Fdn, Creteil, France; [Fauchereau, Fabien; Bourgeron, Thomas] Univ Denis Diderot Paris 7, Paris, France; [Gillberg, Christopher] St Georges Hosp Med Sch, London, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Gothenburg; Lund University; Lund University; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Universite Paris Cite; St Georges University London	Konyukh, M (corresponding author), Inst Pasteur, Paris, France.	thomasb@pasteur.fr	Leboyer, Marion/AAW-3648-2021	Leboyer, Marion/0000-0001-5473-3697; Bourgeron, Thomas/0000-0001-8164-9220; Delorme, Richard/0000-0002-5614-3663; Toro, Roberto/0000-0002-6671-858X	Institut Pasteur; INSERM; CNRS; University Denis Diderot Paris 7; ANR; Fondation FondaMentale; PHRC; Fondation Orange	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); University Denis Diderot Paris 7; ANR(French National Research Agency (ANR)); Fondation FondaMentale; PHRC; Fondation Orange	The Institut Pasteur, INSERM, CNRS, University Denis Diderot Paris 7, ANR, Fondation FondaMentale, PHRC and Fondation Orange supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Cann HM, 2002, SCIENCE, V296, P261; Fernell E, 2010, RES DEV DISABIL, V31, P680, DOI 10.1016/j.ridd.2010.01.007; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; GILLBERG C, 2009, J AUTISM DEV DISORD; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kumar RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004582; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Toro R, 2010, TRENDS GENE IN PRESS; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9	17	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17289	10.1371/journal.pone.0017289	http://dx.doi.org/10.1371/journal.pone.0017289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394203	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500007
J	Ochola, LB; Siddondo, BR; Ocholla, H; Nkya, S; Kimani, EN; Williams, TN; Makale, JO; Liljander, A; Urban, BC; Bull, PC; Szestak, T; Marsh, K; Craig, AG				Ochola, Lucy B.; Siddondo, Bethsheba R.; Ocholla, Harold; Nkya, Siana; Kimani, Eva N.; Williams, Thomas N.; Makale, Johnstone O.; Liljander, Anne; Urban, Britta C.; Bull, Pete C.; Szestak, Tadge; Marsh, Kevin; Craig, Alister G.			Specific Receptor Usage in Plasmodium falciparum Cytoadherence Is Associated with Disease Outcome	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INFECTED ERYTHROCYTES; SEVERE MALARIA; CHONDROITIN SULFATE; CEREBRAL MALARIA; PARASITIZED ERYTHROCYTES; RHINOVIRUS SEROTYPES; CLINICAL-DISEASE; SURFACE-ANTIGENS; IN-VITRO	Our understanding of the basis of severe disease in malaria is incomplete. It is clear that pathology is in part related to the pro-inflammatory nature of the host response but a number of other factors are also thought to be involved, including the interaction between infected erythrocytes and endothelium. This is a complex system involving several host receptors and a major parasite-derived variant antigen (PfEMP1) expressed on the surface of the infected erythrocyte membrane. Previous studies have suggested a role for ICAM-1 in the pathology of cerebral malaria, although these have been inconclusive. In this study we have examined the cytoadherence patterns of 101 patient isolates from varying clinical syndromes to CD36 and ICAM-1, and have used variant ICAM-1 proteins to further characterise this adhesive phenotype. Our results show that increased binding to CD36 is associated with uncomplicated malaria while ICAM-1 adhesion is raised in parasites from cerebral malaria cases.	[Ochola, Lucy B.; Siddondo, Bethsheba R.; Ocholla, Harold; Kimani, Eva N.; Williams, Thomas N.; Makale, Johnstone O.; Urban, Britta C.; Bull, Pete C.; Marsh, Kevin] Ctr Geog Med Res, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Urban, Britta C.; Szestak, Tadge; Craig, Alister G.] Univ Liverpool, Liverpool Sch Trop Med, Dept Mol Parasitol, Liverpool L3 5QA, Merseyside, England; [Nkya, Siana] Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Liljander, Anne] Karolinska Inst, Dept Med, Stockholm, Sweden; [Bull, Pete C.; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Williams, Thomas N.] Univ Oxford, Dept Pediat, Oxford, England	Liverpool School of Tropical Medicine; University of Liverpool; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; University of Oxford; University of Oxford	Ochola, LB (corresponding author), Ctr Geog Med Res, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya.	laochola@gmail.com	Urban, Britta/W-6087-2018	Urban, Britta/0000-0002-4197-8393; Bull, Peter/0000-0002-7674-6752; Ochola, Lucy/0000-0003-0264-5526; Craig, Alister/0000-0003-0914-6164; Nkya, Siana/0000-0001-7576-6279	UK Medical Research Council [70959]; Wellcome Trust [084535]; MRC [G0400417] Funding Source: UKRI; Medical Research Council [G0400417] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (Research Grant 70959) and the Wellcome Trust (Research Grant 084535). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams S, 2000, INFECT IMMUN, V68, P264, DOI 10.1128/IAI.68.1.264-269.2000; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; AlYaman F, 1997, PARASITE IMMUNOL, V19, P207, DOI 10.1046/j.1365-3024.1997.d01-198.x; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bellamy R, 1998, T ROY SOC TROP MED H, V92, P312, DOI 10.1016/S0035-9203(98)91026-4; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Biswas AK, 2007, PLOS PATHOG, V3, P1271, DOI 10.1371/journal.ppat.0030130; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; Bull PC, 2000, J INFECT DIS, V182, P252, DOI 10.1086/315652; Bull PC, 1999, INFECT IMMUN, V67, P733, DOI 10.1128/IAI.67.2.733-739.1999; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; CHAIYAROJ SC, 1994, P NATL ACAD SCI USA, V91, P10805, DOI 10.1073/pnas.91.23.10805; Chakravorty SJ, 2005, EUR J CELL BIOL, V84, P15, DOI 10.1016/j.ejcb.2004.09.002; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chilongola J, 2009, TROP MED INT HEALTH, V14, P810, DOI 10.1111/j.1365-3156.2009.02298.x; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Chong SS, 2000, BLOOD, V95, P360; Cojean S, 2008, PARASITE, V15, P163, DOI 10.1051/parasite/2008152163; COOKE BM, 1994, BRIT J HAEMATOL, V87, P162, DOI 10.1111/j.1365-2141.1994.tb04887.x; Craig A, 2000, HUM MOL GENET, V9, P525, DOI 10.1093/hmg/9.4.525; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; Degen R, 2000, EXP PARASITOL, V95, P113, DOI 10.1006/expr.2000.4512; Elliott SR, 2007, INFECT IMMUN, V75, P3621, DOI 10.1128/IAI.00095-07; ENGELBRECHT F, 1995, EXP PARASITOL, V81, P90, DOI 10.1006/expr.1995.1096; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feng GQ, 2009, J INFECT DIS, V200, P299, DOI 10.1086/599841; FernandezReyes D, 1997, HUM MOL GENET, V6, P1357, DOI 10.1093/hmg/6.8.1357; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gray C, 2003, MOL BIOCHEM PARASIT, V128, P187, DOI 10.1016/S0166-6851(03)00075-6; Gray C, 2002, INFECT IMMUN, V70, P3962, DOI 10.1128/IAI.70.7.3962-3964.2002; GREENWALT DE, 1992, BLOOD, V80, P1105; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Ho M, 1998, BLOOD, V91, P4803, DOI 10.1182/blood.V91.12.4803.412k30_4803_4809; HO M, 1991, INFECT IMMUN, V59, P873, DOI 10.1128/IAI.59.3.873-878.1991; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Horata N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-184; Jenkins NE, 2005, CLIN INFECT DIS, V41, P1817, DOI 10.1086/498156; Klein MM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000147; Kolatkar PR, 1999, EMBO J, V18, P6249, DOI 10.1093/emboj/18.22.6249; Kun JFJ, 1999, AM J TROP MED HYG, V61, P776, DOI 10.4269/ajtmh.1999.61.776; Kyriacou HM, 2006, MOL BIOCHEM PARASIT, V150, P211, DOI 10.1016/j.molbiopara.2006.08.005; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Marsh K, 1997, PHILOS T R SOC B, V352, P1385, DOI 10.1098/rstb.1997.0124; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Maubert B, 2000, PARASITE IMMUNOL, V22, P191, DOI 10.1046/j.1365-3024.2000.00292.x; McCormick CJ, 1997, J CLIN INVEST, V100, P2521, DOI 10.1172/JCI119794; McGilvray ID, 2000, BLOOD, V96, P3231, DOI 10.1182/blood.V96.9.3231; Meerman L, 2005, J INFECT DIS, V192, P1651, DOI 10.1086/496887; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mo M, 2008, INFECT IMMUN, V76, P1837, DOI 10.1128/IAI.00480-07; MOLYNEUX ME, 1989, Q J MED, V71, P441; Montgomery J, 2007, MOL MICROBIOL, V65, P959, DOI 10.1111/j.1365-2958.2007.05837.x; Newbold C, 1997, AM J TROP MED HYG, V57, P389, DOI 10.4269/ajtmh.1997.57.389; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; OCKENHOUSE CF, 1992, CELL, V68, P63, DOI 10.1016/0092-8674(92)90206-R; OCKENHOUSE CF, 1989, J CLIN INVEST, V84, P468, DOI 10.1172/JCI114188; Pain A, 2001, LANCET, V357, P1502, DOI 10.1016/S0140-6736(00)04662-6; Pradhan P, 2009, J VECTOR DIS, V46, P100; REEDER JC, 1994, AM J TROP MED HYG, V51, P45, DOI 10.4269/ajtmh.1994.51.45; Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198; Roberts DJ, 2003, REDOX REP, V8, P304, DOI 10.1179/135100003225002998; ROBERTS DJ, 1992, NATURE, V357, P689, DOI 10.1038/357689a0; Rogerson SJ, 1999, AM J TROP MED HYG, V61, P467, DOI 10.4269/ajtmh.1999.61.467; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2000, J IMMUNOL, V165, P6341, DOI 10.4049/jimmunol.165.11.6341; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Serghides L, 2001, J IMMUNOL, V166, P6742, DOI 10.4049/jimmunol.166.11.6742; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Smith JD, 2000, P NATL ACAD SCI USA, V97, P1766, DOI 10.1073/pnas.040545897; Smith TG, 2003, INFECT IMMUN, V71, P393, DOI 10.1128/IAI.71.1.393-400.2003; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Staalsoe T, 2001, J INFECT DIS, V184, P618, DOI 10.1086/322809; Toure FS, 2007, CLIN MED RES, V5, P106, DOI 10.3121/cmr.2007.696; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tse MT, 2004, MOL MICROBIOL, V51, P1039, DOI 10.1046/j.1365-2958.2003.03895.x; TURNER GDH, 1994, AM J PATHOL, V145, P1057; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Waitumbi JN, 2000, BLOOD, V95, P1481, DOI 10.1182/blood.V95.4.1481.004k15_1481_1486; Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119; Xiao C, 2004, J VIROL, V78, P10034, DOI 10.1128/JVI.78.18.10034-10044.2004	95	88	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14741	10.1371/journal.pone.0014741	http://dx.doi.org/10.1371/journal.pone.0014741			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390226	Green Published, Green Accepted, gold			2022-12-27	WOS:000287965200001
J	Lai, YL; Qiao, M; Song, MH; Weintraub, ST; Shiio, Y				Lai, Yanlai; Qiao, Mei; Song, Meihua; Weintraub, Susan T.; Shiio, Yuzuru			Quantitative Proteomics Identifies the Myb-Binding Protein p160 as a Novel Target of the von Hippel-Lindau Tumor Suppressor	PLOS ONE			English	Article							CODED AFFINITY TAGS; RNA-POLYMERASE-II; TANDEM MASS-SPECTROMETRY; CELL CARCINOMA-CELLS; STATISTICAL-MODEL; LARGE SUBUNIT; HIF2A GENE; APOPTOSIS; TRANSACTIVATION; UBIQUITINATION	Background: The von Hippel-Lindau (VHL) tumor suppressor gene encodes a component of a ubiquitin ligase complex, which is best understood as a negative regulator of hypoxia inducible factor (HIF). VHL ubiquitinates and degrades the a subunits of HIF, and this is proposed to suppress tumorigenesis and tumor angiogenesis. However, several lines of evidence suggest that there are unidentified substrates or targets for VHL that play important roles in tumor suppression. Methodology/Principal Findings: Employing quantitative proteomics, we developed an approach to systematically identify the substrates of ubiquitin ligases and using this method, we identified the Myb-binding protein p160 as a novel substrate of VHL. Conclusions/Significance: A major barrier to understanding the functions of ubiquitin ligases has been the difficulty in pinpointing their ubiquitination substrates. The quantitative proteomics approach we devised for the identification of VHL substrates will be widely applicable to other ubiquitin ligases.	[Lai, Yanlai; Qiao, Mei; Song, Meihua; Shiio, Yuzuru] Greehey Childrens Canc Res Inst, San Antonio, TX USA; [Weintraub, Susan T.; Shiio, Yuzuru] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Lai, YL (corresponding author), Greehey Childrens Canc Res Inst, San Antonio, TX USA.	shiio@uthscsa.edu			National Institutes of Health [R01CA125020, P30CA54174]; National Heart, Blood, and Lung Institute [N01-HV-28179]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA054174, R01CA125020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants R01CA125020 (to YS) and P30CA54174 (San Antonio Cancer Institute - Mass Spectrometry Core) and by federal funding from the National Heart, Blood, and Lung Institute under Contract N01-HV-28179 (Seattle Proteome Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RE, 2004, TRENDS MOL MED, V10, P466, DOI 10.1016/j.molmed.2004.07.008; Bishop T, 2004, PLOS BIOL, V2, P1549, DOI 10.1371/journal.pbio.0020289; CHOI SM, 2006, J BIOL CHEM; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Czyzyk-Krzeska MF, 2004, TRENDS MOL MED, V10, P146, DOI 10.1016/j.molmed.2004.02.004; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han DK, 2001, NAT BIOTECHNOL, V19, P946, DOI 10.1038/nbt1001-946; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim M, 2004, BIOCHEM BIOPH RES CO, V320, P945, DOI 10.1016/j.bbrc.2004.06.042; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kuznetsova AV, 2003, P NATL ACAD SCI USA, V100, P2706, DOI 10.1073/pnas.0436037100; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li XJ, 2003, ANAL CHEM, V75, P6648, DOI 10.1021/ac034633i; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Morrish F, 2003, GENE DEV, V17, P240, DOI 10.1101/gad.1032503; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Qi H, 2003, CANCER RES, V63, P7076; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; Shiio Y, 2003, J AM SOC MASS SPECTR, V14, P696, DOI 10.1016/S1044-0305(03)00204-6; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Shiio Y, 2006, NAT PROTOC, V1, P139, DOI 10.1038/nprot.2006.22; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989	37	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16975	10.1371/journal.pone.0016975	http://dx.doi.org/10.1371/journal.pone.0016975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386990	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400016
J	Gillum, LA; Gouveia, C; Dorsey, ER; Pletcher, M; Mathers, CD; McCulloch, CE; Johnston, SC				Gillum, Leslie A.; Gouveia, Christopher; Dorsey, E. Ray; Pletcher, Mark; Mathers, Colin D.; McCulloch, Charles E.; Johnston, S. Claiborne			NIH Disease Funding Levels and Burden of Disease	PLOS ONE			English	Article							INSTITUTES-OF-HEALTH; FINANCIAL ANATOMY; PUBLIC-HEALTH; GLOBAL BURDEN; QUALITY	Background: An analysis of NIH funding in 1996 found that the strongest predictor of funding, disability-adjusted life-years (DALYs), explained only 39% of the variance in funding. In 1998, Congress requested that the Institute of Medicine (IOM) evaluate priority-setting criteria for NIH funding; the IOM recommended greater consideration of disease burden. We examined whether the association between current burden and funding has changed since that time. Methods: We analyzed public data on 2006 NIH funding for 29 common conditions. Measures of US disease burden in 2004 were obtained from the World Health Organization's Global Burden of Disease study and national databases. We assessed the relationship between disease burden and NIH funding dollars in univariate and multivariable log-linear models that evaluated all measures of disease burden. Sensitivity analyses examined associations with future US burden, current and future measures of world disease burden, and a newly standardized NIH accounting method. Results: In univariate and multivariable analyses, disease-specific NIH funding levels increased with burden of disease measured in DALYs (p = 0.001), which accounted for 33% of funding level variation. No other factor predicted funding in multivariable models. Conditions receiving the most funding greater than expected based on disease burden were AIDS ($2474 M), diabetes mellitus ($390 M), and perinatal conditions ($297 M). Depression ($719 M), injuries ($691 M), and chronic obstructive pulmonary disease ($613 M) were the most underfunded. Results were similar using estimates of future US burden, current and future world disease burden, and alternate NIH accounting methods. Conclusions: Current levels of NIH disease-specific research funding correlate modestly with US disease burden, and correlation has not improved in the last decade.	[Gillum, Leslie A.; Gouveia, Christopher; Johnston, S. Claiborne] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Pletcher, Mark; McCulloch, Charles E.; Johnston, S. Claiborne] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Dorsey, E. Ray] Johns Hopkins Univ, Med Ctr, Dept Neurol, Baltimore, MD 21218 USA; [Mathers, Colin D.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; World Health Organization	Gillum, LA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	Clay.johnston@ucsfmedctr.org		Mathers, Colin/0000-0002-0617-6731	NIH/NCRR/OD UCSF-CTSI [KL2 RR024130]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130, KL2RR024136] Funding Source: NIH RePORTER	NIH/NCRR/OD UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by NIH/NCRR/OD UCSF-CTSI grant KL2 RR024130. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2005, INTR HCUP NAT INP SA; [Anonymous], INV HLTH RES DEV; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BRADU D, 1970, J AM STAT ASSOC, V65, P198, DOI 10.2307/2283587; BURNS L, 2009, BIOPH SECT IMP US EC; *CHAR NAV, 2006, YOUR GUID INT GIV; *DEP VET AFF, 2006, FISC YEAR 2006 PERF; Dorsey ER, 2006, ANN NEUROL, V60, P652, DOI 10.1002/ana.21047; *EUR SCI FDN, 2007, PRES STAT FUT STRAT; Friedman Marc, 2008, pXVII; Gitterman DP, 2008, PEDIATR RES, V64, P462, DOI 10.1203/PDR.0b013e31818912fd; GOLDBERGER AS, 1968, ECONOMETRICA, V36, P464, DOI 10.2307/1909517; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; *HEALTHC COST UT P, 2008, HCUPNET NAT STAT HOS; *I MED, 1998, SCI OPP PUBL NEEDS I; Johnston SC, 2006, LANCET, V367, P1319, DOI 10.1016/S0140-6736(06)68578-4; Katz DA, 2004, JNCI-J NATL CANCER I, V96, P594, DOI 10.1093/jnci/djh103; Lichtenberg FR, 1999, ALLOCATION PUBLIC FU; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lopez AD, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-5; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; MORROW RH, 1995, AM J PUBLIC HEALTH, V85, P1356, DOI 10.2105/AJPH.85.10.1356; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Murray C.J.L., 1996, HARVARD SCH PUBLIC H; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Nahin RL, 2005, FASEB J, V19, P1209, DOI 10.1096/fj.05-3727LFE; *NAT CTR BIOT INF, 2008, PUBMED CENTR; *NAT CTR HLTH STAT, 2008, AMB HLTH CAR DAT NAT; *NAT I ALL INF DIS, 2006, FISC YEAR 2007 BUDG; *NAT I NEUR DIS ST, 2009, GRANT OPP COMP EFF R; *NAT SCI FDN, 2007, 07323 NSF; National Institutes of Health, 1993, NIH PUBL; *NIH, NIH OFF BUDG NIH APP; *NIH, 2007, NIH DIR SEL AM KRENS; *NIH, 2008, EST FUND VAR DIS CON; *NIH, 2008, NIH CAR AW FUND 1998; *NIH ALM, 2008, NAT I DIAB DIG KIDN; Saha S, 2003, J MED LIBR ASSOC, V91, P42; *US FDA, 2008, RFAFD08001 US FDA; *US PAT TRAD OFF, 2008, USPTO PAT FULL TEXT; Varmus H, 1999, NEW ENGL J MED, V340, P1914, DOI 10.1056/NEJM199906173402411; *WHO, 2006, GLOB BURD DIS CAUS C; World Health Organization, 2008, GLOB BURD DIS 2004 U; 2008, LEXISNEXIS NEWS; 2008, VANDERBILT TELEVISIO	46	146	146	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16837	10.1371/journal.pone.0016837	http://dx.doi.org/10.1371/journal.pone.0016837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383981	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700015
J	Ohyashiki, K; Umezu, T; Yoshizawa, S; Ito, Y; Ohyashiki, M; Kawashima, H; Tanaka, M; Kuroda, M; Ohyashiki, JH				Ohyashiki, Kazuma; Umezu, Tomohiro; Yoshizawa, Sei-ichiro; Ito, Yoshikazu; Ohyashiki, Michiyo; Kawashima, Hisashi; Tanaka, Masami; Kuroda, Masahiko; Ohyashiki, Junko H.			Clinical Impact of Down-Regulated Plasma miR-92a Levels in Non-Hodgkin's Lymphoma	PLOS ONE			English	Article							CIRCULATING MICRORNAS; RESPONSE CRITERIA; EXPRESSION; MIR-17-92; CLUSTER; MYC; ANGIOGENESIS; POLYCISTRON; MECHANISM; SERUM	Background: We undertook a study to evaluate the clinical relevance of miR-92a in plasma obtained from non-Hodgkin's lymphoma (NHL) patients, because the miR-17-92 polycistronic miRNA cluster plays a crucial role in lymphomagenesis and affects neo-angiogenesis. Methodology/Principal Findings: Plasma miR-92a values in NHL were extremely low (< 5%), compared with healthy subjects (P <.0001), irrespective of lymphoma sub-type. The very low plasma level of miR-92a increased in the complete response (CR) phase but did not reach the normal range, and the plasma level was lower again in the relapse phase. Patients in CR or CR unconfirmed with a plasma miR-92a level of less than the cut-off level showed a significantly high relapse rate compared with patients with normalized plasma miR-92a level. Conclusions/Significance: The current results therefore indicate that the plasma miR-92a value could be a novel biomarker not only for diagnosis but also for monitoring lymphoma patients after chemotherapy.	[Ohyashiki, Kazuma; Umezu, Tomohiro; Yoshizawa, Sei-ichiro; Ito, Yoshikazu; Ohyashiki, Michiyo] Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan; [Kawashima, Hisashi] Tokyo Med Univ, Dept Pediat, Tokyo, Japan; [Tanaka, Masami; Kuroda, Masahiko] Tokyo Med Univ, Dept Mol Pathol, Tokyo, Japan; [Ohyashiki, Junko H.] Tokyo Med Univ, Intractable Dis Res Ctr, Tokyo, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Ohyashiki, K (corresponding author), Tokyo Med Univ, Dept Internal Med 1, Div Hematol, Tokyo, Japan.	ohyashik@rr.iij4u.or.jp	Umezu, Tomohiro/AAK-9711-2020	Umezu, Tomohiro/0000-0002-0123-8921	MEXT (Ministry of Education, Culture, Sports, and Science), Japan	MEXT (Ministry of Education, Culture, Sports, and Science), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the "Private University Strategic Research Based Support Project: Epigenetics Research Project Aimed at General Cancer Cure Using Epigenetic Targets" from MEXT (Ministry of Education, Culture, Sports, and Science), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Giuliani N, 2003, BLOOD, V102, P638, DOI 10.1182/blood-2002-10-3257; Han L, 2007, CANCER BIOL THER, V6, P1284; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Inomata M, 2009, BLOOD, V113, P396, DOI 10.1182/blood-2008-07-163907; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Koster A, 2005, CURR OPIN ONCOL, V17, P611, DOI 10.1097/01.cco.0000181404.83084.b5; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nagel S, 2009, LEUKEMIA LYMPHOMA, V50, P101, DOI 10.1080/10428190802626632; Navarro A, 2009, CANCER RES, V69, P7071, DOI 10.1158/0008-5472.CAN-09-1095; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Sasaki K, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-17; Shigoka M, 2010, PATHOL INT, V60, P351, DOI 10.1111/j.1440-1827.2010.02526.x; Tagawa H, 2007, CANCER SCI, V98, P1482, DOI 10.1111/j.1349-7006.2007.00531.x; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Zhang J, 2009, BLOOD, V113, P4586, DOI 10.1182/blood-2008-09-178186	40	77	84	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16408	10.1371/journal.pone.0016408	http://dx.doi.org/10.1371/journal.pone.0016408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383985	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700009
J	Wheeler, DW; Thompson, AJ; Corletto, F; Reckless, J; Loke, JCT; Lapaque, N; Grant, AJ; Mastroeni, P; Grainger, DJ; Padgett, CL; O'Brien, JA; Miller, NGA; Trowsdale, J; Lummis, SCR; Menon, DK; Beech, JS				Wheeler, Daniel W.; Thompson, Andrew J.; Corletto, Federico; Reckless, Jill; Loke, Justin C. T.; Lapaque, Nicolas; Grant, Andrew J.; Mastroeni, Pietro; Grainger, David J.; Padgett, Claire L.; O'Brien, John A.; Miller, Nigel G. A.; Trowsdale, John; Lummis, Sarah C. R.; Menon, David K.; Beech, John S.			Anaesthetic Impairment of Immune Function Is Mediated via GABA(A) Receptors	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; OF-THE-LITERATURE; MECHANICAL VENTILATION; BINDING-SITE; IN-VITRO; PROPOFOL; BENZODIAZEPINES; PHAGOCYTOSIS; SUPPRESSION; INHIBITION	Background: GABA(A) receptors are members of the Cys-loop family of neurotransmitter receptors, proteins which are responsible for fast synaptic transmission, and are the site of action of wide range of drugs [1]. Recent work has shown that Cys-loop receptors are present on immune cells, but their physiological roles and the effects of drugs that modify their function in the innate immune system are currently unclear [2]. We are interested in how and why anaesthetics increase infections in intensive care patients; a serious problem as more than 50% of patients with severe sepsis will die [3-6]. As many anaesthetics act via GABA(A) receptors [7], the aim of this study was to determine if these receptors are present on immune cells, and could play a role in immunocompromising patients. Principal Findings: We demonstrate, using RT-PCR, that monocytes express GABA(A) receptors constructed of alpha 1, alpha 4, beta 2, gamma 1 and/or delta subunits. Whole cell patch clamp electrophysiological studies show that GABA can activate these receptors, resulting in the opening of a chloride-selective channel; activation is inhibited by the GABA(A) receptor antagonists bicuculline and picrotoxin, but not enhanced by the positive modulator diazepam. The anaesthetic drugs propofol and thiopental, which can act via GABA(A) receptors, impaired monocyte function in classic immunological chemotaxis and phagocytosis assays, an effect reversed by bicuculline and picrotoxin. Significance: Our results show that functional GABA(A) receptors are present on monocytes with properties similar to CNS GABA(A) receptors. The functional data provide a possible explanation as to why chronic propofol and thiopental administration can increase the risk of infection in critically ill patients: their action on GABA(A) receptors inhibits normal monocyte behaviour. The data also suggest a potential solution: monocyte GABA(A) receptors are insensitive to diazepam, thus the use of benzodiazepines as an alternative anesthetising agent may be advantageous where infection is a life threatening problem.	[Wheeler, Daniel W.; Corletto, Federico; Loke, Justin C. T.; Menon, David K.; Beech, John S.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England; [Thompson, Andrew J.; Padgett, Claire L.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge CB2 2QQ, England; [Reckless, Jill; Grainger, David J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Lapaque, Nicolas; Miller, Nigel G. A.; Trowsdale, John] Univ Cambridge, Dept Pathol, Cambridge CB2 2QQ, England; [Grant, Andrew J.; Mastroeni, Pietro] Univ Cambridge, Dept Vet Med, Cambridge CB2 2QQ, England; [O'Brien, John A.; Lummis, Sarah C. R.] MRC Lab Mol Biol, Div Neurobiol, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; MRC Laboratory Molecular Biology	Wheeler, DW (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge CB2 2QQ, England.	sl120@mole.bio.cam.ac.uk	Lapaque, Nicolas/D-5377-2014; Wheeler, Daniel/A-8690-2008; Lapaque, Nicolas/AAB-4530-2021; Wheeler, Daniel/L-8609-2019	Lapaque, Nicolas/0000-0003-0824-0108; Lapaque, Nicolas/0000-0003-0824-0108; Loke, Justin/0000-0002-0725-069X; Mastroeni, Pietro/0000-0003-3838-4962; Thompson, Andrew/0000-0002-7046-6792; Wheeler, Daniel/0000-0001-7692-6887; Corletto, Federico/0000-0003-2396-4278	Medical Research Council [79588]; Wellcome Trust [08195]; Association of Anaesthetists of Ireland; Biotechnology and Biological Sciences Research Council; Royal College of Anaesthetists; Queen's College, Cambridge; Evelyn Trust; Association of Anaesthetists of Great Britain; Medical Research Council [G84/6409, G9800943, G0001354B, G0401569, G1000183B, G0001354, G0801161, MC_U105184294] Funding Source: researchfish; MRC [G9800943, G84/6409, G0801161, MC_U105184294, G0401569] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Association of Anaesthetists of Ireland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal College of Anaesthetists; Queen's College, Cambridge; Evelyn Trust; Association of Anaesthetists of Great Britain; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (DW, JAOB, DKM, JSB): JSB, DKM: grant number 79588, the Wellcome Trust (FC, AJT, PM, SCRL, DKM) SCRL: grant number 08195, the Association of Anaesthetists of Great Britain and Ireland (DWW), Biotechnology and Biological Sciences Research Council (AJG), Royal College of Anaesthetists (DKM), Queen's College, Cambridge (DKM), the Evelyn Trust (DKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam S, 2006, MOL IMMUNOL, V43, P1432, DOI 10.1016/j.molimm.2005.07.025; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Cestari IN, 1996, NEUROREPORT, V7, P943, DOI 10.1097/00001756-199603220-00023; Cordato DJ, 2001, ANAESTH INTENS CARE, V29, P339, DOI 10.1177/0310057X0102900403; Dawidowicz AL, 2006, CHEM-BIOL INTERACT, V159, P149, DOI 10.1016/j.cbi.2005.10.108; DENEYNDEN JV, 2009, FRONT MOL NEUROSCI, V2, P9; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Ferrer NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012978; Fraser GL, 2007, CURR OPIN ANESTHESIO, V20, P119, DOI 10.1097/ACO.0b013e32808255b4; Frow EK, 2004, MED RES REV, V24, P267, DOI 10.1002/med.10062; GOLDFARB G, 1984, ANESTHESIOLOGY, V60, P57, DOI 10.1097/00000542-198401000-00011; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; HASLETT C, 1985, AM J PATHOL, V119, P101; Hofbauer R, 1999, CRIT CARE MED, V27, P1843, DOI 10.1097/00003246-199909000-00023; HSIEH AHH, 1992, AM REV RESPIR DIS, V146, P290, DOI 10.1164/ajrccm/146.2.290; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; KRUMHOLZ W, 1995, BRIT J ANAESTH, V75, P66, DOI 10.1093/bja/75.1.66; Krumholz W, 1999, EUR J ANAESTH, V16, P547, DOI 10.1046/j.1365-2346.1999.00537.x; Lubick K, 2007, J LEUKOCYTE BIOL, V82, P1062, DOI 10.1189/jlb.0407255; Maddox FN, 2004, DEV BRAIN RES, V149, P143, DOI 10.1016/j.devbrainres.2004.01.001; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MORISAKI H, 1991, BRIT J ANAESTH, V66, P97, DOI 10.1093/bja/66.1.97; Nadal P, 1995, Eur J Emerg Med, V2, P14, DOI 10.1097/00063110-199503000-00004; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shiratsuchi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1400, DOI 10.1152/ajpcell.00345.2008; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sigel E, 1997, TRENDS PHARMACOL SCI, V18, P425, DOI 10.1016/S0165-6147(97)90675-1; Stankevicius D, 2008, NEUROPHARMACOLOGY, V54, P300, DOI 10.1016/j.neuropharm.2007.09.011; Stover JF, 1998, EUR J CLIN PHARMACOL, V54, P529, DOI 10.1007/s002280050508; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Stuart PC, 2000, BRIT J ANAESTH, V84, P638, DOI 10.1093/bja/84.5.638; Stuckey DJ, 2005, J LEUKOCYTE BIOL, V78, P393, DOI 10.1189/jlb.1203604; Tian J, 1999, J NEUROIMMUNOL, V96, P21, DOI 10.1016/S0165-5728(98)00264-1; Tian JD, 2004, J IMMUNOL, V173, P5298, DOI 10.4049/jimmunol.173.8.5298; Vansant G, 2007, AUTOIMMUNITY, V40, P180, DOI 10.1080/08916930701204467; VOLAKLI E, CRIT CARE, V14, pR32; WEISS M, 1993, BRIT J ANAESTH, V70, P317, DOI 10.1093/bja/70.3.317	41	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17152	10.1371/journal.pone.0017152	http://dx.doi.org/10.1371/journal.pone.0017152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390329	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700033
J	Thibodeau, PH; Boroditsky, L				Thibodeau, Paul H.; Boroditsky, Lera			Metaphors We Think With: The Role of Metaphor in Reasoning	PLOS ONE			English	Article							COMPREHENSION; THOUGHT; TIME	The way we talk about complex and abstract ideas is suffused with metaphor. In five experiments, we explore how these metaphors influence the way that we reason about complex issues and forage for further information about them. We find that even the subtlest instantiation of a metaphor (via a single word) can have a powerful influence over how people attempt to solve social problems like crime and how they gather information to make "well-informed" decisions. Interestingly, we find that the influence of the metaphorical framing effect is covert: people do not recognize metaphors as influential in their decisions; instead they point to more "substantive" (often numerical) information as the motivation for their problem-solving decision. Metaphors in language appear to instantiate frame-consistent knowledge structures and invite structurally consistent inferences. Far from being mere rhetorical flourishes, metaphors have profound influences on how we conceptualize and act with respect to important societal issues. We find that exposure to even a single metaphor can induce substantial differences in opinion about how to solve social problems: differences that are larger, for example, than pre-existing differences in opinion between Democrats and Republicans.	[Thibodeau, Paul H.; Boroditsky, Lera] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Thibodeau, PH (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	lera@stanford.edu	Thibodeau, Paul/AAY-7259-2021	Lauwereyns, Jan/0000-0003-0551-2550	NSF [0608514]; Stanford Graduate Fellowship	NSF(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University)	This research was funded by NSF Grant No. 0608514 to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Jay McClelland, Caitlin Fausey, Alexia Toskos, Steve Flusberg, Tania Henetz, and members of the Cognation Lab for inspiration and helpful, critical discussion of the content of this paper and the issues it addresses. We would also like to than Otto Murphy and Nguyen Ngo for their help in coding responses. This material is based on work supported under a Stanford Graduate Fellowship to the first author.	ABELSON RP, 1981, AM PSYCHOL, V36, P715, DOI 10.1037/0003-066X.36.7.715; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Bowdle BF, 2005, PSYCHOL REV, V112, P193, DOI 10.1037/0033-295X.112.1.193; BRANSFORD JD, 1972, J VERB LEARN VERB BE, V11, P717, DOI 10.1016/S0022-5371(72)80006-9; Buhrmester M., PSYCHOL SCI IN PRESS; Caprara GV, 1999, POLIT PSYCHOL, V20, P175; Elman JL, 2004, TRENDS COGN SCI, V8, P301, DOI 10.1016/j.tics.2004.05.003; Federal Bureau of Investigation, 2008, UN CRIM REP; Gentner D, 2001, ANALOGICAL MIND, P199; Gentner D, 2002, LANG COGNITIVE PROC, V17, P537, DOI 10.1080/01690960143000317; GENTNER D, 1983, COGNITIVE SCI, V7, P155, DOI 10.1016/S0364-0213(83)80009-3; GENTNER D, 1985, P INT C SYSTEMS MAN, P607; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; GICK ML, 1980, COGNITIVE PSYCHOL, V12, P306, DOI 10.1016/0010-0285(80)90013-4; GRAESSER AC, 1989, POETICS, V18, P143, DOI 10.1016/0304-422X(89)90026-0; KELLER GH, 1991, COLLECTED WORKS RIVE, P1; Kotlowitz A, 2008, NY TIMES        0504, P52; Lakoff G, 2008, POLITICAL MIND YOU C; Lakoff George, 2003, METAPHOR WE LIVE BY; Lakoff George, 2002, MORAL POLITICS LIBER; Liberman V, 2004, PERS SOC PSYCHOL B, V30, P1175, DOI 10.1177/0146167204264004; LIPTAK A, 2008, NY TIMES        0423; MINSKY M, 1975, REMEMBERING STUDY EX; ORTONY A, 1975, EDUC THEORY, V25, P45, DOI 10.1111/j.1741-5446.1975.tb00666.x; ORTONY A, 1978, J VERB LEARN VERB BE, V17, P465, DOI 10.1016/S0022-5371(78)90283-9; Ortony A., 1978, COGNITIVE SCI, V2, P53, DOI [10.1016/S0364-0213(78)80061-5, DOI 10.1016/S0364-0213(78)80061-5]; Pinker S., 2007, STUFF THOUGHT LANGUA; RUMELHART D, 1975, STUDIES COGNITIVE SC; Rumelhart D., 1977, SCH ACQUISITION KNOW, V1st, DOI [10.4324/9781315271644, DOI 10.4324/9781315271644]; Rumelhart D.E., 1979, METAPHOR THOUGHT; SCHANK RC, 1975, 4 INT JOINT C ART IN, P151; Schon D.A., 1993, METAPHOR THOUGHT, Vsecond; STERNBERG RJ, 1977, PSYCHOL REV, V84, P353, DOI 10.1037/0033-295X.84.4.353; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Walmsley R, 2015, WORLD PRISON POPULAT	39	388	392	8	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16782	10.1371/journal.pone.0016782	http://dx.doi.org/10.1371/journal.pone.0016782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373643	gold, Green Published			2022-12-27	WOS:000287657500017
J	Horn, T; Robertson, BC; Will, M; Eason, DK; Elliott, GP; Gemmell, NJ				Horn, Thorsten; Robertson, Bruce C.; Will, Margaret; Eason, Daryl K.; Elliott, Graeme P.; Gemmell, Neil J.			Inheritance of Telomere Length in a Bird	PLOS ONE			English	Article							KAKAPO STRIGOPS-HABROPTILUS; SEQUENCE; CHICKEN; AGE	Telomere dynamics are intensively studied in human ageing research and epidemiology, with many correlations reported between telomere length and age-related diseases, cancer and death. While telomere length is influenced by environmental factors there is also good evidence for a strong heritable component. In human, the mode of telomere length inheritance appears to be paternal and telomere length differs between sexes, with females having longer telomeres than males. Genetic factors, e.g. sex chromosomal inactivation, and non-genetic factors, e. g. antioxidant properties of oestrogen, have been suggested as possible explanations for these sex-specific telomere inheritance and telomere length differences. To test the influence of sex chromosomes on telomere length, we investigated inheritance and sex-specificity of telomere length in a bird species, the kakapo (Strigops habroptilus), in which females are the heterogametic sex (ZW) and males are the homogametic (ZZ) sex. We found that, contrary to findings in humans, telomere length was maternally inherited and also longer in males. These results argue against an effect of sex hormones on telomere length and suggest that factors associated with heterogamy may play a role in telomere inheritance and sex-specific differences in telomere length.	[Horn, Thorsten; Robertson, Bruce C.; Will, Margaret; Gemmell, Neil J.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Robertson, Bruce C.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Eason, Daryl K.; Elliott, Graeme P.] Dept Conservat, Natl Kakapo Team, Nelson, New Zealand; [Gemmell, Neil J.] Univ Otago, Dept Anat & Struct Biol, Ctr Reprod & Genom, Dunedin, New Zealand	University of Canterbury; University of Otago; University of Otago	Horn, T (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	thorstenhorn@gmx.net	Gemmell, Neil J/C-6774-2009	Gemmell, Neil J/0000-0003-0671-3637	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity' [CO9X0503]; University of Canterbury College of Science; University of Canterbury	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity'; University of Canterbury College of Science; University of Canterbury	Rio Tinto Alcan NZ, NZ Department of Conservation, Landcare Research's FRST OBI 'Sustaining and Restoring Biodiversity' contract CO9X0503 and a University of Canterbury College of Science research grant provided financial support. TH was supported by a University of Canterbury PhD scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Aviv A, 2006, J GERONTOL A-BIOL, V61, P871, DOI 10.1093/gerona/61.8.871; Baird DM, 2008, EXP GERONTOL, V43, P15, DOI 10.1016/j.exger.2007.10.002; Baird DM, 2006, EXP GERONTOL, V41, P1223, DOI 10.1016/j.exger.2006.09.009; BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Bolzan AD, 2006, MUTAT RES-REV MUTAT, V612, P189, DOI 10.1016/j.mrrev.2005.12.003; Clout Mick N., 2006, Notornis, V53, P1; Cockrem JF, 1995, AUK, V112, P253, DOI 10.2307/4088787; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Delany ME, 2003, POULTRY SCI, V82, P917, DOI 10.1093/ps/82.6.917; Eason Daryl K., 2006, Notornis, V53, P27; Elliott Graeme P., 2006, Notornis, V53, P164; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Horn T, 2010, HEREDITY, V105, P497, DOI 10.1038/hdy.2010.113; Horn T, 2008, AUST J ZOOL, V56, P207, DOI 10.1071/ZO08046; McQueen HA, 2009, CHROMOSOME RES, V17, P687, DOI 10.1007/s10577-009-9056-8; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Miller HC, 2003, CONSERV GENET, V4, P265, DOI 10.1023/A:1024037601708; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Nordfjall K, 2005, P NATL ACAD SCI USA, V102, P16374, DOI 10.1073/pnas.0501724102; Nordfjall K, 2010, EUR J HUM GENET, V18, P385, DOI 10.1038/ejhg.2009.178; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Robertson Bruce C., 2006, Notornis, V53, P173; Robertson BC, 2009, MOL ECOL RESOUR, V9, P664, DOI 10.1111/j.1755-0998.2008.02506.x; Saldanha CJ, 1997, GEN COMP ENDOCR, V105, P390, DOI 10.1006/gcen.1996.6841; Swanberg SE, 2010, EXP GERONTOL, V45, P647, DOI 10.1016/j.exger.2010.04.002	31	51	51	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17199	10.1371/journal.pone.0017199	http://dx.doi.org/10.1371/journal.pone.0017199			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364951	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600035
J	Barney, JN; DiTomaso, JM				Barney, Jacob N.; DiTomaso, Joseph M.			Global Climate Niche Estimates for Bioenergy Crops and Invasive Species of Agronomic Origin: Potential Problems and Opportunities	PLOS ONE			English	Article							BIOFUELS; PREDICTIONS; FEEDSTOCK; US	The global push towards a more biomass-based energy sector is ramping up efforts to adopt regionally appropriate high-yielding crops. As potential bioenergy crops are being moved around the world an assessment of the climatic suitability would be a prudent first step in identifying suitable areas of productivity and risk. Additionally, this assessment also provides a necessary step in evaluating the invasive potential of bioenergy crops, which present a possible negative externality to the bioeconomy. Therefore, we provide the first global climate niche assessment for the major graminaceous (9), herbaceous (3), and woody (4) bioenergy crops. Additionally, we contrast these with climate niche assessments for North American invasive species that were originally introduced for agronomic purposes as examples of well-intentioned introductions gone awry. With few exceptions (e. g., Saccharum officinarum, Pennisetum purpureum), the bioenergy crops exhibit broad climatic tolerance, which allows tremendous flexibility in choosing crops, especially in areas with high summer rainfall and long growing seasons (e. g., southeastern US, Amazon Basin, eastern Australia). Unsurprisingly, the invasive species of agronomic origin have very similar global climate niche profiles as the proposed bioenergy crops, also demonstrating broad climatic tolerance. The ecoregional evaluation of bioenergy crops and known invasive species demonstrates tremendous overlap at both high (EI >= 30) and moderate (EI >= 20) climate suitability. The southern and western US ecoregions support the greatest number of invasive species of agronomic origin, especially the Southeastern USA Plains, Mixed Woods Plains, and Mediterranean California. Many regions of the world have a suitable climate for several bioenergy crops allowing selection of agro-ecoregionally appropriate crops. This model knowingly ignores the complex biotic interactions and edaphic conditions, but provides a robust assessment of the climate niche, which is valuable for agronomists, crop developers, and regulators seeking to choose agro-ecoregionally appropriate crops while minimizing the risk of invasive species.	[Barney, Jacob N.] Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [DiTomaso, Joseph M.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Virginia Polytechnic Institute & State University; University of California System; University of California Davis	Barney, JN (corresponding author), Virginia Polytech Inst & State Univ, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	jnbarney@vt.edu	Barney, Jacob/C-2412-2008	Barney, Jacob/0000-0003-2949-5003				Angelini LG, 2009, BIOMASS BIOENERG, V33, P635, DOI 10.1016/j.biombioe.2008.10.005; Barney JN, 2008, BIOL INVASIONS, V10, P259, DOI 10.1007/s10530-007-9127-8; Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Barney JN, 2010, BIOMASS BIOENERG, V34, P124, DOI 10.1016/j.biombioe.2009.10.009; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Buddenhagen CE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005261; Crosti R, 2010, BIOL INVASIONS, V12, P1607, DOI 10.1007/s10530-009-9573-6; DiTomaso J.M., 2007, WEEDS CALIFORNIA OTH, V3488; Evans JM, 2010, GCB BIOENERGY, V2, P63, DOI 10.1111/j.1757-1707.2010.01040.x; Forseth IN, 2004, CRIT REV PLANT SCI, V23, P401, DOI 10.1080/07352680490505150; Gordon DR, 2011, BIOMASS BIOENERG, V35, P74, DOI 10.1016/j.biombioe.2010.08.029; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x; Lemus R, 2005, CRIT REV PLANT SCI, V24, P1, DOI 10.1080/07352680590910393; Lewandowski I, 2003, BIOMASS BIOENERG, V25, P335, DOI 10.1016/S0961-9534(03)00030-8; Low T., 2007, WEEDY TRUTH BIOFUELS; Mack R.N., 2000, BIOL INVASIONS, V2, P111, DOI DOI 10.1023/A:1010088422771; Mika AM, 2008, GLOBAL CHANGE BIOL, V14, P1721, DOI 10.1111/j.1365-2486.2008.01620.x; Olfert O, 2004, CAN ENTOMOL, V136, P277; Omernik JM, 2004, ENVIRON MANAGE, V34, pS27, DOI 10.1007/s00267-003-5197-2; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Quinn LD, 2010, GCB BIOENERGY, V2, P310, DOI 10.1111/j.1757-1707.2010.01062.x; Raghu S, 2006, SCIENCE, V313, P1742, DOI 10.1126/science.1129313; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; Schnoor J, 2008, WATER IMPLICATIONS B; Somerville C, 2010, SCIENCE, V329, P790, DOI 10.1126/science.1189268; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 2007, CLIMEX VERSION 3 0; U.S. Department of Agriculture, 2010, USDA REG ROADM M BIO	32	56	57	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17222	10.1371/journal.pone.0017222	http://dx.doi.org/10.1371/journal.pone.0017222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408056	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170900008
J	Gao, JA; Tortell, R; McClelland, JL				Gao, Juan; Tortell, Rebecca; McClelland, James L.			Dynamic Integration of Reward and Stimulus Information in Perceptual Decision-Making	PLOS ONE			English	Article							RESPONSE BIAS; MODELS; DISCRIMINATION; PAYOFF; CHOICE; AREA	In perceptual decision-making, ideal decision-makers should bias their choices toward alternatives associated with larger rewards, and the extent of the bias should decrease as stimulus sensitivity increases. When responses must be made at different times after stimulus onset, stimulus sensitivity grows with time from zero to a final asymptotic level. Are decision makers able to produce responses that are more biased if they are made soon after stimulus onset, but less biased if they are made after more evidence has been accumulated? If so, how close to optimal can they come in doing this, and how might their performance be achieved mechanistically? We report an experiment in which the payoff for each alternative is indicated before stimulus onset. Processing time is controlled by a "go" cue occurring at different times post stimulus onset, requiring a response within 250 msec. Reward bias does start high when processing time is short and decreases as sensitivity increases, leveling off at a non-zero value. However, the degree of bias is sub-optimal for shorter processing times. We present a mechanistic account of participants' performance within the framework of the leaky competing accumulator model [1], in which accumulators for each alternative accumulate noisy information subject to leakage and mutual inhibition. The leveling off of accuracy is attributed to mutual inhibition between the accumulators, allowing the accumulator that gathers the most evidence early in a trial to suppress the alternative. Three ways reward might affect decision making in this framework are considered. One of the three, in which reward affects the starting point of the evidence accumulation process, is consistent with the qualitative pattern of the observed reward bias effect, while the other two are not. Incorporating this assumption into the leaky competing accumulator model, we are able to provide close quantitative fits to individual participant data.	[Gao, Juan; Tortell, Rebecca; McClelland, James L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Gao, Juan; McClelland, James L.] Stanford Univ, Ctr Mind Brain & Computat, Stanford, CA 94305 USA	Stanford University; Stanford University	Gao, JA (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	mcclelland@stanford.edu	McClelland, James L/F-6004-2011	McClelland, James/0000-0002-8217-405X	Air Force Research Laboratory [FA9550-07-1-0537]	Air Force Research Laboratory	This work is supported by the Air Force Research Laboratory FA9550-07-1-0537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop B, 1998, PSYCHON B REV, V5, P239, DOI 10.3758/BF03212946; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Brown E, 2005, INT J BIFURCAT CHAOS, V15, P803, DOI 10.1142/S0218127405012478; BUSEMEYER JR, 1988, J MATH PSYCHOL, V32, P91, DOI 10.1016/0022-2496(88)90042-9; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; BUSEY TA, 1994, PSYCHOL REV, V101, P446, DOI 10.1037/0033-295X.101.3.446; Dayan P, 2001, COMPUTATIONAL NEUROS; Diederich A, 2008, PERCEPT PSYCHOPHYS, V70, P229, DOI 10.3758/PP.70.2.229; Diederich A, 2006, PERCEPT PSYCHOPHYS, V68, P194, DOI 10.3758/BF03193669; DUSOIR T, 1983, PERCEPT PSYCHOPHYS, V33, P403, DOI 10.3758/BF03202890; Eckhoff P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015006; EDWARDS W, 1965, J MATH PSYCHOL, V2, P312, DOI 10.1016/0022-2496(65)90007-6; Feng S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000284; Gao J, 2009, NEURAL COMPUT, V21, P2407, DOI 10.1162/neco.2009.09-08-866; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Green DM, 1966, SIGNAL DETECTION THE; Kacelnik A, 1997, TRENDS COGN SCI, V1, P304, DOI 10.1016/S1364-6613(97)01093-0; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; MACMILLAN NA, 1990, PSYCHOL BULL, V107, P401, DOI 10.1037/0033-2909.107.3.401; Maddox WT, 2003, J EXP PSYCHOL LEARN, V29, P307, DOI 10.1037/0278-7393.29.2.307; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2006, COGNITIVE PSYCHOL, V53, P195, DOI 10.1016/j.cogpsych.2005.10.002; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rorie AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009308; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; SHADLEN MN, 2006, ANN M SOC NEUR; Simen P, 2009, J EXP PSYCHOL HUMAN, V35, P1865, DOI 10.1037/a0016926; TOWNSEND JT, 1981, ACTA PSYCHOL, V47, P149, DOI 10.1016/0001-6918(81)90006-8; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; USHER M, 2009, PSYCHONOM; WOOD CC, 1976, J ACOUST SOC AM, V60, P1381, DOI 10.1121/1.381231	33	70	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16749	10.1371/journal.pone.0016749	http://dx.doi.org/10.1371/journal.pone.0016749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729QI	21390225	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200005
J	Greenlee, JDW; Jackson, AW; Chen, FX; Larson, CR; Oya, H; Kawasaki, H; Chen, HM; Howard, MA				Greenlee, Jeremy D. W.; Jackson, Adam W.; Chen, Fangxiang; Larson, Charles R.; Oya, Hiroyuki; Kawasaki, Hiroto; Chen, Haiming; Howard, Matthew A., III			Human Auditory Cortical Activation during Self-Vocalization	PLOS ONE			English	Article							COROLLARY DISCHARGE; FUNCTIONAL NEUROANATOMY; CORTEX; SPEECH; RESPONSES; SCHIZOPHRENIA; LOCALIZATION; MODULATION; FREQUENCY; DYNAMICS	During speaking, auditory feedback is used to adjust vocalizations. The brain systems mediating this integrative ability have been investigated using a wide range of experimental strategies. In this report we examined how vocalization alters speechsound processing within auditory cortex by directly recording evoked responses to vocalizations and playback stimuli using intracranial electrodes implanted in neurosurgery patients. Several new findings resulted from these high- resolution invasive recordings in human subjects. Suppressive effects of vocalization were found to occur only within circumscribed areas of auditory cortex. In addition, at a smaller number of sites, the opposite pattern was seen; cortical responses were enhanced during vocalization. This increase in activity was reflected in high gamma power changes, but was not evident in the averaged evoked potential waveforms. These new findings support forward models for vocal control in which efference copies of premotor cortex activity modulate sub- regions of auditory cortex.	[Greenlee, Jeremy D. W.; Jackson, Adam W.; Chen, Fangxiang; Oya, Hiroyuki; Kawasaki, Hiroto; Chen, Haiming; Howard, Matthew A., III] Univ Iowa, Dept Neurosurg, Iowa City, IA 52242 USA; [Larson, Charles R.] Northwestern Univ, Dept Commun Sci & Disorders, Evanston, IL USA	University of Iowa; Northwestern University	Greenlee, JDW (corresponding author), Univ Iowa, Dept Neurosurg, Iowa City, IA 52242 USA.	jeremy-greenlee@uiowa.edu	Oya, Hiroyuki/Q-2989-2018	Oya, Hiroyuki/0000-0002-1733-5478; Kawasaki, Hiroto/0000-0002-7688-9171; Greenlee, Jeremy/0000-0002-8481-8517; Howard, Matthew/0000-0003-3935-8889	National Institute on Deafness and Other Communication Disorders [K23DC009589, R01DC04290]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC009589, R01DC004290] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders (grant numbers K23DC009589, R01DC04290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PP, 2005, HUM BRAIN MAPP, V26, P44, DOI 10.1002/hbm.20120; Behroozmand R, 2009, CLIN NEUROPHYSIOL, V120, P1303, DOI 10.1016/j.clinph.2009.04.022; Bilecen D, 2002, NEUROIMAGE, V17, P710, DOI 10.1006/nimg.2002.1133; Billings CJ, 2007, AUDIOL NEURO-OTOL, V12, P234, DOI 10.1159/000101331; Brugge JF, 2008, HEARING RES, V238, P12, DOI 10.1016/j.heares.2007.11.012; Burnett TA, 1998, J ACOUST SOC AM, V103, P3153, DOI 10.1121/1.423073; Christoffels IK, 2007, HUM BRAIN MAPP, V28, P868, DOI 10.1002/hbm.20315; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; DONCHIN E, 1966, IEEE T BIO-MED ENG, VBM13, P131, DOI 10.1109/TBME.1966.4502423; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Ford JM, 2002, BIOL PSYCHIAT, V51, P485, DOI 10.1016/S0006-3223(01)01335-X; Fu CHY, 2006, CEREB CORTEX, V16, P969, DOI 10.1093/cercor/bhj039; Guenther FH, 2006, BRAIN LANG, V96, P280, DOI 10.1016/j.bandl.2005.06.001; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Gunji A, 2001, CLIN NEUROPHYSIOL, V112, P514, DOI 10.1016/S1388-2457(01)00462-X; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; Hackett TA, 2003, METH NE FRO NEUROSCI, P199; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Heinks-Maldonado TH, 2007, ARCH GEN PSYCHIAT, V64, P286, DOI 10.1001/archpsyc.64.3.286; Heinks-Maldonado TH, 2006, NEUROREPORT, V17, P1375, DOI 10.1097/01.wnr.0000233102.43526.e9; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Howard MA, 2000, J COMP NEUROL, V416, P79, DOI 10.1002/(SICI)1096-9861(20000103)416:1<79::AID-CNE6>3.0.CO;2-2; Kaas JH, 2000, P NATL ACAD SCI USA, V97, P11793, DOI 10.1073/pnas.97.22.11793; Kaiser J, 2009, NEUROIMAGE, V44, P257, DOI 10.1016/j.neuroimage.2008.08.018; Kudo N, 2004, NEUROSCI RES, V48, P59, DOI 10.1016/j.neures.2003.09.008; Leonard CM, 1998, CEREB CORTEX, V8, P397, DOI 10.1093/cercor/8.5.397; Loucks TMJ, 2007, NEUROIMAGE, V36, P131, DOI 10.1016/j.neuroimage.2007.01.049; MULLERPREUSS P, 1981, BRAIN RES, V215, P61, DOI 10.1016/0006-8993(81)90491-1; Numminen J, 1999, NEUROSCI LETT, V265, P119, DOI 10.1016/S0304-3940(99)00218-9; Numminen J, 1999, NEUROSCI LETT, V272, P29, DOI 10.1016/S0304-3940(99)00573-X; Oya H, 2002, J NEUROSCI, V22, P9502; Oya H, 2009, STEREOT FUNCT NEUROS, V87, P219, DOI 10.1159/000225975; PANTEV C, 1989, ELECTROEN CLIN NEURO, V72, P225, DOI 10.1016/0013-4694(89)90247-2; Paus T, 1996, EUR J NEUROSCI, V8, P2236, DOI 10.1111/j.1460-9568.1996.tb01187.x; Price CJ, 1996, BRAIN, V119, P919, DOI 10.1093/brain/119.3.919; Rastatter MP, 1998, PERCEPT MOTOR SKILL, V87, P623, DOI 10.2466/pms.1998.87.2.623; Reale RA, 2007, NEUROSCIENCE, V145, P162, DOI 10.1016/j.neuroscience.2006.11.036; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; Schulz GM, 2005, CEREB CORTEX, V15, P1835, DOI 10.1093/cercor/bhi061; Shuster LI, 2003, J COMMUN DISORD, V36, P1, DOI 10.1016/S0021-9924(02)00132-6; Steinschneider M, 2008, CEREB CORTEX, V18, P610, DOI 10.1093/cercor/bhm094; SUTER CM, 1970, EXP NEUROL, V29, P317, DOI 10.1016/0014-4886(70)90061-0; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; Ture U, 1999, J NEUROSURG, V90, P720, DOI 10.3171/jns.1999.90.4.0720; Ventura MI, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-58; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Wise RJS, 1999, LANCET, V353, P1057, DOI 10.1016/S0140-6736(98)07491-1	53	89	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14744	10.1371/journal.pone.0014744	http://dx.doi.org/10.1371/journal.pone.0014744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390228	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200004
J	Stamatakos, GS; Georgiadi, EC; Graf, N; Kolokotroni, EA; Dionysiou, DD				Stamatakos, Georgios S.; Georgiadi, Eleni C.; Graf, Norbert; Kolokotroni, Eleni A.; Dionysiou, Dimitra D.			Exploiting Clinical Trial Data Drastically Narrows the Window of Possible Solutions to the Problem of Clinical Adaptation of a Multiscale Cancer Model	PLOS ONE			English	Article							IN-SILICO ONCOLOGY; WILMS-TUMOR; SIMULATION-MODEL; LYMPHOBLASTIC-LEUKEMIA; MATHEMATICAL-MODEL; SOLID TUMOR; GROWTH-RATE; CHEMOTHERAPY; RADIOTHERAPY; THERAPY	The development of computational models for simulating tumor growth and response to treatment has gained significant momentum during the last few decades. At the dawn of the era of personalized medicine, providing insight into complex mechanisms involved in cancer and contributing to patient-specific therapy optimization constitute particularly inspiring pursuits. The in silico oncology community is facing the great challenge of effectively translating simulation models into clinical practice, which presupposes a thorough sensitivity analysis, adaptation and validation process based on real clinical data. In this paper, the behavior of a clinically-oriented, multiscale model of solid tumor response to chemotherapy is investigated, using the paradigm of nephroblastoma response to preoperative chemotherapy in the context of the SIOP/GPOH clinical trial. A sorting of the model's parameters according to the magnitude of their effect on the output has unveiled the relative importance of the corresponding biological mechanisms; major impact on the result of therapy is credited to the oxygenation and nutrient availability status of the tumor and the balance between the symmetric and asymmetric modes of stem cell division. The effect of a number of parameter combinations on the extent of chemotherapy-induced tumor shrinkage and on the tumor's growth rate are discussed. A real clinical case of nephroblastoma has served as a proof of principle study case, demonstrating the basics of an ongoing clinical adaptation and validation process. By using clinical data in conjunction with plausible values of model parameters, an excellent fit of the model to the available medical data of the selected nephroblastoma case has been achieved, in terms of both volume reduction and histological constitution of the tumor. In this context, the exploitation of multiscale clinical data drastically narrows the window of possible solutions to the clinical adaptation problem.	[Stamatakos, Georgios S.; Georgiadi, Eleni C.; Kolokotroni, Eleni A.; Dionysiou, Dimitra D.] Natl Tech Univ Athens, Silico Oncol Grp, Inst Commun & Comp Syst, Sch Elect & Comp Engn, Athens, Greece; [Graf, Norbert] Univ Saarland, Klin Pad Onkol & Hamatol, Homburg, Germany	National Technical University of Athens; Saarland University	Stamatakos, GS (corresponding author), Natl Tech Univ Athens, Silico Oncol Grp, Inst Commun & Comp Syst, Sch Elect & Comp Engn, Athens, Greece.	gestam@central.ntua.gr	Graf, Norbert/H-1328-2011	Graf, Norbert/0000-0002-2248-323X	European Commission [FP6-2005-IST-026996, FP7-ICT-2007-2-223979]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported in part by the European Commission under the projects "ACGT: Advancing Clinicogenomic Trials on Cancer" (FP6-2005-IST-026996, http://eu-acgt.org/) and "ContraCancrum: Clinically OrientedTranslationalCancerMultilevel Modeling" (FP7-ICT-2007-2-223979, http://contracancrum.eu/?q = node/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ARA, 2008, NAT REV CANCER, V8, P227, DOI 10.1038/nrc2329; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Beck W, 2000, CANC MED; Berrebi D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002216; Carre A, 2005, AM J MED GENET A, V139A, P165, DOI 10.1002/ajmg.a.31004; Castorina P, 2009, CANCER RES, V69, P8507, DOI 10.1158/0008-5472.CAN-09-0653; Craft AW, 1999, LANCET, V354, P1127, DOI 10.1016/S0140-6736(05)76925-7; DAHL WN, 1976, CANCER RES, V36, P3101; Deisboeck TS, 2009, NAT CLIN PRACT ONCOL, V6, P34, DOI 10.1038/ncponc1237; DEWEY WC, 1995, INT J RADIAT ONCOL, V33, P781, DOI 10.1016/0360-3016(95)00214-8; Dionysiou D D, 2008, Open Biomed Eng J, V2, P43, DOI 10.2174/1874120700802010043; Dionysiou DD, 2004, J THEOR BIOL, V230, P1, DOI 10.1016/j.jtbi.2004.03.024; Dionysiou DD, 2006, CANCER INFORM, V2, P113; DUECHTING W, 1992, Strahlentherapie und Onkologie, V168, P354; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; GEORGIADI EC, 2008, P 8 IEEE INT C BIO B; Graf N, 2000, UROL CLIN N AM, V27, P443, DOI 10.1016/S0094-0143(05)70092-6; Graf N, 2009, KLIN PADIATR, V221, P141, DOI 10.1055/s-0029-1216368; Groninger E, 2002, PEDIATR RES, V52, P113, DOI 10.1203/00006450-200207000-00021; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Kaste SC, 2008, PEDIATR RADIOL, V38, P2, DOI 10.1007/s00247-007-0687-7; Kobayashi H, 1998, BIOCHEM PHARMACOL, V55, P1229, DOI 10.1016/S0006-2952(97)00615-1; LUNZER A, 2010, P 4 INT ADV IN PRESS; MARIAS K, 2009, IFMBE P, V25, P2124; Marias K, 2007, LECT NOTES COMPUT SC, V4561, P703; Maseide K, 2000, RADIOTHER ONCOL, V54, P171, DOI 10.1016/S0167-8140(99)00154-1; PINKERTON CR, 1988, CANCER CHEMOTH PHARM, V22, P271, DOI 10.1007/BF00273423; Powathil G, 2007, PHYS MED BIOL, V52, P3291, DOI 10.1088/0031-9155/52/11/023; REVAZOVA E S, 1981, Byulleten' Eksperimental'noi Biologii i Meditsiny, V92, P335; Ribba B, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-7; Rockne Russell, 2008, P207, DOI 10.1007/978-0-8176-4713-1_8; SALMON SE, 2001, BASIC CLIN PHARM, P923; Sawada K, 2005, BIOL PHARM BULL, V28, P1202, DOI 10.1248/bpb.28.1202; SHACKNEY SE, 1978, ANN INTERN MED, V89, P107, DOI 10.7326/0003-4819-89-1-107; Sottoriva A, 2010, CANCER RES, V70, P46, DOI 10.1158/0008-5472.CAN-09-3663; Stamatakos GS, 2010, J THEOR BIOL, V266, P124, DOI 10.1016/j.jtbi.2010.05.019; Stamatakos GS, 2007, P ANN INT IEEE EMBS, P6629; Stamatakos GS, 2006, IEEE T BIO-MED ENG, V53, P1467, DOI 10.1109/TBME.2006.873761; Stamatakos GS, 2002, P IEEE, V90, P1764, DOI 10.1109/JPROC.2002.804685; Steel G.G., 2002, BASIC CLIN RADIOBIOL, P9; Tan TY, 2006, J PAEDIATR CHILD H, V42, P486, DOI 10.1111/j.1440-1754.2006.00908.x; Titz B, 2008, PHYS MED BIOL, V53, P4471, DOI 10.1088/0031-9155/53/17/001; Veal GJ, 2005, CLIN CANCER RES, V11, P5893, DOI 10.1158/1078-0432.CCR-04-2546; Ventura AC, 2009, CANCER RES, V69, P400, DOI 10.1158/0008-5472.CAN-08-4422; Wein LM, 2000, INT J RADIAT ONCOL, V47, P1073, DOI 10.1016/S0360-3016(00)00534-4; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Zoubek A, 1999, LANCET, V354, P344, DOI 10.1016/S0140-6736(05)75257-0; [No title captured]	49	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17594	10.1371/journal.pone.0017594	http://dx.doi.org/10.1371/journal.pone.0017594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407827	gold, Green Published, Green Submitted			2022-12-27	WOS:000287965200030
J	Bland, DM; Eisele, NA; Keleher, LL; Anderson, PE; Anderson, DM				Bland, David M.; Eisele, Nicholas A.; Keleher, Lauren L.; Anderson, Paul E.; Anderson, Deborah M.			Novel Genetic Tools for Diaminopimelic Acid Selection in Virulence Studies of Yersinia pestis	PLOS ONE			English	Article							SALMONELLA VACCINE STRAINS; ESCHERICHIA-COLI; TRANSFERABLE PLASMID; PASTEURELLA PESTIS; STABLE MAINTENANCE; BUBONIC PLAGUE; EXPRESSION; RESISTANCE; CLONING; PSEUDOTUBERCULOSIS	Molecular studies of bacterial virulence are enhanced by expression of recombinant DNA during infection to allow complementation of mutants and expression of reporter proteins in vivo. For highly pathogenic bacteria, such as Yersinia pestis, these studies are currently limited because deliberate introduction of antibiotic resistance is restricted to those few which are not human treatment options. In this work, we report the development of alternatives to antibiotics as tools for host-pathogen research during Yersinia pestis infections focusing on the diaminopimelic acid (DAP) pathway, a requirement for cell wall synthesis in eubacteria. We generated a mutation in the dapA-nlpB(dapX) operon of Yersinia pestis KIM D27 and CO92 which eliminated the expression of both genes. The resulting strains were auxotrophic for diaminopimelic acid and this phenotype was complemented in trans by expressing dapA in single and multi-copy. In vivo, we found that plasmids derived from the p15a replicon were cured without selection, while selection for DAP enhanced stability without detectable loss of any of the three resident virulence plasmids. The dapAX mutation rendered Y. pestis avirulent in mouse models of bubonic and septicemic plague which could be complemented when dapAX was inserted in single or multi-copy, restoring development of disease that was indistinguishable from the wild type parent strain. We further identified a high level, constitutive promoter in Y. pestis that could be used to drive expression of fluorescent reporters in dapAX strains that had minimal impact to virulence in mouse models while enabling sensitive detection of bacteria during infection. Thus, diaminopimelic acid selection for single or multi-copy genetic systems in Yersinia pestis offers an improved alternative to antibiotics for in vivo studies that causes minimal disruption to virulence.	[Bland, David M.; Eisele, Nicholas A.; Keleher, Lauren L.; Anderson, Paul E.; Anderson, Deborah M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Bland, David M.; Eisele, Nicholas A.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bland, DM (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	andersondeb@missouri.edu		Bland, David/0000-0002-5052-5599	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases; American Recovery and Reinvestment Act [R21AI074635]; NIH/National Institute of General Medical Sciences Cell and Molecular Biology [T32 GM008396]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074603, U01AI074635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Recovery and Reinvestment Act; NIH/National Institute of General Medical Sciences Cell and Molecular Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases PHS award and the American Recovery and Reinvestment Act (R21AI074635) to DMA. NAE is supported by the NIH/National Institute of General Medical Sciences Cell and Molecular Biology training grant (T32 GM008396). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Auerbach RK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000770; BOUVIER J, 1991, J BACTERIOL, V173, P5523, DOI 10.1128/jb.173.17.5523-5531.1991; BRUBAKER RR, 1965, SCIENCE, V149, P422, DOI 10.1126/science.149.3682.422; BUKHARI AI, 1971, J BACTERIOL, V105, P844, DOI 10.1128/JB.105.3.844-854.1971; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; CURTISS R, 1989, IMMUNOL INVEST, V18, P583, DOI 10.3109/08820138909112265; DeBord KL, 2006, INFECT IMMUN, V74, P4910, DOI 10.1128/IAI.01860-05; DONNENBERG MS, 1991, INFECT IMMUN, V59, P4310, DOI 10.1128/IAI.59.12.4310-4317.1991; Eisele NA, 2009, CLIN VACCINE IMMUNOL, V16, P1720, DOI 10.1128/CVI.00333-09; GALAN JE, 1990, GENE, V94, P29, DOI 10.1016/0378-1119(90)90464-3; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Guiyoule A, 2001, EMERG INFECT DIS, V7, P43, DOI 10.3201/eid0701.010106; Hanahan D, 1985, DNA CLONING PRACTICA; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Lee-Lewis H, 2010, INFECT IMMUN, V78, P220, DOI 10.1128/IAI.00559-09; Logsdon LK, 2003, INFECT IMMUN, V71, P4595, DOI 10.1128/IAI.71.8.4595-4607.2003; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Norris MH, 2009, APPL ENVIRON MICROB, V75, P6062, DOI 10.1128/AEM.00820-09; Overheim KA, 2005, INFECT IMMUN, V73, P5152, DOI 10.1128/IAI.73.8.5152-5159.2005; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PARRA F, 1983, J GEN MICROBIOL, V129, P337; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Pollitzer R., 1954, PLAGUE; Rediers H, 2003, APPL ENVIRON MICROB, V69, P6864, DOI 10.1128/AEM.69.11.6864-6874.2003; REED L. J., 1938, AMER JOUR HYG, V27, P493; RICHAUD F, 1986, J BACTERIOL, V166, P297, DOI 10.1128/jb.166.1.297-300.1986; Ruckert C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-121; SIMON R, 1983, BIOTECHNOLOGY, V1; SURGALLA MJ, 1969, APPL MICROBIOL, V18, P834, DOI 10.1128/AEM.18.5.834-837.1969; Team RDC, 2008, COMP RFFS; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17352	10.1371/journal.pone.0017352	http://dx.doi.org/10.1371/journal.pone.0017352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399698	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300019
J	Xu, WY; Yang, RD; Li, MM; Xing, Z; Yang, WQ; Chen, GA; Guo, H; Gong, XJ; Du, Z; Zhang, ZH; Hu, XM; Wang, D; Qian, QA; Wang, T; Su, Z; Xue, YB				Xu, Wenying; Yang, Rendong; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Du, Zhou; Zhang, Zhenhai; Hu, Xingming; Wang, Dong; Qian, Qian; Wang, Tai; Su, Zhen; Xue, Yongbiao			Transcriptome Phase Distribution Analysis Reveals Diurnal Regulated Biological Processes and Key Pathways in Rice Flag Leaves and Seedling Leaves	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; GENE-EXPRESSION; STARCH BIOSYNTHESIS; PERIODIC PATTERNS; ARABIDOPSIS; METABOLISM; LIGHT; PROTEIN; SUGARS; ACCUMULATION	Plant diurnal oscillation is a 24-hour period based variation. The correlation between diurnal genes and biological pathways was widely revealed by microarray analysis in different species. Rice (Oryza sativa) is the major food staple for about half of the world's population. The rice flag leaf is essential in providing photosynthates to the grain filling. However, there is still no comprehensive view about the diurnal transcriptome for rice leaves. In this study, we applied rice microarray to monitor the rhythmically expressed genes in rice seedling and flag leaves. We developed a new computational analysis approach and identified 6,266 (10.96%) diurnal probe sets in seedling leaves, 13,773 (24.08%) diurnal probe sets in flag leaves. About 65% of overall transcription factors were identified as flag leaf preferred. In seedling leaves, the peak of phase distribution was from 2: 00am to 4: 00am, whereas in flag leaves, the peak was from 8: 00pm to 2: 00am. The diurnal phase distribution analysis of gene ontology (GO) and cis-element enrichment indicated that, some important processes were waken by the light, such as photosynthesis and abiotic stimulus, while some genes related to the nuclear and ribosome involved processes were active mostly during the switch time of light to dark. The starch and sucrose metabolism pathway genes also showed diurnal phase. We conducted comparison analysis between Arabidopsis and rice leaf transcriptome throughout the diurnal cycle. In summary, our analysis approach is feasible for relatively unbiased identification of diurnal transcripts, efficiently detecting some special periodic patterns with non-sinusoidal periodic patterns. Compared to the rice flag leaves, the gene transcription levels of seedling leaves were relatively limited to the diurnal rhythm. Our comprehensive microarray analysis of seedling and flag leaves of rice provided an overview of the rice diurnal transcriptome and indicated some diurnal regulated biological processes and key functional pathways in rice.	[Xu, Wenying; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Hu, Xingming; Wang, Dong; Xue, Yongbiao] Chinese Acad Sci, Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Xu, Wenying; Li, Meina; Xing, Zhuo; Yang, Wenqiang; Chen, Guang; Guo, Han; Gong, Xiaojie; Hu, Xingming; Wang, Dong; Xue, Yongbiao] Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Yang, Rendong; Du, Zhou; Zhang, Zhenhai; Su, Zhen] China Agr Univ, State Key Lab Plant Physiol & Biochem, Coll Biol Sci, Beijing 100094, Peoples R China; [Qian, Qian] Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Wang, Tai] Chinese Acad Sci, Res Ctr Mol & Dev Biol, Key Lab Photosynth & Environm Mol Physiol, Inst Bot, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; China Agricultural University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Chinese Academy of Sciences; Institute of Botany, CAS	Xu, WY (corresponding author), Chinese Acad Sci, Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China.	zhensu@cau.edu.cn; ybxue@genetics.ac.cn	xing, zhuo/L-7165-2016; qian, qian/AAH-8708-2021; du, zhou/E-5358-2011; Wang, Tai/G-2544-2010	xing, zhuo/0000-0002-4635-6630; Guo, Han/0000-0001-9118-9897	Ministry of Science and Technology of China [2005CB120804, 90817006]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from the Ministry of Science and Technology of China (2005CB120804 and 90817006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chudova D, 2009, BIOINFORMATICS, V25, P3114, DOI 10.1093/bioinformatics/btp547; Chung HS, 2009, PLANT CELL, V21, P131, DOI 10.1105/tpc.108.064097; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Dietrich P, 2001, J EXP BOT, V52, P1959, DOI 10.1093/jexbot/52.363.1959; Doherty CJ, 2010, ANNU REV GENET, V44, P419, DOI 10.1146/annurev-genet-102209-163432; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Geigenberger P, 2000, PLANT J, V23, P795, DOI 10.1046/j.1365-313x.2000.00848.x; GEIGER DR, 1994, ANNU REV PLANT PHYS, V45, P235, DOI 10.1146/annurev.pp.45.060194.001315; Gibon Y, 2004, PLANT CELL, V16, P3304, DOI 10.1105/tpc.104.025973; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Hannah LC, 2008, CURR OPIN BIOTECH, V19, P160, DOI 10.1016/j.copbio.2008.02.013; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hudson KA, 2010, PLANT GENOME-US, V3, P3, DOI 10.3835/plantgenome2009.08.0025; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; KEVIN RMB, 2010, PLOS ONE, V5; Khan S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-126; Langmead CJ, 2003, J COMPUT BIOL, V10, P521, DOI 10.1089/10665270360688165; Lans H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000941; Lee KH, 2006, CELL, V126, P1109, DOI 10.1016/j.cell.2006.07.034; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Mach J, 2009, PLANT CELL, V21, P14, DOI 10.1105/tpc.108.210111; Mangelsen E, 2010, PLANT PHYSIOL, V153, P14, DOI 10.1104/pp.110.154856; Matt P, 1998, PLANTA, V207, P27, DOI 10.1007/s004250050452; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Mizuno T, 2008, PLANT CELL PHYSIOL, V49, P481, DOI 10.1093/pcp/pcn008; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Mutisya J, 2009, J PLANT PHYSIOL, V166, P428, DOI 10.1016/j.jplph.2008.06.017; Orzechowski S, 2008, ACTA BIOCHIM POL, V55, P435, DOI 10.18388/abp.2008_3049; Park JH, 2009, DNA REPAIR, V8, P29, DOI 10.1016/j.dnarep.2008.08.011; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Roelfsema MRG, 2005, NEW PHYTOL, V167, P665, DOI 10.1111/j.1469-8137.2005.01460.x; Salamone PR, 2000, FEBS LETT, V482, P113, DOI 10.1016/S0014-5793(00)01985-2; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Shaked H, 2006, GENETICS, V173, P985, DOI 10.1534/genetics.105.051664; Shimazaki K, 2007, ANNU REV PLANT BIOL, V58, P219, DOI 10.1146/annurev.arplant.57.032905.105434; STEER BT, 1974, PLANT PHYSIOL, V54, P758, DOI 10.1104/pp.54.5.758; STITT M, 1978, BIOCHIM BIOPHYS ACTA, V544, P200, DOI 10.1016/0304-4165(78)90223-4; STITT M, 1983, PLANT PHYSIOL, V72, P1139, DOI 10.1104/pp.72.4.1139; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tabata M, 2000, HEADACHE, V40, P457, DOI 10.1046/j.1526-4610.2000.00068.x; Tallman G, 2004, J EXP BOT, V55, P1963, DOI 10.1093/jxb/erh212; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; Turner JG, 2007, CURR BIOL, V17, pR847, DOI 10.1016/j.cub.2007.08.014; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Yamada Rikuhiro, 2007, Methods Mol Biol, V362, P245; Yang R, 2010, BIOINFORMATICS, V26, pi168, DOI 10.1093/bioinformatics/btq189; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhao Q, 2009, J BIOL CHEM, V284, P30424, DOI 10.1074/jbc.M109.044982	57	21	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17613	10.1371/journal.pone.0017613	http://dx.doi.org/10.1371/journal.pone.0017613			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407816	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300035
J	Zhu, L; Wang, LD; Wang, X; Luo, XL; Yang, L; Zhang, R; Yin, HK; Xie, D; Pan, Y; Chen, Y				Zhu, Lu; Wang, Lingdi; Wang, Xiao; Luo, Xiaolin; Yang, Ling; Zhang, Rui; Yin, Hongkun; Xie, Dong; Pan, Yi; Chen, Yan			Hepatic Deletion of Smad7 in Mouse Leads to Spontaneous Liver Dysfunction and Aggravates Alcoholic Liver Injury	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; MUTANT MICE; EXTRAEMBRYONIC TISSUES; SIGNAL TRANSDUCER; TRANSGENIC MICE; TRANSCRIPTION 3; DISRUPTION; EXPRESSION; DAMAGE	Background: TGF-beta has been known to play an important role in various liver diseases including fibrosis and alcohol-induced fatty liver. Smad7 is an intracellular negative regulator of TGF-b signaling. It is currently unclear whether endogenous Smad7 has an effect on liver function and alcoholic liver damage. Methodology/Principal Findings: We used Cre/loxP system by crossing Alb-Cre mice with Smad7(loxP/loxP) mice to generate liver-specific deletion of Smad7 with loss of the indispensable MH2 domain. Alcoholic liver injury was achieved by feeding mice with a liquid diet containing 5% ethanol for 6 weeks, followed by a single dose of ethanol gavage. Deletion of Smad7 in the liver was associated with increased Smad2/3 phosphorylation in the liver or upon TGF-b treatment in primary hepatocytes. The majority of mice with liver specific deletion of Smad7 (Smad7(liver-KO)) were viable and phenotypically normal, accompanied by only slight or no reduction of Smad7 expression in the liver. However, about 30% of Smad7(liver-KO) mice with high efficiency of Smad7 deletion had spontaneous liver dysfunction, demonstrated as low body weight, overall deterioration, and increased serum levels of AST and ALT. Degeneration and elevated apoptosis of liver cells were observed with these mice. TGF-b-induced epithelial to mesenchymal transition (EMT) was accelerated in Smad7-deleted primary hepatocytes. In addition, alcohol-induced liver injury and steatosis were profoundly aggravated in Smad7 deficient mice, associated with upregulation of critical genes involved in lipogenesis and inflammation. Furthermore, alcohol-induced ADH1 expression was significantly abrogated by Smad7 deletion in hepatocytes. Conclusion/Significance: In this study, we provided in vivo evidence revealing that endogenous Smad7 plays an important role in liver function and alcohol-induced liver injury.	[Zhu, Lu; Wang, Lingdi; Wang, Xiao; Luo, Xiaolin; Yang, Ling; Zhang, Rui; Yin, Hongkun; Xie, Dong; Pan, Yi; Chen, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Nutr & Metab, Inst Nutr Sci,Grad Sch, Shanghai, Peoples R China.	ychen3@sibs.ac.cn	Luo, Xiaolin/D-7159-2014; Yang, Ling/F-4404-2016; Zhu, Lu/N-1073-2017	Luo, Xiaolin/0000-0003-3215-8112; Zhu, Lu/0000-0003-2716-4649; yin, hongkun/0000-0002-8595-4270; Xie, Dong/0000-0002-1150-8657; Yang, Ling/0000-0002-7586-3922	National Natural Science Foundation of China [30830037, 81021002, 30971660]; Ministry of Science and Technology of China [2007CB947100, 2006CB943900, 2010CB529506]; Shanghai Institutes for Biological Sciences [2009KIP207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences)	This work was supported by research grants from National Natural Science Foundation of China ( 30830037 and 81021002) and the Ministry of Science and Technology of China (2007CB947100 and 2006CB943900) to Y.C. The work was also supported by Ministry of Science and Technology of China (2010CB529506), National Natural Science Foundation of China ( 30971660) and a grant from Shanghai Institutes for Biological Sciences (2009KIP207) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottinger EP, 1996, P NATL ACAD SCI USA, V93, P5877, DOI 10.1073/pnas.93.12.5877; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen Q, 2009, J BIOL CHEM, V284, P292, DOI 10.1074/jbc.M807233200; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Ciuclan L, 2010, J HEPATOL, V52, P407, DOI 10.1016/j.jhep.2009.12.003; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Galvin KM, 2000, NAT GENET, V24, P171, DOI 10.1038/72835; Hamzavi J, 2008, J CELL MOL MED, V12, P2130, DOI 10.1111/j.1582-4934.2008.00262.x; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Horiguchi N, 2008, GASTROENTEROLOGY, V134, P1148, DOI 10.1053/j.gastro.2008.01.016; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Huang Z, 2009, HUM MOL GENET, V18, P2791, DOI 10.1093/hmg/ddp214; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Ki SH, 2010, HEPATOLOGY, V52, P1291, DOI 10.1002/hep.23837; Li RG, 2006, J IMMUNOL, V176, P6777, DOI 10.4049/jimmunol.176.11.6777; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Murray KF, 2008, J PEDIATR GASTR NUTR, V47, P395, DOI 10.1097/MPG.0b013e3181709464; Neufeld D S, 1997, Methods Mol Biol, V75, P145; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Taura K, 2010, HEPATOLOGY, V51, P1027, DOI 10.1002/hep.23368; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Weinstein M, 2000, CYTOKINE GROWTH F R, V11, P49, DOI 10.1016/S1359-6101(99)00028-3; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	37	27	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17415	10.1371/journal.pone.0017415	http://dx.doi.org/10.1371/journal.pone.0017415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386907	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400072
J	Lindstrom, S; Schumacher, F; Siddiq, A; Travis, RC; Campa, D; Berndt, SI; Diver, WR; Severi, G; Allen, N; Andriole, G; Bueno-de-Mesquita, B; Chanock, SJ; Crawford, D; Gaziano, JM; Giles, GG; Giovannucci, E; Guo, C; Haiman, CA; Hayes, RB; Halkjaer, J; Hunter, DJ; Johansson, M; Kaaks, R; Kolonel, LN; Navarro, C; Riboli, E; Sacerdote, C; Stampfer, M; Stram, DO; Thun, MJ; Trichopoulos, D; Virtamo, J; Weinstein, SJ; Yeager, M; Henderson, B; Ma, J; Le Marchand, L; Albanes, D; Kraft, P				Lindstrom, Sara; Schumacher, Fredrick; Siddiq, Afshan; Travis, Ruth C.; Campa, Daniele; Berndt, Sonja I.; Diver, W. Ryan; Severi, Gianluca; Allen, Naomi; Andriole, Gerald; Bueno-de-Mesquita, Bas; Chanock, Stephen J.; Crawford, David; Gaziano, J. Michael; Giles, Graham G.; Giovannucci, Edward; Guo, Carolyn; Haiman, Christopher A.; Hayes, Richard B.; Halkjaer, Jytte; Hunter, David J.; Johansson, Mattias; Kaaks, Rudolf; Kolonel, Laurence N.; Navarro, Carmen; Riboli, Elio; Sacerdote, Carlotta; Stampfer, Meir; Stram, Daniel O.; Thun, Michael J.; Trichopoulos, Dimitrios; Virtamo, Jarmo; Weinstein, Stephanie J.; Yeager, Meredith; Henderson, Brian; Ma, Jing; Le Marchand, Loic; Albanes, Demetrius; Kraft, Peter			Characterizing Associations and SNP-Environment Interactions for GWAS-Identified Prostate Cancer Risk Markers-Results from BPC3	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GROWTH-FACTOR-I; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; BINDING PROTEIN-3; PSA LEVELS; GENES; METAANALYSIS; MULTIPLE; REPLICATION	Genome-wide association studies (GWAS) have identified multiple single nucleotide polymorphisms (SNPs) associated with prostate cancer risk. However, whether these associations can be consistently replicated, vary with disease aggressiveness (tumor stage and grade) and/or interact with non-genetic potential risk factors or other SNPs is unknown. We therefore genotyped 39 SNPs from regions identified by several prostate cancer GWAS in 10,501 prostate cancer cases and 10,831 controls from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). We replicated 36 out of 39 SNPs (P-values ranging from 0.01 to 10(-28)). Two SNPs located near KLK3 associated with PSA levels showed differential association with Gleason grade (rs2735839, P = 0.0001 and rs266849, P = 0.0004; case-only test), where the alleles associated with decreasing PSA levels were inversely associated with low-grade (as defined by Gleason grade,8) tumors but positively associated with high-grade tumors. No other SNP showed differential associations according to disease stage or grade. We observed no effect modification by SNP for association with age at diagnosis, family history of prostate cancer, diabetes, BMI, height, smoking or alcohol intake. Moreover, we found no evidence of pair-wise SNP-SNP interactions. While these SNPs represent new independent risk factors for prostate cancer, we saw little evidence for effect modification by other SNPs or by the environmental factors examined.	[Lindstrom, Sara; Guo, Carolyn; Hunter, David J.; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Lindstrom, Sara; Guo, Carolyn; Stampfer, Meir; Trichopoulos, Dimitrios; Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Schumacher, Fredrick; Haiman, Christopher A.; Stram, Daniel O.; Henderson, Brian] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90089 USA; [Siddiq, Afshan; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Travis, Ruth C.; Allen, Naomi] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Campa, Daniele] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany; [Berndt, Sonja I.; Chanock, Stephen J.; Hayes, Richard B.; Weinstein, Stephanie J.; Yeager, Meredith; Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Diver, W. Ryan; Thun, Michael J.] Amer Canc Soc, Dept Epidemiol, Atlanta, GA 30329 USA; [Severi, Gianluca; Giles, Graham G.] Univ Melbourne, Canc Epidemiol Ctr, Canc Council Victoria, Melbourne, Vic, Australia; [Severi, Gianluca; Giles, Graham G.] Univ Melbourne, Ctr Mol Genet Environm & Analyt Epidemiol, Melbourne, Vic, Australia; [Andriole, Gerald] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63110 USA; [Bueno-de-Mesquita, Bas] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Crawford, David] Univ Colorado, Denver Hlth Sci Ctr, Denver, CO 80202 USA; [Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, Massachusetts Vet Epidemiol & Res Informat Ctr MA, Boston, MA USA; [Gaziano, J. Michael] Boston Vet Affairs Healthcare Syst, GRECC, Boston, MA USA; [Gaziano, J. Michael] Brigham & Womens Hosp, Div Aging, Dept Med, Boston, MA 02115 USA; [Giles, Graham G.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Giovannucci, Edward; Stampfer, Meir] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hayes, Richard B.] NYU Langone Med Ctr, Div Epidemiol, New York, NY USA; [Halkjaer, Jytte] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Hunter, David J.; Stampfer, Meir; Ma, Jing] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Hunter, David J.; Stampfer, Meir; Ma, Jing] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Johansson, Mattias] Int Agcy Res Canc, F-69372 Lyon, France; [Johansson, Mattias] Umea Univ, Dept Surg & Perioperat Sci Urol & Androl, Umea, Sweden; [Kaaks, Rudolf] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Program Epidemiol, Canc Res Ctr, Honolulu, HI 96822 USA; [Navarro, Carmen] Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Navarro, Carmen] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Sacerdote, Carlotta] CPO Piemonte Torino, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn, Turin, Italy; [Trichopoulos, Dimitrios] Ctr Food & Nutr Policies, Athens, Greece; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kraft, Peter] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Southern California; Imperial College London; University of Oxford; Helmholtz Association; German Cancer Research Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; Cancer Council Victoria; University of Melbourne; University of Melbourne; Washington University (WUSTL); Netherlands National Institute for Public Health & the Environment; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Geriatric Research Education & Clinical Center; Harvard University; Brigham & Women's Hospital; Monash University; Harvard University; Harvard T.H. Chan School of Public Health; NYU Langone Medical Center; Danish Cancer Society; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; World Health Organization; International Agency for Research on Cancer (IARC); Umea University; Helmholtz Association; German Cancer Research Center (DKFZ); Cancer Research Center of Hawaii; University of Hawaii System; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health	Lindstrom, S (corresponding author), Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, 665 Huntington Ave, Boston, MA 02115 USA.	pkraft@hsph.harvard.edu	Severi, Gianluca/Q-1824-2019; Weinstein, Stephanie J/P-1627-2017; Johansson, Mattias/ABF-3365-2020; Berndt, Sonja I/J-8423-2016; Diver, Ryan/AAG-3469-2019; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020; Campa, Daniele/K-1617-2016; Schumacher, Fredrick/R-6043-2019; Severi, Gianluca/H-3774-2018	Severi, Gianluca/0000-0001-7157-419X; Weinstein, Stephanie J/0000-0002-3834-1535; Diver, Ryan/0000-0002-5418-9000; Campa, Daniele/0000-0003-3220-9944; Schumacher, Fredrick/0000-0002-3073-7463; Severi, Gianluca/0000-0001-7157-419X; Johansson, Mattias/0000-0002-3116-5081; Giles, Graham/0000-0003-4946-9099; Navarro, Carmen/0000-0001-8896-7483; Hayes, Richard/0000-0002-0918-661X; Riboli, Elio/0000-0001-6795-6080; Siddiq, Afshan/0000-0002-9110-1434; Sacerdote, Carlotta/0000-0002-8008-5096	US National Institutes of Health, National Cancer Institute [U01-CA98233-07, U01-CA98710-06, U01-CA98216-06, U01-CA98758-07]; NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the US National Institutes of Health, National Cancer Institute [cooperative agreements U01-CA98233-07 to David J. Hunter, U01-CA98710-06 to Michael J. Thun, U01-CA98216-06 to Elio Riboli and Rudolf Kaaks, and U01-CA98758-07 to Brian E. Henderson, and Intramural Research Program of NIH/National Cancer Institute, Division of Cancer Epidemiology and Genetics]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON PA, 1988, PROSTATE, V12, P39, DOI 10.1002/pros.2990120106; Ahn J, 2008, NAT GENET, V40, P1032, DOI 10.1038/ng0908-1032; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chan JM, 2002, J NATL CANCER I, V94, P1099; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; FitzGerald LM, 2009, CLIN CANCER RES, V15, P3231, DOI 10.1158/1078-0432.CCR-08-2190; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giovannucci E, 2003, CANCER EPIDEM BIOMAR, V12, P84; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001513; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; Hsu FC, 2009, CANCER RES, V69, P2720, DOI 10.1158/0008-5472.CAN-08-3347; Huncharek M, 2010, AM J PUBLIC HEALTH, V100, P693, DOI 10.2105/AJPH.2008.150508; Hunter DJ, 2005, NAT REV CANCER, V5, P977, DOI 10.1038/nrc1754; Kader AK, 2009, PROSTATE, V69, P1195, DOI 10.1002/pros.20970; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kraft P, 2007, HUM HERED, V63, P111, DOI 10.1159/000099183; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; R Core Team, 2018, R LANG ENV STAT COMP; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1137, DOI 10.1158/1055-9965.EPI-05-0823; SIEMIATYCKI J, 1981, INT J EPIDEMIOL, V10, P383, DOI 10.1093/ije/10.4.383; Skolarus TA, 2007, NAT CLIN PRACT UROL, V4, P605, DOI 10.1038/ncpuro0944; Stevens VL, 2010, PROSTATE, V70, P601, DOI 10.1002/pros.21094; Sun JL, 2009, CANCER RES, V69, P10, DOI 10.1158/0008-5472.CAN-08-3464; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Wiklund F, 2009, PROSTATE, V69, P419, DOI 10.1002/pros.20908; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yeager M, 2009, NAT GENET, V41, P1055, DOI 10.1038/ng.444; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169; Zheng SL, 2009, CANCER EPIDEM BIOMAR, V18, P1815, DOI 10.1158/1055-9965.EPI-08-0983	43	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17142	10.1371/journal.pone.0017142	http://dx.doi.org/10.1371/journal.pone.0017142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390317	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700031
J	Sattar, SA; Ali, M; Tetro, JA				Sattar, Syed A.; Ali, Mohammad; Tetro, Jason A.			In Vivo Comparison of Two Human Norovirus Surrogates for Testing Ethanol-Based Handrubs: The Mouse Chasing the Cat!	PLOS ONE			English	Article							FELINE CALICIVIRUS; MURINE NOROVIRUS; PERSISTENCE; EFFICACY; INACTIVATION; STABILITY; SURFACES; VIRUSES; MS2	Human noroviruses (HuNoV), a major cause of acute gastroenteritis worldwide, cannot be readily cultured in the lab. Therefore, a feline calicivirus (FCV) is often used as its surrogate to, among other things, test alcohol-based handrubs (ABHR). The more recent laboratory culture of a mouse norovirus (MNV) provides an alternative. While MNV is closer to HuNoV in several respects, to date, no comparative testing of FCV and MNV survival and inactivation on human hands has been performed. This study was designed to address the knowledge gap. The rates of loss in viability during drying on hands were -1.91 and -1.65% per minute for FCV and MNV, respectively. When the contaminated skin was exposed for 20 s to either a commercial ABHR with 62% (v/v) ethanol or to 75% (v/v) ethanol in water, FCV infectivity was reduced by <1 log(10) while that of MNV by nearly 2.8 log(10). Extending the contact time to 30 s reduced the FCV titer by almost 2 log(10) by both test substances and that of MNV by >3.5 log(10) by the commercial ABHR while 75% ethanol did not show any noticeable improvement in activity as compared to the 20 s contact. An 80% (v/v) aqueous solution of ethanol gave only a 1.75 log(10) reduction in MNV activity after 20 s. The results show significant differences in the ethanol susceptibility of FCV and MNV in contact times relevant to field use of ABHR and also that 62% ethanol was a more effective virucide than either 75% or 80% ethanol. These findings indicate the need for a review of the continuing use of FCV as a surrogate for HuNoV.	[Sattar, Syed A.; Ali, Mohammad; Tetro, Jason A.] Univ Ottawa, CREM, Ottawa, ON, Canada	University of Ottawa	Sattar, SA (corresponding author), Univ Ottawa, CREM, Ottawa, ON, Canada.	ssattar@uottawa.ca		Tetro, Jason/0000-0001-8759-7281				*ASTM INT, 2010, E183810 ASTM; Bae J, 2008, APPL ENVIRON MICROB, V74, P477, DOI 10.1128/AEM.02095-06; Beekes M, 2010, J GEN VIROL, V91, P580, DOI 10.1099/vir.0.016337-0; Bidawid S, 2004, J FOOD PROTECT, V67, P103, DOI 10.4315/0362-028X-67.1.103; Bidawid S, 2003, J VIROL METHODS, V107, P163, DOI 10.1016/S0166-0934(02)00214-8; Cannon JL, 2006, J FOOD PROTECT, V69, P2761, DOI 10.4315/0362-028X-69.11.2761; Cheeseman KE, 2009, J HOSP INFECT, V72, P319, DOI 10.1016/j.jhin.2009.04.018; D'Souza DH, 2006, INT J FOOD MICROBIOL, V108, P84, DOI 10.1016/j.ijfoodmicro.2005.10.024; D'Souza DH, 2010, FOODBORNE PATHOG DIS, V7, P319, DOI 10.1089/fpd.2009.0426; Gehrke C, 2004, J HOSP INFECT, V56, P49, DOI 10.1016/j.jhin.2003.08.019; Geissler K, 2002, J VET MED B, V49, P55, DOI 10.1046/j.1439-0450.2002.00529.x; GOULD D, 2009, BR J COMMUNITY NURS, V14, P121; GOULD D, 2009, BR J COMMUNITY NURS, V14, P119; Gould Dinah, 2009, Br J Community Nurs, V14, P119; Hansen S, 2007, J HOSP INFECT, V65, P348, DOI 10.1016/j.jhin.2006.12.018; HERSKOVI.TT, 1970, J BIOL CHEM, V245, P2588; *HLTH CAN, 2009, GUID DOC HUM US ANT; Kampf G, 2005, J HOSP INFECT, V60, P144, DOI 10.1016/j.jhin.2004.12.005; Kimura H, 2011, EPIDEMIOL INFECT, V139, P317, DOI 10.1017/S0950268810000981; Koopmans M, 2009, J HOSP INFECT, V73, P331, DOI 10.1016/j.jhin.2009.06.028; Lamhoujeb S, 2008, APPL ENVIRON MICROB, V74, P3349, DOI 10.1128/AEM.02878-07; Parke SA, 1999, FOOD CHEM, V67, P241, DOI 10.1016/S0308-8146(99)00124-7; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Sattar SA, 2002, J VIROL METHODS, V103, P171, DOI 10.1016/S0166-0934(02)00025-3; Sattar SA, 2000, INFECT CONT HOSP EP, V21, P516, DOI 10.1086/501796; STEINMANN J, 1995, ZBL HYG UMWELTMED, V196, P425; Su XW, 2010, FOOD MICROBIOL, V27, P535, DOI 10.1016/j.fm.2010.01.001; Vivancos R, 2010, INT J INFECT DIS, V14, pE135, DOI 10.1016/j.ijid.2010.02.1783; Whitehead K, 2010, AM J INFECT CONTROL, V38, P26, DOI 10.1016/j.ajic.2009.03.015; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; World Health Organization, 2010, WHO GUID HAND HYG HL	31	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17340	10.1371/journal.pone.0017340	http://dx.doi.org/10.1371/journal.pone.0017340			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390325	Green Published, gold			2022-12-27	WOS:000287761700047
J	Van Biesen, W; Williams, JD; Covic, AC; Fan, S; Claes, K; Lichodziejewska-Niemierko, M; Verger, C; Steiger, J; Schoder, V; Wabel, P; Gauly, A; Himmele, R				Van Biesen, Wim; Williams, John D.; Covic, Adrian C.; Fan, Stanley; Claes, Kathleen; Lichodziejewska-Niemierko, Monika; Verger, Christian; Steiger, Jurg; Schoder, Volker; Wabel, Peter; Gauly, Adelheid; Himmele, Rainer		EuroBCM Study Grp	Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort	PLOS ONE			English	Article							RESIDUAL RENAL-FUNCTION; BIOIMPEDANCE SPECTROSCOPY; ANURIC PATIENTS; BLOOD-PRESSURE; CAPD PATIENTS; VOLUME; MANAGEMENT; SURVIVAL; REMOVAL; ULTRAFILTRATION	Background: Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients. However, accurate tools to evaluate volume status in clinical practice and data on volume status in PD patients as compared to healthy population, and the associated factors, have not been available so far. Methods: We used a bio-impedance spectroscopy device, the Body Composition Monitor (BCM) to assess volume status in a cross-sectional cohort of prevalent PD patients in different European countries. The results were compared to an age and gender matched healthy population. Results: Only 40% out of 639 patients from 28 centres in 6 countries were normovolemic. Severe fluid overload was present in 25.2%. There was a wide scatter in the relation between blood pressure and volume status. In a multivariate analysis in the subgroup of patients from countries with unrestricted availability of all PD modalities and fluid types, older age, male gender, lower serum albumin, lower BMI, diabetes, higher systolic blood pressure, and use of at least one exchange per day with the highest hypertonic glucose were associated with higher relative tissue hydration. Neither urinary output nor ultrafiltration, PD fluid type or PD modality were retained in the model (total R 2 of the model = 0.57). Conclusions: The EuroBCM study demonstrates some interesting issues regarding volume status in PD. As in HD patients, hypervolemia is a frequent condition in PD patients and blood pressure can be a misleading clinical tool to evaluate volume status. To monitor fluid balance, not only fluid output but also dietary input should be considered. Close monitoring of volume status, a correct dialysis prescription adapted to the needs of the patient and dietary measures seem to be warranted to avoid hypervolemia.	[Van Biesen, Wim] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Williams, John D.] Univ Wales Hosp, Coll Med, Cardiff CF4 4XW, S Glam, Wales; [Covic, Adrian C.] Univ Gr T Popa, Iasi, Romania; [Covic, Adrian C.] Univ Hosp CI Pharon, Iasi, Romania; [Fan, Stanley] Royal London Hosp, London E1 1BB, England; [Claes, Kathleen] Univ Hosp Leuven, Louvain, Belgium; [Lichodziejewska-Niemierko, Monika] Univ Gdansk, Dialysis Ctr NephroCare, PL-80952 Gdansk, Poland; [Verger, Christian] Univ Hosp Rene Dubos, Pontoise, France; [Steiger, Jurg] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Schoder, Volker; Wabel, Peter; Gauly, Adelheid; Himmele, Rainer] Fresenius Med Care, Bad Homburg, Germany	Ghent University; Ghent University Hospital; Cardiff University; Grigore T Popa University of Medicine & Pharmacy; Barts Health NHS Trust; Royal London Hospital; KU Leuven; University Hospital Leuven; Fahrenheit Universities; University of Gdansk; University of Basel	Van Biesen, W (corresponding author), Ghent Univ Hosp, B-9000 Ghent, Belgium.	wim.vanbiesen@ugent.be	Fan, Stanley/ABA-1363-2020; Gauly, Adelheid/X-7273-2019; Verger, Christian/T-5139-2019; Covic, Adrian/G-5017-2016; Verger, Christian/GQA-4459-2022	Fan, Stanley/0000-0002-7323-1489; Verger, Christian/0000-0002-8009-5366; Covic, Adrian/0000-0002-9985-2486; Lichodziejewska-Niemierko, Monika/0000-0002-0262-3493; Krajewska, Magdalena/0000-0002-2632-2409	Fresenius Medical Care; Baxter; Gambro; Fresenius	Fresenius Medical Care; Baxter; Gambro; Fresenius	Adelheid Gauly, Rainer Himmele, Volker Schoder and Peter Wabel are employees of Fresenius Medical Care. Wim Van Biesen received speaker's fees from Fresenius Medical Care, Baxter and Gambro on different occasions, however none related to the current study. Stanley Fan received speaker's fees from Fresenius Medical Care and Baxter on different occasions, however none related to the current paper. His department received educational and research support grants from Baxter and Fresenius, but none related to the current study. Adrian Covic and John Williams have worked as consultants for Fresenius Medical Care. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Aurigemma GP, 2004, NEW ENGL J MED, V351, P1097, DOI 10.1056/NEJMcp022709; Bellizzi V, 2006, J AM SOC NEPHROL, V17, P1481, DOI 10.1681/ASN.2005070756; Brown EA, 2003, J AM SOC NEPHROL, V14, P2948, DOI 10.1097/01.ASN.0000092146.67909.E2; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Cocchi R, 1999, NEPHROL DIAL TRANSPL, V14, P1536, DOI 10.1093/ndt/14.6.1536; Cooper BA, 2000, KIDNEY INT, V58, P408, DOI 10.1046/j.1523-1755.2000.00180.x; Covic A, 2005, J NEPHROL, V18, P388; Davenport A, 2009, INT J ARTIF ORGANS, V32, P779, DOI 10.1177/039139880903201103; Davies SJ, 2006, PERITON DIALYSIS INT, V26, P458; Davies SJ, 2006, PERITON DIALYSIS INT, V26, P449; Davison SN, 2009, CLIN J AM SOC NEPHRO, V4, P1044, DOI 10.2215/CJN.00020109; DEMIRCI MS, NEPHROL DIAL TRANSPL; DEVOLDER I, PERIT DIAL INT, V30, P208; Engel B, 2007, PERITON DIALYSIS INT, V27, P514; Enia G, 2001, NEPHROL DIAL TRANSPL, V16, P1459, DOI 10.1093/ndt/16.7.1459; Essig M, 2008, NEPHROL DIAL TRANSPL, V23, P239, DOI 10.1093/ndt/gfm542; Foster KR, 1996, AM J CLIN NUTR, V64, P388, DOI 10.1093/ajcn/64.3.388S; Gangji AS, 2009, BLOOD PURIFICAT, V28, P354, DOI 10.1159/000232937; JACOBS LH, 2009, NEPHROL DIAL TRANSPL; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; Johnson DW, 2010, NEPHROL DIAL TRANSPL, V25, P1973, DOI 10.1093/ndt/gfp780; Konings CJAM, 2003, NEPHROL DIAL TRANSPL, V18, P797, DOI 10.1093/ndt/gfg147; Konings CJAM, 2002, PERITON DIALYSIS INT, V22, P477; Kotanko P, 2008, NEPHROL DIAL TRANSPL, V23, P808, DOI 10.1093/ndt/gfm889; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; LEUNISSEN KML, 1993, KIDNEY INT, V43, pS50; Lo WK, 2006, PERITON DIALYSIS INT, V26, P520; Machek P, 2010, NEPHROL DIAL TRANSPL, V25, P538, DOI 10.1093/ndt/gfp487; Matthie JR, 2008, EXPERT REV MED DEVIC, V5, P239, DOI 10.1586/17434440.5.2.239; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Paniagua R, 2000, PERITON DIALYSIS INT, V20, P53; PANIAGUA R, 2010, NEPHROL DIAL TRANSPL, V15; PASSAUER J, 2009, WORLD C NEPHR; Passauer J, 2010, NEPHROL DIAL TRANSPL, V25, P545, DOI 10.1093/ndt/gfp517; Rodriguez-Carmona A, 2002, PERITON DIALYSIS INT, V22, P705; Sommerer C, 2007, CLIN NEPHROL, V68, P392; TWARDOWSKI Z, 1987, PERIT DIAL B, V7; Van Biesen W, 2008, PERITON DIALYSIS INT, V28, P596; van Biesen W, 2010, NEPHROL DIAL TRANSPL, V25, P2052, DOI 10.1093/ndt/gfq100; Wabel P, 2007, J AM SOC NEPHROL, V18, pA255; Wabel P, 2008, NEPHROL DIAL TRANSPL, V23, P2965, DOI 10.1093/ndt/gfn228; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378; Wang J, 1976, J NUTR, V106, P6; Wieskotten S, 2008, PHYSIOL MEAS, V29, P639, DOI 10.1088/0967-3334/29/5/009; Wiggins KJ, 2007, NEPHROLOGY, V12, P218, DOI 10.1111/j.1440-1797.2006.00702.x; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Woodrow G, 2007, PERITON DIALYSIS INT, V27, pS245	49	173	177	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17148	10.1371/journal.pone.0017148	http://dx.doi.org/10.1371/journal.pone.0017148			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390320	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700032
J	Finazzi, S; Poole, D; Luciani, D; Cogo, PE; Bertolini, G				Finazzi, Stefano; Poole, Daniele; Luciani, Davide; Cogo, Paola E.; Bertolini, Guido			Calibration Belt for Quality-of-Care Assessment Based on Dichotomous Outcomes	PLOS ONE			English	Article							LOGISTIC-REGRESSION MODELS; CONFIDENCE BANDS; RESPONSE CURVE	Prognostic models applied in medicine must be validated on independent samples, before their use can be recommended. The assessment of calibration, i.e., the model's ability to provide reliable predictions, is crucial in external validation studies. Besides having several shortcomings, statistical techniques such as the computation of the standardized mortality ratio (SMR) and its confidence intervals, the Hosmer-Lemeshow statistics, and the Cox calibration test, are all non-informative with respect to calibration across risk classes. Accordingly, calibration plots reporting expected versus observed outcomes across risk subsets have been used for many years. Erroneously, the points in the plot (frequently representing deciles of risk) have been connected with lines, generating false calibration curves. Here we propose a methodology to create a confidence band for the calibration curve based on a function that relates expected to observed probabilities across classes of risk. The calibration belt allows the ranges of risk to be spotted where there is a significant deviation from the ideal calibration, and the direction of the deviation to be indicated. This method thus offers a more analytical view in the assessment of quality of care, compared to other approaches.	[Finazzi, Stefano] Scuola Int Super Studi Avanzati, Astrophys Sector, Trieste, Italy; [Finazzi, Stefano] Ist Nazl Fis Nucl Sez Trieste, Trieste, Italy; [Poole, Daniele] San Martino Hosp, Intens Care Unit, Dept Anesthesia & Intens Care, Belluno, Italy; [Luciani, Davide] Mario Negri Inst Pharmacol Res, Unit Clin Knowledge Engn, Lab Clin Epidemiol, I-20157 Milan, Italy; [Cogo, Paola E.] Univ Padua, Dept Pediat, Pediat Intens Care Unit, Padua, Italy; [Bertolini, Guido] Mario Negri Inst Pharmacol Res, Lab Clin Epidemiol, GiViTI Coordinating Ctr, Ranica, Italy	International School for Advanced Studies (SISSA); Istituto Nazionale di Fisica Nucleare (INFN); ULSS 1 Dolomiti; Ospedale di Belluno; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Padua; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Finazzi, S (corresponding author), Scuola Int Super Studi Avanzati, Astrophys Sector, Trieste, Italy.	finazzi@sissa.it	Bertolini, Guido/AAA-8005-2020; Luciani, Davide/ABF-7639-2020; Poole, Daniele/X-7210-2019; Finazzi, Stefano/AAC-1377-2019; Finazzi, Stefano/L-3000-2013; Cogo, Paola P/J-6918-2018	Bertolini, Guido/0000-0002-3101-4259; Poole, Daniele/0000-0001-5279-9844; Finazzi, Stefano/0000-0002-3525-3249; Cogo, Paola P/0000-0002-6235-140X				Bertolini G, 2000, J Epidemiol Biostat, V5, P251; BRAND RJ, 1973, AM STAT, V27, P157, DOI 10.2307/2684046; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; GALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957; HAUCK WW, 1983, AM STAT, V37, P158, DOI 10.2307/2685879; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; MILLER ME, 1991, STAT MED, V10, P1213, DOI 10.1002/sim.4780100805; ROSSI C, 2009, PROGETTO MARGHERITA; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	11	78	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16110	10.1371/journal.pone.0016110	http://dx.doi.org/10.1371/journal.pone.0016110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373178	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500010
J	Frohoff, C; Moodley, M; Fairlie, L; Coovadia, A; Moultrie, H; Kuhn, L; Meyers, T				Frohoff, Cordula; Moodley, Magendhree; Fairlie, Lee; Coovadia, Ashraf; Moultrie, Harry; Kuhn, Louise; Meyers, Tammy			Antiretroviral Therapy Outcomes in HIV-Infected Children after Adjusting Protease Inhibitor Dosing during Tuberculosis Treatment	PLOS ONE			English	Article							HEALTHY-VOLUNTEERS; REVERSE-TRANSCRIPTASE; PHARMACOKINETICS; RITONAVIR; RIFAMPICIN; LOPINAVIR; VIRUS; DEATHS; IMPACT; COHORT	Background: Modification of ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy is required for HIV-infected children co-treated for tuberculosis (TB). We aimed to determine virologic and toxicity outcomes among TB/HIV co-treated children with the following modifications to their antiretroviral therapy (ART): (1) super-boosted LPV/r, (2) double-dose LPV/r or (3) ritonavir. Methods and Findings: A medical record review was conducted at two clinical sites in Johannesburg, South Africa. The records of children 6-24 months of age initiating LPV/r-based therapy were reviewed. Children co-treated for TB were categorized based on the modifications made to their ART regimen and were compared to children of the same age at each site not treated for TB. Included are 526 children, 294 (56%) co-treated for TB. All co-treated children had more severe HIV disease, including lower CD4 percents and worse growth indicators, than comparisons. Children in the super-boosted group (n = 156) were as likely to be virally suppressed (<400 copies/ml) at 6 months as comparisons (69.2% vs. 74.8%, p = 0.36). Children in the double-dose (n = 47) and ritonavir groups (n = 91) were significantly less likely to be virally suppressed at 6 months (53.1% and 49.3%) than comparisons (74.8% and 82.1%; p = 0.02 and p<0.0001, respectively). At 12 months only children in the ritonavir group still had lower rates of virological suppression relative to comparisons (63.9% vs 83.3% p<0.05). Grade 1 or greater ALT elevations were more common in the super-boosted (75%) than double-dose (54.6%) or ritonavir (33.9%) groups (p = 0.09 and p<0.0001) but grade 3/4 elevations were observed in 3 (13.6%) of the super-boosted, 7 (15.9%) of the double-dose and 5 (8.9%) of the ritonavir group (p = 0.81 and p = 0.29). Conclusion: Good short-term virologic outcomes were achieved in children co-treated for TB and HIV who received super-boosted LPV/r. Treatment limiting toxicity was rare. Strategies for increased dosing of LPV/r with TB treatment warrant further investigation.	[Frohoff, Cordula; Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Frohoff, Cordula; Kuhn, Louise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Moodley, Magendhree; Fairlie, Lee; Moultrie, Harry] Univ Witwatersrand, Fac Hlth Sci, Wits Inst Sexual Reprod Hlth HIV & Related Dis, Johannesburg, South Africa; [Coovadia, Ashraf] Univ Witwatersrand, Dept Paediat, Rahima Moosa Mother & Child Hosp, Empilweni Serv & Res Unit,Fac Hlth Sci, Johannesburg, South Africa; [Meyers, Tammy] Univ Witwatersrand, Harriet Shezi Clin, Chris Hani Baragwanath Hosp, Dept Paediat,Fac Hlth Sci, Johannesburg, South Africa	Columbia University; Columbia University; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand	Frohoff, C (corresponding author), Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, Mailman Sch Publ Hlth, New York, NY 10027 USA.	tammy@meyers.net	Moultrie, Harry/AFV-0903-2022; Moultrie, Harry/H-1842-2014	Moultrie, Harry/0000-0001-9722-0699; Moultrie, Harry/0000-0001-9722-0699	National Institutes of Child Health and Human Development (NICHD) [HD 47177]; Bristol Meyers Squibb Secure the Future Foundation; NIH Fogarty International Center [5U2RTW007370, 5U2RTW007373]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047177] Funding Source: NIH RePORTER	National Institutes of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Bristol Meyers Squibb Secure the Future Foundation; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Neverest study was supported by grants from the National Institutes of Child Health and Human Development (NICHD) HD 47177 and Bristol Meyers Squibb Secure the Future Foundation. Tammy Meyers is the recipient of NIH Fogarty International Center grants to the University of North Carolina and University of the Witwatersrand numbers 5U2RTW007370 and 5U2RTW007373. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas JR, 2004, J ANTIMICROB CHEMOTH, V54, P587, DOI 10.1093/jac/dkh384; Barlow-Mosha L, 2009, 16 C RETR OPP INF MO; Burger DM, 2006, ANTIMICROB AGENTS CH, V50, P3336, DOI 10.1128/AAC.00461-06; Burton M. E., 2005, APPL PHARMACOKINETIC; Centers for Disease Control and Prevention, 2009, MAN DRUG INT TREATM; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; Elenga N, 2005, PEDIATR INFECT DIS J, V24, P1077, DOI 10.1097/01.inf.0000190008.91534.b7; Elsherbiny D, 2009, EUR J CLIN PHARMACOL, V65, P71, DOI 10.1007/s00228-008-0481-y; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Hsu A, 1998, CLIN PHARMACOKINET, V35, P275, DOI 10.2165/00003088-199835040-00002; Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; Llibre JM, 2008, HIV MED, V9, P508, DOI 10.1111/j.1468-1293.2008.00581.x; MCILLERON H, 2009, DOUBLE DOSE LOPINAVI; Munderi P, 2010, HIV MED, V11, P334, DOI 10.1111/j.1468-1293.2009.00786.x; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Nijland HMJ, 2008, AIDS, V22, P931, DOI 10.1097/QAD.0b013e3282faa71e; Palme IB, 2002, PEDIATR INFECT DIS J, V21, P1053, DOI 10.1097/00006454-200211000-00016; PALUMBO P, 2009, NEVIRAPINE VS LOPINA; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; *REG COMPL CTR, 2009, TABL GRAD SEV AD PED; Reitz C, 2010, J INFECT DIS, V201, P1121, DOI 10.1086/651454; Ren Y, 2008, JAIDS-J ACQ IMM DEF, V47, P566, DOI 10.1097/QAI.0b013e3181642257; Ren Y, 2009, JAIDS-J ACQ IMM DEF, V50, P439, DOI 10.1097/QAI.0b013e31819c33a3; Sham HL, 1998, ANTIMICROB AGENTS CH, V42, P3218, DOI 10.1128/AAC.42.12.3218; van Zyl GU, 2009, PEDIATR INFECT DIS J, V28, P1125, DOI 10.1097/INF.0b013e3181af829d; Vishnuvardhan D, 2003, AIDS, V17, P1092, DOI 10.1097/00002030-200305020-00023; *WHO, 2005, WHO ANTHR VERS 2 MAC; *WHO, 2008, REV TREATM REC INF; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2010, ANT THER HIV INF INF; ZHANG C, 2010, POPULATION PHARMACOK, P19	32	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17273	10.1371/journal.pone.0017273	http://dx.doi.org/10.1371/journal.pone.0017273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383838	Green Published, gold			2022-12-27	WOS:000287657500047
J	Guterstam, A; Petkova, VI; Ehrsson, HH				Guterstam, Arvid; Petkova, Valeria I.; Ehrsson, H. Henrik			The Illusion of Owning a Third Arm	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; RUBBER HAND ILLUSION; PHANTOM LIMBS; MOTOR CORTEX; NEURAL BASIS; BODY; TOUCH; FEEL; PROPRIOCEPTION; REPRESENTATION	Could it be possible that, in the not-so-distant future, we will be able to reshape the human body so as to have extra limbs? A third arm helping us out with the weekly shopping in the local grocery store, or an extra artificial limb assisting a paralysed person? Here we report a perceptual illusion in which a rubber right hand, placed beside the real hand in full view of the participant, is perceived as a supernumerary limb belonging to the participant's own body. This effect was supported by questionnaire data in conjunction with physiological evidence obtained from skin conductance responses when physically threatening either the rubber hand or the real one. In four well-controlled experiments, we demonstrate the minimal required conditions for the elicitation of this "supernumerary hand illusion''. In the fifth, and final experiment, we show that the illusion reported here is qualitatively different from the traditional rubber hand illusion as it is characterised by less disownership of the real hand and a stronger feeling of having two right hands. These results suggest that the artificial hand 'borrows' some of the multisensory processes that represent the real hand, leading to duplication of touch and ownership of two right arms. This work represents a major advance because it challenges the traditional view of the gross morphology of the human body as a fundamental constraint on what we can come to experience as our physical self, by showing that the body representation can easily be updated to incorporate an additional limb.	[Guterstam, Arvid; Petkova, Valeria I.; Ehrsson, H. Henrik] Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden	Karolinska Institutet	Guterstam, A (corresponding author), Karolinska Inst, Dept Neurosci, Brain Body & Self Lab, Stockholm, Sweden.	arvid.guterstam@ki.se		Guterstam, Arvid/0000-0002-3694-1318	European Research Council; Swedish Foundation for Strategic Research; Human Frontier Science Program; Stockholm Brain Institute	European Research Council(European Research Council (ERC)European Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Human Frontier Science Program(Human Frontier Science Program); Stockholm Brain Institute	This study was funded by the European Research Council (erc.europa.eu), The Swedish Foundation for Strategic Research (www.stratresearch.se/en), The Human Frontier Science Program (www.hfsp.org), and Stockholm Brain Institute (www.stockholmbrain.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Botvinick M, 2004, SCIENCE, V305, P782, DOI 10.1126/science.1101836; Brugger P, 2003, PERCEPT MOTOR SKILL, V97, P3, DOI 10.2466/PMS.97.5.3-10; Brugger P, 2000, P NATL ACAD SCI USA, V97, P6167, DOI 10.1073/pnas.100510697; Brunet I, 2007, TRENDS NEUROSCI, V30, P260, DOI 10.1016/j.tins.2007.03.010; CALFORD MB, 1985, NATURE, V313, P477, DOI 10.1038/313477a0; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; EHRSSON H, 2010, MIT HDB MULTISENSORY; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2009, PERCEPTION, V38, P310, DOI 10.1068/p6304; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2002, ATTENTION PERFORM, V19, P136; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; Kaas JH, 2004, ANAT REC PART A, V281A, P1148, DOI 10.1002/ar.a.20120; KAAS JH, 1993, ANN ANAT, V175, P509, DOI 10.1016/S0940-9602(11)80212-8; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; LACKNER JR, 1988, BRAIN, V111, P281, DOI 10.1093/brain/111.2.281; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; Longo MR, 2008, CONSCIOUS COGN, V17, P1181, DOI 10.1016/j.concog.2008.01.001; Ma WJ, 2006, NAT NEUROSCI, V9, P1432, DOI 10.1038/nn1790; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; McGonigle DJ, 2002, BRAIN, V125, P1265, DOI 10.1093/brain/awf139; MELZACK R, 1990, TRENDS NEUROSCI, V13, P88, DOI 10.1016/0166-2236(90)90179-E; Miyazawa N, 2004, NEUROSURGERY, V54, P228, DOI 10.1227/01.NEU.0000097558.01639.F5; Naito E, 2002, NEURON, V36, P979, DOI 10.1016/S0896-6273(02)00980-7; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Penfield W, 1950, CEREBRAL CORTEX MAN; Petkova VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006933; Petkova VI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003832; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; Rosen B, 2009, SCAND J PLAST RECONS, V43, P260, DOI 10.3109/02844310903113107; Santiago LF, 2007, REV NEUROSCIENCE, V18, P283; Schaefer M, 2009, HUM BRAIN MAPP, V30, P1413, DOI 10.1002/hbm.20609; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Staub F, 2006, NEUROLOGY, V67, P2140, DOI 10.1212/01.wnl.0000249135.78905.75; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, NEUROPSYCHOLOGIA, V46, P3014, DOI 10.1016/j.neuropsychologia.2008.06.004; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; WEINSTEIN EA, 1954, BRAIN, V77, P45, DOI 10.1093/brain/77.1.45	56	141	152	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17208	10.1371/journal.pone.0017208	http://dx.doi.org/10.1371/journal.pone.0017208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21383847	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500043
J	Schmidt, SL; Hickey, MS; Koblenz, KM; Klamer, H; Botero, MF; Pfaffenbach, KT; Pagliassotti, MJ; Melby, CL				Schmidt, Stacy L.; Hickey, Matthew S.; Koblenz, Kathryn M.; Klamer, Holly; Botero, Maria F.; Pfaffenbach, Kyle T.; Pagliassotti, Michael J.; Melby, Christopher L.			Cardiometabolic Plasticity in Response to a Short-Term Diet and Exercise Intervention in Young Hispanic and NonHispanic White Adults	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; NUTRITION EXAMINATION SURVEY; TYPE-2 DIABETES-MELLITUS; MEXICAN-AMERICAN ADULTS; 3RD NATIONAL-HEALTH; INSULIN SENSITIVITY; CARDIOVASCULAR-DISEASE; LIFE-STYLE; METABOLIC SYNDROME; MESSENGER-RNA	Background: Young adult Mexican Americans (MA) exhibit lower insulin sensitivity (Si) than nonHispanic whites (NHW), even when controlling for fitness and adiposity. It is unclear if MA are as responsive to the same lifestyle intervention as NHW. Objective: We developed a model to examine cardiometabolic plasticity (i.e., changes in Si and plasma lipids) in MA compared to NHW adults in response to a diet-exercise intervention. Design: Sedentary subjects (20 NHW: 11F, 9M, 23.0 y, 25.5 kg/m(2); 17 MA: 13F, 4M, 22.7 y, 25.4 kg/m(2)) consumed their habitual diets and remained sedentary for 7 days, after which fasting blood samples were obtained, and a 3-h intravenous glucose tolerance test (IVGTT) was performed with the insulin area under the curve (IAUC) used to estimate Si. Subjects then completed a 7-day diet/exercise intervention (diet: low saturated fat, low added sugar, high fiber; exercise: cycling, six total sessions lasting 40-45 min/session at 65% VO2 max). Pre-intervention tests were repeated. Results: Pre intervention IAUC was 28% higher (p < 0.05) in MA (IAUC pre = 2298 mu U*180 min/mL) than in NHW (IAUC = 1795 mu U*180 min/mL). Following the intervention, there was a significant reduction in IAUC in MA (29%) and NHW (32%), however, the IAUC remained higher (p < 0.05) for MA (post = 1635 mu U*180 min/mL) than for NHW (post = 1211 mu U*180 min/mL). Pre test plasma lipids were not different in MA compared to NHW. Plasma cholesterol and TG concentrations significantly improved in both groups, but concentrations of low density lipoprotein-cholesterol and small dense LDL particles significantly improved only in the NHW. Conclusion: With a short-term diet-exercise intervention, the magnitude of improvements in Si and serum cholesterol and TG in Hispanics are similar to those in NHW. However, because at the outset MA were less insulin sensitive compared to NHW, within the short timeframe studied the ethnic gap in insulin sensitivity remained.	[Schmidt, Stacy L.; Klamer, Holly; Botero, Maria F.; Melby, Christopher L.] Colorado State Univ, Dept Food Sci & Human Nutr, Nutr & Metab Fitness Lab, Ft Collins, CO 80523 USA; [Hickey, Matthew S.; Koblenz, Kathryn M.] Colorado State Univ, Dept Hlth & Exercise Sci, Human Performance Clin Res Lab, Ft Collins, CO 80523 USA; [Pfaffenbach, Kyle T.; Pagliassotti, Michael J.] Colorado State Univ, Dept Food Sci & Human Nutr, Mol Nutr Lab, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Schmidt, SL (corresponding author), Colorado State Univ, Dept Food Sci & Human Nutr, Nutr & Metab Fitness Lab, Ft Collins, CO 80523 USA.	cmelby@cahs.colostate.edu			Agricultural Experiment Station	Agricultural Experiment Station	The funding source was The Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate N, 2003, J DIABETES COMPLICAT, V17, P39, DOI 10.1016/S1056-8727(02)00190-3; Aguirre MA, 1997, J GERONTOL A-BIOL, V52, pM56, DOI 10.1093/gerona/52A.1.M56; Alexander H, 1999, J AM COLL NUTR, V18, P127, DOI 10.1080/07315724.1999.10718840; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Barcenas CH, 2007, OBESITY, V15, P1043, DOI 10.1038/oby.2007.537; Black AE, 2000, EUR J CLIN NUTR, V54, P386, DOI 10.1038/sj.ejcn.1600970; BOGARDUS C, 1989, DIABETES, V38, P1423, DOI 10.2337/diabetes.38.11.1423; Borissova AM, 2005, INT J CLIN PRACT, V59, P422, DOI 10.1111/j.1368-5031.2005.00209.x; *CDC, 2004, NAT DIAB FACT SHEET; Clausen JO, 1996, J CLIN INVEST, V98, P1195, DOI 10.1172/JCI118903; CONONIE CC, 1994, J AM GERIATR SOC, V42, P394, DOI 10.1111/j.1532-5415.1994.tb07487.x; Corpeleijn E, 2006, DIABETIC MED, V23, P907, DOI 10.1111/j.1464-5491.2006.01888.x; Crespo CJ, 2001, AM J PUBLIC HEALTH, V91, P1254, DOI 10.2105/AJPH.91.8.1254; Cruz ML, 2004, J CLIN ENDOCR METAB, V89, P108, DOI 10.1210/jc.2003-031188; Dixon LB, 2000, AM J EPIDEMIOL, V152, P548, DOI 10.1093/aje/152.6.548; Donahue RP, 1996, INT J OBESITY, V20, P76; Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Frosig C, 2009, OBESITY, V17, pS15, DOI 10.1038/oby.2009.383; Garvey WT, 2003, DIABETES, V52, P453, DOI 10.2337/diabetes.52.2.453; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; Haffner SM, 1999, ARTERIOSCL THROM VAS, V19, P2234, DOI 10.1161/01.ATV.19.9.2234; Hanley AJG, 2002, DIABETES CARE, V25, P1177, DOI 10.2337/diacare.25.7.1177; Haskell W L, 1984, Exerc Sport Sci Rev, V12, P205; Ho RC, 2005, CYTOKINE, V30, P14, DOI 10.1016/j.cyto.2004.10.015; Ho RC, 2002, AM J PHYSIOL-ENDOC M, V283, pE799, DOI 10.1152/ajpendo.00105.2002; Ho RC, 2002, METABOLISM, V51, P1478, DOI 10.1053/meta.2002.35577; Houmard JA, 1995, J APPL PHYSIOL, V79, P1936, DOI 10.1152/jappl.1995.79.6.1936; Houmard JA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1055, DOI 10.1152/ajpendo.1999.277.6.E1055; ISBELL JM, DIABETES CARE; Kaline K, 2007, HORM METAB RES, V39, P687, DOI 10.1055/s-2007-985811; Kishimoto H, 2002, HORM METAB RES, V34, P27, DOI 10.1055/s-2002-19963; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kraniou GN, 2004, EXP PHYSIOL, V89, P559, DOI 10.1113/expphysiol.2004.027409; LEFLOCH JP, 1990, DIABETES CARE, V13, P172, DOI 10.2337/diacare.13.2.172; Li CY, 2006, DIABETES CARE, V29, P2396, DOI 10.2337/dc06-0289; Luna MTT, 2005, ARCH MED RES, V36, P210, DOI 10.1016/j.arcmed.2005.03.004; Monda KL, 2009, J LIPID RES, V50, P1685, DOI 10.1194/jlr.P900029-JLR200; OLEFSKY JM, 1974, AM J MED, V57, P551, DOI 10.1016/0002-9343(74)90006-0; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Perez-Escamilla R, 2007, J NUTR, V137, P860, DOI 10.1093/jn/137.4.860; PIATTI PM, 1994, METABOLISM, V43, P1481, DOI 10.1016/0026-0495(94)90005-1; ROGERS MA, 1988, DIABETES CARE, V11, P613, DOI 10.2337/diacare.11.8.613; Srinivasan SR, 2003, METABOLISM, V52, P443, DOI 10.1053/meta.2003.50065; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; West DS, 2008, OBESITY, V16, P1413, DOI 10.1038/oby.2008.224	47	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16987	10.1371/journal.pone.0016987	http://dx.doi.org/10.1371/journal.pone.0016987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364957	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600027
J	Shafat, I; Ilan, N; Zoabi, S; Vlodavsky, I; Nakhoul, F				Shafat, Itay; Ilan, Neta; Zoabi, Samih; Vlodavsky, Israel; Nakhoul, Farid			Heparanase Levels Are Elevated in the Urine and Plasma of Type 2 Diabetes Patients and Associate with Blood Glucose Levels	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; INCREASED EXPRESSION; GENE-EXPRESSION; BREAST-CANCER; TISSUE FACTOR; NEPHROPATHY; SULFATE; HEPARIN; PATHOGENESIS; INFLAMMATION	Heparanase is an endoglycosidase that specifically cleaves heparan sulfate side chains of heparan sulfate proteoglycans. Utilizing an ELISA method capable of detection and quantification of heparanase, we examined heparanase levels in the plasma and urine of a cohort of 29 patients diagnosed with type 2 diabetes mellitus (T2DM), 14 T2DM patients who underwent kidney transplantation, and 47 healthy volunteers. We provide evidence that heparanase levels in the urine of T2DM patients are markedly elevated compared to healthy controls (1162 +/- 181 vs. 156 +/- 29.6 pg/ml for T2DM and healthy controls, respectively), increase that is statistically highly significant (P < 0.0001). Notably, heparanase levels were appreciably decreased in the urine of T2DM patients who underwent kidney transplantation, albeit remained still higher than healthy individuals (P < 0.0001). Increased heparanase levels were also found in the plasma of T2DM patients. Importantly, urine heparanase was associated with elevated blood glucose levels, implying that glucose mediates heparanase upregulation and secretion into the urine and blood. Utilizing an in vitro system, we show that insulin stimulates heparanase secretion by kidney 293 cells, and even higher secretion is observed when insulin is added to cells maintained under high glucose conditions. These results provide evidence for a significant involvement of heparanase in diabetic complications.	[Shafat, Itay; Ilan, Neta; Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Zoabi, Samih] Rambam Hlth Care Campus, Clin Transplantat Unit, Haifa, Israel; [Nakhoul, Farid] Rambam Hlth Care Campus, Dept Nephrol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Rambam Health Care Campus; Rambam Health Care Campus	Shafat, I (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, POB 9649, IL-31096 Haifa, Israel.	vlodavsk@cc.huji.ac.il			Israel Science Foundation [549/06]; National Cancer Institute, NIH [RO1-CA106456]; Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation [JDRF 1-2006-695, 38-2009-635]; NATIONAL CANCER INSTITUTE [R01CA106456] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Israel Cancer Research Fund (ICRF); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Israel Science Foundation (549/06); National Cancer Institute, NIH (RO1-CA106456); the Israel Cancer Research Fund (ICRF); and the Juvenile Diabetes Research Foundation (JDRF 1-2006-695 and 38-2009-635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; Casu B, 2004, CURR PHARM DESIGN, V10, P939, DOI 10.2174/1381612043452794; Casu B, 2010, MATRIX BIOL, V29, P442, DOI 10.1016/j.matbio.2010.04.003; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Cohen I, 2007, CLIN CANCER RES, V13, P4069, DOI 10.1158/1078-0432.CCR-06-2546; Cohen-Mazor M, 2008, AM J PHYSIOL-HEART C, V294, pH651, DOI 10.1152/ajpheart.00952.2007; Dempsey LA, 2000, TRENDS BIOCHEM SCI, V25, P349, DOI 10.1016/S0968-0004(00)01619-4; Elkin M, 2003, CANCER RES, V63, P8821; Ferro V, 2004, MINI-REV MED CHEM, V4, P693, DOI 10.2174/1389557043403729; Fux L, 2009, TRENDS BIOCHEM SCI, V34, P511, DOI 10.1016/j.tibs.2009.06.005; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; Grant PJ, 2007, J INTERN MED, V262, P157, DOI 10.1111/j.1365-2796.2007.01824.x; Hellman B, 2009, UPSALA J MED SCI, V114, P193, DOI 10.3109/03009730903366075; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; KANWAR YS, 1980, J CELL BIOL, V86, P688, DOI 10.1083/jcb.86.2.688; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; Kramer A, 2006, J AM SOC NEPHROL, V17, P2513, DOI 10.1681/ASN.2006020184; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levidiotis V, 2001, KIDNEY INT, V60, P1287, DOI 10.1046/j.1523-1755.2001.00934.x; Lewis EJ, 2008, DIABETES CARE, V31, pS202, DOI 10.2337/dc08-s251; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Miao HQ, 2006, CURR MED CHEM, V13, P2101, DOI 10.2174/092986706777935230; Myler HA, 2006, J BIOCHEM, V139, P339, DOI 10.1093/jb/mvj061; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Nadir Y, 2010, HAEMATOL-HEMATOL J, V95, P1927, DOI 10.3324/haematol.2010.023713; Nadir Y, 2010, THROMB RES, V125, pS72, DOI 10.1016/S0049-3848(10)70018-9; Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Raats CJI, 1999, J AM SOC NEPHROL, V10, P1689; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Shafat I, 2006, BIOCHEM BIOPH RES CO, V341, P958, DOI 10.1016/j.bbrc.2006.01.048; Shafat I, 2007, NEOPLASIA, V9, P909, DOI 10.1593/neo.07673; Shafat I, 2006, J BIOL CHEM, V281, P23804, DOI 10.1074/jbc.M602762200; Simizu S, 2004, CANCER SCI, V95, P553, DOI 10.1111/j.1349-7006.2004.tb02485.x; Szymczak M, 2010, ARCH IMMUNOL THER EX, V58, P45, DOI 10.1007/s00005-009-0061-6; van den Hoven MJ, 2008, KIDNEY INT, V73, P278, DOI 10.1038/sj.ki.5002706; van den Hoven MJ, 2007, KIDNEY INT, V72, P543, DOI 10.1038/sj.ki.5002337; van den Hoven MJ, 2006, KIDNEY INT, V70, P2100, DOI 10.1038/sj.ki.5001985; van den Hoven MJ, 2009, NEPHROL DIAL TRANSPL, V24, P2637, DOI 10.1093/ndt/gfp182; VANDENBORN J, 1993, KIDNEY INT, V43, P454, DOI 10.1038/ki.1993.67; Vlodavsky I., 1999, PROTOCOLS CELL BIOL, DOI DOI 10.4.1-10.4.4; Vlodavsky I, 2008, NEOPLASIA, V10, P125, DOI 10.1593/neo.07875; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Wang F, 2010, CARDIOVASC RES, V87, P127, DOI 10.1093/cvr/cvq051; Wang F, 2009, AM J PHYSIOL-HEART C, V296, pH1108, DOI 10.1152/ajpheart.01312.2008; Weiss R, 2007, DRUGS, V67, P2681, DOI 10.2165/00003495-200767180-00004; Wijnhoven TJM, 2008, DIABETOLOGIA, V51, P372, DOI 10.1007/s00125-007-0879-6	50	76	79	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17312	10.1371/journal.pone.0017312	http://dx.doi.org/10.1371/journal.pone.0017312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364956	Green Published, Green Submitted			2022-12-27	WOS:000287656600039
J	Dave, RK; Ellis, T; Toumpas, MC; Robson, JP; Julian, E; Adolphe, C; Bartlett, PF; Cooper, HM; Reynolds, BA; Wainwright, BJ				Dave, Richa K.; Ellis, Tammy; Toumpas, Melissa C.; Robson, Jonathan P.; Julian, Elaine; Adolphe, Christelle; Bartlett, Perry F.; Cooper, Helen M.; Reynolds, Brent A.; Wainwright, Brandon J.			Sonic Hedgehog and Notch Signaling Can Cooperate to Regulate Neurogenic Divisions of Neocortical Progenitors	PLOS ONE			English	Article							NEURAL STEM-CELLS; RADIAL GLIAL-CELLS; NERVOUS-SYSTEM; ASYMMETRIC DIVISION; CEREBRAL-CORTEX; NEURONS; PATHWAY; GROWTH; DIFFERENTIATION; PRECURSORS	Background: Hedgehog (Hh) signaling is crucial for the generation and maintenance of both embryonic and adult stem cells, thereby regulating development and tissue homeostasis. In the developing neocortex, Sonic Hedgehog (Shh) regulates neural progenitor cell proliferation. During neurogenesis, radial glial cells of the ventricular zone (VZ) are the predominant neocortical progenitors that generate neurons through both symmetric and asymmetric divisions. Despite its importance, relatively little is known of the molecular pathways that control the switch from symmetric proliferative to differentiative/neurogenic divisions in neural progenitors. Principal Findings: Here, we report that conditional inactivation of Patched1, a negative regulator of the Shh pathway, in Nestin positive neural progenitors of the neocortex leads to lamination defects due to improper corticogenesis and an increase in the number of symmetric proliferative divisions of the radial glial cells. Hedgehog-activated VZ progenitor cells demonstrated a concomitant upregulation of Hes1 and Blbp, downstream targets of Notch signaling. The Notch signaling pathway plays a pivotal role in the maintenance of stem/progenitor cells and the regulation of glial versus neuronal identity. To study the effect of Notch signaling on Hh-activated neural progenitors, we inactivated both Patched1 and Rbpj, a transcriptional mediator of Notch signaling, in Nestin positive cells of the neocortex. Conclusions: Our data indicate that by mid neurogenesis (embryonic day 14.5), attenuation of Notch signaling reverses the effect of Patched1 deletion on neurogenesis by restoring the balance between symmetric proliferative and neurogenic divisions. Hence, our results demonstrate that correct corticogenesis is an outcome of the interplay between the Hh and Notch signaling pathways.	[Dave, Richa K.; Ellis, Tammy; Toumpas, Melissa C.; Robson, Jonathan P.; Julian, Elaine; Adolphe, Christelle; Wainwright, Brandon J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Bartlett, Perry F.; Cooper, Helen M.; Reynolds, Brent A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Cooper, Helen M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Dave, RK (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	b.wainwright@imb.uq.edu.au	Cooper, Helen/G-3505-2010; Cooper, Helen M/AAA-2182-2019; Bartlett, Perry/F-3813-2012	Cooper, Helen M/0000-0001-9838-5743; Adolphe, Christelle/0000-0002-3908-1843; Wainwright, Brandon/0000-0003-0406-2092	Australian National Health and Medical Research Council; ARC Special Research Centre for Functional and Applied Genomics; ACRF; Queensland Cancer Fund; John Trivett Foundation	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Special Research Centre for Functional and Applied Genomics(Australian Research Council); ACRF; Queensland Cancer Fund; John Trivett Foundation	This work was supported by grants from the Australian National Health and Medical Research Council and the ARC Special Research Centre for Functional and Applied Genomics. Confocal microscopy was performed at the Australian Cancer Research Foundation (ACRF)/Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology, which was established with the support of the ACRF. R. Dave is supported by the Queensland Cancer Fund. T. Ellis is supported by The John Trivett Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Bultje RS, 2009, NEURON, V63, P189, DOI 10.1016/j.neuron.2009.07.004; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Campbell K, 2002, TRENDS NEUROSCI, V25, P235, DOI 10.1016/S0166-2236(02)02156-2; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Corbin JG, 2008, J NEUROCHEM, V106, P2272, DOI 10.1111/j.1471-4159.2008.05522.x; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Ellis T, 2003, DEV BIOL, V263, P203, DOI 10.1016/S0012-1606(03)00394-4; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Ever L, 2005, CURR OPIN NEUROBIOL, V15, P29, DOI 10.1016/j.conb.2005.01.005; Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8; Fujimoto M, 2009, DEV BIOL, V332, P339, DOI 10.1016/j.ydbio.2009.06.001; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gaiano N, 2008, NEURON, V60, P189, DOI 10.1016/j.neuron.2008.10.009; Gao F, 2009, MOL CELL NEUROSCI, V40, P442, DOI 10.1016/j.mcn.2008.12.008; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Gotz M, 2002, BRAIN RES BULL, V57, P777, DOI 10.1016/S0361-9230(01)00777-8; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; HANSEN DV, NATURE; Hashimoto-Torii K, 2008, NEURON, V60, P273, DOI 10.1016/j.neuron.2008.09.026; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; INGRAM WJ, 2007, ONCOGENE; Julian E, 2010, ONCOGENE, V29, P3465, DOI 10.1038/onc.2010.101; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; KOMADA M, 2008, DEVELOPMENT; Komine O, 2007, DEV BIOL, V311, P238, DOI 10.1016/j.ydbio.2007.08.042; LIU SL, 2005, P AM ASS CANC RES, V46; Lutolf S, 2002, DEVELOPMENT, V129, P373; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mo ZC, 2007, J NEUROSCI, V27, P4132, DOI 10.1523/JNEUROSCI.0111-07.2007; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pevny L, 2005, CURR OPIN NEUROBIOL, V15, P7, DOI 10.1016/j.conb.2005.01.016; Pierfelice TJ, 2008, COLD SH Q B, V73, P367, DOI 10.1101/sqb.2008.73.013; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Qian XM, 1998, DEVELOPMENT, V125, P3143; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Shen Q, 2002, DEVELOPMENT, V129, P4843; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wall DS, 2009, J CELL BIOL, V184, P101, DOI 10.1083/jcb.200805155; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004	69	67	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14680	10.1371/journal.pone.0014680	http://dx.doi.org/10.1371/journal.pone.0014680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379383	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482300002
J	Bollazzi, M; Roces, F				Bollazzi, Martin; Roces, Flavio			Information Needs at the Beginning of Foraging: Grass-Cutting Ants Trade Off Load Size for a Faster Return to the Nest	PLOS ONE			English	Article							ATTA-CEPHALOTES L; HARVESTER ANTS; ACROMYRMEX-LUNDI; LEAF; SELECTION; COLOMBICA; STRATEGIES; BEHAVIOR; FORMICIDAE; DISTANCE	Background: Acquisition of information about food sources is essential for animals that forage collectively like social insects. Foragers deliver two commodities to the nest, food and information, and they may favor the delivery of one at the expenses of the other. We predict that information needs should be particularly high at the beginning of foraging: the decision to return faster to the nest will motivate a grass-cutting ant worker to reduce its loading time, and so to leave the source with a partial load. Principal Findings: Field results showed that at the initial foraging phase, most grass-cutting ant foragers (Acromyrmex heyeri) returned unladen to the nest, and experienced head-on encounters with outgoing workers. Ant encounters were not simply collisions in a probabilistic sense: outgoing workers contacted in average 70% of the returning foragers at the initial foraging phase, and only 20% at the established phase. At the initial foraging phase, workers cut fragments that were shorter, narrower, lighter and tenderer than those harvested at the established one. Foragers walked at the initial phase significantly faster than expected for the observed temperatures, yet not at the established phase. Moreover, when controlling for differences in the fragment-size carried, workers still walked faster at the initial phase. Despite the higher speed, their individual transport rate of vegetable tissue was lower than that of similarly-sized workers foraging later at the same patch. Conclusions/Significance: At the initial foraging phase, workers compromised their individual transport rates of material in order to return faster to the colony. We suggest that the observed flexible cutting rules and the selection of partial loads at the beginning of foraging are driven by the need of information transfer, crucial for the establishment and maintenance of a foraging process to monopolize a discovered resource.	[Bollazzi, Martin; Roces, Flavio] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany; [Bollazzi, Martin] Univ Republica, Fac Agron, Dept Entomol, Montevideo, Uruguay; [Bollazzi, Martin] Univ Republ, Ctr Univ Rivera, Rivera, Uruguay	University of Wurzburg; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Bollazzi, M (corresponding author), Univ Wurzburg, Dept Behav Physiol & Sociobiol, Bioctr, Wurzburg, Germany.	roces@biozentrum.uni-wuerzburg.de		Bollazzi, Martin/0000-0003-3361-5602; Roces, Flavio/0000-0001-9258-3079	German Academic Exchange Service (DAAD); German Research Foundation [DFG - SFB 567]	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); German Research Foundation(German Research Foundation (DFG))	This research was supported by the German Academic Exchange Service (DAAD, fellowship granted to MB) and the German Research Foundation (DFG - SFB 567 "Mechanisms of Interspecific Interactions of Organisms''). The publications costs were covered by the German Research Foundation (DFG) in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes TC, 1932, BIOL BULL-US, V62, P306, DOI 10.2307/1537511; BERTSCH A, 1984, OECOLOGIA, V62, P325, DOI 10.1007/BF00384264; Burd M, 2000, BEHAV ECOL, V11, P125, DOI 10.1093/beheco/11.2.125; Burd M, 2003, INSECT SOC, V50, P3, DOI 10.1007/s000400300001; Burd M, 2000, ANIM BEHAV, V60, P781, DOI 10.1006/anbe.2000.1537; BURD M, 1995, J INSECT BEHAV, V8, P715, DOI 10.1007/BF01997240; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; Daguerre J. B., 1945, REV SOC ENT ARGENTINA, V12, P438; Detrain C, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P331; Detrain C, 2009, CONTEMP TOP ENTOMOL, P29; Dornhaus A, 2006, BEHAV ECOL SOCIOBIOL, V61, P151, DOI 10.1007/s00265-006-0246-5; Dussutour A, 2007, INSECT SOC, V54, P158, DOI 10.1007/s00040-007-0926-9; Farji-Brener AG, 2010, ANIM BEHAV, V79, P343, DOI 10.1016/j.anbehav.2009.11.009; Gordon D. M., 2010, ANT ENCOUNTERS INTER, P167; Gordon DM, 2008, BEHAV ECOL, V19, P217, DOI 10.1093/beheco/arm125; GORDON DM, 1993, ANIM BEHAV, V45, P1083, DOI 10.1006/anbe.1993.1134; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Gordon DM, 1999, BEHAV ECOL SOCIOBIOL, V45, P370, DOI 10.1007/s002650050573; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; HODGSON ES, 1955, ECOLOGY, V36, P293, DOI 10.2307/1933235; HOWARD JJ, 1987, ECOLOGY, V68, P503, DOI 10.2307/1938455; Howard JJ, 1996, ANIM BEHAV, V52, P299, DOI 10.1006/anbe.1996.0175; JAFFE K, 1979, ANIM BEHAV, V27, P930, DOI 10.1016/0003-3472(79)90031-9; JAFFE K, 1985, INSECT SOC, V32, P257, DOI 10.1007/BF02224915; LEWIS T, 1974, J ANIM ECOL, V43, P129, DOI 10.2307/3162; LUGO AE, 1973, ECOLOGY, V54, P1292, DOI 10.2307/1934191; Lutz FE, 1929, AM MUS NOVIT, V388, P1, DOI DOI 10.1206/0003-0082(2006)502[0001:NSAFRS]2.0.CO;2; Moll K, 2010, J COMP PHYSIOL A, V196, P471, DOI 10.1007/s00359-010-0535-3; NUNEZ J A, 1970, Animal Behaviour, V18, P527, DOI 10.1016/0003-3472(70)90049-7; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; Nunez JA, 1996, BEE WORLD, V77, P182, DOI 10.1080/0005772X.1996.11099313; NUNEZ JA, 1982, J APICULT RES, V21, P139, DOI 10.1080/00218839.1982.11100531; PFLUMM W, 1986, ETHOLOGY, V72, P15; ROCES F, 1993, BEHAV ECOL SOCIOBIOL, V33, P183, DOI 10.1007/BF00216599; ROCES F, 1994, OECOLOGIA, V97, P1, DOI 10.1007/BF00317902; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; ROCES F, 1993, ANIM BEHAV, V45, P135, DOI 10.1006/anbe.1993.1012; ROCES F, 1994, INSECT SOC, V41, P235, DOI 10.1007/BF01242294; ROCES F, 1990, ANIM BEHAV, V40, P1181, DOI 10.1016/S0003-3472(05)80185-X; Roces Flavio, 2009, P289; Roces F, 2009, CONTEMP TOP ENTOMOL, P261; Roschard J, 2003, J TROP ECOL, V19, P647, DOI 10.1017/S0266467403006047; Roschard J, 2002, OECOLOGIA, V131, P319, DOI 10.1007/s00442-002-0882-z; RUDOLPH SG, 1986, ECOL ENTOMOL, V11, P401, DOI 10.1111/j.1365-2311.1986.tb00319.x; Saverschek N, 2010, ANIM BEHAV, V79, P689, DOI 10.1016/j.anbehav.2009.12.021; Schafer RJ, 2006, ANIM BEHAV, V71, P815, DOI 10.1016/j.anbehav.2005.05.024; Shapley H, 1924, P NATL ACAD SCI USA, V10, P436, DOI 10.1073/pnas.10.10.436; STRADLING DJ, 1978, J ANIM ECOL, V47, P173, DOI 10.2307/3930; Torres-Contreras H, 2007, ETHOLOGY, V113, P76, DOI 10.1111/j.1439-0310.2006.01302.x; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; YDENBERG R, 1994, TRENDS ECOL EVOL, V9, P491, DOI 10.1016/0169-5347(94)90321-2	52	41	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17667	10.1371/journal.pone.0017667	http://dx.doi.org/10.1371/journal.pone.0017667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408014	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900038
J	John, S; Weiss, JN; Ribalet, B				John, Scott; Weiss, James N.; Ribalet, Bernard			Subcellular Localization of Hexokinases I and II Directs the Metabolic Fate of Glucose	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; HUMAN BRAIN HEXOKINASE; GLYCOGEN-SYNTHASE; MITOCHONDRIAL HEXOKINASE; MAMMALIAN HEXOKINASE; HUMAN MUSCLE; PROTEIN; CELLS; GLUCOSE-6-PHOSPHATE; BINDING	Background: The first step in glucose metabolism is conversion of glucose to glucose 6-phosphate (G-6-P) by hexokinases (HKs), a family with 4 isoforms. The two most common isoforms, HKI and HKII, have overlapping tissue expression, but different subcellular distributions, with HKI associated mainly with mitochondria and HKII associated with both mitochondrial and cytoplasmic compartments. Here we tested the hypothesis that these different subcellular distributions are associated with different metabolic roles, with mitochondrially-bound HK's channeling G-6-P towards glycolysis (catabolic use), and cytoplasmic HKII regulating glycogen formation (anabolic use). Methodology/Principal Findings: To study subcellular translocation of HKs in living cells, we expressed HKI and HKII linked to YFP in CHO cells. We concomitantly recorded the effects on glucose handling using the FRET based intracellular glucose biosensor, FLIPglu-600 mM, and glycogen formation using a glycogen-associated protein, PTG, tagged with GFP. Our results demonstrate that HKI remains strongly bound to mitochondria, whereas HKII translocates between mitochondria and the cytosol in response to glucose, G-6-P and Akt, but not ATP. Metabolic measurements suggest that HKI exclusively promotes glycolysis, whereas HKII has a more complex role, promoting glycolysis when bound to mitochondria and glycogen synthesis when located in the cytosol. Glycogen breakdown upon glucose removal leads to HKII inhibition and dissociation from mitochondria, probably mediated by increases in glycogen-derived G-6-P. Conclusions/Significance: These findings show that the catabolic versus anabolic fate of glucose is dynamically regulated by extracellular glucose via signaling molecules such as intracellular glucose, G-6-P and Akt through regulation and subcellular translocation of HKII. In contrast, HKI, which activity and regulation is much less sensitive to these factors, is mainly committed to glycolysis. This may be an important mechanism by which HK's allow cells to adapt to changing metabolic conditions to maintain energy balance and avoid injury.	[Weiss, James N.; Ribalet, Bernard] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Physiol, Los Angeles, CA 90095 USA; [John, Scott; Weiss, James N.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Med Cardiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	John, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Lab, Dept Med Cardiol, Los Angeles, CA 90095 USA.	bribalet@mednet.ucla.edu		John, Scott/0000-0002-1232-9140	NIH [R37HL60025, P01 HL071870]; Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071870, R37HL060025] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Laubisch and Kawata Endowments; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants R37HL60025 and P01 HL071870, Laubisch and Kawata Endowments to J.N.W. and a Laubsich endowment to S.J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Cesar MD, 2002, ARCH BIOCHEM BIOPHYS, V397, P106, DOI 10.1006/abbi.2001.2639; Cifuentes D, 2008, J BIOL CHEM, V283, P5642, DOI 10.1074/jbc.M706334200; Depre C, 1999, CIRCULATION, V99, P578, DOI 10.1161/01.CIR.99.4.578; ELLISON WR, 1975, J BIOL CHEM, V250, P1864; Fang TY, 1998, J BIOL CHEM, V273, P19548, DOI 10.1074/jbc.273.31.19548; Fehr M, 2003, J BIOL CHEM, V278, P19127, DOI 10.1074/jbc.M301333200; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Galluzzi L, 2008, ONCOGENE, V27, P4633, DOI 10.1038/onc.2008.114; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; John SA, 2008, PFLUG ARCH EUR J PHY, V456, P307, DOI 10.1007/s00424-007-0395-z; Jurczak MJ, 2008, J CELL BIOCHEM, V104, P435, DOI 10.1002/jcb.21634; Lerin C, 2000, J BIOL CHEM, V275, P39991, DOI 10.1074/jbc.M006251200; LOWRY OH, 1964, J BIOL CHEM, V239, P31; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; MANDARINO LJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE701; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; PURICH DL, 1971, J BIOL CHEM, V246, P3456; ROSE IA, 1967, J BIOL CHEM, V242, P1635; Schulz AR, 1998, ARCH BIOCHEM BIOPHYS, V353, P172, DOI 10.1006/abbi.1998.0643; Skaff DA, 2005, J BIOL CHEM, V280, P38403, DOI 10.1074/jbc.M506943200; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Syed NA, 2000, MOL CELL BIOCHEM, V211, P123, DOI 10.1023/A:1007159422667; Taylor AJ, 2006, J ENDOCRINOL, V188, P11, DOI 10.1677/joe.1.06381; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241	30	145	153	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17674	10.1371/journal.pone.0017674	http://dx.doi.org/10.1371/journal.pone.0017674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408025	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170900039
J	Achan, J; Tibenderana, J; Kyabayinze, D; Mawejje, H; Mugizi, R; Mpeka, B; Talisuna, A; D'Alessandro, U				Achan, Jane; Tibenderana, James; Kyabayinze, Daniel; Mawejje, Henry; Mugizi, Rukaaka; Mpeka, Betty; Talisuna, Ambrose; D'Alessandro, Umberto			Case Management of Severe Malaria - A Forgotten Practice: Experiences from Health Facilities in Uganda	PLOS ONE			English	Article							AFRICAN CHILDREN; INPATIENT MORTALITY; FALCIPARUM-MALARIA; PEDIATRIC CARE; HOSPITALS; QUALITY; TRIAGE	Introduction: Severe malaria is a life-threatening medical emergency and requires prompt and effective treatment to prevent death. There is paucity of published information on current practices of severe malaria case management in sub-Saharan Africa; we evaluated the management practices for severe malaria in Ugandan health facilities Methods and Findings: We did a cross sectional survey, using multi-stage sampling methods, of health facilities in 11 districts in the eastern and mid-western parts of Uganda. The study instruments were adapted from the WHO hospital care assessment tools. Between June and August 2009, 105 health facilities were surveyed and 181 health workers and 868 patients/caretakers interviewed. None of the inpatient facilities had all seven components of a basic care package for the management of severe malaria consistently available during the 3 months prior to the survey. Referral practices were appropriate for < 10% (18/196) of the patients. Prompt care at any health facility was reported by 29% (247/868) of patients. Severe malaria was correctly diagnosed in 27% of patients (233). Though the quinine dose and regimen was correct in the majority (611/868, 70.4%) of patients, it was administered in the correct volumes of 5% dextrose in only 18% (147/815). Most patients (80.1%) had several doses of quinine administered in one single 500 ml bottle of 5% dextrose. Medications were purchased by 385 (44%) patients and medical supplies by 478 patients (70.6%). Conclusions: Management of severe malaria in Ugandan health facilities was sub-optimal. These findings highlight the challenges of correctly managing severe malaria in resource limited settings. Priority areas for improvement include triage and emergency care, referral practises, quality of diagnosis and treatment, availability of medicines and supplies, training and support supervision.	[Achan, Jane] Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda; [Tibenderana, James; Mawejje, Henry; Mugizi, Rukaaka; Mpeka, Betty] Malaria Consortium Africa, Kampala, Uganda; [Tibenderana, James] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kyabayinze, Daniel] Malaria Consortium, Communicable Dis Res Programme Consortium, Kampala, Uganda; [Talisuna, Ambrose] Makerere Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Kampala, Uganda; [D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium	Makerere University; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Institute of Tropical Medicine (ITM)	Achan, J (corresponding author), Makerere Univ, Dept Paediat & Child Hlth, Coll Hlth Sci, Kampala, Uganda.	achanj@yahoo.co.uk	Tibenderana, James Kananura/M-2272-2018; D'Alessandro, Umberto/D-3457-2015	Tibenderana, James Kananura/0000-0002-0755-4597; D'Alessandro, Umberto/0000-0001-6341-5009; Kyabayinze, Daniel/0000-0002-0539-1341	Irish Aid	Irish Aid(CGIAR)	Financial support for this study was provided by the Irish Aid through a regional programme in the Malaria Consortium on Health Systems Strengthening for Equitable Access to Malaria and Other Communicable Disease Control. The funders of the study had no role in study design, data collection, data analysis, data interpretation, decision to publish or preparation of the manuscript.	[Anonymous], CDC GROWTH CHARTS; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Day N, 2007, AM J TROP MED HYG, V77, P29; Dondorp AM, 2007, T ROY SOC TROP MED H, V101, P633, DOI 10.1016/j.trstmh.2007.03.011; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Duke T, 2003, ARCH DIS CHILD, V88, P563, DOI 10.1136/adc.88.7.563; English M, 2004, LANCET, V363, P1948, DOI 10.1016/S0140-6736(04)16408-8; Faiz MA, 2005, LANCET, V366, P717; Gwer S, 2007, AM J TROP MED HYG, V77, P6, DOI 10.4269/ajtmh.2007.77.6; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; *MMV, 2010, MED MAL VENT ACH CHA; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; NEWTON CR, 1998, PHARMACOL THERAPEUT, V79, P153; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Planche T, 2003, CLIN INFECT DIS, V37, P890, DOI 10.1086/377536; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Ssekabira U, 2008, AM J TROP MED HYG, V79, P826, DOI 10.4269/ajtmh.2008.79.826; Tamburlini G, 1999, ARCH DIS CHILD, V81, P478, DOI 10.1136/adc.81.6.478; *UG MIN HLTH, UG MAL CONTR STR 200; *UG MIN HLTH, 2003, NAT TREATM GUID; UNICEF, 2014, UG STAT; *USAID, 2003, HLTH SECT HUM RES CR; WHO, 2010, GUID TREATM MAL, V2nd; Winstanley P, 2004, CLIN MICROBIOL REV, V17, P612, DOI 10.1128/CMR.17.3.612-637.2004	25	37	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17053	10.1371/journal.pone.0017053	http://dx.doi.org/10.1371/journal.pone.0017053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390301	Green Published, gold			2022-12-27	WOS:000287932100009
J	Zhang, JY; Zou, ZS; Huang, A; Zhang, Z; Fu, JL; Xu, XS; Chen, LM; Li, BS; Wang, FS				Zhang, Ji-Yuan; Zou, Zheng-Sheng; Huang, Ang; Zhang, Zheng; Fu, Jun-Liang; Xu, Xiang-Sheng; Chen, Li-Ming; Li, Bao-Sen; Wang, Fu-Sheng			Hyper-Activated Pro-Inflammatory CD16(+) Monocytes Correlate with the Severity of Liver Injury and Fibrosis in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							T-CELLS; DISEASE PROGRESSION; VIRUS; DAMAGE; CD14	Background: Extensive mononuclear cell infiltration is strongly correlated with liver damage in patients with chronic hepatitis B virus (CHB) infection. Macrophages and infiltrating monocytes also participate in the development of liver damage and fibrosis in animal models. However, little is known regarding the immunopathogenic role of peripheral blood monocytes and intrahepatic macrophages. Methodology/Principal Findings: The frequencies, phenotypes, and functions of peripheral blood and intrahepatic monocyte/macrophage subsets were analyzed in 110 HBeAg positive CHB patients, including 32 immune tolerant (IT) carriers and 78 immune activated (IA) patients. Liver biopsies from 20 IA patients undergoing diagnosis were collected for immunohistochemical analysis. IA patients displayed significant increases in peripheral blood monocytes and intrahepatic macrophages as well as CD16(+) subsets, which were closely associated with serum alanine aminotransferase (ALT) levels and the liver histological activity index (HAI) scores. In addition, the increased CD16(+) monocytes/macrophages expressed higher levels of the activation marker HLA-DR compared with CD16(-) monocytes/macrophages. Furthermore, peripheral blood CD16(+) monocytes preferentially released inflammatory cytokines and hold higher potency in inducing the expansion of Th17 cells. Of note, hepatic neutrophils also positively correlated with HAI scores. Conclusions: These distinct properties of monocyte/macrophage subpopulations participate in fostering the inflammatory microenvironment and liver damage in CHB patients and further represent a collaborative scenario among different cell types contributing to the pathogenesis of HBV-induced liver disease.	[Zhang, Ji-Yuan; Zhang, Zheng; Fu, Jun-Liang; Xu, Xiang-Sheng; Chen, Li-Ming; Wang, Fu-Sheng] Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China; [Zou, Zheng-Sheng; Huang, Ang; Li, Bao-Sen] Beijing 302 Hosp, Dept Infect Dis, Beijing, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Fifth Medical Center of Chinese PLA General Hospital	Zhang, JY (corresponding author), Beijing 302 Hosp, Res Ctr Biol Therapy, Beijing, Peoples R China.	libaosen16@sina.com; fswang@public.bta.net.cn		Huang, Ang/0000-0001-8876-9903	National Grand Program on Key Infectious Disease [2009ZX10004-103, 2009ZX10004-309, 2008ZX10002-007]; National Natural Science Foundation of China [30801039]	National Grand Program on Key Infectious Disease; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Grand Program on Key Infectious Disease (No. 2009ZX10004-103, No. 2009ZX10004-309 and 2008ZX10002-007) and the National Natural Science Foundation of China (No. 30801039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Dolganiuc A, 2004, GASTROENTEROLOGY, V127, P1513, DOI 10.1053/j.gastro.2004.08.067; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Evans HG, 2009, P NATL ACAD SCI USA, V106, P6232, DOI 10.1073/pnas.0808144106; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Gujral JS, 2003, HEPATOLOGY, V38, P355, DOI 10.1053/jhep.2003.50341; Han JY, 2009, JAIDS-J ACQ IMM DEF, V52, P553, DOI 10.1097/QAI.0b013e3181c1d4fe; Kuang DM, 2010, HEPATOLOGY, V51, P154, DOI 10.1002/hep.23291; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Maini MK, 2000, J EXP MED, V191, P1269, DOI 10.1084/jem.191.8.1269; Matsuzaki G, 2007, MICROBIOL IMMUNOL, V51, P1139, DOI 10.1111/j.1348-0421.2007.tb04008.x; MIROSLAVABLAHOV, 2010, HEPATOLOGY, V51, P2030; O'Quinn DB, 2008, ADV IMMUNOL, V99, P115, DOI 10.1016/S0065-2776(08)00605-6; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sitia G, 2004, J CLIN INVEST, V113, P1158, DOI 10.1172/JCI200421087; WANG FS, 2009, GASTROENTEROL HEPATO, V3, P499; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Yang PL, 2010, P NATL ACAD SCI USA, V107, P798, DOI 10.1073/pnas.0913498107; Zhang JY, 2008, J IMMUNOL, V181, P3741, DOI 10.4049/jimmunol.181.6.3741; Zhang JY, 2010, HEPATOLOGY, V51, P81, DOI 10.1002/hep.23273; Zhang Z, 2008, J HEPATOL, V49, P396, DOI 10.1016/j.jhep.2008.05.017; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Zou ZS, 2009, J CLIN GASTROENTEROL, V43, P182, DOI 10.1097/MCG.0b013e3181624464	28	83	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17484	10.1371/journal.pone.0017484	http://dx.doi.org/10.1371/journal.pone.0017484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390263	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100019
J	Du, JA; Miura, E; Robischon, M; Martinez, C; Groover, A				Du, Juan; Miura, Eriko; Robischon, Marcel; Martinez, Ciera; Groover, Andrew			The Populus Class III HD ZIP Transcription Factor POPCORONA Affects Cell Differentiation during Secondary Growth of Woody Stems	PLOS ONE			English	Article							SHOOT APICAL MERISTEM; GENE FAMILY; LATERAL ORGANS; HOMEOBOX GENE; ARABIDOPSIS; MICRORNAS; BIOSYNTHESIS; GIBBERELLIN; EVOLUTION; POLARITY	The developmental mechanisms regulating cell differentiation and patterning during the secondary growth of woody tissues are poorly understood. Class III HD ZIP transcription factors are evolutionarily ancient and play fundamental roles in various aspects of plant development. Here we investigate the role of a Class III HD ZIP transcription factor, POPCORONA, during secondary growth of woody stems. Transgenic Populus (poplar) trees expressing either a miRNA-resistant POPCORONA or a synthetic miRNA targeting POPCORONA were used to infer function of POPCORONA during secondary growth. Whole plant, histological, and gene expression changes were compared for transgenic and wild-type control plants. Synthetic miRNA knock down of POPCORONA results in abnormal lignification in cells of the pith, while overexpression of a miRNA-resistant POPCORONA results in delayed lignification of xylem and phloem fibers during secondary growth. POPCORONA misexpression also results in coordinated changes in expression of genes within a previously described transcriptional network regulating cell differentiation and cell wall biosynthesis, and hormone-related genes associated with fiber differentiation. POPCORONA illustrates another function of Class III HD ZIPs: regulating cell differentiation during secondary growth.	[Du, Juan; Miura, Eriko; Robischon, Marcel; Groover, Andrew] US Forest Serv, Pacific SW Res Stn, Inst Forest Genet, Davis, CA USA; [Martinez, Ciera; Groover, Andrew] Univ Calif Davis, Plant Biol Grad Grp, Davis, CA 95616 USA	United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Davis	Du, JA (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	agroover@fs.fed.us	Du, Juan/AAQ-5466-2020	DU, JUAN/0000-0001-8263-5189	DOE [DE-A102-05ER64115]	DOE(United States Department of Energy (DOE))	This work was supported by DOE grant DE-A102-05ER64115 to AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONI R, 1982, PLANT PHYSIOL, V70, P1631, DOI 10.1104/pp.70.6.1631; ALONI R, 1979, PLANT PHYSIOL, V63, P609, DOI 10.1104/pp.63.4.609; Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baima S, 1995, DEVELOPMENT, V121, P4171; Baima S, 2001, PLANT PHYSIOL, V126, P643, DOI 10.1104/pp.126.2.643; Du J, 2009, PLANT J, V60, P1000, DOI 10.1111/j.1365-313X.2009.04017.x; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2001, CURR BIOL, V11, P1251, DOI 10.1016/S0960-9822(01)00392-X; Floyd SK, 2007, INT J PLANT SCI, V168, P1, DOI 10.1086/509079; Floyd SK, 2006, GENETICS, V173, P373, DOI 10.1534/genetics.105.054239; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Groover AT, 2006, PLANT MOL BIOL, V61, P917, DOI 10.1007/s11103-006-0059-y; Groover AT, 2010, PLANT GENET GENOMICS, V8, P201, DOI 10.1007/978-1-4419-1541-2_10; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Han KH, 2000, PLANT CELL REP, V19, P315, DOI 10.1007/s002990050019; Hertzberg M, 2001, P NATL ACAD SCI USA, V98, P14732, DOI 10.1073/pnas.261293398; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Izhaki A, 2007, PLANT CELL, V19, P495, DOI 10.1105/tpc.106.047472; Kerstetter RA, 2001, NATURE, V411, P706, DOI 10.1038/35079629; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim YS, 2008, PLANT CELL, V20, P920, DOI 10.1105/tpc.107.057448; Ko JH, 2006, NEW PHYTOL, V169, P469, DOI 10.1111/j.1469-8137.2005.01623.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson, 1994, VASCULAR CAMBIUM; MADDISON WP, 1999, MACGLADE VERSION 3 0; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Nylander J. A. A., 2004, MRAIC; Ochando I, 2008, INT J DEV BIOL, V52, P953, DOI 10.1387/ijdb.072306io; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Ogawa M, 2003, PLANT CELL, V15, P1591, DOI 10.1105/tpc.011650; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Prigge MJ, 2006, EVOL DEV, V8, P350, DOI 10.1111/j.1525-142X.2006.00107.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rieu I, 2008, PLANT CELL, V20, P2420, DOI 10.1105/tpc.108.058818; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Schrader J, 2004, PLANT CELL, V16, P2278, DOI 10.1105/tpc.104.024190; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Serrano-Cartagena J, 2000, GENETICS, V156, P1363; Spicer R, 2010, NEW PHYTOL, V186, P577, DOI 10.1111/j.1469-8137.2010.03236.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Thiel T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-209; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; YAMAGUCHI M, 2010, PLANT PHYSIOL, V110; Yamaguchi M, 2008, PLANT J, V55, P652, DOI 10.1111/j.1365-313X.2008.03533.x; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong RQ, 2001, PLANT PHYSIOL, V126, P549, DOI 10.1104/pp.126.2.549; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	60	77	83	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17458	10.1371/journal.pone.0017458	http://dx.doi.org/10.1371/journal.pone.0017458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386988	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400079
J	Letang, E; Miro, JM; Nhampossa, T; Ayala, E; Gascon, J; Menendez, C; Alonso, PL; Naniche, D				Letang, Emilio; Miro, Jose M.; Nhampossa, Tacilta; Ayala, Edgar; Gascon, Joaquim; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise			Incidence and Predictors of Immune Reconstitution Inflammatory Syndrome in a Rural Area of Mozambique	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-INFECTED PATIENTS; RISK-FACTORS; KAPOSIS-SARCOMA; RESTORATION DISEASE; INITIATION; TUBERCULOSIS; MORTALITY; AFRICA; EUROPE	Background: There is limited data on the epidemiology of Immune Reconstitution Inflammatory Syndrome (IRIS) in rural sub-Saharan Africa. A prospective observational cohort study was conducted to assess the incidence, clinical characteristics, outcome and predictors of IRIS in rural Mozambique. Methods: One hundred and thirty-six consecutive antiretroviral treatment (ART)-naive HIV-1-infected patients initiating ART at the Manhic, a district hospital were prospectively followed for development of IRIS over 16 months. Survival analysis by Cox regression was performed to identify pre-ART predictors of IRIS development. Results: Thirty-six patients developed IRIS [26.5%, incidence rate 3.1 cases/100 persons-month of ART (95% CI 2.2-4.3)]. Median time to IRIS onset was 62 days from ART initiation (IQR 35.5-93.5). Twenty-five cases (69.4%) were "unmasking", 10 (27.8%) were "paradoxical", and 1 (2.8%) developed a paradoxical worsening followed by the unmasking of another condition. Systemic OI (OI-IRIS) accounted for 47% (17/36) of IRIS cases, predominantly of KS (8 cases) and TB (6 cases) IRIS. Mucocutaneous IRIS manifestations (MC-IRIS) accounted for 53% (19/36) of IRIS events, mostly tinea (9 cases) and herpes simplex infection (3 cases). Multivariate analysis identified two independent predictors of IRIS development: pre-ART CD4 count < 50 cells/mu l (HR 2.3, 95% CI 1.19-4.44, p = 0.01) and body mass index (BMI) < 18.5 (HR 2.15, 95% CI 1.07-4.3, p = 0.03). The pre-cART proportion of activated T-cells, as well as the immunologic and virologic response to ART were not associated with IRIS development. All patients continued on ART, 7 (19.4%) required hospitalization and there were 3 deaths (8.3%) attributable to IRIS. Conclusions: IRIS is common in patients initiating ART in rural Mozambique. Pre-ART CD4 counts and BMI can easily be assessed at ART initiation in rural sub-Saharan Africa to identify patients at high risk of IRIS, for whom close supervision is warranted.	[Letang, Emilio; Nhampossa, Tacilta; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise] CISM, Manhica, Maputo, Mozambique; [Miro, Jose M.] Univ Barcelona, Infect Dis Serv, Hosp Clin IDIBAPS, Barcelona, Spain; [Letang, Emilio; Ayala, Edgar; Gascon, Joaquim; Menendez, Clara; Alonso, Pedro L.; Naniche, Denise] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin IDIBAPS, Barcelona, Spain	Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Letang, E (corresponding author), CISM, Manhica, Maputo, Mozambique.	emili.letang@cresib.cat; dsuzanne@clinic.ub.es	Gascon, Joaquim/M-3598-2015; Alonso, Pedro L/AAZ-3645-2020; Menéndez, Clara/Q-3446-2016; Naniche, Denise S/S-1814-2018	Gascon, Joaquim/0000-0002-5045-1585; Alonso, Pedro L/0000-0003-3292-3443; Menéndez, Clara/0000-0002-2641-6907; Naniche, Denise S/0000-0002-4495-6325	Fundacio "la Caixa"; Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development; Agencia Catalana de Cooperacio al Desenvolupament; Spanish Ministry of Education and Science (Rio Hortega); Spanish Ministry of Education and Science (Ramon y Cajal); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain); Spanish Network for AIDS Research (RIS) [ISCIII-RETIC RD06/006]; Madrid (Spain)	Fundacio "la Caixa"(La Caixa FoundationEuropean Commission); Agencia Catalana de Cooperacio al Desenvolupament (ACCD); Spanish Agency for International Cooperation and Development(Spanish Government); Agencia Catalana de Cooperacio al Desenvolupament; Spanish Ministry of Education and Science (Rio Hortega)(Spanish Government); Spanish Ministry of Education and Science (Ramon y Cajal)(Spanish Government); Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain); Spanish Network for AIDS Research (RIS); Madrid (Spain)	Financial support was received from the Fundacio "la Caixa", and the Agencia Catalana de Cooperacio al Desenvolupament (ACCD). The "Centro de Investigacao em Saude de Manhica" receives core funding from the Spanish Agency for International Cooperation and Development. The VCT center is supported by the Agencia Catalana de Cooperacio al Desenvolupament. E. L. is supported by a grant from the Spanish Ministry of Education and Science (Rio Hortega). D.N. was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal). J.M.M. received a Research Grant from the "Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona (Spain), and the Spanish Network for AIDS Research (RIS; ISCIII-RETIC RD06/006), Madrid (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2010, BLOOD, V116, P3818, DOI 10.1182/blood-2010-05-285080; Bonham S, 2008, BIOMARK MED, V2, P349, DOI 10.2217/17520363.2.4.349; Bower M, 2005, J CLIN ONCOL, V23, P5224, DOI 10.1200/JCO.2005.14.597; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Cook PM, 1999, AIDS, V13, P1165, DOI 10.1097/00002030-199907090-00004; DeSimone JA, 2000, ANN INTERN MED, V133, P447, DOI 10.7326/0003-4819-133-6-200009190-00013; French MA, 2004, AIDS, V18, P1615, DOI 10.1097/01.aids.0000131375.21070.06; Funk M, 2010, 18 INT AIDS C VIENN; Geng EH, 2009, CLIN INFECT DIS, V48, P362, DOI 10.1086/595889; Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416; Haddow LJ, 2009, CLIN INFECT DIS, V49, P1424, DOI 10.1086/630208; Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lehloenya R, 2006, DERMATOL CLIN, V24, P549, DOI 10.1016/j.det.2006.06.007; Leidner RS, 2005, AIDS PATIENT CARE ST, V19, P635, DOI 10.1089/apc.2005.19.635; Letang E, 2010, JAIDS-J ACQ IMM DEF, V53, P589, DOI 10.1097/QAI.0b013e3181bc476f; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Nweze EI, 2001, MED MYCOL, V39, P181, DOI 10.1080/714031015; Osei-Sekyere B, 2010, CLIN EXP DERMATOL, V35, P477, DOI 10.1111/j.1365-2230.2009.03620.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Price P, 2009, CLIN MICROBIOL REV, V22, P651, DOI 10.1128/CMR.00015-09; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Seebacher C, 2008, MYCOPATHOLOGIA, V166, P335, DOI 10.1007/s11046-008-9100-9; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Shelburne SA, 2002, MEDICINE, V81, P213, DOI 10.1097/00005792-200205000-00005; Shelburne SA, 2005, CLIN INFECT DIS, V40, P1049, DOI 10.1086/428618; van Hal SJ, 2005, CLIN INFECT DIS, V40, P113; WHO, 2009, TREATM TUB GUID	36	27	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16946	10.1371/journal.pone.0016946	http://dx.doi.org/10.1371/journal.pone.0016946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386993	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400015
J	Wang, CW				Wang, Ching-Wei			Robust Automated Tumour Segmentation on Histological and Immunohistochemical Tissue Images	PLOS ONE			English	Article							QUANTIFICATION; CLASSIFICATION; MICROARRAY	Tissue microarray (TMA) is a high throughput analysis tool to identify new diagnostic and prognostic markers in human cancers. However, standard automated method in tumour detection on both routine histochemical and immunohistochemistry (IHC) images is under developed. This paper presents a robust automated tumour cell segmentation model which can be applied to both routine histochemical tissue slides and IHC slides and deal with finer pixel-based segmentation in comparison with blob or area based segmentation by existing approaches. The presented technique greatly improves the process of TMA construction and plays an important role in automated IHC quantification in biomarker analysis where excluding stroma areas is critical. With the finest pixel-based evaluation (instead of area-based or object-based), the experimental results show that the proposed method is able to achieve 80% accuracy and 78% accuracy in two different types of pathological virtual slides, i.e., routine histochemical H&E and IHC images, respectively. The presented technique greatly reduces labor-intensive workloads for pathologists and highly speeds up the process of TMA construction and provides a possibility for fully automated IHC quantification.	Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan	National Taiwan University of Science & Technology	Wang, CW (corresponding author), Natl Taiwan Univ Sci & Technol, Grad Inst Biomed Engn, Taipei, Taiwan.	cweiwang@mail.ntust.edu.tw	Wang, Ching-Wei/GXV-5212-2022; MA, Lei/I-4597-2014	Wang, Ching-Wei/0000-0001-9992-6863; 				Avninder S, 2008, J POSTGRAD MED, V54, P158, DOI 10.4103/0022-3859.40790; Bast RC, 2005, CLIN CANCER RES, V11, P6103, DOI 10.1158/1078-0432.CCR-04-2213; Berthod M, 1996, IMAGE VISION COMPUT, V14, P285, DOI 10.1016/0262-8856(95)01072-6; BESAG J, 1986, IJ ROY STAT SOC B; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Jawhar NMT, 2009, ANN SAUDI MED, V29, P123, DOI 10.4103/0256-4947.51806; KARACALI B, 2007, BMC MED IMAGING, V7; KATO Z, 1992, INT C AC SPEECH SIGN, V3, P573; LAW KW, 2003, COMPUTER METHODS PRO, V70, P37; Mao KZ, 2006, IEEE T BIO-MED ENG, V53, P1153, DOI 10.1109/TBME.2006.873538; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Seidal T, 2001, AM J SURG PATHOL, V25, P1204, DOI 10.1097/00000478-200109000-00013; VANDERLAAK JA, 2000, CYTOMETRY, V39; Voduc D, 2008, SEMIN RADIAT ONCOL, V18, P89, DOI 10.1016/j.semradonc.2007.10.006; Wang CW, 2010, CELL ONCOL, V32, P235; Zhang DY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-20	22	24	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e15818	10.1371/journal.pone.0015818	http://dx.doi.org/10.1371/journal.pone.0015818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386898	Green Published, gold			2022-12-27	WOS:000287931400005
J	Yao, I; Takao, K; Miyakawa, T; Ito, S; Setou, M				Yao, Ikuko; Takao, Keizo; Miyakawa, Tsuyoshi; Ito, Seiji; Setou, Mitsutoshi			Synaptic E3 Ligase SCRAPPER in Contextual Fear Conditioning: Extensive Behavioral Phenotyping of Scrapper Heterozygote and Overexpressing Mutant Mice	PLOS ONE			English	Article							ACTIVE ZONE; PROTEIN-DEGRADATION; INTERACTING PROTEIN; LATERAL AMYGDALA; CIRCADIAN CLOCK; GENE-EXPRESSION; MEMORY; HIPPOCAMPUS; UBIQUITIN; RIM1-ALPHA	SCRAPPER, an F-box protein coded by FBXL20, is a subunit of SCF type E3 ubiquitin ligase. SCRAPPER localizes synapses and directly binds to Rab3-interacting molecule 1 (RIM1), an essential factor for synaptic vesicle release, thus it regulates neural transmission via RIM1 degradation. A defect in SCRAPPER leads to neurotransmission abnormalities, which could subsequently result in neurodegenerative phenotypes. Because it is likely that the alteration of neural transmission in Scrapper mutant mice affect their systemic condition, we have analyzed the behavioral phenotypes of mice with decreased or increased the amount of SCRAPPER. We carried out a series of behavioral test batteries for Scrapper mutant mice. Scrapper transgenic mice overexpressing SCRAPPER in the hippocampus did not show any significant difference in every test argued in this manuscript by comparison with wild-type mice. On the other hand, heterozygotes of Scrapper knockout [SCR (+/-)] mice showed significant difference in the contextual but not cued fear conditioning test. In addition, SCR (+/-) mice altered in some tests reflecting anxiety, which implies the loss of functions of SCRAPPER in the hippocampus. The behavioral phenotypes of Scrapper mutant mice suggest that molecular degradation conferred by SCRAPPER play important roles in hippocampal-dependent fear memory formation.	[Yao, Ikuko; Ito, Seiji] Kansai Med Univ, Dept Med Chem, Osaka, Japan; [Yao, Ikuko; Setou, Mitsutoshi] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Kyoto Univ, Genet Engn & Funct Genom Grp, Frontier Technol Ctr, Grad Sch Med, Kyoto, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Anal, Aichi, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Aichi, Japan; [Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Mol Anat, Shizuoka, Japan	Kansai Medical University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Fujita Health University; Hamamatsu University School of Medicine	Yao, I (corresponding author), Kansai Med Univ, Dept Med Chem, Osaka, Japan.	yaoik@takii.kmu.ac.jp; setou@hama-med.ac.jp	Takao, Keizo/B-9527-2008; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Miyakawa, Tsuyoshi/0000-0003-0137-8200; ito, Seiji/0000-0002-0942-1624	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study is supported by: Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms on Brain Disorders) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to IY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; AGETA H, LEARN MEM, V17, P176; Ageta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001869; Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dardente H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003530; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; File SE, 1998, BEHAV NEUROSCI, V112, P352, DOI 10.1037/0735-7044.112.2.352; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Gatfield D, 2007, SCIENCE, V316, P1135, DOI 10.1126/science.1144165; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Godsil BP, 2005, BEHAV NEUROSCI, V119, P1339, DOI 10.1037/0735-7044.119.5.1339; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Harrison FE, 2006, LEARN MEMORY, V13, P809, DOI 10.1101/lm.334306; Hashimoto-Gotoh T, 2009, FRONT NEUROSCI-SWITZ, V3, P15, DOI 10.3389/neuro.01.004.2009; Hata Y, 1999, CELL MOL LIFE SCI, V56, P461, DOI 10.1007/s000180050445; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaang BK, 2009, NEUROSCIENTIST, V15, P430, DOI 10.1177/1073858408331374; Kaeser PS, 2008, P NATL ACAD SCI USA, V105, P14680, DOI 10.1073/pnas.0806679105; Kiyonaka S, 2007, NAT NEUROSCI, V10, P691, DOI 10.1038/nn1904; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Levin ED, 2006; Li M, 2008, NAT CELL BIOL, V10, P1083, DOI 10.1038/ncb1768; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; MARKHAM CM, LEARN MEM, V17, P109; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; Maruyama Y, 2008, BIOCHEM BIOPH RES CO, V374, P737, DOI 10.1016/j.bbrc.2008.07.126; Matsumoto M, 2007, NEUROSCI RES, V57, P411, DOI 10.1016/j.neures.2006.11.015; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nakajima R, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-7; Nishi A, 2000, P NATL ACAD SCI USA, V97, P12840, DOI 10.1073/pnas.220410397; PAPE HC, PHYSL REV, V90, P419; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Sakurai M, 2008, EUR J NEUROSCI, V27, P691, DOI 10.1111/j.1460-9568.2008.06047.x; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stork O, 2001, LEARN MEMORY, V8, P209, DOI 10.1101/lm.39401; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Szyndler J, 2005, PHARMACOL BIOCHEM BE, V81, P15, DOI 10.1016/j.pbb.2005.01.020; Takao K, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-11; Tanda K, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-19; Tsujimura A, 2008, FRONT BEHAV NEUROSCI, V2, DOI 10.3389/neuro.08.004.2008; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Virshup DM, 2007, CELL, V129, P857, DOI 10.1016/j.cell.2007.05.015; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wood MA, 2005, HIPPOCAMPUS, V15, P610, DOI 10.1002/hipo.20082; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 1999, J BIOL CHEM, V274, P11889, DOI 10.1074/jbc.274.17.11889; Yao I, 2008, PROTEOMICS, V8, P3692, DOI 10.1002/pmic.200701121; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yasojima K, 1997, BIOCHEM BIOPH RES CO, V231, P481, DOI 10.1006/bbrc.1996.6033; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008	78	23	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17317	10.1371/journal.pone.0017317	http://dx.doi.org/10.1371/journal.pone.0017317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390313	gold, Green Submitted, Green Published			2022-12-27	WOS:000287761700044
J	Wilks, DC; Sharp, SJ; Ekelund, U; Thompson, SG; Mander, AP; Turner, RM; Jebb, SA; Lindroos, AK				Wilks, Desiree C.; Sharp, Stephen J.; Ekelund, Ulf; Thompson, Simon G.; Mander, Adrian P.; Turner, Rebecca M.; Jebb, Susan A.; Lindroos, Anna Karin			Objectively Measured Physical Activity and Fat Mass in Children: A Bias-Adjusted Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							ENERGY-EXPENDITURE; BODY-FAT; OBESITY; CHILDHOOD; PREDICTORS; OVERWEIGHT; ADIPOSITY; HUMANS; WATER	Background: Studies investigating the prevention of weight gain differ considerably in design and quality, which impedes pooling them in conventional meta-analyses, the basis for evidence-based policy making. This study is aimed at quantifying the prospective association between measured physical activity and fat mass in children, using a meta-analysis method that allows inclusion of heterogeneous studies by adjusting for differences through eliciting and incorporating expert opinion. Methods: Studies on prevention of weight gain using objectively measured exposure and outcome were eligible; they were adopted from a recently published systematic review. Differences in study quality and design were considered as internal and external biases and captured in checklists. Study results were converted to correlation coefficients and biases were considered either additive or proportional on this scale. The extent and uncertainty of biases in each study were elicited in a formal process by six quantitatively-trained assessors and five subject-matter specialists. Biases for each study were combined across assessors using median pooling. Results were combined across studies by random-effects meta-analysis. Results: The combined correlation of the unadjusted results from the six studies was -0.04 (95% CI: -0.22, 0.14) with considerable heterogeneity (I-2 = 78%), which makes it difficult to interpret the result. After bias-adjustment the pooled correlation was -0.01 (95% CI: -0.18, 0.16) with apparent study compatibility (I-2 = 0%). Conclusion: By using this method the prospective association between physical activity and fat mass could be quantitatively synthesized; the result suggests no association. Objectively measured physical activity may not be the key determinant of unhealthy weight gain in children.	[Wilks, Desiree C.; Jebb, Susan A.; Lindroos, Anna Karin] MRC, Collaborat Ctr Human Nutr Res, Cambridge, England; [Wilks, Desiree C.] Tech Univ Munich, Dept Prevent & Sports Med, Munich, Germany; [Sharp, Stephen J.; Ekelund, Ulf] MRC, Epidemiol Unit, Cambridge, England; [Thompson, Simon G.; Mander, Adrian P.; Turner, Rebecca M.] MRC, Biostat Unit, Cambridge CB2 2BW, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Technical University of Munich; MRC Biostatistics Unit	Wilks, DC (corresponding author), MRC, Collaborat Ctr Human Nutr Res, Cambridge, England.	Ulf.Ekelund@mrc-epid.cam.ac.uk	Ekelund, Ulf/AAE-8471-2019; Mander, Adrian Paul/E-5261-2010	Ekelund, Ulf/0000-0003-2115-9267; Mander, Adrian Paul/0000-0002-0742-9040; Jebb, Susan/0000-0001-9190-2920	UK Medical Research Council Population, Health Sciences Research Network [27]; MRC [MC_U106179473, MC_U105285807, MC_U105960389, MC_EX_G0800860] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MC_U105285807, MC_U106179473, UD99999931, MC_EX_G0800860, MC_U105960389] Funding Source: researchfish	UK Medical Research Council Population, Health Sciences Research Network; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council Population, Health Sciences Research Network grant number 27. The funders had no role in study design, data collection and analysis, decision to publish, or preparation or the manuscript.	Besson H, 2009, INT J OBESITY, V33, P497, DOI 10.1038/ijo.2009.25; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Clemen RT, 1999, RISK ANAL, V19, P187, DOI 10.1023/A:1006917509560; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; Deckelbaum RJ, 2001, OBES RES, V9, p239S, DOI 10.1038/oby.2001.125; DeLany JP, 2006, AM J CLIN NUTR, V84, P862, DOI 10.1093/ajcn/84.4.862; Department of Health, 2009, HLTH WEIGHT HLTH LIV; Dietz WH, 1998, PEDIATRICS, V101, P518; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Gluud LL, 2006, AM J EPIDEMIOL, V163, P493, DOI 10.1093/aje/kwj069; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; GUO SS, 1994, AM J CLIN NUTR, V59, P810, DOI 10.1093/ajcn/59.4.810; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Johnson MS, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.4.e50; Melanson E L, 1996, Can J Appl Physiol, V21, P109; Moore LL, 2003, PREV MED, V37, P10, DOI 10.1016/S0091-7435(03)00048-3; MURGATROYD PR, 1993, INT J OBESITY, V17, P549; *NHS INF CTR, 2007, HLTH SURV ENGL; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Salbe AD, 2002, PEDIATRICS, V110, P307, DOI 10.1542/peds.110.2.307; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Thompson S, 2011, INT J EPIDEMIOL, V40, P765, DOI 10.1093/ije/dyq248; Treuth MS, 2003, AM J CLIN NUTR, V78, P1212, DOI 10.1093/ajcn/78.6.1212; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Wareham NJ, 2005, P NUTR SOC, V64, P229, DOI 10.1079/PNS2005423; Westerterp KS, 1999, MED SCI SPORT EXER, V31, pS522, DOI 10.1097/00005768-199911001-00006; WILKS DC, 2010, OBES REV, DOI DOI 10.1111/J.1467-789X.2010.00775; Wilks DC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-48; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P, P322	35	44	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17205	10.1371/journal.pone.0017205	http://dx.doi.org/10.1371/journal.pone.0017205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383837	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287657500042
J	Garcia-Dominguez, CA; Martinez, N; Gragera, T; Perez-Rodriguez, A; Retana, D; Leon, G; Sanchez, A; Oliva, JL; Perez-Sala, D; Rojas, JM				Garcia-Dominguez, Carlota A.; Martinez, Natalia; Gragera, Teresa; Perez-Rodriguez, Andrea; Retana, Diana; Leon, Gonzalo; Sanchez, Agustin; Luis Oliva, Jose; Perez-Sala, Dolores; Rojas, Jose M.			Sprouty2 and Spred1-2 Proteins Inhibit the Activation of the ERK Pathway Elicited by Cyclopentenone Prostanoids	PLOS ONE			English	Article							15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); DROSOPHILA-SPROUTY; RECEPTOR; GROWTH; PROSTAGLANDINS; FGF; D-2; DELTA-12-PROSTAGLANDIN-J2; DIFFERENTIATION; IDENTIFICATION	Sprouty and Spred proteins have been widely implicated in the negative regulation of the fibroblast growth factor receptor-extracellular regulated kinase (ERK) pathway. In considering the functional role of these proteins, we explored their effects on ERK activation induced by cyclopentenone prostanoids, which bind to and activate Ras proteins. We therefore found that ectopic overexpression in HeLa cells of human Sprouty2, or human Spred1 or 2, inhibits ERK1/2 and Elk-1 activation triggered by the cyclopentenone prostanoids PGA(1) and 15d-PGJ(2). Furthermore, we found that in HT cells that do not express Sprouty2 due to hypermethylation of its gene-promoter, PGA1-provoked ERK activation was more intense and sustained compared to other hematopoietic cell lines with unaltered Sprouty2 expression. Cyclopentenone prostanoids did not induce Sprouty2 tyrosine phosphorylation, in agreement with its incapability to activate tyrosine-kinase receptors. However, Sprouty2 Y55F, which acts as a defective mutant upon tyrosine-kinase receptor stimulation, did not inhibit cyclopentenone prostanoids-elicited ERK pathway activation. In addition, Sprouty2 did not affect the Ras-GTP levels promoted by cyclopentenone prostanoids. These results unveil both common and differential features in the activation of Ras-dependent pathways by cyclopentenone prostanoids and growth factors. Moreover, they provide the first evidence that Sprouty and Spred proteins are negative regulators of the ERK/Elk-1 pathway activation induced not only by growth-factors, but also by reactive lipidic mediators.	[Garcia-Dominguez, Carlota A.; Martinez, Natalia; Gragera, Teresa; Perez-Rodriguez, Andrea; Retana, Diana; Leon, Gonzalo; Sanchez, Agustin; Luis Oliva, Jose; Rojas, Jose M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain; [Perez-Sala, Dolores] CSIC, Ctr Invest Biol, Dept Biol Fis Quim, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Garcia-Dominguez, CA (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Unidad Biol Celular, Madrid, Spain.	jmrojas@isciii.es	Perez-Sala, Dolores/L-5969-2014; LEON ESPINOSA, GONZALO/I-4135-2015; Rojas, José M/D-3718-2018; Rojas, José M./AAA-3354-2021	Perez-Sala, Dolores/0000-0003-0600-665X; LEON ESPINOSA, GONZALO/0000-0002-9921-2614; Rojas, José M/0000-0002-5383-3482; Rojas, José M./0000-0002-7547-2825; Retana, Diana/0000-0002-8442-2053	Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI); Comunidad de Madrid; Instituto de Salud Carlos III; Ministerio de Educacion y Ciencia; Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCII; Ministerio de Educacion y Ciencia, Spain [SAF2006-04247]; FIS-Intrasalud [PS09/00562]; ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer) [RD06/0020/0003]; Spanish Association Against Cancer (AECC); RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) from ISCIII [RD07/0064/0007]; European Union Cooperation [CM1001];  [SAF2009-11642]	Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI)(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCII(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia, Spain(Spanish Government); FIS-Intrasalud; ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer)(Instituto de Salud Carlos III); Spanish Association Against Cancer (AECC); RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos) from ISCIII; European Union Cooperation; 	CAGD, APR, AS, TG, and GL were recipients of fellowships from the Fondo de Investigaciones Sanitarias (FIS)-Beca de Formacion en Investigacion (BEFI) (to CAGD), Comunidad de Madrid (to APR), Instituto de Salud Carlos III (AS), and the Ministerio de Educacion y Ciencia (to TG and GL). JLO is member of the Miguel Servet Program (Fondo de Investigaciones Sanitarias -FIS-, Instituto de Salud Carlos III -ISCIII-). This work was supported by grants SAF2006-04247 from the Ministerio de Educacion y Ciencia, Spain, FIS-Intrasalud (PS09/00562) and ISCIII-RETIC (Red Tematica de Investigacion Cooperativa en Cancer; RD06/0020/0003) from the Instituto de Salud Carlos III, and the Spanish Association Against Cancer (AECC) to JMR, and by SAF2009-11642 and RETIC (Red de Investigacion de Reacciones Adversas a Alergenos y Farmacos; RD07/0064/0007) from ISCIII, to DPS. Work was also supported by a grant from European Union Cooperation in the field of Scientific and Technical research (COST) Action CM1001 to DPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bundschu K, 2007, BIOESSAYS, V29, P897, DOI 10.1002/bies.20632; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; de Alvaro C, 2005, MOL BIOL CELL, V16, P4454, DOI 10.1091/mbc.E05-05-0419; de Maximy AA, 1999, MECH DEVELOP, V81, P213, DOI 10.1016/S0925-4773(98)00241-X; Diez-Dacal B, 2010, THESCIENTIFICWORLDJO, V10, P655, DOI 10.1100/tsw.2010.69; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Garzon B, 2010, CHEM-BIOL INTERACT, V183, P212, DOI 10.1016/j.cbi.2009.09.019; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Hatanaka M, 2010, J PHARMACOL SCI, V113, P89, DOI 10.1254/jphs.10001SC; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; KATO T, 1986, CANCER RES, V46, P3538; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; KIM IK, 1993, FEBS LETT, V321, P209, DOI 10.1016/0014-5793(93)80110-G; Kondo M, 2001, J BIOL CHEM, V276, P12076, DOI 10.1074/jbc.M009630200; Kramer S, 1999, DEVELOPMENT, V126, P2515; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Martinez N, 2007, CELL SIGNAL, V19, P2277, DOI 10.1016/j.cellsig.2007.07.008; Millan O, 2006, CARCINOGENESIS, V27, P328, DOI 10.1093/carcin/bgi213; Monneret G, 2003, J PHARMACOL EXP THER, V304, P349, DOI 10.1124/jpet.102.042937; NARUMIYA S, 1987, J PHARMACOL EXP THER, V242, P306; Oliva JL, 2003, P NATL ACAD SCI USA, V100, P4772, DOI 10.1073/pnas.0735842100; Parker J, 1995, PROSTAGLANDINS, V50, P359, DOI 10.1016/0090-6980(95)00136-0; Pena-Dos-Santos DR, 2009, NEUROSCIENCE, V163, P1211, DOI 10.1016/j.neuroscience.2009.07.052; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Reich A, 1999, DEVELOPMENT, V126, P4139; Renedo M, 2007, BIOCHEMISTRY-US, V46, P6607, DOI 10.1021/bi602389p; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; Rovin BH, 2002, KIDNEY INT, V61, P1293, DOI 10.1046/j.1523-1755.2002.00282.x; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sanchez A, 2008, ONCOGENE, V27, P4969, DOI 10.1038/onc.2008.129; Santoro MG, 1997, TRENDS MICROBIOL, V5, P276, DOI 10.1016/S0966-842X(97)01066-4; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schuligoi R, 2007, BIOCHEM PHARMACOL, V74, P107, DOI 10.1016/j.bcp.2007.03.023; Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011; Stamatakis K, 2006, J AM SOC NEPHROL, V17, P89, DOI 10.1681/ASN.2005030329; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wilmer WA, 2001, BIOCHEM BIOPH RES CO, V281, P57, DOI 10.1006/bbrc.2001.4301; Yoon HJ, 2008, J IMMUNOL, V180, P8400, DOI 10.4049/jimmunol.180.12.8400; Zarich N, 2000, ONCOGENE, V19, P5872, DOI 10.1038/sj.onc.1203955; Zarich N, 2006, MOL BIOL CELL, V17, P3591, DOI 10.1091/mbc.E05-12-1104	53	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16787	10.1371/journal.pone.0016787	http://dx.doi.org/10.1371/journal.pone.0016787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364986	Green Published, gold			2022-12-27	WOS:000287656600020
J	Reichel, CA; Lerchenberger, M; Uhl, B; Rehberg, M; Berberich, N; Zahler, S; Wymann, MP; Krombach, F				Reichel, Christoph A.; Lerchenberger, Max; Uhl, Bernd; Rehberg, Markus; Berberich, Nina; Zahler, Stefan; Wymann, Matthias P.; Krombach, Fritz			Plasmin Inhibitors Prevent Leukocyte Accumulation and Remodeling Events in the Postischemic Microvasculature	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; IN-VIVO; APROTININ; ADHESION; REPERFUSION; NEUTROPHILS; EXPRESSION; MIGRATION; ISCHEMIA; RECEPTOR	Clinical trials revealed beneficial effects of the broad-spectrum serine protease inhibitor aprotinin on the prevention of ischemia-reperfusion (I/R) injury. The underlying mechanisms remained largely unclear. Using in vivo microscopy on the cremaster muscle of male C57BL/6 mice, aprotinin as well as inhibitors of the serine protease plasmin including tranexamic acid and epsilon-aminocaproic acid were found to significantly diminish I/R-elicited intravascular firm adherence and (subsequent) transmigration of neutrophils. Remodeling of collagen IV within the postischemic perivenular basement membrane was almost completely abrogated in animals treated with plasmin inhibitors or aprotinin. In separate experiments, incubation with plasmin did not directly activate neutrophils. Extravascular, but not intravascular administration of plasmin caused a dose-dependent increase in numbers of firmly adherent and transmigrated neutrophils. Blockade of mast cell activation as well as inhibition of leukotriene synthesis or antagonism of the platelet-activating-factor receptor significantly reduced plasmin-dependent neutrophil responses. In conclusion, our data suggest that extravasated plasmin(ogen) mediates neutrophil recruitment in vivo via activation of perivascular mast cells and secondary generation of lipid mediators. Aprotinin as well as the plasmin inhibitors tranexamic acid and e-aminocaproic acid interfere with this inflammatory cascade and effectively prevent postischemic neutrophil responses as well as remodeling events within the vessel wall.	[Reichel, Christoph A.; Lerchenberger, Max; Uhl, Bernd; Rehberg, Markus; Krombach, Fritz] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Berberich, Nina; Zahler, Stefan] Univ Munich, Dept Pharm, Munich, Germany; [Wymann, Matthias P.] Univ Basel, Inst Biochem & Genet, Dept Biomed, Basel, Switzerland	University of Munich; University of Munich; University of Basel	Reichel, CA (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany.	christoph.reichel@med.uni-muenchen.de	Wymann, Matthias P/C-3227-2008	Wymann, Matthias P/0000-0003-3349-4281; Zahler, Stefan/0000-0002-5140-7287; Rehberg, Markus/0000-0001-7314-6332	Deutsche Forschungsgemeinschaft (DFG) [RE 2885/1-1]; Friedrich-Baur-Stiftung; European Commission [LHSG-CT-2003-502935]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Baur-Stiftung; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by Deutsche Forschungsgemeinschaft (DFG; RE 2885/1-1 to C.A.R.; www.dfg.de), Friedrich-Baur-Stiftung (to C.A.R.; www.baur-stiftung.de), and European Commission grant LHSG-CT-2003-502935 (Network of Excellence 'MAIN' to F.K. and M.P.W.; www.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 2000, J THORAC CARDIOV SUR, V120, P361, DOI 10.1067/mtc.2000.106323; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Boyce JA, 2007, IMMUNOL REV, V217, P168, DOI 10.1111/j.1600-065X.2007.00512.x; Buerke M, 2007, CIRCULATION, V116, pI121, DOI 10.1161/CIRCULATIONAHA.106.680249; Bull DA, 2003, ANN THORAC SURG, V75, pS735, DOI 10.1016/S0003-4975(02)04702-1; Carter JM, 2008, BRIT J PHARMACOL, V155, P93, DOI 10.1038/bjp.2008.223; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Del Rosso M, 2008, FRONT BIOSCI-LANDMRK, V13, P4667, DOI 10.2741/3032; Edagawa M, 1999, TRANSPLANTATION, V67, P944, DOI 10.1097/00007890-199904150-00003; Frangogiannis NG, 2007, THROMB HAEMOSTASIS, V97, P738, DOI 10.1160/TH07-01-0022; GABOURY JP, 1995, J IMMUNOL, V154, P804; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Henry D, 2009, CAN MED ASSOC J, V180, P183, DOI 10.1503/cmaj.081109; Hruby Z, 2000, RES EXP MED, V199, P295, DOI 10.1007/s004330050127; Johnston B, 1999, MICROCIRCULATION, V6, P153; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Lister KJ, 2007, MICROCIRCULATION, V14, P709, DOI 10.1080/10739680701404879; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Majumdar M, 2004, J BIOL CHEM, V279, P37528, DOI 10.1074/jbc.M401372200; Mangano DT, 2007, JAMA-J AM MED ASSOC, V297, P471, DOI 10.1001/jama.297.5.471; Mempel TR, 2003, J VASC RES, V40, P435, DOI 10.1159/000073902; Montrucchio G, 1996, CIRCULATION, V93, P2152, DOI 10.1161/01.CIR.93.12.2152; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramos CDL, 2005, J LEUKOCYTE BIOL, V78, P167, DOI 10.1189/jlb.0404237; Reichel CA, 2008, J LEUKOCYTE BIOL, V83, P864, DOI 10.1189/jlb.1007666; Reichel CA, 2009, ARTERIOSCL THROM VAS, V29, P1787, DOI 10.1161/ATVBAHA.109.193268; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Shaw AD, 2008, NEW ENGL J MED, V358, P784, DOI 10.1056/NEJMoa0707768; Silva AR, 2002, J IMMUNOL, V168, P4112, DOI 10.4049/jimmunol.168.8.4112; Sodha Neel R, 2006, Expert Rev Cardiovasc Ther, V4, P151, DOI 10.1586/14779072.4.2.151; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Triggiani M, 2008, CLIN EXP IMMUNOL, V153, P7, DOI 10.1111/j.1365-2249.2008.03714.x; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Weide I, 1996, THROMB HAEMOSTASIS, V76, P561; Xue MZ, 2001, STROKE, V32, P2164, DOI 10.1161/hs0901.095408; YAMURA TAKUSO, 1961, ACTA MED NAGASAKIENSIA, V5, P142; Young RE, 2007, BRIT J PHARMACOL, V151, P628, DOI 10.1038/sj.bjp.0707267	42	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17229	10.1371/journal.pone.0017229	http://dx.doi.org/10.1371/journal.pone.0017229			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364954	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600036
J	Ishibashi, K; Ishii, K; Oda, K; Mizusawa, H; Ishiwata, K				Ishibashi, Kenji; Ishii, Kenji; Oda, Keiichi; Mizusawa, Hidehiro; Ishiwata, Kiichi			Binding of Pramipexole to Extrastriatal Dopamine D-2/D-3 Receptors in the Human Brain: A Positron Emission Tomography Study Using C-11-FLB 457	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; NONHUMAN PRIMATE BRAIN; BIPOLAR-II DEPRESSION; PARKINSONS-DISEASE; ANTERIOR-PITUITARY; AFFINITY STATES; HUMAN FOREBRAIN; PARALLEL-GROUP; MESSENGER-RNA; D-3 RECEPTORS	The purpose of this study was to determine the binding sites of pramipexole in extrastriatal dopaminergic regions because its antidepressive effects have been speculated to occur by activating the dopamine D-2 receptor subfamily in extrastriatal areas. Dynamic positron emission tomography (PET) scanning using C-11-FLB 457 for quantification of D-2/D-3 receptor subtype was performed on 15 healthy volunteers. Each subject underwent two PET scans before and after receiving a single dose of pramipexole (0, 0.125, or 0.25 mg). The study demonstrated that pramipexole significantly binds to D-2/D-3 receptors in the prefrontal cortex, amygdala, and medial and lateral thalamus at a dose of 0.25 mg. These regions have been indicated to have some relation to depression and may be part of the target sites where pramipexole exerts its antidepressive effects.	[Ishibashi, Kenji; Ishii, Kenji; Oda, Keiichi; Ishiwata, Kiichi] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan; [Ishibashi, Kenji; Mizusawa, Hidehiro] Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental University (TMDU)	Ishibashi, K (corresponding author), Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Tokyo, Japan.	kenji_ishibashi@pet.tmig.or.jp		Ishibashi, Kenji/0000-0002-4590-7146	Japan Society for the Promotion of Science (JSPS) [20390334]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding for this work was supported by a Grant-in-Aid for Scientific Research (B) No. 20390334 (Ishiwata K) by the Japan Society for the Promotion of Science (JSPS). JSPS had no further role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren H, 1992, Clin Neuropharmacol, V15 Suppl 1 Pt A, p235A; Asselin MC, 2007, J CEREBR BLOOD F MET, V27, P378, DOI 10.1038/sj.jcbfm.9600340; Barone P, 2006, J NEUROL, V253, P601, DOI 10.1007/s00415-006-0067-5; Bennett JP, 1999, J NEUROL SCI, V163, P25, DOI 10.1016/S0022-510X(98)00307-4; BOUTHENET ML, 1991, BRAIN RES, V564, P203, DOI 10.1016/0006-8993(91)91456-B; Cabib S, 1996, PSYCHOPHARMACOLOGY, V128, P331, DOI 10.1007/s002130050142; Cassano P, 2004, DEPRESS ANXIETY, V20, P131, DOI 10.1002/da.20038; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; DeBattista C, 2000, J CLIN PSYCHOPHARM, V20, P274, DOI 10.1097/00004714-200004000-00029; DELEAN A, 1982, MOL PHARMACOL, V22, P290; Di Chiara G, 1999, BIOL PSYCHIAT, V46, P1624, DOI 10.1016/S0006-3223(99)00236-X; Diaz J, 2000, J NEUROSCI, V20, P8677; Drevets WC, 1998, ANNU REV MED, V49, P341, DOI 10.1146/annurev.med.49.1.341; Espejo EF, 1999, NEUROSCIENCE, V88, P609, DOI 10.1016/S0306-4522(98)00258-9; Finnema SJ, 2009, SYNAPSE, V63, P378, DOI 10.1002/syn.20615; Garcia-Cabezas MA, 2007, NEUROIMAGE, V34, P965, DOI 10.1016/j.neuroimage.2006.07.032; Garcia-Cabezas MA, 2009, CEREB CORTEX, V19, P424, DOI 10.1093/cercor/bhn093; GEORGE SR, 1985, ENDOCRINOLOGY, V117, P690, DOI 10.1210/endo-117-2-690; Goldberg JF, 2004, AM J PSYCHIAT, V161, P564, DOI 10.1176/appi.ajp.161.3.564; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; HALLDIN C, 1995, J NUCL MED, V36, P1275; Inoue M, 2001, LIFE SCI, V69, P1079, DOI 10.1016/S0024-3205(01)01205-X; Joyce JN, 2001, PHARMACOL THERAPEUT, V90, P231, DOI 10.1016/S0163-7258(01)00139-5; Kaasinen V, 2000, NEUROBIOL AGING, V21, P683, DOI 10.1016/S0197-4580(00)00149-4; Kvernmo T, 2006, CLIN THER, V28, P1065, DOI 10.1016/j.clinthera.2006.08.004; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; LANDWEHRMEYER B, 1993, MOL BRAIN RES, V18, P187, DOI 10.1016/0169-328X(93)90188-U; Lattanzi L, 2002, BIPOLAR DISORD, V4, P307, DOI 10.1034/j.1399-5618.2002.01171.x; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lemke MR, 2005, J NEUROPSYCH CLIN N, V17, P214, DOI 10.1176/appi.neuropsych.17.2.214; Levant B, 1997, PHARMACOL REV, V49, P231; Lieberman A, 1997, NEUROLOGY, V49, P162, DOI 10.1212/WNL.49.1.162; Loch C, 1996, NUCL MED BIOL, V23, P813, DOI 10.1016/0969-8051(96)00078-9; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Maj J, 1997, EUR J PHARMACOL, V324, P31, DOI 10.1016/S0014-2999(97)00066-6; MIERAU J, 1995, EUR J PHARM-MOLEC PH, V290, P29, DOI 10.1016/0922-4106(95)90013-6; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MURRAY AM, 1994, P NATL ACAD SCI USA, V91, P11271, DOI 10.1073/pnas.91.23.11271; Narendran R, 2004, SYNAPSE, V52, P188, DOI 10.1002/syn.20013; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; OHMORI T, 1992, BIOL PSYCHIAT, V32, P57, DOI 10.1016/0006-3223(92)90142-M; Olsson H, 2004, NEUROIMAGE, V22, P794, DOI 10.1016/j.neuroimage.2004.02.002; Olsson H, 1999, J CEREBR BLOOD F MET, V19, P1164, DOI 10.1097/00004647-199910000-00013; Ostow M, 2002, AM J PSYCHIAT, V159, P320, DOI 10.1176/appi.ajp.159.2.320-a; Peng T, 2010, SYNAPSE, V64, P624, DOI 10.1002/syn.20771; Perugi G, 2001, PHARMACOPSYCHIATRY, V34, P137, DOI 10.1055/s-2001-15872; Piercey MF, 1998, CLIN NEUROPHARMACOL, V21, P141; Reichmann H, 2003, CNS DRUGS, V17, P965, DOI 10.2165/00023210-200317130-00003; Rektorova I, 2003, EUR J NEUROL, V10, P399, DOI 10.1046/j.1468-1331.2003.00612.x; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Sanchez-Gonzalez MA, 2005, J NEUROSCI, V25, P6076, DOI 10.1523/JNEUROSCI.0968-05.2005; Seneca N, 2006, SYNAPSE, V59, P260, DOI 10.1002/syn.20238; Shannon KM, 1997, NEUROLOGY, V49, P724, DOI 10.1212/WNL.49.3.724; SIBLEY DR, 1982, J BIOL CHEM, V257, P6351; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Sporn J, 2000, Ann Clin Psychiatry, V12, P137; Sudo Y, 2001, NUCL MED COMMUN, V22, P1215, DOI 10.1097/00006231-200111000-00008; Suhara T, 1999, INT J NEUROPSYCHOP, V2, P73, DOI 10.1017/S1461145799001431; Vilkman H, 2000, EUR J NUCL MED, V27, P1666, DOI 10.1007/s002590000342; WILLNER P, 1994, PSYCHOPHARMACOLOGY, V115, P454, DOI 10.1007/BF02245568; Zarate CA, 2004, BIOL PSYCHIAT, V56, P54, DOI 10.1016/j.biopsych.2004.03.013	63	17	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17723	10.1371/journal.pone.0017723	http://dx.doi.org/10.1371/journal.pone.0017723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408026	gold, Green Published, Green Submitted			2022-12-27	WOS:000288170900043
J	Martins, H; Villesen, P				Martins, Hugo; Villesen, Palle			Improved Integration Time Estimation of Endogenous Retroviruses with Phylogenetic Data	PLOS ONE			English	Article							ENVELOPE PROTEIN; HERV-W; GLYCOPROTEIN; CONSERVATION; PLACENTA; SYNCYTIN; ORIGIN	Background: Endogenous retroviruses f(ERVs) are genetic fossils of ancient retroviral integrations that remain in the genome of many organisms. Most loci are rendered non-functional by mutations, but several intact retroviral genes are known in mammalian genomes. Some have been adopted by the host species, while the beneficial roles of others remain unclear. Besides the obvious possible immunogenic impact from transcribing intact viral genes, endogenous retroviruses have also become an interesting and useful tool to study phylogenetic relationships. The determination of the integration time of these viruses has been based upon the assumption that both 59 and 39 Long Terminal Repeats (LTRs) sequences are identical at the time of integration, but evolve separately afterwards. Similar approaches have been using either a constant evolutionary rate or a range of rates for these viral loci, and only single species data. Here we show the advantages of using different approaches. Results: We show that there are strong advantages in using multiple species data and state-of-the-art phylogenetic analysis. We incorporate both simple phylogenetic information and Monte Carlo Markov Chain (MCMC) methods to date the integrations of these viruses based on a relaxed molecular clock approach over a Bayesian phylogeny model and applied them to several selected ERV sequences in primates. These methods treat each ERV locus as having a distinct evolutionary rate for each LTR, and make use of consensual speciation time intervals between primates to calibrate the relaxed molecular clocks. Conclusions: The use of a fixed rate produces results that vary considerably with ERV family and the actual evolutionary rate of the sequence, and should be avoided whenever multi-species phylogenetic data are available. For genome-wide studies, the simple phylogenetic approach constitutes a better alternative, while still being computationally feasible.	[Martins, Hugo; Villesen, Palle] Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark; [Martins, Hugo] Inst Gulbenkian Ciencias, Computat Biol PhD Program, Oeiras, Portugal	Aarhus University; Instituto Gulbenkian de Ciencia	Martins, H (corresponding author), Univ Aarhus, Bioinformat Res Ctr, Aarhus, Denmark.	palle@birc.au.dk		Villesen, Palle/0000-0001-7589-8781	FCT, Portugal [(SFRH)/BD/33526/2008]	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by research scholarship Servicos, Formacao e Recursos Humanos (SFRH)/BD/33526/2008 from FCT, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2005, GENOMICS, V86, P685, DOI 10.1016/j.ygeno.2005.08.011; Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Belshaw R, 2004, P NATL ACAD SCI USA, V101, P4894, DOI 10.1073/pnas.0307800101; Blaise S, 2004, J VIROL, V78, P1050, DOI 10.1128/JVI.78.2.1050-1054.2004; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Blond JL, 2000, J VIROL, V74, P3321, DOI 10.1128/JVI.74.7.3321-3329.2000; Blond JL, 1999, J VIROL, V73, P1175, DOI 10.1128/JVI.73.2.1175-1185.1999; COFFIN JM, RETROVIRIDAE; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Herve CA, 2004, GENOMICS, V83, P940, DOI 10.1016/j.ygeno.2003.10.003; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; JUNIER T, NEWICK UTILS 0 11; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Prudhomme S, 2005, CYTOGENET GENOME RES, V110, P353, DOI 10.1159/000084967; Romano CM, 2006, ARCH VIROL, V151, P2215, DOI 10.1007/s00705-006-0792-1; Romano CM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001026; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Sotgiu S, 2006, MULT SCLER J, V12, P698, DOI 10.1177/1352458506070773; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; DNA DOTPLOT WEB UTIL	28	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14745	10.1371/journal.pone.0014745	http://dx.doi.org/10.1371/journal.pone.0014745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394200	Green Submitted, gold, Green Published			2022-12-27	WOS:000288025500001
J	Bygrave, H; Kranzer, K; Hilderbrand, K; Jouquet, G; Goemaere, E; Vlahakis, N; Trivino, L; Makakole, L; Ford, N				Bygrave, Helen; Kranzer, Katharina; Hilderbrand, Katherine; Jouquet, Guillaume; Goemaere, Eric; Vlahakis, Nathalie; Trivino, Laura; Makakole, Lipontso; Ford, Nathan			Renal Safety of a Tenofovir-Containing First Line Regimen: Experience from an Antiretroviral Cohort in Rural Lesotho	PLOS ONE			English	Article							DISOPROXIL FUMARATE; THERAPY; HIV; OUTCOMES; ZAMBIA; DF	Introduction: Current guidelines contraindicate TDF use when creatinine clearance (CrCl) falls below 50 ml/min. We report prevalence of abnormal renal function at baseline and factors associated with abnormal renal function from a community cohort in Lesotho. Methods: We calculated changes in CrCl from baseline for patients initiated on TDF at 6 and 12 months and the proportion of patients initiated on TDF who developed renal impairment. Screening algorithms were developed using risk factors determined by multivariate analysis. Results: Among 933 adults for whom baseline creatinine was available, 176 (18.9%) presented with a baseline CrCl < 50 ml/min. Renal function improved during follow-up. 19 patients who developed renal toxicity during follow up remained on TDF; renal function improved (CrCl >= 50 ml/min) in all but 3 of these patients. Among 15 patients with a baseline CrCl,50 ml/min were started in error, none developed severe renal impairment. Conclusion: In this setting TDF-associated renal toxicity is rare and mainly transient. Further studies to assess TDF safety at lower CrCl thresholds are warranted.	[Bygrave, Helen; Jouquet, Guillaume; Vlahakis, Nathalie; Trivino, Laura] Med Sans Frontieres, Morija, Lesotho; [Kranzer, Katharina] London Sch Hyg & Trop Med, London WC1, England; [Hilderbrand, Katherine; Goemaere, Eric; Ford, Nathan] Med Sans Frontieres, Cape Town, South Africa; [Hilderbrand, Katherine; Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7700 Rondebosch, South Africa; [Makakole, Lipontso] Scott Hosp, Morija, Lesotho	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Bygrave, H (corresponding author), Med Sans Frontieres, Morija, Lesotho.	helen.bygrave@joburg.msf.org	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270	M�decins Sans Fronti�res [OCA_pilot_00_Bygrave] Funding Source: researchfish	M�decins Sans Fronti�res		[Anonymous], 2009, RAPID ADVICE ANTIRET; [Anonymous], 2010, ANTIRETROVIRAL THERA; Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Chi BH, 2010, JAIDS-J ACQ IMM DEF, V54, P63, DOI 10.1097/QAI.0b013e3181c6c65c; Clinical guidelines for the management of the open abdomen with ABTheraTM, 2010, CLIN GUIDELINES MANA; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Franey C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-143; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grim SA, 2003, ANN PHARMACOTHER, V37, P849, DOI 10.1345/aph.1C388; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Mulenga LB, 2008, AIDS, V22, P1821, DOI 10.1097/QAD.0b013e328307a051; Pozniak A, 2008, INT J CLIN PRACT, V62, P1285, DOI 10.1111/j.1742-1241.2008.01817.x; Reid A, 2005, 5 IAS C HIV PATH TRE; Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115; STRUIK G, 2010, 18 C INT AIDS SOC C; Verhave JC, 2005, AM J KIDNEY DIS, V46, P233, DOI 10.1053/j.ajkd.2005.05.011; VROUENRAETS S, 2008, 15 C RETR OPP INF BO	19	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17609	10.1371/journal.pone.0017609	http://dx.doi.org/10.1371/journal.pone.0017609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407815	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000287933300034
J	Valbuena, A; Castro-Obregon, S; Lazo, PA				Valbuena, Alberto; Castro-Obregon, Susana; Lazo, Pedro A.			Downregulation of VRK1 by p53 in Response to DNA Damage Is Mediated by the Autophagic Pathway	PLOS ONE			English	Article							HUMAN VACCINIA-RELATED-KINASE-1 VRK1; VACCINIA-RELATED KINASE-1; P53-MDM2 FEEDBACK LOOP; AUTOREGULATORY LOOP; MDM-2 BINDING; CELL-DEATH; IN-VIVO; APOPTOSIS; PROTEIN; PHOSPHORYLATION	Human VRK1 induces a stabilization and accumulation of p53 by specific phosphorylation in Thr18. This p53 accumulation is reversed by its downregulation mediated by Hdm2, requiring a dephosphorylated p53 and therefore also needs the removal of VRK1 as stabilizer. This process requires export of VRK1 to the cytosol and is inhibited by leptomycin B. We have identified that downregulation of VRK1 protein levels requires DRAM expression, a p53-induced gene. DRAM is located in the endosomal-lysosomal compartment. Induction of DNA damage by UV, IR, etoposide and doxorubicin stabilizes p53 and induces DRAM expression, followed by VRK1 downregulation and a reduction in p53 Thr18 phosphorylation. DRAM expression is induced by wild-type p53, but not by common human p53 mutants, R175H, R248W and R273H. Overexpression of DRAM induces VRK1 downregulation and the opposite effect was observed by its knockdown. LC3 and p62 were also downregulated, like VRK1, in response to UV-induced DNA damage. The implication of the autophagic pathway was confirmed by its requirement for Beclin1. We propose a model with a double regulatory loop in response to DNA damage, the accumulated p53 is removed by induction of Hdm2 and degradation in the proteasome, and the p53-stabilizer VRK1 is eliminated by the induction of DRAM that leads to its lysosomal degradation in the autophagic pathway, and thus permitting p53 degradation by Hdm2. This VRK1 downregulation is necessary to modulate the block in cell cycle progression induced by p53 as part of its DNA damage response.	[Valbuena, Alberto; Lazo, Pedro A.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain; [Castro-Obregon, Susana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Dev Genet & Mol Physiol, Cuernavaca 62191, Morelos, Mexico	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad Nacional Autonoma de Mexico	Valbuena, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Expt Therapeut & Translat Oncol Program, E-37008 Salamanca, Spain.	pedro.lazo@usal.es	Castro-Obregon, Susana/AAE-5105-2020; Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025; Castro-Obregon, Susana/0000-0003-0549-5690	Ministerio de Educacion, Ciencia e Innovacion [SAF2007-60242, SAF2010-14935, CSD2007-0017]; Junta de Castilla y Leon (Consejeria de Educacion) [CSI-14A08, GR15]; Consejeria de Sanidad [SAN 673/SA02/08]; Fundacion Sandra Ibarra; Fundacion Samuel Solorzano	Ministerio de Educacion, Ciencia e Innovacion; Junta de Castilla y Leon (Consejeria de Educacion)(Junta de Castilla y Leon); Consejeria de Sanidad; Fundacion Sandra Ibarra; Fundacion Samuel Solorzano	This work was supported by grants from Ministerio de Educacion, Ciencia e Innovacion (SAF2007-60242, SAF2010-14935 and CSD2007-0017), Junta de Castilla y Leon (Consejeria de Educacion, CSI-14A08 and GR15; Consejeria de Sanidad (SAN 673/SA02/08), and Fundacion Sandra Ibarra to P. A. L., and from Fundacion Samuel Solorzano to A. V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blanco S, 2003, FEMS MICROBIOL LETT, V221, P151, DOI 10.1016/S0378-1097(03)00179-4; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Brech A, 2009, MOL ONCOL, V3, P366, DOI 10.1016/j.molonc.2009.05.007; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Falguieres T, 2008, MOL BIOL CELL, V19, P4942, DOI 10.1091/mbc.E08-03-0239; Ferreon JC, 2009, P NATL ACAD SCI USA, V106, P6591, DOI 10.1073/pnas.0811023106; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Jabbur JR, 2002, ONCOGENE, V21, P7100, DOI 10.1038/sj.onc.1205856; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Lopez-Sanchez I, 2009, MOL CELL BIOL, V29, P1189, DOI 10.1128/MCB.01341-08; Lorin S, 2010, AUTOPHAGY, V6, P153, DOI 10.4161/auto.6.1.10537; Lorin S, 2009, CANCER RES, V69, P6924, DOI 10.1158/0008-5472.CAN-09-1270; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; Menendez S, 2003, BRIT J CANCER, V88, P636, DOI 10.1038/sj.bjc.6600752; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Moll UM, 2003, MOL CANCER RES, V1, P1001; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Pursiheimo JP, 2009, ONCOGENE, V28, P334, DOI 10.1038/onc.2008.392; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Saito S, 2003, J BIOL CHEM, V278, P37536, DOI 10.1074/jbc.M305135200; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Sanz-Garcia M., 2010, EMERGING SIGNALING P, P135; Sanz-Garcia M, 2008, MOL CELL PROTEOMICS, V7, P2199, DOI 10.1074/mcp.M700586-MCP200; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; STUCHELL MD, 2004, J BIOL CHEM; Tasdemir E, 2008, AUTOPHAGY, V4, P810, DOI 10.4161/auto.6486; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2007, LUNG CANCER, V58, P303, DOI 10.1016/j.lungcan.2007.06.023; Valbuena A, 2007, ARCH BIOCHEM BIOPHYS, V465, P219, DOI 10.1016/j.abb.2007.06.005; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004	65	42	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17320	10.1371/journal.pone.0017320	http://dx.doi.org/10.1371/journal.pone.0017320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386980	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400055
J	Dubash, AD; Guilluy, C; Srougi, MC; Boulter, E; Burridge, K; Garcia-Mata, R				Dubash, Adi D.; Guilluy, Christophe; Srougi, Melissa C.; Boulter, Etienne; Burridge, Keith; Garcia-Mata, Rafael			The Small GTPase RhoA Localizes to the Nucleus and Is Activated by Net1 and DNA Damage Signals	PLOS ONE			English	Article							EXCHANGE FACTOR NET1; CELL-ADHESION; HUMAN ECT2; PROTEIN; ACTIN; RAC1; CDC42; DEGRADATION; DOWNSTREAM; MECHANISM	Background: Rho GTPases control many cellular processes, including cell survival, gene expression and migration. Rho proteins reside mainly in the cytosol and are targeted to the plasma membrane (PM) upon specific activation by guanine nucleotide exchange factors (GEFs). Accordingly, most GEFs are also cytosolic or associated with the PM. However, Net1, a RhoA-specific GEF predominantly localizes to the cell nucleus at steady-state. Nuclear localization for Net1 has been seen as a mechanism for sequestering the GEF away from RhoA, effectively rendering the protein inactive. However, considering the prominence of nuclear Net1 and the fact that a biological stimulus that promotes Net1 translocation out the nucleus to the cytosol has yet to be discovered, we hypothesized that Net1 might have a previously unidentified function in the nucleus of cells. Principal Findings: Using an affinity precipitation method to pulldown the active form of Rho GEFs from different cellular fractions, we show here that nuclear Net1 does in fact exist in an active form, contrary to previous expectations. We further demonstrate that a fraction of RhoA resides in the nucleus, and can also be found in a GTP-bound active form and that Net1 plays a role in the activation of nuclear RhoA. In addition, we show that ionizing radiation (IR) specifically promotes the activation of the nuclear pool of RhoA in a Net1-dependent manner, while the cytoplasmic activity remains unchanged. Surprisingly, irradiating isolated nuclei alone also increases nuclear RhoA activity via Net1, suggesting that all the signals required for IR-induced nuclear RhoA signaling are contained within the nucleus. Conclusions/Significance: These results demonstrate the existence of a functional Net1/RhoA signaling pathway within the nucleus of the cell and implicate them in the DNA damage response.	[Dubash, Adi D.; Guilluy, Christophe; Srougi, Melissa C.; Boulter, Etienne; Burridge, Keith; Garcia-Mata, Rafael] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC USA; [Srougi, Melissa C.; Burridge, Keith] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dubash, AD (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	rafaelgm@med.unc.edu	Boulter, Etienne/R-1737-2016; guilluy, christophe/C-6002-2014; Guilluy, Christophe/Z-1015-2019	Boulter, Etienne/0000-0001-6597-9086; guilluy, christophe/0000-0003-1141-0809; Guilluy, Christophe/0000-0003-1141-0809; Garcia-Mata, Rafael/0000-0002-7116-4411; Srougi, Melissa/0000-0003-2183-0233	National Institutes of Health [GM029860]; Department of Defense [BC051092]; AHA; Fondation pour la Recherche Medicale; Allocation INSERM InCa/AVENIR [R08227AS]; European Union [254747]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); AHA(American Heart Association); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Allocation INSERM InCa/AVENIR; European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	KB was supported by a National Institutes of Health grant (GM029860), ADD by a Department of Defense Breast Cancer Predoctoral Fellowship (BC051092), RGM by an AHA Beginning Grant in Aid, EB by a Fondation pour la Recherche Medicale Fellowship, an AHA Postdoctoral Fellowship, and an Allocation INSERM InCa/AVENIR (R08227AS), and CG by a Marie Curie Outgoing International Fellowship from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no 254747. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts AS, 2005, J BIOL CHEM, V280, P12152, DOI 10.1074/jbc.M405073200; Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bentle MS, 2006, J MOL HISTOL, V37, P203, DOI 10.1007/s10735-006-9043-8; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; Chan AML, 1996, ONCOGENE, V12, P1259; Dellaire G, 2007, CELL CYCLE, V6, P1864, DOI 10.4161/cc.6.15.4560; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dubash AD, 2007, J CELL SCI, V120, P3989, DOI 10.1242/jcs.003806; Dunford JE, 2006, J BONE MINER RES, V21, P684, DOI 10.1359/JBMR.060118; Frisan T, 2003, CELL MICROBIOL, V5, P695, DOI 10.1046/j.1462-5822.2003.00311.x; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; GARCIAMATA R, 2007, MOL CELL BIOL; Guerra L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002254; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hervy M, 2006, CURR OPIN CELL BIOL, V18, P524, DOI 10.1016/j.ceb.2006.08.006; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kasai M, 2003, CANCER RES, V63, P4927; Lanning CC, 2004, J BIOL CHEM, V279, P44197, DOI 10.1074/jbc.M404977200; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Liu BP, 2000, MOL CELL BIOL, V20, P7160, DOI 10.1128/MCB.20.19.7160-7169.2000; Michaelson D, 2008, J CELL BIOL, V181, P485, DOI 10.1083/jcb.200801047; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262; Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139; Oceguera-Yanez F, 2005, J CELL BIOL, V168, P221, DOI 10.1083/jcb.200408085; Pederson T, 2008, J CELL BIOL, V180, P1061, DOI 10.1083/jcb.200709082; Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Schmidt A, 2002, J BIOL CHEM, V277, P14581, DOI 10.1074/jbc.M111108200; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Tanaka T, 2006, J BIOL CHEM, V281, P15320, DOI 10.1074/jbc.M510954200; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Yokoo T, 2003, J BIOL CHEM, V278, P52919, DOI 10.1074/jbc.M309334200	42	68	72	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17380	10.1371/journal.pone.0017380	http://dx.doi.org/10.1371/journal.pone.0017380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390328	gold, Green Published, Green Submitted			2022-12-27	WOS:000287761700049
J	Hummelgard, M; Zhang, RY; Nilsson, HE; Olin, H				Hummelgard, Magnus; Zhang, Renyun; Nilsson, Hans-Erik; Olin, Hakan			Electrical Sintering of Silver Nanoparticle Ink Studied by In-Situ TEM Probing	PLOS ONE			English	Article							COALESCENCE	Metallic nanoparticle inks are used for printed electronics, but to reach acceptable conductivity the structures need to be sintered, usually using a furnace. Recently, sintering by direct resistive heating has been demonstrated. For a microscopic understanding of this Joule heating sintering method, we studied the entire process in real time inside a transmission electron microscope equipped with a movable electrical probe. We found an onset of Joule heating induced sintering and coalescence of nanoparticles at power levels of 0.1-10 mW/mu m(3). In addition, a carbonization of the organic shells that stabilize the nanoparticles were found, with a conductivity of 4 10(5) Sm-1	[Hummelgard, Magnus; Zhang, Renyun; Olin, Hakan] Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden; [Nilsson, Hans-Erik] Mid Sweden Univ, Dept Informat Technol & Media, Sundsvall, Sweden	Mid-Sweden University; Mid-Sweden University	Hummelgard, M (corresponding author), Mid Sweden Univ, Dept Nat Sci Engn & Math, Sundsvall, Sweden.	magnus.hummelgard@miun.se	Olin, Håkan/A-8175-2008; Zhang, Renyun/C-6617-2009	Olin, Håkan/0000-0001-7329-3359; Hummelgard, Magnus/0000-0001-9137-3440; Zhang, Renyun/0000-0003-2873-7875				Allen ML, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/17/175201; Anto BT, 2010, ADV FUNCT MATER, V20, P296, DOI 10.1002/adfm.200901336; Arcidiacono S, 2004, INT J MULTIPHAS FLOW, V30, P979, DOI 10.1016/j.ijmultiphaseflow.2004.03.006; Bai JG, 2007, J MATER RES, V22, P3494, DOI 10.1557/JMR.2007.0440; Banhart F, 2009, NANOSCALE, V1, P201, DOI 10.1039/b9nr00127a; Bieri NR, 2003, APPL PHYS LETT, V82, P3529, DOI 10.1063/1.1575502; BUFFAT P, 1976, PHYS REV A, V13, P2287, DOI 10.1103/PhysRevA.13.2287; Chen Y, 2006, LANGMUIR, V22, P2851, DOI 10.1021/la0533157; Chung JW, 2004, APPL PHYS LETT, V84, P801, DOI 10.1063/1.1644907; Corio P, 2004, CHEM PHYS LETT, V383, P475, DOI 10.1016/j.cplett.2003.11.061; Coutts MJ, 2009, J PHYS CHEM C, V113, P1325, DOI 10.1021/jp808927t; Erts D, 2001, APPL PHYS A-MATER, V72, pS71, DOI 10.1007/s003390100636; FELBA J, 2010, EL PACK TECHN C 2009, P879; FELBA J, 2010, NAN 2009 IEEE NANO 2, P408; Fuller SB, 2002, J MICROELECTROMECH S, V11, P54, DOI 10.1109/84.982863; Groza JR, 1999, NANOSTRUCT MATER, V12, P987, DOI 10.1016/S0965-9773(99)00284-6; Han SY, 2009, J DISP TECHNOL, V5, P520, DOI 10.1109/JDT.2009.2024330; HAYES D, 2001, P SPIE MICR MICR C, P22; Huang D, 2003, J ELECTROCHEM SOC, V150, pG412, DOI 10.1149/1.1582466; Hummelgard M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/16/165704; IIJIMA S, 1991, J APPL PHYS, V70, P5138, DOI 10.1063/1.348990; Jahn SF, 2010, CHEM MATER, V22, P3067, DOI 10.1021/cm9036428; Jin CH, 2006, J PHYS CHEM B, V110, P5423, DOI 10.1021/jp057240r; Jose-Yacaman M, 2005, J PHYS CHEM B, V109, P9703, DOI 10.1021/jp0509459; Karakaya I., 1988, J PHASE EQUILIB, V9, P226; Kim HS, 2009, APPL PHYS A-MATER, V97, P791, DOI 10.1007/s00339-009-5360-6; Lee HH, 2005, NANOTECHNOLOGY, V16, P2436, DOI 10.1088/0957-4484/16/10/074; Lehtinen KEJ, 2002, J AEROSOL SCI, V33, P357, DOI 10.1016/S0021-8502(01)00177-X; Lu Y, 2010, NAT NANOTECHNOL, V5, P218, DOI [10.1038/nnano.2010.4, 10.1038/NNANO.2010.4]; Magdassi S, 2010, ACS NANO, V4, P1943, DOI 10.1021/nn901868t; Mcnaught A. D., 1997, IUPAC COMPENDIUM CHE; Nanda KK, 2008, J PHYS CHEM C, V112, P13488, DOI 10.1021/jp803934n; Pan H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3082095; Perelaer J, 2006, ADV MATER, V18, P2101, DOI 10.1002/adma.200502422; Priest JW, 1997, SOL FREEFORM FABRIC, P1; REDINGER D, 2004, IEEE T ELECTRON DEV, V51, P12; Reinhold I, 2009, J MATER CHEM, V19, P3384, DOI 10.1039/b823329b; ROBERTI M, 2006, RFID J; Sivaramakrishnan S, 2007, NAT MATER, V6, P149, DOI 10.1038/nmat1806; Svensson K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.145901; Svensson K, 2003, REV SCI INSTRUM, V74, P4945, DOI 10.1063/1.1614872; SZCZECH J, 2002, IEEE T ELECT PACKAGI, V25; Szczech JB, 2004, MICROSCALE THERM ENG, V8, P327, DOI 10.1080/10893950490516884; Valeton JJP, 2010, J MATER CHEM, V20, P543, DOI 10.1039/b917266a; van Huis MA, 2008, NANO LETT, V8, P3959, DOI 10.1021/nl8024467; Woo K, 2009, LANGMUIR, V25, P429, DOI 10.1021/la802182y; Wu JT, 2010, J PHYS CHEM C, V114, P4659, DOI 10.1021/jp100326k; Wu JT, 2009, THIN SOLID FILMS, V517, P5913, DOI 10.1016/j.tsf.2009.04.049; YUNG KC, 2010, J MAT PROCESSING TEC; YUNG KC, 2010, APPL PHYS A, P1; Zhang RY, 2010, CARBON, V48, P424, DOI 10.1016/j.carbon.2009.09.056; Ziegler KJ, 2004, APPL PHYS LETT, V84, P4074, DOI 10.1063/1.1751622	52	52	54	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17209	10.1371/journal.pone.0017209	http://dx.doi.org/10.1371/journal.pone.0017209			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390314	Green Published, gold			2022-12-27	WOS:000287761700035
J	Macha, MA; Matta, A; Chauhan, SS; Siu, KWM; Ralhan, R				Macha, Muzafar A.; Matta, Ajay; Chauhan, Shyam Singh; Siu, K. W. Michael; Ralhan, Ranju			Guggulsterone Targets Smokeless Tobacco Induced PI3K/Akt Pathway in Head and Neck Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; JUN NH2-TERMINAL KINASE; TUMOR-SUPPRESSOR GENES; PROMOTES APOPTOSIS; RB PATHWAY; ACTIVATION; EXPRESSION; CARCINOMA; NICOTINE; PROLIFERATION	Background: Epidemiological association of head and neck cancer with smokeless tobacco (ST) emphasizes the need to unravel the molecular mechanisms implicated in cancer development, and identify pharmacologically safe agents for early intervention and prevention of disease recurrence. Guggulsterone (GS), a biosafe nutraceutical, inhibits the PI3K/Akt pathway that plays a critical role in HNSCC development. However, the potential of GS to suppress ST and nicotine (major component of ST) induced HNSCC remains unexplored. We hypothesized GS can abrogate the effects of ST and nicotine on apoptosis in HNSCC cells, in part by activation of PI3K/Akt pathway and its downstream targets, Bax and Bad. Methods and Results: Our results showed ST and nicotine treatment resulted in activation of PI3K, PDK1, Akt, and its downstream proteins - Raf, GSK3 beta and pS6 while GS induced a time dependent decrease in activation of PI3K/Akt pathway. ST and nicotine treatment also resulted in induction of Bad and Bax phosphorylation, increased the association of Bad with 14-3-3 zeta resulting in its sequestration in the cytoplasm of head and neck cancer cells, thus blocking its pro-apoptotic function. Notably, GS pre-treatment inhibited ST/nicotine induced activation of PI3K/Akt pathway, and inhibited the Akt mediated phosphorylation of Bax and Bad. Conclusions: In conclusion, GS treatment not only inhibited proliferation, but also induced apoptosis by abrogating the effects of ST / nicotine on PI3K/Akt pathway in head and neck cancer cells. These findings provide a rationale for designing future studies to evaluate the chemopreventive potential of GS in ST / nicotine associated head and neck cancer.	[Macha, Muzafar A.; Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Matta, Ajay; Siu, K. W. Michael; Ralhan, Ranju] York Univ, Dept Chem, Toronto, ON M3J 2R7, Canada; [Matta, Ajay; Siu, K. W. Michael; Ralhan, Ranju] York Univ, Ctr Res Mass Spectrometry, Toronto, ON M3J 2R7, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	All India Institute of Medical Sciences (AIIMS) New Delhi; York University - Canada; York University - Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Macha, MA (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	rralhan@mtsinai.on.ca	MACHA, MUZAFAR AHMAD/AAN-5735-2020; MATTA, AJAY/AFT-2977-2022	MACHA, MUZAFAR AHMAD/0000-0003-4468-4435; 	Council of Scientific and Industrial Research (CSIR), New Delhi, India; MITACS Ontario, Canada; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Alex and Simona Shnaider Laboratory of Molecular Oncology; Temmy Latner/Dynacare; Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto; Ontario Institute for Cancer Research (OICR); Ontario Research and Development Challenge Fund	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); MITACS Ontario, Canada; Joseph and Mildred Sonshine Centre for Head and Neck Diseases; Alex and Simona Shnaider Laboratory of Molecular Oncology; Temmy Latner/Dynacare; Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto(University of Toronto); Ontario Institute for Cancer Research (OICR); Ontario Research and Development Challenge Fund(General Electric)	Muzafar A. Macha is a recipient of a Senior Research Fellowship of Council of Scientific and Industrial Research (CSIR), New Delhi, India. Ajay Matta is the recipient of a MITACS Accelerate Fellowship, Ontario, Canada. Ranju Ralhan gratefully acknowledges support from the Joseph and Mildred Sonshine Centre for Head and Neck Diseases, Alex and Simona Shnaider Laboratory of Molecular Oncology, Temmy Latner/Dynacare, and the Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Hospital, University of Toronto. K.W. Michael Siu acknowledges funding from the Ontario Institute for Cancer Research (OICR), and infrastructural support from the Ontario Research and Development Challenge Fund and AB SCIEX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An MJ, 2009, CANCER LETT, V279, P93, DOI 10.1016/j.canlet.2009.01.026; Arora S, 2005, MOL CARCINOGEN, V42, P97, DOI 10.1002/mc.20048; Cogliano V, 2004, LANCET ONCOL, V5, P708, DOI 10.1016/S1470-2045(04)01633-X; Colilla SA, 2010, REGUL TOXICOL PHARM, V56, P197, DOI 10.1016/j.yrtph.2009.09.017; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; De Gottardi A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-48; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Jayasurya R, 2005, MODERN PATHOL, V18, P1056, DOI 10.1038/modpathol.3800387; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kar P, 2006, CANCER LETT, V240, P306, DOI 10.1016/j.canlet.2005.09.023; Kaur J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-168; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kim ES, 2008, ONCOL REP, V20, P1321, DOI 10.3892/or_00000147; KIM MS, 1993, ANTICANCER RES, V13, P1405; Kuhar M, 2006, ANTICANCER RES, V26, P1297; Kurinna SM, 2004, CANCER RES, V64, P7852, DOI 10.1158/0008-5472.CAN-04-1552; Leeman-Neill RJ, 2009, CARCINOGENESIS, V30, P1848, DOI 10.1093/carcin/bgp211; MACHA MA, 2009, J ORAL PATH IN PRESS; Mai HQ, 2003, J BIOL CHEM, V278, P1886, DOI 10.1074/jbc.M209044200; McClave Annette K., 2010, Morbidity and Mortality Weekly Report, V59, P1; Meselhy MR, 2003, PHYTOCHEMISTRY, V62, P213, DOI 10.1016/S0031-9422(02)00388-6; Mishra R, 2005, MOL BIOL REP, V32, P159, DOI 10.1007/s11033-005-0754-9; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Murugan AK, 2008, INT J ONCOL, V32, P101; Nishioka T, 2010, J CELL BIOCHEM, V109, P152, DOI 10.1002/jcb.22392; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rohatgi N, 2005, ORAL ONCOL, V41, P806, DOI 10.1016/j.oraloncology.2005.04.010; SAKAI E, 1992, ONCOGENE, V7, P927; Samudio I, 2005, MOL CANCER THER, V4, P1982, DOI 10.1158/1535-7163.MCT-05-0247; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Sarfaraz S, 2008, CARCINOGENESIS, V29, P2011, DOI 10.1093/carcin/bgn180; Sawhney M, 2009, INT J CANCER, V124, P2098, DOI 10.1002/ijc.24192; Sharma C, 2006, TOXICOLOGY, V228, P1, DOI 10.1016/j.tox.2006.07.027; Shishodia S, 2004, J BIOL CHEM, V279, P47148, DOI 10.1074/jbc.M408093200; Shishodia S, 2008, ANTICANCER RES, V28, P3647; Shishodia S, 2007, BIOCHEM PHARMACOL, V74, P118, DOI 10.1016/j.bcp.2007.03.026; Singh SV, 2007, CANCER RES, V67, P7439, DOI 10.1158/0008-5472.CAN-07-0120; Singh SV, 2005, MOL CANCER THER, V4, P1747, DOI 10.1158/1535-7163.MCT-05-0223; Soni S, 2005, ONCOLOGY-BASEL, V68, P314, DOI 10.1159/000086970; Stepanov I, 2010, CHEM RES TOXICOL, V23, P66, DOI 10.1021/tx900281u; Tzivion G, 2006, SEMIN CANCER BIOL, V16, P203, DOI 10.1016/j.semcancer.2006.03.004; Urizar NL, 2003, ANNU REV NUTR, V23, P303, DOI 10.1146/annurev.nutr.23.011702.073102; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Warnakulasuriya KAAS, 2007, J ORAL PATHOL MED, V36, P63, DOI 10.1111/j.1600-0714.2007.00496.x; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; West R, 2004, BRIT DENT J, V196, P611, DOI 10.1038/sj.bdj.4811286; Xu HB, 2009, PHARMAZIE, V64, P660, DOI 10.1691/ph.2009.9619; Yamada T, 2010, ANTICANCER RES, V30, P1953; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14728	10.1371/journal.pone.0014728	http://dx.doi.org/10.1371/journal.pone.0014728			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383988	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700006
J	Campa, D; Husing, A; Stein, A; Dostal, L; Boeing, H; Pischon, T; Tjonneland, A; Roswall, N; Overvad, K; Ostergaard, JN; Rodriguez, L; Sala, N; Sanchez, MJ; Larranaga, N; Huerta, JM; Barricarte, A; Khaw, KT; Wareham, N; Travis, RC; Allen, NE; Lagiou, P; Trichopoulou, A; Trichopoulos, D; Palli, D; Sieri, S; Tumino, R; Sacerdote, C; van Kranen, H; Bueno-de-Mesquita, HB; Hallmans, G; Johansson, M; Romieu, I; Jenab, M; Cox, DG; Siddiq, A; Riboli, E; Canzian, F; Kaaks, R				Campa, Daniele; Huesing, Anika; Stein, Angelika; Dostal, Lucie; Boeing, Heiner; Pischon, Tobias; Tjonneland, Anne; Roswall, Nina; Overvad, Kim; Ostergaard, Jane Nautrup; Rodriguez, Laudina; Sala, Nuria; Sanchez, Maria-Jose; Larranaga, Nerea; Maria Huerta, Jose; Barricarte, Aurelio; Khaw, Kay-Tee; Wareham, Nicholas; Travis, Ruth C.; Allen, Naomi E.; Lagiou, Pagona; Trichopoulou, Antonia; Trichopoulos, Dimitrios; Palli, Domenico; Sieri, Sabina; Tumino, Rosario; Sacerdote, Carlotta; van Kranen, Henk; Bueno-de-Mesquita, H. Bas; Hallmans, Goran; Johansson, Mattias; Romieu, Isabelle; Jenab, Mazda; Cox, David G.; Siddiq, Afshan; Riboli, Elio; Canzian, Federico; Kaaks, Rudolf			Genetic Variability of the mTOR Pathway and Prostate Cancer Risk in the European Prospective Investigation on Cancer (EPIC)	PLOS ONE			English	Article							KINASE-C-IOTA; TUBEROUS SCLEROSIS; CELL-GROWTH; PKC-IOTA; MAMMALIAN TARGET; PROTEIN; RAPAMYCIN; COMPLEX; LAMBDA/IOTA; EXPRESSION	The mTOR (mammalian target of rapamycin) signal transduction pathway integrates various signals, regulating ribosome biogenesis and protein synthesis as a function of available energy and amino acids, and assuring an appropriate coupling of cellular proliferation with increases in cell size. In addition, recent evidence has pointed to an interplay between the mTOR and p53 pathways. We investigated the genetic variability of 67 key genes in the mTOR pathway and in genes of the p53 pathway which interact with mTOR. We tested the association of 1,084 tagging SNPs with prostate cancer risk in a study of 815 prostate cancer cases and 1,266 controls nested within the European Prospective Investigation into Cancer and Nutrition (EPIC). We chose the SNPs (n = 11) with the strongest association with risk (p<0.01) and sought to replicate their association in an additional series of 838 prostate cancer cases and 943 controls from EPIC. In the joint analysis of first and second phase two SNPs of the PRKCI gene showed an association with risk of prostate cancer (ORallele = 0.85, 95% CI 0.78-0.94, p = 1.3 x 10(-3) for rs546950 and ORallele = 0.84, 95% CI 0.76-0.93, p = 5.6 x 10(-4) for rs4955720). We confirmed this in a meta-analysis using as replication set the data from the second phase of our study jointly with the first phase of the Cancer Genetic Markers of Susceptibility (CGEMS) project. In conclusion, we found an association with prostate cancer risk for two SNPs belonging to PRKCI, a gene which is frequently overexpressed in various neoplasms, including prostate cancer.	[Campa, Daniele; Huesing, Anika; Stein, Angelika; Dostal, Lucie; Canzian, Federico; Kaaks, Rudolf] German Canc Res Ctr, Heidelberg, Germany; [Boeing, Heiner; Pischon, Tobias] Deutsch Inst Ernahrungsforsch, Dept Epidemiol, Potsdam, Germany; [Tjonneland, Anne; Roswall, Nina] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Overvad, Kim; Ostergaard, Jane Nautrup] Aarhus Univ Hosp, Dept Cardiol, Cardiovasc Res Ctr, Aalborg Hosp, Aalborg, Denmark; [Overvad, Kim; Ostergaard, Jane Nautrup] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, DK-8000 Aarhus C, Denmark; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Sala, Nuria] ICO IDIBELL, Barcelona, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Larranaga, Nerea; Maria Huerta, Jose; Barricarte, Aurelio] Consortium Biomed Res Epidemiol & Publ Hlth CIBER, Madrid, Spain; [Larranaga, Nerea] Basque Govt, Publ Hlth Dept Gipuzkoa, Gipuzkoa, Spain; [Maria Huerta, Jose] Murcia Reg Hlth Author, Dept Epidemiol, Murcia, Spain; [Barricarte, Aurelio] Navarre Publ Hlth Inst, Pamplona, Spain; [Khaw, Kay-Tee] Univ Cambridge, Sch Clin Med, Cambridge, England; [Wareham, Nicholas] MRC Epidemiol Unit, Cambridge, England; [Travis, Ruth C.; Allen, Naomi E.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford, England; [Lagiou, Pagona; Trichopoulou, Antonia] Univ Athens, Sch Med, WHO Collaborating Ctr Food & Nutr Policies, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Lagiou, Pagona; Trichopoulos, Dimitrios] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Trichopoulou, Antonia] Hellen Hlth Fdn, Athens, Greece; [Trichopoulos, Dimitrios] Acad Athens, Bur Epidemiol Res, Athens, Greece; [Palli, Domenico] Canc Res & Prevent Inst ISPO, Mol & Nutr Epidemiol Unit, Florence, Italy; [Sieri, Sabina] Fdn IRCCS Ist Nazl Tumori, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Canc Registry, Ragusa, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, Histopathol Unit, Ragusa, Italy; [Sacerdote, Carlotta] Ctr Canc Prevent CPO Piemonte, Turin, Italy; [Sacerdote, Carlotta] Human Genet Fdn HuGeF, Turin, Italy; [van Kranen, Henk; Bueno-de-Mesquita, H. Bas] Natl Inst Publ Hlth & Environm, Ctr Nutr & Hlth CVG, Bilthoven, Netherlands; [Hallmans, Goran; Johansson, Mattias] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Johansson, Mattias; Romieu, Isabelle; Jenab, Mazda] Int Agcy Res Canc, F-69372 Lyon, France; [Cox, David G.; Siddiq, Afshan; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, London, England; [Cox, David G.] Ctr Leon Berard, INSERM, F-69373 Lyon, France	Helmholtz Association; German Cancer Research Center (DKFZ); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Danish Cancer Society; Aalborg University; Aalborg University Hospital; Aarhus University; Aarhus University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Basque Government; Murcia Regional Health Council; Public Health Institute of Navarra; University of Cambridge; University of Oxford; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Academy of Athens; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Netherlands National Institute for Public Health & the Environment; Umea University; World Health Organization; International Agency for Research on Cancer (IARC); Imperial College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Campa, D (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	r.kaaks@dkfz.de	Sánchez, Maria-José/D-1087-2011; Roswall, Nina/AAJ-6700-2020; Hüsing, Anika/U-1296-2019; Huerta, José María/N-8654-2015; Johansson, Mattias/ABF-3365-2020; Khaw, Kay-Tee/AAZ-3209-2021; Pischon, Tobias/HGE-8577-2022; Cox, David G/A-2023-2009; Sieri, Sabina/K-4667-2016; Cox, David/ABA-7454-2020; Canzian, Federico/I-2804-2014; Campa, Daniele/K-1617-2016; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Sala, Nuria/G-8471-2015	Sánchez, Maria-José/0000-0003-4817-0757; Roswall, Nina/0000-0003-3071-1658; Huerta, José María/0000-0002-9637-3869; Pischon, Tobias/0000-0003-1568-767X; Cox, David G/0000-0002-2152-9259; Sieri, Sabina/0000-0001-5201-172X; Campa, Daniele/0000-0003-3220-9944; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Riboli, Elio/0000-0001-6795-6080; Johansson, Mattias/0000-0002-3116-5081; Siddiq, Afshan/0000-0002-9110-1434; Canzian, Federico/0000-0002-4261-4583; Sacerdote, Carlotta/0000-0002-8008-5096; Tjonneland, Anne/0000-0003-4385-2097; Sala, Nuria/0000-0003-3585-7613; PALLI, Domenico/0000-0002-5558-2437; Cox, David/0000-0003-2047-4687; Jenab, Mazda/0000-0002-0573-1852; Ostergaard, Jane Nautrup/0000-0002-0627-1237; tumino, rosario/0000-0003-2666-414X; Husing, Anika/0000-0002-2685-9732; Overvad, Kim/0000-0001-6429-7921; Larranaga, Nerea/0000-0002-9993-9880	US Army Medical Research and Material Command [W81XWH-05-1-0156]; European Commission (SANCO); Ligue contre le Cancer (France); Societe 3M (France); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health; Cancer Research UK; Medical Research Council, UK; Hellenic Ministry of Health and Social Solidarity; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer; Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland); World Cancer Research Fund (WCRF) (The Netherlands); Statistics Netherlands; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society; Medical Research Council [G1000143, MC_U106179471, G0401527] Funding Source: researchfish	US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Ligue contre le Cancer (France); Societe 3M (France)(3M); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); German Cancer Aid(Deutsche Krebshilfe); German Cancer Research Center; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Cancer Research UK(Cancer Research UK); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hellenic Ministry of Health and Social Solidarity; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council(Consiglio Nazionale delle Ricerche (CNR)); Dutch Ministry of Public Health, Welfare and Sports; Dutch Ministry of Health; Netherlands Cancer Registry (NKR); LK Research Funds; Dutch Prevention Funds; Dutch ZON (Zorg Onderzoek Nederland)(Netherlands Organization for Scientific Research (NWO)); World Cancer Research Fund (WCRF) (The Netherlands)(Netherlands GovernmentWorld Cancer Research Fund International (WCRF)); Statistics Netherlands; Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Specific results of this study were obtained with financial support from the US Army Medical Research and Material Command (W81XWH-05-1-0156). http://cdmrp.army.mil/pcrp/default.shtml. The EPIC study was funded by "Europe Against Cancer" Programme of the European Commission (SANCO); Ligue contre le Cancer (France); Societe 3M (France); Mutuelle Generale de l'Education Nationale; Institut National de la Sante et de la Recherche Medicale (INSERM); German Cancer Aid; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health; the participating regional governments and institutions of Spain; Cancer Research UK; Medical Research Council, UK; Hellenic Ministry of Health and Social Solidarity; the Stavros Niarchos Foundation and the Hellenic Health Foundation; Italian Association for Research on Cancer; Italian National Research Council; Dutch Ministry of Public Health, Welfare and Sports (VWS), Dutch Ministry of Health, Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch ZON (Zorg Onderzoek Nederland), World Cancer Research Fund (WCRF) (The Netherlands); Statistics Netherlands; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Skane, Sweden; Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto K, 1998, BIOCHEM J, V335, P417, DOI 10.1042/bj3350417; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catena R, 2004, J BIOL CHEM, V279, P41846, DOI 10.1074/jbc.M405514200; Chen M, 2009, CARCINOGENESIS, V30, P2047, DOI 10.1093/carcin/bgp258; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DIAZMECO MT, 1993, MOL CELL BIOL, V13, P4770, DOI 10.1128/MCB.13.8.4770; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; Gomez-Martin C, 2005, CLIN LUNG CANCER, V7, pS13, DOI 10.3816/CLC.2005.s.003; Gustafson WC, 2004, J BIOL CHEM, V279, P9400, DOI 10.1074/jbc.M312840200; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hudes Gary R, 2007, Clin Adv Hematol Oncol, V5, P772; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Ishiguro H, 2009, P NATL ACAD SCI USA, V106, P16369, DOI 10.1073/pnas.0907044106; Jaeschke A, 2003, CURR TOP MICROBIOL, V279, P283; Jin X, 2007, BIOCHEM BIOPH RES CO, V364, P476, DOI 10.1016/j.bbrc.2007.10.042; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Koren R, 2004, ONCOL REP, V11, P321; KOUTROS S, 2003, CANCER RES, V70, P2389; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Li Q, 2008, HEPATOB PANCREAT DIS, V7, P70; Ligresti G, 2009, CELL CYCLE, V8, P1352, DOI 10.4161/cc.8.9.8255; LODA M, CANC CELL, V17, P311; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; MEHTA MS, BREAST CANC RES TREA; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Murray NR, 2004, J CELL BIOL, V164, P797, DOI 10.1083/jcb.200311011; Nupponen NN, 1998, CANCER GENET CYTOGEN, V101, P53, DOI 10.1016/S0165-4608(97)00060-5; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Regala RP, 2005, J BIOL CHEM, V280, P31109, DOI 10.1074/jbc.M505402200; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rubio-Viqueira B, 2006, CURR OPIN INVEST DR, V7, P501; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; Saleem M, 2005, CANCER RES, V65, P11203, DOI 10.1158/0008-5472.CAN-05-1965; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhang L, 2006, CANCER RES, V66, P4627, DOI 10.1158/0008-5472.CAN-05-4527; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16914	10.1371/journal.pone.0016914	http://dx.doi.org/10.1371/journal.pone.0016914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373201	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000287657500023
J	Chu, TJ; Handley, D; Bunce, K; Surti, U; Hogge, WA; Peters, DG				Chu, Tianjiao; Handley, Daniel; Bunce, Kimberly; Surti, Urvashi; Hogge, W. Allen; Peters, David G.			Structural and Regulatory Characterization of the Placental Epigenome at Its Maternal Interface	PLOS ONE			English	Article							NONINVASIVE-PRENATAL-DIAGNOSIS; DNA METHYLATION; GENE-EXPRESSION; ENDOCRINE DISRUPTORS; DEVELOP PREECLAMPSIA; PLASMA; DISEASE; GENOME; CANCER; PROMOTER	Epigenetics can be loosely defined as the study of cellular "traits" that influence biological phenotype in a fashion that is not dependent on the underlying primary DNA sequence. One setting in which epigenetics is likely to have a profound influence on biological phenotype is during intrauterine development. In this context there is a defined and critical window during which balanced homeostasis is essential for normal fetal growth and development. We have carried out a detailed structural and functional analysis of the placental epigenome at its maternal interface. Specifically, we performed genome wide analysis of DNA methylation in samples of chorionic villus (CVS) and maternal blood cells (MBC) using both commercially available and custom designed microarrays. We then compared these data with genome wide transcription data for the same tissues. In addition to the discovery that CVS genomes are significantly more hypomethylated than their MBC counterparts, we identified numerous tissue-specific differentially methylated regions (T-DMRs). We further discovered that these T-DMRs are clustered spatially along the genome and are enriched for genes with tissue-specific biological functions. We identified unique patterns of DNA methylation associated with distinct genomic structures such as gene bodies, promoters and CpG islands and identified both direct and inverse relationships between DNA methylation levels and gene expression levels in gene bodies and promoters respectively. Furthermore, we found that these relationships were significantly associated with CpG content. We conclude that the early gestational placental DNA methylome is highly organized and is significantly and globally associated with transcription. These data provide a unique insight into the structural and regulatory characteristics of the placental epigenome at its maternal interface and will drive future analyses of the role of placental dysfunction in gestational disease.	[Chu, Tianjiao; Handley, Daniel; Bunce, Kimberly; Surti, Urvashi; Hogge, W. Allen; Peters, David G.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA; [Chu, Tianjiao; Handley, Daniel; Bunce, Kimberly; Peters, David G.] Magee Womens Res Inst, Ctr Fetal Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute	Chu, TJ (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA.	david.peters@mail.hgen.pitt.edu	Peters, David/AAD-4629-2019		Magee-Womens Research Institute and Foundation	Magee-Womens Research Institute and Foundation	This work was supported by a grant to DGP from the Magee-Womens Research Institute and Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolmaleky HM, 2006, HUM MOL GENET, V15, P3132, DOI 10.1093/hmg/ddl253; Anway MD, 2008, REPROD BIOMED ONLINE, V16, P23, DOI 10.1016/S1472-6483(10)60553-6; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; CHU T, 2009, PRENAT DIAGN; Chu TJ, 2009, PRENATAL DIAG, V29, P1020, DOI 10.1002/pd.2335; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Fauque P, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-116; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Iovannisci DM, 2006, GENET TEST, V10, P44, DOI 10.1089/gte.2006.10.44; JABLONKA E, 1989, J THEOR BIOL, V139, P69, DOI 10.1016/S0022-5193(89)80058-X; Leung TN, 2001, CLIN CHEM, V47, P137; Lo YMD, 2005, J HISTOCHEM CYTOCHEM, V53, P293, DOI 10.1369/jhc.4R6362.2005; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Papageorgiou EA, 2009, AM J PATHOL, V174, P1609, DOI 10.2353/ajpath.2009.081038; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Pike BL, 2008, LEUKEMIA, V22, P1035, DOI 10.1038/leu.2008.18; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; ROBERTS JM, 2008, 2 STAGE MODEL PREECL; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Tang WY, 2007, REV ENDOCR METAB DIS, V8, P173, DOI 10.1007/s11154-007-9042-4; Tong YK, 2006, CLIN CHEM, V52, P2194, DOI 10.1373/clinchem.2006.076851; TOST J, 2009, MOL BIOTECHNOL; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Uy GD, 2002, DEVELOPMENT, V129, P3913; van Vliet J, 2007, CELL MOL LIFE SCI, V64, P1531, DOI 10.1007/s00018-007-6526-z; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861	39	18	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14723	10.1371/journal.pone.0014723	http://dx.doi.org/10.1371/journal.pone.0014723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373191	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287657500007
J	Mody, RK; Greene, SA; Gaul, L; Sever, A; Pichette, S; Zambrana, I; Dang, T; Gass, A; Wood, R; Herman, K; Cantwell, LB; Falkenhorst, G; Wannemuehler, K; Hoekstra, RM; McCullum, I; Cone, A; Franklin, L; Austin, J; Delea, K; Behravesh, CB; Sodha, SV; Yee, JC; Emanuel, B; Al-Khaldi, SF; Jefferson, V; Williams, IT; Griffin, PM; Swerdlow, DL				Mody, Rajal K.; Greene, Sharon A.; Gaul, Linda; Sever, Adrianne; Pichette, Sarah; Zambrana, Ingrid; Dang, Thi; Gass, Angie; Wood, Rene; Herman, Karen; Cantwell, Laura B.; Falkenhorst, Gerhard; Wannemuehler, Kathleen; Hoekstra, Robert M.; McCullum, Isaac; Cone, Amy; Franklin, Lou; Austin, Jana; Delea, Kristin; Behravesh, Casey Barton; Sodha, Samir V.; Yee, J. Christopher; Emanuel, Brian; Al-Khaldi, Sufian F.; Jefferson, Val; Williams, Ian T.; Griffin, Patricia M.; Swerdlow, David L.			National Outbreak of Salmonella Serotype Saintpaul Infections: Importance of Texas Restaurant Investigations in Implicating Jalapeno Peppers	PLOS ONE			English	Article							INTERNATIONAL OUTBREAK; FRESH PRODUCE; MULTISTATE OUTBREAK; UNITED-STATES; CONSUMPTION; TOMATOES; GROWTH	Background: In May 2008, PulseNet detected a multistate outbreak of Salmonella enterica serotype Saintpaul infections. Initial investigations identified an epidemiologic association between illness and consumption of raw tomatoes, yet cases continued. In mid-June, we investigated two clusters of outbreak strain infections in Texas among patrons of Restaurant A and two establishments of Restaurant Chain B to determine the outbreak's source. Methodology/Principal Findings: We conducted independent case-control studies of Restaurant A and B patrons. Patients were matched to well controls by meal date. We conducted restaurant environmental investigations and traced the origin of implicated products. Forty-seven case-patients and 40 controls were enrolled in the Restaurant A study. Thirty case-patients and 31 controls were enrolled in the Restaurant Chain B study. In both studies, illness was independently associated with only one menu item, fresh salsa (Restaurant A: matched odds ratio [mOR], 37; 95% confidence interval [CI], 7.2-386; Restaurant B: mOR, 13; 95% CI 1.3-infinity). The only ingredient in common between the two salsas was raw jalapeno peppers. Cultures of jalapeno peppers collected from an importer that supplied Restaurant Chain B and serrano peppers and irrigation water from a Mexican farm that supplied that importer with jalapeno and serrano peppers grew the outbreak strain. Conclusions/Significance: Jalapeno peppers, contaminated before arrival at the restaurants and served in uncooked fresh salsas, were the source of these infections. Our investigations, critical in understanding the broader multistate outbreak, exemplify an effective approach to investigating large foodborne outbreaks. Additional measures are needed to reduce produce contamination.	[Mody, Rajal K.; Sever, Adrianne] Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA; [Mody, Rajal K.; Greene, Sharon A.; Herman, Karen; Cantwell, Laura B.; Falkenhorst, Gerhard; Wannemuehler, Kathleen; Hoekstra, Robert M.; McCullum, Isaac; Austin, Jana; Behravesh, Casey Barton; Sodha, Samir V.; Williams, Ian T.; Griffin, Patricia M.; Swerdlow, David L.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Gaul, Linda; Dang, Thi] Texas Dept State Hlth Serv, Austin, TX USA; [Pichette, Sarah; Zambrana, Ingrid; Yee, J. Christopher; Emanuel, Brian; Al-Khaldi, Sufian F.; Jefferson, Val] US FDA, Silver Spring, MD USA; [Gass, Angie; Wood, Rene; Cone, Amy; Franklin, Lou] Wichita Falls Wichita Cty Publ Hlth Dist, Wichita Falls, TX USA; [Delea, Kristin] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Texas Department of State Health Services; US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Mody, RK (corresponding author), Ctr Dis Control & Prevent, Sci Educ & Profess Dev Program Off, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	rmody@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022	BARTON BEHRAVESH, Casey/0000-0003-2270-5573; Hoekstra, Robert Michael/0000-0002-0340-8015; Wannemuehler, Kathleen/0000-0001-9535-6277; Greene, Sharon/0000-0002-4037-7908	core government	core government	This work was supported by core government funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews W.A., 2007, BACTERIOLOGICAL ANAL; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P325; Beuchat LR, 1997, EMERG INFECT DIS, V3, P459, DOI 10.3201/eid0304.970407; Bowen A, 2006, EPIDEMIOL INFECT, V134, P675, DOI 10.1017/S0950268805005480; Centers for Disease Control and Prevention, 2006, MMWR-MORBID MORTAL W, V55, P1045; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P929; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Gerner-Smidt P, 2006, FOODBORNE PATHOG DIS, V3, P9, DOI 10.1089/fpd.2006.3.9; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Isaacs S, 2005, J FOOD PROTECT, V68, P191, DOI 10.4315/0362-028X-68.1.191; Long S M, 2002, Commun Dis Public Health, V5, P101; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Ma L, 2010, J FOOD PROTECT, V73, P434, DOI 10.4315/0362-028X-73.3.434; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Nutt JD, 2003, BIORESOURCE TECHNOL, V89, P313, DOI 10.1016/S0960-8524(03)00084-1; Pezzoli L, 2008, FOODBORNE PATHOG DIS, V5, P661, DOI 10.1089/fpd.2008.0103; Sivapalasingam S, 2004, J FOOD PROTECT, V67, P2342, DOI 10.4315/0362-028X-67.10.2342; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; Tauxe R, 1997, J FOOD PROTECT, V60, P1400, DOI 10.4315/0362-028X-60.11.1400; U.S. Food and Drug Administration, 2009, FOOD COD 2009; U.S. Food and Drug Administration (FDA), 2009, PROGR INF MAN RET FO; US Food and Drug Administration (US FDA), 2008, SALM SAINTP OUTBR	24	52	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16579	10.1371/journal.pone.0016579	http://dx.doi.org/10.1371/journal.pone.0016579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373185	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500012
J	Micciche, F; Da Riva, L; Fabbi, M; Pilotti, S; Mondellini, P; Ferrini, S; Canevari, S; Pierotti, MA; Bongarzone, I				Micciche, Francesca; Da Riva, Luca; Fabbi, Marina; Pilotti, Silvana; Mondellini, Piera; Ferrini, Silvano; Canevari, Silvana; Pierotti, Marco A.; Bongarzone, Italia			Activated Leukocyte Cell Adhesion Molecule Expression and Shedding in Thyroid Tumors	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; DOWN-REGULATION; CARCINOMA; CANCER; ALCAM; MARKER; ALCAM/CD166; SURVIVAL; PROGRESSION	Activated leukocyte cell adhesion molecule (ALCAM, CD166) is expressed in various tissues, cancers, and cancer-initiating cells. Alterations in expression of ALCAM have been reported in several human tumors, and cell adhesion functions have been proposed to explain its association with cancer. Here we documented high levels of ALCAM expression in human thyroid tumors and cell lines. Through proteomic characterization of ALCAM expression in the human papillary thyroid carcinoma cell line TPC-1, we identified the presence of a full-length membrane-associated isoform in cell lysate and of soluble ALCAM isoforms in conditioned medium. This finding is consistent with proteolytically shed ALCAM ectodomains. Nonspecific agents, such as phorbol myristate acetate (PMA) or ionomycin, provoked increased ectodomain shedding. Epidermal growth factor receptor stimulation also enhanced ALCAM secretion through an ADAM17/TACE-dependent pathway. ADAM17/TACE was expressed in the TPC-1 cell line, and ADAM17/TACE silencing by specific small interfering RNAs reduced ALCAM shedding. In addition, the CGS27023A inhibitor of ADAM17/TACE function reduced ALCAM release in a dose-dependent manner and inhibited cell migration in a wound-healing assay. We also provide evidence for the existence of novel O-glycosylated forms and of a novel 60-kDa soluble form of ALCAM, which is particularly abundant following cell stimulation by PMA. ALCAM expression in papillary and medullary thyroid cancer specimens and in the surrounding non-tumoral component was studied by western blot and immunohistochemistry, with results demonstrating that tumor cells overexpress ALCAM. These findings strongly suggest the possibility that ALCAM may have an important role in thyroid tumor biology.	[Micciche, Francesca; Da Riva, Luca; Mondellini, Piera; Bongarzone, Italia] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Prote Lab, Milan, Italy; [Fabbi, Marina; Ferrini, Silvano] Ist Nazl Ric Canc, Lab Immunol Therapy, I-16132 Genoa, Italy; [Pilotti, Silvana] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Lab Expt Mol Pathol, Milan, Italy; [Canevari, Silvana] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Unit Mol Therapies, Milan, Italy; [Pierotti, Marco A.] Fdn IRCCS Ist Nazl Tumori, Sci Directorate, Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Genoa; IRCCS AOU San Martino IST; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan	Micciche, F (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Prote Lab, Milan, Italy.	italia.bongarzone@istitutotumori.mi.it	Pierotti, Marco Alessandro/AAC-4728-2022; Bongarzone, Italia/B-9544-2017; Fabbi, Marina/I-1290-2012	Pierotti, Marco Alessandro/0000-0002-7431-8332; Bongarzone, Italia/0000-0003-2530-9170; Ferrini, Silvano/0000-0001-7254-2616; Fabbi, Marina/0000-0002-4203-2022	Fondazione Cariplo (Milan, Italy); Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy); Alleanza Contro il Cancro (ACC)	Fondazione Cariplo (Milan, Italy)(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro (ACC)	This work was supported by grants from Fondazione Cariplo (Milan, Italy), the Associazione Italiana per la Ricerca sul Cancro (AIRC) (Milan, Italy), and Alleanza Contro il Cancro (ACC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi V, 1998, THYROID, V8, P23, DOI 10.1089/thy.1998.8.23; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Caccia D, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-278; Corrias MV, 2010, CELL ONCOL, V32, P77, DOI 10.3233/CLO-2009-0494; Davies SR, 2008, ONCOL REP, V19, P555; DeLellis R, 2004, WHO CLASSIFICATION T; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; El Demellawy D, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-5; Faca VM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002425; Fenton CL, 2001, ANN CLIN LAB SCI, V31, P245; Garcia-Rostan G, 2001, AM J PATHOL, V158, P987, DOI 10.1016/S0002-9440(10)64045-X; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gorla L, 2009, MOL CARCINOGEN, V48, P220, DOI 10.1002/mc.20474; Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Jain SJ, 2004, CANCER RES, V64, P3907, DOI 10.1158/0008-5472.CAN-03-3801; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Jezierska A, 2006, MED SCI MONITOR, V12, pBR245; JIN Z, 2010, ONCOGENE; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; King JA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-266; Kulasingam V, 2009, INT J CANCER, V125, P9, DOI 10.1002/ijc.24292; Landriscina M, 2010, ANTICANCER RES, V30, P473; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Mezzanzanica D, 2008, CLIN CANCER RES, V14, P1726, DOI 10.1158/1078-0432.CCR-07-0428; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Piazza T, 2005, J CELL SCI, V118, P1515, DOI 10.1242/jcs.02280; Riesco-Eizaguirre G, 2009, CANCER RES, V69, P8317, DOI 10.1158/0008-5472.CAN-09-1248; Rodriguez-Antona C, 2010, ENDOCR-RELAT CANCER, V17, P7, DOI 10.1677/ERC-08-0304; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Ryder M, 2008, ENDOCR-RELAT CANCER, V15, P1069, DOI 10.1677/ERC-08-0036; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Swart GWM, 2002, EUR J CELL BIOL, V81, P313, DOI 10.1078/0171-9335-00256; van Kempen LCLT, 2000, AM J PATHOL, V156, P769, DOI 10.1016/S0002-9440(10)64943-7; Verma A, 2005, ONCOLOGY-BASEL, V68, P462, DOI 10.1159/000086989; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Wells SA, 2000, WORLD J SURG, V24, P952, DOI 10.1007/s002680010166; Zimmerman AW, 2004, J CELL SCI, V117, P2841, DOI 10.1242/jcs.01139	42	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17141	10.1371/journal.pone.0017141	http://dx.doi.org/10.1371/journal.pone.0017141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364949	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600032
J	Hao, CY; Wang, LF; Ge, HM; Dong, YC; Zhang, XY				Hao, Chenyang; Wang, Lanfen; Ge, Hongmei; Dong, Yuchen; Zhang, Xueyong			Genetic Diversity and Linkage Disequilibrium in Chinese Bread Wheat (Triticum aestivum L.) Revealed by SSR Markers	PLOS ONE			English	Article							SOYBEAN GLYCINE-MAX; ORYZA-SATIVA L.; POPULATION-STRUCTURE; CORE COLLECTION; MICROSATELLITE MARKERS; MOLECULAR DIVERSITY; MINIMUM NUMBER; DURUM-WHEAT; GERMPLASM; GENOME	Two hundred and fifty bread wheat lines, mainly Chinese mini core accessions, were assayed for polymorphism and linkage disequilibrium (LD) based on 512 whole-genome microsatellite loci representing a mean marker density of 5.1 cM. A total of 6,724 alleles ranging from 1 to 49 per locus were identified in all collections. The mean PIC value was 0.650, ranging from 0 to 0.965. Population structure and principal coordinate analysis revealed that landraces and modern varieties were two relatively independent genetic sub-groups. Landraces had a higher allelic diversity than modern varieties with respect to both genomes and chromosomes in terms of total number of alleles and allelic richness. 3,833 (57.0%) and 2,788 (41.5%) rare alleles with frequencies of <5% were found in the landrace and modern variety gene pools, respectively, indicating greater numbers of rare variants, or likely new alleles, in landraces. Analysis of molecular variance (AMOVA) showed that A genome had the largest genetic differentiation and D genome the lowest. In contrast to genetic diversity, modern varieties displayed a wider average LD decay across the whole genome for locus pairs with r(2)>0.05 (P<0.001) than the landraces. Mean LD decay distance for the landraces at the whole genome level was <5 cM, while a higher LD decay distance of 5-10 cM in modern varieties. LD decay distances were also somewhat different for each of the 21 chromosomes, being higher for most of the chromosomes in modern varieties (<5 similar to 25 cM) compared to landraces (<5 similar to 15 cM), presumably indicating the influences of domestication and breeding. This study facilitates predicting the marker density required to effectively associate genotypes with traits in Chinese wheat genetic resources.	[Hao, Chenyang; Wang, Lanfen; Ge, Hongmei; Dong, Yuchen; Zhang, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat, Minist Agr,Natl Key Facil Crop Gene Resources & G, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs	Hao, CY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Germplasm Resources & Utilizat, Minist Agr,Natl Key Facil Crop Gene Resources & G, Beijing, Peoples R China.	xueyongz@caas.net.cn			Chinese Ministry of Science and Technology [2010CB125900, 2004CB117202]; Modern Agricultural Technical System; National Natural Science Foundation of China [30900898]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Modern Agricultural Technical System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chinese Ministry of Science and Technology (2010CB125900, 2004CB117202), Modern Agricultural Technical System, and National Natural Science Foundation of China (30900898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Balfourier F, 2007, THEOR APPL GENET, V114, P1265, DOI 10.1007/s00122-007-0517-1; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chapman MA, 2008, PLANT CELL, V20, P2931, DOI 10.1105/tpc.108.059808; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dong Y.C., 2003, J PLANT GENET RESOUR, V4, P1, DOI DOI 10.13430/J.CNKI.JPGR.2003.01.001; Dreisigacker S, 2004, CROP SCI, V44, P381, DOI 10.2135/cropsci2004.0381; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Garris AJ, 2003, GENETICS, V165, P759; Gaut BS, 2003, PLANT CELL, V15, P1502, DOI 10.1105/tpc.150730; Guo ZA, 2010, NEW PHYTOL, V185, P841, DOI 10.1111/j.1469-8137.2009.03099.x; Gupta PK, 2002, THEOR APPL GENET, V105, P413, DOI 10.1007/s00122-002-0865-9; Hamblin MT, 2004, GENETICS, V167, P471, DOI 10.1534/genetics.167.1.471; Hao CY, 2008, CHINESE SCI BULL, V53, P1518, DOI 10.1007/s11434-008-0212-x; Hao CY, 2006, MOL BREEDING, V17, P69, DOI 10.1007/s11032-005-2453-6; He Z., 2001, HIST WHEAT BREEDING; HEDRICK PW, 1987, GENETICS, V117, P331; Horvath A, 2009, THEOR APPL GENET, V119, P1523, DOI 10.1007/s00122-009-1153-8; Huang XQ, 2002, THEOR APPL GENET, V105, P699, DOI 10.1007/s00122-002-0959-4; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Kraakman ATW, 2004, GENETICS, V168, P435, DOI 10.1534/genetics.104.026831; Li YH, 2010, NEW PHYTOL, V188, P242, DOI 10.1111/j.1469-8137.2010.03344.x; Li YH, 2008, THEOR APPL GENET, V117, P857, DOI 10.1007/s00122-008-0825-0; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Malysheva-Otto LV, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-6; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Payseur BA, 2009, MOL BIOL EVOL, V26, P1369, DOI 10.1093/molbev/msp052; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Roder MS, 1998, GENETICS, V149, P2007; Roder MS, 2002, THEOR APPL GENET, V106, P67, DOI 10.1007/s00122-002-1061-7; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Roussel V, 2004, THEOR APPL GENET, V108, P920, DOI 10.1007/s00122-003-1502-y; SCHOEN DJ, 1993, P NATL ACAD SCI USA, V90, P10623, DOI 10.1073/pnas.90.22.10623; SHARP PJ, 1989, THEOR APPL GENET, V78, P342, DOI 10.1007/BF00265294; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Wang J, 2008, J CEREAL SCI, V48, P836, DOI 10.1016/j.jcs.2008.06.005; Wang RH, 2008, THEOR APPL GENET, V117, P1141, DOI 10.1007/s00122-008-0852-x; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; You GX, 2004, MOL BREEDING, V14, P397, DOI 10.1007/s11032-004-0285-4; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhang XY, 2002, THEOR APPL GENET, V106, P112, DOI 10.1007/s00122-002-1016-z; ZHANG ZW, PLANT AN GEN 14 C SA; Zhu YL, 2003, GENETICS, V163, P1123; Zhuang QS., 2003, CHINESE WHEAT IMPROV	58	122	131	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17279	10.1371/journal.pone.0017279	http://dx.doi.org/10.1371/journal.pone.0017279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365016	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800043
J	McFarland, AP; Savan, R; Wagage, S; Addison, A; Ramakrishnan, K; Karwan, M; Tri, D; Young, HA				McFarland, Adelle P.; Savan, Ram; Wagage, Sagie; Addison, Augustina; Ramakrishnan, Karthika; Karwan, Megan; Tri Duong; Young, Howard A.			Localized Delivery of Interferon-beta by Lactobacillus Exacerbates Experimental Colitis	PLOS ONE			English	Article							ACTIVE ULCERATIVE-COLITIS; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; IN-VITRO; T-CELLS; FUNCTIONAL SPECIALIZATION; GENE-EXPRESSION; IFN-BETA; INFLAMMATION; INDUCTION	Background: There have been conflicting reports of the role of Type I interferons (IFN) in inflammatory bowel disease (IBD). Clinical trials have shown potent efficacy of systemic interferon-beta (IFN-beta) in inducing remission of ulcerative colitis. Likewise, IFNAR1(-/-) mice display an increased sensitivity to dextran sulfate sodium (DSS)-induced colitis, suggesting Type I IFN play a protective role during inflammation of the gut. Curiously, however, there have also been reports detailing the spontaneous development of IBD in patients receiving systemic IFN-beta therapy for multiple sclerosis or hepatitis. Methodology/Principal Findings: To investigate the effects of local administration of IFN-beta on a murine model of colitis, we developed a transgenic Lactobacillus acidophilus strain that constitutively expresses IFN-beta (La-IFN-beta). While pretreatment of mice with control Lactobacillus (La-EV) provided slight protective benefits, La-IFN-beta increased sensitivity to DSS. Analysis showed colitic mice pretreated with L alpha-IFN-beta had increased production of TNF-alpha, IFN-gamma, IL-17A and IL-13 by intestinal tissues and decreased regulatory T cells (Tregs) in their small intestine. Examination of CD103(+) dendritic cells (DCs) in the Peyer's patches revealed that IFNAR1 expression was dramatically reduced by La-IFN-beta. Similarly, bone marrow-derived DCs matured with La-IFN-beta experienced a 3-fold reduction of IFNAR1 and were impaired in their ability to induce Tregs. Conclusions/Significance: Our IFNAR1 expression data identifies a correlation between the loss/downregulation of IFNAR1 on DCs and exacerbation of colitis. Our data show that Lactobacillus secreting IFN-b has an immunological effect that in our model results in the exacerbation of colitis. This study underscores that the selection of therapeutics delivered by a bacterial vehicle must take into consideration the simultaneous effects of the vehicle itself.	[McFarland, Adelle P.; Savan, Ram; Wagage, Sagie; Addison, Augustina; Ramakrishnan, Karthika; Karwan, Megan; Young, Howard A.] NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA; [Tri Duong] N Carolina State Univ, Dept Food Bioproc & Nutr Sci, Raleigh, NC 27695 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; North Carolina State University	McFarland, AP (corresponding author), NCI, Canc & Inflammat Program, Ctr Canc Res, Frederick, MD 21701 USA.	YoungHow@mail.nih.gov	Duong, Tri/F-9458-2019; Duong, Tri/B-5594-2012; Young, Howard/R-5140-2019; Young, Howard/A-6350-2008	Duong, Tri/0000-0002-4803-8564; McFarland, Adelle/0000-0001-7534-1158; Savan, Ram/0000-0002-3087-1355; Young, Howard/0000-0002-3118-5111	Office of Dietary Supplements, National Institutes of Health (NIH); National Cancer Institute (NCI), NIH [HHSN261200800001E]; NIH, NCI, Center for Cancer Research	Office of Dietary Supplements, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This project has been funded in whole or in part with federal funds from the Office of Dietary Supplements, National Institutes of Health (NIH) and the National Cancer Institute (NCI), NIH, under the contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States government. This research was supported by the Intramural Research Program of the NIH, NCI, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2007, P NATL ACAD SCI USA, V104, P17022, DOI 10.1073/pnas.0708469104; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70; Bhattacharya S, 2010, J BIOL CHEM, V285, P2318, DOI 10.1074/jbc.M109.071498; Billiau A, 2006, ANTIVIR RES, V71, P108, DOI 10.1016/j.antiviral.2006.03.006; BLASI E, 1989, CANCER BIOCHEM BIOPH, V10, P303; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Boirivant M, 2008, MUCOSAL IMMUNOL, V1, pS47, DOI 10.1038/mi.2008.52; Braat H, 2006, CLIN GASTROENTEROL H, V4, P754, DOI 10.1016/j.cgh.2006.03.028; BRANCA AA, 1982, J BIOL CHEM, V257, P13291; Corsini E, 1997, J NEUROIMMUNOL, V79, P76, DOI 10.1016/S0165-5728(97)00114-8; del Rio ML, 2010, IMMUNOL REV, V234, P268, DOI 10.1111/j.0105-2896.2009.00874.x; Duong T, 2011, MICROB BIOTECHNOL, V4, P357, DOI 10.1111/j.1751-7915.2010.00200.x; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Foligne B, 2007, GASTROENTEROLOGY, V133, P862, DOI 10.1053/j.gastro.2007.06.018; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kaser A, 1998, CYTOKINE, V10, P75, DOI 10.1006/cyto.1997.0270; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Leppert D, 1996, ANN NEUROL, V40, P846, DOI 10.1002/ana.410400606; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Mannon PJ, 2011, GUT, V60, P449, DOI 10.1136/gut.2010.226860; Mattei F, 2009, EUR J IMMUNOL, V39, P1807, DOI 10.1002/eji.200939233; McRae BL, 1997, EUR J IMMUNOL, V27, P2650, DOI 10.1002/eji.1830271026; Miike Tadashi, 2008, Nihon Shokakibyo Gakkai Zasshi, V105, P1362; Montoya M, 2002, BLOOD, V99, P3263, DOI 10.1182/blood.V99.9.3263; Moschen AR, 2008, IMMUNOBIOLOGY, V213, P779, DOI 10.1016/j.imbio.2008.07.022; Musch E, 2007, Z GASTROENTEROL, V45, P1235, DOI 10.1055/s-2007-963378; Musch E, 2002, ALIMENT PHARM THER, V16, P1233, DOI 10.1046/j.1365-2036.2002.01264.x; Nozell S, 2006, J IMMUNOL, V177, P822, DOI 10.4049/jimmunol.177.2.822; Obermeier F, 2003, CLIN EXP IMMUNOL, V134, P217, DOI 10.1046/j.1365-2249.2003.02288.x; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; OLIVEIRA IC, 1992, P NATL ACAD SCI USA, V89, P9049, DOI 10.1073/pnas.89.19.9049; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pogue SL, 2004, J INTERF CYTOK RES, V24, P131, DOI 10.1089/107999004322813372; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Ragimbeau J, 2003, EMBO J, V22, P537, DOI 10.1093/emboj/cdg038; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Rescigno M, 2008, CURR DRUG TARGETS, V9, P395, DOI 10.2174/138945008784221125; Rescigno M, 2009, IMMUNITY, V31, P454, DOI 10.1016/j.immuni.2009.08.015; Rodrigues S, 2010, INFLAMM BOWEL DIS, V16, P2001, DOI 10.1002/ibd.21242; Russell-Harde D, 1999, BIOCHEM BIOPH RES CO, V255, P539, DOI 10.1006/bbrc.1998.0105; Samson M, 2009, REV MED INTERNE, V30, P816, DOI 10.1016/j.revmed.2008.11.008; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schott E, 2007, WORLD J GASTROENTERO, V13, P3638, DOI 10.3748/wjg.v13.i26.3638; Severa M, 2006, J LEUKOCYTE BIOL, V79, P1286, DOI 10.1189/jlb.1205742; Siddiqui KRR, 2008, MUCOSAL IMMUNOL, V1, pS34, DOI 10.1038/mi.2008.43; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Sprenger R, 2005, GUT, V54, P438; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Triantaphyllopoulos KA, 1999, ARTHRITIS RHEUM, V42, P90, DOI 10.1002/1529-0131(199901)42:1<90::AID-ANR12>3.0.CO;2-A; Trojano M, 2000, J NEUROVIROL, V6, pS47; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; VAN HJ, 2004, ARTHRITIS RES THER, V6, pR239, DOI DOI 10.1186/AR1165; Vandenbroucke K, 2010, MUCOSAL IMMUNOL, V3, P49, DOI 10.1038/mi.2009.116; Watanabe T, 2006, GUT, V55, P1682, DOI 10.1136/gut.2006.105197; Weiss G, 2010, IMMUNOLOGY, V131, P268, DOI 10.1111/j.1365-2567.2010.03301.x; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	70	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16967	10.1371/journal.pone.0016967	http://dx.doi.org/10.1371/journal.pone.0016967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365015	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800024
J	Wang, G; Chen, G; Zheng, DH; Cheng, GH; Tang, H				Wang, Gang; Chen, Gang; Zheng, Dahai; Cheng, Genhong; Tang, Hong			PLP2 of Mouse Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; PAPAIN-LIKE PROTEASE; NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; E3 UBIQUITIN LIGASE; DOUBLE-STRANDED-RNA; IFN-BETA PROMOTER; ANTIVIRAL RESPONSES; INNATE IMMUNITY; SYNDROME CORONAVIRUS	Background: Coronaviruses such as severe acute respiratory syndrome (SARS) coronavirus (SCoV) and mouse hepatitis virus A59 (MHV-A59) have evolved strategies to disable the innate immune system for productive replication and spread of infection. We have previously shown that papain-like protease domain 2 (PLP2), a catalytic domain of the nonstructural protein 3 (nsp3) of MHV-A59, encodes a deubiquitinase (DUB) and inactivates IFN regulatory factor 3 (IRF3) thereby the type I interferon (IFN) response. Principal Findings: Here we provide further evidence that PLP2 may also target TANK-binding kinase-1 (TBK1), the upstream kinase of IRF3 in the IFN signaling pathway. Overexpression experiments showed that PLP2 deubiquitinated TBK1 and reduced its kinase activity, hence inhibited IFN-beta reporter activity. Albeit promiscuous in deubiquitinating cellular proteins, PLP2 inactivated TBK1 and IFN-beta response in TNF receptor associated factor 3 (TRAF3) deficient cells, suggesting that targeting TBK1 would be sufficient for PLP2 to inhibit IRF3 activation. This notion was further supported by in vitro kinase assays, in which prior treatment of TBK1 with PLP2 inhibited its kinase activity to phosphorylate IRF3. Intriguing enough, results of PLP2 overexpression system and MHV-A59 infection system proved that PLP2 formed an inactive complex with TBK1 and IRF3 in the cytoplasm and the presence of PLP2 stabilized the hypo-phosphorylated IRF3-TBK1 complex in a dose-dependent manner. Conclusions: These results suggest that PLP2 not only inactivates TBK1, but also prevents IRF3 nuclear translocation hence inhibits IFN transcription activation. Identification of the conserved DUB activity of PLP2 in suppression of IFN signaling would provide a useful clue to the development of therapeutics against coronaviruses infection.	[Wang, Gang; Chen, Gang; Zheng, Dahai; Tang, Hong] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Wang, Gang; Tang, Hong] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing 100080, Peoples R China; [Wang, Gang] Grad Univ, Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, G (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	tanghong@moon.ibp.ac.cn	Wang, Gang/AEO-7822-2022		Ministry of Science and Technology of China [2007DFC30190, 2009CB522506, 2011CB946104]; Chinese Academy of Sciences [KSCX1-YW-10, 2010-Biols-CAS-0201]; National Natural Science Foundation of China [31030031, 30728006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069120] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by grants from the National Basic Research Program of Ministry of Science and Technology of China (2007DFC30190, 2009CB522506, 2011CB946104) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX1-YW-10, 2010-Biols-CAS-0201) to H. T. and a grant from National Natural Science Foundation of China (31030031) to H. T. and (30728006) to G. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barretto N, 2005, J VIROL, V79, P15189, DOI 10.1128/JVI.79.24.15189-15198.2005; Beutler B, 2007, NAT REV IMMUNOL, V7, P753, DOI 10.1038/nri2174; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Bibeau-Poirier A, 2008, CYTOKINE, V43, P359, DOI 10.1016/j.cyto.2008.07.012; Chen J, 2007, ANNU REV IMMUNOL, V25, P443, DOI 10.1146/annurev.immunol.25.022106.141706; Clement JF, 2008, J VIROL, V82, P3984, DOI 10.1128/JVI.02526-07; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gatot JS, 2007, J BIOL CHEM, V282, P31131, DOI 10.1074/jbc.M701690200; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kuo LL, 2003, J VIROL, V77, P4597, DOI 10.1128/JVI.77.8.4597-4608.2003; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lu LL, 2008, J BIOL CHEM, V283, P14269, DOI 10.1074/jbc.M710089200; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Reghunathan R, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-2; Reily MM, 2006, EMBO J, V25, P108, DOI 10.1038/sj.emboj.7600919; Rose KM, 2010, J VIROL, V84, P5656, DOI 10.1128/JVI.00211-10; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tsuchida T, 2009, CELL RES, V19, P3, DOI 10.1038/cr.2009.1; Uematsu S, 2006, J MOL MED-JMM, V84, P712, DOI 10.1007/s00109-006-0084-y; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014; Verpooten D, 2009, J BIOL CHEM, V284, P1097, DOI 10.1074/jbc.M805905200; Versteeg GA, 2007, VIROLOGY, V361, P18, DOI 10.1016/j.virol.2007.01.020; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu Y, 1996, IMMUNITY, V5, P407, DOI 10.1016/S1074-7613(00)80497-5; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zheng DH, 2008, CELL RES, V18, P1105, DOI 10.1038/cr.2008.294; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	47	41	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17192	10.1371/journal.pone.0017192	http://dx.doi.org/10.1371/journal.pone.0017192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364999	Green Submitted, gold, Green Published			2022-12-27	WOS:000287482800032
J	Gregori-Grgic, R; Balderi, M; de'Sperati, C				Gregori-Grgic, Regina; Balderi, Monica; de'Sperati, Claudio			Delayed Perceptual Awareness in Rapid Perceptual Decisions	PLOS ONE			English	Article							MOTION PERCEPTION; VISUAL-MOTION; TIME-COURSE; BLINDSIGHT; RESPONSES; VISION; DISCRIMINATION; INTEGRATION; PSYCHOLOGY; ATTENTION	The flourishing of studies on the neural correlates of decision-making calls for an appraisal of the relation between perceptual decisions and conscious perception. By exploiting the long integration time of noisy motion stimuli, and by forcing human observers to make difficult speeded decisions - sometimes a blind guess - about stimulus direction, we traced the temporal buildup of motion discrimination capability and perceptual awareness, as assessed trial by trial through direct rating. We found that both increased gradually with motion coherence and viewing time, but discrimination was systematically leading awareness, reaching a plateau much earlier. Sensitivity and criterion changes contributed jointly to the slow buildup of perceptual awareness. It made no difference whether motion discrimination was accomplished by saccades or verbal responses. These findings suggest that perceptual awareness emerges on the top of a developing or even mature perceptual decision. We argue that the middle temporal (MT) cortical region does not confer us the full phenomenic depth of motion perception, although it may represent a precursor stage in building our subjective sense of visual motion.	[Gregori-Grgic, Regina; Balderi, Monica; de'Sperati, Claudio] Univ Vita Salute San Raffaele, Visuo Motor Funct Lab, Milan, Italy	Vita-Salute San Raffaele University	Gregori-Grgic, R (corresponding author), Univ Vita Salute San Raffaele, Visuo Motor Funct Lab, Milan, Italy.	desperati.claudio@unisr.it		de'sperati, claudio/0000-0002-7322-2240	Italian Ministry for Education, University; MIUR [PRIN-2008RBFNLH_002]	Italian Ministry for Education, University(Ministry of Education, Universities and Research (MIUR)); MIUR(Ministry of Education, Universities and Research (MIUR))	This work received partial financial support from the Italian Ministry for Education, University, and Research (MIUR; Grant PRIN-2008RBFNLH_002 to CdS; http://prin.miur.it/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi P, 1997, P NATL ACAD SCI USA, V94, P14190, DOI 10.1073/pnas.94.25.14190; Azzopardi P, 2001, BRAIN, V124, P30, DOI 10.1093/brain/124.1.30; Block N, 2007, BEHAV BRAIN SCI, V30, P481, DOI 10.1017/S0140525X07002786; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Brown GS, 2005, BEHAV RES METHODS, V37, P436, DOI 10.3758/BF03192712; Burr DC, 2001, VISION RES, V41, P1891, DOI 10.1016/S0042-6989(01)00072-4; Cardoso-Leite P, 2009, J NEUROPHYSIOL, V101, P2822, DOI 10.1152/jn.91269.2008; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; Chalmers D.J., 1996, CONSCIOUS MIND SEARC; Cook EP, 2002, NAT NEUROSCI, V5, P985, DOI 10.1038/nn924; Cowey A, 1997, NEUROPSYCHOLOGIA, V35, P929, DOI 10.1016/S0028-3932(97)00021-3; d'Avossa G, 2007, NAT NEUROSCI, V10, P249, DOI 10.1038/nn1824; de'Sperati C, 2003, J COGNITIVE NEUROSCI, V15, P1244, DOI 10.1162/089892903322598184; De'Sperati C, 2008, J NEUROSCI, V28, P4317, DOI 10.1523/JNEUROSCI.0352-08.2008; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Evans S, 2007, SPATIAL VISION, V20, P61, DOI 10.1163/156856807779369742; Galvin SJ, 2003, PSYCHON B REV, V10, P843, DOI 10.3758/BF03196546; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Hegde J, 2008, PROG NEUROBIOL, V84, P405, DOI 10.1016/j.pneurobio.2007.09.001; KAHNEMAN D, 2002, NOB PRIZ LECT DEC 8; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Kiani R, 2009, SCIENCE, V324, P759, DOI 10.1126/science.1169405; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Koch Christof, 2004, QUEST CONSCIOUSNESS; KOLB FC, 1995, NATURE, V377, P336, DOI 10.1038/377336a0; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Libet B, 2004, MIND TIME TEMPORAL F; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; Macmillan NA, 2005, DETECTION THEORY USE; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Melcher D, 2004, VISION RES, V44, P1367, DOI 10.1016/j.visres.2003.11.023; Melloni L, 2007, J NEUROSCI, V27, P2858, DOI 10.1523/JNEUROSCI.4623-06.2007; Merikle PM, 2001, COGNITION, V79, P115, DOI 10.1016/S0010-0277(00)00126-8; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Morgan MJ, 1997, NATURE, V385, P401, DOI 10.1038/385401b0; Mulckhuyse M, 2010, ACTA PSYCHOL, V134, P299, DOI 10.1016/j.actpsy.2010.03.002; NAGEL T, 1974, PHILOS REV, V83, P435, DOI 10.2307/2183914; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; Orban GA, 2003, NEUROPSYCHOLOGIA, V41, P1757, DOI 10.1016/S0028-3932(03)00177-5; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Overgaard M, 2006, CONSCIOUS COGN, V15, P700, DOI 10.1016/j.concog.2006.04.002; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; Prinz W., 2002, COMMON MECH PERCEPTI; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; Sahraie A, 1998, BEHAV BRAIN RES, V96, P71, DOI 10.1016/S0166-4328(97)00194-0; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Sekuler R, 2002, STEVENS HDB EXPT PSY; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Simons DJ, 2000, TRENDS COGN SCI, V4, P147, DOI 10.1016/S1364-6613(00)01455-8; Smith PL, 2004, TRENDS NEUROSCI, V27, P161, DOI 10.1016/j.tins.2004.01.006; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Tosoni A, 2008, NAT NEUROSCI, V11, P1446, DOI 10.1038/nn.2221; Vanrullen Rufin, 2008, Adv Cogn Psychol, V3, P167, DOI 10.2478/v10053-008-0022-3; Weiskrantz L, 2003, PROG BRAIN RES, V144, P229, DOI 10.1016/S0079-6123(03)14401-6; Wilimzig C, 2008, J VISION, V8, DOI 10.1167/8.5.7; Zeki S, 2001, ANNU REV NEUROSCI, V24, P57, DOI 10.1146/annurev.neuro.24.1.57; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; [No title captured]	64	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17079	10.1371/journal.pone.0017079	http://dx.doi.org/10.1371/journal.pone.0017079			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21379582	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300028
J	Schierack, P; Kleta, S; Tedin, K; Babila, JT; Oswald, S; Oelschlaeger, TA; Hiemann, R; Paetzold, S; Wieler, LH				Schierack, Peter; Kleta, Sylvia; Tedin, Karsten; Babila, Julius Tachu; Oswald, Sibylle; Oelschlaeger, Tobias A.; Hiemann, Rico; Paetzold, Susanne; Wieler, Lothar H.			E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells	PLOS ONE			English	Article							NONPATHOGENIC ESCHERICHIA-COLI; ENTERICA SEROVAR TYPHIMURIUM; STRAIN NISSLE-1917; IN-VITRO; INVASION GENES; DIARRHEA; GROWTH; EXPRESSION; INFECTION; PPGPP	Background: The probiotic Escherichia coli strain Nissle 1917 (EcN) has been shown to interfere in a human in vitro model with the invasion of several bacterial pathogens into epithelial cells, but the underlying molecular mechanisms are not known. Methodology/Principal Findings: In this study, we investigated the inhibitory effects of EcN on Salmonella Typhimurium invasion of porcine intestinal epithelial cells, focusing on EcN effects on the various stages of Salmonella infection including intracellular and extracellular Salmonella growth rates, virulence gene regulation, and adhesion. We show that EcN affects the initial Salmonella invasion steps by modulating Salmonella virulence gene regulation and Salmonella SiiE-mediated adhesion, but not extra-and intracellular Salmonella growth. However, the inhibitory activity of EcN against Salmonella invasion always correlated with EcN adhesion capacities. EcN mutants defective in the expression of F1C fimbriae and flagellae were less adherent and less inhibitory toward Salmonella invasion. Another E. coli strain expressing F1C fimbriae was also adherent to IPEC-J2 cells, and was similarly inhibitory against Salmonella invasion like EcN. Conclusions: We propose that EcN affects Salmonella adhesion through secretory components. This mechanism appears to be common to many E. coli strains, with strong adherence being a prerequisite for an effective reduction of SiiE-mediated Salmonella adhesion.	[Schierack, Peter; Kleta, Sylvia; Tedin, Karsten; Wieler, Lothar H.] Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-1000 Berlin, Germany; [Schierack, Peter; Hiemann, Rico] Hsch Lausitz FH, Fachbereich Bio Chem & Verfahrenstech, Senftenberg, Germany; [Kleta, Sylvia] Bundesinst Risikobewertung, Berlin, Germany; [Babila, Julius Tachu] Max Delbruck Ctr Mol Med, Dept Neuroprote, Berlin, Germany; [Oswald, Sibylle; Oelschlaeger, Tobias A.] Univ Wurzburg, Inst Mol Infektbiol, Wurzburg, Germany; [Paetzold, Susanne] Max Planck Inst Infektbiol, Berlin, Germany; [Paetzold, Susanne] Res Ctr Borstel, Borstel, Germany	Free University of Berlin; Brandenburg University of Technology Cottbus; Federal Institute for Risk Assessment; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Max Planck Society; Forschungszentrum Borstel	Schierack, P (corresponding author), Free Univ Berlin, Inst Mikrobiol & Tierseuchen, D-1000 Berlin, Germany.	Peter.Schierack@HS-Lausitz.de	Oelschlaeger, Tobias/B-5624-2015	Wieler, Lothar H./0000-0003-4365-3717; Tedin, Karsten/0000-0003-2109-0730	German Research Foundation (DFG) through the Collaborative Research Centre [852, SFB852/1]; DFG [FOR 438/1-1]; Bundesministerium fur Bildung und Forschung (BMBF, Germany) [InnoProfile IP 03 IP 611]	German Research Foundation (DFG) through the Collaborative Research Centre(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	This study was supported by the German Research Foundation (DFG) through the Collaborative Research Centre 852 (grant no. SFB852/1), by grant FOR 438/1-1 from the DFG and by InnoProfile IP 03 IP 611 funded by the Bundesministerium fur Bildung und Forschung (BMBF, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoefer A, 2004, FEMS IMMUNOL MED MIC, V40, P223, DOI 10.1016/S0928-8244(03)00368-7; Bar F, 2009, NEUROGASTROENT MOTIL, V21, P575, DOI 10.1111/j.1365-2982.2008.01258.x; Bajaj V, 1995, MOL MICROBIOL, V18, P715, DOI 10.1111/j.1365-2958.1995.mmi_18040715.x; Bar F., 2009, NEUROGASTROENT MOTIL, V21, pe516; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Bickert T, 2009, INT ARCH ALLERGY IMM, V149, P219, DOI 10.1159/000199717; Boudeau J, 2003, ALIMENT PHARM THER, V18, P45, DOI 10.1046/j.1365-2036.2003.01638.x; Chiu HH, 2008, J APPL MICROBIOL, V104, P605, DOI 10.1111/j.1365-2672.2007.03573.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Gerlach RG, 2007, INFECT IMMUN, V75, P4697, DOI 10.1128/IAI.00228-07; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Helwig U, 2006, WORLD J GASTROENTERO, V12, P5978, DOI 10.3748/wjg.v12.i37.5978; Henker J, 2008, PEDIATR INFECT DIS J, V27, P494, DOI 10.1097/INF.0b013e318169034c; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Hudault S, 1997, APPL ENVIRON MICROB, V63, P513, DOI 10.1128/AEM.63.2.513-518.1997; Kamada N, 2008, INFECT IMMUN, V76, P214, DOI 10.1128/IAI.01193-07; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Krammer HJ, 2006, Z GASTROENTEROL, V44, P651, DOI 10.1055/s-2006-926909; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Lasaro MA, 2009, APPL ENVIRON MICROB, V75, P246, DOI 10.1128/AEM.01144-08; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Main-Hester KL, 2008, INFECT IMMUN, V76, P1024, DOI 10.1128/IAI.01224-07; Monteiro C, 2009, ENVIRON MICROBIOL, V11, P1105, DOI 10.1111/j.1462-2920.2008.01840.x; Prilassnig M, 2007, WIEN KLIN WOCHENSCHR, V119, P456, DOI 10.1007/s00508-007-0808-1; Reissbrodt R, 2009, FEMS MICROBIOL LETT, V290, P62, DOI 10.1111/j.1574-6968.2008.01405.x; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schierack P, 2009, APPL ENVIRON MICROB, V75, P695, DOI 10.1128/AEM.01650-08; Schroeder B, 2006, DIGEST DIS SCI, V51, P724, DOI 10.1007/s10620-006-3198-8; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Thompson A, 2006, J BIOL CHEM, V281, P30112, DOI 10.1074/jbc.M605616200; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; von Buenau R, 2005, J DAIRY SCI, V88, P317, DOI 10.3168/jds.S0022-0302(05)72690-4; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	34	41	42	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14712	10.1371/journal.pone.0014712	http://dx.doi.org/10.1371/journal.pone.0014712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379575	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287482300012
J	Zhu, WH; Banga, S; Tan, YH; Zheng, C; Stephenson, R; Gately, J; Luo, ZQ				Zhu, Wenhan; Banga, Simran; Tan, Yunhao; Zheng, Cheng; Stephenson, Robert; Gately, Jonathan; Luo, Zhao-Qing			Comprehensive Identification of Protein Substrates of the Dot/Icm Type IV Transporter of Legionella pneumophila	PLOS ONE			English	Article							LEGIONNAIRES-DISEASE; INTRACELLULAR GROWTH; HOST; SYSTEM; TRANSLOCATION; FAMILY; PATHOGENESIS; MACROPHAGES; MEMBERS; REGION	A large number of proteins transferred by the Legionella pneumophila Dot/Icm system have been identified by various strategies. With no exceptions, these strategies are based on one or more characteristics associated with the tested proteins. Given the high level of diversity exhibited by the identified proteins, it is possible that some substrates have been missed in these screenings. In this study, we took a systematic method to survey the L. pneumophila genome by testing hypothetical orfs larger than 300 base pairs for Dot/Icm-dependent translocation. 798 of the 832 analyzed orfs were successfully fused to the carboxyl end of beta-lactamase. The transfer of the fusions into mammalian cells was determined using the beta-lactamase reporter substrate CCF4-AM. These efforts led to the identification of 164 proteins positive in translocation. Among these, 70 proteins are novel substrates of the Dot/Icm system. These results brought the total number of experimentally confirmed Dot/Icm substrates to 275. Sequence analysis of the C-termini of these identified proteins revealed that Lpg2844, which contains few features known to be important for Dot/Icm-dependent protein transfer can be translocated at a high efficiency. Thus, our efforts have identified a large number of novel substrates of the Dot/Icm system and have revealed the diverse features recognizable by this protein transporter.	[Zhu, Wenhan; Banga, Simran; Tan, Yunhao; Stephenson, Robert; Gately, Jonathan; Luo, Zhao-Qing] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Zheng, Cheng] Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhu, WH (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	Luoz@purdue.edu	YAN, JING/J-7233-2015; Banga, Simran/L-8806-2013; Tan, Yunhao/K-7442-2016	Tan, Yunhao/0000-0002-5516-4980; Zhu, Wenhan/0000-0003-3771-0842; Luo, Zhao-Qing/0000-0001-8890-6621	NIH-NIAID [R01AI069344, K02AI085403, R21AI092043]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069344, K02AI085403, R21AI092043] Funding Source: NIH RePORTER	NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH-NIAID grants R01AI069344, K02AI085403 and R21AI092043 (Z.-Q.L). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Zant A, 2007, CELL MICROBIOL, V9, P246, DOI 10.1111/j.1462-5822.2006.00785.x; Altman E, 2008, J BACTERIOL, V190, P1985, DOI 10.1128/JB.01493-07; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Belyi Y, 2008, J BACTERIOL, V190, P3026, DOI 10.1128/JB.01798-07; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Campodonico EM, 2005, MOL MICROBIOL, V56, P918, DOI 10.1111/j.1365-2958.2005.04595.x; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Charpentier X, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000501; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; Dorer MS, 2006, PLOS PATHOG, V2, P315, DOI 10.1371/journal.ppat.0020034; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Huang L, 2011, CELL MICROBIOL, V13, P227, DOI 10.1111/j.1462-5822.2010.01531.x; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lindeberg M, 2009, MOL PLANT PATHOL, V10, P767, DOI 10.1111/j.1364-3703.2009.00587.x; Liu YC, 2008, P NATL ACAD SCI USA, V105, P9385, DOI 10.1073/pnas.0801055105; Lomma M, 2010, CELL MICROBIOL, V12, P1272, DOI 10.1111/j.1462-5822.2010.01467.x; Losick VP, 2006, J EXP MED, V203, P2177, DOI 10.1084/jem.20060766; Losick VP, 2010, CELL MICROBIOL, V12, P1083, DOI 10.1111/j.1462-5822.2010.01452.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Shen XH, 2009, CELL MICROBIOL, V11, P911, DOI 10.1111/j.1462-5822.2009.01301.x; SMITH HO, 1995, SCIENCE, V269, P538, DOI 10.1126/science.7542802; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Swanson MS, 2000, ANNU REV MICROBIOL, V54, P567, DOI 10.1146/annurev.micro.54.1.567; VanRheenen SM, 2006, INFECT IMMUN, V74, P3597, DOI 10.1128/IAI.02060-05; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Zusman T, 2008, INFECT IMMUN, V76, P4581, DOI 10.1128/IAI.00337-08	48	167	172	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17638	10.1371/journal.pone.0017638	http://dx.doi.org/10.1371/journal.pone.0017638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408005	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900034
J	Deshpande, CN; Harrop, SJ; Boucher, Y; Hassan, KA; Di Leo, R; Xu, XH; Cui, H; Savchenko, A; Chang, CS; Labbate, M; Paulsen, IT; Stokes, HW; Curmi, PMG; Mabbutt, BC				Deshpande, Chandrika N.; Harrop, Stephen J.; Boucher, Yan; Hassan, Karl A.; Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Chang, Changsoo; Labbate, Maurizio; Paulsen, Ian T.; Stokes, H. W.; Curmi, Paul M. G.; Mabbutt, Bridget C.			Crystal Structure of an Integron Gene Cassette-Associated Protein from Vibrio cholerae Identifies a Cationic Drug-Binding Module	PLOS ONE			English	Article							RESPONDING TRANSCRIPTIONAL REGULATOR; LIVIDANS TIPAL PROTEIN; MULTIDRUG RECOGNITION; MERR FAMILY; BMRR; MECHANISM; ACTIVATION; DATABASE; PHENIX; TOXIN	Background: The direct isolation of integron gene cassettes from cultivated and environmental microbial sources allows an assessment of the impact of the integron/gene cassette system on the emergence of new phenotypes, such as drug resistance or virulence. A structural approach is being exploited to investigate the modularity and function of novel integron gene cassettes. Methodology/Principal Findings: We report the 1.8 A crystal structure of Cass2, an integron-associated protein derived from an environmental V. cholerae. The structure defines a monomeric beta-barrel protein with a fold related to the effector-binding portion of AraC/XylS transcription activators. The closest homologs of Cass2 are multi-drug binding proteins, such as BmrR. Consistent with this, a binding pocket made up of hydrophobic residues and a single glutamate side chain is evident in Cass2, occupied in the crystal form by polyethylene glycol. Fluorescence assays demonstrate that Cass2 is capable of binding cationic drug compounds with submicromolar affinity. The Cass2 module possesses a protein interaction surface proximal to its drug-binding cavity with features homologous to those seen in multi-domain transcriptional regulators. Conclusions/Significance: Genetic analysis identifies Cass2 to be representative of a larger family of independent effector-binding proteins associated with lateral gene transfer within Vibrio and closely-related species. We propose that the Cass2 family not only has capacity to form functional transcription regulator complexes, but represents possible evolutionary precursors to multi-domain regulators associated with cationic drug compounds.	[Deshpande, Chandrika N.; Hassan, Karl A.; Paulsen, Ian T.; Mabbutt, Bridget C.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW, Australia; [Harrop, Stephen J.; Curmi, Paul M. G.] St Vincents Ctr Appl Med Res, Sydney, NSW, Australia; [Boucher, Yan] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Di Leo, Rosa; Xu, Xiaohui; Cui, Hong; Savchenko, Alexei; Chang, Changsoo] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada; [Labbate, Maurizio; Stokes, H. W.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia	Macquarie University; University of New South Wales Sydney; Massachusetts Institute of Technology (MIT); University of Toronto; University of Technology Sydney	Deshpande, CN (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	bridget.mabbutt@mq.edu.au	Paulsen, Ian T/K-3832-2012; Curmi, Paul/G-7185-2011; Boucher, Yann Felix/H-4576-2019; Boucher, Yan/A-2618-2014; Chang, Changsoo/X-3271-2018; Hassan, Karl/B-2802-2013	Paulsen, Ian T/0000-0001-9015-9418; Curmi, Paul/0000-0001-5762-7638; Boucher, Yann Felix/0000-0002-0036-6083; Deshpande, Chandrika/0000-0002-5557-519X; Chang, Changsoo/0000-0003-1860-2969; Hassan, Karl/0000-0003-2031-9679; Labbate, Maurizio/0000-0003-1428-3382	NHMRC [488502]; National Institutes of Health [GM62414-0]; Ontario Research and Development Challenge Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094585, P50GM062414] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Research and Development Challenge Fund(General Electric); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is funded by Australian NHMRC grant 488502 (http://www.nhmrc.gov.au/) and supported by National Institutes of Health Grant GM62414-0 and the Ontario Research and Development Challenge Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2005, CCP4 NEWSL, V42; AHMED M, 1994, J BIOL CHEM, V269, P28506; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boucher Y, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-3; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Boucher Y, 2006, BIOLOGY OF VIBRIOS, P84; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Chakraborty S, 2000, APPL ENVIRON MICROB, V66, P4022, DOI 10.1128/AEM.66.9.4022-4028.2000; Chiu ML, 2001, BIOCHEMISTRY-US, V40, P12950, DOI 10.1021/bi010328k; Chiu ML, 1999, J BIOL CHEM, V274, P20578, DOI 10.1074/jbc.274.29.20578; Chun J, 2009, P NATL ACAD SCI USA, V106, P15442, DOI 10.1073/pnas.0907787106; COLLIS CM, 1993, MOL MICROBIOL, V9, P41, DOI 10.1111/j.1365-2958.1993.tb01667.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DUTTA NK, 1972, BRIT J PHARMACOL, V44, P153, DOI 10.1111/j.1476-5381.1972.tb07247.x; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Elsaied H, 2007, ENVIRON MICROBIOL, V9, P2298, DOI 10.1111/j.1462-2920.2007.01344.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Faruque SM, 2003, INFECT IMMUN, V71, P1020, DOI 10.1128/IAI.71.2.1020-1025.2003; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; Hall RM, 1998, DRUG RESIST UPDATE, V1, P109, DOI 10.1016/S1368-7646(98)80026-5; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; ISLAM MR, 1982, GASTROENTEROLOGY, V82, P1335; Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOBAYASHI TOSHIKAZU, 1963, JAPAN JOUR BACTERIOL, V18, P387; Koenig JE, 2008, ENVIRON MICROBIOL, V10, P1024, DOI 10.1111/j.1462-2920.2007.01524.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwon HJ, 2000, NAT STRUCT BIOL, V7, P424; Labbate M, 2007, MICROBIOL-SGM, V153, P1488, DOI 10.1099/mic.0.2006/001065-0; Labbate Maurizio, 2009, V532, P103, DOI 10.1007/978-1-60327-853-9_6; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markham PN, 1996, J BACTERIOL, V178, P1473, DOI 10.1128/jb.178.5.1473-1475.1996; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Newberry KJ, 2008, J BIOL CHEM, V283, P26795, DOI 10.1074/jbc.M804191200; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Ramamurthy T, 2003, MICROBES INFECT, V5, P329, DOI 10.1016/S1286-4579(03)00035-2; Rhee S, 1998, P NATL ACAD SCI USA, V95, P10413, DOI 10.1073/pnas.95.18.10413; Romanowski MJ, 2002, PROTEINS, V47, P403, DOI 10.1002/prot.10102; Rowe-Magnus DA, 2003, GENOME RES, V13, P428, DOI 10.1101/gr.617103; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; WEST PA, 1982, J CLIN MICROBIOL, V16, P1110, DOI 10.1128/JCM.16.6.1110-1116.1982; Westbrook J, 2003, METHOD ENZYMOL, V374, P370, DOI 10.1016/S0076-6879(03)74017-8; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yanai I, 2001, P NATL ACAD SCI USA, V98, P7940, DOI 10.1073/pnas.141236298; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	68	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16934	10.1371/journal.pone.0016934	http://dx.doi.org/10.1371/journal.pone.0016934			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390267	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200008
J	Farrar, CT; Kamoun, WS; Ley, CD; Kim, YR; Catana, C; Kwon, SJ; Rosen, BR; Jain, RK; Sorensen, AG				Farrar, Christian T.; Kamoun, Walid S.; Ley, Carsten D.; Kim, Young R.; Catana, Ciprian; Kwon, Seon J.; Rosen, Bruce R.; Jain, Rakesh K.; Sorensen, A. Gregory			Sensitivity of MRI Tumor Biomarkers to VEGFR Inhibitor Therapy in an Orthotopic Mouse Glioma Model	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; BRAIN-BARRIER PERMEABILITY; TYROSINE KINASE INHIBITOR; ARTERIAL INPUT FUNCTION; CONTRAST-ENHANCED MRI; IN-VIVO; GRADIENT-ECHO; VESSEL SIZE; DIFFUSION; ANGIOGENESIS	MRI biomarkers of tumor edema, vascular permeability, blood volume, and average vessel caliber are increasingly being employed to assess the efficacy of tumor therapies. However, the dependence of these biomarkers on a number of physiological factors can compromise their sensitivity and complicate the assessment of therapeutic efficacy. Here we examine the response of these MRI tumor biomarkers to cediranib, a potent vascular endothelial growth factor receptor (VEGFR) inhibitor, in an orthotopic mouse glioma model. A significant increase in the tumor volume and relative vessel caliber index (rVCI) and a slight decrease in the water apparent diffusion coefficient (ADC) were observed for both control and cediranib treated animals. This contrasts with a clinical study that observed a significant decrease in tumor rVCI, ADC and volume with cediranib therapy. While the lack of a difference between control and cediranib treated animals in these biomarker responses might suggest that cediranib has no therapeutic benefit, cediranib treated mice had a significantly increased survival. The increased survival benefit of cediranib treated animals is consistent with the significant decrease observed for cediranib treated animals in the relative cerebral blood volume (rCBV), relative microvascular blood volume (rMBV), transverse relaxation time (T2), blood vessel permeability (K-trans), and extravascular-extracellular space (v(e)). The differential response of pre-clinical and clinical tumors to cediranib therapy, along with the lack of a positive response for some biomarkers, indicates the importance of evaluating the whole spectrum of different tumor biomarkers to properly assess the therapeutic response and identify and interpret the therapy-induced changes in the tumor physiology.	[Farrar, Christian T.; Kim, Young R.; Catana, Ciprian; Kwon, Seon J.; Rosen, Bruce R.; Sorensen, A. Gregory] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Kamoun, Walid S.; Ley, Carsten D.; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Farrar, CT (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.	cfarrar@nmr.mgh.harvard.edu	Catana, Ciprian/A-1246-2013; Jain, Rakesh K/I-1384-2017	Jain, Rakesh K/0000-0001-7571-3548; Catana, Ciprian/0000-0002-3249-5971; Ley, Carsten Dan/0000-0001-8119-2224; Farrar, Christian/0000-0001-6623-8220	National Institutes of Health [P41-RR14075, P01-CA80124, R01-CA115767]; AstraZeneca Pharmaceuticals; National Cancer Institute [T32-CA009502]; National Institute on Aging [K25-AG029415]; NATIONAL CANCER INSTITUTE [R01CA115767, P01CA080124, T32CA009502] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K25AG029415] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca Pharmaceuticals(AstraZeneca); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institutes of Health (P41-RR14075, P01-CA80124, R01-CA115767) and by AstraZeneca Pharmaceuticals. CTF gratefully acknowledges support from the National Cancer Institute (T32-CA009502) and the National Institute on Aging (K25-AG029415). WSK gratefully acknowledges support from the Susan G. Komen foundation. CDL gratefully acknowledges support from the Harboe Foundation, the A.P. Moller Foundation, and the Dagmar-Marshall Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Badruddoja MA, 2003, NEURO-ONCOLOGY, V5, P235, DOI 10.1215/S1152851703000073; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; BOXERMAN JL, 1995, MAGNET RESON MED, V34, P555, DOI 10.1002/mrm.1910340412; Brown EB, 2001, NAT MED, V7, P864, DOI 10.1038/89997; Buckley DL, 2004, RADIOLOGY, V233, P709, DOI 10.1148/radiol.2333032098; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chenevert TL, 1997, CLIN CANCER RES, V3, P1457; Chenevert TL, 2000, JNCI-J NATL CANCER I, V92, P2029, DOI 10.1093/jnci/92.24.2029; Dennie J, 1998, MAGN RESON MED, V40, P793, DOI 10.1002/mrm.1910400602; Donahue KM, 2000, MAGNET RESON MED, V43, P845, DOI 10.1002/1522-2594(200006)43:6<845::AID-MRM10>3.0.CO;2-J; EIS M, 1995, MAGN RESON MED, V34, P835, DOI 10.1002/mrm.1910340608; Ferretti S, 2005, CLIN CANCER RES, V11, P7773, DOI 10.1158/1078-0432.CCR-05-1165; Gerstner ER, 2010, J CLIN ONCOL, V28, pE91, DOI 10.1200/JCO.2009.25.0233; Hall DE, 2004, CLIN CANCER RES, V10, P7852, DOI 10.1158/1078-0432.CCR-04-1218; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Hylton N, 2006, J CLIN ONCOL, V24, P3293, DOI 10.1200/JCO.2006.06.8080; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2009, NAT REV CLIN ONCOL, V6, P327, DOI 10.1038/nrclinonc.2009.63; Jain RK, 2002, NAT REV CANCER, V2, P266, DOI 10.1038/nrc778; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kiselev VG, 2005, MAGNET RESON MED, V53, P553, DOI 10.1002/mrm.20383; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; McGrath DM, 2009, MAGN RESON MED, V61, P1173, DOI 10.1002/mrm.21959; Moffat BA, 2005, P NATL ACAD SCI USA, V102, P5524, DOI 10.1073/pnas.0501532102; Oh J, 2005, J MAGN RESON IMAGING, V21, P701, DOI 10.1002/jmri.20335; Ostergaard L, 1999, J NEUROSURG, V90, P300, DOI 10.3171/jns.1999.90.2.0300; Packard SD, 2003, NEOPLASIA, V5, P330, DOI 10.1016/S1476-5586(03)80026-X; Padhani AR, 2002, J MAGN RESON IMAGING, V16, P407, DOI 10.1002/jmri.10176; Parker GJM, 2006, MAGN RESON MED, V56, P993, DOI 10.1002/mrm.21066; Pathak AP, 2003, J MAGN RESON IMAGING, V18, P397, DOI 10.1002/jmri.10371; Pathak AP, 2008, NEUROIMAGE, V40, P1130, DOI 10.1016/j.neuroimage.2008.01.022; Ross BD, 2003, MOL CANCER THER, V2, P581; Schmainda KM, 2004, AM J NEURORADIOL, V25, P1524; Sorensen AG, 2009, CANCER RES, V69, P5296, DOI 10.1158/0008-5472.CAN-09-0814; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tropres I, 2004, MAGN RESON MED, V51, P533, DOI 10.1002/mrm.20017; Tropres I, 2001, MAGN RESON MED, V45, P397, DOI 10.1002/1522-2594(200103)45:3<397::AID-MRM1052>3.0.CO;2-3; Tyrrell JA, 2007, IEEE T MED IMAGING, V26, P223, DOI 10.1109/TMI.2006.889722; Valable S, 2008, NMR BIOMED, V21, P1043, DOI 10.1002/nbm.1278; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; WEISSKOFF RM, 1994, MAGNET RESON MED, V31, P601, DOI 10.1002/mrm.1910310605; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013; Yankeelov TE, 2007, CURR MED IMAGING REV, V3, P91, DOI 10.2174/157340507780619179; YUAN F, 1994, CANCER RES, V54, P4564	50	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17228	10.1371/journal.pone.0017228	http://dx.doi.org/10.1371/journal.pone.0017228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390238	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200013
J	Yu, HH; Xie, WB; Wang, J; Xing, YZ; Xu, CG; Li, XH; Xiao, JH; Zhang, QF				Yu, Huihui; Xie, Weibo; Wang, Jia; Xing, Yongzhong; Xu, Caiguo; Li, Xianghua; Xiao, Jinghua; Zhang, Qifa			Gains in QTL Detection Using an Ultra-High Density SNP Map Based on Population Sequencing Relative to Traditional RFLP/SSR Markers	PLOS ONE			English	Article							ELITE RICE HYBRID; SINGLE-FEATURE POLYMORPHISMS; FUNCTIONAL GENOMICS; NATURAL VARIATION; EXPRESSION ATLAS; SEEDLING STAGE; GENETIC-BASIS; GRAIN WIDTH; MAJOR QTL; LOCUS	Huge efforts have been invested in the last two decades to dissect the genetic bases of complex traits including yields of many crop plants, through quantitative trait locus (QTL) analyses. However, almost all the studies were based on linkage maps constructed using low-throughput molecular markers, e. g. restriction fragment length polymorphisms (RFLPs) and simple sequence repeats (SSRs), thus are mostly of low density and not able to provide precise and complete information about the numbers and locations of the genes or QTLs controlling the traits. In this study, we constructed an ultra-high density genetic map based on high quality single nucleotide polymorphisms (SNPs) from low-coverage sequences of a recombinant inbred line (RIL) population of rice, generated using new sequencing technology. The quality of the map was assessed by validating the positions of several cloned genes including GS3 and GW5/qSW5, two major QTLs for grain length and grain width respectively, and OsC1, a qualitative trait locus for pigmentation. In all the cases the loci could be precisely resolved to the bins where the genes are located, indicating high quality and accuracy of the map. The SNP map was used to perform QTL analysis for yield and three yield-component traits, number of tillers per plant, number of grains per panicle and grain weight, using data from field trials conducted over years, in comparison to QTL mapping based on RFLPs/SSRs. The SNP map detected more QTLs especially for grain weight, with precise map locations, demonstrating advantages in detecting power and resolution relative to the RFLP/SSR map. Thus this study provided an example for ultra-high density map construction using sequencing technology. Moreover, the results obtained are helpful for understanding the genetic bases of the yield traits and for fine mapping and cloning of QTLs.	[Yu, Huihui; Xie, Weibo; Wang, Jia; Xing, Yongzhong; Xu, Caiguo; Li, Xianghua; Xiao, Jinghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res, Wuhan, Peoples R China.	qifazh@mail.hzau.edu.cn	Yu, Huihui/AAT-7595-2021; Xie, Weibo/B-3771-2008; Xie, Weibo/AAI-2412-2021	Yu, Huihui/0000-0003-2725-1937; Xie, Weibo/0000-0002-2768-3572; Xie, Weibo/0000-0002-2768-3572; Xing, Yongzhong/0000-0003-1376-1514	National Program on Key Basic Research Project; National Special Key Project on Functional Genomics of Major Plants and Animals; National Natural Science Foundation of China	National Program on Key Basic Research Project(National Basic Research Program of China); National Special Key Project on Functional Genomics of Major Plants and Animals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from the National Program on Key Basic Research Project, National Special Key Project on Functional Genomics of Major Plants and Animals, and National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Gupta PK, 2008, HEREDITY, V101, P5, DOI 10.1038/hdy.2008.35; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Krishnan A, 2009, PLANT PHYSIOL, V149, P165, DOI 10.1104/pp.108.128918; Kumar R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000284; Lian XM, 2005, THEOR APPL GENET, V112, P85, DOI 10.1007/s00122-005-0108-y; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; R Core Team, 2020, R LANG ENV STAT COMP; Rostoks N, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r54; Saitoh K, 2004, GENETICS, V168, P997, DOI 10.1534/genetics.103.018390; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Schon CC, 2004, GENETICS, V167, P485, DOI 10.1534/genetics.167.1.485; SCHUSTER S, 2008, NATURE, V200, P8; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Vales MI, 2005, THEOR APPL GENET, V111, P1260, DOI 10.1007/s00122-005-0043-y; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang J, 2010, PLANT J, V63, P1063, DOI 10.1111/j.1365-313X.2010.04303.x; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Wu CY, 2003, PLANT J, V35, P418, DOI 10.1046/j.1365-313X.2003.01808.x; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xie WB, 2009, THEOR APPL GENET, V119, P151, DOI 10.1007/s00122-009-1025-2; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang J, 2007, PLANT J, V49, P947, DOI 10.1111/j.1365-313X.2006.03001.x	43	188	211	4	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17595	10.1371/journal.pone.0017595	http://dx.doi.org/10.1371/journal.pone.0017595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390234	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200031
J	Porotto, M; Yi, F; Moscona, A; LaVan, DA				Porotto, Matteo; Yi, Feng; Moscona, Anne; LaVan, David A.			Synthetic Protocells Interact with Viral Nanomachinery and Inactivate Pathogenic Human Virus	PLOS ONE			English	Article							SUPPORTED LIPID-BILAYERS; NIPAH VIRUS; PARAMYXOVIRUS; DELIVERY; FUSION; ENCEPHALITIS; INHIBITION; BANGLADESH; INFECTION; RECEPTOR	We present a new antiviral strategy and research tool that could be applied to a wide range of enveloped viruses that infect human beings via membrane fusion. We test this strategy on two emerging zoonotic henipaviruses that cause fatal encephalitis in humans, Nipah (NiV) and Hendra (HeV) viruses. In the new approach, artificial cell-like particles (protocells) presenting membrane receptors in a biomimetic manner were developed and found to attract and inactivate henipavirus envelope glycoprotein pseudovirus particles, preventing infection. The protocells do not accumulate virus during the inactivation process. The use of protocells that interact with, but do not accumulate, viruses may provide significant advantages over current antiviral drugs, and this general approach may have wide potential for antiviral development.	[Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA; [Porotto, Matteo; Moscona, Anne] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Yi, Feng; LaVan, David A.] NIST, Mat Measurement Lab, Gaithersburg, MD 20899 USA	Cornell University; Cornell University; National Institute of Standards & Technology (NIST) - USA	Porotto, M (corresponding author), Cornell Univ, Dept Pediat, Weill Med Coll, New York, NY 10021 USA.	anm2047@med.cornell.edu; david.lavan@nist.gov	LaVan, David/C-3943-2012	LaVan, David/0000-0002-1952-0028; POROTTO, Matteo/0000-0003-3866-9220	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) [AI076335]; National Institute of Biomedical Imaging and Bioengineering [EB011707]; NIH (NIAID) Northeast Center of Excellence for Biodefense; National Center for Design of Biomimetic Nanoconductors; National Institutes of Health through the NIH Roadmap for Medical Research [PHS 2 PN2 EY016570B]; PI of Center of Excellence [U54AI057158]; March of Dimes Research Grant [06-322]; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076385] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH (NIAID) Northeast Center of Excellence for Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Design of Biomimetic Nanoconductors; National Institutes of Health through the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PI of Center of Excellence; March of Dimes Research Grant(March of Dimes); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Public Health Service grants AI076335 from National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to AM, EB011707 from the National Institute of Biomedical Imaging and Bioengineering to MP, NIH (NIAID) Northeast Center of Excellence for Biodefense, subcontracts to AM and to DL from the National Center for Design of Biomimetic Nanoconductors, funded by Grant Number PHS 2 PN2 EY016570B from the National Institutes of Health through the NIH Roadmap for Medical Research (PI: E. Jakobsson), Emerging Infectious Disease Research U54AI057158 grants to AM and MP (PI of Center of Excellence grant: W.I. Lipkin), by March of Dimes Research Grant 06-322 to AM, and by a Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buranda T, 2003, LANGMUIR, V19, P1654, DOI 10.1021/la026405+; Chemburu S, 2010, MOLECULES, V15, P1932, DOI 10.3390/molecules15031932; Conti M, 2000, ANGEW CHEM INT EDIT, V39, P215, DOI 10.1002/(SICI)1521-3773(20000103)39:1<215::AID-ANIE215>3.0.CO;2-R; Hossain MJ, 2008, CLIN INFECT DIS, V46, P977, DOI 10.1086/529147; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876; LaVan DA, 2002, NAT REV DRUG DISCOV, V1, P77, DOI 10.1038/nrd707; Leduc PR, 2007, NAT NANOTECHNOL, V2, P3, DOI 10.1038/nnano.2006.180; Liu JW, 2009, J AM CHEM SOC, V131, P1354, DOI 10.1021/ja808018y; Lu YF, 1999, NATURE, V398, P223, DOI 10.1038/18410; Lu YF, 2000, J AM CHEM SOC, V122, P5258, DOI 10.1021/ja9935862; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; Negrete OA, 2005, NATURE, V436, P401, DOI 10.1038/nature03838; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Porotto M, 2007, J VIROL, V81, P10567, DOI 10.1128/JVI.01181-07; Porotto M, 2006, J VIROL, V80, P9837, DOI 10.1128/JVI.00736-06; Porotto M, 2005, J VIROL, V79, P2383, DOI 10.1128/JVI.79.4.2383-2392.2005; Porotto M, 2004, J VIROL, V78, P13911, DOI 10.1128/JVI.78.24.13911-13919.2004; Porotto M, 2009, J VIROL, V83, P5148, DOI 10.1128/JVI.00164-09; Russell CJ, 2001, EMBO J, V20, P4024, DOI 10.1093/emboj/20.15.4024; Sejvar JJ, 2007, ANN NEUROL, V62, P235, DOI 10.1002/ana.21178; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Wang LF, 2001, MICROBES INFECT, V3, P279, DOI 10.1016/S1286-4579(01)01381-8	25	18	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16874	10.1371/journal.pone.0016874	http://dx.doi.org/10.1371/journal.pone.0016874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390296	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100005
J	Croci, DO; Cumashi, A; Ushakova, NA; Preobrazhenskaya, ME; Piccoli, A; Totani, L; Ustyuzhanina, NE; Bilan, MI; Usov, AI; Grachev, AA; Morozevich, GE; Berman, AE; Sanderson, CJ; Kelly, M; Di Gregorio, P; Rossi, C; Tinari, N; Iacobelli, S; Rabinovich, GA; Nifantiev, NE				Croci, Diego O.; Cumashi, Albana; Ushakova, Natalia A.; Preobrazhenskaya, Marina E.; Piccoli, Antonio; Totani, Licia; Ustyuzhanina, Nadezhda E.; Bilan, Maria I.; Usov, Anatolii I.; Grachev, Alexey A.; Morozevich, Galina E.; Berman, Albert E.; Sanderson, Craig J.; Kelly, Maeve; Di Gregorio, Patrizia; Rossi, Cosmo; Tinari, Nicola; Iacobelli, Stefano; Rabinovich, Gabriel A.; Nifantiev, Nikolay E.		CINBO	Fucans, but Not Fucomannoglucuronans, Determine the Biological Activities of Sulfated Polysaccharides from Laminaria saccharina Brown Seaweed	PLOS ONE			English	Article							TOXICOLOGICAL EVALUATION; ANTICOAGULANT ACTIVITY; FUCOIDAN; INHIBITION; AFFINITY; CELLS	Sulfated polysaccharides from Laminaria saccharina (new name: Saccharina latissima) brown seaweed show promising activity for the treatment of inflammation, thrombosis, and cancer; yet the molecular mechanisms underlying these properties remain poorly understood. The aim of this work was to characterize, using in vitro and in vivo strategies, the anti-inflammatory, anti-coagulant, anti-angiogenic, and anti-tumor activities of two main sulfated polysaccharide fractions obtained from L. saccharina: a) L.s.-1.0 fraction mainly consisting of O-sulfated mannoglucuronofucans and b) L.s.-1.25 fraction mainly composed of sulfated fucans. Both fractions inhibited leukocyte recruitment in a model of inflammation in rats, although L.s.-1.25 appeared to be more active than L.s.-1.0. Also, these fractions inhibited neutrophil adhesion to platelets under flow. Only fraction L.s.-1.25, but not L.s.-1.0, displayed anticoagulant activity as measured by the activated partial thromboplastin time. Investigation of these fractions in angiogenesis settings revealed that only L.s.-1.25 strongly inhibited fetal bovine serum (FBS) induced in vitro tubulogenesis. This effect correlated with a reduction in plasminogen activator inhibitor-1 (PAI-1) levels in L.s.-1.25-treated endothelial cells. Furthermore, only parent sulfated polysaccharides from L. saccharina (L.s.-P) and its fraction L.s.-1.25 were powerful inhibitors of basic fibroblast growth factor (bFGF) induced pathways. Consistently, the L.s.-1.25 fraction as well as L.s.-P successfully interfered with fibroblast binding to human bFGF. The incorporation of L.s.-P or L.s.-1.25, but not L.s.-1.0 into Matrigel plugs containing melanoma cells induced a significant reduction in hemoglobin content as well in the frequency of tumor-associated blood vessels. Moreover, i.p. administrations of L.s.-1.25, as well as L.s.-P, but not L.s.-1.0, resulted in a significant reduction of tumor growth when inoculated into syngeneic mice. Finally, L.s.-1.25 markedly inhibited breast cancer cell adhesion to human platelet-coated surfaces. Thus, sulfated fucans are mainly responsible for the anti-inflammatory, anticoagulant, antiangiogenic, and antitumor activities of sulfated polysaccharides from L. saccharina brown seaweed.	[Croci, Diego O.; Rabinovich, Gabriel A.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt IBYME, Lab Inmunopatol, Buenos Aires, Argentina; [Croci, Diego O.; Rabinovich, Gabriel A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, Argentina; [Cumashi, Albana; Rossi, Cosmo; Tinari, Nicola; Iacobelli, Stefano] Univ G DAnnunzio, Med Sch & Fdn, Dept Oncol & Neurosci, Chieti, Italy; [Ushakova, Natalia A.; Preobrazhenskaya, Marina E.; Morozevich, Galina E.; Berman, Albert E.] Russian Acad Med Sci, VN Orekhovich Res Inst Biomed Chem, Moscow, Russia; [Piccoli, Antonio; Totani, Licia] Consorzio Mario Negri Sud, Lab Vasc Biol & Pharmacol, Chieti, Italy; [Ustyuzhanina, Nadezhda E.; Grachev, Alexey A.; Nifantiev, Nikolay E.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Lab Glycoconjugate Chem, Moscow, Russia; [Bilan, Maria I.; Usov, Anatolii I.] Russian Acad Sci, ND Zelinsky Inst Organ Chem, Lab Plant Polysaccharides, Moscow, Russia; [Sanderson, Craig J.; Kelly, Maeve] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Di Gregorio, Patrizia] Univ G DAnnunzio, Sch Med, SS Annunziata Hosp, Chieti, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; University of Buenos Aires; G d'Annunzio University of Chieti-Pescara; Russian Academy of Medical Sciences; Institute of Biomedical Chemistry; Consorzio Mario Negri Sud; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry; UHI Millennium Institute; G d'Annunzio University of Chieti-Pescara	Croci, DO (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Biol & Med Expt IBYME, Lab Inmunopatol, Buenos Aires, Argentina.	gabyrabi@gmail.com; nen@ioc.ac.ru	Morozevich, Galina/ABD-7858-2020; Bilan, Maria/AAK-2041-2021; Usov, Anatolii I/P-7324-2015; Croci, Diego/AAJ-5709-2021; EBerman, Albert/F-5042-2017; Nifantiev, Nikolay E/O-6579-2015	Croci, Diego/0000-0002-8623-0645; Nifantiev, Nikolay E/0000-0002-0727-4050; Tinari, Nicola/0000-0001-8449-5407	Russian Foundation for Basic Research [08-04-00812a]; Russian Federation for young scientists [MK-3901.2009.4]; National Agency for Promotion of Science and Technology [2006-603]; Fundacion Sales for Cancer Research [2001-003]; Natural Environment Research Council [dml010007] Funding Source: researchfish; NERC [dml010007] Funding Source: UKRI	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation for young scientists; National Agency for Promotion of Science and Technology(ANPCyT); Fundacion Sales for Cancer Research; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by the Russian Foundation for Basic Research (web: www.rfbr.ru; grant #08-04-00812a; M. E. P.), the Grant program of the President of Russian Federation for young scientists (web: http://grants.extech.ru; grant MK-3901.2009.4; N.E.U.), the National Agency for Promotion of Science and Technology (web: www.agencia.secyt.gov.ar; grant #2006-603; G. A. R.), and the Fundacion Sales for Cancer Research (web: www.sales.org.ar; 2001-003; G. A. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON LO, 1976, THROMB RES, V9, P575, DOI 10.1016/0049-3848(76)90105-5; Berteau O, 2003, GLYCOBIOLOGY, V13, p29R, DOI 10.1093/glycob/cwg058; Bilan MI, 2010, CARBOHYD RES, V345, P2038, DOI 10.1016/j.carres.2010.07.009; BROWN KJ, 1995, J CELL BIOCHEM, V58, P6, DOI 10.1002/jcb.240580103; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Cumashi A, 2007, GLYCOBIOLOGY, V17, P541, DOI 10.1093/glycob/cwm014; De Stefano I, 2009, BIOCHEM PHARMACOL, V78, P1374, DOI 10.1016/j.bcp.2009.07.011; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; Gasparini G, 2005, J CLIN ONCOL, V23, P1295, DOI 10.1200/JCO.2005.10.022; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; Gideon TP, 2008, J MED FOOD, V11, P638, DOI 10.1089/jmf.2007.0127; Gimbrone M A Jr, 1976, Prog Hemost Thromb, V3, P1; Hejna M, 1999, JNCI-J NATL CANCER I, V91, P22, DOI 10.1093/jnci/91.1.22; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Kim KJ, 2010, TOXICOLOGY, V267, P154, DOI 10.1016/j.tox.2009.11.007; Koyanagi S, 2003, BIOCHEM PHARMACOL, V65, P173, DOI 10.1016/S0006-2952(02)01478-8; Krylov VB, 2008, TETRAHEDRON LETT, V49, P5877, DOI 10.1016/j.tetlet.2008.07.135; Krylov VB, 2011, CARBOHYD RES, V346, P540, DOI 10.1016/j.carres.2011.01.005; Kusaykin Mikhail, 2008, Biotechnology Journal, V3, P904, DOI 10.1002/biot.200700054; Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200; Lane CE, 2006, J PHYCOL, V42, P493, DOI 10.1111/j.1529-8817.2006.00204.x; Li B, 2008, MOLECULES, V13, P1671, DOI 10.3390/molecules13081671; Li N, 2005, FOOD CHEM TOXICOL, V43, P421, DOI 10.1016/j.fct.2004.12.001; Liu RM, 2005, ANTICANCER RES, V25, P2129; Minix R, 1997, THROMB RES, V87, P419, DOI 10.1016/S0049-3848(97)00158-8; Morbidelli L, 1997, LIFE SCI, V62, pPL7, DOI 10.1016/S0024-3205(97)01042-4; Mourao PAS, 2004, CURR PHARM DESIGN, V10, P967, DOI 10.2174/1381612043452730; Narazaki M, 2008, BLOOD, V111, P4126, DOI 10.1182/blood-2007-09-112474; Pereira MS, 1999, J BIOL CHEM, V274, P7656, DOI 10.1074/jbc.274.12.7656; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; Ponce NMA, 2003, CARBOHYD RES, V338, P153, DOI 10.1016/S0008-6215(02)00403-2; Soeda S, 2000, BBA-MOL CELL RES, V1497, P127, DOI 10.1016/S0167-4889(00)00052-5; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Ushakova NA, 1999, VOP MED KHIM, V45, P375; USHAKOVA NA, 2009, BIOCH SUPPLEMENT S B, V3, P77; Usov AI, 2009, RUSS CHEM REV+, V78, P785, DOI 10.1070/RC2009v078n08ABEH004063; Usov AI, 1998, BIOORG KHIM+, V24, P437; USTYUZHANINA N. E., 2009, PROGR SYNTHESIS COMP, P131; Ustyuzhanina N, 2006, SYNTHESIS-STUTTGART, P4017, DOI 10.1055/s-2006-950333; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; Zlotina NS, 2008, J CARBOHYD CHEM, V27, P429, DOI 10.1080/07328300802419865	41	94	99	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17283	10.1371/journal.pone.0017283	http://dx.doi.org/10.1371/journal.pone.0017283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387013	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400047
J	Merrifield, MS; Hines, E; Liu, XH; Beck, MW				Merrifield, Matthew S.; Hines, Ellen; Liu, Xiaohang; Beck, Michael W.			Building Regional Threat-Based Networks for Estuaries in the Western United States	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; COASTAL WATERS; CLASSIFICATION; MANAGEMENT; LAND; RESTORATION; CALIFORNIA; NURSERIES; PATTERNS; IMPACTS	Estuaries are ecologically and economically valuable and have been highly degraded from both land and sea. Estuarine habitats in the coastal zone are under pressure from a range of human activities. In the United States and elsewhere, very few conservation plans focused on estuaries are regional in scope; fewer still address threats to estuary long term viability. We have compiled basic information about the spatial extent of threats to identify commonalities. To do this we classify estuaries into hierarchical networks that share similar threat characteristics using a spatial database (geodatabase) of threats to estuaries from land and sea in the western U. S. Our results show that very few estuaries in this region (16%) have no or minimal stresses from anthropogenic activity. Additionally, one quarter (25%) of all estuaries in this study have moderate levels of all threats. The small number of un-threatened estuaries is likely not representative of the ecological variability in the region and will require working to abate threats at others. We think the identification of these estuary groups can foster sharing best practices and coordination of conservation activities amongst estuaries in any geography.	[Merrifield, Matthew S.] Nature Conservancy, Dept Sci & Planning, San Francisco, CA USA; [Hines, Ellen; Liu, Xiaohang] San Francisco State Univ, Dept Geog & Human Environm Studies, San Francisco, CA 94132 USA; [Beck, Michael W.] Nature Conservancy, Global Marine Initiat, Santa Cruz, CA USA	Nature Conservancy; California State University System; San Francisco State University; Nature Conservancy	Merrifield, MS (corresponding author), Nature Conservancy, Dept Sci & Planning, San Francisco, CA USA.	mmerrifield@tnc.org	Beck, Michael W./AAB-2844-2019	Beck, Michael W./0000-0002-5107-9973				Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Alber M, 2002, ESTUARIES, V25, P1246, DOI 10.1007/BF02692222; [Anonymous], 2006, MARINE COASTAL ECOSY; Armstrong DA, 2003, ESTUARIES, V26, P1174, DOI 10.1007/BF02803372; Beck M. W., 2003, DRAFTING CONSERVATIO, P319; Beck MW, 2011, BIOSCIENCE, V61, P107, DOI 10.1525/bio.2011.61.2.5; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Bodin O, 2006, ECOL SOC, V11; Bottom DL, 2005, ESTUAR COAST SHELF S, V64, P79, DOI 10.1016/j.ecss.2005.02.008; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Dahl T.E., 2006, STATUS TRENDS WETLAN; Douvere F., 2009, ECOSYSTEM BASED MARI; Duffy EJ, 2008, T AM FISH SOC, V137, P165, DOI 10.1577/T07-049.1; Edgar GJ, 2000, BIOL CONSERV, V92, P383, DOI 10.1016/S0006-3207(99)00111-1; Emmett R, 2000, ESTUARIES, V23, P765, DOI 10.2307/1352998; Engle VD, 2007, ENVIRON MONIT ASSESS, V129, P397, DOI 10.1007/s10661-006-9372-9; Everitt B. S., 2001, CLUSTER ANAL; Groves CR, 2002, BIOSCIENCE, V52, P499, DOI 10.1641/0006-3568(2002)052[0499:PFBCPC]2.0.CO;2; Hale SS, 2004, ESTUARIES, V27, P283, DOI 10.1007/BF02803385; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hickey BM, 2003, ESTUARIES, V26, P1010, DOI 10.1007/BF02803360; Higgins JV, 2005, CONSERV BIOL, V19, P432, DOI 10.1111/j.1523-1739.2005.00504.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; Imperial MT, 1996, COAST MANAGE, V24, P115, DOI 10.1080/08920759609362286; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kirby MX, 2004, P NATL ACAD SCI USA, V101, P13096, DOI 10.1073/pnas.0405150101; Komar PD, 2004, J GEOL, V112, P455, DOI 10.1086/421074; Kurtz JC, 2006, ESTUAR COAST, V29, P107, DOI 10.1007/BF02784703; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MORING JR, 1982, HYDROBIOLOGIA, V88, P295, DOI 10.1007/BF00008510; Nedwell DB, 2002, ESTUAR COAST SHELF S, V54, P951, DOI 10.1006/ecss.2001.0867; *ODF, 2009, OR FOR REP 2007 2009; *OFF GOV WASH, 2008, W COAST GOV AGR OC H; Pethick J, 2001, CATENA, V42, P307, DOI 10.1016/S0341-8162(00)00143-0; POC, 2003, AM LIV OC CHART COUR; Ridgway J, 2002, ESTUAR COAST SHELF S, V55, P903, DOI 10.1006/ecss.2002.1035; Sane M, 2007, J ENVIRON MANAGE, V82, P399, DOI 10.1016/j.jenvman.2005.01.030; Schneider M, 2003, AM J POLIT SCI, V47, P143, DOI 10.2307/3186098; Sloan NA, 2007, CONSERV BIOL, V21, P897, DOI 10.1111/j.1523-1739.2007.00731.x; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Team. RDC, 2007, R LANG ENV STAT COMP; *USCOP, 2004, OC BLUEPR 21 CENT FI; Van Dyke E, 2005, ESTUARIES, V28, P173, DOI 10.1007/BF02732853; Vasconcelos RP, 2007, SCI TOTAL ENVIRON, V374, P199, DOI 10.1016/j.scitotenv.2006.12.048; Zacharias MA, 2000, CONSERV BIOL, V14, P1327, DOI 10.1046/j.1523-1739.2000.99191.x; Zedler JB, 1996, ECOL APPL, V6, P84, DOI 10.2307/2269555	51	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17407	10.1371/journal.pone.0017407	http://dx.doi.org/10.1371/journal.pone.0017407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387006	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400070
J	Trathan, PN; Fretwell, PT; Stonehouse, B				Trathan, Philip N.; Fretwell, Peter T.; Stonehouse, Bernard			First Recorded Loss of an Emperor Penguin Colony in the Recent Period of Antarctic Regional Warming: Implications for Other Colonies	PLOS ONE			English	Article							NORTHEAST ATLANTIC WATERS; ENDANGERED TOP PREDATOR; CLIMATE-CHANGE; APTENODYTES-FORSTERI; RANGE EXPANSION; SOUTHERN-OCEAN; ADELIE LAND; SEA-ICE; PENINSULA; POPULATION	In 1948, a small colony of emperor penguins Aptenodytes forsteri was discovered breeding on Emperor Island (67 degrees 51' 52 '' S, 68 degrees 42' 20 '' W), in the Dion Islands, close to the West Antarctic Peninsula (Stonehouse 1952). When discovered, the colony comprised approximately 150 breeding pairs; these numbers were maintained until 1970, after which time the colony showed a continuous decline. By 1999 there were fewer than 20 pairs, and in 2009 high-resolution aerial photography revealed no remaining trace of the colony. Here we relate the decline and loss of the Emperor Island colony to a well-documented rise in local mean annual air temperature and coincident decline in seasonal sea ice duration. The loss of this colony provides empirical support for recent studies (Barbraud & Weimerskirch 2001; Jenouvrier et al 2005, 2009; Ainley et al 2010; Barber-Meyer et al 2005) that have highlighted the vulnerability of emperor penguins to changes in sea ice duration and distribution. These studies suggest that continued climate change is likely to impact upon future breeding success and colony viability for this species. Furthermore, a recent circumpolar study by Fretwell & Trathan (2009) highlighted those Antarctic coastal regions where colonies appear most vulnerable to such changes. Here we examine which other colonies might be at risk, discussing various ecological factors, some previously unexplored, that may also contribute to future declines. The implications of this are important for future modelling work and for understanding which colonies actually are most vulnerable.	[Trathan, Philip N.; Fretwell, Peter T.] British Antarctic Survey, Cambridge CB3 0ET, England; [Stonehouse, Bernard] Univ Cambridge, Scott Polar Res Inst, Cambridge CB2 1ER, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge	Trathan, PN (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	p.trathan@bas.ac.uk			BAS; United Kingdom Overseas Territories Environment Programme [BAT601]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	BAS; United Kingdom Overseas Territories Environment Programme; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported in part by the BAS Ecosystem Programme and by a United Kingdom Overseas Territories Environment Programme Grant (BAT601) to PTF and PNT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Barber-Meyer SM, 2008, ANTARCT SCI, V20, P3, DOI 10.1017/S0954102007000673; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; BARLOW J, 1967, BIOL REPORT ADELAIDE; Barrett BE, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036369; Cheung WWL, 2008, 16 U BRIT COL FISH C; Cook AJ, 2010, CRYOSPHERE, V4, P77, DOI 10.5194/tc-4-77-2010; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Crawford RJM, 2007, ICES J MAR SCI, V64, P570, DOI 10.1093/icesjms/fsm009; CULIK BM, 1995, NATURE, V376, P301, DOI 10.1038/376301b0; Ducklow HW, 2007, PHILOS T R SOC B, V362, P67, DOI 10.1098/rstb.2006.1955; Emslie SD, 1998, ANTARCT SCI, V10, P257, DOI 10.1017/S0954102098000352; EVERSON I, 1977, GLOSO771 FAO SO OC F; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Giles AB, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004139; HASBROOK R, 1970, BASE J 1970 BASE T; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Kerry K.R., 2009, P107; Kirkwood R, 1997, MAR ECOL PROG SER, V156, P205, DOI 10.3354/meps156205; Kock K-H., 1992, ANTARCTIC FISH FISHE; KOOYMAN GL, 1993, ANTARCTIC SCI, V5, P743; Lefebvre W, 2008, CLIM DYNAM, V30, P59, DOI 10.1007/s00382-007-0273-6; Massom RA, 2006, J CLIMATE, V19, P3544, DOI 10.1175/JCLI3805.1; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Massom RA, 2009, MAR ECOL PROG SER, V374, P243, DOI 10.3354/meps07734; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; MOUGIN JL, 1979, CR ACAD SCI D NAT, V289, P157; PONCET J, 1979, ORNITHOLOGICAL REPOR; PROCTER N, 1957, ORNITHOLOGICAL REPOR; ROTHERA JM, 1958, SLEDGING JOURNEY DIO; Sigmond M, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044301; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; STONEHOUSE B, 1964, NATURE, V203, P849, DOI 10.1038/203849a0; STONEHOUSE B, 1952, NATURE, V169, P760, DOI 10.1038/169760a0; Stonehouse B., 1953, FALKLAND ISLANDS DEP, V6; TAYLOR W, 1969, JOURNEY REPORT RABBL; Thomas ER, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040104; Turner J., 2009, ANTARCTIC CLIMATE CH; Turner J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011642; Turner J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037524; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Vaughan DG, 2001, SCIENCE, V293, P1777, DOI 10.1126/science.1065116; Votier SC, 2008, BIOL LETTERS, V4, P204, DOI 10.1098/rsbl.2007.0558; WILLEY IM, 1968, ADELAIDE ISLAND BIRD; WOOLLEY WS, 1963, FIELD DIARY 1962 63; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162	50	51	52	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14738	10.1371/journal.pone.0014738	http://dx.doi.org/10.1371/journal.pone.0014738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386883	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000287931400003
J	de Grave, DDJ; Brenner, E; Smeets, JBJ				de Grave, Denise D. J.; Brenner, Eli; Smeets, Jeroen B. J.			Using a Stick Does Not Necessarily Alter Judged Distances or Reachability	PLOS ONE			English	Article							DYNAMIC SIZE-CHANGE; ACTION-SPECIFIC PERCEPTION; CROSS-MODAL EXTINCTION; TOOL-USE; MULTISENSORY INTERACTIONS; PERCEIVED DISTANCE; PERIPERSONAL SPACE; HAND SPACE; NEGLECT; SHIFT	Background: It has been reported that participants judge an object to be closer after a stick has been used to touch it than after touching it with the hand. In this study we try to find out why this is so. Methodology: We showed six participants a cylindrical object on a table. On separate trials (randomly intermixed) participants either estimated verbally how far the object is from their body or they touched a remembered location. Touching was done either with the hand or with a stick (in separate blocks). In three different sessions, participants touched either the object location or the location halfway to the object location. Verbal judgments were given either in centimeters or in terms of whether the object would be reachable with the hand. No differences in verbal distance judgments or touching responses were found between the blocks in which the stick or the hand was used. Conclusion: Instead of finding out why the judged distance changes when using a tool, we found that using a stick does not necessarily alter judged distances or judgments about the reachability of objects.	[de Grave, Denise D. J.; Brenner, Eli; Smeets, Jeroen B. J.] Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands; [de Grave, Denise D. J.] Unilever Res Labs, Vlaardingen, Netherlands	Vrije Universiteit Amsterdam; Unilever	de Grave, DDJ (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, Res Inst MOVE, Amsterdam, Netherlands.	Denise-de.Grave@unilever.com	Smeets, Jeroen/B-4198-2008	Smeets, Jeroen/0000-0002-3794-0579; Brenner, Eli/0000-0002-3611-2843	Netherlands Organization for Scientific Research (NWO) [051.06.012]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Netherlands Organization for Scientific Research (NWO) Grant 051.06.012. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroyd K, 2002, NEUROCASE, V8, P1, DOI 10.1093/neucas/8.1.1; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Bonifazi S, 2007, J NEUROPSYCHOL, V1, P101, DOI 10.1348/174866407X180846; Canal-Bruland R, 2010, ANXIETY STRESS COPIN, V23, P353, DOI 10.1080/10615800903447588; Canal-Bruland R, 2009, PSYCHON B REV, V16, P1100, DOI 10.3758/PBR.16.6.1100; Collins T, 2008, COGNITION, V109, P363, DOI 10.1016/j.cognition.2008.10.001; CORLETT JT, 1990, J MOTOR BEHAV, V22, P347; de Grave DDJ, 2002, VISION RES, V42, P2279, DOI 10.1016/S0042-6989(02)00189-X; Durgin FH, 2009, PSYCHON B REV, V16, P964, DOI 10.3758/PBR.16.5.964; Farne A, 2000, NEUROREPORT, V11, P1645, DOI 10.1097/00001756-200006050-00010; Farne A, 2007, CORTEX, V43, P436, DOI 10.1016/S0010-9452(08)70468-4; Holmes NP, 2007, EXP BRAIN RES, V183, P465, DOI 10.1007/s00221-007-1060-7; Holmes NP, 2004, NEUROSCI LETT, V372, P62, DOI 10.1016/j.neulet.2004.09.024; Hutchison JJ, 2006, SPAN J PSYCHOL, V9, P332, DOI 10.1017/S1138741600006235; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; Maravita A, 2002, NEUROCASE, V8, P411, DOI 10.1093/neucas/8.6.411; Pegna AJ, 2001, ANN NEUROL, V50, P820, DOI 10.1002/ana.10058; Povinelli DJ, 2010, NEUROPSYCHOLOGIA, V48, P243, DOI 10.1016/j.neuropsychologia.2009.09.010; Veltkamp M, 2008, SOC COGNITION, V26, P720, DOI 10.1521/soco.2008.26.6.720; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Witt JK, 2008, PSYCHON B REV, V15, P581, DOI 10.3758/PBR.15.3.581; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, PSYCHOL SCI, V16, P937, DOI 10.1111/j.1467-9280.2005.01640.x; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880; Witt JK, 2004, PERCEPTION, V33, P577, DOI 10.1068/p5090; Woods AJ, 2009, J EXP PSYCHOL HUMAN, V35, P1104, DOI 10.1037/a0013622	27	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16697	10.1371/journal.pone.0016697	http://dx.doi.org/10.1371/journal.pone.0016697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390215	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700014
J	Swenson, LC; Pollock, G; Wynhoven, B; Mo, T; Dong, W; Hogg, RS; Montaner, JSG; Harrigan, PR				Swenson, Luke C.; Pollock, Graham; Wynhoven, Brian; Mo, Theresa; Dong, Winnie; Hogg, Robert S.; Montaner, Julio S. G.; Harrigan, P. Richard			"Dynamic Range" of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice	PLOS ONE			English	Article							FOLLOW-UP; TRIAL; SUSCEPTIBILITY; THERAPY; VIRADAPT; UTILITY	Background: 'Virtual' or inferred phenotypes (vPhenotypes) are commonly used to assess resistance to antiretroviral agents in patients failing therapy. In this study, we provide a clinical context for understanding vPhenotype values. Methods: All HIV-infected persons enrolled in the British Columbia Drug Treatment Program with a baseline plasma viral load (pVL) and follow-up genotypic resistance and pVL results were included up to October 29, 2008 (N = 5,277). Change from baseline pVL was determined as a function of Virco vPhenotype, and the "dynamic range" (defined here by the 10th and 90th percentiles for fold-change in IC50 amongst all patients) was estimated from the distribution of vPhenotye fold-changes across the cohort. Results: The distribution of vPhenotypes from a large cohort of HIV patients who have failed therapy are presented for all available antiretroviral agents. A maximum change in IC50 of at least 13-fold was observed for all drugs. The dideoxy drugs, tenofovir and most Pls exhibited small "dynamic ranges'' with values of,4-fold change observed in >99% of samples. In contrast, zidovudine, lamivudine, emtricitabine and the non-nucleoside reverse transcriptase inihibitors (excluding etravirine) had large dynamic ranges. Conclusion: We describe the populational distribution of vPhenotypes such that vPhenotype results can be interpreted relative to other patients in a drug-specific manner.	[Swenson, Luke C.; Pollock, Graham; Wynhoven, Brian; Mo, Theresa; Dong, Winnie; Hogg, Robert S.; Montaner, Julio S. G.; Harrigan, P. Richard] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.; Harrigan, P. Richard] Univ British Columbia, Fac Med, Div AIDS, Vancouver, BC, Canada; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada	B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Simon Fraser University	Swenson, LC (corresponding author), St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada.	prharrigan@cfenet.ubc.ca	Swenson, Luke/E-8549-2014; Hogg, Robert S/B-2783-2012; Cano, Jose Maria Bellon/G-3061-2012; Berenguer, Juan/A-1347-2009; Montaner, Julio/K-7621-2012	Swenson, Luke/0000-0001-5381-7709; Hogg, Robert S/0000-0003-3463-5488; Cano, Jose Maria Bellon/0000-0002-8492-1565; Berenguer, Juan/0000-0001-8541-8200; 	Canadian Institutes of Health Research (CIHR); GSK-CIHR Research Chair	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GSK-CIHR Research Chair(Canadian Institutes of Health Research (CIHR))	LCS is supported by a Canadian Institutes of Health Research (CIHR) Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award. PRH is supported by a GSK-CIHR Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001; *BRIT COL CTR EXC, 2003, HIV AIDS DRUG TREATM; BROOKS JI, 2009, 49 INT C ANT AG CHEM; Brooks JI, 2009, CAN C HIV AIDS RES V; Clevenbergh P, 2000, ANTIVIR THER, V5, P65; Dong W, 2002, 14 INT AIDS C BARC S; Dunne AL, 2001, AIDS, V15, P1471, DOI 10.1097/00002030-200108170-00003; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Harrigan PR, 2001, AIDS, V15, P1671, DOI 10.1097/00002030-200109070-00010; Haubrich R, 2001, J ACQ IMMUN DEF SYND, V26, pS51, DOI 10.1097/00126334-200103011-00006; HAUBRICH R, 2001, ADV SUDIES NURSING, V1, P486; Hoffman C, 2007, HIV MED; Huang XQ, 1996, COMPUT APPL BIOSCI, V12, P497; Johnson Victoria A, 2009, Top HIV Med, V17, P138; KELLAM P, 1994, ANTIMICROB AGENTS CH, V38, P23, DOI 10.1128/AAC.38.1.23; Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008; SCHUURMAN R, 1995, J INFECT DIS, V171, P1411, DOI 10.1093/infdis/171.6.1411; Sturmer M, 2003, ANTIVIR THER, V8, P239; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Vandamme AM, 2001, ANTIVIR THER, V6, P21; Winters B, 2008, JAIDS-J ACQ IMM DEF, V48, P26, DOI 10.1097/QAI.0b013e31816d9bf4	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17402	10.1371/journal.pone.0017402	http://dx.doi.org/10.1371/journal.pone.0017402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390218	gold, Green Published, Green Submitted			2022-12-27	WOS:000287761700051
J	Yamaguchi, S; Kazuki, Y; Nakayama, Y; Nanba, E; Oshimura, M; Ohbayashi, T				Yamaguchi, Shigeyuki; Kazuki, Yasuhiro; Nakayama, Yuji; Nanba, Eiji; Oshimura, Mitsuo; Ohbayashi, Tetsuya			A Method for Producing Transgenic Cells Using a Multi-Integrase System on a Human Artificial Chromosome Vector	PLOS ONE			English	Article							SITE-SPECIFIC INTEGRATION; PHI-C31 INTEGRASE; MAMMALIAN-CELLS; STEM-CELLS; PHAGE PHI-C31-INTEGRASE; MYCOBACTERIOPHAGE BXB1; GERMLINE TRANSMISSION; PROTEIN EXPRESSION; XENOPUS-LAEVIS; CRE-LOXP	The production of cells capable of expressing gene(s) of interest is important for a variety of applications in biomedicine and biotechnology, including gene therapy and animal transgenesis. The ability to insert transgenes at a precise location in the genome, using site-specific recombinases such as Cre, FLP, and Phi C31, has major benefits for the efficiency of transgenesis. Recent work on integrases from Phi C31, R4, TP901-1 and Bxb1 phages demonstrated that these recombinases catalyze site-specific recombination in mammalian cells. In the present study, we examined the activities of integrases on site-specific recombination and gene expression in mammalian cells. We designed a human artificial chromosome (HAC) vector containing five recombination sites (Phi C31 attP, R4 attP, TP901-1 attP, Bxb1 attP and FRT; multi-integrase HAC vector) and de novo mammalian codon-optimized integrases. The multi-integrase HAC vector has several functions, including gene integration in a precise locus and avoiding genomic position effects; therefore, it was used as a platform to investigate integrase activities. Integrases carried out site-specific recombination at frequencies ranging from 39.3-96.8%. Additionally, we observed homogenous gene expression in 77.3-87.5% of colonies obtained using the multi-integrase HAC vector. This vector is also transferable to another cell line, and is capable of accepting genes of interest in this environment. These data suggest that integrases have high DNA recombination efficiencies in mammalian cells. The multi-integrase HAC vector enables us to produce transgene-expressing cells efficiently and create platform cell lines for gene expression.	[Yamaguchi, Shigeyuki; Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Yonago, Tottori, Japan; [Yamaguchi, Shigeyuki; Ohbayashi, Tetsuya] Tottori Univ, Div Lab Anim Sci, Res Ctr Biosci & Technol, Yonago, Tottori, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan; [Nakayama, Yuji; Nanba, Eiji] Tottori Univ, Div Funct Genom, Res Ctr Biosci & Technol, Yonago, Tottori, Japan	Tottori University; Tottori University; Tottori University; Tottori University	Yamaguchi, S (corresponding author), Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Yonago, Tottori, Japan.	ohbayashi@grape.med.tottori-u.ac.jp			Core Research for Evolutional Science and Technology (CREST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; New Energy and Industrial Technology Development Organization (NEDO) from the Ministry of Economy, Trade and Industry of Japan; Japan Society for the Promotion of Science for Young Scientists	Core Research for Evolutional Science and Technology (CREST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)); New Energy and Industrial Technology Development Organization (NEDO) from the Ministry of Economy, Trade and Industry of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding was provided by the Core Research for Evolutional Science and Technology (CREST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.jst.go.jp/kisoken/crest/en/index.html); the New Energy and Industrial Technology Development Organization (NEDO) from the Ministry of Economy, Trade and Industry of Japan (http://www.nedo.go.jp/english/index.html); and Research Fellowships from the Japan Society for the Promotion of Science for Young Scientists (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Allen Bryan G., 2009, V518, P113, DOI 10.1007/978-1-59745-202-1_9; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Basu J, 2006, PEDIATR CLIN N AM, V53, P843, DOI 10.1016/j.pcl.2006.08.013; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Christiansen B, 1996, J BACTERIOL, V178, P5164, DOI 10.1128/jb.178.17.5164-5173.1996; Clark AJ, 1997, NUCLEIC ACIDS RES, V25, P1009, DOI 10.1093/nar/25.5.1009; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Ehrhardt A, 2006, HUM GENE THER, V17, P1077, DOI 10.1089/hum.2006.17.1077; Gorman C, 2000, CURR OPIN BIOTECH, V11, P455, DOI 10.1016/S0958-1669(00)00127-0; GRANTHAM R, 1980, NUCLEIC ACIDS RES, V8, P1893, DOI 10.1093/nar/8.9.1893; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Kakeda M, 2005, GENE THER, V12, P852, DOI 10.1038/sj.gt.3302483; Katoh M, 2004, BIOCHEM BIOPH RES CO, V321, P280, DOI 10.1016/j.bbrc.2004.06.145; KAZUKI Y, 2010, GENE THER IN PRESS; Kennard ML, 2009, BIOTECHNOL BIOENG, V104, P540, DOI 10.1002/bit.22406; Kim AI, 2003, MOL MICROBIOL, V50, P463, DOI 10.1046/j.1365-2958.2003.03723.x; Koduri RK, 2001, GENE, V280, P87, DOI 10.1016/S0378-1119(01)00772-7; KUGOH HM, 1990, ONCOGENE, V5, P1637; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; KUHSTOSS S, 1991, J MOL BIOL, V222, P897, DOI 10.1016/0022-2836(91)90584-S; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Larin Z, 2002, TRENDS GENET, V18, P313, DOI 10.1016/S0168-9525(02)02679-3; Lieu PT, 2009, J BIOMOL SCREEN, V14, P1207, DOI 10.1177/1087057109348941; Lindenbaum M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh169; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Matsuura T, 1996, J BACTERIOL, V178, P3374, DOI 10.1128/jb.178.11.3374-3376.1996; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Olivares EC, 2001, GENE, V278, P167, DOI 10.1016/S0378-1119(01)00711-9; Oshimura M, 2008, REPROD BIOMED ONLINE, V16, P57, DOI 10.1016/S1472-6483(10)60557-3; Pilbrough W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008432; Pravtcheva DD, 1995, GENOMICS, V30, P529, DOI 10.1006/geno.1995.1274; Quenneville SP, 2004, MOL THER, V10, P679, DOI 10.1016/j.ymthe.2004.05.034; Ramirez A, 2001, GENETICS, V158, P341; Ren XY, 2005, STEM CELLS, V23, P1608, DOI 10.1634/stemcells.2005-0021; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Russell JP, 2006, BIOTECHNIQUES, V40, P460, DOI 10.2144/000112150; Sasaki Y, 2004, J BIOTECHNOL, V107, P233, DOI 10.1016/j.jbiotec.2003.10.001; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Sone T, 2008, J BIOTECHNOL, V136, P113, DOI 10.1016/j.jbiotec.2008.06.006; Stoll SM, 2002, J BACTERIOL, V184, P3657, DOI 10.1128/JB.184.13.3657-3663.2002; Thorpe HM, 1998, P NATL ACAD SCI USA, V95, P5505, DOI 10.1073/pnas.95.10.5505; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Tomizuka K, 1997, NAT GENET, V16, P133, DOI 10.1038/ng0697-133; Yamaguchi Shigeyuki, 2006, Chromosome Science, V9, P65; Yoshimi K, 2000, NAT BIOTECHNOL, V18, P1086, DOI 10.1038/80287	57	62	67	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17267	10.1371/journal.pone.0017267	http://dx.doi.org/10.1371/journal.pone.0017267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390305	Green Submitted, gold, Green Published			2022-12-27	WOS:000287761700042
J	Anandakumar, S; Boosi, KN; Bugatha, H; Padmanabhan, B; Sadhale, PP				Anandakumar, Soshee; Boosi, Kannan Narayanarao; Bugatha, Harigopalarao; Padmanabhan, Bhavna; Sadhale, Parag P.			Phage Displayed Short Peptides against Cells of Candida albicans Demonstrate Presence of Species, Morphology and Region Specific Carbohydrate Epitopes	PLOS ONE			English	Article							RAPID IDENTIFICATION; DUBLINIENSIS; DIFFERENTIATION; ANTIGENS	Candida albicans is a commensal opportunistic pathogen, which can cause superficial infections as well as systemic infections in immuocompromised hosts. Among nosocomial fungal infections, infections by C. albicans are associated with highest mortality rates even though incidence of infections by other related species is on the rise world over. Since C. albicans and other Candida species differ in their susceptibility to antifungal drug treatment, it is crucial to accurately identify the species for effective drug treatment. Most diagnostic tests that differentiate between C. albicans and other Candida species are time consuming, as they necessarily involve laboratory culturing. Others, which employ highly sensitive PCR based technologies often, yield false positives which is equally dangerous since that leads to unnecessary antifungal treatment. This is the first report of phage display technology based identification of short peptide sequences that can distinguish C. albicans from other closely related species. The peptides also show high degree of specificity towards its different morphological forms. Using fluorescence microscopy, we show that the peptides bind on the surface of these cells and obtained clones that could even specifically bind to only specific regions of cells indicating restricted distribution of the epitopes. What was peculiar and interesting was that the epitopes were carbohydrate in nature. This gives insight into the complexity of the carbohydrate composition of fungal cell walls. In an ELISA format these peptides allow specific detection of relatively small numbers of C. albicans cells. Hence, if used in combination, such a test could help accurate diagnosis and allow physicians to initiate appropriate drug therapy on time.	[Anandakumar, Soshee; Boosi, Kannan Narayanarao; Bugatha, Harigopalarao; Padmanabhan, Bhavna; Sadhale, Parag P.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Anandakumar, S (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	pps@mcbl.iisc.ernet.in		Padmanabhan, Bhavna/0000-0002-2993-2755	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by the Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikandi J, 1998, J CLIN MICROBIOL, V36, P2428, DOI 10.1128/JCM.36.9.2428-2433.1998; Bjorling E, 1999, J GEN VIROL, V80, P1987, DOI 10.1099/0022-1317-80-8-1987; Bliss JM, 2003, J CLIN MICROBIOL, V41, P1152, DOI 10.1128/JCM.41.3.1152-1160.2003; Chen YC, 2000, J CLIN MICROBIOL, V38, P2302; Ehrlich GK, 2001, J BIOCHEM BIOPH METH, V49, P443, DOI 10.1016/S0165-022X(01)00212-3; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Hayden MS, 1997, CURR OPIN IMMUNOL, V9, P201, DOI 10.1016/S0952-7915(97)80136-7; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kay BK, 1998, DRUG DISCOV TODAY, V3, P370, DOI 10.1016/S1359-6446(98)01220-3; Kim D, 2002, YEAST, V19, P957, DOI 10.1002/yea.891; Koshlukova SE, 1999, J BIOL CHEM, V274, P18872, DOI 10.1074/jbc.274.27.18872; Lesinski GB, 2001, J MICROBIOL METH, V47, P135, DOI 10.1016/S0167-7012(01)00290-1; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Morace G, 1997, J CLIN MICROBIOL, V35, P667, DOI 10.1128/JCM.35.3.667-672.1997; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; ODDS FC, 1994, J CLIN MICROBIOL, V32, P1923, DOI 10.1128/JCM.32.8.1923-1929.1994; Pinjon E, 1998, J CLIN MICROBIOL, V36, P2093, DOI 10.1128/JCM.36.7.2093-2095.1998; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; RICHARDSON MD, 1983, MYCOPATHOLOGIA, V83, P97, DOI 10.1007/BF00436889; ROUSSELLE P, 1994, J CLIN MICROBIOL, V32, P3034, DOI 10.1128/JCM.32.12.3034-3036.1994; RUAN E, 2009, MYCOSES, DOI DOI 10.1111/J.1439-0507.2009.01759.X; Salkin IF, 1998, J CLIN MICROBIOL, V36, P1467, DOI 10.1128/JCM.36.5.1467-1467.1998; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sullivan D, 1998, J CLIN MICROBIOL, V36, P329, DOI 10.1128/JCM.36.2.329-334.1998; Sullivan DJ, 1996, J MED MICROBIOL, V44, P399, DOI 10.1099/00222615-44-6-399; Szardenings M, 1997, J BIOL CHEM, V272, P27943, DOI 10.1074/jbc.272.44.27943; Vaneechoutte M, 1996, MOL BIOTECHNOL, V6, P115, DOI 10.1007/BF02740768; White PL, 2003, J MED MICROBIOL, V52, P229, DOI 10.1099/jmm.0.05049-0	29	3	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16868	10.1371/journal.pone.0016868	http://dx.doi.org/10.1371/journal.pone.0016868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364990	Green Published, gold, Green Accepted			2022-12-27	WOS:000287656600022
J	Dhejne, C; Lichtenstein, P; Boman, M; Johansson, ALV; Langstrom, N; Landen, M				Dhejne, Cecilia; Lichtenstein, Paul; Boman, Marcus; Johansson, Anna L. V.; Langstrom, Niklas; Landen, Mikael			Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden	PLOS ONE			English	Article							GENDER IDENTITY DISORDER; QUALITY-OF-LIFE; FEMALE; HORMONES; SATISFACTION; EXPERIENCE; MORTALITY; OUTCOMES; REGRET	Context: The treatment for transsexualism is sex reassignment, including hormonal treatment and surgery aimed at making the person's body as congruent with the opposite sex as possible. There is a dearth of long term, follow-up studies after sex reassignment. Objective: To estimate mortality, morbidity, and criminal rate after surgical sex reassignment of transsexual persons. Design: A population-based matched cohort study. Setting: Sweden, 1973-2003. Participants: All 324 sex-reassigned persons (191 male-to-females, 133 female-to-males) in Sweden, 1973-2003. Random population controls (10: 1) were matched by birth year and birth sex or reassigned (final) sex, respectively. Main Outcome Measures: Hazard ratios (HR) with 95% confidence intervals (Cl) for mortality and psychiatric morbidity were obtained with Cox regression models, which were adjusted for immigrant status and psychiatric morbidity prior to sex reassignment (adjusted HR [aHR]). Results: The overall mortality for sex-reassigned persons was higher during follow-up (aHR 2.8; 95% Cl 1.8-4.3) than for controls of the same birth sex, particularly death from suicide (aHR 19.1; 95% Cl 5.8-62.9). Sex-reassigned persons also had an increased risk for suicide attempts (aHR 4.9; 95% Cl 2.9-8.5) and psychiatric inpatient care (aHR 2.8; 95% Cl 2.0-3.9). Comparisons with controls matched on reassigned sex yielded similar results. Female-to-males, but not male-to-females, had a higher risk for criminal convictions than their respective birth sex controls. Conclusions: Persons with transsexualism, after sex reassignment, have considerably higher risks for mortality, suicidal behaviour, and psychiatric morbidity than the general population. Our findings suggest that sex reassignment, although alleviating gender dysphoria, may not suffice as treatment for transsexualism, and should inspire improved psychiatric and somatic care after sex reassignment for this patient group.	[Dhejne, Cecilia; Landen, Mikael] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Lichtenstein, Paul; Boman, Marcus; Johansson, Anna L. V.; Langstrom, Niklas; Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Langstrom, Niklas] Karolinska Inst, Ctr Violence Prevent, Stockholm, Sweden; [Landen, Mikael] Gothenburg Univ, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg	Dhejne, C (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	mikael.landen@neuro.gu.se	Dhejne, Cecilia/AAH-5737-2019; Landen, Mikael/AAD-7917-2020; Langstrom, Niklas/C-5615-2009	Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287; Johansson, Anna/0000-0002-1191-7231; Dhejne, Cecilia/0000-0003-1743-9012	Stockholm County Council; Karolinska Institutet; Swedish Medical Research Council [K2008-62x-14647-06-3]; Royal Swedish Academy of Sciences (Torsten Amundson's Foundation)	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Royal Swedish Academy of Sciences (Torsten Amundson's Foundation)	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet, and through grants from the Swedish Medical Research Council (K2008-62x-14647-06-3) and the Royal Swedish Academy of Sciences (Torsten Amundson's Foundation). The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. All authors had full access to the data in the study and the final responsibility for the decision to submit for publication was made by the corresponding author.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bodlund O, 1996, ARCH SEX BEHAV, V25, P303, DOI 10.1007/BF02438167; Cohen-Kettenis PT, 1999, J PSYCHOSOM RES, V46, P315, DOI 10.1016/S0022-3999(98)00085-3; De Cuypere G, 2005, ARCH SEX BEHAV, V34, P679, DOI 10.1007/s10508-005-7926-5; DOLMEN L, 2001, BROTTSLIGHETEN OLIKA; Elamin MB, 2010, CLIN ENDOCRINOL, V72, P1, DOI 10.1111/j.1365-2265.2009.03632.x; Eldh J, 1997, SCAND J PLAST RECONS, V31, P39; Fazel S, 2006, AM J PSYCHIAT, V163, P1397, DOI 10.1176/appi.ajp.163.8.1397; Gooren LJ, 2008, J CLIN ENDOCR METAB, V93, P19, DOI 10.1210/jc.2007-1809; Hepp U, 2005, J PSYCHOSOM RES, V58, P259, DOI 10.1016/j.jpsychores.2004.08.010; Hepp U, 2002, NERVENARZT, V73, P283, DOI 10.1007/s00115-001-1225-8; Lobato MII, 2006, ARCH SEX BEHAV, V35, P711, DOI 10.1007/s10508-006-9074-y; Johansson A, 2010, ARCH SEX BEHAV, V39, P1429, DOI 10.1007/s10508-009-9551-1; KAUBE H, 1991, Handchirurgie Mikrochirurgie Plastische Chirurgie, V23, P276; KETTENIS PTC, 1997, J AM ACAD CHILD ADOL, V36, P263; Kuhn A, 2009, FERTIL STERIL, V92, P1685, DOI 10.1016/j.fertnstert.2008.08.126; Landen M, 1996, ACTA PSYCHIAT SCAND, V93, P261, DOI 10.1111/j.1600-0447.1996.tb10645.x; Landen M, 2000, ARCH SEX BEHAV, V29, P375, DOI 10.1023/A:1001970521182; Landen M, 1998, ACTA PSYCHIAT SCAND, V97, P189, DOI 10.1111/j.1600-0447.1998.tb09986.x; Landen M, 1998, ACTA PSYCHIAT SCAND, V97, P284, DOI 10.1111/j.1600-0447.1998.tb10001.x; Lawrence AA, 2003, ARCH SEX BEHAV, V32, P299, DOI 10.1023/A:1024086814364; LEAVITT F, 1980, J NERV MENT DIS, V168, P693, DOI 10.1097/00005053-198011000-00009; LINDEMALM G, 1986, ARCH SEX BEHAV, V15, P187, DOI 10.1007/BF01542412; Meyer W., 2002, J PSYCHOL HUMAN SEXU, V13, P1, DOI [10.1300/J056v13n01_01, DOI 10.1300/J056V13N01_01]; Mueller A, 2008, EUR J ENDOCRINOL, V159, P197, DOI 10.1530/EJE-08-0289; Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x; Newfield E, 2006, QUAL LIFE RES, V15, P1447, DOI 10.1007/s11136-006-0002-3; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Rauchfleisch U, 1998, NERVENARZT, V69, P799, DOI 10.1007/s001150050345; Rehman J, 1999, ARCH SEX BEHAV, V28, P71, DOI 10.1023/A:1018745706354; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Smith YLS, 2001, J AM ACAD CHILD PSY, V40, P472, DOI 10.1097/00004583-200104000-00017; SORENSEN T, 1982, ARCH SEX BEHAV, V11, P133, DOI 10.1007/BF01541980; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Toorians AWFT, 2003, J CLIN ENDOCR METAB, V88, P5723, DOI 10.1210/jc.2003-030520; vanKesteren PJM, 1997, CLIN ENDOCRINOL, V47, P337, DOI 10.1046/j.1365-2265.1997.2601068.x; Vujovic S, 2009, J SEX MED, V6, P1018, DOI 10.1111/j.1743-6109.2008.00799.x; Walinder J., 1975, SOCIAL PSYCHIAT FOLL; WHO, 2012, ICD 10 CLASS MENT BE; Zimmermann A, 2006, CHIRURG, V77, P432, DOI 10.1007/s00104-005-1138-3	40	277	281	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16885	10.1371/journal.pone.0016885	http://dx.doi.org/10.1371/journal.pone.0016885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PA	21364939	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600023
J	Fujiwara, M; Yan, PS; Otsuji, TG; Narazaki, G; Uosaki, H; Fukushima, H; Kuwahara, K; Harada, M; Matsuda, H; Matsuoka, S; Okita, K; Takahashi, K; Nakagawa, M; Ikeda, T; Sakata, R; Mummery, CL; Nakatsuji, N; Yamanaka, S; Nakao, K; Yamashita, JK				Fujiwara, Masataka; Yan, Peishi; Otsuji, Tomomi G.; Narazaki, Genta; Uosaki, Hideki; Fukushima, Hiroyuki; Kuwahara, Koichiro; Harada, Masaki; Matsuda, Hiroyuki; Matsuoka, Satoshi; Okita, Keisuke; Takahashi, Kazutoshi; Nakagawa, Masato; Ikeda, Tadashi; Sakata, Ryuzo; Mummery, Christine L.; Nakatsuji, Norio; Yamanaka, Shinya; Nakao, Kazuwa; Yamashita, Jun K.			Induction and Enhancement of Cardiac Cell Differentiation from Mouse and Human Induced Pluripotent Stem Cells with Cyclosporin-A	PLOS ONE			English	Article							CARDIOVASCULAR PROGENITOR CELLS; SMOOTH-MUSCLE; GENERATION; CARDIOMYOCYTES; FIBROBLASTS; MYOCYTES	Induced pluripotent stem cells (iPSCs) are novel stem cells derived from adult mouse and human tissues by reprogramming. Elucidation of mechanisms and exploration of efficient methods for their differentiation to functional cardiomyocytes are essential for developing cardiac cell models and future regenerative therapies. We previously established a novel mouse embryonic stem cell (ESC) and iPSC differentiation system in which cardiovascular cells can be systematically induced from Flk1(+) common progenitor cells, and identified highly cardiogenic progenitors as Flk1(+)/CXCR4(+)/VE-cadherin(-) (FCV) cells. We have also reported that cyclosporin-A (CSA) drastically increases FCV progenitor and cardiomyocyte induction from mouse ESCs. Here, we combined these technologies and extended them to mouse and human iPSCs. Co-culture of purified mouse iPSC-derived Flk1(+) cells with OP9 stroma cells induced cardiomyocyte differentiation whilst addition of CSA to Flk1(+) cells dramatically increased both cardiomyocyte and FCV progenitor cell differentiation. Spontaneously beating colonies were obtained from human iPSCs by co-culture with END-2 visceral endoderm-like cells. Appearance of beating colonies from human iPSCs was increased approximately 4.3 times by addition of CSA at mesoderm stage. CSA-expanded human iPSC-derived cardiomyocytes showed various cardiac marker expressions, synchronized calcium transients, cardiomyocyte-like action potentials, pharmacological reactions, and ultra-structural features as cardiomyocytes. These results provide a technological basis to obtain functional cardiomyocytes from iPSCs.	[Fujiwara, Masataka; Yan, Peishi; Narazaki, Genta; Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Stem Cell Differentiat, Kyoto, Japan; [Fujiwara, Masataka; Kuwahara, Koichiro; Harada, Masaki; Nakao, Kazuwa] Kyoto Univ, Dept Med & Clin Sci, Grad Sch Med, Kyoto, Japan; [Yan, Peishi; Ikeda, Tadashi; Sakata, Ryuzo] Kyoto Univ, Dept Cardiovasc Surg, Grad Sch Med, Kyoto, Japan; [Otsuji, Tomomi G.] Stem Cell & Drug Discovery Inst, Kyoto, Japan; [Otsuji, Tomomi G.] Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Embryon Stem Cell Res, Kyoto, Japan; [Narazaki, Genta; Uosaki, Hideki; Fukushima, Hiroyuki; Yamashita, Jun K.] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Cell Growth & Differentiat, Kyoto, Japan; [Matsuda, Hiroyuki; Matsuoka, Satoshi] Kyoto Univ, Dept Physiol & Biophys, Grad Sch Med, Kyoto, Japan; [Okita, Keisuke; Takahashi, Kazutoshi; Nakagawa, Masato; Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Dept Reprogramming Sci, Kyoto, Japan; [Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Nakatsuji, Norio] Kyoto Univ, Inst Frontier Med Sci, Dept Dev & Differentiat, Kyoto, Japan; [Nakatsuji, Norio] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Kyoto University; Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Fujiwara, M (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Stem Cell Res Ctr, Lab Stem Cell Differentiat, Kyoto, Japan.	juny@frontier.kyoto-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022; Takahashi, Kazutoshi/ABE-5504-2020; matsuoka, satoshi/GWD-0440-2022; Uosaki, Hideki/AAQ-2619-2020	Kuwahara, Koichiro/0000-0003-2670-7170; Takahashi, Kazutoshi/0000-0002-5329-8395; matsuoka, satoshi/0000-0003-3321-9749; Uosaki, Hideki/0000-0002-8964-8609; Mummery, Christine/0000-0002-4549-6535; Okita, Keisuke/0000-0001-5806-1090; Narazaki, Genta/0000-0003-3063-2570	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labour and Welfare; New Energy and Industrial Development Organization (NEDO) of Japan; Project for Realization of Regenerative Medicine; Grants-in-Aid for Scientific Research [23390210] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Project for Realization of Regenerative Medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Education, Science, Sports and Culture of Japan, the Ministry of Health, Labour and Welfare, the New Energy and Industrial Development Organization (NEDO) of Japan, the Project for Realization of Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHACKO KJ, 1976, J MORPHOL, V150, P681, DOI 10.1002/jmor.1051500305; Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e; Garry DJ, 2006, CELL, V127, P1101, DOI 10.1016/j.cell.2006.11.031; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Reinecke H, 2008, CIRC RES, V103, P1058, DOI 10.1161/CIRCRESAHA.108.180588; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamamizu K, 2009, BLOOD, V114, P3707, DOI 10.1182/blood-2008-12-195750; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yamashita J, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P67, DOI 10.1007/4-431-27378-6_6; Yamashita JK, 2005, FASEB J, V19, P1534, DOI 10.1096/fj.04-3540fje; Yamashita JK, 2004, INT J HEMATOL, V80, P1, DOI 10.1532/ijh97.04043; Yamashita JK, 2007, TRENDS CARDIOVAS MED, V17, P59, DOI 10.1016/j.tcm.2007.01.001; Yan P, 2009, BIOCHEM BIOPH RES CO, V379, P115, DOI 10.1016/j.bbrc.2008.12.019; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885	38	99	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16734	10.1371/journal.pone.0016734	http://dx.doi.org/10.1371/journal.pone.0016734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364991	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600015
J	Lan, TH; Kuravi, S; Lambert, NA				Lan, Tien-Hung; Kuravi, Sudhakiranmayi; Lambert, Nevin A.			Internalization Dissociates beta(2)-Adrenergic Receptors	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; BETA-2-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; HETERODIMERIZATION; OLIGOMERIZATION; TRAFFICKING; ACTIVATION; DYNAMIN	G protein-coupled receptors (GPCRs) self-associate as dimers or higher-order oligomers in living cells. The stability of associated GPCRs has not been extensively studied, but it is generally thought that these receptors move between the plasma membrane and intracellular compartments as intact dimers or oligomers. Here we show that beta(2)-adrenergic receptors (beta(2)ARs) that self-associate at the plasma membrane can dissociate during agonist-induced internalization. We use bioluminescence-resonance energy transfer (BRET) to monitor movement of beta(2)ARs between subcellular compartments. BRET between beta(2)ARs and plasma membrane markers decreases in response to agonist activation, while at the same time BRET between beta(2)ARs and endosome markers increases. Energy transfer between beta(2)ARs is decreased in a similar manner if either the donor-or acceptor-labeled receptor is mutated to impair agonist binding and internalization. These changes take place over the course of 30 minutes, persist after agonist is removed, and are sensitive to several inhibitors of arrestin-and clathrin-mediated endocytosis. The magnitude of the decrease in BRET between donor-and acceptor-labeled beta(2)ARs suggests that at least half of the receptors that contribute to the BRET signal are physically segregated by internalization. These results are consistent with the possibility that beta(2)ARs associate transiently with each other in the plasma membrane, or that beta(2)AR dimers or oligomers are actively disrupted during internalization.	[Lan, Tien-Hung; Kuravi, Sudhakiranmayi; Lambert, Nevin A.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA	University System of Georgia; Augusta University	Lan, TH (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA.	nlambert@georgiahealth.edu			National Institutes of Health [GM078319, GM096762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM096762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM078319 and GM096762). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cao TT, 2005, MOL PHARMACOL, V67, P288, DOI 10.1124/mol.104.003608; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Gregan B, 2004, J BIOL CHEM, V279, P27679, DOI 10.1074/jbc.M403601200; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; He L, 2002, CELL, V108, P271, DOI 10.1016/S0092-8674(02)00613-X; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Krupnick JG, 1997, J BIOL CHEM, V272, P32507, DOI 10.1074/jbc.272.51.32507; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Nankoe SR, 2006, TRENDS CELL BIOL, V16, P607, DOI 10.1016/j.tcb.2006.10.004; Overton MC, 2000, CURR BIOL, V10, P341, DOI 10.1016/S0960-9822(00)00386-9; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Rabiet MJ, 2008, J BIOL CHEM, V283, P31038, DOI 10.1074/jbc.M805260200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Sartania N, 2007, CELL SIGNAL, V19, P1928, DOI 10.1016/j.cellsig.2007.05.002; STRADER CD, 1987, P NATL ACAD SCI USA, V84, P4384, DOI 10.1073/pnas.84.13.4384; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; VONZASTROW M, 1994, J BIOL CHEM, V269, P18448; VONZASTROW M, 1992, J BIOL CHEM, V267, P3530; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Yesilaltay A, 2000, MOL BIOL CELL, V11, P2873, DOI 10.1091/mbc.11.9.2873; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	35	45	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17361	10.1371/journal.pone.0017361	http://dx.doi.org/10.1371/journal.pone.0017361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364942	gold, Green Submitted, Green Published			2022-12-27	WOS:000287656600044
J	Hu, Y; Dong, XX; Wu, AP; Cao, Y; Tian, LQ; Jiang, TJ				Hu, Yun; Dong, Xiaoxi; Wu, Aiping; Cao, Yang; Tian, Liqing; Jiang, Taijiao			Incorporation of Local Structural Preference Potential Improves Fold Recognition	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; HIDDEN MARKOV-MODELS; SEQUENCE PROFILES; SECONDARY STRUCTURE; HOMOLOGY DETECTION; THREADING-SERVER; ALIGNMENT; INFORMATION; SEARCH; IDENTIFICATION	Fold recognition, or threading, is a popular protein structure modeling approach that uses known structure templates to build structures for those of unknown. The key to the success of fold recognition methods lies in the proper integration of sequence, physiochemical and structural information. Here we introduce another type of information, local structural preference potentials of 3-residue and 9-residue fragments, for fold recognition. By combining the two local structural preference potentials with the widely used sequence profile, secondary structure information and hydrophobic score, we have developed a new threading method called FR-t5 (fold recognition by use of 5 terms). In benchmark testings, we have found the consideration of local structural preference potentials in FR-t5 not only greatly enhances the alignment accuracy and recognition sensitivity, but also significantly improves the quality of prediction models.	[Hu, Yun; Dong, Xiaoxi; Wu, Aiping; Cao, Yang; Tian, Liqing; Jiang, Taijiao] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Hu, Yun; Dong, Xiaoxi; Cao, Yang; Tian, Liqing] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Hu, Y (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	taijiao@moon.ibp.ac.cn		dong, xiaoxi/0000-0003-3852-331X; Wu, Aiping/0000-0002-5869-651X; Tian, Liqing/0000-0001-9921-0603	Chinese Ministry of Science and Technology; Project 973 [2009CB918503, 2006CB911002]; National Science and Technology Key Project [2008ZX10004-013]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Project 973(National Basic Research Program of China); National Science and Technology Key Project	This work was supported by grants from the Chinese Ministry of Science and Technology, the National Science and Technology Key Project (2008ZX10004-013) to TJ, Project 973 (2009CB918503 and 2006CB911002) to TJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An YL, 2002, PROTEINS, V48, P352, DOI 10.1002/prot.10145; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Camproux AC, 2004, J MOL BIOL, V339, P591, DOI 10.1016/j.jmb.2004.04.005; Camproux AC, 1999, PROTEIN ENG, V12, P1063, DOI 10.1093/protein/12.12.1063; Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102; Das R, 2007, PROTEINS, V69, P118, DOI 10.1002/prot.21636; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341; Fernandez-Fuentes N, 2007, BIOINFORMATICS, V23, P2558, DOI 10.1093/bioinformatics/btm377; Ginalski K, 2005, NUCLEIC ACIDS RES, V33, P1874, DOI 10.1093/nar/gki327; Ginalski K, 2003, NUCLEIC ACIDS RES, V31, P3804, DOI 10.1093/nar/gkg504; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hou Y, 2003, BIOINFORMATICS, V19, P2294, DOI 10.1093/bioinformatics/btg317; Hunter CG, 2003, PROTEINS, V50, P580, DOI 10.1002/prot.10309; Hunter CG, 2003, PROTEINS, V50, P572, DOI 10.1002/prot.10310; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jones DT, 1999, J MOL BIOL, V287, P797, DOI 10.1006/jmbi.1999.2583; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kanou K, 2009, CHEM PHARM BULL, V57, P1335, DOI 10.1248/cpb.57.1335; Karchin R, 2003, PROTEINS, V51, P504, DOI 10.1002/prot.10369; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Lackner P, 2000, PROTEIN ENG, V13, P745, DOI 10.1093/protein/13.11.745; Li TP, 2003, PROTEIN ENG, V16, P323, DOI 10.1093/protein/gzg044; Lindahl E, 2000, J MOL BIOL, V295, P613, DOI 10.1006/jmbi.1999.3377; Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459; Lundstrom J, 2001, PROTEIN SCI, V10, P2354, DOI 10.1110/ps.08501; Marti-Renom MA, 2004, PROTEIN SCI, V13, P1071, DOI 10.1110/ps.03379804; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Panchenko AR, 2000, J MOL BIOL, V296, P1319, DOI 10.1006/jmbi.2000.3541; Peng JA, 2010, BIOINFORMATICS, V26, pi294, DOI 10.1093/bioinformatics/btq192; Pettitt CS, 2005, BIOINFORMATICS, V21, P3509, DOI 10.1093/bioinformatics/bti540; Poleksic A, 2008, BIOINFORMATICS, V24, P1145, DOI 10.1093/bioinformatics/btn097; Rice DW, 1997, J MOL BIOL, V267, P1026, DOI 10.1006/jmbi.1997.0924; Rotkiewicz P, 2008, J COMPUT CHEM, V29, P1460, DOI 10.1002/jcc.20906; Sadreyev R, 2003, J MOL BIOL, V326, P317, DOI 10.1016/S0022-2836(02)01371-2; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDER O, 2006, BMC BIOINFORMATICS, V7, pIL1; Schenk G, 2008, ALGORITHM MOL BIOL, V3, DOI 10.1186/1748-7188-3-4; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Silva PJ, 2008, PROTEINS, V70, P1588, DOI 10.1002/prot.21803; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Torda AE, 2004, NUCLEIC ACIDS RES, V32, pW532, DOI 10.1093/nar/gkh357; Tress ML, 2009, PROTEINS, V77, P10, DOI 10.1002/prot.22497; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186; Xu JB, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22567; Yan RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-416; Yang JS, 2007, STRUCTURE, V15, P53, DOI 10.1016/j.str.2006.11.010; Zhang W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002325; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhou HY, 2007, BIOPHYS J, V93, P1510, DOI 10.1529/biophysj.107.109959; Zhou HY, 2010, PROTEINS, V78, P2041, DOI 10.1002/prot.22717; Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308; Zhou HY, 2004, PROTEINS, V55, P1005, DOI 10.1002/prot.20007; Zimmermann O, 2008, J CHEM INF MODEL, V48, P1903, DOI 10.1021/ci800178a	69	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17215	10.1371/journal.pone.0017215	http://dx.doi.org/10.1371/journal.pone.0017215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365008	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800035
J	Kreth, S; Thon, N; Eigenbrod, S; Lutz, J; Ledderose, C; Egensperger, R; Tonn, JC; Kretzschmar, HA; Hinske, LC; Kreth, FW				Kreth, Simone; Thon, Niklas; Eigenbrod, Sabina; Lutz, Juergen; Ledderose, Carola; Egensperger, Rupert; Tonn, Joerg C.; Kretzschmar, Hans A.; Hinske, Ludwig C.; Kreth, Friedrich W.			O-6-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation	PLOS ONE			English	Article							DNA METHYLTRANSFERASES; INTRATUMORAL HOMOGENEITY; ADJUVANT TEMOZOLOMIDE; GLIOBLASTOMA PATIENTS; ALKYLATING-AGENTS; GENE-EXPRESSION; LUNG-CANCER; CELL-LINES; PHASE-III; TUMORS	Background: We analyzed prospectively whether MGMT (O-6-methylguanine-DNA methyltransferase) mRNA expression gains prognostic/predictive impact independent of MGMT promoter methylation in malignant glioma patients undergoing radiotherapy with concomitant and adjuvant temozolomide or temozolomide alone. As DNA-methyltransferases (DNMTs) are the enzymes responsible for setting up and maintaining DNA methylation patterns in eukaryotic cells, we analyzed further, whether MGMT promoter methylation is associated with upregulation of DNMT expression. Methodology/Principal Findings: Adult patients with a histologically proven malignant astrocytoma (glioblastoma: N = 53, anaplastic astrocytoma: N = 10) were included. MGMT promoter methylation was determined by methylation-specific PCR (MSP) and sequencing analysis. Expression of MGMT and DNMTs mRNA were analysed by real-time qPCR. Prognostic factors were obtained from proportional hazards models. Correlation between MGMT mRNA expression and MGMT methylation status was validated using data from the Cancer Genome Atlas (TCGA) database (N = 229 glioblastomas). Low MGMT mRNA expression was strongly predictive for prolonged time to progression, treatment response, and length of survival in univariate and multivariate models (p<0.0001); the degree of MGMT mRNA expression was highly correlated with the MGMT promoter methylation status (p<0.0001); however, discordant findings were seen in 12 glioblastoma patients: Patients with methylated tumors with high MGMT mRNA expression (N = 6) did significantly worse than those with low transcriptional activity (p<0.01). Conversely, unmethylated tumors with low MGMT mRNA expression (N = 6) did better than their counterparts. A nearly identical frequency of concordant and discordant findings was obtained by analyzing the TCGA database (p<0.0001). Expression of DNMT1 and DNMT3b was strongly upregulated in tumor tissue, but not correlated with MGMT promoter methylation and MGMT mRNA expression. Conclusions/Significance: MGMT mRNA expression plays a direct role for mediating tumor sensitivity to alkylating agents. Discordant findings indicate methylation-independent pathways of MGMT expression regulation. DNMT1 and DNMT3b are likely to be involved in CGI methylation. However, their exact role yet has to be defined.	[Kreth, Simone; Hinske, Ludwig C.] Univ Munich, Dept Anaesthesiol, Munich, Germany; [Thon, Niklas; Tonn, Joerg C.; Kreth, Friedrich W.] Univ Munich, Dept Neurosurg, Munich, Germany; [Eigenbrod, Sabina; Egensperger, Rupert; Kretzschmar, Hans A.] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Lutz, Juergen] Univ Munich, Dept Radiol, Munich, Germany; [Ledderose, Carola] Univ Med Ctr Mannheim, Dept Anaesthesiol, Mannheim, Germany	University of Munich; University of Munich; University of Munich; University of Munich; Ruprecht Karls University Heidelberg	Kreth, S (corresponding author), Univ Munich, Dept Anaesthesiol, Munich, Germany.	fkreth@med.uni-muenchen.de	Thon, Niklas/AAI-9069-2021; Hinske, Christian/AAN-4805-2021; Tonn, Joerg/AAK-8509-2021	Thon, Niklas/0000-0003-0011-5281; Hinske, Christian/0000-0001-7273-5899; Kreth, Simone/0000-0002-0073-2098	Department of Anaesthesiology, Department of Neurosurgery, LMU Munich	Department of Anaesthesiology, Department of Neurosurgery, LMU Munich	The work was funded by the departmental funds (Department of Anaesthesiology, Department of Neurosurgery, LMU Munich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Christmann M, 2010, INT J CANCER, V127, P2106, DOI 10.1002/ijc.25229; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Everhard S, 2009, NEURO-ONCOLOGY, V11, P348, DOI 10.1215/15228517-2009-001; Girault I, 2003, CLIN CANCER RES, V9, P4415; Grasbon-Frodl EM, 2007, INT J CANCER, V121, P2458, DOI 10.1002/ijc.23020; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karnofsky DA, 1949, CLIN EVALUATION CHEM; Kim HJ, 2006, CANCER, V107, P1042, DOI 10.1002/cncr.22087; Kreth S, 2010, NEURO-ONCOLOGY, V12, P570, DOI 10.1093/neuonc/nop072; Lavon I, 2007, CANCER RES, V67, P8952, DOI 10.1158/0008-5472.CAN-06-3820; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Lorente A, 2009, BRAIN PATHOL, V19, P279, DOI 10.1111/j.1750-3639.2008.00185.x; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mollemann M, 2005, INT J CANCER, V113, P379, DOI 10.1002/ijc.20575; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Sasai K, 2008, AM J SURG PATHOL, V32, P1220, DOI 10.1097/PAS.0b013e318164c3f0; Sato M, 2002, ONCOGENE, V21, P4822, DOI 10.1038/sj.onc.1205581; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; THON N, 2010, J NEUROL NE IN PRESS; Thon N, 2009, J NEUROPATH EXP NEUR, V68, P1219, DOI 10.1097/NEN.0b013e3181bee1f1; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497	33	85	88	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17156	10.1371/journal.pone.0017156	http://dx.doi.org/10.1371/journal.pone.0017156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365007	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800028
J	Weinberg, ME; Roman, MC; Jacob, P; Wen, M; Cheung, P; Walker, UA; Mulligan, K; Schambelan, M				Weinberg, Melissa E.; Roman, Mark C.; Jacob, Peyton; Wen, Michael; Cheung, Polly; Walker, Ulrich A.; Mulligan, Kathleen; Schambelan, Morris			Enhanced Uridine Bioavailability Following Administration of a Triacetyluridine-Rich Nutritional Supplement	PLOS ONE			English	Article							MITOCHONDRIAL TOXICITY; CELLS; PHOSPHORYLASE; INHIBITOR; CHEMOTHERAPY; THERAPY; PRODRUG	Background: Uridine is a therapy for hereditary orotic aciduria and is being investigated in other disorders caused by dysfunction, including toxicities resulting from treatment with nucleoside reverse transcriptase inhibitors in Historically, the use of uridine as a therapeutic agent has been limited by poor bioavailability. A food supplement nucleosides, NucleomaxX (R), has been reported to raise plasma uridine to supraphysiologic levels. Methodology/Principal Findings: Single-and multi-dose PK studies following NucleomaxX (R) were compared to single-dose studies of equimolar doses of pure uridine in healthy human volunteers. Product analysis documented that more than of the nucleoside component of NucleomaxX (R) is in the form of triacetyluridine (TAU). Single and repeated dosing with NucleomaxX (R) resulted in peak plasma uridine concentrations 1-2 hours later of 150.9 +/- 39.3 mu M and 161.4 +/- 31.5 mu M, respectively, levels known to ameliorate mitochondrial toxicity in vitro. C(max) and AUC were four-fold higher after a single of NucleomaxX (R) than after uridine. No adverse effects of either treatment were observed. Conclusions/Significance: NucleomaxX (R), containing predominantly TAU, has significantly greater bioavailability than pure in human subjects and may be useful in the management of mitochondrial toxicity.	[Weinberg, Melissa E.; Jacob, Peyton; Wen, Michael; Cheung, Polly; Mulligan, Kathleen; Schambelan, Morris] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Roman, Mark C.] Tampa Bay Analyt Res Inc, Largo, FL USA; [Walker, Ulrich A.] Univ Basel, Dept Rheumatol, Basel, Switzerland	University of California System; University of California San Francisco; University of Basel	Weinberg, ME (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	melissa.weinberg@gmail.com			National Center for Complementary and Alternative Medicine [AT003374]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NIH [T32-DK07418, P30-DA12393]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003374] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA012393] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding was provided by National Center for Complementary and Alternative Medicine grant number AT003374, NIH/NCRR UCSF-CTSI grant number UL1 RR024131, NIH training grant T32-DK07418, and NIH grant number P30-DA12393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashour OM, 2000, CANCER CHEMOTH PHARM, V46, P235, DOI 10.1007/s002800000138; Ashour OM, 1996, BIOCHEM PHARMACOL, V51, P1601, DOI 10.1016/0006-2952(96)00102-5; BODNAR AG, 1995, BIOCHEM J, V305, P817, DOI 10.1042/bj3050817; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Fairfield KM, 1998, ARCH INTERN MED, V158, P2257, DOI 10.1001/archinte.158.20.2257; KEILBAUGH SA, 1993, MOL PHARMACOL, V44, P702; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; KYPSON J, 1978, J MOL CELL CARDIOL, V10, P545, DOI 10.1016/0022-2828(78)90013-5; LINKER W, 1985, EUR J CELL BIOL, V36, P176; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Setzer B, 2008, AM J PATHOL, V172, P681, DOI 10.2353/ajpath.2008.070613; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; SOMMADOSSI JP, 1988, ANTIMICROB AGENTS CH, V32, P997, DOI 10.1128/AAC.32.7.997; Sutinen J, 2007, ANTIVIR THER, V12, P97; VANGROENINGEN CJ, 1991, J NATL CANCER I, V83, P437; Venhoff N, 2005, AIDS, V19, P739, DOI 10.1097/01.aids.0000166101.44262.52; VONBORSTEL RW, 1989, Patent No. 8903837; Walker UA, 2006, ANTIVIR THER, V11, P25; Walker UA, 2003, ANTIVIR THER, V8, P463; Walker UA, 2004, AIDS, V18, P1085, DOI 10.1097/00002030-200404300-00025	21	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14709	10.1371/journal.pone.0014709	http://dx.doi.org/10.1371/journal.pone.0014709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379380	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482300010
J	Garcia, SP; Pinho, AJ; Rodrigues, JMOS; Bastos, CAC; Ferreira, PJSG				Garcia, Sara P.; Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.			Minimal Absent Words in Prokaryotic and Eukaryotic Genomes	PLOS ONE			English	Article								Minimal absent words have been computed in genomes of organisms from all domains of life. Here, we explore different sets of minimal absent words in the genomes of 22 organisms (one archaeota, thirteen bacteria and eight eukaryotes). We investigate if the mutational biases that may explain the deficit of the shortest absent words in vertebrates are also pervasive in other absent words, namely in minimal absent words, as well as to other organisms. We find that the compositional biases observed for the shortest absent words in vertebrates are not uniform throughout different sets of minimal absent words. We further investigate the hypothesis of the inheritance of minimal absent words through common ancestry from the similarity in dinucleotide relative abundances of different sets of minimal absent words, and find that this inheritance may be exclusive to vertebrates.	[Garcia, Sara P.; Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.] Univ Aveiro, IEETA, Signal Proc Lab, P-3800 Aveiro, Portugal; [Pinho, Armando J.; Rodrigues, Joao M. O. S.; Bastos, Carlos A. C.; Ferreira, Paulo J. S. G.] Univ Aveiro, Dept Elect Telecommun & Informat, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Garcia, SP (corresponding author), Univ Aveiro, IEETA, Signal Proc Lab, P-3800 Aveiro, Portugal.	spgarcia@ua.pt	Rodrigues, João/GVU-7735-2022; Pinho, Armando J/A-2309-2012; RODRIGUES, JOÃO/AAC-6993-2019; Rodrigues, João MOS/G-4821-2011	Rodrigues, João MOS/0000-0001-9187-8094; Garcia, Sara/0000-0003-3312-6454; Pinho, Armando/0000-0002-9164-0016; Bastos, Carlos/0000-0001-6869-4713; Ferreira, Paulo/0000-0002-5147-0948	Portuguese Foundation for Science and Technology; European Social Fund; Portuguese Ministry of Science, Technology and Higher Education	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund(European Social Fund (ESF)); Portuguese Ministry of Science, Technology and Higher Education	This work was supported by the Portuguese Foundation for Science and Technology. SPG acknowledges funding from the European Social Fund and the Portuguese Ministry of Science, Technology and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda MI, 2002, LECT NOTES COMPUT SC, V2452, P449; Acquisti C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001022; BRENDEL V, 1986, J BIOMOL STRUCT DYN, V4, P11, DOI 10.1080/07391102.1986.10507643; Burrows M., 1994, BLOCK SORTING LOSSLE; GENOME A, 2010, GENOMEATLASACCESSED, P15; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Gusfield D., 1997, ALGORITHMS STRINGS T; Hampikian G, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P355; Herold J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-167; KARLIN S, 1994, ANNU REV MICROBIOL, V48, P619, DOI 10.1146/annurev.mi.48.100194.003155; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; KARLIN S, 1995, TRENDS GENET, V11, P283; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; Karlin S, 1998, CURR OPIN MICROBIOL, V1, P598, DOI 10.1016/S1369-5274(98)80095-7; KASAI T, 2001, COMBINATORIAL PATTER, P182; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Margulies EH, 2008, GENOME RES, V18, P199, DOI 10.1101/gr.7228008; PIETROKOVSKI S, 1990, J BIOMOL STRUCT DYN, V7, P1251, DOI 10.1080/07391102.1990.10508563; Pinho AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-137; Simillion C, 2004, BIOESSAYS, V26, P1225, DOI 10.1002/bies.20127; SOKAL RR, 1958, U KANSAS SCI B, V38, P1409; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; GENOME ATLAS WEBSITE	24	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2011	6	1							e16065	10.1371/journal.pone.0016065	http://dx.doi.org/10.1371/journal.pone.0016065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UK	21386877	Green Published, Green Submitted, gold			2022-12-27	WOS:000286834300033
J	Huff, TB; Shi, YZ; Sun, WJ; Wu, W; Shi, RY; Cheng, JX				Huff, Terry B.; Shi, Yunzhou; Sun, Wenjing; Wu, Wei; Shi, Riyi; Cheng, Ji-Xin			Real-Time CARS Imaging Reveals a Calpain-Dependent Pathway for Paranodal Myelin Retraction during High-Frequency Stimulation	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; POTASSIUM CHANNELS; REPETITIVE PROPAGATION; PERIPHERAL NODES; EX-VIVO; SCATTERING; MECHANISMS; RANVIER; ACTIVATION; CONDUCTION	High-frequency electrical stimulation is becoming a promising therapy for neurological disorders, however the response of the central nervous system to stimulation remains poorly understood. The current work investigates the response of myelin to electrical stimulation by laser-scanning coherent anti-Stokes Raman scattering (CARS) imaging of myelin in live spinal tissues in real time. Paranodal myelin retraction at the nodes of Ranvier was observed during 200 Hz electrical stimulation. Retraction was seen to begin minutes after the onset of stimulation and continue for up to 10 min after stimulation was ceased, but was found to reverse after a 2 h recovery period. The myelin retraction resulted in exposure of Kv 1.2 potassium channels visualized by immunofluorescence. Accordingly, treating the stimulated tissue with a potassium channel blocker, 4-aminopyridine, led to the appearance of a shoulder peak in the compound action potential curve. Label- free CARS imaging of myelin coupled with multiphoton fluorescence imaging of immuno- labeled proteins at the nodes of Ranvier revealed that high-frequency stimulation induced paranodal myelin retraction via pathologic calcium influx into axons, calpain activation, and cytoskeleton degradation through spectrin break- down.	[Huff, Terry B.; Cheng, Ji-Xin] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Shi, Yunzhou; Wu, Wei; Shi, Riyi; Cheng, Ji-Xin] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Sun, Wenjing; Shi, Riyi] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huff, TB (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	jcheng@purdue.edu	Wu, Wei/M-9220-2014; Shi, Yunzhou/C-7500-2013	Wu, Wei/0000-0002-7835-4963; 	National Institute of Biomedical Imaging and Bioengineering (NIBIB) [EB007243]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007243] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work is supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) R01 grant EB007243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bel S, 1991, Acta Neurochir Suppl (Wien), V52, P121; BOWE CM, 1985, PROC R SOC SER B-BIO, V224, P355, DOI 10.1098/rspb.1985.0037; Breit S, 2004, CELL TISSUE RES, V318, P275, DOI 10.1007/s00441-004-0936-0; Cheng JX, 2007, APPL SPECTROSC, V61, p197A, DOI 10.1366/000370207781746044; Cheng JX, 2004, J PHYS CHEM B, V108, P827, DOI 10.1021/jp035693v; CHIU SY, 1980, NATURE, V284, P170, DOI 10.1038/284170a0; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Fu Y, 2007, J NEUROSCI RES, V85, P2870, DOI 10.1002/jnr.21403; Fu Y, 2007, BIOPHYS J, V92, P3251, DOI 10.1529/biophysj.106.089011; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Fu Y, 2008, OPT EXPRESS, V16, P19396, DOI 10.1364/OE.16.019396; Gollan L, 2002, J CELL BIOL, V157, P1247, DOI 10.1083/jcb.200203050; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Henry FP, 2009, PLAST RECONSTR SURG, V123, p123S, DOI 10.1097/PRS.0b013e318191c5b8; HILDEBRAND C, 1978, J NEUROL SCI, V38, P421, DOI 10.1016/0022-510X(78)90147-8; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Kemler MA, 2000, NEW ENGL J MED, V343, P618, DOI 10.1056/NEJM200008313430904; Kupsch A, 2003, J NEUROL, V250, P47, DOI 10.1007/s00415-003-1110-2; LEVRAM V, 1995, J NEUROSCI, V15, P2628; Li L, 2008, J PHYS CHEM B, V112, P1576, DOI 10.1021/jp711527v; Li SX, 2000, J NEUROSCI, V20, P1190, DOI 10.1523/JNEUROSCI.20-03-01190.2000; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P1239, DOI 10.1016/j.clinph.2003.12.024; Mertz J, 2004, CURR OPIN NEUROBIOL, V14, P610, DOI 10.1016/j.conb.2004.08.013; Micu I, 2007, NAT MED, V13, P874, DOI 10.1038/nm1568; MORAN O, 1983, NATURE, V304, P344, DOI 10.1038/304344a0; Muller M, 2007, CHEMPHYSCHEM, V8, P2156, DOI 10.1002/cphc.200700202; Nan XL, 2003, J LIPID RES, V44, P2202, DOI 10.1194/jlr.D300022-JLR200; Oakley JC, 2002, SPINE, V27, P2574, DOI 10.1097/00007632-200211150-00034; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; PADRON R, 1982, BIOPHYS J, V39, P183, DOI 10.1016/S0006-3495(82)84506-2; Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Potma EO, 2003, J RAMAN SPECTROSC, V34, P642, DOI 10.1002/jrs.1045; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; SCHOONHOVEN R, 1991, CRIT REV BIOMED ENG, V19, P47; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Shi RY, 1999, J NEUROTRAUM, V16, P727, DOI 10.1089/neu.1999.16.727; Shi RY, 1997, EXP NEUROL, V148, P495, DOI 10.1006/exnr.1997.6706; Stys PK, 2004, CURR MOL MED, V4, P113, DOI 10.2174/1566524043479220; Sun WJ, 2010, J NEUROPHYSIOL, V103, P469, DOI 10.1152/jn.00154.2009; SWADLOW HA, 1978, PHYSL PATHOBIOLOGY A; Wang HF, 2005, BIOPHYS J, V89, P581, DOI 10.1529/biophysj.105.061911; WAXMAN SG, 1991, TRENDS NEUROSCI, V14, P461, DOI 10.1016/0166-2236(91)90046-W; Waxman SG, 1995, AXON STRUCTURE FUNCT; WURTZ CC, 1988, EXP NEUROL, V101, P87, DOI 10.1016/0014-4886(88)90067-2; WURTZ CC, 1986, J NEUROSCI, V6, P3133; ZAGOREN JC, 1982, BRAIN RES, V242, P27, DOI 10.1016/0006-8993(82)90492-9; Zhang CL, 2006, J NEUROPHYSIOL, V96, P695, DOI 10.1152/jn.00083.2006; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	51	39	59	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17176	10.1371/journal.pone.0017176	http://dx.doi.org/10.1371/journal.pone.0017176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390223	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200011
J	Hector, A; Bell, T; Hautier, Y; Isbell, F; Kery, M; Reich, PB; van Ruijven, J; Schmid, B				Hector, Andy; Bell, Thomas; Hautier, Yann; Isbell, Forest; Kery, Marc; Reich, Peter B.; van Ruijven, Jasper; Schmid, Bernhard			BUGS in the Analysis of Biodiversity Experiments: Species Richness and Composition Are of Similar Importance for Grassland Productivity	PLOS ONE			English	Article							PLANT DIVERSITY; ECOLOGICAL APPLICATIONS; FUNCTIONAL DIVERSITY; BAYESIAN-INFERENCE; ECOSYSTEM FUNCTION; ELEVATED CO2; VARIANCE; COMMUNITIES; STATISTICS; WINBUGS	The idea that species diversity can influence ecosystem functioning has been controversial and its importance relative to compositional effects hotly debated. Unfortunately, assessing the relative importance of different explanatory variables in complex linear models is not simple. In this paper we assess the relative importance of species richness and species composition in a multilevel model analysis of net aboveground biomass production in grassland biodiversity experiments by estimating variance components for all explanatory variables. We compare the variance components using a recently introduced graphical Bayesian ANOVA. We show that while the use of test statistics and the R-2 gives contradictory assessments, the variance components analysis reveals that species richness and composition are of roughly similar importance for primary productivity in grassland biodiversity experiments.	[Hector, Andy; Hautier, Yann; Kery, Marc; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Bell, Thomas] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Isbell, Forest] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Reich, Peter B.] Univ Minnesota, Dept Forest Resources, St Paul, MN USA; [van Ruijven, Jasper] Univ Wageningen & Res Ctr, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [Kery, Marc] Swiss Ornithol Inst, Ctr Populat Anal, Sempach, Switzerland	University of Zurich; University of Oxford; McGill University; University of Minnesota System; University of Minnesota Twin Cities; Wageningen University & Research; Swiss Ornithological Institute	Hector, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	andrew.hector@uzh.ch	Schmid, Bernhard/C-8625-2009; van Ruijven, Jasper/D-9848-2011; van Ruijven, Jasper/ABE-7791-2020; Hautier, Yann/D-5426-2015; Isbell, Forest/C-6915-2012; Hector, Andrew/H-4199-2011; Hautier, Yann/I-2526-2019	Schmid, Bernhard/0000-0002-8430-3214; van Ruijven, Jasper/0000-0003-0003-2363; Hautier, Yann/0000-0003-4347-7741; Isbell, Forest/0000-0001-9689-769X; Hector, Andrew/0000-0002-1309-7716; Hautier, Yann/0000-0003-4347-7741; Reich, Peter/0000-0003-4424-662X; Bell, Thomas/0000-0002-2615-3932	Swiss SystemsX.ch initiative [IPP-2008/23]	Swiss SystemsX.ch initiative	This project was financed by the Swiss SystemsX.ch initiative, grant IPP-2008/23 (to Bernhard Schmid, Jasmin Joshi and Prasenjit Saha). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, MIXED EFFECTS MODELS; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BELL T, 2009, AM NATURALIST, V174; BOLKER BM, 2009, TRENDS ECOLOGY EVOLU; Bruno JF, 2008, FRONT ECOL ENVIRON, V6, P539, DOI 10.1890/070136; Bunker D.E., 2009, BIODIVERSITY ECOSYST; CARDINALE BJ, 2011, AM J BOT IN PRESS; CLARK JS, 2001, DESIGN ANAL ECOLOGIC; Dennis B, 1996, ECOL APPL, V6, P1095, DOI 10.2307/2269594; Dixon P, 1996, ECOL APPL, V6, P1034, DOI 10.2307/2269587; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; EFRON B, 1986, AM STAT, V40, P11, DOI 10.2307/2683111; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Faraway JJ., 2005, EXTENDING LINEAR MOD; Galway N. W., 2006, INTRO MIXED MODELLIN; Gelman A, 2005, ANN STAT, V33, P1, DOI 10.1214/009053604000001048; Gelman Andrew, 2007, DATA ANAL USING MULT; GILKS WR, 1994, J R STAT SOC D-STAT, V43, P169, DOI DOI 10.2307/2348941; Graham MH, 2001, OIKOS, V93, P505, DOI 10.1034/j.1600-0706.2001.930317.x; GREEN BF, 1960, PSYCHOMETRIKA, V25, P127, DOI 10.1007/BF02288577; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; HECTOR A, 2009, BIODIVERSITY ECOSYST; Hector A, 2010, J ANIM ECOL, V79, P308, DOI 10.1111/j.1365-2656.2009.01634.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; ISBELL FI, OECOLOGIA IN PRESS; Kery M., 2010, INTRO WINBUGS ECOLOG; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MAINDONALD J, 2010, DATA ANAL GRAPHICS U; Moore DS, 1997, AM STAT, V51, P254, DOI 10.2307/2684897; NELDER JA, 1995, AM STAT, V49, P382, DOI 10.2307/2684580; NELDER JA, 1994, STAT COMPUT, V4, P221, DOI 10.1007/BF00156745; Newman JA, 1997, ECOLOGY, V78, P1312; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; Paul-Victor C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006917; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Qian SS, 2007, ECOLOGY, V88, P2489, DOI 10.1890/06-2041.1; Qian SS, 2010, ECOLOGY, V91, P355, DOI 10.1890/09-1043.1; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Core Team, 2020, R LANG ENV STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P10101, DOI 10.1073/pnas.0306602101; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; Robinson G.K., 1991, STAT SCI, P15, DOI DOI 10.1214/SS/1177011926; Roscher C, 2005, ECOL LETT, V8, P419, DOI 10.1111/j.1461-0248.2005.00736.x; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tilman D, 1997, OIKOS, V80, P185, DOI 10.2307/3546532; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Turnbull LA, 2006, BIOL LETT-UK, V2, P397, DOI 10.1098/rsbl.2006.0476; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; van Ruijven J, 2003, ECOL LETT, V6, P170, DOI 10.1046/j.1461-0248.2003.00427.x; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; van Ruijven J, 2007, OIKOS, V116, P1323, DOI [10.1111/j.2007.0030-1299.16005.x, 10.1111/j.0030-1299.2007.16005.x]; van Ruijven J, 2010, J ECOL, V98, P81, DOI 10.1111/j.1365-2745.2009.01603.x; Viketoft M, 2009, ECOLOGY, V90, P90, DOI 10.1890/08-0382.1; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; YATES F, 1967, P 5 BERK S MATH STAT, V4, P777	64	52	54	4	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17434	10.1371/journal.pone.0017434	http://dx.doi.org/10.1371/journal.pone.0017434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399688	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300024
J	van Hoek, AJ; Underwood, A; Jit, M; Miller, E; Edmunds, WJ				van Hoek, Albert Jan; Underwood, Anthony; Jit, Mark; Miller, Elizabeth; Edmunds, W. John			The Impact of Pandemic Influenza H1N1 on Health-Related Quality of Life: A Prospective Population-Based Study	PLOS ONE			English	Article							COST-EFFECTIVENESS; VACCINATION; OSELTAMIVIR; INFECTION; ENGLAND; UTILITY; ADULTS	Background: While the H1N1v influenza pandemic in 2009 was clinically mild, with a low case-fatality rate, the overall disease burden measured in quality-adjusted life years (QALY) lost has not been estimated. Such a measure would allow comparison with other diseases and assessment of the cost-effectiveness of pandemic control measures. Methods and Findings: Cases of H1N1v confirmed by polymerase chain reaction (PCR) and PCR negative cases with similar influenza-like illness (ILI controls) in 7 regions of England were sent two questionnaires, one within a week of symptom onset and one two weeks later, requesting information on duration of illness, work loss and antiviral use together with EQ-5D questionnaires. Results were compared with those for seasonal influenza from a systematic literature review. A total QALY loss for the 2009 pandemic in England was calculated based on the estimated total clinical cases and reported deaths. A total of 655 questionnaires were sent and 296 (45%) returned. Symptoms and average illness duration were similar between confirmed cases and ILI controls (8.8 days and 8.7 days respectively). Days off work were greater for cases than ILI controls (7.3 and 4.9 days respectively, p = 0.003). The quality-adjusted life days lost was 2.92 for confirmed cases and 2.74 for ILI controls, with a reduction in QALY loss after prompt use of antivirals in confirmed cases. The overall QALY loss in the pandemic was estimated at 28,126 QALYs (22,267 discounted) of which 40% was due to deaths (24% with discounting). Conclusion: Given the global public health significance of influenza, it is remarkable that no previous prospective study of the QALY loss of influenza using standardised and well validated methods has been performed. Although the QALY loss was minor for individual patients, the estimated total burden of influenza over the pandemic was substantial when compared to other infectious diseases.	[van Hoek, Albert Jan; Miller, Elizabeth; Edmunds, W. John] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Underwood, Anthony] Hlth Protect Agcy, Appl Lab & Bioinformat Unit, London, England; [Jit, Mark] Hlth Protect Agcy, Modelling & Econ Unit, London, England; [Edmunds, W. John] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; University of London; London School of Hygiene & Tropical Medicine	van Hoek, AJ (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	AlbertJan.vanHoek@hpa.org.uk	Jit, Mark/HDM-7797-2022	Underwood, Anthony/0000-0002-8547-4277; Jit, Mark/0000-0001-6658-8255	Health Protection Agency	Health Protection Agency	The study was funded by the Health Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, GUID METH TECHN APPR; BEVAN G, 2007, ESTIMATING HLTH PROD, P45; Brisson M, 2003, ARCH DIS CHILD, V88, P862, DOI 10.1136/adc.88.10.862; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Ellis J, 2009, EUROSURVEILLANCE, V14; Griffin AD, 2001, PHARMACOECONOMICS, V19, P293, DOI 10.2165/00019053-200119030-00007; Kind P, 1998, BMJ-BRIT MED J, V316, P736, DOI 10.1136/bmj.316.7133.736; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nishiura Hiroshi, 2010, Expert Rev Respir Med, V4, P329, DOI 10.1586/ers.10.24; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Pebody RG, 2010, EUROSURVEILLANCE, V15; Prosser Lisa A, 2005, Health Qual Life Outcomes, V3, P18, DOI 10.1186/1477-7525-3-18; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Rothberg MB, 2003, ANN INTERN MED, V139, P321, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00007; Sander B, 2006, PHARMACOECONOMICS, V24, P373, DOI 10.2165/00019053-200624040-00007; Sander B, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000256; Siddiqui MR, 2008, EMERG INFECT DIS, V14, P267, DOI 10.3201/eid1402.070478; Turner D, 2003, Health Technol Assess, V7, piii; VANHOEK A, 2009, RESPONSE GUEST EDITO; Wailoo AJ, 2008, VALUE HEALTH, V11, P160, DOI 10.1111/j.1524-4733.2007.00241.x; Wille N, 2010, QUAL LIFE RES, V19, P875, DOI 10.1007/s11136-010-9648-y	23	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17030	10.1371/journal.pone.0017030	http://dx.doi.org/10.1371/journal.pone.0017030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399678	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000287933300007
J	Hashimoto, K; Ishima, T				Hashimoto, Kenji; Ishima, Tamaki			Neurite Outgrowth Mediated by Translation Elongation Factor eEF1A1: A Target for Antiplatelet Agent Cilostazol	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; DOUBLE-BLIND; PC12 CELLS; STROKE; RECEPTORS; POTENTIATION; PREVENTION; INHIBITOR; DONEPEZIL; PLATELET	Cilostazol, a type-3 phosphodiesterase (PDE3) inhibitor, has become widely used as an antiplatelet drug worldwide. A recent second Cilostazol Stroke Prevention Study demonstrated that cilostazol is superior to aspirin for prevention of stroke after an ischemic stroke. However, its precise mechanisms of action remain to be determined. Here, we report that cilostazol, but not the PDE3 inhibitors cilostamide and milrinone, significantly potentiated nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells. Furthermore, specific inhibitors for the endoplasmic reticulum protein inositol 1,4,5-triphosphate (IP3) receptors and several common signaling pathways (PLC-gamma, PI3K, Akt, p38 MAPK, and c-Jun N-terminal kinase (JNK), and the Ras/Raf/ERK/MAPK) significantly blocked the potentiation of NGF-induced neurite outgrowth by cilostazol. Using a proteomics analysis, we identified that levels of eukaryotic translation elongation factor eEF1A1 protein were significantly increased by treatment with cilostazol, but not cilostamide, in PC12 cells. Moreover, the potentiating effects of cilostazol on NGF-induced neurite outgrowth were significantly antagonized by treatment with eEF1A1 RNAi, but not the negative control of eEF1A1. These findings suggest that eEF1A1 and several common cellular signaling pathways might play a role in the mechanism of cilostazol-induced neurite outgrowth. Therefore, agents that can increase the eEF1A1 protein may have therapeutic relevance in diverse conditions with altered neurite outgrowth.	[Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan	Chiba University	Hashimoto, K (corresponding author), Chiba Univ, Div Clin Neurosci, Ctr Forens Mental Hlth, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	Japan Society for the Promotion of Science, Japan	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Japan Society for the Promotion of Science, Japan (to K.H.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2009, AM J GERIAT PSYCHIAT, V17, P353, DOI 10.1097/JGP.0b013e31819431ea; Baba H, 2007, J CLIN PSYCHOPHARM, V27, P727, DOI 10.1097/JCP.0b013e31815a585e; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAPMAN T, 2003, DRUGS, V3, P117; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; FUJII DK, 1982, J NEUROSCI, V2, P1157; 갠지하시모토, 2010, Clinical Psychopharmacology and Neuroscience, V8, P26; 갠지하시모토, 2010, Clinical Psychopharmacology and Neuroscience, V8, P74; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gotoh F, 2000, J Stroke Cerebrovasc Dis, V9, P147, DOI 10.1053/jscd.2000.7216; Hankey GJ, 2008, LANCET NEUROL, V7, P469, DOI 10.1016/S1474-4422(08)70095-4; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Hashimoto K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015430; Hiatt WR, 2005, ATHEROSCLEROSIS SUPP, V6, P21, DOI 10.1016/j.atherosclerosissup.2005.09.004; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2; Iketani M, 2009, NEUROSCIENCE, V161, P743, DOI 10.1016/j.neuroscience.2009.04.019; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kwon SU, 2005, STROKE, V36, P782, DOI 10.1161/01.STR.0000157667.06542.b7; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Liao JK, 2007, CIRCULATION, V115, P1615, DOI 10.1161/CIRCULATIONAHA.106.653741; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Shinohara Y, 2008, CEREBROVASC DIS, V26, P63, DOI 10.1159/000135654; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; Sun B, 2007, CELL SIGNAL, V19, P1765, DOI 10.1016/j.cellsig.2007.03.012; Takahashi K, 2008, PHARMACOPSYCHIATRY, V41, P37, DOI 10.1055/s-2007-993208; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; Uchiyama S, 2009, J STROKE CEREBROVASC, V18, P482, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.010	41	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17431	10.1371/journal.pone.0017431	http://dx.doi.org/10.1371/journal.pone.0017431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390260	Green Published, Green Submitted, gold			2022-12-27	WOS:000287932100017
J	Delaune, A; Poupel, O; Mallet, A; Coic, YM; Msadek, T; Dubrac, S				Delaune, Aurelia; Poupel, Olivier; Mallet, Adeline; Coic, Yves-Marie; Msadek, Tarek; Dubrac, Sarah			Peptidoglycan Crosslinking Relaxation Plays an Important Role in Staphylococcus aureus WalKR-Dependent Cell Viability	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; L-ALANINE AMIDASE; BETA-N-ACETYLGLUCOSAMINIDASE; SIGNAL-TRANSDUCTION PATHWAY; STREPTOCOCCUS-PNEUMONIAE R6; YYCF RESPONSE REGULATOR; 2-COMPONENT SYSTEM; MOLECULAR CHARACTERIZATION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI	The WalKR two-component system is essential for viability of Staphylococcus aureus, a major pathogen. We have shown that WalKR acts as the master controller of peptidoglycan metabolism, yet none of the identified regulon genes explain its requirement for cell viability. Transmission electron micrographs revealed cell wall thickening and aberrant division septa in the absence of WalKR, suggesting its requirement may be linked to its role in coordinating cell wall metabolism and cell division. We therefore tested whether uncoupling autolysin gene expression from WalKR-dependent regulation could compensate for its essential nature. Uncoupled expression of genes encoding lytic transglycosylases or amidases did not restore growth to a WalKR-depleted strain. We identified only two WalKR-regulon genes whose expression restored cell viability in the absence of WalKR: lytM and ssaA. Neither of these two genes are essential under our conditions and a Delta lytM Delta ssaA mutant does not present any growth defect. LytM is a glycyl-glycyl endopeptidase, hydrolyzing the pentaglycine interpeptide crossbridge, and SsaA belongs to the CHAP amidase family, members of which such as LysK and LytA have been shown to have D-alanyl-glycyl endopeptidase activity, cleaving between the crossbridge and the stem peptide. Taken together, our results strongly suggest that peptidoglycan crosslinking relaxation through crossbridge hydrolysis plays a crucial role in the essential requirement of the WalKR system for cell viability.	[Delaune, Aurelia; Poupel, Olivier; Msadek, Tarek; Dubrac, Sarah] Inst Pasteur, Dept Microbiol, Paris, France; [Delaune, Aurelia; Poupel, Olivier; Msadek, Tarek; Dubrac, Sarah] CNRS, URA 2172, Paris, France; [Coic, Yves-Marie] Inst Pasteur, Dept Struct Biol & Chem, Paris, France; [Coic, Yves-Marie] CNRS, URA 2128, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Delaune, A (corresponding author), Inst Pasteur, Dept Microbiol, Paris, France.	tmsadek@pasteur.fr		Sarah, Dubrac/0000-0002-9810-5390	European Commission [LHSM-CT-2006-019064, LSHG-CT-2006-037469]; Centre National de la Recherche Scientifique [CNRS URA 2172]; Agence Nationale de la Recherche; Institut Pasteur (PTR) [256, 336]; Conseil Pasteur-Weizmann	European Commission(European CommissionEuropean Commission Joint Research Centre); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur (PTR); Conseil Pasteur-Weizmann	This work was supported by research funds from the European Commission (StaphDynamics [LHSM-CT-2006-019064] and BaSysBio [LSHG-CT-2006-037469] grants), the Centre National de la Recherche Scientifique (CNRS URA 2172), Agence Nationale de la Recherche (ANR GrabIron and NaBab) and the Institut Pasteur (PTR N degrees 256 and PTR N degrees 336). Aurelia Delaune received a Young Scientist Fellowship from the Conseil Pasteur-Weizmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Bateman A, 2003, TRENDS BIOCHEM SCI, V28, P234, DOI 10.1016/S0968-0004(03)00061-6; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bochtler M, 2004, PROTEIN SCI, V13, P854, DOI 10.1110/ps.03515704; Burian M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010040; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chastanet A, 2003, MOL MICROBIOL, V47, P1061, DOI 10.1046/j.1365-2958.2003.03355.x; Chastanet A, 2003, J BACTERIOL, V185, P683, DOI 10.1128/JB.185.2.683-687.2003; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Firczuk M, 2005, J MOL BIOL, V354, P578, DOI 10.1016/j.jmb.2005.09.082; FOSTER SJ, 1995, J BACTERIOL, V177, P5723, DOI 10.1128/jb.177.19.5723-5725.1995; Francius G, 2008, J BACTERIOL, V190, P7904, DOI 10.1128/JB.01116-08; Gardete S, 2006, ANTIMICROB AGENTS CH, V50, P3424, DOI 10.1128/AAC.00356-06; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; Gotoh Y, 2010, J ANTIBIOT, V63, P127, DOI 10.1038/ja.2010.4; Herbert S, 2007, PLOS PATHOG, V3, P981, DOI 10.1371/journal.ppat.0030102; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lang S, 2000, FEMS IMMUNOL MED MIC, V29, P213, DOI 10.1111/j.1574-695X.2000.tb01525.x; Layec S, 2008, J MOL MICROB BIOTECH, V14, P31, DOI 10.1159/000106080; Ling BD, 1998, ANTIMICROB AGENTS CH, V42, P936, DOI 10.1128/AAC.42.4.936; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; Martin PK, 2002, J BACTERIOL, V184, P5810, DOI 10.1128/JB.184.20.5810-5813.2002; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Okada A, 2010, J ANTIBIOT, V63, P89, DOI 10.1038/ja.2009.128; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Ramadurai L, 1997, J BACTERIOL, V179, P3625, DOI 10.1128/jb.179.11.3625-3631.1997; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; Rohrer S, 1999, P NATL ACAD SCI USA, V96, P9351, DOI 10.1073/pnas.96.16.9351; Sambrook J., 2002, MOL CLONING LAB MANU; SCHINDLER CA, 1964, P NATL ACAD SCI USA, V51, P414, DOI 10.1073/pnas.51.3.414; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Sieradzki K, 2003, J BACTERIOL, V185, P7103, DOI 10.1128/JB.185.24.7103-7110.2003; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUGAI M, 1995, J BACTERIOL, V177, P1491, DOI 10.1128/jb.177.6.1491-1496.1995; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Thumm G, 1997, MOL MICROBIOL, V23, P1251, DOI 10.1046/j.1365-2958.1997.2911657.x; Tschierske M, 1999, FEMS MICROBIOL LETT, V171, P97, DOI 10.1016/S0378-1097(98)00586-2; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yamada S, 1996, J BACTERIOL, V178, P1565, DOI 10.1128/jb.178.6.1565-1571.1996; Yokoi KJ, 2005, GENE, V351, P97, DOI 10.1016/j.gene.2005.03.006; ZOU Y, 2010, COMPUT BIOL CHEM	69	58	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17054	10.1371/journal.pone.0017054	http://dx.doi.org/10.1371/journal.pone.0017054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386961	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400026
J	Omer, H; Rose, G; Jolley, KA; Frapy, E; Zahar, JR; Maiden, MCJ; Bentley, SD; Tinsley, CR; Nassif, X; Bille, E				Omer, Helene; Rose, Graham; Jolley, Keith A.; Frapy, Eric; Zahar, Jean-Ralph; Maiden, Martin C. J.; Bentley, Stephen D.; Tinsley, Colin R.; Nassif, Xavier; Bille, Emmanuelle			Genotypic and Phenotypic Modifications of Neisseria meningitidis after an Accidental Human Passage	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ACQUIRED MENINGOCOCCAL DISEASE; PHASE-VARIABLE GENES; CAPSULE NULL LOCUS; ANTIGENIC VARIATION; PATHOGENIC NEISSERIA; SERUM RESISTANCE; VIRULENCE GENES; HUMAN IMMUNITY; STRAIN MC58	A scientist in our laboratory was accidentally infected while working with Z5463, a Neisseria meningitidis serogroup A strain. She developed severe symptoms (fever, meningism, purpuric lesions) that fortunately evolved with antibiotic treatment to complete recovery. Pulse-field gel electrophoresis confirmed that the isolate obtained from the blood culture (Z5463BC) was identical to Z5463, more precisely to a fourth subculture of this strain used the week before the contamination (Z5463PI). In order to get some insights into genomic modifications that can occur in vivo, we sequenced these three isolates. All the strains contained a mutated mutS allele and therefore displayed an hypermutator phenotype, consistent with the high number of mutations (SNP, Single Nucleotide Polymorphism) detected in the three strains. By comparing the number of SNP in all three isolates and knowing the number of passages between Z5463 and Z5463PI, we concluded that around 25 bacterial divisions occurred in the human body. As expected, the in vivo passage is responsible for several modifications of phase variable genes. This genomic study has been completed by transcriptomic and phenotypic studies, showing that the blood strain used a different haemoglobin-linked iron receptor (HpuA/B) than the parental strains (HmbR). Different pilin variants were found after the in vivo passage, which expressed different properties of adhesion. Furthermore the deletion of one gene involved in LOS biosynthesis (lgtB) results in Z5463BC expressing a different LOS than the L9 immunotype of Z2491. The in vivo passage, despite the small numbers of divisions, permits the selection of numerous genomic modifications that may account for the high capacity of the strain to disseminate.	[Omer, Helene; Frapy, Eric; Zahar, Jean-Ralph; Nassif, Xavier; Bille, Emmanuelle] INSERM, U1002, Paris, France; [Omer, Helene; Frapy, Eric; Nassif, Xavier; Bille, Emmanuelle] Univ Paris 05, Fac Med Necker Enfants Malades, Paris, France; [Rose, Graham; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge, England; [Jolley, Keith A.; Maiden, Martin C. J.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Zahar, Jean-Ralph; Nassif, Xavier; Bille, Emmanuelle] Hop Necker Enfants Malad, AP HP, Microbiol Lab, Paris, France; [Tinsley, Colin R.] INRA AGROPARITECH, UMR Micalis 1319, Thiverval Grignon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Wellcome Trust Sanger Institute; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Omer, H (corresponding author), INSERM, U1002, Paris, France.	xavier.nassif@inserm.fr	Maiden, Martin/N-6805-2019; Jolley, Keith/ABE-8587-2020; Maiden, Martin C J/C-5055-2014	Maiden, Martin/0000-0001-6321-5138; Jolley, Keith/0000-0002-0751-0287; Maiden, Martin C J/0000-0001-6321-5138; Rose, Graham/0000-0002-5097-5426; Nassif, Xavier/0000-0003-2855-3240; /0000-0001-9172-0510; Eric, FRAPY/0000-0002-2958-6960	Fondation pour la Recherche Medicale	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by a grant from the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1988, J EXP MED, V168, P507, DOI 10.1084/jem.168.2.507; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Athlin S, 2007, SCAND J INFECT DIS, V39, P911, DOI 10.1080/00365540701367827; Bentley SD, 2007, PLOS GENET, V3, P230, DOI 10.1371/journal.pgen.0030023; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Bille E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003885; Boutet R, 2001, J HOSP INFECT, V49, P282, DOI 10.1053/jhin.2001.1084; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; *CDC, 1991, MMWR-MORBID MORTAL W, V40, P46; Centers for Disease Control and Prevention (CDC), 2002, MMWR-MORBID MORTAL W, V51, P141; Choudhury B, 2008, CARBOHYD RES, V343, P2971, DOI 10.1016/j.carres.2008.08.026; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Delany I, 2004, MOL MICROBIOL, V52, P1081, DOI 10.1111/j.1365-2958.2004.04030.x; DENSEN P, 1989, CLIN MICROBIOL REV, V2, pS11, DOI 10.1128/CMR.2.Suppl.S11-S17.1989; Findlow H, 2007, J INFECT DIS, V195, P1071, DOI 10.1086/512084; Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303; GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327; GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367; GUIBOURDENCHE M, 1994, J CLIN MICROBIOL, V32, P701, DOI 10.1128/JCM.32.3.701-704.1994; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; HAGBLOM P, 1985, NATURE, V315, P156, DOI 10.1038/315156a0; Hoang LMN, 2005, CLIN INFECT DIS, V40, pE38, DOI 10.1086/427875; Johnson CR, 2001, MOL MICROBIOL, V39, P1345, DOI 10.1111/j.1365-2958.2001.02324.x; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Kawai M, 2005, DNA RES, V12, P389, DOI 10.1093/dnares/dsi021; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Kessler AT, 2007, J OCCUP HEALTH, V49, P399, DOI 10.1539/joh.49.399; Krizova P, 1997, Cent Eur J Public Health, V5, P214; LEGRAIN M, 1993, GENE, V130, P73, DOI 10.1016/0378-1119(93)90348-7; LEWIS LA, 1995, J BACTERIOL, V177, P1299, DOI 10.1128/jb.177.5.1299-1306.1995; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; LEWIS LA, 1027, PLOS PATHOG, V6; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marceau M, 1998, MOL MICROBIOL, V27, P705, DOI 10.1046/j.1365-2958.1998.00706.x; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Morelle S, 2005, MOL MICROBIOL, V55, P853, DOI 10.1111/j.1365-2958.2004.04426.x; NASSIF X, 1993, MOL MICROBIOL, V8, P719, DOI 10.1111/j.1365-2958.1993.tb01615.x; Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655; Pelicic V, 2000, J BACTERIOL, V182, P5391, DOI 10.1128/JB.182.19.5391-5398.2000; Perkins-Balding D, 2004, MICROBIOL MOL BIOL R, V68, P154, DOI 10.1128/MMBR.68.1.154-171.2004; Richardson AR, 2002, P NATL ACAD SCI USA, V99, P6103, DOI 10.1073/pnas.092568699; Richardson AR, 2001, MOL MICROBIOL, V40, P645, DOI 10.1046/j.1365-2958.2001.02408.x; ROUSSELJAZEDE V, INFECT IMMUN, V78, P3083; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Schoen C, 2008, P NATL ACAD SCI USA, V105, P3473, DOI 10.1073/pnas.0800151105; SCHRYVERS AB, 1988, MOL MICROBIOL, V2, P281, DOI 10.1111/j.1365-2958.1988.tb00029.x; SEIFERT HS, 1994, J CLIN INVEST, V93, P2744, DOI 10.1172/JCI117290; Sejvar JJ, 2005, J CLIN MICROBIOL, V43, P4811, DOI 10.1128/JCM.43.9.4811-4814.2005; Snyder LAS, 2001, MICROBIOL-SGM, V147, P2321, DOI 10.1099/00221287-147-8-2321; Snyder LAS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-128; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; TINSLEY CR, 1986, J GEN MICROBIOL, V132, P2483; Tonjum T, 1997, GENE, V192, P155, DOI 10.1016/S0378-1119(97)00018-8; Turner DPJ, 2002, INFECT IMMUN, V70, P4447, DOI 10.1128/IAI.70.8.4447-4461.2002; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; van Ulsen P, 2003, MOL MICROBIOL, V50, P1017, DOI 10.1046/j.1365-2958.2003.03773.x; Vogel U, 1999, MOL MICROBIOL, V32, P1133, DOI 10.1046/j.1365-2958.1999.01469.x; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Weynants V, 2009, INFECT IMMUN, V77, P2084, DOI 10.1128/IAI.01108-08; WHO, 1998, CONTR EP MEN DIS; Yazdankhah SP, 2004, J MED MICROBIOL, V53, P821, DOI 10.1099/jmm.0.45529-0; Zhu PX, 2006, MICROBIOL-SGM, V152, P123, DOI 10.1099/mic.0.28327-0	69	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17145	10.1371/journal.pone.0017145	http://dx.doi.org/10.1371/journal.pone.0017145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386889	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400033
J	Roddy, KA; Prendergast, PJ; Murphy, P				Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula			Mechanical Influences on Morphogenesis of the Knee Joint Revealed through Morphological, Molecular and Computational Analysis of Immobilised Embryos	PLOS ONE			English	Article							ARTICULAR-CARTILAGE FORMATION; DEVELOPING APPENDICULAR SKELETON; CHONDROCYTE PRIMARY CILIUM; MESENCHYMAL STEM-CELLS; SYNOVIAL JOINT; BONE-GROWTH; LONG BONES; DISTRACTION OSTEOGENESIS; HYDROSTATIC-PRESSURE; DYNAMIC COMPRESSION	Very little is known about the regulation of morphogenesis in synovial joints. Mechanical forces generated from muscle contractions are required for normal development of several aspects of normal skeletogenesis. Here we show that biophysical stimuli generated by muscle contractions impact multiple events during chick knee joint morphogenesis influencing differential growth of the skeletal rudiment epiphyses and patterning of the emerging tissues in the joint interzone. Immobilisation of chick embryos was achieved through treatment with the neuromuscular blocking agent Decamethonium Bromide. The effects on development of the knee joint were examined using a combination of computational modelling to predict alterations in biophysical stimuli, detailed morphometric analysis of 3D digital representations, cell proliferation assays and in situ hybridisation to examine the expression of a selected panel of genes known to regulate joint development. This work revealed the precise changes to shape, particularly in the distal femur, that occur in an altered mechanical environment, corresponding to predicted changes in the spatial and dynamic patterns of mechanical stimuli and region specific changes in cell proliferation rates. In addition, we show altered patterning of the emerging tissues of the joint interzone with the loss of clearly defined and organised cell territories revealed by loss of characteristic interzone gene expression and abnormal expression of cartilage markers. This work shows that local dynamic patterns of biophysical stimuli generated from muscle contractions in the embryo act as a source of positional information guiding patterning and morphogenesis of the developing knee joint.	[Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Roddy, Karen A.; Prendergast, Patrick J.; Murphy, Paula] Trinity Coll Dublin, Sch Engn, Trinity Ctr Bioengn, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin	Roddy, KA (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland.	paula.murphy@tcd.ie		Murphy, Paula/0000-0002-8048-6850	Wellcome Trust [083539/Z/07/Z]; Science Foundation Ireland [02/IN1/B267]	Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a TCD Overhead Investment Plan (OIP) Interdiscipinary Award, Wellcome Trust project grant (083539/Z/07/Z) and Science Foundation Ireland (Programme Award 02/IN1/B267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Bastow ER, 2005, J BIOL CHEM, V280, P11749, DOI 10.1074/jbc.M414495200; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; BOHME K, 1995, EXP CELL RES, V216, P191, DOI 10.1006/excr.1995.1024; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604; Cillo JE, 2000, ORAL SURG ORAL MED O, V90, P147, DOI 10.1067/moe.2000.107531; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Davisson T, 2002, J ORTHOPAED RES, V20, P842, DOI 10.1016/S0736-0266(01)00160-7; Dickhut A, 2009, J CELL PHYSIOL, V219, P219, DOI 10.1002/jcp.21673; Dowthwaite GP, 2003, MATRIX BIOL, V22, P311, DOI 10.1016/S0945-053X(03)00037-4; Dowthwaite GP, 1999, MATRIX BIOL, V18, P523, DOI 10.1016/S0945-053X(99)00044-X; Dowthwaite GP, 1998, J HISTOCHEM CYTOCHEM, V46, P641, DOI 10.1177/002215549804600509; DRACHMAN DB, 1966, DEV BIOL, V14, P401, DOI 10.1016/0012-1606(66)90022-4; Duprez D, 1996, MECH DEVELOP, V57, P145, DOI 10.1016/0925-4773(96)00540-0; Fell HB, 1934, PROC R SOC SER B-BIO, V116, P316, DOI 10.1098/rspb.1934.0076; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Fukuda K, 1997, J LAB CLIN MED, V130, P209, DOI 10.1016/S0022-2143(97)90098-6; Garciadiego-Cazares D, 2004, DEVELOPMENT, V131, P4735, DOI 10.1242/dev.01345; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Gomez C, 2007, J ANAT, V210, P259, DOI 10.1111/j.1469-7580.2007.00698.x; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HALL JG, 1986, AM J MED GENET, V25, P99, DOI 10.1002/ajmg.1320250112; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hamburger V., 1940, Physiological Zoology Chicago, V13, P367; Hammond E, 1995, Obstet Gynecol Surv, V50, P240, DOI 10.1097/00006254-199503000-00028; Hartmann C, 2001, CELL, V104, P341, DOI 10.1016/S0092-8674(01)00222-7; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Heegaard JH, 1999, J ORTHOPAED RES, V17, P509, DOI 10.1002/jor.1100170408; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; HOGG DA, 1992, COMP BIOCHEM PHYS A, V103, P25, DOI 10.1016/0300-9629(92)90237-K; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kanbe Katsuaki, 2006, Mod Rheumatol, V16, P131; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kavanagh E, 2006, DEV DYNAM, V235, P826, DOI 10.1002/dvdy.20679; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lamb KJ, 2003, INT J EXP PATHOL, V84, P55, DOI 10.1046/j.1365-2613.2003.00338.x; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lee HS, 2000, J BONE MINER RES, V15, P1501, DOI 10.1359/jbmr.2000.15.8.1501; LELKES G, 1958, J EMBRYOL EXP MORPH, V6, P183; Li CF, 2006, J BONE MINER RES, V21, P946, DOI 10.1359/JBMR.060309; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Lucchinetti E, 2004, CELL TISSUE RES, V315, P385, DOI 10.1007/s00441-003-0836-8; Macias D, 1997, DEVELOPMENT, V124, P1109; McGlashan SR, 2006, J HISTOCHEM CYTOCHEM, V54, P1005, DOI 10.1369/jhc.5A6866.2006; McMahon LA, 2008, J BIOMECH, V41, P2055, DOI 10.1016/j.jbiomech.2008.03.027; McMahon LA, 2008, ANN BIOMED ENG, V36, P185, DOI 10.1007/s10439-007-9416-5; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Mikic B, 2000, J ORTHOPAED RES, V18, P406, DOI 10.1002/jor.1100180312; Mikic B, 2000, J REHABIL RES DEV, V37, P127; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Minina E, 2001, DEVELOPMENT, V128, P4523; MITROVIC D, 1982, CELLS TISSUES ORGANS, V113, P313; MURRAY PDF, 1969, J EMBRYOL EXP MORPH, V22, P349; Murray PDF, 1930, ROUX ARCH DEV BIOL, V122, P629, DOI 10.1007/BF00573594; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nowlan NC, 2008, J BIOMECH, V41, P249, DOI 10.1016/j.jbiomech.2007.09.031; Nowlan NC, 2010, BIRTH DEFECTS RES C, V90, P203, DOI 10.1002/bdrc.20184; Nowlan NC, 2010, BONE, V46, P1275, DOI 10.1016/j.bone.2009.11.026; Nowlan NC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000250; Osborne A. C., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P448; PACIFICI M, 1993, DEV DYNAM, V198, P123, DOI 10.1002/aja.1001980206; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Pacifici Maurizio, 2005, Birth Defects Research, V75, P237, DOI 10.1002/bdrc.20050; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PERSSON M, 1983, J ANAT, V137, P591; PITSILLIDES AA, 1995, J HISTOCHEM CYTOCHEM, V43, P263, DOI 10.1177/43.3.7868856; Pitsillides AA, 2003, CELL BIOCHEM FUNCT, V21, P235, DOI 10.1002/cbf.1079; Poole CA, 1997, CELL BIOL INT, V21, P483, DOI 10.1006/cbir.1997.0177; Poole CA, 2001, J ANAT, V199, P393, DOI 10.1046/j.1469-7580.2001.19940393.x; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; REISER PJ, 1988, EXP NEUROL, V99, P59, DOI 10.1016/0014-4886(88)90127-6; Roddy KA, 2011, J BIOMECH, V44, P143, DOI 10.1016/j.jbiomech.2010.08.039; Roddy KA, 2009, J ANAT, V214, P374, DOI 10.1111/j.1469-7580.2008.01040.x; RODRIGUEZ JI, 1988, J BONE JOINT SURG AM, V70A, P1052, DOI 10.2106/00004623-198870070-00014; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rot-Nikcevic I, 2006, DEV GENES EVOL, V216, P1, DOI 10.1007/s00427-005-0024-9; RUANOGIL D, 1978, ACTA ANAT, V101, P36, DOI 10.1159/000144947; Sato M, 1999, J BONE MINER RES, V14, P1084, DOI 10.1359/jbmr.1999.14.7.1084; Shefelbine SJ, 2004, J ORTHOPAED RES, V22, P346, DOI 10.1016/j.orthres.2003.08.004; Shefelbine SJ, 2002, BONE, V30, P765, DOI 10.1016/S8756-3282(02)00700-7; Sironen RK, 2002, BBA-MOL CELL RES, V1591, P45, DOI 10.1016/S0167-4889(02)00247-1; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Spagnoli A, 2007, J CELL BIOL, V177, P1105, DOI 10.1083/jcb.200611031; Stevens SS, 1999, J ORTHOPAED RES, V17, P646, DOI 10.1002/jor.1100170505; SUMMERHURST K, 2008, GENE EXPR PATTERNS; Tanaka N, 2005, J DENT RES, V84, P64, DOI 10.1177/154405910508400111; THOROGOOD PV, 1983, CARTILAGE; Thorpe SD, 2008, BIOCHEM BIOPH RES CO, V377, P458, DOI 10.1016/j.bbrc.2008.09.154; Whitfield JF, 2008, CELL SIGNAL, V20, P1019, DOI 10.1016/j.cellsig.2007.12.001; Wilsman NJ, 1996, J ORTHOP RES, V14, P927, DOI 10.1002/jor.1100140613; WORTHAM RUBY A., 1960, JOUR MORPHOL, V106, P131, DOI 10.1002/jmor.1051060202; Wu QQ, 2000, EXP CELL RES, V256, P383, DOI 10.1006/excr.2000.4847; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	99	86	88	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17526	10.1371/journal.pone.0017526	http://dx.doi.org/10.1371/journal.pone.0017526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386908	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400084
J	Thiagarajan, RD; Georgas, KM; Rumballe, BA; Lesieur, E; Chiu, HS; Taylor, D; Tang, DTP; Grimmond, SM; Little, MH				Thiagarajan, Rathi D.; Georgas, Kylie M.; Rumballe, Bree A.; Lesieur, Emmanuelle; Chiu, Han Sheng; Taylor, Darrin; Tang, Dave T. P.; Grimmond, Sean M.; Little, Melissa H.			Identification of Anchor Genes during Kidney Development Defines Ontological Relationships, Molecular Subcompartments and Regulatory Pathways	PLOS ONE			English	Article							MICROARRAY ANALYSIS; EXPRESSION; NEPHRON; MESENCHYME; CELLS; PROLIFERATION; EPITHELIUM; REPAIR; MICE; SIX2	The development of the mammalian kidney is well conserved from mouse to man. Despite considerable temporal and spatial data on gene expression in mammalian kidney development, primarily in rodent species, there is a paucity of genes whose expression is absolutely specific to a given anatomical compartment and/or developmental stage, defined here as 'anchor' genes. We previously generated an atlas of gene expression in the developing mouse kidney using microarray analysis of anatomical compartments collected via laser capture microdissection. Here, this data is further analysed to identify anchor genes via stringent bioinformatic filtering followed by high resolution section in situ hybridisation performed on 200 transcripts selected as specific to one of 11 anatomical compartments within the midgestation mouse kidney. A total of 37 anchor genes were identified across 6 compartments with the early proximal tubule being the compartment richest in anchor genes. Analysis of minimal and evolutionarily conserved promoter regions of this set of 25 anchor genes identified enrichment of transcription factor binding sites for Hnf4a and Hnf1b, RbpJ (Notch signalling), PPAR gamma:RxRA and COUP-TF family transcription factors. This was reinforced by GO analyses which also identified these anchor genes as targets in processes including epithelial proliferation and proximal tubular function. As well as defining anchor genes, this large scale validation of gene expression identified a further 92 compartment-enriched genes able to subcompartmentalise key processes during murine renal organogenesis spatially or ontologically. This included a cohort of 13 ureteric epithelial genes revealing previously unappreciated compartmentalisation of the collecting duct system and a series of early tubule genes suggesting that segmentation into proximal tubule, loop of Henle and distal tubule does not occur until the onset of glomerular vascularisation. Overall, this study serves to illuminate previously ill-defined stages of patterning and will enable further refinement of the lineage relationships within mammalian kidney development.	[Thiagarajan, Rathi D.; Georgas, Kylie M.; Rumballe, Bree A.; Lesieur, Emmanuelle; Chiu, Han Sheng; Taylor, Darrin; Tang, Dave T. P.; Grimmond, Sean M.; Little, Melissa H.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Thiagarajan, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	S.Grimmond@imb.uq.edu.au; M.Little@imb.uq.edu.au	Little, Melissa H/A-6170-2010; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Tang, Dave/G-9670-2014	Little, Melissa H/0000-0003-0380-2263; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Tang, Dave/0000-0002-4790-9014	National Institutes of Health, USA [NIDDK DK070136]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070136] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institutes of Health, USA (NIDDK DK070136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Alcorn D, 1999, PEDIATR NEPHROL, V13, P347, DOI 10.1007/s004670050624; Ambrozewicz M, 2007, FASEB J, V21, pA901; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Caruana G, 2006, GENE EXPR PATTERNS, V6, P807, DOI 10.1016/j.modgep.2006.02.001; Challen G, 2005, PHYSIOL GENOMICS, V23, P159, DOI 10.1152/physiolgenomics.00043.2005; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Coffinier C, 1999, MECH DEVELOP, V89, P211, DOI 10.1016/S0925-4773(99)00221-X; D'Angelo A, 2010, DEVELOPMENT, V137, P1573, DOI 10.1242/dev.044420; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Falahatpisheh MH, 2003, ONCOGENE, V22, P2160, DOI 10.1038/sj.onc.1206238; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Ghate A, 2007, NEUROSCIENCE, V146, P1182, DOI 10.1016/j.neuroscience.2007.02.040; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; JACOBSON HR, 1981, AM J PHYSIOL, V241, pF203, DOI 10.1152/ajprenal.1981.241.3.F203; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Kanazawa T, 2009, ANAT HISTOL EMBRYOL, V38, P34, DOI 10.1111/j.1439-0264.2008.00889.x; Kanazawa T, 2010, DEV DYNAM, V239, P1145, DOI 10.1002/dvdy.22276; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Kisseleva Tatiana, 2008, Proc Am Thorac Soc, V5, P338, DOI 10.1513/pats.200711-168DR; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lee CK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r23; Leimeister C, 2003, GENE EXPR PATTERNS, V3, P595, DOI 10.1016/S1567-133X(03)00114-5; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; LITTLE M, 2010, KIDNEY DEV 2 TALES T, P193; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Little MH, 2006, J AM SOC NEPHROL, V17, P2390, DOI 10.1681/ASN.2006030218; Lucas B, 2005, ONCOGENE, V24, P6418, DOI 10.1038/sj.onc.1208794; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Maeda N, 2006, PLOS GENET, V2, P498, DOI 10.1371/journal.pgen.0020062; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; Menke AL, 2002, CANCER RES, V62, P6615; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Potter SS, 2007, GENESIS, V45, P432, DOI 10.1002/dvg.20309; Rae F, 2007, DEV BIOL, V308, P232, DOI 10.1016/j.ydbio.2007.05.027; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Rozen S, 2000, Methods Mol Biol, V132, P365; RUMBALLE B, 2008, CSH PROTOC, P5030; Rumballe B, 2010, PEDIATR NEPHROL, V25, P1005, DOI 10.1007/s00467-009-1392-6; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Schwab K, 2006, DEV BIOL, V293, P540, DOI 10.1016/j.ydbio.2006.02.023; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; SIMONE MRC, 2009, GASTROENTEROLOGY, V136; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Suh JM, 2006, MOL ENDOCRINOL, V20, P3412, DOI 10.1210/me.2006-0312; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wertz K, 1999, MECH DEVELOP, V84, P185, DOI 10.1016/S0925-4773(99)00074-X; Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698	62	56	57	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17286	10.1371/journal.pone.0017286	http://dx.doi.org/10.1371/journal.pone.0017286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386911	Green Published, gold			2022-12-27	WOS:000287931400049
J	Mikkelsen, SR; Long, JM; Zhang, L; Galemore, ER; VandeWoude, S; Dean, GA				Mikkelsen, S. Rochelle; Long, Julie M.; Zhang, Lin; Galemore, Erin R.; VandeWoude, Sue; Dean, Gregg A.			Partial Regulatory T Cell Depletion Prior to Acute Feline Immunodeficiency Virus Infection Does Not Alter Disease Pathogenesis	PLOS ONE			English	Article							LONG TERMINAL REPEAT; IN-VIVO DEPLETION; IMMUNE-RESPONSES; LISTERIA-MONOCYTOGENES; ANTI-CD25 ANTIBODY; LYMPHOID-TISSUES; DENDRITIC CELLS; FIV INFECTION; HIV-INFECTION; CD4(+)CD25(+)	Feline immunodeficiency virus (FIV) infection in cats follows a disease course similar to HIV-1, including a short acute phase characterized by high viremia, and a prolonged asymptomatic phase characterized by low viremia and generalized immune dysfunction. CD4(+)CD25(hi)FoxP3(+) immunosuppressive regulatory T (Treg) cells have been implicated as a possible cause of immune dysfunction during FIV and HIV-1 infection, as they are capable of modulating virus-specific and inflammatory immune responses. Additionally, the immunosuppressive capacity of feline Treg cells has been shown to be increased during FIV infection. We have previously shown that transient in vivo Treg cell depletion during asymptomatic FIV infection reveals FIV-specific immune responses suppressed by Treg cells. In this study, we sought to determine the immunological influence of Treg cells during acute FIV infection. We asked whether Treg cell depletion prior to infection with the highly pathogenic molecular clone FIV-C36 in cats could alter FIV pathogenesis. We report here that partial Treg cell depletion prior to FIV infection does not significantly change provirus, viremia, or CD4(+) T cell levels in blood and lymphoid tissues during the acute phase of disease. The effects of anti-CD25 mAb treatment are truncated in cats acutely infected with FIV-C36 as compared to chronically infected cats or FIV-naive cats, as Treg cell levels were heightened in all treatment groups included in the study within two weeks post-FIV infection. Our findings suggest that the influence of Treg cell suppression during FIV pathogenesis is most prominent after Treg cells are activated in the environment of established FIV infection.	[Mikkelsen, S. Rochelle; Long, Julie M.; Zhang, Lin; Galemore, Erin R.; Dean, Gregg A.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [VandeWoude, Sue] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of North Carolina; North Carolina State University; Colorado State University	Mikkelsen, SR (corresponding author), N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA.	gregg_dean@ncsu.edu	Dean, Gregg A/A-5623-2012	Dean, Gregg A/0000-0001-7025-9550; VandeWoude, Sue/0000-0001-9227-1622	National Institute of Allergy and Infectious Diseases [AI065223]; North Carolina State University [GM008776]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008776] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); North Carolina State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Public Health Service grant AI065223 from the National Institute of Allergy and Infectious Diseases (GAD). Rochelle Mikkelsen was supported by the Ruth L. Kirschstein National Research Service Awards grant GM008776 as a part of North Carolina State University's Biotechnology Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Ansari AA, 2007, J AUTOIMMUN, V28, P152, DOI 10.1016/j.jaut.2007.02.014; Antons AK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002952; Antunes I, 2008, IMMUNITY, V29, P782, DOI 10.1016/j.immuni.2008.09.016; Baker CAR, 2007, CLIN EXP IMMUNOL, V147, P533, DOI 10.1111/j.1365-2249.2006.03319.x; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Burkhard MJ, 2001, AIDS RES HUM RETROV, V17, P1767, DOI 10.1089/08892220152741469; Carrigan SO, 2009, IMMUNOBIOLOGY, V214, P211, DOI 10.1016/j.imbio.2008.07.027; Chuang CM, 2009, VACCINE, V27, P684, DOI 10.1016/j.vaccine.2008.11.042; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; Couper KN, 2007, J IMMUNOL, V178, P4136, DOI 10.4049/jimmunol.178.7.4136; Couper KN, 2009, J IMMUNOL, V182, P3985, DOI 10.4049/jimmunol.0803053; Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; de Parseval A, 2001, J VIROL, V75, P4528, DOI 10.1128/JVI.75.10.4528-4539.2001; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; de Rozieres Sohela, 2004, Retrovirology, V1, P38, DOI 10.1186/1742-4690-1-38; Dean GA, 1998, J VIROL, V72, P9436, DOI 10.1128/JVI.72.12.9436-9440.1998; Dean GA, 2004, VET IMMUNOL IMMUNOP, V100, P49, DOI 10.1016/j.vetimm.2004.03.001; Dunham RM, 2008, J IMMUNOL, V180, P5582, DOI 10.4049/jimmunol.180.8.5582; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; GOLOVINA TN, CANC J, V16, P342; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Holmes D, 2007, J BIOL CHEM, V282, P15973, DOI 10.1074/jbc.M702051200; Ji JX, 2009, INT IMMUNOL, V21, P283, DOI 10.1093/intimm/dxn146; Jiang Q, 2008, BLOOD, V112, P2858, DOI 10.1182/blood-2008-03-145946; Joshi A, 2005, VIROLOGY, V335, P212, DOI 10.1016/j.virol.2005.02.016; Joshi A, 2005, J VIROL, V79, P4965, DOI 10.1128/JVI.79.8.4965-4976.2005; Joshi A, 2004, VIROLOGY, V321, P307, DOI 10.1016/j.virol.2004.01.014; Kim B, 2008, VACCINE, V26, P5601, DOI 10.1016/j.vaccine.2008.07.099; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kinter AL, 2007, AIDS RES HUM RETROV, V23, P438, DOI 10.1089/aid.2006.0162; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; LANKFORD S, 2007, VET IMMUNOL IMMUNOPA; Macatangay BJC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009852; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; MEXAS AM, 2008, VET IMMUNOL IMMUNOPA; Mikkelsen SR, 2010, VIROLOGY, V403, P163, DOI 10.1016/j.virol.2010.04.016; Nishimura Y, 2004, J GEN VIROL, V85, P2585, DOI 10.1099/vir.0.80102-0; OHNO K, 1992, HYBRIDOMA, V11, P595, DOI 10.1089/hyb.1992.11.595; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Pedersen NC, 2001, VET IMMUNOL IMMUNOP, V79, P53, DOI 10.1016/S0165-2427(01)00252-5; Pereira LE, 2007, J VIROL, V81, P4445, DOI 10.1128/JVI.00026-07; Petty CS, 2008, JAIDS-J ACQ IMM DEF, V47, P148, DOI 10.1097/QAI.0b013e318160df70; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; REIMANN KA, 1994, J VIROL, V68, P2362, DOI 10.1128/JVI.68.4.2362-2370.1994; Ruby CE, 2009, J IMMUNOL, V183, P4853, DOI 10.4049/jimmunol.0901112; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Smithberg SR, 2008, J IMMUNOL METHODS, V329, P81, DOI 10.1016/j.jim.2007.09.015; SONG WR, 1992, J VIROL, V66, P5409, DOI 10.1128/JVI.66.9.5409-5417.1992; Staats HF, 1996, J IMMUNOL, V157, P462; Stevens R, 2005, VACCINE, V23, P1479, DOI 10.1016/j.vaccine.2004.09.033; Stevens R, 2004, J VIROL, V78, P8210, DOI 10.1128/JVI.78.15.8210-8218.2004; Tenorio AR, 2008, JAIDS-J ACQ IMM DEF, V48, P577, DOI 10.1097/QAI.0b013e31817bbea5; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; TOMPKINS MB, 1990, VET IMMUNOL IMMUNOP, V26, P305, DOI 10.1016/0165-2427(90)90115-9; Tompkins MB, 2002, J INFECT DIS, V185, P1077, DOI 10.1086/339847; Vahlenkamp TW, 2004, J IMMUNOL, V172, P4752, DOI 10.4049/jimmunol.172.8.4752; Viehl CT, 2006, ANN SURG ONCOL, V13, P1252, DOI 10.1245/s10434-006-9015-y; Walker LSK, 2009, IMMUNOLOGY, V126, P466, DOI 10.1111/j.1365-2567.2009.03053.x; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365; Woo JC, 1997, TISSUE ANTIGENS, V49, P244, DOI 10.1111/j.1399-0039.1997.tb02745.x; Zelinskyy G, 2007, J VIROL, V81, P11881, DOI 10.1128/JVI.01554-07; Zelinskyy G, 2009, BLOOD, V114, P3199, DOI 10.1182/blood-2009-03-208736	70	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17183	10.1371/journal.pone.0017183	http://dx.doi.org/10.1371/journal.pone.0017183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364928	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100033
J	Loset, GA; Roos, N; Bogen, B; Sandlie, I				Loset, Geir Age; Roos, Norbert; Bogen, Bjarne; Sandlie, Inger			Expanding the Versatility of Phage Display II: Improved Affinity Selection of Folded Domains on Protein VII and IX of the Filamentous Phage	PLOS ONE			English	Article							MINOR COAT PROTEIN; ESCHERICHIA-COLI; ANTIBODY LIBRARIES; FOREIGN PEPTIDES; LEADER PEPTIDASE; BACTERIOPHAGE; SIZE; EXPRESSION; COMPLEX; FORMAT	Background: Phage display is a leading technology for selection of binders with affinity for specific target molecules. Polypeptides are normally displayed as fusions to the major coat protein VIII (pVIII) or the minor coat protein III (pIII). Whereas pVIII display suffers from drawbacks such as heterogeneity in display levels and polypeptide fusion size limitations, toxicity and infection interference effects have been described for pIII display. Thus, display on other coat proteins such as pVII or pIX might be more attractive. Neither pVII nor pIX display have gained widespread use or been characterized in detail like pIII and pVIII display. Methodology/Principal Findings: Here we present a side-by-side comparison of display on pIII with display on pVII and pIX. Polypeptides of interest (POIs) are fused to pVII or pIX. The N-terminal periplasmic signal sequence, which is required for phage integration of pIII and pVIII and that has been added to pVII and pIX in earlier studies, is omitted altogether. Although the POI display level on pIII is higher than on pVII and pIX, affinity selection with pVII and pIX display libraries is shown to be particularly efficient. Conclusions/Significance: Display through pVII and/or pIX represent platforms with characteristics that differ from those of the pIII platform. We have explored this to increase the performance and expand the use of phage display. In the paper, we describe effective affinity selection of folded domains displayed on pVII or pIX. This makes both platforms more attractive alternatives to conventional pIII and pVIII display than they were before.	[Loset, Geir Age; Bogen, Bjarne; Sandlie, Inger] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Loset, Geir Age; Roos, Norbert; Sandlie, Inger] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Bogen, Bjarne] Univ Oslo, Inst Immunol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Loset, GA (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.	g.a.loset@imbv.uio.no; inger.sandlie@imbv.uio.no	Løset, Geir/I-6413-2015	Løset, Geir/0000-0002-5257-8571	Research Council of Norway [174796]	Research Council of Norway(Research Council of Norway)	GAL was supported by the Research Council of Norway grant 174796. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balass M, 1996, ANAL BIOCHEM, V243, P264, DOI 10.1006/abio.1996.0515; BOGEN B, 1990, EUR J IMMUNOL, V20, P2359, DOI 10.1002/eji.1830201030; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Bratkovic T, 2010, CELL MOL LIFE SCI, V67, P749, DOI 10.1007/s00018-009-0192-2; ENDEMANN H, 1995, J MOL BIOL, V250, P496, DOI 10.1006/jmbi.1995.0393; GAILUS V, 1994, EUR J BIOCHEM, V222, P927, DOI 10.1111/j.1432-1033.1994.tb18941.x; Gao CS, 1999, P NATL ACAD SCI USA, V96, P6025, DOI 10.1073/pnas.96.11.6025; Gao CS, 2002, P NATL ACAD SCI USA, V99, P12612, DOI 10.1073/pnas.192467999; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; IANNOLO G, 1995, J MOL BIOL, V248, P835, DOI 10.1006/jmbi.1995.0264; Jestin JL, 2001, RES MICROBIOL, V152, P187, DOI 10.1016/S0923-2508(01)01191-3; Karlsson F, 2003, J BACTERIOL, V185, P2628, DOI 10.1128/JB.185.8.2628-2634.2003; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; KRETZSCHMAR T, 1995, GENE, V155, P61, DOI 10.1016/0378-1119(94)00897-2; Kwasnikowski P, 2005, J IMMUNOL METHODS, V307, P135, DOI 10.1016/j.jim.2005.10.002; Loset GA, 2007, PROTEIN ENG DES SEL, V20, P461, DOI 10.1093/protein/gzm044; Loset GA, 2005, J IMMUNOL METHODS, V299, P47, DOI 10.1016/j.jim.2005.01.014; Loset GA, 2008, BIOTECHNIQUES, V44, P551, DOI 10.2144/000112724; MAKOWSKI L, 1993, GENE, V128, P5, DOI 10.1016/0378-1119(93)90146-T; Malik P, 1996, J MOL BIOL, V260, P9, DOI 10.1006/jmbi.1996.0378; Malik P, 1998, FEBS LETT, V436, P263, DOI 10.1016/S0014-5793(98)01140-5; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MARZEC CJ, 1983, BIOPHYS J, V42, P171, DOI 10.1016/S0006-3495(83)84383-5; MICHAELSEN TE, 1990, SCAND J IMMUNOL, V32, P517, DOI 10.1111/j.1365-3083.1990.tb03192.x; Oakley AJ, 1997, J MOL BIOL, V274, P84, DOI 10.1006/jmbi.1997.1364; Pavoni E, 2007, GENE, V391, P120, DOI 10.1016/j.gene.2006.12.009; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sambrook J, 2001, MOL CLONING LAB MANU; Scott N, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-97; SHEN LM, 1991, BIOCHEMISTRY-US, V30, P11775, DOI 10.1021/bi00115a006; Shi BZ, 2007, BIOTECHNIQUES, V42, P760, DOI 10.2144/000112461; Shi L, 2010, J MOL BIOL, V397, P385, DOI 10.1016/j.jmb.2010.01.034; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SIMONS GFM, 1981, P NATL ACAD SCI-BIOL, V78, P4194, DOI 10.1073/pnas.78.7.4194; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; TORNETTA M, 2010, J IMMUNOL METHODS; Weibel E.R, 1979, STEREOLOGICAL METHOD; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902	38	26	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17433	10.1371/journal.pone.0017433	http://dx.doi.org/10.1371/journal.pone.0017433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390283	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700055
J	Major, JM; Klonoff-Cohen, HS; Pierce, JP; Slymen, DJ; Saltzstein, SL; Macera, CA; Mercola, D; Kattan, MW				Major, Jacqueline M.; Klonoff-Cohen, Hillary S.; Pierce, John P.; Slymen, Donald J.; Saltzstein, Sidney L.; Macera, Caroline A.; Mercola, Dan; Kattan, Michael W.			Prostate Cancer Postoperative Nomogram Scores and Obesity	PLOS ONE			English	Article							BODY-MASS INDEX; RADICAL PROSTATECTOMY; YOUNG MEN; RECURRENCE; DISEASE; COHORT; SMOKING; TRENDS; RATES; GRADE	Purpose: Nomograms are tools used in clinical practice to predict cancer outcomes and to help make decisions regarding management of disease. Since its conception, utility of the prostate cancer nomogram has more than tripled. Limited information is available on the relation between the nomograms' predicted probabilities and obesity. The purpose of this study was to examine whether the predictions from a validated postoperative prostate cancer nomogram were associated with obesity. Methods: We carried out a cross-sectional analysis of 1220 patients who underwent radical prostatectomy (RP) in southern California from 2000 to 2008. Progression-free probabilities (PFPs) were ascertained from the 10-year Kattan postoperative nomogram. Multivariable logistic regression models estimated odds ratios (ORs) and 95% confidence intervals (CIs). Results: In the present study, aggressive prostate cancer (Gleason >= 7), but not advanced stage, was associated with obesity (p = 0.01). After adjusting for age, black race, family history of prostate cancer and current smoking, an inverse association was observed for 10-year progression-free predictions (OR = 0.50; 95% CI = 0.28-0.90) and positive associations were observed for preoperative PSA levels (OR = 1.23; 95% CI = 1.01-1.50) and Gleason >7 (OR = 1.45; 95% CI = 1.11-1.90). Conclusion: Obese RP patients were more likely to have lower PFP values than non-obese patients, suggesting a higher risk of experiencing prostate cancer progression. Identifying men with potentially higher risks due to obesity may improve disease prognosis and treatment decision-making.	[Major, Jacqueline M.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Major, Jacqueline M.; Klonoff-Cohen, Hillary S.; Pierce, John P.] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Klonoff-Cohen, Hillary S.; Pierce, John P.; Saltzstein, Sidney L.] UCSD Moores Canc Ctr, La Jolla, CA USA; [Slymen, Donald J.; Macera, Caroline A.] San Diego State Univ, Grad Sch Publ Hlth, Dept Epidemiol & Biostat, San Diego, CA 92182 USA; [Mercola, Dan] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA; [Kattan, Michael W.] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California Irvine; Cleveland Clinic Foundation	Major, JM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	jacqueline.major@nih.gov	FENTON, MIRIAM C/B-6430-2011; Kattan, Michael/AAF-9735-2021; mercola, dan/L-4182-2013	Kattan, Michael/0000-0002-3840-4161; mercola, dan/0000-0002-0281-9840; Pierce, John/0000-0002-0075-7471	UCI Strategic Partners for the Evaluation of Cancer Signatures for Prostate Cancer study [NCI U01CA114810]; NATIONAL CANCER INSTITUTE [P30CA062203, U01CA114810] Funding Source: NIH RePORTER	UCI Strategic Partners for the Evaluation of Cancer Signatures for Prostate Cancer study; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the UCI Strategic Partners for the Evaluation of Cancer Signatures for Prostate Cancer study (NCI U01CA114810). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	American Cancer Society, 2008, CANC FACTS FIG; Amling CL, 2005, CURR OPIN UROL, V15, P167, DOI 10.1097/01.mou.0000165550.94663.fb; Amling CL, 2004, J CLIN ONCOL, V22, P439, DOI 10.1200/JCO.2004.03.132; BLUMBERG JW, 2004, ASCO NEWS, V16, pS4; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chun FKH, 2007, EUR J CANCER, V43, P375, DOI 10.1016/j.ejca.2006.08.037; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Freedland SJ, 2004, J CLIN ONCOL, V22, P446, DOI 10.1200/JCO.2004.04.181; Greene F.L, 2002, AJCC CANC STAGING MA, pxiv; HSING AW, 1991, AM J EPIDEMIOL, V133, P437, DOI 10.1093/oxfordjournals.aje.a115910; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Keetch DW, 1996, J UROLOGY, V155, P1841, DOI 10.1016/S0022-5347(01)66024-5; Kotsis SV, 2002, J UROLOGY, V167, P1659, DOI 10.1016/S0022-5347(05)65173-7; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Loeb S, 2007, J UROLOGY, V177, P102, DOI 10.1016/j.juro.2006.08.097; MAFFEZZINI M, 2008, EUR UROL SWITZERLAND, P872; Mallah KN, 2005, CANCER-AM CANCER SOC, V103, P2030, DOI 10.1002/cncr.20991; MOTAMEDINIA P, 2008, UROLOGY; Newcomer LM, 1997, J UROLOGY, V158, P1427, DOI 10.1016/S0022-5347(01)64231-9; Paaskesen CE, 2008, SCAND J UROL NEPHROL, V42, P230, DOI 10.1080/00365590701777798; Putnam SD, 2000, ANN EPIDEMIOL, V10, P361, DOI 10.1016/S1047-2797(00)00057-0; Roberts WW, 2003, J UROLOGY, V169, P512, DOI 10.1016/S0022-5347(05)63945-6; Rodriguez C, 1997, AM J EPIDEMIOL, V145, P466, DOI 10.1093/oxfordjournals.aje.a009129; Rohrmann S, 2003, PROSTATE, V55, P140, DOI 10.1002/pros.10211; Siddiqui SA, 2006, CANCER-AM CANCER SOC, V107, P521, DOI 10.1002/cncr.22030; Stephenson AJ, 2005, J CLIN ONCOL, V23, P7005, DOI 10.1200/JCO.2005.01.867	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17382	10.1371/journal.pone.0017382	http://dx.doi.org/10.1371/journal.pone.0017382			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390220	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700050
J	Yang, SJ; Choi, JM; Chae, SW; Kim, WJ; Park, SE; Rhee, EJ; Lee, WY; Oh, KW; Park, SW; Kim, SW; Park, CY				Yang, Soo Jin; Choi, Jung Mook; Chae, Seoung Wan; Kim, Won Jun; Park, Se Eun; Rhee, Eun Jung; Lee, Won Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Park, Cheol-Young			Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats	PLOS ONE			English	Article							FATTY LIVER; PROTEIN-KINASE; NONALCOHOLIC STEATOHEPATITIS; MAMMALIAN SIRTUINS; LIPID-METABOLISM; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; THIAZOLIDINEDIONES; DISRUPTION; DISEASE	Background: Sirt6 has been implicated in the regulation of hepatic lipid metabolism and the development of hepatic steatosis. The aim of this study was to address the potential role of Sirt6 in the protective effects of rosiglitazone (RGZ) on hepatic steatosis. Methods: To investigate the effect of RGZ on hepatic steatosis, rats were treated with RGZ (4 mg.kg(-1).day(-1)) by stomach gavage for 6 weeks. The involvement of Sirt6 in the RGZ's regulation was evaluated by Sirt6 knockdown in AML12 mouse hepatocytes. Results: RGZ treatment ameliorated hepatic lipid accumulation and increased expression of Sirt6, peroxisome proliferator-activated receptor gamma coactivtor-1-alpha (Ppargc1a/PGC1-alpha) and Forkhead box O1 (Foxo1) in rat livers. AMP-activated protein kinase (AMPK) phosphorylation was also increased by RGZ, accompanied by alterations in phosphorylation of LKB1. Interestingly, in free fatty acid-treated cells, Sirt6 knockdown increased hepatocyte lipid accumulation measured as increased triglyceride contents (p = 0.035), suggesting that Sirt6 may be beneficial in reducing hepatic fat accumulation. In addition, Sirt6 knockdown abolished the effects of RGZ on hepatocyte fat accumulation, mRNA and protein expression of Ppargc1a/PGC1-alpha and Foxo1, and phosphorylation levels of LKB1 and AMPK, suggesting that Sirt6 is involved in RGZ-mediated metabolic effects. Conclusion: Our results demonstrate that RGZ significantly decreased hepatic lipid accumulation, and that this process appeared to be mediated by the activation of the Sirt6-AMPK pathway. We propose Sirt6 as a possible therapeutic target for hepatic steatosis.	[Yang, Soo Jin; Choi, Jung Mook] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea; [Chae, Seoung Wan] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Pathol, Seoul, South Korea; [Kim, Won Jun; Park, Se Eun; Rhee, Eun Jung; Lee, Won Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Park, Cheol-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Yang, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Diabet Res Inst, Seoul, South Korea.	cydoctor@chol.com	LEE, WON-YOUNG/C-7249-2018; Rhee, Eun-Jung/M-9294-2015; Park, Cheol-Young/C-6690-2018	LEE, WON-YOUNG/0000-0002-1082-7592; Rhee, Eun-Jung/0000-0002-6108-7758; Park, Cheol-Young/0000-0002-9415-9965; Yang, Soo Jin/0000-0001-7892-7648	Korea Institute of Medicine	Korea Institute of Medicine	This work was supported by a grant from the Korea Institute of Medicine (http://www.kiom.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2010, BASIC CLIN PHARMACOL, V107, P663, DOI 10.1111/j.1742-7843.2010.00553.x; Bajaj M, 2003, DIABETES, V52, P1364, DOI 10.2337/diabetes.52.6.1364; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kang JG, 2010, METABOLISM, V59, P46, DOI 10.1016/j.metabol.2009.07.004; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LeBrasseur NK, 2006, AM J PHYSIOL-ENDOC M, V291, pE175, DOI 10.1152/ajpendo.00453.2005; Liu QQ, 2010, FASEB J, V24, P4229, DOI 10.1096/fj.10-159723; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Promrat K, 2004, HEPATOLOGY, V39, P188, DOI 10.1002/hep.20012; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Rector RS, 2008, WORLD J GASTROENTERO, V14, P185, DOI 10.3748/wjg.14.185; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Samaha FF, 2006, ARTERIOSCL THROM VAS, V26, P624, DOI 10.1161/01.ATV.0000200136.56716.30; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yki-Jarvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031	41	55	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17057	10.1371/journal.pone.0017057	http://dx.doi.org/10.1371/journal.pone.0017057			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373642	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500029
J	Ziu, MT; Fletcher, L; Rana, S; Jimenez, DF; Digicaylioglu, M				Ziu, Mateo; Fletcher, Lauren; Rana, Shushan; Jimenez, David F.; Digicaylioglu, Murat			Temporal Differences in MicroRNA Expression Patterns in Astrocytes and Neurons after Ischemic Injury	PLOS ONE			English	Article							GROWTH-FACTOR-I; TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION; REAL-TIME; MICROARRAY ANALYSIS; MIRNA EXPRESSION; BRAIN-INJURY; HYPOXIA; PROLIFERATION; MECHANISMS	MicroRNAs (miRNAs) are small, non-protein-coding RNA molecules that modulate gene translation. Their expression is altered in many central nervous system (CNS) injuries suggesting a role in the cellular response to stress. Current studies in brain tissue have not yet described the cell-specific temporal miRNA expression patterns following ischemic injury. In this study, we analyzed the expression alterations of a set of miRNAs in neurons and astrocytes subjected to 60 minutes of ischemia and collected at different time-points following this injury. To mimic ischemic conditions and reperfusion in vitro, cortical primary neuronal and astrocytic cultures prepared from fetal rats were first placed in oxygen and glucose deprived (OGD) medium for 60 minutes, followed by their transfer into normoxic pre-conditioned medium. Total RNA was extracted at different time-points after the termination of the ischemic insult and the expression levels of miRNAs were measured. In neurons exposed to OGD, expression of miR-29b was upregulated 2-fold within 6 h and up to 4-fold at 24 h post-OGD, whereas induction of miR-21 was upregulated 2-fold after 24 h when compared to expression in neurons under normoxic conditions. In contrast, in astrocytes, miR-29b and miR-21 were upregulated only after 12 h. MiR-30b, 107, and 137 showed expression alteration in astrocytes, but not in neurons. Furthermore, we show that expression of miR-29b was significantly decreased in neurons exposed to Insulin-Like Growth Factor I (IGF-I), a well documented neuroprotectant in ischemic models. Our study indicates that miRNAs expression is altered in neurons and astrocytes after ischemic injury. Furthermore, we found that following OGD, specific miRNAs have unique cell-specific temporal expression patterns in CNS. Therefore the specific role of each miRNA in different intracellular processes in ischemic brain and the relevance of their temporal and spatial expression patterns warrant further investigation that may lead to novel strategies for therapeutic interventions.	[Ziu, Mateo; Fletcher, Lauren; Rana, Shushan; Jimenez, David F.; Digicaylioglu, Murat] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Ziu, MT (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA.	muratd@uthscsa.edu	Ziu, Mateo/AAR-4991-2020; Digicaylioglu, Murat H/D-3302-2009	Ziu, Mateo/0000-0002-3671-2638; Rana, Shushan/0000-0002-9298-1605	University of Texas Health Science Center San Antonio [130267]; Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas	University of Texas Health Science Center San Antonio; Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas	This work was supported in part by the University Research Council Grants Program at the University of Texas Health Science Center San Antonio (Grant 130267) and by the Department of Neurosurgery at the University of Texas Health Science Center at San Antonio, San Antonio, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasyeva EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-52; Alajajian BB, 2009, NEUROREPORT, V20, P579, DOI 10.1097/WNR.0b013e328329a41a; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Anderova M, 2011, J CEREBR BLOOD F MET, V31, P894, DOI 10.1038/jcbfm.2010.168; Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Babar IA, 2008, FUTURE ONCOL, V4, P289, DOI 10.2217/14796694.4.2.289; Barbato C, 2007, BRAIN RES, V1175, P17, DOI 10.1016/j.brainres.2007.07.088; Barbato C, 2008, MAMM GENOME, V19, P541, DOI 10.1007/s00335-008-9129-6; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Cannell IG, 2008, BIOCHEM SOC T, V36, P1224, DOI 10.1042/BST0361224; Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; CHRISTENSEN M, 2009, NEUROSCI LETT; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; COTTRELL JE, 1995, J NEUROSURG ANESTH, V7, P31, DOI 10.1097/00008506-199501000-00007; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; DICHTER MA, 1978, BRAIN RES, V149, P279, DOI 10.1016/0006-8993(78)90476-6; Digicaylioglu M, 2004, P NATL ACAD SCI USA, V101, P9855, DOI 10.1073/pnas.0403172101; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Duisters RF, 2009, CIRC RES, V104, P170, DOI 10.1161/CIRCRESAHA.108.182535; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fletcher L, 2009, J NEUROSURG, V111, P164, DOI 10.3171/2009.2.JNS081199; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Garzon R, 2009, BLOOD, V114, P5331, DOI 10.1182/blood-2009-03-211938; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guimbellot JS, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-15; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kawahigashi Yutaka, 2009, Journal of Nippon Medical School, V76, P188; Kooijman R, 2009, STROKE, V40, pE83, DOI 10.1161/STROKEAHA.108.528356; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, CELL CYCLE, V6, P1426; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; LIU DZ, 2009, J CEREB BLOOD FLOW M; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; LIU NK, 2009, EXP NEUROL; Liu XF, 2001, NEUROSCI LETT, V308, P91, DOI 10.1016/S0304-3940(01)01982-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XCM, 2004, J NEUROSCI RES, V77, P843, DOI 10.1002/jnr.20218; Malagelada C, 2004, STROKE, V35, P2396, DOI 10.1161/01.STR.0000141160.66818.24; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; NELSON PT, 2009, NEUROSCIENCE LETT; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Reger MA, 2008, NEUROLOGY, V70, P440, DOI 10.1212/01.WNL.0000265401.62434.36; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Trivedi S, 2009, INT J NEUROSCI, V119, P1995, DOI 10.1080/00207450903139788; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wang WX, 2008, BBA-GENE REGUL MECH, V1779, P749, DOI 10.1016/j.bbagrm.2008.01.005; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0; Zhang Z, 2009, CELL CYCLE, V8, P2756, DOI 10.4161/cc.8.17.9387	83	93	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14724	10.1371/journal.pone.0014724	http://dx.doi.org/10.1371/journal.pone.0014724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373187	Green Submitted, gold, Green Published			2022-12-27	WOS:000287657500008
J	Cui, H; Kohsaka, A; Waki, H; Bhuiyan, MER; Gouraud, SS; Maeda, M				Cui, He; Kohsaka, Akira; Waki, Hidefumi; Bhuiyan, Mohammad E. R.; Gouraud, Sabine S.; Maeda, Masanobu			Metabolic Cycles Are Linked to the Cardiovascular Diurnal Rhythm in Rats with Essential Hypertension	PLOS ONE			English	Article							PERIPHERAL CIRCADIAN CLOCKS; BLOOD-PRESSURE; GENE-EXPRESSION; MICE; ALPHA; MOUSE; LIVER; HEART; TRANSACTIVATION; RESPONSIVENESS	Background: The loss of diurnal rhythm in blood pressure (BP) is an important predictor of end-organ damage in hypertensive and diabetic patients. Recent evidence has suggested that two major physiological circadian rhythms, the metabolic and cardiovascular rhythms, are subject to regulation by overlapping molecular pathways, indicating that dysregulation of metabolic cycles could desynchronize the normal diurnal rhythm of BP with the daily light/dark cycle. However, little is known about the impact of changes in metabolic cycles on BP diurnal rhythm. Methodology/Principal Findings: To test the hypothesis that feeding-fasting cycles could affect the diurnal pattern of BP, we used spontaneously hypertensive rats (SHR) which develop essential hypertension with disrupted diurnal BP rhythms and examined whether abnormal BP rhythms in SHR were caused by alteration in the daily feeding rhythm. We found that SHR exhibit attenuated feeding rhythm which accompanies disrupted rhythms in metabolic gene expression not only in metabolic tissues but also in cardiovascular tissues. More importantly, the correction of abnormal feeding rhythms in SHR restored the daily BP rhythm and was accompanied by changes in the timing of expression of key circadian and metabolic genes in cardiovascular tissues. Conclusions/Significance: These results indicate that the metabolic cycle is an important determinant of the cardiovascular diurnal rhythm and that disrupted BP rhythms in hypertensive patients can be normalized by manipulating feeding cycles.	[Cui, He; Kohsaka, Akira; Waki, Hidefumi; Bhuiyan, Mohammad E. R.; Gouraud, Sabine S.; Maeda, Masanobu] Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan	Wakayama Medical University	Cui, H (corresponding author), Wakayama Med Univ, Sch Med, Dept Physiol, Wakayama, Japan.	kohsaka@wakayama-med.ac.jp	Gouraud, Sabine S. S/N-3395-2018	Gouraud, Sabine S. S/0000-0002-4917-0647; Waki, Hidefumi/0000-0002-4278-2077	Japan Society for the Promotion of Science [22590226, 20890198]; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mishima Kaiun Memorial Foundation; Suzuken Memorial Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Suzuken Memorial Foundation	This work was supported by Grants-in-Aid for Scientific Research (22590226) and for Young Scientists (20890198) from the Japan Society for the Promotion of Science. Additional support came from the Naito Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Mishima Kaiun Memorial Foundation, and the Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anan F, 2007, EUR J CLIN INVEST, V37, P709, DOI 10.1111/j.1365-2362.2007.01854.x; Anea CB, 2009, CIRCULATION, V119, P1510, DOI 10.1161/CIRCULATIONAHA.108.827477; Buijs RM, 2006, PROG BRAIN RES, V153, P341, DOI 10.1016/S0079-6123(06)53020-1; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Dobrzyn P, 2008, AM J PHYSIOL-ENDOC M, V294, pE357, DOI 10.1152/ajpendo.00471.2007; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Durgan DJ, 2010, CIRC RES, V106, P647, DOI 10.1161/CIRCRESAHA.109.209957; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Elmquist JK, 2001, PHYSIOL BEHAV, V74, P703, DOI 10.1016/S0031-9384(01)00613-8; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Goh BC, 2007, BIOCHEM BIOPH RES CO, V360, P828, DOI 10.1016/j.bbrc.2007.06.136; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lurbe E, 2002, NEW ENGL J MED, V347, P797, DOI 10.1056/NEJMoa013410; Masuki S, 2005, J PHYSIOL-LONDON, V566, P213, DOI 10.1113/jphysiol.2005.086728; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; MILLARCRAIG MW, 1978, LANCET, V1, P795; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; OBRIEN E, 1988, LANCET, V2, P397; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; Reilly DF, 2008, ARTERIOSCL THROM VAS, V28, P121, DOI 10.1161/ATVBAHA.107.152538; Reilly DF, 2007, ARTERIOSCL THROM VAS, V27, P1694, DOI 10.1161/ATVBAHA.107.144923; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rudic RD, 2005, CIRCULATION, V112, P2716, DOI 10.1161/CIRCULATIONAHA.105.568626; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Senador D, 2009, EXP PHYSIOL, V94, P648, DOI 10.1113/expphysiol.2008.046474; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Su W, 2008, AM J PHYSIOL-HEART C, V295, pH1634, DOI 10.1152/ajpheart.00257.2008; Swoap SJ, 2004, AM J PHYSIOL-REG I, V286, pR108, DOI 10.1152/ajpregu.00405.2003; VERDECCHIA P, 1990, CIRCULATION, V81, P528, DOI 10.1161/01.CIR.81.2.528; Vujovic N, 2008, AM J PHYSIOL-REG I, V295, pR355, DOI 10.1152/ajpregu.00498.2007; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wu T, 2008, GENE, V419, P27, DOI 10.1016/j.gene.2008.04.010; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	47	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17339	10.1371/journal.pone.0017339	http://dx.doi.org/10.1371/journal.pone.0017339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364960	Green Submitted, gold, Green Published			2022-12-27	WOS:000287656600041
J	Stockel, J; Jacobs, JM; Elvitigala, TR; Liberton, M; Welsh, EA; Polpitiya, AD; Gritsenko, MA; Nicora, CD; Koppenaal, DW; Smith, RD; Pakrasi, HB				Stoeckel, Jana; Jacobs, Jon M.; Elvitigala, Thanura R.; Liberton, Michelle; Welsh, Eric A.; Polpitiya, Ashoka D.; Gritsenko, Marina A.; Nicora, Carrie D.; Koppenaal, David W.; Smith, Richard D.; Pakrasi, Himadri B.			Diurnal Rhythms Result in Significant Changes in the Cellular Protein Complement in the Cyanobacterium Cyanothece 51142	PLOS ONE			English	Article							LIGHT-INDUCIBLE POLYPEPTIDES; SP PCC 6803; DIAZOTROPHIC CYANOBACTERIUM; SYNECHOCYSTIS PCC6803; PROTEOMIC ANALYSIS; NITROGEN-FIXATION; MASS-SPECTROMETRY; OXYGEN EVOLUTION; PHOTOSYSTEM-I; METABOLISM	Cyanothece sp. ATCC 51142 is a diazotrophic cyanobacterium notable for its ability to perform oxygenic photosynthesis and dinitrogen fixation in the same single cell. Previous transcriptional analysis revealed that the existence of these incompatible cellular processes largely depends on tightly synchronized expression programs involving similar to 30% of genes in the genome. To expand upon current knowledge, we have utilized sensitive proteomic approaches to examine the impact of diurnal rhythms on the protein complement in Cyanothece 51142. We found that 250 proteins accounting for similar to 5% of the predicted ORFs from the Cyanothece 51142 genome and 20% of proteins detected under alternating light/dark conditions exhibited periodic oscillations in their abundances. Our results suggest that altered enzyme activities at different phases during the diurnal cycle can be attributed to changes in the abundance of related proteins and key compounds. The integration of global proteomics and transcriptomic data further revealed that post-transcriptional events are important for temporal regulation of processes such as photosynthesis in Cyanothece 51142. This analysis is the first comprehensive report on global quantitative proteomics in a unicellular diazotrophic cyanobacterium and uncovers novel findings about diurnal rhythms.	[Stoeckel, Jana; Elvitigala, Thanura R.; Liberton, Michelle; Welsh, Eric A.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Jacobs, Jon M.; Gritsenko, Marina A.; Nicora, Carrie D.; Koppenaal, David W.; Smith, Richard D.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Polpitiya, Ashoka D.] Ctr Prote Translat Genom Res Inst, Phoenix, AZ USA	Washington University (WUSTL); United States Department of Energy (DOE); Pacific Northwest National Laboratory; Translational Genomics Research Institute	Stockel, J (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	pakrasi@wustl.edu	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	US Department of Energy (DOE) [DE-AC05-76RL01830]; U.S. Department of Energy	US Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	This project was funded by he US Department of Energy (DOE, # DE-AC05-76RL01830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all members of the Pakrasi Lab for collegial discussions. This work is part of a Membrane Biology Scientific Grand Challenge project at the W. R. Wiley Environmental Molecular Science Laboratory, a national scientific user facility sponsored by the U.S. Department of Energy's Office of Biological and Environmental Research program (Pacific Northwest National Laboratory).	Akimoto H, 2004, BIOCHEM BIOPH RES CO, V315, P306, DOI 10.1016/j.bbrc.2004.01.054; Ashby MK, 1999, FEMS MICROBIOL LETT, V181, P253, DOI 10.1016/S0378-1097(99)00547-9; Berman-Frank I, 2003, RES MICROBIOL, V154, P157, DOI 10.1016/S0923-2508(03)00029-9; Bricker TM, 2004, J BACTERIOL, V186, P8144, DOI 10.1128/JB.186.23.8144-8148.2004; Colon-Lopez MS, 1998, J BACTERIOL, V180, P519; Cooley JW, 2000, J BACTERIOL, V182, P714, DOI 10.1128/JB.182.3.714-722.2000; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Elvitigala T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-226; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Garcia-Dominguez M, 2000, J BACTERIOL, V182, P38, DOI 10.1128/JB.182.1.38-44.2000; Havaux M, 2003, BBA-BIOENERGETICS, V1557, P21, DOI 10.1016/S0005-2728(02)00391-2; He QF, 2001, J BIOL CHEM, V276, P306, DOI 10.1074/jbc.M008686200; Jacobs JM, 2005, J VIROL, V79, P7558, DOI 10.1128/JVI.79.12.7558-7569.2005; Jacobs JM, 2004, J PROTEOME RES, V3, P68, DOI 10.1021/pr034062a; Kappell AD, 2007, ARCH MICROBIOL, V187, P337, DOI 10.1007/s00203-007-0213-1; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Liu T, 2004, ANAL CHEM, V76, P5345, DOI 10.1021/ac049485q; Maillet I, 2007, PROTEOMICS, V7, P1097, DOI 10.1002/pmic.200600599; Meunier PC, 1997, PLANT PHYSIOL, V115, P991, DOI 10.1104/pp.115.3.991; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Muramatsu M, 2009, MICROBIOL-SGM, V155, P989, DOI 10.1099/mic.0.024018-0; Nishimura T, 2008, MOL MICROBIOL, V68, P98, DOI 10.1111/j.1365-2958.2008.06137.x; Qian WJ, 2005, MOL CELL PROTEOMICS, V4, P700, DOI 10.1074/mcp.M500045-MCP200; Qian WJ, 2005, PROTEOMICS, V5, P572, DOI 10.1002/pmic.200400942; REDDY KJ, 1993, J BACTERIOL, V175, P1284, DOI 10.1128/JB.175.5.1284-1292.1993; SCHNEEGURT MA, 1994, J BACTERIOL, V176, P1586, DOI 10.1128/jb.176.6.1586-1597.1994; Seino Y, 2009, J BACTERIOL, V191, P1581, DOI 10.1128/JB.01588-08; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen JR, 1998, BIOCHEMISTRY-US, V37, P1551, DOI 10.1021/bi971676i; Shen YF, 2001, ANAL CHEM, V73, P1766, DOI 10.1021/ac0011336; Sherman LA, 1998, PHOTOSYNTH RES, V58, P25, DOI 10.1023/A:1006137605802; Sowell SM, 2008, APPL ENVIRON MICROB, V74, P4091, DOI 10.1128/AEM.00599-08; Stoeckel J, 2008, P NATL ACAD SCI USA, V105, P6156, DOI 10.1073/pnas.0711068105; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Wegener KM, 2010, MOL CELL PROTEOMICS, V9, DOI 10.1074/mcp.M110.000109; WELSH EA, 2009, COMPUTATIONAL SYSTEM, P51; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Yang C, 2002, METAB ENG, V4, P202, DOI 10.1006/mben.2002.0226; Zhang PP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005331	43	41	41	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16680	10.1371/journal.pone.0016680	http://dx.doi.org/10.1371/journal.pone.0016680			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364985	gold, Green Submitted, Green Published			2022-12-27	WOS:000287656600012
J	Garcia, AP; Palou, M; Sanchez, J; Priego, T; Palou, A; Pico, C				Paula Garcia, Ana; Palou, Mariona; Sanchez, Juana; Priego, Teresa; Palou, Andreu; Pico, Catalina			Moderate Caloric Restriction during Gestation in Rats Alters Adipose Tissue Sympathetic Innervation and Later Adiposity in Offspring	PLOS ONE			English	Article							NEUROPEPTIDE-Y; PREADIPOCYTE PROLIFERATION; PRENATAL UNDERNUTRITION; FOOD-INTAKE; WHITE; LEPTIN; NEURONS; OBESITY; DIET; GENE	Maternal prenatal undernutrition predisposes offspring to higher adiposity in adulthood. Mechanisms involved in these programming effects, apart from those described in central nervous system development, have not been established. Here we aimed to evaluate whether moderate caloric restriction during early pregnancy in rats affects white adipose tissue (WAT) sympathetic innervation in the offspring, and its relationship with adiposity development. For this purpose, inguinal and retroperitoneal WAT (iWAT and rpWAT, respectively) were analyzed in male and female offspring of control and 20% caloric-restricted (from 1-12 d of pregnancy) (CR) dams. Body weight (BW), the weight, DNA-content, morphological features and the immunoreactive tyrosine hydroxylase and Neuropeptide Y area (TH+ and NPY+ respectively, performed by immunohistochemistry) of both fat depots, were studied at 25 d and 6 m of age, the latter after 2 m exposure to high fat diet. At 6 m of life, CR males but not females, exhibited greater BW, and greater weight and total DNA-content in iWAT, without changes in adipocytes size, suggesting the development of hyperplasia in this depot. However, in rpWAT, CR males but not females, showed larger adipocyte diameter, with no changes in DNA-content, suggesting the development of hypertrophy. These parameters were not different between control and CR animals at the age of 25 d. In iWAT, both at 25 d and 6 m, CR males but not females, showed lower TH+ and NPY+, suggesting lower sympathetic innervation in CR males compared to control males. In rpWAT, at 6 m but not at 25 d, CR males but not females, showed lower TH+ and NPY+. Thus, the effects of caloric restriction during gestation on later adiposity and on the differences in the adult phenotype between internal and subcutaneous fat depots in the male offspring may be associated in part with specific alterations in sympathetic innervation, which may impact on WAT architecture.	[Paula Garcia, Ana] Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigenom, Palma de Mallorca, Spain; CIBER Fisiopatol Obesidad Nutr CIBEROBN, Palma de Mallorca, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Garcia, AP (corresponding author), Univ Balearic Isl, Lab Mol Biol Nutr & Biotechnol Nutrigenom, Palma de Mallorca, Spain.	andreu.palou@uib.es	Palou, Mariona/S-2098-2018; Sanchez, Juana/K-9675-2014; Pico, Catalina/H-7115-2015; Palou, Andreu/K-9881-2014; Priego, Teresa/H-9880-2015; Palou, Mariona/H-9208-2015	Palou, Mariona/0000-0001-9918-3764; Sanchez, Juana/0000-0002-9176-8060; Pico, Catalina/0000-0001-6759-5844; Palou, Andreu/0000-0002-0295-4452; Priego, Teresa/0000-0001-5397-0877; Palou, Mariona/0000-0001-9918-3764	Spanish Government [AGL2009-11277]; European Union [244995, FP6-506360]	Spanish Government(Spanish GovernmentEuropean Commission); European Union(European Commission)	The research leading to these results was supported by the Spanish Government (grant AGL2009-11277) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement n<SUP>o</SUP> 244995 (BIOCLAIMS Project). The authors' Laboratory is a member of the European Research Network of Excellence NuGO (The European Nutrigenomics Organization, EU Contract: n<SUP>o</SUP> FP6-506360). The CIBER de Fisiopatologia de la obesidad y nutricion is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Bamshad M, 1998, AM J PHYSIOL-REG I, V275, pR291, DOI 10.1152/ajpregu.1998.275.1.R291; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Bartness TJ, 1998, AM J PHYSIOL-REG I, V275, pR1399, DOI 10.1152/ajpregu.1998.275.5.R1399; BOULOUMIE A, 1994, J BIOL CHEM, V269, P30254; Bowers RR, 2004, AM J PHYSIOL-REG I, V286, pR1167, DOI 10.1152/ajpregu.00558.2003; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; CONBOY VB, 1987, J ANAT, V154, P47; COUSIN B, 1993, ENDOCRINOLOGY, V133, P2255, DOI 10.1210/en.133.5.2255; Delahaye F, 2008, ENDOCRINOLOGY, V149, P470, DOI 10.1210/en.2007-1263; DUMONT Y, 1992, PROG NEUROBIOL, V38, P125, DOI 10.1016/0301-0082(92)90038-G; FAUST IM, 1984, AM J PHYSIOL, V247, P1038; Foster MT, 2006, AM J PHYSIOL-REG I, V291, pR1630, DOI 10.1152/ajpregu.00197.2006; Garcia AP, 2010, DIABETES OBES METAB, V12, P403, DOI 10.1111/j.1463-1326.2009.01174.x; Gerhardt CC, 1999, MOL PHARMACOL, V55, P255, DOI 10.1124/mol.55.2.255; Gettys TW, 1996, ENDOCRINOLOGY, V137, P4054, DOI 10.1210/en.137.9.4054; Giordano A, 1996, J NEUROCYTOL, V25, P125, DOI 10.1007/BF02284791; Giordano A, 2005, J HISTOCHEM CYTOCHEM, V53, P679, DOI 10.1369/jhc.4A6566.2005; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Godfrey K M, 2001, Public Health Nutr, V4, P611; Gomes SP, 2009, J NEUROSCI RES, V87, P3568, DOI 10.1002/jnr.22167; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; HAMILTON BS, 1995, NAT MED, V1, P953, DOI 10.1038/nm0995-953; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; JONES AP, 1982, SCIENCE, V215, P1518, DOI 10.1126/science.7063860; JONES DD, 1992, INT J OBESITY, V16, P349; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBERG JM, 1983, NEUROSCI LETT, V42, P167, DOI 10.1016/0304-3940(83)90401-9; LUNDBERG JM, 1985, BIOCHEM BIOPH RES CO, V133, P30, DOI 10.1016/0006-291X(85)91837-6; MURPHY GJ, 1993, BIOCHEM PHARMACOL, V46, P575, DOI 10.1016/0006-2952(93)90540-D; Oliver P, 2001, PFLUG ARCH EUR J PHY, V442, P383, DOI 10.1007/s004240100540; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Palou M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-69; PRIEGO T, 2008, OBESITY SILVER SPRIN, P780; Roca P, 1999, PFLUG ARCH EUR J PHY, V438, P628, DOI 10.1007/s004240051086; SANTER RM, 1990, J ANAT, V168, P57; Thompson NM, 2007, ENDOCRINOLOGY, V148, P2345, DOI 10.1210/en.2006-1641; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Youngstrom TG, 1998, AM J PHYSIOL-REG I, V275, pR1488, DOI 10.1152/ajpregu.1998.275.5.R1488	43	64	64	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17313	10.1371/journal.pone.0017313	http://dx.doi.org/10.1371/journal.pone.0017313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364997	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800047
J	Zaidman-Remy, A; Poidevin, M; Herve, M; Welchman, DP; Paredes, JC; Fahlander, C; Steiner, H; Mengin-Lecreulx, D; Lemaitre, B				Zaidman-Remy, Anna; Poidevin, Mickael; Herve, Mireille; Welchman, David P.; Paredes, Juan C.; Fahlander, Carina; Steiner, Hakan; Mengin-Lecreulx, Dominique; Lemaitre, Bruno			Drosophila Immunity: Analysis of PGRP-SB1 Expression, Enzymatic Activity and Function	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; HOST-DEFENSE; BACTERIA; TOLL; LB; PHAGOCYTOSIS; ACTIVATION; RECEPTOR; AMIDASE; RELISH	Peptidoglycan is an essential and specific component of the bacterial cell wall and therefore is an ideal recognition signature for the immune system. Peptidoglycan recognition proteins (PGRPs) are conserved from insects to mammals and able to bind PGN (non-catalytic PGRPs) and, in some cases, to efficiently degrade it (catalytic PGRPs). In Drosophila, several non-catalytic PGRPs function as selective peptidoglycan receptors upstream of the Toll and Imd pathways, the two major signalling cascades regulating the systemic production of antimicrobial peptides. Recognition PGRPs specifically activate the Toll pathway in response to Lys-type peptidoglycan found in most Gram-positive bacteria and the Imd pathway in response to DAP-type peptidoglycan encountered in Gram-positive bacilli-type bacteria and in Gram-negative bacteria. Catalytic PGRPs on the other hand can potentially reduce the level of immune activation by scavenging peptidoglycan. In accordance with this, PGRP-LB and PGRP-SC1A/B/2 have been shown to act as negative regulators of the Imd pathway. In this study, we report a biochemical and genetic analysis of PGRP-SB1, a catalytic PGRP. Our data show that PGRP-SB1 is abundantly secreted into the hemolymph following Imd pathway activation in the fat body, and exhibits an enzymatic activity towards DAP-type polymeric peptidoglycan. We have generated a PGRP-SB1/2 null mutant by homologous recombination, but its thorough phenotypic analysis did not reveal any immune function, suggesting a subtle role or redundancy of PGRP-SB1/2 with other molecules. Possible immune functions of PGRP-SB1 are discussed.	[Zaidman-Remy, Anna; Poidevin, Mickael; Lemaitre, Bruno] CNRS, Ctr Genet Mol, Gif Sur Yvette, France; [Herve, Mireille; Mengin-Lecreulx, Dominique] Univ Paris 11, CNRS, Inst Biochim & Biophys Mol Cellulaire, UMR 8619, F-91405 Orsay, France; [Welchman, David P.; Paredes, Juan C.; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, CH-1015 Lausanne, Switzerland; [Fahlander, Carina; Steiner, Hakan] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stockholm University	Zaidman-Remy, A (corresponding author), Univ Lisbon, Fac Med, Inst Mol Med, P-1200 Lisbon, Portugal.	bruno.lemaitre@epfl.ch	Lemaitre, Bruno/T-8146-2019; Zaidman-Rémy, Anna/C-2481-2016	Lemaitre, Bruno/0000-0001-7970-1667; Zaidman-Remy, Anna/0000-0003-2550-1752; Paredes, Juan C./0000-0002-0974-8109; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	Bettencourt Foundation; ERC; Swiss National Science Foundation [3100A0-12079/1]; CNRS; Association pour la Recherche contre le Cancer	Bettencourt Foundation; ERC(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer)	The laboratory of B. L. was funded by the Bettencourt Foundation (www.fondationbs.org), an ERC Advanced Investigators Grant (erc.europa.eu) and the Swiss National Science Foundation (3100A0-12079/1; www.snf.ch/E). A.Z.-R. was supported by fellowships from CNRS (www.dgdr.cnrs.fr) and the Association pour la Recherche contre le Cancer (www.arc-cancer.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggrawal K, 2007, BIOCHEM SOC T, V35, P1496, DOI 10.1042/BST0351496; Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Chaput C, 2007, MICROBES INFECT, V9, P637, DOI 10.1016/j.micinf.2007.01.022; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Cloud-Hansen KA, 2006, NAT REV MICROBIOL, V4, P710, DOI 10.1038/nrmicro1486; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Dziarski R, 2006, CELL MICROBIOL, V8, P1059, DOI 10.1111/j.1462-5822.2006.00726.x; Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Li X, 2007, IMMUNITY, V27, P518, DOI 10.1016/j.immuni.2007.07.020; Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200; Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139; Mengin-Lecreulx D, 2005, J ENDOTOXIN RES, V11, P105, DOI 10.1179/096805105X35233; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Romeo Yves, 2008, V415, P379, DOI 10.1007/978-1-59745-570-1_22; Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620; Saha S, 2010, CELL HOST MICROBE, V8, P147, DOI 10.1016/j.chom.2010.07.005; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339; Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466; Troll JV, 2009, CELL MICROBIOL, V11, P1114, DOI 10.1111/j.1462-5822.2009.01315.x; TROLL JV, 2009, ENV MICROBIOL; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	42	72	78	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17231	10.1371/journal.pone.0017231	http://dx.doi.org/10.1371/journal.pone.0017231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364998	Green Published, gold			2022-12-27	WOS:000287482800036
J	Rittschof, D; Orihuela, B; Harder, T; Stafslien, S; Chisholm, B; Dickinson, GH				Rittschof, Daniel; Orihuela, Beatriz; Harder, Tilmann; Stafslien, Shane; Chisholm, Bret; Dickinson, Gary H.			Compounds from Silicones Alter Enzyme Activity in Curing Barnacle Glue and Model Enzymes	PLOS ONE			English	Article							ANTIFOULING COATINGS; UNDERWATER ADHESIVE; BALANUS-AMPHITRITE; CROSS-LINKING; CEMENT; COAGULATION; RELEASE; SURFACE; MUSSEL; POLYMERIZATION	Background: Attachment strength of fouling organisms on silicone coatings is low. We hypothesized that low attachment strength on silicones is, in part, due to the interaction of surface available components with natural glues. Components could alter curing of glues through bulk changes or specifically through altered enzyme activity. Methodology/Principal Findings: GC-MS analysis of silicone coatings showed surface-available siloxanes when the coatings were gently rubbed with a cotton swab for 15 seconds or given a 30 second rinse with methanol. Mixtures of compounds were found on 2 commercial and 8 model silicone coatings. The hypothesis that silicone components alter glue curing enzymes was tested with curing barnacle glue and with commercial enzymes. In our model, barnacle glue curing involves trypsin-like serine protease(s), which activate enzymes and structural proteins, and a transglutaminase which cross-links glue proteins. Transglutaminase activity was significantly altered upon exposure of curing glue from individual barnacles to silicone eluates. Activity of purified trypsin and, to a greater extent, transglutaminase was significantly altered by relevant concentrations of silicone polymer constituents. Conclusions/Significance: Surface-associated silicone compounds can disrupt glue curing and alter enzyme properties. Altered curing of natural glues has potential in fouling management.	[Rittschof, Daniel; Orihuela, Beatriz; Dickinson, Gary H.] Duke Univ, Marine Lab, MSC Div, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Stafslien, Shane; Chisholm, Bret] N Dakota State Univ, Ctr Nanoscale Sci & Engn, Fargo, ND 58105 USA; [Harder, Tilmann] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	Duke University; North Dakota State University Fargo; University of New South Wales Sydney	Rittschof, D (corresponding author), Duke Univ, Marine Lab, MSC Div, Nicholas Sch Environm, Beaufort, NC 28516 USA.	ritt@duke.edu	Harder, Tilmann/B-6861-2008	Harder, Tilmann/0000-0003-3173-6806; Dickinson, Gary/0000-0003-1073-1483	U. S. Office of Naval Research at Duke [N00014-08-10158, N00014-07-1-0949]; U. S. Office of Naval Research at NDSU [N00014-07-1-1099, N00014-08-1-1149]	U. S. Office of Naval Research at Duke; U. S. Office of Naval Research at NDSU	This research was supported by the U. S. Office of Naval Research at Duke (N00014-08-10158 and N00014-07-1-0949) and at NDSU (N00014-07-1-1099 and N00014-08-1-1149). The funders had no role in study design, data collection an analysis, decision to publish or preparation of the manuscript.	ALBERTSON NH, 1990, APPL ENVIRON MICROB, V56, P218, DOI 10.1128/AEM.56.1.218-223.1990; BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360; Baier RE, 1997, NAV RES REV, VXLIX, P60; Baier RE, 2006, J MATER SCI-MATER M, V17, P1057, DOI 10.1007/s10856-006-0444-8; Berglin M, 2003, COLLOID SURFACE B, V28, P107, DOI 10.1016/S0927-7765(02)00149-2; Berglin M, 1999, J ADHES SCI TECHNOL, V13, P713, DOI 10.1163/156856199X00956; Brady RF, 2000, BIOFOULING, V15, P73, DOI 10.1080/08927010009386299; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Davie EW, 2003, J BIOL CHEM, V278, P50819, DOI 10.1074/jbc.X300009200; Dickinson G. H, 2008, BARNACLE CEMENT POLY; Dickinson GH, 2009, J EXP BIOL, V212, P3499, DOI 10.1242/jeb.029884; Dougherty WJ, 1996, TISSUE CELL, V28, P439, DOI 10.1016/S0040-8166(96)80029-2; Hoffman M, 2000, AQUAT MICROB ECOL, V23, P29, DOI 10.3354/ame023029; Holm ER, 2005, BIOFOULING, V21, P121, DOI 10.1080/08927010512331344188; HOLM ER, 1994, MAR ECOL PROG SER, V113, P247, DOI 10.3354/meps113247; Holm ER, 2009, J EXP MAR BIOL ECOL, V380, P61, DOI 10.1016/j.jembe.2009.06.026; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3; Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8; Kamino K, 2010, J ADHESION, V86, P96, DOI 10.1080/00218460903418139; KAPLAN DB, COMMUNICATION; Kavanagh CJ, 2005, J ADHESION, V81, P843, DOI 10.1080/00218460500189331; LINDNER E, 1984, MARINE CORROSION BIO, P184; MEYER AE, 1994, P 4 INT ZEBR MUSS C, P273; Meyer A, 2006, BIOFOULING, V22, P411, DOI 10.1080/08927010601025473; Monahan J, 2004, LANGMUIR, V20, P3724, DOI 10.1021/la0362728; NALDRETT MJ, 1993, J MAR BIOL ASSOC UK, V73, P689, DOI 10.1017/S0025315400033221; Nendza M, 2007, MAR POLLUT BULL, V54, P1190, DOI 10.1016/j.marpolbul.2007.04.009; PATTEN BM, 1995, PERSPECT BIOL MED, V38, P274; Pitombo FB, 2004, ZOOL SCR, V33, P261, DOI 10.1111/j.0300-3256.2004.00145.x; Rittschof D, 2008, BIOFOULING, V24, P1, DOI 10.1080/08927010701784920; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Smith A. M, 2006, BIOL ADHESIVES; Sritunyalucksana K, 2000, AQUACULTURE, V191, P53, DOI 10.1016/S0044-8486(00)00411-7; Stafslien SJ, 2006, J COMB CHEM, V8, P156, DOI 10.1021/cc050047m; Swain GW, 1996, BIOFOULING, V10, P187, DOI 10.1080/08927019609386279; Swift S, 1999, INFECT IMMUN, V67, P5192, DOI 10.1128/IAI.67.10.5192-5199.1999; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tribou M, 2010, BIOFOULING, V26, P47, DOI 10.1080/08927010903290973; Uilk JM, 2003, MACROMOLECULES, V36, P3689, DOI 10.1021/ma021154x; WAITE JH, 1987, INT J ADHES ADHES, V7, P9, DOI 10.1016/0143-7496(87)90048-0; Wemeke SW, 2007, J EXP BIOL, V210, P2137, DOI 10.1242/jeb.006098; Wendt DE, 2006, BIOFOULING, V22, P1, DOI 10.1080/08927010500499563; Wiegemann M, 2003, J ADHES SCI TECHNOL, V17, P1957, DOI 10.1163/156856103770572070; Zelisko PM, 2003, ACS SYM SER, V838, P212	45	26	26	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16487	10.1371/journal.pone.0016487	http://dx.doi.org/10.1371/journal.pone.0016487			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379573	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300016
J	Jaszai, J; Fargeas, CA; Graupner, S; Tanaka, EM; Brand, M; Huttner, WB; Corbeil, D				Jaszai, Jozsef; Fargeas, Christine A.; Graupner, Sylvi; Tanaka, Elly M.; Brand, Michael; Huttner, Wieland B.; Corbeil, Denis			Distinct and Conserved Prominin-1/CD133-Positive Retinal Cell Populations Identified across Species	PLOS ONE			English	Article							PLASMA-MEMBRANE PROTRUSIONS; PROMININ-1 CD133; HEMATOPOIETIC STEM; RETINITIS-PIGMENTOSA; SPLICE VARIANTS; NEURAL REGENERATION; FRAMESHIFT MUTATION; DISK MORPHOGENESIS; EPITHELIAL-CELLS; BINDING PROTEIN	Besides being a marker of various somatic stem cells in mammals, prominin-1 (CD133) plays a role in maintaining the photoreceptor integrity since mutations in the PROM1 gene are linked with retinal degeneration. In spite of that, little information is available regarding its distribution in eyes of non-mammalian vertebrates endowed with high regenerative abilities. To address this subject, prominin-1 cognates were isolated from axolotl, zebrafish and chicken, and their retinal compartmentalization was investigated and compared to that of their mammalian orthologue. Interestingly, prominin-1 transcripts-except for the axolotl-were not strictly restricted to the outer nuclear layer (i. e., photoreceptor cells), but they also marked distinct subdivisions of the inner nuclear layer (INL). In zebrafish, where the prominin-1 gene is duplicated (i. e., prominin-1a and prominin-1b), a differential expression was noted for both paralogues within the INL being localized either to its vitreal or scleral subdivision, respectively. Interestingly, expression of prominin-1a within the former domain coincided with Pax-6-positive cells that are known to act as progenitors upon injury-induced retino-neurogenesis. A similar, but minute population of prominin-1-positive cells located at the vitreal side of the INL was also detected in developing and adult mice. In chicken, however, prominin-1-positive cells appeared to be aligned along the scleral side of the INL reminiscent of zebrafish prominin-1b. Taken together our data indicate that in addition to conserved expression of prominin-1 in photoreceptors, significant prominin-1-expressing non-photoreceptor retinal cell populations are present in the vertebrate eye that might represent potential sources of stem/progenitor cells for regenerative therapies.	[Jaszai, Jozsef; Fargeas, Christine A.; Graupner, Sylvi; Corbeil, Denis] Tech Univ Dresden, Tissue Engn Labs BIOTEC, Dresden, Germany; [Tanaka, Elly M.; Brand, Michael; Corbeil, Denis] Tech Univ Dresden, DFG Res Ctr & Cluster Excellence Regenerat Therap, Dresden, Germany; [Huttner, Wieland B.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Jaszai, J (corresponding author), Tech Univ Dresden, Tissue Engn Labs BIOTEC, Dresden, Germany.	jozsef.jaszai@biotec.tu-dresden.de; corbeil@biotec.tu-dresden.de	Huttner, Wieland B./P-4080-2018; Corbeil, Denis/AFL-1008-2022; Corbeil, Denis/L-2340-2019; Tanaka, Elly M/F-8572-2010; Corbeil, Denis/A-6519-2010; Brand, Michael/A-5509-2010	Corbeil, Denis/0000-0003-1181-3659; Brand, Michael/0000-0001-5711-6512	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG) [2006, 2008, CO298/5-1]	Medical Faculty of Technische Universitat Dresden; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Intramural funds of the Medical Faculty of Technische Universitat Dresden and Deutsche Forschungsgemeinschaft (DFG) supported J.J. (MeDDrive grants 2006 and 2008 and CO298/5-1, respectively). The DFG supported M. B. (SFB655 A3), E. M. T (SFB655 A4), W. B. H. (SFB655 A2; TRR83 #6) and D. C. (SFB655 B3; TRR83 #6 and CO298/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Bauer N, 2008, CELLS TISSUES ORGANS, V188, P127, DOI 10.1159/000112847; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Brand Michael, 2002, P7; Carter DA, 2009, BMC OPHTHALMOL, V9, DOI 10.1186/1471-2415-9-1; Corbeil D, 2001, BIOCHEM BIOPH RES CO, V285, P939, DOI 10.1006/bbrc.2001.5271; Corbeil D, 2001, TRAFFIC, V2, P82, DOI 10.1034/j.1600-0854.2001.020202.x; Corbeil D, 2000, J BIOL CHEM, V275, P5512, DOI 10.1074/jbc.275.8.5512; Corbeil D, 2010, FEBS LETT, V584, P1659, DOI 10.1016/j.febslet.2010.01.050; Corbeil D, 2009, GLIA, V57, P860, DOI 10.1002/glia.20812; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ernsberger U, 1997, MECH DEVELOP, V68, P115, DOI 10.1016/S0925-4773(97)00135-4; Fargeas CA, 2007, TISSUE ANTIGENS, V69, P602, DOI 10.1111/j.1399-0039.2007.00825.x; Fargeas CA, 2004, J CELL SCI, V117, P4301, DOI 10.1242/jcs.01315; Fargeas CA, 2003, STEM CELLS, V21, P506, DOI 10.1634/stemcells.21-4-506; Fargeas CA, 2003, J BIOL CHEM, V278, P8586, DOI 10.1074/jbc.M210640200; Fargeas CA, 2006, FUTURE LIPIDOL, V1, P213, DOI 10.2217/17460875.1.2.213; Farkas LM, 2008, NEURON, V60, P40, DOI 10.1016/j.neuron.2008.09.020; Filoni S, 2009, SEMIN CELL DEV BIOL, V20, P528, DOI 10.1016/j.semcdb.2008.11.015; Fischer AJ, 2005, PROG RETIN EYE RES, V24, P161, DOI 10.1016/j.preteyeres.2004.07.003; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Florek M, 2005, CELL TISSUE RES, V319, P15, DOI 10.1007/s00441-004-1018-z; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; HALDER G, 1995, CURR OPIN GENET DEV, V5, P602, DOI 10.1016/0959-437X(95)80029-8; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Henderson RH, 2010, MOL VIS, V16, P46; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jaszai J, 2007, HISTOCHEM CELL BIOL, V128, P409, DOI 10.1007/s00418-007-0334-2; JOHNS PR, 1981, NATURE, V293, P141, DOI 10.1038/293141a0; Jovelin R, 2007, J EXP ZOOL PART B, V308B, P730, DOI 10.1002/jez.b.21193; Kaneko J, 2009, NEUROSCI LETT, V450, P252, DOI 10.1016/j.neulet.2008.11.031; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Kemper K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012325; Leung YF, 2005, ZEBRAFISH, V2, P269, DOI 10.1089/zeb.2005.2.269; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Maw MA, 2000, HUM MOL GENET, V9, P27, DOI 10.1093/hmg/9.1.27; McGrail M, 2010, DEV DYNAM, V239, P1849, DOI 10.1002/dvdy.22307; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Moshiri A, 2004, INT J DEV BIOL, V48, P1003, DOI 10.1387/ijdb.041870am; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; Otteson DC, 2003, VISION RES, V43, P927, DOI 10.1016/S0042-6989(02)00400-5; Permanyer J, 2010, INVEST OPHTH VIS SCI, V51, P2656, DOI 10.1167/iovs.09-4857; Pras E, 2009, MOL VIS, V15, P1709; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Rattner A, 2004, J BIOL CHEM, V279, P42202, DOI 10.1074/jbc.M407928200; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; RAYMOND PA, 1995, J COMP NEUROL, V359, P537, DOI 10.1002/cne.903590403; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Rohlich P, 2000, MICROSC RES TECHNIQ, V50, P327; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stenkamp DL, 1997, J COMP NEUROL, V382, P272, DOI 10.1002/(SICI)1096-9861(19970602)382:2<272::AID-CNE10>3.0.CO;2-U; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; Susaki K, 2009, EXP EYE RES, V88, P347, DOI 10.1016/j.exer.2008.06.019; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Westerfield M, 1994, ZEBRAFISH BOOK; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu Y, 2002, J BIOL CHEM, V277, P20711, DOI 10.1074/jbc.M202349200; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang J, 2009, VISION RES, V49, P64, DOI 10.1016/j.visres.2008.09.031; Zhang QJ, 2007, HUM GENET, V122, P293, DOI 10.1007/s00439-007-0395-2	78	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17590	10.1371/journal.pone.0017590	http://dx.doi.org/10.1371/journal.pone.0017590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407811	Green Submitted, Green Published, gold			2022-12-27	WOS:000287933300033
J	Marsh, EK; van den Berg, MCW; May, RC				Marsh, Elizabeth K.; van den Berg, Maaike C. W.; May, Robin C.			A Two-Gene Balance Regulates Salmonella Typhimurium Tolerance in the Nematode Caenorhabditis elegans	PLOS ONE			English	Article							MODEL HOST; RESISTANCE; INFECTION; EVOLUTION; CLUSTERS; SYSTEM; WORM	Lysozymes are antimicrobial enzymes that perform a critical role in resisting infection in a wide-range of eukaryotes. However, using the nematode Caenorhabditis elegans as a model host we now demonstrate that deletion of the protist type lysozyme LYS-7 renders animals susceptible to killing by the fatal fungal human pathogen Cryptococcus neoformans, but, remarkably, enhances tolerance to the enteric bacteria Salmonella Typhimurium. This trade-off in immunological susceptibility in C. elegans is further mediated by the reciprocal activity of lys-7 and the tyrosine kinase abl-1. Together this implies a greater complexity in C. elegans innate immune function than previously thought.	[Marsh, Elizabeth K.; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [van den Berg, Maaike C. W.] Univ Med Ctr Utrecht, Physiol Chem Lab, Utrecht, Netherlands	University of Birmingham; Utrecht University; Utrecht University Medical Center	May, RC (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	R.C.May@bham.ac.uk	May, Robin Charles/ABA-9266-2021	May, Robin Charles/0000-0001-5364-1838; Marsh, Elizabeth/0000-0002-4776-3588	Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F000138/1]; BBSRC [BB/F000138/1] Funding Source: UKRI; MRC [G0601171] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000138/1] Funding Source: researchfish; Medical Research Council [G0601171] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council (MRC) studentship award to EKM and by a Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/F000138/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Amrit FRG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009978; Ayres JS, 2008, PLOS BIOL, V6, P2764, DOI 10.1371/journal.pbio.0060305; Bachali S, 2002, J MOL EVOL, V54, P652, DOI 10.1007/s00239-001-0061-6; BOOKOUT AL, 2003, NUCL RECEPTOR SIGNAL, pE12; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; BRENNER S, 1974, GENETICS, V77, P71; Darby C, 1999, P NATL ACAD SCI USA, V96, P15202, DOI 10.1073/pnas.96.26.15202; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Ewbank JJ, 2002, MICROBES INFECT, V4, P247, DOI 10.1016/S1286-4579(01)01531-3; EWBANK JJ, 2006, WORMBOOK; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Hope IA., 1999, C ELEGANS PRACTICAL; Jolles P., 1996, LYSOZYMES MODEL ENZY; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Nicholson LB, 1996, CURR OPIN IMMUNOL, V8, P837, DOI 10.1016/S0952-7915(96)80013-6; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Schulenburg H, 2004, IMMUNOL REV, V198, P36, DOI 10.1111/j.0105-2896.2004.0125.x; Schulenburg H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-114; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; van den Berg MCW, 2006, GENETICS, V173, P677, DOI 10.1534/genetics.106.056093	32	18	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16839	10.1371/journal.pone.0016839	http://dx.doi.org/10.1371/journal.pone.0016839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399680	Green Published, gold			2022-12-27	WOS:000287933300002
J	Zeitlin, SG; Chapados, BR; Baker, NM; Tai, C; Slupphaug, G; Wang, JYJ				Zeitlin, Samantha G.; Chapados, Brian R.; Baker, Norman M.; Tai, Caroline; Slupphaug, Geir; Wang, Jean Y. J.			Uracil DNA N-Glycosylase Promotes Assembly of Human Centromere Protein A	PLOS ONE			English	Article							BASE EXCISION-REPAIR; CENP-A; CHROMATIN REQUIRES; CRYSTAL-STRUCTURES; UNG; NUCLEAR; DEFICIENCY; COMPLEX; CELLS; VPR	Uracil is removed from DNA by the conserved enzyme Uracil DNA N-glycosylase (UNG). Previously, we observed that inhibiting UNG in Xenopus egg extracts blocked assembly of CENP-A, a histone H3 variant. CENP-A is an essential protein in all species, since it is required for chromosome segregation during mitosis. Thus, the implication of UNG in CENP-A assembly implies that UNG would also be essential, but UNG mutants lacking catalytic activity are viable in all species. In this paper, we present evidence that UNG2 colocalizes with CENP-A and H2AX phosphorylation at centromeres in normally cycling cells. Reduction of UNG2 in human cells blocks CENP-A assembly, and results in reduced cell proliferation, associated with increased frequencies of mitotic abnormalities and rapid cell death. Overexpression of UNG2 induces high levels of CENP-A assembly in human cells. Using a multiphoton laser approach, we demonstrate that UNG2 is rapidly recruited to sites of DNA damage. Taken together, our data are consistent with a model in which the N-terminus of UNG2 interacts with the active site of the enzyme and with chromatin.	[Zeitlin, Samantha G.; Tai, Caroline; Wang, Jean Y. J.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Zeitlin, Samantha G.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Chapados, Brian R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Baker, Norman M.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Slupphaug, Geir] Norwegian Univ Sci & Technol NTNU, Fac Med, Trondheim, Norway	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Scripps Research Institute; University of California System; University of California San Diego; Norwegian University of Science & Technology (NTNU)	Zeitlin, SG (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA.	szeitlin@sciencegeeks.org	Slupphaug, Geir/AAN-3794-2020	Slupphaug, Geir/0000-0002-7498-3500	NCI [5R01CA058320-15]; NIH [5F32GM069297]; California Institute of Regenerative Medicine (CIRM); Don Cleveland in the Ludwig Institute for Cancer Research; UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; UCSD Cancer Center Specialized Support [P30 CA23100]; Research Council of Norway; National Programme for Research in Functional Genomics in Norway (FUGE); Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim; Svanhild; Arne Must Fund for Medical Research; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA043054, R37CA043054, R01CA058320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM069297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Don Cleveland in the Ludwig Institute for Cancer Research; UCSD Neuroscience Microscopy Shared Facility; UCSD Cancer Center Specialized Support; Research Council of Norway(Research Council of Norway); National Programme for Research in Functional Genomics in Norway (FUGE)(Research Council of Norway); Norwegian Cancer Association; Cancer Fund at St. Olavs Hospital, Trondheim; Svanhild; Arne Must Fund for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NCI grant 5R01CA058320-15 to JJYW. SGZ was funded by NIH NRSA fellowship 5F32GM069297, and a fellowship from the California Institute of Regenerative Medicine (CIRM), and Don Cleveland in the Ludwig Institute for Cancer Research. The Deltavision microscopes were funded by the UCSD Neuroscience Microscopy Shared Facility Grant P30 NS047101 and the UCSD Cancer Center Specialized Support Grant P30 CA23100. This research was also supported by the Research Council of Norway, the National Programme for Research in Functional Genomics in Norway (FUGE), the Norwegian Cancer Association, the Cancer Fund at St. Olavs Hospital, Trondheim, and the Svanhild and Arne Must Fund for Medical Research, to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; An Q, 2005, EMBO J, V24, P2205, DOI 10.1038/sj.emboj.7600689; Andersen JL, 2008, EXP MOL PATHOL, V85, P2, DOI 10.1016/j.yexmp.2008.03.015; Andersen S, 2005, DNA REPAIR, V4, P1432, DOI 10.1016/j.dnarep.2005.08.004; Begum NA, 2004, SCIENCE, V305, P1160, DOI 10.1126/science.1098444; Begum NA, 2007, J BIOL CHEM, V282, P731, DOI 10.1074/jbc.M607439200; Begum NA, 2009, P NATL ACAD SCI USA, V106, P2752, DOI 10.1073/pnas.0813252106; Berger SH, 2008, BIOCHEM PHARMACOL, V76, P697, DOI 10.1016/j.bcp.2008.05.019; BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; BURGERS PMJ, 1986, J BACTERIOL, V166, P905, DOI 10.1128/jb.166.3.905-913.1986; Chow JPH, 2010, ADV EXP MED BIOL, V676, P57; D'souza DI, 2003, NUCLEIC ACIDS RES, V31, P4573, DOI 10.1093/nar/gkg493; DIANOV GL, 1991, MOL GEN GENET, V225, P448, DOI 10.1007/BF00261686; DUNCAN BK, 1978, J BACTERIOL, V134, P1039, DOI 10.1128/JB.134.3.1039-1045.1978; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Endres M, 2005, STROKE, V36, P321, DOI 10.1161/01.STR.0000153008.60517.ab; Endres M, 2004, J CLIN INVEST, V113, P1711, DOI 10.1172/JCI200420926; Fischer JA, 2004, DNA REPAIR, V3, P505, DOI 10.1016/j.dnarep.2004.01.012; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gasparri F, 2006, J BIOMOL SCREEN, V11, P586, DOI 10.1177/1087057106289406; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hagen L, 2008, EMBO J, V27, P51, DOI 10.1038/sj.emboj.7601958; Handa P, 2002, NUCLEIC ACIDS RES, V30, P3086, DOI 10.1093/nar/gkf425; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Kavli B, 2005, J EXP MED, V201, P2011, DOI 10.1084/jem.20050042; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Ko R, 2005, DNA REPAIR, V4, P1421, DOI 10.1016/j.dnarep.2005.08.006; Kracker S, 2010, CLIN IMMUNOL, V135, P193, DOI 10.1016/j.clim.2010.01.012; Kracker S, 2010, ADV EXP MED BIOL, V685, P166; Kronenberg G, 2008, J NEUROSCI, V28, P7219, DOI 10.1523/JNEUROSCI.0940-08.2008; Kruman II, 2004, J BIOL CHEM, V279, P43952, DOI 10.1074/jbc.M408025200; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Li G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-59; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Nakamura N, 2008, MUTAGENESIS, V23, P407, DOI 10.1093/mutage/gen030; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Otterlei M, 1998, NUCLEIC ACIDS RES, V26, P4611, DOI 10.1093/nar/26.20.4611; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pan-Hammarstrom Q, 2007, ADV IMMUNOL, V93, P1, DOI 10.1016/S0065-2776(06)93001-6; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pulukuri SMK, 2009, MOL CANCER RES, V7, P1285, DOI 10.1158/1541-7786.MCR-08-0508; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Roederer M, 2001, CYTOMETRY, V45, P37, DOI 10.1002/1097-0320(20010901)45:1<37::AID-CYTO1142>3.0.CO;2-E; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Skjeldam HK, 2010, DNA REPAIR, V9, P861, DOI 10.1016/j.dnarep.2010.04.009; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Studebaker AW, 2005, BIOCHEM BIOPH RES CO, V334, P509, DOI 10.1016/j.bbrc.2005.06.118; VIG BK, 1989, CANCER GENET CYTOGEN, V43, P151, DOI 10.1016/0165-4608(89)90028-9; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zeitlin SG, 2010, EPIGENETICS-US, V5, P34, DOI 10.4161/epi.5.1.10629; Zeitlin SG, 2009, P NATL ACAD SCI USA, V106, P15762, DOI 10.1073/pnas.0908233106; Zeitlin SG, 2005, DNA REPAIR, V4, P760, DOI 10.1016/j.dnarep.2005.02.007; Zeitlin SG, 2001, J CELL SCI, V114, P653	62	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17151	10.1371/journal.pone.0017151	http://dx.doi.org/10.1371/journal.pone.0017151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399697	Green Published, gold			2022-12-27	WOS:000287933300012
J	Capsoni, S; Covaceuszach, S; Marinelli, S; Ceci, M; Bernardo, A; Minghetti, L; Ugolini, G; Pavone, F; Cattaneo, A				Capsoni, Simona; Covaceuszach, Sonia; Marinelli, Sara; Ceci, Marcello; Bernardo, Antonietta; Minghetti, Luisa; Ugolini, Gabriele; Pavone, Flaminia; Cattaneo, Antonino			Taking Pain Out of NGF: A "Painless'' NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; RECEPTOR P75; SIGNALING PATHWAYS; MAST-CELLS; INDUCED HYPERALGESIA; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; TRKA; EXPRESSION	During adulthood, the neurotrophin Nerve Growth Factor (NGF) sensitizes nociceptors, thereby increasing the response to noxious stimuli. The relationship between NGF and pain is supported by genetic evidence: mutations in the NGF TrkA receptor in patients affected by an hereditary rare disease (Hereditary Sensory and Autonomic Neuropathy type IV, HSAN IV) determine a congenital form of severe pain insensitivity, with mental retardation, while a mutation in NGFB gene, leading to the aminoacid substitution R100W in mature NGF, determines a similar loss of pain perception, without overt cognitive neurological defects (HSAN V). The R100W mutation provokes a reduced processing of proNGF to mature NGF in cultured cells and a higher percentage of neurotrophin secreted is in the proNGF form. Moreover, using Surface Plasmon Resonance we showed that the R100W mutation does not affect NGF binding to TrkA, while it abolishes NGF binding to p75NTR receptors. However, it remains to be clarified whether the major impact of the mutation is on the biological function of proNGF or of mature NGF and to what extent the effects of the R100W mutation on the HSAN V clinical phenotype are developmental, or whether they reflect an impaired effectiveness of NGF to regulate and mediate nociceptive transmission in adult sensory neurons. Here we show that the R100 mutation selectively alters some of the signaling pathways activated downstream of TrkA NGF receptors. NGFR100 mutants maintain identical neurotrophic and neuroprotective properties in a variety of cell assays, while displaying a significantly reduced pain-inducing activity in vivo (n = 8-10 mice/group). We also show that proNGF has a significantly reduced nociceptive activity, with respect to NGF. Both sets of results jointly contribute to elucidating the mechanisms underlying the clinical HSAN V manifestations, and to clarifying which receptors and intracellular signaling cascades participate in the pain sensitizing action of NGF.	[Capsoni, Simona; Ceci, Marcello; Cattaneo, Antonino] European Brain Res Inst, Rome, Italy; [Capsoni, Simona; Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy; [Covaceuszach, Sonia; Ugolini, Gabriele] Rottapharm Biotech Srl, Trieste, Italy; [Marinelli, Sara; Pavone, Flaminia] CNR, Inst Neurosci, Rome, Italy; [Bernardo, Antonietta; Minghetti, Luisa] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Scuola Normale Superiore di Pisa; Rottapharm; Consiglio Nazionale delle Ricerche (CNR); Istituto Superiore di Sanita (ISS)	Capsoni, S (corresponding author), European Brain Res Inst, Rome, Italy.	antonino.cattaneo@sns.it	Marinelli, Sara/L-7738-2019; Cattaneo, Antonino/K-4471-2016; Minghetti, Luisa/I-9540-2014; Covaceuszach, Sonia/AAA-4116-2021; Antonietta, Bernardo/H-4415-2016; Cattaneo, Antonino/AAA-7252-2019	Marinelli, Sara/0000-0001-5393-4796; Cattaneo, Antonino/0000-0002-6975-8923; Minghetti, Luisa/0000-0002-7065-4689; Antonietta, Bernardo/0000-0002-6590-7530; Pavone, Flaminia/0000-0001-5189-2748; Capsoni, Simona/0000-0003-2670-8237; Ceci, Marcello/0000-0002-5066-1590	Telethon [GGP05234]; EU [037831]	Telethon(Fondazione Telethon); EU(European Commission)	This work was partially supported by, Telethon ( grant n. GGP05234, www.telethon.it) and EU ( Memories project n. 037831). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Apfel SC, 2002, INT REV NEUROBIOL, V50, P393; Apfel SC, 2000, CLIN J PAIN, V16, pS7, DOI 10.1097/00002508-200006001-00003; BARDE YA, 1980, P NATL ACAD SCI-BIOL, V77, P1199, DOI 10.1073/pnas.77.2.1199; Bergmann I, 1998, NEUROSCI LETT, V255, P87, DOI 10.1016/S0304-3940(98)00713-7; Bernardo A, 2003, J NEUROPATH EXP NEUR, V62, P509, DOI 10.1093/jnen/62.5.509; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Cattaneo A, 1999, J NEUROSCI, V19, P9687; Cattaneo A, 2008, J ALZHEIMERS DIS, V15, P255; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHEVALIER S, 1994, BLOOD, V83, P1479; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Covaceuszach S, 2009, CURR ALZHEIMER RES, V6, P158, DOI 10.2174/156720509787602870; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; de Andrade DC, 2008, EUR J NEUROL, V15, P712, DOI 10.1111/j.1468-1331.2008.02172.x; Doya H, 2005, BIOCHEM BIOPH RES CO, V335, P132, DOI 10.1016/j.bbrc.2005.07.055; Dyck PJ, 1997, NEUROLOGY, V48, P501, DOI 10.1212/WNL.48.2.501; Einarsdottir E, 2004, HUM MOL GENET, V13, P799, DOI 10.1093/hmg/ddh096; ERIKSDOTTER JM, 1998, DEMENT GERIATR COGN, V9, P246, DOI DOI 10.1159/000017069; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEFTI F, 1986, J NEUROSCI, V6, P2155; HORIGOME K, 1993, J BIOL CHEM, V268, P14881; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Kawamoto K, 2002, J IMMUNOL, V168, P6412, DOI 10.4049/jimmunol.168.12.6412; Larsson E, 2009, NEUROBIOL DIS, V33, P221, DOI 10.1016/j.nbd.2008.10.012; Lee X, 2007, J NEUROSCI, V27, P220, DOI 10.1523/JNEUROSCI.4175-06.2007; LEVIMONTALCINI R, 1952, ANN NY ACAD SCI, V55, P330, DOI 10.1111/j.1749-6632.1952.tb26548.x; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LEWIN GR, 1993, J NEUROSCI, V13, P2136; LEWIN GR, 1994, EUR J NEUROSCI, V6, P1903, DOI 10.1111/j.1460-9568.1994.tb00581.x; Limpert AS, 2007, MOL CELL BIOL, V27, P5686, DOI 10.1128/MCB.01109-06; LOPRESTI P, 1992, CELL GROWTH DIFFER, V3, P627; Luvisetto S, 2007, NEUROSCIENCE, V145, P1, DOI 10.1016/j.neuroscience.2006.12.004; Mahapatra S, 2009, J BIOL CHEM, V284, P33600, DOI 10.1074/jbc.M109.058420; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; Matrone C, 2008, P NATL ACAD SCI USA, V105, P13139, DOI 10.1073/pnas.0806133105; Minde J, 2004, MUSCLE NERVE, V30, P752, DOI 10.1002/mus.20172; MINDE J, 2008, J NEUROL NEUROSURG P; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; Nicol GD, 2007, MOL INTERV, V7, P26, DOI 10.1124/mi.7.1.6; Obata K, 2006, J NEUROSCI, V26, P11974, DOI 10.1523/JNEUROSCI.3188-06.2006; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Petersen M, 1998, NEUROSCIENCE, V83, P161, DOI 10.1016/S0306-4522(97)00374-6; PETTY BG, 1994, ANN NEUROL, V36, P244, DOI 10.1002/ana.410360221; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; RITTER AM, 1991, NATURE, V350, P500, DOI 10.1038/350500a0; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Ryden M, 1997, J BIOL CHEM, V272, P16322, DOI 10.1074/jbc.272.26.16322; Sawada J, 2000, BLOOD, V95, P2052, DOI 10.1182/blood.V95.6.2052; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; SONNENFELD KH, 1982, J NEUROSCI RES, V8, P375, DOI 10.1002/jnr.490080226; Svensson P, 2003, PAIN, V104, P241, DOI 10.1016/S0304-3959(03)00012-5; Ugolini G, 2007, P NATL ACAD SCI USA, V104, P2985, DOI 10.1073/pnas.0611253104; Watanabe T, 2008, J NEUROSCI RES, V86, P3566, DOI 10.1002/jnr.21808; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Zhang YH, 2004, NEUROSCI LETT, V366, P187, DOI 10.1016/j.neulet.2004.05.042; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004	68	70	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17321	10.1371/journal.pone.0017321	http://dx.doi.org/10.1371/journal.pone.0017321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387003	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400056
J	Chen, GB; Xu, Y; Xu, HM; Li, MD; Zhu, J; Lou, XY				Chen, Guo-Bo; Xu, Yi; Xu, Hai-Ming; Li, Ming D.; Zhu, Jun; Lou, Xiang-Yang			Practical and Theoretical Considerations in Study Design for Detecting Gene-Gene Interactions Using MDR and GMDR Approaches	PLOS ONE			English	Article							MULTIFACTOR-DIMENSIONALITY REDUCTION; GENOME-WIDE ASSOCIATION; RECEPTOR SUBUNIT GENES; ENVIRONMENT INTERACTIONS; LUNG-CANCER; DETERMINING SUSCEPTIBILITY; COMBINATORIAL APPROACH; EPISTATIC INTERACTIONS; POWER CALCULATIONS; NUCLEAR FAMILIES	Detection of interacting risk factors for complex traits is challenging. The choice of an appropriate method, sample size, and allocation of cases and controls are serious concerns. To provide empirical guidelines for planning such studies and data analyses, we investigated the performance of the multifactor dimensionality reduction (MDR) and generalized MDR (GMDR) methods under various experimental scenarios. We developed the mathematical expectation of accuracy and used it as an indicator parameter to perform a gene-gene interaction study. We then examined the statistical power of GMDR and MDR within the plausible range of accuracy (0.50 similar to 0.65) reported in the literature. The GMDR with covariate adjustment had a power of > 80% in a case-control design with a sample size of >= 2000, with theoretical accuracy ranging from 0.56 to 0.62. However, when the accuracy was < 0.56, a sample size of >= 4000 was required to have sufficient power. In our simulations, the GMDR outperformed the MDR under all models with accuracy ranging from 0.56 similar to 0.62 for a sample size of 1000-2000. However, the two methods performed similarly when the accuracy was outside this range or the sample was significantly larger. We conclude that with adjustment of a covariate, GMDR performs better than MDR and a sample size of 1000 similar to 2000 is reasonably large for detecting gene-gene interactions in the range of effect size reported by the current literature; whereas larger sample size is required for more subtle interactions with accuracy < 0.56.	[Chen, Guo-Bo; Xu, Yi; Xu, Hai-Ming; Zhu, Jun] Zhejiang Univ, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China; [Chen, Guo-Bo; Lou, Xiang-Yang] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Li, Ming D.] Univ Virginia, Dept Psychiat & Neurobehav Sci, Charlottesville, VA USA	Zhejiang University; University of Alabama System; University of Alabama Birmingham; University of Virginia	Chen, GB (corresponding author), Zhejiang Univ, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China.	jzhu@zju.edu.cn; xlou@ms.soph.uab.edu	Lou, Xiang-Yang/B-6291-2013; Zhu, Jun/B-9945-2009; Chen, Guo-Bo/C-2435-2009	Chen, Guo-Bo/0000-0001-5475-8237	National Institutes of Health [DA025095, DA12844, GM081488, DK080100]; National Science Foundation of China [30571131]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012844, R01DA025095] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded in part by the National Institutes of Health Grants DA025095, DA12844, GM081488, DK080100, and the National Science Foundation of China 30571131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Asselbergs FW, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-39; Beuten J, 2009, CANCER EPIDEM BIOMAR, V18, P1869, DOI 10.1158/1055-9965.EPI-09-0076; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Cattaert T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010304; Chan IHS, 2008, ALLERGY, V63, P1031, DOI 10.1111/j.1398-9995.2008.01639.x; Chen WM, 2006, GENET EPIDEMIOL, V30, P471, DOI 10.1002/gepi.20160; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HAHN L, 2004, SILICO BIOL, P4; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Heidema AG, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-23; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Iles MM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040033; Kaplan NL, 2001, THEOR POPUL BIOL, V60, P193, DOI 10.1006/tpbi.2001.1541; Kaplan NL, 1997, AM J HUM GENET, V60, P691; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lee SY, 2007, BIOINFORMATICS, V23, P2589, DOI 10.1093/bioinformatics/btm396; Li MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007055; Li MD, 2008, BIOL PSYCHIAT, V64, P951, DOI 10.1016/j.biopsych.2008.04.026; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; Lou XY, 2008, AM J HUM GENET, V83, P457, DOI 10.1016/j.ajhg.2008.09.001; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Ma DQ, 2005, AM J HUM GENET, V77, P377, DOI 10.1086/433195; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin ER, 2006, GENET EPIDEMIOL, V30, P111, DOI 10.1002/gepi.20128; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Motsinger AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-39; Motsinger AA, 2006, GENET EPIDEMIOL, V30, P546, DOI 10.1002/gepi.20166; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Neuman RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009903; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Qin SY, 2005, EUR J HUM GENET, V13, P807, DOI 10.1038/sj.ejhg.5201418; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Ritchie MD, 2003, GENET EPIDEMIOL, V24, P150, DOI 10.1002/gepi.10218; Shen CD, 2007, ANN HUM GENET, V71, P620, DOI 10.1111/j.1469-1809.2007.00364.x; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110	53	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16981	10.1371/journal.pone.0016981	http://dx.doi.org/10.1371/journal.pone.0016981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386969	gold, Green Published			2022-12-27	WOS:000287931400018
J	Li, JH; Ma, QY; Liu, H; Guo, K; Li, F; Li, W; Han, LA; Wang, FF; Wu, EX				Li, Junhui; Ma, Qingyong; Liu, Han; Guo, Kun; Li, Feng; Li, Wei; Han, Liang; Wang, Fengfei; Wu, Erxi			Relationship between Neural Alteration and Perineural Invasion in Pancreatic Cancer Patients with Hyperglycemia	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; DIABETES-MELLITUS; NEUROPATHY; PAIN; INNERVATION; RISK	Background: Patients with higher levels of fasting serum glucose have higher death rates from pancreatic cancer compared to patients with lower levels of fasting serum glucose. However, the reasons have not been studied. The goal of the current study was to examine the neural alterations in pancreatic cancer patients with hyperglycemia and to identify the relationship between the neural alterations and perineural invasion. Methodology/Principal Findings: The clinical and pathological features of 61 formalin-fixed pancreatic cancer specimens and 10 normal pancreases as controls were analyzed. Furthermore, the expression of Protein Gene Product 9.5 (PGP9.5), Myelin P0 protein (MPP), NGF, TrkA, and p75 were examined by immunohistochemistry. The median number of nerves, the median area of neural tissue, and the median nerve diameter per 10 mm 2 were larger in the hyperglycemia group than those in the euglycemia group (p = 0.007, p = 0.009, and p = 0.004, respectively). The integrated optical density (IOD) of MPP staining was lower in the hyperglycemia group than those in the euglycemia group (p = 0.019), while the expression levels of NGF and p75 were higher in the hyperglycemia group than those in the euglycemia group (p = 0.002, and p = 0.026, respectively). The nerve bundle invasion of pancreatic cancer was more frequent in the hyperglycemia group than in the euglycemia group (p = 0.000). Conclusions/Significance: Nerve damage and regeneration occur simultaneously in the tumor microenvironment of pancreatic cancer patients with hyperglycemia; the simultaneous occurrence may aggravate the process of perineural invasion. The abnormal expression of NGF and p75 may also be involved in this process and subsequently lead to a lower rate of curative surgery.	[Li, Junhui; Ma, Qingyong; Liu, Han; Guo, Kun; Li, Feng; Li, Wei; Han, Liang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China; [Li, Junhui] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Gen Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China; [Wang, Fengfei; Wu, Erxi] N Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	Xi'an Jiaotong University; Xi'an Jiaotong University; North Dakota State University Fargo	Li, JH (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Coll Med, Xian 710049, Shaanxi, Peoples R China.	qyma56@mail.xjtu.edu.cn; erxi.wu@ndsu.edu		Wu, Erxi/0000-0002-1680-3639	National Natural Scientific Foundation of China [30900705]; Scientific Grant from Xi'an City [GG06718]; ND EPSCoR	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Grant from Xi'an City; ND EPSCoR	This study was supported by the National Natural Scientific Foundation of China ( 2009 No. 30900705) and a Scientific Grant from Xi'an City ( 2009 No. GG06718) ( Q. Ma), and partially by ND EPSCoR ( E. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boucek Petr, 2006, Review of Diabetic Studies, V3, P143, DOI 10.1900/RDS.2006.3.143; Ceyhan GO, 2010, ANN SURG, V251, P923, DOI 10.1097/SLA.0b013e3181d974d4; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Ceyhan GO, 2009, AM J GASTROENTEROL, V104, P2555, DOI 10.1038/ajg.2009.380; Ceyhan GO, 2008, BEST PRACT RES CL GA, V22, P31, DOI 10.1016/j.bpg.2007.10.016; Christianson JA, 2003, EXP NEUROL, V179, P188, DOI 10.1016/S0014-4886(02)00017-1; Coughlin SS, 2004, AM J EPIDEMIOL, V159, P1160, DOI 10.1093/aje/kwh161; Dai H, 2007, HUM PATHOL, V38, P299, DOI 10.1016/j.humpath.2006.08.002; di Mola FF, 2008, LANGENBECK ARCH SURG, V393, P919, DOI 10.1007/s00423-007-0277-z; EVERHART J, 1995, JAMA-J AM MED ASSOC, V273, P1605, DOI 10.1001/jama.273.20.1605; Frade JM, 1996, NATURE, V383, P166; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hirai I, 2002, PANCREAS, V24, P15, DOI 10.1097/00006676-200201000-00003; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kayahara M, 2007, PANCREAS, V35, P218, DOI 10.1097/mpa.0b013e3180619677; Liebig C, 2009, CANCER-AM CANCER SOC, V115, P3379, DOI 10.1002/cncr.24396; Liu Bin, 2002, Hepatobiliary Pancreat Dis Int, V1, P469; Malik RA, 2005, DIABETOLOGIA, V48, P578, DOI 10.1007/s00125-004-1663-5; Matsuda M, 1983, Nihon Geka Gakkai Zasshi, V84, P719; Mitsunaga S, 2007, AM J SURG PATHOL, V31, P1636, DOI 10.1097/PAS.0b013e318065bfe6; NAKAO A, 1996, PANCREAS, V12, P361; Okusaka T, 2001, PANCREAS, V22, P279, DOI 10.1097/00006676-200104000-00009; Pannala R, 2008, GASTROENTEROLOGY, V134, P981, DOI 10.1053/j.gastro.2008.01.039; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Tomlinson DR, 2008, NAT REV NEUROSCI, V9, P36, DOI 10.1038/nrn2294; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Wang FR, 2006, CANCER EPIDEM BIOMAR, V15, P1458, DOI 10.1158/1055-9965.EPI-06-0188; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Yi SQ, 2003, PANCREAS, V27, P225, DOI 10.1097/00006676-200310000-00005; Zhan YS, 2010, MED ONCOL, V27, P177, DOI 10.1007/s12032-009-9189-9; Zochodne DW, 2007, MUSCLE NERVE, V36, P144, DOI 10.1002/mus.20785	31	36	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17385	10.1371/journal.pone.0017385	http://dx.doi.org/10.1371/journal.pone.0017385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386984	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400067
J	Burgess, K; Xu, TS; Brown, R; Han, BJ; Welle, S				Burgess, Kerri; Xu, Tianshun; Brown, Roger; Han, Bajin; Welle, Stephen			Effect of Myostatin Depletion on Weight Gain, Hyperglycemia, and Hepatic Steatosis during Five Months of High-Fat Feeding in Mice	PLOS ONE			English	Article							MUSCLE GROWTH; INSULIN-RESISTANCE; TRANSGENIC MICE; DEFICIENT MICE; MATURE MICE; EXPRESSION; KNOCKOUT; OBESITY; DIET; MASS	The marked hypermuscularity in mice with constitutive myostatin deficiency reduces fat accumulation and hyperglycemia induced by high-fat feeding, but it is unclear whether the smaller increase in muscle mass caused by postdevelopmental loss of myostatin activity has beneficial metabolic effects during high-fat feeding. We therefore examined how postdevelopmental myostatin knockout influenced effects of high-fat feeding. Male mice with ubiquitous expression of tamoxifen-inducible Cre recombinase were fed tamoxifen for 2 weeks at 4 months of age. This depleted myostatin in mice with floxed myostatin genes, but not in control mice with normal myostatin genes. Some mice were fed a high-fat diet (60% of energy) for 22 weeks, starting 2 weeks after cessation of tamoxifen feeding. Myostatin depletion increased skeletal muscle mass similar to 30%. Hypermuscular mice had similar to 50% less weight gain than control mice over the first 8 weeks of high-fat feeding. During the subsequent 3 months of high-fat feeding, additional weight gain was similar in control and myostatin-deficient mice. After 5 months of high-fat feeding, the mass of epididymal and retroperitoneal fat pads was similar in control and myostatin-deficient mice even though myostatin depletion reduced the weight gain attributable to the high-fat diet (mean weight with high-fat diet minus mean weight with low-fat diet: 19.9 g in control mice, 14.1 g in myostatin-deficient mice). Myostatin depletion did not alter fasting blood glucose levels after 3 or 5 months of high-fat feeding, but reduced glucose levels measured 90 min after intraperitoneal glucose injection. Myostatin depletion also attenuated hepatic steatosis and accumulation of fat in muscle tissue. We conclude that blocking myostatin signaling after maturity can attenuate some of the adverse effects of a high-fat diet.	[Burgess, Kerri; Welle, Stephen] Univ Rochester, Dept Med, Div Endocrinol & Metab, Rochester, NY 14627 USA; [Xu, Tianshun; Brown, Roger; Han, Bajin] GlaxoSmithKline Res & Dev Ltd, Muscle Metab DPU & Platform Technol & Sci, Res Triangle Pk, NC USA	University of Rochester; GlaxoSmithKline	Burgess, K (corresponding author), Univ Rochester, Dept Med, Div Endocrinol & Metab, Rochester, NY 14627 USA.	stephen_welle@urmc.rochester.edu			National Institutes of Health [AR054366]; GlaxoSmithKline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054366] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported by the National Institutes of Health (grant number AR054366) and GlaxoSmithKline. GlaxoSmithKline scientists listed as coauthors contributed to study design, data collection, and manuscript preparation.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Bernardo BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011307; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hamrick MW, 2006, INT J OBESITY, V30, P868, DOI 10.1038/sj.ijo.0803200; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Koncarevic A, 2010, ENDOCRINOLOGY, V151, P4289, DOI 10.1210/en.2010-0134; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lin J, 2002, BIOCHEM BIOPH RES CO, V291, P701, DOI 10.1006/bbrc.2002.6500; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Morissette MR, 2009, AGING CELL, V8, P573, DOI 10.1111/j.1474-9726.2009.00508.x; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Personius KE, 2010, J APPL PHYSIOL, V109, P886, DOI 10.1152/japplphysiol.00300.2010; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Welle S, 2009, AM J PHYSIOL-ENDOC M, V297, pE935, DOI 10.1152/ajpendo.00179.2009; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Yang JZ, 2006, MOL REPROD DEV, V73, P462, DOI 10.1002/mrd.20452; Yang JZ, 2001, MOL REPROD DEV, V60, P351, DOI 10.1002/mrd.1097; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	23	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17090	10.1371/journal.pone.0017090	http://dx.doi.org/10.1371/journal.pone.0017090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390326	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700029
J	Campana, SE; Dorey, A; Fowler, M; Joyce, W; Wang, ZL; Wright, D; Yashayaev, I				Campana, Steven E.; Dorey, Anna; Fowler, Mark; Joyce, Warren; Wang, Zeliang; Wright, Dan; Yashayaev, Igor			Migration Pathways, Behavioural Thermoregulation and Overwintering Grounds of Blue Sharks in the Northwest Atlantic	PLOS ONE			English	Article							PRIONACE-GLAUCA; DIVING BEHAVIOR; XIPHIAS-GLADIUS; THERMAL BIOLOGY; PELAGIC SHARKS; MOVEMENTS; OCEAN; TEMPERATURE; CEPHALOPODS; SWORDFISH	The blue shark Prionace glauca is the most abundant large pelagic shark in the Atlantic Ocean. Although recaptures of tagged sharks have shown that the species is highly migratory, migration pathways towards the overwintering grounds remain poorly understood. We used archival satellite pop-up tags to track 23 blue sharks over a mean period of 88 days as they departed the coastal waters of North America in the autumn. Within 1-2 days of entering the Gulf Stream (median date of 21 Oct), all sharks initiated a striking diel vertical migration, taking them from a mean nighttime depth of 74 m to a mean depth of 412 m during the day as they appeared to pursue vertically migrating squid and fish prey. Although functionally blind at depth, calculations suggest that there would be a similar to 2.5-fold thermoregulatory advantage to swimming and feeding in the markedly cooler deep waters, even if there was any reduced foraging success associated with the extreme depth. Noting that the Gulf Stream current speeds are reduced at depth, we used a detailed circulation model of the North Atlantic to examine the influence of the diving behaviour on the advection experienced by the sharks. However, there was no indication that the shark diving resulted in a significant modification of their net migratory pathway. The relative abundance of deep-diving sharks, swordfish, and sperm whales in the Gulf Stream and adjacent waters suggests that it may serve as a key winter feeding ground for large pelagic predators in the North Atlantic.	[Campana, Steven E.; Dorey, Anna; Fowler, Mark; Joyce, Warren; Wang, Zeliang; Wright, Dan; Yashayaev, Igor] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada	Bedford Institute of Oceanography; Fisheries & Oceans Canada	Campana, SE (corresponding author), Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1006, Dartmouth, NS B2Y 4A2, Canada.	steven.campana@dfo-mpo.gc.ca	Campana, Steven/C-3420-2013; Campana, Steven/L-7918-2019	Campana, Steven/0000-0001-8802-3976; Campana, Steven/0000-0002-7453-3761; Yashayaev, Igor/0000-0002-6976-7803	Fisheries and Oceans Canada	Fisheries and Oceans Canada	Funding was provided by Fisheries and Oceans Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-da-Silva AM, 2008, FISH RES, V92, P41, DOI 10.1016/j.fishres.2007.12.019; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Buencuerpo V, 1998, FISH B-NOAA, V96, P667; Campana SE, 2006, CAN J FISH AQUAT SCI, V63, P670, DOI 10.1139/f05-251; Campana SE, 2010, CAN J FISH AQUAT SCI, V67, P769, DOI 10.1139/F10-020; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; CAREY FG, 1981, FISH B-NOAA, V79, P277; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; Casey J.G., 1991, Underwater Naturalist, V19-20, P87; Casey JG, 1985, WORLD ANGLING RESOUR, P253; Childress JJ, 1998, J EXP BIOL, V201, P1223; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P949, DOI 10.1017/S0025315400057672; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; DAWE E G, 1985, Vie et Milieu, V35, P139; DAWE EG, 1988, MALACOLOGIA, V29, P235; Dowd WW, 2006, FISH B-NOAA, V104, P323; FEDULOV TP, 1986, OCEANOLOGY, V26, P229; Fristrup KM, 2002, MAR MAMMAL SCI, V18, P42, DOI 10.1111/j.1748-7692.2002.tb01017.x; GRUBER SH, 1967, SHARKS SKATES RAYS, P479; Henderson AC, 2001, J FISH BIOL, V58, P1347, DOI 10.1111/j.1095-8649.2001.tb02291.x; Hendrickson L. C., 2004, NMFSNE191 NOAA; *INT COMM CONS ATL, 2009, REP STAND COMM RES S, P270; *INT COMM CONV ATL, 2008, SCRS2008017 ICCAT; Kawahara S., 1985, NAFO SCI COUN STUDIE, V9, P59; KINZER J, 1985, MAR BIOL, V85, P313, DOI 10.1007/BF00393252; KITIGAWA T, 2006, FISHERIES SCI, V72, P149; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Kohler Nancy E., 2002, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V54, P1231; KOHLER NE, 2008, SHARKS OPEN OCEAN BI, P00339; MADEC G, 1998, NOTES LPSL U P M CUR; Mandelman JW, 2008, REV FISH BIOL FISHER, V18, P427, DOI 10.1007/s11160-008-9084-z; McNeil JD, 1999, J GEOPHYS RES-OCEANS, V104, P15537, DOI 10.1029/1999JC900137; Mejuto J., 2008, 2008045 ICCAT SCRS; MEJUTO J, 2005, AQUAT LIVING RESOUR, V23, P25; Nakamura Yoshikazu, 1993, P331; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; NAKANO H, 2008, J MAR BIOL ASSOC UK, V56, P929; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Parsons T.R., 1984, BIOL OCEANOGRAPHIC P, V3rd; Queiroz N, 2010, MAR ECOL PROG SER, V406, P265, DOI 10.3354/meps08500; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; Roper C.F.E., 1975, Smithsonian Contributions to Zoology, VNo. 209, P1; STEVENS JD, 1990, J MAR BIOL ASSOC UK, V70, P707, DOI 10.1017/S0025315400058999; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Stevens JD, 2010, MAR BIOL, V157, P575, DOI 10.1007/s00227-009-1343-6; Tanaka H, 2000, J EXP BIOL, V203, P1825; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Thompson KR, 2006, OCEAN MODEL, V13, P109, DOI 10.1016/j.ocemod.2005.11.003; VOVK A N, 1978, Malacological Review, V11, P130; Walker TI, 1998, MAR FRESHWATER RES, V49, pIII; Waring Gordon T., 1993, Fisheries Oceanography, V2, P101, DOI 10.1111/j.1365-2419.1993.tb00126.x; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025; Wright DG, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003200; WROBLEWSKI JS, 1989, LIMNOL OCEANOGR, V34, P1563, DOI 10.4319/lo.1989.34.8.1563; [No title captured]	61	90	93	2	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16854	10.1371/journal.pone.0016854	http://dx.doi.org/10.1371/journal.pone.0016854			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373198	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500019
J	Kigen, G; Kimaiyo, S; Nyandiko, W; Faragher, B; Sang, E; Jakait, B; Owen, A; Back, D; Gibbons, S; Seden, K; Khoo, SH				Kigen, Gabriel; Kimaiyo, Sylvester; Nyandiko, Winstone; Faragher, Brian; Sang, Edwin; Jakait, Beatrice; Owen, Andrew; Back, David; Gibbons, Sara; Seden, Kay; Khoo, Saye H.		USAID-Acad Model Prevention	Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort	PLOS ONE			English	Article							HEALTHY-VOLUNTEERS; THERAPY; PHARMACOKINETICS; INHIBITORS; INFECTION; RISK	Background: Clinically significant drug-drug interactions (CSDIs) involving antiretrovirals are frequent and under-recognized in developed countries, but data are lacking for developing countries. Methodology and Principal Findings: To investigate the prevalence of CSDIs between antiretrovirals and coadministered drugs, we surveyed prescriptions dispensed in a large HIV clinic in Kenya. Of 1040 consecutive patients screened, 996 were eligible for inclusion. CSDIs were defined as 'major' (capable of causing severe or permanent damage, contraindicated, avoid or not recommended by the manufacturer, or requiring dose modification) or 'moderate' (manufacturers advise caution, or close monitoring, or capable of causing clinical deterioration). A total of 334 patients (33.5%) were at risk for a CSDI, potentially lowering antiretroviral drug concentrations in 120 (12%) patients. Major interactions most frequently involved rifampicin (12.4%, mostly with efavirenz) and azoles (2.7%) whereas moderate interactions were frequently azoles (13%), steroids (11%), and antimalarials (3%). Multivariable analyses suggested that patients at risk for CSDIs had lower CD4 counts (P = 0.006) and baseline weight (P = 0.023) and WHO Stage 3 or 4 disease (P <= 0.007). Risk for CSDIs was not associated with particular regimens, although only 116 (11.6%) patients were receiving WHO second line regimens. Conclusions: One in three patients receiving antiretrovirals in our programme were at risk of CSDIs. Strategies need to be urgently developed to avoid important drug interactions, to identify early markers of toxicity and to manage unavoidable interactions safely in order to reduce risk of harm, and to maximize the effectiveness of mass antiretroviral deployment in Africa.	[Kigen, Gabriel; Jakait, Beatrice] Moi Univ, Sch Med, Dept Pharmacol & Toxicol, Eldoret, Kenya; [Kigen, Gabriel; Owen, Andrew; Back, David; Gibbons, Sara; Khoo, Saye H.] Univ Liverpool, Dept Pharmacol, Inst Translat Med, Liverpool L69 3BX, Merseyside, England; [Kimaiyo, Sylvester; Nyandiko, Winstone; Sang, Edwin] Moi Univ, Sch Med, USAID Acad Model Providing Access Healthcare AMPA, Eldoret, Kenya; [Faragher, Brian] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Seden, Kay; Khoo, Saye H.] Royal Liverpool Univ Hosp, NIHR Biomed Res Ctr Microbial Dis, Liverpool, Merseyside, England	Moi University; University of Liverpool; Moi University; United States Agency for International Development (USAID); Liverpool School of Tropical Medicine; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool	Kigen, G (corresponding author), Moi Univ, Sch Med, Dept Pharmacol & Toxicol, Eldoret, Kenya.	khoo@liv.ac.uk	Kigen, Gabriel K/C-8494-2018; Owen, Andrew/M-7509-2017	Kigen, Gabriel K/0000-0002-5047-4066; Owen, Andrew/0000-0002-9819-7651; Seden, Kay/0000-0001-6612-7344	United States Agency for International Development; Government of Kenya; British HIV Association; European AIDS Clinical Society; International Conference on Drug Therapies in HIV Infection; Elton John AIDS Foundation; GlaxoSmithKline; Abbott; Merck; Bristol Myers Squibb; Boehringer Ingelheim; Tibotec; Gilead; Pfizer; National Institute of Health Research (NIHR - Department of Health); Northwest Development Agency (NWDA); UK National Institute for Health Research; Medical Research Council [G0901364, G0800247] Funding Source: researchfish; MRC [G0901364, G0800247] Funding Source: UKRI	United States Agency for International Development(United States Agency for International Development (USAID)); Government of Kenya; British HIV Association; European AIDS Clinical Society; International Conference on Drug Therapies in HIV Infection; Elton John AIDS Foundation; GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Merck(Merck & Company); Bristol Myers Squibb(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Tibotec; Gilead(Gilead Sciences); Pfizer(Pfizer); National Institute of Health Research (NIHR - Department of Health)(National Institute for Health Research (NIHR)); Northwest Development Agency (NWDA); UK National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported in part by a grant to the USAID-AMPATH Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR). GK received a scholarship from the Government of Kenya for PhD studies in Liverpool. The Liverpool HIV Drug Interaction Website receives support from the British HIV Association, The European AIDS Clinical Society, the International Conference on Drug Therapies in HIV Infection and the Elton John AIDS Foundation, as well as GlaxoSmithKline, Abbott, Merck, Bristol Myers Squibb, Boehringer Ingelheim, Tibotec, Gilead, Pfizer and infrastructural and project support from the National Institute of Health Research (NIHR - Department of Health) and the Northwest Development Agency (NWDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Liverpool Drug Interactions website (DJB, SK, SG) receives sponsorship from GlaxoSmithKline, Abbott, Merck, Bristol Myers Squibb, Boehringer Ingelheim, Tibotec, Gilead, Pfizer. The website also receives funding from the UK National Institute for Health Research, the British HIV Association, The European AIDS Clinical Society and proceeds from the International Conference on Drug Therapies in HIV Infection. All other authors have declared no other competing interests from other sources with the submitted work and no financial relationships between themselves, their spouses, partners, or children relevant to the submitted work. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Berrey MM, 2001, J INFECT DIS, V183, P1466, DOI 10.1086/320189; *BOEHR ING INT GMB, 2007, VIR SUMM PROD CHAR; Boulanger C, 2009, CLIN INFECT DIS, V49, P1305, DOI 10.1086/606056; Boulle A, 2008, JAMA-J AM MED ASSOC, V300, P530, DOI 10.1001/jama.300.5.530; *BRIST MYERS SQUIB, 2007, SUST SUMM PROD CHAR; Davies G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005159.pub2; DAVIES MA, 2010, J ACQUIR IMMUNE DEFI; de Maat MMR, 2003, CLIN PHARMACOKINET, V42, P223, DOI 10.2165/00003088-200342030-00002; Evans-Jones JG, 2010, CLIN INFECT DIS, V50, P1419, DOI 10.1086/652149; German P, 2009, JAIDS-J ACQ IMM DEF, V51, P424, DOI 10.1097/QAI.0b013e3181acb4ff; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Huang LY, 2001, DRUG METAB DISPOS, V29, P754; la Porte CJL, 2004, ANTIMICROB AGENTS CH, V48, P1553, DOI 10.1128/AAC.48.5.1553-1560.2004; LAMSON M, 1998, INT C AIDS, V12, P55; Maat MMR, 2004, J CLIN PHARM THER, V29, P121, DOI 10.1111/j.1365-2710.2003.00541.x; Marseille E, 2009, APPL HEALTH ECON HEA, V7, P229, DOI 10.2165/11318740-000000000-00000; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; MCILLERON H, 2011, ANTIVIR THE IN PRESS; Miller CD, 2007, PHARMACOTHERAPY, V27, P1379, DOI 10.1592/phco.27.10.1379; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; NASCOP NASCOP, 2005, GUID ANT DRUG THER K; Ramachandran G, 2006, JAIDS-J ACQ IMM DEF, V42, P36; Robertson SM, 2007, EXPERT OPIN PHARMACO, V8, P2947, DOI 10.1517/14656566.8.17.2947; SHAH S, 2007, 14 C RETR OPP INF FE; Smith PF, 2001, CLIN PHARMACOKINET, V40, P893, DOI 10.2165/00003088-200140120-00002; *TATR, 2008, DRUG INT FACTS FACTS; Wakeham K, 2010, J ANTIMICROB CHEMOTH, V65, P316, DOI 10.1093/jac/dkp451; WHO, ANT THER HIV INF AD; Young B, 2005, AIDS PATIENT CARE ST, V19, P286, DOI 10.1089/apc.2005.19.286	29	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16800	10.1371/journal.pone.0016800	http://dx.doi.org/10.1371/journal.pone.0016800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373194	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500018
J	Khan, JM; Ranganathan, S				Khan, Javed Mohammed; Ranganathan, Shoba			Understanding TR Binding to pMHC Complexes: How Does a TR Scan Many pMHC Complexes yet Preferentially Bind to One	PLOS ONE			English	Article							CELL-RECEPTOR RECOGNITION; CLASS-II MOLECULE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CONFORMATIONAL-CHANGES; SELF-PEPTIDE; HIGH-AFFINITY; MEAN FORCE; MHC; TCR	Understanding the basis of the binding of a T cell receptor (TR) to the peptide-MHC (pMHC) complex is essential due to the vital role it plays in adaptive immune response. We describe the use of computed binding (free) energy (BE), TR paratope, pMHC epitope, molecular surface electrostatic potential (MSEP) and calculated TR docking angle (h) to analyse 61 TR/pMHC crystallographic structures to comprehend TR/pMHC interaction. In doing so, we have successfully demonstrated a novel/rational approach for h calculation, obtained a linear correlation between BE and h without any "codon'' or amino acid preference, provided an explanation for TR ability to scan many pMHC ligands yet specifically bind one, proposed a mechanism for pMHC recognition by TR leading to T cell activation and illustrated the importance of the peptide in determining TR specificity, challenging the "germline bias'' theory.	[Khan, Javed Mohammed; Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Khan, Javed Mohammed; Ranganathan, Shoba] Macquarie Univ, ARC Ctr Excellence Bioinformat, Sydney, NSW 2109, Australia; [Ranganathan, Shoba] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Macquarie University; Macquarie University; National University of Singapore	Khan, JM (corresponding author), Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia.	shoba.ranganathan@mq.edu.au		Ranganathan, Shoba/0000-0002-8290-813X	Macquarie University	Macquarie University	JMK gratefully acknowledges the award of a Macquarie University Research Excellence Scholarship. We also thank Mr. H.R. Cheruku, Macquarie University, Sydney for assistance. Open access publication charges were borne by Macquarie University.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Archbold JK, 2009, J EXP MED, V206, P209, DOI 10.1084/jem.20082136; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Buslepp J, 2003, IMMUNITY, V19, P595, DOI 10.1016/S1074-7613(03)00269-3; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Chlewicki LK, 2005, J MOL BIOL, V346, P223, DOI 10.1016/j.jmb.2004.11.057; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hulsmeyer M, 2005, J BIOL CHEM, V280, P2972, DOI 10.1074/jbc.M411323200; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ishizuka J, 2008, IMMUNITY, V28, P171, DOI 10.1016/j.immuni.2007.12.018; Jerne NK, 2004, EUR J IMMUNOL, V34, P1234, DOI 10.1002/eji.200425132; Kaas Q, 2004, NUCLEIC ACIDS RES, V32, pD208, DOI 10.1093/nar/gkh042; Kaas Q, 2008, IMMUNOMICS REV, P19, DOI 10.1007/978-0-387-72968-8_2; Kaas Quentin, 2005, In Silico Biology, V5, P505; Khan Javed Mohammed, 2010, Immunome Res, V6 Suppl 1, pS2, DOI 10.1186/1745-7580-6-S1-S2; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P917, DOI 10.1016/j.dci.2005.03.003; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Lefranc MP, 2001, T CELL RECEPTOR FACT; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Macdonald WA, 2009, IMMUNITY, V31, P897, DOI 10.1016/j.immuni.2009.09.025; Mazza C, 2007, EMBO J, V26, P1972, DOI 10.1038/sj.emboj.7601605; McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987; Miller PJ, 2007, J MOL BIOL, V373, P315, DOI 10.1016/j.jmb.2007.07.028; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Reiser JB, 2000, NAT IMMUNOL, V1, P291, DOI 10.1038/79728; Reiser JB, 2002, IMMUNITY, V16, P345, DOI 10.1016/S1074-7613(02)00288-1; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Stewart-Jones G, 2009, P NATL ACAD SCI USA, V106, P5784, DOI 10.1073/pnas.0901425106; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Wang LM, 2007, NAT STRUCT MOL BIOL, V14, P169, DOI 10.1038/nsmb1193; WEINER PK, 1982, P NATL ACAD SCI-BIOL, V79, P3754, DOI 10.1073/pnas.79.12.3754; Wilson IA, 1999, SCIENCE, V286, P1867, DOI 10.1126/science.286.5446.1867; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51; Yoshida K, 2010, J CLIN INVEST, V120, P1578, DOI 10.1172/JCI41502; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	60	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17194	10.1371/journal.pone.0017194	http://dx.doi.org/10.1371/journal.pone.0017194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364947	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600034
J	Aeby, GS; Williams, GJ; Franklin, EC; Haapkyla, J; Harvell, CD; Neale, S; Page, CA; Raymundo, L; Vargas-Angel, B; Willis, BL; Work, TM; Davy, SK				Aeby, Greta S.; Williams, Gareth J.; Franklin, Erik C.; Haapkyla, Jessica; Harvell, C. Drew; Neale, Stephen; Page, Cathie A.; Raymundo, Laurie; Vargas-Angel, Bernardo; Willis, Bette L.; Work, Thierry M.; Davy, Simon K.			Growth Anomalies on the Coral Genera Acropora and Porites Are Strongly Associated with Host Density and Human Population Size across the Indo-Pacific	PLOS ONE			English	Article							BLACK BAND DISEASE; EMERGING INFECTIOUS-DISEASES; CLIMATE-CHANGE; TRANSMISSION DYNAMICS; METAGENOMIC ANALYSIS; NUTRIENT ENRICHMENT; HAWAIIAN-ISLANDS; GREEN TURTLES; WATER-QUALITY; FLORIDA-KEYS	Growth anomalies (GAs) are common, tumor-like diseases that can cause significant morbidity and decreased fecundity in the major Indo-Pacific reef-building coral genera, Acropora and Porites. GAs are unusually tractable for testing hypotheses about drivers of coral disease because of their pan-Pacific distributions, relatively high occurrence, and unambiguous ease of identification. We modeled multiple disease-environment associations that may underlie the prevalence of Acropora growth anomalies (AGA) (n = 304 surveys) and Porites growth anomalies (PGA) (n = 602 surveys) from across the Indo-Pacific. Nine predictor variables were modeled, including coral host abundance, human population size, and sea surface temperature and ultra-violet radiation anomalies. Prevalence of both AGAs and PGAs were strongly host density-dependent. PGAs additionally showed strong positive associations with human population size. Although this association has been widely posited, this is one of the first broad-scale studies unambiguously linking a coral disease with human population size. These results emphasize that individual coral diseases can show relatively distinct patterns of association with environmental predictors, even in similar diseases (growth anomalies) found on different host genera (Acropora vs. Porites). As human densities and environmental degradation increase globally, the prevalence of coral diseases like PGAs could increase accordingly, halted only perhaps by declines in host density below thresholds required for disease establishment.	[Aeby, Greta S.; Franklin, Erik C.] Hawaii Inst Marine Biol, Kaneohe, HI USA; [Williams, Gareth J.; Davy, Simon K.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Williams, Gareth J.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Haapkyla, Jessica; Neale, Stephen; Page, Cathie A.; Willis, Bette L.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Haapkyla, Jessica; Neale, Stephen; Page, Cathie A.; Willis, Bette L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Harvell, C. Drew] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Raymundo, Laurie] Univ Guam, Marine Lab, Univ Guam UOG Stn, Mangilao, GU 96923 USA; [Vargas-Angel, Bernardo] Univ Hawaii, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Work, Thierry M.] US Geol Survey, Natl Wildlife Hlth Ctr, Honolulu Field Stn, Honolulu, HI USA	Victoria University Wellington; University of California System; University of California San Diego; Scripps Institution of Oceanography; James Cook University; James Cook University; Cornell University; Australian Institute of Marine Science; University of Guam; University of Hawaii System; United States Department of the Interior; United States Geological Survey	Aeby, GS (corresponding author), Hawaii Inst Marine Biol, Kaneohe, HI USA.	greta@hawaii.edu; gareth@ucsd.edu	Raymundo, Laurie/AAE-5230-2020; Work, Thierry M/F-1550-2015	Work, Thierry M/0000-0002-4426-9090; Davy, Simon/0000-0003-3584-5356; Franklin, Erik/0000-0002-8660-3085; Williams, Dr Gareth J./0000-0001-7837-1619	Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); National Aeronautics and Space Administration [NAS5-03117]; Office of National Marine Sanctuaries (NWHICRER) [MOA-2005-008/6882]; Australian Research Council; Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group; NOAA; Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division; Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; National Geographic Society	Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Office of National Marine Sanctuaries (NWHICRER); Australian Research Council(Australian Research Council); Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division; Victoria University of Wellington (VUW); New Zealand International Doctoral Research Scholarship; National Geographic Society(National Geographic Society)	Funding: Human population data was provided by the Center for International Earth Science Information Network (CIESIN), Columbia University; United Nations Food and Agriculture Programme (FAO); and Centro Internacional de Agricultura Tropical (CIAT) with funding from the National Aeronautics and Space Administration under Contract NAS5-03117 for the Continued Operation of the Socioeconomic Data and Applications Center (SEDAC). GA gratefully acknowledges funding from the Office of National Marine Sanctuaries (NWHICRER MOA-2005-008/6882). BW acknowledges funding from the Australian Research Council and the Global Environment Fund (GEF)/World Bank CRTR Program Coral Disease Working Group. BVA's work was supported by the NOAA Coral Reef Conservation Program and the Pacific Islands Fisheries Science Center's Coral Reef Ecosystem Division. GW was supported by a Victoria University of Wellington (VUW) Vice-Chancellor's Strategic Research Scholarship and a New Zealand International Doctoral Research Scholarship. GW was additionally funded by grants from the National Geographic Society and the VUW Research Fund awarded to SD. LR was supported by the GEF/CRTR and the NOAA Coral Reef Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeby GS, 2010, DIS AQUAT ORGAN, V91, P1, DOI 10.3354/dao02247; Aeby GS, 2007, B MAR SCI, V80, P209; Aeby Greta Smith, 2006, Atoll Research Bulletin, P471; Aeby GS, 1998, J PARASITOL, V84, P1259, DOI 10.2307/3284684; Aguirre AA, 2008, ANN NY ACAD SCI, V1149, P1, DOI 10.1196/annals.1428.052; Altizer SM, 1997, P ROY SOC B-BIOL SCI, V264, P807, DOI 10.1098/rspb.1997.0113; ANDERS K, 1994, DIS AQUAT ORGAN, V19, P215, DOI 10.3354/dao019215; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Aronson RB, 2001, HYDROBIOLOGIA, V460, P25, DOI 10.1023/A:1013103928980; BAK RPM, 1983, MAR BIOL, V77, P221, DOI 10.1007/BF00395810; Baker DM, 2007, MAR ECOL PROG SER, V343, P123, DOI 10.3354/meps06937; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Begon M, 1998, ECOL LETT, V1, P82; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berthier K, 2000, P ROY SOC B-BIOL SCI, V267, P2049, DOI 10.1098/rspb.2000.1248; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blanford S, 2003, ECOL LETT, V6, P2, DOI 10.1046/j.1461-0248.2003.00387.x; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Boyett HV, 2007, MAR BIOL, V151, P1711, DOI 10.1007/s00227-006-0603-y; Bradley CA, 2007, TRENDS ECOL EVOL, V22, P95, DOI 10.1016/j.tree.2006.11.001; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown CR, 2004, ECOLOGY, V85, P1619, DOI 10.1890/03-0206; Bruckner AW, 2009, DIS AQUAT ORGAN, V87, P19, DOI 10.3354/dao02120; BRUCKNER AW, 1997, P 8 INT COR REEF S, V1, P601; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cheney D P, 1975, Adv Exp Med Biol, V64, P77; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Coles SL, 1998, CORAL REEFS, V17, P195, DOI 10.1007/s003380050118; Coyner DF, 2002, J WILDLIFE DIS, V38, P483, DOI 10.7589/0090-3558-38.3.483; Daszak P, 2001, ACTA TROP, V78, P103, DOI 10.1016/S0001-706X(00)00179-0; Davy SK, 2006, DIS AQUAT ORGAN, V69, P101, DOI 10.3354/dao069101; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Dobson A, 2001, PHILOS T R SOC B, V356, P1001, DOI 10.1098/rstb.2001.0900; Domart-Coulon IJ, 2006, CORAL REEFS, V25, P531, DOI 10.1007/s00338-006-0133-6; EDMUNDS PJ, 1991, CORAL REEFS, V10, P161, DOI 10.1007/BF00572175; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Garzon-Ferreira J, 2001, HYDROBIOLOGIA, V460, P65, DOI 10.1023/A:1013133818360; Gateno D, 2003, MAR ECOL PROG SER, V258, P97, DOI 10.3354/meps258097; Geiser DM, 1998, NATURE, V394, P137, DOI 10.1038/28079; Gorley C.K., 2006, GETTING STARTED PRIM; Haapkyla J, 2007, J MAR BIOL ASSOC UK, V87, P403, DOI 10.1017/S0025315407055828; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jordan-Dahlgren E, 2004, CORAL HEALTH AND DISEASE, P105; Kaczmarsky L, 2007, J INVERTEBR PATHOL, V94, P218, DOI 10.1016/j.jip.2006.11.007; Kim Kiho, 2002, P813; Kuta KG, 1996, CORAL REEFS, V15, P219, DOI 10.1007/BF01787455; Kuta KG, 2002, CORAL REEFS, V21, P393, DOI 10.1007/s00338-002-0261-6; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCallum H, 2001, TRENDS ECOL EVOL, V16, P295, DOI 10.1016/S0169-5347(01)02144-9; McClanahan TR, 2009, GLOBAL CHANGE BIOL, V15, P1804, DOI 10.1111/j.1365-2486.2008.01799.x; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Myers RL, 2009, DIS AQUAT ORGAN, V87, P97, DOI 10.3354/dao02139; Nugues MM, 2002, MAR ECOL PROG SER, V229, P61, DOI 10.3354/meps229061; Page C, 2006, DIS AQUAT ORGAN, V69, P41, DOI 10.3354/dao069041; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Peters EC, 1997, ENVIRON TOXICOL CHEM, V16, P12, DOI [10.1002/etc.5620160103, 10.1897/1551-5028(1997)016&lt;0012:EOTME&gt;2.3.CO;2]; PETERS EC, 1986, JNCI-J NATL CANCER I, V76, P895; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Ramsey D, 2002, J APPL ECOL, V39, P806, DOI 10.1046/j.1365-2664.2002.00760.x; Raymundo LJ, 2005, DIS AQUAT ORGAN, V64, P181, DOI 10.3354/dao064181; Raymundo LJH, 2003, DIS AQUAT ORGAN, V56, P95, DOI 10.3354/dao056095; Richardson LL, 2009, DIS AQUAT ORGAN, V87, P79, DOI 10.3354/dao02083; Richardson LL, 2005, MAR ECOL PROG SER, V297, P147, DOI 10.3354/meps297147; Richardson LL, 2004, CORAL HEALTH AND DISEASE, P325; Rosenberg E, 1999, MICROBIAL ECOLOGY AND INFECTIOUS DISEASE, P242; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Santavy DL, 2001, HYDROBIOLOGIA, V460, P39, DOI 10.1023/A:1013194422440; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Selig ER, 2010, GLOBAL ECOL BIOGEOGR, V19, P397, DOI 10.1111/j.1466-8238.2009.00522.x; Smith GW, 1996, NATURE, V383, P487, DOI 10.1038/383487a0; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Thurber RLV, 2008, P NATL ACAD SCI USA, V105, P18413, DOI 10.1073/pnas.0808985105; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Van Houtan KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012900; Vargas-Angel B, 2009, B MAR SCI, V84, P211; Veron J. E., 2000, CORALS WORLD, V1; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Ward JR, 2007, MAR ECOL PROG SER, V329, P115, DOI 10.3354/meps329115; Wetz JJ, 2004, MAR POLLUT BULL, V48, P698, DOI 10.1016/j.marpolbul.2003.09.008; Williams GJ, 2008, CORAL REEFS, V27, P207, DOI 10.1007/s00338-007-0314-y; Williams GJ, 2011, J INVERTEBR PATHOL, V106, P165, DOI 10.1016/j.jip.2010.08.002; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Williams GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009264; Winkler R, 2004, MAR ECOL-P S Z N I, V25, P129, DOI 10.1111/j.1439-0485.2004.00020.x; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011; Work TM, 2008, DIS AQUAT ORGAN, V78, P255, DOI 10.3354/dao01881; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2001, J WILDLIFE DIS, V37, P574, DOI 10.7589/0090-3558-37.3.574; Yamashiro H, 2000, DIS AQUAT ORGAN, V41, P211, DOI 10.3354/dao041211; [No title captured]; [No title captured]; [No title captured]	108	60	60	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16887	10.1371/journal.pone.0016887	http://dx.doi.org/10.1371/journal.pone.0016887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365011	Green Published, Green Accepted, gold			2022-12-27	WOS:000287482800020
J	Celino, FT; Yamaguchi, S; Miura, C; Ohta, T; Tozawa, Y; Iwai, T; Miura, T				Celino, Fritzie T.; Yamaguchi, Sonoko; Miura, Chiemi; Ohta, Takashi; Tozawa, Yuzuru; Iwai, Toshiharu; Miura, Takeshi			Tolerance of Spermatogonia to Oxidative Stress Is Due to High Levels of Zn and Cu/Zn Superoxide Dismutase	PLOS ONE			English	Article							PROTEIN-SYNTHESIS SYSTEM; MALE JAPANESE EEL; REACTIVE OXYGEN; ANGUILLA-JAPONICA; ZINC-DEFICIENCY; FREE-RADICALS; HEAT-STRESS; FISH SPERMATOGENESIS; MALE-INFERTILITY; GENE-EXPRESSION	Background: Spermatogonia are highly tolerant to reactive oxygen species (ROS) attack while advanced-stage germ cells such as spermatozoa are much more susceptible, but the precise reason for this variation in ROS tolerance remains unknown. Methodology/Principal Findings: Using the Japanese eel testicular culture system that enables a complete spermatogenesis in vitro, we report that advanced-stage germ cells undergo intense apoptosis and exhibit strong signal for 8-hydroxy-29-deoxyguanosine, an oxidative DNA damage marker, upon exposure to hypoxanthine-generated ROS while spermatogonia remain unaltered. Activity assay of antioxidant enzyme, superoxide dismutase (SOD) and Western blot analysis using an anti-Copper/Zinc (Cu/Zn) SOD antibody showed a high SOD activity and Cu/Zn SOD protein concentration during early spermatogenesis. Immunohistochemistry showed a strong expression for Cu/Zn SOD in spermatogonia but weak expression in advanced-stage germ cells. Zn deficiency reduced activity of the recombinant eel Cu/Zn SOD protein. Cu/Zn SOD siRNA decreased Cu/Zn SOD expression in spermatogonia and led to increased oxidative damage. Conclusions/Significance: These data indicate that the presence of high levels of Cu/Zn SOD and Zn render spermatogonia resistant to ROS, and consequently protected from oxidative stress. These findings provide the biochemical basis for the high tolerance of spermatogonia to oxidative stress.	[Celino, Fritzie T.; Yamaguchi, Sonoko; Miura, Chiemi; Iwai, Toshiharu; Miura, Takeshi] Ehime Univ, Res Grp Reprod Physiol, S Ehime Fisheries Res Ctr, Ainan, Ehime, Japan; [Ohta, Takashi; Tozawa, Yuzuru] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan	Ehime University; Ehime University	Celino, FT (corresponding author), Ehime Univ, Res Grp Reprod Physiol, S Ehime Fisheries Res Ctr, Ainan, Ehime, Japan.	miutake@agr.ehime-u.ac.jp	Tozawa, Yuzuru/G-2657-2013; Tozawa, Yuzuru/AAM-9620-2020	Tozawa, Yuzuru/0000-0002-3885-1105; 	Japan Society for the Promotion of Science (JSPS)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding: This study was supported in part by Grant-in-Aid for Scientific Research (B) to TM and Grant-in-Aid for Young Scientists 2008 by Global COE Program from the Japan Society for the Promotion of Science (JSPS) to FTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Aitken RJ, 1999, J REPROD FERTIL, V115, P1; AITKEN RJ, 1987, J REPROD FERTIL, V81, P459; Aruldhas MM, 2005, HUM REPROD, V20, P2801, DOI 10.1093/humrep/dei148; BAUCHE F, 1994, FEBS LETT, V349, P392, DOI 10.1016/0014-5793(94)00709-8; Bedwal R. S., 1994, CELL MOL LIFE SCI, V50, P624; BEEM KM, 1974, J BIOL CHEM, V249, P7298; BORDERS CL, 1985, BIOCHEM J, V230, P771, DOI 10.1042/bj2300771; BRAY TM, 1990, FREE RADICAL BIO MED, V8, P281, DOI 10.1016/0891-5849(90)90076-U; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; CLIFTON DK, 1983, J ANDROL, V4, P387; de Lamirande E, 1997, Rev Reprod, V2, P48, DOI 10.1530/revreprod/2.1.48; Desco MC, 2002, DIABETES, V51, P1118, DOI 10.2337/diabetes.51.4.1118; Dowling DK, 2009, P ROY SOC B-BIOL SCI, V276, P1737, DOI 10.1098/rspb.2008.1791; El-Tawil AM, 2003, ANDROLOGIA, V35, P337, DOI 10.1046/j.0303-4569.2003.00588.x; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Fridovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI 10.1111/j.1749-6632.1999.tb07814.x; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Halliwell B, 1996, BIOCHEM SOC T, V24, P1023, DOI 10.1042/bst0241023; HIDIROGLOU M, 1984, J DAIRY SCI, V67, P1147, DOI 10.3168/jds.S0022-0302(84)81416-2; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; JOW WW, 1993, J ANDROL, V14, P439; Kaur P, 2003, INDIAN J BIOCHEM BIO, V40, P246; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; MARKLUND SL, 1986, FREE RADICALS AGING, P509; Merker HJ, 1997, J TRACE ELEM MED BIO, V11, P19, DOI 10.1016/S0946-672X(97)80004-1; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Miura T, 2003, FISH PHYSIOL BIOCHEM, V28, P181, DOI 10.1023/B:FISH.0000030522.71779.47; MIURA T, 1991, ZOOL SCI, V8, P63; Miura T, 2006, P NATL ACAD SCI USA, V103, P7333, DOI 10.1073/pnas.0508419103; NONOGAKI T, 1992, HUM REPROD, V7, P81, DOI 10.1093/oxfordjournals.humrep.a137565; Oteiza PL, 1996, P SOC EXP BIOL MED, V213, P85, DOI 10.3181/00379727-213-44040; Ozaki Y, 2006, COMP BIOCHEM PHYS B, V143, P309, DOI 10.1016/j.cbpb.2005.12.008; Ozaki Y, 2006, ENDOCRINOLOGY, V147, P5139, DOI 10.1210/en.2006-0391; Papagiannis I, 2004, ENVIRON INT, V30, P357, DOI 10.1016/j.envint.2003.08.002; Paul C, 2008, REPRODUCTION, V136, P73, DOI 10.1530/REP-08-0036; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; PELTOLA V, 1992, J ANDROL, V13, P450; Sanocka Dorota, 2004, Reprod Biol Endocrinol, V2, P12, DOI 10.1186/1477-7827-2-12; Sawasaki T, 2002, P NATL ACAD SCI USA, V99, P14652, DOI 10.1073/pnas.232580399; Sawasaki T, 2002, FEBS LETT, V514, P102, DOI 10.1016/S0014-5793(02)02329-3; SOHAL R S, 1986, Journal of Free Radicals in Biology and Medicine, V2, P175, DOI 10.1016/S0748-5514(86)80067-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Winn RN, 2000, P NATL ACAD SCI USA, V97, P12655, DOI 10.1073/pnas.220428097; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yamaguchi S, 2009, P NATL ACAD SCI USA, V106, P10859, DOI 10.1073/pnas.0900602106; Yousef MI, 2002, TOXICOLOGY, V175, P223, DOI 10.1016/S0300-483X(02)00049-5; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	53	81	87	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16938	10.1371/journal.pone.0016938	http://dx.doi.org/10.1371/journal.pone.0016938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364994	Green Submitted, Green Published, gold			2022-12-27	WOS:000287482800022
J	Mahon, AR; Barnes, MA; Senapati, S; Feder, JL; Darling, JA; Chang, HC; Lodge, DM				Mahon, Andrew R.; Barnes, Matthew A.; Senapati, Satyajyoti; Feder, Jeffrey L.; Darling, John A.; Chang, Hsueh-Chia; Lodge, David M.			Molecular Detection of Invasive Species in Heterogeneous Mixtures Using a Microfluidic Carbon Nanotube Platform	PLOS ONE			English	Article							AMERICAN GREAT-LAKES; BALLAST-WATER	Screening methods to prevent introductions of invasive species are critical for the protection of environmental and economic benefits provided by native species and uninvaded ecosystems. Coastal ecosystems worldwide remain vulnerable to damage from aquatic species introductions, particularly via ballast water discharge from ships. Because current ballast management practices are not completely effective, rapid and sensitive screening methods are needed for on-site testing of ships in transit. Here, we describe a detection technology based on a microfluidic chip containing DNA oligonucleotide functionalized carbon nanotubes. We demonstrate the efficacy of the chip using three ballast-transported species either established (Dreissena bugensis) or of potential threat (Eriocheir sinensis and Limnoperna fortuneii) to the Laurentian Great Lakes. With further refinement for on-board application, the technology could lead to real-time ballast water screening to improve ship-specific management and control decisions.	[Mahon, Andrew R.; Barnes, Matthew A.; Feder, Jeffrey L.; Lodge, David M.] Univ Notre Dame, Dept Biol Sci, Ctr Aquat Conservat, Notre Dame, IN 46556 USA; [Senapati, Satyajyoti; Chang, Hsueh-Chia] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA; [Darling, John A.] US EPA, Natl Exposure Res Lab, Mol Ecol Res Branch, Cincinnati, OH 45268 USA	University of Notre Dame; University of Notre Dame; United States Environmental Protection Agency	Mahon, AR (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Aquat Conservat, Notre Dame, IN 46556 USA.	amahon@nd.edu	Chang, Hsueh-Chia/E-8048-2012; Lodge, David Michael/AAX-1781-2021; Barnes, Matthew A/K-5113-2012; Darling, John/B-5451-2014	Chang, Hsueh-Chia/0000-0003-2147-9260; Barnes, Matthew A/0000-0002-5550-8587; Darling, John/0000-0002-4776-9533; Mahon, Andrew/0000-0002-5074-8725	Great Lakes Protection Fund [867]	Great Lakes Protection Fund	This work was funded to DML, JLF and HCC through a grant from the Great Lakes Protection Fund (Proposal # 867). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basuray S, 2009, ACS NANO, V3, P1823, DOI 10.1021/nn9004632; Boltovskoy D, 2009, HYDROBIOLOGIA, V636, P271, DOI 10.1007/s10750-009-9956-9; Bott NJ, 2010, BIOTECHNOL ADV, V28, P706, DOI 10.1016/j.biotechadv.2010.05.018; Costello C, 2007, ECOL APPL, V17, P655, DOI 10.1890/06-0190; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Drake John M., 2007, Aquatic Invasions, V2, P121, DOI 10.3391/ai.2007.2.2.7; Drake JM, 2007, CAN J FISH AQUAT SCI, V64, P530, DOI 10.1139/F07-029; Duggan IC, 2005, CAN J FISH AQUAT SCI, V62, P2463, DOI 10.1139/F05-160; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Herborg LM, 2007, ECOL APPL, V17, P663, DOI 10.1890/06-0239; IMO, 2004, INT CONV CONTR MAN S; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Lawrence DJ, 2010, BIOL CONSERV, V143, P700, DOI 10.1016/j.biocon.2009.12.008; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Marquette CA, 2005, TOP CURR CHEM, V261, P113, DOI 10.1007/b107356; MILLS EL, 1993, J GREAT LAKES RES, V19, P1, DOI 10.1016/S0380-1330(93)71197-1; Pie MR, 2006, J MOLLUS STUD, V72, P218, DOI 10.1093/mollus/eyi070; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; Tam PD, 2009, J IMMUNOL METHODS, V350, P118, DOI 10.1016/j.jim.2009.08.002; Tepolt CK, 2007, J GREAT LAKES RES, V33, P658, DOI 10.3394/0380-1330(2007)33[658:GAOTCM]2.0.CO;2; Tsolaki E, 2010, J CHEM TECHNOL BIOT, V85, P19, DOI 10.1002/jctb.2276	23	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17280	10.1371/journal.pone.0017280	http://dx.doi.org/10.1371/journal.pone.0017280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364993	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800044
J	Bjerg, A; Ekerljung, L; Middelveld, R; Dahlen, SE; Forsberg, B; Franklin, K; Larsson, K; Lotvall, J; Olafsdottir, IS; Toren, K; Lundback, B; Janson, C				Bjerg, Anders; Ekerljung, Linda; Middelveld, Roelinde; Dahlen, Sven-Erik; Forsberg, Bertil; Franklin, Karl; Larsson, Kjell; Lotvall, Jan; Olafsdottir, Inga Sif; Toren, Kjell; Lundback, Bo; Janson, Christer			Increased Prevalence of Symptoms of Rhinitis but Not of Asthma between 1990 and 2008 in Swedish Adults: Comparisons of the ECRHS and GA(2)LEN Surveys	PLOS ONE			English	Article							RESPIRATORY-HEALTH; TRENDS; QUESTIONNAIRE; BURDEN	Background: The increase in asthma prevalence until 1990 has been well described. Thereafter, time trends are poorly known, due to the low number of high quality studies. The preferred method for studying time trends in prevalence is repeated surveys of similar populations. This study aimed to compare the prevalence of asthma symptoms and their major determinants, rhinitis and smoking, in Swedish young adults in 1990 and 2008. Methods: In 1990 the European Community Respiratory Health Survey (ECRHS) studied respiratory symptoms, asthma, rhinitis and smoking in a population-based sample (86% participation) in Sweden. In 2008 the same symptom questions were included in the Global Allergy and Asthma European Network (GA(2)LEN) survey (60% participation). Smoking questions were however differently worded. The regions (Gothenburg, Uppsala, Umea) and age interval (20-44 years) surveyed both in 1990 (n = 8,982) and 2008 (n = 9,156) were analysed. Results: The prevalence of any wheeze last 12 months decreased from 20% to 16% (p<0.001), and the prevalence of "asthma-related symptoms" was unchanged at 7%. However, either having asthma attacks or using asthma medications increased from 6% to 8% (p<0.001), and their major risk factor, rhinitis, increased from 22% to 31%. Past and present smoking decreased. Conclusion: From 1990 to 2008 the prevalence of obstructive airway symptoms common in asthma did not increase in Swedish young adults. This supports the few available international findings suggesting the previous upward trend in asthma has recently reached a plateau. The fact that wheeze did not increase despite the significant increment in rhinitis, may at least in part be due to the decrease in smoking.	[Bjerg, Anders] Sunderby Cent Hosp Norrbotten, Dept Med, OLIN Studies, Lulea, Sweden; [Bjerg, Anders; Franklin, Karl] Univ Umea, Dept Resp Med & Allergy, Umea, Sweden; [Ekerljung, Linda; Lotvall, Jan] Univ Gothenburg, Krefting Res Ctr, Dept Internal Med, Gothenburg, Sweden; [Middelveld, Roelinde; Dahlen, Sven-Erik] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Middelveld, Roelinde; Dahlen, Sven-Erik; Larsson, Kjell] Karolinska Inst, Inst Environm Med, Ctr Allergy Res, S-10401 Stockholm, Sweden; [Forsberg, Bertil] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Franklin, Karl] Univ Umea, Dept Surg, Umea, Sweden; [Olafsdottir, Inga Sif; Toren, Kjell] Univ Gothenburg, Sahlgrenska Sch Publ Hlth, Gothenburg, Sweden; [Larsson, Kjell] Sahlgrens Univ Hosp, Dept Resp Med & Allergol, S-41345 Gothenburg, Sweden; [Janson, Christer] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Umea University; University of Gothenburg; Karolinska Institutet; Karolinska Institutet; Umea University; Umea University; University of Gothenburg; Sahlgrenska University Hospital; Uppsala University	Bjerg, A (corresponding author), Sunderby Cent Hosp Norrbotten, Dept Med, OLIN Studies, Lulea, Sweden.	anders.bjerg@lung.umu.se	Bjerg, Anders/GRR-3443-2022	Lotvall, Jan/0000-0001-9195-9249; Franklin, Karl/0000-0002-5306-1697	EU [FOOD-CT-2004-506378]; Swedish Heart and Lung Foundation; Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	EU(European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Foundation; Swedish Association against Heart and Lung Diseases; VBG Group Centre for Asthma and Allergy Research	This study was carried out as part of the GA<SUP>2</SUP>LEN survey and was financially supported by the EU Sixth Framework programme for research, contract no. FOOD-CT-2004-506378. The study was also financially supported by the Swedish Heart and Lung Foundation, the Swedish Asthma and Allergy Foundation and the Swedish Association against Heart and Lung Diseases. The Gothenburg part of the study was mainly funded by VBG Group Centre for Asthma and Allergy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Barraclough R, 2002, EUR RESPIR J, V20, P826, DOI 10.1183/09031936.02.00822002; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; BJORNSSON E, 1994, EUR RESPIR J, V7, P2146, DOI 10.1183/09031936.94.07122146; Bousquet J, 2009, ALLERGY, V64, P969, DOI 10.1111/j.1398-9995.2009.02059.x; Brogger J, 2003, EUR RESPIR J, V21, P468, DOI 10.1183/09031936.03.00056103; BURNEY PGJ, 1989, EUR RESPIR J, V2, P940; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; de Marco R, 1998, EUR RESPIR J, V11, P599; DEMARCO R, 1994, EUR RESPIR J, V7, P2139, DOI 10.1183/09031936.94.07122139; EIDE GE, 2006, CTR CLIN RES REPORT, V4, P1; EVANS R, 1987, CHEST, V91, pS65, DOI 10.1378/chest.91.6_Supplement.65S; Ginde AA, 2008, J ALLERGY CLIN IMMUN, V122, P313, DOI 10.1016/j.jaci.2008.04.024; HAAHTELA T, 1990, BRIT MED J, V301, P266, DOI 10.1136/bmj.301.6746.266; Hansen EF, 2000, THORAX, V55, P833, DOI 10.1136/thorax.55.10.833; Kotaniemi JT, 2001, ALLERGY, V56, P169, DOI 10.1034/j.1398-9995.2001.056002169.x; Linneberg A, 1999, ALLERGY, V54, P1194, DOI 10.1034/j.1398-9995.1999.00180.x; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; LUNDBACK B, 1993, THESIS UMEA U UMEA; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Ronmark EP, 2009, RESP MED, V103, P1807, DOI 10.1016/j.rmed.2009.07.014; Sears MR, 1997, LANCET, V350, P1015, DOI 10.1016/S0140-6736(97)01468-2; Senthilselvan A, 2003, CHEST, V124, P438, DOI 10.1378/chest.124.2.438; *STAT SWED, 2004, UND IEVN; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; Vargas MH, 2004, CHEST, V125, P1993, DOI 10.1378/chest.125.6.1993; Verlato G, 2003, J ALLERGY CLIN IMMUN, V111, P1232, DOI 10.1067/mai.2003.1484; Viegi G, 1999, INT J TUBERC LUNG D, V3, P1034; WOODS RK, 2001, ANN ALLERG ASTHMA IM, V87, P89	30	89	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16082	10.1371/journal.pone.0016082	http://dx.doi.org/10.1371/journal.pone.0016082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379386	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300013
J	Lefebvre, V; Fortabat, MN; Ducamp, A; North, HM; Maia-Grondard, A; Trouverie, J; Boursiac, Y; Mouille, G; Durand-Tardif, M				Lefebvre, Valerie; Fortabat, Marie-Noelle; Ducamp, Aloise; North, Helen M.; Maia-Grondard, Alessandra; Trouverie, Jacques; Boursiac, Yann; Mouille, Gregory; Durand-Tardif, Mylene			ESKIMO1 Disruption in Arabidopsis Alters Vascular Tissue and Impairs Water Transport	PLOS ONE			English	Article							ABSCISIC-ACID; CELLULOSE BIOSYNTHESIS; PROTEIN-KINASE; FT-IR; STRESS; MUTANTS; DROUGHT; GENES; COLD; MODEL	Water economy in agricultural practices is an issue that is being addressed through studies aimed at understanding both plant water-use efficiency (WUE), i.e. biomass produced per water consumed, and responses to water shortage. In the model species Arabidopsis thaliana, the ESKIMO1 (ESK1) gene has been described as involved in freezing, cold and salt tolerance as well as in water economy: esk1 mutants have very low evapo-transpiration rates and high water-use efficiency. In order to establish ESK1 function, detailed characterization of esk1 mutants has been carried out. The stress hormone ABA (abscisic acid) was present at high levels in esk1 compared to wild type, nevertheless, the weak water loss of esk1 was independent of stomata closure through ABA biosynthesis, as combining mutant in this pathway with esk1 led to additive phenotypes. Measurement of root hydraulic conductivity suggests that the esk1 vegetative apparatus suffers water deficit due to a defect in water transport. ESK1 promoter-driven reporter gene expression was observed in xylem and fibers, the vascular tissue responsible for the transport of water and mineral nutrients from the soil to the shoots, via the roots. Moreover, in cross sections of hypocotyls, roots and stems, esk1 xylem vessels were collapsed. Finally, using Fourier-Transform Infrared (FTIR) spectroscopy, severe chemical modifications of xylem cell wall composition were highlighted in the esk1 mutants. Taken together our findings show that ESK1 is necessary for the production of functional xylem vessels, through its implication in the laying down of secondary cell wall components.	[Lefebvre, Valerie; Fortabat, Marie-Noelle; Ducamp, Aloise; North, Helen M.; Maia-Grondard, Alessandra; Mouille, Gregory; Durand-Tardif, Mylene] INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech, UMR1318, Versailles, France; [Trouverie, Jacques] Univ Caen Basse Normandie, UMR INRA UCBN, Ecophysiol Vegetale Agron & Nutr NCS, Caen, France; [Boursiac, Yann] Univ Montpellier 2, CNRS, Inst Biol Integrat Plantes, Montpellier SupAgro,INRA,UMR 5004,UMR 0386, Montpellier, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Caen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Lefebvre, V (corresponding author), INRA Ctr Versailles Grignon, Inst Jean Pierre Bourgin, INRA AgroParisTech, UMR1318, Versailles, France.	Mylene.Durand-Tardif@versailles.inra.fr	North, Helen/AAD-4964-2020; Trouverie, Jacques/AAT-1271-2021; Boursiac, Yann/GQP-1267-2022; Trouverie, Jacques/G-5035-2011	North, Helen/0000-0002-5749-2603; Boursiac, Yann/0000-0002-9545-9003; Trouverie, Jacques/0000-0002-1450-896X; Mouille, Gregory/0000-0002-5493-754X; Mylene, Durand-Tardif/0000-0003-1568-6941	Agence Nationale pour la Recherche - Genoplante [ANR-07-GPLA-003]	Agence Nationale pour la Recherche - Genoplante(French National Research Agency (ANR))	This work was supported by the ANR-07-GPLA-003 grant (Agence Nationale pour la Recherche - Genoplante). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-1; Bischoff V, 2010, PLANT SIGNAL BEHAV, V5, P1057, DOI 10.4161/psb.5.8.12414; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Bosca S, 2006, PLANT PHYSIOL, V142, P1353, DOI 10.1104/pp.106.087700; Bouchabke-Coussa O, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-125; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Burton RA, 2000, PLANT CELL, V12, P691, DOI 10.1105/tpc.12.5.691; Chaffey N, 2002, PHYSIOL PLANTARUM, V114, P594, DOI 10.1034/j.1399-3054.2002.1140413.x; Chen ZZ, 2005, PLANT J, V43, P273, DOI 10.1111/j.1365-313X.2005.02452.x; Cholet C, 2002, AUST J GRAPE WINE R, V8, P126, DOI 10.1111/j.1755-0238.2002.tb00221.x; Christmann A, 2007, PLANT J, V52, P167, DOI 10.1111/j.1365-313X.2007.03234.x; Desikan R, 2001, PLANT PHYSIOL, V127, P159, DOI 10.1104/pp.127.1.159; Elo A, 2009, SEMIN CELL DEV BIOL, V20, P1097, DOI 10.1016/j.semcdb.2009.09.009; Fukuda Y, 2000, PLANT MOL BIOL, V44, P91, DOI 10.1023/A:1006416929665; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Javot H, 2003, PLANT CELL, V15, P509, DOI 10.1105/tpc.008888; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7; Keppler BD, 2010, MOL PLANT, V3, P834, DOI 10.1093/mp/ssq028; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; Lefebvre V, 2009, INT J MOL SCI, V10, P3547, DOI 10.3390/ijms10083547; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Lugan R, 2009, PLANT CELL ENVIRON, V32, P95, DOI 10.1111/j.1365-3040.2008.01898.x; Maurel C, 2010, J EXP BOT, V61, P3191, DOI 10.1093/jxb/erq150; Merlot S, 2002, PLANT J, V30, P601, DOI 10.1046/j.1365-313X.2002.01322.x; Mouille G, 2003, PLANT J, V35, P393, DOI 10.1046/j.1365-313X.2003.01807.x; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nilson SE, 2007, PLANT PHYSIOL, V143, P19, DOI 10.1104/pp.106.093161; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Persson S, 2007, PLANT CELL, V19, P237, DOI 10.1105/tpc.106.047720; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Reyes-Diaz M, 2006, J EXP BOT, V57, P3687, DOI 10.1093/jxb/erl125; Sanchez-Rodriguez C, 2010, TRENDS PLANT SCI, V15, P291, DOI 10.1016/j.tplants.2010.03.002; Schwartz SH, 1997, PLANT PHYSIOL, V114, P161, DOI 10.1104/pp.114.1.161; SCOTT TA, 1953, ANAL CHEM, V25, P1656, DOI 10.1021/ac60083a023; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2001, PLANT CELL, V13, P61, DOI 10.1105/tpc.13.1.61; Sibout R, 2005, PLANT CELL, V17, P2059, DOI 10.1105/tpc.105.030767; Steudle E, 1998, J EXP BOT, V49, P775, DOI 10.1093/jexbot/49.322.775; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; THOMASHOW MF, 1994, ARABIDOPSIS, P807, DOI DOI 10.1101/0.807-834; Turner SR, 1997, PLANT CELL, V9, P689, DOI 10.1105/tpc.9.5.689; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Wolf S, 2009, MOL PLANT, V2, P851, DOI 10.1093/mp/ssp066; Xie XD, 2006, CURR BIOL, V16, P882, DOI 10.1016/j.cub.2006.03.028; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Xin ZG, 2007, PLANT J, V49, P786, DOI 10.1111/j.1365-313X.2006.02994.x; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	57	54	58	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2011	6	2							e16645	10.1371/journal.pone.0016645	http://dx.doi.org/10.1371/journal.pone.0016645			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	714UR	21408051	Green Published, gold			2022-12-27	WOS:000286835000004
J	Prosser, DJ; Cui, P; Takekawa, JY; Tang, MJ; Hou, YS; Collins, BM; Yan, BP; Hill, NJ; Li, TX; Li, YD; Lei, FM; Guo, S; Xing, Z; He, YB; Zhou, YC; Douglas, DC; Perry, WM; Newman, SH				Prosser, Diann J.; Cui, Peng; Takekawa, John Y.; Tang, Mingjie; Hou, Yuansheng; Collins, Bridget M.; Yan, Baoping; Hill, Nichola J.; Li, Tianxian; Li, Yongdong; Lei, Fumin; Guo, Shan; Xing, Zhi; He, Yubang; Zhou, Yuanchun; Douglas, David C.; Perry, William M.; Newman, Scott H.			Wild Bird Migration across the Qinghai-Tibetan Plateau: A Transmission Route for Highly Pathogenic H5N1	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; CHINA; INFECTION; PERSISTENCE; WATERFOWL; OUTBREAK; GEESE; LAKE; EPIDEMIOLOGY	Background: Qinghai Lake in central China has been at the center of debate on whether wild birds play a role in circulation of highly pathogenic avian influenza virus H5N1. In 2005, an unprecedented epizootic at Qinghai Lake killed more than 6000 migratory birds including over 3000 bar-headed geese (Anser indicus). H5N1 subsequently spread to Europe and Africa, and in following years has re-emerged in wild birds along the Central Asia flyway several times. Methodology/Principal Findings: To better understand the potential involvement of wild birds in the spread of H5N1, we studied the movements of bar-headed geese marked with GPS satellite transmitters at Qinghai Lake in relation to virus outbreaks and disease risk factors. We discovered a previously undocumented migratory pathway between Qinghai Lake and the Lhasa Valley of Tibet where 93% of the 29 marked geese overwintered. From 2003-2009, sixteen outbreaks in poultry or wild birds were confirmed on the Qinghai-Tibet Plateau, and the majority were located within the migratory pathway of the geese. Spatial and temporal concordance between goose movements and three potential H5N1 virus sources (poultry farms, a captive bar-headed goose facility, and H5N1 outbreak locations) indicated ample opportunities existed for virus spillover and infection of migratory geese on the wintering grounds. Their potential as a vector of H5N1 was supported by rapid migration movements of some geese and genetic relatedness of H5N1 virus isolated from geese in Tibet and Qinghai Lake. Conclusions/Significance: This is the first study to compare phylogenetics of the virus with spatial ecology of its host, and the combined results suggest that wild birds play a role in the spread of H5N1 in this region. However, the strength of the evidence would be improved with additional sequences from both poultry and wild birds on the Qinghai-Tibet Plateau where H5N1 has a clear stronghold.	[Prosser, Diann J.; Collins, Bridget M.] US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD USA; [Prosser, Diann J.] Univ Maryland, Marine Estuarine Environm Sci, College Pk, MD 20742 USA; [Cui, Peng; Lei, Fumin] Chinese Acad Sci, Inst Zool, Beijing, Peoples R China; [Cui, Peng; Tang, Mingjie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Takekawa, John Y.; Hill, Nichola J.; Perry, William M.] US Geol Survey, Western Ecol Res Ctr, Vallejo, CA USA; [Tang, Mingjie; Yan, Baoping; Zhou, Yuanchun] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China; [Hou, Yuansheng; Xing, Zhi; He, Yubang] State Forestry Adm, Qinghai Lake Natl Nat Reserve, Xining, Qinghai, Peoples R China; [Li, Tianxian; Li, Yongdong] Chinese Acad Sci, Wuhan Inst Virol, Wuhan, Hubei, Peoples R China; [Guo, Shan] Chinese Acad Sci, Inst Remote Sensing Applicat, Beijing, Peoples R China; [Douglas, David C.] US Geol Survey, Alaska Sci Ctr, Juneau, AK USA; [Newman, Scott H.] Food & Agr Org United Nations, Anim Prod & Hlth Div, EMPRES Wildlife Unit, Rome, Italy	United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland College Park; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of the Interior; United States Geological Survey; Chinese Academy of Sciences; Computer Network Information Center, CAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; United States Department of the Interior; United States Geological Survey; Food & Agriculture Organization of the United Nations (FAO)	Prosser, DJ (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Beltsville, MD USA.	dprosser@usgs.gov	Hill, Nichola/G-4003-2011; Douglas, David C./AAU-1087-2021	Douglas, David C./0000-0003-0186-1104; Palm, Eric/0000-0002-5330-4804; /0000-0003-3213-6693; Prosser, Diann/0000-0002-5251-1799	Patuxent Wildlife Research Center; Western Ecological Research Center; Alaska Science Center; Avian Influenza Program; United Nations FAO, Animal Production and Health Division,; EMPRES Wildlife Unit; National Science Foundation [0713027]; Chinese Academy of Sciences [2007FY210700, INFO-115-D02, KSCX2-YW-N-063, 2005CB523007]	Patuxent Wildlife Research Center; Western Ecological Research Center; Alaska Science Center; Avian Influenza Program; United Nations FAO, Animal Production and Health Division,; EMPRES Wildlife Unit; National Science Foundation(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the United States Geological Survey (Patuxent Wildlife Research Center, Western Ecological Research Center, Alaska Science Center, and Avian Influenza Program); the United Nations FAO, Animal Production and Health Division, EMPRES Wildlife Unit; National Science Foundation Small Grants for Exploratory Research (No. 0713027); and the Chinese Academy of Sciences (No. 2007FY210700, INFO-115-D02, KSCX2-YW-N-063 and 2005CB523007). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2006, J WILDLIFE MANAGE, V70, P965, DOI 10.2193/0022-541X(2006)70[965:SUBWGW]2.0.CO;2; AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Alexander DJ, 2008, WORLD POULTRY SCI J, V64, P513, DOI 10.1017/S0043933908000184; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; [Anonymous], 2010, R PROJ STAT COMP; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; Bin Muzaffar S, 2010, WATERBIRDS, V33, P219, DOI 10.1675/063.033.s116; Bishop MA, 2007, CHINA CRANE NEWS, V11, P24; Bishop Mary A., 1997, Wildfowl, V48, P118; Boere CG, 2006, WATERBIRDS WORLD, P40; Breiman L., 1984, CLASSIFICATION REGRE; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Butler D, 2006, NATURE, V441, P263, DOI 10.1038/441263a; Chan S., 2009, DIRECTORY IMPORTANT; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Costa TP, 2010, AVIAN DIS, V54, P1286, DOI 10.1637/9480-072210-Reg.1; Dzubin A. E., 1992, MEASUREMENTS GEESE G; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; FAO, 2007, GRIDD LIV WORLD 2007; FAO, 2007, WILD BIRDS AV INFL I; Feare CJ, 2010, J WILDLIFE DIS, V46, P1340, DOI 10.7589/0090-3558-46.4.1340; Fereidouni SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006706; Fisher R. A., 1946, Statistical methods for research workers.; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fouchier RAM, 2007, J WILDLIFE DIS, V43, pS7; GAIDET N, 2010, J APPL ECOLOGY; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Guo Y, 1998, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V12, P322; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Horne JS, 2006, ECOLOGY, V87, P1146, DOI 10.1890/0012-9658(2006)87[1146:STBHRM]2.0.CO;2; HORNE JS, 2009, ANIMAL SPACE USE VER; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lang Aaron, 2007, Forktail, V23, P1; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Li L., 2001, CHINA CRANE NEWS, V5, P36; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275; Liu JY, 2003, INT J REMOTE SENS, V24, P2485, DOI 10.1080/01431160110115582; Manly B., 2002, RESOURCE SELECTION A, V2, DOI 10.1007/978-94-011-1558-2; Miyabayashi Y, 1999, ATLAS KEY SITES ANAT; *MOA, 2009, PREV CONTR AV INFL; MUZAFFAR SB, 2006, WATERBIRDS, V29, P243, DOI DOI 10.1675/1524-4695(2006)29[243:AIAEAE]2.0.CO;2; *NAT BIRD BAND CTR, 1987, CHIN BIRD BAND ALM 1; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Normile D, 2006, SCIENCE, V311, P1225, DOI 10.1126/science.311.5765.1225; *OIE, 2010, UPD HIGHL PATH AV IN; *OIE, 2004, AV INFL, P465; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Ramsar Convention Secretariat, 2007, DES RAMS SIT STRAT F; Rhode D, 2010, QUATERN INT, V218, P29, DOI 10.1016/j.quaint.2009.03.004; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sims L. S., 2008, AVIAN INFLUENZA, P251; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Therneau T. M., 1997, INTRO RECURSIVE PART; UTTANGI J, 1987, J BOMBAY NAT HIST SO, V10, P22; Weber TP, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-57; Xu H, 2007, PALAEOGEOGR PALAEOCL, V254, P541, DOI 10.1016/j.palaeo.2007.07.007; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Yasue M, 2006, BIOSCIENCE, V56, P923, DOI 10.1641/0006-3568(2006)56[923:TEOHAI]2.0.CO;2; Zhang Guo-Gang, 2008, Chinese Journal of Zoology, V43, P51	71	91	99	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17622	10.1371/journal.pone.0017622	http://dx.doi.org/10.1371/journal.pone.0017622			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408010	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900031
J	Teruel, R; Corral, J; Perez-Andreu, V; Martinez-Martinez, I; Vicente, V; Martinez, C				Teruel, Raul; Corral, Javier; Perez-Andreu, Virginia; Martinez-Martinez, Irene; Vicente, Vicente; Martinez, Constantino			Potential Role of miRNAs in Developmental Haemostasis	PLOS ONE			English	Article							BREAST-CANCER CELLS; TARGET RECOGNITION; MICRORNAS	MicroRNAs (miRNAs) are an abundant class of small non-coding RNAs that are negative regulators in a crescent number of physiological and pathological processes. However, their role in haemostasis, a complex physiological process involving multitude of effectors, is just beginning to be characterized. We evaluated the changes of expression of miRNAs in livers of neonates (day one after birth) and adult mice by microarray and qRT-PCR trying to identify miRNAs that potentially may also be involved in the control of the dramatic change of hepatic haemostatic protein levels associated with this transition. Twenty one out of 41 miRNAs overexpressed in neonate mice have hepatic haemostatic mRNA as potential targets. Six of them identified by two in silico algorithms potentially bind the 3'UTR regions of F7, F9, F12, FXIIIB, PLG and SERPINC1 mRNA. Interestingly, miR-18a and miR-19b, overexpressed 5.4 and 8.2-fold respectively in neonates, have antithrombin, a key anticoagulant with strong anti-angiogenic and anti-inflammatory roles, as a potential target. The levels of these two miRNAs inversely correlated with antithrombin mRNA levels during development (miR-19b: R = 0.81; p = 0.03; miR-18a: R = 0.91; p<0.001). These data suggest that miRNAs could be potential modulators of the haemostatic system involved in developmental haemostasis.	[Teruel, Raul; Corral, Javier; Perez-Andreu, Virginia; Martinez-Martinez, Irene; Vicente, Vicente; Martinez, Constantino] Univ Murcia, Ctr Reg Hemodonac, E-30001 Murcia, Spain	University of Murcia	Teruel, R (corresponding author), Univ Murcia, Ctr Reg Hemodonac, E-30001 Murcia, Spain.	constant@um.es	Vicente, Vicente/L-6185-2019; Martinez, Constantino/R-8972-2019; Teruel-Montoya, Raúl/H-9012-2017; Martínez-Martínez, Irene/AAM-8862-2020	Vicente, Vicente/0000-0002-4278-3264; Teruel-Montoya, Raúl/0000-0002-6741-9725; Martínez-Martínez, Irene/0000-0002-1067-6464; Corral, Javier/0000-0003-0288-1107; Martinez, Constantino/0000-0002-2976-2354	Spanish Ministry of Science and Innovation [BES-2007-16973]; ISCIII; FEDER [PI08/1506, EMER07/035, RECAVA RD06/0014/0039, SAF2009-08993]; MCYT; Fundacion Seneca [07703/GERM/07]; Fundacion Mutua Madrilena	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); MCYT(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca(Fundacion Seneca); Fundacion Mutua Madrilena(Instituto de Salud Carlos III)	RT holds an FPI fellowship from the Spanish Ministry of Science and Innovation (BES-2007-16973). VPA holds a Research Fellowship Rio Hortega from ISCIII. CM and IMM are investigators from Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia (FFIS). This work was supported by research grants from ISCIII (www.isciii.es) and FEDER (PI08/1506, EMER07/035 and RECAVA RD06/0014/0039), MCYT (www.mityc.es) & FEDER (SAF2009-08993), Fundacion Seneca (www.f-seneca.org) 07703/GERM/07 and Fundacion Mutua Madrilena (www.fundacionmutua.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ANDREW M, 1987, BLOOD, V70, P165, DOI 10.1182/blood.V70.1.165.165; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Fort A, 2010, BLOOD, V116, P2608, DOI 10.1182/blood-2010-02-268011; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Monagle P, 2010, BLOOD REV, V24, P63, DOI 10.1016/j.blre.2009.12.001; Muth M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-33; Schedin-Weiss S, 2008, BIOCHEMISTRY-US, V47, P13610, DOI 10.1021/bi801656u; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Wan HY, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-16	20	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17648	10.1371/journal.pone.0017648	http://dx.doi.org/10.1371/journal.pone.0017648			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408009	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900035
J	Robertson, BA; Doran, PJ; Loomis, ER; Robertson, JR; Schemske, DW				Robertson, Bruce A.; Doran, Patrick J.; Loomis, Elizabeth R.; Robertson, J. Roy; Schemske, Douglas W.			Avian Use of Perennial Biomass Feedstocks as Post-Breeding and Migratory Stopover Habitat	PLOS ONE			English	Article							GRASSLAND BIRDS; FARMLAND BIODIVERSITY; PASSERINE MIGRANTS; LANDSCAPE; ASSOCIATIONS; ABUNDANCE; COMPETITION; DIVERSITY; LANDBIRDS; SELECTION	Increased production of biomass crops in North America will require new agricultural land, intensify the cultivation of land already under production and introduce new types of biomass crops. Assessing the potential biodiversity impacts of novel agricultural systems is fundamental to the maintenance of biodiversity in agricultural landscapes, yet the consequences of expanded biomass production remain unclear. We evaluate the ability of two candidate second generation biomass feedstocks (switchgrass, Panicum virgatum, and mixed-grass prairie) not currently managed as crops to act as post-breeding and fall migratory stopover habitat for birds. In total, we detected 41 bird species, including grassland specialists and species of state and national conservation concern ( e. g. Henslow's Sparrow, Ammodramus henslowii). Avian species richness was generally comparable in switchgrass and prairie and increased with patch size in both patch types. Grassland specialists were less abundant and less likely to occur in patches within highly forested landscapes and were more common and likely to occur in larger patches, indicating that this group is also area-sensitive outside of the breeding season. Variation in the biomass and richness of arthropod food within patches was generally unrelated to richness and abundance metrics. Total bird abundance and that of grassland specialists was higher in patches with greater vegetation structural heterogeneity. Collectively, we find that perennial biomass feedstocks have potential to provide post-breeding and migratory stopover habitat for birds, but that the placement and management of crops will be critical factors in determining their suitability for species of conservation concern. Industrialization of cellulosic bioenergy production that results in reduced crop structural heterogeneity is likely to dramatically reduce the suitability of perennial biomass crops for birds.	[Robertson, Bruce A.; Loomis, Elizabeth R.] Michigan State Univ, Kellogg Biol Stn, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA; [Doran, Patrick J.] Nature Conservancy, Lansing, MI USA; [Schemske, Douglas W.] Michigan State Univ, Dept Plant Biol, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA	Michigan State University; United States Department of Energy (DOE); Nature Conservancy; Michigan State University; United States Department of Energy (DOE)	Robertson, BA (corresponding author), Michigan State Univ, Kellogg Biol Stn, US DOE, Great Lakes Bioenergy Res Ctr, E Lansing, MI 48824 USA.	RobertsonBr@si.edu			DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE))	This work was funded by the DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; BAIRLEIN F, 1983, ORNIS SCAND, V14, P239, DOI 10.2307/3676157; Bakker KK, 2002, CONSERV BIOL, V16, P1638, DOI 10.1046/j.1523-1739.2002.01328.x; Bakker KK, 2009, WEST N AM NATURALIST, V69, P235, DOI 10.3398/064.069.0212; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Buler JJ, 2007, ECOLOGY, V88, P1789, DOI 10.1890/06-1871.1; Burnham K. P., 1998, MODEL SELECTION INFE; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Champlin TB, 2009, ECOLOGY, V90, P1586, DOI 10.1890/08-1190.1; Chartier AT, 2004, BIRDERS GUIDE MICHIG; Cimprich DA, 2005, ANIM BEHAV, V69, P1173, DOI 10.1016/j.anbehav.2004.07.021; COLWELL RK, 1997, ESITIMATES STAT ESTI; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Deppe JL, 2008, ECOL MONOGR, V78, P461, DOI 10.1890/07-0163.1; Diehl RH, 2003, AUK, V120, P278, DOI 10.1642/0004-8038(2003)120[0278:ROOBMO]2.0.CO;2; Eggers J, 2009, GCB BIOENERGY, V1, P18, DOI 10.1111/j.1757-1707.2009.01002.x; EMLEN JT, 1977, AUK, V94, P455; ESRI, 2008, ARCGIS; Fargione JE, 2009, BIOSCIENCE, V59, P767, DOI 10.1525/bio.2009.59.9.8; Fletcher RJ, 2000, J FIELD ORNITHOL, V71, P321, DOI 10.1648/0273-8570-71.2.321; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Forman R.T.T., 1986, LANDSCAPE ECOL; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Greenberg R., 2005, BIRDS 2 WORLDS ECOLO; GRZYBOWSKI JA, 1983, BEHAV ECOL SOCIOBIOL, V13, P211, DOI 10.1007/BF00299925; Harmoney KR, 1997, AGRON J, V89, P665, DOI 10.2134/agronj1997.00021962008900040020x; Herkert JR, 2007, J WILDLIFE MANAGE, V71, P2749, DOI 10.2193/2007-002; HERKERT JR, 1994, ECOL APPL, V4, P461, DOI 10.2307/1941950; Hodar JA, 1996, ACTA OECOL, V17, P421; HOSMER DW, 1989, APPL LOGISTIC REGRES; HUTTO RL, 1985, AUK, V102, P120, DOI 10.2307/4086827; HUTTO RL, 1981, AUK, V98, P765; Igl LD, 1999, CONDOR, V101, P771, DOI 10.2307/1370064; Keller GS, 2007, WILSON J ORNITHOL, V119, P410, DOI 10.1676/04-034.1; King DI, 2006, J ZOOL, V269, P414, DOI 10.1111/j.1469-7998.2006.00158.x; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Legendre P., 1991, R PACKAGE MULTIDIMEN; Legendre P., 2012, NUMERICAL ECOLOGY; LIMA SL, 1990, OIKOS, V58, P151, DOI 10.2307/3545422; MARTIN TE, 1980, CONDOR, V82, P430, DOI 10.2307/1367570; Matthews SN, 2010, LANDSCAPE ECOL, V25, P955, DOI 10.1007/s10980-010-9475-0; Matthews SN, 2010, CONDOR, V112, P96, DOI 10.1525/cond.2010.090049; Melles S, 2003, CONSERV ECOL, V7; MOORE FR, 1990, WILSON BULL, V102, P487; MOORE FR, 1991, BEHAV ECOL SOCIOBIOL, V28, P85; Moore Frank R., 1995, P121; Murphy MT, 2003, AUK, V120, P20, DOI 10.1642/0004-8038(2003)120[0020:APTWTE]2.0.CO;2; *NAT AUD SOC, 2010, IMP BIRD AR US; NOSS RF, 1995, 0611R01 MF NAT BIOL; Petit DR, 2000, STUD AVIAN BIOL-SER, P15; REMPEL R, 2010, PATCH ANAL 4 2 THUND; Renfrew RB, 2008, LANDSCAPE ECOL, V23, P181, DOI 10.1007/s10980-007-9179-2; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; Ribic CA, 2009, AUK, V126, P233, DOI 10.1525/auk.2009.1409; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; ROBERTSON BA, GLOBAL CHAN IN PRESS; Rodewald PG, 2007, AUK, V124, P1063, DOI 10.1642/0004-8038(2007)124[1063:SHUBSM]2.0.CO;2; Rodewald PG, 2004, AUK, V121, P1040, DOI 10.1642/0004-8038(2004)121[1040:SHOLDF]2.0.CO;2; ROGERS LE, 1976, ANN ENTOMOL SOC AM, V69, P387, DOI 10.1093/aesa/69.2.387; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; ROTENBERRY JT, 1980, ECOL MONOGR, V50, P93, DOI 10.2307/2937248; Roth AM, 2005, BIOMASS BIOENERG, V28, P490, DOI 10.1016/j.biombioe.2004.11.001; SAMPLE D, 1989, THESIS U WISCONSIN M; SAMPLE DW, 1997, MANAGEMENT HABITAT G; Sauer J.R., 2008, N AM BREEDING BIRD S; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Skagen SK, 1998, CONSERV BIOL, V12, P896, DOI 10.1046/j.1523-1739.1998.96384.x; SPSS (Statistical package for the Social Sciences), 2006, SPSS VERS 15 WIND; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Twedt DJ, 2008, SOUTHEAST NAT, V7, P11, DOI 10.1656/1528-7092(2008)7[11:WBPSAP]2.0.CO;2; *USDA, 2010, 2009 CROPL DAT LAY; Vickery PD, 1999, STUD AVIAN BIOL, P2; Vickery Peter D., 2000, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V16, P74; WIENS JA, 1974, AM MIDL NAT, V91, P195, DOI 10.2307/2424522	76	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16941	10.1371/journal.pone.0016941	http://dx.doi.org/10.1371/journal.pone.0016941			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390274	Green Published, gold, Green Submitted			2022-12-27	WOS:000287965200009
J	Hadi-Alijanvand, H; Rouhani, M; Proctor, EA; Dokholyan, NV; Moosavi-Movahedi, AA				Hadi-Alijanvand, Hamid; Rouhani, Maryam; Proctor, Elizabeth A.; Dokholyan, Nikolay V.; Moosavi-Movahedi, Ali A.			A Folding Pathway-Dependent Score to Recognize Membrane Proteins	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; CA2+-ACTIVATED K+ CHANNELS; LONG-TERM POTENTIATION; GATED CA2+ CHANNELS; SMALL-CONDUCTANCE; CALCIUM-CHANNELS; SUBCELLULAR-LOCALIZATION; HIPPOCAMPAL-NEURONS; INTERMEDIATE-CONDUCTANCE; TRANSMEMBRANE SEGMENTS	While various approaches exist to study protein localization, it is still a challenge to predict where proteins localize. Here, we consider a mechanistic viewpoint for membrane localization. Taking into account the steps for the folding pathway of alpha-helical membrane proteins and relating biophysical parameters to each of these steps, we create a score capable of predicting the propensity for membrane localization and call it FP(3)mem. This score is driven from the principal component analysis (PCA) of the biophysical parameters related to membrane localization. FP3mem allows us to rationalize the colocalization of a number of channel proteins with the Cav1.2 channel by their fewer propensities for membrane localization.	[Hadi-Alijanvand, Hamid; Rouhani, Maryam; Moosavi-Movahedi, Ali A.] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Proctor, Elizabeth A.; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of Tehran; University of North Carolina; University of North Carolina Chapel Hill	Hadi-Alijanvand, H (corresponding author), Univ Tehran, Inst Biochem & Biophys, Tehran, Iran.	moosavi@ibb.ut.ac.ir	Hadi-Alijanvand, Hamid/AAE-3921-2020; Proctor, Elizabeth A./K-2350-2012; Moosavi-Movahedi, Ali A./K-7453-2013; Rouhani, Maryam/AAY-1557-2021; Dokholyan, Nikolay/D-8081-2018	Hadi-Alijanvand, Hamid/0000-0001-8289-2214; Proctor, Elizabeth A./0000-0002-7627-2198; Rouhani, Maryam/0000-0003-2094-6568; Dokholyan, Nikolay/0000-0002-8225-4025; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432	Research Council of the University of Tehran; Iran National Science Foundation (INSF)	Research Council of the University of Tehran(University of Tehran); Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	The support of the Research Council of the University of Tehran and Iran National Science Foundation (INSF) is gratefully acknowledged.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107; Bowden SEH, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-20-j0006.2001; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CHEN HF, 1995, J BIOL CHEM, V270, P14115, DOI 10.1074/jbc.270.23.14115; Curnow P, 2009, P NATL ACAD SCI USA, V106, P773, DOI 10.1073/pnas.0806953106; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Emanuelsson Olof, 2002, Brief Bioinform, V3, P361, DOI 10.1093/bib/3.4.361; Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2; Faber ES, 2009, CELL BIOCHEM BIOPHYS, V55, P127, DOI 10.1007/s12013-009-9062-7; Freeman TC, 2010, BIOINFORMATICS, V26, P1965, DOI 10.1093/bioinformatics/btq308; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guda C, 2006, NUCLEIC ACIDS RES, V34, pW210, DOI 10.1093/nar/gkl093; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HELL JW, 1993, J BIOL CHEM, V268, P19451; Hirschberg B, 1998, J GEN PHYSIOL, V111, P565, DOI 10.1085/jgp.111.4.565; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hristova K, 2005, BIOCHEMISTRY-US, V44, P12614, DOI 10.1021/bi051193b; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; Joiner WJ, 1997, P NATL ACAD SCI USA, V94, P11013, DOI 10.1073/pnas.94.20.11013; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Koschak A, 2007, J NEUROSCI, V27, P3855, DOI 10.1523/JNEUROSCI.4028-06.2007; Li SC, 1996, P NATL ACAD SCI USA, V93, P6676, DOI 10.1073/pnas.93.13.6676; Liang J, 2005, TRENDS BIOCHEM SCI, V30, P355, DOI 10.1016/j.tibs.2005.05.003; LODISH H, 2003, MOL CELL BIOL; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; Makhatadze GI, 1995, ADV PROTEIN CHEM, V47, P307, DOI 10.1016/S0065-3233(08)60548-3; MAKHATADZE GI, 1994, BIOPHYS CHEM, V51, P291, DOI 10.1016/0301-4622(94)00050-6; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; McMurry JL, 1999, J BIOL CHEM, V274, P6776, DOI 10.1074/jbc.274.10.6776; Mokrab Y, 2009, PROTEINS, V74, P32, DOI 10.1002/prot.22130; Moller S, 2000, BIOINFORMATICS, V16, P1159, DOI 10.1093/bioinformatics/16.12.1159; Montgomerie S, 2008, NUCLEIC ACIDS RES, V36, pW202, DOI 10.1093/nar/gkn255; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Obermair GJ, 2004, EUR J NEUROSCI, V19, P2109, DOI 10.1111/j.0953-816X.2004.03272.x; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PARK Y, 1994, J PHYSIOL-LONDON, V481, P555, DOI 10.1113/jphysiol.1994.sp020463; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Pierleoni A, 2007, NUCLEIC ACIDS RES, V35, pD208, DOI 10.1093/nar/gkl775; Pilpel Y, 1999, J MOL BIOL, V294, P921, DOI 10.1006/jmbi.1999.3257; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Rimini R, 2000, MOL BRAIN RES, V85, P218, DOI 10.1016/S0169-328X(00)00255-2; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; Sinnegger-Brauns MJ, 2004, J CLIN INVEST, V113, P1430, DOI 10.1172/JCI200420208; Sprenger J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S3; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842; Striessnig J, 2006, BIOCHEM SOC T, V34, P903, DOI 10.1042/BST0340903; Striessnig J, 2004, BIOCHEM BIOPH RES CO, V322, P1341, DOI 10.1016/j.bbrc.2004.08.039; Szafron D, 2004, NUCLEIC ACIDS RES, V32, pW365, DOI 10.1093/nar/gkh485; Tacconi S, 2001, NEUROSCIENCE, V102, P209, DOI 10.1016/S0306-4522(00)00486-3; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Townend J., 2002, PRACTICAL STAT ENV B; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Van Rijsbergen C, 1980, INFORM RETRIEVAL; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WHITE SH, 1994, MEMBRANE PROTEIN STR; White SH, 2007, J GEN PHYSIOL, V129, P363, DOI 10.1085/jgp.200709741; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang SN, 1999, P NATL ACAD SCI USA, V96, P10164, DOI 10.1073/pnas.96.18.10164; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhou HY, 2004, PROTEINS, V54, P315, DOI 10.1002/prot.10584	84	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16778	10.1371/journal.pone.0016778	http://dx.doi.org/10.1371/journal.pone.0016778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390303	Green Submitted, Green Published, gold			2022-12-27	WOS:000287932100003
J	Metz, MC; Vucetich, JA; Smith, DW; Stahler, DR; Peterson, RO				Metz, Matthew C.; Vucetich, John A.; Smith, Douglas W.; Stahler, Daniel R.; Peterson, Rolf O.			Effect of Sociality and Season on Gray Wolf (Canis lupus) Foraging Behavior: Implications for Estimating Summer Kill Rate	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; DOGS LYCAON-PICTUS; PACK SIZE; PREDATION; WOLVES; SYSTEM; PREY; POPULATION; SELECTION; ECOLOGY	Background: Understanding how kill rates vary among seasons is required to understand predation by vertebrate species living in temperate climates. Unfortunately, kill rates are only rarely estimated during summer. Methodology/Principal Findings: For several wolf packs in Yellowstone National Park, we used pairs of collared wolves living in the same pack and the double-count method to estimate the probability of attendance (PA) for an individual wolf at a carcass. PA quantifies an important aspect of social foraging behavior (i.e., the cohesiveness of foraging). We used PA to estimate summer kill rates for packs containing GPS-collared wolves between 2004 and 2009. Estimated rates of daily prey acquisition (edible biomass per wolf) decreased from 8.4 +/- 0.9 kg (mean 6 SE) in May to 4.1 +/- 0.4 kg in July. Failure to account for PA would have resulted in underestimating kill rate by 32%. PA was 0.72 +/- 0.05 for large ungulate prey and 0.46 +/- 0.04 for small ungulate prey. To assess seasonal differences in social foraging behavior, we also evaluated PA during winter for VHF-collared wolves between 1997 and 2009. During winter, PA was 0.95 +/- 0.01. PA was not influenced by prey size but was influenced by wolf age and pack size. Conclusions/Significance: Our results demonstrate that seasonal patterns in the foraging behavior of social carnivores have important implications for understanding their social behavior and estimating kill rates. Synthesizing our findings with previous insights suggests that there is important seasonal variation in how and why social carnivores live in groups. Our findings are also important for applications of GPS collars to estimate kill rates. Specifically, because the factors affecting the PA of social carnivores likely differ between seasons, kill rates estimated through GPS collars should account for seasonal differences in social foraging behavior.	[Metz, Matthew C.; Vucetich, John A.; Peterson, Rolf O.] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Metz, Matthew C.; Smith, Douglas W.; Stahler, Daniel R.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Wolf Project, Yellowstone Natl Pk, WY 82190 USA	Michigan Technological University; United States Department of the Interior	Metz, MC (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	mcmetz@mtu.edu			United States National Science Foundation [DEB-06137730]; Yellowstone National Park, Yellowstone Park Foundation; Natural Resources Defense Council	United States National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park, Yellowstone Park Foundation; Natural Resources Defense Council	Funding was provided by the United States National Science Foundation (DEB-06137730), Yellowstone National Park, Yellowstone Park Foundation, an anonymous donor, Annie and Bob Graham, Frank and Kay Yeager, Marc McCurry, Masterfoods, Patagonia, and the Natural Resources Defense Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almberg ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007042; Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Ballard Warren B., 2003, P259; BALLARD WB, 1987, WILDLIFE MONOGR, P1; Feldhamer G., 2003, WILD MAMMALS N AM, V2; FULLER TK, 1990, AFR J ECOL, V28, P330, DOI 10.1111/j.1365-2028.1990.tb01168.x; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; HENSCHEL JR, 1990, AFR J ECOL, V28, P69, DOI 10.1111/j.1365-2028.1990.tb01138.x; Houston D.B., 1982, NO YELLOWSTONE ELK E; Jedrzejewski W, 2002, ECOLOGY, V83, P1341, DOI 10.2307/3071948; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; MacNulty DR, 2009, J ANIM ECOL, V78, P532, DOI 10.1111/j.1365-2656.2008.01517.x; MALCOLM JR, 1982, BEHAV ECOL SOCIOBIOL, V10, P1, DOI 10.1007/BF00296390; MEAGHER M, 1986, MAMMALIAN SPECIES, V266, P1; Mech L. David, 2003, P131; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; METZ MC, 2010, THESIS MICHIGAN TECH; Mills L. S., 2007, CONSERVATION WILDLIF; Mosser A, 2009, ANIM BEHAV, V78, P359, DOI 10.1016/j.anbehav.2009.04.024; Murphy KM, 1998, URSUS-SERIES, V10, P55; Nilsen EB, 2009, J ANIM ECOL, V78, P741, DOI 10.1111/j.1365-2656.2009.01547.x; O'Donoghue M, 1998, ECOLOGY, V79, P1193, DOI 10.1890/0012-9658(1998)079[1193:FROCAL]2.0.CO;2; PETERSON RO, 1984, WILDLIFE MONOGR, V88, P1; Peterson Rolf O., 2003, P104; RICKLEFS RE, 2000, ECOLOGY; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Schmidt PA, 1997, AM NAT, V150, P513, DOI 10.1086/286079; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Smith Douglas W., 2009, P92, DOI 10.1002/9781444312034.ch5; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Vucetich JA, 2004, ANIM BEHAV, V67, P1117, DOI 10.1016/j.anbehav.2003.06.018; Vucetich JA, 2002, ECOLOGY, V83, P3003; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wilmers CC, 2003, J ANIM ECOL, V72, P909, DOI 10.1046/j.1365-2656.2003.00766.x	39	50	50	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17332	10.1371/journal.pone.0017332	http://dx.doi.org/10.1371/journal.pone.0017332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390256	Green Submitted, gold, Green Published			2022-12-27	WOS:000287932100013
J	Patton, DT; Wilson, MD; Rowan, WC; Soond, DR; Okkenhaug, K				Patton, Daniel T.; Wilson, Marcus D.; Rowan, Wendy C.; Soond, Dalya R.; Okkenhaug, Klaus			The PI3K p110 delta Regulates Expression of CD38 on Regulatory T Cells	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; CUTTING EDGE; PHOSPHATIDYLINOSITOL 3-KINASE; FOXP3 EXPRESSION; B-CELL; INDUCTION; ANTIGEN; MICE; DIFFERENTIATION; SIGNAL	The PI3K pathway has emerged as a key regulator of regulatory T cell ( Treg) development and homeostasis and is required for full Treg-mediated suppression. To identify new genes involved in PI3K-dependent suppression, we compared the transcriptome of WT and p110 delta(D910A) Tregs. Among the genes that were differentially expressed was the gene for the transmembrane cyclic ADP ribose hydrolase CD38. Here we show that CD38 is expressed mainly by a subset of Foxp3(+)CD25(+)CD4(+) T cells originating in the thymus and on Tregs in the spleen. CD38(high) WT Tregs showed superior suppressive activity to CD38(low) Tregs, which failed to upregulate CD73, a surface protein which is important for suppression. However, Tregs from heterozygous CD38(+/-) mice were unimpaired despite lower levels of CD38 expression. Therefore, CD38 can be used as a marker for Tregs with high suppressive activity and the impaired Treg function in p110 delta(D910A) mice can in part be explained by the failure of CD38(high) cells to develop.	[Patton, Daniel T.; Wilson, Marcus D.; Soond, Dalya R.; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Rowan, Wendy C.] GlaxoSmithKline Res & Dev Ltd, Tool Monoclonal Antibody Grp, Stevenage, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; GlaxoSmithKline	Patton, DT (corresponding author), Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England.	klaus.okkenhaug@bbsrc.ac.uk	Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Wilson, Marcus/0000-0001-9551-5514	BBSRC; GlaxoSmithKline; BBSRC [BBS/E/B/0000H262, BBS/E/B/0000C236, BB/E009867/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000H262, BB/C509890/1, BBS/E/B/0000C236, BB/E009867/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work described in this manuscript was funded by the BBSRC and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Aswad F, 2006, CELL IMMUNOL, V243, P58, DOI 10.1016/j.cellimm.2006.12.003; Basu S, 2008, J IMMUNOL, V180, P5794, DOI 10.4049/jimmunol.180.9.5794; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Bynoel MS, 2008, TRENDS IMMUNOL, V29, P99, DOI 10.1016/j.it.2007.12.005; Chen J, 2006, J IMMUNOL, V176, P4590, DOI 10.4049/jimmunol.176.8.4590; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cosker F, 2010, J BIOL CHEM, V285, P38251, DOI 10.1074/jbc.M110.125864; Daniel C, 2010, P NATL ACAD SCI USA, V107, P16246, DOI 10.1073/pnas.1007422107; Deaglio S, 2010, MOL MED, V16, P87, DOI 10.2119/molmed.2009.00146; DRACH J, 1994, CANCER RES, V54, P1746; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gao Y, 2007, LEUKEMIA RES, V31, P455, DOI 10.1016/j.leukres.2006.07.004; Garcon F, 2008, BLOOD, V111, P1464, DOI 10.1182/blood-2007-08-108050; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hedrick SM, 2009, NAT IMMUNOL, V10, P1057, DOI 10.1038/ni.1784; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hubert S, 2010, J EXP MED, V207, P2561, DOI 10.1084/jem.20091154; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; Lannutti BJ, 2011, BLOOD, V117, P591, DOI 10.1182/blood-2010-03-275305; Liu D, 2009, J IMMUNOL, V183, P1921, DOI 10.4049/jimmunol.0901099; Lund FE, 1998, IMMUNOL REV, V161, P79, DOI 10.1111/j.1600-065X.1998.tb01573.x; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Ma LA, 2010, P NATL ACAD SCI USA, V107, P19461, DOI 10.1073/pnas.1011748107; Maynard CL, 2007, NAT IMMUNOL, V8, P931, DOI 10.1038/ni1504; Merkenschlager M, 2010, J EXP MED, V207, P1347, DOI 10.1084/jem.20101156; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Munoz P, 2003, J BIOL CHEM, V278, P50791, DOI 10.1074/jbc.M308034200; Oak JS, 2006, P NATL ACAD SCI USA, V103, P16882, DOI 10.1073/pnas.0607984103; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Park SG, 2010, IMMUNITY, V33, P791, DOI 10.1016/j.immuni.2010.10.014; Patton DT, 2006, J IMMUNOL, V177, P6598, DOI 10.4049/jimmunol.177.10.6598; Peola S, 1996, J IMMUNOL, V157, P4354; Read S, 1998, EUR J IMMUNOL, V28, P3435, DOI 10.1002/(SICI)1521-4141(199811)28:11<3435::AID-IMMU3435>3.3.CO;2-G; Salmond RJ, 2009, J IMMUNOL, V183, P7388, DOI 10.4049/jimmunol.0902294; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	52	60	72	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17359	10.1371/journal.pone.0017359	http://dx.doi.org/10.1371/journal.pone.0017359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390257	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100014
J	Damasco, C; Lembo, A; Somma, MP; Gatti, M; Di Cunto, F; Provero, P				Damasco, Christian; Lembo, Antonio; Somma, Maria Patrizia; Gatti, Maurizio; Di Cunto, Ferdinando; Provero, Paolo			A Signature Inferred from Drosophila Mitotic Genes Predicts Survival of Breast Cancer Patients	PLOS ONE			English	Article							EXPRESSION SIGNATURE; PROGNOSTIC VALUE; PROLIFERATION; MICROARRAY; HYPOXIA; GRADE; IDENTIFICATION; BIOCONDUCTOR; CARCINOMA; ASPM	Introduction: The classification of breast cancer patients into risk groups provides a powerful tool for the identification of patients who will benefit from aggressive systemic therapy. The analysis of microarray data has generated several gene expression signatures that improve diagnosis and allow risk assessment. There is also evidence that cell proliferation-related genes have a high predictive power within these signatures. Methods: We thus constructed a gene expression signature (the DM signature) using the human orthologues of 108 Drosophila melanogaster genes required for either the maintenance of chromosome integrity (36 genes) or mitotic division (72 genes). Results: The DM signature has minimal overlap with the extant signatures and is highly predictive of survival in 5 large breast cancer datasets. In addition, we show that the DM signature outperforms many widely used breast cancer signatures in predictive power, and performs comparably to other proliferation-based signatures. For most genes of the DM signature, an increased expression is negatively correlated with patient survival. The genes that provide the highest contribution to the predictive power of the DM signature are those involved in cytokinesis. Conclusion: This finding highlights cytokinesis as an important marker in breast cancer prognosis and as a possible target	[Damasco, Christian; Lembo, Antonio; Di Cunto, Ferdinando; Provero, Paolo] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Damasco, Christian; Lembo, Antonio; Di Cunto, Ferdinando; Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Somma, Maria Patrizia; Gatti, Maurizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, CNR, Rome, Italy; [Somma, Maria Patrizia; Gatti, Maurizio] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Rome, Italy	University of Turin; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Damasco, C (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	paolo.provero@unito.it	Gatti, Maurizio/S-2877-2019; Di Cunto, Ferdinando/K-5575-2016; Gatti, Maurizio/J-9703-2013; Provero, Paolo/AAC-1930-2019	Gatti, Maurizio/0000-0003-3777-300X; somma, maria patrizia/0000-0002-7585-3484; di cunto, ferdinando/0000-0001-9367-6357	"Associazione Italiana per la Ricerca sul Cancro" (AIRC); FIRB-Italbionet program	"Associazione Italiana per la Ricerca sul Cancro" (AIRC)(Fondazione AIRC per la ricerca sul cancro); FIRB-Italbionet program	The financial support of the "Associazione Italiana per la Ricerca sul Cancro" (AIRC) to M. G. and P. P. and of the FIRB-Italbionet program to F. D. C. and P. P. are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baak JPA, 2008, ANN ONCOL, V19, P649, DOI 10.1093/annonc/mdm535; Baak JPA, 2009, BREAST CANCER RES TR, V115, P241, DOI 10.1007/s10549-008-0126-y; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Coppola D, 2009, J CANCER RES CLIN, V135, P1287, DOI 10.1007/s00432-009-0570-z; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; FIELDS AP, 2009, ADV ENZYME REGUL; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; PELLEGRINO R, 2009, HEPATOLOGY; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schmit TL, 2009, J INVEST DERMATOL, V129, P2843, DOI 10.1038/jid.2009.172; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shimizu S, 2007, ONCOL REP, V18, P1489; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Skaland I, 2009, BREAST CANCER RES TR, V114, P39, DOI 10.1007/s10549-008-9980-x; Skrzypski M, 2008, CLIN CANCER RES, V14, P4794, DOI 10.1158/1078-0432.CCR-08-0576; Somma MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000126; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Starmans MHW, 2008, BRIT J CANCER, V99, P1884, DOI 10.1038/sj.bjc.6604746; Sung FL, 2007, CANCER LETT, V253, P74, DOI 10.1016/j.canlet.2007.01.012; Suzuki C, 2005, CANCER RES, V65, P11314, DOI 10.1158/0008-5472.CAN-05-1507; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Diest PJ, 2004, J CLIN PATHOL, V57, P675, DOI 10.1136/jcp.2003.010777; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; VANDIEST PJ, 1992, HUM PATHOL, V23, P603, DOI 10.1016/0046-8177(92)90313-R; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Winter SC, 2007, CANCER RES, V67, P3441, DOI 10.1158/0008-5472.CAN-06-3322; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhao HJ, 2006, PLOS MED, V3, P115, DOI 10.1371/journal.pmed.0030013	48	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14737	10.1371/journal.pone.0014737	http://dx.doi.org/10.1371/journal.pone.0014737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386884	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400002
J	Montagu, D; Yamey, G; Visconti, A; Harding, A; Yoong, J				Montagu, Dominic; Yamey, Gavin; Visconti, Adam; Harding, April; Yoong, Joanne			Where Do Poor Women in Developing Countries Give Birth? A Multi-Country Analysis of Demographic and Health Survey Data	PLOS ONE			English	Article							MATERNAL MORTALITY; INTEGRATED MANAGEMENT; CHILDHOOD ILLNESS; PRIVATE-SECTOR; ALMA-ATA; CARE; SURVIVAL; INTERVENTIONS; STRATEGIES; DELIVERY	Background: In 2008, over 300,000 women died during pregnancy or childbirth, mostly in poor countries. While there are proven interventions to make childbirth safer, there is uncertainty about the best way to deliver these at large scale. In particular, there is currently a debate about whether maternal deaths are more likely to be prevented by delivering effective interventions through scaled up facilities or via community-based services. To inform this debate, we examined delivery location and attendance and the reasons women report for giving birth at home. Methodology/Principal Findings: We conducted a secondary analysis of maternal delivery data from Demographic and Health Surveys in 48 developing countries from 2003 to the present. We stratified reported delivery locations by wealth quintile for each country and created weighted regional summaries. For sub-Saharan Africa (SSA), where death rates are highest, we conducted a subsample analysis of motivations for giving birth at home. In SSA, South Asia, and Southeast Asia, more than 70% of all births in the lowest two wealth quintiles occurred at home. In SSA, 54.1% of the richest women reported using public facilities compared with only 17.7% of the poorest women. Among home births in SSA, 56% in the poorest quintile were unattended while 41% were attended by a traditional birth attendant (TBA); 40% in the wealthiest quintile were unattended, while 33% were attended by a TBA. Seven per cent of the poorest women reported cost as a reason for not delivering in a facility, while 27% reported lack of access as a reason. The most common reason given by both the poorest and richest women for not delivering in a facility was that it was deemed "not necessary" by a household decision maker. Among the poorest women, "not necessary" was given as a reason by 68% of women whose births were unattended and by 66% of women whose births were attended. Conclusions: In developing countries, most poor women deliver at home. This suggests that, at least in the near term, efforts to reduce maternal deaths should prioritize community-based interventions aimed at making home births safer.	[Montagu, Dominic; Yamey, Gavin; Visconti, Adam] Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA; [Harding, April] World Bank, Washington, DC 20433 USA; [Yoong, Joanne] RAND Corp, Arlington, VA USA	University of California System; University of California San Francisco; The World Bank; RAND Corporation	Montagu, D (corresponding author), Univ Calif San Francisco, Global Hlth Grp, San Francisco, CA 94143 USA.	montagud@globalhealth.ucsf.edu		Visconti, Adam/0000-0001-6257-1691; Yoong, Joanne/0000-0002-0162-9885	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was partially funded by The Bill & Melinda Gates Foundation under an individual contract for research with DM. The funder played no role in the preparation of this manuscript or in the decision to submit to PLoS ONE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no other sources of funding support.	Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bustreo F, 2003, B WORLD HEALTH ORGAN, V81, P886; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; *CONT CAR, 2010, PARTN MAT NEWB CHILD; Gwatkin DR, 2006, B WORLD HEALTH ORGAN, V84, P768, DOI 10.2471/BLT.06.035006; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lambrechts T, 1999, B WORLD HEALTH ORGAN, V77, P582; *LANC, 2006, MAT SURV SER; LAWN JE, 2005, LANCET, V365; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Marek T., 2005, TRENDS OPPORTUNITIES; *MEASURE DHS, 2010, SURV METH SURV PROC; *MEASURE DHS, 2010, DHS MOD QUEST PHAS 5; *MEASURE DHS, 2010, DHS SAMPL WEIGHTS; *MEASURE DHS, 2010, METH WEALTH IND; *MICR CORP, 2007, EXC PART MICR OFF PR; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Paxton A, 2006, INT J GYNECOL OBSTET, V93, P300, DOI 10.1016/j.ijgo.2006.01.030; Prata N, 2005, B WORLD HEALTH ORGAN, V83, P274; RONSMANS C, 2009, B WORLD HEALTH ORGAN, V87, P410; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; RUSTEIN S, 2004, 6 DHS; StataCorp, 2001, STAT SOFTW REL 10 0; SUPON L, 2008, PUBLIC PRIVATE MIX W; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; UN, MILL DEV GOALS; UNICEF, 2005, ACC CHILD SURV DEV R; UNICEF, 2007, STATE WORLDS CHILDRE; *WHO, 2010, LANC NEON SURV SER; *WORLD BANK, 2010, POVCAL IND; World Bank, 2010, WORLD DEV IND POP TO; World Health Organization, 2004, NEON PER MORT COUNTR; Yoong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013243; DELIVER W INVEST WOM; 2010, PARTNERSHIP MATERNAL	40	187	188	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17155	10.1371/journal.pone.0017155	http://dx.doi.org/10.1371/journal.pone.0017155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386886	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400034
J	Hu, XL; Pickering, E; Liu, YC; Hall, S; Fournier, H; Katz, E; Dechairo, B; John, S; Van Eerdewegh, P; Soares, H				Hu, Xiaolan; Pickering, Eve; Liu, Yingxue Cathy; Hall, Stephanie; Fournier, Helene; Katz, Elyse; Dechairo, Bryan; John, Sally; Van Eerdewegh, Paul; Soares, Holly		Alzheimer's Dis Neuroimaging Initi	Meta-Analysis for Genome-Wide Association Study Identifies Multiple Variants at the BIN1 Locus Associated with Late-Onset Alzheimer's Disease	PLOS ONE			English	Article							SUSCEPTIBILITY; ENDOCYTOSIS; GENE; CLU; AMPHIPHYSIN-2; GENOTYPE; REVEALS; PROTEIN; PICALM; RISK	Recent GWAS studies focused on uncovering novel genetic loci related to AD have revealed associations with variants near CLU, CR1, PICALM and BIN1. In this study, we conducted a genome-wide association study in an independent set of 1034 cases and 1186 controls using the Illumina genotyping platforms. By coupling our data with available GWAS datasets from the ADNI and GenADA, we replicated the original associations in both PICALM (rs3851179) and CR1 (rs3818361). The PICALM variant seems to be non-significant after we adjusted for APOE e4 status. We further tested our top markers in 751 independent cases and 751 matched controls. Besides the markers close to the APOE locus, a marker (rs12989701) upstream of BIN1 locus was replicated and the combined analysis reached genome-wide significance level (p = 5E-08). We combined our data with the published Harold et al. study and meta-analysis with all available 6521 cases and 10360 controls at the BIN1 locus revealed two significant variants (rs12989701, p = 1.32E-10 and rs744373, p = 3.16E-10) in limited linkage disequilibrium (r(2) = 0.05) with each other. The independent contribution of both SNPs was supported by haplotype conditional analysis. We also conducted multivariate analysis in canonical pathways and identified a consistent signal in the downstream pathways targeted by Gleevec (P = 0.004 in Pfizer; P = 0.028 in ADNI and P = 0.04 in GenADA). We further tested variants in CLU, PICALM, BIN1 and CR1 for association with disease progression in 597 AD patients where longitudinal cognitive measures are sufficient. Both the PICALM and CLU variants showed nominal significant association with cognitive decline as measured by change in Clinical Dementia Rating-sum of boxes (CDR-SB) score from the baseline but did not pass multiple-test correction. Future experiments will help us better understand potential roles of these genetic loci in AD pathology.	[Hu, Xiaolan; Hall, Stephanie; Katz, Elyse; Dechairo, Bryan; John, Sally] Pfizer Inc, Mol Med, Groton, CT 06340 USA; [Pickering, Eve] Pfizer Inc, Res Stat, Groton, CT 06340 USA; [Liu, Yingxue Cathy] Pfizer Inc, Clin Stat, Shanghai, Peoples R China; [Fournier, Helene; Van Eerdewegh, Paul] Genizon Biosci Inc, Montreal, PQ, Canada; [Soares, Holly] Pfizer Inc, Translat Med, Groton, CT 06340 USA	Pfizer; Pfizer; Pfizer; Pfizer	Hu, XL (corresponding author), Pfizer Inc, Mol Med, Groton, CT 06340 USA.	xiaolan.hu@pfizer.com	Scharre, Douglas W/E-4030-2011		Pfizer; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; GlaxoSmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co.; Medpace, Inc.; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING [U01AG024904, U19AG010483] Funding Source: NIH RePORTER	Pfizer(Pfizer); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); GlaxoSmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co.(Eli Lilly); Medpace, Inc.; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Pfizer provided funding for the experiments and had a role in study design, data collection and analysis as well as the decision to publish the manuscript.; We acknowledge all the patients who contributed samples included in the study. We greatly appreciate the efforts from GERAD1 consortium, GenADA and ADNI investigators to provide open access to summary statistics or genotype data in previous GWAS studies. The genotypic and associated phenotypic data used in the GenADA study were provided by the GlaxoSmithKline, R&D Limited and the datasets were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000219.v1.p1. Pfizer provided funding for generating GWAS data in the Pfizer samples. Mathew Pletcher and David King reviewed the manuscript and provided valuable inputs. We thank Kelly Bales, David Riddell, Philip Iredale, Jia Li, Craig Hyde, Joanne Bells, Rebecca Evans, Michael Swietek, Robert Peitzsch, Baohong Zhao, Manuel Duval, Albert Seymour, Joe Paulauskis, Kelly Longo, Lea Harty and Douglas Lee at Pfizer for assistance and useful discussions. Li Yun at UNC provided valuable guidance on the Mach imputation tool. We included ADNI (www.loni.ucla.edu/ADNI) genotype data in the preparation of this article. The ADNI investigators contributed to the design and implementation of ADNI and/or provided data but did not participate in the analysis or writing of this report. The complete listing of ADNI investigators is available at http://www.loni.ucla.edu/ADNI/Collaboration/ADNI_Manuscript_Citations.pdf. The following statements were cited from ADNI: Data collection and sharing for ADNI was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles.	Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Carrasquillo MM, 2009, NAT GENET, V41, P192, DOI 10.1038/ng.305; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Cruts M, 1998, ANN MED, V30, P560, DOI 10.3109/07853899809002605; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Di Paolo G, 2002, NEURON, V33, P789, DOI 10.1016/S0896-6273(02)00601-3; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Jones L, 2010, BBA-MOL CELL BIOL L, V1801, P754, DOI 10.1016/j.bbalip.2010.04.005; Jones RW, 2008, ALZHEIMERS DEMENT, V4, P145, DOI 10.1016/j.jalz.2008.02.001; Kelly BL, 2005, J BIOL CHEM, V280, P31746, DOI 10.1074/jbc.M503259200; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Li H, 2008, ARCH NEUROL-CHICAGO, V65, P45, DOI 10.1001/archneurol.2007.3; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Routhier EL, 2003, ONCOGENE, V22, P637, DOI 10.1038/sj.onc.1206162; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Saykin AJ, 2010, ALZHEIMERS DEMENT, V6, P265, DOI 10.1016/j.jalz.2010.03.013; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Zelhof AC, 2001, DEVELOPMENT, V128, P5005	43	70	76	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16616	10.1371/journal.pone.0016616	http://dx.doi.org/10.1371/journal.pone.0016616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390209	gold, Green Submitted, Green Published			2022-12-27	WOS:000287761700012
J	Koller, B; Muller-Wiefel, AS; Rupec, R; Korting, HC; Ruzicka, T				Koller, Barbara; Mueller-Wiefel, Alisa Sophie; Rupec, Rudolph; Korting, Hans Christian; Ruzicka, Thomas			Chitin Modulates Innate Immune Responses of Keratinocytes	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; INFLAMMATION; EXPRESSION; PROTEINS; TISSUE; ACTIVATION; ALLERGY; MOUSE; HOST	Background: Chitin, after cellulose the second most abundant polysaccharide in nature, is an essential component of exoskeletons of crabs, shrimps and insects and protects these organisms from harsh conditions in their environment. Unexpectedly, chitin has been found to activate innate immune cells and to elicit murine airway inflammation. The skin represents the outer barrier of the human host defense and is in frequent contact with chitin-bearing organisms, such as house-dust mites or flies. The effects of chitin on keratinocytes, however, are poorly understood. Methodology/Principal Findings: We hypothesized that chitin stimulates keratinocytes and thereby modulates the innate immune response of the skin. Here we show that chitin is bioactive on primary and immortalized keratinocytes by triggering production of pro-inflammatory cytokines and chemokines. Chitin stimulation further induced the expression of the Toll-like receptor (TLR) TLR4 on keratinocytes at mRNA and protein level. Chitin-induced effects were mainly abrogated when TLR2 was blocked, suggesting that TLR2 senses chitin on keratinocytes. Conclusions/Significance: We speculate that chitin-bearing organisms modulate the innate immune response towards pathogens by upregulating secretion of cytokines and chemokines and expression of MyD88-associated TLRs, two major components of innate immunity. The clinical relevance of this mechanism remains to be defined.	[Koller, Barbara; Mueller-Wiefel, Alisa Sophie; Rupec, Rudolph; Korting, Hans Christian; Ruzicka, Thomas] Univ Munich, Dept Dermatol & Allergy, Munich, Germany	University of Munich	Koller, B (corresponding author), Univ Munich, Dept Dermatol & Allergy, Munich, Germany.	barbara.koller@med.uni-muenchen.de			Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Barbara Koller is supported by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Baker BS, 2003, BRIT J DERMATOL, V148, P670, DOI 10.1046/j.1365-2133.2003.05287.x; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Da Silva CA, 2009, J IMMUNOL, V182, P3573, DOI 10.4049/jimmunol.0802113; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Hartl D, 2007, NAT MED, V13, P1423, DOI 10.1038/nm1690; Herrera-Estrella A, 1999, EXS, V87, P171; Huang CH, 2003, J INVEST DERMATOL, V121, P289, DOI 10.1046/j.1523-1747.2003.12356.x; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; LEE CG, 2010, ANNU REV PHYSIOL, V19, P19; Lee CG, 2009, YONSEI MED J, V50, P22, DOI 10.3349/ymj.2009.50.1.22; Lee CG, 2008, CURR OPIN IMMUNOL, V20, P684, DOI 10.1016/j.coi.2008.10.002; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Motulsky H., 1995, INTUITIVE BIOSTATIST; Nathan P, 1973, CRC Crit Rev Clin Lab Sci, V4, P61, DOI 10.3109/10408367309151684; Pivarcsi A, 2003, INT IMMUNOL, V15, P721, DOI 10.1093/intimm/dxg068; Pivarcsi A., 2004, Acta Microbiologica et Immunologica Hungarica, V51, P303, DOI 10.1556/AMicr.51.2004.3.8; Pivarcsi A, 2004, ARCH DERMATOL RES, V296, P120, DOI 10.1007/s00403-004-0475-2; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Reynolds P, 2000, Nurs Times, V96, P6; Shibata Y, 1997, INFECT IMMUN, V65, P1734, DOI 10.1128/IAI.65.5.1734-1741.1997; Shibata Y, 1997, J IMMUNOL, V159, P2462; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Strong P, 2002, CLIN EXP ALLERGY, V32, P1794, DOI 10.1046/j.1365-2222.2002.01551.x; Terhorst D, 2010, AM J CLIN DERMATOL, V11, P1, DOI 10.2165/11311110-000000000-00000; Weindl G, 2007, J CLIN INVEST, V117, P3664, DOI 10.1172/JCI28115; White A, 1975, Adv Intern Med, V20, P23; WOLFSON JS, 1983, ANNU REV MED, V34, P205, DOI 10.1146/annurev.me.34.020183.001225; Young L S, 1972, CRC Crit Rev Clin Lab Sci, V3, P291, DOI 10.3109/10408367209151698; Zhang Z, 2006, CELL MOL LIFE SCI, V63, P2901, DOI 10.1007/s00018-006-6189-1	32	82	86	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16594	10.1371/journal.pone.0016594	http://dx.doi.org/10.1371/journal.pone.0016594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383982	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700011
J	Quan, L; Stassen, APM; Ruivenkamp, CAL; van Wezel, T; Fijneman, RJA; Hutson, A; Kakarlapudi, N; Hart, AAM; Demant, P				Quan, Lei; Stassen, Alphons P. M.; Ruivenkamp, Claudia A. L.; van Wezel, Tom; Fijneman, Remond J. A.; Hutson, Alan; Kakarlapudi, Neelima; Hart, Augustinus A. M.; Demant, Peter			Most Lung and Colon Cancer Susceptibility Genes Are Pair-Wise Linked in Mice, Humans and Rats	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCUS; RECOMBINANT CONGENIC STRAINS; ADENOMA RESISTANCE LOCUS; POSITIVE BREAST-CANCER; MOUSE-CHROMOSOME 3; COLORECTAL-CANCER; TUMOR-SUSCEPTIBILITY; PROSTATE-CANCER; CONFER SUSCEPTIBILITY	Genetic predisposition controlled by susceptibility quantitative trait loci (QTLs) contributes to a large proportion of common cancers. Studies of genetics of cancer susceptibility, however, did not address systematically the relationship between susceptibility to cancers in different organs. We present five sets of data on genetic architecture of colon and lung cancer susceptibility in mice, humans and rats. They collectively show that the majority of genes for colon and lung cancer susceptibility are linked pair-wise and are likely identical or related. Four CcS/Dem recombinant congenic strains, each differing from strain BALB/cHeA by a different small random subset of +/- 12.5% of genes received from strain STS/A, suggestively show either extreme susceptibility or extreme resistance for both colon and lung tumors, which is unlikely if the two tumors were controlled by independent susceptibility genes. Indeed, susceptibility to lung cancer (Sluc) loci underlying the extreme susceptibility or resistance of such CcS/Dem strains, mapped in 226 (CcS-10xCcS-19)F2 mice, co-localize with susceptibility to colon cancer (Scc) loci. Analysis of additional Sluc loci that were mapped in OcB/Dem strains and Scc loci in CcS/Dem strains, respectively, shows their widespread pair-wise co-localization (P = 0.0036). Finally, the majority of published human and rat colon cancer susceptibility genes map to chromosomal regions homologous to mouse Sluc loci. 12/12 mouse Scc loci, 9/11 human and 5/7 rat colon cancer susceptibility loci are close to a Sluc locus or its homologous site, forming 21 clusters of lung and colon cancer susceptibility genes from one, two or three species. Our data shows that cancer susceptibility QTLs can have much broader biological effects than presently appreciated. It also demonstrates the power of mouse genetics to predict human susceptibility genes. Comparison of molecular mechanisms of susceptibility genes that are organ-specific and those with trans-organ effects can provide a new dimension in understanding individual cancer susceptibility.	[Quan, Lei; Kakarlapudi, Neelima; Demant, Peter] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Stassen, Alphons P. M.] Maastricht Univ, Dept Genet & Cell Biol Clin Genet, Maastricht, Netherlands; [Ruivenkamp, Claudia A. L.; van Wezel, Tom] Leiden Univ, Dept Human & Clin Genet, Med Ctr, Leiden, Netherlands; [Fijneman, Remond J. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Hutson, Alan] Roswell Pk Canc Inst, Dept Biostat, Buffalo, NY 14263 USA; [Hart, Augustinus A. M.] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Hart, Augustinus A. M.] Netherlands Canc Inst, Div Radiotherapy, Amsterdam, Netherlands	Roswell Park Cancer Institute; Maastricht University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Roswell Park Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute	Quan, L (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA.	Peter.Demant@roswellpark.org	Fijneman, Remond/X-4199-2019; Quan, Lei/GXN-1280-2022; van Wezel, Tom/AAL-5626-2021; van Wezel, Tom/Z-3092-2019; van Wezel, Tom/A-9599-2008	Fijneman, Remond/0000-0003-2076-5521; van Wezel, Tom/0000-0001-5773-7730; van Wezel, Tom/0000-0001-5773-7730; Quan, Lei/0000-0002-6572-0530	National Institutes of Health-National Cancer Institute [R01CA116158b]; Ralph C. Wilson Sr. and Jr. Medical Foundation; Roswell Park Cancer Institute	National Institutes of Health-National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ralph C. Wilson Sr. and Jr. Medical Foundation; Roswell Park Cancer Institute	The work has been funded by the National Institutes of Health-National Cancer Institute grant R01CA116158b, Ralph C. Wilson Sr. and Jr. Medical Foundation, and an institutional grant from the Roswell Park Cancer Institute to Peter Demant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Angel J M, 1999, Prog Exp Tumor Res, V35, P143; Angel JM, 2000, MOL CARCINOGEN, V27, P47, DOI 10.1002/(SICI)1098-2744(200001)27:1<47::AID-MC7>3.0.CO;2-7; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bilusic M, 2004, HYPERTENSION, V44, P695, DOI 10.1161/01.HYP.0000144542.57306.5e; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cordes SP, 2005, MICROBIOL MOL BIOL R, V69, P426, DOI 10.1128/MMBR.69.3.426-439.2005; De Miglio MR, 2007, CARCINOGENESIS, V28, P2367, DOI 10.1093/carcin/bgm119; DEMANT P, 1986, IMMUNOGENETICS, V24, P416, DOI 10.1007/BF00377961; DEMANT P, 1989, ADV CANCER RES, V53, P117; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Festing MFW, 1998, GENOMICS, V53, P129, DOI 10.1006/geno.1998.5450; Fijneman RJA, 2004, CANCER RES, V64, P3458, DOI 10.1158/0008-5472.CAN-03-3767; Fijneman RJA, 1998, CANCER RES, V58, P4794; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hunter DJ, 2010, J NATL CANCER I, V102, P836, DOI 10.1093/jnci/djq197; Huppi K, 2007, SEMIN CANCER BIOL, V17, P65, DOI 10.1016/j.semcancer.2006.10.004; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Ioannidis JPA, 2010, JNCI-J NATL CANCER I, V102, P846, DOI 10.1093/jnci/djq173; JACOBY RF, 1994, GENOMICS, V22, P381, DOI 10.1006/geno.1994.1399; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Kakarlapudi N, 2008, CANCER IMMUNOL IMMUN, V57, P217, DOI 10.1007/s00262-007-0367-3; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; Kouso H, 2008, J SURG ONCOL, V98, P377, DOI 10.1002/jso.21108; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lesueur F, 2005, HUM MOL GENET, V14, P2349, DOI 10.1093/hmg/ddi237; Lipoldova M, 2005, INT J CANCER, V114, P394, DOI 10.1002/ijc.20731; Liu PY, 2006, NAT GENET, V38, P888, DOI 10.1038/ng1849; Lynch PM, 2009, SURG ONCOL CLIN N AM, V18, P611, DOI 10.1016/j.soc.2009.08.002; Manenti G, 1996, NAT GENET, V12, P455, DOI 10.1038/ng0496-455; Manenti G, 2004, ONCOGENE, V23, P4495, DOI 10.1038/sj.onc.1207584; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Mao JH, 2006, P NATL ACAD SCI USA, V103, P8125, DOI 10.1073/pnas.0602581103; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; MOEN CJA, 1992, ONCOGENE, V7, P563; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; Nagase H, 1999, P NATL ACAD SCI USA, V96, P15032, DOI 10.1073/pnas.96.26.15032; Obata M, 1996, ONCOGENE, V13, P1599; Pataer A, 1997, CANCER RES, V57, P2904; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ruivenkamp CAL, 2003, ONCOGENE, V22, P7258, DOI 10.1038/sj.onc.1207096; Ruivenkamp CAL, 2002, NAT GENET, V31, P295, DOI 10.1038/ng903; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Santos CAF, 2002, MOL GENET GENOMICS, V268, P122, DOI 10.1007/s00438-002-0735-9; Schork NJ, 1996, HYPERTENSION, V28, P1104; Sevignani C, 2007, P NATL ACAD SCI USA, V104, P8017, DOI 10.1073/pnas.0702177104; SHIBUYA T, 1993, MUTAT RES, V297, P3, DOI 10.1016/0165-1110(93)90005-8; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun J, 2008, NAT GENET, V40, P1153, DOI 10.1038/ng.214; TENESA A, 2008, NAT GENET; Thomas A, 1999, COMPUT BIOMED RES, V32, P517, DOI 10.1006/cbmr.1999.1525; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; TOMLINSON IP, 2008, NAT GENET; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; van Wezel T, 1999, CANCER RES, V59, P4216; vanWezel T, 1996, NAT GENET, V14, P468, DOI 10.1038/ng1296-468; Wali RK, 1999, CARCINOGENESIS, V20, P2355, DOI 10.1093/carcin/20.12.2355; Wang YD, 2009, CANCER LETT, V285, P134, DOI 10.1016/j.canlet.2009.05.005; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yi S, 2006, MOL CARCINOGEN, V45, P409, DOI 10.1002/mc.20231; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100	91	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14727	10.1371/journal.pone.0014727	http://dx.doi.org/10.1371/journal.pone.0014727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390212	gold, Green Published, Green Submitted			2022-12-27	WOS:000287761700005
J	Howard, MA; Krause, K; Khawaja, N; Massat, N; Zelaya, F; Schumann, G; Huggins, JP; Vennart, W; Williams, SCR; Renton, TF				Howard, Matthew A.; Krause, Kristina; Khawaja, Nadine; Massat, Nathalie; Zelaya, Fernando; Schumann, Gunter; Huggins, John P.; Vennart, William; Williams, Steven C. R.; Renton, Tara F.			Beyond Patient Reported Pain: Perfusion Magnetic Resonance Imaging Demonstrates Reproducible Cerebral Representation of Ongoing Post-Surgical Pain	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HUMAN BRAIN; BLOOD-FLOW; BACK-PAIN; RESPONSES; FMRI; PET; STIMULATION; PERCEPTION; ACTIVATION	Development of treatments for acute and chronic pain conditions remains a challenge, with an unmet need for improved sensitivity and reproducibility in measuring pain in patients. Here we used pulsed-continuous arterial spin-labelling [pCASL], a relatively novel perfusion magnetic-resonance imaging technique, in conjunction with a commonly-used post-surgical model, to measure changes in regional cerebral blood flow [rCBF] associated with the experience of being in ongoing pain. We demonstrate repeatable, reproducible assessment of ongoing pain that is independent of patient self-report. In a crossover trial design, 16 participants requiring bilateral removal of lower-jaw third molars underwent pain-free pre-surgical pCASL scans. Following extraction of either left or right tooth, repeat scans were acquired during post-operative ongoing pain. When pain-free following surgical recovery, the pre/post-surgical scanning procedure was repeated for the remaining tooth. Voxelwise statistical comparison of pre and post-surgical scans was performed to reveal rCBF changes representing ongoing pain. In addition, rCBF values in predefined pain and control brain regions were obtained. rCBF increases (5-10%) representing post-surgical ongoing pain were identified bilaterally in a network including primary and secondary somatosensory, insula and cingulate cortices, thalamus, amygdala, hippocampus, midbrain and brainstem (including trigeminal ganglion and principal-sensory nucleus), but not in a control region in visual cortex. rCBF changes were reproducible, with no rCBF differences identified across scans within-session or between post-surgical pain sessions. This is the first report of the cerebral representation of ongoing post-surgical pain without the need for exogenous tracers. Regions of rCBF increases are plausibly associated with pain and the technique is reproducible, providing an attractive proposition for testing interventions for on-going pain that do not rely solely on patient self-report. Our findings have the potential to improve our understanding of the cerebral representation of persistent painful conditions, leading to improved identification of specific patient sub-types and implementation of mechanism-based treatments.	[Howard, Matthew A.; Krause, Kristina; Zelaya, Fernando; Williams, Steven C. R.] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Krause, Kristina; Schumann, Gunter] Kings Coll London, MRC Social Genet & Dev Psychiat Ctr, Inst Psychiat, London WC2R 2LS, England; [Khawaja, Nadine; Renton, Tara F.] Kings Coll London, Inst Dent, London WC2R 2LS, England; [Massat, Nathalie; Huggins, John P.; Vennart, William] Pfizer Ltd, Global Res & Dev, Sandwich CT13 9NJ, Kent, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; Pfizer	Howard, MA (corresponding author), Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England.	Matthew.Howard@kcl.ac.uk	Schumann, Gunter/H-1013-2013; Howard, Matt A/B-7190-2012; Zelaya, Fernando O/I-3125-2012; Massat, Nathalie/K-4011-2019; Williams, Steve C/D-6979-2011	Howard, Matt A/0000-0002-9359-3057; Zelaya, Fernando O/0000-0002-9525-1560; Williams, Steve C/0000-0003-4299-1941; opoku, anita/0000-0001-7243-8157	Pfizer Global Research and Development; Pfizer; Medical Research Council [G9817803B] Funding Source: researchfish; National Institute for Health Research [ACF-2008-17-024] Funding Source: researchfish	Pfizer Global Research and Development(Pfizer); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The funders of this project were Pfizer Global Research and Development. The project forms part of an ongoing five year allied industrial-academic collaboration between King's College London and Pfizer. Pfizer scientists were involved in the design, analysis and dissemination of the research and feature as named authors.; Dr. Howard, Professors Schumann, Renton and Williams are all named principal investigators on a grant to do this work funded by Pfizer Global Research and Development. The salaries of Dr. Howard and Ms. Krause are funded by Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Apkarian AV, 2001, NEUROSCI LETT, V299, P57, DOI 10.1016/S0304-3940(01)01504-X; Barden J, 2004, PAIN, V107, P86, DOI 10.1016/j.pain.2003.09.021; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; Borsook D, 2008, NEUROIMAGE, V42, P461, DOI 10.1016/j.neuroimage.2008.04.268; Butler R. W., 1989, PSYCHOL ASSESSMENT J, V1, P41; Cahana A, 2004, ANESTH ANALG, V98, P1581, DOI 10.1213/01.ANE.0000113258.31039.C8; Cauda F, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-138; Cauda F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004542; Chen LC, 2004, J CLIN PHARM THER, V29, P215, DOI 10.1111/j.1365-2710.2004.00558.x; Chizh BA, 2009, BRAIN RES REV, V60, P243, DOI 10.1016/j.brainresrev.2008.12.016; Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; de Leeuw R, 2005, ORAL SURG ORAL MED O, V100, P308, DOI 10.1016/j.tripleo.2004.11.014; Derbyshire SWG, 2006, PAIN, V122, P217, DOI 10.1016/j.pain.2006.02.031; DERBYSHIRE SWG, 1994, J NEUROL NEUROSUR PS, V57, P1166, DOI 10.1136/jnnp.57.10.1166; Derbyshire SWG, 1998, PAIN, V76, P127, DOI 10.1016/S0304-3959(98)00034-7; Derbyshire SWG, 1999, EUR J PAIN, V3, P103, DOI 10.1053/eujp.1998.0102; Derbyshire SWG, 1997, PAIN, V73, P431, DOI 10.1016/S0304-3959(97)00138-3; DEROGATIS L, 2005, SCL 90 R SYMPTOM CHE, P90; Dessem D, 2007, J NEUROPHYSIOL, V98, P214, DOI 10.1152/jn.00990.2006; DIPIERO V, 1991, PAIN, V46, P9, DOI 10.1016/0304-3959(91)90026-T; Eccleston C, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007407.pub2; Jaaskelainen SK, 2001, PAIN, V90, P257, DOI 10.1016/S0304-3959(00)00409-7; Jantsch HHF, 2005, PAIN, V118, P390, DOI 10.1016/j.pain.2005.09.017; Kupers R, 2006, LANCET NEUROL, V5, P1033, DOI 10.1016/S1474-4422(06)70624-X; LIN LD, 1993, J NEUROPHYSIOL, V70, P985, DOI 10.1152/jn.1993.70.3.985; Maihofner C, 2004, NEUROLOGY, V63, P693, DOI 10.1212/01.WNL.0000134661.46658.B0; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; May A, 2008, PAIN, V137, P7, DOI 10.1016/j.pain.2008.02.034; Melzack R, 2001, J Dent Educ, V65, P1378; MELZACK R, 1968, P423; Mitsis GD, 2008, NEUROIMAGE, V40, P121, DOI 10.1016/j.neuroimage.2007.11.026; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Moore RA, 1998, PAIN, V78, P209, DOI 10.1016/S0304-3959(98)00140-7; Nash PG, 2009, HUM BRAIN MAPP, V30, P3772, DOI 10.1002/hbm.20805; *NICE NHS, 2000, 1 NICENHS; Nieuwenhuys R., 2008, HUMAN CENTRAL NERVOU; Owen AM, 2008, NAT REV NEUROSCI, V9, P235, DOI 10.1038/nrn2330; Owen DG, 2008, PAIN, V136, P85, DOI 10.1016/j.pain.2007.06.021; Owen DG, 2010, PAIN, V148, P375, DOI 10.1016/j.pain.2009.10.003; Penfield W, 1950, CEREBRAL CORTEX MAN; Petersen ET, 2006, BRIT J RADIOL, V79, P688, DOI 10.1259/bjr/67705974; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Pogatzki-Zahn EM, 2007, BEST PRACT RES-CLIN, V21, P3, DOI 10.1016/j.bpa.2006.11.003; Pogatzki-Zahn EM, 2010, ANESTHESIOLOGY, V112, P406, DOI 10.1097/ALN.0b013e3181ca4c82; Popping DM, 2008, BRIT J ANAESTH, V101, P832, DOI 10.1093/bja/aen300; Price D. D., 1999, PSYCHOL MECH PAIN AN; Renton T, 2001, BRIT DENT J, V190, P607, DOI 10.1038/sj.bdj.4801052a; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SZMYD L, 1965, J ORAL THER PHARMACO, V1, P491; Teepker M, 2010, NEUROPSYCHOBIOLOGY, V61, P131, DOI 10.1159/000279303; Thunberg J, 2005, EUR J PAIN, V9, P185, DOI 10.1016/j.ejpain.2004.05.003; Tracey I, 2010, PAIN, V148, P359, DOI 10.1016/j.pain.2009.11.009; Tracey I, 2009, J PAIN, V10, P1113, DOI 10.1016/j.jpain.2009.09.001; Wagner KJ, 2001, ANESTHESIOLOGY, V94, P732, DOI 10.1097/00000542-200105000-00008; Weigelt A, 2010, PAIN, V149, P529, DOI 10.1016/j.pain.2010.03.027; WEISSMAN MM, 1977, AM J EPIDEMIOL, V106, P203, DOI 10.1093/oxfordjournals.aje.a112455; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589; Woodcock J, 2007, NAT REV DRUG DISCOV, V6, P703, DOI 10.1038/nrd2335; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	67	43	44	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17096	10.1371/journal.pone.0017096	http://dx.doi.org/10.1371/journal.pone.0017096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373203	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500032
J	Wojcicki, JM; Holbrook, K; Lustig, RH; Epel, E; Caughey, AB; Munoz, RF; Shiboski, SC; Heyman, MB				Wojcicki, Janet M.; Holbrook, Katherine; Lustig, Robert H.; Epel, Elissa; Caughey, Aaron B.; Munoz, Ricardo F.; Shiboski, Stephen C.; Heyman, Melvin B.			Chronic Maternal Depression Is Associated with Reduced Weight Gain in Latino Infants from Birth to 2 Years of Age	PLOS ONE			English	Article							MEXICAN-AMERICAN CHILDREN; POSTNATAL DEPRESSION; RISK-FACTORS; PREGNANCY; GROWTH; IMPACT; PREVALENCE; SYMPTOMS; CORTISOL; STRESS	Background: Latino children are at increased risk for mirconutrient deficiencies and problems of overweight and obesity. Exposures in pregnancy and early postpartum may impact future growth trajectories. Objectives: To evaluate the relationship between prenatal and postnatal maternal depressive symptoms experienced in pregnancy and infant growth from birth to 2 years of age in a cohort of Latino infants. Methods: We recruited pregnant Latina mothers at two San Francisco hospitals and followed their healthy infants to 24 months of age. At 6, 12 and 24 months of age, infants were weighed and measured. Maternal depressive symptoms were assessed prenatally and at 4-6 weeks postpartum. Women who had high depressive symptoms at both time periods were defined as having chronic depression. Logistic mixed models were applied to compare growth curves and risk for overweight and underweight based on exposure to maternal depression. Results: We followed 181 infants to 24 months. At 12 and 24 months, respectively, 27.4% and 40.5% were overweight, and 5.6% and 2.2% were underweight. Exposure to chronic maternal depression was associated with underweight (OR = 12.12, 95% CI 1.86-78.78) and with reduced weight gain in the first 2 years of life (Coef = -0.48, 95% CI -0.94-0.01) compared with unexposed infants or infants exposed to episodic depression (depression at one time point). Exposure to chronic depression was also associated with reduced risk for overweight in the first 2 years of life (OR 0.28, 95% CI 0.03-0.92). Conclusions: Exposure to chronic maternal depression in the pre- and postnatal period was associated with reduced weight gain in the first two years of life and greater risk for failure to thrive, in comparison with unexposed infants or those exposed episodically. The infants of mothers with chronic depression may need additional nutritional monitoring and intervention.	[Wojcicki, Janet M.; Holbrook, Katherine; Heyman, Melvin B.] Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol & Nutr, San Francisco, CA 94143 USA; [Lustig, Robert H.] Univ Calif San Francisco, Dept Pediat, Div Pediat Endocrinol, San Francisco, CA 94143 USA; [Caughey, Aaron B.] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA; [Shiboski, Stephen C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wojcicki, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, Div Pediat Gastroenterol & Nutr, San Francisco, CA 94143 USA.	wojcicki@gmail.com	Lustig, Robert/O-9380-2019	Lustig, Robert/0000-0001-6983-2639	Hellman Family Foundation; Children's Digestive Health and Nutrition Foundation (CDHF); NIH [DK060617, DK080825]; NIH/NCRR UCSF-CTSI [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080825, K24DK060617, T32DK007762] Funding Source: NIH RePORTER	Hellman Family Foundation; Children's Digestive Health and Nutrition Foundation (CDHF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the Hellman Family Foundation, the Children's Digestive Health and Nutrition Foundation (CDHF), NIH grant DK060617, DK080825 and by NIH/NCRR UCSF-CTSI Grant Number UL1 RR024131. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Adewuya AO, 2008, J AFFECT DISORDERS, V108, P191, DOI 10.1016/j.jad.2007.09.013; Ajslev TA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011136; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dennis CL, 2009, PEDIATRICS, V123, pE736, DOI 10.1542/peds.2008-1629; Ertel KA, 2010, PAEDIATR PERINAT EP, V24, P179, DOI 10.1111/j.1365-3016.2010.01098.x; Essex MJ, 2002, BIOL PSYCHIAT, V52, P776, DOI 10.1016/S0006-3223(02)01553-6; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Field T, 2006, INFANT BEHAV DEV, V29, P268, DOI 10.1016/j.infbeh.2005.12.010; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Grote V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-14; Hurley KM, 2008, J NUTR, V138, P799, DOI 10.1093/jn/138.4.799; Kim YN, 2006, J AM DIET ASSOC, V106, P385, DOI 10.1016/j.jada.2005.12.010; Melville JL, 2010, OBSTET GYNECOL, V116, P1064, DOI 10.1097/AOG.0b013e3181f60b0a; National Center for Health Statistics, 2000, CDC GROWTH CHARTS; O'Brien LM, 2004, PEDIATRICS, V113, P1242, DOI 10.1542/peds.113.5.1242; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Sandstead HH, 2008, AM J CLIN NUTR, V88, P1067, DOI 10.1093/ajcn/88.4.1067; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Skelton JA, 2009, ACAD PEDIATR, V9, P322, DOI 10.1016/j.acap.2009.04.005; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Taveras EM, 2010, PEDIATRICS, V125, P686, DOI 10.1542/peds.2009-2100; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; WOJCICKI JM, 2011, J HUMAN LAC IN PRESS; World Health Organization, 1995, PHYS STAT US INT ANT; Wright CM, 2006, ARCH DIS CHILD, V91, P312, DOI 10.1136/adc.2005.077750	29	40	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16737	10.1371/journal.pone.0016737	http://dx.doi.org/10.1371/journal.pone.0016737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373638	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500016
J	Edwards, YJK; Beecham, GW; Scott, WK; Khuri, S; Bademci, G; Tekin, D; Martin, ER; Jiang, ZJ; Mash, DC; Ffrench-Mullen, J; Pericak-Vance, MA; Tsinoremas, N; Vance, JM				Edwards, Yvonne J. K.; Beecham, Gary W.; Scott, William K.; Khuri, Sawsan; Bademci, Guney; Tekin, Demet; Martin, Eden R.; Jiang, Zhijie; Mash, Deborah C.; Ffrench-Mullen, Jarlath; Pericak-Vance, Margaret A.; Tsinoremas, Nicholas; Vance, Jeffery M.			Identifying Consensus Disease Pathways in Parkinson's Disease Using an Integrative Systems Biology Approach	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BRAIN-BARRIER DISRUPTION; GENE-EXPRESSION; AXON GUIDANCE; NEURONAL VULNERABILITY; COMPLEX DISEASE; RISK-FACTORS; CALCIUM; BIOINFORMATICS; SUSCEPTIBILITY	Parkinson's disease (PD) has had six genome-wide association studies (GWAS) conducted as well as several gene expression studies. However, only variants in MAPT and SNCA have been consistently replicated. To improve the utility of these approaches, we applied pathway analyses integrating both GWAS and gene expression. The top 5000 SNPs (p < 0.01) from a joint analysis of three existing PD GWAS were identified and each assigned to a gene. For gene expression, rather than the traditional comparison of one anatomical region between sets of patients and controls, we identified differentially expressed genes between adjacent Braak regions in each individual and adjusted using average control expression profiles. Over-represented pathways were calculated using a hyper-geometric statistical comparison. An integrated, systems meta-analysis of the over-represented pathways combined the expression and GWAS results using a Fisher's combined probability test. Four of the top seven pathways from each approach were identical. The top three pathways in the meta-analysis, with their corrected p-values, were axonal guidance (p = 2.8E-07), focal adhesion (p = 7.7E-06) and calcium signaling (p = 2.9E-05). These results support that a systems biology (pathway) approach will provide additional insight into the genetic etiology of PD and that these pathways have both biological and statistical support to be important in PD.	[Edwards, Yvonne J. K.; Beecham, Gary W.; Scott, William K.; Bademci, Guney; Tekin, Demet; Martin, Eden R.; Pericak-Vance, Margaret A.; Vance, Jeffery M.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Khuri, Sawsan; Jiang, Zhijie; Tsinoremas, Nicholas] Univ Miami, Miller Sch Med, Ctr Computat Sci, Miami, FL 33136 USA; [Mash, Deborah C.] Univ Miami, Miller Sch Med, Dept Neurol & Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Ffrench-Mullen, Jarlath] Gene Log, Gaithersburg, MD USA	University of Miami; University of Miami; University of Miami	Edwards, YJK (corresponding author), Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA.	jvance@med.miami.edu		Edwards, Yvonne/0000-0001-8505-3168; Bademci, Guney/0000-0002-4052-8833; Scott, William/0000-0001-9336-6404; Vance, Jeffery/0000-0003-3815-8199; Khuri, Sawsan/0000-0003-1372-1133	Gene Logic, Inc.; Ocimum Biosciences;  [NS39764];  [MH074059-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH074059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER	Gene Logic, Inc.; Ocimum Biosciences; ; ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants NS39764 and MH074059-02, and in part by Gene Logic, Inc. and Ocimum Biosciences (http://www.genelogic.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bossers K, 2009, BRAIN PATHOL, V19, P91, DOI 10.1111/j.1750-3639.2008.00171.x; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bras J, 2008, FEBS J, V275, P5767, DOI 10.1111/j.1742-4658.2008.06709.x; Brown RC, 2002, STROKE, V33, P1706, DOI 10.1161/01.STR.0000016405.06729.83; Caltagarone J, 2007, BBA-MOL BASIS DIS, V1772, P438, DOI 10.1016/j.bbadis.2006.11.007; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Chan CS, 2009, TRENDS NEUROSCI, V32, P249, DOI 10.1016/j.tins.2009.01.006; Dagda RK, 2009, MITOCHONDRION, V9, P289, DOI 10.1016/j.mito.2009.06.001; Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Edwards YJK, 2006, COMP BIOCHEM PHYS D, V1, P46, DOI 10.1016/j.cbd.2005.03.001; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Gao X, 2009, NEUROLOGY, V73, P1286, DOI 10.1212/WNL.0b013e3181bd13a1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hatano T, 2009, J NEUROCHEM, V111, P1075, DOI 10.1111/j.1471-4159.2009.06403.x; Hauser MA, 2005, ARCH NEUROL-CHICAGO, V62, P917, DOI 10.1001/archneur.62.6.917; Hernandez EH, 2009, ANN NEUROL, V65, P759, DOI 10.1002/ana.21688; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Kraft P, 2009, EPIDEMIOLOGY, V20, P508, DOI 10.1097/EDE.0b013e3181a93b98; Lesnick TG, 2007, PLOS GENET, V3, P984, DOI 10.1371/journal.pgen.0030098; Lin L, 2009, TRENDS NEUROSCI, V32, P142, DOI 10.1016/j.tins.2008.11.006; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Moran LB, 2008, NEUROGENETICS, V9, P1, DOI 10.1007/s10048-007-0116-y; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Noureddine MA, 2005, MOVEMENT DISORD, V20, P1299, DOI 10.1002/mds.20573; O'Dushlaine C, 2009, BIOINFORMATICS, V25, P2762, DOI 10.1093/bioinformatics/btp448; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Rite I, 2007, J NEUROCHEM, V101, P1567, DOI 10.1111/j.1471-4159.2007.04567.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Surmeier DJ, 2010, CELL CALCIUM, V47, P175, DOI 10.1016/j.ceca.2009.12.003; Sutherland GT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004955; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zanetti R, 2006, MELANOMA RES, V16, P201, DOI 10.1097/01.cmr.0000215043.61306.d7; KEGG KYOTO ENCY GENE	55	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16917	10.1371/journal.pone.0016917	http://dx.doi.org/10.1371/journal.pone.0016917			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364952	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600025
J	Friedman, N; Barzily-Rokni, M; Isaac, S; Eden, A				Friedman, Nathalie; Barzily-Rokni, Michal; Isaac, Sara; Eden, Amir			The Histone H2A Variant MacroH2A1 Does Not Localize to the Centrosome	PLOS ONE			English	Article							X-CHROMOSOME INACTIVATION; EMBRYONIC STEM-CELLS; NONHISTONE REGION; EXPRESSION; MICE; ISOFORMS; DELETION; GENES	MacroH2A1 is a histone H2A variant which contains a large non-histone C-terminal region of largely unknown function. Within this region is a macro domain which can bind ADP-ribose and related molecules. Most studies of macroH2A1 focus on the involvement of this variant in transcriptional repression. Studies in mouse embryos and in embryonic stem cells suggested that during early development macroH2A can be found at the centrosome. Centrosomal localization of macroH2A was later reported in somatic cells. Here we provide data showing that macroH2A1 does not localize to the centrosome and that the centrosomal signal observed with antibodies directed against the macroH2A1 non-histone region may be the result of antibody cross-reactivity.	[Friedman, Nathalie; Barzily-Rokni, Michal; Isaac, Sara; Eden, Amir] Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Inst Life Sci, Jerusalem, Israel	Hebrew University of Jerusalem	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Dept Cell & Dev Biol, Inst Life Sci, Jerusalem, Israel.	eden@vms.huji.ac.il			Israeli Science Foundation [1174/05, 1149/09]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by the Israeli Science Foundation (www.isf.org.il) grant numbers 1174/05 and 1149/09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos M, 2006, EMBO J, V25, P4843, DOI 10.1038/sj.emboj.7601364; BARZILYROKNI M, 2010, NUCLEIC ACIDS RES; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Boulard M, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-8; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Chadwick BP, 2002, J CELL BIOL, V157, P1113, DOI 10.1083/jcb.200112074; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Costanzi C, 2000, DEVELOPMENT, V127, P2283; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Csankovszki G, 1999, NAT GENET, V22, P323, DOI 10.1038/11887; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Kustatscher G, 2005, NAT STRUCT MOL BIOL, V12, P624, DOI 10.1038/nsmb956; Ma YH, 2005, J CELL SCI, V118, P1607, DOI 10.1242/jcs.02291; MCMAHON A, 1983, J EMBRYOL EXP MORPH, V74, P207; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; Mermoud JE, 2001, EXP CELL RES, V268, P245, DOI 10.1006/excr.2001.5277; MITCHISON TJ, 1986, METHOD ENZYMOL, V134, P261; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nashun B, 2010, DEVELOPMENT, V137, P3785, DOI 10.1242/dev.051805; Nesterova TB, 2002, DIFFERENTIATION, V69, P216, DOI 10.1046/j.1432-0436.2002.690415.x; Ouararhni K, 2006, GENE DEV, V20, P3324, DOI 10.1101/gad.396106; PEHRSON JR, 1992, SCIENCE, V257, P1398; Rasmussen TP, 1999, NUCLEIC ACIDS RES, V27, P3685, DOI 10.1093/nar/27.18.3685; Rasmussen TP, 2000, J CELL BIOL, V150, P1189, DOI 10.1083/jcb.150.5.1189; Rasmussen TP, 2001, CHROMOSOMA, V110, P411, DOI 10.1007/s004120100158; Sporn JC, 2009, ONCOGENE, V28, P3423, DOI 10.1038/onc.2009.26; VIJAYKUMAR S, 1995, PROTEINS, V22, P290	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17262	10.1371/journal.pone.0017262	http://dx.doi.org/10.1371/journal.pone.0017262			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364955	gold, Green Submitted, Green Published			2022-12-27	WOS:000287656600038
J	Hensley, SE; Das, SR; Gibbs, JS; Bailey, AL; Schmidt, LM; Bennink, JR; Yewdell, JW				Hensley, Scott E.; Das, Suman R.; Gibbs, James S.; Bailey, Adam L.; Schmidt, Loren M.; Bennink, Jack R.; Yewdell, Jonathan W.			Influenza A Virus Hemagglutinin Antibody Escape Promotes Neuraminidase Antigenic Variation and Drug Resistance	PLOS ONE			English	Article							IN-VITRO; 4-GUANIDINO-NEU5AC2EN; MUTATIONS; VARIANTS; SENSITIVITY; GENERATION; ZANAMIVIR	Drugs inhibiting the influenza A virus (IAV) neuraminidase (NA) are the cornerstone of anti-IAV chemotherapy and prophylaxis in man. Drug-resistant mutations in NA arise frequently in human isolates, limiting the therapeutic application of NA inhibitors. Here, we show that antibody-driven antigenic variation in one domain of the H1 hemagglutinin Sa site leads to compensatory mutations in NA, resulting in NA antigenic variation and acquisition of drug resistance. These findings indicate that influenza A virus resistance to NA inhibitors can potentially arise from antibody driven HA escape, confounding analysis of influenza NA evolution in nature.	[Hensley, Scott E.; Das, Suman R.; Gibbs, James S.; Bailey, Adam L.; Schmidt, Loren M.; Bennink, Jack R.; Yewdell, Jonathan W.] NIAID, Viral Dis Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hensley, SE (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	jyewdell@niaid.nih.gov	Das, Suman R/C-8760-2009; Das, Suman/ABB-7273-2020; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Das, Suman/0000-0003-2496-9724; 	National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001055] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett JM, 1999, VIROLOGY, V265, P286, DOI 10.1006/viro.1999.0058; Blick TJ, 1998, VIROLOGY, V246, P95, DOI 10.1006/viro.1998.9194; Blick TJ, 1995, VIROLOGY, V214, P475, DOI 10.1006/viro.1995.0058; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Hauge SH, 2009, EMERG INFECT DIS, V15, P155, DOI 10.3201/eid1502.081031; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; LACKENBY A, 2008, EURO SURVEILL; LARISA AVG, 2001, J INFECT DIS, V183, P523; LENTZ MR, 1984, VIROLOGY, V135, P257, DOI 10.1016/0042-6822(84)90135-1; McKimmBreschkin JL, 1996, ANTIMICROB AGENTS CH, V40, P40, DOI 10.1128/AAC.40.1.40; MEMOLI MJ, J INFECT DIS, V201, P1397; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Staschke KA, 1995, VIROLOGY, V214, P642, DOI 10.1006/viro.1995.0078; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Wang MZ, 2002, ANTIMICROB AGENTS CH, V46, P3809, DOI 10.1128/AAC.46.12.3809-3816.2002; Yang P, 1997, VIROLOGY, V229, P155, DOI 10.1006/viro.1996.8421	21	56	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e15190	10.1371/journal.pone.0015190	http://dx.doi.org/10.1371/journal.pone.0015190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364978	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600003
J	Lee, CS; Dykema, KJ; Hawkins, DM; Cherba, DM; Webb, CP; Furge, KA; Duesbery, NS				Lee, Chih-Shia; Dykema, Karl J.; Hawkins, Danielle M.; Cherba, David M.; Webb, Craig P.; Furge, Kyle A.; Duesbery, Nicholas S.			MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells	PLOS ONE			English	Article							ANTHRAX LETHAL FACTOR; MAP-KINASE-KINASE; PROTEOLYTIC INHIBITOR; FACTOR CLEAVES; GENE; ERK; BRAF; P38; INACTIVATION; ACTIVATION	Mitogen-activated protein kinase kinases (MKK or MEK) 1 and 2 are usually treated as redundant kinases. However, in assessing their relative contribution towards ERK-mediated biologic response investigators have relied on tests of necessity, not sufficiency. In response we developed a novel experimental model using lethal toxin (LeTx), an anthrax toxin-derived pan-MKK protease, and genetically engineered protease resistant MKK mutants (MKKcr) to test the sufficiency of MEK signaling in melanoma SK-MEL-28 cells. Surprisingly, ERK activity persisted in LeTx-treated cells expressing MEK2cr but not MEK1cr. Microarray analysis revealed non-overlapping downstream transcriptional targets of MEK1 and MEK2, and indicated a substantial rescue effect of MEK2cr on proliferation pathways. Furthermore, LeTx efficiently inhibited the cell proliferation and anchorage-independent growth of SK-MEL-28 cells expressing MKK1cr but not MEK2cr. These results indicate in SK-MEL-28 cells MEK1 and MEK2 signaling pathways are not redundant and interchangeable for cell proliferation. We conclude that in the absence of other MKK, MEK2 is sufficient for SK-MEL-28 cell proliferation. MEK1 conditionally compensates for loss of MEK2 only in the presence of other MKK.	[Lee, Chih-Shia; Hawkins, Danielle M.; Duesbery, Nicholas S.] Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI USA; [Lee, Chih-Shia] Michigan State Univ, Grad Program Biochem & Mol Biol, E Lansing, MI 48824 USA; [Dykema, Karl J.; Furge, Kyle A.] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI USA; [Cherba, David M.; Webb, Craig P.] Van Andel Res Inst, Program Translat Med, Grand Rapids, MI USA	Van Andel Institute; Michigan State University; Van Andel Institute; Van Andel Institute	Lee, CS (corresponding author), Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI USA.	duesbery@vai.org	Webb, Craig/I-8123-2012	DUESBERY, NICK/0000-0002-4258-5655; Duesbery, Nicholas/0000-0002-5708-4984				Abi-Habib RJ, 2005, MOL CANCER THER, V4, P1303, DOI 10.1158/1535-7163.MCT-05-0145; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bardwell AJ, 2004, BIOCHEM J, V378, P569, DOI 10.1042/BJ20031382; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bromberg-White JL, 2008, METHOD ENZYMOL, V438, P355, DOI 10.1016/S0076-6879(07)38025-7; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cohen C, 2002, CLIN CANCER RES, V8, P3728; Collisson EA, 2003, CANCER RES, V63, P5669; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Ding Y, 2008, MOL CANCER THER, V7, P648, DOI 10.1158/1535-7163.MCT-07-2229; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duesbery NS, 2001, P NATL ACAD SCI USA, V98, P4089, DOI 10.1073/pnas.061031898; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Estrada Y, 2009, PIGM CELL MELANOMA R, V22, P66, DOI 10.1111/j.1755-148X.2008.00520.x; Furge KA, 2007, ONCOGENE, V26, P1346, DOI 10.1038/sj.onc.1210256; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giroux S, 1999, CURR BIOL, V9, P369, DOI 10.1016/S0960-9822(99)80164-X; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Koo HM, 2002, P NATL ACAD SCI USA, V99, P3052, DOI 10.1073/pnas.052707699; LEE CS, 2010, CURRENT ENZ IN PRESS; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; MacKeigan JP, 2000, J BIOL CHEM, V275, P38953, DOI 10.1074/jbc.C000684200; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Scholl FA, 2009, ONCOGENE, V28, P1485, DOI 10.1038/onc.2008.459; Scholl FA, 2007, DEV CELL, V12, P615, DOI 10.1016/j.devcel.2007.03.009; Scholl FA, 2009, CANCER RES, V69, P3772, DOI 10.1158/0008-5472.CAN-08-1963; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Singh Yogendra, 2005, P285; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tanami H, 2004, ONCOGENE, V23, P8796, DOI 10.1038/sj.onc.1208152; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Tsao H, 2000, CANCER RES, V60, P1800; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Voisin L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-337; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	52	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17165	10.1371/journal.pone.0017165	http://dx.doi.org/10.1371/journal.pone.0017165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365009	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800029
J	Komarova, TV; Kosorukov, VS; Frolova, OY; Petrunia, IV; Skrypnik, KA; Gleba, YY; Dorokhov, YL				Komarova, Tatiana V.; Kosorukov, Vyacheslav S.; Frolova, Olga Y.; Petrunia, Igor V.; Skrypnik, Ksenia A.; Gleba, Yuri Y.; Dorokhov, Yuri L.			Plant-Made Trastuzumab (Herceptin) Inhibits HER2/Neu+ Cell Proliferation and Retards Tumor Growth	PLOS ONE			English	Article							HER2-POSITIVE BREAST-CANCER; MONOCLONAL-ANTIBODY; ADJUVANT CHEMOTHERAPY; TRANSIENT EXPRESSION; VIRAL VECTORS; IN-VIVO; PROTEINS; PHARMACEUTICALS; VACCINES; SYSTEMS	Background: Plant biotechnology provides a valuable contribution to global health, in part because it can decrease the cost of pharmaceutical products. Breast cancer can now be successfully treated by a humanized monoclonal antibody (mAb), trastuzumab (Herceptin). A course of treatment, however, is expensive and requires repeated administrations of the mAb. Here we used an Agrobacterium-mediated transient expression system to produce trastuzumab in plant cells. Methodology/Principal Findings: We describe the cloning and expression of gene constructs in Nicotiana benthamiana plants using intron-optimized Tobacco mosaic virus-and Potato virus X-based vectors encoding, respectively, the heavy and light chains of trastuzumab. Full-size antibodies extracted and purified from plant tissues were tested for functionality and specificity by (i) binding to HER2/neu on the surface of a human mammary gland adenocarcinoma cell line, SK-BR-3, in fluorescence-activated cell sorting assay and (ii) testing the in vitro and in vivo inhibition of HER-2-expressing cancer cell proliferation. We show that plant-made trastuzumab (PMT) bound to the Her2/neu oncoprotein of SK-BR-3 cells and efficiently inhibited SK-BR-3 cell proliferation. Furthermore, mouse intraperitoneal PMT administration retarded the growth of xenografted tumors derived from human ovarian cancer SKOV3 Her2+ cells. Conclusions/Significance: We conclude that PMT is active in suppression of cell proliferation and tumor growth.	[Komarova, Tatiana V.; Dorokhov, Yuri L.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia; [Kosorukov, Vyacheslav S.; Skrypnik, Ksenia A.] Russian Acad Med Sci, NN Blokhin Natl Canc Res Ctr, Moscow, Russia; [Frolova, Olga Y.; Petrunia, Igor V.; Dorokhov, Yuri L.] Russian Acad Sci, NI Vavilov Inst Gen Genet, Moscow, Russia; [Gleba, Yuri Y.] Nomad Biosci GmbH, Biozentrum Halle, Halle, Saale, Germany	Lomonosov Moscow State University; N.N. Blokhin Russian Cancer Research Center; Russian Academy of Medical Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics	Komarova, TV (corresponding author), Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow, Russia.	dorokhov@genebee.msu.su	Dorokhov, Yuri L/D-3565-2012; Komarova, Tatiana V./D-5824-2012; Kosorukov, Viacheslav S/A-3901-2014	Dorokhov, Yuri L/0000-0002-4066-8940; Komarova, Tatiana V./0000-0001-6558-8755; Kosorukov, Viacheslav S/0000-0002-8462-2178; Gleba, Yuri/0000-0003-4675-7474	Moscow Government [41-10-GeneM]; Nomad Bioscience GmbH	Moscow Government; Nomad Bioscience GmbH	This work was partly supported by grants from Moscow Government(#41-10-GeneM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by Nomad Bioscience GmbH, who did have a role in data collection and analysis. No additional external funding was received for this study.	Arntzen CJ, 2008, SCIENCE, V321, P1052, DOI 10.1126/science.1163420; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Cervera M, 2010, TRANSGENIC RES, V19, P1001, DOI 10.1007/s11248-010-9378-5; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; Daniell H, 2001, TRENDS PLANT SCI, V6, P219, DOI 10.1016/S1360-1385(01)01922-7; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Dorokhov YL, 2006, J GEN VIROL, V87, P2693, DOI 10.1099/vir.0.82095-0; Frolova OY, 2010, VIROLOGY, V407, P7, DOI 10.1016/j.virol.2010.08.005; Galeffi P, 2005, VACCINE, V23, P1823, DOI 10.1016/j.vaccine.2004.11.025; Garrett JT, 2007, J IMMUNOL, V178, P7120, DOI 10.4049/jimmunol.178.11.7120; Gijsen M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000563; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2005, VACCINE, V23, P2042, DOI 10.1016/j.vaccine.2005.01.006; Gleba Y, 2004, CURR OPIN PLANT BIOL, V7, P182, DOI 10.1016/j.pbi.2004.01.003; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gleba Yuri, 2004, Biotechnol Genet Eng Rev, V21, P325; Gomord W, 2004, PLANT BIOTECHNOL J, V2, P83, DOI 10.1111/j.1467-7652.2004.00062.x; Gomord W, 2005, TRENDS BIOTECHNOL, V23, P559, DOI 10.1016/j.tibtech.2005.09.003; Grohs BM, 2010, J AGR FOOD CHEM, V58, P10056, DOI 10.1021/jf102284f; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Jobling SA, 2003, NAT BIOTECHNOL, V21, P77, DOI 10.1038/nbt772; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KNABLEIN J, 2003, TRENDS DRUG DISCOVER, V6, P33; Ko K, 2005, P NATL ACAD SCI USA, V102, P7026, DOI 10.1073/pnas.0502533102; Komarova TV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P846, DOI 10.1134/S0006297906080049; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107; Lienard D, 2007, BIOTECHNOL ANN REV, V13, P115, DOI 10.1016/S1387-2656(07)13006-4; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Martin VS, 2006, APPL SPECTROSC, V60, P994, DOI 10.1366/000370206778397498; McCormick AA, 2008, P NATL ACAD SCI USA, V105, P10131, DOI 10.1073/pnas.0803636105; Mison D, 2000, BIOPHARM-APPL T BIO, V13, P48; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Orzaez Diego, 2009, Biotechnology Journal, V4, P1712, DOI 10.1002/biot.200900223; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pujol M, 2007, TRENDS BIOTECHNOL, V25, P455, DOI 10.1016/j.tibtech.2007.09.001; Scaltriti M, 2009, ONCOGENE, V28, P803, DOI 10.1038/onc.2008.432; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schwartz AM, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1377, DOI 10.1134/S0006297906120145; Semenyuk EG, 2007, BIOCHIMIE, V89, P31, DOI 10.1016/j.biochi.2006.07.012; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sourrouille Christophe, 2009, V483, P1, DOI 10.1007/978-1-59745-407-0_1; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Vancanneyt Guy, 2009, V483, P209, DOI 10.1007/978-1-59745-407-0_12; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Yajima W, 2010, NEW BIOTECHNOL, V27, P816, DOI 10.1016/j.nbt.2010.09.010	54	31	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17541	10.1371/journal.pone.0017541	http://dx.doi.org/10.1371/journal.pone.0017541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390232	Green Submitted, gold, Green Published			2022-12-27	WOS:000287965200021
J	dos Santos, HF; Cury, JC; do Carmo, FL; dos Santos, AL; Tiedje, J; van Elsas, JD; Rosado, AS; Peixoto, RS				dos Santos, Henrique Fragoso; Cury, Juliano Carvalho; do Carmo, Flavia Lima; dos Santos, Adriana Lopes; Tiedje, James; van Elsas, Jan Dirk; Rosado, Alexandre Soares; Peixoto, Raquel Silva			Mangrove Bacterial Diversity and the Impact of Oil Contamination Revealed by Pyrosequencing: Bacterial Proxies for Oil Pollution	PLOS ONE			English	Article							SP-NOV.; MICROBIAL DIVERSITY; SOIL; GAMMAPROTEOBACTERIA; DEGRADATION; ECOSYSTEMS; SEDIMENTS; MEMBER; BAY	Background: Mangroves are transitional coastal ecosystems in tropical and sub-tropical regions and represent biologically important and productive ecosystems. Despite their great ecological and economic importance, mangroves are often situated in areas of high anthropogenic influence, being exposed to pollutants, such as those released by oil spills. Methodology/Principal Findings: A microcosm experiment was conducted, which simulated an oil spill in previously pristine mangrove sediment. The effect of the oil spill on the extant microbial community was studied using direct pyrosequencing. Extensive bacterial diversity was observed in the pristine mangrove sediment, even after oil contamination. The number of different OTUs only detected in contaminated samples was significantly higher than the number of OTUs only detected in non-contaminated samples. The phylum Proteobacteria, in particular the classes Gammaproteobacteria and Deltaproteobacteria, were prevalent before and after the simulated oil spill. On the other hand, the order Chromatiales and the genus Haliea decreased upon exposure to 2 and 5% oil, these are proposed as sensitive indicators of oil contamination. Three other genera, Marinobacterium, Marinobacter and Cycloclasticus increased their prevalence when confronted with oil. These groups are possible targets for the biomonitoring of the impact of oil in mangrove settings. Conclusions/Significance: We suggest the use of sequences of the selected genera as proxies for oil pollution, using qPCR assessments. The quantification of these genera in distinct mangrove systems in relation to the local oil levels would permit the evaluation of the level of perturbance of mangroves, being useful in field monitoring. Considering the importance of mangroves to many other environments and the susceptibility of such areas to oil spills this manuscript will be of broad interest.	[dos Santos, Henrique Fragoso; Cury, Juliano Carvalho; do Carmo, Flavia Lima; dos Santos, Adriana Lopes; Rosado, Alexandre Soares; Peixoto, Raquel Silva] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Gen Microbiol, Lab Mol Microbial Ecol, Rio De Janeiro, Brazil; [Tiedje, James] Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA; [van Elsas, Jan Dirk] Univ Groningen, Dept Microbial Ecol, Groningen, Netherlands	Universidade Federal do Rio de Janeiro; Michigan State University; University of Groningen	dos Santos, HF (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Gen Microbiol, Lab Mol Microbial Ecol, Rio De Janeiro, Brazil.	raquelpeixoto@micro.ufrj.br	Rosado, Alexandre Soares/G-1955-2012; dos Santos, Adriana Lopes/B-7252-2018; surname, name s/A-2183-2010; Santos, Henrique/AAI-9410-2020; Santos, Henrique Fragoso dos/G-3697-2014; bardakov, Dima/E-6747-2011; dos Santos, Adriana Lopes/J-6960-2019; Peixoto, Raquel/V-2554-2019	Rosado, Alexandre Soares/0000-0001-5135-1394; dos Santos, Adriana Lopes/0000-0002-0736-4937; Santos, Henrique/0000-0001-8850-7399; Santos, Henrique Fragoso dos/0000-0001-8850-7399; dos Santos, Adriana Lopes/0000-0002-0736-4937; Cury, Juliano/0000-0002-1450-5726; Peixoto, Raquel/0000-0002-9536-3132	Petrobras fellowship; Brazilian National Research Council (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian Army; Colonel Cardoso	Petrobras fellowship; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Army; Colonel Cardoso	H.F.S. was awarded with a Petrobras fellowship. A.S.R. and R.S.P. also greatly appreciate the support of Brazilian National Research Council (CNPq) and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To the Brazilian Army and to the Colonel Cardoso, who have supported and allowed us to sampling in Restinga da Marambaia mangrove.	Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bordoloi NK, 2009, J HAZARD MATER, V170, P495, DOI 10.1016/j.jhazmat.2009.04.136; BURNS KA, 1993, MAR POLLUT BULL, V26, P239, DOI 10.1016/0025-326X(93)90062-O; Castine SA, 2009, AQUACULTURE, V297, P91, DOI 10.1016/j.aquaculture.2009.09.013; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Hara A, 2003, ENVIRON MICROBIOL, V5, P746, DOI 10.1046/j.1468-2920.2003.00468.x; Holguin G, 2001, BIOL FERT SOILS, V33, P265, DOI 10.1007/s003740000319; Jukes T.H., 1969, MAMMALIAN PROTEIN ME; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kathiresan K, 2005, BIODIVERSITY MANGROV; Kumar S, 2007, REV BIOL TROP, V55, P777; Li CH, 2009, SCI TOTAL ENVIRON, V407, P5772, DOI 10.1016/j.scitotenv.2009.07.034; Li HL, 2007, MAR POLLUT BULL, V54, P1146, DOI 10.1016/j.marpolbul.2007.04.015; Liang JB, 2007, MAR BIOL, V150, P739, DOI 10.1007/s00227-006-0377-2; Lucena T, 2010, INT J SYST EVOL MICR, V60, P1844, DOI 10.1099/ijs.0.017061-0; Peixoto RS, 2010, ANTON LEEUW INT J G, V98, P403, DOI 10.1007/s10482-010-9454-0; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Brito EM, 2006, RES MICROBIOL, V157, P752, DOI 10.1016/j.resmic.2006.03.005; Santos HF, 2011, WATER AIR SOIL POLL, V216, P329, DOI 10.1007/s11270-010-0536-4; Santos HF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012437; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STALEY JT, 2010, HDB HYDROCARBON LIPI, V19, P1781; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; Tian Y, 2008, MAR POLLUT BULL, V56, P1184, DOI 10.1016/j.marpolbul.2008.02.014; Urios L, 2008, INT J SYST EVOL MICR, V58, P1233, DOI 10.1099/ijs.0.65470-0; Urios L, 2009, INT J SYST EVOL MICR, V59, P1188, DOI 10.1099/ijs.0.002220-0; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yakimov MM, 2005, ENVIRON MICROBIOL, V7, P1426, DOI 10.1111/j.1462-5822.2005.00829.x	35	173	180	2	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16943	10.1371/journal.pone.0016943	http://dx.doi.org/10.1371/journal.pone.0016943			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399677	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300003
J	Evans, HC; Elliot, SL; Hughes, DP				Evans, Harry C.; Elliot, Simon L.; Hughes, David P.			Hidden Diversity Behind the Zombie-Ant Fungus Ophiocordyceps unilateralis: Four New Species Described from Carpenter Ants in Minas Gerais, Brazil	PLOS ONE			English	Article							TROPICAL FOREST ECOSYSTEMS; CORDYCEPS; COMPLEX; FORMICIDAE	Background: Ophiocordyceps unilateralis (Clavicipitaceae: Hypocreales) is a fungal pathogen specific to ants of the tribe Camponotini (Formicinae: Formicidae) with a pantropical distribution. This so-called zombie or brain-manipulating fungus alters the behaviour of the ant host, causing it to die in an exposed position, typically clinging onto and biting into the adaxial surface of shrub leaves. We (HCE and DPH) are currently undertaking a worldwide survey to assess the taxonomy and ecology of this highly variable species. Methods: We formally describe and name four new species belonging to the O. unilateralis species complex collected from remnant Atlantic rainforest in the south-eastern region (Zona da Mata) of the State of Minas Gerais, Brazil. Fully illustrated descriptions of both the asexual (anamorph) and sexual (teleomorph) stages are provided for each species. The new names are registered in Index Fungorum (registration. indexfungorum.org) and have received IF numbers. This paper is also a test case for the electronic publication of new names in mycology. Conclusions: We are only just beginning to understand the taxonomy and ecology of the Ophiocordyceps unilateralis species complex associated with carpenter ants; macroscopically characterised by a single stalk arising from the dorsal neck region of the ant host on which the anamorph occupies the terminal region and the teleomorph occurs as lateral cushions or plates. Each of the four ant species collected - Camponotus rufipes, C. balzani, C. melanoticus and C. novogranadensis - is attacked by a distinct species of Ophiocordyceps readily separated using traditional micromorphology. The new taxa are named according to their ant host.	[Evans, Harry C.; Elliot, Simon L.] Univ Fed Vicosa, Dept Anim Biol, Minas Gerais, Brazil; [Evans, Harry C.] CAB Int, E UK, Surrey, England; [Hughes, David P.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Hughes, David P.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hughes, David P.] Univ Exeter, Sch Biosci, Exeter, Devon, England	Universidade Federal de Vicosa; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Exeter	Evans, HC (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Minas Gerais, Brazil.	h.evans@cabi.org; dhughes@psu.edu	Elliot, Simon Luke/A-5557-2013	Elliot, Simon Luke/0000-0002-7469-2949	Brazilian National Council for Research (CNPq) [401610/2009-8]; Individual International Marie Curie Fellowship [PIOF-GA-2008-221041]	Brazilian National Council for Research (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Individual International Marie Curie Fellowship	When this study was undertaken, HCE was a visiting scientist at the Postgraduate Programme in Entomology (UFV), whilst in receipt of a scholarship from the Brazilian National Council for Research (CNPq, grant no. 401610/2009-8). DPH was supported by an Individual International Marie Curie Fellowship (PIOF-GA-2008-221041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Evans HC, 2010, FUNGAL BIOL-UK, V114, P451, DOI 10.1016/j.funbio.2010.03.007; EVANS HC, 1982, T BRIT MYCOL SOC, V79, P431, DOI 10.1016/S0007-1536(82)80037-5; EVANS HC, 1984, T BRIT MYCOL SOC, V82, P127, DOI 10.1016/S0007-1536(84)80219-3; Evans HC, 2002, TRICHOMYCETES OTHER, P119; Hughes DP, 2009, ECOL ENTOMOL, V34, P214, DOI 10.1111/j.1365-2311.2008.01066.x; KOBAYASI Y., 1941, Science Reports of the Tokyo Bunrika Daigaku, V5, P53; MAINS EB, 1958, MYCOLOGIA, V50, P169, DOI 10.2307/3756193; PETCH T., 1931, Transactions of the British Mycological Society, V16, P55; SILVA GL, 2007, AN 8 C EC BRAS SOC E; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Tulasne LR, 1865, SELECTA FUNGORUM CAR, V3, P1; TZEAN SS, 1997, ATLAS ENTOMOPATHOGEN, P1	12	79	83	2	180	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17024	10.1371/journal.pone.0017024	http://dx.doi.org/10.1371/journal.pone.0017024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399679	gold, Green Published			2022-12-27	WOS:000287933300006
J	Jayaraman, A; Pappas, C; Raman, R; Belser, JA; Viswanathan, K; Shriver, Z; Tumpey, TM; Sasisekharan, R				Jayaraman, Akila; Pappas, Claudia; Raman, Rahul; Belser, Jessica A.; Viswanathan, Karthik; Shriver, Zachary; Tumpey, Terrence M.; Sasisekharan, Ram			A Single Base-Pair Change in 2009 H1N1 Hemagglutinin Increases Human Receptor Affinity and Leads to Efficient Airborne Viral Transmission in Ferrets	PLOS ONE			English	Article							A(H1N1) INFLUENZA-VIRUSES; A VIRUSES	The 2009 H1N1 influenza A virus continues to circulate among the human population as the predominant H1N1 subtype. Epidemiological studies and airborne transmission studies using the ferret model have shown that the transmission efficiency of 2009 H1N1 viruses is lower than that of previous seasonal strains and the 1918 pandemic H1N1 strain. We recently correlated this reduced transmission efficiency to the lower binding affinity of the 2009 H1N1 hemagglutinin (HA) to alpha 2 -> 6 sialylated glycan receptors (human receptors). Here we report that a single point mutation (Ile219 -> Lys; a base pair change) in the glycan receptor-binding site (RBS) of a representative 2009 H1N1 influenza A virus, A/California/04/09 or CA04/09, quantitatively increases its human receptor-binding affinity. The increased human receptor-affinity is in the same range as that of the HA from highly transmissible seasonal and 1918 pandemic H1N1 viruses. Moreover, a 2009 H1N1 virus carrying this mutation in the RBS (generated using reverse genetics) transmits efficiently in ferrets by respiratory droplets thereby reestablishing our previously observed correlation between human receptor-binding affinity and transmission efficiency. These findings are significant in the context of monitoring the evolution of the currently circulating 2009 H1N1 viruses.	[Jayaraman, Akila; Raman, Rahul; Viswanathan, Karthik; Shriver, Zachary; Sasisekharan, Ram] MIT, Harvard Mit Div Hlth Sci & Technol, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Pappas, Claudia; Belser, Jessica A.; Tumpey, Terrence M.] Centers Dis Control & Prevent CDC, Influenza Div, Atlanta, GA USA	Harvard University; Massachusetts Institute of Technology (MIT); Singapore-MIT Alliance for Research & Technology Centre (SMART); Centers for Disease Control & Prevention - USA	Jayaraman, A (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, Singapore MIT Alliance Res & Technol, Dept Biol Engn,Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.	rams@mit.edu			National Institutes of Health and the Singapore-MIT Alliance for Research and Technology [R37 GM057073-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM057073] Funding Source: NIH RePORTER	National Institutes of Health and the Singapore-MIT Alliance for Research and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by a merit award to RS (R37 GM057073-13) from the National Institutes of Health and the Singapore-MIT Alliance for Research and Technology. The authors acknowledge the Consortium for Functional Glycomics for providing the glycan standards. The confocal microscopy analysis of the human tissue sections was performed at the W. M. Keck Imaging Facility in the Whitehead Institute at MIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barr IG, 2010, EURO SURVEILL, V15; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Doyle TJ, 2011, EPIDEMIOL INFECT, V139, P45, DOI 10.1017/S095026881000141X; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Morens DM, 2010, MBIO, V1, DOI 10.1128/mBio.00211-10; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Pappas C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011158; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Soundararajan V, 2009, NAT BIOTECHNOL, V27, P510, DOI 10.1038/nbt0609-510; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Viswanathan K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013768; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008905	34	44	50	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17616	10.1371/journal.pone.0017616	http://dx.doi.org/10.1371/journal.pone.0017616			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407805	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300036
J	Yu, JY; Chau, KF; Vodyanik, MA; Jiang, JL; Jiang, Y				Yu, Junying; Chau, Kevin Fongching; Vodyanik, Maxim A.; Jiang, Jinlan; Jiang, Yong			Efficient Feeder-Free Episomal Reprogramming with Small Molecules	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; INDUCTION; VIRUS; ADULT; VECTOR; DNA; FIBROBLASTS; GROWTH	Genetic reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) could offer replenishable cell sources for transplantation therapies. To fulfill their promises, human iPSCs will ideally be free of exogenous DNA (footprint-free), and be derived and cultured in chemically defined media free of feeder cells. Currently, methods are available to enable efficient derivation of footprint-free human iPSCs. However, each of these methods has its limitations. We have previously derived footprint-free human iPSCs by employing episomal vectors for transgene delivery, but the process was inefficient and required feeder cells. Here, we have greatly improved the episomal reprogramming efficiency using a cocktail containing MEK inhibitor PD0325901, GSK3 beta inhibitor CHIR99021, TGF-beta/Activin/Nodal receptor inhibitor A-83-01, ROCK inhibitor HA-100 and human leukemia inhibitory factor. Moreover, we have successfully established a feeder-free reprogramming condition using chemically defined medium with bFGF and N2B27 supplements and chemically defined human ESC medium mTeSR1 for the derivation of footprint-free human iPSCs. These improvements enabled the routine derivation of footprint-free human iPSCs from skin fibroblasts, adipose tissue-derived cells and cord blood cells. This technology will likely be valuable for the production of clinical-grade human iPSCs.	[Yu, Junying; Chau, Kevin Fongching; Vodyanik, Maxim A.; Jiang, Jinlan; Jiang, Yong] Cellular Dynam Int Inc, Adv Dev Programs, Madison, WI 53711 USA		Yu, JY (corresponding author), Cellular Dynam Int Inc, Adv Dev Programs, Madison, WI 53711 USA.	jyu@cellulardynamics.com		Chau, Kevin Fongching/0000-0002-7899-3247	Cellular Dynamics International, Inc.	Cellular Dynamics International, Inc.	This study was supported by Cellular Dynamics International, Inc. (http://www.cellulardynamics.com/). The funder had a role in the decision to publish the manuscript.	Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kameda T, 2006, BIOCHEM BIOPH RES CO, V349, P1269, DOI 10.1016/j.bbrc.2006.08.175; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; MIDDLETON T, 1994, J VIROL, V68, P4067, DOI 10.1128/JVI.68.6.4067-4071.1994; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Nanbo A, 2007, EMBO J, V26, P4252, DOI 10.1038/sj.emboj.7601853; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Shimada H, 2010, MOL REPROD DEV, V77, P2, DOI 10.1002/mrd.21117; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; YATES JL, 1991, J VIROL, V65, P483, DOI 10.1128/JVI.65.1.483-488.1991; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Ziegler K, 2004, J VIROL METHODS, V122, P123, DOI 10.1016/j.jviromet.2004.08.012	37	163	172	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17557	10.1371/journal.pone.0017557	http://dx.doi.org/10.1371/journal.pone.0017557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390254	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100023
J	Chen, C; Grennan, K; Badner, J; Zhang, DD; Gershon, E; Jin, L; Liu, CY				Chen, Chao; Grennan, Kay; Badner, Judith; Zhang, Dandan; Gershon, Elliot; Jin, Li; Liu, Chunyu			Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods	PLOS ONE			English	Article							GENE-EXPRESSION; OLIGONUCLEOTIDE ARRAYS; GENOME; HYBRIDIZATION; PERFORMANCE; QUALITY; BRAIN; MODEL	The expression microarray is a frequently used approach to study gene expression on a genome-wide scale. However, the data produced by the thousands of microarray studies published annually are confounded by "batch effects," the systematic error introduced when samples are processed in multiple batches. Although batch effects can be reduced by careful experimental design, they cannot be eliminated unless the whole study is done in a single batch. A number of programs are now available to adjust microarray data for batch effects prior to analysis. We systematically evaluated six of these programs using multiple measures of precision, accuracy and overall performance. ComBat, an Empirical Bayes method, outperformed the other five programs by most metrics. We also showed that it is essential to standardize expression data at the probe level when testing for correlation of expression profiles, due to a sizeable probe effect in microarray data that can inflate the correlation among replicates and unrelated samples.	[Chen, Chao; Jin, Li] Fudan Univ, Natl Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Chen, Chao; Grennan, Kay; Badner, Judith; Gershon, Elliot; Liu, Chunyu] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [Zhang, Dandan] Zhejiang Univ, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China	Fudan University; University of Chicago; Zhejiang University	Chen, C (corresponding author), Fudan Univ, Natl Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China.	cliu@yoda.bsd.uchicago.edu	Liu, chunyu/Q-3901-2017; Jin, Li/M-5063-2019; Zhang, Dandan/ABA-9747-2020; Jin, Li/C-1468-2009; Liu, Chunyu/G-7561-2012	Jin, Li/0000-0002-4546-2415; Liu, Chunyu/0000-0002-5986-4415; zhang, dandan/0000-0001-5305-9856	National Institute of Mental Health [R01MH080425, R33MH083521]; Brain Research Foundation; China Scholarship Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH083521, R01MH080425] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Brain Research Foundation; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by National Institute of Mental Health R01MH080425, R33MH083521, Brain Research Foundation (to CYL), and the China Scholarship Council (to CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, AFF EXPR CONS SOFTW; Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fare TL, 2003, ANAL CHEM, V75, P4672, DOI 10.1021/ac034241b; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Kerr MK, 2003, BIOMETRICS, V59, P822; Kitchen RR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-134; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; LUO J, 2010, PHARMACOGENOMI S OCT, pS48, DOI DOI 10.1038/TPJ.2010.57; McCall MN, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn430; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; OGLE DH, 2010, NCSTATS HELPER FUNCT; Scharpf RB, 2011, BIOSTATISTICS, V12, P33, DOI 10.1093/biostatistics/kxq043; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; SCHERER A., 2009, BATCH EFFECTS NOISE; Shi Leming, 2010, Nature Biotechnology, pS5, DOI 10.1038/nbt.1665; Sims AH, 2009, J CLIN PATHOL, V62, P879, DOI 10.1136/jcp.2008.060376; Sims AH, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-42; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sokal R.R., 2012, BIOMETRY; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	35	269	278	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17238	10.1371/journal.pone.0017238	http://dx.doi.org/10.1371/journal.pone.0017238			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386892	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400040
J	Ghirardo, A; Gutknecht, J; Zimmer, I; Bruggemann, N; Schnitzler, JP				Ghirardo, Andrea; Gutknecht, Jessica; Zimmer, Ina; Brueggemann, Nicolas; Schnitzler, Joerg-Peter			Biogenic Volatile Organic Compound and Respiratory CO2 Emissions after C-13-Labeling: Online Tracing of C Translocation Dynamics in Poplar Plants	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; ISOPRENE BIOSYNTHESIS; NATURAL-ABUNDANCE; LEAF DEVELOPMENT; PHOTOSYNTHESIS; LEAVES; HYDROCARBONS; (CO2)-C-13; DELTA-C-13; METHANOL	Background: Globally plants are the primary sink of atmospheric CO2, but are also the major contributor of a large spectrum of atmospheric reactive hydrocarbons such as terpenes (e. g. isoprene) and other biogenic volatile organic compounds (BVOC). The prediction of plant carbon (C) uptake and atmospheric oxidation capacity are crucial to define the trajectory and consequences of global environmental changes. To achieve this, the biosynthesis of BVOC and the dynamics of C allocation and translocation in both plants and ecosystems are important. Methodology: We combined tunable diode laser absorption spectrometry (TDLAS) and proton transfer reaction mass spectrometry (PTR-MS) for studying isoprene biosynthesis and following C fluxes within grey poplar (Populus x canescens) saplings. This was achieved by feeding either (CO2)-C-13 to leaves or C-13-glucose to shoots via xylem uptake. The translocation of (CO2)-C-13 from the source to other plant parts could be traced by C-13-labeled isoprene and respiratory (CO2)-C-13 emission. Principal Finding: In intact plants, assimilated (CO2)-C-13 was rapidly translocated via the phloem to the roots within 1 hour, with an average phloem transport velocity of 20.3 +/- 2.5 cm h(-1).C-13 label was stored in the roots and partially reallocated to the plants' apical part one day after labeling, particularly in the absence of photosynthesis. The daily C loss as BVOC ranged between 1.6% in mature leaves and 7.0% in young leaves. Non-isoprene BVOC accounted under light conditions for half of the BVOC C loss in young leaves and one-third in mature leaves. The C loss as isoprene originated mainly (76-78%) from recently fixed CO2, to a minor extent from xylem-transported sugars (7-11%) and from photosynthetic intermediates with slower turnover rates (8-11%). Conclusion: We quantified the plants' C loss as respiratory CO2 and BVOC emissions, allowing in tandem with metabolic analysis to deepen our understanding of ecosystem C flux.	[Ghirardo, Andrea; Gutknecht, Jessica; Zimmer, Ina; Brueggemann, Nicolas; Schnitzler, Joerg-Peter] Inst Meteorol & Climate Res, Karlsruhe Inst Technol, Garmisch Partenkirchen, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Ghirardo, A (corresponding author), Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Dept Environm Engn, Neuherberg, Germany.	jp.schnitzler@helmholtz-muenchen.de	Ghirardo, Andrea/P-1764-2019; Brueggemann, Nicolas/C-4263-2014; Zimmer, Ina/M-1295-2015; Schnitzler, Joerg-Peter/C-5268-2011	Ghirardo, Andrea/0000-0003-1973-4007; Brueggemann, Nicolas/0000-0003-3851-2418; Zimmer, Ina/0000-0002-6441-8495; Schnitzler, Joerg-Peter/0000-0002-9825-867X	Human Frontier Science Program; German Research Foundation [DFG SCHN653/4]	Human Frontier Science Program(Human Frontier Science Program); German Research Foundation(German Research Foundation (DFG))	Financial support was given by the Human Frontier Science Program ( to J. P. S. and A. G.) and the German Research Foundation ( to J. P. S., DFG SCHN653/4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affek HP, 2003, PLANT PHYSIOL, V131, P1727, DOI 10.1104/pp.102.012294; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Behnke K, 2007, PLANT J, V51, P485, DOI 10.1111/j.1365-313X.2007.03157.x; Brandes E, 2006, GLOBAL CHANGE BIOL, V12, P1922, DOI 10.1111/j.1365-2486.2006.01205.x; Brilli F, 2007, NEW PHYTOL, V175, P244, DOI 10.1111/j.1469-8137.2007.02094.x; Brilli F, 2009, PLANT CELL ENVIRON, V32, P542, DOI 10.1111/j.1365-3040.2009.01948.x; Bruggemann N, 2002, PHYSIOL PLANTARUM, V115, P190, DOI 10.1034/j.1399-3054.2002.1150203.x; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Cinege G, 2009, PLANT MOL BIOL, V69, P593, DOI 10.1007/s11103-008-9441-2; Coplen TB, 2006, ANAL CHEM, V78, P2439, DOI 10.1021/ac052027c; DELWICHE CF, 1993, PLANT CELL ENVIRON, V16, P587, DOI 10.1111/j.1365-3040.1993.tb00907.x; DICKSON RE, 1981, PLANTA, V152, P461, DOI 10.1007/BF00385364; Ehlting B, 2007, PLANT CELL ENVIRON, V30, P796, DOI 10.1111/j.1365-3040.2007.01668.x; Ekblad A, 2001, OECOLOGIA, V127, P305, DOI 10.1007/s004420100667; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; FROMMER WB, 1995, J EXP BOT, V46, P587, DOI 10.1093/jxb/46.6.587; Ghirardo A, 2010, PLANT CELL ENVIRON, V33, P781, DOI 10.1111/j.1365-3040.2009.02104.x; Graus M, 2004, PLANT PHYSIOL, V135, P1967, DOI 10.1104/pp.104.043240; Hakola H, 1998, ATMOS ENVIRON, V32, P1825, DOI 10.1016/S1352-2310(97)00482-2; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; Heizmann U, 2001, PLANT BIOLOGY, V3, P132, DOI 10.1055/s-2001-12898; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; JACOB DJ, 1988, J GEOPHYS RES-ATMOS, V93, P1477, DOI 10.1029/JD093iD02p01477; Knohl A, 2005, OECOLOGIA, V142, P70, DOI 10.1007/s00442-004-1702-4; Kreuzwieser J, 1999, J EXP BOT, V50, P757, DOI 10.1093/jexbot/50.335.757; Kreuzwieser J, 2002, NEW PHYTOL, V156, P171, DOI 10.1046/j.1469-8137.2002.00516.x; LARSON PR, 1969, AM J BOT, V56, P1058, DOI 10.2307/2440930; Lehning A, 1999, PLANT CELL ENVIRON, V22, P495, DOI 10.1046/j.1365-3040.1999.00425.x; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Magel E, 2006, ATMOS ENVIRON, V40, pS138, DOI 10.1016/j.atmosenv.2005.09.091; Mayrhofer S, 2004, PLANT BIOLOGY, V6, P730, DOI 10.1055/s-2004-821268; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; NOVAKOV T, 1993, NATURE, V365, P823, DOI 10.1038/365823a0; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rasulov B, 2009, PLANT PHYSIOL, V149, P1609, DOI 10.1104/pp.108.133512; Schnitzler JP, 2010, PLANT BIOLOGY, V12, P302, DOI 10.1111/j.1438-8677.2009.00284.x; Schnitzler JP, 2004, PLANT PHYSIOL, V135, P152, DOI 10.1104/pp.103.037374; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Subke JA, 2009, NEW PHYTOL, V183, P349, DOI 10.1111/j.1469-8137.2009.02883.x; TRAINER M, 1987, J GEOPHYS RES-ATMOS, V92, P11879, DOI 10.1029/JD092iD10p11879; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258	47	53	53	4	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17393	10.1371/journal.pone.0017393	http://dx.doi.org/10.1371/journal.pone.0017393			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387007	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400068
J	Zhang, YY; Post, WS; Dalal, D; Blasco-Colmenares, E; Tomaselli, GF; Guallar, E				Zhang, Yiyi; Post, Wendy S.; Dalal, Darshan; Blasco-Colmenares, Elena; Tomaselli, Gordon F.; Guallar, Eliseo			Coffee, Alcohol, Smoking, Physical Activity and QT Interval Duration: Results from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SUDDEN CARDIAC DEATH; CIGARETTE-SMOKING; PROLONGED QTC; VENTRICULAR REPOLARIZATION; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; RISK-FACTORS; DISPERSION; ASSOCIATION	Background: Abnormalities in the electrocardiographic QT interval duration have been associated with an increased risk of ventricular arrhythmias and sudden cardiac death. However, there is substantial uncertainty about the effect of modifiable factors such as coffee intake, cigarette smoking, alcohol consumption, and physical activity on QT interval duration. Methods: We studied 7795 men and women from the Third National Health and Nutrition Survey (NHANES III, 1988-1994). Baseline QT interval was measured from the standard 12-lead electrocardiogram. Coffee and tea intake, alcohol consumption, leisure-time physical activities over the past month, and lifetime smoking habits were determined using validated questionnaires during the home interview. Results: In the fully adjusted model, the average differences in QT interval comparing participants drinking >= 6 cups/day to those who did not drink any were -1.2 ms (95% CI -4.4 to 2.0) for coffee, and -2.0 ms (-11.2 to 7.3) for tea, respectively. The average differences in QT interval duration comparing current to never smokers was 1.2 ms (-0.6 to 2.9) while the average difference in QT interval duration comparing participants drinking >= 7 drinks/week to non-drinkers was 1.8 ms (-0.5 to 4.0). The age, race/ethnicity, and RR-interval adjusted differences in average QT interval duration comparing men with binge drinking episodes to non-drinkers or drinkers without binge drinking were 2.8 ms (0.4 to 5.3) and 4.0 ms (1.6 to 6.4), respectively. The corresponding differences in women were 1.1 (-2.9 to 5.2) and 1.7 ms (-2.3 to 5.7). Finally, the average differences in QT interval comparing the highest vs. the lowest categories of total physical activity was 20.8 ms (-3.0 to 1.4). Conclusion: Binge drinking was associated with longer QT interval in men but not in women. QT interval duration was not associated with other modifiable factors including coffee and tea intake, smoking, and physical activity.	[Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Zhang, Yiyi; Post, Wendy S.; Blasco-Colmenares, Elena; Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Post, Wendy S.; Dalal, Darshan; Tomaselli, Gordon F.] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Dept Cardiovasc Epidemiol & Populat Genet, Madrid, Spain	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Zhang, YY (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	eguallar@jhsph.edu	zhang, yiyi/J-2592-2012; Guallar, Eliseo/D-3807-2014	Guallar, Eliseo/0000-0002-4471-9565	National Center for Cardiovascular Research (CNIC Translational Cardiology) [2008-03]; National Institutes of Health [ES015597, HL091062]; Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University; Fondation Leducq.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015597] Funding Source: NIH RePORTER	National Center for Cardiovascular Research (CNIC Translational Cardiology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University(Johns Hopkins University); Fondation Leducq.(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The present study was funded in part by grants from the National Center for Cardiovascular Research (CNIC Translational Cardiology grant 2008-03), the National Institutes of Health (grants ES015597 and HL091062), the Donald W. Reynolds Cardiovascular Clinical Research Center at Johns Hopkins University and the Fondation Leducq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agarwal S, 2009, ANGIOLOGY, V60, P335, DOI 10.1177/0003319708330526; AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; ALGRA A, 1993, BRIT HEART J, V70, P43; Ammar R, 2001, PHARMACOTHERAPY, V21, P437, DOI 10.1592/phco.21.5.437.34502; Andrassy G, 2003, AM J CARDIOL, V92, P489, DOI 10.1016/S0002-9149(03)00678-7; [Anonymous], 1994, VITAL HLTH STAT, P1; [Anonymous], DRUGS PROLONG QT INT; Benoit SR, 2005, EUR J CARDIOV PREV R, V12, P363, DOI 10.1097/01.hjr.0000173110.21851.a9; Bernert JT, 1997, CLIN CHEM, V43, P2281; *CDC, 2010, 4 CDC HUM EXP ENV CH; Choi HK, 2007, ARTHRIT RHEUM-ARTHR, V57, P816, DOI 10.1002/art.22762; DAY CP, 1993, LANCET, V341, P1423; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Dilaveris P, 2001, AM HEART J, V142, P833, DOI 10.1067/mhj.2001.118737; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; FANKUSHEN D, 1964, AM J MED, V37, P802, DOI 10.1016/0002-9343(64)90028-2; Fauchier L, 2000, AM J CARDIOL, V86, P557, DOI 10.1016/S0002-9149(00)01015-8; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; GIACOBINI E, 1960, EXPERIENTIA, V16, P467, DOI 10.1007/BF02171159; Gussak I, 2000, CARDIOLOGY, V94, P99, DOI 10.1159/000047299; HOGNESTAD J, 1973, ACTA PATH MICRO IM A, VA 81, P315; Ileri M, 2001, AM J CARDIOL, V88, P322, DOI 10.1016/S0002-9149(01)01653-8; Kao WHL, 2009, CIRCULATION, V119, P940, DOI 10.1161/CIRCULATIONAHA.108.791723; Karjalainen J, 1997, HEART, V77, P543, DOI 10.1136/hrt.77.6.543; KINO M, 1981, BRIT HEART J, V46, P545; Kobza R, 2009, HEART RHYTHM, V6, P652, DOI 10.1016/j.hrthm.2009.01.009; KOIDE T, 1980, JPN HEART J, V21, P451; Lewis MJ, CLIN PHYSL FUNCT IMA, V30, P43; LIM P, 1972, METABOLISM, V21, P1045, DOI 10.1016/0026-0495(72)90035-2; LINUMA H, 1978, EUR J CARDIOL, V7, P465; Montanez A, 2004, ARCH INTERN MED, V164, P943, DOI 10.1001/archinte.164.9.943; Nilsson G, 2006, EUROPACE, V8, P233, DOI 10.1093/europace/euj040; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Perkiomaki JS, 2001, ANN NONINVAS ELECTRO, V6, P183, DOI 10.1111/j.1542-474X.2001.tb00106.x; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Pytlak A, 2000, ANE, V5, P322; Rautaharju PM, 2006, CIRCULATION, V113, P473, DOI 10.1161/CIRCULATIONAHA.104.496091; RAUTAHARJU PM, 1990, METHOD INFORM MED, V29, P362; Robbins J, 2003, AM J MED, V115, P689, DOI 10.1016/j.amjmed.2003.07.014; Romero Mestre J C, 1996, Rev Esp Cardiol, V49, P259; Rossinen J, 1999, CLIN CARDIOL, V22, P591, DOI 10.1002/clc.4960220910; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; SCHENK EA, 1970, PATHOL MICROBIOL, V35, P96, DOI 10.1159/000162206; Schimpf R, 2008, CURR OPIN CARDIOL, V23, P192, DOI 10.1097/HCO.0b013e3282fbf756; Sheehan J, 2004, EUR J CARDIOV PREV R, V11, P63, DOI 10.1097/01.hjr.0000114970.39211.9e; Shiels MS, 2009, CANCER CAUSE CONTROL, V20, P877, DOI 10.1007/s10552-009-9318-y; Singh K, 2004, Indian Heart J, V56, P140; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; SUTHERLAND DJ, 1985, CHEST, V87, P319, DOI 10.1378/chest.87.3.319; Tsai CS, 2005, ALCOHOL CLIN EXP RES, V29, P1787, DOI 10.1097/01.alc.0000183512.31705.74; VETTER WR, 1967, ARCH INTERN MED, V120, P536, DOI 10.1001/archinte.120.5.536	54	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17584	10.1371/journal.pone.0017584	http://dx.doi.org/10.1371/journal.pone.0017584			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386989	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400086
J	Kormos, B; Belso, N; Bebes, A; Szabad, G; Bacsa, S; Szell, M; Kemeny, L; Bata-Csorgo, Z				Kormos, Bernadett; Belso, Nora; Bebes, Attila; Szabad, Gabor; Bacsa, Sarolta; Szell, Marta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna			In Vitro Dedifferentiation of Melanocytes from Adult Epidermis	PLOS ONE			English	Article							C-KIT EXPRESSION; FIBROBLAST-GROWTH-FACTOR; NEURAL CREST; MELANOMA-CELLS; TRANSCRIPTION FACTOR; ALPHA-MELANOTROPIN; PRECURSOR CELLS; CHOLERA-TOXIN; CYCLIC-AMP; PROLIFERATION	In previous work we described a novel culture technique using a cholera toxin and PMA-free medium (Mel-mix) for obtaining pure melanocyte cultures from human adult epidermis. In Mel-mix medium the cultured melanocytes are bipolar, unpigmented and highly proliferative. Further characterization of the cultured melanocytes revealed the disappearance of c-Kit and TRP-1 and induction of nestin expression, indicating that melanocytes dedifferentiated in this in vitro culture. Cholera toxin and PMA were able to induce c-Kit and TRP-1 protein expressions in the cells, reversing dedifferentiation. TRP-1 mRNA expression was induced in dedifferentiated melanocytes by UV-B irradiated keratinocyte supernatants, however direct UV-B irradiation of the cells resulted in further decrease of TRP-1 mRNA expression. These dedifferentiated, easily accessible cultured melanocytes provide a good model for studying melanocyte differentiation and possibly transdifferentiation. Because melanocytes in Mel-mix medium can be cultured with human serum as the only supplement, this culture system is also suitable for autologous cell transplantation.	[Kormos, Bernadett; Szell, Marta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna] Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary; [Belso, Nora; Bebes, Attila; Szabad, Gabor; Bacsa, Sarolta; Kemeny, Lajos; Bata-Csoergo, Zsuzsanna] Univ Szeged, Fac Med, Dept Dermatol & Allergol, Szeged, Hungary	Hungarian Academy of Sciences; Szeged University	Kormos, B (corresponding author), Hungarian Acad Sci, Dermatol Res Grp, Szeged, Hungary.	kormosbetti@mail.derma.szote.u-szeged.hu	Kemeny, Lajos/ABF-1339-2021	Kemeny, Lajos/0000-0002-2119-9501; Bata-Csorgo, Zsuzsanna/0000-0002-3732-1743	Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board [ETT 429-07];  [TAMOP-4.2.2-08/1-2008-0001];  [OTKA NK77434];  [OTKA K77436]	Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board; ; ; 	This work was supported by grants ETT 429-07 (Egeszsegugyi Tudomanyos Tanacs, Medical Scientific Board), TAMOP-4.2.2-08/1-2008-0001, OTKA NK77434, and OTKA K77436. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Brychtova S, 2007, J CUTAN PATHOL, V34, P370, DOI 10.1111/j.1600-0560.2006.00627.x; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; DONATIEN P, 1993, ARCH DERMATOL RES, V285, P385, DOI 10.1007/BF00372130; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Dupin E, 2003, ONCOGENE, V22, P3016, DOI 10.1038/sj.onc.1206460; Ehrmann J, 2005, J CLIN PATHOL, V58, P222, DOI 10.1136/jcp.2004.021238; EISINGER M, 1982, P NATL ACAD SCI-BIOL, V79, P2018, DOI 10.1073/pnas.79.6.2018; FALABELLA R, 1989, J AM ACAD DERMATOL, V21, P257, DOI 10.1016/S0190-9622(89)70170-5; Flammiger A, 2009, J INVEST DERMATOL, V129, P945, DOI 10.1038/jid.2008.316; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Grichnik JM, 2006, J INVEST DERMATOL, V126, P945, DOI 10.1038/sj.jid.5700164; Grichnik JM, 1996, J INVEST DERMATOL, V106, P967, DOI 10.1111/1523-1747.ep12338471; HALABAN R, 1987, IN VITRO CELL DEV B, V23, P47; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; HARA H, 1994, J INVEST DERMATOL, V102, P495, DOI 10.1111/1523-1747.ep12373136; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1992, DEVELOPMENT, V114, P435; Im SB, 1998, CANCER RES, V58, P47; Kawaguchi Y, 2001, J INVEST DERMATOL, V116, P920, DOI 10.1046/j.0022-202x.2001.01370.x; Kim NS, 2000, ARCH DERMATOL RES, V292, P233, DOI 10.1007/s004030050480; LASSAM N, 1992, ONCOGENE, V7, P51; LERNER AB, 1987, J INVEST DERMATOL, V89, P219, DOI 10.1111/1523-1747.ep12470973; Liu B, 2007, J NEUROSCI RES, V85, P3523, DOI 10.1002/jnr.21364; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; LUO D, 1995, MELANOMA RES, V5, P303, DOI 10.1097/00008390-199510000-00002; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MENGEAUD V, 1994, PIGM CELL RES, V7, P245, DOI 10.1111/j.1600-0749.1994.tb00059.x; Montone KT, 1997, MODERN PATHOL, V10, P939; Nakazawa K, 1998, J INVEST DERMATOL, V110, P972, DOI 10.1046/j.1523-1747.1998.00204.x; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Papageorgiou N, 2008, NEUROREPORT, V19, P1787, DOI 10.1097/WNR.0b013e3283193e82; Park HY, 2009, INT J CELL BIOL, V2009; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Prince S, 2003, PIGM CELL RES, V16, P26, DOI 10.1034/j.1600-0749.2003.00008.x; Real C, 2006, DEV BIOL, V300, P656, DOI 10.1016/j.ydbio.2006.09.032; Sarangarajan R, 2001, PIGM CELL RES, V14, P437, DOI 10.1034/j.1600-0749.2001.140603.x; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Suh Y, 2009, MOL CELL NEUROSCI, V42, P308, DOI 10.1016/j.mcn.2009.08.003; SWOPE VB, 1995, EXP CELL RES, V217, P453, DOI 10.1006/excr.1995.1109; Szabad G, 2007, ARCH DERMATOL RES, V299, P191, DOI 10.1007/s00403-007-0742-0; Szell M, 2004, J INVEST DERMATOL, V123, P537, DOI 10.1111/j.0022-202X.2004.23224.x; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Varga B, 2009, NEUROSCI LETT, V462, P257, DOI 10.1016/j.neulet.2009.06.051; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yaar M, 1997, J CLIN INVEST, V100, P2333, DOI 10.1172/JCI119772; Yaar M, 1997, ARCH DERMATOL, V133, P1287, DOI 10.1001/archderm.133.10.1287	49	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17197	10.1371/journal.pone.0017197	http://dx.doi.org/10.1371/journal.pone.0017197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383848	gold, Green Published, Green Submitted			2022-12-27	WOS:000287657500041
J	Panouilleres, M; Urquizar, C; Salemme, R; Pelisson, D				Panouilleres, Muriel; Urquizar, Christian; Salemme, Romeo; Pelisson, Denis			Sensory Processing of Motor Inaccuracy Depends on Previously Performed Movement and on Subsequent Motor Corrections: A Study of the Saccadic System	PLOS ONE			English	Article							SHORT-TERM ADAPTATION; EYE-MOVEMENTS; VOLUNTARY SACCADES; GAIN ADAPTATION; VOLITIONAL SACCADES; ANTISACCADE TASK; CORTICAL CONTROL; VISUAL ERROR; REFLEXIVE; SEPARATE	When goal-directed movements are inaccurate, two responses are generated by the brain: a fast motor correction toward the target and an adaptive motor recalibration developing progressively across subsequent trials. For the saccadic system, there is a clear dissociation between the fast motor correction (corrective saccade production) and the adaptive motor recalibration (primary saccade modification). Error signals used to trigger corrective saccades and to induce adaptation are based on post-saccadic visual feedback. The goal of this study was to determine if similar or different error signals are involved in saccadic adaptation and in corrective saccade generation. Saccadic accuracy was experimentally altered by systematically displacing the visual target during motor execution. Post-saccadic error signals were studied by manipulating visual information in two ways. First, the duration of the displaced target after primary saccade termination was set at 15, 50, 100 or 800 ms in different adaptation sessions. Second, in some sessions, the displaced target was followed by a visual mask that interfered with visual processing. Because they rely on different mechanisms, the adaptation of reactive saccades and the adaptation of voluntary saccades were both evaluated. We found that saccadic adaptation and corrective saccade production were both affected by the manipulations of post-saccadic visual information, but in different ways. This first finding suggests that different types of error signal processing are involved in the induction of these two motor corrections. Interestingly, voluntary saccades required a longer duration of post-saccadic target presentation to reach the same amount of adaptation as reactive saccades. Finally, the visual mask interfered with the production of corrective saccades only during the voluntary saccades adaptation task. These last observations suggest that post-saccadic perception depends on the previously performed action and that the differences between saccade categories of motor correction and adaptation occur at an early level of visual processing.	[Panouilleres, Muriel] Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, IMPACT Integrat Multisensory Percept Act & Cognit, Lyon, France; Univ Lyon 1, F-69365 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Panouilleres, M (corresponding author), Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, IMPACT Integrat Multisensory Percept Act & Cognit, Lyon, France.	muriel.panouilleres@inserm.fr	Pelisson, Denis/H-2916-2017	Pelisson, Denis/0000-0002-9114-7758; Panouilleres, Muriel/0000-0003-0264-2093	Agence Nationale pour la Recherche; Institut National de la Sante et de la Recherche Medicale [U864]; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by an Agence Nationale pour la Recherche grant (ANR Adapt-Eye) and Institut National de la Sante et de la Recherche Medicale U864. MP was supported by Universite Claude Bernard Lyon 1, and DP was supported by Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo AP, 2000, OPTOMETRY VISION SCI, V77, P321, DOI 10.1097/00006324-200006000-00012; Alahyane N, 2008, CEREBELLUM, V7, P595, DOI 10.1007/s12311-008-0065-5; Alahyane N, 2007, BRAIN RES, V1135, P107, DOI 10.1016/j.brainres.2006.11.077; Albano JE, 1996, VISION RES, V36, P2087, DOI 10.1016/0042-6989(96)89627-1; Bahcall DO, 2000, VISION RES, V40, P2779, DOI 10.1016/S0042-6989(00)00117-6; Cameron BD, 2009, EXP BRAIN RES, V195, P445, DOI 10.1007/s00221-009-1812-7; Collins T, 2008, J NEUROPHYSIOL, V99, P2708, DOI 10.1152/jn.01082.2007; Collins T, 2006, VISION RES, V46, P3659, DOI 10.1016/j.visres.2006.04.004; Cotti J, 2007, J NEUROPHYSIOL, V98, P602, DOI 10.1152/jn.00293.2007; Cotti J, 2009, J PHYSIOL-LONDON, V587, P127, DOI 10.1113/jphysiol.2008.159459; DEGRAAF JB, 1995, NEUROREPORT, V6, P1733, DOI 10.1097/00001756-199509000-00007; DEUBEL H, 1995, VISION RES, V35, P3529, DOI 10.1016/0042-6989(95)00058-M; DEUBEL H, 1986, HUM NEUROBIOL, V5, P245; DEUBEL H, 1987, BIOL CYBERN, V57, P37, DOI 10.1007/BF00318714; ERKELENS CJ, 1993, EXP BRAIN RES, V93, P157; FRENS MA, 1994, EXP BRAIN RES, V100, P293, DOI 10.1007/BF00227199; Fuchs AF, 1996, J NEUROPHYSIOL, V76, P2522, DOI 10.1152/jn.1996.76.4.2522; Fujita M, 2002, COGNITIVE BRAIN RES, V13, P41, DOI 10.1016/S0926-6410(01)00088-X; Gaveau V, 2003, NEUROREPORT, V14, P875, DOI 10.1097/00001756-200305060-00020; Hernandez TD, 2008, J VISION, V8, DOI 10.1167/8.8.3; Hopp J, 2004, PROG NEUROBIOL, V72, P27, DOI 10.1016/j.pneurobio.2003.12.002; Iwamoto Y, 2010, EXP BRAIN RES, V204, P145, DOI 10.1007/s00221-010-2314-3; Kroller J, 1996, EXP BRAIN RES, V111, P477; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; MCLAUGHLIN SC, 1967, PERCEPT PSYCHOPHYS, V2, P359, DOI 10.3758/BF03210071; Montagnini A, 2005, VISION RES, V45, P3391, DOI 10.1016/j.visres.2005.07.013; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Noto CT, 2001, COGNITIVE BRAIN RES, V12, P301, DOI 10.1016/S0926-6410(01)00062-3; Panouilleres M, 2009, J NEUROPHYSIOL, V101, P1550, DOI 10.1152/jn.90988.2008; Pelisson D, 2010, NEUROSCI BIOBEHAV R, V34, P1103, DOI 10.1016/j.neubiorev.2009.12.010; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Reingold EM, 2004, J EXP PSYCHOL HUMAN, V30, P194, DOI 10.1037/0096-1523.30.1.194; Reingold EM, 2002, J COGNITIVE NEUROSCI, V14, P371, DOI 10.1162/089892902317361903; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Shafer JL, 2000, J NEUROPHYSIOL, V84, P88, DOI 10.1152/jn.2000.84.1.88; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Wallman J, 1998, J NEUROPHYSIOL, V80, P2405, DOI 10.1152/jn.1998.80.5.2405; Watanabe S, 2003, AURIS NASUS LARYNX, V30, pS41; Zimmermann E, 2009, J NEUROSCI, V29, P11055, DOI 10.1523/JNEUROSCI.1604-09.2009	43	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17329	10.1371/journal.pone.0017329	http://dx.doi.org/10.1371/journal.pone.0017329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383849	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500051
J	Gnocchi, VF; Scharner, J; Huang, Z; Brady, K; Lee, JS; White, RB; Morgan, JE; Sun, YB; Ellis, JA; Zammit, PS				Gnocchi, Viola F.; Scharner, Juergen; Huang, Zhe; Brady, Ken; Lee, Jaclyn S.; White, Robert B.; Morgan, Jennifer E.; Sun, Yin-Biao; Ellis, Juliet A.; Zammit, Peter S.			Uncoordinated Transcription and Compromised Muscle Function in the Lmna-Null Mouse Model of Emery-Dreifuss Muscular Dystrophy	PLOS ONE			English	Article							CHROMATIN BINDING-SITE; LAMIN-A/C DEFICIENCY; A-TYPE LAMINS; NUCLEAR-ENVELOPE; DILATED CARDIOMYOPATHY; SKELETAL-MUSCLE; SATELLITE CELLS; C-FOS; MUTATION; EXPRESSION	LMNA encodes both lamin A and C: major components of the nuclear lamina. Mutations in LMNA underlie a range of tissue-specific degenerative diseases, including those that affect skeletal muscle, such as autosomal-Emery-Dreifuss muscular dystrophy (A-EDMD) and limb girdle muscular dystrophy 1B. Here, we examine the morphology and transcriptional activity of myonuclei, the structure of the myotendinous junction and the muscle contraction dynamics in the lmna-null mouse model of A-EDMD. We found that there were fewer myonuclei in lmna-null mice, of which similar to 50% had morphological abnormalities. Assaying transcriptional activity by examining acetylated histone H3 and PABPN1 levels indicated that there was a lack of coordinated transcription between myonuclei lacking lamin A/C. Myonuclei with abnormal morphology and transcriptional activity were distributed along the length of the myofibre, but accumulated at the myotendinous junction. Indeed, in addition to the presence of abnormal myonuclei, the structure of the myotendinous junction was perturbed, with disorganised sarcomeres and reduced interdigitation with the tendon, together with lipid and collagen deposition. Functionally, muscle contraction became severely affected within weeks of birth, with specific force generation dropping as low as similar to 65% and similar to 27% of control values in the extensor digitorum longus and soleus muscles respectively. These observations illustrate the importance of lamin A/C for correct myonuclear function, which likely acts synergistically with myotendinous junction disorganisation in the development of A-EDMD, and the consequential reduction in force generation and muscle wasting.	[Gnocchi, Viola F.; Scharner, Juergen; Huang, Zhe; Lee, Jaclyn S.; White, Robert B.; Sun, Yin-Biao; Ellis, Juliet A.; Zammit, Peter S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Brady, Ken] Kings Coll London, Ctr Ultrastruct Imaging, London WC2R 2LS, England; [Morgan, Jennifer E.] UCL, Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; University College London	Gnocchi, VF (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London WC2R 2LS, England.	peter.zammit@kcl.ac.uk	Sun, Yin-Biao/F-9988-2018; Scharner, Juergen/N-9534-2014; Zammit, peter/GXV-7746-2022; White, Robert/H-6080-2014	Sun, Yin-Biao/0000-0002-4992-8198; Scharner, Juergen/0000-0002-1110-8688; zammit, peter/0000-0001-9562-3072; Huang, Zhe/0000-0003-4943-3723; White, Robert/0000-0002-2854-0936	Medical Research Council [G0700307, G0601065]; Biomedical School, King's College London; EC [511978]; Wellcome Trust [085137/Z/08/Z]; Wellcome Trust University [084241/Z/07/Z]; British Heart Foundation [FS/09/001/26329]; laboratory of PSZ [223098]; European Commission; Muscular Dystrophy Campaign; MRC [G0601065, G0601943, G0700307] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical School, King's College London; EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Wellcome Trust University(Wellcome Trust); British Heart Foundation(British Heart Foundation); laboratory of PSZ; European Commission(European CommissionEuropean Commission Joint Research Centre); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	VFG was supported by The Medical Research Council project grant G0700307 (http://www.mrc.ac.uk/) awarded to PSZ, JEM and JAE. JS received funding from the Biomedical School, King's College London and the EC Network of Excellence MYORES (contract 511978). RBW and JSL were supported by The Wellcome Trust project grant 085137/Z/08/Z (http://www.wellcome.ac.uk/), JEM is financed by a Wellcome Trust University Award (084241/Z/07/Z), Y-BS has a British Heart Foundation Senior Research Fellowship (FS/09/001/26329) and ZH is funded by Medical Research Council grant G0601065, awarded to Professor Malcolm Irving. The laboratory of PSZ is also supported by OPTISTEM Grant Agreement number: 223098, from the European Commission 7th Framework Programme and The Muscular Dystrophy Campaign. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cohen TV, 2008, CURR TOP DEV BIOL, V84, P351, DOI 10.1016/S0070-2153(08)00607-8; Collins Charlotte A., 2009, V482, P319, DOI 10.1007/978-1-59745-060-7_20; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X; Fidzianska A, 2003, J NEUROL SCI, V210, P47, DOI 10.1016/S0022-510X(03)00012-1; Galiova G, 2008, EUR J CELL BIOL, V87, P291, DOI 10.1016/j.ejcb.2008.01.013; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; GLASS CA, 1993, EMBO J, V12, P4413, DOI 10.1002/j.1460-2075.1993.tb06126.x; Gnocchi VF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005205; Grattan M. J., 2005, V264, P118, DOI 10.1002/0470093765.ch9; GRATTAN MJ, 2005, NOVART FDN SYMP, V264, P133; GRATTAN MJ, 2005, NOVART FDN SYMP, V264, P227; Hakelien AM, 2008, EXP CELL RES, V314, P1869, DOI 10.1016/j.yexcr.2008.02.018; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; Kandert S, 2009, EUR J CELL BIOL, V88, P593, DOI 10.1016/j.ejcb.2009.06.002; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marmiroli S, 2009, J CELL PHYSIOL, V220, P553, DOI 10.1002/jcp.21807; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; MENDEZ J, 1960, METABOLISM, V9, P184; Mittelbronn M, 2008, BRAIN PATHOL, V18, P338, DOI 10.1111/j.1750-3639.2008.00123.x; Monti RJ, 1999, J BIOMECH, V32, P371, DOI 10.1016/S0021-9290(98)00189-4; Morgan JE, 2010, EXP CELL RES, V316, P3100, DOI 10.1016/j.yexcr.2010.05.014; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Muchir A, 2007, HUM MOL GENET, V16, P1884, DOI 10.1093/hmg/ddm137; Muchir A, 2007, J CLIN INVEST, V117, P1282, DOI 10.1172/JCI29042; Munshi A, 2009, J GENET GENOMICS, V36, P75, DOI 10.1016/S1673-8527(08)60094-6; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Park YE, 2009, NEUROMUSCULAR DISORD, V19, P29, DOI 10.1016/j.nmd.2008.09.018; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12; RIDGE JC, 1994, EXP MOL PATHOL, V61, P58, DOI 10.1006/exmp.1994.1025; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; ROSENBLATT JD, 1992, J APPL PHYSIOL, V73, P2538, DOI 10.1152/jappl.1992.73.6.2538; Sabatelli P, 2001, MUSCLE NERVE, V24, P826, DOI 10.1002/mus.1076; Sandri M, 1999, INT J BIOCHEM CELL B, V31, P1373, DOI 10.1016/S1357-2725(99)00063-1; Scharner J, 2011, HUM MUTAT, V32, P152, DOI 10.1002/humu.21361; Scharner J, 2010, BIOCHEM SOC T, V38, P257, DOI 10.1042/BST0380257; Schirmer EC, 2008, MUTAT RES-FUND MOL M, V647, P112, DOI 10.1016/j.mrfmmm.2008.07.012; Sewry CA, 2001, NEUROPATH APPL NEURO, V27, P281, DOI 10.1046/j.0305-1846.2001.00323.x; Sewry CA, 2010, ACTA NEUROPATHOL, V120, P343, DOI 10.1007/s00401-010-0727-5; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; TIDBALL JG, 1992, ACTA NEUROPATHOL, V84, P135, DOI 10.1007/BF00311385; TIDBALL JG, 1991, J BIOMECH, V24, P43, DOI 10.1016/0021-9290(91)90376-X; TIDBALL JG, 1992, J APPL PHYSIOL, V73, P59, DOI 10.1152/jappl.1992.73.1.59; van Engelen BGM, 2005, NEUROLOGY, V64, P374, DOI 10.1212/01.WNL.0000149763.15180.00; Vaughan OA, 2001, J CELL SCI, V114, P2577; Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Worman HJ, 2006, BBA-MOL CELL BIOL L, V1761, P626, DOI 10.1016/j.bbalip.2006.02.010; Zammit PS, 2008, J CELL SCI, V121, P2975, DOI 10.1242/jcs.019661	64	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16651	10.1371/journal.pone.0016651	http://dx.doi.org/10.1371/journal.pone.0016651			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364987	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600011
J	Goldstien, SJ; Dupont, L; Viard, F; Hallas, PJ; Nishikawa, T; Schiel, DR; Gemmell, NJ; Bishop, JDD				Goldstien, Sharyn J.; Dupont, Lise; Viard, Frederique; Hallas, Paul J.; Nishikawa, Teruaki; Schiel, David R.; Gemmell, Neil J.; Bishop, John D. D.			Global Phylogeography of the Widely Introduced North West Pacific Ascidian Styela clava	PLOS ONE			English	Article							CRABS CARCINUS-MAENAS; PRINCE-EDWARD-ISLAND; GENETIC DIVERSITY; EVOLUTIONARY GENETICS; BIOLOGICAL INVASIONS; POPULATIONS; TUNICATA; CONNECTIVITY; EXPANSION; INVADER	The solitary ascidian Styela clava Herdman, 1882 is considered to be native to Japan, Korea, northern China and the Russian Federation in the NW Pacific, but it has spread globally over the last 80 years and is now established as an introduced species on the east and west coasts of North America, Europe, Australia and New Zealand. In eastern Canada it reaches sufficient density to be a serious pest to aquaculture concerns. We sequenced a fragment of the cytochrome oxidase subunit I mitochondrial gene (COI) from a total of 554 individuals to examine the genetic relationships of 20 S. clava populations sampled throughout the introduced and native ranges, in order to investigate invasive population characteristics. The data presented here show a moderate level of genetic diversity throughout the northern hemisphere. The southern hemisphere (particularly New Zealand) displays a greater amount of haplotype and nucleotide diversity in comparison. This species, like many other invasive species, shows a range of genetic diversities among introduced populations independent of the age of incursion. The successful establishment of this species appears to be associated with multiple incursions in many locations, while other locations appear to have experienced rapid expansion from a potentially small population with reduced genetic diversity. These contrasting patterns create difficulties when attempting to manage and mitigate a species that continues to spread among ports and marinas around the world.	[Goldstien, Sharyn J.; Schiel, David R.] Univ Canterbury, Christchurch 1, New Zealand; [Dupont, Lise; Hallas, Paul J.; Bishop, John D. D.] Marine Biol Assoc UK, Plymouth, Devon, England; [Dupont, Lise] Univ Paris Est Creteil, Equipe IBIOS, UMR BioEMCo 7618, Creteil, France; [Viard, Frederique] UPMC Univ Paris, Stn Biol Roscoff, Lab AD2M, Roscoff, France; [Viard, Frederique] UPMC, CNRS, UMR 7144, Stn Biol Roscoff,DivCo Team, Roscoff, France; [Hallas, Paul J.] Univ Glamorgan, Pontypridd CF37 1DL, M Glam, Wales; [Hallas, Paul J.; Bishop, John D. D.] Univ Plymouth, Plymouth PL4 8AA, Devon, England; [Nishikawa, Teruaki] Toho Univ, Chiba 2748510, Japan; [Gemmell, Neil J.] Univ Otago, Dunedin, New Zealand	University of Canterbury; Marine Biological Association United Kingdom; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; AgroParisTech; Institut de Recherche pour le Developpement (IRD); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; University of South Wales; University of Plymouth; Toho University; University of Otago	Goldstien, SJ (corresponding author), Univ Canterbury, Christchurch 1, New Zealand.	sharyn.goldstien@canterbury.ac.nz	Gemmell, Neil J/C-6774-2009; Dupont, Lise/M-1712-2013; Viard, Frédérique/O-4360-2018	Gemmell, Neil J/0000-0003-0671-3637; Dupont, Lise/0000-0003-4824-2685; Viard, Frédérique/0000-0001-5603-9527	University of Canterbury; NIWA [CO1X0502]; European Network of Excellence "Marine Genomics Europe" [505403]; NERC (UK) Oceans [2025]; AXA Research Funds; NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004] Funding Source: researchfish	University of Canterbury; NIWA; European Network of Excellence "Marine Genomics Europe"; NERC (UK) Oceans(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); AXA Research Funds(AXA Research Fund); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by a University of Canterbury Postdoctoral Fellowship and subcontract to NJG from NIWA as part of the FRST OBI "Biodiversity and biosecurity" contract CO1X0502, as well as the European Network of Excellence "Marine Genomics Europe" (contract no. 505403), the NERC (UK) Oceans 2025 programme, and the AXA Research Funds (project 'MAAC') (see url http://www.axa-research.org/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by a University of Canterbury Postdoctoral Fellowship and subcontract to NJG from NIWA as part of the FRST OBI "Biodiversity and biosecurity" contract CO1X0502, as well as the European Network of Excellence "Marine Genomics Europe" (contract no. 505403), the NERC (UK) Oceans 2025 programme, and the AXA Research Fund (project 'MAAC'). This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Agius BP, 2007, J EXP MAR BIOL ECOL, V342, P30, DOI 10.1016/j.jembe.2006.10.012; Arsenault Garth, 2009, Aquatic Invasions, V4, P189, DOI 10.3391/ai.2009.4.1.19; Ashton GV, 2008, MOL ECOL, V17, P1293, DOI 10.1111/j.1365-294X.2007.03668.x; Blum JC, 2007, J EXP MAR BIOL ECOL, V342, P5, DOI 10.1016/j.jembe.2006.10.010; Bourque D, 2007, J EXP MAR BIOL ECOL, V342, P78, DOI 10.1016/j.jembe.2006.10.017; Briggs JC, 2007, J BIOGEOGR, V34, P193, DOI 10.1111/j.1365-2699.2006.01632.x; CARLISLE D, 1954, J MAR BIOL ASSOC UK, V33, P239; Castilla JC, 2002, MOL ECOL, V11, P1579, DOI 10.1046/j.1365-294X.2002.01524.x; Chandler EA, 2008, MOL ECOL, V17, P4079, DOI 10.1111/j.1365-294X.2008.03897.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Corander J, 2006, FISH B-NOAA, V104, P550; Coutts ADM, 2007, J EXP MAR BIOL ECOL, V342, P154, DOI 10.1016/j.jembe.2006.10.042; Daleo P, 2009, DIVERS DISTRIB, V15, P547, DOI 10.1111/j.1472-4642.2009.00576.x; Darling JA, 2007, BIOL INVASIONS, V9, P751, DOI 10.1007/s10530-006-9079-4; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; DAVIDSON J, 2005, REPROD EPIDEMIOLOGY; Davis M, 2006, PORCUPINE MAR NAT HI, V20, P1; Davis MH, 2007, J EXP MAR BIOL ECOL, V342, P182, DOI 10.1016/j.jembe.2006.10.039; Davis Martin H., 2009, Aquatic Invasions, V4, P283, DOI 10.3391/ai.2009.4.1.29; Davis MH, 2005, J MAR BIOL ASSOC UK, V85, P403, DOI 10.1017/S002531540501132Xh; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dlugosch KM, 2008, MOL ECOL, V17, P4583, DOI 10.1111/j.1365-294X.2008.03932.x; Dodgshun TJ., 2007, HUMAN MEDIATED PATHW; Dupont L, 2010, BIOL INVASIONS, V12, P2707, DOI 10.1007/s10530-009-9676-0; Dupont L, 2009, MOL ECOL, V18, P442, DOI 10.1111/j.1365-294X.2008.04045.x; Eastwood MM, 2007, BIOL INVASIONS, V9, P397, DOI 10.1007/s10530-006-9041-5; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Geller J, 2008, MAR ECOL PROG SER, V358, P211, DOI 10.3354/meps07466; Gittenberger A, 2007, J EXP MAR BIOL ECOL, V342, P122, DOI 10.1016/j.jembe.2006.10.022; Goldstien SJ, 2010, MOL ECOL, V19, P874, DOI 10.1111/j.1365-294X.2010.04527.x; Grosholz E, 2002, TRENDS ECOL EVOL, V17, P22, DOI 10.1016/S0169-5347(01)02358-8; Hall T., 1997, BIOEDIT V 5 0 6; Hewitt CL, 1999, MARINE BIOL INVASION; HOLMES N, 1976, Proceedings of the Royal Society of Victoria, V88, P115; KELLY D, 2006, MOL ECOL, V15; Lambert CC, 1998, MAR BIOL, V130, P675, DOI 10.1007/s002270050289; Lambert G, 2007, J EXP MAR BIOL ECOL, V342, P3, DOI 10.1016/j.jembe.2006.10.009; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lee PLM, 2004, INT J PLANT SCI, V165, P833, DOI 10.1086/422043; Locke A, 2007, J EXP MAR BIOL ECOL, V342, P69, DOI 10.1016/j.jembe.2006.10.016; LOPESLEGENTIL S, 2006, MEDITERRANEAN SEA, V88, P203; Lopez-Legentil S, 2006, MOL ECOL, V15, P3957, DOI 10.1111/j.1365-294X.2006.03087.x; Moksnes PO, 2002, J EXP MAR BIOL ECOL, V271, P41, DOI 10.1016/S0022-0981(02)00041-2; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Nei M., 2000, MOL EVOLUTION PHYLOG; Osman RW, 2007, J EXP MAR BIOL ECOL, V342, P40, DOI 10.1016/j.jembe.2006.10.013; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Rius M, 2008, DIVERS DISTRIB, V14, P818, DOI 10.1111/j.1472-4642.2008.00485.x; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Schneider S., 2000, ARLEQUIN VER 2 000 S; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tepolt CK, 2009, DIVERS DISTRIB, V15, P997, DOI 10.1111/j.1472-4642.2009.00605.x; Thompson RC, 2004, PEI DEP AGR FISHERIE, V234, P29; Uwai SY, 2006, PHYCOLOGIA, V45, P687, DOI 10.2216/05-66.1; Voisin M, 2005, P NATL ACAD SCI USA, V102, P5432, DOI 10.1073/pnas.0501754102; WHITLATCH R, 1995, P NE C NON AQ NUIS S, V29, P48	60	52	54	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16755	10.1371/journal.pone.0016755	http://dx.doi.org/10.1371/journal.pone.0016755			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364988	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600016
J	Kirkby, NS; Low, L; Seckl, JR; Walker, BR; Webb, DJ; Hadoke, PWF				Kirkby, Nicholas S.; Low, Lucinda; Seckl, Jonathan R.; Walker, Brian R.; Webb, David J.; Hadoke, Patrick W. F.			Quantitative 3-Dimensional Imaging of Murine Neointimal and Atherosclerotic Lesions by Optical Projection Tomography	PLOS ONE			English	Article							ARTERY; QUANTIFICATION; MICE	Objective: Traditional methods for the analysis of vascular lesion formation are labour intensive to perform - restricting study to 'snapshots' within each vessel. This study was undertaken to determine the suitability of optical projection tomographic (OPT) imaging for the 3-dimensional representation and quantification of intimal lesions in mouse arteries. Methods and Results: Vascular injury was induced by wire-insertion or ligation of the mouse femoral artery or administration of an atherogenic diet to apoE-deficient mice. Lesion formation was examined by OPT imaging of autofluorescent emission. Lesions could be clearly identified and distinguished from the underlying vascular wall. Planimetric measurements of lesion area correlated well with those made from histological sections subsequently produced from the same vessels (wire-injury: R(2) = 0.92; ligation-injury: R(2) = 0.89; atherosclerosis: R(2) = 0.85), confirming both the accuracy of this methodology and its non-destructive nature. It was also possible to record volumetric measurements of lesion and lumen and these were highly reproducible between scans (coefficient of variation = 5.36%, 11.39% and 4.79% for wire-and ligation-injury and atherosclerosis, respectively). Conclusions: These data demonstrate the eminent suitability of OPT for imaging of atherosclerotic and neointimal lesion formation, providing a much needed means for the routine 3-dimensional analysis of vascular morphology in studies of this type.	[Kirkby, Nicholas S.; Low, Lucinda; Seckl, Jonathan R.; Walker, Brian R.; Webb, David J.; Hadoke, Patrick W. F.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Kirkby, NS (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland.	phadoke@staffmail.ed.ac.uk	Seckl, Jonathan R/C-3555-2013	Kirkby, Nicholas/0000-0003-3509-8549	University of Edinburgh; Carnegie Trust; British Heart Foundation [RG/05/008, PG/05/007]; Wellcome Trust [08314/Z/07/Z]; BHF; British Heart Foundation [PG/08/068/25461, RG/11/4/28734] Funding Source: researchfish	University of Edinburgh; Carnegie Trust(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome Trust); BHF(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by studentships from the University of Edinburgh (NSK) and Carnegie Trust (LL; Henri Dryerre scheme) and funding from the British Heart Foundation (PWFH, BRW, DJW; RG/05/008; PG/05/007) and Wellcome Trust (JRS, BRW, DJW; 08314/Z/07/Z). The Centre for Cardiovascular Science is a BHF-funded Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; Ambrosi CM, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3213604; Bucher D, 2000, J NEUROSCI METH, V100, P135, DOI 10.1016/S0165-0270(00)00245-4; HADOKE P, 1995, CORONARY ARTERY DIS, V6, P403, DOI 10.1097/00019501-199505000-00008; Kerwin J, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-27; Ku G, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3339912; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Langheinrich AC, 2004, RADIOLOGY, V231, P675, DOI 10.1148/radiol.2313021718; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Martinez HG, 2009, CIRCULATION, V120, P821, DOI 10.1161/CIRCULATIONAHA.108.829531; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; RichardsKortum R, 1996, ANNU REV PHYS CHEM, V47, P555, DOI 10.1146/annurev.physchem.47.1.555; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sharpe J, 2004, ANNU REV BIOMED ENG, V6, P209, DOI 10.1146/annurev.bioeng.6.040803.140210; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Walls JR, 2007, PHYS MED BIOL, V52, P2775, DOI 10.1088/0031-9155/52/10/010; Walls JR, 2005, PHYS MED BIOL, V50, P4645, DOI 10.1088/0031-9155/50/19/015; You D, 2006, CIRCULATION, V114, P328, DOI 10.1161/CIRCULATIONAHA.105.589937	19	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16906	10.1371/journal.pone.0016906	http://dx.doi.org/10.1371/journal.pone.0016906			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379578	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300025
J	Carvalho, R; de Sonneville, J; Stockhammer, OW; Savage, NDL; Veneman, WJ; Ottenhoff, THM; Dirks, RP; Meijer, AH; Spaink, HP				Carvalho, Ralph; de Sonneville, Jan; Stockhammer, Oliver W.; Savage, Nigel D. L.; Veneman, Wouter J.; Ottenhoff, Tom H. M.; Dirks, Ron P.; Meijer, Annemarie H.; Spaink, Herman P.			A High-Throughput Screen for Tuberculosis Progression	PLOS ONE			English	Article							MYCOBACTERIUM-MARINUM INFECTION; TRANSGENIC ZEBRAFISH; GRANULOMA-FORMATION; BACTERIAL-GROWTH; MACROPHAGE; INFLAMMATION; IMMUNITY; HOST; PATHOGENESIS; SALMONELLAE	One-third of the world population is infected with Mycobacterium tuberculosis and multi-drug resistant strains are rapidly evolving. The noticeable absence of a whole organism high-throughput screening system for studying the progression of tuberculosis is fast becoming the bottleneck in tuberculosis research. We successfully developed such a system using the zebrafish Mycobacterium marinum infection model, which is a well-characterized model for tuberculosis progression with biomedical significance, mimicking hallmarks of human tuberculosis pathology. Importantly, we demonstrate the suitability of our system to directly study M. tuberculosis, showing for the first time that the human pathogen can propagate in this vertebrate model, resulting in similar early disease symptoms to those observed upon M. marinum infection. Our system is capable of screening for disease progression via robotic yolk injection of early embryos and visual flow screening of late-stage larvae. We also show that this system can reliably recapitulate the standard caudal vein injection method with a throughput level of 2,000 embryos per hour. We additionally demonstrate the possibility of studying signal transduction leading to disease progression using reverse genetics at high-throughput levels. Importantly, we use reference compounds to validate our system in the testing of molecules that prevent tuberculosis progression, making it highly suited for investigating novel anti-tuberculosis compounds in vivo.	[Carvalho, Ralph; Dirks, Ron P.] ZF Screens BV, Leiden, Netherlands; [de Sonneville, Jan] Leiden Univ, Inst Chem, Leiden, Netherlands; [Carvalho, Ralph; Stockhammer, Oliver W.; Veneman, Wouter J.; Meijer, Annemarie H.; Spaink, Herman P.] Leiden Univ, Inst Biol, Leiden, Netherlands; [Savage, Nigel D. L.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Carvalho, R (corresponding author), ZF Screens BV, Leiden, Netherlands.	h.p.spaink@biology.leidenuniv.nl	Spaink, Herman P./S-3586-2017; Meijer, Annemarie/W-3726-2019	Spaink, Herman P./0000-0003-4128-9501; de Sonneville, Jan/0000-0002-6399-7042; Meijer, Annemarie H./0000-0002-1325-0725	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO) [834.10.004]; European community [LSHG-CT-2006-037220, Health-F2-2008-201439]; Cyttron; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Netherlands Leprosy Relief Foundation; European Commission; Bill and Melinda Gates Foundation	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; Division for Earth and Life Sciences; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European community(European Commission); Cyttron; Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Netherlands Leprosy Relief Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The authors gratefully acknowledge the financial support of the Smart Mix Program (http://www.nwo.nl/nwohome.nsf/pages/NWOA_6QY9BM_Eng) of The Netherlands Ministry of Economic Affairs and of The Netherlands Ministry of Education, Culture and Science awarded to Leiden University and to ZF-screens B. V. The COPAS system acquisition was in part supported by the Division for Earth and Life Sciences (ALW; http://www.nwo.nl/NWOHOME.nsf/pages/ACPP_4WMJGH_Eng) with financial aid from the Netherlands Organization for Scientific Research (NWO, 834.10.004; http://www.nwo.nl/). Additionally, A. H. M. and H. P. S were supported by the European community ZF-TOOLS project (contract LSHG-CT-2006-037220; http://ec.europa.eu/research/fp6/index_en.cfm), and H. P. S. and R. C. were supported by the European community ZF-Cancer project (contract Health-F2-2008-201439; http://cordis.europa.eu/fp7/home_en.html). The authors acknowledge financial support from Cyttron, in the Besluit Subsidies Investeringen Kennisinfrastructuur program (J.S.), which in turn is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek. Finally, T.H.M.O. and N.D.L.S. received support from the Netherlands Leprosy Relief Foundation (http://www.leprastichting.nl/), the European Commission and the Bill and Melinda Gates Foundation (http://www. gatesfoundation.org/Pages/home.aspx). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DO, 1976, AM J PATHOL, V84, P164; Agarwal N, 2010, SCIENCE, V327, P417, DOI 10.1126/science.1185569; Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lesley R, 2008, CURR OPIN MICROBIOL, V11, P277, DOI 10.1016/j.mib.2008.05.013; Mathias JR, 2007, J CELL SCI, V120, P3372, DOI 10.1242/jcs.009159; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Toole R, 2010, ADV APPL MICROBIOL, V71, P75, DOI 10.1016/S0065-2164(10)71003-0; Ottenhoff THM, 2002, NAT GENET, V32, P97, DOI 10.1038/ng0902-97; Ottenhoff THM, 2009, EUR J IMMUNOL, V39, P2014, DOI 10.1002/eji.200939518; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Tobin DM, 2010, CELL, V140, P717, DOI 10.1016/j.cell.2010.02.013; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van de Vosse E, 2004, LANCET INFECT DIS, V4, P739, DOI 10.1016/S1473-3099(04)01203-4; van der Sar AM, 2009, MOL IMMUNOL, V46, P2317, DOI 10.1016/j.molimm.2009.03.024; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wang WH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000862; Williams A, 2009, TUBERCULOSIS, V89, P389, DOI 10.1016/j.tube.2009.08.004	35	93	97	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 16	2011	6	2							e16779	10.1371/journal.pone.0016779	http://dx.doi.org/10.1371/journal.pone.0016779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721YC	21390204	Green Submitted, Green Published, gold			2022-12-27	WOS:000287392700024
J	Hayasaka, N; Aoki, K; Kinoshita, S; Yamaguchi, S; Wakefield, JK; Tsuji-Kawahara, S; Horikawa, K; Ikegami, H; Wakana, S; Murakami, T; Ramabhadran, R; Miyazawa, M; Shibata, S				Hayasaka, Naoto; Aoki, Kazuyuki; Kinoshita, Saori; Yamaguchi, Shoutaroh; Wakefield, John K.; Tsuji-Kawahara, Sachiyo; Horikawa, Kazumasa; Ikegami, Hiroshi; Wakana, Shigeharu; Murakami, Takamichi; Ramabhadran, Ram; Miyazawa, Masaaki; Shibata, Shigenobu			Attenuated Food Anticipatory Activity and Abnormal Circadian Locomotor Rhythms in Rgs16 Knockdown Mice	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; LENTIVIRAL VECTORS; ANIMAL TRANSGENESIS; FEEDING SCHEDULES; OSCILLATORS; LESIONS; RATS; REGULATORS; MELATONIN	Regulators of G protein signaling (RGS) are a multi-functional protein family, which functions in part as GTPase-activating proteins (GAPs) of G protein alpha-subunits to terminate G protein signaling. Previous studies have demonstrated that the Rgs16 transcripts exhibit robust circadian rhythms both in the suprachiasmatic nucleus (SCN), the master circadian light-entrainable oscillator (LEO) of the hypothalamus, and in the liver. To investigate the role of RGS16 in the circadian clock in vivo, we generated two independent transgenic mouse lines using lentiviral vectors expressing short hairpin RNA (shRNA) targeting the Rgs16 mRNA. The knockdown mice demonstrated significantly shorter free-running period of locomotor activity rhythms and reduced total activity as compared to the wild-type siblings. In addition, when feeding was restricted during the daytime, food-entrainable oscillator (FEO)-driven elevated food-anticipatory activity (FAA) observed prior to the scheduled feeding time was significantly attenuated in the knockdown mice. Whereas the restricted feeding phase-advanced the rhythmic expression of the Per2 clock gene in liver and thalamus in the wild-type animals, the above phase shift was not observed in the knockdown mice. This is the first in vivo demonstration that a common regulator of G protein signaling is involved in the two separate, but interactive circadian timing systems, LEO and FEO. The present study also suggests that liver and/or thalamus regulate the food-entrained circadian behavior through G protein-mediated signal transduction pathway(s).	[Hayasaka, Naoto] Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan; [Aoki, Kazuyuki; Yamaguchi, Shoutaroh; Horikawa, Kazumasa; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Dept Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan; [Kinoshita, Saori; Tsuji-Kawahara, Sachiyo; Miyazawa, Masaaki] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan; [Wakefield, John K.; Ramabhadran, Ram] Tranzyme Pharma, Durham, NC USA; [Ikegami, Hiroshi] Kinki Univ, Sch Med, Dept Endocrinol Metab & Dis, Osaka 589, Japan; [Wakana, Shigeharu] RIKEN, Bioresource Ctr, Technol & Dev Team Mouse Phenotype Anal, Japan Mouse Clin, Tsukuba, Ibaraki, Japan; [Murakami, Takamichi] Kinki Univ, Sch Med, Dept Radiol, Osaka 589, Japan	Kindai University (Kinki University); Waseda University; Kindai University (Kinki University); Kindai University (Kinki University); RIKEN; Kindai University (Kinki University)	Hayasaka, N (corresponding author), Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osaka 589, Japan.	hayasaka@med.kindai.ac.jp	Hayasaka, Naoto/C-9370-2011; Miyazawa, Masaaki/AAA-3916-2020; Ikegami, Hiroshi/AGP-9878-2022	Miyazawa, Masaaki/0000-0002-7300-119X; 	Japan Society for the Promotion of Science [19590235, 21590264]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [21390143] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research: No. 19590235 and 21590264 from the Japan Society for the Promotion of Science, Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan including the High-Tech Research Center and Anti-aging Center grants, those from the Ministry of Health, Labor and Welfare of Japan for Research on HIV/AIDS, and those from the Japan Health Sciences Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2004, EUR J NEUROSCI, V20, P3054, DOI 10.1111/j.1460-9568.2004.03749.x; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Blum ID, 2009, NEUROSCIENCE, V164, P351, DOI 10.1016/j.neuroscience.2009.08.009; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dubocovich ML, 2007, SLEEP MED, V8, pS34, DOI 10.1016/j.sleep.2007.10.007; Escobar C, 2009, EUR J NEUROSCI, V30, P1665, DOI 10.1111/j.1460-9568.2009.06972.x; Gillette MU, 2002, CELL TISSUE RES, V309, P99, DOI 10.1007/s00441-002-0576-1; Grafstein-Dunn E, 2001, MOL BRAIN RES, V88, P113, DOI 10.1016/S0169-328X(01)00038-9; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Huang Jie, 2006, Comp Hepatol, V5, P8, DOI 10.1186/1476-5926-5-8; KRIEGER DT, 1977, SCIENCE, V197, P398, DOI 10.1126/science.877566; Lamont EW, 2007, SLEEP MED, V8, P547, DOI 10.1016/j.sleep.2006.11.002; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Maywood ES, 2007, ENDOCRINOLOGY, V148, P5624, DOI 10.1210/en.2007-0660; Mendoza J, 2007, J NEUROENDOCRINOL, V19, P127, DOI 10.1111/j.1365-2826.2006.01510.x; Mieda M, 2004, J NEUROSCI, V24, P10493, DOI 10.1523/JNEUROSCI.3171-04.2004; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Park F, 2007, PHYSIOL GENOMICS, V31, P159, DOI 10.1152/physiolgenomics.00069.2007; Pevet P, 2006, CHRONOBIOL INT, V23, P39, DOI 10.1080/07420520500482074; Rashotte ME, 1996, PHYSIOL BEHAV, V59, P1005, DOI 10.1016/0031-9384(95)02125-6; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Shaughnessy L, 2004, J MOL NEUROSCI, V24, P23, DOI 10.1385/JMN:24:1:023; Singer O, 2008, CURR GENE THER, V8, P483, DOI 10.2174/156652308786848067; Sosa MAG, 2010, BRAIN STRUCT FUNCT, V214, P91, DOI 10.1007/s00429-009-0230-8; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P545, DOI 10.1016/S0163-1047(79)90332-7; STEPHAN FK, 1979, BEHAV NEURAL BIOL, V25, P346, DOI 10.1016/S0163-1047(79)90415-1; Stephan FK, 1997, PHYSIOL BEHAV, V62, P995, DOI 10.1016/S0031-9384(97)00204-7; STEPHAN FK, 2001, CIRCADIAN CLOCKS, V12, P223; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Wu XY, 2000, MOL THER, V2, P47, DOI 10.1006/mthe.2000.0095	38	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17655	10.1371/journal.pone.0017655	http://dx.doi.org/10.1371/journal.pone.0017655			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408016	gold, Green Submitted, Green Published			2022-12-27	WOS:000288170900036
J	El Baroudi, M; Cora, D; Bosia, C; Osella, M; Caselle, M				El Baroudi, Mariama; Cora, Davide; Bosia, Carla; Osella, Matteo; Caselle, Michele			A Curated Database of miRNA Mediated Feed-Forward Loops Involving MYC as Master Regulator	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENE NETWORKS; MICRORNAS; CANCER; IDENTIFICATION; INTEGRATION; CIRCUITS; FEEDBACK; TARGETS	Background: The MYC transcription factors are known to be involved in the biology of many human cancer types. But little is known about the Myc/microRNAs cooperation in the regulation of genes at the transcriptional and post- transcriptional level. Methodology/Principal Findings: Employing independent databases with experimentally validated data, we identified several mixed microRNA/Transcription Factor Feed-Forward Loops regulated by Myc and characterized completely by experimentally supported regulatory interactions, in human. We then studied the statistical and functional properties of these circuits and discussed in more detail a few interesting examples involving E2F1, PTEN, RB1 and VEGF. Conclusions/Significance: We have assembled and characterized a catalogue of human mixed Transcription Factor/microRNA Feed- Forward Loops, having Myc as master regulator and completely defined by experimentally verified regulatory interactions.	[El Baroudi, Mariama; Bosia, Carla; Osella, Matteo; Caselle, Michele] Univ Turin, Dept Theoret Phys, Turin, Italy; [El Baroudi, Mariama; Bosia, Carla; Osella, Matteo; Caselle, Michele] Natl Inst Nucl Phys, Turin, Italy; [El Baroudi, Mariama; Cora, Davide; Bosia, Carla; Osella, Matteo; Caselle, Michele] Univ Turin, Ctr Complex Syst Mol Biol & Med, Turin, Italy; [Cora, Davide] Univ Turin, Sch Med, Inst Canc Res & Treatment IRCC, Syst Biol Lab, Turin, Italy	University of Turin; Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia; University of Turin	El Baroudi, M (corresponding author), Univ Turin, Dept Theoret Phys, Turin, Italy.	caselle@to.infn.it	El Baroudi, Mariama/B-3865-2013; Caselle, Michele/E-3724-2013; Osella, Matteo/AAB-3888-2019	Caselle, Michele/0000-0001-5488-142X; Osella, Matteo/0000-0002-4916-5434; Cora', Davide/0000-0003-4123-1705; Bosia, Carla/0000-0002-8960-3443				Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lotterman CD, 2008, CELL CYCLE, V7, P2493, DOI 10.4161/cc.7.16.6452; Martinez NJ, 2009, BIOESSAYS, V31, P435, DOI 10.1002/bies.200800212; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; MUKHERJEE B, 1992, GENE DEV, V6, P1480, DOI 10.1101/gad.6.8.1480; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OSELLA M, PLOS COMPUT IN PRESS; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SINHA AU, 2008, BMC GENOMICS, V23, P9; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WANG J, 2009, NUCLEIC ACIDS RES, V1, P4; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	33	38	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e14742	10.1371/journal.pone.0014742	http://dx.doi.org/10.1371/journal.pone.0014742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390222	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200002
J	Michel, J; DeLeon-Rangel, J; Zhu, ST; Van Ree, K; Vik, SB				Michel, Jose; DeLeon-Rangel, Jessica; Zhu, Shaotong; Van Ree, Kalie; Vik, Steven B.			Mutagenesis of the L, M, and N Subunits of Complex I from Escherichia coli Indicates a Common Role in Function	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; IRON-SULFUR CLUSTERS; AEROBIC RESPIRATORY-CHAIN; QUINONE OXIDOREDUCTASE; MEMBRANE DOMAIN; NADHUBIQUINONE OXIDOREDUCTASE; TRANSMEMBRANE TOPOLOGY; PHOTOAFFINITY ANALOG; EPR CHARACTERIZATION; ELECTRON-TRANSFER	Background: The membrane arm of Complex I (NADH: ubiquinone oxidoreductase) contains three large, and closely related subunits, which are called L, M, and N in E. coli. These subunits are homologous to components of multi-subunit Na+/H+ antiporters, and so are implicated in proton translocation. Methodology/Principal Findings: Nineteen site-specific mutations were constructed at two corresponding positions in each of the three subunits. Two positions were selected in each subunit: L_K169, M_K173, N_K158 and L_Q236, M_H241, N_H224. Membrane vesicles were prepared from all of the resulting mutant strains, and were assayed for deamino-NADH oxidase activity, proton translocation, ferricyanide reductase activity, and sensitivity to capsaicin. Corresponding mutations in the three subunits were found to have very similar effects on all activities measured. In addition, the effect of adding exogenous decylubiquinone on these activities was tested. 50 mM decylubiquinone stimulated both deamino-NADH oxidase activity and proton translocation by wild type membrane vesicles, but was inhibitory towards the same activities by membrane vesicles bearing the lysine substitution at the L236/M241/N224 positions. Conclusions/Significance: The results show a close correlation with reduced activity among the corresponding mutations, and provide evidence that the L, M, and N subunits have a common role in Complex I.	[Michel, Jose; DeLeon-Rangel, Jessica; Zhu, Shaotong; Van Ree, Kalie; Vik, Steven B.] So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA	Southern Methodist University	Michel, J (corresponding author), So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA.	svik@smu.edu	zhu, shaotong/ABE-6352-2020	Vik, Steven/0000-0002-5285-015X; ZHU, SHAOTONG/0000-0002-5066-3166	Welch Foundation [N-1378]; American Heart Association, Texas [0455139Y]	Welch Foundation(The Welch Foundation); American Heart Association, Texas(American Heart Association)	This work was funded in part from grants from the Welch Foundation (N-1378; http://www.welch1.org/) and from the American Heart Association, Texas Affiliate (# 0455139Y; http://www.heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Amarneh B, 2006, BBA-BIOENERGETICS, V1757, P1557, DOI 10.1016/j.bbabio.2006.08.003; Amarneh B, 2010, J BIOENERG BIOMEMBR, V42, P511, DOI 10.1007/s10863-010-9318-3; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Birrell JA, 2010, FEBS LETT, V584, P4247, DOI 10.1016/j.febslet.2010.09.017; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Dutton PL, 1998, BBA-BIOENERGETICS, V1364, P245, DOI 10.1016/S0005-2728(98)00031-0; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Euro L, 2008, BIOCHEMISTRY-US, V47, P3185, DOI 10.1021/bi702063t; Flemming D, 2003, J BIOL CHEM, V278, P47602, DOI 10.1074/jbc.M308967200; Gong X, 2003, J BIOL CHEM, V278, P25731, DOI 10.1074/jbc.M302361200; Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668; Guenebaut V, 1998, J MOL BIOL, V276, P105, DOI 10.1006/jmbi.1997.1518; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Holt PJ, 2003, J BIOL CHEM, V278, P43114, DOI 10.1074/jbc.M308247200; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Magnitsky S, 2002, J BIOENERG BIOMEMBR, V34, P193, DOI 10.1023/A:1016083419979; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; MEINHARDT SW, 1989, BIOCHEMISTRY-US, V28, P2153, DOI 10.1021/bi00431a029; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2003, BIOCHEMISTRY-US, V42, P746, DOI 10.1021/bi0269660; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Nakamaru-Ogiso E, 2010, FEBS LETT, V584, P883, DOI 10.1016/j.febslet.2010.01.004; Ohnishi ST, 2010, BBA-BIOENERGETICS, V1797, P1891, DOI 10.1016/j.bbabio.2010.06.010; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Ohnishi T, 1998, BBA-BIOENERGETICS, V1365, P301, DOI 10.1016/S0005-2728(98)00082-6; Ohnishi T, 2010, FEBS LETT, V584, P4131, DOI 10.1016/j.febslet.2010.08.039; Pohl T, 2007, BIOCHEMISTRY-US, V46, P6588, DOI 10.1021/bi700371c; PRUSS BM, 1994, J BACTERIOL, V176, P2143; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sherwood S, 2006, BIOCHEM J, V400, P541, DOI 10.1042/BJ20060766; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WEIDNER U, 1993, J MOL BIOL, V233, P109, DOI 10.1006/jmbi.1993.1488; Yakovlev G, 2007, P NATL ACAD SCI USA, V104, P12720, DOI 10.1073/pnas.0705593104; Yano T, 2005, BIOCHEMISTRY-US, V44, P1744, DOI 10.1021/bi048132i; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	46	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17420	10.1371/journal.pone.0017420	http://dx.doi.org/10.1371/journal.pone.0017420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387012	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400073
J	Kim, ML; Sorg, I; Arrieumerlou, C				Kim, Man Lyang; Sorg, Isabel; Arrieumerlou, Cecile			Endocytosis-Independent Function of Clathrin Heavy Chain in the Control of Basal NF-kappa B Activation	PLOS ONE			English	Article							RECEPTOR TRAFFICKING; PROTEINS; CELLS; TRANSCRIPTION; INHIBITOR; PATHWAYS; MICE	Background: Nuclear factor-kappa B (NF-kappa B) is a transcription factor that regulates the transcription of genes involved in a variety of biological processes, including innate and adaptive immunity, stress responses and cell proliferation. Constitutive or excessive NF-kappa B activity has been associated with inflammatory disorders and higher risk of cancer. In contrast to the mechanisms controlling inducible activation, the regulation of basal NF-kappa B activation is not well understood. Here we test whether clathrin heavy chain (CHC) contributes to the regulation of basal NF-kappa B activity in epithelial cells. Methodology: Using RNA interference to reduce endogenous CHC expression, we found that CHC is required to prevent constitutive activation of NF-kappa B and gene expression. Immunofluorescence staining showed constitutive nuclear localization of the NF-kappa B subunit p65 in absence of stimulation after CHC knockdown. Elevated basal p65 nuclear localization is caused by constitutive phosphorylation and degradation of inhibitor of NF-kappa B alpha (I kappa B alpha) through an I kappa B kinase alpha (IKK alpha)-dependent mechanism. The role of CHC in NF-kappa B signaling is functionally relevant as constitutive expression of the proinflammatory chemokine interleukin-8 (IL-8), whose expression is regulated by NF-kappa B, was found after CHC knockdown. Disruption of clathrin-mediated endocytosis by chemical inhibition or depletion of the mu 2-subunit of the endocytosis adaptor protein AP-2, and knockdown of clathrin light chain a (CHLa), failed to induce constitutive NF-kappa B activation and IL-8 expression, showing that CHC acts on NF-kappa B independently of endocytosis and CLCa. Conclusions: We conclude that CHC functions as a built-in molecular brake that ensures a tight control of basal NF-kappa B activation and gene expression in unstimulated cells. Furthermore, our data suggest a potential link between a defect in CHC expression and chronic inflammation disorder and cancer.	[Kim, Man Lyang; Sorg, Isabel; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	cecile.arrieumerlou@unibas.ch		ARRIEUMERLOU, Cecile/0000-0002-6463-2897	Swiss National Science Foundation [3100A0-113561]; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	This work was funded by the Swiss National Science Foundation (grant 3100A0-113561 to CA; www.snf.ch) and the University of Basel (www.unibas.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adli M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009428; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; BEG AA, 1995, GENE DEV, V9, P2736, DOI 10.1101/gad.9.22.2736; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Deng JO, 2010, CANCER PREV RES, V3, P424, DOI 10.1158/1940-6207.CAPR-10-0032; Enari M, 2006, GENE DEV, V20, P1087, DOI 10.1101/gad.1381906; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; GIBSON AE, 1989, AM J PHYSIOL, V257, pC182, DOI 10.1152/ajpcell.1989.257.2.C182; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Hayden Matthew S, 2006, Cell, V127, P1286; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Jiang YP, 1999, SCIENCE, V283, P543, DOI 10.1126/science.283.5401.543; Kim ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015371; Liberatore RA, 2009, P NATL ACAD SCI USA, V106, P17823, DOI 10.1073/pnas.0905935106; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Perkins ND, 2006, ONCOGENE, V25, P6717, DOI 10.1038/sj.onc.1209937; Pilecka I, 2007, EUR J CELL BIOL, V86, P533, DOI 10.1016/j.ejcb.2007.04.004; Poupon V, 2008, P NATL ACAD SCI USA, V105, P168, DOI 10.1073/pnas.0707269105; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Prescott JL, 1998, ENDOCRINOLOGY, V139, P2111, DOI 10.1210/en.139.4.2111; Royle SJ, 2006, CELL MOL LIFE SCI, V63, P1823, DOI 10.1007/s00018-005-5587-0; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Weil R, 2003, IMMUNITY, V18, P13, DOI 10.1016/S1074-7613(02)00506-X; Yamaguchi N, 2009, CANCER SCI, V100, P1668, DOI 10.1111/j.1349-7006.2009.01228.x	33	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17158	10.1371/journal.pone.0017158	http://dx.doi.org/10.1371/journal.pone.0017158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364927	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100032
J	Cheng, WC; Chang, CW; Chen, CR; Tsai, ML; Shu, WY; Li, CY; Hsu, IC				Cheng, Wei-Chung; Chang, Cheng-Wei; Chen, Chaang-Ray; Tsai, Min-Lung; Shu, Wun-Yi; Li, Chia-Yang; Hsu, Ian C.			Identification of Reference Genes across Physiological States for qRT-PCR through Microarray Meta-Analysis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENDOGENOUS REFERENCE GENES; NORMAL HUMAN TISSUES; TIME RT-PCR; HOUSEKEEPING GENES; EXPRESSION ARRAYS; RIBOSOMAL-RNA; NORMALIZATION; CANCER; VARIABILITY	Background: The accuracy of quantitative real-time PCR (qRT-PCR) is highly dependent on reliable reference gene(s). Some housekeeping genes which are commonly used for normalization are widely recognized as inappropriate in many experimental conditions. This study aimed to identify reference genes for clinical studies through microarray meta-analysis of human clinical samples. Methodology/Principal Findings: After uniform data preprocessing and data quality control, 4,804 Affymetrix HU-133A arrays performed by clinical samples were classified into four physiological states with 13 organ/tissue types. We identified a list of reference genes for each organ/tissue types which exhibited stable expression across physiological states. Furthermore, 102 genes identified as reference gene candidates in multiple organ/tissue types were selected for further analysis. These genes have been frequently identified as housekeeping genes in previous studies, and approximately 71% of them fall into Gene Expression (GO: 0010467) category in Gene Ontology. Conclusions/Significance: Based on microarray meta-analysis of human clinical sample arrays, we identified sets of reference gene candidates for various organ/tissue types and then examined the functions of these genes. Additionally, we found that many of the reference genes are functionally related to transcription, RNA processing and translation. According to our results, researchers could select single or multiple reference gene(s) for normalization of qRT-PCR in clinical studies.	[Cheng, Wei-Chung; Chang, Cheng-Wei; Chen, Chaang-Ray; Li, Chia-Yang; Hsu, Ian C.] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan; [Tsai, Min-Lung] Natl Taiwan Sport Univ, Inst Athlet, Taichung, Taiwan; [Shu, Wun-Yi] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University	Cheng, WC (corresponding author), Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu, Taiwan.	ichsu@mx.nthu.edu.tw		LI, CHIA-YANG/0000-0001-5689-9850; Cheng, Wei-Chung/0000-0002-1229-4857; Chen, Chaang-Ray/0000-0003-2106-8699	National Science Council (NSC), Taiwan [97-2623-7-007-015-NU]	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by the National Science Council (NSC), Taiwan grant number 97-2623-7-007-015-NU (http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arcuri F, 2005, BIOL REPROD, V73, P745, DOI 10.1095/biolreprod.105.042077; Asare AL, 2009, BIOINFORMATICS, V25, P48, DOI 10.1093/bioinformatics/btn591; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Beillard E, 2003, LEUKEMIA, V17, P2474, DOI 10.1038/sj.leu.2403136; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Cheng WC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-421; Cicinnati VR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-350; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Dezso Z, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-49; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Erkens T, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-41; Espinosa E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005911; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fedrigo O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012545; Folkersen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-516; Fu LY, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-49; Gur-Dedeoglu B, 2009, ONCOL RES, V17, P353, DOI 10.3727/096504009788428460; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Larsson O, 2006, NAT BIOTECHNOL, V24, P1322, DOI 10.1038/nbt1106-1322; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Liu ZQ, 2005, MOL CELL BIOL, V25, P2819, DOI 10.1128/MCB.25.7.2819-2831.2005; Lyng MB, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-20; Maccoux LJ, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-62; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; Mieczkowski J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-104; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nguewa PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-103; Owzar K, 2008, CLIN CANCER RES, V14, P5959, DOI 10.1158/1078-0432.CCR-07-4532; Pilbrow AP, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-64; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Rizzi F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003617; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Schmid H, 2003, KIDNEY INT, V64, P356, DOI 10.1046/j.1523-1755.2003.00074.x; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Shulzhenko N, 2005, BIOCHEM BIOPH RES CO, V337, P306, DOI 10.1016/j.bbrc.2005.09.048; Silvia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-200; Su LJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-140; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Waxman S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-243; Wu YY, 2000, ACTA DERM-VENEREOL, V80, P2; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou LH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-75; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172	58	42	43	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17347	10.1371/journal.pone.0017347	http://dx.doi.org/10.1371/journal.pone.0017347			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390309	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700048
J	Van Ziffle, J; Yang, WD; Chehab, FF				Van Ziffle, Jessica; Yang, Wendy; Chehab, Farid F.			Homozygous Deletion of Six Olfactory Receptor Genes in a Subset of Individuals with Beta-Thalassemia	PLOS ONE			English	Article							GLOBIN GENE; FETAL-HEMOGLOBIN; MOLECULAR-BASIS; FAMILY; IDENTIFICATION; CLUSTER; ASSOCIATION; EXPRESSION; DIAGNOSIS; MALAYSIA	Progress in the functional studies of human olfactory receptors has been largely hampered by the lack of a reliable experimental model system. Although transgenic approaches in mice could characterize the function of individual olfactory receptors, the presence of over 300 functional genes in the human genome becomes a daunting task. Thus, the characterization of individuals with a genetic susceptibility to altered olfaction coupled with the absence of particular olfactory receptor genes will allow phenotype/genotype correlations and vindicate the function of specific olfactory receptors with their cognate ligands. We characterized a 118 kb beta-globin deletion and found that its 3' end breakpoint extends to the neighboring olfactory receptor region downstream of the beta-globin gene cluster. This deletion encompasses six contiguous olfactory receptor genes (OR51V1, OR52Z1, OR51A1P, OR52A1, OR52A5, and OR52A4) all of which are expressed in the brain. Topology analysis of the encoded proteins from these olfactory receptor genes revealed that OR52Z1, OR52A1, OR52A5, and OR52A4 are predicted to be functional receptors as they display integral characteristics of G-proteins coupled receptors. Individuals homozygous for the 118 kb beta-globin deletion are afflicted with beta-thalassemia due to a homozygous deletion of the beta-globin gene and have no alleles for the above mentioned olfactory receptors genes. This is the first example of a homozygous deletion of olfactory receptor genes in human. Although altered olfaction remains to be ascertained in these individuals, such a study can be carried out in beta-thalassemia patients from Malaysia, Indonesia and the Philippines where this mutation is common. Furthermore, OR52A1 contains a gamma-globin enhancer, which was previously shown to confer continuous expression of the fetal gamma-globin genes. Thus, the hypothesis that beta-thalassemia individuals, who are homozygous for the 118 kb deletion, may also have an exacerbation of their anemia due to the deletion of two copies of the gamma-globin enhancer element is worthy of consideration.	[Van Ziffle, Jessica; Yang, Wendy; Chehab, Farid F.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Van Ziffle, J (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	chehabf@labmed2.ucsf.edu			Department of Laboratory Medicine at the University of California, San Francisco	Department of Laboratory Medicine at the University of California, San Francisco	This work was supported by funds from the Department of Laboratory Medicine at the University of California, San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers MW, 2006, CURR NEUROL NEUROSCI, V6, P379, DOI 10.1007/s11910-996-0018-7; ANSARI KA, 1975, J CHRON DIS, V28, P493, DOI 10.1016/0021-9681(75)90058-2; Brantberg A, 2009, HAEMATOL-HEMATOL J, V94, P1157, DOI 10.3324/haematol.2009.007534; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bulger M, 2000, P NATL ACAD SCI USA, V97, P14560, DOI 10.1073/pnas.97.26.14560; ENG B, 1993, HUM MUTAT, V2, P375, DOI 10.1002/humu.1380020509; FEINGOLD EA, 1989, BLOOD, V74, P2178; Feingold EA, 1999, GENOMICS, V61, P15, DOI 10.1006/geno.1999.5935; Game L, 2003, BRIT J HAEMATOL, V123, P154, DOI 10.1046/j.1365-2141.2003.04564.x; GEORGE E, 1992, HEMOGLOBIN, V16, P51, DOI 10.3109/03630269209005676; Hasin Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000249; Hatt H, 1999, CELL MOL BIOL, V45, P285; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; KALLMANN F, 1944, AM J MENT DEFIC, V158, P203; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Ko TM, 1998, ANN HEMATOL, V77, P257, DOI 10.1007/s002770050454; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; MORTON CC, 1984, AM J HUM GENET, V36, P576; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Niimura Y, 2006, J HUM GENET, V51, P505, DOI 10.1007/s10038-006-0391-8; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Setianingsih I, 1998, MOL DIAGN, V3, P11, DOI 10.1016/S1084-8592(98)80022-2; Sherva R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-51; Sofro A S, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P221; Solovieff N, 2010, BLOOD, V115, P1815, DOI 10.1182/blood-2009-08-239517; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tahmaz F E, 2001, J Med Genet, V38, pE9, DOI 10.1136/jmg.38.3.e9; Thong M K, 1999, Hum Mutat, V13, P413, DOI 10.1002/(SICI)1098-1004(1999)13:5<413::AID-HUMU14>3.0.CO;2-H; WAYE JS, 1994, HUM GENET, V94, P530; Wee YC, 2008, COMMUNITY GENET, V11, P129, DOI 10.1159/000113874; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Zhang XH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r86	36	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17327	10.1371/journal.pone.0017327	http://dx.doi.org/10.1371/journal.pone.0017327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390308	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700046
J	Lintas, C; Guidi, F; Manzi, B; Mancini, A; Curatolo, P; Persico, AM				Lintas, Carla; Guidi, Francesco; Manzi, Barbara; Mancini, Antonio; Curatolo, Paolo; Persico, Antonio M.			Lack of Infection with XMRV or Other MLV-Related Viruses in Blood, Post-Mortem Brains and Paternal Gametes of Autistic Individuals	PLOS ONE			English	Article							CYTOMEGALOVIRUS; ASSOCIATION; CHILDREN	Background: Autistic spectrum disorder (ASD) is characterized by impaired language, communication and social skills, as well as by repetitive and stereotypic patterns of behavior. Many autistic subjects display a dysregulation of the immune system which is compatible with an unresolved viral infection with prenatal onset, potentially due to vertical viral transmission. Recently, the xenotropic murine leukemia virus-related virus (XMRV) has been implicated in chronic fatigue syndrome (CFS) and in prostate cancer by several, though not all studies. Methodology/Principal Findings: We assessed whether XMRV or other murine leukemia virus (MLV)-related viruses are involved in autistic disorder. Using nested PCR targeted to gag genomic sequences, we screened DNA samples from: (i) peripheral blood of 102 ASD patients and 97 controls, (ii) post-mortem brain samples of 20 ASD patients and 17 sex- and age-matched controls, (iii) semen samples of 11 fathers of ASD children, 25 infertile individuals and 7 fertile controls. No XMRV gag DNA sequences were detected, whereas peripheral blood samples of 3/97 (3.1%) controls were positive for MLV. Conclusions/Significance: No MLV-related virus was detected in blood, brain, and semen samples of ASD patients or fathers. Hence infection with XMRV or other MLV-related viruses is unlikely to contribute to autism pathogenesis.	[Lintas, Carla; Persico, Antonio M.] Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Rome, Italy; [Lintas, Carla; Persico, Antonio M.] IRCCS Fdn Santa Lucia, Lab Mol Psychiat & Psychiat Genet, Dept Expt Neurosci, Rome, Italy; [Guidi, Francesco] Univ Cattolica Sacro Cuore, Inst Hematol, I-00168 Rome, Italy; [Manzi, Barbara; Curatolo, Paolo] Univ Tor Vergata, Dept Child Neuropsychiat, Rome, Italy; [Mancini, Antonio] Univ Cattolica Sacro Cuore, Dept Internal Med, I-00168 Rome, Italy	University Campus Bio-Medico - Rome Italy; IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Lintas, C (corresponding author), Univ Campus Biomed, Lab Mol Psychiat & Neurogenet, Univ Campus Biomed, Rome, Italy.	A.Persico@unicampus.it	LINTAS, CARLA/AAB-6248-2022; Persico, Antonio/AAB-9504-2022; Guidi, Francesco/AAS-9209-2021	Lintas, Carla/0000-0003-1209-8554; Persico, Antonio/0000-0001-8910-4479	Italian Ministry for University, Scientific Research and Technology [2006058195, 2008BACT54]; Italian Ministry of Health [RFPS-2007-5-640174]; Fondazione Gaetano e Mafalda Luce (Milan, Italy); Autism Speaks (Princeton, N.J.); Autism Research Institute (San Diego, CA)	Italian Ministry for University, Scientific Research and Technology(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); Fondazione Gaetano e Mafalda Luce (Milan, Italy); Autism Speaks (Princeton, N.J.); Autism Research Institute (San Diego, CA)	This work was supported by the Italian Ministry for University, Scientific Research and Technology (P.R.I.N. n.2006058195 and 2008BACT54), the Italian Ministry of Health (RFPS-2007-5-640174), the Fondazione Gaetano e Mafalda Luce (Milan, Italy), a Trailblazer Award by Autism Speaks (Princeton, N.J.), and the Autism Research Institute (San Diego, CA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALOIA AL, 2010, CANC RES        1021; Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2; BARNES E, 2010, J INFECT DIS    1011; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Cornelissen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012040; DANIELSON BX, 2010, J INFECT DIS    0903; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; HENRICH TX, 2010, J INFECT DIS    1011; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Hong P, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-224; IVARSSON SA, 1990, NEUROPEDIATRICS, V21, P102, DOI 10.1055/s-2008-1071471; Jeziorski E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-63; Kawatani M, 2010, PEDIATR INT, V52, P304, DOI 10.1111/j.1442-200X.2010.03027.x; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Lintas C, 2009, MOL PSYCHIATR, V14, P705, DOI 10.1038/mp.2008.21; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Lintas C, 2010, J NEUROVIROL, V16, P141, DOI 10.3109/13550281003685839; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lopez-Pison J, 2005, REV NEUROLOGIA, V40, P733, DOI 10.33588/rn.4012.2004511; MARKOWITZ PI, 1983, J AUTISM DEV DISORD, V13, P249, DOI 10.1007/BF01531564; PERSICO AM, 2010, J NEUROVIROL; Rutter M, 2005, ACTA PAEDIATR, V94, P2, DOI 10.1080/08035250410023124; Satterfield BC, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-14; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; STUBBS EG, 1978, J AUTISM CHILD SCHIZ, V8, P37, DOI 10.1007/BF01550276; STUBBS EG, 1984, J AUTISM DEV DISORD, V14, P183, DOI 10.1007/BF02409660; Sweeten TL, 2004, J AUTISM DEV DISORD, V34, P583, DOI 10.1007/s10803-004-2552-y; Switzer WM, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-57; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van den Pol AN, 2006, TRENDS NEUROSCI, V29, P398, DOI 10.1016/j.tins.2006.06.002; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; VERHAEGH GW, 2010, PROSTATE        0928; Yamashita Y, 2003, J AUTISM DEV DISORD, V33, P455, DOI 10.1023/A:1025023131029; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	44	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16609	10.1371/journal.pone.0016609	http://dx.doi.org/10.1371/journal.pone.0016609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373179	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500013
J	Enerly, E; Steinfeld, I; Kleivi, K; Leivonen, SK; Aure, MR; Russnes, HG; Ronneberg, JA; Johnsen, H; Navon, R; Rodland, E; Makela, R; Naume, B; Perala, M; Kallioniemi, O; Kristensen, VN; Yakhini, Z; Borresen-Dale, AL				Enerly, Espen; Steinfeld, Israel; Kleivi, Kristine; Leivonen, Suvi-Katri; Aure, Miriam R.; Russnes, Hege G.; Ronneberg, Jo Anders; Johnsen, Hilde; Navon, Roy; Rodland, Einar; Makela, Rami; Naume, Bjorn; Perala, Merja; Kallioniemi, Olli; Kristensen, Vessela N.; Yakhini, Zohar; Borresen-Dale, Anne-Lise			miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors	PLOS ONE			English	Article							GENE-EXPRESSION DATA; BONE-MARROW; CANCER; MICRORNAS; SUBTYPES; MIR-150; DIFFERENTIATION; CLASSIFICATION; PROLIFERATION; PROFILES	Introduction: Few studies have performed expression profiling of both miRNA and mRNA from the same primary breast carcinomas. In this study we present and analyze data derived from expression profiling of 799 miRNAs in 101 primary human breast tumors, along with genome-wide mRNA profiles and extensive clinical information. Methods: We investigate the relationship between these molecular components, in terms of their correlation with each other and with clinical characteristics. We use a systems biology approach to examine the correlative relationship between miRNA and mRNAs using statistical enrichment methods. Results: We identify statistical significant differential expression of miRNAs between molecular intrinsic subtypes, and between samples with different levels of proliferation. Specifically, we point to miRNAs significantly associated with TP53 and ER status. We also show that several cellular processes, such as proliferation, cell adhesion and immune response, are strongly associated with certain miRNAs. We validate the role of miRNAs in regulating proliferation using high-throughput lysate-microarrays on cell lines and point to potential drivers of this process. Conclusion: This study provides a comprehensive dataset as well as methods and system-level results that jointly form a basis for further work on understanding the role of miRNA in primary breast cancer.	[Enerly, Espen; Kleivi, Kristine; Aure, Miriam R.; Russnes, Hege G.; Ronneberg, Jo Anders; Johnsen, Hilde; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway; [Steinfeld, Israel; Yakhini, Zohar] Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; [Kleivi, Kristine; Leivonen, Suvi-Katri; Makela, Rami; Perala, Merja; Kallioniemi, Olli] VTT Tech Res Ctr Finland, Turku, Finland; [Enerly, Espen; Ronneberg, Jo Anders; Kristensen, Vessela N.; Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Navon, Roy; Yakhini, Zohar] Agilent Labs, Tel Aviv, Israel; [Rodland, Einar] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Naume, Bjorn] Oslo Univ Hosp, Dept Oncol, Div Surg & Canc, Oslo, Norway; [Kallioniemi, Olli] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kristensen, Vessela N.] Inst Clin Epidemiol & Mol Biol EPIGEN, Nordbyhagen, Norway; [Russnes, Hege G.] Oslo Univ Hosp, Div Pathol, Oslo, Norway	University of Oslo; Technion Israel Institute of Technology; VTT Technical Research Center Finland; University of Oslo; Agilent Technologies; University of Oslo; University of Oslo; University of Helsinki; University of Oslo	Enerly, E (corresponding author), Radiumhosp, Oslo Univ Hosp, Inst Canc Res, Div Surg & Canc,Dept Genet, Oslo, Norway.	zohar_yakhini@agilent.com; a.l.borresen-dale@medisin.uio.no	Kallioniemi, Olli P/H-5111-2011; Leivonen, Suvi-Katri/AAK-3096-2021; Russnes, Hege Elisabeth Giercksky/N-6170-2015; Enerly, Espen/P-4666-2019	Kallioniemi, Olli P/0000-0002-3231-0332; Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891; Enerly, Espen/0000-0002-2974-2273; Kleivi Sahlberg, Kristine/0000-0002-7281-2759; Yakhini, Zohar/0000-0002-0420-5412; Leivonen, Suvi-Katri/0000-0003-3224-0757	Norwegian Research Council [183621/S10, 175240/S10]; Norwegian Cancer Society [PK80108002, PK60287003]; EMBIO, University of Oslo	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); EMBIO, University of Oslo	This study has been supported with grants from Norwegian Research Council (# 183621/S10 and # 175240/S10) and Norwegian Cancer Society (PK80108002, PK60287003). EE has a Post Doctoral Research Fellowship from EMBIO, University of Oslo. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergamaschi A, 2008, J PATHOL, V214, P357, DOI 10.1002/path.2278; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r90; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CORNEY DC, 2007, MICRORNA 34B MICRORN; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kim H, 2005, BIOINFORMATICS, V21, P187, DOI 10.1093/bioinformatics/bth499; Kutalik Z, 2008, NAT BIOTECHNOL, V26, P531, DOI 10.1038/nbt1397; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; LEIVONEN SK, 2009, ONCOGENE; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Liu WH, 2009, GASTROENTEROLOGY, V136, P683, DOI 10.1053/j.gastro.2008.10.029; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Marsit CJ, 2006, CANCER RES, V66, P10843, DOI 10.1158/0008-5472.CAN-06-1894; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Nass D, 2009, BRAIN PATHOL, V19, P375, DOI 10.1111/j.1750-3639.2008.00184.x; Naume B, 2001, CLIN CANCER RES, V7, P4122; Naume B, 2007, MOL ONCOL, V1, P160, DOI 10.1016/j.molonc.2007.03.004; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Nevins JR, 2007, NAT REV GENET, V8, P601, DOI 10.1038/nrg2137; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; SORLIE T, 2001, GENE EXPR PATTERNS, P10869; Sorlie T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-127; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; SUN Y, 2008, BREAST CANC RES TREA; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104	62	239	241	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16915	10.1371/journal.pone.0016915	http://dx.doi.org/10.1371/journal.pone.0016915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364938	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600024
J	Sala, E; Kizilkaya, Z; Yildirim, D; Ballesteros, E				Sala, Enric; Kizilkaya, Zafer; Yildirim, Derya; Ballesteros, Enric			Alien Marine Fishes Deplete Algal Biomass in the Eastern Mediterranean	PLOS ONE			English	Article							SPATIAL VARIATION; ISOTOPE; COMMUNITY; SHIFTS; REEFS	One of the most degraded states of the Mediterranean rocky infralittoral ecosystem is a barren composed solely of bare rock and patches of crustose coralline algae. Barrens are typically created by the grazing action of large sea urchin populations. In 2008 we observed extensive areas almost devoid of erect algae, where sea urchins were rare, on the Mediterranean coast of Turkey. To determine the origin of those urchin-less 'barrens', we conducted a fish exclusion experiment. We found that, in the absence of fish grazing, a well-developed algal assemblage grew within three months. Underwater fish censuses and observations suggest that two alien herbivorous fish from the Red Sea (Siganus luridus and S. rivulatus) are responsible for the creation and maintenance of these benthic communities with extremely low biomass. The shift from well-developed native algal assemblages to 'barrens' implies a dramatic decline in biogenic habitat complexity, biodiversity and biomass. A targeted Siganus fishery could help restore the macroalgal beds of the rocky infralittoral on the Turkish coast.	[Sala, Enric; Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Sala, Enric] Natl Geog Soc, Washington, DC USA; [Kizilkaya, Zafer; Yildirim, Derya] SAD EKOG, Ankara, Turkey	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); National Geographic Society	Sala, E (corresponding author), CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain.	esala@ngs.org	Ballesteros, Enric/K-6497-2012		Pew Charitable Trusts; Oak Foundation; Spanish Ministry of Science and Innovation [C5D2007-00067]	Pew Charitable Trusts; Oak Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was funded by Pew Charitable Trusts, Oak Foundation, and the GRACCIE project C5D2007-00067 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTEROS E, 1990, Scientia Marina, V54, P155; BALLESTEROS E, 1992, VEGETALS ZONACIO LIT; Bariche M, 2006, CYBIUM, V30, P41; BARICHE M, 2002, THESIS U MEDITERRANE; Ben-Tuvia A., 1964, Bulletin of the State of Israel Sea Fishing Research Station, V37, P3; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Daniel B, 2009, CYBIUM, V33, P163; Deudero S, 2004, MAR BIOL, V145, P971, DOI 10.1007/s00227-004-1374-y; GOLANI D, 2010, CIESM ATLAS EXOTIC S, V1; Guidetti P, 2007, MAR ENVIRON RES, V63, P168, DOI 10.1016/j.marenvres.2006.08.002; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; HARMELINVIVIEN ML, 1985, REV ECOL-TERRE VIE, V40, P466; Jennings S, 1997, MAR ECOL PROG SER, V146, P109, DOI 10.3354/meps146109; Lundberg B, 1999, ISR J ZOOL, V45, P127; Pinnegar JK, 2000, OECOLOGIA, V122, P399, DOI 10.1007/s004420050046; Renones O, 2002, J FISH BIOL, V61, P122, DOI [10.1006/jfbi.2002.2024, 10.1111/j.1095-8649.2002.tb01741.x]; RUITTON S, 2001, ESTUARINE COASTAL SH, V50, P217; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 1997, J EXP MAR BIOL ECOL, V212, P25, DOI 10.1016/S0022-0981(96)02745-1; Sala E, 1997, MAR ECOL PROG SER, V152, P273, DOI 10.3354/meps152273; Soltan D, 2001, MAR POLLUT BULL, V42, P59, DOI 10.1016/S0025-326X(00)00116-8; Tortonese E., 1970, Doriana, V4, P1; VERLAQUE M, 1987, C INT PARACENTROTUS	23	154	163	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17356	10.1371/journal.pone.0017356	http://dx.doi.org/10.1371/journal.pone.0017356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364943	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600042
J	Davis, JS; Darcy, CJ; Yeo, TW; Jones, C; McNeil, YR; Stephens, DP; Celermajer, DS; Anstey, NM				Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Stephens, Dianne P.; Celermajer, David S.; Anstey, Nicholas M.			Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis	PLOS ONE			English	Article							ORGAN BLOOD-FLOW; ENDOGENOUS INHIBITOR; CARDIOVASCULAR RISK; UNITED-STATES; DYSFUNCTION; ADMA; ANGIOPOIETIN-2; EPIDEMIOLOGY; THERAPIES; AMPLITUDE	Background: Plasma concentrations of asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, are raised in patients with chronic vascular disease, causing increased cardiovascular risk and endothelial dysfunction, but the role of ADMA in acute inflammatory states is less well defined. Methods and Results: In a prospective longitudinal study in 67 patients with acute sepsis and 31 controls, digital microvascular reactivity was measured by peripheral arterial tonometry and blood was collected at baseline and 2-4 days later. Plasma ADMA and L-arginine concentrations were determined by high performance liquid chromatography. Baseline plasma L-arginine: ADMA ratio was significantly lower in sepsis patients (median [IQR] 63 [45-103]) than in hospital controls (143 [123-166], p<0.0001) and correlated with microvascular reactivity (r = 0.34, R-2 = 0.12, p = 0.02). Baseline plasma ADMA was independently associated with 28-day mortality (Odds ratio [95% CI] for death in those in the highest quartile (>= 0.66 mu mol/L) = 20.8 [2.2-195.0], p = 0.008), and was independently correlated with severity of organ failure. Increase in ADMA over time correlated with increase in organ failure and decrease in microvascular reactivity. Conclusions: Impaired endothelial and microvascular function due to decreased endothelial NO bioavailability is a potential mechanism linking increased plasma ADMA with organ failure and death in sepsis.	[Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Anstey, Nicholas M.] Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT, Australia; [Davis, Joshua S.; Darcy, Christabelle J.; Yeo, Tsin W.; Jones, Catherine; McNeil, Yvette R.; Anstey, Nicholas M.] Charles Darwin Univ, Darwin, NT 0909, Australia; [Davis, Joshua S.; Yeo, Tsin W.; Anstey, Nicholas M.] Royal Darwin Hosp, Div Med, Darwin, NT, Australia; [Celermajer, David S.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Celermajer, David S.] Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; [Stephens, Dianne P.] Royal Darwin Hosp, Intens Care Unit, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of Sydney; University of Sydney	Davis, JS (corresponding author), Menzies Sch Hlth Res, Int Hlth Div, Darwin, NT, Australia.	Joshua.Davis@menzies.edu.au	Yeo, Tsin Wen/F-9505-2015; Davis, Joshua/N-2288-2013	Celermajer, David/0000-0001-7640-0439; Jones, Catherine/0000-0002-1779-6231; Davis, Joshua/0000-0001-9864-5699; Stephens, Dianne/0000-0002-3785-6828	National Health and Medical Research Council of Australia (NHMRC) [290208, 496600]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council of Australia (NHMRC Program Grants 290208, 496600; Fellowships to NMA and TWY, scholarship to JSD). The funding source played no role in the design or conduct of the study, nor in the drafting of the manuscript or the decision to submit it for publication.	Abbasi F, 2001, AM J CARDIOL, V88, P1201, DOI 10.1016/S0002-9149(01)02063-X; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bode-Boger SM, 2007, PHARMACOL THERAPEUT, V114, P295, DOI 10.1016/j.pharmthera.2007.03.002; Boger RH, 1997, CIRCULATION, V95, P2068, DOI 10.1161/01.CIR.95.8.2068; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Colonna VDG, 2007, EUR J PHARMACOL, V557, P178, DOI 10.1016/j.ejphar.2006.11.034; Colonna VDG, 2009, MED SCI MONITOR, V15, pRA91; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Davis JS, 2009, CRIT CARE, V13, DOI 10.1186/cc8055; Di Giantomasso D, 2003, CHEST, V124, P1053, DOI 10.1378/chest.124.3.1053; ENGELBERGER RP, 2010, SHOCK; Hamburg NM, 2009, TRENDS CARDIOVAS MED, V19, P6, DOI 10.1016/j.tcm.2009.03.001; Iapichino G, 2010, MINERVA ANESTESIOL, V76, P325; Jones CE, 2010, J CHROMATOGR B, V878, P8, DOI 10.1016/j.jchromb.2009.10.035; Juonala M, 2007, CIRCULATION, V116, P1367, DOI 10.1161/CIRCULATIONAHA.107.690016; KAO CC, 2008, CLIN SCI LOND; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kuvin JT, 2007, VASC MED, V12, P13, DOI 10.1177/1358863x06076227; LANG CH, 1984, AM J PHYSIOL, V246, pR331, DOI 10.1152/ajpregu.1984.246.3.R331; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; NAKAMURA T, 2009, PHARM RES; Nijveldt RJ, 2003, NEPHROL DIAL TRANSPL, V18, P2542, DOI 10.1093/ndt/gfg452; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; O'Dwyer MJ, 2006, CRIT CARE, V10, DOI 10.1186/cc5053; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Surdacki A, 1999, J CARDIOVASC PHARM, V33, P652, DOI 10.1097/00005344-199904000-00020; Trzeciak S, 2008, ACAD EMERG MED, V15, P399, DOI 10.1111/j.1553-2712.2008.00109.x; Valkonen VP, 2001, LANCET, V358, P2127, DOI 10.1016/S0140-6736(01)07184-7; VALLANCE P, 1992, LANCET, V339, P572; Vallet B, 2003, CRIT CARE, V7, P130, DOI 10.1186/cc1864; vanWandelen C, 1997, J CHROMATOGR A, V763, P11, DOI 10.1016/S0021-9673(96)00891-6; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105; Yeo TW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000868; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8; Zoccali C, 2007, NEPHROL DIAL TRANSPL, V22, P801, DOI 10.1093/ndt/gfl719	41	59	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17260	10.1371/journal.pone.0017260	http://dx.doi.org/10.1371/journal.pone.0017260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21364995	gold, Green Published, Green Submitted			2022-12-27	WOS:000287482800040
J	van Passel, MWJ; Kant, R; Zoetendal, EG; Plugge, CM; Derrien, M; Malfatti, SA; Chain, PSG; Woyke, T; Palva, A; de Vos, WM; Smidt, H				van Passel, Mark W. J.; Kant, Ravi; Zoetendal, Erwin G.; Plugge, Caroline M.; Derrien, Muriel; Malfatti, Stephanie A.; Chain, Patrick S. G.; Woyke, Tanja; Palva, Airi; de Vos, Willem M.; Smidt, Hauke			The Genome of Akkermansia muciniphila, a Dedicated Intestinal Mucin Degrader, and Its Use in Exploring Intestinal Metagenomes	PLOS ONE			English	Article							GUT MICROBIOTA; DIVERSITY; BACTERIA; TOOL; PROKARYOTES; RESISTANCE; SELECTION; SEQUENCE; INFANTS; TRACT	Background: The human gastrointestinal tract contains a complex community of microbes, fulfilling important health-promoting functions. However, this vast complexity of species hampers the assignment of responsible organisms to these functions. Recently, Akkermansia muciniphila, a new species from the deeply branched phylum Verrucomicrobia, was isolated from the human intestinal tract based on its capacity to efficiently use mucus as a carbon and nitrogen source. This anaerobic resident is associated with the protective mucus lining of the intestines. Methodology/Principal Findings: In order to uncover the functional potential of A. muciniphila, its genome was sequenced and annotated. It was found to contain numerous candidate mucinase-encoding genes, but lacking genes encoding canonical mucus-binding domains. Numerous phage-associated sequences found throughout the genome indicate that viruses have played an important part in the evolution of this species. Furthermore, we mined 37 GI tract metagenomes for the presence, and genetic diversity of Akkermansia sequences. Out of 37, eleven contained 16S ribosomal RNA gene sequences that are > 95% identical to that of A. muciniphila. In addition, these libraries were found to contain large amounts of Akkermansia DNA based on average nucleotide identity scores, which indicated in one subject co-colonization by different Akkermansia phylotypes. An additional 12 libraries also contained Akkermansia sequences, making a total of similar to 16 Mbp of new Akkermansia pangenomic DNA. The relative abundance of Akkermansia DNA varied between,0.01% to nearly 4% of the assembled metagenomic reads. Finally, by testing a large collection of full length 16S sequences, we find at least eight different representative species in the genus Akkermansia. Conclusions/Significance: These large repositories allow us to further mine for genetic heterogeneity and species diversity in the genus Akkermansia, providing novel insight towards the functionality of this abundant inhabitant of the human intestinal tract.	[van Passel, Mark W. J.; Zoetendal, Erwin G.; Plugge, Caroline M.; Derrien, Muriel; de Vos, Willem M.; Smidt, Hauke] Wageningen Univ, Microbiol Lab, Wageningen, Netherlands; [Kant, Ravi; Palva, Airi; de Vos, Willem M.] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Malfatti, Stephanie A.; Chain, Patrick S. G.; Woyke, Tanja] DOE Joint Genome Inst, Walnut Creek, CA USA; [Malfatti, Stephanie A.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Chain, Patrick S. G.] Los Alamos Natl Lab, Los Alamos, NM USA	Wageningen University & Research; University of Helsinki; United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	van Passel, MWJ (corresponding author), Wageningen Univ, Microbiol Lab, Wageningen, Netherlands.	mark.vanpassel@wur.nl	Derrien, Muriel/AAS-6845-2021; van Passel, Mark WJ/K-5698-2012; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Kant, Ravi/F-7025-2013; Kant, Ravi/AAF-8495-2021; Smidt, Hauke/D-7054-2014	Derrien, Muriel/0000-0001-8841-9153; Chain, Patrick/0000-0003-3949-3634; Kant, Ravi/0000-0003-3878-9775; Kant, Ravi/0000-0003-3878-9775; Smidt, Hauke/0000-0002-6138-5026; Malfatti, Stephanie/0000-0003-4225-9857	Netherlands Organization for Scientific Research (NWO); Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland(Academy of Finland); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	MWJvP and WMdV are funded by the Netherlands Organization for Scientific Research (NWO) via a VENI and SPINOZA grant. RK was supported by the Center of Excellence in Microbial Food Safety Research (MiFoSa), Academy of Finland. The work conducted by the U. S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2006, PLOS GENET, V2, P224, DOI 10.1371/journal.pgen.0020022; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boekhorst J, 2006, MICROBIOL-SGM, V152, P273, DOI 10.1099/mic.0.28415-0; Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haft DH, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-29; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Klaassens ES, 2009, APPL ENVIRON MICROB, V75, P2668, DOI 10.1128/AEM.02492-08; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; MELLO LV, 2010, FEBS LETT; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; OPHIR T, 1994, APPL ENVIRON MICROB, V60, P740, DOI 10.1128/AEM.60.2.740-745.1994; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; PNG CW, 2010, AM J GASTROENTEROL; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Saunders NJ, 2000, MOL MICROBIOL, V37, P207, DOI 10.1046/j.1365-2958.2000.02000.x; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van Passel MWJ, 2007, TRENDS GENET, V23, P601, DOI 10.1016/j.tig.2007.08.017; van Passel MWJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-596; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603	45	237	380	10	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e16876	10.1371/journal.pone.0016876	http://dx.doi.org/10.1371/journal.pone.0016876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390229	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200007
J	Williams, RJ				Williams, Richard J.			Biology, Methodology or Chance? The Degree Distributions of Bipartite Ecological Networks	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; FOOD-WEB STRUCTURE; ASYMMETRIC SPECIALIZATION; COEVOLUTIONARY NETWORKS; NULL MODEL; POLLINATION; PATTERNS; CONNECTANCE; ENTROPY	The distribution of the number of links per species, or degree distribution, is widely used as a summary of the topology of complex networks. Degree distributions have been studied in a range of ecological networks, including both mutualistic bipartite networks of plants and pollinators or seed dispersers and antagonistic bipartite networks of plants and their consumers. The shape of a degree distribution, for example whether it follows an exponential or power-law form, is typically taken to be indicative of the processes structuring the network. The skewed degree distributions of bipartite mutualistic and antagonistic networks are usually assumed to show that ecological or co-evolutionary processes constrain the relative numbers of specialists and generalists in the network. I show that a simple null model based on the principle of maximum entropy cannot be rejected as a model for the degree distributions in most of the 115 bipartite ecological networks tested here. The model requires knowledge of the number of nodes and links in the network, but needs no other ecological information. The model cannot be rejected for 159 (69%) of the 230 degree distributions of the 115 networks tested. It performed equally well on the plant and animal degree distributions, and cannot be rejected for 81 (70%) of the 115 plant distributions and 78 (68%) of the animal distributions. There are consistent differences between the degree distributions of mutualistic and antagonistic networks, suggesting that different processes are constraining these two classes of networks. Fit to the MaxEnt null model is consistently poor among the largest mutualistic networks. Potential ecological and methodological explanations for deviations from the model suggest that spatial and temporal heterogeneity are important drivers of the structure of these large networks.	Microsoft Res, Cambridge, England	Microsoft	Williams, RJ (corresponding author), Microsoft Res, Cambridge, England.	ricw@microsoft.com	Williams, Richard J/B-8344-2011	Williams, Richard J/0000-0001-8847-3213				Alarcon R, 2008, OIKOS, V117, P1796, DOI 10.1111/j.0030-1299.2008.16987.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Camacho J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228102; Clements F. E., 1916, PLANT SUCCESSION ANA; COHEN JE, 1993, ECOLOGY, V74, P252, DOI 10.2307/1939520; COHEN JE, 1978, FOOD WEBS NICHE SPAC; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; DEWAR R, 2008, J THEORETICAL BIOL; Diamond J.M., 1975, P342; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Dunne JA, 2006, SFI S SCI C, P27; Elton C., 1927, ANIMAL ECOLOGY; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Haegeman B, 2010, AM NAT, V175, pE74, DOI 10.1086/650718; Harte J, 2008, ECOLOGY, V89, P2700, DOI 10.1890/07-1369.1; JAYNES ET, 1957, PHYS REV, V106, P620, DOI 10.1103/PhysRev.106.620; JORDANO P, 1987, AM NAT, V129, P657, DOI 10.1086/284665; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Laird S, 2006, EUROPHYS LETT, V76, P710, DOI 10.1209/epl/i2006-10319-x; Martinez ND, 1998, COM ECO SYS, P207; May RM, 2006, TRENDS ECOL EVOL, V21, P394, DOI 10.1016/j.tree.2006.03.013; MCMULLEN CK, 1993, PAN-PAC ENTOMOL, V69, P95; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Morales JM, 2008, OIKOS, V117, P1362, DOI 10.1111/j.0030-1299.2008.16737.x; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Okuyama T, 2008, ECOL COMPLEX, V5, P59, DOI 10.1016/j.ecocom.2007.06.006; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Petanidou T., 1993, Biodiversity Letters, V1, P9, DOI 10.2307/2999643; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Philipp M, 2006, ECOGRAPHY, V29, P531, DOI 10.1111/j.0906-7590.2006.04546.x; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Rossberg AG, 2006, J THEOR BIOL, V238, P401, DOI 10.1016/j.jtbi.2005.05.025; Santamaria L, 2007, PLOS BIOL, V5, P354, DOI 10.1371/journal.pbio.0050031; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Stang M, 2007, OECOLOGIA, V151, P442, DOI 10.1007/s00442-006-0585-y; Storch D, 2008, ECOL LETT, V11, P771, DOI 10.1111/j.1461-0248.2008.01206.x; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vazquez DP, 2003, ECOLOGY, V84, P2493, DOI 10.1890/02-0587; Vermaat JE, 2009, ECOLOGY, V90, P278, DOI 10.1890/07-0978.1; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; Williams RJ, 2010, THEOR ECOL-NETH, V3, P45, DOI 10.1007/s12080-009-0052-6	51	32	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17645	10.1371/journal.pone.0017645	http://dx.doi.org/10.1371/journal.pone.0017645			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390231	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200034
J	Barone-Adesi, F; Gasparrini, A; Vizzini, L; Merletti, F; Richiardi, L				Barone-Adesi, Francesco; Gasparrini, Antonio; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo			Effects of Italian Smoking Regulation on Rates of Hospital Admission for Acute Coronary Events: A Country-Wide Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FREE LEGISLATION; HEART-DISEASE; BAN; TIME; ACT	Background: Several studies have reported a reduction in acute coronary events (ACEs) in the general population after the enforcement of smoking regulations, although there is uncertainty concerning the magnitude of the effect of such interventions. We conducted a country-wide evaluation of the health effects of the introduction of a smoking ban in public places, using data on hospital admissions for ACEs from the Italian population after the implementation of a national smoking regulation in January 2005. Methods and Findings: Rates of admission for ACEs in the 20 Italian regions from January 2002 to November 2006 were analysed using mixed-effect regression models that allowed for long-term trends and seasonality. Standard methods for interrupted time-series were adopted to assess the immediate and gradual effects of the smoking ban. Effect modification by age was investigated, with the assumption that exposure to passive smoking in public places would be greater among young people. In total, 936,519 hospital admissions for ACEs occurred in the Italian population during the study period. A 4% reduction in hospital admissions for ACEs among persons aged less than 70 years was evident after the introduction of the ban (Rate Ratio [RR], 0.96; 95% Confidence Interval [CI], 0.95-0.98). No effect was found among persons aged at least 70 years (RR 1.00; 95% CI 0.99-1.02). Effect modification by age was further suggested by analyses using narrower age categories. Conclusions: Smoke-free policies can constitute a simple and inexpensive intervention for the prevention of cardiovascular diseases and thus should be included in prevention programmes.	[Barone-Adesi, Francesco; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Canc Epidemiol Unit, CeRMS, Turin, Italy; [Barone-Adesi, Francesco; Vizzini, Loredana; Merletti, Franco; Richiardi, Lorenzo] Univ Turin, CPO Piemonte, Turin, Italy; [Gasparrini, Antonio] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England	University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Turin; University of London; London School of Hygiene & Tropical Medicine	Barone-Adesi, F (corresponding author), Univ Turin, Canc Epidemiol Unit, CeRMS, Turin, Italy.	fbaroneadesi@yahoo.it	Gasparrini, Antonio/F-7627-2012; Barone-Adesi, Francesco/ABG-1580-2020; richiardi, lorenzo/J-3480-2018	Gasparrini, Antonio/0000-0002-2271-3568; Barone-Adesi, Francesco/0000-0003-1550-436X; richiardi, lorenzo/0000-0003-0316-9402	Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS); Regione Piemonte	Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS)(Compagnia di San Paolo); Regione Piemonte(Regione Piemonte)	This work was partially supported by the Compagnia San Paolo/Fondazione Internazionale in Medicina Sperimentale (FIRMS) and the Regione Piemonte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett R, 2009, AUST NZ J PUBL HEAL, V33, P515, DOI 10.1111/j.1753-6405.2009.00446.x; Barnoya J, 2005, CIRCULATION, V112, P456, DOI 10.1161/CIRCULATIONAHA.105.554741; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Brocco S, 2006, J CARDIOVASC MED, V7, P45, DOI 10.2459/01.JCM.0000199787.45940.68; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; CHENG TO, 2010, INT J CARDI IN PRESS; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; *EPA CAL OFF ENV H, HLTH EFF ASS ENV TOB; Gallus S, 2006, ANN ONCOL, V17, P346, DOI 10.1093/annonc/mdj070; Gasparrini A, 2009, EUR J EPIDEMIOL, V24, P597, DOI 10.1007/s10654-009-9377-0; Gorini G, 2007, ANN ONCOL, V18, P1620, DOI 10.1093/annonc/mdm279; Gorini G, 2007, PREV MED, V45, P123, DOI 10.1016/j.ypmed.2007.06.019; Hunsberger S, 2002, BIOSTATISTICS, V3, P289, DOI 10.1093/biostatistics/3.2.289; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Mackay D, 2010, NEW ENGL J MED, V363, P1139, DOI 10.1056/NEJMoa1002861; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Palmieri L, 2010, AM J PUBLIC HEALTH, V100, P684, DOI 10.2105/AJPH.2008.147173; Panagiotakos DB, 2004, INT J CARDIOL, V94, P229, DOI 10.1016/j.ijcard.2003.04.050; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; *PRACT MAN INF COR, 1993, INT CLASS DIS CLIN M; Richiardi L, 2009, PREV MED, V48, P167, DOI 10.1016/j.ypmed.2008.11.013; Salomaa V, 2005, EUR HEART J, V26, P1719, DOI 10.1093/eurheartj/ehi185; SCHULZE A, 2006, SOZIALE UNTERSCHIEDE; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Twose J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-194; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x	31	50	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17419	10.1371/journal.pone.0017419	http://dx.doi.org/10.1371/journal.pone.0017419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729FF	21399685	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000287933300022
J	Tajino, K; Hosokawa, H; Maegawa, S; Matsumura, K; Dhaka, A; Kobayashi, S				Tajino, Koji; Hosokawa, Hiroshi; Maegawa, Shingo; Matsumura, Kiyoshi; Dhaka, Ajay; Kobayashi, Shigeo			Cooling-Sensitive TRPM8 Is Thermostat of Skin Temperature against Cooling	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; COLD SENSITIVITY; TRPA1 CHANNELS; MENTHOL; NEURONS; MICE; THERMOREGULATION; IDENTIFICATION; HYPOTHALAMUS; SENSATION	We have shown that cutaneous cooling-sensitive receptors can work as thermostats of skin temperature against cooling. However, molecule of the thermostat is not known. Here, we studied whether cooling-sensitive TRPM8 channels act as thermostats. TRPM8 in HEK293 cells generated output (y) when temperature (T) was below threshold of 28.4 degrees C. Output (y) is given by two equations: At T > 28.4 degrees C, y=0; At T < 28.4 degrees C, y = -k(T -28.4 degrees C). These equations show that TRPM8 is directional comparator to elicits output (y) depending on negative value of thermal difference (Delta T = T -28.4 degrees C). If negative Delta T-dependent output of TRPM8 in the skin induces responses to warm the skin for minimizing Delta T recursively, TRPM8 acts as thermostats against cooling. With TRPM8-deficient mice, we explored whether TRPM8 induces responses to warm the skin against cooling. In behavioral regulation, when room temperature was 10 degrees C, TRPM8 induced behavior to move to heated floor (35 degrees C) for warming the sole skin. In autonomic regulation, TRPM8 induced activities of thermogenic brown adipose tissue (BAT) against cooling. When menthol was applied to the whole trunk skin at neutral room temperature (27 degrees C), TRPM8 induced a rise in core temperature, which warmed the trunk skin slightly. In contrast, when room was cooled from 27 to 10 degrees C, TRPM8 induced a small rise in core temperature, but skin temperature was severely reduced in both TRPM8-deficient and wild-type mice by a large heat leak to the surroundings. This shows that TRPM8-driven endothermic system is less effective for maintenance of skin temperature against cooling. In conclusion, we found that TRPM8 is molecule of thermostat of skin temperature against cooling.	[Tajino, Koji; Hosokawa, Hiroshi; Maegawa, Shingo; Kobayashi, Shigeo] Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Kyoto, Japan; [Matsumura, Kiyoshi] Osaka Inst Technol, Fac Informat Sci & Technol, Osaka 535, Japan; [Dhaka, Ajay] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	Kyoto University; Osaka Institute of Technology; University of Washington; University of Washington Seattle	Tajino, K (corresponding author), Kyoto Univ, Dept Intelligence Sci & Technol, Grad Sch Informat, Kyoto, Japan.	skoba@i.kyoto-u.ac.jp	Maegawa, Shingo/AAB-3924-2021		Ministry of Education, Science, Sports and Culture and Technology; Grants-in-Aid for Scientific Research [22687016] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Ministry of Education, Science, Sports and Culture and Technology Grant-in-Aid for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Abe J, 2005, MOL BRAIN RES, V136, P91, DOI 10.1016/j.molbrainres.2005.01.013; Adrian E.D., 1928, BASIS SENSATION; Alberts B, 2008, MOL BIOL CELL; Almeida MC, 2006, EUR J NEUROSCI, V23, P3359, DOI 10.1111/j.1460-9568.2006.04854.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; BENZINGER TH, 1969, PHYSIOL REV, V49, P671, DOI 10.1152/physrev.1969.49.4.671; Bligh J, 1973, TEMPERATURE REGULATI; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; GONZALEZ RR, 1971, J APPL PHYSIOL, V31, P728, DOI 10.1152/jappl.1971.31.5.728; Green BG, 2007, BEHAV BRAIN RES, V176, P284, DOI 10.1016/j.bbr.2006.10.013; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; HARDY JD, 1961, PHYSIOL REV, V41, P521, DOI 10.1152/physrev.1961.41.3.521; HENSEL H, 1973, PHYSIOL REV, V53, P948, DOI 10.1152/physrev.1973.53.4.948; Hensel H, 1981, THERMORECEPTION TEMP; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; KOBAYASHI S, 1989, PROG NEUROBIOL, V32, P103, DOI 10.1016/0301-0082(89)90012-9; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Mazzarello P, 1999, NAT CELL BIOL, V1, pE13, DOI 10.1038/8964; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MITCHELL D, 1970, PFLUG ARCH EUR J PHY, V321, P293, DOI 10.1007/BF00588644; Nakamura K, 2008, NAT NEUROSCI, V11, P62, DOI 10.1038/nn2027; Nakamura K, 2007, AM J PHYSIOL-REG I, V292, pR127, DOI 10.1152/ajpregu.00427.2006; NAKAYAMA T, 1961, SCIENCE, V134, P560, DOI 10.1126/science.134.3478.560; Okazawa M, 2002, J NEUROSCI, V22, P3994, DOI 10.1523/JNEUROSCI.22-10-03994.2002; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Penfield W, 1950, CEREBRAL CORTEX MAN; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; SATINOFF E, 1978, SCIENCE, V201, P16, DOI 10.1126/science.351802; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Sherkheli MA, 2010, J PHARM PHARM SCI, V13, P242, DOI 10.18433/J3N88N; Tajino K, 2007, AM J PHYSIOL-REG I, V293, pR2128, DOI 10.1152/ajpregu.00377.2007; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Zhang JF, 2006, NATURE, V439, P340, DOI 10.1038/nature04368; ZOTTERMAN Y, 1936, SCANDINAVICA ARCHIV, V75, P105	41	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17504	10.1371/journal.pone.0017504	http://dx.doi.org/10.1371/journal.pone.0017504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407809	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300030
J	Sam, LT; Lipson, D; Raz, T; Cao, XH; Thompson, J; Milos, PM; Robinson, D; Chinnaiyan, AM; Kumar-Sinha, C; Maher, CA				Sam, Lee T.; Lipson, Doron; Raz, Tal; Cao, Xuhong; Thompson, John; Milos, Patrice M.; Robinson, Dan; Chinnaiyan, Arul M.; Kumar-Sinha, Chandan; Maher, Christopher A.			A Comparison of Single Molecule and Amplification Based Sequencing of Cancer Transcriptomes	PLOS ONE			English	Article							PROSTATE-CANCER; RNA-SEQ; REARRANGEMENTS; MELANOMA; GENOME; MODEL	The second wave of next generation sequencing technologies, referred to as single-molecule sequencing (SMS), carries the promise of profiling samples directly without employing polymerase chain reaction steps used by amplification-based sequencing (AS) methods. To examine the merits of both technologies, we examine mRNA sequencing results from single-molecule and amplification-based sequencing in a set of human cancer cell lines and tissues. We observe a characteristic coverage bias towards high abundance transcripts in amplification-based sequencing. A larger fraction of AS reads cover highly expressed genes, such as those associated with translational processes and housekeeping genes, resulting in relatively lower coverage of genes at low and mid-level abundance. In contrast, the coverage of high abundance transcripts plateaus off using SMS. Consequently, SMS is able to sequence lower-abundance transcripts more thoroughly, including some that are undetected by AS methods; however, these include many more mapping artifacts. A better understanding of the technical and analytical factors introducing platform specific biases in high throughput transcriptome sequencing applications will be critical in cross platform meta-analytic studies.	[Sam, Lee T.; Cao, Xuhong; Robinson, Dan; Chinnaiyan, Arul M.; Kumar-Sinha, Chandan; Maher, Christopher A.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Sam, Lee T.; Maher, Christopher A.] Univ Michigan, Ctr Computat Med & Biol, Ann Arbor, MI 48109 USA; [Sam, Lee T.] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA; [Lipson, Doron; Raz, Tal; Thompson, John; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA USA; [Cao, Xuhong; Robinson, Dan; Chinnaiyan, Arul M.; Kumar-Sinha, Chandan; Maher, Christopher A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Chinnaiyan, Arul M.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Chinnaiyan, Arul M.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sam, LT (corresponding author), Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu; chakumar@umich.edu; chrmaher@umich.edu		Thompson, John/0000-0001-8568-3311; Kumar, Chandan/0000-0002-8696-3400	Doris Duke Charitable Foundation; Burroughs Welcome Foundation; Prostate Cancer Foundation; American Association of Cancer Research; Canary Foundation; American Cancer Society; University of Michigan	Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Burroughs Welcome Foundation(Burroughs Wellcome Fund); Prostate Cancer Foundation; American Association of Cancer Research; Canary Foundation; American Cancer Society(American Cancer Society); University of Michigan(University of Michigan System)	AMC is supported by the Doris Duke Charitable Foundation Clinical Scientist Award, a Burroughs Welcome Foundation Award in Clinical Translational Research, and the Prostate Cancer Foundation. AMC is an American Cancer Society Research Professor. CAM currently derives support from the American Association of Cancer Research Amgen Fellowship in Clinical/Translational Research, the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship, and a Prostate Cancer Foundation Young Investigator Award. LTS is supported by the University of Michigan Bioinformatics Training Program. DL, TR, JT, and PMM are employees of Helicos BioSciences Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU KF, 2010, NUCL ACIDS RES; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Korenchuk S, 2001, IN VIVO, V15, P163; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Maher CA, 2009, P NATL ACAD SCI USA, V106, P12353, DOI 10.1073/pnas.0904720106; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mamanova L, 2010, NAT METHODS, V7, P130, DOI [10.1038/NMETH.1417, 10.1038/nmeth.1417]; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Ozsolak F, 2009, NATURE, V461, P814, DOI 10.1038/nature08390; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; R Core Team, 2020, R LANG ENV STAT COMP; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuch BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009317	31	36	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17305	10.1371/journal.pone.0017305	http://dx.doi.org/10.1371/journal.pone.0017305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390249	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100012
J	Tanton, C; Weiss, HA; Le Goff, J; Changalucha, J; Rusizoka, M; Baisley, K; Everett, D; Ross, DA; Belec, L; Hayes, RJ; Watson-Jones, D				Tanton, Clare; Weiss, Helen A.; Le Goff, Jerome; Changalucha, John; Rusizoka, Mary; Baisley, Kathy; Everett, Dean; Ross, David A.; Belec, Laurent; Hayes, Richard J.; Watson-Jones, Deborah			Correlates of HIV-1 Genital Shedding in Tanzanian Women	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; BACTERIAL VAGINOSIS; INFECTED WOMEN; RISK-FACTORS; CERVICOVAGINAL SECRETIONS; HORMONAL CONTRACEPTION; INTERVENTION TRIALS	Background: Understanding the correlates of HIV shedding is important to inform strategies to reduce HIV infectiousness. We examined correlates of genital HIV-1 RNA in women who were seropositive for both herpes simplex virus (HSV)-2 and HIV-1 and who were enrolled in a randomised controlled trial of HSV suppressive therapy (aciclovir 400 mg b.i.d vs. placebo) in Tanzania. Methodology: Samples, including a cervico-vaginal lavage, were collected and tested for genital HIV-1 and HSV and reproductive tract infections (RTIs) at randomisation and 6, 12 and 24 months follow-up. Data from all women at randomisation and women in the placebo arm during follow-up were analysed using generalised estimating equations to determine the correlates of cervico-vaginal HIV-1 RNA detection and load. Principal Findings: Cervico-vaginal HIV-1 RNA was detected at 52.0% of 971 visits among 482 women, and was independently associated with plasma viral load, presence of genital ulcers, pregnancy, bloody cervical or vaginal discharge, abnormal vaginal discharge, cervical ectopy, Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, an intermediate bacterial vaginosis score and HSV DNA detection. Similar factors were associated with genital HIV-1 RNA load. Conclusions: RTIs were associated with increased presence and quantity of genital HIV-1 RNA in this population. These results highlight the importance of integrating effective RTI treatment into HIV care services.	[Tanton, Clare; Weiss, Helen A.; Baisley, Kathy; Everett, Dean; Ross, David A.; Hayes, Richard J.; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England; [Tanton, Clare; Changalucha, John; Baisley, Kathy] NIMR, Natl Inst Med Res NIMR Mwanza Ctr, Mwanza, Tanzania; [Le Goff, Jerome] Hop St Louis, Microbiol Lab, Paris, France; [Rusizoka, Mary] AMREF, African Med & Res Fdn AMREF Lake Zone Off, Mwanza, Tanzania; [Everett, Dean; Watson-Jones, Deborah] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England; [Belec, Laurent] Hop Europeen Georges Pompidou, Virol Lab, Paris, France; [Belec, Laurent] Univ Paris 05, Paris, France	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; African Medical & Research Foundation (AMREF); University of London; London School of Hygiene & Tropical Medicine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tanton, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	c.tanton@ucl.ac.uk	le goff, jerome/B-3447-2016; weiss, helen/ABC-7823-2021; LeGoff, jerome/AAP-7880-2021	le goff, jerome/0000-0001-7111-1865; weiss, helen/0000-0003-3547-7936; Everett, Dean/0000-0002-8458-6779; Tanton, Clare/0000-0002-4612-1858; Hayes, Richard/0000-0002-1729-9892	Wellcome Trust [066688]; UK Medical Research Council [G0400456]; UK Department for International Development; Medical Research Council [G0700837, G0400456, G0901756] Funding Source: researchfish; MRC [G0700837, G0400456, G0901756] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding for the study was provided by the Wellcome Trust (066688, www.wellcome.ac.uk), the UK Medical Research Council (G0400456, www.mrc.ac.uk) and the UK Department for International Development (www.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Harthi L, 1999, J ACQ IMMUN DEF SYND, V21, P194, DOI 10.1097/00126334-199907010-00003; Baeten JM, 2008, J INFECT DIS, V198, P1804, DOI 10.1086/593214; Baisley K, 2009, SEX TRANSM INFECT, V85, P370, DOI 10.1136/sti.2008.035543; BELEC L, 1995, CLIN DIAGN LAB IMMUN, V2, P57; Benki S, 2004, J INFECT DIS, V189, P2192, DOI 10.1086/421298; CELUM C, 2002, NEW ENGL J MED, V362, P427; CLARK RA, 2007, SEX TRANSM DIS; CLEMETSON DBA, 1993, JAMA-J AM MED ASSOC, V269, P2860, DOI 10.1001/jama.269.22.2860; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Cu-Uvin S, 2001, CLIN INFECT DIS, V33, P894, DOI 10.1086/322613; Delany S, 2009, AIDS, V23, P461, DOI 10.1097/QAD.0b013e32831db217; Dunne EF, 2008, JAIDS-J ACQ IMM DEF, V49, P77, DOI 10.1097/QAI.0b013e3181831832; Ghys PD, 1997, AIDS, V11, pF85, DOI 10.1097/00002030-199712000-00001; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Hashemi FB, 1999, J INFECT DIS, V179, P924, DOI 10.1086/314674; HAYES R, AIDS S4, V24, pS15; HENIN Y, 1993, J ACQ IMMUN DEF SYND, V6, P72; Ison CA, 2002, SEX TRANSM INFECT, V78, P413, DOI 10.1136/sti.78.6.413; JOHNSON LF, 2008, SEX TRANSM DIS; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kessler HH, 2000, J CLIN MICROBIOL, V38, P2638, DOI 10.1128/JCM.38.7.2638-2642.2000; Korenromp EL, 2005, J INFECT DIS, V191, pS168, DOI 10.1086/425274; MAYAUD P, 2008, SEX TRANSM INFECT; Mayaud P, 2009, J INFECT DIS, V200, P216, DOI 10.1086/599991; McClelland RS, 2001, AIDS, V15, P105, DOI 10.1097/00002030-200101050-00015; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Nagot N, 2007, NEW ENGL J MED, V356, P790, DOI 10.1056/NEJMoa062607; Ouedraogo A, 2006, AIDS, V20, P2305, DOI 10.1097/QAD.0b013e328010238d; PAZBAILEY G, 2007, IMPACT EPISODIC ACYC; PHIRI S, SEX TRANSM INFECT; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Seck K, 2001, SEX TRANSM INFECT, V77, P190, DOI 10.1136/sti.77.3.190; Sha BE, 2005, J INFECT DIS, V191, P25, DOI 10.1086/426394; TANTON C, J INFECT DIS, V201, P1285; Wang CC, 2004, AIDS, V18, P205, DOI 10.1097/00002030-200401230-00009; Wang CC, 2001, J INFECT DIS, V183, P1017, DOI 10.1086/319287; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; White RG, 2004, JAIDS-J ACQ IMM DEF, V37, P1500, DOI 10.1097/01.qai.0000127062.94627.31; Wolday D, 2004, AIDS, V18, P781, DOI 10.1097/00002030-200403260-00009; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	46	46	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17480	10.1371/journal.pone.0017480	http://dx.doi.org/10.1371/journal.pone.0017480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390251	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000287932100018
J	Jin, JS; Kwon, SO; Moon, DC; Gurung, M; Lee, JH; Kim, SI; Lee, JC				Jin, Jong Sook; Kwon, Sang-Oh; Moon, Dong Chan; Gurung, Mamata; Lee, Jung Hwa; Kim, Seung Il; Lee, Je Chul			Acinetobacter baumannii Secretes Cytotoxic Outer Membrane Protein A via Outer Membrane Vesicles	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEOMICS; PATHOGEN; ACTIVATION; VIRULENCE; BIOFILM; EXPORT; TOXIN; CELLS	Acinetobacter baumannii is an important nosocomial pathogen that causes a high morbidity and mortality rate in infected patients, but pathogenic mechanisms of this microorganism regarding the secretion and delivery of virulence factors to host cells have not been characterized. Gram-negative bacteria naturally secrete outer membrane vesicles (OMVs) that play a role in the delivery of virulence factors to host cells. A. baumannii has been shown to secrete OMVs when cultured in vitro, but the role of OMVs in A. baumannii pathogenesis is not well elucidated. In the present study, we evaluated the secretion and delivery of virulence factors of A. baumannii to host cells via the OMVs and assessed the cytotoxic activity of outer membrane protein A (AbOmpA) packaged in the OMVs. A. baumannii ATCC 19606(T) secreted OMVs during in vivo infection as well as in vitro cultures. Potential virulence factors, including AbOmpA and tissue-degrading enzymes, were associated with A. baumannii OMVs. A. baumannii OMVs interacted with lipid rafts in the plasma membranes and then delivered virulence factors to host cells. The OMVs from A. baumannii ATCC 19606(T) induced apoptosis of host cells, whereas this effect was not detected in the OMVs from the DompA mutant, thereby reflecting AbOmpA-dependent host cell death. The N-terminal region of AbOmpA(22-170) was responsible for host cell death. In conclusion, the OMV-mediated delivery of virulence factors to host cells may well contribute to pathogenesis during A. baumannii infection.	[Jin, Jong Sook; Moon, Dong Chan; Gurung, Mamata; Lee, Jung Hwa; Lee, Je Chul] Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea; [Kwon, Sang-Oh; Kim, Seung Il] Korea Basic Sci Inst, Proteome Res Team, Taejon, South Korea	Kyungpook National University; Korea Basic Science Institute (KBSI)	Jin, JS (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Microbiol, Taegu, South Korea.	ksi@kbsi.re.kr; leejc@knu.ac.kr			Korea government (MEST) [R01-2008-000-11083-0]; Korea Basic Science Institute [K-MeP T30100]	Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Basic Science Institute	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) (Project No. R01-2008-000-11083-0). SI Kim & SO Kwon were supported by a grant (K-MeP T30100) from the Korea Basic Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bauman SJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-26; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, CELL MICROBIOL, V10, P309, DOI 10.1111/j.1462-5822.2007.01041.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Falagas ME, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-24; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Galka F, 2008, INFECT IMMUN, V76, P1825, DOI 10.1128/IAI.01396-07; Gordon NC, 2010, INT J ANTIMICROB AG, V35, P219, DOI 10.1016/j.ijantimicag.2009.10.024; Horstman AL, 2000, J BIOL CHEM, V275, P12489, DOI 10.1074/jbc.275.17.12489; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Keenan JI, 2008, INNATE IMMUN, V14, P279, DOI 10.1177/1753425908096857; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; KONDO K, 1993, MICROBIOL IMMUNOL, V37, P149, DOI 10.1111/j.1348-0421.1993.tb03192.x; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Kwon SO, 2009, FEMS MICROBIOL LETT, V297, P150, DOI 10.1111/j.1574-6968.2009.01669.x; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee HW, 2008, CLIN MICROBIOL INFEC, V14, P49, DOI 10.1111/j.1469-0691.2007.01842.x; Lee JC, 2001, APMIS, V109, P679, DOI 10.1034/j.1600-0463.2001.d01-132.x; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2007, BIOCHEM PHARMACOL, V74, P86, DOI 10.1016/j.bcp.2007.02.012; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Lindmark B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-220; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; OCALLAGHAN CH, 1972, ANTIMICROB AGENTS CH, V1, P283, DOI 10.1128/AAC.1.4.283; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Scorza FB, 2008, MOL CELL PROTEOMICS, V7, P473, DOI 10.1074/mcp.M700295-MCP200; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Van Faassen H, 2007, INFECT IMMUN, V75, P5597, DOI 10.1128/IAI.00762-07; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yun SH, 2008, J MICROBIOL, V46, P720, DOI 10.1007/s12275-008-0202-3; Zimbler D, 2009, BIOMETALS, V22, P23, DOI 10.1007/s10534-008-9202-3	44	171	184	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17027	10.1371/journal.pone.0017027	http://dx.doi.org/10.1371/journal.pone.0017027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386968	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400024
J	Reichmann, WM; Katz, JN; Losina, E				Reichmann, William M.; Katz, Jeffrey N.; Losina, Elena			Differences in Self-Reported Health in the Osteoarthritis Initiative (OAI) and Third National Health and Nutrition Examination Survey (NHANES-III)	PLOS ONE			English	Article							QUALITY-OF-LIFE; RATED HEALTH; KNEE OSTEOARTHRITIS; DETERMINANTS; PREVALENCE; MORTALITY; DISEASE	Objective: To assess self-reported health status (SRHS) in two cohorts of participants with radiographic knee osteoarthritis (OA) and examine the extent that differences in SRHS are due to study design. Method: We used data from the Third National Health and Nutritional Examination Survey (NHANES-III; population-based national survey) and the Osteoarthritis Initiative (OAI; prospective cohort study). Inclusion criteria for this analysis were age 60-79 and presence of radiographic knee OA. SRHS, elicited as a five-item domain (excellent, very good, good, fair, poor), was analyzed by dichotomizing the general health status measure as "fair/poor'' versus all other states. We estimated the proportion of participants in fair/poor health from each study. Propensity score methodology was used to adjust for the differences in sampling strategies between the two studies. Results: Thirty-four percent (N = 1,608) of OAI and 29% (N = 756) of NHANES-III participants satisfied inclusion criteria. The proportion in fair/poor health was higher in NHANES-III (28%) than in OAI (5%). After adjusting for the propensity score, the proportion in fair/poor health was four times higher in NHANES-III than in OAI. Conclusion: SRHS was substantially better in OAI than in NHANES-III. Self-selection bias may contribute to overestimation of SRHS in prospective cohort studies such as OAI.	[Reichmann, William M.; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Reichmann, William M.; Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Reichmann, WM (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, 75 Francis St, Boston, MA 02115 USA.	wreichmann@partners.org		Losina, ELENA/0000-0002-3424-0892	National Institutes of Health (NIAMS) [RO1 AR 053112, K24 AR 02123, T32 103756]; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR002123, K24AR057827, R01AR053112, T32AR055885] Funding Source: NIH RePORTER	National Institutes of Health (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work is supported by the National Institutes of Health (NIAMS) RO1 AR 053112, K24 AR 02123, T32 103756, and an Innovative Research Grant to Dr. Losina from Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; [Anonymous], VITAL HLTH STAT; Chandola T, 2000, ETHNIC HEALTH, V5, P151, DOI 10.1080/713667451; COOK DJ, 1993, J CLIN EPIDEMIOL, V46, P529, DOI 10.1016/0895-4356(93)90125-K; Cott CA, 1999, J EPIDEMIOL COMMUN H, V53, P731, DOI 10.1136/jech.53.11.731; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; D'Souza JC, 2008, AM J IND MED, V51, P37, DOI 10.1002/ajim.20512; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; Finn L, 1998, SLEEP, V21, P701; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Hayes DK, 2008, J HYPERTENS, V26, P641, DOI 10.1097/HJH.0b013e3282f3eb50; Jordan JM, 2007, J RHEUMATOL, V34, P172; Lemesle G, 2009, AM HEART J, V157, P375, DOI 10.1016/j.ahj.2008.09.013; Manor O, 2000, INT J EPIDEMIOL, V29, P149, DOI 10.1093/ije/29.1.149; MCCALLUM J, 1994, AM J PUBLIC HEALTH, V84, P1100, DOI 10.2105/AJPH.84.7.1100; McGee DL, 1999, AM J EPIDEMIOL, V149, P41; Miilunpalo S, 1997, J CLIN EPIDEMIOL, V50, P517, DOI 10.1016/S0895-4356(97)00045-0; *OST IN, 2004, OAI SCREEN KNEE XRA; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Reeves MJ, 2008, STROKE, V39, P1779, DOI 10.1161/STROKEAHA.107.501700; Reichmann WM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008728; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Szklo M, 1998, EPIDEMIOL REV, V20, P81, DOI 10.1093/oxfordjournals.epirev.a017974; U.S. Department of Health and Human Services (DHHS), 3 NAT HLTH NUTR EX S, V11; *US BUR LAB STAT, INFL CALC BUR LAB ST; Winkelmayer WC, 2004, NEPHROL DIAL TRANSPL, V19, P1671, DOI 10.1093/ndt/gfh104; World Health Organization, GLOB DAT BOD MASS IN; YE Y, 2009, DRUG ALCOHOL DEPEND	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17345	10.1371/journal.pone.0017345	http://dx.doi.org/10.1371/journal.pone.0017345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387001	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400059
J	Vilas-Zornoza, A; Agirre, X; Martin-Palanco, V; Martin-Subero, JI; San Jose-Eneriz, E; Garate, L; Alvarez, S; Miranda, E; Rodriguez-Otero, P; Rifon, J; Torres, A; Calasanz, MJ; Cigudosa, JC; Roman-Gomez, J; Prosper, F				Vilas-Zornoza, Amaia; Agirre, Xabier; Martin-Palanco, Vanesa; Ignacio Martin-Subero, Jose; San Jose-Eneriz, Edurne; Garate, Leire; Alvarez, Sara; Miranda, Estibaliz; Rodriguez-Otero, Paula; Rifon, Jose; Torres, Antonio; Jose Calasanz, Maria; Cruz Cigudosa, Juan; Roman-Gomez, Jose; Prosper, Felipe			Frequent and Simultaneous Epigenetic Inactivation of TP53 Pathway Genes in Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; DOWN-REGULATION; ABERRANT METHYLATION; TUMOR-SUPPRESSOR; DNA METHYLATION; PROMOTER HYPERMETHYLATION; PETHEMA ALL-89; POOR-PROGNOSIS; CPG ISLANDS; EXPRESSION	Aberrant DNA methylation is one of the most frequent alterations in patients with Acute Lymphoblastic Leukemia (ALL). Using methylation bead arrays we analyzed the methylation status of 807 genes implicated in cancer in a group of ALL samples at diagnosis (n = 48). We found that 154 genes were methylated in more than 10% of ALL samples. Interestingly, the expression of 13 genes implicated in the TP53 pathway was downregulated by hypermethylation. Direct or indirect activation of TP53 pathway with 5-aza-29-deoxycitidine, Curcumin or Nutlin-3 induced an increase in apoptosis of ALL cells. The results obtained with the initial group of 48 patients was validated retrospectively in a second cohort of 200 newly diagnosed ALL patients. Methylation of at least 1 of the 13 genes implicated in the TP53 pathway was observed in 78% of the patients, which significantly correlated with a higher relapse (p = 0.001) and mortality (p < 0.001) rate being an independent prognostic factor for disease-free survival (DFS) (p = 0.006) and overall survival (OS) (p = 0.005) in the multivariate analysis. All these findings indicate that TP53 pathway is altered by epigenetic mechanisms in the majority of ALL patients and correlates with prognosis. Treatments with compounds that may reverse the epigenetic abnormalities or activate directly the p53 pathway represent a new therapeutic alternative for patients with ALL.	[Vilas-Zornoza, Amaia; Agirre, Xabier; San Jose-Eneriz, Edurne; Garate, Leire; Miranda, Estibaliz; Rodriguez-Otero, Paula; Rifon, Jose; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Hematol Serv, Univ Navarra Clin, E-31080 Pamplona, Spain; [Vilas-Zornoza, Amaia; Agirre, Xabier; San Jose-Eneriz, Edurne; Garate, Leire; Miranda, Estibaliz; Rodriguez-Otero, Paula; Rifon, Jose; Prosper, Felipe] Univ Navarra, Fdn Appl Med Res, Area Cell Therapy, Univ Navarra Clin, E-31080 Pamplona, Spain; [Martin-Palanco, Vanesa; Torres, Antonio; Roman-Gomez, Jose] Reina Sofia Hosp, Maimonides Inst Biomed Res, Dept Hematol, Cordoba, Spain; [Ignacio Martin-Subero, Jose] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain; [Alvarez, Sara; Cruz Cigudosa, Juan] Ctr Invest Enfermedades Raras CIBER, CNIO, Mol Cytogenet Grp, Madrid, Spain; [Jose Calasanz, Maria] Univ Navarra, Dept Genet, Navarra, Spain	University of Navarra; University of Navarra; Hospital Universitario Reina Sofia - Cordoba; University of Barcelona; Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Navarra	Vilas-Zornoza, A (corresponding author), Univ Navarra, Fdn Appl Med Res, Hematol Serv, Univ Navarra Clin, E-31080 Pamplona, Spain.	peperosa@teleline.es	Prosper, Felipe/H-6859-2017; Calasanz, MJ/R-5813-2016; Torres, Antoni/H-6128-2017; San Jose-Eneriz, Edurne/AAD-7288-2020; Vilas-Zornoza, Amaia/AAD-4004-2020; Agirre, Xabier/ABE-4110-2020; Otero, Paula Rodríguez/C-7651-2018	Prosper, Felipe/0000-0001-6115-8790; Calasanz, MJ/0000-0002-0374-3008; Torres, Antoni/0000-0002-8643-2167; San Jose-Eneriz, Edurne/0000-0001-5786-5273; Vilas-Zornoza, Amaia/0000-0001-6693-0989; Martin-Subero, Jose Ignacio/0000-0001-8809-5195	Ministerio de Ciencia e Innovacion [SAF2009-08663, AP2008/03686]; Instituto de Salud Carlos III (ISCIII) [PI07/0602, PI10/00110, PI10/01691, RTICC RD06/0020]; Contrato Miguel Servet [CP07/00215]; European FEDER; Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; Beca Ortiz de Landazuri [6/2009]; UTE; Junta de Andalucia [0004/2007, 0206/2009]; Asociacion Espanola Contra el Cancer	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); Contrato Miguel Servet; European FEDER(European Commission); Programa Tu Eliges; Tu Decides (CAN); Gobierno de Navarra; Departamento de Salud; Beca Ortiz de Landazuri; UTE; Junta de Andalucia(Junta de Andalucia); Asociacion Espanola Contra el Cancer	The work was supported in part by grants to FP and XA from Ministerio de Ciencia e Innovacion and Instituto de Salud Carlos III (ISCIII) PI07/0602, PI10/00110, PI10/01691 and RTICC RD06/0020, Contrato Miguel Servet CP07/00215, European FEDER funds Interreg IVA (CITTIL), Programa Tu Eliges, Tu Decides (CAN), Gobierno de Navarra, Departamento de Salud, Beca Ortiz de Landazuri 2009 (6/2009) and funds from the "UTE project CIMA", to JR-G from Junta de Andalucia 0004/2007 and 0206/2009 and to JIM-S from Ministerio Ciencia e Innovacion (SAF2009-08663). AV-Z is supported by Ministerio Ciencia e Innovacion (AP2008/03686), and VM by ISCIII (Program Rio Hortega) and a collaborative project of the Asociacion Espanola Contra el Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Agirre X, 2003, MOL CARCINOGEN, V38, P201, DOI 10.1002/mc.10159; Agirre X, 2009, CANCER RES, V69, P4443, DOI 10.1158/0008-5472.CAN-08-4025; Ambrosini G, 2007, ONCOGENE, V26, P3473, DOI 10.1038/sj.onc.1210136; Aranda P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007809; Armstrong SA, 2005, J CLIN ONCOL, V23, P6306, DOI 10.1200/JCO.2005.05.047; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Chim CS, 2008, J CLIN PATHOL, V61, P844, DOI 10.1136/jcp.2007.047324; Davidsson J, 2009, HUM MOL GENET, V18, P4054, DOI 10.1093/hmg/ddp354; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Epstein J, 2010, BRIT J NUTR, V103, P824, DOI 10.1017/S0007114509992510; Esteller M, 2002, J NATL CANCER I, V94, P26; Faderl S, 1998, BLOOD, V91, P3995, DOI 10.1182/blood.V91.11.3995; Furukawa Y, 2005, MOL CANCER RES, V3, P325, DOI 10.1158/1541-7786.MCR-04-0105; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Garcia-Manero G, 2002, CLIN CANCER RES, V8, P2217; Garcia-Manero G, 2009, SEMIN HEMATOL, V46, P24, DOI 10.1053/j.seminhematol.2008.09.008; Hagiwara K, 2010, LEUKEMIA RES, V34, P50, DOI 10.1016/j.leukres.2009.06.028; Henken FE, 2007, BRIT J CANCER, V97, P1457, DOI 10.1038/sj.bjc.6604055; Hinoue T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008357; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Izumi H, 2005, HUM MOL GENET, V14, P997, DOI 10.1093/hmg/ddi092; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lo KW, 2001, CANCER RES, V61, P3877; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Martin-Subero JI, 2009, BLOOD, V113, P2488, DOI 10.1182/blood-2008-04-152900; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Milani L, 2010, BLOOD, V115, P1214, DOI 10.1182/blood-2009-04-214668; Milani L, 2009, GENOME RES, V19, P1, DOI 10.1101/gr.083931.108; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ortega JJ, 2001, HAEMATOLOGICA, V86, P586; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Ribera JM, 2002, HAEMATOLOGICA, V87, P154; Ribera JM, 1998, HAEMATOLOGICA, V83, P222; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Roman-Gomez J, 2005, J CLIN ONCOL, V23, P7043, DOI 10.1200/JCO.2005.01.4944; Roman-Gomez J, 2002, BLOOD, V99, P2291, DOI 10.1182/blood.V99.7.2291; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Roman-Gomez J, 2007, BLOOD, V109, P3462, DOI 10.1182/blood-2006-09-047043; Roman-Gomez J, 2006, CLIN CANCER RES, V12, P4845, DOI 10.1158/1078-0432.CCR-05-2592; Roman-Gomez J, 2009, J CLIN ONCOL, V27, P1316, DOI 10.1200/JCO.2008.19.3441; San Jose-Eneriz E, 2006, BRIT J HAEMATOL, V134, P137, DOI 10.1111/j.1365-2141.2006.06131.x; Jose-Eneriz ES, 2009, EUR J CANCER, V45, P1877, DOI 10.1016/j.ejca.2009.04.005; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; SCHAFER E, 2010, BLOOD; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Stumpel DJPM, 2009, BLOOD, V114, P5490, DOI 10.1182/blood-2009-06-227660; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; WADA M, 1993, BLOOD, V82, P3163; Wang HL, 2007, WORLD J GASTROENTERO, V13, P5060, DOI 10.3748/wjg.v13.i38.5060; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhao J, 2010, HEPATOLOGY, V51, P142, DOI 10.1002/hep.23247	58	37	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17012	10.1371/journal.pone.0017012	http://dx.doi.org/10.1371/journal.pone.0017012			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386967	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400021
J	Bol, SM; Moerland, PD; Limou, S; van Remmerden, Y; Coulonges, C; van Manen, D; Herbeck, JT; Fellay, J; Sieberer, M; Sietzema, JG; van't Slot, R; Martinson, J; Zagury, JF; Schuitemaker, H; van't Wout, AB				Bol, Sebastiaan M.; Moerland, Perry D.; Limou, Sophie; van Remmerden, Yvonne; Coulonges, Cedric; van Manen, Danielle; Herbeck, Joshua T.; Fellay, Jacques; Sieberer, Margit; Sietzema, Jantine G.; van't Slot, Ruben; Martinson, Jeremy; Zagury, Jean-Francois; Schuitemaker, Hanneke; van't Wout, Angelique B.			Genome-Wide Association Study Identifies Single Nucleotide Polymorphism in DYRK1A Associated with Replication of HIV-1 in Monocyte-Derived Macrophages	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; MNB/DYRK1A PROTEIN-KINASE; CENTRAL-NERVOUS-SYSTEM; INFECTED MACROPHAGES; DOWN-SYNDROME; IN-VITRO; GENETIC ASSOCIATION; DUAL-SPECIFICITY	Background: HIV-1 infected macrophages play an important role in rendering resting T cells permissive for infection, in spreading HIV-1 to T cells, and in the pathogenesis of AIDS dementia. During highly active anti-retroviral treatment (HAART), macrophages keep producing virus because tissue penetration of antiretrovirals is suboptimal and the efficacy of some is reduced. Thus, to cure HIV-1 infection with antiretrovirals we will also need to efficiently inhibit viral replication in macrophages. The majority of the current drugs block the action of viral enzymes, whereas there is an abundance of yet unidentified host factors that could be targeted. We here present results from a genome-wide association study identifying novel genetic polymorphisms that affect in vitro HIV-1 replication in macrophages. Methodology/Principal Findings: Monocyte-derived macrophages from 393 blood donors were infected with HIV-1 and viral replication was determined using Gag p24 antigen levels. Genomic DNA from individuals with macrophages that had relatively low (n = 96) or high (n = 96) p24 production was used for SNP genotyping with the Illumina 610 Quad beadchip. A total of 494,656 SNPs that passed quality control were tested for association with HIV-1 replication in macrophages, using linear regression. We found a strong association between in vitro HIV-1 replication in monocyte-derived macrophages and SNP rs12483205 in DYRK1A (p = 2.16 x 10(-5)). While the association was not genome-wide significant (p < 1 x 10(-7)), we could replicate this association using monocyte-derived macrophages from an independent group of 31 individuals (p = 0.0034). Combined analysis of the initial and replication cohort increased the strength of the association (p = 4.84 x 10(-6)). In addition, we found this SNP to be associated with HIV-1 disease progression in vivo in two independent cohort studies (p = 0.035 and p = 0.0048). Conclusions/Significance: These findings suggest that the kinase DYRK1A is involved in the replication of HIV-1, in vitro in macrophages as well as in vivo.	[Bol, Sebastiaan M.; van Remmerden, Yvonne; van Manen, Danielle; Sieberer, Margit; Sietzema, Jantine G.; Schuitemaker, Hanneke; van't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, NL-1105 AZ Amsterdam, Netherlands; [Bol, Sebastiaan M.; van Remmerden, Yvonne; van Manen, Danielle; Sieberer, Margit; Sietzema, Jantine G.; Schuitemaker, Hanneke; van't Wout, Angelique B.] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Bioinformat Lab, NL-1105 AZ Amsterdam, Netherlands; [Moerland, Perry D.] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands; [Limou, Sophie; Coulonges, Cedric; Zagury, Jean-Francois] Conservatoire Natl Arts & Metiers, Chaire Bioinformat, Paris, France; [Limou, Sophie; Coulonges, Cedric; Zagury, Jean-Francois] Univ Paris 12, INSERM, U955, Paris, France; [Herbeck, Joshua T.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Fellay, Jacques] Duke Univ, Ctr Human Genome Variat, Durham, NC USA; [van't Slot, Ruben] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, Utrecht, Netherlands; [Martinson, Jeremy] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Washington; University of Washington Seattle; Duke University; Utrecht University; Utrecht University Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bol, SM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab,Sanquin Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.b.vantwout@amc.uva.nl	Fellay, Jacques/A-6681-2009; Moerland, Perry/AAG-1425-2020; Limou, Sophie/AHD-3272-2022	Fellay, Jacques/0000-0002-8240-939X; Moerland, Perry/0000-0002-2357-3659; Limou, Sophie/0000-0002-7702-8234; Martinson, Jeremy/0000-0003-4673-7238; Bol, Sebastiaan/0000-0002-3843-6657; van 't Wout, Angelique/0000-0003-3705-2392	Landsteiner Foundation Blood Research [0526]; European Union [029167]; National Institute of Allergy and Infectious Diseases; National Cancer Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140, R37AI047734, U01AI035039, U01AI035042, U01AI035040, U01AI035043, P30AI027757, U01AI035041] Funding Source: NIH RePORTER	Landsteiner Foundation Blood Research; European Union(European Commission); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge funding from the Landsteiner Foundation Blood Research (registration number 0526) and the European Union (Marie Curie International Reintegration Grant 029167). The MACS is funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute. UO1-AI-35042, UL1-RR025005 (GCRC), UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1994, AIDS, V8, P1237, DOI 10.1097/00002030-199409000-00004; Anthony IC, 2005, J NEUROPATH EXP NEUR, V64, P529, DOI 10.1093/jnen/64.6.529; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Badley AD, 1997, J EXP MED, V185, P55, DOI 10.1084/jem.185.1.55; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Bergamaschi A, 2009, J VIROL, V83, P12253, DOI 10.1128/JVI.01395-09; Bol SM, 2009, VIROLOGY, V390, P205, DOI 10.1016/j.virol.2009.05.027; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Broder S, 2010, ANTIVIR RES, V85, P1, DOI 10.1016/j.antiviral.2009.10.002; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Chang J, 1996, J VIROL, V70, P7792, DOI 10.1128/JVI.70.11.7792-7803.1996; Chong YH, 1998, J MOL NEUROSCI, V10, P129, DOI 10.1007/BF02737124; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Ciuffi A, 2004, J VIROL, V78, P10747, DOI 10.1128/JVI.78.19.10747-10754.2004; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Crowe SM, 2006, CURR OPIN HIV AIDS, V1, P129, DOI 10.1097/01.COH.0000209583.89952.9d; DeGruttola V, 2000, ANTIVIR THER, V5, P41; Dierssen M, 2006, THESCIENTIFICWORLDJO, V6, P1911, DOI 10.1100/tsw.2006.319; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Eisert V, 2001, VIROLOGY, V286, P31, DOI 10.1006/viro.2001.0940; Fellay J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000791; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; FOUCHIER RAM, 1994, J CLIN INVEST, V94, P1806, DOI 10.1172/JCI117529; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Gardiner K, 2006, BEHAV GENET, V36, P439, DOI 10.1007/s10519-006-9051-1; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Gougeon ML, 2003, NAT REV IMMUNOL, V3, P392, DOI 10.1038/nri1087; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hammerle B, 2003, J NEURAL TRANSM-SUPP, P129; Hawkins T, 2010, ANTIVIR RES, V85, P201, DOI 10.1016/j.antiviral.2009.10.016; Hayes MM, 2002, CELL IMMUNOL, V215, P61, DOI 10.1016/S0008-8749(02)00017-5; Henderson AJ, 1997, P NATL ACAD SCI USA, V94, P8714, DOI 10.1073/pnas.94.16.8714; Herbeck JT, 2010, J INFECT DIS, V201, P618, DOI 10.1086/649842; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Herbein G, 1998, NATURE, V395, P189, DOI 10.1038/26026; Huang YL, 2006, J IMMUNOL, V177, P2304, DOI 10.4049/jimmunol.177.4.2304; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Huysentruyt LC, 2010, J LEUKOCYTE BIOL, V87, P627, DOI 10.1189/jlb.0809564; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lambotte O, 2005, AIDS, V19, P217, DOI 10.1097/00002030-200501280-00018; Le Clerc S, 2009, J INFECT DIS, V200, P1194, DOI 10.1086/605892; Lee ES, 2002, VIROLOGY, V299, P20, DOI 10.1006/viro.2002.1500; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Limou S, 2009, J INFECT DIS, V199, P419, DOI 10.1086/596067; Lopez-Herrera A, 2005, BBA-MOL BASIS DIS, V1741, P55, DOI 10.1016/j.bbadis.2004.12.001; Luciano-Montalvo C, 2009, PLACENTA, V30, P464, DOI 10.1016/j.placenta.2009.03.003; Lum JJ, 2001, J VIROL, V75, P11128, DOI 10.1128/JVI.75.22.11128-11136.2001; MANN DL, 1990, J IMMUNOL, V144, P2152; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mayer KH, 1999, CLIN INFECT DIS, V28, P1252, DOI 10.1086/514775; Mulder LCF, 2000, J BIOL CHEM, V275, P29749, DOI 10.1074/jbc.M004670200; Naif HM, 1999, J VIROL, V73, P4866, DOI 10.1128/JVI.73.6.4866-4881.1999; Nakada M, 2001, CANCER RES, V61, P8896; NETTERWALD J, 2007, DRUG DISCOVERY DEV, V10, P18; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; PERNO CF, 1994, J LEUKOCYTE BIOL, V56, P381, DOI 10.1002/jlb.56.3.381; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Richman DD, 2004, AIDS, V18, P1393, DOI 10.1097/01.aids.0000131310.52526.c7; Schacker T, 2000, J INFECT DIS, V181, P354, DOI 10.1086/315178; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tan KO, 2001, J BIOL CHEM, V276, P2802, DOI 10.1074/jbc.M008955200; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tatusova T, 2010, METHODS MOL BIOL, V609, P17, DOI 10.1007/978-1-60327-241-4_2; Toschi E, 2001, MOL BIOL CELL, V12, P2934, DOI 10.1091/mbc.12.10.2934; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Wu W, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-41; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zauli G, 2001, FASEB J, V15, P483, DOI 10.1096/fj.00-0354com; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	97	30	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17190	10.1371/journal.pone.0017190	http://dx.doi.org/10.1371/journal.pone.0017190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364930	Green Published, gold, Green Accepted			2022-12-27	WOS:000287764100034
J	Lin, AY; Chua, MS; Choi, YL; Yeh, W; Kim, YH; Azzi, R; Adams, GA; Sainani, K; van de Rijn, M; So, SK; Pollack, JR				Lin, Albert Y.; Chua, Mei-Sze; Choi, Yoon-La; Yeh, William; Kim, Young H.; Azzi, Raymond; Adams, Gregg A.; Sainani, Kristin; van de Rijn, Matt; So, Samuel K.; Pollack, Jonathan R.			Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker	PLOS ONE			English	Article							BREAST-CANCER METASTASIS; GENE-EXPRESSION PROFILES; COLON-CANCER; TUMOR PROGRESSION; CDNA MICROARRAY; ALPHA-ENHANCER; OSTEOPONTIN; PREDICTS; STATISTICS; ACTIVATION	Purpose: We sought to identify genes of clinical significance to predict survival and the risk for colorectal liver metastasis (CLM), the most common site of metastasis from colorectal cancer (CRC). Patients and Methods: We profiled gene expression in 31 specimens from primary CRC and 32 unmatched specimens of CLM, and performed Significance Analysis of Microarrays (SAM) to identify genes differentially expressed between these two groups. To characterize the clinical relevance of two highly-ranked differentially-expressed genes, we analyzed the expression of secreted phosphoprotein 1 (SPP1 or osteopontin) and lymphoid enhancer factor-1 (LEF1) by immunohistochemistry using a tissue microarray (TMA) representing an independent set of 154 patients with primary CRC. Results: Supervised analysis using SAM identified 963 genes with significantly higher expression in CLM compared to primary CRC, with a false discovery rate of < 0.5%. TMA analysis showed SPP1 and LEF1 protein overexpression in 60% and 44% of CRC cases, respectively. Subsequent occurrence of CLM was significantly correlated with the overexpression of LEF1 (chi-square p = 0.042), but not SPP1 (p = 0.14). Kaplan Meier analysis revealed significantly worse survival in patients with overexpression of LEF1 (p < 0.01), but not SPP1 (p = 0.11). Both univariate and multivariate analyses identified stage (p < 0.0001) and LEF1 overexpression (p < 0.05) as important prognostic markers, but not tumor grade or SPP1. Conclusion: Among genes differentially expressed between CLM and primary CRC, we demonstrate overexpression of LEF1 in primary CRC to be a prognostic factor for poor survival and increased risk for liver metastasis.	[Lin, Albert Y.; Yeh, William] Santa Clara Valley Med Ctr, Dept Med, San Jose, CA 95128 USA; [Lin, Albert Y.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Chua, Mei-Sze; So, Samuel K.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Chua, Mei-Sze; So, Samuel K.] Stanford Univ, Asian Liver Ctr, Stanford, CA 94305 USA; [Choi, Yoon-La; Kim, Young H.; van de Rijn, Matt; Pollack, Jonathan R.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Choi, Yoon-La] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Azzi, Raymond] Santa Clara Valley Med Ctr, Dept Pathol, San Jose, CA 95128 USA; [Adams, Gregg A.] Santa Clara Valley Med Ctr, Dept Surg, San Jose, CA 95128 USA; [Sainani, Kristin] Stanford Univ, Div Epidemiol Hlth Res & Policy, Stanford, CA 94305 USA	Santa Clara Valley Medical Center; Stanford University; Stanford University; Stanford University; Stanford University; Sungkyunkwan University (SKKU); Samsung Medical Center; Santa Clara Valley Medical Center; Santa Clara Valley Medical Center; Stanford University	Lin, AY (corresponding author), Santa Clara Valley Med Ctr, Dept Med, San Jose, CA 95128 USA.	albert.lin@hhs.sccgov.org		van de Rijn, Matt/0000-0002-1909-9739; Chua, Mei-Sze/0000-0002-3282-4894; Sainani, Kristin/0000-0003-0614-303X	NIH [CA112016]; Valley Foundation; Lui Hac Minh and C. J. Huang Foundations; Paul and Tammy Davis Research Fund; NATIONAL CANCER INSTITUTE [R01CA112016] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Valley Foundation; Lui Hac Minh and C. J. Huang Foundations; Paul and Tammy Davis Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by NIH grant CA112016 (JRP); The Valley Foundation (AYL); Lui Hac Minh and C. J. Huang Foundations and the Paul and Tammy Davis Research Fund (MSC and SKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2002, J NATL CANCER I, V94, P513; Agrawal D, 2003, CR BIOL, V326, P1041, DOI 10.1016/j.crvi.2003.09.007; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen X, 2002, MOL BIOL CELL, V13, P1929, DOI 10.1091/mbc.02-02-0023; Demeter J, 2007, NUCLEIC ACIDS RES, V35, pD766, DOI 10.1093/nar/gkl1019; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Friederichs J, 2005, INT J COLORECTAL DIS, V20, P391, DOI 10.1007/s00384-004-0722-1; Fuerer C, 2008, EMBO REP, V9, P134, DOI 10.1038/sj.embor.7401159; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Inokuchi M, 2004, CANCER CHEMOTH PHARM, V53, P391, DOI 10.1007/s00280-003-0747-0; Jarnagin WR, 2001, CANCER, V91, P1121, DOI 10.1002/1097-0142(20010315)91:6<1121::AID-CNCR1108>3.0.CO;2-2; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ki DH, 2007, INT J CANCER, V121, P2005, DOI 10.1002/ijc.22975; Kleivi K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-2; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Li MH, 2004, INT J ONCOL, V24, P305; Li TWH, 2006, MOL CELL BIOL, V26, P5284, DOI 10.1128/MCB.00105-06; Lin HM, 2007, ONCOL REP, V17, P1541; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Matsuyama R, 2006, INT J CANCER, V119, P406, DOI 10.1002/ijc.21843; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Notterman DA, 2001, CANCER RES, V61, P3124; Nusse R, 1999, TRENDS GENET, V15, P1, DOI 10.1016/S0168-9525(98)01634-5; Pollack JR, 2007, AM J PATHOL, V171, P375, DOI 10.2353/ajpath.2007.070342; PRINCE CW, 1987, J BIOL CHEM, V262, P2900; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; RAMASWAMY S, 2003, MOL SIGNATURE METAST, P49; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rohde F, 2007, INT J CANCER, V121, P1717, DOI 10.1002/ijc.22868; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Tackels-Horne D, 2001, CANCER-AM CANCER SOC, V92, P395, DOI 10.1002/1097-0142(20010715)92:2<395::AID-CNCR1335>3.0.CO;2-U; Takahashi Y, 2006, CANCER GENET CYTOGEN, V168, P30, DOI 10.1016/j.cancergencyto.2005.12.011; Takata O, 2006, SURG TODAY, V36, P608, DOI 10.1007/s00595-006-3210-0; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; Tuck AB, 2007, J CELL BIOCHEM, V102, P859, DOI 10.1002/jcb.21520; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Wong SCC, 2004, CLIN CANCER RES, V10, P1401, DOI 10.1158/1078-0432.CCR-0157-03; Yanagawa R, 2001, NEOPLASIA, V3, P395, DOI 10.1038/sj.neo.7900185; Yeatman TJ, 2003, CLIN EXP METASTAS, V20, P85, DOI 10.1023/A:1022502805474; Zeelenberg IS, 2003, CANCER RES, V63, P3833	49	57	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16636	10.1371/journal.pone.0016636	http://dx.doi.org/10.1371/journal.pone.0016636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383983	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700013
J	Wang, D; Li, YJ; Wu, CY; Liu, YH				Wang, Dan; Li, Yingjian; Wu, Chuanyue; Liu, Youhua			PINCH1 Is Transcriptional Regulator in Podocytes That Interacts with WT1 and Represses Podocalyxin Expression	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; TO-MESENCHYMAL TRANSITION; CELL-SHAPE MODULATION; ONLY PROTEIN PINCH; MOLECULAR DISSECTION; GLOMERULAR PODOCYTE; ACTIN CYTOSKELETON; INJURY; NEPHRIN; ILK	Background: PINCH1, an adaptor protein containing five LIM domains, plays an important role in regulating the integrin-mediated cell adhesion, migration and epithelial-mesenchymal transition. PINCH1 is induced in the fibrotic kidney after injury, and it primarily localizes at the sites of focal adhesion. Whether it can translocate to the nucleus and directly participate in gene regulation is completely unknown. Methodology/Principal Findings: Using cultured glomerular podocytes as a model system, we show that PINCH1 expression was induced by TGF-beta 1, a fibrogenic cytokine that promotes podocyte dysfunction. Interestingly, increased PINCH1 not only localized at the sites of focal adhesions, but also underwent nuclear translocation after TGF-beta 1 stimulation. This nuclear translocation of PINCH1 was apparently dependent on the putative nuclear export/localization signals (NES/NLS) at its C-terminus, as deletion or site-directed mutations abolished its nuclear shuttling. Co-immunoprecipitation and pull-down experiments revealed that PINCH1 interacted with Wilms tumor 1 protein (WT1), a nuclear transcription factor that is essential for regulating podocyte-specific gene expression in adult kidney. Interaction of PINCH1 and WT1 was mediated by the LIM1 domain of PINCH1 and C-terminal zinc-finger domain of WT1, which led to the suppression of the WT1-mediated podocalyxin expression in podocytes. PINCH1 also repressed podocalyxin gene transcription in a promoter-luciferase reporter assay. Conclusion/Significance: These results indicate that PINCH1 can shuttle into the nucleus from cytoplasm in podocytes, wherein it interacts with WT1 and suppresses podocyte-specific gene expression. Our studies reveal a previously unrecognized, novel function of PINCH1, in which it acts as a transcriptional regulator through controlling specific gene expression.	[Wang, Dan; Li, Yingjian; Wu, Chuanyue; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, D (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK054639]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064005, R01DK061408, R01DK054639] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants DK061408 and DK064005 (Y.L.), and DK054639 (C.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Campana WM, 2003, GLIA, V41, P213, DOI 10.1002/glia.10138; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Guo G, 2004, J AM SOC NEPHROL, V15, P2851, DOI 10.1097/01.ASN.0000143474.91362.C4; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Jung KY, 2007, J AM SOC NEPHROL, V18, P66, DOI 10.1681/ASN.2006050421; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kim JH, 2010, J BIOL CHEM, V285, P9995, DOI 10.1074/jbc.M109.061671; Lahiri D, 2007, MOL REPROD DEV, V74, P300, DOI 10.1002/mrd.20491; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Li YJ, 2007, J AM SOC NEPHROL, V18, P2534, DOI 10.1681/ASN.2007030315; Li YJ, 2009, J AM SOC NEPHROL, V20, P1907, DOI 10.1681/ASN.2008090930; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Macconi D, 2006, AM J PATHOL, V168, P42, DOI 10.2353/ajpath.2006.050398; Menke AL, 2003, J PATHOL, V200, P667, DOI 10.1002/path.1390; Morrison AA, 2008, AM J PHYSIOL-RENAL, V295, pF12, DOI 10.1152/ajprenal.00597.2007; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wagner KD, 2003, J CELL SCI, V116, P1653, DOI 10.1242/jcs.00405; Wagner N, 2004, J AM SOC NEPHROL, V15, P3044, DOI 10.1097/01.ASN.0000146687.99058.25; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Yang YW, 2009, J BIOL CHEM, V284, P5836, DOI 10.1074/jbc.M805319200	42	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17048	10.1371/journal.pone.0017048	http://dx.doi.org/10.1371/journal.pone.0017048			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390327	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287761700027
J	Vandenborre, G; Smagghe, G; Ghesquiere, B; Menschaert, G; Rao, RN; Gevaert, K; Van Damme, EJM				Vandenborre, Gianni; Smagghe, Guy; Ghesquiere, Bart; Menschaert, Gerben; Rao, Rameshwaram Nagender; Gevaert, Kris; Van Damme, Els J. M.			Diversity in Protein Glycosylation among Insect Species	PLOS ONE			English	Article							SNOWDROP LECTIN; FERRITIN ACTS; CELL-ADHESION; DROSOPHILA; GLYCOSYLTRANSFERASE; MIDGUT; BIOSYNTHESIS; INFORMATION; SPECIFICITY; ANNOTATION	Background: A very common protein modification in multicellular organisms is protein glycosylation or the addition of carbohydrate structures to the peptide backbone. Although the Class of the Insecta is the largest animal taxon on Earth, almost all information concerning glycosylation in insects is derived from studies with only one species, namely the fruit fly Drosophila melanogaster. Methodology/Principal Findings: In this report, the differences in glycoproteomes between insects belonging to several economically important insect orders were studied. Using GNA (Galanthus nivalis agglutinin) affinity chromatography, different sets of glycoproteins with mannosyl-containing glycan structures were purified from the flour beetle (Tribolium castaneum), the silkworm (Bombyx mori), the honeybee (Apis mellifera), the fruit fly (D. melanogaster) and the pea aphid (Acyrthosiphon pisum). To identify and characterize the purified glycoproteins, LC-MS/MS analysis was performed. For all insect species, it was demonstrated that glycoproteins were related to a broad range of biological processes and molecular functions. Moreover, the majority of glycoproteins retained on the GNA column were unique to one particular insect species and only a few glycoproteins were present in the five different glycoprotein sets. Furthermore, these data support the hypothesis that insect glycoproteins can be decorated with mannosylated O-glycans. Conclusions/Significance: The results presented here demonstrate that oligomannose N-glycosylation events are highly specific depending on the insect species. In addition, we also demonstrated that protein O-mannosylation in insect species may occur more frequently than currently believed.	[Vandenborre, Gianni; Smagghe, Guy; Rao, Rameshwaram Nagender] Univ Ghent, Lab Agrozool, Fac Biosci Engn, B-9000 Ghent, Belgium; [Vandenborre, Gianni; Rao, Rameshwaram Nagender; Van Damme, Els J. M.] Univ Ghent, Lab Biochem & Glycobiol, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Ghesquiere, Bart; Gevaert, Kris] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Menschaert, Gerben] Univ Ghent, Lab Bioinformat & Computat Genom, Dept Mol Biotechnol, Fac Biosci Engn, B-9000 Ghent, Belgium	Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Vandenborre, G (corresponding author), Univ Ghent, Lab Agrozool, Fac Biosci Engn, B-9000 Ghent, Belgium.	guy.smagghe@ugent.be	Gevaert, Kris/D-6489-2017; Gevaert, Kris/H-3637-2013; Gevaert, Kris/AAE-4212-2019; Smagghe, Guy/AAE-8914-2019; Ghesquiere, Bart/HGU-8736-2022; Van Damme, Els J/B-4410-2015; Van Damme, Els/U-3904-2019	Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Smagghe, Guy/0000-0001-8334-3313; Ghesquiere, Bart/0000-0003-1547-1705; Van Damme, Els/0000-0001-9848-766X; Menschaert, Gerben/0000-0002-7575-2085	Research Council of Ghent University [BOF07/GOA/017, BOF10/GOA/003]; Fund for Scientific Research-Flanders [3G016306]; Fund for Scientific Research-Flanders (Belgium) [3G028007]; Ghent University; Inter University Attraction Poles [BOF07/GOA/012, IUAP06]	Research Council of Ghent University(Ghent University); Fund for Scientific Research-Flanders(FWO); Fund for Scientific Research-Flanders (Belgium)(FWO); Ghent University(Ghent University); Inter University Attraction Poles(Belgian Federal Science Policy Office)	This work was supported by the Research Council of Ghent University (project BOF07/GOA/017 and BOF10/GOA/003), the Fund for Scientific Research-Flanders (3G016306) to GS and EV. BG is a postdoctoral research fellow of the Fund for Scientific Research-Flanders (Belgium). The UGent/VIB lab acknowledges support by research grants from the Fund for Scientific Research-Flanders (Belgium) (project 3G028007), the Concerted Research Actions from the Ghent University and the Inter University Attraction Poles (project BOF07/GOA/012 and IUAP06). The authors also acknowledge the Consortium for Functional Glycomics for glycan array analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700; Brower DL, 2003, CURR OPIN CELL BIOL, V15, P607, DOI 10.1016/S0955-0674(03)00102-9; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Correia T, 2003, P NATL ACAD SCI USA, V100, P6404, DOI 10.1073/pnas.1131007100; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Dahms NM, 2008, GLYCOBIOLOGY, V18, P664, DOI 10.1093/glycob/cwn061; Dehennaut V, 2008, MOL CELL PROTEOMICS, V7, P2229, DOI 10.1074/mcp.M700494-MCP200; Down RE, 2001, TRANSGENIC RES, V10, P223, DOI 10.1023/A:1016612912999; Du JP, 2000, INSECT BIOCHEM MOLEC, V30, P297, DOI 10.1016/S0965-1748(99)00130-7; EGDE AS, 1981, ANAL BIOCHEM, V118, P131; Fitches E, 1998, J INSECT PHYSIOL, V44, P1213, DOI 10.1016/S0022-1910(98)00090-0; Fitches E, 2008, INSECT BIOCHEM MOLEC, V38, P905, DOI 10.1016/j.ibmb.2008.07.002; Fouquaert E, 2009, BIOCHEM BIOPH RES CO, V380, P260, DOI 10.1016/j.bbrc.2009.01.048; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hino M, 2003, ZOOL SCI, V20, P709, DOI 10.2108/zsj.20.709; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Kametaka S, 2010, J CELL SCI, V123, P460, DOI 10.1242/jcs.055103; Kanie Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005434; Kaplan N, 2006, GENOME RES, V16, P1431, DOI 10.1101/gr.4916306; Kim HS, 2010, NUCLEIC ACIDS RES, V38, pD437, DOI 10.1093/nar/gkp807; Kim YK, 2009, GLYCOBIOLOGY, V19, P301, DOI 10.1093/glycob/cwn138; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x; Lehrman MA, 2001, J BIOL CHEM, V276, P8623, DOI 10.1074/jbc.R100002200; Li GY, 2005, PEST MANAG SCI, V61, P390, DOI 10.1002/ps.990; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Nakamura N, 2010, GLYCOBIOLOGY, V20, P381, DOI 10.1093/glycob/cwp189; Pepper Duncan S., 1994, Molecular Biotechnology, V2, P157, DOI 10.1007/BF02824808; Rendic D, 2007, ELECTROPHORESIS, V28, P4484, DOI 10.1002/elps.200700098; Sadeghi A, 2008, INSECT SCI, V15, P513, DOI 10.1111/j.1744-7917.2008.00240.x; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sanderson MJ, 2008, SCIENCE, V321, P121, DOI 10.1126/science.1154449; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Severson DW, 2004, J HERED, V95, P103, DOI 10.1093/jhered/esh023; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Soin T, 2010, PEST MANAG SCI, V66, P526, DOI 10.1002/ps.1903; Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Vandenborre G, 2010, J PROTEOME RES, V9, P3235, DOI 10.1021/pr1001753; Vaudel M, 2010, PROTEOMICS, V10, P650, DOI 10.1002/pmic.200900481; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yano H, 2009, CELL TISSUE RES, V336, P137, DOI 10.1007/s00441-009-0753-6; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zapata N, 2010, IND CROP PROD, V32, P405, DOI 10.1016/j.indcrop.2010.06.005; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang LP, 2010, J BIOL CHEM, V285, P19491, DOI 10.1074/jbc.M109.098145; Zhang LP, 2008, J BIOL CHEM, V283, P34076, DOI 10.1074/jbc.M804267200	53	56	56	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16682	10.1371/journal.pone.0016682	http://dx.doi.org/10.1371/journal.pone.0016682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373189	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500014
J	Volkow, ND; Tomasi, D; Wang, GJ; Fowler, JS; Telang, F; Goldstein, RZ; Alia-Klein, N; Wong, C				Volkow, Nora D.; Tomasi, Dardo; Wang, Gene-Jack; Fowler, Joanna S.; Telang, Frank; Goldstein, Rita Z.; Alia-Klein, Nelly; Wong, Christopher			Reduced Metabolism in Brain "Control Networks" following Cocaine-Cues Exposure in Female Cocaine Abusers	PLOS ONE			English	Article							GENDER-DIFFERENCES; TREATMENT-SEEKING; DEPENDENT WOMEN; SUBSTANCE-ABUSE; SMOKED COCAINE; PROGESTERONE; STRESS; ACTIVATION; REACTIVITY; MEN	Objective: Gender differences in vulnerability for cocaine addiction have been reported. Though the mechanisms are not understood, here we hypothesize that gender differences in reactivity to conditioned-cues, which contributes to relapse, are involved. Method: To test this we compared brain metabolism (using PET and (18)FDG) between female (n = 10) and male (n = 16) active cocaine abusers when they watched a neutral video (nature scenes) versus a cocaine-cues video. Results: Self-reports of craving increased with the cocaine-cue video but responses did not differ between genders. In contrast, changes in whole brain metabolism with cocaine-cues differed by gender (p<0.05); females significantly decreased metabolism (-8.6%+/- 10) whereas males tended to increase it (+5.5% +/- 18). SPM analysis (Cocaine-cues vs Neutral) in females revealed decreases in frontal, cingulate and parietal cortices, thalamus and midbrain (p<0.001) whereas males showed increases in right inferior frontal gyrus (BA 44/45) (only at p<0.005). The gender-cue interaction showed greater decrements with Cocaine-cues in females than males (p<0.001) in frontal (BA 8, 9, 10), anterior cingulate (BA 24, 32), posterior cingulate (BA 23, 31), inferior parietal (BA 40) and thalamus (dorsomedial nucleus). Conclusions: Females showed greater brain reactivity to cocaine-cues than males but no differences in craving, suggesting that there may be gender differences in response to cues that are not linked with craving but could affect subsequent drug use. Specifically deactivation of brain regions from "control networks" (prefrontal, cingulate, inferior parietal, thalamus) in females could increase their vulnerability to relapse since it would interfere with executive function (cognitive inhibition). This highlights the importance of gender tailored interventions for cocaine addiction.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD USA; [Volkow, Nora D.; Tomasi, Dardo; Telang, Frank] NIAAA, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Goldstein, Rita Z.; Alia-Klein, Nelly; Wong, Christopher] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Bethesda, MD USA.	nvolkow@nida.nih.gov	Alia-Klein, Nelly/C-3154-2013; Tomasi, Dardo/J-2127-2015		NIH (NIAAA); DOE [DE-AC01-76CH00016]; Medical Directions, Inc.; Federal Judicial Center; Gruter Institute for Law and Behavioral Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NIH (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); DOE(United States Department of Energy (DOE)); Medical Directions, Inc.; Federal Judicial Center; Gruter Institute for Law and Behavioral Research; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by NIH's Intramural Research Program (NIAAA), and by DOE (DE-AC01-76CH00016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Volkow reports no competing interests; Dr. Tomasi reports no competing interests; Dr. Wang reports no competing interests; Dr. Fowler reports no competing interests; Dr. Telang reports no competing interests; Dr. Goldstein received consultation fee from Medical Directions, Inc. and honoraria fee from Federal Judicial Center and the Gruter Institute for Law and Behavioral Research; Dr. Klein reports no competing interests; Mr. Wong reports no competing interests. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANGLIN MD, 1987, AM J DRUG ALCOHOL AB, V13, P59, DOI 10.3109/00952998709001500; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; AVANTS SK, 1995, ADDICT BEHAV, V20, P215, DOI 10.1016/0306-4603(94)00066-2; Brecht ML, 2004, ADDICT BEHAV, V29, P89, DOI 10.1016/S0306-4603(03)00082-0; Castells X, 2007, ADDICTION, V102, P1871, DOI 10.1111/j.1360-0443.2007.01943.x; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Duncan E, 2007, AM J ADDICTION, V16, P174, DOI 10.1080/10550490701375285; Elman I, 2001, AM J DRUG ALCOHOL AB, V27, P193, DOI 10.1081/ADA-100103705; Epstein DH, 2009, ARCH GEN PSYCHIAT, V66, P88, DOI 10.1001/archgenpsychiatry.2008.509; Evans SM, 2002, PSYCHOPHARMACOLOGY, V159, P397, DOI 10.1007/s00213-001-0944-7; Evans SM, 2007, EXP CLIN PSYCHOPHARM, V15, P418, DOI 10.1037/1064-1297.15.5.418; Fox HC, 2009, ALCOHOL ALCOHOLISM, V44, P575, DOI 10.1093/alcalc/agp060; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gallop RJ, 2007, J CONSULT CLIN PSYCH, V75, P95, DOI 10.1037/0022-006X.75.1.95; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Goldstein RZ, 2010, P NATL ACAD SCI USA, V107, P16667, DOI 10.1073/pnas.1011455107; Goldstein RZ, 2009, TRENDS COGN SCI, V13, P372, DOI 10.1016/j.tics.2009.06.004; GRIFFIN ML, 1989, ARCH GEN PSYCHIAT, V46, P122; Heesch CM, 1996, J PHARMACOL EXP THER, V278, P1195; Hernandez-Avila CA, 2004, DRUG ALCOHOL DEPEN, V74, P265, DOI 10.1016/j.drugalcdep.2004.02.001; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kohtz AS, 2010, HORM BEHAV, V57, P474, DOI 10.1016/j.yhbeh.2010.02.005; Kosten T.R., 1992, AM J ADDICTION, V1, P230; LI CS, 2010, P NATL ACAD SCI 0726; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; OBRIEN CP, 1990, ADDICT BEHAV, V15, P355, DOI 10.1016/0306-4603(90)90045-Y; Quinones-Jenab V, 2008, PHARMACOL BIOCHEM BE, V89, P292, DOI 10.1016/j.pbb.2007.12.024; Renshaw PF, 1999, PSYCHOPHARMACOLOGY, V142, P132, DOI 10.1007/s002130050871; Robbins SJ, 1999, DRUG ALCOHOL DEPEN, V53, P223, DOI 10.1016/S0376-8716(98)00135-5; Sinha R, 2007, EXP CLIN PSYCHOPHARM, V15, P445, DOI 10.1037/1064-1297.15.5.445; Sofuoglu M, 2002, PHARMACOL BIOCHEM BE, V72, P431, DOI 10.1016/S0091-3057(02)00716-5; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sterling RC, 2004, J SUBST ABUSE TREAT, V27, P39, DOI 10.1016/j.jsat.2004.03.008; Terner JM, 2006, DRUG ALCOHOL DEPEN, V84, P1, DOI 10.1016/j.drugalcdep.2005.12.007; TIFFANY ST, 1993, DRUG ALCOHOL DEPEN, V34, P19, DOI 10.1016/0376-8716(93)90042-O; Vadhan NP, 2007, AM J DRUG ALCOHOL AB, V33, P727, DOI 10.1080/00952990701523722; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011509; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Waldrop AE, 2010, PSYCHONEUROENDOCRINO, V35, P798, DOI 10.1016/j.psyneuen.2009.11.005; Wang GJ, 2009, P NATL ACAD SCI USA, V106, P1249, DOI 10.1073/pnas.0807423106; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; Weiss RD, 2003, AM J PSYCHIAT, V160, P1320, DOI 10.1176/appi.ajp.160.7.1320; Westermeyer J, 2000, AM J DRUG ALCOHOL AB, V26, P523, DOI 10.1081/ADA-100101893; Zilberman M, 2003, J ADDICT DIS, V22, P61, DOI 10.1300/J069v22n04_06	47	63	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16573	10.1371/journal.pone.0016573	http://dx.doi.org/10.1371/journal.pone.0016573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373180	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500011
J	Wu, JY; Anelli, CM; Sheppard, WS				Wu, Judy Y.; Anelli, Carol M.; Sheppard, Walter S.			Sub-Lethal Effects of Pesticide Residues in Brood Comb on Worker Honey Bee (Apis mellifera) Development and Longevity	PLOS ONE			English	Article							VARROA-DESTRUCTOR; MITE; INSECTICIDES; SENSITIVITY; JACOBSONI; TOXICITY; POLLEN	Background: Numerous surveys reveal high levels of pesticide residue contamination in honey bee comb. We conducted studies to examine possible direct and indirect effects of pesticide exposure from contaminated brood comb on developing worker bees and adult worker lifespan. Methodology/Principal Findings: Worker bees were reared in brood comb containing high levels of known pesticide residues (treatment) or in relatively uncontaminated brood comb (control). Delayed development was observed in bees reared in treatment combs containing high levels of pesticides particularly in the early stages (day 4 and 8) of worker bee development. Adult longevity was reduced by 4 days in bees exposed to pesticide residues in contaminated brood comb during development. Pesticide residue migration from comb containing high pesticide residues caused contamination of control comb after multiple brood cycles and provided insight on how quickly residues move through wax. Higher brood mortality and delayed adult emergence occurred after multiple brood cycles in contaminated control combs. In contrast, survivability increased in bees reared in treatment comb after multiple brood cycles when pesticide residues had been reduced in treatment combs due to residue migration into uncontaminated control combs, supporting comb replacement efforts. Chemical analysis after the experiment confirmed the migration of pesticide residues from treatment combs into previously uncontaminated control comb. Conclusions/Significance: This study is the first to demonstrate sub-lethal effects on worker honey bees from pesticide residue exposure from contaminated brood comb. Sub-lethal effects, including delayed larval development and adult emergence or shortened adult longevity, can have indirect effects on the colony such as premature shifts in hive roles and foraging activity. In addition, longer development time for bees may provide a reproductive advantage for parasitic Varroa destructor mites. The impact of delayed development in bees on Varroa mite fecundity should be examined further.	[Wu, Judy Y.; Anelli, Carol M.; Sheppard, Walter S.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA	Washington State University	Wu, JY (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	shepp@wsu.edu			State Beekeeping Associations from WA; State Beekeeping Associations from OR; State Beekeeping Associations from ID; State Beekeeping Associations from CA; State Beekeeping Associations from MT	State Beekeeping Associations from WA; State Beekeeping Associations from OR; State Beekeeping Associations from ID; State Beekeeping Associations from CA; State Beekeeping Associations from MT	Sources of funding that supported this work included State Beekeeping Associations from WA, OR, ID, CA and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Amdam GV, 2004, J ECON ENTOMOL, V97, P741, DOI 10.1603/0022-0493(2004)097[0741:APIWHB]2.0.CO;2; Berry JA, 2001, J APICULT RES, V40, P3, DOI 10.1080/00218839.2001.11101042; BOGDANOV S, 1996, BEE PRODUCTS PROPERT, P247; Bonmatin JM, 2005, ENVIRONMENTAL CHEMISTRY: GREEN CHEMISTRY AND POLLUTANTS IN ECOSYSTEMS, P483; Bowen-Walker PL, 2001, ENTOMOL EXP APPL, V101, P207, DOI 10.1023/A:1019254727879; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; DEJONG D, 1997, HONEY BEE PESTS PRED, P281; Donze G, 1997, J INSECT BEHAV, V10, P371, DOI 10.1007/BF02765605; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; LADAS A, 1972, Apidologie, V3, P55, DOI 10.1051/apido:19720103; MACKENSEN O, 1951, GENETICS, V36, P500; MEDRZYCKI P, 2009, J APICULT RES, V49, pS52; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Pettis JS, 2004, APIDOLOGIE, V35, P605, DOI 10.1051/apido:2004056; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sparling DW, 2007, ENVIRON POLLUT, V147, P535, DOI 10.1016/j.envpol.2006.10.036; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Thompson HM, 2007, PEST MANAG SCI, V63, P1081, DOI 10.1002/ps.1457; *USDA, VARR JAC REPR VARR M; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Visscher PK, 1997, INSECT SOC, V44, P1, DOI 10.1007/s000400050017; WAHL O, 1983, OECOLOGIA, V59, P106, DOI 10.1007/BF00388082; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260	30	229	245	2	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14720	10.1371/journal.pone.0014720	http://dx.doi.org/10.1371/journal.pone.0014720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373182	gold, Green Published			2022-12-27	WOS:000287657500004
J	Blainey, PC; Mosier, AC; Potanina, A; Francis, CA; Quake, SR				Blainey, Paul C.; Mosier, Annika C.; Potanina, Anastasia; Francis, Christopher A.; Quake, Stephen R.			Genome of a Low-Salinity Ammonia-Oxidizing Archaeon Determined by Single-Cell and Metagenomic Analysis	PLOS ONE			English	Article							PACIFIC SUBTROPICAL GYRE; MARINE CRENARCHAEOTA; NITRIFYING ARCHAEA; RELATIVE ABUNDANCE; PROKARYOTIC CELLS; NORTH-ATLANTIC; WATER MASSES; BACTERIA; OCEAN; DIVERSITY	Ammonia-oxidizing archaea (AOA) are thought to be among the most abundant microorganisms on Earth and may significantly impact the global nitrogen and carbon cycles. We sequenced the genome of AOA in an enrichment culture from low-salinity sediments in San Francisco Bay using single-cell and metagenomic genome sequence data. Five single cells were isolated inside an integrated microfluidic device using laser tweezers, the cells' genomic DNA was amplified by multiple displacement amplification (MDA) in 50 nL volumes and then sequenced by high-throughput DNA pyrosequencing. This microscopy-based approach to single-cell genomics minimizes contamination and allows correlation of high-resolution cell images with genomic sequences. Statistical properties of coverage across the five single cells, in combination with the contrasting properties of the metagenomic dataset allowed the assembly of a high-quality draft genome. The genome of this AOA, which we designate Candidatus Nitrosoarchaeum limnia SFB1,is similar to 1.77 Mb with >2100 genes and a G+C content of 32%. Across the entire genome, the average nucleotide identity to Nitrosopumilus maritimus, the only AOA in pure culture, is similar to 70%, suggesting this AOA represents a new genus of Crenarchaeota. Phylogenetically, the 16S rRNA and ammonia monooxygenase subunit A (amoA) genes of this AOA are most closely related to sequences reported from a wide variety of freshwater ecosystems. Like N. maritimus, the low-salinity AOA genome appears to have an ammonia oxidation pathway distinct from ammonia oxidizing bacteria (AOB). In contrast to other described AOA, these low-salinity AOA appear to be motile, based on the presence of numerous motility-and chemotaxis-associated genes in the genome. This genome data will be used to inform targeted physiological and metabolic studies of this novel group of AOA, which may ultimately advance our understanding of AOA metabolism and their impacts on the global carbon and nitrogen cycles.	[Blainey, Paul C.; Potanina, Anastasia; Quake, Stephen R.] Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA; [Mosier, Annika C.; Francis, Christopher A.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Blainey, PC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Bioengn, Stanford, CA 94305 USA.	caf@stanford.edu; quake@stanford.edu	t, lf/AAJ-4924-2020	Francis, Christopher/0000-0001-7557-631X; Mosier, Annika/0000-0001-5333-4854; Blainey, Paul/0000-0002-4889-8783	National Science Foundation [MCB-0604270, OCE-0847266]; NIH [5R01HG004863-02]; EPA STAR; Division Of Ocean Sciences [0847266] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004863] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA STAR(United States Environmental Protection Agency); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported in part by National Science Foundation Grants MCB-0604270 and OCE-0847266 (to C. A. F.), NIH Director's Pioneer Award and NIH 5R01HG004863-02 (to S. R. Q.) and an EPA STAR Graduate Fellowship (to A. C. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1992, APPL ENVIRON MICROB, V58, P3007, DOI 10.1128/AEM.58.9.3007-3011.1992; Arp DJ, 2002, ARCH MICROBIOL, V178, P250, DOI 10.1007/s00203-002-0452-0; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Beman JM, 2010, ENVIRON MICROBIOL, V12, P1282, DOI 10.1111/j.1462-2920.2010.02172.x; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Burton SAQ, 2001, APPL ENVIRON MICROB, V67, P2952, DOI 10.1128/AEM.67.7.2952-2957.2001; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hallam SJ, 2006, P NATL ACAD SCI USA, V103, P18296, DOI 10.1073/pnas.0608549103; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Herfort L, 2007, FEMS MICROBIOL ECOL, V62, P242, DOI 10.1111/j.1574-6941.2007.00397.x; Herndl GJ, 2005, APPL ENVIRON MICROB, V71, P2303, DOI 10.1128/AEM.71.5.2303-2309.2005; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; HOOPER A, 2005, EUROPEAN J BIOCH, V141, P565; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ingalls AE, 2006, P NATL ACAD SCI USA, V103, P6442, DOI 10.1073/pnas.0510157103; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; Kemnitz D, 2007, FEMS MICROBIOL ECOL, V60, P442, DOI 10.1111/j.1574-6941.2007.00310.x; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Luo X, 2007, J BACTERIOL, V189, P403, DOI 10.1128/JB.01246-06; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Maddison WP, 2000, J THEOR BIOL, V202, P195, DOI 10.1006/jtbi.1999.1050; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Moin NS, 2009, APPL ENVIRON MICROB, V75, P7461, DOI 10.1128/AEM.01001-09; Mosier AC, 2008, ENVIRON MICROBIOL, V10, P3002, DOI 10.1111/j.1462-2920.2008.01764.x; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Pernthaler Annelie, 2007, Methods Mol Biol, V353, P153; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sandaa RA, 1999, APPL ENVIRON MICROB, V65, P3293; Santoro AE, 2008, ENVIRON MICROBIOL, V10, P1068, DOI 10.1111/j.1462-2920.2007.01547.x; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stahl D.A., 1991, SEQUENCING HYBRIDIZA, P205; Teira E, 2006, LIMNOL OCEANOGR, V51, P2131, DOI 10.4319/lo.2006.51.5.2131; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; White RA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-116; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103	69	233	248	3	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16626	10.1371/journal.pone.0016626	http://dx.doi.org/10.1371/journal.pone.0016626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364937	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600009
J	Koch, N; Zacharias, M; Konig, A; Temme, S; Neumann, J; Springer, S				Koch, Norbert; Zacharias, Martin; Koenig, Angelika; Temme, Sebastian; Neumann, Juergen; Springer, Sebastian			Stoichiometry of HLA Class II-Invariant Chain Oligomers	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSMEMBRANE DOMAIN; TRANSPORT-PROPERTIES; ESCHERICHIA-COLI; CELL-SURFACE; IA-ANTIGENS; DR-BETA; MOLECULES; RECEPTOR; BINDING	Background: The HLA gene complex encodes three class II isotypes, DR, DQ, and DP. HLA class II molecules are peptide receptors that present antigens for recognition by T lymphocytes. In antigen presenting cells, the assembly of matched alpha and beta subunits to heterodimers is chaperoned by invariant chain (Ii). Ii forms a homotrimer with three binding sites for class II heterodimers. The current model of class II and Ii structure states that three alpha beta heterodimers bind to an Ii trimer. Methology/Principal Findings: We have now analyzed the composition and size of the complexes of class II and Ii using epitope tagged class II subunits and density gradient experiments. We show here that class II-Ii oligomers consist of one class II heterodimer associated with one Ii trimer, such that the DR, DQ and DP isotypes are contained within separate complexes with Ii. Conclusion/Significance: We propose a structural model of the class II-Ii oligomer and speculate that the pentameric class II-Ii complex is bent towards the cell membrane, inhibiting the binding of additional class II heterodimers to Ii.	[Koch, Norbert; Koenig, Angelika; Temme, Sebastian; Neumann, Juergen] Univ Bonn, Inst Genet, Div Immunobiol, D-5300 Bonn, Germany; [Zacharias, Martin] Tech Univ Munich, Dept Phys, D-8000 Munich, Germany; [Springer, Sebastian] Jacobs Univ Bremen, Mol Life Sci Ctr, Bremen, Germany	University of Bonn; Technical University of Munich; University of Munich; Jacobs University	Koch, N (corresponding author), Univ Bonn, Inst Genet, Div Immunobiol, D-5300 Bonn, Germany.	norbert.koch@uni-bonn.de	Springer, Sebastian/AAJ-7036-2021	Springer, Sebastian/0000-0002-5527-6149	Deutsche Forschungsgemeinschaft [Ko 810/6]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft Ko 810/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ANDERSON KS, 1994, EMBO J, V13, P675, DOI 10.1002/j.1460-2075.1994.tb06306.x; ARNESON LS, 1995, J CELL BIOL, V129, P1217, DOI 10.1083/jcb.129.5.1217; ARUNACHALAM B, 1994, INT IMMUNOL, V6, P439, DOI 10.1093/intimm/6.3.439; Ashman JB, 1999, J IMMUNOL, V163, P2704; AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castellino F, 2001, EUR J IMMUNOL, V31, P841, DOI 10.1002/1521-4141(200103)31:3<841::AID-IMMU841>3.0.CO;2-D; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9; Dixon AM, 2006, BIOCHEMISTRY-US, V45, P5228, DOI 10.1021/bi052112e; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; GRAF L, 1985, MOL IMMUNOL, V22, P1371, DOI 10.1016/0161-5890(85)90059-8; Gruneberg U, 1997, HUM IMMUNOL, V53, P34, DOI 10.1016/S0198-8859(97)00025-6; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Hofmann MW, 1999, J BIOL CHEM, V274, P36153, DOI 10.1074/jbc.274.51.36153; JASANOFF A, 1995, P NATL ACAD SCI USA, V92, P9900, DOI 10.1073/pnas.92.21.9900; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Jasanoff A, 1999, IMMUNITY, V10, P761, DOI 10.1016/S1074-7613(00)80075-8; JONES PP, 1978, J EXP MED, V148, P925, DOI 10.1084/jem.148.4.925; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; KOCH N, 1986, J BIOL CHEM, V261, P3434; Koch N, 2007, TRENDS BIOCHEM SCI, V32, P532, DOI 10.1016/j.tibs.2007.09.007; KOCH S, 1987, J IMMUNOL METHODS, V103, P211, DOI 10.1016/0022-1759(87)90292-4; LAMB CA, 1992, J IMMUNOL, V148, P3478; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Leng L, 2006, CELL RES, V16, P162, DOI 10.1038/sj.cr.7310022; Lennon-Dumenil AM, 2001, EMBO J, V20, P4055, DOI 10.1093/emboj/20.15.4055; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARKS MS, 1995, J BIOL CHEM, V270, P10475, DOI 10.1074/jbc.270.18.10475; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; Mitra AK, 2004, CURR BIOL, V14, P718, DOI 10.1016/j.cub.2004.04.004; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Neumann J, 2005, J IMMUNOL METHODS, V301, P66, DOI 10.1016/j.jim.2005.03.014; Neumann J, 2001, J BIOL CHEM, V276, P13469, DOI 10.1074/jbc.M010629200; Neumann J, 2006, J CELL SCI, V119, P4207, DOI 10.1242/jcs.03177; Nordeng TW, 2002, MOL BIOL CELL, V13, P1846, DOI 10.1091/mbc.01-10-0478; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; PESANDO JM, 1986, J IMMUNOL, V136, P4311; POLLET RJ, 1981, J BIOL CHEM, V256, P2118; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Rodionov DG, 2002, J BIOL CHEM, V277, P47436, DOI 10.1074/jbc.M207149200; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schwartz V, 2009, FEBS LETT, V583, P2749, DOI 10.1016/j.febslet.2009.07.058; Siebenkotten IM, 1998, J IMMUNOL, V160, P3355; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; SUNG E, 1981, MOL IMMUNOL, V18, P899, DOI 10.1016/0161-5890(81)90013-4; Verreck FAW, 2001, EUR J IMMUNOL, V31, P1029, DOI 10.1002/1521-4141(200104)31:4<1029::AID-IMMU1029>3.0.CO;2-Q; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; WRAIGHT CJ, 1990, J BIOL CHEM, V265, P5787; Ye LL, 2008, J IMMUNOL, V181, P2572, DOI 10.4049/jimmunol.181.4.2572; Zhong GM, 1996, J EXP MED, V184, P2061, DOI 10.1084/jem.184.5.2061	58	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17257	10.1371/journal.pone.0017257	http://dx.doi.org/10.1371/journal.pone.0017257			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364959	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600037
J	Hamada, M; Kiryu, H; Iwasaki, W; Asai, K				Hamada, Michiaki; Kiryu, Hisanori; Iwasaki, Wataru; Asai, Kiyoshi			Generalized Centroid Estimators in Bioinformatics	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; STRUCTURE PREDICTION; WEB SERVER; PARTITION-FUNCTION; NONCODING RNAS; SEQUENCE; ALIGNMENT; PROBABILITIES; ALGORITHMS; INFERENCE	In a number of estimation problems in bioinformatics, accuracy measures of the target problem are usually given, and it is important to design estimators that are suitable to those accuracy measures. However, there is often a discrepancy between an employed estimator and a given accuracy measure of the problem. In this study, we introduce a general class of efficient estimators for estimation problems on high-dimensional binary spaces, which represent many fundamental problems in bioinformatics. Theoretical analysis reveals that the proposed estimators generally fit with commonly-used accuracy measures (e.g. sensitivity, PPV, MCC and F-score) as well as it can be computed efficiently in many cases, and cover a wide range of problems in bioinformatics from the viewpoint of the principle of maximum expected accuracy (MEA). It is also shown that some important algorithms in bioinformatics can be interpreted in a unified manner. Not only the concept presented in this paper gives a useful framework to design MEA-based estimators but also it is highly extendable and sheds new light on many problems in bioinformatics.	[Hamada, Michiaki; Kiryu, Hisanori; Iwasaki, Wataru; Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan; [Hamada, Michiaki; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Hamada, M (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan.	mhamada@k.u-tokyo.ac.jp	Iwasaki, Wataru/O-4917-2014; Hamada, Michiaki/L-9371-2018; Asai, Kiyoshi/AAT-8344-2020	Iwasaki, Wataru/0000-0002-9169-9245; Hamada, Michiaki/0000-0001-9466-1034; Asai, Kiyoshi/0000-0003-0909-4982	New Energy Technology Development Organization (NEDO)	New Energy Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	Funding: This work was supported in part by the "Functional RNA Project" of the New Energy Technology Development Organization (NEDO), and in part by a Grant-in-Aid for Scientific Innovative Areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronescu M, 2007, BIOINFORMATICS, V23, pI19, DOI 10.1093/bioinformatics/btm223; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bernhart Stephan H., 2009, Briefings in Functional Genomics & Proteomics, V8, P461, DOI 10.1093/bfgp/elp043; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bradley RK, 2008, BIOINFORMATICS, V24, P2677, DOI 10.1093/bioinformatics/btn495; Carvalho LE, 2008, P NATL ACAD SCI USA, V105, P3209, DOI 10.1073/pnas.0712329105; Chan CY, 2005, BIOINFORMATICS, V21, P3926, DOI 10.1093/bioinformatics/bti632; Ding Y, 2005, RNA, V11, P1157, DOI 10.1261/rna.2500605; Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Do CB, 2006, BIOINFORMATICS, V22, pE90, DOI 10.1093/bioinformatics/btl246; Do CB, 2006, LECT NOTES COMPUT SC, V3909, P160, DOI 10.1007/11732990_15; Dowell RD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-71; Durbin R., 1998, BIOL SEQUENCE ANAL P; Frith MC, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq010; Frith MC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-80; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Gross SS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r269; Hamada M, 2011, NUCLEIC ACIDS RES, V39, P393, DOI 10.1093/nar/gkq792; Hamada M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-586; Hamada M, 2009, BIOINFORMATICS, V25, P3236, DOI 10.1093/bioinformatics/btp580; Hamada M, 2009, BIOINFORMATICS, V25, pI330, DOI 10.1093/bioinformatics/btp228; Hamada M, 2009, BIOINFORMATICS, V25, P465, DOI 10.1093/bioinformatics/btn601; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holmes I, 1998, J COMPUT BIOL, V5, P493, DOI 10.1089/cmb.1998.5.493; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iwasaki W, 2010, SYST BIOL, V59, P584, DOI 10.1093/sysbio/syq044; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Kato Y, 2010, BIOINFORMATICS, V26, pi460, DOI 10.1093/bioinformatics/btq372; Kiryu H, 2007, BIOINFORMATICS, V23, P434, DOI 10.1093/bioinformatics/btl636; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Miyazawa S, 1995, PROTEIN ENG, V8, P999, DOI 10.1093/protein/8.10.999; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; NUSSINOV R, 1978, SIAM J APPL MATH, V35, P68, DOI 10.1137/0135006; Okada Y, 2010, BIOCOMPUT-PAC SYM, P88; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; SANKOFF D, 1985, SIAM J APPL MATH, V45, P810, DOI 10.1137/0145048; Sato K, 2009, NUCLEIC ACIDS RES, V37, pW277, DOI 10.1093/nar/gkp367; Schroeder SJ, 2009, J VIROL, V83, P6326, DOI 10.1128/JVI.00251-09; SCHWARTZ AS, 2005, ALIGNMENT METRIC ACC; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	52	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16450	10.1371/journal.pone.0016450	http://dx.doi.org/10.1371/journal.pone.0016450			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365017	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800006
J	Leiberg, S; Klimecki, O; Singer, T				Leiberg, Susanne; Klimecki, Olga; Singer, Tania			Short-Term Compassion Training Increases Prosocial Behavior in a Newly Developed Prosocial Game	PLOS ONE			English	Article							LOVING-KINDNESS MEDITATION; SEX-DIFFERENCES; DICTATOR GAMES; ALTRUISM; FAIRNESS; EMPATHY; ADULTS; PERFORMANCE; RECIPROCITY; VALIDATION	Compassion has been suggested to be a strong motivator for prosocial behavior. While research has demonstrated that compassion training has positive effects on mood and health, we do not know whether it also leads to increases in prosocial behavior. We addressed this question in two experiments. In Experiment 1, we introduce a new prosocial game, the Zurich Prosocial Game (ZPG), which allows for repeated, ecologically valid assessment of prosocial behavior and is sensitive to the influence of reciprocity, helping cost, and distress cues on helping behavior. Experiment 2 shows that helping behavior in the ZPG increased in participants who had received short-term compassion training, but not in participants who had received short-term memory training. Interindividual differences in practice duration were specifically related to changes in the amount of helping under no-reciprocity conditions. Our results provide first evidence for the positive impact of short-term compassion training on prosocial behavior towards strangers in a training-unrelated task.	[Leiberg, Susanne; Klimecki, Olga; Singer, Tania] Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland; [Klimecki, Olga; Singer, Tania] Max Planck Inst Human Cognit & Brain Sci, Dept Social Neurosci, Leipzig, Germany	University of Zurich; Max Planck Society	Leiberg, S (corresponding author), Univ Zurich, Dept Econ, Lab Social & Neural Syst Res, Zurich, Switzerland.	susanne.leiberg@econ.uzh.ch	Girault, Johann/B-2430-2012; Klimecki, Olga M/L-5034-2016	Klimecki, Olga M/0000-0003-0757-7761; Leiberg, Susanne/0000-0001-9427-7614	European Research Council under the European Community/ERC [205557]; Swiss National Science Foundation through the National Centre of Competence in Research; University of Zurich; Mind and Life Institute	European Research Council under the European Community/ERC(European Research Council (ERC)); Swiss National Science Foundation through the National Centre of Competence in Research(Swiss National Science Foundation (SNSF)); University of Zurich; Mind and Life Institute	This research was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement number 205557 [EMPATHICBRAIN] (http://erc.europa.eu); by the Swiss National Science Foundation through the National Centre of Competence in Research "Neural Plasticity and Repair,"Project 5: Cortical Plasticity (http://www.nccr-neuro.ethz.ch); by the University of Zurich (http://www.uzh.ch); and by the Mind and Life Institute (http://www.mindandlife.org). The authors gratefully acknowledge support by the Research Priority Program "Foundations of Human Social Behavior" at the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Batson C. D., 1981, ALTRUISM HELP BEHAV, P167; Batson CD, 2007, J PERS SOC PSYCHOL, V93, P65, DOI 10.1037/0022-3514.93.1.65; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Batson CD., 1991, ALTRUISM QUESTION SO; Baumeister R.F., 2007, ENCY SOCIAL PSYCHOL; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Bohnet I, 1999, J ECON BEHAV ORGAN, V38, P43, DOI 10.1016/S0167-2681(98)00121-8; Bolton GE, 1998, INT J GAME THEORY, V27, P269, DOI 10.1007/s001820050072; BOWER GH, 1970, AM SCI, V58, P496; BURNSTEIN E, 1994, J PERS SOC PSYCHOL, V67, P773, DOI 10.1037/0022-3514.67.5.773; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Caprara GV, 2005, EUR J PSYCHOL ASSESS, V21, P77, DOI 10.1027/1015-5759.21.2.77; CARLO G, 1991, J PERS SOC PSYCHOL, V61, P450, DOI 10.1037/0022-3514.61.3.450; Carson JW, 2005, J HOLIST NURS, V23, P287, DOI 10.1177/0898010105277651; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Depue RA, 2005, BEHAV BRAIN SCI, V28, P313; Dovidio J.F., 1991, PROSOCIAL BEHAV, P86; Eckel CC, 1996, GAME ECON BEHAV, V16, P181, DOI 10.1006/game.1996.0081; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr C., 2009, SCI COMPASSIONATE LO; FEHR E, 2006, RECIPROCITY ALTRUISM, P615; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fredrickson BL, 2008, J PERS SOC PSYCHOL, V95, P1045, DOI 10.1037/a0013262; Gentili R, 2010, J NEUROPHYSIOL, V104, P774, DOI 10.1152/jn.00257.2010; Gilbert P, 2007, PSYCHOTHERAPY COUNSE, DOI DOI 10.4135/9781446279830; Gilbert P., 2005, COMPASSION CONCEPTUA, P263, DOI [DOI 10.4324/9780203003459, 10.4324/9780203003459]; Gilbert P., 2022, COMPASSION FOCUSED T; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; Golan O, 2010, J AUTISM DEV DISORD, V40, P269, DOI 10.1007/s10803-009-0862-9; Greitemeyer T, 2009, PERS SOC PSYCHOL B, V35, P1500, DOI 10.1177/0146167209341648; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Kring AM, 1998, J PERS SOC PSYCHOL, V74, P686, DOI 10.1037/0022-3514.74.3.686; LEVINE RV, 1994, J PERS SOC PSYCHOL, V67, P69, DOI 10.1037/0022-3514.67.1.69; Lustig C, 2009, NEUROPSYCHOL REV, V19, P504, DOI 10.1007/s11065-009-9119-9; McCullough ME, 1997, J PERS SOC PSYCHOL, V73, P321, DOI 10.1037/0022-3514.73.2.321; Nelson JudithKay., 2005, SEEING TEARS CRYING; Nowak MA, 2000, SCIENCE, V289, P1773, DOI 10.1126/science.289.5485.1773; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Pace TWW, 2009, PSYCHONEUROENDOCRINO, V34, P87, DOI 10.1016/j.psyneuen.2008.08.011; Rockliff H., 2008, J CLIN NEUROPSYCHIAT, V5, P132; Salzberg S., 1995, LOVING KINDNESS REVO; Singer T, 2009, ANN NY ACAD SCI, V1167, P41, DOI 10.1111/j.1749-6632.2009.04733.x; Slaski M, 2003, STRESS HEALTH, V19, P233, DOI 10.1002/smi.979; Sprecher S, 2005, J SOC PERS RELAT, V22, P629, DOI 10.1177/0265407505056439; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Twenge JM, 2007, J PERS SOC PSYCHOL, V92, P56, DOI 10.1037/0022-3514.92.1.56; Van Lange PAM, 2007, BASIC APPL SOC PSYCH, V29, P375, DOI 10.1080/01973530701665223; Verhaeghen P, 1996, PSYCHOL AGING, V11, P164, DOI 10.1037/0882-7974.11.1.164; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WILKE H, 1970, J EXP SOC PSYCHOL, V6, P488, DOI 10.1016/0022-1031(70)90058-2; Wittchen H-U., 1997, STRUCTURED CLIN INTE	61	227	230	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17798	10.1371/journal.pone.0017798	http://dx.doi.org/10.1371/journal.pone.0017798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	732FR	21408020	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900049
J	Silveira, CB; Vieira, RP; Cardoso, AM; Paranhos, R; Albano, RM; Martins, OB				Silveira, Cynthia B.; Vieira, Ricardo P.; Cardoso, Alexander M.; Paranhos, Rodolfo; Albano, Rodolpho M.; Martins, Orlando B.			Influence of Salinity on Bacterioplankton Communities from the Brazilian Rain Forest to the Coastal Atlantic Ocean	PLOS ONE			English	Article							BACTERIAL DIVERSITY; MICROBIAL ECOLOGY; GUANABARA BAY; MARINE; FRESH; BIOGEOCHEMISTRY; ENVIRONMENT; LINEAGES; ARCHAEAL; REVEAL	Background: Planktonic bacteria are recognized as important drivers of biogeochemical processes in all aquatic ecosystems, however, the taxa that make up these communities are poorly known. The aim of this study was to investigate bacterial communities in aquatic ecosystems at IIha Grande, Rio de Janeiro, Brazil, a preserved insular environment of the Atlantic rain forest and how they correlate with a salinity gradient going from terrestrial aquatic habitats to the coastal Atlantic Ocean. Methodology/Principal Findings: We analyzed chemical and microbiological parameters of water samples and constructed 16S rRNA gene libraries of free living bacteria obtained at three marine (two coastal and one offshore) and three freshwater (water spring, river, and mangrove) environments. A total of 836 sequences were analyzed by MOTHUR, yielding 269 freshwater and 219 marine operational taxonomic units (OTUs) grouped at 97% stringency. Richness and diversity indexes indicated that freshwater environments were the most diverse, especially the water spring. The main bacterial group in freshwater environments was Betaproteobacteria (43.5%), whereas Cyanobacteria (30.5%), Alphaproteobacteria (25.5%), and Gammaproteobacteria (26.3%) dominated the marine ones. Venn diagram showed no overlap between marine and freshwater OTUs at 97% stringency. LIBSHUFF statistics and PCA analysis revealed marked differences between the freshwater and marine libraries suggesting the importance of salinity as a driver of community composition in this habitat. The phylogenetic analysis of marine and freshwater libraries showed that the differences in community composition are consistent. Conclusions/Significance: Our data supports the notion that a divergent evolutionary scenario is driving community composition in the studied habitats. This work also improves the comprehension of microbial community dynamics in tropical waters and how they are structured in relation to physicochemical parameters. Furthermore, this paper reveals for the first time the pristine bacterioplankton communities in a tropical island at the South Atlantic Ocean.	[Silveira, Cynthia B.; Vieira, Ricardo P.; Martins, Orlando B.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Paranhos, Rodolfo] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Cardoso, Alexander M.] Inst Nacl Metrol Normalizacao & Qualidade Ind, Rio De Janeiro, Brazil; [Albano, Rodolpho M.] Univ Estado Rio de Janeiro, Dept Bioquim, BR-20550011 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade do Estado do Rio de Janeiro	Silveira, CB (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	amcardoso@bioqmed.ufrj.br	Paranhos, Rodolfo/F-1927-2011; Cardoso, Alexander/S-6687-2017; Cardoso, Alexander/AAX-2505-2021; Silveira, Cynthia/D-6829-2013	Cardoso, Alexander/0000-0003-2974-0232; Albano, Rodolpho/0000-0002-0643-901X; Silveira, Cynthia/0000-0002-9533-5588	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida WI, 2009, EXTREMOPHILES, V13, P263, DOI 10.1007/s00792-008-0214-2; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrade L, 2003, J MICROBIOL METH, V55, P841, DOI 10.1016/j.mimet.2003.08.002; Baltazar LD, 2008, REV SOC BRAS MED TRO, V41, P449; Brown MV, 2009, ISME J, V3, P1374, DOI 10.1038/ismej.2009.86; Carlson CA, 2004, LIMNOL OCEANOGR, V49, P1073, DOI 10.4319/lo.2004.49.4.1073; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho FRS, 2007, CURR MICROBIOL, V55, P288, DOI 10.1007/s00284-006-0589-1; Cole JR, 2003, NUCLEIC ACIDS RES, V31, P442, DOI 10.1093/nar/gkg039; Cottrell MT, 2005, ENVIRON MICROBIOL, V7, P1883, DOI 10.1111/j.1462-2920.2005.00762.x; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fuhrman JA, 2002, ANTON LEEUW INT J G, V81, P521, DOI 10.1023/A:1020513506777; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Giovannoni SJ, 1995, NATO ADV SCI INST SE, V38, P217; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; Gonzalez AM, 2000, BRAZ ARCH BIOL TECHN, V43, P493, DOI 10.1590/S1516-89132000000500008; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Grasshoff K., 1999, METHODS SEAWATER ANA, V3rd, P600, DOI DOI 10.1002/9783527613984; Hahn MW, 2006, CURR OPIN BIOTECH, V17, P256, DOI 10.1016/j.copbio.2006.05.006; HOBBIE JE, 1988, LIMNOL OCEANOGR, V33, P750, DOI 10.4319/lo.1988.33.4_part_2.0750; Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Kan JJ, 2006, LIMNOL OCEANOGR, V51, P2157, DOI 10.4319/lo.2006.51.5.2157; Karl DM, 2002, NATURE, V415, P590, DOI 10.1038/415590b; KIRCHMAN D, 1985, APPL ENVIRON MICROB, V49, P599, DOI 10.1128/AEM.49.3.599-607.1985; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lambais MR, 2006, SCIENCE, V312, P1917, DOI 10.1126/science.1124696; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lima-Bittencourt CI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-58; Logares R, 2010, MOL BIOL EVOL, V27, P347, DOI 10.1093/molbev/msp239; Logares R, 2009, TRENDS MICROBIOL, V17, P414, DOI 10.1016/j.tim.2009.05.010; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; MARENGO JA, 2001, ACAO AMBIENTAL, V4, P10; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; Methe BA, 1998, LIMNOL OCEANOGR, V43, P368, DOI 10.4319/lo.1998.43.2.0368; Morellato LPC, 2000, BIOTROPICA, V32, P786, DOI 10.1111/j.1744-7429.2000.tb00618.x; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RIEMANN L, 2006, APPL ENVIRON MICROB, V74, P503; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Sigee DC, 2005, FRESHWATER MICROBIOL, P287; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Smith MW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013312; Souchie EL, 2006, AN ACAD BRAS CIENC, V78, P183, DOI 10.1590/S0001-37652006000100016; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbach E, 2001, LIMNOL OCEANOGR, V46, P557, DOI 10.4319/lo.2001.46.3.0557; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Vieira RP, 2008, ENVIRON MICROBIOL, V10, P189, DOI 10.1111/j.1462-2920.2007.01443.x; Vieira RP, 2007, MICROB ECOL, V54, P460, DOI 10.1007/s00248-007-9261-y; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YILMAZ P, 2010, NATURE P, DOI DOI 10.1038/NPRE.2010.5252.1	64	28	28	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17789	10.1371/journal.pone.0017789	http://dx.doi.org/10.1371/journal.pone.0017789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408023	Green Published, Green Submitted, gold			2022-12-27	WOS:000288170900048
J	Malaviya, P; Picado, A; Singh, P; Hasker, E; Singh, RP; Boelaert, M; Sundar, S				Malaviya, Paritosh; Picado, Albert; Singh, Shri Prakash; Hasker, Epco; Singh, Rudra Pratap; Boelaert, Marleen; Sundar, Shyam			Visceral Leishmaniasis in Muzaffarpur District, Bihar, India from 1990 to 2008	PLOS ONE			English	Article							PHLEBOTOMUS-ARGENTIPES DIPTERA; KALA-AZAR; PSYCHODIDAE; ELIMINATION	Background: Visceral Leishmaniasis (VL) is a vector-borne disease transmitted by Phlebotomus argentipes. To understand the VL seasonality, annual and monthly variations of VL incidence and its relationship to meteorological variables, the numbers of VL cases reported in Muzaffarpur district, Bihar, India from 1990 to 2008 were studied. Methods: Annual VL incidence per 10,000 and the total number of annual VL cases reported at block Community Health Centres (CHC), Public Hospitals or Non-Governmental Organisations (NGO) and the number of VL cases per month from 2000 to 2008 as well as the monthly average of cases for 2000-08, 2000-04 and 2005-08 periods along with the monthly averages of temperature, rainfall and relative humidity were plotted. VL Standardised Incidence Ratios per block were computed for the periods of 1990-1993, 1994-1998, 1999-2004 and 2005-2008 and month wise from 2002 to 2008. A negative binomial regression model was used to evaluate the association between meteorological variables and the number of VL cases per month from 2000 to 2008. Results: A total of 68,358 VL cases were reported in Muzaffarpur district from 1990 to 2008, ranging from 1,2481 in 1992 to 1,161 in 2001. The blocks with the highest number of cases shifted from East (1990-98) to West (1999-2008). Monthly averages of cases ranged from 149 to 309, highest peak in March-April and another one in July. Monthly VL incidence was associated positively to rainfall and negatively to relative humidity and the numbers of VL cases in the previous month. Interpretation: The number of cases reported to the public health sector allowed the describing of the spatial distribution and temporal variations in the Muzaffarpur from 1990 to 2008. However, to assess the actual VL burden, as well as the efficacy of the control measures applied in the district, reporting from private practices and NGOs should be encouraged.	[Malaviya, Paritosh; Singh, Shri Prakash; Singh, Rudra Pratap; Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Picado, Albert; Hasker, Epco; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium	Banaras Hindu University (BHU); Institute of Tropical Medicine (ITM)	Malaviya, P (corresponding author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Singh, Priyanka/N-1372-2018; Singh, Priyanka/GRF-6098-2022; Malaviya, Paritosh/B-1819-2012; Boelaert, Marleen/E-2698-2012	Singh, Priyanka/0000-0003-0841-1544; Malaviya, Paritosh/0000-0002-7558-152X; Boelaert, Marleen/0000-0001-8051-6776; Picado, Albert/0000-0001-7344-628X	National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC [1P50AI074321]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI074321] Funding Source: NIH RePORTER	National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergic and Infectious Diseases, National Institutes of Health, TMRC Grant No. 1P50AI074321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya SK, 2006, INDIAN J MED RES, V123, P195; Bhunia GS, 2010, ANN TROP MED PARASIT, V104, P35, DOI 10.1179/136485910X12607012373678; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; Dinesh DS, 2001, ANN TROP MED PARASIT, V95, P197, DOI 10.1080/00034980120041071; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ghosh K, 1999, J MED ENTOMOL, V36, P588, DOI 10.1093/jmedent/36.5.588; Haghdoost AA, 2008, TROP MED INT HEALTH, V13, P1501, DOI 10.1111/j.1365-3156.2008.02166.x; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Joshi A., 2008, Journal of Vector Borne Diseases, V45, P105; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; OSTYN B, 2008, TROP MED INT HLTH; Picado A, 2010, J MED ENTOMOL, V47, P283, DOI 10.1603/ME09175; *PROGR NVBDG, KAL CONTR EFF IND; Singh A, 2008, J ECOPHYSIOLOGY OCCU, V8; Singh NS, 2009, SE ASIAN J TROP MED, V40, P458; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Thakur CP, 2007, INDIAN J MED RES, V126, P447; 2010, KALAAZAR FREQUENTLY; PERCENTAGE DECADAL V	20	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e14751	10.1371/journal.pone.0014751	http://dx.doi.org/10.1371/journal.pone.0014751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394195	Green Submitted, gold, Green Published			2022-12-27	WOS:000288025500003
J	Pavli, OI; Kelaidi, GI; Tampakaki, AP; Skaracis, GN				Pavli, Ourania I.; Kelaidi, Georgia I.; Tampakaki, Anastasia P.; Skaracis, George N.			The hrpZ Gene of Pseudomonas syringae pv. phaseolicola Enhances Resistance to Rhizomania Disease in Transgenic Nicotiana benthamiana and Sugar Beet	PLOS ONE			English	Article							YELLOW-VEIN-VIRUS; SYSTEMIC ACQUIRED-RESISTANCE; HYPERSENSITIVE CELL-DEATH; BNYVV COAT PROTEIN; ERWINIA-AMYLOVORA; BIOCONTROL BACTERIUM; MEDIATED RESISTANCE; SALICYLIC-ACID; III EFFECTOR; HARPIN	To explore possible sources of transgenic resistance to the rhizomania-causing Beet necrotic yellow vein virus ( BNYVV), Nicotiana benthamiana plants were constructed to express the harpin of Pseudomonas syringae pv. phaseolicola (HrpZ(Psph)). The HrpZ protein was expressed as an N-terminal fusion to the PR1 signal peptide (SP/HrpZ) to direct harpin accumulation to the plant apoplast. Transgene integration was verified by mPCR in all primary transformants (T0), while immunoblot analysis confirmed that the protein HrpZPsph was produced and the signal peptide was properly processed. Neither T0 plants nor selfed progeny (T1) showed macroscopically visible necrosis or any other macroscopic phenotypes. However, plants expressing the SP/HrpZPsph showed increased vigor and grew faster in comparison with non-transgenic control plants. Transgenic resistance was assessed after challenge inoculation with BNYVV on T1 progeny by scoring of disease symptoms and by DAS-ELISA at 20 and 30 dpi. Transgenic and control lines showed significant differences in terms of the number of plants that became infected, the timing of infection and the disease symptoms displayed. Plants expressing the SP/HrpZPsph developed localized leaf necrosis in the infection area and had enhanced resistance upon challenge with BNYVV. In order to evaluate the SP/HrpZ-based resistance in the sugar beet host, A. rhizogenes-mediated root transformation was exploited as a transgene expression platform. Upon BNYVV inoculation, transgenic sugar beet hairy roots showed high level of BNYVV resistance. In contrast, the aerial non-transgenic parts of the same seedlings had virus titers that were comparable to those of the seedlings that were untransformed or transformed with wild type R1000 cells. These findings indicate that the transgenically expressed SP/HrpZ protein results in enhanced rhizomania resistance both in a model plant and sugar beet, the natural host of BNYVV. Possible molecular mechanisms underlying the enhanced resistance and plant growth phenotypes observed in SP/HrpZ transgenic plants are discussed.	[Pavli, Ourania I.; Kelaidi, Georgia I.; Skaracis, George N.] Univ Agr, Dept Crop Sci, Athens, Greece; [Tampakaki, Anastasia P.] Univ Agr, Dept Agr Biotechnol, Athens, Greece	Agricultural University of Athens; Agricultural University of Athens	Pavli, OI (corresponding author), Univ Agr, Dept Crop Sci, Athens, Greece.	tampakaki@aua.gr	Tampakaki, Anastasia/ABF-8966-2021	Tampakaki, Anastasia/0000-0003-4439-0920; Pavli, Ourania/0000-0002-5276-2184	Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens	Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens	The work was supported by the Laboratory of Plant Breeding and Biometry of the Agricultural University of Athens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Leal R, 2008, VIROLOGY, V376, P60, DOI 10.1016/j.virol.2008.03.008; Ahmad M, 2001, MOL PLANT MICROBE IN, V14, P1223, DOI 10.1094/MPMI.2001.14.10.1223; Andika IB, 2005, MOL PLANT MICROBE IN, V18, P194, DOI 10.1094/MPMI-18-0194; ARLAT M, 1994, EMBO J, V13, P543, DOI 10.1002/j.1460-2075.1994.tb06292.x; Biancardi E, 2002, EUPHYTICA, V127, P383, DOI 10.1023/A:1020310718166; BleykastenGrosshans C, 1997, MOL PLANT MICROBE IN, V10, P240, DOI 10.1094/MPMI.1997.10.2.240; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Charkowski AO, 1998, J BACTERIOL, V180, P5211, DOI 10.1128/JB.180.19.5211-5217.1998; Chen L, 2008, PHYTOPATHOLOGY, V98, P792, DOI 10.1094/PHYTO-98-7-0792; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Dong HP, 2004, PLANT PHYSIOL, V136, P3628, DOI 10.1104/pp.104.048900; Dong HP, 2005, PLANTA, V221, P313, DOI 10.1007/s00425-004-1444-x; Dong HS, 1999, PLANT J, V20, P207, DOI 10.1046/j.1365-313x.1999.00595.x; *EFSA, 2008, SCI OP PAN GUID RISK; Engelhardt S, 2009, PLANT J, V57, P706, DOI 10.1111/j.1365-313X.2008.03723.x; Fecker LF, 1997, ARCH VIROL, V142, P1857, DOI 10.1007/s007050050203; Gaudriault S, 1998, FEBS LETT, V428, P224, DOI 10.1016/S0014-5793(98)00534-1; Gopalan S, 1996, PLANT J, V10, P591, DOI 10.1046/j.1365-313X.1996.10040591.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hoyos ME, 1996, MOL PLANT MICROBE IN, V9, P608, DOI 10.1094/MPMI-9-0608; Huo R, 2010, TRANSGENIC RES, V19, P841, DOI 10.1007/s11248-010-9365-x; Jang YS, 2006, PLANTA, V223, P449, DOI 10.1007/s00425-005-0100-4; Johansson E., 1985, Sveriges Utsadesforenings Tidskrift, V95, P115; *JRC, 2006, JRC TECHN REP SER; Kim JF, 2000, FIRE BLIGHT, P141, DOI 10.1079/9780851992945.0141; Kim JF, 1998, J BACTERIOL, V180, P5203, DOI 10.1128/JB.180.19.5203-5210.1998; Kim JG, 2004, J BACTERIOL, V186, P6239, DOI 10.1128/JB.186.18.6239-6247.2004; Kim JG, 2003, J BACTERIOL, V185, P3155, DOI 10.1128/JB.185.10.3155-3166.2003; Kvitko BH, 2007, J BACTERIOL, V189, P8059, DOI 10.1128/JB.01146-07; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lennefors BL, 2006, MOL BREEDING, V18, P313, DOI 10.1007/s11032-006-9030-5; LEWELLEN RT, 1988, P 5 INT C PLANT PATH; Lewer R. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P139; Li JG, 2010, MOL PLANT PATHOL, V11, P371, DOI [10.1111/j.1364-3703.2010.00610.x, 10.1111/J.1364-3703.2010.00610.X]; Mannerlof M, 1996, EUPHYTICA, V90, P293, DOI 10.1007/BF00027479; Miao WG, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-67; Oh CS, 2007, PLANT PHYSIOL, V145, P426, DOI 10.1104/pp.107.103432; PAVLI OI, 2010, PROTOCOLS NETWORK NA, DOI DOI 10.1038/NPROT.2010.98; PAVLI OI, 2010, EUR J PLANT PATHOL; Pavli OI, 2010, TRANSGENIC RES, V19, P915, DOI 10.1007/s11248-010-9364-y; Peng JL, 2004, PHYTOPATHOLOGY, V94, P1048, DOI 10.1094/PHYTO.2004.94.10.1048; Peng JL, 2003, PHYSIOL MOL PLANT P, V62, P317, DOI 10.1016/S0885-5765(03)00078-X; Racape J, 2005, MOL MICROBIOL, V58, P1406, DOI 10.1111/j.1365-2958.2004.04910.x; Rairdan GJ, 2001, MOL PLANT MICROBE IN, V14, P1235, DOI 10.1094/MPMI.2001.14.10.1235; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Ren DT, 2002, J BIOL CHEM, V277, P559, DOI 10.1074/jbc.M109495200; Ren HY, 2006, ANN MICROBIOL, V56, P281, DOI 10.1007/BF03175019; Ren HY, 2006, J BIOSCIENCES, V31, P617, DOI 10.1007/BF02708414; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Schirmer A, 2005, J GEN VIROL, V86, P2897, DOI 10.1099/vir.0.81167-0; SEO S, 1995, SCIENCE, V270, P1988, DOI 10.1126/science.270.5244.1988; Shao M, 2008, PLANT BIOTECHNOL J, V6, P73, DOI 10.1111/j.1467-7652.2007.00304.x; Spoel SH, 2003, PLANT CELL, V15, P760, DOI 10.1105/tpc.009159; Strobel NE, 1996, PLANT J, V9, P431, DOI 10.1046/j.1365-313X.1996.09040431.x; Takakura Y, 2004, PHYSIOL MOL PLANT P, V64, P83, DOI 10.1016/j.pmpp.2004.06.002; Tamada T., 1999, ENCY VIROLOGY, P154; Tampakaki AP, 2000, MOL PLANT MICROBE IN, V13, P1366, DOI 10.1094/MPMI.2000.13.12.1366; TAMPAKAKI AP, 2010, ANNU REV PHYTOPATHOL, V48; Ward L, 2007, ARCH VIROL, V152, P59, DOI 10.1007/s00705-006-0832-x; WEI ZM, 1992, SCIENCE, V257, P85, DOI 10.1126/science.1621099; [闻伟刚 Wen Weigang], 2003, [农业生物技术学报, Journol of Agricultural Biotechnology], V11, P192; Wu XJ, 2007, J BIOSCIENCES, V32, P1119, DOI 10.1007/s12038-007-0113-1	63	23	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17306	10.1371/journal.pone.0017306	http://dx.doi.org/10.1371/journal.pone.0017306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394206	Green Submitted, Green Published, gold			2022-12-27	WOS:000288025500009
J	Zampighi, GA; Schietroma, C; Zampighi, LM; Woodruff, M; Wright, EM; Brecha, NC				Zampighi, Guido A.; Schietroma, Cataldo; Zampighi, Lorenzo M.; Woodruff, Michael; Wright, Ernest M.; Brecha, Nicholas C.			Conical Tomography of a Ribbon Synapse: Structural Evidence for Vesicle Fusion	PLOS ONE			English	Article							RETINAL BIPOLAR CELLS; FROG NEUROMUSCULAR-JUNCTION; SENSITIVE CALCIUM-CHANNEL; SALAMANDER ROD SYNAPSE; OUTER PLEXIFORM LAYER; ACTIVE ZONE PROTEINS; SACCULAR HAIR-CELLS; TRANSMITTER RELEASE; ELECTRON TOMOGRAPHY; PHOTORECEPTOR TERMINALS	To characterize the sites of synaptic vesicle fusion in photoreceptors, we evaluated the three-dimensional structure of rod spherules from mice exposed to steady bright light or dark-adapted for periods ranging from 3 to 180 minutes using conical electron tomography. Conical tilt series from mice retinas were reconstructed using the weighted back projection algorithm, refined by projection matching and analyzed using semiautomatic density segmentation. In the light, rod spherules contained similar to 470 vesicles that were hemi-fused and similar to 187 vesicles that were fully fused (omega figures) with the plasma membrane. Active zones, defined by the presence of fully fused vesicles, extended along the entire area of contact between the rod spherule and the horizontal cell ending, and included the base of the ribbon, the slope of the synaptic ridge and ribbon-free regions apposed to horizontal cell axonal endings. There were transient changes of the rod spherules during dark adaptation. At early periods in the dark (3-15 minutes), there was a) an increase in the number of fully fused synaptic vesicles, b) a decrease in rod spherule volume, and c) an increase in the surface area of the contact between the rod spherule and horizontal cell endings. These changes partially compensate for the increase in the rod spherule plasma membrane following vesicle fusion. After 30 minutes of dark-adaptation, the rod spherules returned to dimensions similar to those measured in the light. These findings show that vesicle fusion occurs at both ribbon-associated and ribbon-free regions, and that transient changes in rod spherules and horizontal cell endings occur shortly after dark onset.	[Zampighi, Guido A.; Schietroma, Cataldo; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Zampighi, Guido A.; Zampighi, Lorenzo M.; Wright, Ernest M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Woodruff, Michael] Univ Calif Los Angeles, Coll Letters & Sci, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Zampighi, GA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	nbrecha@ucla.edu		Schietroma, Cataldo/0000-0002-0865-9956	National Institutes of Health [EY04410, DK44602, EY15573]; Jules Stein Eye Institute; NATIONAL EYE INSTITUTE [R01EY015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jules Stein Eye Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health EY04410 (GZ), DK44602 (EMW), EY15573 (NCB) and the Jules Stein Eye Institute. NCB is a VA Career Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Bayley PR, 2007, J COMP NEUROL, V500, P286, DOI 10.1002/cne.21188; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BRANDON C, 1983, J COMP NEUROL, V217, P167, DOI 10.1002/cne.902170205; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; BUNT AH, 1971, BRAIN RES, V25, P571, DOI 10.1016/0006-8993(71)90461-6; Buran BN, 2010, J NEUROSCI, V30, P7587, DOI 10.1523/JNEUROSCI.0389-10.2010; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Cantele F, 2007, J STRUCT BIOL, V158, P59, DOI 10.1016/j.jsb.2006.10.015; Chang B, 2006, VISUAL NEUROSCI, V23, P11, DOI 10.1017/S095252380623102X; Chol SY, 2008, VISUAL NEUROSCI, V25, P693, DOI 10.1017/S0952523808080814; COOPER NGF, 1982, J ULTRA MOL STRUCT R, V79, P58, DOI 10.1016/S0022-5320(82)90052-1; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; COUTEAUX R, 1970, Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences Serie D Sciences Naturelles, V271, P2346; Deguchi-Tawarada M, 2006, J COMP NEUROL, V495, P480, DOI 10.1002/cne.20893; Dick O, 2003, NEURON, V37, P775, DOI 10.1016/S0896-6273(03)00086-2; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Edmonds BW, 2004, J PHYSIOL-LONDON, V560, P439, DOI 10.1113/jphysiol.2004.066035; EVANS EM, 1966, Z ZELLFORSCH MIK ANA, V71, P499, DOI 10.1007/BF00349610; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; HEUSER JE, 1989, Q J EXP PHYSIOL CMS, V74, P1051, DOI 10.1113/expphysiol.1989.sp003333; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hoopmann P, 2010, P NATL ACAD SCI USA, V107, P19055, DOI 10.1073/pnas.1007037107; Hosoya O, 2004, EUR J NEUROSCI, V19, P2179, DOI 10.1111/j.0953-816X.2004.03340.x; Jackman SL, 2009, NAT NEUROSCI, V12, P303, DOI 10.1038/nn.2267; Jarsky T, 2010, J NEUROSCI, V30, P11885, DOI 10.1523/JNEUROSCI.1415-10.2010; Khimich D, 2005, NATURE, V434, P889, DOI 10.1038/nature03418; Krizaj D, 2003, J PHYSIOL-LONDON, V547, P761, DOI 10.1113/jphysiol.2002.035683; Kroger RHH, 1996, VISION RES, V36, P3879, DOI 10.1016/S0042-6989(96)00132-0; Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Lenzi D, 2002, NEURON, V36, P649, DOI 10.1016/S0896-6273(02)01025-5; Li GL, 2009, J NEUROSCI, V29, P7558, DOI 10.1523/JNEUROSCI.0514-09.2009; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; Llobet A, 2003, J NEUROSCI, V23, P2706; LoGiudice L, 2009, NEUROSCIENCE, V164, P1546, DOI 10.1016/j.neuroscience.2009.09.023; LoGiudice L, 2008, J NEUROSCI, V28, P3150, DOI 10.1523/JNEUROSCI.5753-07.2008; LoGiudice L, 2009, NEUROSCIENTIST, V15, P380, DOI 10.1177/1073858408331373; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2008, J NEUROSCI, V28, P5403, DOI 10.1523/JNEUROSCI.0935-08.2008; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; MERCER AJ, 2010, PHYSIOLOGY IN PRESS; Midorikawa M, 2007, NAT NEUROSCI, V10, P1268, DOI 10.1038/nn1963; MISSOTTEN L, 1966, THESIS KATHOLIEKE U; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Mukherjee K, 2010, P NATL ACAD SCI USA, V107, P6504, DOI 10.1073/pnas.1002307107; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Nachman-Clewner M, 1999, J COMP NEUROL, V415, P1, DOI 10.1002/(SICI)1096-9861(19991206)415:1<1::AID-CNE1>3.0.CO;2-G; Neef A, 2007, J NEUROSCI, V27, P12933, DOI 10.1523/JNEUROSCI.1996-07.2007; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Peters A., 1991, FINE STRUCTURE NERVO; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Prescott ED, 2005, CURR OPIN NEUROBIOL, V15, P431, DOI 10.1016/j.conb.2005.07.005; PUMPLIN DW, 1981, P NATL ACAD SCI-BIOL, V78, P7210, DOI 10.1073/pnas.78.11.7210; Rabl K, 2005, J NEUROSCI, V25, P4633, DOI 10.1523/JNEUROSCI.4298-04.2005; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RAYNAULD JP, 1979, SCIENCE, V204, P1436, DOI 10.1126/science.451577; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; RIPPS H, 1976, J CELL BIOL, V70, P86, DOI 10.1083/jcb.70.1.86; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Salvi E, 2008, J STRUCT BIOL, V161, P287, DOI 10.1016/j.jsb.2007.06.011; SCHACHER S, 1976, J CELL BIOL, V70, P178, DOI 10.1083/jcb.70.1.178; SCHAEFFER SF, 1978, J CELL BIOL, V79, P802, DOI 10.1083/jcb.79.3.802; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; SEJNOWSKI TJ, 1982, J NEUROCYTOL, V11, P897, DOI 10.1007/BF01148307; Sherry DM, 2005, J COMP NEUROL, V484, P440, DOI 10.1002/cne.20504; Siksou L, 2007, J NEUROSCI, V27, P6868, DOI 10.1523/JNEUROSCI.1773-07.2007; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SJOSTRAND FS, 1958, J ULTRA MOL STRUCT R, V2, P122, DOI 10.1016/S0022-5320(58)90050-9; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; Steele EC, 2005, J NEUROPHYSIOL, V94, P4544, DOI 10.1152/jn.01193.2004; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Suryanarayanan A, 2006, J NEUROSCI, V26, P1759, DOI 10.1523/JNEUROSCI.3895-05.2006; Szikra T, 2006, NEUROSCIENCE, V141, P143, DOI 10.1016/j.neuroscience.2006.03.054; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; TOWNESANDERSON E, 1985, J CELL BIOL, V100, P175, DOI 10.1083/jcb.100.1.175; Trifonov I U, 1968, Biofizika, V13, P809; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F; WAGNER HJ, 1980, J NEUROCYTOL, V9, P573, DOI 10.1007/BF01205026; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Xu JW, 2005, J NEUROSCI, V25, P7660, DOI 10.1523/JNEUROSCI.1572-05.2005; Zampighi GA, 2006, BIOPHYS J, V91, P2910, DOI 10.1529/biophysj.106.084814; Zampighi GA, 2005, J STRUCT BIOL, V151, P263, DOI 10.1016/j.jsb.2005.05.008; Zampighi GA, 2003, CELL COMMUN ADHES, V10, P265, DOI 10.1080/15419060390263001; Zampighi GA, 2008, J NEUROSCI, V28, P4151, DOI 10.1523/JNEUROSCI.4639-07.2008; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zenisek D, 2003, J NEUROSCI, V23, P2538; Zenisek D, 2008, P NATL ACAD SCI USA, V105, P4922, DOI 10.1073/pnas.0709067105; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	119	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16944	10.1371/journal.pone.0016944	http://dx.doi.org/10.1371/journal.pone.0016944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390245	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000287932100008
J	Ambatipudi, S; Gerstung, M; Gowda, R; Pai, P; Borges, AM; Schaffer, AA; Beerenwinkel, N; Mahimkar, MB				Ambatipudi, Srikant; Gerstung, Moritz; Gowda, Ravindra; Pai, Prathamesh; Borges, Anita M.; Schaeffer, Alejandro A.; Beerenwinkel, Niko; Mahimkar, Manoj B.			Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR GENE; COPY NUMBER; NECK-CANCER; HEAD; AMPLICON; ARRAY; AMPLIFICATION; EXPRESSION; DISTAL	Identifying oral cancer lesions associated with high risk of relapse and predicting clinical outcome remain challenging questions in clinical practice. Genomic alterations may add prognostic information and indicate biological aggressiveness thereby emphasizing the need for genome-wide profiling of oral cancers. High-resolution array comparative genomic hybridization was performed to delineate the genomic alterations in clinically annotated primary gingivo-buccal complex and tongue cancers (n = 60). The specific genomic alterations so identified were evaluated for their potential clinical relevance. Copy-number changes were observed on chromosomal arms with most frequent gains on 3q (60%), 5p (50%), 7p (50%), 8q (73%), 11q13 (47%), 14q11.2 (47%), and 19p13.3 (58%) and losses on 3p14.2 (55%) and 8p (83%). Univariate statistical analysis with correction for multiple testing revealed chromosomal gain of region 11q22.1-q22.2 and losses of 17p13.3 and 11q23-q25 to be associated with loco-regional recurrence (P = 0.004, P = 0.003, and P = 0.0003) and shorter survival (P = 0.009, P = 0.003, and P 0.0001) respectively. The gain of 11q22 and loss of 11q23-q25 were validated by interphase fluorescent in situ hybridization (I-FISH). This study identifies a tractable number of genomic alterations with few underlying genes that may potentially be utilized as biological markers for prognosis and treatment decisions in oral cancers.	[Ambatipudi, Srikant; Gowda, Ravindra; Mahimkar, Manoj B.] Adv Ctr Treatment Res & Educ Canc, Tata Mem Ctr, Canc Res Inst, Navi Mumbai, India; [Gerstung, Moritz; Beerenwinkel, Niko] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Gerstung, Moritz; Beerenwinkel, Niko] Swiss Inst Bioinformat, Lausanne, Switzerland; [Pai, Prathamesh] Tata Mem Hosp, Tata Mem Ctr, Head & Neck Unit, Mumbai 400012, Maharashtra, India; [Borges, Anita M.] SL Raheja Hosp, Dept Pathol & Lab Med, Mumbai, Maharashtra, India; [Schaeffer, Alejandro A.] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, DHHS, Bethesda, MD 20892 USA	Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC); Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Institute of Bioinformatics; Tata Memorial Centre (TMC); Tata Memorial Hospital; National Institutes of Health (NIH) - USA	Ambatipudi, S (corresponding author), Adv Ctr Treatment Res & Educ Canc, Tata Mem Ctr, Canc Res Inst, Navi Mumbai, India.	mmahimkar@actrec.gov.in	Ambatipudi, Srikant/GLV-6259-2022; Ambatipudi, Srikant/J-4648-2012; Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Pai, Prathamesh/0000-0001-9989-5534; Ambatipudi, Srikant/0000-0003-3102-3603; Gerstung, Moritz/0000-0001-6709-963X	Council of Scientific and Industrial Research [CSIR] [27(0207)/09/EMR-II]; Tata Memorial Center; SystemsX.ch, Swiss initiative in systems biology [2009/024]; National Institutes of Health, NLM; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	Council of Scientific and Industrial Research [CSIR](Council of Scientific & Industrial Research (CSIR) - India); Tata Memorial Center; SystemsX.ch, Swiss initiative in systems biology; National Institutes of Health, NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are thankful to the Council of Scientific and Industrial Research [CSIR Grant No: 27(0207)/09/EMR-II]; Tata Memorial Center - Intramural Research Grant for funding the project. MG and NB have been funded by SystemsX.ch, the Swiss initiative in systems biology, under grant No. 2009/024, evaluated by the Swiss National Science Foundation. This research was supported in part by the Intramural research Program of the National Institutes of Health, NLM. The authors thank CSIR for providing a fellowship to SA during his tenure as a PhD student. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akervall J, 2004, ACTA OTO-LARYNGOL, V124, P851, DOI 10.1080/00016480410017323; Akervall J, 2006, EUR ARCH OTO-RHINO-L, V263, P297, DOI 10.1007/s00405-006-1039-1; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chigurupati S, 2010, CANCER RES, V70, P418, DOI 10.1158/0008-5472.CAN-09-2654; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Fakhry C, 2008, JNCI-J NATL CANCER I, V100, P261, DOI 10.1093/jnci/djn011; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Frohling S, 2008, NEW ENGL J MED, V359, P722, DOI 10.1056/NEJMra0803109; Garnis C, 2004, ONCOGENE, V23, P2582, DOI 10.1038/sj.onc.1207367; Gillison ML, 2004, SEMIN ONCOL, V31, P744, DOI 10.1053/j.seminoncol.2004.09.011; Goi T, 2002, ONCOL REP, V9, P1189; Gollin SM, 2001, HEAD NECK-J SCI SPEC, V23, P238, DOI 10.1002/1097-0347(200103)23:3<238::AID-HED1025>3.0.CO;2-H; Henson BJ, 2009, GENE CHROMOSOME CANC, V48, P569, DOI 10.1002/gcc.20666; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jarvinen AK, 2008, GENE CHROMOSOME CANC, V47, P500, DOI 10.1002/gcc.20551; Jin C, 2006, CYTOGENET GENOME RES, V115, P99, DOI 10.1159/000095228; Jin YS, 1998, GENE CHROMOSOME CANC, V22, P312, DOI 10.1002/(SICI)1098-2264(199808)22:4<312::AID-GCC7>3.0.CO;2-Y; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Kohno T, 2010, GENE CHROMOSOME CANC, V49, P342, DOI 10.1002/gcc.20746; Konishi H, 1998, ONCOGENE, V17, P2095, DOI 10.1038/sj.onc.1202128; la Cour JM, 2008, MOL ONCOL, V1, P431, DOI 10.1016/j.molonc.2007.08.002; Lippman SM, 2001, NEW ENGL J MED, V344, P1323, DOI 10.1056/NEJM200104263441710; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Liu CJ, 2006, MOL CARCINOGEN, V45, P721, DOI 10.1002/mc.20213; Liu T, 2010, DNA REPAIR, V9, P1241, DOI 10.1016/j.dnarep.2010.09.016; Nakamura E, 2008, CANCER SCI, V99, P1390, DOI 10.1111/j.1349-7006.2008.00838.x; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Parikh RA, 2007, GENE CHROMOSOME CANC, V46, P761, DOI 10.1002/gcc.20462; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paterson IC, 1996, ORAL ONCOL, V32B, P150, DOI 10.1016/0964-1955(95)00065-8; Reshmi SC, 2007, CYTOGENET GENOME RES, V116, P46, DOI 10.1159/000097425; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Scully C, 2000, ORAL ONCOL, V36, P311, DOI 10.1016/S1368-8375(00)00021-X; Shah JP, 2006, LANCET ONCOL, V7, P356, DOI 10.1016/S1470-2045(06)70667-2; Shu ST, 2010, ANTICANCER RES, V30, P1937; Smith JS, 1999, GENOMICS, V59, P97, DOI 10.1006/geno.1999.5864; Smith M, 2006, SNAPCGH SEGMENTATION; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Suzuki E, 2007, ONCOGENE, V26, P7921, DOI 10.1038/sj.onc.1210589; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Veeriah S, 2009, P NATL ACAD SCI USA, V106, P9435, DOI 10.1073/pnas.0900571106; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646	49	42	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17250	10.1371/journal.pone.0017250	http://dx.doi.org/10.1371/journal.pone.0017250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386901	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400043
J	D'auria, L; Van Der Smissen, P; Bruyneel, F; Courtoy, PJ; Tyteca, D				D'auria, Ludovic; Van Der Smissen, Patrick; Bruyneel, Frederic; Courtoy, Pierre J.; Tyteca, Donatienne			Segregation of Fluorescent Membrane Lipids into Distinct Micrometric Domains: Evidence for Phase Compartmentation of Natural Lipids?	PLOS ONE			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; PLASMA-MEMBRANE; ERYTHROCYTE-MEMBRANES; CELL-MEMBRANES; IMMUNOLOGICAL SYNAPSE; BIOLOGICAL-MEMBRANES; PHYSICAL-PROPERTIES; EPITHELIAL-CELLS; MODEL MEMBRANES; RAFTS	Background: We recently reported that sphingomyelin (SM) analogs substituted on the alkyl chain by various fluorophores (e. g. BODIPY) readily inserted at trace levels into the plasma membrane of living erythrocytes or CHO cells and spontaneously concentrated into micrometric domains. Despite sharing the same fluorescent ceramide backbone, BODIPY-SM domains segregated from similar domains labelled by BODIPY-D-e-lactosylceramide (D-e-LacCer) and depended on endogenous SM. Methodology/Principal Findings: We show here that BODIPY-SM further differed from BODIPY-D-e-LacCer or glucosylceramide (GlcCer) domains in temperature dependence, propensity to excimer formation, association with a glycosylphosphatidylinositol (GPI)-anchored fluorescent protein reporter, and lateral diffusion by FRAP, thus demonstrating different lipid phases and boundaries. Whereas BODIPY-D-e-LacCer behaved like BODIPY-GlcCer, its artificial stereoisomer, BODIPY-L-t-LacCer, behaved like BODIPY-and NBD-phosphatidylcholine (PC). Surprisingly, these two PC analogs also formed micrometric patches yet preferably at low temperature, did not show excimer, never associated with the GPI reporter and showed major restriction to lateral diffusion when photobleached in large fields. This functional comparison supported a three-phase micrometric compartmentation, of decreasing order: BODIPY-GSLs > -SM > -PC (or artificial L-t-LacCer). Co-existence of three segregated compartments was further supported by double labelling experiments and was confirmed by additive occupancy, up to similar to 70% cell surface coverage. Specific alterations of BODIPY-analogs domains by manipulation of corresponding endogenous sphingolipids suggested that distinct fluorescent lipid partition might reflect differential intrinsic propensity of endogenous membrane lipids to form large assemblies. Conclusions/Significance: We conclude that fluorescent membrane lipids spontaneously concentrate into distinct micrometric assemblies. We hypothesize that these might reflect preexisting compartmentation of endogenous PM lipids into non-overlapping domains of differential order: GSLs > SM > PC, resulting into differential self-adhesion of the two former, with exclusion of the latter.	[D'auria, Ludovic; Van Der Smissen, Patrick; Courtoy, Pierre J.; Tyteca, Donatienne] de Duve Inst, CELL Unit, Brussels, Belgium; [D'auria, Ludovic; Van Der Smissen, Patrick; Courtoy, Pierre J.; Tyteca, Donatienne] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Bruyneel, Frederic] Catholic Univ Louvain, CHOM Unit, B-1348 Louvain, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	D'auria, L (corresponding author), de Duve Inst, CELL Unit, Brussels, Belgium.	donatienne.tyteca@uclouvain.be		d'auria, ludovic/0000-0001-6270-7739	UCL; F.R.S./FNRS; Region wallonne; Region bruxelloise; Loterie Nationale; ARC (Belgium); IUAP (Belgium); EuReGene (EU); EuNephron (EU)	UCL; F.R.S./FNRS(Fonds de la Recherche Scientifique - FNRS); Region wallonne; Region bruxelloise(Innoviris); Loterie Nationale; ARC (Belgium); IUAP (Belgium); EuReGene (EU)(European Commission); EuNephron (EU)(European Commission)	This work was supported by grants from UCL, F.R.S./FNRS, Region wallonne, Region bruxelloise, Loterie Nationale, ARC and IUAP (Belgium), EuReGene and EuNephron (EU). D. T. was Research Associate at the FNRS/FRIA, at which L. D. was Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2000, KIDNEY INT, V57, P446, DOI 10.1046/j.1523-1755.2000.t01-1-00864.x; Almeida PFF, 2005, BBA-BIOMEMBRANES, V1720, P1, DOI 10.1016/j.bbamem.2005.12.004; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Cheng ZJ, 2006, MOL BIOL CELL, V17, P3197, DOI 10.1091/mbc.E05-12-1101; CLOWES AW, 1971, BIOCHIM BIOPHYS ACTA, V249, P301, DOI 10.1016/0005-2736(71)90108-8; CUPERS P, 1994, J CELL BIOL, V127, P725, DOI 10.1083/jcb.127.3.725; de Diesbach P, 2008, EXP CELL RES, V314, P1465, DOI 10.1016/j.yexcr.2008.01.015; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fooksman DR, 2009, J IMMUNOL, V182, P5179, DOI 10.4049/jimmunol.0801797; Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gousset K, 2002, J CELL PHYSIOL, V190, P117, DOI 10.1002/jcp.10039; GUPTA G, 2009, FEBS LETT; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279; Hao MM, 2001, P NATL ACAD SCI USA, V98, P13072, DOI 10.1073/pnas.231377398; Heiner AL, 2008, BIOPHYS J, V94, P3084, DOI 10.1529/biophysj.107.118356; Iwabuchi K, 1998, J BIOL CHEM, V273, P33766, DOI 10.1074/jbc.273.50.33766; Iwamoto K, 2004, GENES CELLS, V9, P891, DOI 10.1111/j.1365-2443.2004.00782.x; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; KOYNOVA R, 1995, BBA-LIPID LIPID MET, V1255, P213, DOI 10.1016/0005-2760(94)00202-A; LINGWOOD D, SCIENCE, V327, P46; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Montes LR, 2008, BIOCHEMISTRY-US, V47, P11222, DOI 10.1021/bi801139z; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Ramstedt B, 2002, FEBS LETT, V531, P33, DOI 10.1016/S0014-5793(02)03406-3; RODGERS W, 1991, P NATL ACAD SCI USA, V88, P1364, DOI 10.1073/pnas.88.4.1364; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; SCHWARZMANN G, 1987, METHOD ENZYMOL, V138, P319; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Singh RD, 2006, J BIOL CHEM, V281, P30660, DOI 10.1074/jbc.M606194200; Stott BM, 2008, J LIPID RES, V49, P1202, DOI 10.1194/jlr.M700479-JLR200; Tavano R, 2004, J IMMUNOL, V173, P5392, DOI 10.4049/jimmunol.173.9.5392; Tyteca D, 2005, EXP CELL RES, V310, P293, DOI 10.1016/j.yexcr.2005.07.027; TYTECA D, BIOCH BIOPHYS ACTA, V1798, P909; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Tiel CM, 2000, BIOCHEM J, V346, P537, DOI 10.1042/0264-6021:3460537; vanIjzendoorn SCD, 1997, J CELL BIOL, V137, P347, DOI 10.1083/jcb.137.2.347; Westerlund B, 2009, BBA-BIOMEMBRANES, V1788, P194, DOI 10.1016/j.bbamem.2008.11.010; Wolkers WF, 2002, MOL MEMBR BIOL, V19, P59, DOI 10.1080/09687680110103613; YECHIEL E, 1987, J CELL BIOL, V105, P755, DOI 10.1083/jcb.105.2.755; ZACHOWSKI A, 1985, J CLIN INVEST, V75, P1713, DOI 10.1172/JCI111880	53	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17021	10.1371/journal.pone.0017021	http://dx.doi.org/10.1371/journal.pone.0017021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386970	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400022
J	Garaulet, M; Sanchez-Moreno, C; Smith, CE; Lee, YC; Nicolas, F; Ordovas, JM				Garaulet, Marta; Sanchez-Moreno, Carmen; Smith, Caren E.; Lee, Yu-Chi; Nicolas, Francisco; Ordovas, Jose M.			Ghrelin, Sleep Reduction and Evening Preference: Relationships to CLOCK 3111 T/C SNP and Weight Loss	PLOS ONE			English	Article							MEDITERRANEAN DIET; BEHAVIORAL-THERAPY; METABOLIC SYNDROME; OBESITY; ASSOCIATION; GENE; POPULATION; QUESTIONNAIRE; TISSUE; FAT	Background: Circadian Locomotor Output Cycles Kaput (CLOCK), an essential element of the positive regulatory arm in the human biological clock, is involved in metabolic regulation. The aim was to investigate the behavioral (sleep duration, eating patterns and chronobiological characteristics) and hormonal (plasma ghrelin and leptin concentrations) factors which could explain the previously reported association between the CLOCK 3111T/C SNP and weight loss. Methodology/Principal Findings: We recruited 1495 overweight/obese subjects (BMI: 25-40 kg/m(2)) of 20-65 y. who attended outpatient obesity clinics in Murcia, in southeastern Spain. We detected an association between the CLOCK 3111T/C SNP and weight loss, which was particularly evident after 12-14 weeks of treatment (P = 0.038). Specifically, carriers of the minor C allele were more resistant to weight loss than TT individuals (Mean +/- SEM) (8.71 +/- 0.59 kg vs 10.4 +/- 0.57 kg) C and TT respectively. In addition, our data show that minor C allele carriers had: 1. shorter sleep duration Mean +/- SEM (7.0 +/- 0.05 vs 7.3 +/- 0.05) C and TT respectively (P = 0.039), 2. higher plasma ghrelin concentrations Mean +/- SEM (pg/ml) (1108 +/- 49 vs 976 +/- 47)(P = 0.034); 3. delayed breakfast time; 4. evening preference and 5. less compliance with a Mediterranean Diet pattern, as compared with TT homozygotes. Conclusions/Significance: Sleep reduction, changes in ghrelin values, alterations of eating behaviors and evening preference that characterized CLOCK 3111C carriers could be affecting weight loss. Our results support the hypothesis that the influence of the CLOCK gene may extend to a broad range of variables linked with human behaviors.	[Garaulet, Marta; Sanchez-Moreno, Carmen] Univ Murcia, Fac Biol, Dept Physiol, Murcia, Spain; [Smith, Caren E.; Lee, Yu-Chi; Ordovas, Jose M.] Tufts Univ, Sch Med, Jean Mayer S Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Ordovas, Jose M.] Populat Genet Ctr Nacl Invest Cardiovasc CNIC, Dept Epidemiol, Madrid, Spain; [Nicolas, Francisco] Arrixaca Hosp, Dept Nucl Med, Murcia, Spain	University of Murcia; Tufts University; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Clinico Universitario Virgen de la Arrixaca	Garaulet, M (corresponding author), Univ Murcia, Fac Biol, Dept Physiol, Murcia, Spain.	garaulet@um.es	Garaulet, Marta/K-6625-2014; Ordovas, Jose/B-8727-2013	Garaulet, Marta/0000-0002-4066-3509; Nicolas Ruiz, Francisco/0000-0002-8260-6131; Ordovas, Jose/0000-0002-7581-5680	Government of Education, Science and Research of Murcia [BIO/FFA 07/01-0004]; Spanish Government of Science and Innovation [AGL2008-01655/ALI]; National Heart, Lung, and Blood Institute [HL-54776]; National Institute of Diabetes and Digestive and Kidney Diseases [DK075030]; US Department of Agriculture Research [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075030] Funding Source: NIH RePORTER	Government of Education, Science and Research of Murcia; Spanish Government of Science and Innovation(Spanish Government); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); US Department of Agriculture Research(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Government of Education, Science and Research of Murcia (Project BIO/FFA 07/01-0004) and by The Spanish Government of Science and Innovation (projects AGL2008-01655/ALI) National Heart, Lung, and Blood Institute grants HL-54776, National Institute of Diabetes and Digestive and Kidney Diseases, Grant Number DK075030 and by contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle J, 2008, MOL GENET METAB, V95, P188, DOI 10.1016/j.ymgme.2008.07.008; Adamantidis A, 2008, TRENDS ENDOCRIN MET, V19, P362, DOI 10.1016/j.tem.2008.08.007; Benedetti F, 2008, GENES BRAIN BEHAV, V7, P20, DOI 10.1111/j.1601-183X.2007.00312.x; Benedetti F, 2007, AM J MED GENET B, V144B, P631, DOI 10.1002/ajmg.b.30475; Buckland G, 2008, OBES REV, V9, P582, DOI 10.1111/j.1467-789X.2008.00503.x; Chandler Alexa J., MED AMP SCI SPORTS A, V48, P705, DOI [DOI 10.1249/01.MSS.0000078924.61453.FB, 10.1249/01.mss.0000487120.85128.40, DOI 10.1249/01.MSS.0000487120.85128.40]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Corbalan MD, 2009, NUTRITION, V25, P861, DOI 10.1016/j.nut.2009.02.013; Ferrario VF, 1995, J ANAT, V187, P593; Gangwisch JE, 2009, OBES REV, V10, P37, DOI 10.1111/j.1467-789X.2009.00663.x; Garaulet M, 2010, INT J OBESITY, V34, P516, DOI 10.1038/ijo.2009.255; Garaulet M, 2010, NUTR HOSP, V25, P9, DOI 10.3305/nh.2010.25.1.4265; Garaulet M, 2009, NUTR HOSP, V24, P629, DOI 10.3305/nh.2009.24.6.4546; Garaulet M, 1999, J HUM NUTR DIET, V12, P219, DOI 10.1046/j.1365-277x.1999.00163.x; Garaulet M, 2006, INT J OBESITY, V30, P899, DOI 10.1038/sj.ijo.0803219; GARAULET M, 2010, ADV DRUG DELIV  0522; Garaulet M, 2010, CLIN LIPIDOL, V5, P181, DOI 10.2217/CLP.10.18; Garaulet M, 2009, AM J CLIN NUTR, V90, P1466, DOI 10.3945/ajcn.2009.27536; Giugliano D, 2008, CURR OPIN LIPIDOL, V19, P63, DOI 10.1097/MOL.0b013e3282f2fa4d; Hamet P, 2006, METABOLISM, V55, pS7, DOI 10.1016/j.metabol.2006.07.006; Haupt A, 2008, OBESITY, V16, P1969, DOI 10.1038/oby.2008.283; Horne JA, 1976, INT J CHRONOBIOL, V4, P97; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Knutson KL, 2005, AM J HUM BIOL, V17, P418, DOI 10.1002/ajhb.20405; Kotronoulas G, 2009, HORM-INT J ENDOCRINO, V8, P232, DOI 10.14310/horm.2002.1239; LAMONT EW, 2009, DIALOGUES CLIN NEURO, V9, P333; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P17241; LeSauter J, 2009, P NATL ACAD SCI USA, V106, P13582, DOI 10.1073/pnas.0906426106; Mataix J., 1995, TABLA COMPOSICION AL; Mendez MA, 2006, J NUTR, V136, P2934, DOI 10.1093/jn/136.11.2934; Monteleone P, 2008, NEUROSCI LETT, V435, P30, DOI 10.1016/j.neulet.2008.02.003; Pérez-Llamas F., 2004, Nutr. Hosp., V19, P160; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Serra-Majem L, 2001, PUBLIC HEALTH NUTR, V4, P1409, DOI 10.1079/PHN2001229; SHAW PJ, 2005, SLEEP DEPRIVATION BA, P319, DOI DOI 10.1530/EJE-08-0298; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; SORENSEN TIA, 2006, PLOS CLIN TRIALS, V1, pNIL10, DOI DOI 10.1038/OBY.2008.283; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Taillard J, 2004, J BIOL RHYTHM, V19, P76, DOI 10.1177/0748730403259849; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; VanItallie TB, 2006, METABOLISM, V55, pS30, DOI 10.1016/j.metabol.2006.07.010; Von Schantz M, 2008, J GENET, V87, P513, DOI 10.1007/s12041-008-0074-7; 2010, HELIXTREE MANUAL VER	44	89	97	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17435	10.1371/journal.pone.0017435	http://dx.doi.org/10.1371/journal.pone.0017435			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386998	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400076
J	Latasa, MJ; Cosgaya, JM				Latasa, Maria-Jesus; Miguel Cosgaya, Jose			Regulation of Retinoid Receptors by Retinoic Acid and Axonal Contact in Schwann Cells	PLOS ONE			English	Article							PERIPHERAL NERVOUS-SYSTEM; X-RECEPTOR; IN-VITRO; GENE-EXPRESSION; GROWTH-FACTOR; STEM-CELLS; RAR-BETA-2 PROMOTER; HUMAN NEUROBLASTOMA; STROMAL CELLS; NEURAL CREST	Background: Schwann cells (SCs) are the cell type responsible for the formation of the myelin sheath in the peripheral nervous system (PNS). As retinoic acid (RA) and other retinoids have a profound effect as regulators of the myelination program, we sought to investigate how their nuclear receptors levels were regulated in this cell type. Methodology/Principal Findings: In the present study, by using Schwann cells primary cultures from neonatal Wistar rat pups, as well as myelinating cocultures of Schwann cells with embryonic rat dorsal root ganglion sensory neurons, we have found that sustained expression of RXR-gamma depends on the continuous presence of a labile activator, while axonal contact mimickers produced an increase in RXR-gamma mRNA and protein levels, increment that could be prevented by RA. The upregulation by axonal contact mimickers and the transcriptional downregulation by RA were dependent on de novo protein synthesis and did not involve changes in mRNA stability. On the other hand, RAR-beta mRNA levels were only slightly modulated by axonal contact mimickers, while RA produced a strong transcriptional upregulation that was independent of de novo protein synthesis without changes in mRNA stability. Conclusions/Significance: All together, our results show that retinoid receptors are regulated in a complex manner in Schwann cells, suggesting that they could have a prominent role as regulators of Schwann cell physiology.	[Latasa, Maria-Jesus; Miguel Cosgaya, Jose] Univ Autonoma Madrid, Dept Endocrine & Nervous Syst Physiopathol, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Latasa, MJ (corresponding author), Univ Autonoma Madrid, Dept Endocrine & Nervous Syst Physiopathol, Inst Invest Biomed, Consejo Super Invest Cient, Madrid, Spain.	jmcosgaya@iib.uam.es	Latasa, Maria-Jesus/M-8704-2014; Cosgaya, Jose M/B-4936-2008	Latasa, Maria-Jesus/0000-0003-2840-8692; Cosgaya, Jose Miguel/0000-0002-6005-2916	Spanish Ministerio de Educacion y Ciencia [SAF2003-02528, SAF2004-05343, SAF2007-61693]; Comunidad de Madrid-CSIC; Fundacion Mutua Madrilena; Spanish Ministerio de Eduacion y Ciencia	Spanish Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid-CSIC(Comunidad de Madrid); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministerio de Eduacion y Ciencia(Spanish Government)	This work was supported by grants to JMC from the Spanish Ministerio de Educacion y Ciencia (SAF2003-02528; SAF2004-05343; SAF2007-61693), Comunidad de Madrid-CSIC, and Fundacion Mutua Madrilena. MJL was supported by the Ramon y Cajal program from the Spanish Ministerio de Eduacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; ASTROM A, 1990, BIOCHEM BIOPH RES CO, V173, P339, DOI 10.1016/S0006-291X(05)81062-9; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Ballow M, 2003, J CLIN IMMUNOL, V23, P46, DOI 10.1023/A:1021900331580; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chan JR, 2001, P NATL ACAD SCI USA, V98, P14661, DOI 10.1073/pnas.251543398; Corcoran J, 1999, NAT NEUROSCI, V2, P307, DOI 10.1038/7214; Cosgaya JM, 1997, ONCOGENE, V14, P579, DOI 10.1038/sj.onc.1200865; Cosgaya JM, 1996, J NEUROCHEM, V66, P89; Cosgaya JM, 2001, J NEUROCHEM, V76, P661, DOI 10.1046/j.1471-4159.2001.00078.x; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; DIMITROULAKOS J, 1994, CELL GROWTH DIFFER, V5, P373; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Escriva H, 2002, DEVELOPMENT, V129, P2905; Garbay B, 2000, PROG NEUROBIOL, V61, P267, DOI 10.1016/S0301-0082(99)00049-0; Georgiades P, 1998, ANAT EMBRYOL, V197, P477, DOI 10.1007/s004290050158; Han QX, 1997, DIAGN MOL PATHOL, V6, P42, DOI 10.1097/00019606-199702000-00007; HAUSSLER M, 1983, P NATL ACAD SCI-BIOL, V80, P5525, DOI 10.1073/pnas.80.18.5525; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Jang SW, 2006, J NEUROCHEM, V98, P1678, DOI 10.1111/j.1471-4159.2006.04069.x; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JESSEN KR, 1994, NEURON, V12, P509, DOI 10.1016/0896-6273(94)90209-7; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jiang L, 2008, NEUROREPORT, V19, P1015, DOI 10.1097/WNR.0b013e3283040efc; Johann V, 2003, NEUROSCI LETT, V339, P13, DOI 10.1016/S0304-3940(02)01427-1; Kazakova N, 2006, DEV BIOL, V297, P1, DOI 10.1016/j.ydbio.2006.03.020; Kinameri E, 2003, MOL BRAIN RES, V117, P221, DOI 10.1016/S0169-328X(03)00326-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; KRUYT FAE, 1992, NUCLEIC ACIDS RES, V20, P6393, DOI 10.1093/nar/20.23.6393; Latasa MJ, 2010, GLIA, V58, P1451, DOI 10.1002/glia.21020; LEMKE G, 1988, DEVELOPMENT, V102, P499; LOVAT PE, 1993, NEUROSCI LETT, V162, P109, DOI 10.1016/0304-3940(93)90572-3; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Matsuse D, 2010, J NEUROPATH EXP NEUR, V69, P973, DOI 10.1097/NEN.0b013e3181eff6dc; McCaffery P, 2000, CYTOKINE GROWTH F R, V11, P233, DOI 10.1016/S1359-6101(00)00002-2; Mey J, 2007, GLIA, V55, P152, DOI 10.1002/glia.20444; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Murphy P, 1996, DEVELOPMENT, V122, P2847; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Nikawa T, 2001, AM J PHYSIOL-GASTR L, V280, pG510, DOI 10.1152/ajpgi.2001.280.3.G510; PERRIMON N, 1995, CELL, V80, P517, DOI 10.1016/0092-8674(95)90503-0; Ponnamperuma RM, 2000, NUTR CANCER, V37, P82, DOI 10.1207/S15327914NC3701_11; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; ROWE A, 1995, ANAT EMBRYOL, V192, P1; ROWE A, 1991, DEVELOPMENT, V111, P1007; SCHEIBE RJ, 1991, J CELL BIOL, V113, P1173, DOI 10.1083/jcb.113.5.1173; SEAMON KB, 1981, J CYCLIC NUCL PROT, V7, P201; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Tong L, 2010, BIOCHEM BIOPH RES CO, V401, P592, DOI 10.1016/j.bbrc.2010.09.107; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WAN YJY, 1994, EXP CELL RES, V210, P56, DOI 10.1006/excr.1994.1009; Zhelyaznik N, 2006, NEUROSCIENCE, V141, P1761, DOI 10.1016/j.neuroscience.2006.05.021; Zhelyaznik N, 2003, EUR J NEUROSCI, V18, P1033, DOI 10.1046/j.1460-9568.2003.02834.x	58	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17023	10.1371/journal.pone.0017023	http://dx.doi.org/10.1371/journal.pone.0017023			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386894	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400023
J	McMullan, R; Nurrish, SJ				McMullan, Rachel; Nurrish, Stephen J.			The RHO-1 RhoGTPase Modulates Fertility and Multiple Behaviors in Adult C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; NEUROTRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; MENTAL-RETARDATION; SIGNALING PATHWAY; CELLULAR BASIS; GTPASES; KINASE; MUTANTS; RAC2	The Rho family of small GTPases are essential during early embryonic development making it difficult to study their functions in adult animals. Using inducible transgenes expressing either a constitutively active version of the single C. elegans Rho ortholog, RHO-1, or an inhibitor of endogenous Rho (C3 transferase), we demonstrate multiple defects caused by altering Rho signaling in adult C. elegans. Changes in RHO-1 signaling in cholinergic neurons affected locomotion, pharyngeal pumping and fecundity. Changes in RHO-1 signaling outside the cholinergic neurons resulted in defective defecation, ovulation, and changes in C. elegans body morphology. Finally both increased and decreased RHO-1 signaling in adults resulted in death within hours. The multiple post-developmental roles for Rho in C. elegans demonstrate that RhoA signaling pathways continue to be used post-developmentally and the resulting phenotypes provide an opportunity to further study post-developmental Rho signaling pathways using genetic screens.	UCL, MRC Lab Mol Cell Biol, MRC Cell Biol Unit, London, England; UCL, Dept Neurosci Physiol & Pharmacol, London, England	MRC Laboratory Molecular Biology; University of London; University College London; University of London; University College London	McMullan, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Div Cell & Mol Biol, London, England.	s.nurrish@ucl.ac.uk	McMullan, Rachel/ABJ-3519-2022	McMullan, Rachel/0000-0003-2677-8016; Nurrish, Stephen/0000-0002-2653-9384	UK Medical Research Council; MRC [MC_U122665004] Funding Source: UKRI; Medical Research Council [MC_U122665004] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a core grant to the MRC Cell Biology Unit from the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Bany IA, 2003, J NEUROSCI, V23, P8060; Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; BRENNER S, 1974, GENETICS, V77, P71; Bustelo XR, 2002, BIOESSAYS, V24, P602, DOI 10.1002/bies.10107; Canevascini S, 2005, EMBO REP, V6, P1169, DOI 10.1038/sj.embor.7400574; Chechlacz M, 2003, PEDIATR NEUROL, V29, P11, DOI 10.1016/S0887-8994(03)00152-8; Chen JC, 2003, J BIOL CHEM, V278, P2807, DOI 10.1074/jbc.M207943200; Corbetta S, 2005, MOL CELL BIOL, V25, P5763, DOI 10.1128/MCB.25.13.5763-5776.2005; Davis MW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000028; Diogon M, 2007, DEVELOPMENT, V134, P2469, DOI 10.1242/dev.005074; Eisenmann DM, 2000, GENETICS, V156, P1097; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gu Y, 2003, SCIENCE, V302, P445, DOI 10.1126/science.1088485; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hiley E, 2006, EMBO J, V25, P5884, DOI 10.1038/sj.emboj.7601458; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; KAYNE PS, 1995, CURR OPIN GENET DEV, V5, P38, DOI 10.1016/S0959-437X(95)90051-9; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Li SJ, 2002, J IMMUNOL, V169, P5043, DOI 10.4049/jimmunol.169.9.5043; Li WQ, 2001, J BIOL CHEM, V276, P34728, DOI 10.1074/jbc.M103496200; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; LIU DWC, 1994, J NEUROSCI, V14, P1953; Lundquist Erik A, 2006, WormBook, P1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; McMullan R, 2007, GENE DEV, V21, P2077, DOI 10.1101/gad.1615807; Meng YH, 2004, NEUROPHARMACOLOGY, V47, P746, DOI 10.1016/j.neuropharm.2004.06.030; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; Nicholas HR, 2004, CURR BIOL, V14, P1256, DOI 10.1016/j.cub.2004.07.022; Norman KR, 2005, CELL, V123, P119, DOI 10.1016/j.cell.2005.08.001; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; RAIZEN DM, 1995, GENETICS, V141, P1365; Ramakers GJA, 2002, TRENDS NEUROSCI, V25, P191, DOI 10.1016/S0166-2236(00)02118-4; RAND JB, 1984, GENETICS, V106, P227; Rand JB., 2007, ACETYLCHOLINE, V1, DOI [10.1895/wormbook.1.131.1, DOI 10.1895/WORMBOOK.1.131.1]; Rogers CM, 2001, J NEUROBIOL, V49, P235, DOI 10.1002/neu.1078; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Schafer William R, 2005, WormBook, P1; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Sharpe CC, 2003, J AM SOC NEPHROL, V14, P261, DOI 10.1097/01.ASN.0000048223.05219.E4; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soto MC, 2002, GENE DEV, V16, P620, DOI 10.1101/gad.955702; Steven R, 2005, GENE DEV, V19, P2016, DOI 10.1101/gad.1319905; STIERNAGLE T, COMMUNITY TCER; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; SUNDARAM MV, 2006, RTK RAS MAPK SIGNALI, P1, DOI DOI 10.1895/WORMBOOK.1.80.1; Sward K, 2003, CURR HYPERTENS REP, V5, P66, DOI 10.1007/s11906-003-0013-1; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; Williams DA, 2000, BLOOD, V96, P1646; Williams SL, 2007, GENE DEV, V21, P2731, DOI 10.1101/gad.1592007; Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Zallen JA, 2000, MOL BIOL CELL, V11, P3177, DOI 10.1091/mbc.11.9.3177	74	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17265	10.1371/journal.pone.0017265	http://dx.doi.org/10.1371/journal.pone.0017265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387015	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400045
J	Petnicki-Ocwieja, T; DeFrancesco, AS; Chung, E; Darcy, CT; Bronson, RT; Kobayashi, KS; Hu, LT				Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Chung, Erin; Darcy, Courtney T.; Bronson, Roderick T.; Kobayashi, Koichi S.; Hu, Linden T.			Nod2 Suppresses Borrelia burgdorferi Mediated Murine Lyme Arthritis and Carditis through the Induction of Tolerance	PLOS ONE			English	Article							INNATE IMMUNE ACTIVATION; TOLL-LIKE RECEPTOR-2; CROHNS-DISEASE; HOST-DEFENSE; INFLAMMATORY RESPONSES; I IFN; BINDING; RECOGNITION; PLAYS; MICE	The internalization of Borrelia burgdorferi, the causative agent of Lyme disease, by phagocytes is essential for an effective activation of the immune response to this pathogen. The intracellular, cytosolic receptor Nod2 has been shown to play varying roles in either enhancing or attenuating inflammation in response to different infectious agents. We examined the role of Nod2 in responses to B. burgdorferi. In vitro stimulation of Nod2 deficient bone marrow derived macrophages (BMDM) resulted in decreased induction of multiple cytokines, interferons and interferon regulated genes compared with wild-type cells. However, B. burgdorferi infection of Nod2 deficient mice resulted in increased rather than decreased arthritis and carditis compared to control mice. We explored multiple potential mechanisms for the paradoxical response in in vivo versus in vitro systems and found that prolonged stimulation with a Nod2 ligand, muramyl dipeptide (MDP), resulted in tolerance to stimulation by B. burgdorferi. This tolerance was lost with stimulation of Nod2 deficient cells that cannot respond to MDP. Cytokine patterns in the tolerance model closely paralleled cytokine profiles in infected Nod2 deficient mice. We propose a model where Nod2 has an enhancing role in activating inflammation in early infection, but moderates inflammation after prolonged exposure to the organism through induction of tolerance.	[Petnicki-Ocwieja, Tanja; DeFrancesco, Alicia S.; Chung, Erin; Darcy, Courtney T.; Hu, Linden T.] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Kobayashi, Koichi S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Tufts Medical Center; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Petnicki-Ocwieja, T (corresponding author), Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA.	lhu@tuftsmedicalcenter.org	Hu, Linden/L-6314-2016; Chung, Erin/AAZ-8699-2021	Hu, Linden/0000-0003-1659-5558; Chung, Erin/0000-0002-9324-8544; Kobayashi, Koichi/0000-0003-2930-0114	 [R01AI071107];  [R56AI80646];  [T32AI007329]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071107, R56AI080646, T32AI007329, R01AI050043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074738] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01AI071107 ( L. T. H.), R56AI80646 ( L. T. H.), and T32AI007329 (T.P.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; Behera AK, 2006, INFECT IMMUN, V74, P1462, DOI 10.1128/IAI.74.3.1462-1470.2006; Behera AK, 2006, ARTHRITIS RHEUM-US, V54, P3319, DOI 10.1002/art.22128; Behera AK, 2006, J IMMUNOL, V177, P657, DOI 10.4049/jimmunol.177.1.657; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bolz DD, 2004, J IMMUNOL, V173, P2003, DOI 10.4049/jimmunol.173.3.2003; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Cruz AR, 2008, INFECT IMMUN, V76, P56, DOI 10.1128/IAI.01039-07; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Frutuoso MS, 2010, MICROBES INFECT, V12, P819, DOI 10.1016/j.micinf.2010.05.006; Geddes K, 2010, INFECT IMMUN, V78, P5107, DOI 10.1128/IAI.00759-10; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; GIRARDIN SE, 2003, J BIOL CHEM; HEDL M, 2010, GASTROENTEROLOGY; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Heilpern AJ, 2009, INFECT IMMUN, V77, P2643, DOI 10.1128/IAI.00214-09; Herskovits AA, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030051; Hirschfeld M, 1999, J IMMUNOL, V163, P2382; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; KRAMER M, 2006, J LEUKOC BIOL; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Lee PY, 2008, J IMMUNOL, V180, P5101, DOI 10.4049/jimmunol.180.7.5101; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Liu N, 2009, INFECT IMMUN, V77, P3320, DOI 10.1128/IAI.00100-09; Liu NY, 2004, INFECT IMMUN, V72, P3195, DOI 10.1128/IAI.72.6.3195-3203.2004; Liu XJ, 2010, NEUROSCI LETT, V474, P93, DOI 10.1016/j.neulet.2010.03.013; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Marques A, 2008, INFECT DIS CLIN N AM, V22, P341, DOI 10.1016/j.idc.2007.12.011; Marques AR, 2010, CURR ALLERGY ASTHM R, V10, P13, DOI 10.1007/s11882-009-0077-3; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miller JC, 2010, INFECT IMMUN, V78, P3144, DOI 10.1128/IAI.01070-09; Miller JC, 2008, J IMMUNOL, V181, P8492, DOI 10.4049/jimmunol.181.12.8492; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Moore MW, 2007, INFECT IMMUN, V75, P2046, DOI 10.1128/IAI.01666-06; Netea MG, 2004, EUR J IMMUNOL, V34, P2052, DOI 10.1002/eji.200425229; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oosting M, 2010, J INFECT DIS, V201, P1849, DOI 10.1086/652871; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Petzke MM, 2009, J IMMUNOL, V183, P5279, DOI 10.4049/jimmunol.0901390; Puius YA, 2008, INFECT DIS CLIN N AM, V22, P289, DOI 10.1016/j.idc.2007.12.014; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Saha S, 2009, CELL HOST MICROBE, V5, P137, DOI 10.1016/j.chom.2008.12.010; Sahay B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000687; Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444; Shin OS, 2008, INFECT IMMUN, V76, P2341, DOI 10.1128/IAI.01600-07; Varoga D, 2005, ANN ANAT, V187, P499, DOI 10.1016/j.aanat.2005.03.004; Vignal C, 2007, MICROBES INFECT, V9, P658, DOI 10.1016/j.micinf.2007.01.016; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Wooten RM, 2002, VECTOR-BORNE ZOONOT, V2, P275, DOI 10.1089/153036602321653860; Wooten RM, 2002, J IMMUNOL, V168, P348, DOI 10.4049/jimmunol.168.1.348; Yamamoto S, 2009, MICROBES INFECT, V11, P912, DOI 10.1016/j.micinf.2009.06.005; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	69	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17414	10.1371/journal.pone.0017414	http://dx.doi.org/10.1371/journal.pone.0017414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387014	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400071
J	Wilson, JA; D'Emic, MD; Ikejiri, T; Moacdieh, EM; Whitlock, JA				Wilson, Jeffrey A.; D'Emic, Michael D.; Ikejiri, Takehito; Moacdieh, Emile M.; Whitlock, John A.			A Nomenclature for Vertebral Fossae in Sauropods and Other Saurischian Dinosaurs	PLOS ONE			English	Article							RAPETOSAURUS-KRAUSEI SAUROPODA; POSTCRANIAL PNEUMATICITY; EVOLUTION; ANATOMY; LAMINAE; TITANOSAURIA; PHYLOGENY; OSTEOLOGY; PATAGONIA; SKELETON	Background: The axial skeleton of extinct saurischian dinosaurs (i.e., theropods, sauropodomorphs), like living birds, was pneumatized by epithelial outpocketings of the respiratory system. Pneumatic signatures in the vertebral column of fossil saurischians include complex branching chambers within the bone (internal pneumaticity) and large chambers visible externally that are bounded by neural arch laminae (external pneumaticity). Although general aspects of internal pneumaticity are synapomorphic for saurischian subgroups, the individual internal pneumatic spaces cannot be homologized across species or even along the vertebral column, due to their variability and absence of topographical landmarks. External pneumatic structures, in contrast, are defined by ready topological landmarks (vertebral laminae), but no consistent nomenclatural system exists. This deficiency has fostered confusion and limited their use as character data in phylogenetic analysis. Methodology/Principal Findings: We present a simple system for naming external neural arch fossae that parallels the one developed for the vertebral laminae that bound them. The nomenclatural system identifies fossae by pointing to reference landmarks (e. g., neural spine, centrum, costal articulations, zygapophyses). We standardize the naming process by creating tripartite names from "primary landmarks," which form the zygodiapophyseal table, "secondary landmarks," which orient with respect to that table, and "tertiary landmarks," which further delineate a given fossa. Conclusions/Significance: The proposed nomenclatural system for lamina-bounded fossae adds clarity to descriptions of complex vertebrae and allows these structures to be sourced as character data for phylogenetic analyses. These anatomical terms denote potentially homologous pneumatic structures within Saurischia, but they could be applied to any vertebrate with vertebral laminae that enclose spaces, regardless of their developmental origin or phylogenetic distribution.	[Wilson, Jeffrey A.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Wilson, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	wilsonja@umich.edu	Wilson, Jeffrey/C-2737-2008; Ikejiri, Takehito/AAW-8933-2020; Whitlock, John/G-5814-2018; Whitlock, John/A-3079-2009	Whitlock, John/0000-0002-1118-2925; Whitlock, John/0000-0002-1118-2925	National Science Foundation [DEB-0640434]	National Science Foundation(National Science Foundation (NSF))	Research was supported by National Science Foundation grant DEB-0640434 (to JAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2004, CR PALEVOL, V3, P199, DOI 10.1016/j.crpv.2004.03.001; Allain R, 2008, GEODIVERSITAS, V30, P345; [Anonymous], 1993, PNEUMATIC POSTCRANIA; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; Calvo JO, 2003, REV GEOL CHILE, V30, P333; Calvo Jorge O., 2007, Arquivos do Museu Nacional (Rio de Janeiro), V65, P485; CAMP CHARLES L., 1930, MEM UNIV CALIFORNIA, V10, P1; Campos D.D.A., 2005, ARQ MUS NAC, V63, P565; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Cope ED, 1877, PALEONTOLOGICAL B, V25, P5; Coria R., 2000, GAIA, V102, P89; Farke AA, 2010, ZOOL J LINN SOC-LOND, V159, P988, DOI 10.1111/j.1096-3642.2009.00586.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; Gilmore C. W., 1936, Memoirs of the Carnegie Museum, V11, P175; Gomani EM, 2005, PALAEONTOL ELECTRON, V8; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Harris JD, 2006, PALAEONTOLOGY, V49, P1091, DOI 10.1111/j.1475-4983.2006.00577.x; Hatcher JB., 1901, MEM CARNEGIE MUS, V1, P1, DOI [10.5962/p.234818, DOI 10.5962/P.234818]; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P21; Ikejiri T, 2005, LIFE O PAST, P154; Janensch W., 1950, PALAEONTOGRAPHICA, V3, P27; Lull R. S., 1942, Geological Society of America Special Paper, V40, P1; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; McIntosh J.S., 1990, P345; McIntosh John S., 1996, Bulletin of Gunma Museum of Natural History, V1, P1; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; Osborn H. F., 1921, MEMOIRS AM MUSEUM NA, V3, P249; OUYANG H, 2001, 1 MAMENCHISAURIAN SK, P111; Paul G.S., 1988, HUNTERIA, V2, P1; Riga BJG, 2003, AMEGHINIANA, V40, P155; Rogers KC, 2001, NATURE, V412, P530, DOI 10.1038/35087566; Rogers KC, 2004, J VERTEBR PALEONTOL, V24, P121, DOI 10.1671/A1109-10; Rogers KC, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P50; Rogers KC, 2009, J VERTEBR PALEONTOL, V29, P1046, DOI 10.1671/039.029.0432; Salgado Leonardo, 2006, Revista del Museo Argentino de Ciencias Naturales, V8, P69; Salgado L, 2010, J VERTEBR PALEONTOL, V30, P1760, DOI 10.1080/02724634.2010.520783; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno PC, 1999, SCIENCE, V286, P1342, DOI 10.1126/science.286.5443.1342; Suteethorn S, 2010, NEUES JAHRB GEOL P-A, V256, P109, DOI 10.1127/0077-7749/2010/0036; Taylor MP, 2009, J VERTEBR PALEONTOL, V29, P787, DOI 10.1671/039.029.0309; Upchurch P., 2004, NATL SCI MUS MONOGR, V26, P1; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; WHITLOCK JA, ZOOLOGICAL IN PRESS; WHITLOCK JA, PALAEONTOLO IN PRESS; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217; WILSON JA, 1998, SOC VERTEBRATE PALEO, V5, P1, DOI DOI 10.2307/3889325; Wilson JA, 2006, J VERTEBR PALEONTOL, V26, P511, DOI 10.1671/0272-4634(2006)26[511:ANOFVS]2.0.CO;2; Wilson JA, 2009, J SYST PALAEONTOL, V7, P199, DOI 10.1017/S1477201908002691; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Young C.C., 1972, I VERTEBRATE PALEO A, V8, P1; Young C. C., 1954, ACTA SCI SINICA, V3, P491	61	171	177	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17114	10.1371/journal.pone.0017114	http://dx.doi.org/10.1371/journal.pone.0017114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386963	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400030
J	Yin, XH; Zhu, J; Feng, YN; Chambers, JR; Gong, J; Gyles, CL				Yin, Xianhua; Zhu, Jing; Feng, Yanni; Chambers, James R.; Gong, Joshua; Gyles, Carlton L.			Differential Gene Expression and Adherence of Escherichia coli O157:H7 In Vitro and in Ligated Pig Intestines	PLOS ONE			English	Article							LEE PATHOGENICITY ISLAND; ENTEROCYTE EFFACEMENT; III SECRETION; CATABOLITE REPRESSION; ACID RESISTANCE; VIRULENCE; LOCUS; IDENTIFICATION; O157-H7; SYSTEM	Background: Escherichia coli O157:H7 strain 86-24 grown in MacConkey broth (MB) shows almost no adherence to cultured epithelial cells but adheres well in pig ligated intestines. This study investigated the mechanisms associated with the difference between in-vitro and in-vivo adherence of the MB culture. Methodology/Principal Findings: It was found that decreased adherence in vitro by bacteria grown in MB was mainly due to lactose, possibly implicating the involvement of carbon catabolite repression (CCR). Expression of selected virulence-related genes associated with adherence and CCR was then examined by quantitative PCR. When bacteria were grown in MB and Brain Heart Infusion with NaHCO3 (BHIN) plus lactose, pH was reduced to 5.5-5.9 and there was a significant decrease in expression of the locus of enterocyte effacement (LEE) genes eae, tir, espD, grlA/R and ler, and an increase in cya (cAMP), and two negative regulators of the LEE, gadE and hfq. Putative virulence genes stcE, hlyA, ent and nleA were also decreased in vitro. Reversal of these changes was noted for bacteria recovered from the intestine, where transcripts for qseF and fis and putative virulence factors AidA15, TerC and Ent/EspL2 were significantly increased, and transcripts for AIDA48, Iha, UreC, Efa1A, Efa1B, ToxB, EhxA, StcE, NleA and NleB were expressed at high levels. Conclusions/Significance: Presence of lactose resulted in decreased expression of LEE genes and the failure of EHEC O157: H7 to adhere to epithelial cells in vitro but this repression was overcome in vivo. CCR and/or acidic pH may have played a role in repression of the LEE genes. Bacterial pathogens need to integrate their nutritional metabolism with expression of virulence genes but little is known of how this is done in E. coli O157: H7. This study indicates one aspect of the subject that should be investigated further.	[Yin, Xianhua; Chambers, James R.; Gong, Joshua] Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada; [Zhu, Jing] Shanghai Jiao Tong Univ, Coll Life Sci & Biotechnol, Shanghai 200030, Peoples R China; [Feng, Yanni] Qingdao Agr Univ, Coll Anim Sci & Technol, Qingdao, Peoples R China; [Yin, Xianhua; Gyles, Carlton L.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Agriculture & Agri Food Canada; Shanghai Jiao Tong University; Qingdao Agricultural University; University of Guelph	Yin, XH (corresponding author), Agr & Agri Food Canada, Guelph Food Res Ctr, Guelph, ON, Canada.	cgyles@ovc.uoguelph.ca		Feng, Yanni/0000-0002-3590-788X	Guelph Food Research Centre, Agriculture and Agri-Food Canada	Guelph Food Research Centre, Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada)	The research was supported financially by Guelph Food Research Centre, Agriculture and Agri-Food Canada. There is no grant number. The URL is http://www4.agr.gc.ca/AAFC-AAC/display-afficher. do?id=1180620168432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea L, 2003, MICROB PATHOGENESIS, V34, P205, DOI 10.1016/S0882-4010(03)00026-3; Balsalobre C, 2006, J BACTERIOL, V188, P5935, DOI 10.1128/JB.00235-06; Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; Coldewey SM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-21; Coombes BK, 2008, APPL ENVIRON MICROB, V74, P2153, DOI 10.1128/AEM.02566-07; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Dziva F, 2007, FEMS MICROBIOL LETT, V271, P258, DOI 10.1111/j.1574-6968.2007.00724.x; Elliott SJ, 1999, MOL MICROBIOL, V33, P1176, DOI 10.1046/j.1365-2958.1999.01559.x; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Gosset G, 2004, J BACTERIOL, V186, P3516, DOI 10.1128/JB.186.11.3516-3524.2004; Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hogema BM, 1997, MOL MICROBIOL, V24, P857, DOI 10.1046/j.1365-2958.1997.3991761.x; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; KAILASAN V, 2009, J BACTERIOLOGY, V0191; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Karmali MA, 2003, J CLIN MICROBIOL, V41, P4930, DOI 10.1128/JCM.41.11.4930-4940.2003; KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Z, 2003, MOL MICROBIOL, V49, P1309, DOI 10.1046/j.1365-2958.2003.03633.x; Maurer JJ, 1999, APPL ENVIRON MICROB, V65, P2954; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Metzner M, 2004, MOL MICROBIOL, V51, P799, DOI 10.1046/j.1365-2958.2003.03867.x; Mika F, 2005, GENE DEV, V19, P2770, DOI 10.1101/gad.353705; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Muffler A, 1996, GENE DEV, V10, P1143, DOI 10.1101/gad.10.9.1143; Muller CM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000303; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; PEASE AJ, 1994, J BACTERIOL, V176, P115, DOI 10.1128/JB.176.1.115-122.1994; Perna NT, 2002, ESCHERICHIA COLI VIR, P3; Poncet S, 2009, CONTRIB MICROBIOL, V16, P88, DOI 10.1159/000219374; Pullinger GD, 2010, INFECT IMMUN, V78, P372, DOI 10.1128/IAI.01203-09; Rashid RA, 2006, INFECT IMMUN, V74, P4142, DOI 10.1128/IAI.00299-06; Reading NC, 2007, J BACTERIOL, V189, P2468, DOI 10.1128/JB.01848-06; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Shakhnovich EA, 2009, MOL MICROBIOL, V74, P347, DOI 10.1111/j.1365-2958.2009.06856.x; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Stevens MP, 2004, INFECT IMMUN, V72, P5402, DOI 10.1128/IAI.72.9.5402-5411.2004; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tatsuno I, 2003, INFECT IMMUN, V71, P2598, DOI 10.1128/IAI.71.5.2598-2606.2003; Taylor DE, 2002, J BACTERIOL, V184, P4690, DOI 10.1128/JB.184.17.4690-4698.2002; Toma C, 2004, J CLIN MICROBIOL, V42, P4937, DOI 10.1128/JCM.42.11.4937-4946.2004; Torres AG, 2007, INT J MED MICROBIOL, V297, P177, DOI 10.1016/j.ijmm.2007.01.005; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Walters M, 2006, INFECT IMMUN, V74, P5445, DOI 10.1128/IAI.00099-06; Wickham ME, 2006, J INFECT DIS, V194, P819, DOI 10.1086/506620; YIN X, 2010, J VET RES IN PRESS; Yin XH, 2009, APPL ENVIRON MICROB, V75, P5779, DOI 10.1128/AEM.00507-09; Yin XH, 2009, APPL ENVIRON MICROB, V75, P4975, DOI 10.1128/AEM.00297-09; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004; Zheng DL, 2004, NUCLEIC ACIDS RES, V32, P5874, DOI 10.1093/nar/gkh908; Zwir I, 2005, P NATL ACAD SCI USA, V102, P2862, DOI 10.1073/pnas.0408238102	68	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17424	10.1371/journal.pone.0017424	http://dx.doi.org/10.1371/journal.pone.0017424			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387009	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400074
J	Zhu, T; Tian, JA; Zhang, SY; Wu, NF; Fan, YL				Zhu, Tao; Tian, Jian; Zhang, Shuangyu; Wu, Ningfeng; Fan, Yunliu			Identification of the Transcriptional Regulator NcrB in the Nickel Resistance Determinant of Leptospirillum ferriphilum UBK03	PLOS ONE			English	Article							ONE-HYBRID SYSTEM; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; ALCALIGENES-EUTROPHUS; HELICOBACTER-PYLORI; XYLOSOXIDANS 31A; COBALT; GENE; BIOOXIDATION; CADMIUM	The nickel resistance determinant ncrABCY was identified in Leptospirillum ferriphilum UBK03. Within this operon, ncrA and ncrC encode two membrane proteins that form an efflux system, and ncrB encodes NcrB, which belongs to an uncharacterized family (DUF156) of proteins. How this determinant is regulated remains unknown. Our data indicate that expression of the nickel resistance determinant is induced by nickel. The promoter of ncrA, designated pncrA, was cloned into the promoter probe vector pPR9TT, and co-transformed with either a wild-type or mutant nickel resistance determinant. The results revealed that ncrB encoded a transcriptional regulator that could regulate the expression of ncrA, ncrB, and ncrC. A GC-rich inverted repeat sequence was identified in the promoter pncrA. Electrophoretic mobility shift assays (EMSAs) and footprinting assays showed that purified NcrB could specifically bind to the inverted repeat sequence of pncrA in vitro; this was confirmed by bacterial one-hybrid analysis. Moreover, this binding was inhibited in the presence of nickel ions. Thus, we classified NcrB as a transcriptional regulator that recognizes the inverted repeat sequence binding motif to regulate the expression of the key nickel resistance gene, ncrA.	[Zhu, Tao; Tian, Jian; Zhang, Shuangyu; Wu, Ningfeng; Fan, Yunliu] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhu, T (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	wunf@caas.net.cn	Zhu, Tao/I-5069-2019; , 田健/AAX-7731-2020; Tian, Jian/D-1052-2011	Zhu, Tao/0000-0003-0228-3916; , 田健/0000-0002-9997-6518; Tian, Jian/0000-0002-9997-6518	National Natural Science Foundation of China [30770038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant no. 30770038) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YJ, 2008, ACTA CRYSTALLOGR F, V64, P130, DOI 10.1107/S1744309108001760; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bornberg-Bauer E, 1998, NUCLEIC ACIDS RES, V26, P2740, DOI 10.1093/nar/26.11.2740; Coram NJ, 2002, APPL ENVIRON MICROB, V68, P838, DOI 10.1128/AEM.68.2.838-845.2002; EITINGER T, 1994, MOL MICROBIOL, V12, P1025, DOI 10.1111/j.1365-2958.1994.tb01090.x; Ernst FD, 2005, INFECT IMMUN, V73, P7252, DOI 10.1128/IAI.73.11.7252-7258.2005; Grass G, 2000, J BACTERIOL, V182, P1390, DOI 10.1128/JB.182.5.1390-1398.2000; Grass G, 2001, J BACTERIOL, V183, P2803, DOI 10.1128/JB.183.9.2803-2807.2001; Grosse C, 1999, J BACTERIOL, V181, P2385; Haritha A, 2009, J BACTERIOL, V191, P5976, DOI 10.1128/JB.00465-09; Hebbeln P, 2004, FEMS MICROBIOL LETT, V230, P129, DOI 10.1016/S0378-1097(03)00885-1; Iwig JS, 2008, J AM CHEM SOC, V130, P7592, DOI 10.1021/ja710067d; Iwig JS, 2006, MOL MICROBIOL, V62, P252, DOI 10.1111/j.1365-2958.2006.05369.x; Kunito T, 1996, BIOSCI BIOTECH BIOCH, V60, P699, DOI 10.1271/bbb.60.699; LATCHMAN D, 1999, TRANSCRIPTION FACTOR; Li R, 2010, MOL MICROBIOL, V75, P349, DOI 10.1111/j.1365-2958.2009.06968.x; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; Meng X, 2006, NAT PROTOC, V1, P30, DOI 10.1038/nprot.2006.6; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; NIES DH, 1995, J IND MICROBIOL, V14, P186, DOI 10.1007/BF01569902; NIES DH, 1992, PLASMID, V27, P17, DOI 10.1016/0147-619X(92)90003-S; NIES DH, 2007, MOL MICROBIOLOGY HEA; Quatrini R, 2007, NUCLEIC ACIDS RES, V35, P2153, DOI 10.1093/nar/gkm068; Rawlings DE, 1999, MICROBIOL-UK, V145, P5, DOI 10.1099/13500872-145-1-5; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Santos PM, 2001, FEMS MICROBIOL LETT, V195, P91, DOI 10.1111/j.1574-6968.2001.tb10503.x; SCHMIDT T, 1994, J BACTERIOL, V176, P7045, DOI 10.1128/JB.176.22.7045-7054.1994; Siunova T V, 2009, Genetika, V45, P336; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Stoof J, 2010, BIOMETALS, V23, P145, DOI 10.1007/s10534-009-9275-7; Tian J, 2007, APPL ENVIRON MICROB, V73, P2364, DOI 10.1128/AEM.00207-07; Tuffin IM, 2006, APPL ENVIRON MICROB, V72, P2247, DOI 10.1128/AEM.72.3.2247-2253.2006; Yang H, 2007, MOL MICROBIOL, V65, P1064, DOI 10.1111/j.1365-2958.2007.05848.x	37	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17367	10.1371/journal.pone.0017367	http://dx.doi.org/10.1371/journal.pone.0017367			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387010	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400064
J	Cavel, E; Pillot, M; Pontier, D; Lahmy, S; Bies-Etheve, N; Vega, D; Grimanelli, D; Lagrange, T				Cavel, Emilie; Pillot, Marion; Pontier, Dominique; Lahmy, Sylvie; Bies-Etheve, Natacha; Vega, Danielle; Grimanelli, Daniel; Lagrange, Thierry			A Plant-Specific Transcription Factor IIB-Related Protein, pBRP2, Is Involved in Endosperm Growth Control	PLOS ONE			English	Article							RNA-POLYMERASE-II; TFIIB-RELATED PROTEIN; SEED DEVELOPMENT; CORE PROMOTER; ARABIDOPSIS; DNA; EXPRESSION; IV; COMPLEX; ELEMENT	General transcription factor IIB (TFIIB) and TFIIB-related factor (BRF), are conserved RNA polymerase II/III (RNAPII/III) selectivity factors that are involved in polymerase recruitment and transcription initiation in eukaryotes. Recent findings have shown that plants have evolved a third type of B-factor, plant-specific TFIIB-related protein 1 (pBRP1), which seems to be involved in RNAPI transcription. Here, we extend the repertoire of B-factors in plants by reporting the characterization of a novel TFIIB-related protein, plant-specific TFIIB-related protein 2 (pBRP2), which is found to date only in the Brassicacea family. Unlike other B-factors that are ubiquitously expressed, PBRP2 expression is restricted to reproductive organs and seeds as shown by RT-PCR, immunofluorescence labelling and GUS staining experiments. Interestingly, pbrp2 loss-of-function specifically affects the development of the syncytial endosperm, with both parental contributions required for wild-type development. pBRP2, is the first B-factor to exhibit cell-specific expression and regulation in eukaryotes, and might play a role in enforcing bi-parental reproduction in angiosperms.	[Cavel, Emilie; Pontier, Dominique; Lahmy, Sylvie; Bies-Etheve, Natacha; Vega, Danielle; Lagrange, Thierry] Univ Perpignan, Lab Genome & Dev Plantes, CNRS, Inst Rech Dev, F-66025 Perpignan, France; [Pillot, Marion; Grimanelli, Daniel] Inst Rech Dev, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD)	Cavel, E (corresponding author), Umea Univ, Dept Plant Physiol, S-90187 Umea, Sweden.	daniel.grimanelli@ird.fr; lagrange@univ-perp.fr	Grimanelli, Daniel/ABE-4777-2020	Pontier, Dominique/0000-0001-9032-4620; Grimanelli, Daniel/0000-0001-5424-114X; Lagrange, Thierry/0000-0003-3090-0918	Centre National de la Recherche Scientifique (CNRS); Ministere de la Recherche et de l'Enseignement Superieur (MRES); Institut de Recherche et Developpement (IRD); Agence Nationale de la Recherche (ANR) [ANR-BLANC-07]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche et de l'Enseignement Superieur (MRES); Institut de Recherche et Developpement (IRD); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by Centre National de la Recherche Scientifique (CNRS) and Ministere de la Recherche et de l'Enseignement Superieur (MRES) funding to TL and EC, and by Institut de Recherche et Developpement (IRD) and Agence Nationale de la Recherche (ANR) (ANR-BLANC-07) funding to DG and MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baroux C, 2007, CURR OPIN GENET DEV, V17, P473, DOI 10.1016/j.gde.2007.09.004; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Gazdag E, 2009, GENE DEV, V23, P2210, DOI 10.1101/gad.535209; Haig D, 2006, NAT GENET, V38, P271, DOI 10.1038/ng0306-271; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; KANNO T, 2005, NAT GENET, V37, P61; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lagrange T, 2003, MOL CELL BIOL, V23, P3274, DOI 10.1128/MCB.23.9.3274-3286.2003; Lagrange T, 1998, GENE DEV, V12, P34, DOI 10.1101/gad.12.1.34; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; MULLER F, 2010, J BIOL, V8, P97; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nowack MK, 2007, NATURE, V447, P312, DOI 10.1038/nature05770; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schramm L, 2000, GENE DEV, V14, P2650, DOI 10.1101/gad.836400; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; SURANI MAH, 1987, NATURE, V326, P395, DOI 10.1038/326395a0; Zhang D, 2001, SCIENCE, V292, P1153, DOI 10.1126/science.1059188	33	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17216	10.1371/journal.pone.0017216	http://dx.doi.org/10.1371/journal.pone.0017216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390310	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700036
J	FitzGerald, J; Moureau, S; Drogaris, P; O'Connell, E; Abshiru, N; Verreault, A; Thibault, P; Grenon, M; Lowndes, NF				FitzGerald, Jennifer; Moureau, Sylvie; Drogaris, Paul; O'Connell, Enda; Abshiru, Nebiyu; Verreault, Alain; Thibault, Pierre; Grenon, Muriel; Lowndes, Noel F.			Regulation of the DNA Damage Response and Gene Expression by the Dot1L Histone Methyltransferase and the 53Bp1 Tumour Suppressor	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; SILENCING PROTEIN; MAMMALIAN-CELLS; ENAC-ALPHA; METHYLATION; CHROMATIN; H3; NUCLEOSOME; LYSINE-79; DIMETHYLATION	Background: Dot1L, a histone methyltransferase that targets histone H3 lysine 79 (H3K79), has been implicated in gene regulation and the DNA damage response although its functions in these processes remain poorly defined. Methodology/Principal Findings: Using the chicken DT40 model system, we generated cells in which the Dot1L gene is disrupted to examine the function and focal recruitment of the 53Bp1 DNA damage response protein. Detailed kinetic and dose response assays demonstrate that, despite the absence of H3K79 methylation demonstrated by mass spectrometry, 53Bp1 focal recruitment is not compromised in these cells. We also describe, for the first time, the phenotypes of a cell line lacking both Dot1L and 53Bp1. Dot1L(-/-) and wild type cells are equally resistant to ionising radiation, whereas 53Bp1(-/-)/Dot1L(-/-) cells display a striking DNA damage resistance phenotype. Dot1L and 53Bp1 also affect the expression of many genes. Loss of Dot1L activity dramatically alters the mRNA levels of over 1200 genes involved in diverse biological functions. These results, combined with the previously reported list of differentially expressed genes in mouse ES cells knocked down for Dot1L, demonstrates surprising cell type and species conservation of Dot1L-dependent gene expression. In 53Bp1(-/-) cells, over 300 genes, many with functions in immune responses and apoptosis, were differentially expressed. To date, this is the first global analysis of gene expression in a 53Bp1-deficient cell line. Conclusions/Significance: Taken together, our results uncover a negative role for Dot1L and H3K79 methylation in the DNA damage response in the absence of 53Bp1. They also enlighten the roles of Dot1L and 53Bp1 in gene expression and the control of DNA double-strand repair pathways in the context of chromatin.	[FitzGerald, Jennifer; Moureau, Sylvie; Grenon, Muriel; Lowndes, Noel F.] Natl Univ Ireland Galway, Ctr Chromosome Biol, Genome Stabil Lab, Sch Nat Sci, Galway, Ireland; [O'Connell, Enda] Natl Univ Ireland Galway, Natl Ctr Biomed Engn Sci, Galway, Ireland; [Drogaris, Paul; Abshiru, Nebiyu; Verreault, Alain; Thibault, Pierre] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Verreault, Alain] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Thibault, Pierre] Univ Montreal, Dept Chim, Montreal, PQ H3C 3J7, Canada	Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Universite de Montreal; Universite de Montreal; Universite de Montreal	FitzGerald, J (corresponding author), Natl Univ Ireland Galway, Ctr Chromosome Biol, Genome Stabil Lab, Sch Nat Sci, Galway, Ireland.	muriel.grenon@nuigalway.ie; noel.lowndes@nuigalway.ie	Grenon, Muriel/D-5228-2011; Lowndes, Noel F/B-9084-2008	Lowndes, Noel F/0000-0002-3216-4427; O'Connell, Enda/0000-0001-7441-0262; Thibault, Pierre/0000-0001-5993-0331; Grenon, Muriel/0000-0002-9910-5974	Irish Research Council for Science, Engineering and Technology; European Union [F16R-CT-2003-508842]; Science Foundation Ireland [07/IN1/B958]; Canadian Institutes for Health Research [FRN 89928]; Natural Sciences and Engineering Research Council of Canada; Canadian Centre of Excellence in Commercialisation and Research; Canadian Foundation for Innovation; Fonds de Recherche en Sante du Quebec; Cancer Research Ireland [CR105GRE]	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); European Union(European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Centre of Excellence in Commercialisation and Research; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Cancer Research Ireland	This work was supported by an Irish Research Council for Science, Engineering and Technology (http://www.ircset.ie/) grant to JF, a Cancer Research Ireland project grant (http://www.cancer.ie/) to MG (CR105GRE), the European Union FP6 Integrated Project "Radiosensitivity of Individuals and Susceptibility to Cancer induced by Ionising RADiations" (http://www.riscrad.org/) contract number F16R-CT-2003-508842 and Science Foundation Ireland (http://www.sfi.ie/) Principal Investigator award 07/IN1/B958 to NL. AV's laboratory is funded by the Canadian Institutes for Health Research (http://www.cihr-irsc.gc.ca/) grant FRN 89928. PT's research is funded by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). IRIC's infrastructure is supported by funds from the Canadian Centre of Excellence in Commercialisation and Research, the Canadian Foundation for Innovation, and the Fonds de Recherche en Sante du Quebec. The funding agencies played no role in experimental design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; ARAKAWA H, 2001, BMC BIOTECHNOLOGY, V1; Barry ER, 2009, STEM CELLS, V27, P1538, DOI 10.1002/stem.86; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; BREE RT, 2007, CELL CYCLE, V10, P6; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; BUNTING SF, 2010, CELL; Costelloe T, 2006, EXP CELL RES, V312, P2677, DOI 10.1016/j.yexcr.2006.06.031; Dlakic M, 2001, TRENDS BIOCHEM SCI, V26, P405, DOI 10.1016/S0968-0004(01)01856-4; Downs JA, 2003, MOL CELL, V11, P1685, DOI 10.1016/S1097-2765(03)00197-7; Drogaris P, 2009, ANAL CHEM, V81, P6300, DOI 10.1021/ac9004259; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Grenon M, 2007, YEAST, V24, P105, DOI 10.1002/yea.1441; Habermann FA, 2001, CHROMOSOME RES, V9, P569, DOI 10.1023/A:1012447318535; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; *INT CHICK GEN SEQ, 2004, SEQ COMP AN CHICK GE, P695; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Iwabuchi K, 1998, J BIOL CHEM, V273, P26061, DOI 10.1074/jbc.273.40.26061; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Lin YH, 2009, BLOOD, V114, P651, DOI 10.1182/blood-2009-03-209395; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Nakamura K, 2006, DNA REPAIR, V5, P741, DOI 10.1016/j.dnarep.2006.03.008; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; PAIK WK, 1975, FEBS LETT, V58, P39, DOI 10.1016/0014-5793(75)80220-1; Rauch T, 2005, CELL CYCLE, V4, P1078; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Saba J, 2009, J PROTEOME RES, V8, P3355, DOI 10.1021/pr801106a; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; SCHULZE JM, 2009, MOL CELL; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Singer MS, 1998, GENETICS, V150, P613; Smith J, 2000, ANIM GENET, V31, P96, DOI 10.1046/j.1365-2052.2000.00565.x; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Verzijlbergen KF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-76; Winding P, 2001, J IMMUNOL METHODS, V249, P1, DOI 10.1016/S0022-1759(00)00333-1; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Zhang KL, 2004, PROTEOMICS, V4, P3765, DOI 10.1002/pmic.200400819; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	69	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14714	10.1371/journal.pone.0014714	http://dx.doi.org/10.1371/journal.pone.0014714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383990	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700003
J	Lubell, Y; Staedke, SG; Greenwood, BM; Kamya, MR; Molyneux, M; Newton, PN; Reyburn, H; Snow, RW; D'Alessandro, U; English, M; Day, N; Kremsner, P; Dondorp, A; Mbacham, W; Dorsey, G; Owusu-Agyei, S; Maitland, K; Krishna, S; Newton, C; Pasvol, G; Taylor, T; von Seidlein, L; White, NJ; Binka, F; Mills, A; Whitty, CJM				Lubell, Yoel; Staedke, Sarah G.; Greenwood, Brian M.; Kamya, Moses R.; Molyneux, Malcolm; Newton, Paul N.; Reyburn, Hugh; Snow, Robert W.; D'Alessandro, Umberto; English, Mike; Day, Nick; Kremsner, Peter; Dondorp, Arjen; Mbacham, Wilfred; Dorsey, Grant; Owusu-Agyei, Seth; Maitland, Kathryn; Krishna, Sanjeev; Newton, Charles; Pasvol, Geoffrey; Taylor, Terrie; von Seidlein, Lorenz; White, Nicholas J.; Binka, Fred; Mills, Anne; Whitty, Christopher J. M.			Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; COST-EFFECTIVENESS; COMBINATION THERAPY; SOUTH-AFRICA; MALARIA; CHILDREN	Background: Modelling is widely used to inform decisions about management of malaria and acute febrile illnesses. Most models depend on estimates of the probability that untreated patients with malaria or bacterial illnesses will progress to severe disease or death. However, data on these key parameters are lacking and assumptions are frequently made based on expert opinion. Widely diverse opinions can lead to conflicting outcomes in models they inform. Methods and Findings: A Delphi survey was conducted with malaria experts aiming to reach consensus on key parameters for public health and economic models, relating to the outcome of untreated febrile illnesses. Survey questions were stratified by malaria transmission intensity, patient age, and HIV prevalence. The impact of the variability in opinion on decision models is illustrated with a model previously used to assess the cost-effectiveness of malaria rapid diagnostic tests. Some consensus was reached around the probability that patients from higher transmission settings with untreated malaria would progress to severe disease (median 3%, inter-quartile range (IQR) 1-5%), and the probability that a non-malaria illness required antibiotics in areas of low HIV prevalence (median 20%). Children living in low transmission areas were considered to be at higher risk of progressing to severe malaria (median 30%, IQR 10-58%) than those from higher transmission areas (median 13%, IQR 7-30%). Estimates of the probability of dying from severe malaria were high in all settings (medians 60-73%). However, opinions varied widely for most parameters, and did not converge on resurveying. Conclusions: This study highlights the uncertainty around potential consequences of untreated malaria and bacterial illnesses. The lack of consensus on most parameters, the wide range of estimates, and the impact of variability in estimates on model outputs, demonstrate the importance of sensitivity analysis for decision models employing expert opinion. Results of such models should be interpreted cautiously. The diversity of expert opinion should be recognised when policy options are debated.	[Lubell, Yoel; Staedke, Sarah G.; Greenwood, Brian M.; Reyburn, Hugh; Mills, Anne; Whitty, Christopher J. M.] London Sch Hyg & Trop Med, London WC1, England; [Lubell, Yoel; Day, Nick; Dondorp, Arjen; White, Nicholas J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Staedke, Sarah G.] Univ Calif San Francisco, Res Collaborat, Mulago Hosp, Kampala, Uganda; [Molyneux, Malcolm] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi; [Newton, Paul N.] Mahosot Hosp, Wellcome Trust Mahosot Hosp, Oxford Trop Med Res Collaborat, Viangchan, Lao Pdr, Laos; [Newton, Paul N.; Snow, Robert W.; White, Nicholas J.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Reyburn, Hugh] Kilimanjaro Christian Med Ctr, Joint Malaria Programme, Moshi, Tanzania; [Snow, Robert W.; English, Mike] Kenya Govt Med Res Ctr, Ctr Geog Med, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya; [D'Alessandro, Umberto] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Kremsner, Peter] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Kremsner, Peter] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Mbacham, Wilfred] Univ Yaounde, Ctr Biotechnol, Yaounde, Cameroon; [Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Ghana Hlth Serv, Kintampo, Ghana; [Maitland, Kathryn; Newton, Charles] Ctr Geog Med Res Coast, Kenya Med Res Inst, Wellcome Trust Res Programme, Kilifi, Kenya; [Krishna, Sanjeev] St George Hosp, Sch Med, Fac Med & Biomed Sci, London, England; [Pasvol, Geoffrey] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England; [Taylor, Terrie] Coll Med, Blantyre Malaria Project, Blantyre, Malawi; [Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA; [von Seidlein, Lorenz] Hosp Teule, Joint Malaria Programme, Muheza, Tanzania; [Binka, Fred] Demog Evaluat Populat & Their Hlth Developing Cou, Int Network, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Makerere University; Mulago National Referral Hospital; University of Malawi; University of Oxford; Kilimanjaro Christian Medical Centre; Kenya Medical Research Institute; Institute of Tropical Medicine (ITM); Eberhard Karls University of Tubingen; University of Yaounde I; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Ghana Health Service; Kintampo Health Research Centre; Kenya Medical Research Institute; St Georges University London; Imperial College London; University of Malawi; Michigan State University; Michigan State University College of Osteopathic Medicine	Lubell, Y (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	yoel@tropmedres.ac	White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Newton, Charles RJC/B-7578-2014; Snow, Robert William/AFR-1436-2022; Newton, Charles/V-7872-2019; Whitty, Christopher/C-7740-2012; D'Alessandro, Umberto/D-3457-2015	White, Nick/0000-0002-1897-1978; Newton, Charles RJC/0000-0002-6999-5507; Snow, Robert William/0000-0003-3725-6088; Newton, Charles/0000-0002-6999-5507; D'Alessandro, Umberto/0000-0001-6341-5009; Lubell, Yoel/0000-0002-0237-1070; Whitty, Christopher/0000-0002-6076-5027; Maitland, Kathryn/0000-0002-0007-0645; Newton, Paul/0000-0002-4608-6431; Mbacham, Wilfred/0000-0002-3934-3233; English, Michael/0000-0002-7427-0826; Mills, Anne/0000-0001-9863-9950; Krishna, Sanjeev/0000-0003-0066-0634; Owusu-Agyei, Seth/0000-0002-0807-1781	Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	This research was supported by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, WORLD MAL REP 2009; Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; BRUCE-CHWATT L J, 1954, Br Med J, V1, P169; BUTTERWORTH T, 1995, J ADV NURS, V22, P24, DOI 10.1046/j.1365-2648.1995.22010024.x; Coleman PG, 2004, AM J TROP MED HYG, V71, P196, DOI 10.4269/ajtmh.2004.71.196; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Evans D, 2003, J CLIN NURS, V12, P77, DOI 10.1046/j.1365-2702.2003.00662.x; Goodman CA, 1999, LANCET, V354, P378, DOI 10.1016/S0140-6736(99)02141-8; Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x; Graham B, 2003, J CLIN EPIDEMIOL, V56, P1150, DOI 10.1016/S0895-4356(03)00211-7; GREENWOOD B, 1991, PARASITOL TODAY, V7, P277, DOI 10.1016/0169-4758(91)90096-7; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Haynes RB, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-3; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Lubell Y, 2008, BMJ-BRIT MED J, V336, P202, DOI 10.1136/bmj.39395.696065.47; Lubell Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-21; Morel C. M, 2005, BMJ-BRIT MED J; Muheki C, 2004, TROP MED INT HEALTH, V9, P959, DOI 10.1111/j.1365-3156.2004.01292.x; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Shillcutt S, 2008, B WORLD HEALTH ORGAN, V86, P101, DOI 10.2471/BLT.07.042259; SUDRE P, 1992, INT J EPIDEMIOL, V21, P146, DOI 10.1093/ije/21.1.146; Suputtamongkol Y, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000610; White NJ, 2003, AM J RESP CRIT CARE, V167, P673, DOI 10.1164/rccm.2212001; *WHO, 2000, MAN SEV MAL	29	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17439	10.1371/journal.pone.0017439	http://dx.doi.org/10.1371/journal.pone.0017439			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726XY	21390277	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700057
J	Nagata-Kuroiwa, R; Furutani, N; Hara, J; Hondo, M; Ishii, M; Abe, T; Mieda, M; Tsujino, N; Motoike, T; Yanagawa, Y; Kuwaki, T; Yamamoto, M; Yanagisawa, M; Sakurai, T				Nagata-Kuroiwa, Ruby; Furutani, Naoki; Hara, Junko; Hondo, Mari; Ishii, Makoto; Abe, Tomomi; Mieda, Michihiro; Tsujino, Natsuko; Motoike, Toshiyuki; Yanagawa, Yuchio; Kuwaki, Tomoyuki; Yamamoto, Miyuki; Yanagisawa, Masashi; Sakurai, Takeshi			Critical Role of Neuropeptides B/W Receptor 1 Signaling in Social Behavior and Fear Memory	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; AMYGDALA; GPR7; IDENTIFICATION; ANXIETY; SOMATOSTATIN; LIGANDS; NUCLEUS; MODEL	Neuropeptide B/W receptor 1 (NPBWR1) is a G-protein coupled receptor, which was initially reported as an orphan receptor, and whose ligands were identified by this and other groups in 2002 and 2003. To examine the physiological roles of NPBWR1, we examined phenotype of Npbwr1(-/-) mice. When presented with an intruder mouse, Npbwr1(-/-) mice showed impulsive contact with the strange mice, produced more intense approaches toward them, and had longer contact and chasing time along with greater and sustained elevation of heart rate and blood pressure compared to wild type mice. Npbwr1(-/-) mice also showed increased autonomic and neuroendocrine responses to physical stress, suggesting that impairment of NPBWR1 leads to stress vulnerability. We also observed that these mice show abnormality in the contextual fear conditioning test. These data suggest that NPBWR1 plays a critical role in limbic system function and stress responses. Histological and electrophysiological studies showed that NPBWR1 acts as an inhibitory regulator on a subpopulation of GABAergic neurons in the lateral division of the CeA and terminates stress responses. These findings suggest important roles of NPBWR1 in regulating amygdala function during physical and social stress.	[Nagata-Kuroiwa, Ruby; Furutani, Naoki; Hara, Junko; Hondo, Mari; Abe, Tomomi; Mieda, Michihiro; Tsujino, Natsuko; Sakurai, Takeshi] Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan; [Nagata-Kuroiwa, Ruby; Ishii, Makoto; Motoike, Toshiyuki; Yanagisawa, Masashi; Sakurai, Takeshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO Yanagisawa Orph, Tokyo, Japan; [Ishii, Makoto] Cornell Univ, New York Presbyterian Hosp, Dept Neurol, Weill Med Coll, New York, NY 10021 USA; [Motoike, Toshiyuki; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Motoike, Toshiyuki; Yanagisawa, Masashi] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Yanagawa, Yuchio] Gunma Univ, Grad Sch Med, Dept Genet & Behav Neurosci, Maebashi, Gunma 371, Japan; [Yanagawa, Yuchio] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Kuwaki, Tomoyuki] Kagoshima Univ, Dept Physiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Yamamoto, Miyuki] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Cornell University; NewYork-Presbyterian Hospital; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Gunma University; Japan Science & Technology Agency (JST); Kagoshima University; University of Tsukuba	Nagata-Kuroiwa, R (corresponding author), Kanazawa Univ, Dept Mol Neurosci & Integrat Physiol, Fac Med, Kanazawa, Ishikawa, Japan.	tsakurai@med.kanazawa-u.ac.jp	Kuwaki, Tomoyuki/B-3247-2019	Kuwaki, Tomoyuki/0000-0003-4226-3610; Mieda, Michihiro/0000-0002-2451-7034; Ishii, Makoto/0000-0003-3397-9908	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; ERATO from the Japan Science and Technology Agency; Takeda Science Foundation; Uehara Memorial Foundation	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ERATO from the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas "System study on higher-order brain functions", the 21st Century COE Program for University of Tsukuba and Kanazawa University from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, ERATO from the Japan Science and Technology Agency, Takeda Science Foundation and Uehara Memorial Foundation. M.Y. is an investigator at the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwknecht JA, 2007, NEUROSCI BIOBEHAV R, V31, P41, DOI 10.1016/j.neubiorev.2006.02.002; Brezillon S, 2003, J BIOL CHEM, V278, P776, DOI 10.1074/jbc.M206396200; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Fujii R, 2002, J BIOL CHEM, V277, P34010, DOI 10.1074/jbc.M205883200; Hondo Mari, 2008, V46, P239, DOI 10.1007/400_2007_056; Ishii M, 2003, P NATL ACAD SCI USA, V100, P10540, DOI 10.1073/pnas.1334189100; Kalueff AV, 2007, BEHAV BRAIN RES, V179, P1, DOI 10.1016/j.bbr.2007.01.023; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kitamura Y, 2006, BRAIN RES, V1093, P123, DOI 10.1016/j.brainres.2006.03.041; Lee DK, 1999, MOL BRAIN RES, V71, P96, DOI 10.1016/S0169-328X(99)00171-0; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; Mason WA, 2006, EMOTION, V6, P73, DOI 10.1037/1528-3542.6.1.73; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; ODOWD BF, 1995, GENOMICS, V28, P84, DOI 10.1006/geno.1995.1109; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Rogan MT, 2005, NEURON, V46, P309, DOI 10.1016/j.neuron.2005.02.017; RUSSELL JA, 1977, J RES PERS, V11, P273, DOI 10.1016/0092-6566(77)90037-X; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Tanaka H, 2003, P NATL ACAD SCI USA, V100, P6251, DOI 10.1073/pnas.0837789100; Zhang W, 2010, J PHYSIOL-LONDON, V588, P4117, DOI 10.1113/jphysiol.2010.195099	24	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16972	10.1371/journal.pone.0016972	http://dx.doi.org/10.1371/journal.pone.0016972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390312	gold, Green Published			2022-12-27	WOS:000287761700024
J	Hasenberg, M; Kohler, A; Bonifatius, S; Borucki, K; Riek-Burchardt, M; Achilles, J; Mann, L; Baumgart, K; Schraven, B; Gunzer, M				Hasenberg, Mike; Koehler, Anja; Bonifatius, Susanne; Borucki, Katrin; Riek-Burchardt, Monika; Achilles, Julia; Maenn, Linda; Baumgart, Kathleen; Schraven, Burkhart; Gunzer, Matthias			Rapid Immunomagnetic Negative Enrichment of Neutrophil Granulocytes from Murine Bone Marrow for Functional Studies In Vitro and In Vivo	PLOS ONE			English	Article							T-LYMPHOCYTES; ASPERGILLUS-FUMIGATUS; L-SELECTIN; CELLS; MOBILIZATION; CHEMOKINES; MICE; RECRUITMENT; MACROPHAGES; CHEMOTAXIS	Polymorphonuclear neutrophils (PMN) mediate early immunity to infection but can also cause host damage if their effector functions are not controlled. Their lack or dysfunction is associated with severe health problems and thus the analysis of PMN physiology is a central issue. One prerequisite for PMN analysis is the availability of purified cells from primary organs. While human PMN are easily isolated from peripheral blood, this approach is less suitable for mice due to limited availability of blood. Instead, bone marrow (BM) is an easily available reservoir of murine PMN, but methods to obtain pure cells from BM are limited. We have developed a novel protocol allowing the isolation of highly pure untouched PMN from murine BM by negative immunomagnetic isolation using a complex antibody cocktail. The protocol is simple and fast (similar to 1 h), has a high yield (5-10*10(6) PMN per animal) and provides a purity of cells equivalent to positive selection (>80%). Most importantly, cells obtained by this method are non-activated and remain fully functional in vitro or after adoptive transfer into recipient animals. This method should thus greatly facilitate the study of primary murine PMN in vitro and in vivo.	[Hasenberg, Mike; Koehler, Anja; Bonifatius, Susanne; Riek-Burchardt, Monika; Achilles, Julia; Maenn, Linda; Baumgart, Kathleen; Schraven, Burkhart; Gunzer, Matthias] Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany; [Borucki, Katrin] Otto VonGuericke Univ Magdegurg, Inst Clin Chem & Pathobiochem, D-39016 Magdeburg, Germany; [Riek-Burchardt, Monika] Otto VonGuericke Univ Magdegurg, Leibniz Inst Neurobiol, Res Grp Neuropharmacol, D-39016 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Hasenberg, M (corresponding author), Otto VonGuericke Univ Magdegurg, Inst Mol & Clin Immunol, D-39016 Magdeburg, Germany.	matthias.gunzer@med.ovgu.de	Gunzer, Matthias/AAW-7026-2021	Gunzer, Matthias/0000-0002-5534-6055	Deutsche Forschungsgemeinschaft (DFG) [GU769/1-3, GU769/2 1, SFB854]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, GU769/1-3, 2 1 and SFB854) to M. G. www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbitt KB, 2009, J LEUKOCYTE BIOL, V85, P55, DOI 10.1189/jlb.0507305; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; BECKER EL, 1985, J CELL BIOL, V100, P1641, DOI 10.1083/jcb.100.5.1641; Behnsen J, 2007, PLOS PATHOG, V3, P138, DOI 10.1371/journal.ppat.0030013; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Bruns S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000873; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Cotter MJ, 2001, AM J PATHOL, V159, P473, DOI 10.1016/S0002-9440(10)61719-1; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; Duriancik DM, 2010, CELL IMMUNOL, V265, P156, DOI 10.1016/j.cellimm.2010.08.006; Eash KJ, 2010, J CLIN INVEST, V120, P2423, DOI 10.1172/JCI41649; Entschladen F, 2000, CELL IMMUNOL, V199, P104, DOI 10.1006/cimm.1999.1605; Faust N, 2000, BLOOD, V96, P719; Furze RC, 2008, IMMUNOLOGY, V125, P281, DOI 10.1111/j.1365-2567.2008.02950.x; Galkina E, 2003, J EXP MED, V198, P1323, DOI 10.1084/jem.20030485; Gunzer M, 2000, J LEUKOCYTE BIOL, V67, P622, DOI 10.1002/jlb.67.5.622; Gunzer M, 2001, J IMMUNOL METHODS, V258, P55, DOI 10.1016/S0022-1759(01)00466-5; HESTDAL K, 1991, J IMMUNOL, V147, P22; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; KOHLER A, 2011, BLOOD; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Norman KE, 2003, BLOOD, V101, P921, DOI 10.1182/blood-2001-12-0190; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Pruijt JFM, 2002, P NATL ACAD SCI USA, V99, P6228, DOI 10.1073/pnas.092112999; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Reichardt Peter, 2007, Methods Mol Biol, V380, P253; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x; Stegemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004840; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648	33	37	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17314	10.1371/journal.pone.0017314	http://dx.doi.org/10.1371/journal.pone.0017314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383835	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500050
J	Li, JL; Dohna, HZ; Cardona, CJ; Miller, J; Carpenter, TE				Li, Jinling; Dohna, Heinrich Zu; Cardona, Carol J.; Miller, Joy; Carpenter, Tim E.			Emergence and Genetic Variation of Neuraminidase Stalk Deletions in Avian Influenza Viruses	PLOS ONE			English	Article							A VIRUS; SOUTHERN CHINA; HONG-KONG; HEMAGGLUTININ GLYCOSYLATION; INTERSPECIES TRANSMISSION; SEQUENCE-ANALYSIS; DOMESTIC POULTRY; HUMAN INFECTION; WILD BIRDS; H5N1	When avian influenza viruses (AIVs) are transmitted from their reservoir hosts (wild waterfowl and shorebirds) to domestic bird species, they undergo genetic changes that have been linked to higher virulence and broader host range. Common genetic AIV modifications in viral proteins of poultry isolates are deletions in the stalk region of the neuraminidase (NA) and additions of glycosylation sites on the hemagglutinin (HA). Even though these NA deletion mutations occur in several AIV subtypes, they have not been analyzed comprehensively. In this study, 4,920 NA nucleotide sequences, 5,596 HA nucleotide and 4,702 HA amino acid sequences were analyzed to elucidate the widespread emergence of NA stalk deletions in gallinaceous hosts, the genetic polymorphism of the deletion patterns and association between the stalk deletions in NA and amino acid variants in HA. Forty-seven different NA stalk deletion patterns were identified in six NA subtypes, N1-N3 and N5-N7. An analysis that controlled for phylogenetic dependence due to shared ancestry showed that NA stalk deletions are statistically correlated with gallinaceous hosts and certain amino acid features on the HA protein. Those HA features included five glycosylation sites, one insertion and one deletion. The correlations between NA stalk deletions and HA features are HA-NA-subtype-specific. Our results demonstrate that stalk deletions in the NA proteins of AIV are relatively common. Understanding the NA stalk deletion and related HA features may be important for vaccine and drug development and could be useful in establishing effective early detection and warning systems for the poultry industry.	[Li, Jinling; Dohna, Heinrich Zu; Carpenter, Tim E.] Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Davis, CA 95616 USA; [Cardona, Carol J.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Miller, Joy] Natl Ctr Med Intelligence, Ft Detrick, MD USA	University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities	Li, JL (corresponding author), Univ Calif Davis, Ctr Anim Dis Modeling & Surveillance, Davis, CA 95616 USA.	tecarpenter@ucdavis.edu			National Center for Medical Intelligence through United States Department of Agriculture [2009-39556-20244]	National Center for Medical Intelligence through United States Department of Agriculture	National Center for Medical Intelligence through United States Department of Agriculture grant #2009-39556-20244. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent SJ, 1999, VIROLOGY, V263, P323, DOI 10.1006/viro.1999.9931; Baigent SJ, 2003, BIOESSAYS, V25, P657, DOI 10.1002/bies.10303; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Belser JA, 2008, P NATL ACAD SCI USA, V105, P7558, DOI 10.1073/pnas.0801259105; Bin L, 2005, J VIROL, V79, P6763, DOI 10.1128/JVI.79.11.6763-6771.2005; BLOK J, 1982, VIROLOGY, V118, P229, DOI 10.1016/0042-6822(82)90337-3; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; CAPPUCCI DT, 1985, AVIAN DIS, V29, P1195, DOI 10.2307/1590473; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Cauthen AN, 2000, J VIROL, V74, P6592, DOI 10.1128/JVI.74.14.6592-6599.2000; Cheung CL, 2007, J VIROL, V81, P10402, DOI 10.1128/JVI.01157-07; Choi YK, 2004, J VIROL, V78, P8609, DOI 10.1128/JVI.78.16.8609-8614.2004; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Di Trani L, 2004, AVIAN DIS, V48, P376, DOI 10.1637/7088; Dunn PA, 2003, AVIAN DIS, V47, P812, DOI 10.1637/0005-2086-47.s3.812; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Guo YJ, 2000, VIROLOGY, V267, P279, DOI 10.1006/viro.1999.0115; Hirst M, 2004, EMERG INFECT DIS, V10, P2192, DOI 10.3201/eid1012.040743; Hoffmann E, 2000, J VIROL, V74, P6309, DOI 10.1128/JVI.74.14.6309-6315.2000; Hossain MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003170; Keawcharoen J, 2004, EMERG INFECT DIS, V10, P2189, DOI 10.3201/eid1012.040759; Kinde H, 2003, AVIAN DIS, V47, P1214, DOI 10.1637/0005-2086-47.s3.1214; Lee CW, 2004, AVIAN PATHOL, V33, P288, DOI 10.1080/0307945042000203407; Lee MS, 2006, AVIAN DIS, V50, P561, DOI 10.1637/7640-050106R.1; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li JL, 2010, VIRUS RES, V147, P40, DOI 10.1016/j.virusres.2009.10.002; Li JL, 2010, GENOMICS, V95, P29, DOI 10.1016/j.ygeno.2009.09.005; Li KS, 2003, J VIROL, V77, P6988, DOI 10.1128/JVI.77.12.6988-6994.2003; Li Y, 2006, ARCH VIROL, V151, P1615, DOI 10.1007/s00705-006-0738-7; LIU CG, 1993, VIROLOGY, V194, P403, DOI 10.1006/viro.1993.1276; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu JH, 2003, AVIAN PATHOL, V32, P551, DOI 10.1080/0307-9450310001596728; Liu JH, 2003, VIRUS GENES, V27, P197, DOI 10.1023/A:1025736829103; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Marangon S, 2003, AVIAN DIS, V47, P1006, DOI 10.1637/0005-2086-47.s3.1006; Mishin VP, 2005, J VIROL, V79, P12416, DOI 10.1128/JVI.79.19.12416-12424.2005; Mitnaul LJ, 2000, J VIROL, V74, P6015, DOI 10.1128/JVI.74.13.6015-6020.2000; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Munster VJ, 2009, VACCINE, V27, P6340, DOI 10.1016/j.vaccine.2009.02.082; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okamatsu M, 2007, VET MICROBIOL, V124, P35, DOI 10.1016/j.vetmic.2007.04.025; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; PARADISE E, 2006, ANAL PHYLOGENETICS; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; *REAM RDC, 2009, LANG ENV STAT COMP 2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Senne DA, 1996, AVIAN DIS, V40, P425, DOI 10.2307/1592241; Skehel J, 2009, BIOLOGICALS, V37, P177, DOI 10.1016/j.biologicals.2009.02.012; Sorrell EM, 2007, AVIAN DIS, V51, P264, DOI 10.1637/7538-032906R.1; Spackman E, 2003, J VIROL, V77, P13399, DOI 10.1128/JVI.77.24.13399-13402.2003; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Tsukamoto K, 2009, J CLIN MICROBIOL, V47, P2301, DOI 10.1128/JCM.02366-08; Wagner R, 2000, J VIROL, V74, P6316, DOI 10.1128/JVI.74.14.6316-6323.2000; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Woolcock PR, 2003, AVIAN DIS, V47, P872, DOI 10.1637/0005-2086-47.s3.872; Zhang PH, 2009, J VIROL, V83, P8428, DOI 10.1128/JVI.00659-09; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	70	74	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14722	10.1371/journal.pone.0014722	http://dx.doi.org/10.1371/journal.pone.0014722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373190	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500006
J	Martin, C; Uribe, KB; Gomez-Bilbao, G; Ostolaza, H				Martin, Cesar; Uribe, Kepa B.; Gomez-Bilbao, Geraxane; Ostolaza, Helena			Adenylate Cyclase Toxin Promotes Internalisation of Integrins and Raft Components and Decreases Macrophage Adhesion Capacity	PLOS ONE			English	Article							BORDETELLA-PERTUSSIS; LIPID RAFTS; ESCHERICHIA-COLI; BACTERIAL INVASION; EPITHELIAL-CELLS; ALPHA-HEMOLYSIN; MEMBRANE RAFTS; INFECTION; CLATHRIN; PHOSPHORYLATION	Bordetella pertussis, the bacterium that causes whooping cough, secretes an adenylate cyclase toxin (ACT) that must be post-translationally palmitoylated in the bacterium cytosol to be active. The toxin targets phagocytes expressing the CD11b/CD18 integrin receptor. It delivers a catalytic adenylate cyclase domain into the target cell cytosol producing a rapid increase of intracellular cAMP concentration that suppresses bactericidal functions of the phagocyte. ACT also induces calcium fluxes into target cells. Biochemical, biophysical and cell biology approaches have been applied here to show evidence that ACT and integrin molecules, along with other raft components, are rapidly internalized by the macrophages in a toxin-induced calcium rise-dependent process. The toxin-triggered internalisation events occur through two different routes of entry, chlorpromazine-sensitive receptor-mediated endocytosis and clathrin-independent internalisation, maybe acting in parallel. ACT locates into raft-like domains, and is internalised, also in cells devoid of receptor. Altogether our results suggest that adenylate cyclase toxin, and maybe other homologous pathogenic toxins from the RTX (Repeats in Toxin) family to which ACT belongs, may be endowed with an intrinsic capacity to, directly and efficiently, insert into raft-like domains, promoting there its multiple activities. One direct consequence of the integrin removal from the cell surface of the macrophages is the hampering of their adhesion ability, a fundamental property in the immune response of the leukocytes that could be instrumental in the pathogenesis of Bordetella pertussis.	[Martin, Cesar] Univ Basque Country, Unidad Biofis, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Martin, C (corresponding author), Univ Basque Country, Unidad Biofis, E-48080 Bilbao, Spain.	gbzoseth@ehu.es	martin, cesar/L-1303-2014; Uribe, Kepa B./AGZ-5717-2022; Uribe, Kepa B./AAC-2163-2019	martin, cesar/0000-0002-4087-8729; Uribe, Kepa B./0000-0002-4502-4853; Uribe, Kepa B./0000-0002-4502-4853; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministerio de Ciencia y Tecnologia [BFU 2007-62062]; Basque Government; University of Basque Country (UPV/EHU) [UE06/10]; University of Basque Country; Bizkaia Biophysics Foundation	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government(Basque Government); University of Basque Country (UPV/EHU); University of Basque Country; Bizkaia Biophysics Foundation	This study was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2007-62062), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10). G. G. B. was the recipient of a pre-doctoral fellowship from the University of Basque Country and K. B. U. was the recipient of a fellowship from the Bizkaia Biophysics Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAOUT MA, 1990, BLOOD, V75, P1037; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; BENZ R, 1994, J BIOL CHEM, V269, P27231; Berkowitz S.A., 1980, ANN NY ACAD SCI, V1, P356, DOI DOI 10.1111/J.1749-6632.1980.TB29626.X6263154; BRETSCHER MS, 1992, EMBO J, V11, P383, DOI 10.1002/j.1460-2075.1992.tb05066.x; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brown DA, 1997, BIOCHEM BIOPH RES CO, V240, P1, DOI 10.1006/bbrc.1997.7575; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; BUYON JP, 1990, J IMMUNOL, V144, P191; Carbonetti NH, 2005, INFECT IMMUN, V73, P2698, DOI 10.1128/IAI.73.5.2698-2703.2005; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; Eby JC, 2010, J BIOL CHEM, V285, P10662, DOI 10.1074/jbc.M109.089219; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fivaz M, 1999, TRENDS CELL BIOL, V9, P212, DOI 10.1016/S0962-8924(99)01567-6; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gargalovic P, 2001, J BIOL CHEM, V276, P26164, DOI 10.1074/jbc.M011291200; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; HEWLETT EL, 1989, J BIOL CHEM, V264, P19379; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Khelef N, 2001, CELL MICROBIOL, V3, P721, DOI 10.1046/j.1462-5822.2001.00151.x; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; LADANT D, 1986, J BIOL CHEM, V261, P6264; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Leitinger B, 2002, J CELL SCI, V115, P963; Levitan I, 2010, SUBCELL BIOCHEM, V51, P509, DOI 10.1007/978-90-481-8622-8_19; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Martin C, 2004, J BACTERIOL, V186, P3760, DOI 10.1128/JB.186.12.3760-3765.2004; Martin C, 2010, J BIOL CHEM, V285, P357, DOI 10.1074/jbc.M109.003491; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; MOUALLEM M, 1990, INFECT IMMUN, V58, P3759, DOI 10.1128/IAI.58.11.3759-3764.1990; Olsson S, 2006, MOL IMMUNOL, V43, P607, DOI 10.1016/j.molimm.2005.04.011; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Pizarro-Cerda J, 2010, BIOESSAYS, V32, P496, DOI 10.1002/bies.200900172; ROGEL A, 1991, J BIOL CHEM, V266, P3154; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Veiga E, 2007, CELL HOST MICROBE, V2, P340, DOI 10.1016/j.chom.2007.10.001; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85	49	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17383	10.1371/journal.pone.0017383	http://dx.doi.org/10.1371/journal.pone.0017383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383852	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500053
J	Tanabe, Y; Shitara, T; Kashino, Y; Hara, Y; Kudoh, S				Tanabe, Yukiko; Shitara, Tomofumi; Kashino, Yasuhiro; Hara, Yoshiaki; Kudoh, Sakae			Utilizing the Effective Xanthophyll Cycle for Blooming of Ochromonas smithii and O. itoi (Chrysophyceae) on the Snow Surface	PLOS ONE			English	Article							LIGHT-HARVESTING FUNCTION; IN-VIVO; CAROTENOIDS; ALGAE; PHOTOINHIBITION; INACTIVATION; CHLOROMONAS; VOLVOCALES; PIGMENT	Snow algae inhabit unique environments such as alpine and high latitudes, and can grow and bloom with visualizing on snow or glacier during spring-summer. The chrysophytes Ochromonas smithii and Ochromonas itoi are dominant in yellow-colored snow patches in mountainous heavy snow areas from late May to early June. It is considered to be effective utilizing the xanthophyll cycle and holding sunscreen pigments as protective system for snow algae blooming in the vulnerable environment such as low temperature and nutrients, and strong light, however the study on the photoprotection of chrysophytes snow algae has not been shown. To dissolve how the chrysophytes snow algae can grow and bloom under such an extreme environment, we studied with the object of light which is one point of significance to this problem. We collected the yellow snows and measured photosynthetically active radiation at Mt. Gassan in May 2008 when the bloom occurred, then tried to establish unialgal cultures of O. smithii and O. itoi, and examined their photosynthetic properties by a PAM chlorophyll fluorometer and analyzed the pigment compositions before and after illumination with high-light intensities to investigate the working xanthophyll cycle. This experimental study using unialgal cultures revealed that both O. smithii and O. itoi utilize only the efficient violaxanthin cycle for photoprotection as a dissipation system of surplus energy under prolonged high-light stress, although they possess chlorophyll c with diadinoxanthin.	[Tanabe, Yukiko; Kudoh, Sakae] Natl Inst Polar Res, Tachikawa, Tokyo, Japan; [Shitara, Tomofumi] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 990, Japan; [Kashino, Yasuhiro] Univ Hyogo, Grad Sch Life Sci, Hyogo, Japan; [Hara, Yoshiaki] Yamagata Univ, Fac Sci, Dept Biol, Yamagata 990, Japan; [Kudoh, Sakae] Grad Univ Adv Studies SOKENDAI, Dept Polar Sci, Tokyo, Japan	Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Yamagata University; University of Hyogo; Yamagata University; Graduate University for Advanced Studies - Japan	Tanabe, Y (corresponding author), Natl Inst Polar Res, Tachikawa, Tokyo, Japan.	ukko@nipr.ac.jp			Japan Society for the Promotion of Science [21810035]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	21810035, Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BIDIGARE RR, 1993, J PHYCOL, V29, P427, DOI 10.1111/j.1529-8817.1993.tb00143.x; Britton G., 1999, PHOTOCHEMISTRY CAROT; Cox E.R., 1980, PHYTOFLAGELLATES, P61; DEMMIG B, 1987, PLANT PHYSIOL, V84, P218, DOI 10.1104/pp.84.2.218; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Elster H.J., 1968, BINNENGEWASSER, V24; FALKOWSKI PG, 1997, AQUATIC PHOTOSYNTHET; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; FUKUSHIMA H, 1963, J YOKOHAMA MUNICIP C, V43, P1; Harker M, 1999, EUR J PHYCOL, V34, P35, DOI 10.1080/09670269910001736062; HIRANO M, 1965, MONOGRAPHIAE BIOL, V15, P127; Hoham Ronald W., 2001, P168; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Hoham RW, 2001, SNOW ECOLOGY INTERDI, P166; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Kashino Yasuhiro, 2003, Phycological Research, V51, P168, DOI 10.1111/j.1440-1835.2003.tb00184.x; Kohshima S, 1984, GLACIAL STUDIES LANG, P91; Kol E, 1963, ANN HIST NAT MUS NAT, V55, P155; Koyama Y, 1996, PHOTOCHEM PHOTOBIOL, V63, P243, DOI 10.1111/j.1751-1097.1996.tb03021.x; Kudoh S., 2003, POLAR BIOSCI, V16, P86; LICHTLE C, 1995, J PHYCOL, V31, P380, DOI 10.1111/j.0022-3646.1995.00380.x; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; McMinn A, 2004, J MAR BIOL ASSOC UK, V84, P865, DOI 10.1017/S0025315404010112h; Muller T, 1998, POLAR BIOL, V20, P14, DOI 10.1007/s003000050272; OLAIZOLA M, 1994, PHOTOSYNTH RES, V41, P357, DOI 10.1007/BF00019413; Owens T. G., 1994, PHOTOINHIBITION PHOT, P95; Remias D, 2005, EUR J PHYCOL, V40, P259, DOI 10.1080/09670260500202148; SAPOZHNIKOV DI, 1957, DOKL AKAD NAUK SSSR+, V113, P465; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Sonoike K, 1996, PLANT CELL PHYSIOL, V37, P239, DOI 10.1093/oxfordjournals.pcp.a028938; STRANSKY H, 1970, ARCH MIKROBIOL, V73, P315, DOI 10.1007/BF00412298; TANAKA K, 1982, PLANT CELL PHYSIOL, V23, P1009; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; YAMAMOTO HY, 1972, BIOCHIM BIOPHYS ACTA, V267, P538, DOI 10.1016/0005-2728(72)90182-X; YAMAMOTO HY, 1996, OXYGENIC PHOTOSYNTHE, P539, DOI DOI 10.1007/0-306-48127-8_30	43	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14690	10.1371/journal.pone.0014690	http://dx.doi.org/10.1371/journal.pone.0014690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373183	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500001
J	Ackerman, SH; Gatti, DL				Ackerman, Sharon H.; Gatti, Domenico L.			The Contribution of Coevolving Residues to the Stability of KDO8P Synthase	PLOS ONE			English	Article							3-DEOXY-D-MANNO-OCTULOSONATE 8-PHOSPHATE SYNTHASE; MULTIPLE SEQUENCE ALIGNMENTS; LOCALLY WEIGHTED REGRESSION; PROTEIN STABILITY; MUTUAL INFORMATION; ESCHERICHIA-COLI; MOLECULAR-DYNAMICS; METAL; MUTATION; BINDING	Background: The evolutionary tree of 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P) synthase (KDO8PS), a bacterial enzyme that catalyzes a key step in the biosynthesis of bacterial endotoxin, is evenly divided between metal and non-metal forms, both having similar structures, but diverging in various degrees in amino acid sequence. Mutagenesis, crystallographic and computational studies have established that only a few residues determine whether or not KDO8PS requires a metal for function. The remaining divergence in the amino acid sequence of KDO8PSs is apparently unrelated to the underlying catalytic mechanism. Methodology/Principal Findings: The multiple alignment of all known KDO8PS sequences reveals that several residue pairs coevolved, an indication of their possible linkage to a structural constraint. In this study we investigated by computational means the contribution of coevolving residues to the stability of KDO8PS. We found that about 1/4 of all strongly coevolving pairs probably originated from cycles of mutation (decreasing stability) and suppression (restoring it), while the remaining pairs are best explained by a succession of neutral or nearly neutral covarions. Conclusions/Significance: Both sequence conservation and coevolution are involved in the preservation of the core structure of KDO8PS, but the contribution of coevolving residues is, in proportion, smaller. This is because small stability gains or losses associated with selection of certain residues in some regions of the stability landscape of KDO8PS are easily offset by a large number of possible changes in other regions. While this effect increases the tolerance of KDO8PS to deleterious mutations, it also decreases the probability that specific pairs of residues could have a strong contribution to the thermodynamic stability of the protein.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA	Wayne State University; Wayne State University	Ackerman, SH (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu			U.S. Public Health Service [GM41857, GM69840]; Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069840] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by U.S. Public Health Service Grants GM41857 to SHA, GM69840 to DLG, and by a Wayne State University Research Enhancement Program in Computational Biology Grant to DLG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison TM, 2010, BBA-PROTEINS PROTEOM, V1804, P1526, DOI 10.1016/j.bbapap.2010.04.005; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; Bershtein S, 2006, NATURE, V444, P929, DOI 10.1038/nature05385; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, P NATL ACAD SCI USA, V106, P9995, DOI 10.1073/pnas.0901522106; Bowers K. J., 2006, P 2006 ACM IEEE C SU, P43, DOI DOI 10.1145/1188455.1188544; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S6; Chaparro-Riggers Javier F., 2007, Biotechnology Journal, V2, P180, DOI 10.1002/biot.200600170; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cochrane FC, 2009, J MOL BIOL, V390, P646, DOI 10.1016/j.jmb.2009.05.014; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Codoner FM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-106; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Deutsch C, 2007, BIOINFORMATICS, V23, P3009, DOI 10.1093/bioinformatics/btm481; Duewel HS, 2001, J BIOL CHEM, V276, P8393, DOI 10.1074/jbc.M007884200; Duewel HS, 2000, J BIOL CHEM, V275, P22824, DOI 10.1074/jbc.M000133200; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Eddy S., 2001, HMMER USERS GUIDE BI; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; Fernandes AD, 2010, BIOINFORMATICS, V26, P1135, DOI 10.1093/bioinformatics/btq111; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Horovitz A, 1996, FOLD DES, V1, pR121, DOI 10.1016/S1359-0278(96)00056-9; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kiel C, 2006, J MOL BIOL, V355, P821, DOI 10.1016/j.jmb.2005.10.010; KLIG LS, 1988, GENETICS, V120, P651; Kona F, 2007, BIOCHEMISTRY-US, V46, P4532, DOI 10.1021/bi6024879; Kona F, 2009, BIOCHEMISTRY-US, V48, P3610, DOI 10.1021/bi801955h; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kowarsch A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000923; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; KULLBACK S, 1987, AM STAT, V41, P340; Kullback S., 1978, INFORM THEORY STAT; Lehmann M, 2001, CURR OPIN BIOTECH, V12, P371, DOI 10.1016/S0958-1669(00)00229-9; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Li JJ, 2004, J AM CHEM SOC, V126, P7448, DOI 10.1021/ja0480872; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MATTHEWS BW, 1993, ANNU REV BIOCHEM, V62, P139, DOI 10.1146/annurev.bi.62.070193.001035; Mendes J, 2002, CURR OPIN STRUC BIOL, V12, P441, DOI 10.1016/S0959-440X(02)00345-7; Merlo LMF, 2007, P NATL ACAD SCI USA, V104, P10938, DOI 10.1073/pnas.0701900104; Nagatani RA, 2007, BIOCHEMISTRY-US, V46, P6688, DOI 10.1021/bi700507d; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohage EC, 1997, PROTEIN SCI, V6, P233; Oliynyk Z, 2004, PROTEIN ENG DES SEL, V17, P383, DOI 10.1093/protein/gzh046; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; Poon A, 2005, GENETICS, V170, P1323, DOI 10.1534/genetics.104.037259; Poon A, 2005, GENETICS, V170, P989, DOI 10.1534/genetics.104.039438; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Press WH, 1992, NUMERICAL RECIPES C, P626; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reza F. M., 1994, INTRO INFORM THEORY; Roca M, 2007, BIOCHEMISTRY-US, V46, P15076, DOI 10.1021/bi701732a; Romero PA, 2009, NAT REV MOL CELL BIO, V10, P866, DOI 10.1038/nrm2805; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Shulami S, 2004, J BIOL CHEM, V279, P45110, DOI 10.1074/jbc.M404561200; Sigala PA, 2008, J AM CHEM SOC, V130, P13696, DOI 10.1021/ja803928m; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Tao P, 2010, J INORG BIOCHEM, V104, P1267, DOI 10.1016/j.jinorgbio.2010.08.008; Tao P, 2009, BIOCHEMISTRY-US, V48, P11706, DOI 10.1021/bi901341h; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Tokuriki N, 2007, J MOL BIOL, V369, P1318, DOI 10.1016/j.jmb.2007.03.069; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Wagner T, 2000, J MOL BIOL, V301, P233, DOI 10.1006/jmbi.2000.3956; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; Warshel A, 2001, Q REV BIOPHYS, V34, P563, DOI 10.1017/S0033583501003730; Weil P, 2009, COMPUT BIOL CHEM, V33, P440, DOI 10.1016/j.compbiolchem.2009.10.003; Witten I. H., 2005, DATA MINING PRACTICA; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002; ZWANZIG RW, 1954, J CHEM PHYS, V22, P1420, DOI 10.1063/1.1740409	106	14	15	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17459	10.1371/journal.pone.0017459	http://dx.doi.org/10.1371/journal.pone.0017459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408011	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900019
J	Amrouni, D; Meiller, A; Gautier-Sauvigne, S; Piraud, M; Bouteille, B; Vincendeau, P; Buguet, A; Cespuglio, R				Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Piraud, Monique; Bouteille, Bernard; Vincendeau, Philippe; Buguet, Alain; Cespuglio, Raymond			Cerebral Changes Occurring in Arginase and Dimethylarginine Dimethylaminohydrolase (DDAH) in a Rat Model of Sleeping Sickness	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ASYMMETRIC DIMETHYLARGININE; L-ARGININE; CORTICAL INTERNEURONS; AMINO-ACIDS; EXPRESSION; INFECTION; GAMBIENSE; TISSUE; BRAIN	Background: Involvement of nitric oxide (NO) in the pathophysiology of human African trypanosomiasis (HAT) was analyzed in a HAT animal model (rat infected with Trypanosoma brucei brucei). With this model, it was previously reported that trypanosomes were capable of limiting trypanocidal properties carried by NO by decreasing its blood concentration. It was also observed that brain NO concentration, contrary to blood, increases throughout the infection process. The present approach analyses the brain impairments occurring in the regulations exerted by arginase and N-G, N-G-dimethylarginine dimethylaminohydrolase (DDAH) on NO Synthases (NOS). In this respect: (i) cerebral enzymatic activities, mRNA and protein expression of arginase and DDAH were determined; (ii) immunohistochemical distribution and morphometric parameters of cells expressing DDAH-1 and DDAH-2 isoforms were examined within the diencephalon; (iii) amino acid profiles relating to NOS/arginase/DDAH pathways were established. Methodology/Principal Findings: Arginase and DDAH activities together with mRNA (RT-PCR) and protein (western-blot) expressions were determined in diencephalic brain structures of healthy or infected rats at various days post-infection (D5, D10, D16, D22). While arginase activity remained constant, that of DDAH increased at D10 (+65%) and D16 (+51%) in agreement with western-blot and amino acids data (liquid chromatography tandem-mass spectrometry). Only DDAH-2 isoform appeared to be up-regulated at the transcriptional level throughout the infection process. Immunohistochemical staining further revealed that DDAH-1 and DDAH-2 are contained within interneurons and neurons, respectively. Conclusion/Significance: In the brain of infected animals, the lack of change observed in arginase activity indicates that polyamine production is not enhanced. Increases in DDAH-2 isoform may contribute to the overproduction of NO. These changes are at variance with those reported in the periphery. As a whole, the above processes may ensure additive protection against trypanosome entry into the brain, i. e., maintenance of NO trypanocidal pressure and limitation of polyamine production, necessary for trypanosome growth.	[Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Buguet, Alain; Cespuglio, Raymond] Univ Lyon 1, Fac Med, EA 4170, F-69365 Lyon, France; [Piraud, Monique] Hosp Civils Lyon, Lab Malad Hereditaires Metab, Ctr Biol Est, Lyon, France; [Bouteille, Bernard] Univ Limoges, Fac Med, EA 3174, Limoges, France; [Bouteille, Bernard] IFR 145 GEIST, Limoges, France; [Vincendeau, Philippe] Univ Bordeaux 2, UMR IRD CIRAD 177, F-33076 Bordeaux, France; [Amrouni, Donia; Meiller, Anne; Gautier-Sauvigne, Sabine; Buguet, Alain; Cespuglio, Raymond] Plateau NeuroChem, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Limoges; CIRAD; UDICE-French Research Universities; Universite de Bordeaux	Amrouni, D (corresponding author), Univ Lyon 1, Fac Med, EA 4170, F-69365 Lyon, France.	cespuglio@univ-lyon1.fr	Bouteille, Bernard/M-4547-2018; Buguet, Alain/W-1610-2019; Bouteille, Bernard/T-6519-2019	Bouteille, Bernard/0000-0001-9661-0302; MEILLER, Anne/0000-0001-5546-3035; CESPUGLIO, Raymond/0000-0003-2246-8643	University of Lyon	University of Lyon	University of Lyon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, NEUROSCI LETT, V312, P177, DOI 10.1016/S0304-3940(01)02214-5; ABOLARIN MO, 1982, BRIT MED J, V285, P1380, DOI 10.1136/bmj.285.6352.1380; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Amrouni D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009211; Antoine-Moussiaux N, 2008, TRENDS PARASITOL, V24, P411, DOI 10.1016/j.pt.2008.05.010; Bertini G, 1996, BRAIN RES BULL, V39, P261, DOI 10.1016/0361-9230(95)02133-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buguet A, 2001, SLEEP MED REV, V5, P139, DOI 10.1053/smrv.2000.0130; Cespuglio R, 2005, PHYSIOLOGIC NATURE OF SLEEP, P3, DOI 10.1142/9781860947186_0001; Cua DJ, 2001, J IMMUNOL, V166, P602, DOI 10.4049/jimmunol.166.1.602; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; De Baetselier P, 2001, INT J PARASITOL, V31, P575, DOI 10.1016/S0020-7519(01)00170-9; Duleu S, 2004, J IMMUNOL, V172, P6298, DOI 10.4049/jimmunol.172.10.6298; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Fliser D, 2005, EUR J CLIN INVEST, V35, P71, DOI 10.1111/j.1365-2362.2005.01457.x; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Gow AJ, 2002, J BIOL CHEM, V277, P9637, DOI 10.1074/jbc.C100746200; HECKER M, 1995, FEBS LETT, V359, P251, DOI 10.1016/0014-5793(95)00039-C; Koliatsos VE, 2006, ACTA NEUROPATHOL, V112, P147, DOI 10.1007/s00401-006-0068-6; Kurz K, 2009, PHARMACOL RES, V60, P508, DOI 10.1016/j.phrs.2009.07.009; Leiper J, 2002, P NATL ACAD SCI USA, V99, P13527, DOI 10.1073/pnas.212269799; Liu P, 2003, HIPPOCAMPUS, V13, P859, DOI 10.1002/hipo.10138; Masocha W, 2007, PHYSIOL BEHAV, V92, P110, DOI 10.1016/j.physbeh.2007.05.045; MATTERN P, 1972, CR ACAD SCI D NAT, V274, P1513; Meiller A, 2007, NUCLEIC ACIDS RES, V35, P6924, DOI 10.1093/nar/gkm824; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; NEWPORT GR, 1977, J PARASITOL, V63, P15, DOI 10.2307/3280098; ORMEROD WE, 1971, T ROY SOC TROP MED H, V65, P736, DOI 10.1016/0035-9203(71)90088-5; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P3287, DOI 10.1002/rcm.2197; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Quan N, 1999, J COMP NEUROL, V414, P114, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;114::AID-CNE9&gt;3.0.CO;2-G; Schroecksnadel K, 2007, SCAND J IMMUNOL, V65, P525, DOI 10.1111/j.1365-3083.2007.01935.x; Schwedhelm E, 2005, CLIN CHEM, V51, P1268, DOI 10.1373/clinchem.2004.046037; Stoppini L, 2000, INT J MED MICROBIOL, V290, P105; Swamy M, 2009, DRUG CHEM TOXICOL, V32, P326, DOI 10.1080/01480540903130641; Tran CTL, 2000, GENOMICS, V68, P101, DOI 10.1006/geno.2000.6262; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; Tsikas D, 2000, FEBS LETT, V478, P1, DOI 10.1016/S0014-5793(00)01686-0; Ueda S, 2003, CIRC RES, V92, P226, DOI 10.1161/01.RES.0000052990.68216.EF; Uzonna JE, 1999, PARASITE IMMUNOL, V21, P57, DOI 10.1046/j.1365-3024.1999.00202.x; VANMARCK EAE, 1981, ANN SOC BELG MED TR, V61, P57; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e16891	10.1371/journal.pone.0016891	http://dx.doi.org/10.1371/journal.pone.0016891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408057	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900005
J	Davies, SJA; Shih, CH; Noble, M; Mayer-Proschel, M; Davies, JE; Proschel, C				Davies, Stephen J. A.; Shih, Chung-Hsuan; Noble, Mark; Mayer-Proschel, Margot; Davies, Jeannette E.; Proschel, Christoph			Transplantation of Specific Human Astrocytes Promotes Functional Recovery after Spinal Cord Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; GLIAL-RESTRICTED PRECURSORS; EMBRYONIC STEM-CELLS; ADULT-RAT-BRAIN; GAP-JUNCTIONS; OLIGODENDROCYTE PROGENITORS; GLUTAMATE TRANSPORTERS; AXONAL REGENERATION; REACTIVE ASTROCYTES; LOCOMOTOR RECOVERY	Repairing trauma to the central nervous system by replacement of glial support cells is an increasingly attractive therapeutic strategy. We have focused on the less-studied replacement of astrocytes, the major support cell in the central nervous system, by generating astrocytes from embryonic human glial precursor cells using two different astrocyte differentiation inducing factors. The resulting astrocytes differed in expression of multiple proteins thought to either promote or inhibit central nervous system homeostasis and regeneration. When transplanted into acute transection injuries of the adult rat spinal cord, astrocytes generated by exposing human glial precursor cells to bone morphogenetic protein promoted significant recovery of volitional foot placement, axonal growth and notably robust increases in neuronal survival in multiple spinal cord laminae. In marked contrast, human glial precursor cells and astrocytes generated from these cells by exposure to ciliary neurotrophic factor both failed to promote significant behavioral recovery or similarly robust neuronal survival and support of axon growth at sites of injury. Our studies thus demonstrate functional differences between human astrocyte populations and suggest that pre-differentiation of precursor cells into a specific astrocyte subtype is required to optimize astrocyte replacement therapies. To our knowledge, this study is the first to show functional differences in ability to promote repair of the injured adult central nervous system between two distinct subtypes of human astrocytes derived from a common fetal glial precursor population. These findings are consistent with our previous studies of transplanting specific subtypes of rodent glial precursor derived astrocytes into sites of spinal cord injury, and indicate a remarkable conservation from rat to human of functional differences between astrocyte subtypes. In addition, our studies provide a specific population of human astrocytes that appears to be particularly suitable for further development towards clinical application in treating the traumatically injured or diseased human central nervous system.	[Davies, Stephen J. A.; Davies, Jeannette E.] Univ Colorado Denver, Dept Neurosurg, Aurora, CO USA; [Shih, Chung-Hsuan; Noble, Mark; Mayer-Proschel, Margot; Proschel, Christoph] Univ Rochester, Med Ctr, Dept Biomed Genet, Inst Stem Cell & Regenerat Med, Rochester, NY 14642 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Rochester	Davies, SJA (corresponding author), Univ Colorado Denver, Dept Neurosurg, Anschutz Med Campus, Aurora, CO USA.	Jeannette.Davies@ucdenver.edu			National Institutes of Health [RO1-NS046442, RO1-NS42820]; CareCure SCI community; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046442, R01NS042820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CareCure SCI community; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health [grant numbers RO1-NS046442, RO1-NS42820]; and the CareCure SCI community. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAL M, 1992, J COMP NEUROL, V325, P22, DOI 10.1002/cne.903250103; Archer DR, 1997, NAT MED, V3, P54, DOI 10.1038/nm0197-54; Barami K, 2001, NEUROL RES, V23, P321, DOI 10.1179/016164101101198686; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brunet JF, 2004, GLIA, V46, P8, DOI 10.1002/glia.10348; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469; Davies J. E., 2006, J BIOL, V5; Davies Jeannette E, 2008, J Biol, V7, P24, DOI 10.1186/jbiol85; Davies SJA, 1996, EXP NEUROL, V142, P203, DOI 10.1006/exnr.1996.0192; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; Dietrich J, 2005, NAT MED, V11, P277, DOI 10.1038/nm1195; Dietrich J, 2002, GLIA, V40, P65, DOI 10.1002/glia.10116; Gomori E, 2006, INT J DEV NEUROSCI, V24, P295, DOI 10.1016/j.ijdevneu.2006.05.003; GRANT G, 2004, SPINAL CORD CYTOARCH; GUMPEL M, 1987, ANN NY ACAD SCI, V495, P71, DOI 10.1111/j.1749-6632.1987.tb23666.x; HAGLID KG, 1976, J NEUROSCI RES, V2, P175, DOI 10.1002/jnr.490020302; HOLSTEGE JC, 1987, NEUROSCIENCE, V23, P809, DOI 10.1016/0306-4522(87)90160-6; Huang WL, 2007, EUR J NEUROSCI, V25, P362, DOI 10.1111/j.1460-9568.2006.05284.x; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; JONES SL, 1990, J COMP NEUROL, V297, P267, DOI 10.1002/cne.902970209; Joosten EAJ, 2004, J NEUROSCI RES, V77, P127, DOI 10.1002/jnr.20088; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; KLIOT M, 1990, EXP NEUROL, V109, P57, DOI 10.1016/S0014-4886(05)80008-1; Lee SY, 2003, J IND ENG CHEM, V9, P9; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Massey JM, 2008, EXP NEUROL, V209, P426, DOI 10.1016/j.expneurol.2007.03.029; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; Muir GD, 2000, EUR J NEUROSCI, V12, P1113, DOI 10.1046/j.1460-9568.2000.00987.x; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakase T, 2003, CELL COMMUN ADHES, V10, P413, DOI 10.1080/714040461; Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127; O'Carroll SJ, 2008, CELL COMMUN ADHES, V15, P27, DOI 10.1080/15419060802014164; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; Ochalski PAY, 1997, NEUROSCIENCE, V76, P931; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; SEIFERT G, 2009, BRAIN RES REV; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; SMITH GM, 1988, PROG BRAIN RES, V78, P353; Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523; WANG JJ, 1995, NEUROSCIENCE, V65, P973, DOI 10.1016/0306-4522(94)00519-B; WARRINGTON AE, 1993, J NEUROSCI RES, V34, P1, DOI 10.1002/jnr.490340102; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Windrem MS, 2008, CELL STEM CELL, V2, P553, DOI 10.1016/j.stem.2008.03.020; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; WUNDERLICH G, 1994, GLIA, V10, P49, DOI 10.1002/glia.440100107; Xu L, 2009, NEUROBIOL DIS, V34, P291, DOI 10.1016/j.nbd.2009.01.010; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zuo J, 1998, EXP NEUROL, V154, P654, DOI 10.1006/exnr.1998.6951	66	107	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17328	10.1371/journal.pone.0017328	http://dx.doi.org/10.1371/journal.pone.0017328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407803	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300017
J	Wang, GZ; Liu, JA; Wang, W; Zhang, HY; Lercher, MJ				Wang, Guang-Zhong; Liu, Jian; Wang, Wei; Zhang, Hong-Yu; Lercher, Martin J.			A Gene's Ability to Buffer Variation Is Predicted by Its Fitness Contribution and Genetic Interactions	PLOS ONE			English	Article							EVOLUTIONARY CAPACITANCE; HSP90	Background: Many single-gene knockouts result in increased phenotypic (e.g., morphological) variability among the mutant's offspring. This has been interpreted as an intrinsic ability of genes to buffer genetic and environmental variation. A phenotypic capacitor is a gene that appears to mask phenotypic variation: when knocked out, the offspring shows more variability than the wild type. Theory predicts that this phenotypic potential should be correlated with a gene's knockout fitness and its number of negative genetic interactions. Based on experimentally measured phenotypic capacity, it was suggested that knockout fitness was unimportant, but that phenotypic capacitors tend to be hubs in genetic and physical interaction networks. Methodology/Principal Findings: We re-analyse the available experimental data in a combined model, which includes knockout fitness and network parameters as well as expression level and protein length as predictors of phenotypic potential. Contrary to previous conclusions, we find that the strongest predictor is in fact haploid knockout fitness (responsible for 9% of the variation in phenotypic potential), with an additional contribution from the genetic interaction network (5%); once these two factors are taken into account, protein-protein interactions do not make any additional contribution to the variation in phenotypic potential. Conclusions/Significance: We conclude that phenotypic potential is not a mysterious "emergent" property of cellular networks. Instead, it is very simply determined by the overall fitness reduction of the organism (which in its compromised state can no longer compensate for multiple factors that contribute to phenotypic variation), and by the number (and presumably nature) of genetic interactions of the knocked-out gene. In this light, Hsp90, the prototypical phenotypic capacitor, may not be representative: typical phenotypic capacitors are not direct "buffers" of variation, but are simply genes encoding central cellular functions.	[Wang, Guang-Zhong; Lercher, Martin J.] Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany; [Liu, Jian; Wang, Wei] Shandong Univ Technol, Shandong Prov Res Ctr Bioinformat Engn & Tech, Ctr Adv Study, Zibo, Peoples R China; [Zhang, Hong-Yu] Huazhong Agr Univ, Inst Bioinformat, Wuhan, Peoples R China; [Zhang, Hong-Yu] Huazhong Agr Univ, State Key Lab Crop Genet Improvement, Coll Life Sci & Technol, Wuhan, Peoples R China	Heinrich Heine University Dusseldorf; Shandong University of Technology; Huazhong Agricultural University; Huazhong Agricultural University	Wang, GZ (corresponding author), Univ Dusseldorf, Inst Comp Sci, Dusseldorf, Germany.	lercher@cs.uni-duesseldorf.de	Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621; Wang, Wei/0000-0001-5060-4185				Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bogumil D, 2010, GENOME BIOL EVOL, V2, P602, DOI 10.1093/gbe/evq044; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hermisson J, 2004, GENETICS, V168, P2271, DOI 10.1534/genetics.104.029173; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KIMURA M, 1969, GENETICS, V61, P763; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Lehar J, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.51; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Masel J, 2005, GENETICS, V170, P1359, DOI 10.1534/genetics.105.040493; Milton CC, 2003, P NATL ACAD SCI USA, V100, P13396, DOI 10.1073/pnas.1835613100; Mitchell-Olds T, 2002, SCIENCE, V296, P2348, DOI 10.1126/science.1073846; Pal C, 2006, NAT REV GENET, V7, P337, DOI 10.1038/nrg1838; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Wagner GP, 2003, CURR BIOL, V13, pR958, DOI 10.1016/j.cub.2003.11.042; Warnecke T, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.94; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; [No title captured]	22	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17650	10.1371/journal.pone.0017650	http://dx.doi.org/10.1371/journal.pone.0017650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407817	Green Submitted, Green Published, gold			2022-12-27	WOS:000287933300040
J	Kveiborg, M; Instrell, R; Rowlands, C; Howell, M; Parker, PJ				Kveiborg, Marie; Instrell, Rachael; Rowlands, Christina; Howell, Michael; Parker, Peter J.			PKC alpha and PKC delta Regulate ADAM17-Mediated Ectodomain Shedding of Heparin Binding-EGF through Separate Pathways	PLOS ONE			English	Article							PROTEIN-KINASE-C; CONVERTING-ENZYME; GROWTH-FACTOR; HB-EGF; CELL-MIGRATION; BREAST-CANCER; TUMOR PROGRESSION; CALCIUM INFLUX; POTENTIAL ROLE; TGF-ALPHA	Epidermal growth factor receptor (EGFR) signalling is initiated by the release of EGFR-ligands from membrane-anchored precursors, a process termed ectodomain shedding. This proteolytic event, mainly executed by A Disintegrin And Metalloproteases (ADAMs), is regulated by a number of signal transduction pathways, most notably those involving protein kinase C (PKC). However, the molecular mechanisms of PKC-dependent ectodomain shedding of EGFR-ligands, including the involvement of specific PKC isoforms and possible functional redundancy, are poorly understood. To address this issue, we employed a cell-based system of PMA-induced PKC activation coupled with shedding of heparin binding (HB)-EGF. In agreement with previous studies, we demonstrated that PMA triggers a rapid ADAM17-mediated release of HB-EGF. However, PMA-treatment also results in a protease-independent loss of cell surface HB-EGF. We identified PKC alpha as the key participant in the activation of ADAM17 and suggest that it acts in parallel with a pathway linking PKC delta and ERK activity. While PKC alpha specifically regulated PMA-induced shedding, PKC delta and ERK influenced both constitutive and inducible shedding by apparently affecting the level of HB-EGF on the cell surface. Together, these findings indicate the existence of multiple modes of regulation controlling EGFR-ligand availability and subsequent EGFR signal transduction.	[Kveiborg, Marie; Rowlands, Christina; Parker, Peter J.] Canc Res UK, London Res Inst, Prot Phosphorylat Lab, London, England; [Kveiborg, Marie] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Kveiborg, Marie] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Instrell, Rachael; Howell, Michael] Canc Res UK, London Res Inst, High Throughput Screening Lab, London, England; [Parker, Peter J.] Kings Coll London, Div Canc Studies, London WC2R 2LS, England	Cancer Research UK; University of Copenhagen; University of Copenhagen; Cancer Research UK; University of London; King's College London	Kveiborg, M (corresponding author), Canc Res UK, London Res Inst, Prot Phosphorylat Lab, London, England.	marie.kveiborg@bric.ku.dk	Parker, Peter j/D-5192-2013; Kveiborg, Marie/AAM-3019-2020	Kveiborg, Marie/0000-0002-1293-1019; parker, peter/0000-0002-6218-2933; Howell, Michael/0000-0003-0912-0079	Cancer Research UK through the London Research Institute	Cancer Research UK through the London Research Institute	This work was supported by Cancer Research UK through the London Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arribas J, 2006, CANCER METAST REV, V25, P57, DOI 10.1007/s10555-006-7889-6; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Dean-Colomb W, 2008, EUR J CANCER, V44, P2806, DOI 10.1016/j.ejca.2008.09.013; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Gechtman Z, 1999, J BIOL CHEM, V274, P28828, DOI 10.1074/jbc.274.40.28828; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Herrlich A, 2008, FASEB J, V22, P4281, DOI 10.1096/fj.08-113852; Higashiyama S, 2005, BBA-PROTEINS PROTEOM, V1751, P110, DOI 10.1016/j.bbapap.2004.11.009; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Izumi Y, 1998, EMBO J, V17, P7260, DOI 10.1093/emboj/17.24.7260; Kenny PA, 2007, J CLIN INVEST, V117, P337, DOI 10.1172/JCI29518; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kveiborg M, 2005, CANCER RES, V65, P4754, DOI 10.1158/0008-5472.CAN-05-0262; Li XJ, 2004, J BIOL CHEM, V279, P27365, DOI 10.1074/jbc.M401690200; Lonne GK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-76; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Parker PJ, 2004, J CELL SCI, V117, P131, DOI 10.1242/jcs.00982; Peduto L, 2006, ONCOGENE, V25, P5462, DOI 10.1038/sj.onc.1209536; Peduto L, 2005, CANCER RES, V65, P9312, DOI 10.1158/0008-5472.CAN-05-1063; Pories SE, 2008, CANCER EPIDEM BIOMAR, V17, P1034, DOI 10.1158/1055-9965.EPI-07-0365; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Thabard W, 2001, BIOCHEM J, V358, P193, DOI 10.1042/0264-6021:3580193; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; von Tresckow B, 2004, J IMMUNOL, V172, P4324, DOI 10.4049/jimmunol.172.7.4324; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; YAMAMOTO T, 2010, OBESITY SILVER SPRIN; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	43	47	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17168	10.1371/journal.pone.0017168	http://dx.doi.org/10.1371/journal.pone.0017168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386996	gold, Green Submitted, Green Published			2022-12-27	WOS:000287931400035
J	Lise, S; Buchan, D; Pontil, M; Jones, DT				Lise, Stefano; Buchan, Daniel; Pontil, Massimiliano; Jones, David T.			Predictions of Hot Spot Residues at Protein-Protein Interfaces Using Support Vector Machines	PLOS ONE			English	Article							HIGH-AFFINITY INTERACTION; RECEPTOR-ALPHA CHAIN; DRUG DISCOVERY; COMPLEXES; SERVER	Protein-protein interactions are critically dependent on just a few 'hot spot' residues at the interface. Hot spots make a dominant contribution to the free energy of binding and they can disrupt the interaction if mutated to alanine. Here, we present HSPred, a support vector machine(SVM)-based method to predict hot spot residues, given the structure of a complex. HSPred represents an improvement over a previously described approach (Lise et al, BMC Bioinformatics 2009, 10: 365). It achieves higher accuracy by treating separately predictions involving either an arginine or a glutamic acid residue. These are the amino acid types on which the original model did not perform well. We have therefore developed two additional SVM classifiers, specifically optimised for these cases. HSPred reaches an overall precision and recall respectively of 61% and 69%, which roughly corresponds to a 10% improvement. An implementation of the described method is available as a web server at http://bioinf.cs.ucl.ac.uk/hspred. It is free to non-commercial users.	[Lise, Stefano; Buchan, Daniel; Pontil, Massimiliano; Jones, David T.] UCL, Dept Comp Sci, London, England	University of London; University College London	Lise, S (corresponding author), UCL, Dept Comp Sci, London, England.	d.jones@cs.ucl.ac.uk	Lise, Stefano/E-6759-2012	Lise, Stefano/0000-0003-4472-6893	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E017452/1]; BBSRC [BB/E017452/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017452/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by grant reference BB/E017452/1, from the Biotechnology and Biological Sciences Research Council (BBSRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Darnell SJ, 2007, PROTEINS, V68, P813, DOI 10.1002/prot.21474; Gao Y, 2004, J MOL MODEL, V10, P44, DOI 10.1007/s00894-003-0168-3; Gonzalez-Ruiz D, 2006, CURR MED CHEM, V13, P2607, DOI 10.2174/092986706778201530; Grosdidier S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-447; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hage T, 1999, CELL, V97, P271, DOI 10.1016/S0092-8674(00)80736-9; JOACHIMS T, 1999, ADV IN KERNEL METHOD; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; Li L, 2006, BIOINFORMATION, V1, P121, DOI 10.6026/97320630001121; LISE S, PREDICTING DRU UNPUB; Lise S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-365; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Wang YH, 1997, P NATL ACAD SCI USA, V94, P1657, DOI 10.1073/pnas.94.5.1657; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Zhang JL, 2002, J MOL BIOL, V315, P399, DOI 10.1006/jmbi.2001.5243	26	65	68	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16774	10.1371/journal.pone.0016774	http://dx.doi.org/10.1371/journal.pone.0016774			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386962	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400012
J	Mishina, M; Ishiwata, K; Naganawa, M; Kimura, Y; Kitamura, S; Suzuki, M; Hashimoto, M; Ishibashi, K; Oda, K; Sakata, M; Hamamoto, M; Kobayashi, S; Katayama, Y; Ishii, K				Mishina, Masahiro; Ishiwata, Kiichi; Naganawa, Mika; Kimura, Yuichi; Kitamura, Shin; Suzuki, Masahiko; Hashimoto, Masaya; Ishibashi, Kenji; Oda, Keiichi; Sakata, Muneyuki; Hamamoto, Makoto; Kobayashi, Shiro; Katayama, Yasuo; Ishii, Kenji			Adenosine A(2A) Receptors Measured with [C-11]TMSX PET in the Striata of Parkinson's Disease Patients	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CENTRAL-NERVOUS-SYSTEM; HUMAN BRAIN; DOPAMINE TRANSPORTERS; C-11 RACLOPRIDE; BASAL GANGLIA; LEWY BODIES; DIAGNOSIS; ANTAGONIST; THEOPHYLLINE	Adenosine A(2A) receptors (A2ARs) are thought to interact negatively with the dopamine D2 receptor (D2R), so selective A2AR antagonists have attracted attention as novel treatments for Parkinson's disease (PD). However, no information about the receptor in living patients with PD is available. The purpose of this study was to investigate the relationship between A2ARs and the dopaminergic system in the striata of drug-naive PD patients and PD patients with dyskinesia, and alteration of these receptors after antiparkinsonian therapy. We measured binding ability of striatal A2ARs using positron emission tomography (PET) with [7-methyl-C-11]-(E)-8-(3,4,5-trimethoxystyryl)-1,3,7-trimethylxanthine ([C-11]TMSX) in nine drug-naive patients with PD, seven PD patients with mild dyskinesia and six elderly control subjects using PET. The patients and eight normal control subjects were also examined for binding ability of dopamine transporters and D2Rs. Seven of the drug-naive patients underwent a second series of PET scans following therapy. We found that the distribution volume ratio of A2ARs in the putamen were larger in the dyskinesic patients than in the control subjects (p < 0.05, Tukey-Kramer post hoc test). In the drug-naive patients, the binding ability of the A2ARs in the putamen, but not in the head of caudate nucleus, was significantly lower on the more affected side than on the less affected side (p < 0.05, paired t-test). In addition, the A2ARs were significantly increased after antiparkinsonian therapy in the bilateral putamen of the drug-naive patients (p < 0.05, paired t-test) but not in the bilateral head of caudate nucleus. Our study demonstrated that the A2ARs in the putamen were increased in the PD patients with dyskinesia, and also suggest that the A2ARs in the putamen compensate for the asymmetrical decrease of dopamine in drug-naive PD patients and that antiparkinsonian therapy increases the A2ARs in the putamen. The A2ARs may play an important role in regulation of parkinsonism in PD.	[Mishina, Masahiro; Ishiwata, Kiichi; Naganawa, Mika; Kimura, Yuichi; Suzuki, Masahiko; Hashimoto, Masaya; Ishibashi, Kenji; Oda, Keiichi; Sakata, Muneyuki; Ishii, Kenji] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan; [Mishina, Masahiro; Kitamura, Shin; Hamamoto, Makoto; Katayama, Yasuo] Nippon Med Sch, Dept Internal Med 2, Bunkyo Ku, Tokyo 113, Japan; [Mishina, Masahiro; Hamamoto, Makoto] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Neurol, Inzai, Chiba, Japan; [Naganawa, Mika] Yale Univ, Dept Diagnost Radiol, PET Ctr, New Haven, CT 06510 USA; [Kimura, Yuichi] Natl Inst Radiol Sci, Biophys Grp, Mol Imaging Ctr, Chiba 260, Japan; [Kitamura, Shin] Musashi Kosugi Hosp, Nippon Med Sch, Dept Internal Med, Kawasaki Ku, Kanagawa, Japan; [Suzuki, Masahiko; Hashimoto, Masaya] Jikei Univ, Sch Med, Dept Neurol, Minato Ku, Tokyo, Japan; [Ishibashi, Kenji] Tokyo Med & Dent Univ, Dept Neurol, Tokyo 113, Japan; [Ishibashi, Kenji] Tokyo Med & Dent Univ, Neurol Sci Grad Sch, Tokyo 113, Japan; [Kobayashi, Shiro] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Neurosurg, Inzai, Chiba, Japan	Tokyo Metropolitan Institute of Gerontology; Nippon Medical School; Nippon Medical School; Yale University; National Institutes for Quantum Science & Technology; Nippon Medical School; Jikei University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Nippon Medical School	Mishina, M (corresponding author), Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan.	mishina@nms.ac.jp	Kimura, Yuichi/B-3045-2008; Naganawa, Mika/H-1688-2014; soler, martha maricel m gomez/L-6025-2014; Mishina, Masahiro/F-3636-2010; SUZUKI, MASAHIKO/AAK-7309-2020	Naganawa, Mika/0000-0002-4408-2621; soler, martha maricel m gomez/0000-0002-4412-8108; Mishina, Masahiro/0000-0002-8227-0930; 	Japan Society for the Promotion of Science [16390348, 20390334, 17590901, 20591033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was funded by Grants-in-Aid for Scientific Research (B) No. 16390348, (B) No. 20390334, (C) No. 17590901 and (C) No. 20591033 from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONINI A, 1994, NEUROLOGY, V44, P1325, DOI 10.1212/WNL.44.7.1325; Antonini A, 1997, BRAIN, V120, P2187, DOI 10.1093/brain/120.12.2187; Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052; Bara-Jimenez W, 2003, NEUROLOGY, V61, P293, DOI 10.1212/01.WNL.0000073136.00548.D4; Bauer Andreas, 2009, Handb Exp Pharmacol, P617, DOI 10.1007/978-3-540-89615-9_19; Calon F, 2004, BRAIN, V127, P1075, DOI 10.1093/brain/awh128; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm Bertil B., 2003, Neurology, V61, pS5; Fujiwara T, 1997, Ann Nucl Med, V11, P307; Fukumitsu N, 2005, J NUCL MED, V46, P32; Fukumitsu N, 2003, ANN NUCL MED, V17, P511, DOI 10.1007/BF03006445; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Ishibashi K, 2010, NUCL MED COMMUN, V31, P159, DOI 10.1097/MNM.0b013e328333e3cb; Ishibashi K, 2010, EUR J NUCL MED MOL I, V37, P3, DOI 10.1007/s00259-009-1202-1; Ishibashi K, 2009, SYNAPSE, V63, P282, DOI 10.1002/syn.20603; Ishiwata K, 2005, SYNAPSE, V55, P133, DOI 10.1002/syn.20099; Ishiwata K, 2003, ANN NUCL MED, V17, P205, DOI 10.1007/BF02990023; Ishiwata K, 2000, J NUCL MED, V41, P345; Ishiwata K, 2010, GERIATR GERONTOL INT, V10, pS180, DOI 10.1111/j.1447-0594.2010.00594.x; Ishiwata Kiichi, 2007, Central Nervous System Agents in Medicinal Chemistry, V7, P57, DOI 10.2174/187152407780059259; Jankovic J, 2005, ARCH NEUROL-CHICAGO, V62, P351, DOI 10.1001/archneur.62.3.351; Kaasinen V, 2000, J NUCL MED, V41, P65; Kase H, 2001, BIOSCI BIOTECH BIOCH, V65, P1447, DOI 10.1271/bbb.65.1447; Kawamura K, 2003, ANN NUCL MED, V17, P249, DOI 10.1007/BF02990030; Koller WC, 1997, NEUROLOGY, V49, pS10, DOI 10.1212/WNL.49.1_Suppl_1.S10; Kostic VS, 1999, NEUROLOGY, V52, P1916, DOI 10.1212/WNL.52.9.1916; Kulisevsky J, 2002, CLIN NEUROPHARMACOL, V25, P25, DOI 10.1097/00002826-200201000-00005; Langer O, 1999, J LABELLED COMPD RAD, V42, P1183; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; MARTINEZMIR MI, 1991, NEUROSCIENCE, V42, P697, DOI 10.1016/0306-4522(91)90038-P; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCNEILL TH, 1988, BRAIN RES, V455, P148, DOI 10.1016/0006-8993(88)90124-2; Mishina M, 2000, ANN NUCL MED, V14, P193, DOI 10.1007/BF02987859; Mishina M, 2005, ACTA NEUROL SCAND, V112, P103, DOI 10.1111/j.1600-0404.2005.00432.x; Mishina M, 2007, SYNAPSE, V61, P778, DOI 10.1002/syn.20423; Mori Akihisa, 2003, Neurology, V61, pS44; Morissette M, 2006, SYNAPSE, V60, P239, DOI 10.1002/syn.20295; Piggott MA, 1999, BRAIN, V122, P1449, DOI 10.1093/brain/122.8.1449; Ribeiro MJ, 2002, ARCH NEUROL-CHICAGO, V59, P580, DOI 10.1001/archneur.59.4.580; RINNE JO, 1995, J NEUROL SCI, V132, P156, DOI 10.1016/0022-510X(95)00137-Q; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; SCHIFFMANN SN, 1991, J NEUROCHEM, V57, P1062, DOI 10.1111/j.1471-4159.1991.tb08257.x; Schwarzschild MA, 2002, NEUROLOGY, V58, P1154, DOI 10.1212/WNL.58.8.1154; Svenningsson P, 1997, SYNAPSE, V27, P322, DOI 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E; XIAO D, 2010, BRAIN RES IN PRESS; Zaja-Milatovic S, 2005, NEUROLOGY, V64, P545, DOI 10.1212/01.WNL.0000150591.33787.A4; Zappia M, 2005, ARCH NEUROL-CHICAGO, V62, P601, DOI 10.1001/archneur.62.4.601	49	97	98	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17338	10.1371/journal.pone.0017338	http://dx.doi.org/10.1371/journal.pone.0017338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386999	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400058
J	Wang, BB; Zhang, YB; Zhang, F; Lin, HB; Wang, XM; Wan, N; Ye, ZQ; Weng, HY; Zhang, LL; Li, X; Yan, JW; Wang, PP; Wu, TT; Cheng, LF; Wang, J; Wang, DM; Ma, X; Yu, J				Wang, Binbin; Zhang, Yong-Biao; Zhang, Feng; Lin, Hongbin; Wang, Xumin; Wan, Ning; Ye, Zhenqing; Weng, Haiyu; Zhang, Lili; Li, Xin; Yan, Jiangwei; Wang, Panpan; Wu, Tingting; Cheng, Longfei; Wang, Jing; Wang, Duen-Mei; Ma, Xu; Yu, Jun			On the Origin of Tibetans and Their Genetic Basis in Adapting High-Altitude Environments	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; OXYGEN-TRANSPORT; ADAPTATION; POPULATION; HYPOXIA; GENOME; HIF-2-ALPHA; HIF-1-ALPHA; PATTERNS	Since their arrival in the Tibetan Plateau during the Neolithic Age, Tibetans have been well-adapted to extreme environmental conditions and possess genetic variation that reflect their living environment and migratory history. To investigate the origin of Tibetans and the genetic basis of adaptation in a rigorous environment, we genotyped 30 Tibetan individuals with more than one million SNP markers. Our findings suggested that Tibetans, together with the Yi people, were descendants of Tibeto-Burmans who diverged from ancient settlers of East Asia. The valleys of the Hengduan Mountain range may be a major migration route. We also identified a set of positively-selected genes that belong to functional classes of the embryonic, female gonad, and blood vessel developments, as well as response to hypoxia. Most of these genes were highly correlated with population-specific and beneficial phenotypes, such as high infant survival rate and the absence of chronic mountain sickness.	[Wang, Binbin; Cheng, Longfei; Wang, Jing; Ma, Xu] Natl Res Inst Family Planning, Beijing, Peoples R China; [Wang, Binbin; Cheng, Longfei; Wang, Jing; Ma, Xu] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhang, Yong-Biao; Zhang, Feng; Lin, Hongbin; Wang, Xumin; Wan, Ning; Ye, Zhenqing; Zhang, Lili; Li, Xin; Yan, Jiangwei; Wang, Panpan; Wu, Tingting; Wang, Duen-Mei; Yu, Jun] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Weng, Haiyu] Publ Secur Dept, Technol Div CID Regiment, Lhasa, Peoples R China; [Ma, Xu] World Hlth Org Collaborating Ctr Res Human Reprod, Beijing, Peoples R China	National Research Institute for Family Planning - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; World Health Organization	Wang, BB (corresponding author), Natl Res Inst Family Planning, Beijing, Peoples R China.	wangdm@big.ac.cn; NICGR@263.net; junyu@big.ac.cn	郑, 征/C-8514-2011; wang, xumin/HII-8627-2022; Ye, Zhenqing/L-7954-2019; Ye, Zhenqing/ABF-1433-2020	Wang, Binbin/0000-0002-1597-5930	National Infrastructure Program of Chinese Genetic Resources [2006DKA21300]; Ministry of Science and Technology [2009AA01A130]	National Infrastructure Program of Chinese Genetic Resources; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the National Infrastructure Program of Chinese Genetic Resources (2006DKA21300) and 863 Program of the Ministry of Science and Technology (2009AA01A130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Biswas S, 2006, TRENDS GENET, V22, P437, DOI 10.1016/j.tig.2006.06.005; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; GARNIERGERE P, 1992, J HERED, V83, P239, DOI 10.1093/oxfordjournals.jhered.a111204; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Geva E, 2002, J CLIN ENDOCR METAB, V87, P4213, DOI 10.1210/jc.2002-020195; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; HARRELL S, 2001, PERSPECTIVES YI SW C, P28; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jiang HQ, 2001, P NATL ACAD SCI USA, V98, P7916, DOI 10.1073/pnas.141234698; Kang LL, 2010, J HUM GENET, V55, P270, DOI 10.1038/jhg.2010.21; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; MONGE C, 1991, PHYSIOL REV, V71, P1135, DOI 10.1152/physrev.1991.71.4.1135; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, AM J PHYS ANTHROPOL, V114, P42, DOI 10.1002/1096-8644(200101)114:1<42::AID-AJPA1004>3.0.CO;2-B; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SHIS, 2008, J SW U NATL, V29, P1; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spencer CCA, 2006, PLOS GENET, V2, P1375, DOI 10.1371/journal.pgen.0020148; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhang DD, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013749; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	48	107	122	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17002	10.1371/journal.pone.0017002	http://dx.doi.org/10.1371/journal.pone.0017002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386899	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400019
J	Jia, PL; Ewers, JM; Zhao, ZM				Jia, Peilin; Ewers, Jeffrey M.; Zhao, Zhongming			Prioritization of Epilepsy Associated Candidate Genes by Convergent Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TEMPORAL-LOBE EPILEPSY; COPY NUMBER VARIATION; HIPPOCAMPAL-NEURONS; SCHIZOPHRENIA; EXPRESSION; DISEASE; DISORDERS; NETWORKS; SUBUNITS	Background: Epilepsy is a severe neurological disorder affecting a large number of individuals, yet the underlying genetic risk factors for epilepsy remain unclear. Recent studies have revealed several recurrent copy number variations (CNVs) that are more likely to be associated with epilepsy. The responsible gene(s) within these regions have yet to be definitively linked to the disorder, and the implications of their interactions are not fully understood. Identification of these genes may contribute to a better pathological understanding of epilepsy, and serve to implicate novel therapeutic targets for further research. Methodology/Principal Findings: In this study, we examined genes within heterozygous deletion regions identified in a recent large-scale study, encompassing a diverse spectrum of epileptic syndromes. By integrating additional protein-protein interaction data, we constructed subnetworks for these CNV-region genes and also those previously studied for epilepsy. We observed 20 genes common to both networks, primarily concentrated within a small molecular network populated by GABA receptor, BDNF/MAPK signaling, and estrogen receptor genes. From among the hundreds of genes in the initial networks, these were designated by convergent evidence for their likely association with epilepsy. Importantly, the identified molecular network was found to contain complex interrelationships, providing further insight into epilepsy's underlying pathology. We further performed pathway enrichment and crosstalk analysis and revealed a functional map which indicates the significant enrichment of closely related neurological, immune, and kinase regulatory pathways. Conclusions/Significance: The convergent framework we proposed here provides a unique and powerful approach to screening and identifying promising disease genes out of typically hundreds to thousands of genes in disease-related CNV-regions. Our network and pathway analysis provides important implications for the underlying molecular mechanisms for epilepsy. The strategy can be applied for the study of other complex diseases.	[Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Dept Psychiat, Nashville, TN 37212 USA; [Jia, Peilin; Zhao, Zhongming] Vanderbilt Univ, Sch Med, Bioinformat Resource Ctr, Nashville, TN 37212 USA; [Zhao, Zhongming] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Jia, PL (corresponding author), Vanderbilt Univ, Sch Med, Dept Biomed Informat, Nashville, TN 37212 USA.	zhongming.zhao@vanderbilt.edu	Jia, Peilin/B-4519-2013		National Institutes of Health [AA017437]; NARSAD; Department of Psychiatry at the Vanderbilt University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); Department of Psychiatry at the Vanderbilt University; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grant No. AA017437, a 2009 NARSAD Maltz Investigator Award to Z.Z., and the Department of Psychiatry at the Vanderbilt University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; ATHANASIU L, 2010, J PSYCHIAT RES; Baranzini SE, 2009, HUM MOL GENET, V18, P2078, DOI 10.1093/hmg/ddp120; Bouilleret V, 2000, HIPPOCAMPUS, V10, P305; Cascella NG, 2009, NEUROSCI RES, V63, P227, DOI 10.1016/j.neures.2009.01.002; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colmers William F., 2003, Epilepsy Curr, V3, P53, DOI 10.1046/j.1535-7597.2003.03208.x; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; DING L, 2010, J BIOL CHEM; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Fucic A, 2009, MED HYPOTHESES, V73, P703, DOI 10.1016/j.mehy.2009.03.051; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Heinzen EL, 2010, J ALZHEIMERS DIS, V19, P69, DOI 10.3233/JAD-2010-1212; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Ikeda T, 2006, J NEUROSCI RES, V84, P1771, DOI 10.1002/jnr.21083; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Jacobsen NW, 2008, TOXICOL IN VITRO, V22, P146, DOI 10.1016/j.tiv.2007.09.004; Jia PL, 2011, BIOINFORMATICS, V27, P95, DOI 10.1093/bioinformatics/btq615; Kimura N, 2008, J MOL ENDOCRINOL, V40, P75, DOI 10.1677/JME-07-0108; KLEIN P, 1995, J ALGORITHM, V19, P104, DOI 10.1006/jagm.1995.1029; KURIAN SM, 2009, MOL PSYCHIAT; Lerner JT, 2008, CELL MOL LIFE SCI, V65, P1864, DOI 10.1007/s00018-008-8161-8; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; ORTEGA JA, 2009, CEREB CORTEX; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pirker S, 2003, J NEUROPATH EXP NEUR, V62, P820, DOI 10.1093/jnen/62.8.820; Roberts DS, 2006, J BIOL CHEM, V281, P29431, DOI 10.1074/jbc.C600167200; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Smialowska M, 2009, NEUROPEPTIDES, V43, P235, DOI 10.1016/j.npep.2009.02.002; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Sun J, 2008, AM J MED GENET B, V147B, P1173, DOI 10.1002/ajmg.b.30743; Sun JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011351; Sun JC, 2009, BIOINFORMATICS, V25, P2595, DOI 10.1093/bioinformatics/btp428; Winum JY, 2004, EXPERT OPIN THER PAT, V14, P1273, DOI 10.1517/13543776.14.9.1273; Yoshii A, 2010, DEV NEUROBIOL, V70, P304, DOI 10.1002/dneu.20765; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	40	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17162	10.1371/journal.pone.0017162	http://dx.doi.org/10.1371/journal.pone.0017162			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390307	Green Submitted, Green Published, gold			2022-12-27	WOS:000287761700034
J	Morales, E; Bustamante, M; Gonzalez, JR; Guxens, M; Torrent, M; Mendez, M; Garcia-Esteban, R; Julvez, J; Forns, J; Vrijheid, M; Molto-Puigmarti, C; Lopez-Sabater, C; Estivill, X; Sunyer, J				Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Torrent, Maties; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen; Estivill, Xavier; Sunyer, Jordi			Genetic Variants of the FADS Gene Cluster and ELOVL Gene Family, Colostrums LC-PUFA Levels, Breastfeeding, and Child Cognition	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; LINOLEIC-ACID; HUMAN-MILK; ASSOCIATION; EXPOSURE; BRAIN; N-6; NEURODEVELOPMENT; PHOSPHOLIPIDS; ENVIRONMENT	Introduction: Breastfeeding effects on cognition are attributed to long-chain polyunsaturated fatty acids (LC-PUFAs), but controversy persists. Genetic variation in fatty acid desaturase (FADS) and elongase (ELOVL) enzymes has been overlooked when studying the effects of LC-PUFAs supply on cognition. We aimed to: 1) to determine whether maternal genetic variants in the FADS cluster and ELOVL genes contribute to differences in LC-PUFA levels in colostrum; 2) to analyze whether these maternal variants are related to child cognition; and 3) to assess whether children's variants modify breastfeeding effects on cognition. Methods: Data come from two population-based birth cohorts (n = 400 mother-child pairs from INMA-Sabadell; and n = 340 children from INMA-Menorca). LC-PUFAs were measured in 270 colostrum samples from INMA-Sabadell. Tag SNPs were genotyped both in mothers and children (13 in the FADS cluster, 6 in ELOVL2, and 7 in ELOVL5). Child cognition was assessed at 14 mo and 4 y using the Bayley Scales of Infant Development and the McCarthy Scales of Children's Abilities, respectively. Results: Children of mothers carrying genetic variants associated with lower FADS1 activity (regulating AA and EPA synthesis), higher FADS2 activity (regulating DHA synthesis), and with higher EPA/AA and DHA/AA ratios in colostrum showed a significant advantage in cognition at 14 mo (3.5 to 5.3 points). Not being breastfed conferred an 8- to 9-point disadvantage in cognition among children GG homozygote for rs174468 (low FADS1 activity) but not among those with the A allele. Moreover, not being breastfed resulted in a disadvantage in cognition (5 to 8 points) among children CC homozygote for rs2397142 (low ELOVL5 activity), but not among those carrying the G allele. Conclusion: Genetically determined maternal supplies of LC-PUFAs during pregnancy and lactation appear to be crucial for child cognition. Breastfeeding effects on cognition are modified by child genetic variation in fatty acid desaturase and elongase enzymes.	[Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Sunyer, Jordi] Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain; [Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Sunyer, Jordi] Hosp Mar Res Inst IMIM, Barcelona, Catalonia, Spain; [Morales, Eva; Bustamante, Mariona; Ramon Gonzalez, Juan; Guxens, Monica; Mendez, Michelle; Garcia-Esteban, Raquel; Julvez, Jordi; Forns, Joan; Vrijheid, Martine; Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen; Estivill, Xavier; Sunyer, Jordi] CIBER Epidemiol & Salud Publ, Barcelona, Catalonia, Spain; [Bustamante, Mariona; Estivill, Xavier] CRG, Genes & Dis Program, Genet Causes Dis Grp, Barcelona, Catalonia, Spain; [Torrent, Maties] IB SALUT, Area Salud Menorca, Menorca, Spain; [Molto-Puigmarti, Carolina; Lopez-Sabater, Carmen] Univ Barcelona, Fac Pharm, Dept Nutr & Food Sci, Barcelona, Catalonia, Spain; [Estivill, Xavier] Pompeu Fabra Univ, Dept Hlth & Expt Life Sci, Genet Unit, Barcelona, Catalonia, Spain; [Sunyer, Jordi] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Catalonia, Spain	Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Atencio Primaria de Menorca; University of Barcelona; Pompeu Fabra University; Pompeu Fabra University	Morales, E (corresponding author), Ctr Res Environm Epidemiol CREAL, Barcelona, Catalonia, Spain.	emorales1@creal.cat	Estivill, Xavier/A-3125-2013; Gonzalez, Juan R/B-7860-2018; Sunyer, Jordi/G-6909-2014; Guxens, Monica/T-2285-2018; Bustamante, Mariona/M-7277-2015; Bustamante, Mariona/ABB-9142-2021; Estivill, Xavier/E-2957-2012; Julvez, Jordi/R-4531-2017; Vrijheid, Martine/H-2702-2014; Morales, Eva/HHS-0651-2022	Estivill, Xavier/0000-0002-0723-2256; Gonzalez, Juan R/0000-0003-3267-2146; Sunyer, Jordi/0000-0002-2602-4110; Guxens, Monica/0000-0002-8624-0333; Bustamante, Mariona/0000-0003-0127-2860; Bustamante, Mariona/0000-0003-0127-2860; Julvez, Jordi/0000-0003-0818-4003; Vrijheid, Martine/0000-0002-7090-1758; Morales, Eva/0000-0003-3145-7022; Lopez-Sabater, Maria Carmen/0000-0002-8670-7044; Forns, Joan/0000-0002-1066-0358; Molto-Puigmarti, Carolina/0000-0001-6831-6210; Garcia, Raquel/0000-0002-5663-6388	Instituto de Salud Carlos III [Red INMA G03/176, CB06/02/0041]; Spanish Ministry of Health [FIS-PI041436, FIS-PI081151, 97/0588, 00/0021-2, PI061756, PS0901958]; Generalitat de Catalunya-CIRIT [1999SGR 00241]; Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC [QLK4-CT-2000-00263]; Fundacion Roger Torne, and Fundacio La Marato de TV3 [090430]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya-CIRIT(Generalitat de Catalunya); Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC(European CommissionEuropean Commission Joint Research Centre); Fundacion Roger Torne, and Fundacio La Marato de TV3; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176, CB06/02/0041), Spanish Ministry of Health (FIS-PI041436, FIS-PI081151, 97/0588, 00/0021-2, PI061756 and PS0901958), Generalitat de Catalunya-CIRIT 1999SGR 00241, Beca de la IV convocatoria de Ayudas a la Investigacion en Enfermedades Neurodegenerativas de La Caixa, EC Contract No. QLK4-CT-2000-00263, Fundacion Roger Torne, and Fundacio La Marato de TV3 (Project No. 090430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Bayley N., 1977, ESCALAS BAYLEY DESAR; Bokor S, 2010, J LIPID RES, V51, P2325, DOI 10.1194/jlr.M006205; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Haag M, 2003, CAN J PSYCHIAT, V48, P195, DOI 10.1177/070674370304800308; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Heird WC, 2005, ANNU REV NUTR, V25, P549, DOI 10.1146/annurev.nutr.24.012003.132254; Innis SM, 2000, DEV NEUROSCI-BASEL, V22, P474, DOI 10.1159/000017478; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Julvez J, 2007, INT J EPIDEMIOL, V36, P825, DOI 10.1093/ije/dym107; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Kothapalli KSD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000370; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Leonard AE, 2002, LIPIDS, V37, P733, DOI 10.1007/s11745-002-0955-6; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Marza E, 2006, BIOCHEM SOC T, V34, P77, DOI 10.1042/BST0340077; McCarthy D., 1972, MANUAL MCCARTHY SCAL; Molto-Puigmarti C, 2007, ANAL CHIM ACTA, V602, P122, DOI 10.1016/j.aca.2007.09.011; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Morales E, 2009, AM J EPIDEMIOL, V169, P1327, DOI 10.1093/aje/kwp067; Mortensen EL, 2002, JAMA-J AM MED ASSOC, V287, P2365, DOI 10.1001/jama.287.18.2365; Polk S, 2004, AM J RESP CRIT CARE, V170, P273, DOI 10.1164/rccm.200310-1348OC; Posthuma D, 2005, AM J HUM GENET, V77, P318, DOI 10.1086/432647; Ribas-Fito N, 2003, PEDIATRICS, V111, pE580, DOI 10.1542/peds.111.5.e580; Ribas-Fito N, 2007, AM J EPIDEMIOL, V166, P1198, DOI 10.1093/aje/kwm207; Ribas-Fito N, 2006, PAEDIATR PERINAT EP, V20, P403, DOI 10.1111/j.1365-3016.2006.00745.x; Robson LG, 2010, NEUROBIOL AGING, V31, P678, DOI 10.1016/j.neurobiolaging.2008.05.027; Rodriguez-Cruz M, 2006, J LIPID RES, V47, P553, DOI 10.1194/jlr.M500407-JLR200; Salvati S, 2008, J NEUROSCI RES, V86, P776, DOI 10.1002/jnr.21537; Sauerwald TU, 2001, LIPIDS, V36, P991, DOI 10.1007/s11745-001-0810-9; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Simmer K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000375.pub3; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Sorgi PJ, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-16; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1; Vrijheid M, 2010, EPIDEMIOLOGY, V21, P259, DOI 10.1097/EDE.0b013e3181cb41e0; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; World Health Organization (Department of Child and Adolescent Health and Development), 2008, CONCL CONS M HELD 6; Xiang M, 2000, ACTA PAEDIATR, V89, P142, DOI 10.1080/080352500750028735; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	50	88	91	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17181	10.1371/journal.pone.0017181	http://dx.doi.org/10.1371/journal.pone.0017181			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383846	Green Published, gold			2022-12-27	WOS:000287657500039
J	van Buul, GM; Kotek, G; Wielopolski, PA; Farrell, E; Bos, PK; Weinans, H; Grohnert, AU; Jahr, H; Verhaar, JAN; Krestin, GP; van Osch, GJVM; Bernsen, MR				van Buul, Gerben M.; Kotek, Gyula; Wielopolski, Piotr A.; Farrell, Eric; Bos, P. Koen; Weinans, Harrie; Grohnert, Anja U.; Jahr, Holger; Verhaar, Jan A. N.; Krestin, Gabriel P.; van Osch, Gerjo J. V. M.; Bernsen, Monique R.			Clinically Translatable Cell Tracking and Quantification by MRI in Cartilage Repair Using Superparamagnetic Iron Oxides	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; FERUMOXIDES-PROTAMINE SULFATE; IN-VIVO; REGENERATIVE MEDICINE; TRANSFECTION AGENT; EXPRESSION; KNEE; NANOPARTICLES; DEFECTS; DIFFERENTIATION	Background: Articular cartilage has very limited intrinsic regenerative capacity, making cell-based therapy a tempting approach for cartilage repair. Cell tracking can be a major step towards unraveling and improving the repair process of these therapies. We studied superparamagnetic iron oxides (SPIO) for labeling human bone marrow-derived mesenchymal stem cells (hBMSCs) regarding effectivity, cell viability, long term metabolic cell activity, chondrogenic differentiation and hBMSC secretion profile. We additionally examined the capacity of synovial cells to endocytose SPIO from dead, labeled cells, together with the use of magnetic resonance imaging (MRI) for intra-articular visualization and quantification of SPIO labeled cells. Methodology/Prinicipal Findings: Efficacy and various safety aspects of SPIO cell labeling were determined using appropriate assays. Synovial SPIO re-uptake was investigated in vitro by co-labeling cells with SPIO and green fluorescent protein (GFP). MRI experiments were performed on a clinical 3.0T MRI scanner. Two cell-based cartilage repair techniques were mimicked for evaluating MRI traceability of labeled cells: intra-articular cell injection and cell implantation in cartilage defects. Cells were applied ex vivo or in vitro in an intra-articular environment and immediately scanned. SPIO labeling was effective and did not impair any of the studied safety aspects, including hBMSC secretion profile. SPIO from dead, labeled cells could be taken up by synovial cells. Both injected and implanted SPIO-labeled cells could accurately be visualized by MRI in a clinically relevant sized joint model using clinically applied cell doses. Finally, we quantified the amount of labeled cells seeded in cartilage defects using MR-based relaxometry. Conclusions: SPIO labeling appears to be safe without influencing cell behavior. SPIO labeled cells can be visualized in an intra-articular environment and quantified when seeded in cartilage defects.	[van Buul, Gerben M.; Kotek, Gyula; Wielopolski, Piotr A.; Krestin, Gabriel P.; Bernsen, Monique R.] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [van Buul, Gerben M.; Farrell, Eric; Bos, P. Koen; Weinans, Harrie; Jahr, Holger; Verhaar, Jan A. N.; van Osch, Gerjo J. V. M.] Erasmus MC, Dept Orthopaed, Rotterdam, Netherlands; [Farrell, Eric; van Osch, Gerjo J. V. M.] Erasmus MC, Dept Otorhinolaryngol, Rotterdam, Netherlands; [Weinans, Harrie] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Grohnert, Anja U.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Erasmus University Rotterdam; Erasmus MC	van Buul, GM (corresponding author), Erasmus MC, Dept Radiol, Rotterdam, Netherlands.	m.bernsen@erasmusmc.nl	Verhaar, Jan/AAH-1372-2020; Farrell, Eric/J-9379-2012; Jahr, Holger/M-3099-2015	Jahr, Holger/0000-0001-7308-5584; Farrell, Eric/0000-0001-6886-6693; Bos, Pieter K/0000-0001-9285-2320; Bernsen, Monique/0000-0002-5203-5083; Weinans, Harrie/0000-0002-2275-6170; Verhaar, Jan/0000-0003-3016-9600	Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science [SSM06004]; European Community [HEALTH-F5-2008-201842]	Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; European Community(European Commission)	The authors gratefully acknowledge the support of the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science (grant # SSM06004); and the ENCITE consortium of the European Community under the 7th framework programme (grant # HEALTH-F5-2008-201842). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Montet K, 2005, MOL IMAGING, V4, P165; Arbab AS, 2003, RADIOLOGY, V229, P838, DOI 10.1148/radiol.2293021215; Bastiaansen-Jenniskens YM, 2009, J TISSUE ENG REGEN M, V3, P117, DOI 10.1002/term.147; Bos PK, 2001, OSTEOARTHR CARTILAGE, V9, P382, DOI 10.1053/joca.2000.0399; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bulte JWM, 2009, AM J ROENTGENOL, V193, P314, DOI 10.2214/AJR.09.3107; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796; Centeno CJ, 2008, PAIN PHYSICIAN, V11, P343; CHANDA D, 2010, J CELL BIOCH; Das RHJ, 2010, J ORTHOP RES, V28, P537, DOI 10.1002/jor.20994; de Mos M, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-16; Farrell E, 2009, OSTEOARTHR CARTILAGE, V17, P961, DOI 10.1016/j.joca.2008.11.016; Farrell E, 2008, BIOCHEM BIOPH RES CO, V369, P1076, DOI 10.1016/j.bbrc.2008.02.159; HAUSELMANN HJ, 1992, MATRIX, V12, P116; HELLINGMAN CA, 2009, TISSUE ENG A; Henning TD, 2009, CONTRAST MEDIA MOL I, V4, P165, DOI 10.1002/cmmi.276; Jing XH, 2008, JOINT BONE SPINE, V75, P432, DOI 10.1016/j.jbspin.2007.09.013; Kedziorek DA, 2010, MAGN RESON MED, V63, P1031, DOI 10.1002/mrm.22290; Kijowski R, 2010, AM J ROENTGENOL, V195, P618, DOI 10.2214/AJR.10.4661; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Lee Kuan-Der, 2008, Chang Gung Med J, V31, P228; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Pawelczyk E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006712; Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037; Rad AM, 2007, J MAGN RESON IMAGING, V26, P366, DOI 10.1002/jmri.20978; SALDANHA KJ, 2010, MAGN RESON IMAGING; Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095; Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195; Uitterlinden EJ, 2006, OSTEOARTHR CARTILAGE, V14, P250, DOI 10.1016/j.joca.2005.10.001; van Buul GM, 2009, CONTRAST MEDIA MOL I, V4, P230, DOI 10.1002/cmmi.289; van Osch GJVM, 2009, J CELL MOL MED, V13, P792, DOI 10.1111/j.1582-4934.2009.00789.x; van Tiel ST, 2010, CONTRAST MEDIA MOL I, V5, P247, DOI 10.1002/cmmi.379; Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8	35	65	65	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17001	10.1371/journal.pone.0017001	http://dx.doi.org/10.1371/journal.pone.0017001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373640	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500027
J	Millet, GY; Tomazin, K; Verges, S; Vincent, C; Bonnefoy, R; Boisson, RC; Gergele, L; Feasson, L; Martin, V				Millet, Guillaume Y.; Tomazin, Katja; Verges, Samuel; Vincent, Christopher; Bonnefoy, Regis; Boisson, Renee-Claude; Gergele, Laurent; Feasson, Leonard; Martin, Vincent			Neuromuscular Consequences of an Extreme Mountain Ultra-Marathon	PLOS ONE			English	Article							PROLONGED RUNNING EXERCISE; LOW-FREQUENCY FATIGUE; MUSCLE FATIGUE; ECCENTRIC EXERCISE; STRENGTH LOSS; ULTRAMARATHON; RECOVERY; HUMANS; RACE; RUN	We investigated the physiological consequences of one of the most extreme exercises realized by humans in race conditions: a 166-km mountain ultra-marathon (MUM) with 9500 m of positive and negative elevation change. For this purpose, (i) the fatigue induced by the MUM and (ii) the recovery processes over two weeks were assessed. Evaluation of neuromuscular function (NMF) and blood markers of muscle damage and inflammation were performed before and immediately following (n = 22), and 2, 5, 9 and 16 days after the MUM (n = 11) in experienced ultra-marathon runners. Large maximal voluntary contraction decreases occurred after MUM (-35% [95% CI: -28 to -42%] and -39% [95% CI: -32 to -46%] for KE and PF, respectively), with alteration of maximal voluntary activation, mainly for KE (-19% [ 95% CI: -7 to -32%]). Significant modifications in markers of muscle damage and inflammation were observed after the MUM as suggested by the large changes in creatine kinase (from 144 +/- 94 to 13,633 +/- 12,626 UI L-1), myoglobin (from 32 +/- 22 to 1,432 +/- 1,209 mg L-1), and C-Reactive Protein (from < 2.0 to 37.7 +/- 26.5 mg L-1). Moderate to large reductions in maximal compound muscle action potential amplitude, high-frequency doublet force, and low frequency fatigue (index of excitation-contraction coupling alteration) were also observed for both muscle groups. Sixteen days after MUM, NMF had returned to initial values, with most of the recovery process occurring within 9 days of the race. These findings suggest that the large alterations in NMF after an ultra-marathon race are multi-factorial, including failure of excitation-contraction coupling, which has never been described after prolonged running. It is also concluded that as early as two weeks after such an extreme running exercise, maximal force capacities have returned to baseline.	[Millet, Guillaume Y.; Tomazin, Katja; Vincent, Christopher; Bonnefoy, Regis; Gergele, Laurent; Feasson, Leonard] Univ Lyon, F-42023 St Etienne, France; [Millet, Guillaume Y.; Tomazin, Katja; Vincent, Christopher; Bonnefoy, Regis; Feasson, Leonard] Univ St Etienne, Exercise Physiol Lab, St Etienne, France; [Verges, Samuel] Univ Grenoble 1, INSERM, Lab HP2, Grenoble, France; [Verges, Samuel] Univ Hosp, Exercise Res Unit, Grenoble, France; [Boisson, Renee-Claude] Hosp Civils Lyon, Univ Hosp Ctr Lyon Sud, Biochem Lab, Lyon, France; [Martin, Vincent] Univ Clermont Ferrand, Lab Exercise Biol, Clermont Ferrand, France	Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; CHU Lyon	Millet, GY (corresponding author), Univ Lyon, F-42023 St Etienne, France.	guillaume.millet@univ-st-etienne.fr	Martin, Vincent/ABF-7135-2020; Verges, Samuel/M-7040-2014; Millet, Guillaume/AAO-6520-2020	Martin, Vincent/0000-0002-6681-1610; Verges, Samuel/0000-0002-0831-9222; Millet, Guillaume/0000-0002-6395-0762; GERGELE, Laurent/0000-0002-7283-6793	Saint-Etienne Metropole	Saint-Etienne Metropole	Katja Tomazin was supported by a grant from Saint-Etienne Metropole. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; CANU P, 2009, CARDIOL SPORT, V20, P5; DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611, DOI 10.1152/jappl.1986.61.2.611; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; FELLMANN N, 1989, INT J SPORTS MED, V10, P406, DOI 10.1055/s-2007-1024934; Foissac MJ, 2008, MED SCI SPORT EXER, V40, P1117, DOI 10.1249/MSS.0b013e318167228a; Gauche E, 2006, MED SCI SPORT EXER, V38, P2110, DOI 10.1249/01.mss.0000235351.01438.5a; Goussetis E, 2009, BLOOD CELL MOL DIS, V42, P294, DOI 10.1016/j.bcmd.2009.01.003; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Hill CA, 2001, J PHYSIOL-LONDON, V531, P871, DOI 10.1111/j.1469-7793.2001.0871h.x; Hoffman MD, 2008, MED SCI SPORT EXER, V40, P1681, DOI 10.1249/MSS.0b013e318177eb63; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Hoheisel U, 2005, PAIN, V114, P168, DOI 10.1016/j.pain.2004.12.020; HOWELL JN, 1993, J PHYSIOL-LONDON, V464, P183, DOI 10.1113/jphysiol.1993.sp019629; Jones DA, 1996, ACTA PHYSIOL SCAND, V156, P265, DOI 10.1046/j.1365-201X.1996.192000.x; Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y; Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; Margeli A, 2005, J CLIN ENDOCR METAB, V90, P3914, DOI 10.1210/jc.2004-2346; Martin V, 2004, MED SCI SPORT EXER, V36, P1907, DOI 10.1249/01.MSS.0000145526.43208.08; Martin V, 2004, J APPL PHYSIOL, V97, P1923, DOI 10.1152/japplphysiol.00376.2004; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; MERTON PA, 1954, J PHYSIOL-LONDON, V123, P553, DOI 10.1113/jphysiol.1954.sp005070; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Millet GY, 2003, J APPL PHYSIOL, V94, P193, DOI 10.1152/japplphysiol.00600.2002; MILLET GY, 2010, SCAND J MED IN PRESS; MILLET GY, 2011, SPORTS MED IN PRESS; Mounier R, 2003, INT J SPORTS MED, V24, P523; Neumayr G, 2005, INT J SPORTS MED, V26, P2, DOI 10.1055/s-2004-815717; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Noakes TD, 2007, SPORTS MED, V37, P374, DOI 10.2165/00007256-200737040-00026; Nosaka K, 1996, MED SCI SPORT EXER, V28, P953, DOI 10.1097/00005768-199608000-00003; Ostrowski K, 1998, J PHYSIOL-LONDON, V513, P889, DOI 10.1111/j.1469-7793.1998.889ba.x; Overgaard K, 2002, J APPL PHYSIOL, V92, P1891, DOI 10.1152/japplphysiol.00669.2001; Pearson H, 2006, NATURE, V444, P1000, DOI 10.1038/4441000a; Peters EM, 2001, INT J SPORTS MED, V22, P537, DOI 10.1055/s-2001-17610; Petersen K, 2007, EUR J APPL PHYSIOL, V101, P385, DOI 10.1007/s00421-007-0504-x; Place N, 2004, MED SCI SPORT EXER, V36, P1347, DOI 10.1249/01.MSS.0000135786.22996.77; Raastad T, 2010, MED SCI SPORT EXER, V42, P86, DOI 10.1249/MSS.0b013e3181ac7afa; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Skurvydas A, 2006, J ELECTROMYOGR KINES, V16, P629, DOI 10.1016/j.jelekin.2005.11.002; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; WEGELIN JA, 2011, EUR J APPL IN PRESS; Yokozawa T, 2007, J BIOMECH, V40, P3467, DOI 10.1016/j.jbiomech.2007.05.028	47	174	174	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17059	10.1371/journal.pone.0017059	http://dx.doi.org/10.1371/journal.pone.0017059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364944	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600028
J	Aubert, M; Ryu, BY; Banks, L; Rawlings, DJ; Scharenberg, AM; Jerome, KR				Aubert, Martine; Ryu, Byoung Y.; Banks, Lindsey; Rawlings, David J.; Scharenberg, Andrew M.; Jerome, Keith R.			Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; GENE-THERAPY; DESIGN; VIRUS; HIV-1; MEGANUCLEASES; SPECIFICITY; MECHANISMS; BINDING; REPAIR	Current antiviral therapy does not cure HIV-infected individuals because the virus establishes lifelong latent infection within long-lived memory T cells as integrated HIV proviral DNA. Here, we report a new therapeutic approach that aims to cure cells of latent HIV infection by rendering latent virus incapable of replication and pathogenesis via targeted cellular mutagenesis of essential viral genes. This is achieved by using a homing endonuclease to introduce DNA double-stranded breaks (dsb) within the integrated proviral DNA, which is followed by triggering of the cellular DNA damage response and error-prone repair. To evaluate this concept, we developed an in vitro culture model of viral latency, consisting of an integrated lentiviral vector with an easily evaluated reporter system to detect targeted mutagenesis events. Using this system, we demonstrate that homing endonucleases can efficiently and selectively target an integrated reporter lentivirus within the cellular genome, leading to mutation in the proviral DNA and loss of reporter gene expression. This new technology offers the possibility of selectively disabling integrated HIV provirus within latently infected cells.	[Aubert, Martine; Banks, Lindsey; Jerome, Keith R.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Jerome, Keith R.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Ryu, Byoung Y.; Rawlings, David J.; Scharenberg, Andrew M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Ryu, Byoung Y.; Rawlings, David J.; Scharenberg, Andrew M.] Seattle Childrens Hosp, Seattle, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Aubert, M (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	kjerome@fhcrc.org	Rawlings, David/CAI-4751-2022		Northwest Genome Engineering Consortium; Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center; Bill and Melinda Gates Foundation [51763]; NATIONAL CANCER INSTITUTE [RL1CA133832] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [PL1HL092557] Funding Source: NIH RePORTER	Northwest Genome Engineering Consortium; Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by pilot awards from the Northwest Genome Engineering Consortium and the Vaccine and Infectious Disease Division of the Fred Hutchinson Cancer Research Center, and also Grand Challenges Explorations grant 51763 from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashworth J., 2010, NUCL ACIDS RES; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Aubert M, 2006, VIRAL IMMUNOL, V19, P391, DOI 10.1089/vim.2006.19.391; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Cradick TJ, 2010, MOL THER, V18, P947, DOI 10.1038/mt.2010.20; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Eklund JL, 2007, NUCLEIC ACIDS RES, V35, P5839, DOI 10.1093/nar/gkm624; Fajardo-Sanchez E, 2008, NUCLEIC ACIDS RES, V36, P2163, DOI 10.1093/nar/gkn059; Galetto R, 2009, EXPERT OPIN BIOL TH, V9, P1289, DOI 10.1517/14712590903213669; Havranek JJ, 2009, PROTEIN SCI, V18, P1293, DOI 10.1002/pro.142; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; HOLT N, 2010, NAT BIOTECHNOL; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jarjour J., 2009, NUCL ACIDS RES; Jeggo PA, 1998, ADV GENET, V38, P185, DOI 10.1016/S0065-2660(08)60144-3; Kerns HM, 2010, BLOOD, V115, P2146, DOI 10.1182/blood-2009-09-241869; Kitsera N, 2007, BIOTECHNIQUES, V43, P222, DOI 10.2144/000112479; Kuo LJ, 2008, IN VIVO, V22, P305; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; Sarkar I, 2007, SCIENCE, V316, P1912, DOI 10.1126/science.1141453; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Takeuchi R, 2009, NUCLEIC ACIDS RES, V37, P877, DOI 10.1093/nar/gkn1007; Thyme SB, 2009, NATURE, V461, P1300, DOI 10.1038/nature08508; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	29	38	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 9	2011	6	2							e16825	10.1371/journal.pone.0016825	http://dx.doi.org/10.1371/journal.pone.0016825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721NN	21399673	Green Submitted, gold, Green Published			2022-12-27	WOS:000287361700038
J	Grimsley, JMS; Monaghan, JJM; Wenstrup, JJ				Grimsley, Jasmine M. S.; Monaghan, Jessica J. M.; Wenstrup, Jeffrey J.			Development of Social Vocalizations in Mice	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; CATEGORICAL PERCEPTION; CORTICAL DETECTION; VOCAL PRODUCTION; LABORATORY MICE; INBRED STRAINS; MUS-MUSCULUS; MOUSE; BEHAVIOR; CALLS	Adult mice are highly vocal animals, with both males and females vocalizing in same sex and cross sex social encounters. Mouse pups are also highly vocal, producing isolation vocalizations when they are cold or removed from the nest. This study examined patterns in the development of pup isolation vocalizations, and compared these to adult vocalizations. In three litters of CBA/CaJ mice, we recorded isolation vocalizations at ages postnatal day 5 (p5), p7, p9, p11, and p13. Adult vocalizations were obtained in a variety of social situations. Altogether, 28,384 discrete vocal signals were recorded using high-frequency-sensitive equipment and analyzed for syllable type, spectral and temporal features, and the temporal sequencing within bouts. We found that pups produced all but one of the 11 syllable types recorded from adults. The proportions of syllable types changed developmentally, but even the youngest pups produced complex syllables with frequency-time variations. When all syllable types were pooled together for analysis, changes in the peak frequency or the duration of syllables were small, although significant, from p5 through p13. However, individual syllable types showed different, large patterns of change over development, requiring analysis of each syllable type separately. Most adult syllables were substantially lower in frequency and shorter in duration. As pups aged, the complexity of vocal bouts increased, with a greater tendency to switch between syllable types. Vocal bouts from older animals, p13 and adult, had significantly more sequential structure than those from younger mice. Overall, these results demonstrate substantial changes in social vocalizations with age. Future studies are required to identify whether these changes result from developmental processes affecting the vocal tract or control of vocalization, or from vocal learning. To provide a tool for further research, we developed a MATLAB program that generates bouts of vocalizations that correspond to mice of different ages.	[Grimsley, Jasmine M. S.; Wenstrup, Jeffrey J.] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Grimsley, Jasmine M. S.; Wenstrup, Jeffrey J.] Northeastern Ohio Univ Coll Med & Pharm, Coll Pharm, Dept Anat & Neurobiol, Rootstown, OH 44272 USA; [Monaghan, Jessica J. M.] MRC Inst Hearing Res, Nottingham, England	Northeast Ohio Medical University (NEOMED); Northeast Ohio Medical University (NEOMED)	Grimsley, JMS (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat & Neurobiol, Rootstown, OH 44272 USA.	jgrimsley@neoucom.edu		WENSTRUP, JEFFREY/0000-0002-3566-2480; Monaghan, Jessica/0000-0003-1416-4164; Grimsley, Jasmine/0000-0002-7993-9699	NIH [R01-DC000937-20, DC000937-18S1]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC000937, R01DC000937] Funding Source: NIH RePORTER; Medical Research Council [MC_U135097132, MC_U135088477] Funding Source: researchfish; MRC [MC_U135088477, MC_U135097132] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by NIH R01-DC000937-20 and DC000937-18S1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubin T, 2002, J EXP BIOL, V205, P3793; BELL RW, 1972, BEHAV BIOL, V7, P805, DOI 10.1016/S0091-6773(72)80172-X; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; CHATFIELD C, 1970, J THEOR BIOL, V29, P427, DOI 10.1016/0022-5193(70)90107-4; Doyle LR, 2011, ACTA ASTRONAUT, V68, P406, DOI 10.1016/j.actaastro.2009.11.018; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; EHRET G, 1981, NATURWISSENSCHAFTEN, V68, P208, DOI 10.1007/BF01047208; Ehret G, 1976, J Am Audiol Soc, V1, P179; EHRET G, 1987, NATURWISSENSCHAFTEN, V74, P47, DOI 10.1007/BF00367047; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; FITCH WT, 1995, AM J PRIMATOL, V37, P191, DOI 10.1002/ajp.1350370303; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Galindo-Leon EE, 2009, NEURON, V62, P705, DOI 10.1016/j.neuron.2009.05.001; GANDELMAN R, 1978, DEV PSYCHOBIOL, V11, P235, DOI 10.1002/dev.420110307; Gourbal BEF, 2004, NATURWISSENSCHAFTEN, V91, P381, DOI 10.1007/s00114-004-0543-7; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; Hahn ME, 1998, BEHAV GENET, V28, P315, DOI 10.1023/A:1021679615792; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; MAGGIO JC, 1985, J COMP PSYCHOL, V99, P420, DOI 10.1037/0735-7036.99.4.420; Marler Peter, 2004, P1, DOI 10.1016/B978-012473070-0/50004-9; McCowan Brenda, 1997, P178, DOI 10.1017/CBO9780511758843.010; Motomura N, 2002, EXP ANIM TOKYO, V51, P187, DOI 10.1538/expanim.51.187; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Rendall D, 1996, ANIM BEHAV, V51, P1007, DOI 10.1006/anbe.1996.0103; ROMAND R, 1990, DEV BRAIN RES, V54, P221, DOI 10.1016/0165-3806(90)90145-O; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; Tokuda I, 2002, J ACOUST SOC AM, V111, P2908, DOI 10.1121/1.1474440; TOOZE TJ, 1990, ANIM BEHAV, V40, P723; Williams WO, 2008, J AM ASSOC LAB ANIM, V47, P8; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; Zipf GK, 1968, PSYCHOBIOLOGY LANGUA	42	162	166	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17460	10.1371/journal.pone.0017460	http://dx.doi.org/10.1371/journal.pone.0017460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408007	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900020
J	Wu, WW; de Folter, S; Shen, X; Zhang, WQ; Tao, SH				Wu, Wenwu; de Folter, Stefan; Shen, Xia; Zhang, Wenqian; Tao, Shiheng			Vertebrate Paralogous MEF2 Genes: Origin, Conservation, and Evolution	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MEF2C; DETECTING POSITIVE SELECTION; SERUM RESPONSE FACTOR; MADS-BOX GENES; ADAPTIVE EVOLUTION; HIGHER RATES; DNA-BINDING; MUSCLE; EXPRESSION; ACTIVATION	Background: The myocyte enhancer factor 2 (MEF2) gene family is broadly expressed during the development and maintenance of muscle cells. Although a great deal has been elucidated concerning MEF2 transcription factors' regulation of specific gene expression in diverse programs and adaptive responses, little is known about the origin and evolution of the four members of the MEF2 gene family in vertebrates. Methodology/Principal Findings: By phylogenetic analyses, we investigated the origin, conservation, and evolution of the four MEF2 genes. First, among the four MEF2 paralogous branches, MEF2B is clearly distant from the other three branches in vertebrates, mainly because it lacks the HJURP_C (Holliday junction recognition protein C-terminal) region. Second, three duplication events might have occurred to produce the four MEF2 paralogous genes and the latest duplication event occurred near the origin of vertebrates producing MEF2A and MEF2C. Third, the ratio (K-a/K-s) of non-synonymous to synonymous nucleotide substitution rates showed that MEF2B evolves faster than the other three MEF2 proteins despite purifying selection on all of the four MEF2 branches. Moreover, a pair model of M0 versus M3 showed that variable selection exists among MEF2 proteins, and branch-site analysis presented that sites 53 and 64 along the MEF2B branch are under positive selection. Finally, and interestingly, substitution rates showed that type II MADS genes (i.e., MEF2-like genes) evolve as slowly as type I MADS genes (i.e., SRF-like genes) in animals, which is inconsistent with the fact that type II MADS genes evolve much slower than type I MADS genes in plants. Conclusion: Our findings shed light on the relationship of MEF2A, B, C, and D with functional conservation and evolution in vertebrates. This study provides a rationale for future experimental design to investigate distinct but overlapping regulatory roles of the four MEF2 genes in various tissues.	[Wu, Wenwu; Zhang, Wenqian; Tao, Shiheng] Northwest A& F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Wu, Wenwu; Tao, Shiheng] Northwest A& F Univ, Bioinformat Ctr, Yangling, Shaanxi, Peoples R China; [de Folter, Stefan] Inst Politecn Nacl, Ctr Invest Estudios Avanzados, Lab Nacl Genom Biodiversidad Langebio, Guanajuato, Mexico; [Shen, Xia] Shaanxi Univ Chinese Med, Coll Drug Res, Xian, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Shaanxi University of Chinese Medicine	Tao, SH (corresponding author), Northwest A& F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn	Wu, Wenwu/HDO-7873-2022; /E-9373-2013; de Folter, Stefan/S-6428-2019; Wu, Wenwu/AAP-1966-2021	Wu, Wenwu/0000-0003-2996-8675; /0000-0003-4363-7274; de Folter, Stefan/0000-0003-4363-7274; Wu, Wenwu/0000-0003-2996-8675	PhD Programs Foundation of Ministry of Education of China [20100204110026]; Ministry of Education; Mexican Science Council [CONACyT 82826]	PhD Programs Foundation of Ministry of Education of China(Ministry of Education, China); Ministry of Education; Mexican Science Council	The authors gratefully acknowledge The PhD Programs Foundation of Ministry of Education of China (20100204110026) in SHT Lab, The Scholarship Award for Excellent Doctoral Student granted by Ministry of Education to WWW, and the Mexican Science Council (CONACyT 82826) in SDF Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla ER, 2010, SEMIN CELL DEV BIOL, V21, P108, DOI 10.1016/j.semcdb.2009.11.010; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; ANDRES V, 1995, MOL CELL BIOL, V15, P4272; ANDRES V, 1995, J BIOL CHEM, V270, P23246, DOI 10.1074/jbc.270.40.23246; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bielawski JP, 2005, STAT BIOL HEALTH, P103, DOI 10.1007/0-387-27733-1_5; Black B., 2010, HEART DEV REGENERATI, V2, P673; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Brand NJ, 1997, INT J BIOCHEM CELL B, V29, P1467, DOI 10.1016/S1357-2725(97)00084-8; Bromham L, 2009, BIOL LETTERS, V5, P401, DOI 10.1098/rsbl.2009.0136; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; CHOI DW, 1994, ANN NY ACAD SCI, V747, P162; Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007; Cripps RM, 1999, DEV BIOL, V215, P420, DOI 10.1006/dbio.1999.9446; De Bodt S, 2003, TRENDS PLANT SCI, V8, P475, DOI 10.1016/j.tplants.2003.09.006; De Bodt S, 2003, J MOL EVOL, V56, P573, DOI 10.1007/s00239-002-2426-x; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Gu X, 1992, MOL PHYLOGENET EVOL, V1, P211, DOI 10.1016/1055-7903(92)90017-B; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; HOBSON GM, 1995, GENOMICS, V29, P704, DOI 10.1006/geno.1995.9007; Hosking BM, 2001, BIOCHEM BIOPH RES CO, V287, P493, DOI 10.1006/bbrc.2001.5589; Huang K, 2000, EMBO J, V19, P2615, DOI 10.1093/emboj/19.11.2615; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Jimenez S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-81; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kimura M, 1985, NEUTRAL THEORY MOL E; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Litt A, 2010, SEMIN CELL DEV BIOL, V21, P129, DOI 10.1016/j.semcdb.2009.11.019; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; MARTIN JF, 1994, MOL CELL BIOL, V14, P1647, DOI 10.1128/MCB.14.3.1647; MARTIN JF, 1993, P NATL ACAD SCI USA, V90, P5282, DOI 10.1073/pnas.90.11.5282; Martinez-Castilla LP, 2003, P NATL ACAD SCI USA, V100, P13407, DOI 10.1073/pnas.1835864100; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nadruz W, 2003, CIRC RES, V92, P243, DOI 10.1161/01.RES.0000053184.94618.97; Nam J, 2004, P NATL ACAD SCI USA, V101, P1910, DOI 10.1073/pnas.0308430100; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nowakowska BA, 2010, AM J MED GENET B, V153B, P1042, DOI 10.1002/ajmg.b.31071; Ornatsky OI, 1997, J BIOL CHEM, V272, P33271, DOI 10.1074/jbc.272.52.33271; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Rao S, 1998, J BIOL CHEM, V273, P26123, DOI 10.1074/jbc.273.40.26123; Sablowski R, 2010, SEMIN CELL DEV BIOL, V21, P94, DOI 10.1016/j.semcdb.2009.08.008; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Sharma G, 2005, MOL CELL ENDOCRINOL, V245, P93, DOI 10.1016/j.mce.2005.10.027; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vanpoucke G, 2004, NUCLEIC ACIDS RES, V32, P4155, DOI 10.1093/nar/gkh727; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; Vision TJ, 2000, SCIENCE, V290, P2114, DOI 10.1126/science.290.5499.2114; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Wallin JJ, 1999, J BIOL CHEM, V274, P15959, DOI 10.1074/jbc.274.22.15959; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Wilker PR, 2008, NAT IMMUNOL, V9, P603, DOI 10.1038/ni.1609; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; Wu WW, 2011, MOL BIOL EVOL, V28, P501, DOI 10.1093/molbev/msq214; Wu WW, 2010, MAMM GENOME, V21, P104, DOI 10.1007/s00335-009-9238-x; Yan C, 1999, J BIOL CHEM, V274, P143, DOI 10.1074/jbc.274.1.143; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	80	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17334	10.1371/journal.pone.0017334	http://dx.doi.org/10.1371/journal.pone.0017334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394201	Green Submitted, Green Published, gold			2022-12-27	WOS:000288025500010
J	Fiorim, J; Ribeiro, RF; Silveira, EA; Padilha, AS; Vescovi, MVA; de Jesus, HC; Stefanon, I; Salaices, M; Vassallo, DV				Fiorim, Jonaina; Ribeiro Junior, Rogerio F.; Silveira, Edna A.; Padilha, Alessandra S.; Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.; Stefanon, Ivanita; Salaices, Mercedes; Vassallo, Dalton V.			Low-Level Lead Exposure Increases Systolic Arterial Pressure and Endothelium-Derived Vasodilator Factors in Rat Aortas	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SOLUBLE GUANYLATE-CYCLASE; INDUCED HYPERTENSION; BLOOD-PRESSURE; CYCLOOXYGENASE PATHWAYS; POTASSIUM CHANNELS; CALCIUM; DYSFUNCTION; EXPRESSION; SYSTEM	Chronic lead exposure induces hypertension and alters endothelial function. However, treatment with low lead concentrations was not yet explored. We analyzed the effects of 7 day exposure to low lead concentrations on endothelium-dependent responses. Wistar rats were treated with lead (1st dose 4 mu g/100 g, subsequent dose 0.05 mu g/100 g, i.m. to cover daily loss) or vehicle; blood levels attained at the end of treatment were 9.98 mu g/dL. Lead treatment had the following effects: increase in systolic blood pressure (SBP); reduction of contractile response to phenylephrine (1 nM-100 mu M) of aortic rings; unaffected relaxation induced by acetylcholine (0.1 nM-300 mu M) or sodium nitroprusside (0.01 nM-0.3 mu M). Endothelium removal, N-G-nitro-L-arginine methyl ester (100 mu M) and tetraethylammonium (2 mM) increased the response to phenylephrine in treated rats more than in untreated rats. Aminoguanidine (50 mu M) increased but losartan (10 mu M) and enalapril (10 mu M) reduced the response to phenylephrine in treated rats. Lead treatment also increased aortic Na+/K+-ATPase functional activity, plasma angiotensin-converting enzyme (ACE) activity, protein expression of the Na+/K+-ATPase alpha-1 subunit, phosphorylated endothelial nitric oxide synthase (p-eNOS), and inducible nitric oxide synthase (iNOS). Our results suggest that on initial stages of lead exposure, increased SBP is caused by the increase in plasma ACE activity. This effect is accompanied by increased p-eNOS, iNOS protein expression and Na+/K+-ATPase functional activity. These factors might be a compensatory mechanism to the increase in SBP.	[Fiorim, Jonaina; Ribeiro Junior, Rogerio F.; Silveira, Edna A.; Padilha, Alessandra S.; Vescovi, Marcos Vinicius A.; de Jesus, Honerio C.; Stefanon, Ivanita; Vassallo, Dalton V.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Espirito Santo, Brazil; [Vassallo, Dalton V.] EMESCAM, Hlth Sci Ctr Vitoria, Vitoria, Espirito Santo, Brazil; [Salaices, Mercedes] Univ Autonoma Madrid, Dept Farmacol, Madrid, Spain	Universidade Federal do Espirito Santo; Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; Autonomous University of Madrid	Fiorim, J (corresponding author), Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Espirito Santo, Brazil.	daltonv2@terra.com.br	Stefanon, Ivanita/J-4729-2014; Ribeiro, Rogerio/F-7116-2012; Vassallo, Dalton/K-8289-2016	Ribeiro, Rogerio/0000-0002-9725-3869; Salaices Sanchez, Mercedes/0000-0003-3323-1692; Stefanon, Ivanita/0000-0003-2638-5183; Vassallo, Dalton/0000-0002-4463-4174	CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior); CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Apoio a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil [39767531/07]; MCINN [SAF 2009-07201]; ISCIII (Red RECAVA), Spain [RD06/0014/0011]	CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Apoio a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCINN(European Commission); ISCIII (Red RECAVA), Spain(Instituto de Salud Carlos III)	This study was supported by grants from CAPES (Coordenacao de Aperfeicoamento Pessoal de Nivel Superior) and CNPq (Conselho Nacional de desenvolvimento Cientifico e Tecnologico)/FAPES (Fundacao de Apoio a Pesquisa do Espirito Santo)/FUNCITEC (Fundacao de Ciencia e Tecnologia) (39767531/07), Brazil and from MCINN (SAF 2009-07201) and ISCIII (Red RECAVA, RD06/0014/0011), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2005, TOX PROF LEAD; Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P513; Bener A, 2001, INT ARCH OCC ENV HEA, V74, P375, DOI 10.1007/s004200100231; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BOSCOLO P, 1988, ENVIRON HEALTH PERSP, V78, P101, DOI 10.2307/3430508; BROCK TA, 1982, P NATL ACAD SCI-BIOL, V79, P1438, DOI 10.1073/pnas.79.5.1438; CAMPBELL BC, 1985, TOXICOL LETT, V25, P25, DOI 10.1016/0378-4274(85)90096-7; Carmignani M, 2000, LIFE SCI, V68, P401, DOI 10.1016/S0024-3205(00)00954-1; Carmignani M, 1999, IMMUNOPHARMACOLOGY, V44, P105, DOI 10.1016/S0162-3109(99)00115-0; Chang HR, 1997, ARCH TOXICOL, V71, P778, DOI 10.1007/s002040050460; Courtois E, 2003, J AM SOC NEPHROL, V14, P1464, DOI 10.1097/01.ASN.0000064947.14997.69; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ehrlich R, 1998, OCCUP ENVIRON MED, V55, P453, DOI 10.1136/oem.55.7.453; Feletou M, 2009, BRIT J PHARMACOL, V156, P545, DOI 10.1111/j.1476-5381.2009.00052.x; Glenn BS, 2006, EPIDEMIOLOGY, V17, P538, DOI 10.1097/01.ede.0000231284.19078.4b; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; Gonick HC, 1997, HYPERTENSION, V30, P1487, DOI 10.1161/01.HYP.30.6.1487; GOODFRIEND TL, 1995, HYPERTENSION, V25, P785, DOI 10.1161/01.HYP.25.4.785; Grizzo LT, 2008, TOXICOL SCI, V103, P207, DOI 10.1093/toxsci/kfn018; GUPTA S, 1994, AM J PHYSIOL, V266, pH577, DOI 10.1152/ajpheart.1994.266.2.H577; HARLAN WR, 1988, ENVIRON HEALTH PERSP, V78, P9; Healey N, 2009, RADIAT PROT DOSIM, V134, P143, DOI 10.1093/rpd/ncp068; Heydari A, 2006, TOXICOL LETT, V166, P88, DOI 10.1016/j.toxlet.2006.05.014; Isenovic ER, 2004, ENDOCRINOLOGY, V145, P1151, DOI 10.1210/en.2003-0100; Karimi G, 2002, PHARMACOL RES, V46, P31, DOI 10.1016/S1043-6618(02)00035-X; KoreckovaSysalova J, 1997, BIOL TRACE ELEM RES, V56, P321, DOI 10.1007/BF02785303; Kosnett MJ, 2007, ENVIRON HEALTH PERSP, V115, P463, DOI 10.1289/ehp.9784; Marques M, 2001, J AM SOC NEPHROL, V12, P2594, DOI 10.1681/ASN.V12122594; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Muntner P., 1996, KIDNEY INT, V63, P104; Navas-Acien A, 2008, EPIDEMIOLOGY, V19, P496, DOI 10.1097/EDE.0b013e31816a2400; Navas-Acien A, 2007, ENVIRON HEALTH PERSP, V115, P472, DOI 10.1289/ehp.9785; Oliveira EM, 2000, BRAZ J MED BIOL RES, V33, P755, DOI 10.1590/S0100-879X2000000700005; Patrick L, 2006, ALTERN MED REV, V11, P2; PICCININI F, 1977, TOXICOLOGY, V8, P43, DOI 10.1016/0300-483X(77)90022-1; PUEYO ME, 1998, AM J PHYSIOL, V247, P214; Roncal C, 2007, AM J PHYSIOL-RENAL, V293, pF1391, DOI 10.1152/ajprenal.00216.2007; Rossoni LV, 2002, BRIT J PHARMACOL, V135, P771, DOI 10.1038/sj.bjp.0704501; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Silveira EA, 2010, BRAZ J MED BIOL RES, V43, P492, DOI 10.1590/S0100-879X2010007500027; Triggle Chris R., 2003, Journal of Smooth Muscle Research, V39, P249, DOI 10.1540/jsmr.39.249; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Vaziri ND, 2008, INDIAN J MED RES, V128, P426; Vaziri ND, 1999, HYPERTENSION, V34, P558, DOI 10.1161/01.HYP.34.4.558; Vaziri ND, 1997, KIDNEY INT, V52, P1042, DOI 10.1038/ki.1997.426; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; Vaziri ND, 2001, J PHARMACOL EXP THER, V298, P679; Vaziri ND, 2001, HYPERTENSION, V37, P223, DOI 10.1161/01.HYP.37.2.223; WATTS SW, 1995, TOXICOLOGY, V99, P55, DOI 10.1016/0300-483X(94)03003-K; WEBB RC, 1978, BLOOD VESSELS, V15, P198; WEILER E, 1988, ENV HLTH PRESP, P113; Zhang LF, 2009, TOXICOL LETT, V186, P78, DOI 10.1016/j.toxlet.2009.01.004	53	41	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2011	6	2							e17117	10.1371/journal.pone.0017117	http://dx.doi.org/10.1371/journal.pone.0017117			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726YS	21364929	Green Published, Green Submitted, gold			2022-12-27	WOS:000287764100029
J	Zhong, P; Yan, Z				Zhong, Ping; Yan, Zhen			Differential Regulation of the Excitability of Prefrontal Cortical Fast-Spiking Interneurons and Pyramidal Neurons by Serotonin and Fluoxetine	PLOS ONE			English	Article							PROTEIN-KINASE-C; WORKING-MEMORY; IN-VIVO; MEMBRANE EXCITABILITY; MAJOR DEPRESSION; 5-HT2A RECEPTORS; FRONTAL-CORTEX; RAT; TRANSMISSION; OSCILLATIONS	Serotonin exerts a powerful influence on neuronal excitability. In this study, we investigated the effects of serotonin on different neuronal populations in prefrontal cortex (PFC), a major area controlling emotion and cognition. Using whole-cell recordings in PFC slices, we found that bath application of 5-HT dose-dependently increased the firing of FS (fast spiking) interneurons, and decreased the firing of pyramidal neurons. The enhancing effect of 5-HT in FS interneurons was mediated by 5-HT2 receptors, while the reducing effect of 5-HT in pyramidal neurons was mediated by 5-HT1 receptors. Fluoxetine, the selective serotonin reuptake inhibitor, also induced a concentration-dependent increase in the excitability of FS interneurons, but had little effect on pyramidal neurons. In rats with chronic fluoxetine treatment, the excitability of FS interneurons was significantly increased, while pyramidal neurons remained unchanged. Fluoxetine injection largely occluded the enhancing effect of 5-HT in FS interneurons, but did not alter the reducing effect of 5-HT in pyramidal neurons. These data suggest that the excitability of PFC interneurons and pyramidal neurons is regulated by exogenous 5-HT in an opposing manner, and FS interneurons are the major target of Fluoxetine. It provides a framework for understanding the action of 5-HT and antidepressants in altering PFC network activity.	[Zhong, Ping; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhong, P (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14260 USA.	zhenyan@buffalo.edu			National Institutes of Health [MH84233]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grant MH84233 to ZY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanian GK, 1997, NEUROPHARMACOLOGY, V36, P589, DOI 10.1016/S0028-3908(97)00051-8; Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Andrade R, 1998, ANN NY ACAD SCI, V861, P190, DOI 10.1111/j.1749-6632.1998.tb10191.x; ARANEDA R, 1991, NEUROSCIENCE, V40, P399, DOI 10.1016/0306-4522(91)90128-B; AZMITIA EC, 1978, J COMP NEUROL, V179, P641, DOI 10.1002/cne.901790311; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beique JC, 2004, J NEUROSCI, V24, P4807, DOI 10.1523/JNEUROSCI.5113-03.2004; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; CACCIA S, 1992, NEUROPHARMACOLOGY, V31, P343, DOI 10.1016/0028-3908(92)90066-X; Cauli B, 1997, J NEUROSCI, V17, P3894; Contreras CM, 2001, J PSYCHOPHARMACOL, V15, P231, DOI 10.1177/026988110101500401; Cornelisse LN, 2007, J NEUROPHYSIOL, V98, P196, DOI 10.1152/jn.00109.2007; Deng PY, 2007, MOL PHARMACOL, V72, P208, DOI 10.1124/mol.107.034389; DOLAN RJ, 1994, PSYCHOL MED, V24, P849, DOI 10.1017/S0033291700028944; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Feng J, 2001, J NEUROSCI, V21, P6502, DOI 10.1523/JNEUROSCI.21-17-06502.2001; Foehring RC, 1996, J NEUROPHYSIOL, V75, P648, DOI 10.1152/jn.1996.75.2.648; Gao WJ, 2003, J NEUROSCI, V23, P1622; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; Gronier BS, 2003, NEUROSCI LETT, V349, P196, DOI 10.1016/S0304-3940(03)00851-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; JACOBS BL, 1992, PHYSIOL REV, V72, P165, DOI 10.1152/physrev.1992.72.1.165; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Lambe EK, 2000, CEREB CORTEX, V10, P974, DOI 10.1093/cercor/10.10.974; Lei WB, 2001, J BIOL CHEM, V276, P16720, DOI 10.1074/jbc.M100207200; Lemonde S, 2003, J NEUROSCI, V23, P8788; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Liu ZP, 2003, J NEUROPHYSIOL, V90, P3201, DOI 10.1152/jn.00281.2003; Meltzer HY, 2008, PROG BRAIN RES, V172, P177, DOI 10.1016/S0079-6123(08)00909-6; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Mizoguchi K, 2004, J NEUROSCI, V24, P5492, DOI 10.1523/JNEUROSCI.0086-04.2004; Mukherjee J, 1999, SYNAPSE, V31, P285, DOI 10.1002/(SICI)1098-2396(19990315)31:4<285::AID-SYN6>3.0.CO;2-5; Nierenberg AA, 2000, AM J PSYCHIAT, V157, P1423, DOI 10.1176/appi.ajp.157.9.1423; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Schenberg LC, 2001, NEUROSCI BIOBEHAV R, V25, P647, DOI 10.1016/S0149-7634(01)00060-4; Shakesby AC, 2002, J NEUROSCI, V22, P3638; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; STARK P, 1985, J CLIN PSYCHIAT, V46, P7; Stockmeier CA, 1997, ANN NY ACAD SCI, V836, P220, DOI 10.1111/j.1749-6632.1997.tb52362.x; Traboulsie A, 2006, MOL PHARMACOL, V69, P1963, DOI 10.1124/mol.105.020842; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432; Whittington MA, 2003, TRENDS NEUROSCI, V26, P676, DOI 10.1016/j.tins.2003.09.016; Williams GV, 2002, J NEUROSCI, V22, P2843, DOI 10.1523/JNEUROSCI.22-07-02843.2002; WONG DT, 1995, LIFE SCI, V57, P411, DOI 10.1016/0024-3205(95)00209-O; Zhang ZW, 2003, J NEUROSCI, V23, P3373; Zhong P, 2004, NEUROSCIENCE, V129, P65, DOI 10.1016/j.neuroscience.2004.06.072; Zhong P, 2003, J BIOL CHEM, V278, P26888, DOI 10.1074/jbc.M302789200; Zhong P, 2008, MOL CELL NEUROSCI, V38, P290, DOI 10.1016/j.mcn.2008.03.003; Zhou FM, 1999, J NEUROPHYSIOL, V82, P2989, DOI 10.1152/jn.1999.82.6.2989	56	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16970	10.1371/journal.pone.0016970	http://dx.doi.org/10.1371/journal.pone.0016970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383986	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700023
J	Akl, EA; Gaddam, S; Mustafa, R; Wilson, MC; Symons, A; Grifasi, A; McGuigan, D; Schunemann, HJ				Akl, Elie A.; Gaddam, Swarna; Mustafa, Reem; Wilson, Mark C.; Symons, Andrew; Grifasi, Ann; McGuigan, Denise; Schuenemann, Holger J.			The Effects of Tracking Responses and the Day of Mailing on Physician Survey Response Rate: Three Randomized Trials	PLOS ONE			English	Article							FACTORIAL TRIALS; MAILED SURVEY; QUESTIONNAIRE; ANONYMITY; POSTCARD; LENGTH; SIZE; COST	Background: The response rates to physician postal surveys remain modest. The primary objective of this study was to assess the effect of tracking responses on physician survey response rate (i.e., determining whether each potential participant has responded or not). A secondary objective was to assess the effects of day of mailing (Monday vs. Friday) on physician survey response rate. Methods: We conducted 3 randomized controlled trials. The first 2 trials had a 262 factorial design and tested the effect of day of mailing (Monday vs. Friday) and of tracking vs. no tracking responses. The third trial tested the effect of day of mailing (Monday vs. Friday). We meta-analyzed these 3 trials using a random effects model. Results: The total number of participants in the 3 trials was 1339. The response rate with tracked mailing was not statistically different from that with non-tracked mailing by the time of the first reminder (RR = 1.01 95% CI 0.84, 1.22; I-2 = 0%). There was a trend towards lower response rate with tracked mailing by the time of the second reminder (RR = 0.91; 95% CI 0.78, 1.06; I-2 = 0%). The response rate with mailing on Mondays was not statistically different from that with Friday mailing by the time of first reminder (RR = 1.01; 95% CI 0.87, 1.17; I-2 = 0%), and by the time of the 2(nd) reminder (RR = 1.08; 95% CI 0.84, 1.39; I-2 = 77%). Conclusions: Tracking response may negatively affect physicians' response rate. The day of mailing does not appear to affect physicians' response rate.	[Akl, Elie A.; Grifasi, Ann] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Akl, Elie A.; Gaddam, Swarna; Symons, Andrew; McGuigan, Denise] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA; [Akl, Elie A.; Mustafa, Reem; Schuenemann, Holger J.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Wilson, Mark C.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McMaster University; University of Iowa	Akl, EA (corresponding author), SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA.	elieakl@buffalo.edu	Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Akl, Elie A/0000-0002-3444-8618; Mustafa, Reem/0000-0002-2091-0875; Schunemann, Holger/0000-0003-3211-8479; Wilson, Mark/0000-0003-1271-9664	Research for Health in Erie County, Inc.; Graduate Medical Education of the University at Buffalo; Lebanese American University; Society of General Internal Medicine	Research for Health in Erie County, Inc.; Graduate Medical Education of the University at Buffalo; Lebanese American University; Society of General Internal Medicine	Research for Health in Erie County, Inc., and the Graduate Medical Education of the University at Buffalo funded the first study. The Lebanese American University funded the second study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ethel Sharp and Karen Devlin for their administrative assistance. We thank Dr. Sameer K Gunukula for his input. We also thank all those who participated in the surveys. EAA was a recipient of the Society of General Internal Medicine Founders Award.	Aitken C, 2008, AUST NZ J PUBL HEAL, V32, P288, DOI 10.1111/j.1753-6405.2008.00232.x; Akl EA, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-26; Akl EA, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-59; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Asch DA, 1996, EPIDEMIOLOGY, V7, P550, DOI 10.1097/00001648-199609000-00020; Beebe TJ, 2007, J CLIN EPIDEMIOL, V60, P1184, DOI 10.1016/j.jclinepi.2007.01.006; Beebe TJ, 2005, MED CARE, V43, P411, DOI 10.1097/01.mlr.0000156858.81146.0e; CAMPBELL MJ, 1990, J EPIDEMIOL COMMUN H, V44, P75, DOI 10.1136/jech.44.1.75; Collins RL, 2000, EVALUATION REV, V24, P347, DOI 10.1177/0193841X0002400401; Curtis Elizabeth A, 2009, Nurse Res, V16, P76; Delnevo CD, 2004, AM J PREV MED, V26, P234, DOI 10.1016/j.amepre.2003.12.013; DelValle M, 1997, EVAL HEALTH PROF, V20, P389, DOI 10.1177/016327879702000402; Drummond FJ, 2008, J CLIN EPIDEMIOL, V61, P177, DOI 10.1016/j.jclinepi.2007.04.012; Edwards P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; Field TS, 2002, MED CARE, V40, P596, DOI 10.1097/00005650-200207000-00006; Harris IA, 2008, J CLIN EPIDEMIOL, V61, P609, DOI 10.1016/j.jclinepi.2007.07.012; Jepson C, 2005, J CLIN EPIDEMIOL, V58, P103, DOI 10.1016/j.jclinepi.2004.06.004; John Esther M., 1994, Annals of Epidemiology, V4, P231; Kalantar JS, 1999, J CLIN EPIDEMIOL, V52, P1117, DOI 10.1016/S0895-4356(99)00051-7; LUBSEN J, 1994, EUR HEART J, V15, P585, DOI 10.1093/oxfordjournals.eurheartj.a060552; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; McColl E., 2001, HLTH TECHNOLOGY ASSE; MCDANIEL SW, 1981, J MARKET RES SOC, V23, P150; MCKEE DO, 1992, MARKET RES SOC; OLIVARIUS ND, 1995, SCAND J PRIM HLTH CA, V13; Pirotta M, 1999, AUST NZ J PUBL HEAL, V23, P196, DOI 10.1111/j.1467-842X.1999.tb01234.x; PRESSLEY MM, 1985, AMA ED C P, P356; Rikard-Bell G, 2000, AUST DENT J, V45, P46, DOI 10.1111/j.1834-7819.2000.tb00241.x	29	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16942	10.1371/journal.pone.0016942	http://dx.doi.org/10.1371/journal.pone.0016942			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373197	Green Published, gold, Green Submitted			2022-12-27	WOS:000287657500024
J	Zimmerman, SW; Manandhar, G; Yi, YJ; Gupta, SK; Sutovsky, M; Odhiambo, JF; Powell, MD; Miller, DJ; Sutovsky, P				Zimmerman, Shawn W.; Manandhar, Gaurishankar; Yi, Young-Joo; Gupta, Satish K.; Sutovsky, Miriam; Odhiambo, John F.; Powell, Michael D.; Miller, David J.; Sutovsky, Peter			Sperm Proteasomes Degrade Sperm Receptor on the Egg Zona Pellucida during Mammalian Fertilization	PLOS ONE			English	Article							ACROSOMAL EXOCYTOSIS; MONOCLONAL-ANTIBODIES; CATALYTIC-PROPERTIES; BOAR SPERMATOZOA; PROTEIN; PENETRATION; MOUSE; UBIQUITIN; MEMBRANE; GLYCOPROTEINS	Despite decades of research, the mechanism by which the fertilizing spermatozoon penetrates the mammalian vitelline membrane, the zona pellucida (ZP) remains one of the unexplained fundamental events of human/mammalian development. Evidence has been accumulating in support of the 26S proteasome as a candidate for echinoderm, ascidian and mammalian egg coat lysin. Monitoring ZP protein degradation by sperm during fertilization is nearly impossible because those few spermatozoa that penetrate the ZP leave behind a virtually untraceable residue of degraded proteins. We have overcome this hurdle by designing an experimentally consistent in vitro system in which live boar spermatozoa are co-incubated with ZP-proteins (ZPP) solubilized from porcine oocytes. Using this assay, mimicking sperm-egg interactions, we demonstrate that the sperm-borne proteasomes can degrade the sperm receptor protein ZPC. Upon coincubation with motile spermatozoa, the solubilized ZPP, which appear to be ubiquitinated, adhered to sperm acrosomal caps and induced acrosomal exocytosis/formation of the acrosomal shroud. The degradation of the sperm receptor protein ZPC was assessed by Western blotting band-densitometry and proteomics. A nearly identical pattern of sperm receptor degradation, evident already within the first 5 min of coincubation, was observed when the spermatozoa were replaced with the isolated, enzymatically active, sperm-derived proteasomes. ZPC degradation was blocked by proteasomal inhibitors and accelerated by ubiquitin-aldehyde(UBAL), a modified ubiquitin protein that stimulates proteasomal proteolysis. Such a degradation pattern of ZPC is consistent with in vitro fertilization studies, in which proteasomal inhibitors completely blocked fertilization, and UBAL increased fertilization and polyspermy rates. Preincubation of intact zona-enclosed ova with isolated active sperm proteasomes caused digestion, abrasions and loosening of the exposed zonae, and significantly reduced the fertilization/polyspermy rates after IVF, accompanied by en-mass detachment of zona bound sperm. Thus, the sperm borne 26S proteasome is a candidate zona lysin in mammals. This new paradigm has implications for contraception and assisted reproductive technologies in humans, as well as animals.	[Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Obstet, Columbia, MO USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Gynecol, Columbia, MO USA; [Zimmerman, Shawn W.; Manandhar, Gaurishankar; Sutovsky, Miriam; Odhiambo, John F.; Sutovsky, Peter] Univ Missouri, Dept Womens Hlth, Columbia, MO USA; [Yi, Young-Joo] Chungnam Natl Univ, Res Ctr Transgen Cloned Pigs, Taejon, South Korea; [Gupta, Satish K.] Natl Inst Immunol, Reprod Cell Biol Lab, New Delhi 110067, India; [Powell, Michael D.] Morehouse Univ, Morehouse Sch Med, Atlanta, GA USA; [Miller, David J.] Univ Illinois, Dept Anim Sci, Urbana, IL USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Chungnam National University; Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Morehouse College; Morehouse School of Medicine; University of Illinois System; University of Illinois Urbana-Champaign	Zimmerman, SW (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	SutovskyP@missouri.edu	Miller, David J/ABC-2156-2020; Gupta, Satish/B-9934-2009; odhiambo, john/AAC-2444-2020	Miller, David J/0000-0001-7147-5546; Gupta, Satish/0000-0003-3717-0436; odhiambo, john/0000-0002-1005-3486; Sutovsky, Peter/0000-0002-9231-2823	National Research Initiative Competitive [2007-01319]; Missouri Life Sciences Trust Fund [13324]; University of Missouri	National Research Initiative Competitive(United States Department of Agriculture (USDA)); Missouri Life Sciences Trust Fund; University of Missouri	National Research Initiative Competitive Grant no. 2007-01319 Missouri Life Sciences Trust Fund award number 13324 Seed funding was provided by the Food for the 21st Century Program of The University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; AUSTIN CR, 1958, PROC R SOC SER B-BIO, V149, P241, DOI 10.1098/rspb.1958.0066; AUSTIN CR, 1975, J REPROD FERTIL, V44, P155, DOI 10.1530/jrf.0.0440155; BABA T, 1989, J BIOL CHEM, V264, P11920; BABA T, 1994, J BIOL CHEM, V269, P31845; BABA T, 1994, J BIOL CHEM, V269, P10133; BAGOLA K, BIOCH BIOPHYS ACTA; Bedford JM, 2008, INT J DEV BIOL, V52, P415, DOI 10.1387/ijdb.072551jb; Bedford JM, 1998, BIOL REPROD, V59, P1275, DOI 10.1095/biolreprod59.6.1275; Blackmore DG, 2004, BIOL REPROD, V71, P661, DOI 10.1095/biolreprod.104.028779; BLEIL JD, 1980, CELL, V20, P873, DOI 10.1016/0092-8674(80)90334-7; Bohring C, 2003, AM J REPROD IMMUNOL, V50, P411, DOI 10.1034/j.1600-0897.2003.00103.x; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Burkin Heather R, 2004, Methods Mol Biol, V253, P79; Chakravarty S, 2008, REPROD BIOMED ONLINE, V16, P391, DOI 10.1016/S1472-6483(10)60601-3; Diaz ES, 2007, HUM REPROD, V22, P1420, DOI 10.1093/humrep/dem023; EINSPANIER R, 1993, THERIOGENOLOGY, V40, P181, DOI 10.1016/0093-691X(93)90351-5; Flechon Jacques E, 2003, Reprod Biol Endocrinol, V1, P124, DOI 10.1186/1477-7827-1-124; GOECKELER JL, DIABETES OBES MET S2, V12, P32; GREEN DPL, 1984, BIOPHYS J, V45, P659, DOI 10.1016/S0006-3495(84)84207-1; GREEN DPL, 1987, EXP CELL RES, V169, P31, DOI 10.1016/0014-4827(87)90221-7; Gupta Manju, 1994, Indian Journal of Experimental Biology, V32, P376; GUPTA SK, 1995, MOL REPROD DEV, V42, P220, DOI 10.1002/mrd.1080420211; GUPTA SK, 1993, AM J REPROD IMMUNOL, V30, P95, DOI 10.1111/j.1600-0897.1993.tb00608.x; Guterman A, 2004, CURR PROTEIN PEPT SC, V5, P201, DOI 10.2174/1389203043379756; Hagaman JR, 1998, P NATL ACAD SCI USA, V95, P2552, DOI 10.1073/pnas.95.5.2552; Honda A, 2002, J BIOL CHEM, V277, P16976, DOI 10.1074/jbc.M112470200; Kawano N, 2010, BIOL REPROD; Kolle S, 1996, HISTOCHEM J, V28, P441, DOI 10.1007/BF02331435; Lambert CC, 2002, J EXP ZOOL, V292, P88, DOI 10.1002/jez.1145; Lee VH, 2000, BIOL REPROD, V63, P401, DOI 10.1095/biolreprod63.2.401; Luria A, 2002, BIOL REPROD, V66, P429, DOI 10.1095/biolreprod66.2.429; Morales P, 2003, HUM REPROD, V18, P1010, DOI 10.1093/humrep/deg111; Morales Patricio, 2007, Soc Reprod Fertil Suppl, V65, P269; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; NAZ RK, J REPROD IMMUNOL, V84, P24; Olds-Clarke P, 2003, INT REV CYTOL, V232, P129, DOI 10.1016/S0074-7696(03)32004-2; Pasten C, 2005, MOL REPROD DEV, V71, P209, DOI 10.1002/mrd.20280; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Qi HY, 2002, MOL BIOL CELL, V13, P530, DOI 10.1091/mbc.01-09-0440; Reidlinger J, 1997, J BIOL CHEM, V272, P24899, DOI 10.1074/jbc.272.40.24899; Rivkin E, 2009, DEV DYNAM, V238, P1851, DOI 10.1002/dvdy.22004; Rodriguez-Miranda E, 2008, BIOL REPROD, V79, P164, DOI 10.1095/biolreprod.107.065565; Rossato M, 1999, HUM REPROD, V14, P694, DOI 10.1093/humrep/14.3.694; Sakai N, 2004, INT J BIOCHEM CELL B, V36, P776, DOI 10.1016/S1357-2725(03)00263-2; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Sixt SU, 2008, BBA-MOL BASIS DIS, V1782, P817, DOI 10.1016/j.bbadis.2008.06.005; Sutovsky P, 2004, BIOL REPROD, V71, P1625, DOI 10.1095/biolreprod.104.032532; Sutovsky Peter, 2004, Methods Mol Biol, V253, P59; Tengowski MW, 2007, BIOL REPROD, V76, P149, DOI 10.1095/biolreprod.106.053173; Vazquez JM, 1996, ACTA HISTOCHEM, V98, P93, DOI 10.1016/S0065-1281(96)80056-0; Yanagimachi R, 1994, MAMMALIAN FERTILIZAT; Yi Young-Joo, 2007, Soc Reprod Fertil Suppl, V63, P385; Yi YJ, 2007, BIOL REPROD, V77, P780, DOI 10.1095/biolreprod.107.061275; Yi YJ, 2009, SYST BIOL REPROD MED, V55, P85, DOI 10.1080/19396360802699074; Yokota N, 2007, DEV BIOL, V308, P222, DOI 10.1016/j.ydbio.2007.05.025; Yu Y, 2006, DEV BIOL, V290, P32, DOI 10.1016/j.ydbio.2005.11.003; Yurewicz EC, 1998, J BIOL CHEM, V273, P7488, DOI 10.1074/jbc.273.13.7488; Zimmerman S, 2009, J REPROD IMMUNOL, V83, P19, DOI 10.1016/j.jri.2009.07.006	59	58	59	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17256	10.1371/journal.pone.0017256	http://dx.doi.org/10.1371/journal.pone.0017256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383844	gold, Green Submitted, Green Published			2022-12-27	WOS:000287657500046
J	Project, E; Nachliel, E; Gutman, M				Project, Elad; Nachliel, Esther; Gutman, Menachem			The Dynamics of Ca2+ Ions within the Solvation Shell of Calbindin D9k	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; MOLECULAR-DYNAMICS; SURFACE-CHARGES; FORCE-FIELD; SIMULATIONS; CALMODULIN; TRANSITION; GROMACS; MODELS; WATER	The encounter of a Ca2+ ion with a protein and its subsequent binding to specific binding sites is an intricate process that cannot be fully elucidated from experimental observations. We have applied Molecular Dynamics to study this process with atomistic details, using Calbindin D9k (CaB) as a model protein. The simulations show that in most of the time the Ca2+ ion spends within the Debye radius of CaB, it is being detained at the 1st and 2nd solvation shells. While being detained near the protein, the diffusion coefficient of the ion is significantly reduced. However, due to the relatively long period of detainment, the ion can scan an appreciable surface of the protein. The enhanced propagation of the ion on the surface has a functional role: significantly increasing the ability of the ion to scan the protein's surface before being dispersed to the bulk. The contribution of this mechanism to Ca2+ binding becomes significant at low ion concentrations, where the intervals between successive encounters with the protein are getting longer. The efficiency of the surface diffusion is affected by the distribution of charges on the protein's surface. Comparison of the Ca2+ binding dynamics in CaB and its E60D mutant reveals that in the wild type (WT) protein the carboxylate of E60 function as a preferred landing-site for the Ca2+ arriving from the bulk, followed by delivering it to the final binding site. Replacement of the glutamate by aspartate significantly reduced the ability to transfer Ca2+ ions from D60 to the final binding site, explaining the observed decrement in the affinity of the mutated protein to Ca2+.	[Project, Elad; Nachliel, Esther; Gutman, Menachem] Tel Aviv Univ, Laser Lab Fast React, IL-69978 Tel Aviv, Israel	Tel Aviv University	Project, E (corresponding author), Tel Aviv Univ, Laser Lab Fast React, IL-69978 Tel Aviv, Israel.	me@hemi.tau.ac.il						Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cox B.G., 1992, COORDINATION TRANSPO; DASILVA ACR, 1991, TRENDS BIOCHEM SCI, V16, P53, DOI 10.1016/0968-0004(91)90024-P; David R. L., 2010, CRC HDB CHEM PHYS; Eigen M., 1963, PURE APPL CHEM, V6, P97, DOI [10.1351/pac196306010097, DOI 10.1351/PAC196306010097]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; FORSEN S, 1993, ACCOUNTS CHEM RES, V26, P7, DOI 10.1021/ar00025a002; Friedman R, 2005, BIOPHYS J, V89, P768, DOI 10.1529/biophysj.105.058917; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida H, 2002, BIOCHEMISTRY-US, V41, P15536, DOI 10.1021/bi020330r; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Komeiji Y, 2002, FEBS LETT, V521, P133, DOI 10.1016/S0014-5793(02)02853-3; Kordel J, 1997, J BIOMOL NMR, V10, P231, DOI 10.1023/A:1018383102870; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Kuntz I D Jr, 1974, Adv Protein Chem, V28, P239, DOI 10.1016/S0065-3233(08)60232-6; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LINSE S, 1988, NATURE, V335, P651, DOI 10.1038/335651a0; LINSE S, 1994, BIOCHEMISTRY-US, V33, P12478, DOI 10.1021/bi00207a015; MARCUS Y, 1985, ION SOLVATION; MARTIN SR, 1990, BIOCHEMISTRY-US, V29, P4188, DOI 10.1021/bi00469a023; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Paquin R, 2008, J AM CHEM SOC, V130, P15805, DOI 10.1021/ja803794g; PATARGIAS GN, J CHEM PHYS, V132; Project E, 2008, J COMPUT CHEM, V29, P1163, DOI 10.1002/jcc.20876; Project E, 2006, BIOPHYS J, V90, P3842, DOI 10.1529/biophysj.105.077792; Project E, 2010, J COMPUT CHEM, V31, P1864, DOI 10.1002/jcc.21473; Robinson R.A., 1959, ELECTROLYTE SOLUTION, DOI DOI 10.1073?PNAS.0305836101; SEATON BA, 1985, BIOCHEMISTRY-US, V24, P6740, DOI 10.1021/bi00345a002; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; SZEBENYI DME, 1986, J BIOL CHEM, V261, P8761; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VENABLE RM, 1988, BIOPOLYMERS, V27, P1001, DOI 10.1002/bip.360270609; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; [No title captured]	44	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e14718	10.1371/journal.pone.0014718	http://dx.doi.org/10.1371/journal.pone.0014718			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364983	gold, Green Published, Green Submitted			2022-12-27	WOS:000287656600002
J	Barthelmes, D; Bosch, MM; Merz, TM; Petrig, BL; Truffer, F; Bloch, KE; Holmes, TA; Cattin, P; Hefti, U; Sellner, M; Sutter, FKP; Maggiorini, M; Landau, K				Barthelmes, Daniel; Bosch, Martina M.; Merz, Tobias M.; Petrig, Benno L.; Truffer, Frederic; Bloch, Konrad E.; Holmes, Timothy A.; Cattin, Philippe; Hefti, Urs; Sellner, Miriam; Sutter, Florian K. P.; Maggiorini, Marco; Landau, Klara			Delayed Appearance of High Altitude Retinal Hemorrhages	PLOS ONE			English	Article							ACUTE MOUNTAIN-SICKNESS; BLOOD-FLOW; SUPEROXIDE ANION; RETINOPATHY; ASCENT; CIRCULATION; CLIMBERS; ILLNESS	Background: Retinal hemorrhages have been described as a component of high altitude retinopathy (HAR) in association with altitude illness. In this prospective high altitude study, we aimed to gain new insights into the pathophysiology of HAR and explored whether HAR could be a valid early indicator of altitude illness. Methodology/Principal Findings: 28 mountaineers were randomly assigned to two ascent profiles during a research expedition to Mt. Muztagh Ata (7546 m/24,751 ft). Digital fundus photographs were taken prior to expedition at 490 m (1,607 ft), during expedition at 4497 m (14,750 ft = base camp), 5533 m (18,148 ft), 6265 m (20,549 ft), 6865 m (22,517 ft) and 4.5 months thereafter at 490 m. Number, size and time of occurrence of hemorrhages were recorded. Oxygen saturation (SpO(2)) and hematocrit were also assessed. 79% of all climbers exhibited retinal hemorrhages during the expedition. Number and area of retinal bleeding increased moderately to medium altitudes (6265 m). Most retinal hemorrhages were detected after return to base camp from a high altitude. No post-expeditional ophthalmic sequelae were detected. Significant negative (SpO(2) Beta: -0.4, p<0.001) and positive (hematocrit Beta: 0.2, p = 0.002, time at altitude Beta: 0.33, p = 0.003) correlations with hemorrhages were found. Conclusions/Significance: When closely examined, a very large amount of climbers exhibit retinal hemorrhages during exposure to high altitudes. The incidence of retinal hemorrhages may be greater than previously appreciated as a definite time lag was observed between highest altitude reached and development of retinal bleeding. Retinal hemorrhages should not be considered warning signs of impending severe altitude illness due to their delayed appearance.	[Barthelmes, Daniel; Bosch, Martina M.; Holmes, Timothy A.; Sellner, Miriam; Sutter, Florian K. P.; Landau, Klara] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland; [Merz, Tobias M.] Univ Hosp Bern, Dept Intens Care Med, Inselspital, CH-3010 Bern, Switzerland; [Merz, Tobias M.] Univ Bern, Bern, Switzerland; [Petrig, Benno L.; Truffer, Frederic] Inst Rech Ophtalmol, Sion, Switzerland; [Bloch, Konrad E.] Univ Zurich Hosp, Div Pulm, CH-8091 Zurich, Switzerland; [Bloch, Konrad E.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland; [Cattin, Philippe] Univ Basel, Fac Med, Med Image Anal Ctr, Basel, Switzerland; [Hefti, Urs] State Hosp Liestal, Dept Surg, Liestal, Switzerland; [Maggiorini, Marco] Univ Zurich Hosp, Med Intens Care Unit, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Bern; University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Basel; University of Geneva; University of Zurich; University Zurich Hospital	Barthelmes, D (corresponding author), Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland.	martina.boesch@usz.ch	Landau, Klara/N-3739-2015; Merz, Tobias M/M-6724-2015; Merz, Tobias/AAE-8323-2020; Cattin, Philippe/B-1301-2009	Landau, Klara/0000-0001-9384-8905; Merz, Tobias M/0000-0002-3149-5873; Maggiorini, Marco/0000-0001-8180-2117; Cattin, Philippe C./0000-0001-8785-2713	Swiss National Research Science Foundation [EK 11 1146]; Swiss Society of Mountain Medicine; Pfizer, Switzerland; Pfizer	Swiss National Research Science Foundation; Swiss Society of Mountain Medicine; Pfizer, Switzerland(Pfizer); Pfizer(Pfizer)	This project was supported by a research grant from the Swiss National Research Science Foundation (Grant No. EK 11 1146), a research grant by the Swiss Society of Mountain Medicine, a private grant to the Department of Ophthalmology, University Hospital Zurich, and by an unconditional grant from Pfizer, Switzerland. These grants were utilized for logistics during the expedition, acquisition of material and research devices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; There were no financial interests or any consultancy, patents, products in development or marketed products in conjunction with the different grants received that were relevant to the study. The company Pfizer granted a certain amount of funding to the entire expedition for logistics including transport of medical devices and personal belongings of both researchers as well as participants, which was all unconditional. None of the researchers can financially profit from the data published. Thus this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bloch KE, 2009, HIGH ALT MED BIOL, V10, P25, DOI 10.1089/ham.2008.1043; Bosch MM, 2009, J APPL PHYSIOL, V106, P454, DOI 10.1152/japplphysiol.90904.2008; Bosch MM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1; BOSCH MM, INVEST OPHTHALMOL VI, V51, P1609; CLARKE G, 1976, BRIT MED J, V2, P495; Delaey C, 2000, OPHTHALMIC RES, V32, P249, DOI 10.1159/000055622; DUANE TD, 1980, OPHTHALMOLOGY, V87, P66; FRAYSER R, 1971, ARCH INTERN MED, V127, P708, DOI 10.1001/archinte.127.4.708; FRAYSER R, 1970, NEW ENGL J MED, V282, P1183, DOI 10.1056/NEJM197005212822106; FREISCHLAG JA, 1991, J SURG RES, V50, P565, DOI 10.1016/0022-4804(91)90042-K; Geiser MH, 1999, J BIOMED OPT, V4, P459, DOI 10.1117/1.429960; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Hackett PH, 1998, JAMA-J AM MED ASSOC, V280, P1920, DOI 10.1001/jama.280.22.1920; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Jansen GFA, 2002, RESP PHYSIOL NEUROBI, V133, P65, DOI 10.1016/S1569-9048(02)00152-0; Ling R, 1998, POSTGRAD MED J, V74, P581, DOI 10.1136/pgmj.74.876.581; Maggiorini M, 1998, AVIAT SPACE ENVIR MD, V69, P1186; MCFADDEN DM, 1981, JAMA-J AM MED ASSOC, V245, P581, DOI 10.1001/jama.245.6.581; Patton N, 2005, J ANAT, V206, P319, DOI 10.1111/j.1469-7580.2005.00395.x; RENNIE D, 1975, ARCH OPHTHALMOL-CHIC, V93, P395; RIVA CE, 1994, INVEST OPHTH VIS SCI, V35, P4273; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Roth M., 1872, DTSCH Z CHIR, V1, P471, DOI 10.1007/bf02800420; Schneider M, 2002, MED SCI SPORT EXER, V34, P1886, DOI 10.1097/00005768-200212000-00005; SHULTS WT, 1975, ARCH OPHTHALMOL-CHIC, V93, P404; SINGH I, 1969, NEW ENGL J MED, V280, P175, DOI 10.1056/NEJM196901232800402; Van Osta A, 2005, STROKE, V36, P557, DOI 10.1161/01.STR.0000155735.85888.13; Wiedman M, 1999, OPHTHALMOLOGY, V106, P1924, DOI 10.1016/S0161-6420(99)90402-5; WIEDMAN M, 1975, ARCH OPHTHALMOL-CHIC, V93, P401; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6	31	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e11532	10.1371/journal.pone.0011532	http://dx.doi.org/10.1371/journal.pone.0011532			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379571	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300001
J	Feng, YX; Wang, YM; Li, L; Wu, LA; Hoffmann, S; Gretz, N; Hammes, HP				Feng, Yuxi; Wang, Yumei; Li, Li; Wu, Liang; Hoffmann, Sigrid; Gretz, Norbert; Hammes, Hans-Peter			Gene Expression Profiling of Vasoregression in the Retina-Involvement of Microglial Cells	PLOS ONE			English	Article							DEGENERATION; ACTIVATION; PATHOGENESIS; MIGRATION; PERICYTES	Vasoregression is a hallmark of vascular eye diseases but the mechanisms involved are still largely unknown. We have recently characterized a rat ciliopathy model which develops primary photoreceptor degeneration and secondary vasoregression. To improve the understanding of secondary vasoregression in retinal neurodegeneration, we used microarray techniques to compare gene expression profiles in this new model before and after retinal vasoregression. Differential gene expression was validated by quantitative RT-PCR, Western blot and immunofluorescence. Of the 157 genes regulated more than twofold, the MHC class II invariant chain CD74 yielded the strongest upregulation, and was allocated to activated microglial cells close to the vessels undergoing vasoregression. Pathway clustering identified genes of the immune system including inflammatory signaling, and components of the complement cascade upregulated during vasoregression. Together, our data suggest that microglial cells involved in retinal immune response participate in the initiation of vasoregression in the retina.	[Feng, Yuxi; Wang, Yumei; Wu, Liang; Hammes, Hans-Peter] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, D-6800 Mannheim, Germany; [Li, Li; Hoffmann, Sigrid; Gretz, Norbert] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr, D-6800 Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Feng, YX (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, D-6800 Mannheim, Germany.	hans-peter.hammes@med5.ma.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019		Deutsche Forschungsgemeinschaft [Ha 1755/8-1, GRK 880]; Deutsche Diabetes-Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Diabetes-Gesellschaft	This study was supported by the Deutsche Forschungsgemeinschaft (Ha 1755/8-1 to YF and HPH; GRK 880 to YW, YF, and HPH) and the Deutsche Diabetes-Gesellschaft (to YF, YW, and HPH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beswick EJ, 2005, J IMMUNOL, V175, P171, DOI 10.4049/jimmunol.175.1.171; Bryan KJ, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-13; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Feit-Leichman RA, 2005, INVEST OPHTH VIS SCI, V46, P4281, DOI 10.1167/iovs.04-1361; Feng YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007328; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; Gerhardinger C, 2005, INVEST OPHTH VIS SCI, V46, P349, DOI 10.1167/iovs.04-0860; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Martin-Ventura JL, 2009, CARDIOVASC RES, V83, P586, DOI 10.1093/cvr/cvp141; Matsuda S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-41; Matza D, 2003, TRENDS IMMUNOL, V24, P264, DOI 10.1016/S1471-4906(03)00073-5; Pennesi ME, 2008, EXP EYE RES, V87, P561, DOI 10.1016/j.exer.2008.09.004; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Zeng HY, 2008, ARCH OPHTHALMOL-CHIC, V126, P227, DOI 10.1001/archophthalmol.2007.65; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118; Zhang C, 2005, EXP EYE RES, V81, P700, DOI 10.1016/j.exer.2005.04.008; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	27	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16865	10.1371/journal.pone.0016865	http://dx.doi.org/10.1371/journal.pone.0016865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379381	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482300022
J	Weger, BD; Sahinbas, M; Otto, GW; Mracek, P; Armant, O; Dolle, D; Lahiri, K; Vallone, D; Ettwiller, L; Geisler, R; Foulkes, NS; Dickmeis, T				Weger, Benjamin D.; Sahinbas, Meltem; Otto, Georg W.; Mracek, Philipp; Armant, Olivier; Dolle, Dirk; Lahiri, Kajori; Vallone, Daniela; Ettwiller, Laurence; Geisler, Robert; Foulkes, Nicholas S.; Dickmeis, Thomas			The Light Responsive Transcriptome of the Zebrafish: Function and Regulation	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; CIRCADIAN CLOCK; GENE ONTOLOGY; DNA-REPAIR; CELL-CYCLE; EXPRESSION; CYTOSCAPE; ACTIVATION; MECHANISMS; MELANOPSIN	Most organisms possess circadian clocks that are able to anticipate the day/night cycle and are reset or "entrained'' by the ambient light. In the zebrafish, many organs and even cultured cell lines are directly light responsive, allowing for direct entrainment of the clock by light. Here, we have characterized light induced gene transcription in the zebrafish at several organizational levels. Larvae, heart organ cultures and cell cultures were exposed to 1- or 3-hour light pulses, and changes in gene expression were compared with controls kept in the dark. We identified 117 light regulated genes, with the majority being induced and some repressed by light. Cluster analysis groups the genes into five major classes that show regulation at all levels of organization or in different subset combinations. The regulated genes cover a variety of functions, and the analysis of gene ontology categories reveals an enrichment of genes involved in circadian rhythms, stress response and DNA repair, consistent with the exposure to visible wavelengths of light priming cells for UV-induced damage repair. Promoter analysis of the induced genes shows an enrichment of various short sequence motifs, including E-and D-box enhancers that have previously been implicated in light regulation of the zebrafish period2 gene. Heterologous reporter constructs with sequences matching these motifs reveal light regulation of D-box elements in both cells and larvae. Morpholino-mediated knock-down studies of two homologues of the D-box binding factor Tef indicate that these are differentially involved in the cell autonomous light induction in a gene-specific manner. These findings suggest that the mechanisms involved in period2 regulation might represent a more general pathway leading to light induced gene expression.	[Weger, Benjamin D.; Sahinbas, Meltem; Mracek, Philipp; Armant, Olivier; Lahiri, Kajori; Vallone, Daniela; Foulkes, Nicholas S.; Dickmeis, Thomas] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Otto, Georg W.; Geisler, Robert] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Dolle, Dirk; Ettwiller, Laurence] Heidelberg Univ, Heidelberg Inst Zool, Heidelberg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Max Planck Society; Ruprecht Karls University Heidelberg	Weger, BD (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	nicholas.foulkes@kit.edu; thomas.dickmeis@kit.edu	Sahinbas, Meltem/H-6482-2013; Geisler, Robert/K-6201-2013; Weger, Meltem/AAG-6735-2019; Vallone, Daniela/S-2244-2019; Foulkes, Nicholas S/K-7003-2013; Weger, Benjamin D/AAG-7551-2019; Dickmeis, Thomas/H-1355-2013	Geisler, Robert/0000-0002-3909-8311; Weger, Meltem/0000-0002-9452-2373; Foulkes, Nicholas S/0000-0002-1794-9891; Weger, Benjamin D/0000-0002-1831-3561; Dolle, Dirk-Dominik/0000-0003-1786-6452; Ettwiller, Laurence/0000-0002-3957-6539; Otto, Georg W/0000-0002-3929-948X; armant, olivier/0000-0001-7101-9209	Max-Planck-Society; Karlsruhe Institute of Technology; EMBO; DFG; Studienstiftung des Deutschen Volkes; European Commission [LSHG-CT-2003-503496]; EU	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Karlsruhe Institute of Technology(Helmholtz Association); EMBO(European Molecular Biology Organization (EMBO)); DFG(German Research Foundation (DFG)); Studienstiftung des Deutschen Volkes; European Commission(European CommissionEuropean Commission Joint Research Centre); EU(European Commission)	This work was supported by the Max-Planck-Society (GWO, PM, KL, DV, RG, NSF and TD) and the Karlsruhe Institute of Technology (MS, PM, KL, DV, NSF and TD) as well as by grants from EMBO (TD), DFG (TD and BDW), the Studienstiftung des Deutschen Volkes (MS), the European Commission's 6th Framework Programme (Contract No LSHG-CT-2003-503496, ZF-MODELS) (GWO and RG) and the EU 6th Framework STREP Project ZF-TOOLS (KL, DV and NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; BAILES IIJ, 2009, CELL MOL LIFE SCI; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Ben-Moshe Z, 2010, CHRONOBIOL INT, V27, P1509, DOI 10.3109/07420528.2010.510229; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Cermakian N, 2002, CURR BIOL, V12, P844, DOI 10.1016/S0960-9822(02)00835-7; CIRCU ML, FREE RADIC BIOL MED, V48, P749; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dickmeis T, 2009, J ENDOCRINOL, V200, P3, DOI 10.1677/JOE-08-0415; Dunlap J., 2004, CHRONOBIOLOGY; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gavriouchkina D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012542; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girotti AW, 2004, ANTIOXID REDOX SIGN, V6, P301, DOI 10.1089/152308604322899369; Guler AD, 2007, COLD SPRING HARB SYM, V72, P509, DOI 10.1101/sqb.2007.72.074; GUO C, CELL, V140, pE751; GUO C, CELL, V140, P754; Haudry Y, 2010, NAT PROTOC, V5, P323, DOI 10.1038/nprot.2009.158; Herrlich P, 2008, MOL CELL, V29, P279, DOI 10.1016/j.molcel.2008.01.001; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Hirayama J, 2009, CELL CYCLE, V8, P2794, DOI 10.4161/cc.8.17.9447; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; Kaneko M, 2005, PLOS BIOL, V3, P313, DOI 10.1371/journal.pbio.0030034; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lee I, 2008, BBA-PROTEINS PROTEOM, V1784, P727, DOI 10.1016/j.bbapap.2008.02.010; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nusslein-Volhard C, 2002, ZEBRAFISH; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Pando MP, 2001, P NATL ACAD SCI USA, V98, P10178, DOI 10.1073/pnas.181228598; PAUL KN, 2009, REV ENDOCR METAB DIS; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pinzar E, 2000, P NATL ACAD SCI USA, V97, P4903, DOI 10.1073/pnas.090093997; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Pulivarthy SR, 2007, P NATL ACAD SCI USA, V104, P20356, DOI 10.1073/pnas.0708877104; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schibler U, 2009, J BIOL RHYTHM, V24, P3, DOI 10.1177/0748730408329383; Selby CP, 2006, P NATL ACAD SCI USA, V103, P17696, DOI 10.1073/pnas.0607993103; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siu TL, 2008, CLIN EXP OPHTHALMOL, V36, P176, DOI 10.1111/j.1442-9071.2008.01699.x; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamai TK, 2007, P NATL ACAD SCI USA, V104, P14712, DOI 10.1073/pnas.0704588104; Tamai TK, 2004, CURR BIOL, V14, pR104, DOI 10.1016/j.cub.2004.01.014; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Team. RDC, 2007, R LANG ENV STAT COMP; UCHIDA Y, BIOL PHARM B, V33, P535; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone D, 2007, DEV DYNAM, V236, P142, DOI 10.1002/dvdy.20998; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; WU Z, 2004, MODEL BASED BACKGROU, P1; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Ziv L, 2005, J NEUROENDOCRINOL, V17, P314, DOI 10.1111/j.1365-2826.2005.01315.x	74	70	73	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 15	2011	6	2							e17080	10.1371/journal.pone.0017080	http://dx.doi.org/10.1371/journal.pone.0017080			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721QH	21390203	Green Submitted, gold, Green Published			2022-12-27	WOS:000287369200019
J	George, M; Rainey, MA; Naramura, M; Foster, KW; Holzapfel, MS; Willoughby, LL; Ying, GG; Goswami, RM; Gurumurthy, CB; Band, V; Satchell, SC; Band, H				George, Manju; Rainey, Mark A.; Naramura, Mayumi; Foster, Kirk W.; Holzapfel, Melissa S.; Willoughby, Laura L.; Ying, GuoGuang; Goswami, Rasna M.; Gurumurthy, Channabasavaiah B.; Band, Vimla; Satchell, Simon C.; Band, Hamid			Renal Thrombotic Microangiopathy in Mice with Combined Deletion of Endocytic Recycling Regulators EHD3 and EHD4	PLOS ONE			English	Article							GLOMERULAR-FILTRATION BARRIER; NEPHROTIC SYNDROME; ENDOTHELIAL-CELLS; PROTEINS; NEPHRIN; KIDNEY; CYTOSKELETON; COMPARTMENT; EXPRESSION; PARACRINE	Eps15 Homology Domain-containing 3 (EHD3), a member of the EHD protein family that regulates endocytic recycling, is the first protein reported to be specifically expressed in the glomerular endothelium in the kidney; therefore we generated Ehd3(-/-) mice and assessed renal development and pathology. Ehd3(-/-) animals showed no overt defects, and exhibited no proteinuria or glomerular pathology. However, as the expression of EHD4, a related family member, was elevated in the glomerular endothelium of Ehd3(-/-) mice and suggested functional compensation, we generated and analyzed Ehd3(-/-); Ehd4(-/-) mice. These mice were smaller, possessed smaller and paler kidneys, were proteinuric and died between 3-24 weeks of age. Detailed analyses of Ehd3(-/-) ; Ehd4(-/-) kidneys demonstrated thrombotic microangiopathy (TMA)-like glomerular lesions including thickening and duplication of glomerular basement membrane, endothelial swelling and loss of fenestrations. Other changes included segmental podocyte foot process effacement, mesangial interposition, and abnormal podocytic and mesangial marker expression. The glomerular lesions observed were strikingly similar to those seen in human pre-eclampsia and mouse models of reduced VEGF expression. As altered glomerular endothelial VEGFR2 expression and localization and increased apoptosis was observed in the absence of EHD3 and EHD4, we propose that EHD-mediated endocytic traffic of key surface receptors such as VEGFR2 is essential for physiological control of glomerular function. Furthermore, Ehd3(-/-); Ehd4(-/-) mice provide a unique model to elucidate mechanisms of glomerular endothelial injury which is observed in a wide variety of human renal and extra-renal diseases.	[George, Manju; Naramura, Mayumi; Willoughby, Laura L.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Rainey, Mark A.] Creighton Univ, Dept Pharmacol, Omaha, NE 68178 USA; [Foster, Kirk W.; Holzapfel, Melissa S.; Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE USA; [Ying, GuoGuang] Tianjin Med Univ, Oncol Cent Lab, Canc Inst & Hosp, Tianjin, Peoples R China; [Goswami, Rasna M.] Abbott Labs, Abbott Pk, IL 60064 USA; [Gurumurthy, Channabasavaiah B.; Band, Vimla; Band, Hamid] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE USA; [Satchell, Simon C.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; Creighton University; University of Nebraska System; University of Nebraska Medical Center; Tianjin Medical University; Abbott Laboratories; University of Nebraska System; University of Nebraska Medical Center; University of Bristol; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	George, M (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	manjuggm@gmail.com; mnaramura@unmc.edu; hband@unmc.edu	Gurumurthy, Channabasavaiah B/H-8268-2016; Band, Hamid/AAF-4701-2020; Gurumurthy, Channabasavaiah B/E-7205-2011	Gurumurthy, Channabasavaiah B/0000-0002-8022-4033; Naramura, Mayumi/0000-0003-3658-0767	NIH [CA105489, CA099163, CA879862, CA116552, CA096844, P20RR018788]; Department of Defense Breast Cancer Research [DAMD W81XWH-07-1-0351, W81XWH-11-1-0171, W81XWH-11-1-0166, W81 XWH-10-1-0740, W81XWH-08-1-0621]; National Center for Research Resources (NCRR); UNMC-Eppley Cancer Center Pilot Grant; NCI; NATIONAL CANCER INSTITUTE [R01CA105489, R01CA116552, R01CA099163, R01CA087986, R01CA096844] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research(United States Department of Defense); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UNMC-Eppley Cancer Center Pilot Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	NIH Grants CA105489, CA099163, CA87986, CA116552 (HB), CA096844 (VB); Department of Defense Breast Cancer Research Grant DAMD W81XWH-07-1-0351, W81XWH-11-1-0171 (VB), W81XWH-11-1-0166 (HB), W81 XWH-10-1-0740 (MN), W81XWH-08-1-0621 (MG); CoBRE Pilot funding (MG) from NIH grant 2P20RR018788 from the CoBRE Program of the National Center for Research Resources (NCRR); UNMC-Eppley Cancer Center Pilot Grant (MN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the UNMC Comparative Medicine Core Facility for animal husbandry and veterinary care; Maureen Harmon of Tissue sciences core facility and Janice Taylor and James Talaska of the Confocal Core Facility at the University of Nebraska Medical Center (supported by the Nebraska Research Initiative and the Eppley Cancer Center Core Grant from the NCI) for technical assistance; and Dr. Babu Padanilam, Dr. Dale Abrahamson and the Band Lab members for helpful discussions.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Ballermann BJ, 2007, NEPHRON PHYSIOL, V106, P19, DOI 10.1159/000101796; Blume JJ, 2007, EXP CELL RES, V313, P219, DOI 10.1016/j.yexcr.2006.10.006; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Brunskill EW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012034; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Eremina V, 2007, NEPHRON PHYSIOL, V106, P32, DOI 10.1159/000101798; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; Foster RR, 2009, NEPHRON EXP NEPHROL, V113, pE8, DOI 10.1159/000228078; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; George M, 2010, GENESIS, V48, P328, DOI 10.1002/dvg.20620; GRANT BD, 2008, MECH EHD REM 1 PROTE; GUDMUNDSSON H, 2010, CIRC RES; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Huber TB, 2009, J AM SOC NEPHROL, V20, P798, DOI 10.1681/ASN.2008080871; Jarad G, 2009, CURR OPIN NEPHROL HY, V18, P226, DOI 10.1097/MNH.0b013e3283296044; Jia JH, 2010, PROTEOMICS, V10, P224, DOI 10.1002/pmic.200900607; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2007, J BIOL CHEM, V282, P16612, DOI 10.1074/jbc.M609493200; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; PORTER GA, 1990, EUR J CELL BIOL, V51, P85; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Rainey MA, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-37; Sano H, 2002, AM J PATHOL, V161, P135, DOI 10.1016/S0002-9440(10)64165-X; Scott A, 2009, BIOCHEM SOC T, V37, P1184, DOI 10.1042/BST0371184; Sengupta S, 2009, J BIOL CHEM, V284, P20121, DOI 10.1074/jbc.M109.025668; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Stillman IE, 2007, J AM SOC NEPHROL, V18, P2281, DOI 10.1681/ASN.2007020255; Takeda T, 2001, J CLIN INVEST, V108, P289, DOI 10.1172/JCI12539; Yap CCC, 2010, J NEUROSCI, V30, P6646, DOI 10.1523/JNEUROSCI.5428-09.2010	43	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17838	10.1371/journal.pone.0017838	http://dx.doi.org/10.1371/journal.pone.0017838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408024	Green Submitted, Green Published, gold			2022-12-27	WOS:000288170900050
J	Huang, T; Xu, ZP; Chen, L; Cai, YD; Kong, XY				Huang, Tao; Xu, Zhongping; Chen, Lei; Cai, Yu-Dong; Kong, Xiangyin			Computational Analysis of HIV-1 Resistance Based on Gene Expression Profiles and the Virus-Host Interaction Network	PLOS ONE			English	Article							INFECTION; LYMPHOCYTES; PROSTITUTES; NAIROBI; ANTIGEN	A very small proportion of people remain negative for HIV infection after repeated HIV-1 viral exposure, which is called HIV-1 resistance. Understanding the mechanism of HIV-1 resistance is important for the development of HIV-1 vaccines and Acquired Immune Deficiency Syndrome (AIDS) therapies. In this study, we analyzed the gene expression profiles of CD4+ T cells from HIV-1-resistant individuals and HIV-susceptible individuals. One hundred eighty-five discriminative HIV-1 resistance genes were identified using the Minimum Redundancy-Maximum Relevance (mRMR) and Incremental Feature Selection (IFS) methods. The virus protein target enrichment analysis of the 185 HIV-1 resistance genes suggested that the HIV-1 protein nef might play an important role in HIV-1 infection. Moreover, we identified 29 infection information exchanger genes from the 185 HIV-1 resistance genes based on a virus-host interaction network analysis. The infection information exchanger genes are located on the shortest paths between virus-targeted proteins and are important for the coordination of virus infection. These proteins may be useful targets for AIDS prevention or therapy, as intervention in these pathways could disrupt communication with virus-targeted proteins and HIV-1 infection.	[Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Huang, Tao] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China; [Xu, Zhongping; Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, RuiJin Hosp, State Key Lab Med Genom,Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Chen, Lei; Cai, Yu-Dong] Fudan Univ, Ctr Computat Syst Biol, Shanghai 200433, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Kong, Xiangyin] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Jiao Tong University; Fudan University; Shanghai Maritime University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	cai_yud@yahoo.com.cn; xykong@sibs.ac.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National High-Tech R&D Program of China (863 Program) [2006AA02Z334, 2007DFA31040]; China National Key Projects for Infectious Disease [2008ZX10002-021]; National Basic Research Program of China [2006CB910700]; National Natural Science Foundation of China [31070752]; CAS [KSCX2-YW-R-112]	National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); China National Key Projects for Infectious Disease; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS(Chinese Academy of Sciences)	This work was supported by grants from National High-Tech R&D Program of China (863 Program) (2006AA02Z334, 2007DFA31040), China National Key Projects for Infectious Disease (2008ZX10002-021), National Basic Research Program of China (2006CB910700), National Natural Science Foundation of China (Grant No. 31070752) and Key Research Program (CAS) (KSCX2-YW-R-112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernasconi P, 2005, CANCER GENET CYTOGEN, V162, P146, DOI 10.1016/j.cancergencyto.2005.04.002; Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3; Chakrabarti LA, 2010, CURR OPIN IMMUNOL, V22, P488, DOI 10.1016/j.coi.2010.06.006; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Das SR, 2005, INDIAN J MED RES, V121, P315; De Keersmaecker K, 2008, Verh K Acad Geneeskd Belg, V70, P245; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Fowke KR, 2000, IMMUNOL CELL BIOL, V78, P586, DOI 10.1046/j.1440-1711.2000.00944.x; FREDRICKSON TN, 1984, J NATL CANCER I, V72, P447; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Hakansson P, 2004, EXP HEMATOL, V32, P476, DOI 10.1016/j.exphem.2004.02.012; HUANG T, 2010, INT J COMPU IN PRESS; HUANG T, 2010, WORKSH GEN NETW PATH; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011900; Huang Tao, 2010, BMC Res Notes, V3, P142, DOI 10.1186/1756-0500-3-142; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008126; Huang T, 2009, BIOCHEM BIOPH RES CO, V390, P1111, DOI 10.1016/j.bbrc.2009.08.131; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kaul R, 2001, J CLIN INVEST, V107, P341, DOI 10.1172/JCI10714; Kharas NG, 2005, CANCER RES, V65, P2047, DOI 10.1158/0008-5472.CAN-04-3888; Kulkarni Prasad S., 2003, AIDS Reviews, V5, P87; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; LECRON JC, 1987, CR ACAD SCI III-VIE, V305, P639; PAUL JM, 2010, J INFECT DIS, V202, pS339; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Simmons A, 2005, IMMUNITY, V23, P621, DOI 10.1016/j.immuni.2005.11.003; Temesgen Z, 1999, ANN ALLERG ASTHMA IM, V83, P1, DOI 10.1016/S1081-1206(10)63503-X; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; WEISS RA, 1993, SCIENCE, V260, P1273, DOI 10.1126/science.8493571; Yang PL, 2005, VIROLOGY, V336, P219, DOI 10.1016/j.virol.2005.03.021; Yi XF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012495; ZOLA H, 1991, CLIN IMMUNOL IMMUNOP, V59, P16, DOI 10.1016/0090-1229(91)90078-O	38	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17291	10.1371/journal.pone.0017291	http://dx.doi.org/10.1371/journal.pone.0017291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394196	Green Published, gold, Green Submitted			2022-12-27	WOS:000288025500008
J	Fiuza-Luces, C; Ruiz, JR; Rodriguez-Romo, G; Santiago, C; Gomez-Gallego, F; Yvert, T; Cano-Nieto, A; Garatachea, N; Moran, M; Lucia, A				Fiuza-Luces, Carmen; Ruiz, Jonatan R.; Rodriguez-Romo, Gabriel; Santiago, Catalina; Gomez-Gallego, Felix; Yvert, Thomas; Cano-Nieto, Amalia; Garatachea, Nuria; Moran, Maria; Lucia, Alejandro			Are 'Endurance' Alleles 'Survival' Alleles? Insights from the ACTN3 R577X Polymorphism	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MUSCLE POWER PHENOTYPES; NON-ATHLETIC ADULTS; ALPHA-ACTININ-3 DEFICIENCY; PHYSICAL-ACTIVITY; HUMAN LONGEVITY; PERFORMANCE; GENOTYPE; ASSOCIATION; POPULATION	Exercise phenotypes have played a key role for ensuring survival over human evolution. We speculated that some genetic variants that influence exercise phenotypes could be associated with exceptional survival (i.e. reaching >= 100years of age). Owing to its effects on muscle structure/function, a potential candidate is the Arg(R) 577Ter(X) polymorphism (rs1815739) in ACTN3, the structural gene encoding the skeletal muscle protein alpha-actinin-3. We compared the ACTN3 R577X genotype/allele frequencies between the following groups of ethnically-matched (Spanish) individuals: centenarians (cases, n = 64; 57 female; age range: 100-108 years), young healthy controls (n = 283, 67 females, 216 males; 21 +/- 2 years), and humans who are at the two end-points of exercise capacity phenotypes, i.e. muscle endurance (50 male professional road cyclists) and muscle power (63 male jumpers/sprinters). Although there were no differences in genotype/allele frequencies between centenarians (RR: 28.8%; RX: 47.5%; XX:23.7%), and controls (RR: 31.8%; RX: 49.8%; XX:18.4%) or endurance athletes (RR:28.0%; RX:46%; XX:26.0%), we observed a significantly higher frequency of the X allele (P = 0.019) and XX genotype (P = 0.011) in centenarians compared with power athletes (RR:47.6%; RX:36.5%; XX:15.9%). Notably, the frequency of the null XX (alpha-actinin-3 deficient) genotype in centenarians was the highest ever reported in non-athletic Caucasian populations. In conclusion, despite there were no significant differences with the younger, control population, overall the ACTN3 genotype of centenarians resembles that of world-class elite endurance athletes and differs from that of elite power athletes. Our preliminary data would suggest a certain 'survival' advantage brought about by alpha-actinin-3 deficiency and the 'endurance'/oxidative muscle phenotype that is commonly associated with this condition.	[Fiuza-Luces, Carmen; Santiago, Catalina; Gomez-Gallego, Felix; Yvert, Thomas; Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Ruiz, Jonatan R.] Univ Granada, Dept Phys Educ, Sch Phys Activ & Sport Sci, Granada, Spain; [Ruiz, Jonatan R.] Karolinska Inst, Dept Biosci & Nutr, Novum, Unit Prevent Nutr, Stockholm, Sweden; [Rodriguez-Romo, Gabriel] Univ Politecn Madrid, INEF, Madrid, Spain; [Cano-Nieto, Amalia] Hosp Morales Meseguer, SUAP Archena, Murcia, Spain; [Garatachea, Nuria] Univ Zaragoza, Fac Hlth & Sport Sci, Dept Physiotherapy & Nursing, Zaragoza, Spain; [Moran, Maria] Hosp 12 Octubre, Ctr Invest, E-28041 Madrid, Spain; [Moran, Maria] CIBERER, Madrid, Spain	European University of Madrid; University of Granada; Karolinska Institutet; Universidad Politecnica de Madrid; Facultad de Ciencias de la Actividad Fisica del Deporte (INEF); University of Zaragoza; Hospital Universitario 12 de Octubre; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Lucia, A (corresponding author), Univ Europea Madrid, Madrid, Spain.	alejandro.lucia@uem.es	Rodriguez-Romo, Gabriel/AAD-1603-2022; RUIZ, JONATAN R/M-1338-2015; Gomez-Gallego, Felix/AAD-9617-2020; Santiago, Catalina/P-8177-2019; Moran, Maria/HHS-1798-2022; Gomez-Gallego, Felix/H-6925-2013; Santiago, Catalina/K-6803-2014; Lucia, Alejandro/M-2759-2014; Garatachea, Nuria/ABF-8732-2020	Rodriguez-Romo, Gabriel/0000-0003-3111-6340; RUIZ, JONATAN R/0000-0002-7548-7138; Santiago, Catalina/0000-0003-3852-8217; Gomez-Gallego, Felix/0000-0002-1968-1761; Santiago, Catalina/0000-0003-3852-8217; Lucia, Alejandro/0000-0002-3025-2060; Garatachea Vallejo, Nuria/0000-0001-8374-9081; Yvert, Thomas/0000-0002-9451-9799; Fiuza-Luces, Carmen/0000-0001-8131-7007; Lucia, Alejandro/0000-0002-5565-0997	Fondo de Investigaciones Sanitarias (FIS) [PS09/00194]; Swedish Council for Working Life and Social Research (FAS)	Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by the Fondo de Investigaciones Sanitarias (FIS, ref. # PS09/00194), and Swedish Council for Working Life and Social Research (FAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bustamante-Ara N, 2010, INT J SPORTS MED, V31, P221, DOI 10.1055/s-0030-1247529; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cordain L, 1998, INT J SPORTS MED, V19, P328, DOI 10.1055/s-2007-971926; Delmonico MJ, 2007, J GERONTOL A-BIOL, V62, P206, DOI 10.1093/gerona/62.2.206; Galinsky D, 1997, ATHEROSCLEROSIS, V129, P177, DOI 10.1016/S0021-9150(96)06027-3; GARLAND T, 1990, EXPERIENTIA, V46, P530, DOI 10.1007/BF01954257; Giaccaglia V, 2008, INT J SPORTS MED, V29, P40, DOI 10.1055/s-2007-964842; Koch LG, 2008, J PHYSIOL-LONDON, V586, P83, DOI 10.1113/jphysiol.2007.144709; Liebenberg L, 2008, J HUM EVOL, V55, P1156, DOI 10.1016/j.jhevol.2008.07.004; Lucia A, 2006, INT J SPORTS MED, V27, P880, DOI 10.1055/s-2006-923862; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Lucia A, 2008, NAT CLIN PRACT CARD, V5, P372, DOI 10.1038/ncpcardio1241; Lucia A, 2007, NEUROMUSCULAR DISORD, V17, P603, DOI 10.1016/j.nmd.2007.04.006; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; MacArthur DG, 2007, EXERC SPORT SCI REV, V35, P30, DOI 10.1097/JES.0b013e31802d8874; Manini TM, 2009, BRIT J SPORT MED, V43, P28, DOI 10.1136/bjsm.2008.053736; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; O'Keefe JH, 2004, MAYO CLIN PROC, V79, P101, DOI 10.4065/79.1.101; Rodriguez-Romo G, 2010, EUR J APPL PHYSIOL, V110, P1099, DOI 10.1007/s00421-010-1608-2; San Juan AF, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019539; Santiago C, 2010, SCAND J MED SCI SPOR, V20, P771, DOI 10.1111/j.1600-0838.2009.01017.x; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Seripa D, 2006, J GERONTOL A-BIOL, V61, P918, DOI 10.1093/gerona/61.9.918; SETO JT, 2010, EXP GERONTOL; Solvioli Stefano, 2008, Biotechnology Journal, V3, P740, DOI 10.1002/biot.200800046; Tejedor D, 2005, CLIN CHEM, V51, P1137, DOI 10.1373/clinchem.2004.045203; Van Damme R, 2002, NATURE, V415, P755, DOI 10.1038/415755b; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh S, 2008, J APPL PHYSIOL, V105, P1486, DOI 10.1152/japplphysiol.90856.2008; Williams SB, 2009, BIOL LETTERS, V5, P610, DOI 10.1098/rsbl.2009.0360; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yang JK, 2009, J RENIN-ANGIO-ALDO S, V10, P115, DOI 10.1177/1470320309104873; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	37	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17558	10.1371/journal.pone.0017558	http://dx.doi.org/10.1371/journal.pone.0017558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21407828	Green Submitted, Green Published, gold			2022-12-27	WOS:000287965200026
J	Maiti, S; Kumar, KHBG; Castellani, CA; O'Reilly, R; Singh, SM				Maiti, Sujit; Kumar, Kiran Halagur Bhoge Gowda; Castellani, Christina A.; O'Reilly, Richard; Singh, Shiva M.			Ontogenetic De Novo Copy Number Variations (CNVs) as a Source of Genetic Individuality: Studies on Two Families with MZD Twins for Schizophrenia	PLOS ONE			English	Article							DISCORDANT; GENOME; INSTABILITY; PATHWAYS; COMMON	Genetic individuality is the foundation of personalized medicine, yet its determinants are currently poorly understood. One issue is the difference between monozygotic twins that are assumed identical and have been extensively used in genetic studies for decades [1]. Here, we report genome-wide alterations in two nuclear families each with a pair of monozygotic twins discordant for schizophrenia evaluated by the Affymetrix 6.0 human SNP array. The data analysis includes characterization of copy number variations (CNVs) and single nucleotide polymorphism (SNPs). The results have identified genomic differences between twin pairs and a set of new provisional schizophrenia genes. Samples were found to have between 35 and 65 CNVs per individual. The majority of CNVs (similar to 80%) represented gains. In addition, similar to 10% of the CNVs were de novo (not present in parents), of these, 30% arose during parental meiosis and 70% arose during developmental mitosis. We also observed SNPs in the twins that were absent from both parents. These constituted 0.12% of all SNPs seen in the twins. In 65% of cases these SNPs arose during meiosis compared to 35% during mitosis. The developmental mitotic origin of most CNVs that may lead to MZ twin discordance may also cause tissue differences within individuals during a single pregnancy and generate a high frequency of mosaics in the population. The results argue for enduring genome-wide changes during cellular transmission, often ignored in most genetic analyses.	[Maiti, Sujit; Kumar, Kiran Halagur Bhoge Gowda; Castellani, Christina A.; Singh, Shiva M.] Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada; [O'Reilly, Richard; Singh, Shiva M.] Univ Western Ontario, Dept Psychiat, London, ON N6A 3K7, Canada; [O'Reilly, Richard; Singh, Shiva M.] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario)	Maiti, S (corresponding author), Univ Western Ontario, Dept Biol, Mol Genet Unit, London, ON, Canada.	ssingh@uwo.ca		Castellani, Christina/0000-0003-2737-0549	Canadian Institutes of Health Research (CIHR) [R2258A15]; Ontario Mental Health Foundation (OMHF) [R2258A14]; Schizophrenia Society of Ontario (SSO) [R2258A10]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation (OMHF); Schizophrenia Society of Ontario (SSO)	Work was supported by the Canadian Institutes of Health Research (CIHR) http://www.cihr-irsc.gc.ca/ Grant number: R2258A15; Ontario Mental Health Foundation (OMHF) http://www.omhf.on.ca/ Grant number: R2258A14; and the Schizophrenia Society of Ontario (SSO) http://www.schizophrenia.on.ca/ Grant number: R2258A10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2010, NATURE, V464, P1351, DOI 10.1038/nature08990; Belge G, 1998, CANCER GENET CYTOGEN, V101, P42, DOI 10.1016/S0165-4608(97)00057-5; Booth HAF, 2007, GENE, V387, P7, DOI 10.1016/j.gene.2006.07.034; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Daelemans C, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-25; Fisher RA, 1919, GENETICS, V4, P489; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; GOTTESMAN II, 1989, ARCH GEN PSYCHIAT, V46, P867; Grozeva D, 2010, ARCH GEN PSYCHIAT, V67, P318, DOI 10.1001/archgenpsychiatry.2010.25; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hoyle J, 1996, GENOMICS, V31, P115, DOI 10.1006/geno.1996.0017; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Konradi C, 2005, BRAIN RES REV, V50, P142, DOI 10.1016/j.brainresrev.2005.05.004; Ku CS, 2010, HUM MUTAT, V31, P851, DOI 10.1002/humu.21287; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lee YW, 2004, MOL MED, V10, P19, DOI 10.2119/2004-00024.Lee; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; Meiboom M, 2003, CYTOGENET GENOME RES, V101, P113, DOI 10.1159/000074165; Michalak K, 2008, BIOCHEM BIOPH RES CO, V368, P273, DOI 10.1016/j.bbrc.2008.01.052; Milo R, 2010, AUTOIMMUN REV, V9, pA387, DOI 10.1016/j.autrev.2009.11.010; Mirnics K, 2006, BIOL PSYCHIAT, V60, P163, DOI 10.1016/j.biopsych.2006.02.003; Mkrtchyan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009591; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; OLLIKAINEN M, 2010, HUM MOL GENET; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Schwartz M, 2010, MOL PSYCHIATR, V15, P337, DOI 10.1038/mp.2010.22; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Singh SM, 2009, MOL PSYCHIATR, V14, P356, DOI 10.1038/mp.2008.149; Singh SM, 2009, GENOME, V52, P8, DOI 10.1139/G08-095; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Tanahashi N, 1998, BIOCHEM BIOPH RES CO, V243, P229, DOI 10.1006/bbrc.1997.7892; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wu H, 2001, BBA-GENE STRUCT EXPR, V1518, P190, DOI 10.1016/S0167-4781(01)00172-5; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	42	53	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17125	10.1371/journal.pone.0017125	http://dx.doi.org/10.1371/journal.pone.0017125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399695	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300010
J	Schmidt, JP; Drake, JM				Schmidt, John Paul; Drake, John M.			Time since Introduction, Seed Mass, and Genome Size Predict Successful Invaders among the Cultivated Vascular Plants of Hawaii	PLOS ONE			English	Article							INVASION SUCCESS; RISK-ASSESSMENT; ECOLOGICAL STRATEGIES; ALIEN PLANTS; INVASIVENESS; EVOLUTION; HISTORY; HYBRIDIZATION; PATTERNS; TRAITS	Extensive economic and environmental damage has been caused by invasive exotic plant species in many ecosystems worldwide. Many comparative studies have therefore attempted to predict, from biological traits, which species among the pool of naturalized non-natives become invasive. However, few studies have investigated which species establish and/or become pests from the larger pool of introduced species and controlled for time since introduction. Here we present results from a study aimed at quantifying predicting three classes of invasive species cultivated in Hawaii. Of 7,866 ornamental species cultivated in Hawaii between 1840 and 1999, 420 (5.3%) species naturalized, 141 (1.8%) have been classified as weeds, and 39 (0.5%) were listed by the state of Hawaii as noxious. Of the 815 species introduced > 80 years ago, 253 (31%) have naturalized, 90 (11%) are classed as weeds, and 22 (3%) as noxious by the state of Hawaii. Using boosted regression trees we classified each group with nearly 90% accuracy, despite incompleteness of data and the low proportion of naturalized or pest species. Key biological predictors were seed mass and highest chromosome number standardized by genus which, when data on residence time was removed, were able to predict all three groups with 76-82% accuracy. We conclude that, when focused on a single region, screening for potential weeds or noxious plants based on a small set of biological traits can be achieved with sufficient accuracy for policy and management purposes.	[Schmidt, John Paul; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schmidt, JP (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	jps@uga.edu	Schmidt, John Paul/A-3583-2013; Drake, John/D-6622-2012	Drake, John/0000-0003-4646-1235; Schmidt, John Paul/0000-0001-8549-0587	United States Department of Agriculture [10-21-RR551]	United States Department of Agriculture(United States Department of Agriculture (USDA))	Research was funded by United States Department of Agriculture agreement no. 10-21-RR551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Beaulieu JM, 2007, NEW PHYTOL, V173, P422, DOI 10.1111/j.1469-8137.2006.01919.x; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Bucharova A, 2009, J ECOL, V97, P230, DOI 10.1111/j.1365-2745.2008.01469.x; Cadotte MW, 2006, BIOL INVASIONS, V8, P809, DOI 10.1007/s10530-005-3839-4; Caley P, 2008, DIVERS DISTRIB, V14, P196, DOI 10.1111/j.1472-4642.2007.00440.x; Daehler CC, 2004, CONSERV BIOL, V18, P360, DOI 10.1111/j.1523-1739.2004.00066.x; De'ath G, 2007, ECOLOGY, V88, P243, DOI 10.1890/0012-9658(2007)88[243:BTFEMA]2.0.CO;2; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2003, STAT MED, V22, P1365, DOI 10.1002/sim.1501; Gordon DR, 2008, DIVERS DISTRIB, V14, P234, DOI 10.1111/j.1472-4642.2007.00460.x; Grotkopp E, 2004, EVOLUTION, V58, P1705, DOI 10.1111/j.0014-3820.2004.tb00456.x; Hamilton MA, 2005, ECOL LETT, V8, P1066, DOI 10.1111/j.1461-0248.2005.00809.x; Herron PM, 2007, DIVERS DISTRIB, V13, P633, DOI 10.1111/j.1472-4642.2007.00381.x; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hurka Herbert, 2003, Biological Invasions, V5, P281; Keller RP, 2007, P NATL ACAD SCI USA, V104, P203, DOI 10.1073/pnas.0605787104; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; KOWARIK I, 1995, PLANT INVASIONS, P15; Kuster EC, 2008, J ECOL, V96, P860, DOI 10.1111/j.1365-2745.2008.01406.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Pheloung PC, 1999, J ENVIRON MANAGE, V57, P239, DOI 10.1006/jema.1999.0297; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pysek P, 2004, TAXON, V53, P131, DOI 10.2307/4135498; PYSEK P, 1995, PLANT INVASIONS, P39; Pysek Petr, 2007, V193, P97; Pysek P, 2009, DIVERS DISTRIB, V15, P891, DOI 10.1111/j.1472-4642.2009.00602.x; Reichard SH, 1997, CONSERV BIOL, V11, P193, DOI 10.1046/j.1523-1739.1997.95473.x; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Rejmanek M, 2000, AUSTRAL ECOL, V25, P497, DOI 10.1046/j.1442-9993.2000.01080.x; Ridgeway G., 1999, COMPUT SCI STAT, P172; Ridgeway G., GEN BOOSTED REGRESSI; Schlaepfer DR, 2010, OECOLOGIA, V163, P661, DOI 10.1007/s00442-010-1595-3; SCHMIDT JP, 2010, COST SENSITIVE RISK; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Thuiller W, 2006, ECOLOGY, V87, P1755, DOI 10.1890/0012-9658(2006)87[1755:IBESTA]2.0.CO;2; van Kleunen M, 2003, ECOLOGY, V84, P2816, DOI 10.1890/02-0494; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Williamson M, 1999, ECOGRAPHY, V22, P5, DOI 10.1111/j.1600-0587.1999.tb00449.x; Williamson M., 1996, BIOL INVASIONS; Wilson JRU, 2007, DIVERS DISTRIB, V13, P11, DOI 10.1111/j.1366-9516.2006.00302.x	47	19	19	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17391	10.1371/journal.pone.0017391	http://dx.doi.org/10.1371/journal.pone.0017391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407804	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300020
J	Teixeira, TF; Dezen, D; Cibulski, SP; Varela, APM; Holz, CL; Franco, AC; Roehe, PM				Teixeira, Thais Fumaco; Dezen, Diogenes; Cibulski, Samuel Paulo; Muterle Varela, Ana Paula; Holz, Carine Lidiane; Franco, Ana Claudia; Roehe, Paulo Michel			Torque Teno Sus Virus (TTSuV) in Cell Cultures and Trypsin	PLOS ONE			English	Article							MULTISYSTEMIC WASTING SYNDROME; SPECIES-SPECIFIC TTVS; NONHUMAN-PRIMATES; HIGHLY PREVALENT; GNOTOBIOTIC PIGS; DNA VIRUS; SWINE; GENOMES; HUMANS; IDENTIFICATION	Torque teno sus virus (TTSuV), a member of the family Anelloviridae, is a single-stranded, circular DNA virus, widely distributed in swine populations. Presently, two TTSuV genogroups are recognized: Torque teno sus virus 1 (TTSuV1) and Torque teno sus virus 2 (TTSuV2). TTSuV genomes have been found in commercial vaccines for swine, enzyme preparations and other drugs containing components of porcine origin. However, no studies have been made looking for TTSuV in cell cultures. In the present study, a search for TTSuV genomes was carried out in cell culture lineages, in sera used as supplement for cell culture media as well as in trypsin used for cell disaggregation. DNA obtained from twenty-five cell lineages (ten from cultures in routine multiplication and fifteen from frozen ampoules), nine samples of sera used in cell culture media and five batches of trypsin were examined for the presence of TTSuV DNA. Fifteen cell lineages, originated from thirteen different species contained amplifiable TTSuV genomes, including an ampoule with a cell lineage frozen in 1985. Three cell lineages of swine origin were co-infected with both TTSuV1 and TTSuV2. One batch of trypsin contained two distinct TTSuV1 plus one TTSuV2 genome, suggesting that this might have been the source of contamination, as supported by phylogenetic analyses of sequenced amplicons. Samples of fetal bovine and calf sera used in cell culture media did not contain amplifiable TTSuV DNA. This is the first report on the presence of TTSuV as contaminants in cell lineages. In addition, detection of the viral genome in an ampoule frozen in 1985 provides evidence that TTSuV contamination is not a recent event. These findings highlight the risks of TTSuV contamination in cell cultures, what may be source for contamination of biological products or compromise results of studies involving in vitro multiplied cells.	[Teixeira, Thais Fumaco; Dezen, Diogenes; Cibulski, Samuel Paulo; Muterle Varela, Ana Paula; Roehe, Paulo Michel] FEPAGRO Anim Hlth Inst Pesquisas Vet Desiderio Fi, Equipe Virol, Eldorado Do Sul, RS, Brazil; [Teixeira, Thais Fumaco; Franco, Ana Claudia; Roehe, Paulo Michel] Univ Fed Rio Grande do Sul, Virol Lab, Dept Microbiol Immunol & Parasitol, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Holz, Carine Lidiane] CIRAD, Dept Syst Biol, UR 15, Montpellier, France	Universidade Federal do Rio Grande do Sul; CIRAD	Teixeira, TF (corresponding author), FEPAGRO Anim Hlth Inst Pesquisas Vet Desiderio Fi, Equipe Virol, Eldorado Do Sul, RS, Brazil.	proehe@gmail.com	Cibulski, Samuel P/G-5190-2017; ROEHE, PAULO MICHEL/K-1208-2012; Dezen, Diogenes/Q-3581-2019; Franco, Ana Cláudia AC/N-4373-2015	ROEHE, PAULO MICHEL/0000-0002-2370-7661; Dezen, Diogenes/0000-0002-0941-9954; Cibulski, Samuel/0000-0003-0503-8692; Franco, Ana/0000-0001-7747-5125	Brazilian National Research Council (CNPq); Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by the Brazilian National Research Council (CNPq), Financiadora de Estudos e Projetos (FINEP) and by Fundacao de Amparo a Pesquisa do Rio Grande do Sul (FAPERGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2005, VIRUS TAXONOMY, P335; Biagini P, 2007, J GEN VIROL, V88, P2696, DOI 10.1099/vir.0.83071-0; Bigarre L, 2005, J GEN VIROL, V86, P631, DOI 10.1099/vir.0.80573-0; Brassard J, 2008, VET MICROBIOL, V126, P271, DOI 10.1016/j.vetmic.2007.07.014; Ellis JA, 2008, AM J VET RES, V69, P1608, DOI 10.2460/ajvr.69.12.1608; Freshney R, 1992, ANIMAL CELL CULTURE; Griffiths P, 1999, REV MED VIROL, V9, P73, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;73::AID-RMV254&gt;3.0.CO;2-5; Kekarainen T, 2007, THERIOGENOLOGY, V68, P966, DOI 10.1016/j.theriogenology.2007.07.010; Kekarainen T, 2006, J GEN VIROL, V87, P833, DOI 10.1099/vir.0.81586-0; Kekarainen T, 2009, J GEN VIROL, V90, P648, DOI 10.1099/vir.0.006841-0; Krakowka S, 2008, AM J VET RES, V69, P1615, DOI 10.2460/ajvr.69.12.1615; Leary TP, 1999, J GEN VIROL, V80, P2115, DOI 10.1099/0022-1317-80-8-2115; Martelli F, 2006, J VET MED B, V53, P234, DOI 10.1111/j.1439-0450.2006.00949.x; Martinez L, 2006, VET MICROBIOL, V118, P223, DOI 10.1016/j.vetmic.2006.07.022; Martinez-Guino L, 2009, THERIOGENOLOGY, V71, P1390, DOI 10.1016/j.theriogenology.2009.01.010; McKeown NE, 2004, VET MICROBIOL, V104, P113, DOI 10.1016/j.vetmic.2004.08.013; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Ninomiya M, 2007, ARCH VIROL, V152, P1961, DOI 10.1007/s00705-007-1046-6; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2000, VIROLOGY, V277, P368, DOI 10.1006/viro.2000.0588; Okamoto H, 2002, J GEN VIROL, V83, P1291, DOI 10.1099/0022-1317-83-6-1291; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 2001, J GEN VIROL, V82, P2041, DOI 10.1099/0022-1317-82-9-2041; Sambrook J, 2001, MOL CLONING LAB MANU; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Segales J, 2009, VET MICROBIOL, V134, P199, DOI 10.1016/j.vetmic.2008.08.002; Takahashi K, 2000, ARCH VIROL, V145, P979, DOI 10.1007/s007050050689; TEIXEIRA T, 2008, THESIS U FEDERAL RIO	28	17	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17501	10.1371/journal.pone.0017501	http://dx.doi.org/10.1371/journal.pone.0017501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21407810	Green Submitted, Green Published, gold			2022-12-27	WOS:000287933300029
J	Chen, Q; Hooper, DU; Lin, S				Chen, Qing; Hooper, David U.; Lin, Shan			Shifts in Species Composition Constrain Restoration of Overgrazed Grassland Using Nitrogen Fertilization in Inner Mongolian Steppe, China	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; TERRESTRIAL ECOSYSTEMS; SEMIARID STEPPE; USE EFFICIENCY; SOIL-WATER; LAND-USE; PRECIPITATION; MANAGEMENT; DEPOSITION; DIVERSITY	Long-term livestock over-grazing causes nitrogen outputs to exceed inputs in Inner Mongolia, suggesting that low levels of nitrogen fertilization could help restore grasslands degraded by overgrazing. However, the effectiveness of such an approach depends on the response of production and species composition to the interactive drivers of nitrogen and water availability. We conducted a five-year experiment manipulating precipitation (NP: natural precipitation and SWP: simulated wet year precipitation) and nitrogen (0, 25 and 50 kg N ha(-1) yr(-1)) addition in Inner Mongolia. We hypothesized that nitrogen fertilization would increase forage production when water availability was relatively high. However, the extent to which nitrogen would co-limit production under average or below average rainfall in these grasslands was unknown. Aboveground net primary production (ANPP) increased in response to nitrogen when precipitation was similar to or higher than the long-term average, but not when precipitation was below average. This shift in limitation was also reflected by water and nitrogen use efficiency. Belowground live biomass significantly increased with increasing water availability, but was not affected by nitrogen addition. Under natural precipitation (NP treatment), the inter-annual variation of ANPP was 3-fold greater than with stable water availability (CVANPP = 61 +/- 6% and 17 +/- 3% for NP and SWP treatment, respectively) and nitrogen addition increased CVANPP even more (89 +/- 14%). This occurred in part because fertilizer nitrogen left in the soil in dry years remained available for uptake during wet years and because of high production by unpalatable annual species in wet years in the NP treatment. In summary, plant growth by residual fertilizer nitrogen could lead to sufficient yields to offset lack of additional production in dry years. However, the utility of fertilization for restoration may be constrained by shifts in species composition and the lack of response by belowground biomass, which reduces replacement of soil carbon and nitrogen.	[Chen, Qing; Lin, Shan] China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China; [Hooper, David U.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA	China Agricultural University; Western Washington University	Chen, Q (corresponding author), China Agr Univ, Dept Plant Nutr, Beijing 100094, Peoples R China.	linshan@cau.edu.cn		Chen, Qing/0000-0002-4589-0161	National Nature Science Foundation of China [NSFC 41071207/30821003]; Deutsche Forschungsgemeinschaft (DFG) [546/3-2]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the National Nature Science Foundation of China (NSFC 41071207/30821003, www.nfsc.gov.cn) and partly by the Deutsche Forschungsgemeinschaft (DFG, project DI 546/3-2, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Tsuyoshi, 2007, Grassland Science, V53, P1, DOI 10.1111/j.1744-697X.2007.00073.x; Austin AT, 2002, ECOLOGY, V83, P328, DOI 10.1890/0012-9658(2002)083[0328:DEOPOP]2.0.CO;2; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2008, ECOLOGY, V89, P2140, DOI 10.1890/07-0992.1; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bationo A, 2001, NUTR CYCL AGROECOSYS, V61, P131, DOI 10.1023/A:1013355822946; Bobbink R, 1998, J ECOL, V86, P717, DOI 10.1046/j.1365-2745.1998.8650717.x; BROUWER R, 1983, NETH J AGR SCI, V31, P335; Camill P, 2004, ECOL APPL, V14, P1680, DOI 10.1890/03-5273; Christensen L, 2004, CLIMATIC CHANGE, V63, P351, DOI 10.1023/B:CLIM.0000018513.60904.fe; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Dutt HR, 1997, J FUTURES MARKETS, V17, P341, DOI 10.1002/(SICI)1096-9934(199705)17:3<341::AID-FUT5>3.0.CO;2-I; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fay PA, 2000, ECOSYSTEMS, V3, P308, DOI 10.1007/s100210000028; Fay PA, 2003, OECOLOGIA, V137, P245, DOI 10.1007/s00442-003-1331-3; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Fenn ME, 2003, BIOSCIENCE, V53, P404, DOI [10.1641/0006-3568(2003)053[0404:EEONDI]2.0.CO;2, 10.1641/0006-3568(2003)053[0391:NEDAMI]2.0.CO;2]; GIBBENS RP, 1988, J RANGE MANAGE, V41, P186, DOI 10.2307/3899165; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Han JG, 2008, RANGELAND J, V30, P233, DOI 10.1071/RJ08009; Harpole WS, 2007, GLOBAL CHANGE BIOL, V13, P2341, DOI 10.1111/j.1365-2486.2007.01447.x; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; Hooper DU, 1999, BIOGEOCHEMISTRY, V46, P247, DOI 10.1007/BF01007582; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; Jobbagy EG, 2002, ECOLOGY, V83, P307, DOI 10.1890/0012-9658(2002)083[0307:PACOPP]2.0.CO;2; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; LAUENROTH WK, 1994, ECOL APPL, V4, P741, DOI 10.2307/1942004; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li SG, 2000, AGR FOREST METEOROL, V102, P125, DOI 10.1016/S0168-1923(00)00101-5; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Ngugi MR, 2003, NEW FOREST, V26, P187, DOI 10.1023/A:1024493917483; Ni J, 2000, J ARID ENVIRON, V46, P313, DOI 10.1006/jare.2000.0667; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Paruelo JM, 1999, ECOSYSTEMS, V2, P64, DOI 10.1007/s100219900058; Schonbach P, 2009, CROP PASTURE SCI, V60, P963, DOI 10.1071/CP09048; Schonbach P, 2011, PLANT SOIL, V340, P103, DOI 10.1007/s11104-010-0366-6; SEAGLE SW, 1993, BIOGEOCHEMISTRY, V22, P157, DOI 10.1007/BF00000645; Sneath D, 1998, SCIENCE, V281, P1147, DOI 10.1126/science.281.5380.1147; Steffens M, 2008, GEODERMA, V143, P63, DOI 10.1016/j.geoderma.2007.09.004; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Su YZ, 2005, CATENA, V59, P267, DOI 10.1016/j.catena.2004.09.001; Swemmer AM, 2007, J ECOL, V95, P780, DOI 10.1111/j.1365-2745.2007.01237.x; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Verburg PH, 1999, AGR SYST, V62, P51, DOI 10.1016/S0308-521X(99)00055-4; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Wang J. W., 1988, Research on Grassland Ecosystem, P23; Wang WY, 2006, ECOL RES, V21, P181, DOI 10.1007/s11284-005-0108-z; Weltzin JF, 2003, BIOSCIENCE, V53, P941, DOI 10.1641/0006-3568(2003)053[0941:ATROTE]2.0.CO;2; Xie YZ, 2004, ACTA OECOL, V25, P197, DOI 10.1016/j.actao.2004.01.004; Xu ZZ, 2005, PHYSIOL PLANTARUM, V123, P272, DOI 10.1111/j.1399-3054.2005.00455.x; Zhou Z, 2006, FUNCT ECOL, V20, P753, DOI 10.1111/j.1365-2435.2006.01175.x	57	40	46	8	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16909	10.1371/journal.pone.0016909	http://dx.doi.org/10.1371/journal.pone.0016909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390304	gold, Green Published, Green Submitted			2022-12-27	WOS:000287932100007
J	Bogaert, D; Keijser, B; Huse, S; Rossen, J; Veenhoven, R; van Gils, E; Bruin, J; Montijn, R; Bonten, M; Sanders, E				Bogaert, Debby; Keijser, Bart; Huse, Susan; Rossen, John; Veenhoven, Reinier; van Gils, Elske; Bruin, Jacob; Montijn, Roy; Bonten, Marc; Sanders, Elisabeth			Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis	PLOS ONE			English	Article							CARRIAGE; COLONIZATION	The nasopharynx is the ecological niche for many commensal bacteria and for potential respiratory or invasive pathogens like Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. Disturbance of a balanced nasopharyngeal (NP) microbiome might be involved in the onset of symptomatic infections with these pathogens, which occurs primarily in fall and winter. It is unknown whether seasonal infection patterns are associated with concomitant changes in NP microbiota. As young children are generally prone to respiratory and invasive infections, we characterized the NP microbiota of 96 healthy children by barcoded pyrosequencing of the V5-V6 hypervariable region of the 16S-rRNA gene, and compared microbiota composition between children sampled in winter/fall with children sampled in spring. The approximately 1000000 sequences generated represented 13 taxonomic phyla and approximately 250 species-level phyla types (OTUs). The 5 most predominant phyla were Proteobacteria (64%), Firmicutes (21%), Bacteroidetes (11%), Actinobacteria (3%) and Fusobacteria (1,4%) with Moraxella, Haemophilus, Streptococcus, Flavobacteria, Dolosigranulum, Corynebacterium and Neisseria as predominant genera. The inter-individual variability was that high that on OTU level a core microbiome could not be defined. Microbiota profiles varied strongly with season, with in fall/winter a predominance of Proteobacteria (relative abundance (% of all sequences): 75% versus 51% in spring) and Fusobacteria (absolute abundance (% of children): 14% versus 2% in spring), and in spring a predominance of Bacteroidetes (relative abundance: 19% versus 3% in fall/winter, absolute abundance: 91% versus 54% in fall/winter), and Firmicutes. The latter increase is mainly due to (Brevi) bacillus and Lactobacillus species (absolute abundance: 96% versus 10% in fall/winter) which are like Bacteroidetes species generally related to healthy ecosystems. The observed seasonal effects could not be attributed to recent antibiotics or viral co-infection. The NP microbiota of young children is highly diverse and appears different between seasons. These differences seem independent of antibiotic use or viral co-infection.	[Bogaert, Debby; van Gils, Elske; Sanders, Elisabeth] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Paediat Infect Dis & Immunol, Utrecht, Netherlands; [Keijser, Bart; Montijn, Roy] TNO Qual Life, Microbial Genom Grp, Business Unit Food & Biotechnol Innovat, Zeist, Netherlands; [Huse, Susan] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA; [Rossen, John] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Veenhoven, Reinier] Spaarne Hosp, Linnaeus Inst, Hoofddorp, Netherlands; [Bruin, Jacob] Reg Publ Hlth Lab, Haarlem, Netherlands; [Bonten, Marc] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Bonten, Marc] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Netherlands Organization Applied Science Research; Marine Biological Laboratory - Woods Hole; Elisabeth-TweeSteden Ziekenhuis (ETZ); Spaarne Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Bogaert, D (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Paediat Infect Dis & Immunol, Utrecht, Netherlands.	d.bogaert@umcutrecht.nl	Keijser, Bart J f/C-5402-2012; Rossen, John W/G-7564-2011	Rossen, John W/0000-0002-7167-8623; Bogaert, Debby/0000-0003-2651-7000	Netherlands Organisation for Scientific Research [91610121, 91876611]; GlaxoSmith Kline; Wyeth; Baxter	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); GlaxoSmith Kline(GlaxoSmithKline); Wyeth(Wyeth); Baxter	This work was supported by grants from The Netherlands Organisation for Scientific Research through NWO-VENI grant 91610121 (D. B.) and NWO-VICI grant 91876611 (M.J.M.B.). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors B. K. and R. M. are employed by TNO Quality of Life and had a role in data collection and analysis.; Dr. Veenhoven reports receiving grant support from GlaxoSmith Kline and Wyeth for vaccine studies and consulting fees for GlaxoSmithKline. Dr. Sanders reports receiving unrestricted grants from Wyeth and Baxter for research, consulting fees for Wyeth and GlaxoSmithKline, lecturing fees from Wyeth and grant support from Wyeth and GlaxoSmithKline for vaccine studies. These grants were not received for the research described in this paper. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Authors employed by TNO (B. K., R. M.) have a potential conflict of interest as their organizations may benefit from a product or patent generated on the basis of the published data. In these cases, the authors will however not receive additional salary, additional personal income, or any form of financial support. In a dition, it does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. For all other authors no potential conflicts reported.	[Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Brook I, 2005, ARCH OTOLARYNGOL, V131, P509, DOI 10.1001/archotol.131.6.509; Brook I, 1999, CRIT REV MICROBIOL, V25, P155, DOI 10.1080/10408419991299211; Brook I, 2010, INT J PEDIATR OTORHI, V74, P447, DOI 10.1016/j.ijporl.2010.01.006; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Kinlin LM, 2009, AM J EPIDEMIOL, V169, P588, DOI 10.1093/aje/kwn383; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Oztuna F, 2006, RESPIRATION, V73, P546, DOI 10.1159/000090160; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Senok AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006289.pub2; Sevillano D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002717; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Trotter CL, 2007, LANCET INFECT DIS, V7, P797, DOI 10.1016/S1473-3099(07)70288-8; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Pol AC, 2009, EMERG INFECT DIS, V15, P454, DOI 10.3201/eid1503.081203; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; White ANJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-196	29	281	292	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17035	10.1371/journal.pone.0017035	http://dx.doi.org/10.1371/journal.pone.0017035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386965	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400025
J	Komiya, T; Fujita, S; Watanabe, K				Komiya, Takefumi; Fujita, Sari; Watanabe, Katsutoshi			A Novel Resource Polymorphism in Fish, Driven by Differential Bottom Environments: An Example from an Ancient Lake in Japan	PLOS ONE			English	Article							GASTEROSTEUS-ACULEATUS L; FRESH-WATER FISHES; ECOLOGICAL SPECIATION; COTTID FISHES; MORPHOLOGY; POPULATION; BLUEGILL; HABITAT; SARCOCHEILICHTHYS; DIVERSIFICATION	Divergent natural selection rooted in differential resource use can generate and maintain intraspecific eco-morphological divergence (i. e., resource polymorphism), ultimately leading to population splitting and speciation. Differing bottom environments create lake habitats with different benthos communities, which may cause selection in benthivorous fishes. Here, we document the nature of eco-morphological and genetic divergence among local populations of the Japanese gudgeon Sarcocheilichthys (Cyprinidae), which inhabits contrasting habitats in the littoral zones (rocky vs. pebbly habitats) in Lake Biwa, a representative ancient lake in East Asia. Eco-morphological analyses revealed that Sarcocheilichthys variegatus microoculus from rocky and pebbly zones differed in morphology and diet, and that populations from rocky environments had longer heads and deeper bodies, which are expected to be advantageous for capturing cryptic and/or attached prey in structurally complex, rocky habitats. Sarcocheilichthys biwaensis, a rock-dwelling specialist, exhibited similar morphologies to the sympatric congener, S. v. microoculus, except for body/fin coloration. Genetic analyses based on mitochondrial and nuclear microsatellite DNA data revealed no clear genetic differentiation among local populations within/between the gudgeon species. Although the morphogenetic factors that contribute to morphological divergence remain unclear, our results suggest that the gudgeon populations in Lake Biwa show a state of resource polymorphism associated with differences in the bottom environment. This is a novel example of resource polymorphism in fish within an Asian ancient lake, emphasizing the importance and generality of feeding adaptation as an evolutionary mechanism that generates morphological diversification.	[Komiya, Takefumi; Fujita, Sari; Watanabe, Katsutoshi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Kyoto University	Komiya, T (corresponding author), Kyoto Univ, Grad Sch Sci, Kyoto, Japan.	komiya@terra.zool.kyoto-u.ac.jp	Watanabe, Katsutoshi/H-3414-2011		Ministry of Education, Culture, Sports, Science, and Technology, Japan [18570086, 21370035]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (nos. 18570086, 21370035, Biodiversity Research of the 21st Century COE: A14 http://ethol.zool.kyoto-u.ac.jp/coe/eng/coe.htm, and "Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem" of the GCOE http://gcoe.biol.sci.kyoto-u.ac.jp/gcoe/) and by the Foundation of Ito Grant for Ichthyology, Fujiwara Natural History Foundation http://fujiwara-nh.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aoyama J, 2000, ICHTHYOL RES, V47, P157, DOI 10.1007/BF02684236; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; EHLINGER TJ, 1990, ECOLOGY, V71, P886, DOI 10.2307/1937360; EHLINGER TJ, 1988, P NATL ACAD SCI USA, V85, P1878, DOI 10.1073/pnas.85.6.1878; EHLINGER TJ, 1989, ANIM BEHAV, V38, P643, DOI 10.1016/S0003-3472(89)80010-7; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fujita S, 2008, MOL ECOL RESOUR, V8, P1335, DOI 10.1111/j.1755-0998.2008.02303.x; Horne A.J., 1994, LIMNOLOGY; HOSOYA K, 1982, JPN J ICHTHYOL, V29, P127; HOSOYA K, 1994, GLOSSY ATLAS FISH AN, P78; Hosoya K, 2001, FRESHWATER FISHES JA, P310; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Kawabe T., 1989, J GEOSCI-OSAKA CITY, V32, P39; Kawanabe H, 1996, ENVIRON BIOL FISH, V47, P219, DOI 10.1007/BF00000495; Klemetsen Anders, 1997, Nordic Journal of Freshwater Research, V73, P13; KORNFIELD I, 1982, EVOLUTION, V36, P658, DOI 10.1111/j.1558-5646.1982.tb05433.x; Kristjansson BK, 2002, EVOL ECOL RES, V4, P659; Kristjansson BK, 2002, BIOL J LINN SOC, V76, P247, DOI 10.1046/j.1095-8312.2002.00063.x; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Langerhans RB, 2004, EVOLUTION, V58, P2305, DOI 10.1111/j.0014-3820.2004.tb01605.x; MARCUS LF, 1996, ADV MORPHOMETRICS; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MEYERS PA, 1993, QUATERNARY RES, V39, P154, DOI 10.1006/qres.1993.1019; Nakamura M., 1969, CYPRINID FISHES JAPA; Nemeth DH, 1997, J EXP BIOL, V200, P2155; NISHINO M, 1991, LANDSCAPE ECOLOGICAL, P47; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P61, DOI 10.1007/BF00005907; NORTON SF, 1991, ECOLOGY, V72, P1807, DOI 10.2307/1940980; Nosil P, 2006, P NATL ACAD SCI USA, V103, P9090, DOI 10.1073/pnas.0601575103; OKSANEN J, 2008, VEGAN COMMUNITY ECOL, V1, P17; Palumbi S, 1991, SIMPLE FOOLS GUIDE P; Pritchard JK, 2000, GENETICS, V155, P945; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rohlf F. J., 2008, TPSDIG2 PROGRAM LAND; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; ROHLF FJ, 2006, TPSPLS PROGRAM LANDM; ROHLF FJ, 2009, TPSREGR PROGRAM LAND; Ruzzante DE, 2003, BIOL J LINN SOC, V78, P497, DOI 10.1046/j.0024-4066.2002.00159.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Skulason S, 1999, EVOLUTION OF BIOLOGICAL DIVERSITY, P70; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; TAKAHASHI S, 1988, Journal of Paleolimnology, V1, P279; Tomoda Y, 1991, NATURAL HIST SHIGA P, P1399; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Via S, 2008, MOL ECOL, V17, P4334, DOI 10.1111/j.1365-294X.2008.03921.x; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Watanabe K, 2010, ICHTHYOL RES, V57, P107, DOI 10.1007/s10228-009-0129-7; WEBB PW, 1984, AM ZOOL, V24, P107; WEBB PW, 1986, T AM FISH SOC, V115, P115, DOI 10.1577/1548-8659(1986)115<115:FLMOEL>2.0.CO;2; Wu CI, 2001, J EVOLUTION BIOL, V14, P851, DOI 10.1046/j.1420-9101.2001.00335.x; YOKOYAMA T, 1992, MOVING HIST LAKE BIW; YOKOYAMA T, 1984, MONOGRAPHIAE BIOL, V54, P43; Yuma M, 1998, ENVIRON BIOL FISH, V52, P97, DOI 10.1023/A:1007451417556	63	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17430	10.1371/journal.pone.0017430	http://dx.doi.org/10.1371/journal.pone.0017430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387005	gold, Green Submitted, Green Published			2022-12-27	WOS:000287931400075
J	Sahar, T; Reddy, KS; Bharadwaj, M; Pandey, AK; Singh, S; Chitnis, CE; Gaur, D				Sahar, Tajali; Reddy, K. Sony; Bharadwaj, Mitasha; Pandey, Alok K.; Singh, Shailja; Chitnis, Chetan E.; Gaur, Deepak			Plasmodium falciparum Reticulocyte Binding-Like Homologue Protein 2 (PfRH2) Is a Key Adhesive Molecule Involved in Erythrocyte Invasion	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; RECEPTOR SPECIFICITY; MEROZOITE PROTEINS; MALARIA PARASITES; CELL INVASION; VIVAX; EXPRESSION; IDENTIFICATION; POLYMORPHISM; ANTIBODIES	Erythrocyte invasion by Plasmodium merozoites is a complex, multistep process that is mediated by a number of parasite ligand-erythrocyte receptor interactions. One such family of parasite ligands includes the P. falciparum reticulocyte binding homologue (PfRH) proteins that are homologous with the P. vivax reticulocyte binding proteins and have been shown to play a role in erythrocyte invasion. There are five functional PfRH proteins of which only PfRH2a/2b have not yet been demonstrated to bind erythrocytes. In this study, we demonstrated that native PfRH2a/2b is processed near the N-terminus yielding fragments of 220 kDa and 80 kDa that exhibit differential erythrocyte binding specificities. The erythrocyte binding specificity of the 220 kDa processed fragment of native PfRH2a/2b was sialic acid-independent, trypsin resistant and chymotrypsin sensitive. This specific binding phenotype is consistent with previous studies that disrupted the PfRH2a/2b genes and demonstrated that PfRH2b is involved in a sialic acid independent, trypsin resistant, chymotrypsin sensitive invasion pathway. Interestingly, we found that the smaller 80 kDa PfRH2a/2b fragment is processed from the larger 220 kDa fragment and binds erythrocytes in a sialic acid dependent, trypsin resistant and chymotrypsin sensitive manner. Thus, the two processed fragments of PfRH2a/2b differed with respect to their dependence on sialic acids for erythrocyte binding. Further, we mapped the erythrocyte binding domain of PfRH2a/2b to a conserved 40 kDa N-terminal region (rPfRH2(40)) in the ectodomain that is common to both PfRH2a and PfRH2b. We demonstrated that recombinant rPfRH2(40) bound human erythrocytes with the same specificity as the native 220 kDa processed protein. Moreover, antibodies generated against rPfRH2(40) blocked erythrocyte invasion by P. falciparum through a sialic acid independent pathway. PfRH2a/2b thus plays a key role in erythrocyte invasion and its conserved receptor-binding domain deserves attention as a promising candidate for inclusion in a blood-stage malaria vaccine.	[Sahar, Tajali; Reddy, K. Sony; Bharadwaj, Mitasha; Pandey, Alok K.; Singh, Shailja; Chitnis, Chetan E.; Gaur, Deepak] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sahar, T (corresponding author), Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India.	dgaur@icgeb.res.in	Pandey, Alok Kumar/ABD-9897-2021; Sahar, Tajali/AAI-5707-2020; Reddy, K Sony/AAR-6285-2020; Gaur, Deepak/AAF-4379-2019	Reddy, K. Sony/0000-0002-8437-5250; Chitnis, Chetan/0000-0002-8773-9865	Department of Biotechnology, Government of India; Bill and Melinda Gates Foundation; European Commission	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre)	Deepak Gaur, Chetan Chitnis, and Shailja Singh are recipients of the Ramalingaswami Fellowship, TATA Innovation Fellowship, and Innovative Young Biotechnologist Award, respectively, from the Department of Biotechnology, Government of India. The work has been funded by grants from the Department of Biotechnology, Government of India through the Rapid Grant Scheme for Young Investigators (Deepak Gaur) and Indo-Australia Biotechnology Fund (Chetan Chitnis). Deepak Gaur is also the recipient of the Grand Challenges Exploration grant from the Bill and Melinda Gates Foundation. Work in the laboratory of Chetan Chitnis was supported by MalSig and EVIMalaR grants from the European Commission (FP7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Blackman MJ, 2004, CELL MICROBIOL, V6, P893, DOI 10.1111/j.1462-5822.2004.00437.x; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; CAMUS D, 1985, SCIENCE, V230, P553, DOI 10.1126/science.3901257; Chandra BR, 2005, MOL BIOCHEM PARASIT, V142, P237, DOI 10.1016/j.molbiopara.2005.04.006; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; DeSimone TM, 2009, MOL MICROBIOL, V72, P578, DOI 10.1111/j.1365-2958.2009.06667.x; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Dvorin JD, 2010, MOL MICROBIOL, V75, P990, DOI 10.1111/j.1365-2958.2009.07040.x; GALINSKI MR, 1992, CELL, V69, P1213, DOI 10.1016/0092-8674(92)90642-P; Gao XH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000104; Gaur D, 2006, MOL BIOCHEM PARASIT, V145, P205, DOI 10.1016/j.molbiopara.2005.10.004; Gaur D, 2004, INT J PARASITOL, V34, P1413, DOI 10.1016/j.ijpara.2004.10.010; Gaur D, 2007, P NATL ACAD SCI USA, V104, P17789, DOI 10.1073/pnas.0708772104; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Howell SA, 2001, J BIOL CHEM, V276, P31311, DOI 10.1074/jbc.M103076200; Iyer J, 2007, MOL MICROBIOL, V65, P231, DOI 10.1111/j.1365-2958.2007.05791.x; KAIN KC, 1993, J EXP MED, V178, P1497, DOI 10.1084/jem.178.5.1497; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Liang H, 2000, INFECT IMMUN, V68, P3564, DOI 10.1128/IAI.68.6.3564-3568.2000; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Mayer DCG, 2004, P NATL ACAD SCI USA, V101, P2518, DOI 10.1073/pnas.0307318101; Mayer DCG, 2002, J EXP MED, V196, P1523, DOI 10.1084/jem.20020750; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Reiling L, 2010, J IMMUNOL, V185, P6157, DOI 10.4049/jimmunol.1001555; SIM BKL, 1994, SCIENCE, V264, P1941, DOI 10.1126/science.8009226; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stubbs J, 2005, SCIENCE, V309, P1384, DOI 10.1126/science.1115257; Taylor HM, 2002, INFECT IMMUN, V70, P5779, DOI 10.1128/IAI.70.10.5779-5789.2002; Taylor HM, 2001, INFECT IMMUN, V69, P3635, DOI 10.1128/IAI.69.6.3635-3645.2001; Tham WH, 2009, INFECT IMMUN, V77, P2427, DOI 10.1128/IAI.00048-09; Triglia T, 2005, MOL MICROBIOL, V55, P162, DOI 10.1111/j.1365-2958.2004.04388.x; Triglia T, 2001, MOL BIOCHEM PARASIT, V116, P55, DOI 10.1016/S0166-6851(01)00303-6; Triglia T, 2001, INFECT IMMUN, V69, P1084, DOI 10.1128/IAI.69.2.1084-1092.2001; Triglia T, 2009, CELL MICROBIOL, V11, P1671, DOI 10.1111/j.1462-5822.2009.01358.x	40	52	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17102	10.1371/journal.pone.0017102	http://dx.doi.org/10.1371/journal.pone.0017102			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386888	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400028
J	Sartori, SB; Hauschild, M; Bunck, M; Gaburro, S; Landgraf, R; Singewald, N				Sartori, Simone B.; Hauschild, Markus; Bunck, Mirjam; Gaburro, Stefano; Landgraf, Rainer; Singewald, Nicolas			Enhanced Fear Expression in a Psychopathological Mouse Model of Trait Anxiety: Pharmacological Interventions	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; GLUCOCORTICOID-INDUCED IMPAIRMENT; NATIONAL COMORBIDITY SURVEY; C-FOS EXPRESSION; CONDITIONED FEAR; MEMORY RETRIEVAL; POTENTIATED STARTLE; CONTEXTUAL FEAR; INDIVIDUAL-DIFFERENCES; CIRCADIAN MODULATION	The propensity to develop an anxiety disorder is thought to be determined by genetic and environmental factors. Here we investigated the relationship between a genetic predisposition to trait anxiety and experience-based learned fear in a psychopathological mouse model. Male CD-1 mice selectively bred for either high (HAB), or normal (NAB) anxiety-related behaviour on the elevated plus maze were subjected to classical fear conditioning. During conditioning both mouse lines showed increased fear responses as assessed by freezing behaviour. However, 24 h later, HAB mice displayed more pronounced conditioned responses to both a contextual or cued stimulus when compared with NAB mice. Interestingly, 6 h and already 1 h after fear conditioning, freezing levels were high in HAB mice but not in NAB mice. These results suggest that trait anxiety determines stronger fear memory and/or a weaker ability to inhibit fear responses in the HAB line. The enhanced fear response of HAB mice was attenuated by treatment with either the alpha(2,3,5)-subunit selective benzodiazepine partial agonist L-838,417, corticosterone or the selective neurokinin-1 receptor antagonist L-822,429. Overall, the HAB mouse line may represent an interesting model (i) for identifying biological factors underlying misguided conditioned fear responses and (ii) for studying novel anxiolytic pharmacotherapies for patients with fear-associated disorders, including post-traumatic stress disorder and phobias.	[Sartori, Simone B.; Hauschild, Markus; Gaburro, Stefano; Singewald, Nicolas] Univ Innsbruck, Dept Pharmacol & Toxicol, CMBI, A-6020 Innsbruck, Austria; [Sartori, Simone B.; Hauschild, Markus; Gaburro, Stefano; Singewald, Nicolas] Univ Innsbruck, Inst Pharm, A-6020 Innsbruck, Austria; [Bunck, Mirjam; Landgraf, Rainer] Max Planck Inst Psychiat, Dept Behav Neuroendocrinol, D-80804 Munich, Germany	University of Innsbruck; University of Innsbruck; Max Planck Society	Sartori, SB (corresponding author), Univ Innsbruck, Dept Pharmacol & Toxicol, CMBI, A-6020 Innsbruck, Austria.	simone.sartori@uibk.ac.at	Gaburro, Stefano/AAN-3752-2020	Singewald, Nicolas/0000-0002-0166-3370; , Markus/0000-0003-3539-7661; Sartori, Simone B./0000-0002-2396-1838; Gaburro, Stefano/0000-0001-9297-3472	Austrian Science Fund (FWF) [NFN-S102]; University of Innsbruck	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); University of Innsbruck	This work was supported by the Austrian Science Fund (FWF): NFN-S102 to NS and a Young Investigator Funding by the University of Innsbruck to SBS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B, 2002, BEHAV BRAIN RES, V133, P351, DOI 10.1016/S0166-4328(02)00020-7; Aerni A, 2004, AM J PSYCHIAT, V161, P1488, DOI 10.1176/appi.ajp.161.8.1488; ASMUNDSON GJG, 1995, BEHAV RES THER, V33, P771, DOI 10.1016/0005-7967(95)00012-M; Atack JR, 2003, CNS NEUROL DISORD-DR, V2, P213, DOI 10.2174/1568007033482841; BARNES CA, 1977, SCIENCE, V197, P91, DOI 10.1126/science.194313; Barrett J, 2009, PSYCHOL MED, V39, P255, DOI 10.1017/S0033291708003516; Bentz D, 2010, J ANXIETY DISORD, V24, P223, DOI 10.1016/j.janxdis.2009.10.011; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Borta A, 2006, BEHAV BRAIN RES, V166, P271, DOI 10.1016/j.bbr.2005.08.009; Brigman JL, 2009, BEHAV PHARMACOL, V20, P204, DOI 10.1097/FBP.0b013e32830c368c; Bunck M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005129; Burns JW, 2006, EMOTION, V6, P180, DOI 10.1037/1528-3542.6.2.180; Bush DEA, 2007, J TRAUMA STRESS, V20, P413, DOI 10.1002/jts.20261; Busquet P, 2008, LEARN MEMORY, V15, P378, DOI 10.1101/lm.886208; Chambers JA, 2004, J ANXIETY DISORD, V18, P587, DOI 10.1016/j.janxdis.2003.09.001; Chaudhury D, 2005, J BIOL RHYTHM, V20, P225, DOI 10.1177/0748730405276352; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Czeh B, 2006, EXPERT OPIN INV DRUG, V15, P479, DOI 10.1517/13543784.15.5.479; DAVIS A, 2000, AMYGDALA FUNCTIONAL, P213; DAVIS M, 1979, PSYCHOPHARMACOLOGY, V62, P1, DOI 10.1007/BF00426027; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Defrin R, 2008, PAIN, V138, P450, DOI 10.1016/j.pain.2008.05.006; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Ebner K, 2006, AMINO ACIDS, V31, P251, DOI 10.1007/s00726-006-0335-9; Ebner K, 2009, CURR PHARM DESIGN, V15, P1647, DOI 10.2174/138161209788168074; EVANS WO, 1961, PSYCHOPHARMACOLOGIA, V2, P318, DOI 10.1007/BF00404119; Falconer D. S., 1996, INTRO QUANTITATIVE G; FANSELOW MS, 1980, PAVLOVIAN J BIOL SCI, V15, P177; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fernandez RI, 2003, P NATL ACAD SCI USA, V100, P14415, DOI 10.1073/pnas.2336172100; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; Heim C, 2009, CNS SPECTRUMS, V14, P13; Jovanovic T, 2010, AM J PSYCHIAT, V167, P648, DOI 10.1176/appi.ajp.2009.09071074; Kart-Teke E, 2007, NEUROBIOL LEARN MEM, V87, P324, DOI 10.1016/j.nlm.2006.09.007; Keogh E, 2001, EUR J PAIN, V5, P11, DOI 10.1053/eujp.2000.0210; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kraus A, 2009, PAIN, V143, P179, DOI 10.1016/j.pain.2008.12.018; Kromer SA, 2005, J NEUROSCI, V25, P4375, DOI 10.1523/JNEUROSCI.0115-05.2005; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lehner M, 2010, ACTA NEUROBIOL EXP, V70, P56; Lissek S, 2005, BEHAV RES THER, V43, P1391, DOI 10.1016/j.brat.2004.10.007; Lopez-Aumatell R, 2009, BEHAV BRAIN RES, V202, P92, DOI 10.1016/j.bbr.2009.03.024; Lopez-Aumatell R, 2009, PSICOTHEMA, V21, P27; Maren S, 2008, EUR J NEUROSCI, V28, P1661, DOI 10.1111/j.1460-9568.2008.06485.x; Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Mikics E, 2006, BEHAV PHARMACOL, V17, P223; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Muigg P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005346; Muigg P, 2008, EUR J NEUROSCI, V28, P2299, DOI 10.1111/j.1460-9568.2008.06511.x; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pape HC, 2003, ANN NY ACAD SCI, V985, P92; Pavlov I.P., 1927, CONDITIONED REFLEXES; PITMAN RK, 1990, ARCH GEN PSYCHIAT, V47, P541; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Risbrough VB, 2003, NEUROPSYCHOPHARMACOL, V28, P654, DOI 10.1038/sj.npp.1300079; Roeska K, 2009, NEUROSCI LETT, V464, P160, DOI 10.1016/j.neulet.2009.08.031; Roozendaal B, 2004, NEUROBIOL LEARN MEM, V81, P150, DOI 10.1016/j.nlm.2003.10.001; Roozendaal B, 2004, J NEUROSCI, V24, P8161, DOI 10.1523/JNEUROSCI.2574-04.2004; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Santos JM, 2005, EUR NEUROPSYCHOPHARM, V15, P239, DOI 10.1016/j.euroneuro.2004.10.004; Singewald N, 2008, J NEUROCHEM, V106, P2476, DOI 10.1111/j.1471-4159.2008.05596.x; Skorzewska A, 2007, HORM BEHAV, V52, P317, DOI 10.1016/j.yhbeh.2007.05.007; Skorzewska A, 2006, PHARMACOL BIOCHEM BE, V85, P522, DOI 10.1016/j.pbb.2006.10.001; Soravia LM, 2006, P NATL ACAD SCI USA, V103, P5585, DOI 10.1073/pnas.0509184103; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Thompson BL, 2004, BEHAV BRAIN RES, V149, P209, DOI 10.1016/S0166-4328(03)00216-X; Valentinuzzi VS, 1998, LEARN MEMORY, V5, P391; Watson JB, 1920, J EXP PSYCHOL, V3, P1, DOI 10.1037/h0069608; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Wolf OT, 2004, ANN NY ACAD SCI, V1032, P195, DOI 10.1196/annals.1314.019; Xu K, 2006, NEUROINFORMATICS, V4, P51, DOI 10.1385/NI:4:1:51; Yehuda R, 2004, PSYCHIATRY, V67, P391, DOI 10.1521/psyc.67.4.391.56572	82	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16849	10.1371/journal.pone.0016849	http://dx.doi.org/10.1371/journal.pone.0016849			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386891	Green Published, gold			2022-12-27	WOS:000287931400013
J	Thomas, DJ; Husmann, RJ; Villamar, M; Winship, TR; Buck, RH; Zuckermann, FA				Thomas, Debra J.; Husmann, Robert J.; Villamar, Mauricio; Winship, Timothy R.; Buck, Rachael H.; Zuckermann, Federico A.			Lactobacillus rhamnosus HN001 Attenuates Allergy Development in a Pig Model	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; INTERFERON-GAMMA RESPONSES; ATOPIC-DERMATITIS; PRIMARY PREVENTION; YOUNG-CHILDREN; DOUBLE-BLIND; IN-VIVO; PROBIOTICS; ASTHMA	Background: Probiotics have been studied as immunomodulatory agents of allergy. Several human probiotic trials tracking the development of eczema and other forms of allergy have yielded inconsistent results. A recent infant study demonstrated that pre and postnatal Lactobacillus rhamnosus HN001 (HN001) supplementation decreased the prevalence of eczema and IgE associated eczema. However, the influence of HN001 on the incidence of wheeze, asthma, and/or other allergic manifestations has yet to be reported. Objective: This study was conducted to determine the effects of the probiotic HN001 on the development of allergic lung disease in a pig model. Methods: Allergy was induced by a series of subcutaneous and intratracheal sensitizations with Ascaris suum allergen (ASA) during a six week time frame in post-weanling pigs supplemented daily with HN001, or without supplementation. One week following final sensitization intradermal skin tests and respiratory challenges were conducted. Results: In response to intradermal and respiratory challenges, ASA-sensitized pigs fed HN001 had less severe skin flare reactions, smaller increases in pleural pressure, and trends towards lower changes in arterial oxygen and carbon dioxide partial pressure levels compared to control pigs. The frequency of ASA-specific IFN-gamma-secreting peripheral blood mononuclear cells, as well as the amount of IL-10 produced by ASA-specific cells, was of greater magnitude in probiotic-fed pigs compared to control animals. These observations suggest that differences in clinical responses to the allergen challenges may be related to probiotic-induced modulation of Th1 (IFN-gamma) and regulatory (IL-10) cytokine expression. Conclusions: Probiotic supplementation decreased the severity of allergic skin and lung responses in allergen-sensitized pigs with a corresponding increase in IFN-gamma expression. A similar correlation between certain allergic responses and increased IFN-gamma expression has been reported in human clinical studies of allergy; this pig model of allergy may be indicative of potential probiotic modulation of allergic lung disease in humans.	[Thomas, Debra J.; Winship, Timothy R.; Buck, Rachael H.] Abbott Nutr, Columbus, OH USA; [Husmann, Robert J.; Villamar, Mauricio; Zuckermann, Federico A.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Thomas, DJ (corresponding author), Abbott Nutr, Columbus, OH USA.	debra.thomas@abbott.com	Zuckermann, Federico/GRS-5597-2022	Zuckermann, Federico/0000-0002-8408-5659	Abbott Nutrition	Abbott Nutrition(Abbott Laboratories)	The authors were funded by Abbott Nutrition. D. Thomas, T. Winship, and R. Buck are employees of Abbott Nutrition and had a role in study design, data analysis, preparation of the manuscript, and decision to publish the manuscript.	ALLEN JE, 2009, PULM PHARMACOL THER, V22, P155; Borrego LM, 2009, CLIN EXP ALLERGY, V39, P1160, DOI 10.1111/j.1365-2222.2009.03253.x; Brouwer ML, 2006, CLIN EXP ALLERGY, V36, P899, DOI 10.1111/j.1365-2222.2006.02513.x; Dawson HD, 2005, INFECT IMMUN, V73, P1116, DOI 10.1128/IAI.73.2.1116-1128.2005; de Antonio EM, 1998, VET IMMUNOL IMMUNOP, V61, P265, DOI 10.1016/S0165-2427(97)00141-4; Dunstan JA, 2005, CLIN EXP ALLERGY, V35, P1309, DOI 10.1111/j.1365-2222.2005.02348.x; Feleszko W, 2007, CLIN EXP ALLERGY, V37, P498, DOI 10.1111/j.1365-2222.2006.02629.x; FORNHEM C, 1995, EUR RESPIR J, V8, P928; Forsythe P, 2007, AM J RESP CRIT CARE, V175, P561, DOI 10.1164/rccm.200606-821OC; FRY DL, 1952, J LAB CLIN MED, V40, P664; Guerra S, 2004, AM J RESP CRIT CARE, V169, P70, DOI 10.1164/rccm.200304-499OC; Hisbergues M, 2007, CLIN EXP ALLERGY, V37, P1286, DOI 10.1111/j.1365-2222.2007.02792.x; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC; Kay AB, 2005, TRENDS MOL MED, V11, P148, DOI 10.1016/j.molmed.2005.02.002; Kopp MV, 2008, CLIN EXP ALLERGY, V38, P602, DOI 10.1111/j.1365-2222.2007.02911.x; Kopp MV, 2008, PEDIATRICS, V121, pE850, DOI 10.1542/peds.2007-1492; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Meier WA, 2003, VIROLOGY, V309, P18, DOI 10.1016/S0042-6822(03)00009-6; Mitchell HW, 1999, J APPL PHYSIOL, V86, P932, DOI 10.1152/jappl.1999.86.3.932; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Pohjavuori E, 2004, J ALLERGY CLIN IMMUN, V114, P131, DOI 10.1016/j.jaci.2004.03.036; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Prescott SL, 2008, CLIN EXP ALLERGY, V38, P1606, DOI 10.1111/j.1365-2222.2008.03061.x; Prescott SL, 2005, CLIN EXP ALLERGY, V35, P1557, DOI 10.1111/j.1365-2222.2005.02376.x; Stern DA, 2007, J ALLERGY CLIN IMMUN, V120, P835, DOI 10.1016/j.jaci.2007.05.050; Taylor AL, 2007, J ALLERGY CLIN IMMUN, V119, P184, DOI 10.1016/j.jaci.2006.08.036; West CE, 2009, PEDIATR ALLERGY IMMU, V20, P430, DOI 10.1111/j.1399-3038.2009.00745.x; Weston S, 2005, ARCH DIS CHILD, V90, P892, DOI 10.1136/adc.2004.060673; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011	32	36	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16577	10.1371/journal.pone.0016577	http://dx.doi.org/10.1371/journal.pone.0016577			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386995	Green Submitted, gold, Green Published			2022-12-27	WOS:000287931400008
J	Liljander, A; Bejon, P; Mwacharo, J; Kai, O; Ogada, E; Peshu, N; Marsh, K; Farnert, A				Liljander, Anne; Bejon, Philip; Mwacharo, Jedidah; Kai, Oscar; Ogada, Edna; Peshu, Norbert; Marsh, Kevin; Faernert, Anna			Clearance of Asymptomatic P. falciparum Infections Interacts with the Number of Clones to Predict the Risk of Subsequent Malaria in Kenyan Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CLINICAL MALARIA; REDUCED RISK; TRANSMISSION; COMPLEXITY; IMMUNITY; AGE; RESPONSES; EPIDEMIOLOGY; POPULATION	Background: Protective immunity to malaria is acquired after repeated infections in endemic areas. Asymptomatic multiclonal P. falciparum infections are common and may predict host protection. Here, we have investigated the effect of clearing asymptomatic infections on the risk of clinical malaria. Methods: Malaria episodes were continuously monitored in 405 children (1-6 years) in an area of moderate transmission, coastal Kenya. Blood samples collected on four occasions were assessed by genotyping the polymorphic P. falciparum merozoite surface protein 2 using fluorescent PCR and capillary electrophoresis. Following the second survey, asymptomatic infections were cleared with a full course of dihydroartemisinin. Results: Children who were parasite negative by PCR had a lower risk of subsequent malaria regardless of whether treatment had been given. Children with >= 2 clones had a reduced risk of febrile malaria compared with 1 clone after clearance of asymptomatic infections, but not if asymptomatic infections were not cleared. Multiclonal infection was associated with an increased risk of re-infection after drug treatment. However, among the children who were re-infected, multiclonal infections were associated with a shift from clinical malaria to asymptomatic parasitaemia. Conclusion: The number of clones was associated with exposure as well as blood stage immunity. These effects were distinguished by clearing asymptomatic infection with anti-malarials. Exposure to multiple P. falciparum infections is associated with protective immunity, but there appears to be an additional effect in untreated multiclonal infections that offsets this protective effect.	[Liljander, Anne; Faernert, Anna] Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden; [Bejon, Philip; Mwacharo, Jedidah; Kai, Oscar; Ogada, Edna; Peshu, Norbert; Marsh, Kevin] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Bejon, Philip; Marsh, Kevin] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	Karolinska Institutet; Kenya Medical Research Institute; University of Oxford	Liljander, A (corresponding author), Karolinska Inst, Infect Dis Unit, Dept Med Solna, Stockholm, Sweden.	Anna.Farnert@ki.se		Farnert, Anna/0000-0001-7583-282X; Ogada, Edna/0000-0003-0181-2505	Swedish International Development Agency; Anna Whitlocks Foundation; Erik and Edith Fernstroms Foundation; Sigurd and Elsa Goljes Foundation; Swedish Society for Tropical Medicine and International Health; NIHR Biomedical Research Centre Oxford	Swedish International Development Agency; Anna Whitlocks Foundation; Erik and Edith Fernstroms Foundation; Sigurd and Elsa Goljes Foundation; Swedish Society for Tropical Medicine and International Health; NIHR Biomedical Research Centre Oxford(National Institute for Health Research (NIHR))	The project was supported by the Swedish International Development Agency, Anna Whitlocks Foundation, Erik and Edith Fernstroms Foundation, Sigurd and Elsa Goljes Foundation and the Swedish Society for Tropical Medicine and International Health. Philip Bejon is supported by the NIHR Biomedical Research Centre Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; AlYaman F, 1997, T ROY SOC TROP MED H, V91, P602, DOI 10.1016/S0035-9203(97)90046-8; Bejon P, 2007, J IMMUNOL, V179, P4193, DOI 10.4049/jimmunol.179.6.4193; Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Bejon P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008321; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bendixen M, 2001, T ROY SOC TROP MED H, V95, P143, DOI 10.1016/S0035-9203(01)90140-3; Bereczky S, 2007, MICROBES INFECT, V9, P103, DOI 10.1016/j.micinf.2006.10.014; Branch OH, 2001, INFECT IMMUN, V69, P7783, DOI 10.1128/IAI.69.12.7783-7792.2001; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Farnert A, 1999, J INFECT DIS, V179, P989, DOI 10.1086/314652; Farnert A, 2001, T ROY SOC TROP MED H, V95, P225, DOI 10.1016/S0035-9203(01)90175-0; Farnert A, 2008, TRENDS PARASITOL, V24, P340, DOI 10.1016/j.pt.2008.04.008; Farnert A, 2009, J INFECT DIS, V200, P1166, DOI 10.1086/605652; FRUH K, 1991, INFECT IMMUN, V59, P1319; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Henning L, 2004, T ROY SOC TROP MED H, V98, P687, DOI 10.1016/j.trstmh.2004.03.010; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Konate L, 1999, T ROY SOC TROP MED H, V93, pS21, DOI 10.1016/S0035-9203(99)90323-1; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Liljander A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013649; Liljander A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-78; Mayor A, 2003, TROP MED INT HEALTH, V8, P3, DOI 10.1046/j.1365-3156.2003.00968.x; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; NTOUMI F, 1995, AM J TROP MED HYG, V52, P81, DOI 10.4269/ajtmh.1995.52.81; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; OTOO LN, 1988, T ROY SOC TROP MED H, V82, P59, DOI 10.1016/0035-9203(88)90263-5; OTOO LN, 1989, T ROY SOC TROP MED H, V83, P778, DOI 10.1016/0035-9203(89)90324-6; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P421, DOI 10.1046/j.1365-3156.2002.00881.x; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Roper C, 1998, PARASITOLOGY, V116, P501, DOI 10.1017/S0031182098002650; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726	36	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16940	10.1371/journal.pone.0016940	http://dx.doi.org/10.1371/journal.pone.0016940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383984	Green Published, gold, Green Submitted			2022-12-27	WOS:000287761700021
J	An, YF; Meresse, P; Mas, PJ; Hart, DJ				An, Yingfeng; Meresse, Patrick; Mas, Philippe J.; Hart, Darren J.			CoESPRIT: A Library-Based Construct Screening Method for Identification and Expression of Soluble Protein Complexes	PLOS ONE			English	Article							METAL AFFINITY-CHROMATOGRAPHY; ESCHERICHIA-COLI; RNA-POLYMERASE; RECOMBINANT PROTEIN; DOMAINS; SUBUNIT; YEAST; PURIFICATION; COEXPRESSION; BINDING	Structural and biophysical studies of protein complexes require multi-milligram quantities of soluble material. Subunits are often unstable when expressed separately so co-expression strategies are commonly employed since in vivo complex formation can provide stabilising effects. Defining constructs for subunit co-expression experiments is difficult if the proteins are poorly understood. Even more problematic is when subunit polypeptide chains co-fold since individually they do not have predictable domains. We have developed CoESPRIT, a modified version of the ESPRIT random library construct screen used previously on single proteins, to express soluble protein complexes. A random library of target constructs is screened against a fixed bait protein to identify stable complexes. In a proof-of-principle study, C-terminal fragments of the influenza polymerase PB2 subunit containing folded domains were isolated using importin alpha as bait. Separately, a C-terminal fragment of the PB1 subunit was used as bait to trap N-terminal fragments of PB2 resulting in co-folded complexes. Subsequent expression of the target protein without the bait indicates whether the target is independently stable, or co-folds with its partner. This highly automated method provides an efficient strategy for obtaining recombinant protein complexes at yields compatible with structural, biophysical and functional studies.	[An, Yingfeng; Mas, Philippe J.; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble, France; [An, Yingfeng; Meresse, Patrick; Mas, Philippe J.; Hart, Darren J.] CNRS, EMBL, UJF, Unit Virus Host Cell Interact,UMI3265, Grenoble, France	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	An, YF (corresponding author), European Mol Biol Lab, Grenoble Outstn, BP181, F-38042 Grenoble, France.	hart@embl.fr	; Hart, Darren/C-4858-2015	Mas, Philippe/0000-0002-8060-0289; Hart, Darren/0000-0002-3502-2002	European Union [SP5B-CT-2007-044263]; SPINE2-COMPLEXES Project [LSHG-CT-2006-031220]; P-CUBE [INFRA-2008-227764]	European Union(European Commission); SPINE2-COMPLEXES Project; P-CUBE	This work was supported by European Union Contracts FLUPOL [SP5B-CT-2007-044263]; and SPINE2-COMPLEXES Project [LSHG-CT-2006-031220]; and P-CUBE [INFRA-2008-227764]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini A, 2009, FEBS J, V276, P816, DOI 10.1111/j.1742-4658.2008.06826.x; Bieniossek C, 2009, NAT METHODS, V6, P447, DOI [10.1038/NMETH.1326, 10.1038/nmeth.1326]; BOIVIN S, 2010, J BIOL CHEM; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; Bonneau F, 2009, PROTEIN EXPRES PURIF, V65, P30, DOI 10.1016/j.pep.2008.12.001; Brooks MA, 2010, STRUCTURE, V18, P1075, DOI 10.1016/j.str.2010.08.001; Bussow K, 1998, NUCLEIC ACIDS RES, V26, P5007, DOI 10.1093/nar/26.21.5007; Cornvik T, 2006, PROTEINS, V65, P266, DOI 10.1002/prot.21090; DELALUNA S, 1989, VIRUS RES, V13, P143, DOI 10.1016/0168-1702(89)90012-9; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Droit A, 2005, J MOL ENDOCRINOL, V34, P263, DOI 10.1677/jme.1.01693; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Dyson MR, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn151; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hart DJ, 2006, ACTA CRYSTALLOGR D, V62, P19, DOI 10.1107/S0907444905036097; Hashimoto J, 2009, J BIOMOL SCREEN, V14, P970, DOI 10.1177/1087057109341406; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Kawasaki M, 2001, BIOCHEM BIOPH RES CO, V280, P842, DOI 10.1006/bbrc.2000.4229; Li C, 1997, P NATL ACAD SCI USA, V94, P2278, DOI 10.1073/pnas.94.6.2278; LI SJ, 1992, J BIOL CHEM, V267, P855; Mayer Michael R., 2004, Journal of Structural and Functional Genomics, V5, P159, DOI 10.1023/B:JSFG.0000029202.77832.34; Mooij WTM, 2009, NUCLEIC ACIDS RES, V37, pW402, DOI 10.1093/nar/gkp256; NADAL M, 2010, P NATL ACAD SCI US; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Nottebaum S, 2008, NUCLEIC ACIDS RES, V36, P245, DOI 10.1093/nar/gkm1044; Parrish JR, 2006, CURR OPIN BIOTECH, V17, P387, DOI 10.1016/j.copbio.2006.06.006; Parsy CB, 2007, J CHROMATOGR B, V853, P314, DOI 10.1016/j.jchromb.2007.03.046; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Poole EL, 2007, FEBS LETT, V581, P5300, DOI 10.1016/j.febslet.2007.10.025; Prodromou C, 2007, DRUG DISCOV TODAY, V12, P931, DOI 10.1016/j.drudis.2007.08.012; RAWLINGS AE, 2010, PROTEIN ENG DES SEL; Reich S, 2006, PROTEIN SCI, V15, P2356, DOI 10.1110/ps.062082606; Romier C, 2006, ACTA CRYSTALLOGR D, V62, P1232, DOI 10.1107/S0907444906031003; Ruigrok RWH, 2010, CURR OPIN STRUC BIOL, V20, P104, DOI 10.1016/j.sbi.2009.12.007; Sagemark J, 2010, PROTEIN EXPRES PURIF, V72, P175, DOI 10.1016/j.pep.2010.03.020; Savva R, 2007, DRUG DISCOV TODAY, V12, P939, DOI 10.1016/j.drudis.2007.08.016; Scheich C, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-12; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Shen Weiping, 2005, Proteome Sci, V3, P3, DOI 10.1186/1477-5956-3-3; Sorensen HP, 2003, PROTEIN EXPRES PURIF, V31, P149, DOI 10.1016/S1046-5928(03)00133-5; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tolia NH, 2006, NAT METHODS, V3, P55, DOI 10.1038/nmeth0106-55; Wang HY, 2003, P NATL ACAD SCI USA, V100, P478, DOI 10.1073/pnas.0236088100; Werner F, 2002, MOL CELL, V10, P635, DOI 10.1016/S1097-2765(02)00629-9; YUMEREFENDI H, 2010, J STRUCT BIOL	53	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16261	10.1371/journal.pone.0016261	http://dx.doi.org/10.1371/journal.pone.0016261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364980	Green Published, gold, Green Submitted			2022-12-27	WOS:000287656600004
J	Labroussaa, F; Dubrana, MP; Arricau-Bouvery, N; Beven, L; Saillard, C				Labroussaa, Fabien; Dubrana, Marie-Pierre; Arricau-Bouvery, Nathalie; Beven, Laure; Saillard, Colette			Involvement of a Minimal Actin-Binding Region of Spiroplasma citri Phosphoglycerate Kinase in Spiroplasma Transmission by Its Leafhopper Vector	PLOS ONE			English	Article							CIRCULIFER-HAEMATOCEPS; INSECT TRANSMISSIBILITY; MYCOPLASMA-PNEUMONIAE; IN-VITRO; PROTEIN; SPIRALIN; CELLS; PLANT; PATHOGENICITY; DEHYDROGENASE	Background: Spiroplasma citri is a wall-less bacterium that colonizes phloem vessels of a large number of host plants. Leafhopper vectors transmit S. citri in a propagative and circulative manner, involving colonization and multiplication of bacteria in various insect organs. Previously we reported that phosphoglycerate kinase (PGK), the well-known glycolytic enzyme, bound to leafhopper actin and was unexpectedly implicated in the internalization process of S. citri into Circulifer haematoceps cells. Methodology/Principal Findings: In an attempt to identify the actin-interacting regions of PGK, several overlapping PGK truncations were generated. Binding assays, using the truncations as probes on insect protein blots, revealed that the actin-binding region of PGK was located on the truncated peptide designated PGK-FL5 containing amino acids 49-154. To investigate the role of PGK-FL5-actin interaction, competitive spiroplasma attachment and internalization assays, in which His6-tagged PGK-FL5 was added to Ciha-1 cells prior to infection with S. citri, were performed. No effect on the efficiency of attachment of S. citri to leafhopper cells was observed while internalization was drastically reduced. The in vivo effect of PGK-FL5 was confirmed by competitive experimental transmission assays as injection of PGK-FL5 into S. citri infected leafhoppers significantly affected spiroplasmal transmission. Conclusion: These results suggest that S. citri transmission by its insect vector is correlated to PGK ability to bind actin.	[Labroussaa, Fabien] INRA, Villenave Dornon, France; Univ Bordeaux, UMR Biol Fruit & Pathol 1332, Villenave Dornon, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux	Labroussaa, F (corresponding author), INRA, Villenave Dornon, France.	saillard@bordeaux.inra.fr	Labroussaa, Fabien/AAN-2833-2021; Beven, Laure/Q-1096-2018	Labroussaa, Fabien/0000-0002-8712-3024; Beven, Laure/0000-0003-4407-3255; Arricau-Bouvery, Nathalie/0000-0001-9505-4834	INRA; Universite Victor Segalen Bordeaux 2; Ministere de l'Enseignement et de la Recherche	INRA; Universite Victor Segalen Bordeaux 2; Ministere de l'Enseignement et de la Recherche	This work was supported with funding from INRA and Universite Victor Segalen Bordeaux 2. F.L. was supported by a Ph.D. fellowship from the Ministere de l'Enseignement et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammar E, 2004, ARCH MICROBIOL, V181, P97, DOI 10.1007/s00203-003-0630-8; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Berho N, 2006, MICROBIOL-SGM, V152, P873, DOI 10.1099/mic.0.28541-0; Berho N, 2006, MICROBIOL-SGM, V152, P2703, DOI 10.1099/mic.0.29085-0; Boutareaud A, 2004, APPL ENVIRON MICROB, V70, P3960, DOI 10.1128/AEM.70.7.3960-3967.2004; Bove JM, 2003, ANNU REV PHYTOPATHOL, V41, P483, DOI 10.1146/annurev.phyto.41.052102.104034; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; DALLO SF, 1990, INFECT IMMUN, V58, P4163, DOI 10.1128/IAI.58.12.4163-4165.1990; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Duret S, 2003, APPL ENVIRON MICROB, V69, P6225, DOI 10.1128/AEM.69.10.6225-6234.2003; DURET S, 2009, MICROBIOLOGY; Fletcher J, 1998, PHYTOPATHOLOGY, V88, P1351, DOI 10.1094/PHYTO.1998.88.12.1351; Foissac X, 1996, J BACTERIOL, V178, P2934, DOI 10.1128/jb.178.10.2934-2940.1996; Gouin E, 2005, CURR OPIN MICROBIOL, V8, P35, DOI 10.1016/j.mib.2004.12.013; Killiny N, 2006, MICROBIOL-SGM, V152, P1221, DOI 10.1099/mic.0.28602-0; Killiny N, 2005, PHYTOPATHOLOGY, V95, P541, DOI 10.1094/PHYTO-95-0541; Kwon MO, 1999, PHYTOPATHOLOGY, V89, P1144, DOI 10.1094/PHYTO.1999.89.12.1144; Labroussaa F, 2010, APPL ENVIRON MICROB, V76, P1879, DOI 10.1128/AEM.02384-09; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Ozbek E, 2003, J INVERTEBR PATHOL, V82, P167, DOI 10.1016/S0022-2011(03)00031-4; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; SAGLIO P, 1973, INT J SYST BACTERIOL, V23, P191, DOI 10.1099/00207713-23-3-191; SAGLIO P, 1971, CR ACAD SCI D NAT, V272, P1387; SHERMAN MA, 1990, J BIOL CHEM, V265, P10659; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; TULLY JG, 1977, SCIENCE, V195, P892, DOI 10.1126/science.841314; VIGNAULT JC, 1980, CR ACAD SCI D NAT, V290, P775; WATSON HC, 1982, EMBO J, V1, P1635, DOI 10.1002/j.1460-2075.1982.tb01366.x; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07	29	14	15	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17357	10.1371/journal.pone.0017357	http://dx.doi.org/10.1371/journal.pone.0017357			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364953	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600043
J	Esbjornsson, J; Mild, M; Mansson, F; Norrgren, H; Medstrand, P				Esbjornsson, Joakim; Mild, Mattias; Mansson, Fredrik; Norrgren, Hans; Medstrand, Patrik			HIV-1 Molecular Epidemiology in Guinea-Bissau, West Africa: Origin, Demography and Migrations	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUBTYPE-C; OCCUPATIONAL COHORT; SEQUENCE ALIGNMENT; DUAL INFECTIONS; CIVIL-WAR; TYPE-1; PREVALENCE; RECOMBINANT; INFERENCE	The HIV-1 epidemic in West Africa has been dominated by subtype A and the recombinant form CRF02_AG. Little is known about the origins and the evolutionary history of HIV-1 in this region. We employed Maximum likelihood and Bayesian methods in combination with temporal and spatial information to reconstruct the HIV-1 subtype distribution, demographic history and migration patterns over time in Guinea-Bissau, West Africa. We found that CRF02_AG and subsubtype A3 were the dominant forms of HIV-1 in Guinea-Bissau and that they were introduced into the country on at least six different occasions between 1976 and 1981. These estimates also corresponded well with the first reported HIV-1 cases in Guinea-Bissau. Migration analyses suggested that (1) the HIV-1 epidemic started in the capital Bissau and then dispersed into more rural areas, and (2) the epidemic in Guinea-Bissau was connected to both Cameroon and Mali. This is the first study that describes the HIV-1 molecular epidemiology in a West African country by combining the results of subtype distribution with analyses of epidemic origin and epidemiological linkage between locations. The multiple introductions of HIV-1 into Guinea-Bissau, during a short time-period of five years, coincided with and were likely influenced by the major immigration wave into the country that followed the end of the independence war (1963-1974).	[Esbjornsson, Joakim; Medstrand, Patrik] Lund Univ, Dept Expt Med Sci, Sect Mol Virol, Lund, Sweden; [Mild, Mattias] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Mild, Mattias] Swedish Inst Infect Dis Control, Dept Virol, Solna, Sweden; [Mansson, Fredrik] Lund Univ, Dept Clin Sci, Infect Dis Res Unit, Malmo, Sweden; [Norrgren, Hans] Lund Univ, Div Infect Med, Dept Clin Sci, Lund, Sweden	Lund University; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Lund University; Lund University	Esbjornsson, J (corresponding author), Lund Univ, Dept Expt Med Sci, Sect Mol Virol, Lund, Sweden.	joakim.esbjornsson@med.lu.se		Norrgren, Hans/0000-0001-5780-530X; Esbjornsson, Joakim/0000-0002-3822-4953; Esbjornsson, Joakim/0000-0002-6088-7796	Swedish Research Council; Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); Crafoord Foundation, Lund, Sweden; Royal Physiographic Society, Lund, Sweden; Lars Hierta Memorial Foundation, Stockholm, Sweden; Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); Crafoord Foundation, Lund, Sweden; Royal Physiographic Society, Lund, Sweden; Lars Hierta Memorial Foundation, Stockholm, Sweden; Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden	Funding: This work was supported by The Swedish Research Council; The Swedish International Development Cooperation Agency/Department for Research Cooperation (SIDA/SAREC); The Crafoord Foundation, Lund, Sweden; The Royal Physiographic Society, Lund, Sweden; The Lars Hierta Memorial Foundation, Stockholm, Sweden and Konsul Thure Carlsson Fund for Medical Research, Lund, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2000, ARCH INTERN MED, V160, P3286, DOI 10.1001/archinte.160.21.3286; Andersson S, 1999, VIROLOGY, V262, P312, DOI 10.1006/viro.1999.9867; [Anonymous], 2008, EP FACT SHEET HIV AI; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; CHABAL P, 1983, CAN J AFR STUD, V17, P189, DOI 10.2307/484213; Cham F, 2000, AIDS RES HUM RETROV, V16, P1915, DOI 10.1089/08892220050195874; da Silva ZJ, 2008, AIDS, V22, P1195, DOI 10.1097/QAD.0b013e328300a33d; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; FULTZ PN, 1988, AIDS, V2, P129, DOI 10.1097/00002030-198804000-00010; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; KANKI PJ, 1987, SCIENCE, V236, P827, DOI 10.1126/science.3033826; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; Leitner T, 1996, AIDS RES HUM RETROV, V12, P1595, DOI 10.1089/aid.1996.12.1595; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lewis PO, 1998, MOL BIOL EVOL, V15, P277, DOI 10.1093/oxfordjournals.molbev.a025924; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Mansson F, 2007, SEX TRANSM INFECT, V83, P463, DOI 10.1136/sti.2007.025353; Mansson F, 2009, AIDS, V23, P1575, DOI 10.1097/QAD.0b013e32832cedfb; Meloni ST, 2004, J VIROL, V78, P12455, DOI 10.1128/JVI.78.22.12455-12461.2004; Meloni ST, 2004, J VIROL, V78, P12438, DOI 10.1128/JVI.78.22.12438-12445.2004; Mild M, 2007, J VIROL, V81, P3369, DOI 10.1128/JVI.01295-06; Montavon C, 2000, J ACQ IMMUN DEF SYND, V23, P363; Njai HF, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-40; Nkengasong JN, 2000, J ACQ IMMUN DEF SYND, V23, P430; Norrgren H, 1999, AIDS, V13, P701, DOI 10.1097/00002030-199904160-00011; NORRGREN H, 1995, J ACQ IMMUN DEF SYND, V9, P422, DOI 10.1097/00042560-199508000-00014; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Peeters M, 2000, AIDS RES HUM RETROV, V16, P315, DOI 10.1089/088922200309197; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quinn TC, 1998, BIOMED RES REP, P327; Rambaut A., 2007, TRACER V1 5; RAMBAUT A, 2005, TREE STAT CALC TOOL, P2005; Salemi M, 2008, MOL PHYLOGENET EVOL, V49, P618, DOI 10.1016/j.ympev.2008.08.017; Schierup M H, 2000, Genetics, V156, P879; Seo TK, 2002, BIOINFORMATICS, V18, P115, DOI 10.1093/bioinformatics/18.1.115; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SWOFFORD DL, 2003, PAUP SUNDERLANDMASSA; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toure-Kane C, 2000, AIDS RES HUM RETROV, V16, P603, DOI 10.1089/088922200309025; VANTIENEN C, 2009, J ACQUIR IMMUNE DEFI; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Zwickl D. J, 2006, GENETIC ALGORITHM AP; LOS ALAMOS SEQUENCE	57	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17025	10.1371/journal.pone.0017025	http://dx.doi.org/10.1371/journal.pone.0017025			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365013	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482800025
J	Tumurbaatar, I; Cizmecioglu, O; Hoffmann, I; Grummt, I; Voit, R				Tumurbaatar, Indra; Cizmecioglu, Onur; Hoffmann, Ingrid; Grummt, Ingrid; Voit, Renate			Human Cdc14B Promotes Progression through Mitosis by Dephosphorylating Cdc25 and Regulating Cdk1/Cyclin B Activity	PLOS ONE			English	Article							RIBOSOMAL-RNA SYNTHESIS; MITOTIC EXIT; INHIBITORY PHOSPHORYLATION; CHROMOSOME SEGREGATION; PHOSPHATASE CDC14B; CDK1; DEGRADATION; TRANSITION	Entry into and progression through mitosis depends on phosphorylation and dephosphorylation of key substrates. In yeast, the nucleolar phosphatase Cdc14 is pivotal for exit from mitosis counteracting Cdk1-dependent phosphorylations. Whether hCdc14B, the human homolog of yeast Cdc14, plays a similar function in mitosis is not yet known. Here we show that hCdc14B serves a critical role in regulating progression through mitosis, which is distinct from hCdc14A. Unscheduled overexpression of hCdc14B delays activation of two master regulators of mitosis, Cdc25 and Cdk1, and slows down entry into mitosis. Depletion of hCdc14B by RNAi prevents timely inactivation of Cdk1/cyclin B and dephosphorylation of Cdc25, leading to severe mitotic defects, such as delay of metaphase/anaphase transition, lagging chromosomes, multipolar spindles and binucleation. The results demonstrate that hCdc14B-dependent modulation of Cdc25 phosphatase and Cdk1/cyclin B activity is tightly linked to correct chromosome segregation and bipolar spindle formation, processes that are required for proper progression through mitosis and maintenance of genomic stability.	[Tumurbaatar, Indra; Grummt, Ingrid; Voit, Renate] German Canc Res Ctr, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Tumurbaatar, I (corresponding author), German Canc Res Ctr, DKFZ ZMBH Alliance, D-6900 Heidelberg, Germany.	r.voit@dkfz.de	Cizmecioglu, Onur/AAA-6289-2020; Cizmecioglu, Onur/AAF-5874-2020	Cizmecioglu, Onur/0000-0002-7608-6950	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; DKFZ	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); DKFZ(Helmholtz Association)	This work was supported by the Deutsche Forschungsgemeinschaft, the Fonds der Chemischen Industrie, and the Intramural Program (DKFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berdougo E, 2008, CELL CYCLE, V7, P1184, DOI 10.4161/cc.7.9.5792; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Esteban V, 2006, CELL CYCLE, V5, P2894, DOI 10.4161/cc.5.24.3566; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Hassepass I, 2003, J BIOL CHEM, V278, P29824, DOI 10.1074/jbc.M302704200; Hassepass Ingo, 2004, Methods Mol Biol, V281, P153; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Hoppe S, 2009, P NATL ACAD SCI USA, V106, P17781, DOI 10.1073/pnas.0909873106; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Kaiser BK, 2002, MOL BIOL CELL, V13, P2289, DOI 10.1091/mbc.01-11-0535; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Lammer C, 1998, J CELL SCI, V111, P2445; Lanzetti L, 2007, J BIOL CHEM, V282, P15258, DOI 10.1074/jbc.M700914200; Li LW, 2000, J BIOL CHEM, V275, P2410, DOI 10.1074/jbc.275.4.2410; Lindqvist A, 2005, J CELL BIOL, V171, P35, DOI 10.1083/jcb.200503066; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rodier G, 2008, EMBO J, V27, P679, DOI 10.1038/emboj.2008.6; Rosso L, 2008, PLOS BIOL, V6, P1281, DOI 10.1371/journal.pbio.0060140; Schmitz MHA, 2010, NAT CELL BIOL, V12, P886, DOI 10.1038/ncb2092; Schokraie E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009502; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Watrin E, 2006, CURR BIOL, V16, P863, DOI 10.1016/j.cub.2006.03.049; Wolfe BA, 2004, EMBO J, V23, P919, DOI 10.1038/sj.emboj.7600103; Wu J, 2008, J CELL BIOL, V181, P475, DOI 10.1083/jcb.200710127	50	29	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14711	10.1371/journal.pone.0014711	http://dx.doi.org/10.1371/journal.pone.0014711			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379580	Green Submitted, gold, Green Published			2022-12-27	WOS:000287482300011
J	Song, Z; Yue, W; Wei, B; Wang, N; Li, T; Guan, LD; Shi, SS; Zeng, QA; Pei, XT; Chen, L				Song, Zhou; Yue, Wen; Wei, Bo; Wang, Ning; Li, Tao; Guan, Lidong; Shi, Shuangshuang; Zeng, Quan; Pei, Xuetao; Chen, Lin			Sonic Hedgehog Pathway Is Essential for Maintenance of Cancer Stem-Like Cells in Human Gastric Cancer	PLOS ONE			English	Article							SIDE POPULATION; MYELOID-LEUKEMIA; SELF-RENEWAL; IDENTIFICATION; GLIOBLASTOMA; TUMORS; LINE; GROWTH	Abnormal activation of the Sonic hedgehog (SHH) pathway has been described in a wide variety of human cancers and in cancer stem cells (CSCs), however, the role of SHH pathway in gastric CSCs has not been reported. In this study, we investigated the possibility that abnormal activation of the SHH pathway maintained the characteristics of gastric CSCs. First, we identified cancer stem-like cells (CSLCs) from human gastric cancer cell lines (HGC-27, MGC-803 and MKN-45) using tumorsphere culture. Compared with adherent cells, the floating tumorsphere cells had more self-renewing capacity and chemoresistance. The cells expressing CSCs markers (CD44, CD24 and CD133) were also significantly more in tumorsphere cells than in adherent cells. More importantly, in vivo xenograft studies showed that tumors could be generated with 2610 4 tumorsphere cells, which was 100-fold less than those required for tumors seeding by adherent cells. Next, RT-PCR and Western blot showed that the expression levels of Ptch and Gli1 (SHH pathway target genes) were significantly higher in tumorsphere cells than in adherent cells. The results of quantitative real-time PCR were similar to those of RT-PCR and Western blot. Further analysis revealed that SHH pathway blocked by cyclopamine or 5E1 caused a higher reduction in self-renewing capacity of HGC-27 tumorsphere cells than that of adherent cells. We also found that SHH pathway blocking strongly enhanced the efficacy of chemotherapeutic drugs in HGC-27 tumorsphere cells in vitro and in vivo but had no significant effect in adherent cells. Finally, we isolated the tumorspheres from gastric cancer specimen, these cells also had chemoresistance and tumorigenic capacity, and SHH pathway maintained the gastric CSLCs characteristics of tumorsphere cells from primary tumor samples. In conclusion, our data suggested that SHH pathway was essential for maintenance of CSLCs in human gastric cancer.	[Song, Zhou; Wei, Bo; Wang, Ning; Li, Tao; Chen, Lin] Gen Hosp Chinese PLA, Dept Gen Surg, Beijing, Peoples R China; [Yue, Wen; Guan, Lidong; Shi, Shuangshuang; Zeng, Quan; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing, Peoples R China		Song, Z (corresponding author), Gen Hosp Chinese PLA, Dept Gen Surg, Beijing, Peoples R China.	peixt@nic.bmi.ac.cn; chenlinbj@vip.sina.com		Yue, Wen/0000-0002-3935-360X	National High Technology Research and Development Program of China [2006AA402A04, 2006AA02A107]; Major State Basic Research Program of China [2009CB521704]; National Nature Science Foundation of China [30872468, 30873031]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Major State Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology Research and Development Program of China (# 2006AA402A04, # 2006AA02A107), the Major State Basic Research Program of China (# 2009CB521704), and the National Nature Science Foundation of China (# 30872468, # 30873031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Christgen M, 2007, MOL CELL BIOCHEM, V306, P201, DOI 10.1007/s11010-007-9570-y; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kang SK, 2006, STEM CELLS DEV, V15, P423, DOI 10.1089/scd.2006.15.423; Kobune M, 2009, CANCER SCI, V100, P948, DOI 10.1111/j.1349-7006.2009.01111.x; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee J, 1997, DEVELOPMENT, V124, P2537; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Ma XL, 2005, CARCINOGENESIS, V26, P1698, DOI 10.1093/carcin/bgi130; Ohta M, 2005, CANCER RES, V65, P10822, DOI 10.1158/0008-5472.CAN-05-0777; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Setoguchi T, 2004, CELL CYCLE, V3, P414; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Vermeulen L, 2008, CELL DEATH DIFFER, V15, P947, DOI 10.1038/cdd.2008.20; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2007, CANCER RES, V67, P3716, DOI 10.1158/0008-5472.CAN-06-4343; Yi L, 2007, MODERN PATHOL, V20, P1061, DOI 10.1038/modpathol.3800942; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zhong XF, 2007, INT J CANCER, V121, P2125, DOI 10.1002/ijc.22880	30	133	144	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17687	10.1371/journal.pone.0017687	http://dx.doi.org/10.1371/journal.pone.0017687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394208	Green Published, Green Submitted, gold			2022-12-27	WOS:000288025500020
J	Valkov, A; Sorbye, SW; Kilvaer, TK; Donnem, T; Smeland, E; Bremnes, RM; Busund, LT				Valkov, Andrej; Sorbye, Sveinung W.; Kilvaer, Thomas K.; Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.; Busund, Lill-Tove			The Prognostic Impact of TGF-beta 1, Fascin, NF-kappa B and PKC-zeta Expression in Soft Tissue Sarcomas	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; KINASE-C-ZETA; CELL LUNG-CANCER; TGF-BETA; E-CADHERIN; GROWTH; PROGRESSION; CARCINOMA; RHABDOMYOSARCOMA; METASTASIS	Aims: Transforming growth factor-beta (TGF-beta), fascin, nuclear factor-kappa B (NF-kappa B) p105, protein-kinase C-zeta (PKC-zeta), partioning-defective protein-6 (Par-6), E-cadherin and vimentin are tumor promoting molecules through mechanisms involved in cell dedifferentiation. In soft tissue sarcomas, their expression profile is poorly defined and their significance is uncertain. We aimed to investigate the prognostic impact of TGF-beta 1, NF-kappa B p105, PKC-zeta, Par-6 alpha, E-cadherin and vimentin in non-gastrointestinal stromal tumor soft tissue sarcomas (non-GIST STSs). Patients and Methods: Tumor samples and clinical data from 249 patients with non-GIST STS were obtained, and tissue microarrays (TMAs) were constructed for each specimen. Immunohistochemistry (IHC) was used to evaluate marker expression in tumor cells. Results: In univariate analysis, the expression levels of TGF-b1 (P = 0.016), fascin (P = 0.006), NF-kappa B p105 (P = 0.022) and PKCf, (P = 0.042) were significant indicators for disease specific survival (DSS). In the multivariate analysis, high TGF-beta 1 expression was an independent negative prognostic factor for DSS (HR = 1.6, 95% CI = 1.1-2.4, P = 0.019) in addition to tumor depth, malignancy grade, metastasis at diagnosis, surgery and positive resection margins. Conclusion: Expression of TGF- b1 was significantly associated with aggressive behavior and shorter DSS in non- GIST STSs.	[Valkov, Andrej; Sorbye, Sveinung W.; Busund, Lill-Tove] Univ Hosp No Norway, Dept Clin Pathol, Tromso, Norway; [Valkov, Andrej; Sorbye, Sveinung W.; Kilvaer, Thomas K.; Busund, Lill-Tove] Univ Tromso, Inst Med Biol, Tromso, Norway; [Donnem, Tom; Smeland, Eivind; Bremnes, Roy M.] Univ Hosp No Norway, Dept Oncol, Tromso, Norway; [Donnem, Tom; Bremnes, Roy M.] Univ Tromso, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Valkov, A (corresponding author), Univ Hosp No Norway, Dept Clin Pathol, Tromso, Norway.	Andrej.Yurjevic.Valkov@unn.no	Kilvaer, Thomas/AAI-7418-2020; Sorbye, Sveinung Wergeland/AAE-7208-2020	Kilvaer, Thomas/0000-0003-1669-0117; Sorbye, Sveinung Wergeland/0000-0002-8250-3992	Norwegian Childhood Cancer Network; Norwegian Sarcoma Group; Norwegian Cancer Society	Norwegian Childhood Cancer Network; Norwegian Sarcoma Group; Norwegian Cancer Society(Norwegian Cancer Society)	This study was funded by the Helse Nord, the Norwegian Childhood Cancer Network, the Norwegian Sarcoma Group and the Norwegian Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saad S, 2008, BRIT J CANCER, V99, P1476, DOI 10.1038/sj.bjc.6604713; Beck AH, 2010, VIRCHOWS ARCH, V456, P141, DOI 10.1007/s00428-009-0774-2; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blaukovitsch M, 2006, VIRCHOWS ARCH, V449, P455, DOI 10.1007/s00428-006-0256-8; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Campbell KJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-101; Chen MF, 2009, J MOL MED-JMM, V87, P307, DOI 10.1007/s00109-008-0430-3; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; Dickinson IC, 2006, ANZ J SURG, V76, P104, DOI 10.1111/j.1445-2197.2006.03615.x; Engellau J, 2004, CANCER-AM CANCER SOC, V100, P2233, DOI 10.1002/cncr.20254; Guillou L, 2009, VIRCHOWS ARCH; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Guo H, 2007, CHINESE MED J-PEKING, V120, P515, DOI 10.1097/00029330-200703020-00016; Guo H, 2009, J NEUROCHEM, V109, P203, DOI 10.1111/j.1471-4159.2009.05946.x; GUSTAFSON P, 1994, ACTA ORTHOP SCAND, V65, P1; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Javelaud D, 2002, INT J CANCER, V98, P193, DOI 10.1002/ijc.10192; Kefeli M, 2009, INT J GYNECOL PATHOL, V28, P328, DOI 10.1097/PGP.0b013e318195da9f; Kiatisevi Piya, 2006, Journal of the Medical Association of Thailand, V89, P334; Kilvaer TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015368; Kim MA, 2009, HISTOPATHOLOGY, V54, P442, DOI 10.1111/j.1365-2559.2009.03247.x; Kloen P, 1997, CANCER, V80, P2230; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Liu J, 2006, MOL CANCER RES, V4, P803, DOI 10.1158/1541-7786.MCR-06-0201; Liu LK, 2009, MOD PATHOL; Liu XF, 2004, MOL CELL BIOL, V24, P6665, DOI 10.1128/mcb.24.15.6665-6675.2004; Masi L, 2002, VIRCHOWS ARCH, V440, P491, DOI 10.1007/s00428-001-0544-2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mendenhall WM, 2005, CANCER-AM CANCER SOC, V104, P669, DOI 10.1002/cncr.21264; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; RANEY RB, 1983, CANCER-AM CANCER SOC, V52, P44, DOI 10.1002/1097-0142(19830701)52:1<44::AID-CNCR2820520110>3.0.CO;2-V; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014611; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2005, DEV CELL, V8, P456, DOI 10.1016/j.devcel.2005.03.002; Verweij J, 2010, EUR J CANCER, V46, P863, DOI 10.1016/j.ejca.2010.01.016; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Vora HH, 2009, INT J BIOL MARKER, V24, P38, DOI 10.1177/172460080902400106; Wibmer C, 2010, ANN ONCOL, V21, P1106, DOI 10.1093/annonc/mdp415; Yamamoto T, 2004, CLIN CANCER RES, V10, P5804, DOI 10.1158/1078-0432.CCR-0770-03; Yang L, 2010, TRENDS IMMUNOL, V31, P220, DOI 10.1016/j.it.2010.04.002; YANG RS, 1995, CANCER-AM CANCER SOC, V76, P1398, DOI 10.1002/1097-0142(19951015)76:8<1398::AID-CNCR2820760815>3.0.CO;2-B; Zagars GK, 2003, INT J RADIAT ONCOL, V57, P739, DOI 10.1016/S0360-3016(03)00714-4; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zou J, 2010, EUR J CANCER PREV, V19, P11, DOI 10.1097/CEJ.0b013e32832f9aa6	48	29	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17507	10.1371/journal.pone.0017507	http://dx.doi.org/10.1371/journal.pone.0017507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390241	Green Published, gold			2022-12-27	WOS:000287965200017
J	Gao, P; Tang, Q; An, XM; Yan, XX; Liang, DC				Gao, Pu; Tang, Qun; An, XiaoMin; Yan, XiaoXue; Liang, DongCai			Structure of HsdS Subunit from Thermoanaerobacter tengcongensis Sheds Lights on Mechanism of Dynamic Opening and Closing of Type I Methyltransferase	PLOS ONE			English	Article							RESTRICTION-ENDONUCLEASE; DNA METHYLTRANSFERASES; CRYSTAL-STRUCTURE; MODEL; RECOGNITION; M.ECOR124I; SEQUENCE; COMPLEX; SYSTEM; ENZYME	Type I DNA methyltransferases contain one specificity subunit (HsdS) and two modification subunits (HsdM). The electron microscopy model of M.EcoKI-M2S1 methyltransferase shows a reasonable closed state of this clamp-like enzyme, but the structure of the open state is still unclear. The 1.95 angstrom crystal structure of the specificity subunit from Thermoanaerobacter tengcongensis (TTE-HsdS) shows an unreported open form inter-domain orientation of this subunit. Based on the crystal structure of TTE-HsdS and the closed state model of M.EcoKI-M2S1, we constructed a potential open state model of type I methyltransferase. Mutational studies indicated that two alpha-helices (aa30-59 and aa466-495) of the TTE-HsdM subunit are important inter-subunit interaction sites in the TTE-M2S1 complex. DNA binding assays also highlighted the importance of the C-terminal region of TTE-HsdM for DNA binding by the TTE-M2S1 complex. On the basis of structural analysis, biochemical experiments and previous studies, we propose a dynamic opening and closing mechanism for type I methyltransferase.	[Gao, Pu; Tang, Qun; An, XiaoMin; Yan, XiaoXue; Liang, DongCai] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Gao, Pu] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, P (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	snow@moon.ibp.ac.cn; dcliang@sun5.ibp.ac.cn	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012	National Program on Key Basic Research [2007CB914302, 2011CB966303, 2011CB910302, 2011CB911101]; National Natural Science Foundation of China [30600102, 31070684]; Institute of Biophysics, Chinese Academy of Sciences	National Program on Key Basic Research(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Institute of Biophysics, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Program on Key Basic Research Project "973 Program" No. 2007CB914302, No. 2011CB966303, No. 2011CB910302 and No. 2011CB911101. Additional support was provided by the National Natural Science Foundation of China, No. 30600102 and No. 31070684. Funding for open access charge: Institute of Biophysics, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABADJIEVA A, 1994, J MOL BIOL, V241, P35, DOI 10.1006/jmbi.1994.1471; Bao QY, 2002, GENOME RES, V12, P689, DOI 10.1101/gr.219302; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calisto RM, 2005, J MOL BIOL, V351, P749, DOI 10.1016/j.jmb.2005.06.050; Chang Q, 2008, PROTEINS, V73, P254, DOI 10.1002/prot.22151; COOPER LP, 1994, J MOL BIOL, V236, P1011, DOI 10.1016/0022-2836(94)90008-6; DRYDEN DTF, 1993, J BIOL CHEM, V268, P13228; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDLICH B, 1985, J BIOL CHEM, V260, P5729; Goedecke K, 2001, NAT STRUCT BIOL, V8, P121, DOI 10.1038/84104; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; KELLEHER JE, 1991, J MOL BIOL, V221, P431, DOI 10.1016/0022-2836(91)80064-2; Kennaway CK, 2009, NUCLEIC ACIDS RES, V37, P762, DOI 10.1093/nar/gkn988; Kim JS, 2005, P NATL ACAD SCI USA, V102, P3248, DOI 10.1073/pnas.0409851102; KNEALE GG, 1994, J MOL BIOL, V243, P1, DOI 10.1006/jmbi.1994.1624; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; O'Neill M, 2001, J MOL BIOL, V307, P951, DOI 10.1006/jmbi.2001.4543; O'Neill M, 1998, EMBO J, V17, P7118, DOI 10.1093/emboj/17.23.7118; Obarska A, 2006, NUCLEIC ACIDS RES, V34, P1992, DOI 10.1093/nar/gkl132; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; PITTARD J, 1964, J BACTERIOL, V87, P1256, DOI 10.1128/JB.87.5.1256-1257.1964; Redaschi N, 1996, J MOL BIOL, V257, P790, DOI 10.1006/jmbi.1996.0202; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Szczelkun MD, 1996, EMBO J, V15, P6335, DOI 10.1002/j.1460-2075.1996.tb01023.x; TAYLOR IA, 1994, EMBO J, V13, P5772, DOI 10.1002/j.1460-2075.1994.tb06915.x; Taylor JE, 2010, J MOL BIOL, V398, P391, DOI 10.1016/j.jmb.2010.03.008; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215	32	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17346	10.1371/journal.pone.0017346	http://dx.doi.org/10.1371/journal.pone.0017346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399684	Green Submitted, Green Published, gold			2022-12-27	WOS:000287933300018
J	Lazzarino, AI; Palmer, W; Bottle, A; Aylin, P				Lazzarino, Antonio Ivan; Palmer, William; Bottle, Alex; Aylin, Paul			Inequalities in Stroke Patients' Management in English Public Hospitals: A Survey on 200,000 Patients	PLOS ONE			English	Article								Background: According to clinical guidelines, every patient affected by stroke should be given a brain-imaging scan (BIS) Computerized Tomography or Magnetic Resonance Imaging - immediately after being admitted to hospital. Aim of the study: To describe the variation in use of BIS among English public hospitals and identify any patient groups being excluded from appropriate care. Methods: We collected hospital administrative data for all patients admitted to any English public hospital with a principal diagnosis of stroke from 2006 to 2009. We calculated the proportion of patients treated with BIS in the whole sample and after stratification by hospital. We compared hospitals' performance using funnel plots. We performed a multiple logistic regression analysis using BIS as outcome and age, gender, socio-economic deprivation, and comorbidity as covariates. Results: In English public hospitals there are about 70,000 emergency admissions for stroke per year. Nationally, only 35% receive a BIS immediately, and only 84% receive it within the admission. There is large variation in the use of BIS for stroke patients among English public hospitals, with some of them approaching the recommended 100% and some having very low rates. Young (P < 0.001), male (P=0.012), and least socio-economically deprived patients (P=0.001), as well as patients with fewer comorbidities (P < 0.001) appear to have more chance of being selected for a brain scan. Conclusion: Some English public hospitals appear to be falling well below the clinical guideline standards for scanning stroke patients and inappropriate patient selection criteria may be being applied, leading to health inequalities.	[Lazzarino, Antonio Ivan; Palmer, William; Bottle, Alex; Aylin, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Lazzarino, AI (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	a.lazzarino@imperial.ac.uk	Lazzarino, Antonio Ivan/F-9011-2010; Aylin, Paul/A-1073-2014	Lazzarino, Antonio Ivan/0000-0001-8045-2346; Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743	Dr Foster intelligence; National Institute of Health Research; National Institute for Health Research Biomedical Research Centre	Dr Foster intelligence; National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR))	WP, AB, and PA have support from the Dr Foster Unit at Imperial College London for the submitted work. The Dr Foster Unit at Imperial College is funded by the Dr Foster intelligence, an independent health care information company. The Dr Foster Unit at Imperial is affiliated with the Imperial Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. The Department of Primary Care and Public Health is grateful for support from the National Institute for Health Research Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; [Anonymous], 2008, 68 NICE, V68; Beech R, 1996, STROKE, V27, P1958, DOI 10.1161/01.STR.27.11.1958; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; *DEP HLTH LOND, 2007, NAT STROK STRAT; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Feigin VL, 2005, LANCET, V365, P2160, DOI 10.1016/S0140-6736(05)66755-4; National Audit Office, 2010, PROGR IMPR STROK CAR; *ROYAL COLL PHYS C, 2008, NAT SENT STROK AUD P; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970	12	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17219	10.1371/journal.pone.0017219	http://dx.doi.org/10.1371/journal.pone.0017219			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399683	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000287933300014
J	Dharia, S; Rabbitt, RD				Dharia, Sameera; Rabbitt, Richard D.			Monitoring Voltage-Dependent Charge Displacement of Shaker B-IR K+ Ion Channels Using Radio Frequency Interrogation	PLOS ONE			English	Article							OUTER HAIR-CELLS; IMPEDANCE SPECTROSCOPY; POTASSIUM CHANNELS; INACTIVATION; ELECTRODES; MOVEMENT; PRESTIN; SENSOR; MOTOR	Here we introduce a new technique that probes voltage-dependent charge displacements of excitable membrane-bound proteins using extracellularly applied radio frequency (RF, 500 kHz) electric fields. Xenopus oocytes were used as a model cell for these experiments, and were injected with cRNA encoding Shaker B-IR (ShB-IR) K+ ion channels to express large densities of this protein in the oocyte membranes. Two-electrode voltage clamp (TEVC) was applied to command whole-cell membrane potential and to measure channel-dependent membrane currents. Simultaneously, RF electric fields were applied to perturb the membrane potential about the TEVC level and to measure voltage-dependent RF displacement currents. ShB-IR expressing oocytes showed significantly larger changes in RF displacement currents upon membrane depolarization than control oocytes. Voltage-dependent changes in RF displacement currents further increased in ShB-IR expressing oocytes after,120 mM Cu2+ addition to the external bath. Cu2+ is known to bind to the ShB-IR ion channel and inhibit Shaker K+ conductance, indicating that changes in the RF displacement current reported here were associated with RF vibration of the Cu2+-linked mobile domain of the ShB-IR protein. Results demonstrate the use of extracellular RF electrodes to interrogate voltage-dependent movement of charged mobile protein domains-capabilities that might enable detection of small changes in charge distribution associated with integral membrane protein conformation and/ or drug-protein interactions.	[Dharia, Sameera; Rabbitt, Richard D.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Dharia, S (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	sameera_dharia@yahoo.com		Rabbitt, Richard/0000-0002-2959-7248	National Institutes of Health [R01 DC004928, R01 DC006685]; National Science Foundation [IGERT DGE-9987616]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC006685, R01DC004928, R01DC006685] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant numbers R01 DC004928 and R01 DC006685, and National Science Foundation grant number IGERT DGE-9987616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Ayliffe HE, 1999, J MICROELECTROMECH S, V8, P50, DOI 10.1109/84.749402; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cheung K, 2005, CYTOM PART A, V65A, P124, DOI 10.1002/cyto.a.20141; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; DHARIA S, 2010, P ANN INT C IEEE EMB, P889; Dharia S, 2009, LAB CHIP, V9, P3370, DOI 10.1039/b912881f; Elinder F, 2003, Q REV BIOPHYS, V36, P373, DOI 10.1017/S0033583504003932; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gritsch S, 1998, LANGMUIR, V14, P3118, DOI 10.1021/la9710381; Han A, 2006, LAB CHIP, V6, P1412, DOI 10.1039/b608930e; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; IVERSON LE, 1990, J NEUROSCI, V10, P2903; Ma ZM, 2008, J GEN PHYSIOL, V131, P483, DOI 10.1085/jgp.200809980; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Rabbitt RD, 2005, BIOPHYS J, V88, P2257, DOI 10.1529/biophysj.104.050872; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Sigg D, 1997, J GEN PHYSIOL, V109, P27, DOI 10.1085/jgp.109.1.27; SIGG D, 1994, SCIENCE, V264, P578, DOI 10.1126/science.8160016; STUHMER W, 1992, METHOD ENZYMOL, V207, P319; Werdich AA, 2004, LAB CHIP, V4, P357, DOI 10.1039/B315648F; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17363	10.1371/journal.pone.0017363	http://dx.doi.org/10.1371/journal.pone.0017363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387000	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400062
J	Knutsen, JHJ; Rein, ID; Rothe, C; Stokke, T; Grallert, B; Boye, E				Knutsen, Jon Halvor Jonsrud; Rein, Idun Dale; Rothe, Christiane; Stokke, Trond; Grallert, Beata; Boye, Erik			Cell-Cycle Analysis of Fission Yeast Cells by Flow Cytometry	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; START; GENE	The cell cycle of the fission yeast, Schizosaccharomyces pombe, does not easily lend itself to analysis by flow cytometry, mainly because cells in G(1) and G(2) phase contain the same amount of DNA. This occurs because fission yeast cells under standard growth conditions do not complete cytokinesis until after G(1) phase. We have devised a flow cytometric method exploiting the fact that cells in G(1) phase contain two nuclei, whereas cells in G(2) are mononuclear. Measurements of the width as well as the total area of the DNA-associated fluorescence signal allows the discrimination between cells in G(1) and in G(2) phase and the cell-cycle progression of fission yeast can be followed in detail by flow cytometry. Furthermore, we show how this method can be used to monitor the timing of cell entry into anaphase. Fission yeast cells tend to form multimers, which represents another problem of flow cytometry-based cell-cycle analysis. Here we present a method employing light-scatter measurements to enable the exclusion of cell doublets, thereby further improving the analysis of fission yeast cells by flow cytometry.	[Knutsen, Jon Halvor Jonsrud; Rothe, Christiane; Grallert, Beata; Boye, Erik] Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway; [Rein, Idun Dale; Stokke, Trond] Oslo Univ Hosp, Inst Canc Res, Dept Radiat Biol, Oslo, Norway; [Rothe, Christiane; Boye, Erik] Univ Oslo, Inst Mol Biosci, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Knutsen, JHJ (corresponding author), Oslo Univ Hosp, Inst Canc Res, Dept Cell Biol, Oslo, Norway.	eboye@rr-research.no		Rein, Idun Dale/0000-0002-2002-8946	Norwegian Research Council; Norwegian Cancer Society; Simon Fougner Hartmann Family Legacy	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Simon Fougner Hartmann Family Legacy	This work was funded by several grants from the Norwegian Research Council (www.forskningradet.no), from the Norwegian Cancer Society (www.kreftforeningen.no) and one from the Simon Fougner Hartmann Family Legacy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlson CR, 1999, J CELL SCI, V112, P939; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; LATT SA, 1977, J HISTOCHEM CYTOCHEM, V25, P927, DOI 10.1177/25.7.70460; LEUPOLD U., 1950, Comptes rendus des Travaux du Laboratoire Carlsberg, V24, P381; MORENO S, 1991, METHOD ENZYMOL, V194, P795; REYMOND A, 1992, MOL GEN GENET, V234, P449, DOI 10.1007/BF00538705; SABATINOS SA, 2008, METHODS MOL BIOL; SAZER S, 1990, J CELL SCI, V97, P509; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; van de Hulst H.C., 1981, LIGHT SCATTERING SMA	13	30	31	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17175	10.1371/journal.pone.0017175	http://dx.doi.org/10.1371/journal.pone.0017175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386895	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400036
J	Pons, M; Marin-Castano, ME				Pons, Marianne; Marin-Castano, Maria E.			Cigarette Smoke-Related Hydroquinone Dysregulates MCP-1, VEGF and PEDF Expression in Retinal Pigment Epithelium in Vitro and in Vivo	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; NONLETHAL OXIDANT INJURY; SUB-RPE DEPOSITS; MACULAR DEGENERATION; BRUCHS MEMBRANE; CHOROIDAL NEOVASCULARIZATION; OXIDATIVE STRESS; PROTEIN-1 MCP-1; GENE-EXPRESSION	Background: Age-related macular degeneration (AMD) is the leading cause of legal blindness in the elderly population. Debris (termed drusen) below the retinal pigment epithelium (RPE) have been recognized as a risk factor for dry AMD and its progression to wet AMD, which is characterized by choroidal neovascularization (CNV). The underlying mechanism of how drusen might elicit CNV remains undefined. Cigarette smoking, oxidative damage to the RPE and inflammation are postulated to be involved in the pathophysiology of the disease. To better understand the cellular mechanism(s) linking oxidative stress and inflammation to AMD, we examined the expression of pro-inflammatory monocyte chemoattractant protein-1 (MCP-1), pro-angiogenic vascular endothelial growth factor (VEGF) and anti-angiogenic pigment epithelial derived factor (PEDF) in RPE from smoker patients with AMD. We also evaluated the effects of hydroquinone (HQ), a major pro-oxidant in cigarette smoke on MCP-1, VEGF and PEDF expression in cultured ARPE-19 cells and RPE/choroids from C57BL/6 mice. Principal Findings: MCP-1, VEGF and PEDF expression was examined by real-time PCR, Western blot, and ELISA. Low levels of MCP-1 protein were detected in RPE from AMD smoker patients relative to controls. Both MCP-1 mRNA and protein were downregulated in ARPE-19 cells and RPE/choroids from C57BL/6 mice after 5 days and 3 weeks of exposure to HQ-induced oxidative injury. VEGF protein expression was increased and PEDF protein expression was decreased in RPE from smoker patients with AMD versus controls resulting in increased VEGF/PEDF ratio. Treatment with HQ for 5 days and 3 weeks increased the VEGF/PEDF ratio in vitro and in vivo. Conclusion: We propose that impaired RPE-derived MCP-1-mediated scavenging macrophages recruitment and phagocytosis might lead to incomplete clearance of proinflammatory debris and infiltration of proangiogenic macrophages which along with increased VEGF/PEDF ratio favoring angiogenesis might promote drusen accumulation and progression to CNV in smoker patients with dry AMD.	[Pons, Marianne; Marin-Castano, Maria E.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Pons, M (corresponding author), Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	Mcastano@med.miami.edu			Flight Attendant Medical Research Institute [072100_CIA]; Research to Prevent Blindness [P30-EY14801]; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by a Flight Attendant Medical Research Institute 072100_CIA grant and an unrestricted grant from Research to Prevent Blindness to the University of Miami P30-EY14801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript file.	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Apte RS, 2004, INVEST OPHTH VIS SCI, V45, P4491, DOI 10.1167/iovs.04-0172; Augood CA, 2006, ARCH OPHTHALMOL-CHIC, V124, P529, DOI 10.1001/archopht.124.4.529; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Bhutto IA, 2006, EXP EYE RES, V82, P99, DOI 10.1016/j.exer.2005.05.007; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; DASTGHEIB K, 1994, ARCH OPHTHALMOL-CHIC, V112, P813, DOI 10.1001/archopht.1994.01090180111045; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Delcourt C, 1998, ARCH OPHTHALMOL-CHIC, V116, P1031, DOI 10.1001/archopht.116.8.1031; Dhubhghaill SSN, 2010, ADV EXP MED BIOL, V664, P437, DOI 10.1007/978-1-4419-1399-9_50; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Evans JR, 2001, PROG RETIN EYE RES, V20, P227, DOI 10.1016/S1350-9462(00)00023-9; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Grossniklaus HE, 2002, MOL VIS, V8, P119; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Holekamp NM, 2002, AM J OPHTHALMOL, V134, P220, DOI 10.1016/S0002-9394(02)01549-0; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Husain Deeba, 2002, Ophthalmol Clin North Am, V15, P87, DOI 10.1016/S0896-1549(01)00009-8; Javitt JC, 2003, OPHTHALMOLOGY, V110, P1534, DOI 10.1016/S0161-6420(03)00495-0; Joly S, 2009, INVEST OPHTH VIS SCI, V50, P1423, DOI 10.1167/iovs.08-2432; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; KILLINGSWORTH MC, 1990, EYE, V4, P613, DOI 10.1038/eye.1990.86; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Kliffen M, 1997, BRIT J OPHTHALMOL, V81, P154, DOI 10.1136/bjo.81.2.154; Kvanta A, 1996, INVEST OPHTH VIS SCI, V37, P1929; Kwak N, 2000, INVEST OPHTH VIS SCI, V41, P3158; Lommatzsch A, 2008, GRAEF ARCH CLIN EXP, V246, P803, DOI 10.1007/s00417-007-0749-4; LOPEZ PF, 1991, AM J OPHTHALMOL, V112, P647, DOI 10.1016/S0002-9394(14)77270-8; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Marin-Castano ME, 2006, INVEST OPHTH VIS SCI, V47, P4098, DOI 10.1167/iovs.05-1230; Marin-Castano ME, 2005, INVEST OPHTH VIS SCI, V46, P3331, DOI 10.1167/iovs.04-1224; Ogata N, 2002, INVEST OPHTH VIS SCI, V43, P1168; Oh H, 1999, INVEST OPHTH VIS SCI, V40, P1891; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Ohno-Matsui K, 2001, J CELL PHYSIOL, V189, P323, DOI 10.1002/jcp.10026; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Pons M, 2010, AM J PATHOL, V177, P1198, DOI 10.2353/ajpath.2010.091108; Praddaude F, 2009, EXP EYE RES, V89, P109, DOI 10.1016/j.exer.2009.02.020; Reich S, 2003, MOL VIS, V9, P210; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; SARKS SH, 1980, T OPHTHAL SOC UK, V100, P414; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Smith W, 1996, ARCH OPHTHALMOL-CHIC, V114, P1518, DOI 10.1001/archopht.1996.01100140716016; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Strunnikova N, 2004, INVEST OPHTH VIS SCI, V45, P3767, DOI 10.1167/iovs.04-0311; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tamakoshi A, 1997, BRIT J OPHTHALMOL, V81, P901, DOI 10.1136/bjo.81.10.901; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Tong HP, 2006, CLIN BIOCHEM, V39, P267, DOI 10.1016/j.clinbiochem.2005.11.013; Tuo JS, 2007, INVEST OPHTH VIS SCI, V48, P3827, DOI 10.1167/iovs.07-0051; Uetama T, 2003, J CELL PHYSIOL, V197, P77, DOI 10.1002/jcp.10342; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VINDING T, 1990, ACTA OPHTHALMOL, V68, P410; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yang H, 2006, MOL VIS, V12, P511; Yi XJ, 1996, JPN J OPHTHALMOL, V40, P192; Yi XJ, 1997, GRAEF ARCH CLIN EXP, V235, P313, DOI 10.1007/BF01739641; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645	73	57	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16722	10.1371/journal.pone.0016722	http://dx.doi.org/10.1371/journal.pone.0016722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386905	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400011
J	Mello, MAR; Marquitti, FMD; Guimaraes, PR; Kalko, EKV; Jordano, P; de Aguiar, MAM				Ribeiro Mello, Marco Aurelio; Darcie Marquitti, Flavia Maria; Guimaraes, Paulo Roberto, Jr.; Viktoria Kalko, Elisabeth Klara; Jordano, Pedro; Martinez de Aguiar, Marcus Aloizio			The Missing Part of Seed Dispersal Networks: Structure and Robustness of Bat-Fruit Interactions	PLOS ONE			English	Article							CAROLLIA-PERSPICILLATA; MUTUALISTIC NETWORKS; FRUGIVOROUS BATS; NESTEDNESS; SPECIALIZATION; ARCHITECTURE; CONSTRAINTS; CHIROPTERA; TOLERANCE; PHENOLOGY	Mutualistic networks are crucial to the maintenance of ecosystem services. Unfortunately, what we know about seed dispersal networks is based only on bird-fruit interactions. Therefore, we aimed at filling part of this gap by investigating bat-fruit networks. It is known from population studies that: (i) some bat species depend more on fruits than others, and (ii) that some specialized frugivorous bats prefer particular plant genera. We tested whether those preferences affected the structure and robustness of the whole network and the functional roles of species. Nine bat-fruit datasets from the literature were analyzed and all networks showed lower complementary specialization (H-2' = 0.3760.10, mean 6 SD) and similar nestedness (NODF = 0.5660.12) than pollination networks. All networks were modular (M=0.32 +/- 0.07), and had on average four cohesive subgroups (modules) of tightly connected bats and plants. The composition of those modules followed the genus-genus associations observed at population level (Artibeus-Ficus, Carollia-Piper, and Sturnira-Solanum), although a few of those plant genera were dispersed also by other bats. Bat-fruit networks showed high robustness to simulated cumulative removals of both bats (R = 0.55 +/- 0.10) and plants (R = 0.68 +/- 0.09). Primary frugivores interacted with a larger proportion of the plants available and also occupied more central positions; furthermore, their extinction caused larger changes in network structure. We conclude that bat-fruit networks are highly cohesive and robust mutualistic systems, in which redundancy is high within modules, although modules are complementary to each other. Dietary specialization seems to be an important structuring factor that affects the topology, the guild structure and functional roles in bat-fruit networks.	[Ribeiro Mello, Marco Aurelio; Viktoria Kalko, Elisabeth Klara] Univ Ulm, Inst Expt Ecol, Ulm, Germany; [Darcie Marquitti, Flavia Maria] Univ Estadual Campinas, Programa Posgrad Ecol, Campinas, SP, Brazil; [Guimaraes, Paulo Roberto, Jr.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Viktoria Kalko, Elisabeth Klara] Smithsonian Trop Res Inst, Balboa, Panama; [Jordano, Pedro] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Martinez de Aguiar, Marcus Aloizio] Univ Estadual Campinas, Inst Fis Gleb Wataghin, Campinas, SP, Brazil	Ulm University; Universidade Estadual de Campinas; Universidade de Sao Paulo; Smithsonian Institution; Smithsonian Tropical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade Estadual de Campinas	Mello, MAR (corresponding author), Univ Ulm, Inst Expt Ecol, Ulm, Germany.	marmello@gmail.com	Marquitti, Flavia Maria/B-2697-2013; Jordano, Pedro/A-5162-2008; de Aguiar, Marcus A. M./N-1377-2019; Habe, Neusa K/D-6316-2011; Guimarães-Junior, Paulo R/M-1298-2016; Mello, Marco A. R./B-1095-2008; Guimaraes, Paulo R./E-1915-2016; de Aguiar, Marcus A M/C-9137-2012; Guimaraes, Paulo/B-1099-2008	Marquitti, Flavia Maria/0000-0003-0510-3992; Jordano, Pedro/0000-0003-2142-9116; Mello, Marco A. R./0000-0002-9098-9427; Guimaraes, Paulo R./0000-0001-9161-8305; de Aguiar, Marcus A M/0000-0003-1379-7568; 	Humboldt Foundation [1134644]; DFG; MEC;  [2006/00265-0]	Humboldt Foundation(Alexander von Humboldt Foundation); DFG(German Research Foundation (DFG)); MEC(European Commission); 	Fapesp (http://www.fapesp.br) sponsored M. A. R. Mello (2006/00265-0), F. M. D. Marquitti, M. A. M. Aguiar, and P. R. Guimaraes. M. A. R. Mello was also supported (1134644) by the Humboldt Foundation (http://www.humboldt-foundation.de), E. K. V. Kalko by DFG (http://www.dfg.de), and P. Jordano by MEC (http://www.educacion.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BATAGELJ V, 2008, PAJEK PROGRAM LARGE; Bianconi GV, 2007, BIOTROPICA, V39, P136, DOI 10.1111/j.1744-7429.2006.00236.x; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluethgen Nico, 2006, BMC Ecology, V6, P9, DOI 10.1186/1472-6785-6-9; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; Bravo A, 2010, J TROP ECOL, V26, P173, DOI 10.1017/S0266467409990472; Burgos E, 2007, J THEOR BIOL, V249, P307, DOI 10.1016/j.jtbi.2007.07.030; Campbell P, 2006, ANIM BEHAV, V72, P687, DOI 10.1016/j.anbehav.2006.03.002; Cipollini ML, 1997, ECOLOGY, V78, P782; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Dennis A.J., 2007, SEED DISPERSAL THEOR; Dormann C.F., 2008, R NEWS, V8, P8; Elton, 2001, ANIMAL ECOLOGY; Fleming, 1986, FRUGIVORES SEED DISP, P105, DOI DOI 10.1007/978-94-009-4812-9_11; Fleming T.H., 1982, P287; Galindo-Gonzalez J, 2000, CONSERV BIOL, V14, P1693, DOI [10.1046/j.1523-1739.2000.99072.x, 10.1111/j.1523-1739.2000.99072.x]; Geiselman C.K., 2002, DATABASE NEOTROPICAL; Giannini NP, 2004, OIKOS, V105, P209, DOI 10.1111/j.0030-1299.2004.12690.x; da Silva AG, 2008, J MAMMAL, V89, P43, DOI 10.1644/06-MAMM-A-300.1; Guimaraes PR, 2007, CURR BIOL, V17, P1797, DOI 10.1016/j.cub.2007.09.059; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Heithaus E.R., 1982, P327; HOWE HF, 1984, AM NAT, V123, P764, DOI 10.1086/284238; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; JOHNSON S, 2002, EMERGENCE CONNECTED, P288; Kalko Elisabeth K.V., 1996, P503, DOI 10.1016/B978-012178075-3/50017-9; Kissling WD, 2009, GLOBAL ECOL BIOGEOGR, V18, P150, DOI 10.1111/j.1466-8238.2008.00431.x; Lobova TA, 2009, SEED DISPERSAL BATS; MARINHOFILHO JS, 1991, J TROP ECOL, V7, P59, DOI 10.1017/S0266467400005083; Mello MAR, 2004, MAMMALIA, V68, P49, DOI 10.1515/mamm.2004.006; MELLO MAR, 2008, BIOTROPICA, V40, P777; Mello MAR, 2008, J MAMMAL, V89, P485, DOI 10.1644/06-MAMM-A-411R.1; MELO FPL, 2009, BIOTROPICA IN PRESS; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Muscarella R, 2007, BIOL REV, V82, P573, DOI 10.1111/j.1469-185X.2007.00026.x; Nogueira MR, 2003, J MAMMAL, V84, P225, DOI 10.1644/1545-1542(2003)084<0225:FSPBSO>2.0.CO;2; NOOY WD, 2005, EXPLORATORY SOCIAL N; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ollerton J, 2007, P ROY SOC B-BIOL SCI, V274, P591, DOI 10.1098/rspb.2006.3758; ROOT RB, 1967, ECOL MONOGR, V37, P317, DOI 10.2307/1942327; Shanahan M, 2001, BIOL REV, V76, P529, DOI 10.1017/S1464793101005760; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Thies W, 2004, OIKOS, V104, P362, DOI 10.1111/j.0030-1299.2004.12747.x; Thompson J. N., 2005, INTERSPEC INTERACT; Tschapka M, 2005, BIOTROPICA, V37, P409, DOI 10.1111/j.1744-7429.2005.00054.x; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zortéa M., 2003, Braz. J. Biol., V63, P159, DOI 10.1590/S1519-69842003000100020	56	66	73	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17395	10.1371/journal.pone.0017395	http://dx.doi.org/10.1371/journal.pone.0017395			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386981	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400069
J	Galdzicki, M; Rodriguez, C; Chandran, D; Sauro, HM; Gennari, JH				Galdzicki, Michal; Rodriguez, Cesar; Chandran, Deepak; Sauro, Herbert M.; Gennari, John H.			Standard Biological Parts Knowledgebase	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; DESIGN; GENE; ONTOLOGY; SYNBIOSS; ACID; TOOL	We have created the Knowledgebase of Standard Biological Parts (SBPkb) as a publically accessible Semantic Web resource for synthetic biology (sbolstandard.org). The SBPkb allows researchers to query and retrieve standard biological parts for research and use in synthetic biology. Its initial version includes all of the information about parts stored in the Registry of Standard Biological Parts (partsregistry.org). SBPkb transforms this information so that it is computable, using our semantic framework for synthetic biology parts. This framework, known as SBOL-semantic, was built as part of the Synthetic Biology Open Language (SBOL), a project of the Synthetic Biology Data Exchange Group. SBOL-semantic represents commonly used synthetic biology entities, and its purpose is to improve the distribution and exchange of descriptions of biological parts. In this paper, we describe the data, our methods for transformation to SBPkb, and finally, we demonstrate the value of our knowledgebase with a set of sample queries. We use RDF technology and SPARQL queries to retrieve candidate "promoter" parts that are known to be both negatively and positively regulated. This method provides new web based data access to perform searches for parts that are not currently possible.	[Galdzicki, Michal; Chandran, Deepak; Sauro, Herbert M.; Gennari, John H.] Univ Washington, Seattle, WA 98195 USA; [Rodriguez, Cesar] Univ Calif Berkeley, BIOFAB, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of California System; University of California Berkeley	Galdzicki, M (corresponding author), Univ Washington, Seattle, WA 98195 USA.	gennari@uw.edu	Galdzicki, Michal/F-5682-2010	Galdzicki, Michal/0000-0002-8392-8183; Sauro, Herbert/0000-0002-3659-6817; Gennari, John/0000-0001-8254-4957	National Library of Medicine [R41 LM010745, T15 LM007442]; National Institute of Biomedical Imaging and Bioengineering [BE08407]; NATIONAL LIBRARY OF MEDICINE [R41LM010745, T15LM007442] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was partially supported by grants from the National Library of Medicine (R41 LM010745, T15 LM007442), and the National Institute of Biomedical Imaging and Bioengineering (BE08407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Belkin S, 2003, CURR OPIN MICROBIOL, V6, P206, DOI 10.1016/S1369-5274(03)00059-6; BROEKSTRA J, 2002, INT SEM WEB C, P54; BROWN J, 2005, SYNTHETIC BIOL IET, V1, P3; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Cai YZ, 2010, NUCLEIC ACIDS RES, V38, P2637, DOI 10.1093/nar/gkq086; Cai YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000529; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chandran D., 2010, BIOENG BUGS, V1, P276, DOI [10.4161/bbug.1.4.12506, DOI 10.4161/BBUG.1.4.12506]; Chandran Deepak, 2009, J Biol Eng, V3, P19, DOI 10.1186/1754-1611-3-19; Clancy K, 2010, CURR OPIN BIOTECH, V21, P572, DOI 10.1016/j.copbio.2010.07.005; Cooling MT, 2010, BIOINFORMATICS, V26, P925, DOI 10.1093/bioinformatics/btq063; DENSMORE D, 2009, P 5 R TAP CEL DIV CO, P24; DENSMORE D, 2010, NUCLEIC ACIDS RES, P1; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Galdzicki M., 2009, 31 BBF RFC; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GOLER JA, 2004, BIOJADE DESIGN SIMUL; Goler JA, 2008, TRENDS BIOTECHNOL, V26, P538, DOI 10.1016/j.tibtech.2008.06.003; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; Grunberg R., 2009, 30 BBF RFC; HAM T, 2010, P INT WORKSH BIOD AU; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hearst M. A., 2009, SEARCH USER INTERFAC; Hill AD, 2008, BIOINFORMATICS, V24, P2551, DOI 10.1093/bioinformatics/btn468; Joshi N, 2009, DESALINATION, V248, P517, DOI 10.1016/j.desal.2008.05.096; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; KNIGHT TF, 1921, SYNTHETIC BIOL WORKI; Luciano JS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S3; Motik B, 2009, ARTIF INTELL, V173, P1275, DOI 10.1016/j.artint.2009.06.003; Peccoud J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002671; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rialle S, 2010, BIOINFORMATICS, V26, P2298, DOI 10.1093/bioinformatics/btq409; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Rouilly V, 2007, BMC SYS BIOL S1, V1, pP79; Sahoo SS, 2008, J BIOMED INFORM, V41, P752, DOI 10.1016/j.jbi.2008.02.006; Savageau MA, 2001, CHAOS, V11, P142, DOI 10.1063/1.1349892; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Sirin E, 2007, J WEB SEMANT, V5, P51, DOI 10.1016/j.websem.2007.03.004; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Steen EJ, 2010, NATURE, V463, P559, DOI 10.1038/nature08721; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Tsarkov D, 2006, LECT NOTES ARTIF INT, V4130, P292; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Weeding E, 2010, BRIEF BIOINFORM, V11, P394, DOI 10.1093/bib/bbq002; Young E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/130781	52	60	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17005	10.1371/journal.pone.0017005	http://dx.doi.org/10.1371/journal.pone.0017005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390321	gold, Green Submitted, Green Published			2022-12-27	WOS:000287761700025
J	Viergever, RF; Ghersi, D				Viergever, Roderik F.; Ghersi, Davina			The Quality of Registration of Clinical Trials	PLOS ONE			English	Article							STATEMENT; REGISTER	Background: Lack of transparency in clinical trial conduct, publication bias and selective reporting bias are still important problems in medical research. Through clinical trials registration, it should be possible to take steps towards resolving some of these problems. However, previous evaluations of registered records of clinical trials have shown that registered information is often incomplete and non-meaningful. If these studies are accurate, this negates the possible benefits of registration of clinical trials. Methods and Findings: A 5% sample of records of clinical trials that were registered between 17 June 2008 and 17 June 2009 was taken from the International Clinical Trials Registry Platform (ICTRP) database and assessed for the presence of contact information, the presence of intervention specifics in drug trials and the quality of primary and secondary outcome reporting. 731 records were included. More than half of the records were registered after recruitment of the first participant. The name of a contact person was available in 94.4% of records from non-industry funded trials and 53.7% of records from industry funded trials. Either an email address or a phone number was present in 76.5% of non-industry funded trial records and in 56.5% of industry funded trial records. Although a drug name or company serial number was almost always provided, other drug intervention specifics were often omitted from registration. Of 3643 reported outcomes, 34.9% were specific measures with a meaningful time frame. Conclusions: Clinical trials registration has the potential to contribute substantially to improving clinical trial transparency and reducing publication bias and selective reporting. These potential benefits are currently undermined by deficiencies in the provision of information in key areas of registered records.	[Viergever, Roderik F.; Ghersi, Davina] WHO, ICTRP, Dept Res Policy & Cooperat, CH-1211 Geneva, Switzerland	World Health Organization	Viergever, RF (corresponding author), WHO, ICTRP, Dept Res Policy & Cooperat, CH-1211 Geneva, Switzerland.	ghersid@who.int	Viergever, Roderik F./I-4847-2019	Viergever, Roderik F./0000-0001-5328-2580				[Anonymous], 2002, INT C HARMONISATION; Baleta A, 2010, LANCET, V375, P1423, DOI 10.1016/S0140-6736(10)60604-6; *BIREME PAHO WHO, 2009, CLIN TRIALS REG ADV, DOI DOI 10.1007/S00103-009-0833-5; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Claxton LD, 2005, MUTAT RES-REV MUTAT, V589, P17, DOI 10.1016/j.mrrev.2004.07.003; *CLINICALTRIALS GO, 2010, PROT DAT EL IN PRESS; De Angelis CD, 2005, CAN MED ASSOC J, V172, P1700, DOI 10.1503/cmaj.050600; Drazen JM, 2007, NEW ENGL J MED, V356, P184, DOI 10.1056/NEJMe068291; Dreier G, 2009, BUNDESGESUNDHEITSBLA, V52, P463, DOI 10.1007/s00103-009-0833-5; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Feczko J, 2006, NEW ENGL J MED, V354, P1426; Ghersi D, 2008, B WORLD HEALTH ORGAN, V86, P492, DOI 10.2471/BLT.08.053769; Ghersi Davina, 2009, J Evid Based Med, V2, P1, DOI 10.1111/j.1756-5391.2009.01014.x; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Hooft L, 2004, Ned Tijdschr Geneeskd, V148, P1866; Horton R, 2004, LANCET, V364, P1995, DOI 10.1016/S0140-6736(04)17523-5; IFPMA/EFPIA/JPMA/PhRMA, 2009, JOINT POS DISCL CLIN; *INT COMM MED J, 2004, CLIN TRIAL REG STAT; *JAP MIN HLTH LAB, 2008, STAT JAP PRIM REG NE; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kreymann B., LANCET, V330, P1300, DOI [10.1016/s0140-6736(87)91194-9, DOI 10.1016/S0140-6736(87)91194-9, DOI 10.1016/S0140-6736(09)60329-9]; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Laine C, 2007, LANCET, V369, P1909, DOI 10.1016/S0140-6736(07)60894-0; LI YP, 2006, JOINT STAT EST CHIN; Liu Xuemei, 2009, J Evid Based Med, V2, P8, DOI 10.1111/j.1756-5391.2009.01007.x; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moja Lorenzo P, 2009, Trials, V10, P56, DOI 10.1186/1745-6215-10-56; Pandey A, 2009, INDIAN J MED RES, V130, P85; Ranawaka Udaya K, 2007, Ceylon Med J, V52, P117; Rogers WH, 1993, STATA TECHN B, V13, P19; Ross DB, 2007, NEW ENGL J MED, V356, P1601, DOI 10.1056/NEJMp078032; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Scherer M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-18; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]; Scoggins JF, 2009, CONTEMP CLIN TRIALS, V30, P289, DOI 10.1016/j.cct.2009.02.005; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Shafer SL, 2009, ANESTH ANALG, V108, P1351, DOI 10.1213/ane.0b013e31819e3de7; Solaymani-Dodaran Masoud, 2009, J Evid Based Med, V2, P32, DOI 10.1111/j.1756-5391.2009.01002.x; Tonkin A, 2005, BRIT J PSYCHIAT, V187, P304, DOI 10.1192/bjp.187.4.304; *WHO, 2010, WHO INT CLIN TRIALS; Willyard C, 2007, NAT MED, V13, P763, DOI 10.1038/nm0707-763; *WORLD ASS MED ED, 2005, REG CLIN TRIALS; World Health Organization, WHO TRIAL REG DAT SE; *WORLD MED ASS, 2008, DECL HELS, DOI DOI 10.1038//NM0707-763; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234	45	98	98	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e14701	10.1371/journal.pone.0014701	http://dx.doi.org/10.1371/journal.pone.0014701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383991	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700001
J	Hao, PL; Guo, TN; Sze, SK				Hao, Piliang; Guo, Tiannan; Sze, Siu Kwan			Simultaneous Analysis of Proteome, Phospho- and Glycoproteome of Rat Kidney Tissue with Electrostatic Repulsion Hydrophilic Interaction Chromatography	PLOS ONE			English	Article							PHOSPHOPROTEOME ANALYSIS; MASS-SPECTROMETRY; AFFINITY-CHROMATOGRAPHY; AXONAL-TRANSPORT; N-GLYCOSYLATION; MOUSE-BRAIN; PHOSPHORYLATION; ENRICHMENT; IDENTIFICATION; PHOSPHOPEPTIDES	Protein post-translational modifications (PTMs) are regulated separately from protein expression levels. Thus, simultaneous characterization of the proteome and its PTMs is pivotal to an understanding of protein regulation, function and activity. However, concurrent analysis of the proteome and its PTMs by mass spectrometry is a challenging task because the peptides bearing PTMs are present in sub-stoichiometric amounts and their ionization is often suppressed by unmodified peptides of high abundance. We describe here a method for concurrent analysis of phosphopeptides, glycopeptides and unmodified peptides in a tryptic digest of rat kidney tissue with a sequence of ERLIC and RP-LC-MS/MS in a single experimental run, thereby avoiding inter-experimental variation. Optimization of loading solvents and elution gradients permitted ERLIC to be performed with totally volatile solvents. Two SCX and four ERLIC gradients were compared in details, and one ERLIC gradient was found to perform the best, which identified 2929 proteins, 583 phosphorylation sites in 338 phosphoproteins and 722 N-glycosylation sites in 387 glycoproteins from rat kidney tissue. Two hundred low-abundance proteins with important functions were identified only from the glyco-or phospho-subproteomes, reflecting the importance of the enrichment and separation of modified peptides by ERLIC. In addition, this strategy enables identification of unmodified and corresponding modified peptides (partial phosphorylation and N-glycosylation) from the same protein. Interestingly, partially modified proteins tend to occur on proteins involved in transport. Moreover, some membrane or extracellular proteins, such as versican core protein and fibronectin, were found to have both phosphorylation and N-glycosylation, which may permit an assessment of the potential for cross talk between these two vital PTMs and their roles in regulation.	[Hao, Piliang; Guo, Tiannan; Sze, Siu Kwan] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hao, PL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.	sksze@ntu.edu.sg	Guo, Tiannan/AAR-3568-2020; Sze, Siu Kwan/AAO-3342-2020; Sze, Siu_kwan Newman/A-2199-2011	Guo, Tiannan/0000-0003-3869-7651; Sze, Siu Kwan/0000-0002-5652-1687; Sze, Siu_kwan Newman/0000-0002-5652-1687	Ministry of Education [ARC: T206B3211]; Agency for Science, Technology and Research of Singapore [BMRC: 08/1/22/19/575]	Ministry of Education; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR))	This work is supported by grants from the Ministry of Education (ARC: T206B3211) and the Agency for Science, Technology and Research (BMRC: 08/1/22/19/575) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Alpert AJ, 2008, ANAL CHEM, V80, P62, DOI 10.1021/ac070997P; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; BULLER HA, 1989, BIOCHEM J, V263, P249; Calvano CD, 2008, J PROTEOMICS, V71, P304, DOI 10.1016/j.jprot.2008.06.013; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Cuchillo-Ibanez I, 2008, FASEB J, V22, P3186, DOI 10.1096/fj.08-109181; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Dorn M, 2009, FEBS LETT, V583, P1631, DOI 10.1016/j.febslet.2009.04.037; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Feng S, 2007, MOL CELL PROTEOMICS, V6, P1656, DOI 10.1074/mcp.T600071-MCP200; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Gan CS, 2008, J PROTEOME RES, V7, P4869, DOI 10.1021/pr800473j; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Guo T, 2008, J PROTEOME RES, V7, P4831, DOI 10.1021/pr800403z; Han GH, 2008, PROTEOMICS, V8, P1346, DOI 10.1002/pmic.200700884; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Hu P, 2010, FEBS LETT, V584, P2526, DOI 10.1016/j.febslet.2010.04.044; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ito Shigeyasu, 2009, V534, P195, DOI 10.1007/978-1-59745-022-5_14; Kehlenbach RH, 2000, J BIOL CHEM, V275, P17848, DOI 10.1074/jbc.M001455200; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lewandrowski U., 2008, CLIN PROTEOM, V4, P25, DOI [10.1007/s12014-008-9006-z, DOI 10.1007/S12014-008-9006-Z]; Lewandrowski U, 2007, MOL CELL PROTEOMICS, V6, P1933, DOI 10.1074/mcp.M600390-MCP200; Miida T, 2008, ATHEROSCLEROSIS, V200, P329, DOI 10.1016/j.atherosclerosis.2007.12.031; Moon PG, 2008, ELECTROPHORESIS, V29, P4324, DOI 10.1002/elps.200800070; Morelle W, 2006, PROTEOMICS, V6, P3993, DOI 10.1002/pmic.200600129; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Ren Y, 2007, J PROTEOME RES, V6, P2812, DOI 10.1021/pr070047k; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Shea TB, 2004, J NEUROSCI RES, V76, P795, DOI 10.1002/jnr.20099; Temporini C, 2008, MASS SPECTROM REV, V27, P207, DOI 10.1002/mas.20164; Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Wu YB, 2009, MOL CELL PROTEOMICS, V8, P2809, DOI 10.1074/mcp.M900293-MCP200; Zhang H, 2007, MOL CELL PROTEOMICS, V6, P64, DOI 10.1074/mcp.M600160-MCP200; Zhang HM, 2010, MOL CELL PROTEOMICS, V9, P635, DOI 10.1074/mcp.M900314-MCP200	50	46	48	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16884	10.1371/journal.pone.0016884	http://dx.doi.org/10.1371/journal.pone.0016884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373199	Green Published, gold			2022-12-27	WOS:000287657500021
J	Roodenburg, AJC; Schlatmann, A; Dotsch-Klerk, M; Daamen, R; Dong, J; Guarro, M; Stergiou, M; Sayed, N; Ronoh, E; Jansen, L; Seidell, JC				Roodenburg, Annet J. C.; Schlatmann, Anke; Doetsch-Klerk, Mariska; Daamen, Robert; Dong, Jie; Guarro, Marta; Stergiou, Margarita; Sayed, Nazeeia; Ronoh, Eunice; Jansen, Leon; Seidell, Jacob C.			Potential Effects of Nutrient Profiles on Nutrient Intakes in the Netherlands, Greece, Spain, USA, Israel, China and South-Africa	PLOS ONE			English	Article							NUTRITIONAL QUALITY; FOOD-CONSUMPTION; VALIDATION; SCHEMES; DIET; TOOL	Introduction: Nutrient profiling is defined as the science of categorising foods based on their nutrient composition. Choices Programme is a nutrient profile system with criteria that determine whether foods are eligible to carry a "option" stamp. The Daily Menu Method which has been developed to evaluate these criteria is described here. This simulates the change in calculated nutrient intakes which would be the result of consumers changing their diets in favour food products that comply with the criteria. Methods: Average intakes of energy, trans fatty acids (TFA), saturated fatty acids (SAFA), sodium, added sugar and were derived from dietary intake studies and food consumption surveys of 7 countries: The Netherlands, Greece, Spain, USA, Israel, China and South Africa. For each of the key nutrients, these average intakes were translated into three Daily Menus per country. Average intakes based on these three menus were compared with average intakes from Choices Daily Menus. To compose the Choices Menus, foods from the Typical Menus that did not comply with the criteria were replaced with foods that did comply and are available on the market. Results: Comparison of intakes from the Choices Menus with the survey data showed that calculated intakes of SAFA, TFA, sodium and added sugar were reduced. Fibre intakes were increased. The size of the effect differed per Conclusion: The Daily Menu Method is a useful means to predict the potential effects of nutrient profiles such as Choices criteria, on daily nutrient intakes. The method can be applied internationally and confirms that the criteria of Choices Programme are in line with the aim of the programme: to improve nutrient intakes in the direction of recommendations.	[Roodenburg, Annet J. C.; Seidell, Jacob C.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [Roodenburg, Annet J. C.; Doetsch-Klerk, Mariska; Daamen, Robert] Unilever Res Labs, Vlaardingen, Netherlands; [Schlatmann, Anke] Unilever Benelux, Rotterdam, Netherlands; [Dong, Jie] Unilever Discover, Shanghai, Peoples R China; [Guarro, Marta] Unilever Spain, Barcelona, Spain; [Stergiou, Margarita] Unilever Greece, Athens, Greece; [Sayed, Nazeeia] Unilever S Africa, Durban, South Africa; [Ronoh, Eunice] Unilever Israel, Tel Aviv, Israel; [Jansen, Leon] Choices Int Fdn, Brussels, Belgium	Vrije Universiteit Amsterdam; Unilever; Unilever; Unilever; Unilever; Unilever; Unilever; Unilever	Roodenburg, AJC (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands.	annet.roodenburg@falw.vu.nl	seidell, jacob/AAF-5362-2019; seidell, jacob c/N-7427-2013; jansen, leon/W-9159-2019	seidell, jacob/0000-0002-9262-9062; 	Netherlands Organisation for Scientific Research (NWO) [018.003.012]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The preparation of this manuscript study was supported by a grant (018.003.012) from the Netherlands Organisation for Scientific Research (NWO). Website: http://www.nwo.nl/. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Regarding the authors: AR is seconded to VU University Amsterdam and employed by Unilever. The authors AR, AS, RD, JD, MG, MS, NS, ER, MDK are employed by Unilever.	Arambepola C, 2008, PUBLIC HEALTH NUTR, V11, P371, DOI 10.1017/S1368980007000377; Azais-Braesco V, 2006, PUBLIC HEALTH NUTR, V9, P613, DOI 10.1079/PHN2006966; BEYERS T, 1998, NUTR EPIDEMIOLOGY, P347; Charlton KE, 2005, NUTRITION, V21, P39, DOI 10.1016/j.nut.2004.09.007; Committee on Medical Aspects of Food Policy, 1991, REP HLTH SOC SUBJ; *CONS NAC AL COM E, 1997, REC ED AL POP PORT R; Darmon N, 2009, AM J CLIN NUTR, V89, P1227, DOI 10.3945/ajcn.2008.26465; Drewnowski A, 2005, AM J CLIN NUTR, V82, P721, DOI 10.1093/ajcn/82.4.721; Drewnowski A, 2008, NUTR REV, V66, P23, DOI 10.1111/j.1753-4887.2007.00003.x; *DTSCH GES ERN OST, 2000, REF NAHRST 2000; EC, 2007, OFFICIAL J EUROPEA L, VL12, P3; FAO/WHO Consultation, 2003, WHO TECHN REP SER, V916; Farran A., 2004, FOOD COMPOSITION TAB; *FOOD NUTR SERV PU, 2008, ISR NUTR DAT BINAT; *FOOD STAND AG, 2003, NAT DIET NUTR SURV A, V2; Food Standards Agency, 2002, MCCANCE WIDD COMP FO; Fulgoni VL, 2009, J NUTR, V139, P1549, DOI 10.3945/jn.108.101360; Garsetti M, 2007, EUR J NUTR, V46, P15, DOI 10.1007/s00394-007-2002-7; *HEA, 1994, BAL GOOD HLTH; *HLTH COUNC NETH, 2006, PUBL HLGH COUNC NETH; Hulshof KFAM, 1999, EUR J CLIN NUTR, V53, P143, DOI 10.1038/sj.ejcn.1600692; *ISR CTR DIS CONTR, 2001, MABAT 1 ISR HLTH N 2; JANSEN L, 2007, VOEDING NU, V4, P21; Labouze E, 2007, PUBLIC HEALTH NUTR, V10, P690, DOI 10.1017/S1368980007382505; *LIVSM NAT FOOD AD, 2009, KEYH SYMB; Luzzi A. F., 2001, Public Health Nutrition, V4, P437; MacIntyre UE, 2002, NUTR RES, V22, P239, DOI 10.1016/S0271-5317(01)00392-X; Mammas I, 2004, INT J FOOD SCI NUTR, V55, P17, DOI 10.1080/09637480310001642448; *MIN AGR PESC AL P, 2008, AL ESP 2006 EST COMM; *MIN HLTH MIN SCI, 2008, NUTR HLTH STAT CHIN; *MRC, 2002, FOODF 3 FOOD COMP AN; Naska A, 2005, ARCH HELL MED, V22, P259; *NAT AC I MED, 2002, DIET REF INT CARB FI; *NAT HEART FDN NZ, 2002, PICK TICK FOOD INF P; Nijman CAJ, 2007, EUR J CLIN NUTR, V61, P461, DOI 10.1038/sj.ejcn.1602548; OTERO ML, 2000, CARDIOVASC RISK FACT, V9, P319; Quinio C, 2007, EUR J NUTR, V46, P37, DOI 10.1007/s00394-007-2005-4; Rayner M, 2005, NUTR PROFILES APPL C; Rayner M., 2005, FINAL REPORT; Roodenburg AJC, 2009, NUTR BULL, V34, P318, DOI 10.1111/j.1467-3010.2009.01767.x; Scarborough P, 2007, PUBLIC HEALTH NUTR, V10, P337, DOI 10.1017/S1368980007666671; Steyn NP, 2003, PUBLIC HEALTH NUTR, V6, P631, DOI 10.1079/PHN2003482; *STICHT NED VOED, 2006, NEVO FOOD COMP DAT; Townsend MS, 2010, AM J CLIN NUTR, V91, p1109S, DOI 10.3945/ajcn.2010.28450F; TRICHOPOULOU A, 2007, COMPOSITION TABLES F; United States Department of Agriculture ARS [USDA] USDA Nutrient Data Laboratory., 2008, USDA NAT NUTR DAT ST; *USDA, 2005, USDA DAT ADD SUG CON; *USDA, 1993, USDA DAT FATT AC CON; Van Raaij J, 2008, PUBLIC HEALTH NUTR, V12, P1; *VOED, 1998, ZO EET RESULTATEN VO; Volatier JL, 2007, EUR J NUTR, V46, P29, DOI 10.1007/s00394-007-2004-5; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Waxman Amalia, 2004, Food and Nutrition Bulletin, V25, P292; WRIGHT JD, 2003, CDC ADV DATA VITAL H, V334; Yang Y., 2002, CHINA FOOD COMPOSITI, V2002nd ed.; Zhou BF, 2003, J HUM HYPERTENS, V17, P623, DOI 10.1038/sj.jhh.1001605	56	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14721	10.1371/journal.pone.0014721	http://dx.doi.org/10.1371/journal.pone.0014721			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373186	Green Published, gold			2022-12-27	WOS:000287657500005
J	Wachtler, B; Wilson, D; Haedicke, K; Dalle, F; Hube, B				Waechtler, Betty; Wilson, Duncan; Haedicke, Katja; Dalle, Frederic; Hube, Bernhard			From Attachment to Damage: Defined Genes of Candida albicans Mediate Adhesion, Invasion and Damage during Interaction with Oral Epithelial Cells	PLOS ONE			English	Article							PROTEIN-KINASE; TRANSCRIPTIONAL RESPONSE; EXPRESSION; VIRULENCE; PATHOGEN; DISRUPTION; MORPHOGENESIS; MECHANISMS; EFFICIENT; ISOFORMS	Candida albicans frequently causes superficial infections by invading and damaging epithelial cells, but may also cause systemic infections by penetrating through epithelial barriers. C. albicans is an unusual pathogen because it can invade epithelial cells via two distinct mechanisms: induced endocytosis, analogous to facultative intracellular enteropathogenic bacteria, and active penetration, similar to plant pathogenic fungi. Here we investigated the molecular basis of C. albicans epithelial interactions. By systematically assessing the contributions of defined fungal pathways and factors to different stages of epithelial interactions, we provide an expansive portrait of the processes and activities involved in epithelial infection. We strengthen the concept that hyphal formation is critical for epithelial invasion. Importantly, our data support a model whereby initial epithelial invasion per se does not elicit host damage, but that C. albicans relies on a combination of contact-sensing, directed hyphal extension, active penetration and the expression of novel pathogenicity factors for further inter-epithelial invasion, dissemination and ultimate damage of host cells. Finally, we explore the transcriptional landscape of C. albicans during the early stages of epithelial interaction, and, via genetic analysis, identify ICL1 and PGA34 as novel oral epithelial pathogenicity factors.	[Waechtler, Betty; Wilson, Duncan; Haedicke, Katja; Hube, Bernhard] Hans Knoell Inst Jena, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany; [Dalle, Frederic] Univ Bourgogne, Fac Med, Lab Interact Muqueuses Agents Transmissibles, IFR Sante STIC,EA 562, Dijon, France; [Dalle, Frederic] Univ Hosp, Dijon, France; [Hube, Bernhard] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Universite de Bourgogne; CHU Dijon Bourgogne; Friedrich Schiller University of Jena	Wachtler, B (corresponding author), Hans Knoell Inst Jena, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogen Mech, Jena, Germany.	bernhard.hube@hki-jena.de		Hube, Bernhard/0000-0002-6028-0425; Wilson, Duncan/0000-0001-6617-0123	Deutsche Forschungsgemeinschaft [Hu528/10, Sch897/3]; Hans Knoell Institute Jena	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans Knoell Institute Jena	This work was supported by the Deutsche Forschungsgemeinschaft Hu528/10 and Sch897/3 with the URL www.dfg.de and the Hans Knoell Institute Jena with the URL www.hki-jena.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonazzi M, 2006, FEBS LETT, V580, P2962, DOI 10.1016/j.febslet.2006.04.010; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Brand A, 2008, EUKARYOT CELL, V7, P712, DOI 10.1128/EC.00453-07; Brand A, 2009, CURR OPIN MICROBIOL, V12, P350, DOI 10.1016/j.mib.2009.05.007; Bruno VM, 2005, MOL MICROBIOL, V56, P559, DOI 10.1111/j.1365-2958.2005.04562.x; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cantero PD, 2007, MOL MICROBIOL, V64, P1115, DOI 10.1111/j.1365-2958.2007.05723.x; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Chiang LY, 2007, CELL MICROBIOL, V9, P233, DOI 10.1111/j.1462-5822.2006.00784.x; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; DENFERT C, 2007, COMP FUNCTIONAL GENE; Dennison PMJ, 2005, FUNGAL GENET BIOL, V42, P737, DOI 10.1016/j.fgb.2005.05.006; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Filler SG, 2006, PLOS PATHOG, V2, P1099, DOI 10.1371/journal.ppat.0020129; FONZI WA, 1993, GENETICS, V134, P717; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; Hromatka BS, 2005, MOL BIOL CELL, V16, P4814, DOI 10.1091/mbc.E05-05-0435; Hube B, 2004, CURR OPIN MICROBIOL, V7, P336, DOI 10.1016/j.mib.2004.06.003; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Kumamoto CA, 2008, NAT REV MICROBIOL, V6, P667, DOI 10.1038/nrmicro1960; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Liu HP, 2001, CURR OPIN MICROBIOL, V4, P728, DOI 10.1016/S1369-5274(01)00275-2; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Monteoliva L, 1996, YEAST, V12, P1097, DOI 10.1002/(SICI)1097-0061(19960915)12:11<1097::AID-YEA990>3.0.CO;2-E; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Negredo A, 1997, MICROBIOL-UK, V143, P297, DOI 10.1099/00221287-143-2-297; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Odds F, 1988, ECOLOGY EPIDEMIOLOGY; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Phan QT, 2005, J BIOL CHEM, V280, P10455, DOI 10.1074/jbc.M412592200; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Prill SKH, 2005, MOL MICROBIOL, V55, P546, DOI 10.1111/j.1365-2958.2004.04401.x; Rouabhia M, 2005, INFECT IMMUN, V73, P4571, DOI 10.1128/IAI.73.8.4571-4580.2005; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; RUHNKE M, 2002, SKIN MUCOUS MEMBRANE, P307; RUPNIAK HT, 1985, J NATL CANCER I, V75, P621; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Sundstrom P, 2002, CELL MICROBIOL, V4, P461, DOI 10.1046/j.1462-5822.2002.00206.x; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Thissen D, 2002, J EDUC BEHAV STAT, V27, P77, DOI 10.3102/10769986027001077; Tronchin G, 2008, MED MYCOL, V46, P749, DOI 10.1080/13693780802206435; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wang A, 2009, MOL CELL BIOL, V29, P4406, DOI 10.1128/MCB.01502-08; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x	58	174	207	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17046	10.1371/journal.pone.0017046	http://dx.doi.org/10.1371/journal.pone.0017046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21407800	Green Submitted, gold, Green Published			2022-12-27	WOS:000287657500028
J	Erb-Downward, JR; Thompson, DL; Han, MK; Freeman, CM; McCloskey, L; Schmidt, LA; Young, VB; Toews, GB; Curtis, JL; Sundaram, B; Martinez, FJ; Huffnagle, GB				Erb-Downward, John R.; Thompson, Deborah L.; Han, Meilan K.; Freeman, Christine M.; McCloskey, Lisa; Schmidt, Lindsay A.; Young, Vincent B.; Toews, Galen B.; Curtis, Jeffrey L.; Sundaram, Baskaran; Martinez, Fernando J.; Huffnagle, Gary B.			Analysis of the Lung Microbiome in the "Healthy" Smoker and in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE; RESPIRATORY-INFECTION; REFERENCE VALUES; CYSTIC-FIBROSIS; DIVERSITY; EXACERBATIONS; BURDEN; ADULTS	Although culture-independent techniques have shown that the lungs are not sterile, little is known about the lung microbiome in chronic obstructive pulmonary disease (COPD). We used pyrosequencing of 16S amplicons to analyze the lung microbiome in two ways: first, using bronchoalveolar lavage (BAL) to sample the distal bronchi and air-spaces; and second, by examining multiple discrete tissue sites in the lungs of six subjects removed at the time of transplantation. We performed BAL on three never-smokers (NS) with normal spirometry, seven smokers with normal spirometry ("heathy smokers", HS), and four subjects with COPD (CS). Bacterial 16s sequences were found in all subjects, without significant quantitative differences between groups. Both taxonomy-based and taxonomy-independent approaches disclosed heterogeneity in the bacterial communities between HS subjects that was similar to that seen in healthy NS and two mild COPD patients. The moderate and severe COPD patients had very limited community diversity, which was also noted in 28% of the healthy subjects. Both approaches revealed extensive membership overlap between the bacterial communities of the three study groups. No genera were common within a group but unique across groups. Our data suggests the existence of a core pulmonary bacterial microbiome that includes Pseudomonas, Streptococcus, Prevotella, Fusobacterium, Haemophilus, Veillonella, and Porphyromonas. Most strikingly, there were significant micro-anatomic differences in bacterial communities within the same lung of subjects with advanced COPD. These studies are further demonstration of the pulmonary microbiome and highlight global and micro-anatomic changes in these bacterial communities in severe COPD patients.	[Erb-Downward, John R.; Thompson, Deborah L.; Han, Meilan K.; Freeman, Christine M.; McCloskey, Lisa; Schmidt, Lindsay A.; Young, Vincent B.; Toews, Galen B.; Curtis, Jeffrey L.; Sundaram, Baskaran; Martinez, Fernando J.; Huffnagle, Gary B.] Univ Michigan, Ann Arbor, MI 48109 USA; [Freeman, Christine M.; McCloskey, Lisa; Toews, Galen B.; Curtis, Jeffrey L.] Vet Affairs Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Erb-Downward, JR (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	ghuff@umich.edu	Young, Vincent Bensan/M-9916-2019; Huffnagle, Gary B./ABF-1323-2020; Young, Vincent B/B-3179-2009	Young, Vincent Bensan/0000-0003-3687-2364; Young, Vincent B/0000-0003-3687-2364; Curtis, Jeffrey/0000-0001-5191-4847	Department of Internal Medicine [U020559]; Michigan Institute for Clinical and Health Research [UL1 RR024986]; National Heart, Lung and Blood Institute [R01 HL082480]; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK070875, T32 HL07749]; Biomedical Laboratory Research and Development Service, Department of Veterans Affairs; Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center [P30 CA46952]; Lung Tissue Research Consortium (Clinical Centers) [N01 HR046162]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749, R01HL082480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070875] Funding Source: NIH RePORTER	Department of Internal Medicine; Michigan Institute for Clinical and Health Research; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Biomedical Laboratory Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center; Lung Tissue Research Consortium (Clinical Centers); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These investigations were supported by Department of Internal Medicine Pilot Grant U020559; the Michigan Institute for Clinical and Health Research, Grant UL1 RR024986; National Heart, Lung and Blood Institute grant R01 HL082480; National Institute of Diabetes and Digestive and Kidney Diseases R01 grant R01 DK070875; T32 HL07749; and by a Research Enhancement Award Program and a Career Development Award (C. M. F.) from the Biomedical Laboratory Research and Development Service, Department of Veterans Affairs. Partial support also came from by the Tissue Procurement Core of the University of Michigan Comprehensive Cancer Center, Grant P30 CA46952, and by the Lung Tissue Research Consortium (Clinical Centers), Grant N01 HR046162. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, EUR J CLIN MICROBIOL, V28, P1151, DOI 10.1007/s10096-009-0749-x; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Barnes P., 2008, ASTHMA COPD BASIC ME, V2nd; BAUGHMAN RP, 1987, CHEST, V91, P233, DOI 10.1378/chest.91.2.233; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CURTIS J, 2007, P AM THORACIC, V4, P412; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; FLETCHER CM, 1978, J EPIDEMIOL COMMUN H, V32, P282, DOI 10.1136/jech.32.4.282; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hattotuwa K, 2002, CHEST, V122, P1909, DOI 10.1378/chest.122.6.1909; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; JARIOKSANEN, 2010, VEGAN COMMUNITY ECOL; KAHN FW, 1987, J INFECT DIS, V155, P862, DOI 10.1093/infdis/155.5.862; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marion MS, 2001, CHEST, V120, P489, DOI 10.1378/chest.120.2.489; Martinez FD, 1999, CLIN EXP ALLERGY, V29, P53; Martinez Fernando J, 2006, Expert Rev Anti Infect Ther, V4, P101, DOI 10.1586/14787210.4.1.101; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; Murray CJL, 1996, SCIENCE, V274, P740, DOI 10.1126/science.274.5288.740; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Papi Alberto, 2006, Proc Am Thorac Soc, V3, P245, DOI 10.1513/pats.200512-125SF; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sartor RB, 2008, P NATL ACAD SCI USA, V105, P16413, DOI 10.1073/pnas.0809363105; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; THORPE JE, 1987, J INFECT DIS, V155, P855, DOI 10.1093/infdis/155.5.855; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	38	594	625	7	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16384	10.1371/journal.pone.0016384	http://dx.doi.org/10.1371/journal.pone.0016384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364979	Green Submitted, Green Published, gold			2022-12-27	WOS:000287656600006
J	Poulsen, M; Oh, DC; Clardy, J; Currie, CR				Poulsen, Michael; Oh, Dong-Chan; Clardy, Jon; Currie, Cameron R.			Chemical Analyses of Wasp-Associated Streptomyces Bacteria Reveal a Prolific Potential for Natural Products Discovery	PLOS ONE			English	Article							DRUG DISCOVERY; METABOLITES; XENORHABDUS	Identifying new sources for small molecule discovery is necessary to help mitigate the continuous emergence of antibiotic-resistance in pathogenic microbes. Recent studies indicate that one potentially rich source of novel natural products is Actinobacterial symbionts associated with social and solitary Hymenoptera. Here we test this possibility by examining two species of solitary mud dauber wasps, Sceliphron caementarium and Chalybion californicum. We performed enrichment isolations from 33 wasps and obtained more than 200 isolates of Streptomyces Actinobacteria. Chemical analyses of 15 of these isolates identified 11 distinct and structurally diverse secondary metabolites, including a novel polyunsaturated and polyoxygenated macrocyclic lactam, which we name sceliphrolactam. By pairing the 15 Streptomyces strains against a collection of fungi and bacteria, we document their antifungal and antibacterial activity. The prevalence and anti-microbial properties of Actinobacteria associated with these two solitary wasp species suggest the potential role of these Streptomyces as antibiotic-producing symbionts, potentially helping defend their wasp hosts from pathogenic microbes. Finding phylogenetically diverse and chemically prolific Actinobacteria from solitary wasps suggests that insect-associated Actinobacteria can provide a valuable source of novel natural products of pharmaceutical interest.	[Poulsen, Michael; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Poulsen, Michael] Univ Copenhagen, Dept Biol, Sect Ecol & Evolut, Copenhagen, Denmark; [Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Oh, Dong-Chan] Seoul Natl Univ, Coll Pharm, Inst Nat Prod Res, Seoul, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Copenhagen; Harvard University; Harvard Medical School; Seoul National University (SNU)	Poulsen, M (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu	Poulsen, Michael/C-6276-2012	Poulsen, Michael/0000-0002-2839-1715	Carlsberg Foundation; Ministry of Education, Science and Technology [2010-0010141]; NIH [CA24487, GM086258, GM096347]; NSF [DEB-0747002]; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC4GM096347, R01GM086258] Funding Source: NIH RePORTER	Carlsberg Foundation(Carlsberg Foundation); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Carlsberg Foundation to MP, Basic Science Research Program through NRF funded by the Ministry of Education, Science and Technology (No. 2010-0010141) to DCO, NIH grants CA24487 and GM086258 to JC, NIH grant GM096347 to JC and CC, and NSF grant DEB-0747002 to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Michael Poulsen received support from Carlsberg Foundation for his post-doctoral studies. This philanthropic program developed by Carlsberg beer company is designed to support pure science research in Denmark, and as such, does not constitute competing interests. Further, this does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; Clardy J, 2009, CURR BIOL, V19, pR437, DOI 10.1016/j.cub.2009.04.001; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Davelos AL, 2004, APPL ENVIRON MICROB, V70, P1051, DOI 10.1128/AEM.70.2.1051-1058.2004; DIMARCO A, 1964, NATURE, V201, P706, DOI 10.1038/201706a0; DRAUTZ H, 1981, HELV CHIM ACTA, V64, P1752, DOI 10.1002/hlca.19810640605; DUNSHEE BR, 1949, J AM CHEM SOC, V71, P2436, DOI 10.1021/ja01175a057; Fenical W, 2006, NAT CHEM BIOL, V2, P666, DOI 10.1038/nchembio841; FERGUSON CS, 1989, J INSECT BEHAV, V2, P315, DOI 10.1007/BF01068058; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; GRABLEY VS, 1987, ANGEW CHEM, V99, P692; Haygood Margo G., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P33; ITANO S, 1995, HEPATOLOGY, V22, P1305; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Khosla C, 2003, NAT REV DRUG DISCOV, V2, P1019, DOI 10.1038/nrd1256; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Leng FF, 1997, J CELL BIOCHEM, V64, P476, DOI 10.1002/(SICI)1097-4644(19970301)64:3<476::AID-JCB14>3.0.CO;2-E; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Li WQ, 2006, J BIOL CHEM, V281, P23785, DOI 10.1074/jbc.M605269200; Maddison D.R., 2005, MACCLADE 4 07 OS X; Miao V, 2009, MICROBIOL MONOGR, V10, P161, DOI 10.1007/7171_2008_8; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; OH DC, 2011, ORG LETT IN PRESS; Oh DC, 2009, NAT CHEM BIOL, V5, P391, DOI 10.1038/nchembio.159; Oh DC, 2009, ORG LETT, V11, P633, DOI 10.1021/ol802709x; Peraud O, 2009, APPL ENVIRON MICROB, V75, P6820, DOI 10.1128/AEM.01238-09; Piel J, 2005, J NAT PROD, V68, P472, DOI 10.1021/np049612d; Piel J, 2004, NAT PROD REP, V21, P519, DOI 10.1039/b310175b; Piel J, 2002, P NATL ACAD SCI USA, V99, P14002, DOI 10.1073/pnas.222481399; Poulsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000960; Poulsen M, 2010, ENV MICROBIOL REP, V2, P534, DOI 10.1111/j.1758-2229.2009.00098.x; Puder C, 2000, J NAT PROD, V63, P1258, DOI 10.1021/np0001373; Rau P., 1916, J ANIM BEHAV, V6, P27; RICHARDSON WH, 1988, APPL ENVIRON MICROB, V54, P1602, DOI 10.1128/AEM.54.6.1602-1605.1988; Schmidt EW, 2008, NAT CHEM BIOL, V4, P466, DOI 10.1038/nchembio.101; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Staley JT, 2006, PHILOS T R SOC B, V361, P1899, DOI 10.1098/rstb.2006.1914; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Thawai C, 2004, CHEM BIODIVERS, V1, P640, DOI 10.1002/cbdv.200490055; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; WERNER G, 1983, TETRAHEDRON LETT, V24, P5193, DOI 10.1016/S0040-4039(00)88394-X	57	100	107	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16763	10.1371/journal.pone.0016763	http://dx.doi.org/10.1371/journal.pone.0016763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364940	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600018
J	Hong, CS; Cui, JA; Ni, ZH; Su, YY; Puett, D; Li, F; Xu, Y				Hong, Celine S.; Cui, Juan; Ni, Zhaohui; Su, Yingying; Puett, David; Li, Fan; Xu, Ying			A Computational Method for Prediction of Excretory Proteins and Application to Identification of Gastric Cancer Markers in Urine	PLOS ONE			English	Article							BIOMARKER DISCOVERY; ENDOTHELIAL LIPASE; PROTEOMICS	A novel computational method for prediction of proteins excreted into urine is presented. The method is based on the identification of a list of distinguishing features between proteins found in the urine of healthy people and proteins deemed not to be urine excretory. These features are used to train a classifier to distinguish the two classes of proteins. When used in conjunction with information of which proteins are differentially expressed in diseased tissues of a specific type versus control tissues, this method can be used to predict potential urine markers for the disease. Here we report the detailed algorithm of this method and an application to identification of urine markers for gastric cancer. The performance of the trained classifier on 163 proteins was experimentally validated using antibody arrays, achieving >80% true positive rate. By applying the classifier on differentially expressed genes in gastric cancer vs normal gastric tissues, it was found that endothelial lipase (EL) was substantially suppressed in the urine samples of 21 gastric cancer patients versus 21 healthy individuals. Overall, we have demonstrated that our predictor for urine excretory proteins is highly effective and could potentially serve as a powerful tool in searches for disease biomarkers in urine in general.	[Hong, Celine S.; Cui, Juan; Puett, David; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Hong, Celine S.; Cui, Juan; Puett, David; Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Ni, Zhaohui; Su, Yingying; Li, Fan] Jilin Univ, Dept Pathogenobiol, Changchun, Jilin, Peoples R China; [Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun, Jilin, Peoples R China	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Hong, CS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	xyn@bmb.uga.edu	Puett, J. David/AIE-8612-2022		National Science Foundation [CCF-0621700, DBI0542119004, 1R01GM075331]; Jilin University; University of Georgia; Georgia Cancer Coalition; Georgia Research Alliance; National Institutes of Health [1R01GM075331, DK69711]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075331] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Jilin University(Jilin University); University of Georgia; Georgia Cancer Coalition; Georgia Research Alliance; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This study was supported in part by the National Science Foundation (CCF-0621700, DBI0542119004, 1R01GM075331), Jilin University, the University of Georgia, the Georgia Cancer Coalition, the Georgia Research Alliance and the National Institutes of Health (1R01GM075331, DK69711). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r80; *AFF, 2005, ALT TRANSCR AN METH; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barratt J, 2007, CAN MED ASSOC J, V177, P361, DOI 10.1503/cmaj.061590; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Castagna A, 2005, J PROTEOME RES, V4, P1917, DOI 10.1021/pr050153r; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CUI J, 2008, BIOINFORMATICS, V42; CUI J, 2010, NUCL ACIDS IN PRESS; Decramer S, 2008, MOL CELL PROTEOMICS, V7, P1850, DOI 10.1074/mcp.R800001-MCP200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; GILMORE RE, 1973, HDB PHYSL, P185; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Griffon N, 2009, J BIOL CHEM, V284, P23322, DOI 10.1074/jbc.M109.037002; Hand DJ, 2001, MACH LEARN, V45, P171, DOI 10.1023/A:1010920819831; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Osicka TM, 1997, CLIN SCI, V93, P557, DOI 10.1042/cs0930557; Pang JX, 2002, J PROTEOME RES, V1, P161, DOI 10.1021/pr015518w; Pieper R, 2004, PROTEOMICS, V4, P1159, DOI 10.1002/pmic.200300661; PLATT JC, 1999, ADV KERNEL METHODS V; Rader DJ, 2000, CURR OPIN LIPIDOL, V11, P141, DOI 10.1097/00041433-200004000-00006; Rasband W.S., 1997, IMAGEJ; Wang LJ, 2006, MOL CELL PROTEOMICS, V5, P560, DOI 10.1074/mcp.D500013-MCP200; Weissinger EM, 2007, BLOOD, V109, P5511, DOI 10.1182/blood-2007-01-069757; Wu JM, 2006, NUCLEIC ACIDS RES, V34, pW720, DOI 10.1093/nar/gkl167; Zimmerli LU, 2008, MOL CELL PROTEOMICS, V7, P290, DOI 10.1074/mcp.M700394-MCP200	29	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16875	10.1371/journal.pone.0016875	http://dx.doi.org/10.1371/journal.pone.0016875			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365014	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482800018
J	Denning, WL; Xu, J; Guo, SQ; Klug, CA; Hel, Z				Denning, Warren L.; Xu, Jun; Guo, Siqi; Klug, Christopher A.; Hel, Zdenek			Limited Transplantation of Antigen-Expressing Hematopoietic Stem Cells Induces Long-Lasting Cytotoxic T Cell Responses	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; DENDRITIC CELLS; LENTIVIRAL VECTORS; GENE-THERAPY; CANCER-IMMUNOTHERAPY; IN-VIVO; BLOOD DISORDERS; INDUCTION; INFECTION; MEMORY	Harnessing the ability of cytotoxic T lymphocytes (CTLs) to recognize and eradicate tumor or pathogen-infected cells is a critical goal of modern immune-based therapies. Although multiple immunization strategies efficiently induce high levels of antigen-specific CTLs, the initial increase is typically followed by a rapid contraction phase resulting in a sharp decline in the frequency of functional CTLs. We describe a novel approach to immunotherapy based on a transplantation of low numbers of antigen-expressing hematopoietic stem cells (HSCs) following nonmyeloablative or partially myeloablative conditioning. Continuous antigen presentation by a limited number of differentiated transgenic hematopoietic cells results in an induction and prolonged maintenance of fully functional effector T cell responses in a mouse model. Recipient animals display high levels of antigen-specific CTLs four months following transplantation in contrast to dendritic cell-immunized animals in which the response typically declines at 4-6 weeks post-immunization. Majority of HSC-induced antigen-specific CD8(+) T cells display central memory phenotype, efficiently kill target cells in vivo, and protect recipients against tumor growth in a preventive setting. Furthermore, we confirm previously published observation that high level engraftment of antigen-expressing HSCs following myeloablative conditioning results in tolerance and an absence of specific cytotoxic activity in vivo. In conclusion, the data presented here supports potential application of immunization by limited transplantation of antigen-expressing HSCs for the prevention and treatment of cancer and therapeutic immunization of chronic infectious diseases such as HIV-1/AIDS.	[Denning, Warren L.; Klug, Christopher A.; Hel, Zdenek] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Xu, Jun; Guo, Siqi; Hel, Zdenek] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Denning, WL (corresponding author), Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA.	zhel@uab.edu		Hel, Zdenek/0000-0002-4923-4794; Denning, Warren/0000-0003-0781-4288	National Institutes of Health [AI063967]; Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI063967 and by internal funds from the Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardavin C, 2003, NAT REV IMMUNOL, V3, P582, DOI 10.1038/nri1127; Baron F, 2006, MOL THER, V13, P26, DOI 10.1016/j.ymthe.2005.09.011; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Blanchard N, 2010, ANN NY ACAD SCI, V1183, P237, DOI 10.1111/j.1749-6632.2009.05135.x; Bondanza A, 2006, BLOOD, V107, P1828, DOI 10.1182/blood-2005-09-3716; Breckpot K, 2007, GENE THER, V14, P847, DOI 10.1038/sj.gt.3302947; Case SS, 1999, P NATL ACAD SCI USA, V96, P2988, DOI 10.1073/pnas.96.6.2988; Chan J, 2008, J IMMUNOL, V181, P7571, DOI 10.4049/jimmunol.181.11.7571; COLIGAN JE, 2010, CURRENT PROTOCOLS IM, P1991; Cui Y, 2003, NAT MED, V9, P952, DOI 10.1038/nm882; Dresch C, 2008, J IMMUNOL, V181, P4495, DOI 10.4049/jimmunol.181.7.4495; Eggert AAO, 1999, CANCER RES, V59, P3340; Emmanouilidis N, 2005, METH MOLEC MED, V109, P459; Finn OJ, 2003, NAT REV IMMUNOL, V3, P630, DOI 10.1038/nri1150; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gratwohl A, 2009, BONE MARROW TRANSPL, V43, P275, DOI 10.1038/bmt.2009.7; Guo S, 2009, GENE THER, V16, P1300, DOI 10.1038/gt.2009.93; Hel Z, 2000, NAT MED, V6, P1140, DOI 10.1038/80481; Hel Z, 2001, J IMMUNOL, V167, P7180, DOI 10.4049/jimmunol.167.12.7180; HEL Z, 2007, CANCER GENE THER, P139; Hel Z, 2006, TRENDS IMMUNOL, V27, P274, DOI 10.1016/j.it.2006.04.007; Hsieh MM, 2007, EXP HEMATOL, V35, P1415, DOI 10.1016/j.exphem.2007.05.009; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Kemball CC, 2005, J IMMUNOL, V174, P7950, DOI 10.4049/jimmunol.174.12.7950; Klebanoff CA, 2005, P NATL ACAD SCI USA, V102, P9571, DOI 10.1073/pnas.0503726102; Klebanoff CA, 2006, IMMUNOL REV, V211, P214, DOI 10.1111/j.0105-2896.2006.00391.x; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Lu B, 2008, CELL DEATH DIFFER, V15, P70, DOI 10.1038/sj.cdd.4402274; Marodon G, 2006, BLOOD, V108, P2972, DOI 10.1182/blood-2006-03-010900; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Naldini L, 2006, NAT MED, V12, P386, DOI 10.1038/nm0406-386; Nienhuis AW, 2008, BLOOD, V111, P4431, DOI 10.1182/blood-2007-11-078121; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Powell DJ, 2004, J IMMUNOTHER, V27, P36, DOI 10.1097/00002371-200401000-00004; Roberts AD, 2005, J EXP MED, V202, P123, DOI 10.1084/jem.20050137; Rosenberg SA, 2005, J IMMUNOL, V175, P6169, DOI 10.4049/jimmunol.175.9.6169; Ruedl C, 2000, J IMMUNOL, V165, P4910, DOI 10.4049/jimmunol.165.9.4910; Saccardi R, 2005, BLOOD, V105, P2601, DOI 10.1182/blood-2004-08-3205; Sandmaier BM, 2007, BIOL BLOOD MARROW TR, V13, P87, DOI 10.1016/j.bbmt.2006.10.015; Schultze JL, 2004, TRENDS IMMUNOL, V25, P659, DOI 10.1016/j.it.2004.09.016; Storb Rainer, 2009, Curr Opin Oncol, V21 Suppl 1, pS3, DOI 10.1097/01.cco.0000357467.45843.ba; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Tryniszewska E, 2002, J IMMUNOL, V169, P5347, DOI 10.4049/jimmunol.169.9.5347; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Vulink A, 2008, ADV CANCER RES, V99, P363, DOI 10.1016/S0065-230X(07)99006-5; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2009, CURR OPIN GENET DEV, V19, P461, DOI 10.1016/j.gde.2009.08.005; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702; Zhang X, 2008, CANCER GENE THER, V15, P73, DOI 10.1038/sj.cgt.7701108; Zhao PL, 2006, EXP HEMATOL, V34, P951, DOI 10.1016/j.exphem.2006.04.015; Zheng XC, 2004, EUR J IMMUNOL, V34, P3126, DOI 10.1002/eji.200425177	56	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16897	10.1371/journal.pone.0016897	http://dx.doi.org/10.1371/journal.pone.0016897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379572	Green Published, gold, Green Submitted			2022-12-27	WOS:000287482300024
J	Guo, Y; He, B; Xu, XB; Wang, JD				Guo, Yong; He, Bin; Xu, Xiangbo; Wang, Jiedong			Comprehensive Analysis of Leukocytes, Vascularization and Matrix Metalloproteinases in Human Menstrual Xenograft Model	PLOS ONE			English	Article							HUMAN ENDOMETRIUM; NUDE-MICE; IMMUNODEFICIENT MICE; SILASTIC IMPLANTS; MOUSE; PROGESTERONE; BREAKDOWN; UTERUS; TISSUE	In our previous study, menstrual-like changes in mouse were provoked through the pharmacologic withdrawal of progesterone with mifepristone following induction of decidualization. However, mouse is not a natural menstruation animal, and the menstruation model using external stimuli may not truly reflect the occurrence and development of the human menstrual process. Therefore, we established a model of menstruation based on human endometrial xenotransplantation. In this model, human endometrial tissues were transplanted subcutaneously into SCID mice that were ovarectomized and supplemented with estrogen and progestogen by silastic implants with a scheme imitating the endocrinological milieu of human menstrual cycle. Morphology, hormone levels, and expression of vimentin and cytokeratin markers were evaluated to confirm the menstrual-like changes in this model. With 28 days of hormone treatment, transplanted human endometrium survived and underwent proliferation, differentiation and disintegration, similar to human endometrium in vivo. Human CD45(+) cells showed a peak of increase 28 days post-transplantation. Three days after progesterone withdrawal, mouse CD45(+) cells increased rapidly in number and were significantly greater than human CD45(+) cell counts. Mouse CD31(+) blood vascular-like structures were detected in both transplanted and host tissues. After progesterone withdrawal, the expression levels of matrix metalloproteinases (MMP) 1, 2, and 9 were increased. In summary, we successfully established a human endometrial xenotransplantation model in SCID mice, based on the results of menstrual-like changes in which MMP-1, 2 and 9 are involved. We showed that leukocytes are originated from in situ proliferation in human xenografts and involved in the occurrence of menstruation. This model will help to further understand the occurrence, growth, and differentiation of the endometrium and the underlying mechanisms of menstruation.	[Guo, Yong] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Guo, Yong; He, Bin; Xu, Xiangbo; Wang, Jiedong] Natl Res Inst Family Planning, Dept Cell Biol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Research Institute for Family Planning - China	Guo, Y (corresponding author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China.	hebox@263.net; jdwangmail-hr@yahoo.com.cn		Guo, Yong/0000-0002-3148-4525	Fundamental Research Funds for the Central Institutes [2007GJSSJKA07]; National Nature Science Foundation of China [30872766]	Fundamental Research Funds for the Central Institutes; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Funds for the Central Institutes (No. 2007GJSSJKA07) and the National Nature Science Foundation of China (No. 30872766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beliard A, 2002, FERTIL STERIL, V78, P973, DOI 10.1016/S0015-0282(02)03370-8; BERGQVIST A, 1985, AM J PATHOL, V121, P337; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Brenner RM, 1996, HUM REPROD, V11, P150, DOI 10.1093/humrep/11.suppl_2.150; COHEN PE, 1993, J REPROD FERTIL, V99, P219, DOI 10.1530/jrf.0.0990219; DALLENBACHHELLW.G, 1987, HISTOPATHOLOGY ENDOM, P158; FINN CA, 1984, J ENDOCRINOL, V100, P295, DOI 10.1677/joe.0.1000295; Gonzalez MLA, 2009, HUM REPROD, V24, P697, DOI 10.1093/humrep/den437; Gordon H, 1936, AM J PATHOL, V12, P545; Grummer R, 2001, HUM REPROD, V16, P1736, DOI 10.1093/humrep/16.8.1736; Jabbour HN, 2006, ENDOCR REV, V27, P17, DOI 10.1210/er.2004-0021; Kaitu'u TJ, 2005, BIOL REPROD, V73, P672, DOI 10.1095/biolreprod.105.042473; King AE, 2010, J STEROID BIOCHEM, V120, P116, DOI 10.1016/j.jsbmb.2010.01.003; Marbaix E, 1996, P NATL ACAD SCI USA, V93, P9120, DOI 10.1073/pnas.93.17.9120; Masuda H, 2007, P NATL ACAD SCI USA, V104, P1925, DOI 10.1073/pnas.0604310104; Matsuura-Sawada R, 2005, HUM REPROD, V20, P1477, DOI 10.1093/humrep/deh783; MILLIGAN SR, 1994, REPROD FERT DEVELOP, V6, P235, DOI 10.1071/RD9940235; Nisolle M, 2000, HUM REPROD, V15, P572, DOI 10.1093/humrep/15.3.572; Ozawa Y, 2006, FERTIL STERIL, V86, P1146, DOI 10.1016/j.fertnstert.2006.01.057; Popovici RM, 2006, ENDOCRINOLOGY, V147, P5662, DOI 10.1210/en.2006-0916; Salamonsen LA, 2002, J REPROD IMMUNOL, V57, P95, DOI 10.1016/S0165-0378(02)00011-6; Tibbetts TA, 1999, BIOL REPROD, V60, P1158, DOI 10.1095/biolreprod60.5.1158; Xu XB, 2007, HUM REPROD, V22, P3184, DOI 10.1093/humrep/dem312	24	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16840	10.1371/journal.pone.0016840	http://dx.doi.org/10.1371/journal.pone.0016840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379384	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482300021
J	Mukherjee, A; Tria, F; Baronchelli, A; Puglisi, A; Loreto, V				Mukherjee, Animesh; Tria, Francesca; Baronchelli, Andrea; Puglisi, Andrea; Loreto, Vittorio			Aging in Language Dynamics	PLOS ONE			English	Article							SPIN-GLASSES; COLOR; BRIGHTNESS; CATEGORIES; EMERGENCE; EVOLUTION; MODEL; HUE	Human languages evolve continuously, and a puzzling problem is how to reconcile the apparent robustness of most of the deep linguistic structures we use with the evidence that they undergo possibly slow, yet ceaseless, changes. Is the state in which we observe languages today closer to what would be a dynamical attractor with statistically stationary properties or rather closer to a non-steady state slowly evolving in time? Here we address this question in the framework of the emergence of shared linguistic categories in a population of individuals interacting through language games. The observed emerging asymptotic categorization, which has been previously tested - with success - against experimental data from human languages, corresponds to a metastable state where global shifts are always possible but progressively more unlikely and the response properties depend on the age of the system. This aging mechanism exhibits striking quantitative analogies to what is observed in the statistical mechanics of glassy systems. We argue that this can be a general scenario in language dynamics where shared linguistic conventions would not emerge as attractors, but rather as metastable states.	[Mukherjee, Animesh; Tria, Francesca; Loreto, Vittorio] ISI, Turin, Italy; [Baronchelli, Andrea] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Barcelona, Spain; [Puglisi, Andrea] CNR ISC, Rome, Italy; [Puglisi, Andrea; Loreto, Vittorio] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Universitat Politecnica de Catalunya; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Mukherjee, A (corresponding author), ISI, Turin, Italy.	Vittorio.Loreto@roma1.infn.it	Baronchelli, Andrea/F-9550-2016; Galantucci, Bruno/E-5770-2010; Puglisi, Andrea/C-5566-2008	Baronchelli, Andrea/0000-0002-0255-0829; Puglisi, Andrea/0000-0002-7229-9457	Spanish Ministerio de Ciencia e Innovacion; Fondo Europeo de Desarrollo Regional [FIS2007-66485-C02-01]; Junta de Andalucia [P09-FQM4682]; Italian MIUR [RBID08Z9JE]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fondo Europeo de Desarrollo Regional(European Commission); Junta de Andalucia(Junta de Andalucia); Italian MIUR(Ministry of Education, Universities and Research (MIUR))	A. Baronchelli acknowledges support from the Spanish Ministerio de Ciencia e Innovacion through the Juan de la Cierva program, as well as from project FIS2007-66485-C02-01 (Fondo Europeo de Desarrollo Regional), and from the Junta de Andalucia project P09-FQM4682. A. Puglisi acknowledges support by the Italian MIUR under the FIRB-IDEAS grant RBID08Z9JE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baronchelli A, 2008, INT J MOD PHYS C, V19, P785, DOI 10.1142/S0129183108012522; Baronchelli A, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/06/P06014; Baronchelli A, 2010, P NATL ACAD SCI USA, V107, P2403, DOI 10.1073/pnas.0908533107; Berlin B., 1969, BASIC COLOR TERMS; Berlin B., 1991, BASIC COLOR TERMS TH; Casson R. W., 1997, COLOR CATEGORIES THO, P224, DOI DOI 10.1017/CB09780511519819.010; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Cook R S, 2005, HDB CATEGORISATION C; Croft W., 2000, EXPLAINING LANGUAGE; Emberts Zachary, 2020, EVOLUTION, V74, P897, DOI [10.1111/evo.13948, DOI 10.1111/EVO.13580]; Gardner Howard, 1985, MINDS NEW SCI HIST C; Garner W. R., 1974, PROCESSING INFORM ST; Halliday M, 1976, SYSTEM FUNCTION LANG; Halliday M.A.K, 1989, LANGUAGE CONTEXT TEX, V2; Hruschka DJ, 2009, TRENDS COGN SCI, V13, P464, DOI 10.1016/j.tics.2009.08.008; Jameson K., 1997, COLOR CATEGORIES THO, P295, DOI DOI 10.1017/CBO9780511519819.014; Jameson KA, 2005, CROSS-CULT RES, V39, P159, DOI 10.1177/1069397104273766; Kay P, 2003, P NATL ACAD SCI USA, V100, P9085, DOI 10.1073/pnas.1532837100; Labov W., 1994, PRINCIPLES LINGUISTI, V1; Labov W, 2007, LANGUAGE, V83, P344, DOI 10.1353/lan.2007.0082; Lakoff George, 1987, WOMEN FIRE, DOI DOI 10.7208/CHICAGO/9780226471013.001.0001; Lieberman E, 2007, NATURE, V449, P713, DOI 10.1038/nature06137; MACLAURY RE, 1992, CURR ANTHROPOL, V33, P137, DOI 10.1086/204049; Milroy James, 1992, LINGUISTIC VARIATION; Pagel M, 2007, NATURE, V449, P717, DOI 10.1038/nature06176; Picco M, 2001, EUR PHYS J B, V21, P211, DOI 10.1007/PL00011122; Puglisi A, 2008, P NATL ACAD SCI USA, V105, P7936, DOI 10.1073/pnas.0802485105; Regier T, 2007, P NATL ACAD SCI USA, V104, P1436, DOI 10.1073/pnas.0610341104; Steels Luc, 1995, Artificial Life, V2, P319; Taylor John R., 2003, LINGUISTIC CATEGORIZ; Tomasello M., 2005, CONSTRUCTING LANGUAG; Toulouse G., 1987, SPIN GLASS THEORY IN, V9, P99; Vincent E, 1997, LECT NOTES PHYS, V492, P184; William Labov, 2001, PRINCIPLES LINGUISTI, V2; Wittgenstein Ludwig, 1968, PHILOS INVESTIGATION; YAMAGUCHI N, 1996, 4 C JAP ASS SYST FUN	39	14	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e16677	10.1371/journal.pone.0016677	http://dx.doi.org/10.1371/journal.pone.0016677			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21390207	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000287482300019
J	Yew, JY; Dreisewerd, K; de Oliveira, CC; Etges, WJ				Yew, Joanne Y.; Dreisewerd, Klaus; de Oliveira, Cassia Cardoso; Etges, William J.			Male-Specific Transfer and Fine Scale Spatial Differences of Newly Identified Cuticular Hydrocarbons and Triacylglycerides in a Drosophila Species Pair	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; CACTOPHILIC DROSOPHILA; PREMATING ISOLATION; EPICUTICULAR HYDROCARBONS; REPRODUCTIVE ISOLATION; ISOLATED POPULATIONS; SEXUAL ISOLATION; INCIPIENT SPECIATION; STENOCEREUS-GUMMOSUS; MOJAVENSIS CLUSTER	We analyzed epicuticular hydrocarbon variation in geographically isolated populations of D. mojavensis cultured on different rearing substrates and a sibling species, D. arizonae, with ultraviolet laser desorption/ionization mass spectrometry (UV-LDI MS). Different body parts, i.e. legs, proboscis, and abdomens, of both species showed qualitatively similar hydrocarbon profiles consisting mainly of long-chain monoenes, dienes, trienes, and tetraenes. However, D. arizonae had higher amounts of most hydrocarbons than D. mojavensis and females of both species exhibited greater hydrocarbon amounts than males. Hydrocarbon profiles of D. mojavensis populations were significantly influenced by sex and rearing substrates, and differed between body parts. Lab food-reared flies had lower amounts of most hydrocarbons than flies reared on fermenting cactus substrates. We discovered 48 male-and species-specific hydrocarbons ranging in size from C-22 to C-50 in the male anogenital region of both species, most not described before. These included several oxygen-containing hydrocarbons in addition to high intensity signals corresponding to putative triacylglycerides, amounts of which were influenced by larval rearing substrates. Some of these compounds were transferred to female cuticles in high amounts during copulation. This is the first study showing that triacylglycerides may be a separate class of courtship-related signaling molecules in drosophilids. This study also extends the kind and number of epicuticular hydrocarbons in these species and emphasizes the role of larval ecology in influencing amounts of these compounds, many of which mediate courtship success within and between species.	[Yew, Joanne Y.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Yew, Joanne Y.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Yew, Joanne Y.; Dreisewerd, Klaus] Univ Munster, Inst Med Phys & Biophys, Munster, Germany; [de Oliveira, Cassia Cardoso; Etges, William J.] Univ Arkansas, Dept Biol Sci, Program Ecol & Evolutionary Biol, Fayetteville, AR 72701 USA	National University of Singapore; National University of Singapore; University of Munster; University of Arkansas System; University of Arkansas Fayetteville	Yew, JY (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	wetges@uark.edu	Dreisewerd, Klaus/K-3884-2015; Yew, Joanne/D-6562-2014	Dreisewerd, Klaus/0000-0002-7619-808X; 	National Science Foundations [NSF EF-0723930]; Alexander von Humboldt Foundation; Singapore National Research Foundation [RF001-363]	National Science Foundations(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Singapore National Research Foundation(National Research Foundation, Singapore)	National Science Foundations grant NSF EF-0723930, http://www.nsf.gov; Alexander von Humboldt Foundation, no grant number; Singapore National Research Foundation RF001-363. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALCORN SM, 1991, INT J SYST BACTERIOL, V41, P197, DOI 10.1099/00207713-41-2-197; ALONSOPIMENTEL H, 1992, J INSECT BEHAV, V5, P131, DOI 10.1007/BF01049164; Atchison J., 1986, STAT ANAL COMPOSITIO; Barker J.S.F., 1982, ECOLOGICAL GENETICS; Blows MW, 1998, AM NAT, V152, P826, DOI 10.1086/286211; BRAZNER JC, 1993, EVOL ECOL, V7, P605, DOI 10.1007/BF01237824; Byrne BC, 1999, THESIS U LEICESTER L; Capy P, 2000, HEREDITY, V84, P468, DOI 10.1046/j.1365-2540.2000.00711.x; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; COYNE JA, 1995, P NATL ACAD SCI USA, V92, P9505, DOI 10.1073/pnas.92.21.9505; Cvacka J, 2006, J CHEM ECOL, V32, P409, DOI 10.1007/s10886-005-9008-5; Dreisewerd K, 2005, ANAL CHEM, V77, P4098, DOI 10.1021/ac048373w; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Etges WJ, 2008, J EVOLUTION BIOL, V21, P1641, DOI 10.1111/j.1420-9101.2008.01601.x; Etges WJ, 2006, J CHEM ECOL, V32, P2629, DOI 10.1007/s10886-006-9187-8; Etges WJ, 2006, ANIM BEHAV, V71, P1205, DOI 10.1016/j.anbehav.2005.11.006; Etges WJ, 2010, EVOLUTION, V64, P3549, DOI 10.1111/j.1558-5646.2010.01096.x; Etges WJ, 2009, EVOLUTION, V63, P1712, DOI 10.1111/j.1558-5646.2009.00661.x; Etges William J., 1999, P164; Etges WJ, 2001, J CHEM ECOL, V27, P2125, DOI 10.1023/A:1012203222876; ETGES WJ, 1987, OECOLOGIA, V71, P375, DOI 10.1007/BF00378710; ETGES WJ, 1992, EVOLUTION, V46, P1945, DOI [10.2307/2410042, 10.1111/j.1558-5646.1992.tb01180.x]; Etges WJ, 2001, AM NAT, V158, P585, DOI 10.1086/323587; Everaerts C, 2010, ANIM BEHAV, V79, P1135, DOI 10.1016/j.anbehav.2010.02.013; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; FELLOWS DP, 1972, ECOLOGY, V53, P850, DOI 10.2307/1934300; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; FOGLEMAN JC, 1981, P NATL ACAD SCI-BIOL, V78, P4435, DOI 10.1073/pnas.78.7.4435; FOGLEMAN JC, 1989, APPL ENVIRON MICROB, V55, P100, DOI 10.1128/AEM.55.1.100-105.1989; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Heed W.G., 1986, P311; Heed W.B., 1982, P65; Heed W. B., 1978, ECOLOGICAL GENETICS, P109, DOI DOI 10.1007/978-1-4612-6330-2; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JACKSON LL, 1974, INSECT BIOCHEM, V4, P369, DOI 10.1016/0020-1790(74)90074-2; JALLON JM, 1981, CR ACAD SCI III-VIE, V292, P1147; Jennings JH, 2010, EVOLUTION, V64, P587, DOI 10.1111/j.1558-5646.2009.00834.x; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; MARKOW TA, 1983, EVOLUTION, V37, P649, DOI 10.1111/j.1558-5646.1983.tb05585.x; Mas F, 2005, J CHEM ECOL, V31, P2747, DOI 10.1007/s10886-005-7570-5; Millar JG, 2000, ANNU REV ENTOMOL, V45, P575, DOI 10.1146/annurev.ento.45.1.575; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Mori K, 2010, TETRAHEDRON, V66, P7161, DOI 10.1016/j.tet.2010.06.080; RUIZ A, 1988, J ANIM ECOL, V57, P237, DOI 10.2307/4775; RUIZ A, 1990, J HERED, V81, P30, DOI 10.1093/oxfordjournals.jhered.a110922; SAS-Institute, 2004, SAS STAT 9 1 2; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Starmer W.T., 1982, P159; STARMER WT, 1982, MICROBIAL ECOL, V8, P71, DOI 10.1007/BF02011463; STARMER WT, 1990, EVOL BIOL, V24, P253; Stennett MD, 1997, J CHEM ECOL, V23, P2803, DOI 10.1023/A:1022519228346; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TOOLSON EC, 1990, ANN ENTOMOL SOC AM, V83, P1165, DOI 10.1093/aesa/83.6.1165; Wasserman Marvin, 1992, P455; Xu A, 2002, CELL TISSUE RES, V307, P381, DOI 10.1007/s00441-002-0524-0; Yew JY, 2008, P NATL ACAD SCI USA, V105, P7135, DOI 10.1073/pnas.0802692105; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; ZAWISTOWSKI S, 1986, J INSECT PHYSIOL, V32, P189, DOI 10.1016/0022-1910(86)90057-0	61	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2011	6	2							e16898	10.1371/journal.pone.0016898	http://dx.doi.org/10.1371/journal.pone.0016898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	721PR	21369358	gold, Green Submitted, Green Published			2022-12-27	WOS:000287367600022
J	Schultz, KM; Banisadr, G; Lastra, RO; McGuire, T; Kessler, JA; Miller, RJ; McGarry, TJ				Schultz, Kathryn M.; Banisadr, Ghazal; Lastra, Ruben O.; McGuire, Tammy; Kessler, John A.; Miller, Richard J.; McGarry, Thomas J.			Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal Neurogenesis	PLOS ONE			English	Article							DNA-REPLICATION; DEVELOPMENTAL-CHANGES; CYCLE; XENOPUS; EXPRESSION; CNS; DIFFERENTIATION; RESPONSIVENESS; PROLIFERATION; REREPLICATION	Neural stem cells (NSCs) are the progenitors of neurons and glial cells during both embryonic development and adult life. The unstable regulatory protein Geminin (Gmnn) is thought to maintain neural stem cells in an undifferentiated state while they proliferate. Geminin inhibits neuronal differentiation in cultured cells by antagonizing interactions between the chromatin remodeling protein Brg1 and the neural-specific transcription factors Neurogenin and NeuroD. Geminin is widely expressed in the CNS during throughout embryonic development, and Geminin expression is down-regulated when neuronal precursor cells undergo terminal differentiation. Over-expression of Geminin in gastrula-stage Xenopus embryos can expand the size of the neural plate. The role of Geminin in regulating vertebrate neurogenesis in vivo has not been rigorously examined. To address this question, we created a strain of Nestin-Cre/Gmnn(fl/fl) mice in which the Geminin gene was specifically deleted from NSCs. Interestingly, we found no major defects in the development or function of the central nervous system. Neural-specific Gmnn(Delta/Delta) mice are viable and fertile and display no obvious neurological or neuroanatomical abnormalities. They have normal numbers of BrdU(+) NSCs in the subgranular zone of the dentate gyrus, and Gmnn(Delta/Delta) NSCs give rise to normal numbers of mature neurons in pulse-chase experiments. Gmnn(Delta/Delta) neurosphere cells differentiate normally into both neurons and glial cells when grown in growth factor-deficient medium. Both the growth rate and the cell cycle distribution of cultured Gmnn(Delta/Delta) neurosphere cells are indistinguishable from controls. We conclude that Geminin is largely dispensable for most of embryonic and adult mammalian neurogenesis.	[Schultz, Kathryn M.; Lastra, Ruben O.; McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Schultz, Kathryn M.; Lastra, Ruben O.; McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [McGarry, Thomas J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Banisadr, Ghazal; Miller, Richard J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [McGuire, Tammy; Kessler, John A.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Schultz, KM (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	t-mcgarry@northwestern.edu			American Heart Association [0630290N]; Illinois Division of the American Cancer Society; National Heart Lung and Blood Institute [R21HL093500]; Schweppe Foundation; NATIONAL CANCER INSTITUTE [P30CA060553, U54CA151880] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Illinois Division of the American Cancer Society(American Cancer Society); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Schweppe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants to TJM from the American Heart Association (#0630290N, www.aha.org), the Illinois Division of the American Cancer Society (www.cancer.org), the National Heart Lung and Blood Institute (R21HL093500), and the Schweppe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner S, 2005, DEV CELL, V9, P171, DOI 10.1016/j.devcel.2005.07.005; Arias EE, 2005, GENE DEV, V19, P114, DOI 10.1101/gad.1255805; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Benjamin JM, 2004, J BIOL CHEM, V279, P45957, DOI 10.1074/jbc.M407726200; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Darzynkiewicz Z, 2001, CURRENT PROTOCOLS CY; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Hara K, 2006, GENES CELLS, V11, P1281, DOI 10.1111/j.1365-2443.2006.01019.x; Harlow E., 1988, ANTIBODIES LAB MANUA, VVolume 1, P726; Karamitros D, 2010, J IMMUNOL, V184, P2432, DOI 10.4049/jimmunol.0901983; Kerns SL, 2007, J BIOL CHEM, V282, P5514, DOI 10.1074/jbc.M609289200; Kim MY, 2006, P NATL ACAD SCI USA, V103, P13074, DOI 10.1073/pnas.0601915103; Kroll KL, 1998, DEVELOPMENT, V125, P3247; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li A, 2005, EMBO J, V24, P395, DOI 10.1038/sj.emboj.7600520; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Luo LF, 2004, CELL CYCLE, V3, P711; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; McGarry TJ, 2002, MOL BIOL CELL, V13, P3662, DOI 10.1091/mbc.E02-04-0199; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Prophet E, 1992, AFIP LAB METHODS HIS; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Seo S, 2006, CELL CYCLE, V5, P374, DOI 10.4161/cc.5.4.2438; SHINNICK KM, 2010, J CLIN INVE IN PRESS; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spella M, 2007, NEUROSCIENCE, V147, P373, DOI 10.1016/j.neuroscience.2007.03.050; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Yanagi K, 2005, J BIOL CHEM, V280, P19689, DOI 10.1074/jbc.C500070200; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I	40	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17736	10.1371/journal.pone.0017736	http://dx.doi.org/10.1371/journal.pone.0017736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408022	Green Published, gold, Green Submitted			2022-12-27	WOS:000288170900044
J	English, P; Blount, B; Wong, M; Copan, L; Olmedo, L; Patton, S; Haas, R; Atencio, R; Xu, JH; Valentin-Blasini, L				English, Paul; Blount, Ben; Wong, Michelle; Copan, Lori; Olmedo, Luis; Patton, Sharyle; Haas, Robert; Atencio, Ryan; Xu, Juhua; Valentin-Blasini, Liza			Direct Measurement of Perchlorate Exposure Biomarkers in a Highly Exposed Population: A Pilot Study	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; SODIUM-IODIDE SYMPORTER; UNITED-STATES; INHIBITORS; CREATININE; PREGNANCY; NITRATE; HEALTH; WOMEN	Exposure to perchlorate is ubiquitous in the United States and has been found to be widespread in food and drinking water. People living in the lower Colorado River region may have perchlorate exposure because of perchlorate in ground water and locally-grown produce. Relatively high doses of perchlorate can inhibit iodine uptake and impair thyroid function, and thus could impair neurological development in utero. We examined human exposures to perchlorate in the Imperial Valley among individuals consuming locally grown produce and compared perchlorate exposure doses to state and federal reference doses. We collected 24-hour urine specimen from a convenience sample of 31 individuals and measured urinary excretion rates of perchlorate, thiocyanate, nitrate, and iodide. In addition, drinking water and local produce were also sampled for perchlorate. All but two of the water samples tested negative for perchlorate. Perchlorate levels in 79 produce samples ranged from non-detect to 1816 ppb. Estimated perchlorate doses ranged from 0.02 to 0.51 mu g/kg of body weight/day. Perchlorate dose increased with the number of servings of dairy products consumed and with estimated perchlorate levels in produce consumed. The geometric mean perchlorate dose was 70% higher than for the NHANES reference population. Our sample of 31 Imperial Valley residents had higher perchlorate dose levels compared with national reference ranges. Although none of our exposure estimates exceeded the U. S. EPA reference dose, three participants exceeded the acceptable daily dose as defined by bench mark dose methods used by the California Office of Environmental Health Hazard Assessment.	[English, Paul; Wong, Michelle] Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA; [Blount, Ben; Valentin-Blasini, Liza] Ctr Dis Control & Prevent, Div Sci Lab, Atlanta, GA USA; [Copan, Lori] Calif Dept Publ Hlth, Environm Hlth Invest Branch, Richmond, CA USA; [Olmedo, Luis] Comite Civ Valle, Brawley, CA USA; [Patton, Sharyle] Commonweal, Bolinas, CA USA; [Haas, Robert; Xu, Juhua] Calif Dept Publ Hlth, Food & Drug Lab Branch, Richmond, CA USA; [Atencio, Ryan] Calif Dept Tox Subst & Control, El Centro, CA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA; California Department of Public Health; California Department of Public Health	English, P (corresponding author), Calif Dept Publ Hlth, Calif Environm Hlth Tracking Program, Richmond, CA 94804 USA.	penglish@dhs.ca.gov	English, Paul/GQB-1018-2022		Centers for Disease Control and Prevention (CDC) [1U38EH000186-01]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U38EH000186] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded in part by Grant/Cooperative Agreement Number 1U38EH000186-01 from the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berbel P, 2009, THYROID, V19, P511, DOI 10.1089/thy.2008.0341; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; Blount BC, 2010, ENVIRON SCI TECHNOL, V44, P9564, DOI 10.1021/es1025195; Blount BC, 2009, ENVIRON SCI TECHNOL, V43, P7543, DOI 10.1021/es9008486; California Environmental Protection Agency (CalEPA), 2004, PUBL HLTH GOALS CHEM; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corder G. W., 2009, NONPARAMETRIC STAT N, DOI DOI 10.1002/; De Groef B, 2006, EUR J ENDOCRINOL, V155, P17, DOI 10.1530/eje.1.02190; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; HARVEY GJ, 2005, GEOL SOC AM 2005 SAL; Kirk AB, 2006, ANAL CHIM ACTA, V567, P4, DOI 10.1016/j.aca.2006.03.047; Klein RZ, 2001, J MED SCREEN, V8, P18, DOI 10.1136/jms.8.1.18; Krynitsky AJ, 2004, ANAL CHEM, V76, P5518, DOI 10.1021/ac049281+; Mage DT, 2004, J EXPO ANAL ENV EPID, V14, P457, DOI 10.1038/sj.jea.7500343; Murray CW, 2008, J EXPO SCI ENV EPID, V18, P571, DOI 10.1038/sj.jes.7500648; NAS, 2005, HLTH IMPL PERCHL ING; Poppe K, 2008, NAT CLIN PRACT ENDOC, V4, P394, DOI 10.1038/ncpendmet0846; Sanchez CA, 2008, J AGR FOOD CHEM, V56, P5443, DOI 10.1021/jf0733923; Sanchez CA, 2009, J EXPO SCI ENV EPID, V19, P359, DOI 10.1038/jes.2008.26; Tonacchera M, 2004, THYROID, V14, P1012, DOI 10.1089/thy.2004.14.1012; U.S. Environ. Prot. Agency, 2007, METH 6850 PERCHL WAT; *US EPA, 2005, OCC DAT ACC UNR CONT; US EPA (U.S. Environmental Protection Agency), 2005, PERCHL PERCHL SALTS; Valentin-Blasini L, 2007, J CHROMATOGR A, V1155, P40, DOI 10.1016/j.chroma.2007.04.014; Yu L, 2004, ECOTOX ENVIRON SAFE, V58, P44, DOI 10.1016/S0147-6513(03)00108-8	26	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17015	10.1371/journal.pone.0017015	http://dx.doi.org/10.1371/journal.pone.0017015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21394205	Green Published, gold, Green Submitted			2022-12-27	WOS:000288025500005
J	Persson, C; Jia, YB; Pettersson, H; Dillner, J; Nyren, O; Ye, WM				Persson, Christina; Jia, Yanbin; Pettersson, Helena; Dillner, Joakim; Nyren, Olof; Ye, Weimin			H. pylori Seropositivity before Age 40 and Subsequent Risk of Stomach Cancer: A Glimpse of the True Relationship?	PLOS ONE			English	Article							HELICOBACTER-PYLORI; GASTRIC-CANCER; ATROPHIC GASTRITIS; INFECTION; EPIDEMIOLOGY; ADENOCARCINOMAS; COMPLETENESS; METAANALYSIS; IMMUNOBLOT; CARCINOMA	Stomach carcinogenesis involves mucosal and luminal changes that favor spontaneous disappearance of Helicobacter pylori. Therefore, the association between the infection and cancer risk might typically be underestimated. As acquisition of the infection almost invariably occurs before adulthood, the serostatus at age 16-40 should best reflect the lifetime occurrence of the infection. We therefore conducted a case-control study nested within a historic cohort of about 400,000 individuals who donated sera before age 40 to either of two large Swedish Biobanks between 1968 and 2006, and whose records were linked to complete nationwide registers. For each stomach adenocarcinoma case occurring at least 5 years after serum donation 2 controls were selected matched on age, sex and year of donation and biobank. Serum immunoglobulin G antibodies against H. pylori cell-surface antigens (Hp-CSAs) were measured with an enzyme-linked immunosorbent assay and antibodies against CagA with an immunoblot assay. Conditional logistic regression models were used to estimate odds ratios (ORs) for stomach adenocarcinoma among H. pylori infected relative to uninfected. We confirmed 59 incident cases of stomach adenocarcinoma (41 non-cardia tumors) during follow-up. ORs for non-cardia stomach adenocarcinoma among subjects with Hp-CSA antibodies (regardless of CagA serostatus), antibodies against CagA (regardless of Hp-CSA serostatus), and antibodies to both, relative to those who were seronegative to both, were 17.1 (95% confidence interval [CI] 4.0-72.9), 10.9 (95% CI 3.2-36.9), and 48.5 (95% CI 5.8-407.4), respectively. H. pylori infection is a much stronger risk factor for non-cardia stomach adenocarcinoma than initially realized. However, further studies are needed to answer whether it is a necessary cause, as the possibility of misclassification of H. pylori status could not be ruled out in our study.	[Persson, Christina; Jia, Yanbin; Dillner, Joakim; Nyren, Olof; Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Pettersson, Helena] Swedish Inst Infect Dis Control, Solna, Sweden; [Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet	Persson, C (corresponding author), NCI, Div Canc Epidemiol & Genet, Hormonal & Reprod Epidemiol Branch, Bethesda, MD 20892 USA.	Weimin.Ye@ki.se			Martin Rind Stiftelse; Swedish Research Council [K2009-69X-15372-05-2]	Martin Rind Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by a grant from Martin Rind Stiftelse and partly by a grant from the Swedish Research Council (K2009-69X-15372-05-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamu MA, 2010, EUR J EPIDEMIOL, V25, P439, DOI 10.1007/s10654-010-9482-0; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; CAVALEIROPINTO M, 2010, CANC CAUSES CONTROL; CRABTREE JE, 1995, J CLIN PATHOL, V48, P41, DOI 10.1136/jcp.48.1.41; de Vries AC, 2007, HELICOBACTER, V12, P22, DOI 10.1111/j.1523-5378.2007.00562.x; Ekstrom AM, 2001, GASTROENTEROLOGY, V121, P784, DOI 10.1053/gast.2001.27999; Eslick GD, 1999, AM J GASTROENTEROL, V94, P2373, DOI 10.1111/j.1572-0241.1999.01360.x; FORMAN D, 1994, LANCET, V343, P243, DOI 10.1016/S0140-6736(94)91034-0; Forman D, 2006, BEST PRACT RES CL GA, V20, P633, DOI 10.1016/j.bpg.2006.04.008; Hsu PI, 2007, AM J GASTROENTEROL, V102, P725, DOI 10.1111/j.1572-0241.2006.01109.x; IARC, 1994, IARC MONOGRAPHS EVAL, VVolume 61, P1; Kamangar F, 2006, JNCI-J NATL CANCER I, V98, P1445, DOI 10.1093/jnci/djj393; Klaamas K, 1996, INT J CANCER, V67, P1, DOI 10.1002/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Malaty HM, 2003, HELICOBACTER, V8, P8, DOI 10.1046/j.1523-5378.2003.00163.x; MATTSSON B, 1984, ACTA RADIOL ONCOL, V23, P305, DOI 10.3109/02841868409136026; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Storskrubb T, 2008, SCAND J GASTROENTERO, V43, P1448, DOI 10.1080/00365520802273025; Takashima M, 2001, GUT, V48, P765, DOI 10.1136/gut.48.6.765; TALLEY NJ, 1991, J CLIN MICROBIOL, V29, P1635, DOI 10.1128/JCM.29.8.1635-1639.1991; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Veijola L, 2008, CLIN VACCINE IMMUNOL, V15, P1705, DOI 10.1128/CVI.00165-08; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; WEILAND O, 1980, SCAND J INFECT DIS, V12, P171, DOI 10.3109/inf.1980.12.issue-3.03; Yanaoka K, 2008, INT J CANCER, V123, P917, DOI 10.1002/ijc.23571	27	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17404	10.1371/journal.pone.0017404	http://dx.doi.org/10.1371/journal.pone.0017404			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399687	Green Submitted, gold, Green Published			2022-12-27	WOS:000287933300021
J	Smith, ZJ; Chu, KQ; Espenson, AR; Rahimzadeh, M; Gryshuk, A; Molinaro, M; Dwyre, DM; Lane, S; Matthews, D; Wachsmann-Hogiu, S				Smith, Zachary J.; Chu, Kaiqin; Espenson, Alyssa R.; Rahimzadeh, Mehdi; Gryshuk, Amy; Molinaro, Marco; Dwyre, Denis M.; Lane, Stephen; Matthews, Dennis; Wachsmann-Hogiu, Sebastian			Cell-Phone-Based Platform for Biomedical Device Development and Education Applications	PLOS ONE			English	Article								In this paper we report the development of two attachments to a commercial cell phone that transform the phone's integrated lens and image sensor into a 350x microscope and visible-light spectrometer. The microscope is capable of transmission and polarized microscopy modes and is shown to have 1.5 micron resolution and a usable field-of-view of similar to 150x150 mu m with no image processing, and approximately 350x350 mu m when post-processing is applied. The spectrometer has a 300 nm bandwidth with a limiting spectral resolution of close to 5 nm. We show applications of the devices to medically relevant problems. In the case of the microscope, we image both stained and unstained blood-smears showing the ability to acquire images of similar quality to commercial microscope platforms, thus allowing diagnosis of clinical pathologies. With the spectrometer we demonstrate acquisition of a white-light transmission spectrum through diffuse tissue as well as the acquisition of a fluorescence spectrum. We also envision the devices to have immediate relevance in the educational field.	[Smith, Zachary J.; Chu, Kaiqin; Gryshuk, Amy; Molinaro, Marco; Lane, Stephen; Matthews, Dennis; Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA; [Espenson, Alyssa R.] Calif Lutheran Univ, Thousand Oaks, CA USA; [Rahimzadeh, Mehdi] Calif State Univ Sacramento, Sacramento, CA 95819 USA; [Dwyre, Denis M.; Wachsmann-Hogiu, Sebastian] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA; [Lane, Stephen; Matthews, Dennis] Univ Calif Davis, Dept Neurol Surg, Sacramento, CA 95817 USA	University of California System; University of California Davis; California Lutheran University; California State University System; California State University Sacramento; University of California System; University of California Davis; University of California System; University of California Davis	Smith, ZJ (corresponding author), Univ Calif Davis, Ctr Biophoton Sci & Technol, Sacramento, CA 95817 USA.	swachsmann@ucdavis.edu	Smith, Zachary/S-2211-2019; Smith, Zachary/K-6888-2016	Smith, Zachary/0000-0002-7946-7863; Molinaro, Marco/0000-0001-8922-6978	Center for Biophotonics Science & Technology, a designated National Science Foundation Science	Center for Biophotonics Science & Technology, a designated National Science Foundation Science	This work was supported by the Center for Biophotonics Science & Technology, a designated National Science Foundation Science and Technology Center managed by the University of California Davis under Cooperative Agreement No. PHY0120999. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargo PR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921907; Bishara W, 2010, OPT EXPRESS, V18, P11181, DOI 10.1364/OE.18.011181; Brancaleon L, 2001, PHOTOCHEM PHOTOBIOL, V73, P178, DOI 10.1562/0031-8655(2001)073<0178:IVFSON>2.0.CO;2; Breslauer DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006320; Wei H, 2007, PATTERN RECOGN LETT, V28, P493, DOI 10.1016/j.patrec.2006.09.005; Lin BV, 2010, OPT EXPRESS, V18, P21074, DOI 10.1364/OE.18.021074; Lu Y, 2006, IEEE IMAGE PROC, P1629, DOI 10.1109/ICIP.2006.312657; Mudanyali O, 2010, LAB CHIP, V10, P2419, DOI 10.1039/c004829a; Qu Xiao-bo, 2009, Optics and Precision Engineering, V17, P1203; Rajaram N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2981797; Selinummi J, 2005, BIOTECHNIQUES, V39, P859, DOI 10.2144/000112018; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Thekkek N, 2008, NAT REV CANCER, V8, P725, DOI 10.1038/nrc2462; Tseng D, 2010, LAB CHIP, V10, P1787, DOI 10.1039/c003477k; Wang S. X., 2008, U.S. Patent, Patent No. [7,420,663, 7420663]; Wu JG, 2010, OPT LETT, V35, P2188, DOI 10.1364/OL.35.002188; Wu T, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3365940	17	247	263	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17150	10.1371/journal.pone.0017150	http://dx.doi.org/10.1371/journal.pone.0017150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399693	Green Published, gold, Green Submitted			2022-12-27	WOS:000287933300011
J	Baye, TM; Kovacic, MB; Myers, JMB; Martin, LJ; Lindsey, M; Patterson, TL; He, H; Ericksen, MB; Gupta, J; Tsoras, AM; Lindsley, A; Rothenberg, ME; Wills-Karp, M; Eissa, NT; Borish, L; Hershey, GKK				Baye, Tesfaye M.; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Martin, Lisa J.; Lindsey, Mark; Patterson, Tia L.; He, Hua; Ericksen, Mark B.; Gupta, Jayanta; Tsoras, Anna M.; Lindsley, Andrew; Rothenberg, Marc E.; Wills-Karp, Marsha; Eissa, N. Tony; Borish, Larry; Hershey, Gurjit K. Khurana			Differences in Candidate Gene Association between European Ancestry and African American Asthmatic Children	PLOS ONE			English	Article							POLYMORPHISMS; PROMOTER; IL-4; PATHWAY; IGE; CLUSTER; REGION; LONG; IL4	Background: Candidate gene case-control studies have identified several single nucleotide polymorphisms (SNPs) that are associated with asthma susceptibility. Most of these studies have been restricted to evaluations of specific SNPs within a single gene and within populations from European ancestry. Recently, there is increasing interest in understanding racial differences in genetic risk associated with childhood asthma. Our aim was to compare association patterns of asthma candidate genes between children of European and African ancestry. Methodology/Principal Findings: Using a custom-designed Illumina SNP array, we genotyped 1,485 children within the Greater Cincinnati Pediatric Clinic Repository and Cincinnati Genomic Control Cohort for 259 SNPs in 28 genes and evaluated their associations with asthma. We identified 14 SNPs located in 6 genes that were significantly associated (p-values < 0.05) with childhood asthma in African Americans. Among Caucasians, 13 SNPs in 5 genes were associated with childhood asthma. Two SNPs in IL4 were associated with asthma in both races (p-values < 0.05). Gene-gene interaction studies identified race specific sets of genes that best discriminate between asthmatic children and non-allergic controls. Conclusions/Significance: We identified IL4 as having a role in asthma susceptibility in both African American and Caucasian children. However, while IL4 SNPs were associated with asthma in asthmatic children with European and African ancestry, the relative contributions of the most replicated asthma-associated SNPs varied by ancestry. These data provides valuable insights into the pathways that may predispose to asthma in individuals with European vs. African ancestry.	[Baye, Tesfaye M.; Kovacic, Melinda Butsch; Myers, Jocelyn M. Biagini; Martin, Lisa J.; Lindsey, Mark; Patterson, Tia L.; He, Hua; Ericksen, Mark B.; Gupta, Jayanta; Tsoras, Anna M.; Lindsley, Andrew; Rothenberg, Marc E.; Wills-Karp, Marsha; Hershey, Gurjit K. Khurana] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA; [Eissa, N. Tony] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Borish, Larry] Univ Virginia, Dept Med, Charlottesville, VA USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Baylor College of Medicine; University of Virginia	Baye, TM (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45221 USA.	Gurjit.Khurana.Hershey@cchmc.org	Martin, Lisa/E-2425-2016	Martin, Lisa/0000-0001-8702-9946; Biagini, Jocelyn/0000-0002-4378-6133	National Institutes of Health [U19A170235-01, 1K01HL103165]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant U19A170235-01 (G. K. H.) and 1K01HL103165 (T. M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baye TM, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-1; Burchard EG, 1999, AM J RESP CRIT CARE, V160, P919, DOI 10.1164/ajrccm.160.3.9812024; Chinchilli VM, 2007, J ALLERGY CLIN IMMUN, V119, P303, DOI 10.1016/j.jaci.2006.11.632; Chouchane L, 1999, INT ARCH ALLERGY IMM, V120, P50, DOI 10.1159/000024219; Cooper RS, 2008, HUM MOL GENET, V17, pR151, DOI 10.1093/hmg/ddn263; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ganter B, 2008, CURR OPIN DRUG DISC, V11, P86; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gervaziev YV, 2006, INT ARCH ALLERGY IMM, V141, P257, DOI 10.1159/000095295; Haller G, 2009, J ALLERGY CLIN IMMUN, V124, P1204, DOI 10.1016/j.jaci.2009.09.013; Hosseini-Farahabadi S, 2007, IRAN J ALLERGY ASTHM, V6, P9; HOTHORN T, 2010, J COMPUTATIONAL GRAP, V15, P651; Izuhara K, 1999, INT J MOL MED, V3, P3; Kabesch M, 2006, J ALLERGY CLIN IMMUN, V117, P269, DOI 10.1016/j.jaci.2005.10.024; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V112, P893, DOI 10.1016/j.jaci.2003.08.033; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Noguchi E, 2001, Am J Pharmacogenomics, V1, P251, DOI 10.2165/00129785-200101040-00002; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oh CK, 2010, EUR RESPIR REV, V19, P46, DOI 10.1183/09059180.00007609; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; ROMAGNANI S, 1991, IMMUNOL TODAY, V12, P256, DOI 10.1016/0167-5699(91)90120-I; ROSENWASSER LJ, 1995, CLIN EXP ALLERGY, V25, P74, DOI 10.1111/j.1365-2222.1995.tb00428.x; Sandford AJ, 2000, J ALLERGY CLIN IMMUN, V106, P135, DOI 10.1067/mai.2000.107926; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Spielman RS, 1996, AM J HUM GENET, V59, P983; Suzuki I, 2000, CLIN EXP ALLERGY, V30, P1746, DOI 10.1046/j.1365-2222.2000.00983.x; Szalai C, 2008, BRIT J PHARMACOL, V153, P1602, DOI 10.1038/bjp.2008.55; Walley AJ, 1996, J MED GENET, V33, P689, DOI 10.1136/jmg.33.8.689; Zhang J, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-4; Zhu SK, 2000, AM J RESP CRIT CARE, V161, P1655, DOI 10.1164/ajrccm.161.5.9906086	34	60	59	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16522	10.1371/journal.pone.0016522	http://dx.doi.org/10.1371/journal.pone.0016522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21387019	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400007
J	Morales-Garcia, JA; Redondo, M; Alonso-Gil, S; Gil, C; Perez, C; Martinez, A; Santos, A; Perez-Castillo, A				Morales-Garcia, Jose A.; Redondo, Miriam; Alonso-Gil, Sandra; Gil, Carmen; Perez, Concepcion; Martinez, Ana; Santos, Angel; Perez-Castillo, Ana			Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; BINDING-PROTEIN-BETA; ANTIINFLAMMATORY DRUGS; SUBSTANTIA-NIGRA; PDE7 INHIBITORS; MESSENGER-RNA; RAT-BRAIN; CAMP; CREB; CELLS	Background: Phosphodiesterase 7 plays a major role in down-regulation of protein kinase A activity by hydrolyzing cAMP in many cell types. This cyclic nucleotide plays a key role in signal transduction in a wide variety of cellular responses. In the brain, cAMP has been implicated in learning, memory processes and other brain functions. Methodology/Principal Findings: Here we show a novel function of phosphodiesterase 7 inhibition on nigrostriatal dopaminergic neuronal death. We found that S14, a heterocyclic small molecule inhibitor of phosphodiesterase 7, conferred significant neuronal protection against different insults both in the human dopaminergic cell line SH-SY5Y and in primary rat mesencephalic cultures. S14 treatment also reduced microglial activation, protected dopaminergic neurons and improved motor function in the lipopolysaccharide rat model of Parkinson disease. Finally, S14 neuroprotective effects were reversed by blocking the cAMP signaling pathways that operate through cAMP-dependent protein kinase A. Conclusions/Significance: Our findings demonstrate that phosphodiesterase 7 inhibition can protect dopaminergic neurons against different insults, and they provide support for the therapeutic potential of phosphodiesterase 7 inhibitors in the treatment of neurodegenerative disorders, particularly Parkinson disease.	[Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana] CSIC UAM, Inst Invest Biomed, Madrid, Spain; [Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Redondo, Miriam; Gil, Carmen; Perez, Concepcion; Martinez, Ana] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Santos, Angel] Univ Complutense Madrid, Fac Med, Dept Bioquim & Biol Mol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Complutense University of Madrid	Morales-Garcia, JA (corresponding author), CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid, Spain.	aperez@iib.uam.es	Perez-Castillo, Ana/A-9505-2015; Perez, Concepcion/K-3684-2014; Morales-Garcia, Jose A/L-4552-2014; Martinez, Ana/L-6414-2014; Gil, Carmen/J-8932-2014; Martin, Perez/B-4158-2015; Santos, Angel/K-3744-2014	Perez, Concepcion/0000-0001-7183-4035; Morales-Garcia, Jose A/0000-0001-9008-0056; Martinez, Ana/0000-0002-2707-8110; Gil, Carmen/0000-0002-3882-6081; Martin, Perez/0000-0001-7183-4035; Santos, Angel/0000-0002-7551-8483; Perez-Castillo, Ana/0000-0002-2632-5853	Ministerio de Ciencia y Tecnologia [SAF2007-62811, SAF 2010-16365, SAF2009-13015-C02-01]; ARACLON [PET2008-0245]; Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple); Araclon Biotech	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ARACLON; Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple)(Instituto de Salud Carlos III); Araclon Biotech	This work was supported by the Ministerio de Ciencia y Tecnologia (www.micinn.es) (SAF2007-62811 and SAF 2010-16365 to A.P.-C.), and SAF2009-13015-C02-01 to A.M., and by the Ministerio de Ciencia y Tecnologia (www.micinn.es) and ARACLON (www.araclon.com) in the joint project PET2008-0245 and by Instituto de Salud Carlos III (Red Tematica de Investigacion en Esclerosis Multiple (to A.M.)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors state that Araclon Biotech has been a commercial funder, together with the MICINN, for this work, but they have not participated in the experimental design on the manuscript and none of the authors is an employee of the company. This funding does not alter the authors' adherence to the PloS ONE policies on sharing data and materials. Some of the results here presented are protected by patent application P200930189 (owner CSIC). A license transfer agreement has been recently reached with ARACLON.	ANDEN NE, 1966, ACTA PHARMACOL TOX, V24, P263; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castro A, 2005, MED RES REV, V25, P229, DOI 10.1002/med.20020; Castro A, 2008, EUR J MED CHEM, V43, P1349, DOI 10.1016/j.ejmech.2007.10.027; Charles MP, 2003, BIOCHEM BIOPH RES CO, V304, P795, DOI 10.1016/S0006-291X(03)00666-1; Chen HQ, 2008, NEUROSCI LETT, V448, P175, DOI 10.1016/j.neulet.2008.10.046; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cortes-Canteli M, 2004, J BIOL CHEM, V279, P14409, DOI 10.1074/jbc.M313253200; Cortes-Canteli M, 2008, J CELL SCI, V121, P1224, DOI 10.1242/jcs.025031; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dutta G, 2008, FUND CLIN PHARMACOL, V22, P453, DOI 10.1111/j.1472-8206.2008.00616.x; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Giembycz MA, 2006, CURR PHARM DESIGN, V12, P3207, DOI 10.2174/138161206778194123; Gil C, 2008, EXPERT OPIN THER PAT, V18, P1127, DOI 10.1517/13543776.18.10.1127; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hald A, 2005, EXP NEUROL, V193, P279, DOI 10.1016/j.expneurol.2005.01.013; Heneka MT, 2000, J NEUROSCI, V20, P6862, DOI 10.1523/JNEUROSCI.20-18-06862.2000; Houslay MD, 2000, MOL PHARMACOL, V58, P659, DOI 10.1124/mol.58.4.659; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kleppisch Thomas, 2009, V191, P71, DOI 10.1007/978-3-540-68964-5_5; Lastres-Becker I, 2008, MOL CELL NEUROSCI, V39, P291, DOI 10.1016/j.mcn.2008.07.009; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Luna-Medina R, 2005, J BIOL CHEM, V280, P21453, DOI 10.1074/jbc.M414390200; Luna-Medina R, 2007, J NEUROSCI, V27, P5766, DOI 10.1523/JNEUROSCI.1004-07.2007; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Martinez A, 2000, J MED CHEM, V43, P683, DOI 10.1021/jm990382n; Mccoy MK, 2006, J NEUROSCI, V26, P9365, DOI 10.1523/JNEUROSCI.1504-06.2006; McGeer EG, 2007, CNS DRUGS, V21, P789, DOI 10.2165/00023210-200721100-00001; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mehats C, 2002, TRENDS ENDOCRIN MET, V13, P29, DOI 10.1016/S1043-2760(01)00523-9; Miro X, 2001, SYNAPSE, V40, P201, DOI 10.1002/syn.1043; Morales-Garcia JA, 2009, J NEUROSCI RES, V87, P3687, DOI 10.1002/jnr.22165; Nakata A, 2002, CLIN EXP IMMUNOL, V128, P460, DOI 10.1046/j.1365-2249.2002.01856.x; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Ouyang MX, 2006, J NEUROCHEM, V97, P234, DOI 10.1111/j.1471-4159.2006.03730.x; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Reyes-Irisarri E, 2005, NEUROSCIENCE, V132, P1173, DOI 10.1016/j.neuroscience.2005.01.050; Sasaki T, 2002, BIOCHEM J, V361, P211, DOI 10.1042/0264-6021:3610211; Schwarting RKW, 1996, PROG NEUROBIOL, V50, P275, DOI 10.1016/S0301-0082(96)00040-8; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Stetler RA, 2010, P NATL ACAD SCI USA, V107, P3204, DOI 10.1073/pnas.1000030107; TAKAHASHI T, 1994, J NEURAL TRANSM-GEN, V98, P107, DOI 10.1007/BF01277014; Tansey MG, 2007, EXP NEUROL, V208, P1, DOI 10.1016/j.expneurol.2007.07.004; Toledo-Aral JJ, 2002, BRAIN RES BULL, V57, P847, DOI 10.1016/S0361-9230(01)00771-7; Townsend KP, 2005, FASEB J, V19, P1592, DOI 10.1096/fj.04-3620rev; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107	56	74	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17240	10.1371/journal.pone.0017240	http://dx.doi.org/10.1371/journal.pone.0017240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390306	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700039
J	Chen, LH; Shi, ZH; Muller, HJ				Chen, Lihan; Shi, Zhuanghua; Mueller, Hermann J.			Interaction of Perceptual Grouping and Crossmodal Temporal Capture in Tactile Apparent-Motion	PLOS ONE			English	Article							VISION; ORDER; VENTRILOQUIST; INFORMATION; TOUCH	Previous studies have shown that in tasks requiring participants to report the direction of apparent motion, task-irrelevant mono-beeps can "capture'' visual motion perception when the beeps occur temporally close to the visual stimuli. However, the contributions of the relative timing of multimodal events and the event structure, modulating uni- and/or crossmodal perceptual grouping, remain unclear. To examine this question and extend the investigation to the tactile modality, the current experiments presented tactile two-tap apparent-motion streams, with an SOA of 400 ms between successive, left-/right-hand middle-finger taps, accompanied by task-irrelevant, non-spatial auditory stimuli. The streams were shown for 90 seconds, and participants' task was to continuously report the perceived (left-or rightward) direction of tactile motion. In Experiment 1, each tactile stimulus was paired with an auditory beep, though odd-numbered taps were paired with an asynchronous beep, with audiotactile SOAs ranging from -75 ms to 75 ms. Perceived direction of tactile motion varied systematically with audiotactile SOA, indicative of a temporal-capture effect. In Experiment 2, two audiotactile SOAs-one short (75 ms), one long (325 ms)-were compared. The long-SOA condition preserved the crossmodal event structure (so the temporal-capture dynamics should have been similar to that in Experiment 1), but both beeps now occurred temporally close to the taps on one side (even-numbered taps). The two SOAs were found to produce opposite modulations of apparent motion, indicative of an influence of crossmodal grouping. In Experiment 3, only odd-numbered, but not even-numbered, taps were paired with auditory beeps. This abolished the temporal-capture effect and, instead, a dominant percept of apparent motion from the audiotactile side to the tactile-only side was observed independently of the SOA variation. These findings suggest that asymmetric crossmodal grouping leads to an attentional modulation of apparent motion, which inhibits crossmodal temporal-capture effects.	[Chen, Lihan] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Chen, Lihan] Peking Univ, Minist Educ, Key Lab Machine Percept, Beijing 100871, Peoples R China; [Chen, Lihan; Shi, Zhuanghua; Mueller, Hermann J.] Univ Munich, Dept Psychol, Munich, Germany; [Mueller, Hermann J.] Univ London, Birkbeck Coll, Sch Psychol Sci, London, England	Peking University; Peking University; University of Munich; University of London; Birkbeck University London	Chen, LH (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	shi@psy.lmu.de	Shi, Zhuanghua/J-2236-2019	Shi, Zhuanghua/0000-0003-2388-6695; Chen, Lihan/0000-0002-0337-4177	German DFG [SFB453]; China Postdoctoral Science Foundation [20100470113]	German DFG(German Research Foundation (DFG)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The study was support by German DFG SFB453 (http://www.sfb453.de) and China Postdoctoral Science Foundation (20100470113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Berman RA, 2002, COGNITIVE BRAIN RES, V14, P64, DOI 10.1016/S0926-6410(02)00061-7; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Bresciani JP, 2007, NEUROREPORT, V18, P1157, DOI 10.1097/WNR.0b013e3281ace0ca; Bruns P, 2008, ACTA PSYCHOL, V129, P273, DOI 10.1016/j.actpsy.2008.08.002; CAVANAGH P, 1992, SCIENCE, V257, P1563, DOI 10.1126/science.1523411; Desimone R, 1998, PHILOS T R SOC B, V353, P1245, DOI 10.1098/rstb.1998.0280; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Exner S., 1875, SITZUNGBERICHTE ACAD, V72, P156; Freeman E, 2008, CURR BIOL, V18, P1262, DOI 10.1016/j.cub.2008.07.066; Gepshtein S, 2005, J VISION, V5, P1013, DOI 10.1167/5.11.7; Getzmann S, 2007, PERCEPTION, V36, P1089, DOI 10.1068/p5741; HIRSH IJ, 1961, J EXP PSYCHOL, V62, P423, DOI 10.1037/h0045283; Keetels M, 2007, EXP BRAIN RES, V180, P449, DOI 10.1007/s00221-007-0881-8; Koffka K, 1935, PRINCIPLES GESTALT P; Kohler Wolfgang, 1929, GESTALT PSYCHOL; LU ZL, 1995, NATURE, V377, P237, DOI 10.1038/377237a0; Mamassian P, 2005, J VISION, V5, P361, DOI 10.1167/5.4.7; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; OLEARY A, 1984, PERCEPT PSYCHOPHYS, V35, P565, DOI 10.3758/BF03205954; Pastukhov A, 2007, J VISION, V7, DOI 10.1167/7.10.5; Recanzone GH, 2009, HEARING RES, V258, P89, DOI 10.1016/j.heares.2009.04.009; Scheier CR, 1999, INVEST OPHTH VIS SCI, V40, pS792; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shi ZH, 2010, EXP BRAIN RES, V203, P723, DOI 10.1007/s00221-010-2286-3; Shimojo S, 1997, VISION RES, V37, P1575, DOI 10.1016/S0042-6989(96)00313-6; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Soto-Faraco S, 2004, J EXP PSYCHOL HUMAN, V30, P330, DOI 10.1037/0096-1523.30.2.330; Soto-Faraco S, 2002, COGNITIVE BRAIN RES, V14, P139, DOI 10.1016/S0926-6410(02)00068-X; SPENCE C, 2007, PSYCHOL BEAUTY KANSE; Stein B. E., 2004, HDB MULTISENSORY PRO, P141; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; VONBEKESY G, 1959, PSYCHOL REV, V66, P1, DOI 10.1037/h0046967; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Welch R. B., 1999, COGNITIVE CONTRIBUTI, V129, P371; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Zampini M, 2005, ACTA PSYCHOL, V118, P277, DOI 10.1016/j.actpsy.2004.10.017	40	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17130	10.1371/journal.pone.0017130	http://dx.doi.org/10.1371/journal.pone.0017130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21383834	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000287657500035
J	Gupta, DK; Shah, P; Misra, A; Bharadwaj, S; Gulati, S; Gupta, N; Sharma, R; Pandey, RM; Goel, K				Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Pandey, Ravindra M.; Goel, Kashish			Secular Trends in Prevalence of Overweight and Obesity from 2006 to 2009 in Urban Asian Indian Adolescents Aged 14-17 Years	PLOS ONE			English	Article							BODY-MASS INDEX; ABDOMINAL ADIPOSE-TISSUE; METABOLIC SYNDROME; INSULIN-RESISTANCE; SCHOOL-CHILDREN; UNITED-STATES; US CHILDREN; ADULTS; SCHOOLCHILDREN; EPIDEMIOLOGY	The present study examines the secular trends in prevalence of overweight and obesity among urban Asian Indian adolescents in New Delhi (North India). The data were derived from cross-sectional sampling of children, 3493 in year 2006 and 4908 in year 2009, aged 14-17 years studying in privately-funded and government-funded schools. Age, gender and Asian Indian-specific cut offs of body mass index (BMI) were used to define overweight and obesity. The prevalence of obesity increased significantly from 9.8% in 2006 to 11.7% in 2009 (p<0.01), whereas underweight decreased from 11.3% to 3.9% (p<0.001). There was a significantly higher risk of being overweight (OR 1.28; 95% CI, 1.15-1.42) and obese (OR 1.44; 95% CI, 1.24-1.66) in year 2009 than 2006, after adjusting for age, gender and type of school. Males and privately-funded school children had significantly higher increase in prevalence and risk of being overweight and obese over the three years. In conclusion, this study showed an increasing trend in prevalence of overweight and obesity in urban Asian Indian adolescents. More specifically, the study showed the association of this increasing trend of overweight and obesity prevalence with male gender and high socio-economic status, calling for an urgent need for immediate and targeted preventive measures.	[Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Goel, Kashish] Natl Diabet Obes & Cholesterol Dis Fdn, SDA, New Delhi, India; [Gupta, Deepak Kumar; Shah, Priyali; Misra, Anoop; Bharadwaj, Swati; Gulati, Seema; Gupta, Nidhi; Sharma, Rekha; Goel, Kashish] Diabet Fdn India, SDA, New Delhi, India; [Misra, Anoop] Fortis Flt Lt Rajan Dhall Hosp, Dept Diabet & Metab Dis, New Delhi, India; [Pandey, Ravindra M.] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Gupta, Nidhi] Children Hosp Michigan, Dept Pediat, Detroit, MI USA; [Goel, Kashish] Wayne State Univ, Dept Internal Med, Detroit, MI 48202 USA	All India Institute of Medical Sciences (AIIMS) New Delhi; Children's Hospital of Michigan; Wayne State University	Gupta, DK (corresponding author), Natl Diabet Obes & Cholesterol Dis Fdn, SDA, New Delhi, India.	anoopmisra@metabolicresearchindia.com	Gupta, Deepak/U-4569-2019; GARG, RAKESH/H-4591-2011; Goel, Kashish/E-4916-2011	Gupta, Deepak/0000-0002-0722-9030; GARG, RAKESH/0000-0001-5842-8024; Gupta, Nidhi/0000-0001-6485-3318; Shah (Pathak), Priyali/0000-0003-2806-6100	World Diabetes Foundation; Rotary Club Delhi, South East	World Diabetes Foundation; Rotary Club Delhi, South East	World Diabetes Foundation (http://www.worlddiabetesfoundation.org/) and Rotary Club Delhi, South East. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; ADLAKHA A, 1996, POPULATION TRENDS IN; Bhardwaj S, 2008, ASIA PAC J CLIN NUTR, V17, P172; Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dietz WH, 1999, AM J CLIN NUTR, V70, p123S; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Goel K, 2010, HEART, V96, P579, DOI 10.1136/hrt.2009.183236; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; GUPTA A K, 1990, Indian Pediatrics, V27, P333; Gupta N, 2010, J AM COLL NUTR, V29, P81, DOI 10.1080/07315724.2010.10719820; Gupta R, 1998, Indian Heart J, V50, P511; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Kapil Umesh, 2002, Indian Pediatr, V39, P449; Kaur S, 2008, ASIA PAC J CLIN NUTR, V17, P592; Kelishadi R, 2007, EPIDEMIOL REV, V29, P62, DOI 10.1093/epirev/mxm003; Lissner L, 2010, OBES REV, V11, P553, DOI 10.1111/j.1467-789X.2009.00696.x; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Misra A, 2007, NUTRITION, V23, P895, DOI 10.1016/j.nut.2007.08.018; Misra A, 2010, METAB SYNDR RELAT D, V8, P243, DOI 10.1089/met.2009.0046; Mohan Bishav, 2004, Indian Heart J, V56, P310; Mukherjee D., 1999, SOCIOECONOMIC STATUS; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Neovius M, 2005, INT J OBESITY, V29, P163, DOI 10.1038/sj.ijo.0802867; *NFHS, 2005, KEY FIND REP NAT FAM; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Pandey RM, 2009, METAB SYNDR RELAT D, V7, P133, DOI 10.1089/met.2008.0053; Pohlmann VC, 1956, J EDUC SOCIOL, V29, P392, DOI 10.2307/2264801; Popkin BM, 1998, NUTR REV, V56, P106; Premanath M, 2010, INDIAN PEDIATR, V47, P171, DOI 10.1007/s13312-010-0027-0; Raj M, 2007, NATL MED J INDIA, V20, P288; Ramachandran A, 2002, DIABETES RES CLIN PR, V57, P185, DOI 10.1016/S0168-8227(02)00056-6; Rasheed P, 1998, PUBLIC HEALTH, V112, P409, DOI 10.1016/S0033-3506(98)00288-1; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Shah P, 2010, BRIT J NUTR, V104, P427, DOI 10.1017/S0007114510000681; Sharma A, 2007, PUBLIC HEALTH NUTR, V10, P485, DOI 10.1017/S1368980007223894; Singhal N, 2010, ANN NUTR METAB, V56, P176, DOI 10.1159/000282281; Subramanyam MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011392; Troiano RP, 1998, PEDIATRICS, V101, P497; Wang Y, 2009, OBES REV, V10, P456, DOI 10.1111/j.1467-789X.2009.00568.x; Wasir JS, 2004, METAB SYNDR RELAT D, V2, P14, DOI 10.1089/met.2004.2.14	53	68	69	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17221	10.1371/journal.pone.0017221	http://dx.doi.org/10.1371/journal.pone.0017221			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21383840	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500044
J	Leuner, K; Kraus, M; Woelfle, U; Beschmann, H; Harteneck, C; Boehncke, WH; Schempp, CM; Muller, WE				Leuner, Kristina; Kraus, Margarethe; Woelfle, Ute; Beschmann, Heike; Harteneck, Christian; Boehncke, Wolf-Henning; Schempp, Christoph M.; Mueller, Walter E.			Reduced TRPC Channel Expression in Psoriatic Keratinocytes Is Associated with Impaired Differentiation and Enhanced Proliferation	PLOS ONE			English	Article							CALCIUM-INDUCED DIFFERENTIATION; HUMAN GINGIVAL KERATINOCYTES; SENSING RECEPTOR; POTENTIAL ROLE; SKIN; ACTIVATION; DISEASE; CELLS	Psoriasis is a characteristic inflammatory and scaly skin condition with typical histopathological features including increased proliferation and hampered differentiation of keratinocytes. The activation of innate and adaptive inflammatory cellular immune responses is considered to be the main trigger factor of the epidermal changes in psoriatic skin. However, the molecular players that are involved in enhanced proliferation and impaired differentiation of psoriatic keratinocytes are only partly understood. One important factor that regulates differentiation on the cellular level is Ca(2+). In normal epidermis, a Ca(2+) gradient exists that is disturbed in psoriatic plaques, favoring impaired keratinocyte proliferation. Several TRPC channels such as TRPC1, TRPC4, or TRPC6 are key proteins in the regulation of high [Ca(2+)] ex induced differentiation. Here, we investigated if TRPC channel function is impaired in psoriasis using calcium imaging, RT-PCR, western blot analysis and immunohistochemical staining of skin biopsies. We demonstrated substantial defects in Ca(2+) influx in psoriatic keratinocytes in response to high extracellular Ca(2+) levels, associated with a downregulation of all TRPC channels investigated, including TRPC6 channels. As TRPC6 channel activation can partially overcome this Ca(2+) entry defect, specific TRPC channel activators may be potential new drug candidates for the topical treatment of psoriasis.	[Leuner, Kristina; Kraus, Margarethe; Mueller, Walter E.] Goethe Univ Frankfurt, Inst Pharmacol, Bioctr Niederursel, Frankfurt, Germany; [Woelfle, Ute; Schempp, Christoph M.] Univ Med Ctr, Dept Dermatol, Freiburg, Germany; [Beschmann, Heike; Boehncke, Wolf-Henning] Goethe Univ Frankfurt, Dept Dermatol, Frankfurt, Germany; [Harteneck, Christian] Univ Tubingen, Inst Pharmacol & Toxicol, Tubingen, Germany; [Harteneck, Christian] Univ Tubingen, Interfac Ctr Pharmacogenom & Drug Res, Tubingen, Germany	Goethe University Frankfurt; University of Freiburg; Goethe University Frankfurt; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Leuner, K (corresponding author), Goethe Univ Frankfurt, Inst Pharmacol, Bioctr Niederursel, Frankfurt, Germany.	Leuner@em.uni-frankfurt.de	Wölfle, Ute/AAG-6972-2021; Friedland, Kristina/G-4651-2015	Wölfle, Ute/0000-0003-0093-560X; Friedland, Kristina/0000-0001-8603-5957; Muller, Werner E.G./0000-0002-8223-3689	Cassella-med GmbH & Co. KG, Cologne, Germany	Cassella-med GmbH & Co. KG, Cologne, Germany	This study was supported by Cassella-med GmbH & Co. KG, Cologne, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; W.E. Muller and C.M. Schempp received research grants from Cassella-med GmbH & Co. KG, Cologne, Germany. This does not alter the authors' adherence to all PLoS ONE policies of sharing.	Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Beck B, 2008, CELL CALCIUM, V43, P492, DOI 10.1016/j.ceca.2007.08.005; Beck B, 2006, J INVEST DERMATOL, V126, P1982, DOI 10.1038/sj.jid.5700352; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Cai SW, 2006, PFLUG ARCH EUR J PHY, V452, P43, DOI 10.1007/s00424-005-0001-1; Cai SW, 2005, J DERMATOL SCI, V40, P21, DOI 10.1016/j.jdermsci.2005.06.005; Fatherazi S, 2007, PFLUG ARCH EUR J PHY, V453, P879, DOI 10.1007/s00424-006-0156-4; GERDES J, 1984, J IMMUNOL, V133, P1710; HANCOCK GE, 1988, J EXP MED, V168, P1395, DOI 10.1084/jem.168.4.1395; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; JONES KT, 1994, EXP CELL RES, V210, P71, DOI 10.1006/excr.1994.1011; Karvonen SL, 2000, J INVEST DERMATOL, V114, P693, DOI 10.1046/j.1523-1747.2000.00926.x; KRUEGER GG, 1981, J CLIN INVEST, V68, P1548, DOI 10.1172/JCI110409; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; Leuner K, 2007, FASEB J, V21, P4101, DOI 10.1096/fj.07-8110com; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MENON GK, 1991, ARCH DERMATOL, V127, P57, DOI 10.1001/archderm.127.1.57; Montell C, 2006, CHEM SENSES, V31, pA45; Muller M, 2008, J BIOL CHEM, V283, P33942, DOI 10.1074/jbc.M801844200; OLANIRAN AK, 1995, ARCH DERMATOL RES, V287, P231, DOI 10.1007/BF01105071; Pani B, 2008, CELL MOL LIFE SCI, V65, P205, DOI 10.1007/s00018-007-7397-z; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Sabat R, 2007, EXP DERMATOL, V16, P779, DOI 10.1111/j.1600-0625.2007.00629.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Tschachler E, 2007, CLIN DERMATOL, V25, P589, DOI 10.1016/j.clindermatol.2007.09.021; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2004, CELL CALCIUM, V35, P265, DOI 10.1016/j.ceca.2003.10.019; Woelfle U, 2010, J INVEST DERMATOL, V130, P113, DOI 10.1038/jid.2009.248; Wolk K, 2007, EXP DERMATOL, V16, P234; Wolk K, 2006, J INVEST DERMATOL, V126, P122; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227	32	55	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e14716	10.1371/journal.pone.0014716	http://dx.doi.org/10.1371/journal.pone.0014716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364982	gold, Green Published, Green Submitted			2022-12-27	WOS:000287656600001
J	Zehendner, CM; Librizzi, L; de Curtis, M; Kuhlmann, CRW; Luhmann, HJ				Zehendner, Christoph M.; Librizzi, Laura; de Curtis, Marco; Kuhlmann, Christoph R. W.; Luhmann, Heiko J.			Caspase-3 Contributes to ZO-1 and Cl-5 Tight-Junction Disruption in Rapid Anoxic Neurovascular Unit Damage	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; FOCAL ISCHEMIA; NEURONAL DEATH; MOUSE MODEL; PERMEABILITY; EXPRESSION; VESSELS; REPERFUSION; INHIBITION	Background: Tight-junction (TJ) protein degradation is a decisive step in hypoxic blood-brain barrier (BBB) breakdown in stroke. In this study we elucidated the impact of acute cerebral ischemia on TJ protein arrangement and the role of the apoptotic effector protease caspase-3 in this context. Methodology/Principal Findings: We used an in vitro model of the neurovascular unit and the guinea pig whole brain preparation to analyze with immunohistochemical methods the BBB properties and neurovascular integrity. In both methodological approaches we observed rapid TJ protein disruptions after 30 min of oxygen and glucose deprivation or middle cerebral artery occlusion, which were accompanied by strong caspase-3 activation in brain endothelial cells (BEC). Surprisingly only few DNA-fragmentations were detected with TUNEL stainings in BEC. Z-DEVD-fmk, an irreversible caspase-3 inhibitor, partly blocked TJ disruptions and was protective on trans-endothelial electrical resistance. Conclusions/Significance: Our data provide evidence that caspase-3 is rapidly activated during acute cerebral ischemia predominantly without triggering DNA-fragmentation in BEC. Further we detected fast TJ protein disruptions which could be partly blocked by caspase-3 inhibition with Z-DEVD-fmk. We suggest that the basis for clinically relevant BBB breakdown in form of TJ disruptions is initiated within minutes during ischemia and that caspase-3 contributes to this process.	[Zehendner, Christoph M.; Kuhlmann, Christoph R. W.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, D-6500 Mainz, Germany; [Librizzi, Laura; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unit Expt Neurophysiol & Epileptol, Milan, Italy	Johannes Gutenberg University of Mainz; IRCCS Istituto Neurologico Besta	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Saarstr 21, D-6500 Mainz, Germany.	luhmann@uni-mainz.de	de Curtis, Marco M/J-8704-2016; Librizzi, Laura/J-7889-2016; Luhmann, Heiko J./N-8797-2019	de Curtis, Marco M/0000-0001-7443-6737; Librizzi, Laura/0000-0002-2741-4452; Luhmann, Heiko J./0000-0002-7934-8661; de Curtis, Marco/0000-0002-5608-929X	neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz [DFG GRK 1044]; TALIAN HEALTH MINISTRY; FONDAZIONE CARIPLO [2005.1208/10.4963]; EC [LSH-CT-2006-037315]	neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz; TALIAN HEALTH MINISTRY; FONDAZIONE CARIPLO(Fondazione Cariplo); EC(European CommissionEuropean Commission Joint Research Centre)	CMZ was supported by the neuroscience graduate school at the University Medical Center of the Johannes Gutenberg University of Mainz (DFG GRK 1044). LL and MdC were supported by the ITALIAN HEALTH MINISTRY and by a FONDAZIONE CARIPLO grant 2005.1208/10.4963. HJL and MdC receive funding by the EC (LSH-CT-2006-037315, EPICURE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bendfeldt K, 2007, J NEUROSCI, V27, P3260, DOI 10.1523/JNEUROSCI.4033-06.2007; Bojarski C, 2004, J CELL SCI, V117, P2097, DOI 10.1242/jcs.01071; Brillault J, 2002, J NEUROCHEM, V83, P807, DOI 10.1046/j.1471-4159.2002.01186.x; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Chen J, 1998, J NEUROSCI, V18, P4914; Chen M, 2000, NAT MED, V6, P797, DOI 10.1038/77528; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dimitrijevic OB, 2006, J CEREBR BLOOD F MET, V26, P797, DOI 10.1038/sj.jcbfm.9600229; Fischer S, 2002, MICROVASC RES, V63, P70, DOI 10.1006/mvre.2001.2367; Garnier P, 2004, EUR J NEUROSCI, V20, P937, DOI 10.1111/j.1460-9568.2004.03551.x; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gerriets T, 2009, J NEUROSURG, V111, P1036, DOI 10.3171/2009.3.JNS081040; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Jin R, 2010, NEUROBIOL DIS, V38, P376, DOI 10.1016/j.nbd.2010.03.008; Karatas H, 2009, J NEUROSCI, V29, P13761, DOI 10.1523/JNEUROSCI.4246-09.2009; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Kuhlmann CRW, 2007, J NEUROCHEM, V102, P501, DOI 10.1111/j.1471-4159.2007.04506.x; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; Lee SR, 2004, J CEREBR BLOOD F MET, V24, P720, DOI 10.1097/01.WCB.0000122747.72175.47; Li H, 2000, STROKE, V31, P176, DOI 10.1161/01.STR.31.1.176; LLINAS R, 1981, FED PROC, V40, P2240; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pastori C, 2007, EXP NEUROL, V204, P95, DOI 10.1016/j.expneurol.2006.09.023; Rosell A, 2008, NEUROSCI LETT, V430, P1, DOI 10.1016/j.neulet.2007.05.006; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Wang ZY, 2009, FREE RADICAL BIO MED, V46, P1032, DOI 10.1016/j.freeradbiomed.2008.11.027; Yang Y, 2007, J CEREBR BLOOD F MET, V27, P697, DOI 10.1038/sj.jcbfm.9600375; Yenari MA, 2006, STROKE, V37, P1087, DOI 10.1161/01.STR.0000206281.77178.ac; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	47	67	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16760	10.1371/journal.pone.0016760	http://dx.doi.org/10.1371/journal.pone.0016760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364989	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600017
J	Lawler, K; Jeremiah, K; Mosepele, M; Ratcliffe, SJ; Cherry, C; Seloilwe, E; Steenhoff, AP				Lawler, Kathy; Jeremiah, Kealeboga; Mosepele, Mosepele; Ratcliffe, Sarah J.; Cherry, Catherine; Seloilwe, Esther; Steenhoff, Andrew P.			Neurobehavioral Effects in HIV-Positive Individuals Receiving Highly Active Antiretroviral Therapy (HAART) in Gaborone, Botswana	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FORMER PLASMA DONORS; COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL IMPAIRMENT; NEUROCOGNITIVE DISORDERS; PRIMARY-CARE; DEMENTIA; INFECTION; VALIDITY; IMPACT	Objective: To explore the prevalence and features of HIV-associated neurocognitive disorders (HANDS) in Botswana, a sub-Saharan country at the center of the HIV epidemic. Design and Methods: A cross sectional study of 60 HIV-positive individuals, all receiving highly active antiretroviral therapy (HAART), and 80 demographically matched HIV-seronegative control subjects. We administered a comprehensive neuropsychological test battery and structured psychiatric interview. The lowest 10(th) percentile of results achieved by control subjects was used to define the lower limit of normal performance on cognitive measures. Subjects who scored abnormal on three or more measures were classified as cognitively impaired. To determine the clinical significance of any cognitive impairment, we assessed medication adherence, employment, and independence in activities of daily living (ADL). Results: HIV+ subjects were impaired for all cognitive-motor ability areas compared with matched, uninfected control subjects. Thirty seven percent of HIV+ patients met criteria for cognitive impairment. Conclusion: These findings indicate that neurocognitive impairment is likely to be an important feature of HIV infection in resource-limited countries; underscoring the need to develop effective treatments for subjects with, or at risk of developing, cognitive impairment.	[Lawler, Kathy; Ratcliffe, Sarah J.; Steenhoff, Andrew P.] Univ Penn, Ctr AIDS Res & Botswana UPenn Partnership, Philadelphia, PA 19104 USA; [Seloilwe, Esther] Univ Botswana, Ctr Study HIV & AIDS, Gaborone, Botswana; [Mosepele, Mosepele] Princess Marina Hosp, Infect Dis Care Ctr, Gaborone, Botswana; [Lawler, Kathy] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Ratcliffe, Sarah J.; Steenhoff, Andrew P.] Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Mosepele, Mosepele] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Jeremiah, Kealeboga; Cherry, Catherine] Monash Univ, Melbourne, Vic 3004, Australia; [Cherry, Catherine] Burnet Inst, Ctr Virol, Melbourne, Vic, Australia; [Cherry, Catherine] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia	University of Pennsylvania; University of Botswana; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Monash University; Burnet Institute; Florey Institute of Neuroscience & Mental Health	Lawler, K (corresponding author), Univ Penn, Ctr AIDS Res & Botswana UPenn Partnership, Philadelphia, PA 19104 USA.	kathy.lawler@uphs.upenn.edu	Ratcliffe, Sarah J/GYR-1110-2022	Ratcliffe, Sarah J/0000-0002-6644-8284; Cherry, Catherine Louise/0000-0001-9816-5193				*AIDSTAR ON, 2008, BOTSW NAT HIV AIDS T; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Clifford DB, 2007, J NEUROVIROL, V13, P67, DOI 10.1080/13550280601169837; Cysique LAJ, 2006, NEUROLOGY, V66, P1447, DOI 10.1212/01.wnl.0000210477.63851.d3; Cysique LA, 2007, J INT NEUROPSYCH SOC, V13, P1, DOI 10.1017/S1355617707070026; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Das Gupta J, 2007, J NEUROVIROL, V13, P195, DOI 10.1080/13550280701258407; Dawes S, 2008, J CLIN EXP NEUROPSYC, V30, P613, DOI 10.1080/13803390701565225; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; HEATON RK, 2009, 16 C RETR OPP INF MO, P396; Heaton RK, 2008, J NEUROVIROL, V14, P536, DOI 10.1080/13550280802378880; Jin H, 2006, J AFFECT DISORDERS, V94, P269, DOI 10.1016/j.jad.2006.04.013; JOSKA JA, 2010, AIDS BEHAV       JUL; Kanmogne GD, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-60; *LAF INSTR, LAF INSTR GROOV PEG; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Lawler K, 2011, AIDS BEHAV, V15, P204, DOI 10.1007/s10461-009-9622-2; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Liner KJ, 2007, J NEUROVIROL, V13, P291, DOI 10.1080/13550280701422383; Livingston J, 2009, CULT ANTHROPOL, V24, P652, DOI 10.1111/j.1548-1360.2009.01043.x; MAJ M, 1993, ARCH CLIN NEUROPSYCH, V8, P123, DOI 10.1016/0887-6177(93)90030-5; MAJ M, 1994, ARCH GEN PSYCHIAT, V51, P51; Osowiecki DM, 2000, AIDS, V14, P1327, DOI 10.1097/00002030-200007070-00004; Reitan RM, 1985, HALSTEAD REITAN NEUR; Robertson K, 2009, NEUROPSYCHOL REV, V19, P232, DOI 10.1007/s11065-009-9096-z; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Sacktor NC, 2005, AIDS, V19, P1367; Sacktor N, 2007, NAT CLIN PRACT NEURO, V3, P436, DOI 10.1038/ncpneuro0559; SCARAVILLI F, 1993, NEUROPATHOLOGY HIV I; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Suarez SV, 2000, EUR J NEUROL, V7, P151, DOI 10.1046/j.1468-1331.2000.00050.x; Tommasello AC, 2006, AIDS CARE, V18, P911, DOI 10.1080/09540120500331297; Tozzi V, 2009, JAIDS-J ACQ IMM DEF, V52, P56, DOI 10.1097/QAI.0b013e3181af83d6; *UNAIDS, NACA BOTSW 2010 COUN; Wechsler D, WECHSLER ADULT INTEL; Wong M, 2004, NEUROLOGY, V62, pA444; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Wright E, 2008, NEUROLOGY, V71, P50, DOI 10.1212/01.wnl.0000316390.17248.65	45	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17233	10.1371/journal.pone.0017233	http://dx.doi.org/10.1371/journal.pone.0017233			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723CC	21365002	gold, Green Submitted, Green Published			2022-12-27	WOS:000287482800037
J	Ferrari, S; Sanguinetti, M; Torelli, R; Posteraro, B; Sanglard, D				Ferrari, Selene; Sanguinetti, Maurizio; Torelli, Riccardo; Posteraro, Brunella; Sanglard, Dominique			Contribution of CgPDR1-Regulated Genes in Enhanced Virulence of Azole-Resistant Candida glabrata	PLOS ONE			English	Article							TRANSPORTER-ENCODING GENE; GENOME-WIDE EXPRESSION; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CRYPTOCOCCUS-NEOFORMANS; TRANSCRIPTION FACTOR; ANTIFUNGAL AGENTS; IN-VIVO; YEAST	In Candida glabrata, the transcription factor CgPdr1 is involved in resistance to azole antifungals via upregulation of ATP binding cassette (ABC)-transporter genes including at least CgCDR1, CgCDR2 and CgSNQ2. A high diversity of GOF (gain-of-function) mutations in CgPDR1 exists for the upregulation of ABC-transporters. These mutations enhance C. glabrata virulence in animal models, thus indicating that CgPDR1 might regulate the expression of yet unidentified virulence factors. We hypothesized that CgPdr1-dependent virulence factor(s) should be commonly regulated by all GOF mutations in CgPDR1. As deduced from transcript profiling with microarrays, a high number of genes (up to 385) were differentially regulated by a selected number (7) of GOF mutations expressed in the same genetic background. Surprisingly, the transcriptional profiles resulting from expression of GOF mutations showed minimal overlap in co-regulated genes. Only two genes, CgCDR1 and PUP1 (for PDR1 upregulated and encoding a mitochondrial protein), were commonly upregulated by all tested GOFs. While both genes mediated azole-resistance, although to different extents, their deletions in an azoleresistant isolate led to a reduction of virulence and decreased tissue burden as compared to clinical parents. As expected from their role in C. glabrata virulence, the two genes were expressed as well in vitro and in vivo. The individual overexpression of these two genes in a CgPDR1-independent manner could partially restore phenotypes obtained in clinical isolates. These data therefore demonstrate that at least these two CgPDR1-dependent and -upregulated genes contribute to the enhanced virulence of C. glabrata that acquired azole resistance.	[Sanguinetti, Maurizio; Torelli, Riccardo; Posteraro, Brunella] Univ Cattolica Sacro Cuore, Inst Microbiol, Rome, Italy; [Ferrari, Selene; Sanglard, Dominique] Univ Lausanne, Inst Microbiol, Lausanne, Switzerland; [Ferrari, Selene; Sanglard, Dominique] Univ Hosp Ctr, Lausanne, Switzerland	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Lausanne	Ferrari, S (corresponding author), Univ Lausanne, Inst Microbiol, Lausanne, Switzerland.	dominique.sanglard@chuv.ch	Sanglard, Dominique/K-6032-2017; Sanguinetti, Maurizio/A-1453-2019; Torelli, Riccardo/N-8813-2019; Posteraro, Brunella/K-8499-2018; Torelli, Riccardo/K-8822-2018	Sanglard, Dominique/0000-0002-5244-4178; Sanguinetti, Maurizio/0000-0002-9780-7059; Posteraro, Brunella/0000-0002-1663-7546; Torelli, Riccardo/0000-0001-7927-4343	Swiss Research National Foundation [31003A_127378]; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Italy); Universita Cattolica del S. Cuore	Swiss Research National Foundation; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Italy); Universita Cattolica del S. Cuore	This work was supported by a grant of the Swiss Research National Foundation 31003A_127378 to DS. M. S. was supported by a grant from the Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) "Lazzaro Spallanzani" (Strategic Research Program 2006, Italy) and from Universita Cattolica del S. Cuore (Linea D1, 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2004, J BIOL CHEM, V279, P27855, DOI 10.1074/jbc.M403487200; Akache B, 2002, J BIOL CHEM, V277, P21254, DOI 10.1074/jbc.M202566200; Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Andersson DI, 2006, CURR OPIN MICROBIOL, V9, P461, DOI 10.1016/j.mib.2006.07.002; Bennett JE, 2004, ANTIMICROB AGENTS CH, V48, P1773, DOI 10.1128/AAC.48.5.1773-1777.2004; Berila N, 2010, MYCOPATHOLOGIA, V170, P99, DOI 10.1007/s11046-010-9298-1; Borst A, 2005, ANTIMICROB AGENTS CH, V49, P783, DOI 10.1128/AAC.49.2.783-787.2005; Coste AT, 2004, EUKARYOT CELL, V3, P1639, DOI 10.1128/EC.3.6.1639-1652.2004; Devauz F, 2001, EMBO REP, V2, P493, DOI 10.1093/embo-reports/kve114; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dryden MW, 2005, VET THER, V6, P260; FERRARI S, 2011, ANTIMICROB IN PRESS; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Gulshan K, 2007, EUKARYOT CELL, V6, P1933, DOI 10.1128/EC.00254-07; Hellauer K, 2002, J BIOL CHEM, V277, P17671, DOI 10.1074/jbc.M201637200; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jacobsen ID, 2010, INFECT IMMUN, V78, P1066, DOI 10.1128/IAI.01244-09; Kaur R, 2005, CURR OPIN MICROBIOL, V8, P378, DOI 10.1016/j.mib.2005.06.012; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Keppler-Ross S, 2008, GENETICS, V179, P705, DOI 10.1534/genetics.108.087080; Kretschmer M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000696; Lass-Florl C, 2009, MYCOSES, V52, P197, DOI 10.1111/j.1439-0507.2009.01691.x; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Mamnun YM, 2002, MOL MICROBIOL, V46, P1429, DOI 10.1046/j.1365-2958.2002.03262.x; Martens JA, 1996, J BIOL CHEM, V271, P15884, DOI 10.1074/jbc.271.27.15884; Morschhauser J, 2007, PLOS PATHOG, V3, P1603, DOI 10.1371/journal.ppat.0030164; Orsi CF, 2009, FEMS YEAST RES, V9, P301, DOI 10.1111/j.1567-1364.2008.00470.x; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, DIAGN MICR INFEC DIS, V67, P162, DOI 10.1016/j.diagmicrobio.2010.01.002; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Ruhnke M, 2006, CURR DRUG TARGETS, V7, P495, DOI 10.2174/138945006776359421; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Sanglard D, 2002, LANCET INFECT DIS, V2, P73, DOI 10.1016/S1473-3099(02)00181-0; Sanglard D, 2001, ANTIMICROB AGENTS CH, V45, P1174, DOI 10.1128/AAC.45.4.1174-1183.2001; Sanguinetti M, 2006, INFECT IMMUN, V74, P1352, DOI 10.1128/IAI.74.2.1352-1359.2006; Sanguinetti M, 2005, ANTIMICROB AGENTS CH, V49, P668, DOI 10.1128/AAC.49.2.668-679.2005; Shahi P, 2010, MOL BIOL CELL, V21, P2469, DOI 10.1091/mbc.E09-10-0899; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sionov E, 2009, ANTIMICROB AGENTS CH, V53, P2804, DOI 10.1128/AAC.00295-09; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; Torelli R, 2008, MOL MICROBIOL, V68, P186, DOI 10.1111/j.1365-2958.2008.06143.x; Tsai HF, 2006, ANTIMICROB AGENTS CH, V50, P1384, DOI 10.1128/AAC.50.4.1384-1392.2006; Tsai HF, 2010, ANTIMICROB AGENTS CH, V54, P3308, DOI 10.1128/AAC.00535-10; Tudela JLR, 2008, CLIN MICROBIOL INFEC, V14, P193, DOI 10.1111/j.1469-0691.2007.01899.x; Vermitsky JP, 2006, MOL MICROBIOL, V61, P704, DOI 10.1111/j.1365-2958.2006.05235.x; Zhang XT, 2001, J BIOL CHEM, V276, P8812, DOI 10.1074/jbc.M010686200	48	86	103	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17589	10.1371/journal.pone.0017589	http://dx.doi.org/10.1371/journal.pone.0017589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408004	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170900028
J	Neiman, M; Lundin, S; Savolainen, P; Ahmadian, A				Neiman, Marten; Lundin, Sverker; Savolainen, Peter; Ahmadian, Afshin			Decoding a Substantial Set of Samples in Parallel by Massive Sequencing	PLOS ONE			English	Article							HIGH-THROUGHPUT; HIGH-RESOLUTION; DNA; PROBES	There has been a dramatic increase of throughput of sequenced bases in the last years but sequencing a multitude of samples in parallel has not yet developed equally. Here we present a novel strategy where the combination of two tags is used to link sequencing reads back to their origins from a pool of samples. By incorporating the tags in two steps sample-handling complexity is lowered by nearly 100 times compared to conventional indexing protocols. In addition, the method described here enables accurate identification and typing of thousands of samples in parallel. In this study the system was designed to test 4992 samples using only 122 tags. To prove the concept of the two-tagging method, the highly polymorphic 2(nd) exon of DLA-DRB1 in dogs and wolves was sequenced using the 454 GS FLX Titanium Chemistry. By requiring a minimum sequence depth of 20 reads per sample, 94% of the successfully amplified samples were genotyped. In addition, the method allowed digital detection of chimeric fragments. These results demonstrate that it is possible to sequence thousands of samples in parallel without complex pooling patterns or primer combinations. Furthermore, the method is highly scalable as only a limited number of additional tags leads to substantial increase of the sample size.	[Neiman, Marten; Lundin, Sverker; Savolainen, Peter; Ahmadian, Afshin] Royal Inst Technol KTH, Sch Biotechnol, Dept Gene Technol, Sci Life Lab, Solna, Sweden	Royal Institute of Technology	Neiman, M (corresponding author), Royal Inst Technol KTH, Sch Biotechnol, Dept Gene Technol, Sci Life Lab, Solna, Sweden.	afshin.ahmadian@scilifelab.se			Swedish Board of Agriculture (Jordbruksverket); Knut and Alice Wallenberg Foundation	Swedish Board of Agriculture (Jordbruksverket); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by a grant from The Swedish Board of Agriculture (Jordbruksverket). Peter Savolainen is a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babik W, 2009, MOL ECOL RESOUR, V9, P713, DOI 10.1111/j.1755-0998.2009.02622.x; Bentley G, 2009, TISSUE ANTIGENS, V74, P393, DOI 10.1111/j.1399-0039.2009.01345.x; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Kennedy LJ, 2005, J HERED, V96, P836, DOI 10.1093/jhered/esi112; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Lundin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010029; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Parameswaran P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm760; Pettersson E, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl103; Pettersson E, 2008, HUM MUTAT, V29, P323, DOI 10.1002/humu.20655; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Wegner KM, 2009, MOL ECOL, V18, P1818, DOI 10.1111/j.1365-294X.2009.04173.x; Zajac P, 2008, GENOMICS, V91, P209, DOI 10.1016/j.ygeno.2007.10.012	23	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 9	2011	6	3							e17785	10.1371/journal.pone.0017785	http://dx.doi.org/10.1371/journal.pone.0017785			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FR	21408018	Green Submitted, gold, Green Published			2022-12-27	WOS:000288170900047
J	Colomer-Lluch, M; Jofre, J; Muniesa, M				Colomer-Lluch, Marta; Jofre, Juan; Muniesa, Maite			Antibiotic Resistance Genes in the Bacteriophage DNA Fraction of Environmental Samples	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ESCHERICHIA-COLI STRAINS; WASTE-WATER; STAPHYLOCOCCUS-AUREUS; PHAGE; TRANSDUCTION; EVOLUTION; TRANSFORMATION; DISSEMINATION; INACTIVATION	Antibiotic resistance is an increasing global problem resulting from the pressure of antibiotic usage, greater mobility of the population, and industrialization. Many antibiotic resistance genes are believed to have originated in microorganisms in the environment, and to have been transferred to other bacteria through mobile genetic elements. Among others, beta-lactam antibiotics show clinical efficacy and low toxicity, and they are thus widely used as antimicrobials. Resistance to beta-lactam antibiotics is conferred by beta-lactamase genes and penicillin-binding proteins, which are chromosomal-or plasmid-encoded, although there is little information available on the contribution of other mobile genetic elements, such as phages. This study is focused on three genes that confer resistance to beta-lactam antibiotics, namely two b-lactamase genes (blaTEM and blaCTX-M9) and one encoding a penicillin-binding protein (mecA) in bacteriophage DNA isolated from environmental water samples. The three genes were quantified in the DNA isolated from bacteriophages collected from 30 urban sewage and river water samples, using quantitative PCR amplification. All three genes were detected in the DNA of phages from all the samples tested, in some cases reaching 104 gene copies (GC) of blaTEM or 102 GC of blaCTX-M and mecA. These values are consistent with the amount of fecal pollution in the sample, except for mecA, which showed a higher number of copies in river water samples than in urban sewage. The bla genes from phage DNA were transferred by electroporation to sensitive host bacteria, which became resistant to ampicillin. blaTEM and blaCTX were detected in the DNA of the resistant clones after transfection. This study indicates that phages are reservoirs of resistance genes in the environment.	[Colomer-Lluch, Marta; Jofre, Juan; Muniesa, Maite] Univ Barcelona, Dept Microbiol, Barcelona, Spain	University of Barcelona	Colomer-Lluch, M (corresponding author), Univ Barcelona, Dept Microbiol, Barcelona, Spain.	mmuniesa@ub.edu	Muniesa, Maite/K-4577-2014	Muniesa, Maite/0000-0001-5549-1394	Generalitat de Catalunya [2009SGR1043]; Spanish Ministry of Education and Science [AGL2009-07576, SOSTAQUA-CENIT]; Xarxa de Referencia en Biotecnologia (XRB)	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministry of Education and Science(Spanish Government); Xarxa de Referencia en Biotecnologia (XRB)	This study was supported by the Generalitat de Catalunya (2009SGR1043), the Spanish Ministry of Education and Science (AGL2009-07576 and SOSTAQUA-CENIT) and the Xarxa de Referencia en Biotecnologia (XRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Microbiology, 2009, ANT RES EC PERSP OLD; Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; [Anonymous], 2000, 107052 ISO; [Anonymous], 1996, WORLD HLTH REP; [Anonymous], 1998, STANDARD METHODS EXA; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Barlow M, 2008, EMERG INFECT DIS, V14, P423, DOI 10.3201/eid1403.070405; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Berger-Bachi B, 2002, ARCH MICROBIOL, V178, P165, DOI 10.1007/s00203-002-0436-0; BLAHOVA J, 1993, ACTA VIROL, V37, P429; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Borjesson S, 2009, WATER RES, V43, P925, DOI 10.1016/j.watres.2008.11.036; Brabban AD, 2005, FOODBORNE PATHOG DIS, V2, P287, DOI 10.1089/fpd.2005.2.287; CANGELOSI GA, 2004, ENV MICROORGANISMS H; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; COOKE MD, 1976, ANTIMICROB AGENTS CH, V9, P885, DOI 10.1128/AAC.9.6.885; Coque TM, 2008, EURO SURVEILL, V13; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Diaz MA, 2010, J CLIN MICROBIOL, V48, P2840, DOI 10.1128/JCM.02147-09; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dupray E, 1997, J APPL MICROBIOL, V82, P507, DOI 10.1046/j.1365-2672.1997.00143.x; Duran AE, 2002, J APPL MICROBIOL, V92, P338, DOI 10.1046/j.1365-2672.2002.01536.x; Edge TA, 2005, CAN J MICROBIOL, V51, P501, DOI 10.1139/W05-028; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; HYDER SL, 1978, J INFECT DIS, V138, P281, DOI 10.1093/infdis/138.3.281; Imamovic L, 2009, APPL ENVIRON MICROB, V75, P1764, DOI 10.1128/AEM.02273-08; Ito T, 2003, DRUG RESIST UPDATE, V6, P41, DOI 10.1016/S1368-7646(03)00003-7; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lingohr EJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-122; LORENZ MG, 1994, MICROBIOL REV, V58, P563, DOI 10.1128/MMBR.58.3.563-602.1994; Lucena F, 2004, J APPL MICROBIOL, V97, P1069, DOI 10.1111/j.1365-2672.2004.02397.x; McShan WM, 2000, GRAM-POSITIVE PATHOGENS, P105; Muniesa M, 2005, APPL ENVIRON MICROB, V71, P4269, DOI 10.1128/AEM.71.8.4269-4275.2005; Muniesa M, 2004, EMERG INFECT DIS, V10, P1134, DOI 10.3201/eid1006.030472; Muniesa M, 2003, ANTON LEEUW INT J G, V83, P305, DOI 10.1023/A:1023384714481; Muniesa M, 1999, APPL ENVIRON MICROB, V65, P5615; MURRAY BE, 1992, PHARMACOTHERAPY, V12, pS86; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Oliver A, 2005, ANTIMICROB AGENTS CH, V49, P1567, DOI 10.1128/AAC.49.4.1567-1571.2005; Parsley LC, 2010, APPL ENVIRON MICROB, V76, P3753, DOI 10.1128/AEM.03080-09; Patterson JE, 2003, SEMIN RESP CRIT CARE, V24, P79, DOI 10.1055/s-2003-37919; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; Sambrook J., 2001, MOL CLONING LAB MANU; Sander M, 2001, APPL ENVIRON MICROB, V67, P1490, DOI 10.1128/AEM.67.4.1490-1493.2001; Schmieger H, 1999, FEMS MICROBIOL LETT, V170, P251, DOI 10.1016/S0378-1097(98)00553-9; Schuch R, 2006, J BACTERIOL, V188, P3037, DOI 10.1128/JB.188.8.3037-3051.2006; Schwartz T, 2003, FEMS MICROBIOL ECOL, V43, P325, DOI 10.1111/j.1574-6941.2003.tb01073.x; SMITH HW, 1972, NATURE-NEW BIOL, V238, P205, DOI 10.1038/newbio238205a0; Volkmann H, 2004, J MICROBIOL METH, V56, P277, DOI 10.1016/j.mimet.2003.10.014; Walther-Rasmussen J, 2004, CAN J MICROBIOL, V50, P137, DOI 10.1139/W03-111; Willi K, 1997, CELL MOL LIFE SCI, V53, P904, DOI 10.1007/s000180050109; Witte W, 2004, INFECT GENET EVOL, V4, P187, DOI 10.1016/j.meegid.2003.12.005; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Zhu B, 2006, WATER RES, V40, P3231, DOI 10.1016/j.watres.2006.06.040	61	213	227	5	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2011	6	3							e17549	10.1371/journal.pone.0017549	http://dx.doi.org/10.1371/journal.pone.0017549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729QI	21390233	Green Published, Green Submitted, gold			2022-12-27	WOS:000287965200023
J	Lee, VJ; Yap, J; Cook, AR; Tan, CH; Loh, JP; Koh, WH; Lim, EAS; Liaw, JCW; Chew, JSW; Hossain, I; Chan, KW; Ting, PJ; Ng, SH; Gao, QH; Kelly, PM; Chen, MI; Tambyah, PA; Tan, BH				Lee, Vernon J.; Yap, Jonathan; Cook, Alex R.; Tan, Chi Hsien; Loh, Jin-Phang; Koh, Wee-Hong; Lim, Elizabeth A. S.; Liaw, Jasper C. W.; Chew, Janet S. W.; Hossain, Iqbal; Chan, Ka Wei; Ting, Pei-Jun; Ng, Sock-Hoon; Gao, Qiuhan; Kelly, Paul M.; Chen, Mark I.; Tambyah, Paul A.; Tan, Boon Huan			A Clinical Diagnostic Model for Predicting Influenza among Young Adult Military Personnel with Febrile Respiratory Illness in Singapore	PLOS ONE			English	Article							SYMPTOMS	Introduction: Influenza infections present with wide-ranging clinical features. We aim to compare the differences in presentation between influenza and non-influenza cases among those with febrile respiratory illness (FRI) to determine predictors of influenza infection. Methods: Personnel with FRI (defined as fever >= 37.5 degrees C, with cough or sore throat) were recruited from the sentinel surveillance system in the Singapore military. Nasal washes were collected, and tested using the Resplex II and additional PCR assays for etiological determination. Interviewer-administered questionnaires collected information on patient demographics and clinical features. Univariate comparison of the various parameters was conducted, with statistically significant parameters entered into a multivariate logistic regression model. The final multivariate model for influenza versus non-influenza cases was used to build a predictive probability clinical diagnostic model. Results: 821 out of 2858 subjects recruited from 11 May 2009 to 25 Jun 2010 had influenza, of which 434 (52.9%) had 2009 influenza A (H1N1), 58 (7.1%) seasonal influenza A (H3N2) and 269 (32.8%) influenza B. Influenza-positive cases were significantly more likely to present with running nose, chills and rigors, ocular symptoms and higher temperature, and less likely with sore throat, photophobia, injected pharynx, and nausea/vomiting. Our clinical diagnostic model had a sensitivity of 65% (95% CI: 58%, 72%), specificity of 69% (95% CI: 62%, 75%), and overall accuracy of 68% (95% CI: 64%, 71%), performing significantly better than conventional influenza-like illness (ILI) criteria. Conclusions: Use of a clinical diagnostic model may help predict influenza better than the conventional ILI definition among young adults with FRI.	[Lee, Vernon J.; Yap, Jonathan; Tan, Chi Hsien; Gao, Qiuhan] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.; Chen, Mark I.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Lee, Vernon J.; Kelly, Paul M.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Loh, Jin-Phang; Koh, Wee-Hong; Lim, Elizabeth A. S.; Liaw, Jasper C. W.; Chew, Janet S. W.; Hossain, Iqbal; Chan, Ka Wei; Ting, Pei-Jun; Ng, Sock-Hoon; Tan, Boon Huan] Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; Australian National University; National University of Singapore; Tan Tock Seng Hospital; National University of Singapore	Lee, VJ (corresponding author), Minist Def, Biodef Ctr, Singapore, Singapore.	vernonljm@hotmail.com	Chen, Mark/CAG-2949-2022; Yap, Jonathan/AAJ-7266-2020; Tan, Boon Huan/ABB-8381-2021; Cook, Alex/S-3576-2019; Cook, Alex/B-5941-2011; Chen, Mark/AGC-5338-2022	Chen, Mark/0000-0001-9369-5830; Yap, Jonathan/0000-0002-5227-8536; Tan, Boon Huan/0000-0002-4976-7988; Cook, Alex/0000-0002-6271-5832; Chen, Mark/0000-0001-9369-5830	Singapore Ministry of Defence; GSK; Baxter; Adamas; Merlion Pharma; Novartis	Singapore Ministry of Defence(Ministry of Defence, Singapore); GSK(GlaxoSmithKline); Baxter; Adamas; Merlion Pharma; Novartis(Novartis)	The work was supported by a Singapore Ministry of Defence funded operational research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; VJL has received unrelated research support from GSK. PAT has received research support and honoraria from Baxter, Adamas, Merlion Pharma, and Novartis, as well as travel support from Pfizer and Wyeth, and sits on the boards of the Asia Pacific Advisory Committee on Influenza and the Asian Hygiene Council. The rest of the authors declare no conflict of interests, financial or otherwise, in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Angoulvant F, 2011, EMERG MED J, V28, P924, DOI 10.1136/emj.2010.098533; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; *CDCP, 2010, COLD VERS FLU QUEST; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Ciblak MA, 2010, SCAND J INFECT DIS, V42, P902, DOI 10.3109/00365548.2010.502903; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; Gavin P.J., 2004, CLIN APPL IMMUNOL RE, V4, P151, DOI DOI 10.1016/S1529-1049(03)00064-3; Hong CY, 2004, FAM PRACT, V21, P317, DOI 10.1093/fampra/cmh319; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lee VJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008096; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; *MIN HLTH SING, 2009, 11 CONF NEW CAS INFL; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Ong AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008453; Spyridaki IS, 2009, J VIROL METHODS, V156, P102, DOI 10.1016/j.jviromet.2008.10.027; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Tang JWT, 2010, ARCH INTERN MED, V170, P861, DOI 10.1001/archinternmed.2010.108; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; WHO, 2009, CDC PROT REALT RT PC	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17468	10.1371/journal.pone.0017468	http://dx.doi.org/10.1371/journal.pone.0017468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399686	gold, Green Published, Green Submitted			2022-12-27	WOS:000287933300026
J	Chen, GD; Cheng, YB; Zhang, ZZ; Martinka, M; Li, G				Chen, Guangdi; Cheng, Yabin; Zhang, Zhizhong; Martinka, Magdalena; Li, Gang			Cytoplasmic Skp2 Expression Is Increased in Human Melanoma and Correlated with Patient Survival	PLOS ONE			English	Article							KINASE-ASSOCIATED PROTEIN-2; UBIQUITIN LIGASE; CUL1 EXPRESSION; CELL-GROWTH; CYCLIN D1; OVEREXPRESSION; METASTASIS; P27(KIP1); P27; AMPLIFICATION	Background: S-phase kinase protein 2 (Skp2), an F-box protein, targets cell cycle regulators via ubiquitin-mediated degradation. Skp2 is frequently overexpressed in a variety of cancers and associated with patient survival. In melanoma, however, the prognostic significance of subcellular Skp2 expression remains controversial. Methods: To investigate the role of Skp2 in melanoma development, we constructed tissue microarrays and examined Skp2 expression in melanocytic lesions at different stages, including 30 normal nevi, 61 dysplastic nevi, 290 primary melanomas and 146 metastatic melanomas. The TMA was assessed for cytoplasmic and nuclear Skp2 expression by immunohistochemistry. The Kaplan-Meier method was used to evaluate the patient survival. The univariate and multivariate Cox regression models were performed to estimate the harzard ratios (HR) at five-year follow-up. Results: Cytoplasmic but not nuclear Skp2 expression was gradually increased from normal nevi, dysplastic nevi, primary melanomas to metastatic melanomas. Cytoplasmic Skp2 expression correlated with AJCC stages (I vs II-IV, P < 0.001), tumor thickness (<= 2.00 vs > 2.00 mm, P < 0.001) and ulceration (P = 0.005). Increased cytoplasmic Skp2 expression was associated with a poor five-year disease-specific survival of patients with primary melanoma (P = 0.018) but not metastatic melanoma (P > 0.05). Conclusion: This study demonstrates that cytoplasmic Skp2 plays an important role in melanoma pathogenesis and its expression correlates with patient survival. Our data indicate that cytoplasmic Skp2 may serve as a potential biomarker for melanoma progression and a therapeutic target for this disease.	[Chen, Guangdi; Cheng, Yabin; Zhang, Zhizhong; Li, Gang] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada; [Martinka, Magdalena] Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Pathol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; Vancouver Coastal Health Research Institute	Chen, GD (corresponding author), Univ British Columbia, Vancouver Coastal Hlth Res Inst, Jack Bell Res Ctr, Dept Dermatol & Skin Sci, Vancouver, BC V5Z 1M9, Canada.	gangli@interchange.ubc.ca	Li, Gang/A-8257-2011; Cheng, Yabin/P-7071-2015; Cheng, Yabin/AAY-2178-2020	Cheng, Yabin/0000-0002-6205-3648; Cheng, Yabin/0000-0002-6205-3648	Canadian Institutes of Health Research [MOP-84559, MOP-93810]; Canadian Dermatology Foundation; Michael Smith Foundation; VGH & UBC Hospital Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Dermatology Foundation; Michael Smith Foundation(Michael Smith Foundation for Health Research); VGH & UBC Hospital Foundation	This work is supported by Canadian Institutes of Health Research (MOP-84559 and MOP-93810) and Canadian Dermatology Foundation (G.L.). G.C. is a recipient of Postdoctoral Trainee Award from Michael Smith Foundation for Health Research jointly funded with VGH & UBC Hospital Foundation. Y.C. is a recipient of Canadian Institutes of Health Research Skin Research Training Centre PhD Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2001, J CLIN ONCOL, V19, P3635, DOI 10.1200/JCO.2001.19.16.3635; Barnhill RL, 2010, ADV ANAT PATHOL, V17, P73, DOI 10.1097/PAP.0b013e3181cfe758; Bhatt KV, 2007, ONCOGENE, V26, P1056, DOI 10.1038/sj.onc.1209861; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chen G, 2010, ONCOGENE, V29, P1498, DOI 10.1038/onc.2009.424; Chen GD, 2010, INT J ONCOL, V37, P1339, DOI 10.3892/ijo_00000786; Chen GD, 2010, PIGM CELL MELANOMA R, V23, P572, DOI 10.1111/j.1755-148X.2010.00725.x; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Crowson AN, 2007, SEMIN ONCOL, V34, P476, DOI 10.1053/j.seminoncol.2007.09.007; Dai DL, 2005, J CLIN ONCOL, V23, P1473, DOI 10.1200/JCO.2005.07.168; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Einama T, 2006, PANCREAS, V32, P376, DOI 10.1097/01.mpa.0000220862.78248.c4; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Friedman RJ, 2009, CLIN DERMATOL, V27, P103, DOI 10.1016/j.clindermatol.2008.09.008; Geller AC, 2007, J AM ACAD DERMATOL, V57, P555, DOI 10.1016/j.jaad.2007.06.032; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2005, ANTICANCER RES, V25, P2471; HERLYN M, 1987, LAB INVEST, V56, P461; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Houghton AN, 2002, CANCER CELL, V2, P275, DOI 10.1016/S1535-6108(02)00161-7; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Hu R, 2008, MOL BIOL CELL, V19, P4602, DOI 10.1091/mbc.E07-11-1137; Hung WC, 2010, CANCER LETT, V288, P156, DOI 10.1016/j.canlet.2009.06.032; Ibrahim N, 2009, ANNU REV PATHOL-MECH, V4, P551, DOI 10.1146/annurev.pathol.3.121806.151541; Katagiri Y, 2006, J DERMATOL SCI, V42, P215, DOI 10.1016/j.jdermsci.2005.12.016; Li JQ, 2004, INT J ONCOL, V25, P87; Li Q, 2004, J CUTAN PATHOL, V31, P633, DOI 10.1111/j.0303-6987.2004.00243.x; Li Y, 2002, SEMIN ONCOL, V29, P413, DOI 10.1053/sonc.2002.35237; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu SC, 2009, CANCER LETT, V286, P240, DOI 10.1016/j.canlet.2009.05.038; Ma XM, 2005, WORLD J GASTROENTERO, V11, P6716, DOI 10.3748/wjg.v11.i42.6716; Motti ML, 2007, CELL CYCLE, V6, P2817, DOI 10.4161/cc.6.22.4883; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; REMMELE W, 1987, PATHOLOGE, V8, P138; ROSE AE, PIGMENT CEL IN PRESS; Salon C, 2007, ONCOGENE, V26, P6927, DOI 10.1038/sj.onc.1210499; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sumimoto H, 2006, INT J CANCER, V118, P472, DOI 10.1002/ijc.21286; TOSCO P, ORAL DIS IN PRESS; Trinh VA, 2008, AM J HEALTH-SYST PH, V65, pS3, DOI 10.2146/ajhp080460; Wang XC, 2009, MOL CANCER RES, V7, P12, DOI 10.1158/1541-7786.MCR-08-0092; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Woenckhaus C, 2005, HISTOL HISTOPATHOL, V20, P501, DOI 10.14670/HH-20.501; Yokoi S, 2004, AM J PATHOL, V165, P175, DOI 10.1016/S0002-9440(10)63286-5	51	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17578	10.1371/journal.pone.0017578	http://dx.doi.org/10.1371/journal.pone.0017578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386910	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400085
J	Lu, HX; Khurana, S; Verma, N; Manischewitz, J; King, L; Beigel, JH; Golding, H				Lu, Hanxin; Khurana, Surender; Verma, Nitin; Manischewitz, Jody; King, Lisa; Beigel, John H.; Golding, Hana			A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells	PLOS ONE			English	Article							EFFICACY; SAFETY; ANTIBODIES	Background: Continuing transmissions of highly pathogenic H5N1 viruses in poultry and humans underscores the need for a rapid response to potential pandemic in the form of vaccine. Recombinant technologies for production of immunogenic hemagglutinin (HA) could provide an advantage over the traditional inactivated vaccine manufacturing process. Generation of stably transfected mammalian cells secreting properly folded HA proteins is important for scalable controlled manufacturing. Methodology/Principal Findings: We have developed a Flp-In based 293 stable cell lines through targeted site-specific recombination for expression of secreted hemagglutinin (HA) proteins and evaluated their immunogenicity. H5N1 globular domain HA1(1-330) and HA0(1-500) proteins were purified from the supernatants of 293 Flp-In stable cell lines. Both proteins were properly folded as confirmed by binding to H5N1-neutralizing conformation-dependent human monoclonal antibodies. The HA0 (with unmodified cleavage site) was monomeric, while the HA1 contained oligomeric forms. Upon rabbit immunization, both HA proteins elicited neutralizing antibodies against the homologous virus (A/Vietnam/1203/2004, clade 1) as well as cross-neutralizing antibodies against heterologous H5N1 clade 2 strains, including A/Indonesia/5/2005. These results exceeded the human antibody responses against the inactivated sub-virion H5N1 vaccine. Conclusions/Significance: Our data suggest that the 293 Flp-In system could serve as a platform for rapid expression of HA immunogens in mammalian cells from emerging influenza strains.	[Lu, Hanxin; Khurana, Surender; Verma, Nitin; Manischewitz, Jody; King, Lisa; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Beigel, John H.] NIAID, Immunoregulat Lab, Div Intramural Res, SAIC Frederick,NCI Frederick, Frederick, MD USA	US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Allergy & Infectious Diseases (NIAID); Science Applications International Corporation (SAIC); SAIC-Frederick	Lu, HX (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	hana.golding@fda.hhs.gov	Beigel, John H/GNP-2628-2022; Beigel, John/AAQ-4289-2021	Beigel, John/0000-0002-4879-4941; Tripp, Ralph/0000-0002-2924-9956	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases, National Institutes of Health	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract no. HHSN261200800001E and in part by the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel JH, 2009, J INFECT DIS, V200, P501, DOI 10.1086/599992; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10; Carmona A, 2010, VACCINE, V28, P5837, DOI 10.1016/j.vaccine.2010.06.065; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Huang Y, 2007, J IMMUNOL METHODS, V322, P28, DOI 10.1016/j.jim.2007.01.022; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kim JK, 2008, J VIROL, V82, P11374, DOI 10.1128/JVI.01176-08; Kuhl A, 2010, J IMMUNOL, V185, P387, DOI 10.4049/jimmunol.0903887; Lakey DL, 1996, J INFECT DIS, V174, P838, DOI 10.1093/infdis/174.4.838; Steensels M, 2007, AVIAN DIS, V51, P325, DOI 10.1637/7628-042806R.1; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Suguitan AL, 2009, VIROLOGY, V395, P280, DOI 10.1016/j.virol.2009.09.017; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; van den Berg T, 2008, COMP IMMUNOL MICROB, V31, P121, DOI 10.1016/j.cimid.2007.07.004; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Wiberg FC, 2006, BIOTECHNOL BIOENG, V94, P396, DOI 10.1002/bit.20865; Wiesner O, 2005, FEBS LETT, V579, P5305, DOI 10.1016/j.febslet.2005.08.056	23	16	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17297	10.1371/journal.pone.0017297	http://dx.doi.org/10.1371/journal.pone.0017297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386997	Green Published, Green Submitted, gold			2022-12-27	WOS:000287931400050
J	Paul, D; Kumar, R; Nanduri, B; French, T; Pendarvis, K; Brown, A; Lawrence, ML; Burgess, SC				Paul, Debarati; Kumar, Ranjit; Nanduri, Bindu; French, Todd; Pendarvis, Ken; Brown, Ashli; Lawrence, Mark L.; Burgess, Shane C.			Proteome and Membrane Fatty Acid Analyses on Oligotropha carboxidovorans OM5 Grown under Chemolithoautotrophic and Heterotrophic Conditions	PLOS ONE			English	Article							GAS-CHROMATOGRAPHIC QUANTIFICATION; CARBON-MONOXIDE DEHYDROGENASE; CYCLE ENZYME-ACTIVITIES; ESCHERICHIA-COLI; BRADYRHIZOBIUM-JAPONICUM; GLYOXYLATE CYCLE; MEGAPLASMID PHCG3; METHYL-ESTERS; GENE-CLUSTER; PURIFICATION	Oligotropha carboxidovorans OM5 T. (DSM 1227, ATCC 49405) is a chemolithoautotrophic bacterium able to utilize CO and H(2) to derive energy for fixation of CO(2). Thus, it is capable of growth using syngas, which is a mixture of varying amounts of CO and H(2) generated by organic waste gasification. O. carboxidovorans is capable also of heterotrophic growth in standard bacteriologic media. Here we characterize how the O. carboxidovorans proteome adapts to different lifestyles of chemolithoautotrophy and heterotrophy. Fatty acid methyl ester (FAME) analysis of O. carboxidovorans grown with acetate or with syngas showed that the bacterium changes membrane fatty acid composition. Quantitative shotgun proteomic analysis of O. carboxidovorans grown in the presence of acetate and syngas showed production of proteins encoded on the megaplasmid for assimilating CO and H(2) as well as proteins encoded on the chromosome that might have contributed to fatty acid and acetate metabolism. We found that adaptation to chemolithoautotrophic growth involved adaptations in cell envelope, oxidative homeostasis, and metabolic pathways such as glyoxylate shunt and amino acid/cofactor biosynthetic enzymes.	[Paul, Debarati; Kumar, Ranjit; Nanduri, Bindu; Lawrence, Mark L.; Burgess, Shane C.] Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA; [French, Todd; Burgess, Shane C.] Mississippi State Univ, Dept Chem Engn, Mississippi State, MS 39762 USA; [Pendarvis, Ken] Mississippi State Univ, Life Sci & Biotechnol Inst, Mississippi State, MS 39762 USA; [Brown, Ashli] Mississippi State Univ, Dept Biochem & Mol Biol, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University; Mississippi State University; Mississippi State University	Paul, D (corresponding author), Mississippi State Univ, Coll Vet Med, Mississippi State, MS 39762 USA.	lawrence@cvm.msstate.edu	Paul, Debarati/ABE-8692-2020	Paul, Debarati/0000-0002-3893-658X	United States Department of Energy [DE-FG3606GO86025]	United States Department of Energy(United States Department of Energy (DOE))	This research was supported by the United States Department of Energy under award number DE-FG3606GO86025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro SE, 2002, CAN J MICROBIOL, V48, P239, DOI 10.1139/W02-012; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges SM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S24; CLAASSEN PAM, 1986, ARCH MICROBIOL, V145, P148, DOI 10.1007/BF00446772; CRONAN JE, 1972, BIOCHIM BIOPHYS ACTA, V265, P25, DOI 10.1016/0304-4157(72)90018-4; Denich TJ, 2003, J MICROBIOL METH, V52, P149, DOI 10.1016/S0167-7012(02)00155-0; Dodds ED, 2005, LIPIDS, V40, P419, DOI 10.1007/s11745-006-1399-8; ESCHENBRENNER M, 1995, J BIOL CHEM, V270, P20550, DOI 10.1074/jbc.270.35.20550; Fuhrmann S, 2003, GENE, V322, P67, DOI 10.1016/j.gene.2003.08.027; Green LS, 1998, ARCH MICROBIOL, V169, P445, DOI 10.1007/s002030050595; GUTNIKOV G, 1995, J CHROMATOGR B, V671, P71, DOI 10.1016/0378-4347(95)00116-Z; Han L, 1997, J BACTERIOL, V179, P5157, DOI 10.1128/jb.179.16.5157-5164.1997; HAYASHI M, 1990, BIOCHIM BIOPHYS ACTA, V1035, P230, DOI 10.1016/0304-4165(90)90122-D; Henstra AM, 2007, CURR OPIN BIOTECH, V18, P200, DOI 10.1016/j.copbio.2007.03.008; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jones P, 2006, NUCLEIC ACIDS RES, V34, pD659, DOI 10.1093/nar/gkj138; KEEFE RG, 1993, BIOCHIM BIOPHYS ACTA, V1183, P91, DOI 10.1016/0005-2728(93)90008-4; Kieft TL, 1997, APPL ENVIRON MICROB, V63, P1531, DOI 10.1128/AEM.63.4.1531-1542.1997; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kutchma AJ, 1999, J BACTERIOL, V181, P5498, DOI 10.1128/JB.181.17.5498-5504.1999; Lorite MJ, 2000, APPL ENVIRON MICROB, V66, P1871, DOI 10.1128/AEM.66.5.1871-1876.2000; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; MARUYAMA Y, 1958, INFLUENCE GROWTH PHA, P169; MEYER O, 1978, ARCH MICROBIOL, V118, P35, DOI 10.1007/BF00406071; Meyer O, 2000, BIOL CHEM, V381, P865, DOI 10.1515/BC.2000.108; MEYER O, 1983, ANNU REV MICROBIOL, V37, P277, DOI 10.1146/annurev.mi.37.100183.001425; Nanduri B, 2005, PROTEOMICS, V5, P4852, DOI 10.1002/pmic.200500112; Neilan BA, 2008, ADV EXP MED BIOL, V619, P417; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Orchard Sandra, 2007, Proteomics, V7 Suppl 1, P28, DOI 10.1002/pmic.200700286; Oshiro G, 2002, GENOME RES, V12, P1210, DOI 10.1101/gr.226802; Paul D, 2008, J BACTERIOL, V190, P5531, DOI 10.1128/JB.00614-08; Santiago B, 1999, GENE, V236, P115, DOI 10.1016/S0378-1119(99)00245-0; Santiago B, 1997, J BACTERIOL, V179, P6053, DOI 10.1128/jb.179.19.6053-6060.1997; SINENSKY M, 1974, P NATL ACAD SCI USA, V71, P522, DOI 10.1073/pnas.71.2.522; Thurnhofer S, 2006, J AGR FOOD CHEM, V54, P3209, DOI 10.1021/jf053022j; Unnikrishnan M, 1999, INFECT IMMUN, V67, P5495, DOI 10.1128/IAI.67.10.5495-5499.1999	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17111	10.1371/journal.pone.0017111	http://dx.doi.org/10.1371/journal.pone.0017111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386900	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400029
J	Terry, AJ; Sturrock, M; Dale, JK; Maroto, M; Chaplain, MAJ				Terry, Alan J.; Sturrock, Marc; Dale, J. Kim; Maroto, Miguel; Chaplain, Mark A. J.			A Spatio-Temporal Model of Notch Signalling in the Zebrafish Segmentation Clock: Conditions for Synchronised Oscillatory Dynamics	PLOS ONE			English	Article							GENETIC-CONTROL; EXPRESSION; SOMITOGENESIS; HES1; MECHANISM; DIFFUSION; TRANSPORT; NUMBER; HER1; ACTIVATION	In the vertebrate embryo, tissue blocks called somites are laid down in head-to-tail succession, a process known as somitogenesis. Research into somitogenesis has been both experimental and mathematical. For zebrafish, there is experimental evidence for oscillatory gene expression in cells in the presomitic mesoderm (PSM) as well as evidence that Notch signalling synchronises the oscillations in neighbouring PSM cells. A biological mechanism has previously been proposed to explain these phenomena. Here we have converted this mechanism into a mathematical model of partial differential equations in which the nuclear and cytoplasmic diffusion of protein and mRNA molecules is explictly considered. By performing simulations, we have found ranges of values for the model parameters (such as diffusion and degradation rates) that yield oscillatory dynamics within PSM cells and that enable Notch signalling to synchronise the oscillations in two touching cells. Our model contains a Hill coefficient that measures the co-operativity between two proteins (Her1, Her7) and three genes (her1, her7, deltaC) which they inhibit. This coefficient appears to be bounded below by the requirement for oscillations in individual cells and bounded above by the requirement for synchronisation. Consistent with experimental data and a previous spatially non-explicit mathematical model, we have found that signalling can increase the average level of Her1 protein. Biological pattern formation would be impossible without a certain robustness to variety in cell shape and size; our results possess such robustness. Our spatially-explicit modelling approach, together with new imaging technologies that can measure intracellular protein diffusion rates, is likely to yield significant new insight into somitogenesis and other biological processes.	[Terry, Alan J.; Sturrock, Marc; Chaplain, Mark A. J.] Univ Dundee, Div Math, Dundee, Scotland; [Dale, J. Kim; Maroto, Miguel] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland	University of Dundee; University of Dundee	Terry, AJ (corresponding author), Univ Dundee, Div Math, Dundee, Scotland.	aterry@maths.dundee.ac.uk	Chaplain, Mark AJ/A-5355-2010; Dale, Kim J/A-4480-2016	Chaplain, Mark AJ/0000-0001-5727-2160; Dale, Kim J/0000-0002-9294-947X	European Research Council [227619]; Wellcome Trust [089357/Z/09/Z]; University of Dundee; Medical Research Council [G120/989] Funding Source: researchfish; MRC [G120/989] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); University of Dundee; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	AJT, MS, and MAJC were supported by the European Research Council, Advanced Investigator Grant 227619, "M5CGS - From Mutations to Metastases: Multiscale Mathematical Modelling of Cancer Growth and Spread." JKD is a Royal Society University Research Fellow and was supported by a Wellcome Trust 3y project grant; number: 089357/Z/09/Z. MM was supported by the University of Dundee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda-Estudillo Y, 2010, CURR BIOL, V20, P161, DOI 10.1016/j.cub.2009.11.036; Armstrong N, 2009, B MATH BIOL, V71, P1, DOI 10.1007/s11538-008-9350-1; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Baker RE, 2006, DEV BIOL, V293, P116, DOI 10.1016/j.ydbio.2006.01.018; Baker RE, 2008, CURR TOP DEV BIOL, V81, P183, DOI 10.1016/S0070-2153(07)81006-4; Barik D, 2008, BIOPHYS J, V95, P3563, DOI 10.1529/biophysj.108.129155; Barik D, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.55; Brend T, 2009, DEV DYNAM, V238, P2745, DOI 10.1002/dvdy.22100; BUSENBERG S, 1985, J MATH BIOL, V22, P313, DOI 10.1007/BF00276489; CAMPANELLI M, 2009, THESIS MONTANA STATE; Cangiani A, 2010, J THEOR BIOL, V267, P614, DOI 10.1016/j.jtbi.2010.08.017; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Cinquin O, 2003, J THEOR BIOL, V224, P459, DOI 10.1016/S0022-5193(03)00193-0; Cinquin O, 2007, PLOS COMPUT BIOL, V3, P293, DOI 10.1371/journal.pcbi.0030032; Cooke J, 1998, TRENDS GENET, V14, P85, DOI 10.1016/S0168-9525(98)01396-1; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herrgen L, 2010, CURR BIOL, V20, P1244, DOI 10.1016/j.cub.2010.06.034; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirokawa N, 1997, CURR OPIN NEUROBIOL, V7, P605, DOI 10.1016/S0959-4388(97)80079-7; Holley SA, 2002, DEVELOPMENT, V129, P1175; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Hughes DST, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-30; Ishimatsu K, 2010, DEVELOPMENT, V137, P1595, DOI 10.1242/dev.046888; Jaeger J, 2001, J THEOR BIOL, V213, P171, DOI 10.1006/jtbi.2001.2414; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kaern M, 2000, J THEOR BIOL, V207, P473, DOI 10.1006/jtbi.2000.2183; Kar S, 2009, P NATL ACAD SCI USA, V106, P6471, DOI 10.1073/pnas.0810034106; Klonis N, 2002, EUR BIOPHYS J BIOPHY, V31, P36, DOI 10.1007/s00249-001-0202-2; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lewis Julian, 2009, Journal of Biology (London), V8, P44, DOI 10.1186/jbiol145; LI MG, 1994, J CELL BIOL, V126, P1475, DOI 10.1083/jcb.126.6.1475; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; MAHAFFY JM, 1988, MATH BIOSCI, V90, P519, DOI 10.1016/0025-5564(88)90081-8; MAHAFFY JM, 1984, J MATH BIOL, V20, P39, DOI 10.1007/BF00275860; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; McLean DR, 2004, NEUROCOMPUTING, V58, P511, DOI 10.1016/j.neucom.2004.01.088; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; Meinhardt H., 1982, MODELS BIOL PATTERN; Momiji H, 2008, J THEOR BIOL, V254, P784, DOI 10.1016/j.jtbi.2008.07.013; Monk NAM, 2003, CURR BIOL, V13, P1409, DOI 10.1016/S0960-9822(03)00494-9; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Oates AC, 2002, DEVELOPMENT, V129, P2929; Ozbudak EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040015; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Parks AL, 2000, DEVELOPMENT, V127, P1373; Pourquie O, 2001, ANNU REV CELL DEV BI, V17, P311, DOI 10.1146/annurev.cellbio.17.1.311; Prinz Heino, 2010, J Chem Biol, V3, P37, DOI 10.1007/s12154-009-0029-3; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Rodriguez-Gonzalez JG, 2007, J THEOR BIOL, V248, P37, DOI 10.1016/j.jtbi.2007.05.003; Santillan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001561; Sawada A, 2001, DEVELOPMENT, V128, P4873; Schnell S, 2002, CR BIOL, V325, P179, DOI 10.1016/S1631-0691(01)01418-4; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; Schroter C, 2010, CURR BIOL, V20, P1254, DOI 10.1016/j.cub.2010.05.071; SEGEL LA, 1972, SIAM REV, V14, P547, DOI 10.1137/1014099; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Smolen P, 1999, AM J PHYSIOL-CELL PH, V277, pC777, DOI 10.1152/ajpcell.1999.277.4.C777; Soussi T, 2007, CANCER CELL, V12, P303, DOI 10.1016/j.ccr.2007.10.001; Stickney HL, 2000, DEV DYNAM, V219, P287; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Takke C, 1999, DEVELOPMENT, V126, P3005; Tenin G, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-24; Tiedemann HB, 2007, J THEOR BIOL, V248, P120, DOI 10.1016/j.jtbi.2007.05.014; Uriu K, 2009, J THEOR BIOL, V257, P385, DOI 10.1016/j.jtbi.2009.01.003; Verdugo A, 2008, COMMUN NONLINEAR SCI, V13, P235, DOI 10.1016/j.cnsns.2006.05.001; WEINBERG R, 2007, BIOL CANC, P195; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Zeiser S, 2008, COMPUT BIOL CHEM, V32, P48, DOI 10.1016/j.compbiolchem.2007.09.004; Zeiser S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-11; Zeiser S, 2007, J COMPUT BIOL, V14, P984, DOI 10.1089/cmb.2007.0029; Zhdanov VP, 2008, CHEM PHYS LETT, V456, P247, DOI 10.1016/j.cplett.2008.03.047	76	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16980	10.1371/journal.pone.0016980	http://dx.doi.org/10.1371/journal.pone.0016980			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386903	gold, Green Published, Green Submitted			2022-12-27	WOS:000287931400017
J	Zhou, JW; Tsui, SKW; Ng, MCY; Geng, H; Li, SK; So, WY; Ma, RC; Wang, Y; Tao, QA; Chen, ZY; Chan, JCN; Ho, YY				Zhou, Jun-Wei; Tsui, Stephen K. W.; Ng, Maggie C. Y.; Geng, Hua; Li, Sai-Kam; So, Wing-Yee; Ma, Ronald C.; Wang, Ying; Tao, Qian; Chen, Zhen-Yu; Chan, Juliana C. N.; Ho, Yuan-Yuan			Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes	PLOS ONE			English	Article							CHINESE; LINKAGE; ATHEROSCLEROSIS; SUSCEPTIBILITY; CHOLESTEROL; POPULATION; EXPRESSION; MULTIPLE; DATABASE; BROWSER	This study aimed at substantiating the associations of the apolipoproein M gene (APOM) with type 2 diabetes (T2D) as well as with metabolic traits in Hong Kong Chinese. In addition, APOM gene function was further characterized to elucidate its activity in cholesterol metabolism. Seventeen APOM SNPs documented in the NCBI database were genotyped. Five SNPs were confirmed in our study cohort of 1234 T2D and 606 control participants. Three of the five SNPs rs707921(C+1871A), rs707922(G+1837T) and rs805264(G+203A) were in linkage disequilibrium (LD). We chose rs707922 to tag this LD region for down stream association analyses and characterized the function of this SNP at molecular level. No association between APOM and T2D susceptibility was detected in our Hong Kong Chinese cohort. Interestingly, the C allele of rs805297 was significantly associated with T2D duration of longer than 10 years (OR = 1.245, p = 0.015). The rs707922 TT genotype was significantly associated with elevated plasma total-and LDL- cholesterol levels (p = 0.006 and p = 0.009, respectively) in T2D patients. Molecular analyses of rs707922 lead to the discoveries of a novel transcript APOM5 as well as the cryptic nature of exon 5 of the gene. Ectopic expression of APOM5 transcript confirmed rs707922 allele-dependent activity of the transcript in modifying cholesterol homeostasis in vitro. In conclusion, the results here did not support APOM as a T2D susceptibility gene in Hong Kong Chinese. However, in T2D patients, a subset of APOM SNPs was associated with disease duration and metabolic traits. Further molecular analysis proved the functional activity of rs707922 in APOM expression and in regulation of cellular cholesterol content.	[Zhou, Jun-Wei] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ng, Maggie C. Y.] Wake Forest Univ Hlth Sci, Dept Pediat, Ctr Diabet Res, Winston Salem, NC USA; [Geng, Hua; Tao, Qian] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, State Key Lab Oncol S China, Canc Epigenet Lab,Dept Clin Oncol,Sir YK Pao Ctr, Hong Kong, Hong Kong, Peoples R China; [So, Wing-Yee; Ma, Ronald C.; Wang, Ying; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Chan, Juliana C. N.] Hong Kong Inst Diabet & Obes, Hong Kong, Hong Kong, Peoples R China; [Ho, Yuan-Yuan] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Biostat, New York, NY USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Psychiat, New York, NY USA	Chinese University of Hong Kong; Wake Forest University; Wake Forest University School of Medicine; Chinese University of Hong Kong; Chinese University of Hong Kong; Columbia University; Columbia University; Columbia University	Zhou, JW (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	yyh2@columbia.edu	Tao, Qian/T-4743-2018; Tsui, Stephen Kwok-Wing/E-4385-2015; Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009	Tao, Qian/0000-0001-5383-4808; Tsui, Stephen Kwok-Wing/0000-0003-0686-4259; Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X	National Institute of Mental Health, USA [T32-MH-65213]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065213] Funding Source: NIH RePORTER	National Institute of Mental Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	T32-MH-65213, National Institute of Mental Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Dahlback B, 2006, CURR OPIN LIPIDOL, V17, P291, DOI 10.1097/01.mol.0000226122.10005.88; Geng H, 2005, FEBS LETT, V579, P6763, DOI 10.1016/j.febslet.2005.11.007; Han Xiu-jie, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P350; Hao GQ, 2007, CLIN BIOCHEM, V40, P1108, DOI 10.1016/j.clinbiochem.2007.04.023; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Lee KY, 2008, ONCOGENE, V27, P5267, DOI 10.1038/onc.2008.147; Niu NF, 2007, DIABETES-METAB RES, V23, P21, DOI 10.1002/dmrr.641; OOI EM, ATHEROSCLEROSIS, V210, P326; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Richter S, 2003, DIABETES, V52, P2989, DOI 10.2337/diabetes.52.12.2989; Sambrook J., 2001, MOL CLONING; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skupien Jan, 2007, Rev Diabet Stud, V4, P231, DOI 10.1900/RDS.2007.4.231; Stenger JE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-95; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Su WQ, 2009, CLIN BIOCHEM, V42, P365, DOI 10.1016/j.clinbiochem.2008.11.010; Tao Q, 1998, BLOOD, V91, P1373, DOI 10.1182/blood.V91.4.1373; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wolfrum C, 2005, NAT MED, V11, P418, DOI 10.1038/nm1211; Xiang KS, 2004, DIABETES, V53, P228, DOI 10.2337/diabetes.53.1.228; Xu N, 2004, J NUTR BIOCHEM, V15, P579, DOI 10.1016/j.jnutbio.2004.03.001; Xu N, 1999, J BIOL CHEM, V274, P31286, DOI 10.1074/jbc.274.44.31286; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; ZHAO D, J MOL NEURO IN PRESS; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	28	24	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17324	10.1371/journal.pone.0017324	http://dx.doi.org/10.1371/journal.pone.0017324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390319	gold, Green Published, Green Submitted			2022-12-27	WOS:000287761700045
J	Cinti, C; Taranta, M; Naldi, I; Grimaldi, S				Cinti, Caterina; Taranta, Monia; Naldi, Ilaria; Grimaldi, Settimio			Newly Engineered Magnetic Erythrocytes for Sustained and Targeted Delivery of Anti-Cancer Therapeutic Compounds	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; DRUG-DELIVERY; CARRIER ERYTHROCYTES; DNA METHYLTRANSFERASE; MASS-SPECTROMETRY; POLY(LACTIDE-CO-GLYCOLIDE) MICROSPHERES; 5-AZA-2'-DEOXYCYTIDINE DECITABINE; MYELODYSPLASTIC SYNDROMES; MICROBUBBLE DESTRUCTION; PHASE-I	Cytotoxic chemotherapy of cancer is limited by serious, sometimes life-threatening, side effects that arise from toxicities to sensitive normal cells because the therapies are not selective for malignant cells. So how can they be selectively improved? Alternative pharmaceutical formulations of anti-cancer agents have been investigated in order to improve conventional chemotherapy treatment. These formulations are associated with problems like severe toxic side effects on healthy organs, drug resistance and limited access of the drug to the tumor sites suggested the need to focus on site-specific controlled drug delivery systems. In response to these concerns, we have developed a new drug delivery system based on magnetic erythrocytes engineered with a viral spike fusion protein. This new erythrocyte-based drug delivery system has the potential for magnetic-controlled site-specific localization and highly efficient fusion capability with the targeted cells. Here we show that the erythro-magneto-HA virosomes drug delivery system is able to attach and fuse with the target cells and to efficiently release therapeutic compounds inside the cells. The efficacy of the anti-cancer drug employed is increased and the dose required is 10 time less than that needed with conventional therapy.	[Cinti, Caterina; Taranta, Monia; Naldi, Ilaria] CNR, Inst Clin Physiol, Siena, Italy; [Grimaldi, Settimio] CNR, Inst Translat Pharmacol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR)	Cinti, C (corresponding author), CNR, Inst Clin Physiol, Siena, Italy.	ccinti@ifc.cnr.it		Cinti, Caterina/0000-0001-8049-0369				Agnihotri SA, 2004, J CONTROL RELEASE, V100, P5, DOI 10.1016/j.jconrel.2004.08.010; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Appleton K, 2007, J CLIN ONCOL, V25, P4603, DOI 10.1200/JCO.2007.10.8688; Bittner B, 1998, J MICROENCAPSUL, V15, P495, DOI 10.3109/02652049809006876; Carrasquillo KG, 2001, J CONTROL RELEASE, V76, P199, DOI 10.1016/S0168-3659(01)00430-8; CESTMIR A, 2008, CANC LETT, V270, P191; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Gorantla S, 2006, J LEUKOCYTE BIOL, V80, P1165, DOI 10.1189/jlb.0206110; Millan CG, 2008, TRANSL RES, V152, P59, DOI 10.1016/j.trsl.2008.05.008; Millan CG, 2008, J ANTIMICROB CHEMOTH, V61, P375, DOI 10.1093/jac/dkm477; Hamidi M, 2003, DRUG DELIV, V10, P9, DOI 10.1080/713840329; Hamidi M, 2007, J CONTROL RELEASE, V118, P145, DOI 10.1016/j.jconrel.2006.06.032; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Johansen P, 1998, PHARMACEUT RES, V15, P1103, DOI 10.1023/A:1011998615267; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069; Leone G, 2002, HAEMATOLOGICA, V87, P1324; Liu MJ, 2000, J CONTROL RELEASE, V65, P121, DOI 10.1016/S0168-3659(99)00245-X; Liu ZF, 2006, RAPID COMMUN MASS SP, V20, P1117, DOI 10.1002/rcm.2423; Magnani M, 2002, GENE THER, V9, P749, DOI 10.1038/sj.gt.3301758; Mayer CR, 2008, EXPERT OPIN DRUG DEL, V5, P1121, DOI 10.1517/17425247.5.10.1121 ; Millan CG, 2004, BLOOD CELL MOL DIS, V33, P132, DOI 10.1016/j.bcmd.2004.06.004; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Moghimi SM, 2001, CRIT REV THER DRUG, V18, P527; Momparler RL, 2005, SEMIN HEMATOL, V42, pS9, DOI 10.1053/j.seminhematol.2005.05.002; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; OREKHOVA NM, 1990, THROMB RES, V57, P611, DOI 10.1016/0049-3848(90)90078-Q; Patel K, 2008, J CHROMATOGR B, V863, P19, DOI 10.1016/j.jchromb.2007.12.014; Pierige F, 2008, ADV DRUG DELIVER REV, V60, P286, DOI 10.1016/j.addr.2007.08.029; Price RJ, 1998, CIRCULATION, V98, P1264, DOI 10.1161/01.CIR.98.13.1264; Provotorov V M, 2009, Klin Med (Mosk), V87, P4; Rogstad DK, 2009, CHEM RES TOXICOL, V22, P1194, DOI 10.1021/tx900131u; Roney C, 2005, J CONTROL RELEASE, V108, P193, DOI 10.1016/j.jconrel.2005.07.024; Rossi Luiga, 2005, Expert Opin Drug Deliv, V2, P311, DOI 10.1517/17425247.2.2.311; Schrump DS, 2006, CLIN CANCER RES, V12, P5777, DOI 10.1158/1078-0432.CCR-06-0669; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; SPRANDEL U, 1987, METHOD ENZYMOL, V149, P301; SPRANDEL U, 1987, ADV BIOSCI, V67, P243; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Studeny M, 2002, CANCER RES, V62, P3603; Wallace SS, 2002, FREE RADICAL BIO MED, V33, P1, DOI 10.1016/S0891-5849(02)00827-4; ZIMMERMANN U, 1983, POLYM BIOL MED, V2, P153	43	38	42	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17132	10.1371/journal.pone.0017132	http://dx.doi.org/10.1371/journal.pone.0017132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373641	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500036
J	Granier-Deferre, C; Bassereau, S; Ribeiro, A; Jacquet, AY; DeCasper, AJ				Granier-Deferre, Carolyn; Bassereau, Sophie; Ribeiro, Aurelie; Jacquet, Anne-Yvonne; DeCasper, Anthony J.			A Melodic Contour Repeatedly Experienced by Human Near-Term Fetuses Elicits a Profound Cardiac Reaction One Month after Birth	PLOS ONE			English	Article							PRIMARY AUDITORY-CORTEX; HEART-RATE-VARIABILITY; HUMAN FETAL RESPONSES; VIBROACOUSTIC STIMULATION; PRENATAL EXPERIENCE; SOUND ENVIRONMENT; NEWBORNS PREFER; MATERNAL SPEECH; BRAIN ACTIVITY; EVOKED FIELDS	Background: Human hearing develops progressively during the last trimester of gestation. Near-term fetuses can discriminate acoustic features, such as frequencies and spectra, and process complex auditory streams. Fetal and neonatal studies show that they can remember frequently recurring sounds. However, existing data can only show retention intervals up to several days after birth. Methodology/Principal Findings: Here we show that auditory memories can last at least six weeks. Experimental fetuses were given precisely controlled exposure to a descending piano melody twice daily during the 35(th), 36(th), and 37(th) weeks of gestation. Six weeks later we assessed the cardiac responses of 25 exposed infants and 25 naive control infants, while in quiet sleep, to the descending melody and to an ascending control piano melody. The melodies had precisely inverse contours, but similar spectra, identical duration, tempo and rhythm, thus, almost identical amplitude envelopes. All infants displayed a significant heart rate change. In exposed infants, the descending melody evoked a cardiac deceleration that was twice larger than the decelerations elicited by the ascending melody and by both melodies in control infants. Conclusions/Significance: Thus, 3-weeks of prenatal exposure to a specific melodic contour affects infants 'auditory processing' or perception, i.e., impacts the autonomic nervous system at least six weeks later, when infants are 1-month old. Our results extend the retention interval over which a prenatally acquired memory of a specific sound stream can be observed from 3-4 days to six weeks. The long-term memory for the descending melody is interpreted in terms of enduring neurophysiological tuning and its significance for the developmental psychobiology of attention and perception, including early speech perception, is discussed.	[Granier-Deferre, Carolyn; Bassereau, Sophie; Ribeiro, Aurelie] Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Paris, France; [Jacquet, Anne-Yvonne] Univ Paris 05, CNRS, UMR 8158, Lab Psychol Percept, Paris, France; [DeCasper, Anthony J.] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; University of North Carolina; University of North Carolina Greensboro	Granier-Deferre, C (corresponding author), Univ Paris 05, CNRS, FRE 3292, Lab Psychol & Neuropsychol Cognit, Paris, France.	carolyn.granier-deferre@parisdescartes.fr			Centre National de la Recherche Scientifique, France	Centre National de la Recherche Scientifique, France(Centre National de la Recherche Scientifique (CNRS))	Centre National de la Recherche Scientifique, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RM, 1997, OBSTET GYNECOL, V90, P216, DOI 10.1016/S0029-7844(97)00229-9; Abrams RM, 1998, MUSIC PERCEPT, V15, P307; ANDO Y, 1977, J ACOUST SOC AM, V62, P199, DOI 10.1121/1.381482; ARMITAGE SE, 1980, SCIENCE, V208, P1173, DOI 10.1126/science.7375927; BENZAQUEN S, 1990, AM J OBSTET GYNECOL, V163, P484, DOI 10.1016/0002-9378(90)91180-K; Byers-Heinlein K, 2010, PSYCHOL SCI, V21, P343, DOI 10.1177/0956797609360758; COOPER RP, 1989, CAN J PSYCHOL, V43, P247, DOI 10.1037/h0084216; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; DECASPER AJ, 1994, INFANT BEHAV DEV, V17, P159, DOI 10.1016/0163-6383(94)90051-5; DECASPER AJ, 1991, INFANT ATTENTION, P142; DeCasper AJ, 2009, HEARING RES, V255, P135, DOI 10.1016/j.heares.2009.06.012; Dirix CEH, 2009, CHILD DEV, V80, P1251, DOI 10.1111/j.1467-8624.2009.01329.x; DMITRIEVA LP, 1994, BEHAV NEURAL BIOL, V61, P19, DOI 10.1016/S0163-1047(05)80040-8; Draganova R, 2007, EARLY HUM DEV, V83, P199, DOI 10.1016/j.earlhumdev.2006.05.018; Eldredge L, 1996, EARLY HUM DEV, V45, P215, DOI 10.1016/0378-3782(96)01732-X; FERNALD A, 1997, INFANT BEHAV DEV, V10, P279; Fifer W.P., 1995, FETAL DEV PSYCHOBIOL, P351; Fulford J, 2004, HUM BRAIN MAPP, V22, P116, DOI 10.1002/hbm.20019; Gonzalez-Gonzalez NL, 2006, ACTA OBSTET GYN SCAN, V85, P1160, DOI 10.1080/00016340600855854; GOTTLIEB G, 1982, DEV PSYCHOBIOL, V15, P507, DOI 10.1002/dev.420150603; GRAHAM EM, 1991, AM J OBSTET GYNECOL, V164, P1140, DOI 10.1016/0002-9378(91)90602-N; GRAHAM FK, 1992, ATTENTION AND INFORMATION PROCESSING IN INFANTS AND ADULTS, P3; GRANIERDEFERRE C, 1985, ACTA OTO-LARYNGOL, P93; GRANIERDEFERRE C, 1987, PROGR NEONATALOGIE, V7, P236; GRANIERDEFERRE C, 2010, DEVELOPMENTAL SCI, DOI DOI 10.1111/J1467-7687201000978X; GRIFFITHS SK, 1994, J ACOUST SOC AM, V96, P2055, DOI 10.1121/1.410147; Groome LJ, 1999, EARLY HUM DEV, V54, P39, DOI 10.1016/S0378-3782(98)00083-8; Guyomarc'h JC, 1974, REV COMPORT ANIM, V8, P3; HEPPER PG, 1988, LANCET, V1, P1347, DOI 10.1016/S0140-6736(88)92170-8; Hepper PG, 1996, ACTA PAEDIATR, V85, P16, DOI 10.1111/j.1651-2227.1996.tb14272.x; Holst M, 2005, CLIN NEUROPHYSIOL, V116, P1949, DOI 10.1016/j.clinph.2005.04.008; Huotilainen M, 2005, NEUROREPORT, V16, P81, DOI 10.1097/00001756-200501190-00019; Insanally MN, 2009, J NEUROSCI, V29, P5456, DOI 10.1523/JNEUROSCI.5311-08.2009; James DK, 2002, ULTRASOUND OBST GYN, V20, P431, DOI 10.1046/j.1469-0705.2002.00845.x; Jardri R, 2008, NEUROIMAGE, V42, P10, DOI 10.1016/j.neuroimage.2008.04.247; Kawai N, 2004, DEV PSYCHOBIOL, V44, P116, DOI 10.1002/dev.10160; Keuroghlian AS, 2007, PROG NEUROBIOL, V82, P109, DOI 10.1016/j.pneurobio.2007.03.005; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; KISILEVSKY BS, 1992, CHILD DEV, V63, P1497; Krueger C, 2004, INFANT BEHAV DEV, V27, P537, DOI 10.1016/j.infbeh.2004.03.001; LEADER LR, 1982, EARLY HUM DEV, V7, P211, DOI 10.1016/0378-3782(82)90084-6; Lecanuet J., 1995, FETAL DEV PSYCHOBIOL, P239; Lecanuet J.P., 1993, EARLY DEV PARENTING, V2, P217, DOI [https://doi.org/10.1002/edp.2430020405, DOI 10.1002/EDP.2430020405]; LECANUET JP, 1987, CR ACAD SCI III-VIE, V305, P161; LECANUET JP, 1992, Q J EXP PSYCHOL-B, V44B, P279; LECANUET JP, 1989, SEMIN PERINATOL, V13, P421; LECANUET JP, 1988, EARLY HUM DEV, V18, P81, DOI 10.1016/0378-3782(88)90045-X; LECANUET JP, 1986, EARLY HUM DEV, V13, P269, DOI 10.1016/0378-3782(86)90061-7; Lecanuet JP, 2000, DEV PSYCHOBIOL, V36, P29, DOI 10.1002/(SICI)1098-2302(200001)36:1<29::AID-DEV4>3.3.CO;2-A; LECANUET JP, 1993, NATO ADV SCI INST SE, V69, P237; LEON M, 1987, PERINATAL DEV PSYCHO, P145; LICKLITER R, 1992, Q J EXP PSYCHOL-B, V44B, P199; MADISON LS, 1986, J DEV BEHAV PEDIATR, V7, P14, DOI 10.1097/00004703-198602000-00003; MAMPE B, 2009, CURR BIOL, V19, P1; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; Mastropieri D, 1999, DEV PSYCHOBIOL, V35, P204, DOI 10.1002/(SICI)1098-2302(199911)35:3<204::AID-DEV5>3.0.CO;2-V; Mehl MR, 2007, SCIENCE, V317, P82, DOI 10.1126/science.1139940; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; Moore RJ, 2001, HUM BRAIN MAPP, V12, P94, DOI 10.1002/1097-0193(200102)12:2<94::AID-HBM1006>3.0.CO;2-E; MORLET T, 1993, ACTA OTO-LARYNGOL, V113, P271, DOI 10.3109/00016489309135808; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Peters A. J. M., 1993, Journal of Low Frequency Noise & Vibration, V12, P16; PORGES SW, 1974, MERRILL PALMER QUART, V20, P231; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; PUJOL R, 1998, DEV AUDITORY SYSTEM, P146; QUERLEU D, 1989, SEMIN PERINATOL, V13, P409; Querleu D, 1988, Rev Fr Gynecol Obstet, V83, P43; Rayson Paul., 1997, INT J CORPUS LINGUIS, V2, P133, DOI DOI 10.1075/IJCL.2.1.07RAY; RICHARDS DS, 1992, OBSTET GYNECOL, V80, P186; ROTTEVEEL JJ, 1987, HEARING RES, V27, P95, DOI 10.1016/0378-5955(87)90029-3; Rovee-Collier C, 2009, DEV PSYCHOL, V45, P160, DOI 10.1037/a0014538; Sandman CA, 2003, DEV NEUROSCI-BASEL, V25, P41, DOI 10.1159/000071467; Sandman CA, 1997, CHILD DEV, V68, P1031; Sanes DH, 2009, CURR OPIN NEUROBIOL, V19, P188, DOI 10.1016/j.conb.2009.05.014; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Schleussner E, 2004, EXP NEUROL, V190, pS59, DOI 10.1016/j.expneurol.2004.04.008; SEEBACH BS, 1994, P NATL ACAD SCI USA, V91, P7473, DOI 10.1073/pnas.91.16.7473; SHAHIDULLAH S, 1994, EARLY HUM DEV, V36, P13, DOI 10.1016/0378-3782(94)90029-9; SMITH CV, 1995, CLIN OBSTET GYNECOL, V38, P68, DOI 10.1097/00003081-199503000-00009; Smith LS, 2007, DEV PSYCHOBIOL, V49, P543, DOI 10.1002/dev.20229; SMOTHERMAN WP, 1982, BEHAV NEURAL BIOL, V36, P61, DOI 10.1016/S0163-1047(82)90245-X; SPELT DK, 1948, J EXP PSYCHOL, V38, P338, DOI 10.1037/h0059632; Spence MJ, 1996, INFANT BEHAV DEV, V19, P199, DOI 10.1016/S0163-6383(96)90019-3; SPENCE MJ, 1987, INFANT BEHAV DEV, V10, P133, DOI 10.1016/0163-6383(87)90028-2; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; van Heteren CF, 2000, LANCET, V356, P1169, DOI 10.1016/S0140-6736(00)02766-5; VINCE MA, 1979, ANIM BEHAV, V27, P908, DOI 10.1016/0003-3472(79)90029-0; VISSER GHA, 1993, AM J IND MED, V23, P531, DOI 10.1002/ajim.4700230403; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; Xu JH, 2009, BEHAV BRAIN RES, V196, P49, DOI 10.1016/j.bbr.2008.07.018	94	70	73	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e17304	10.1371/journal.pone.0017304	http://dx.doi.org/10.1371/journal.pone.0017304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21383836	Green Submitted, gold, Green Published			2022-12-27	WOS:000287657500049
J	Aguado-Llera, D; Martinez-Gomez, AI; Prieto, J; Marenchino, M; Traverso, JA; Gomez, J; Chueca, A; Neira, JL				Aguado-Llera, David; Isabel Martinez-Gomez, Ana; Prieto, Jesus; Marenchino, Marco; Angel Traverso, Jose; Gomez, Javier; Chueca, Ana; Neira, Jose L.			The Conformational Stability and Biophysical Properties of the Eukaryotic Thioredoxins of Pisum Sativum Are Not Family-Conserved	PLOS ONE			English	Article							H-TYPE THIOREDOXINS; CIRCULAR-DICHROISM; CRYSTAL-STRUCTURES; PLASTIDIAL THIOREDOXINS; PROTEIN-STRUCTURE; MOLTEN GLOBULE; IDENTIFICATION; ARABIDOPSIS; SYSTEM; NMR	Thioredoxins (TRXs) are ubiquitous proteins involved in redox processes. About forty genes encode TRX or TRX-related proteins in plants, grouped in different families according to their subcellular localization. For instance, the h-type TRXs are located in cytoplasm or mitochondria, whereas f-type TRXs have a plastidial origin, although both types of proteins have an eukaryotic origin as opposed to other TRXs. Herein, we study the conformational and the biophysical features of TRXh1, TRXh2 and TRXf from Pisum sativum. The modelled structures of the three proteins show the well-known TRX fold. While sharing similar pH-denaturations features, the chemical and thermal stabilities are different, being PsTRXh1 (Pisum sativum thioredoxin h1) the most stable isoform; moreover, the three proteins follow a three-state denaturation model, during the chemical-denaturations. These differences in the thermal-and chemical-denaturations result from changes, in a broad sense, of the several ASAs (accessible surface areas) of the proteins. Thus, although a strong relationship can be found between the primary amino acid sequence and the structure among TRXs, that between the residue sequence and the conformational stability and biophysical properties is not. We discuss how these differences in the biophysical properties of TRXs determine their unique functions in pea, and we show how residues involved in the biophysical features described (pH-titrations, dimerizations and chemical-denaturations) belong to regions involved in interaction with other proteins. Our results suggest that the sequence demands of protein-protein function are relatively rigid, with different protein-binding pockets (some in common) for each of the three proteins, but the demands of structure and conformational stability per se (as long as there is a maintained core), are less so.	[Aguado-Llera, David; Gomez, Javier; Neira, Jose L.] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Isabel Martinez-Gomez, Ana] Univ Almeria, Dept Quim Fis Bioquim & Quim Inorgan, Almeria, Spain; [Prieto, Jesus; Marenchino, Marco] CNIO, Dept Biol Estruct & Biocomp, Madrid, Spain; [Angel Traverso, Jose; Chueca, Ana] CSIC, Estn Expt Zaidin, Dept Bioquim Biol Celular & Mol Plantas, Granada, Spain; [Neira, Jose L.] Biocomputat & Complex Syst Phys Inst, Zaragoza, Spain	Universidad Miguel Hernandez de Elche; Universidad de Almeria; Centro Nacional de Investigaciones Oncologicas (CNIO); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Aguado-Llera, D (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	jlneira@umh.es	Neira, Jose/ABF-4210-2021; Gomez, Javier/N-9820-2013; Traverso, Jose/B-4342-2008; Llera, David Aguado/A-4349-2017; Traverso, Jose A./I-6038-2014	Gomez, Javier/0000-0001-9612-5075; Traverso, Jose/0000-0003-2519-5185; Llera, David Aguado/0000-0002-8333-2857; Neira, Jose Luis/0000-0002-4933-0428; Traverso, Jose A./0000-0003-4623-6118	Junta de Andalucia, Spain [CVI 154]; Spanish Research Council (CSIC); Spanish Ministerio de Ciencia e Innovacion (MCINN) [SAF2008-05742-C02-01]; Generalitat Valenciana (GV) [ACOMP/2010/114]; Spanish MCINN [SAF2008-05742-C02-01, CSD-2008-00005]; FIPSE Foundation [Exp. 36557/06]	Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Spanish Research Council (CSIC); Spanish Ministerio de Ciencia e Innovacion (MCINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat Valenciana (GV)(Center for Forestry Research & Experimentation (CIEF)); Spanish MCINN(Spanish Government); FIPSE Foundation	This work was supported by Junta de Andalucia, Spain (grant no. CVI 154) to AC. JAT was supported by the program JAE-DOC 2009 from the Spanish Research Council (CSIC). The work of JG was supported by Projects SAF2008-05742-C02-01 from the Spanish Ministerio de Ciencia e Innovacion (MCINN) and Generalitat Valenciana (GV) (ACOMP/2010/114). The work of JLN was supported by Projects SAF2008-05742-C02-01 and CSD-2008-00005 from the Spanish MCINN, FIPSE Foundation (Exp. 36557/06) and GV (ACOMP/2010/114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERS GK, 1967, J BIOL CHEM, V242, P3026; ALBERTS B, 1994, MOL BIOL CELL, P630; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Atkins P., 2006, PHYS CHEM; Bader MW, 2001, EMBO J, V20, P1555, DOI 10.1093/emboj/20.7.1555; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; BARAJASLOPEZ J, 2007, PLANT PHYIOSL, V145, P945; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Buchanan BB, 1997, P NATL ACAD SCI USA, V94, P5372, DOI 10.1073/pnas.94.10.5372; BUCHANAN BB, 1980, ANNU REV PLANT PHYS, V31, P341, DOI 10.1146/annurev.pp.31.060180.002013; Capitani G, 2000, J MOL BIOL, V302, P135, DOI 10.1006/jmbi.2000.4006; CLARKE J, 1993, BIOCHEMISTRY-US, V32, P4322, DOI 10.1021/bi00067a022; Collin V, 2004, PLANT PHYSIOL, V136, P4088, DOI 10.1104/pp.104.052233; Collin V, 2003, J BIOL CHEM, V278, P23747, DOI 10.1074/jbc.M302077200; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Coudevylle N, 2005, BIOCHEMISTRY-US, V44, P2001, DOI 10.1021/bi047816n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FLORENCIO FJ, 1988, ARCH BIOCHEM BIOPHYS, V266, P496, DOI 10.1016/0003-9861(88)90282-2; FRESKGARD PO, 1994, BIOCHEMISTRY-US, V33, P14281, DOI 10.1021/bi00251a041; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gronenborn AM, 1999, PROTEIN SCI, V8, P426; HARDING SE, 1997, PROTEIN STRUCTURE PR, P219; Hinkle A, 1999, J BIOL CHEM, V274, P7157, DOI 10.1074/jbc.274.11.7157; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Issakidis-Bourguet E, 2001, PLANT J, V25, P127, DOI 10.1046/j.0960-7412.2000.00943.x; Itzhaki LS, 1997, J MOL BIOL, V270, P89, DOI 10.1006/jmbi.1997.1049; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Laloi C, 2001, P NATL ACAD SCI USA, V98, P14144, DOI 10.1073/pnas.241340898; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LANGSETMO K, 1989, BIOCHEMISTRY-US, V28, P3211, DOI 10.1021/bi00434a015; Laue T.M., 1992, COMPUTER AIDED INTER; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lopez-Redondo ML, 2010, FEBS LETT, V584, P989, DOI 10.1016/j.febslet.2010.01.043; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Maeda K, 2008, PROTEIN SCI, V17, P1015, DOI 10.1110/ps.083460308; Meyer Y, 2005, PHOTOSYNTH RES, V86, P419, DOI 10.1007/s11120-005-5220-y; Meyer Y, 2006, PHOTOSYNTH RES, V89, P179, DOI 10.1007/s11120-006-9095-3; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Montrichard F, 2003, PLANT PHYSIOL, V132, P1707, DOI 10.1104/pp.102.019562; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Mottonen JM, 2009, PROTEINS, V75, P610, DOI 10.1002/prot.22273; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Neira JL, 2001, BIOCHEMISTRY-US, V40, P15246, DOI 10.1021/bi011186x; Pace CN, 2009, NAT STRUCT MOL BIOL, V16, P681, DOI 10.1038/nsmb0709-681; Pedroso I, 2002, BIOCHEMISTRY-US, V41, P9873, DOI 10.1021/bi025742e; Perez-Jimenez R, 2009, NAT STRUCT MOL BIOL, V16, P890, DOI 10.1038/nsmb.1627; Pettifer S, 2009, BIOINFORMATICS, V25, P2090, DOI 10.1093/bioinformatics/btp329; Privalov Peter L., 1992, P83; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Richardson JM, 2000, BIOCHEMISTRY-US, V39, P11154, DOI 10.1021/bi000610b; Royer C A, 1995, Methods Mol Biol, V40, P65; Sahrawy M, 1996, J MOL EVOL, V42, P422; Sahrawy M, 1997, J MOL BIOL, V269, P623, DOI 10.1006/jmbi.1997.1054; Schmid F. Z., 1997, PROTEIN STRUCTURE PR, P261; Schmidtke P, 2010, NUCLEIC ACIDS RES, V38, pW582, DOI 10.1093/nar/gkq383; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; SOULIE JM, 1985, EUR J BIOCHEM, V152, P565, DOI 10.1111/j.1432-1033.1985.tb09232.x; Spyrou G, 1997, J BIOL CHEM, V272, P2936, DOI 10.1074/jbc.272.5.2936; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Traverso JA, 2008, J EXP BOT, V59, P1267, DOI 10.1093/jxb/ern037; Traverso JA, 2007, PLANT PHYSIOL, V143, P300, DOI 10.1104/pp.106.089524; Traverso JA, 2007, PLANT SIGNAL BEHAV, V2, P426, DOI 10.4161/psb.2.5.4419; Traverso JA, 2010, J PLANT PHYSIOL, V167, P423, DOI 10.1016/j.jplph.2009.10.017; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; Wani AH, 2006, BIOCHEMISTRY-US, V45, P11226, DOI 10.1021/bi060647h; Weichsel A, 1996, STRUCTURE, V4, P735, DOI 10.1016/S0969-2126(96)00079-2; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WISHART DS, 1993, BIOCHIM BIOPHYS ACTA, V1164, P36, DOI 10.1016/0167-4838(93)90109-5; WOLLMAN EE, 1988, J BIOL CHEM, V263, P15506; WOODY RW, 1995, METHOD ENZYMOL, V246, P34	82	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17068	10.1371/journal.pone.0017068	http://dx.doi.org/10.1371/journal.pone.0017068			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364950	Green Submitted, gold, Green Published			2022-12-27	WOS:000287656600029
J	Poninska, J; Samolinski, B; Tomaszewska, A; Raciborski, F; Samel-Kowalik, P; Walkiewicz, A; Lipiec, A; Piekarska, B; Komorowski, J; Krzych-Falta, E; Namyslowski, A; Borowicz, J; Kostrzewa, G; Majewski, S; Ploski, R				Poninska, Joanna; Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Komorowski, Jaroslaw; Krzych-Falta, Edyta; Namyslowski, Andrzej; Borowicz, Jacek; Kostrzewa, Grazyna; Majewski, Slawomir; Ploski, Rafal			Filaggrin Gene Defects Are Independent Risk Factors for Atopic Asthma in a Polish Population: A Study in ECAP Cohort	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; EARLY-ONSET; ICHTHYOSIS VULGARIS; ALLERGIC RHINITIS; DERMATITIS; ECZEMA; PREDISPOSE; METAANALYSIS; PREVALENT; VARIANTS	Background: FLG null variants of which 2282del4 and R501X are the most frequent in Caucasians are established risk factors for atopic dermatitis (AD) with an effect probably mediated through impairment of epidermal barrier. Among subjects with AD FLG defects are also consistently associated with asthma and allergic rhinitis (AR) but it is less clear to what extent these associations are also present independently from skin disease. The aim of the present study was to evaluate the role of 2282del4 and R501X in predisposing to these allergic phenotypes in a Polish population. Methodology: 2282del4 and R501X were typed among 3,802 participants of the Epidemiology of Allergic Diseases in Poland (ECAP) survey, a cross-sectional population-based study using ECRHS II and ISAAC questionnaires, and ambulatory examination. Principal Findings: The FLG null variants were associated with AD (OR = 2.01, CI: 1.20-3.36, P = 0.007), allergic rhinitis (in particular persistent form, OR = 1.69, CI: 1.12-2.54, P = 0.011), and asthma (in particular atopic asthma, OR = 2.22, CI: 1.24-3.96, P = 0.006). Association with atopic asthma (but not persistent allergic rhinitis) was also present in the absence of AD, (OR = 2.02, CI: 1.07-3.81, P = 0.027) as well as in the absence of AD and history of broadly defined inflammatory skin disease (OR = 2.30, CI: 1.07-4.93, P = 0.03). Association to atopic asthma would have not been found if diagnosis was made by questionnaire only (OR = 1.15, CI: 0.58-2.32, P = 0.8). We did not observe an association between FLG variants and allergic sensitizations (P = 0.8) or total IgE. (P = 0.6). Conclusions/Significance: In a Polish population FLG 2282del4 and R501X carriage increases risk for development of AD and atopic asthma (also in the absence of AD or history thereof). This suggests that interventions aimed at restoring epidermal barrier may have a general role in asthma prophylaxis/treatment.	[Poninska, Joanna; Kostrzewa, Grazyna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Komorowski, Jaroslaw; Krzych-Falta, Edyta; Namyslowski, Andrzej; Borowicz, Jacek] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Medical University of Warsaw	Poninska, J (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Piekarska, Barbara/AAJ-7354-2020; Tomaszewska, Aneta/X-8906-2018; Lipiec, Agnieszka/X-7523-2018; Samel-Kowalik, Piotr/M-3239-2018	Piekarska, Barbara/0000-0002-6800-7781; Tomaszewska, Aneta/0000-0001-6730-6352; Lipiec, Agnieszka/0000-0003-3037-2326; Samel-Kowalik, Piotr/0000-0002-9047-0414; Ploski, Rafal/0000-0001-6286-5526; Raciborski, Filip/0000-0003-0562-0260; Poninska, Joanna/0000-0002-0890-611X; Krzych-Falta, Edyta/0000-0002-9857-7136	Polish Ministry of Science and Higher Education, Ministry of Health [6P052005C/06572]; Warsaw Medical University [1WY/NK1W/2009]	Polish Ministry of Science and Higher Education, Ministry of Health; Warsaw Medical University	Funding: The work was financed by grants from Polish Ministry of Science and Higher Education, Ministry of Health grant nr 6P052005C/06572, and Warsaw Medical University grant nr 1WY/NK1W/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER JNW, 2006, J INVEST DERMATOL, V127, P654; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bonnelykke K, 2010, PEDIAT ALLERG IMM-UK, V21, P954, DOI 10.1111/j.1399-3038.2010.01073.x; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Brown SJ, 2008, J INVEST DERMATOL, V128, P1591, DOI 10.1038/sj.jid.5701206; DEBELIC M, 1996, MANUALE ALLERGOLOGIC, V4; Global Initiative for Asthma, 2009, GLOB STRAT ASTHM MAN; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121, P872, DOI 10.1016/j.jaci.2008.01.026; JOHANSSON GOS, 1998, CLIN WORKSH IGE ANT; Kulig M, 2000, J ALLERGY CLIN IMMUN, V105, P274, DOI 10.1016/S0091-6749(00)90076-9; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mueller-Malesinska M, 2001, J AUDIOLOGICAL MED, V10, P136; O'Regan GM, 2008, J ALLERGY CLIN IMMUN, V122, P689, DOI 10.1016/j.jaci.2008.08.002; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630	24	46	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e16933	10.1371/journal.pone.0016933	http://dx.doi.org/10.1371/journal.pone.0016933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365004	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482800021
J	Rosas, SR; Kagan, JM; Schouten, JT; Slack, PA; Trochim, WMK				Rosas, Scott R.; Kagan, Jonathan M.; Schouten, Jeffrey T.; Slack, Perry A.; Trochim, William M. K.			Evaluating Research and Impact: A Bibliometric Analysis of Research by the NIH/NIAID HIV/AIDS Clinical Trials Networks	PLOS ONE			English	Article							RESEARCH PERFORMANCE; SCIENTIFIC-RESEARCH; AIDS; CITATION	Evaluative bibliometrics uses advanced techniques to assess the impact of scholarly work in the context of other scientific work and usually compares the relative scientific contributions of research groups or institutions. Using publications from the National Institute of Allergy and Infectious Diseases (NIAID) HIV/AIDS extramural clinical trials networks, we assessed the presence, performance, and impact of papers published in 2006-2008. Through this approach, we sought to expand traditional bibliometric analyses beyond citation counts to include normative comparisons across journals and fields, visualization of co-authorship across the networks, and assess the inclusion of publications in reviews and syntheses. Specifically, we examined the research output of the networks in terms of the a) presence of papers in the scientific journal hierarchy ranked on the basis of journal influence measures, b) performance of publications on traditional bibliometric measures, and c) impact of publications in comparisons with similar publications worldwide, adjusted for journals and fields. We also examined collaboration and interdisciplinarity across the initiative, through network analysis and modeling of co-authorship patterns. Finally, we explored the uptake of network produced publications in research reviews and syntheses. Overall, the results suggest the networks are producing highly recognized work, engaging in extensive interdisciplinary collaborations, and having an impact across several areas of HIV-related science. The strengths and limitations of the approach for evaluation and monitoring research initiatives are discussed.	[Rosas, Scott R.; Slack, Perry A.] Concept Syst Inc, Ithaca, NY USA; [Kagan, Jonathan M.] NIAID, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Schouten, Jeffrey T.] Fred Hutchinson Canc Res Ctr, HIV AIDS Network Coordinat Project, Seattle, WA 98104 USA; [Trochim, William M. K.] Cornell Univ, Dept Policy Anal & Management, Ithaca, NY USA	Concept Systems Incorporated; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Fred Hutchinson Cancer Center; Cornell University	Rosas, SR (corresponding author), Concept Syst Inc, Ithaca, NY USA.	srosas@conceptsystems.com	Rosas, Scott/J-1679-2019	Rosas, Scott/0000-0001-5212-1478	National Institute of Allergy & Infectious Diseases (NIAID) [N01-AI-50022]; National Center for Research Resources (NCRR) [UL1-RR-024996]; NIAID [U01 AI068614, U01AI068636, U01AI068619, U01AI068632, U01AI068641, U01AI068633]; NCRR are components of the National Institutes of Health, Department of Health and Human Services, United States Government; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068641, U01AI068619, U01AI068632, U01AI068614, U01AI068636, U01AI068633] Funding Source: NIH RePORTER	National Institute of Allergy & Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR are components of the National Institutes of Health, Department of Health and Human Services, United States Government; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by Contract No. N01-AI-50022, "HIV Clinical Research Support'' from the National Institute of Allergy & Infectious Diseases (NIAID), in part by Grant No. UL1-RR-024996, from the National Center for Research Resources (NCRR) and in part by grants U01 AI068614, U01AI068636, U01AI068619, U01AI068632, U01AI068641, and U01AI068633 (NIAID). NIAID and NCRR are components of the National Institutes of Health, Department of Health and Human Services, United States Government. No additional external funding was received for this study. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SRR and PAS are employed by Concept Systems, Inc and WMKT is a co-owner of the company. All three served as consultants to NIAID and contributed to the study design, analysis, and manuscript preparation.	Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; Archambault E, 2006, SCIENTOMETRICS, V68, P329, DOI 10.1007/s11192-006-0115-z; Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; BIERBAUM EG, 1995, J AM SOC INFORM SCI, V46, P530, DOI 10.1002/(SICI)1097-4571(199508)46:7<530::AID-ASI6>3.0.CO;2-C; Campbell D, 2010, AM J EVAL, V31, P66, DOI 10.1177/1098214009354774; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cozzens SE, 1997, EVAL PROGRAM PLANN, V20, P77, DOI 10.1016/S0149-7189(96)00038-9; Falagas ME, 2006, AIDS RES HUM RETROV, V22, P1199, DOI 10.1089/aid.2006.22.1199; Franks AL, 2006, AM J PREV MED, V30, P211, DOI 10.1016/j.amepre.2005.10.025; Grant J, 2000, BMJ-BRIT MED J, V320, P1107, DOI 10.1136/bmj.320.7242.1107; Green LA, 2005, J AM BOARD FAM PRACT, V18, P541, DOI 10.3122/jabfm.18.6.541; HAYNES RB, 1983, ARCH INTERN MED, V143, P1971, DOI 10.1001/archinte.143.10.1971; HAYNES RB, 1990, ANN INTERN MED, V113, P724, DOI 10.7326/0003-4819-113-9-724; Hicks D, 2004, RES EVALUAT, V13, P78; Ioannidis JPA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002778; Kagan Jonathan M, 2009, Health Res Policy Syst, V7, P12, DOI 10.1186/1478-4505-7-12; King D., 2009, INF SERV USE, V28, P215, DOI [10.3233/ISU-2008-0579, DOI 10.3233/ISU-2008-0579]; Koskinen J, 2008, NORD J PSYCHIAT, V62, P136, DOI 10.1080/08039480801961667; Kovacic N, 2004, CAN MED ASSOC J, V170, P1929, DOI 10.1503/cmaj.1040513; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Macias-Chapula CA, 2002, SCIENTOMETRICS, V54, P309, DOI 10.1023/A:1016074230843; Macias-Chapula CA, 2000, B MED LIBR ASSOC, V88, P56; Macias-Chapula CA, 1998, SCIENTOMETRICS, V41, P41, DOI 10.1007/BF02457965; Macias-Chapula CA, 1999, SCIENTOMETRICS, V46, P563, DOI 10.1007/BF02459612; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; NARIN F, 1994, EVALUATION REV, V18, P65, DOI 10.1177/0193841X9401800107; Noyons E. C. M., 2003, MAPPING EXCELLENCE 1; NOYONS ECM, 2003, MAPPING EXCELLENCE 2; Onyancha OB, 2004, LIBR INFORM SCI RES, V26, P434, DOI 10.1016/j.lisr.2004.04.005; Onyancha OB, 2008, AJAR-AFR J AIDS RES, V7, P55, DOI 10.2989/AJAR.2008.7.1.7.435; Patra SK, 2007, LIBR INFORM SCI RES, V29, P124, DOI 10.1016/j.lisr.2006.08.010; Pendlebury DA, 2009, ARCH IMMUNOL THER EX, V57, P1, DOI 10.1007/s00005-009-0008-y; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; SENGUPTA IN, 1991, SCIENTOMETRICS, V20, P297, DOI 10.1007/BF02018160; SMALL H, 1994, SCIENTOMETRICS, V30, P229, DOI 10.1007/BF02017225; SMALL H, 1989, COMMUN RES, V16, P642, DOI 10.1177/009365089016005006; Smith K, 2005, MATH COMPUT SIMULAT, V69, P177, DOI 10.1016/j.matcom.2005.02.027; STROTMANN A, 2009, P AM SOC INFORM SCI; Trochim WM, 2008, AM J EVAL, V29, P8, DOI 10.1177/1098214007309280; Uthman OA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-19; van Leeuwen T, 2000, RES EVALUAT, V9, P183, DOI 10.3152/147154400781777241; Van Leeuwen TN, 2007, RES EVALUAT, V16, P93, DOI 10.3152/095820207X227529; Van Raan AFJ, 2005, SCIENTOMETRICS, V62, P133, DOI 10.1007/s11192-005-0008-6; van Raan AFJ, 2005, MEAS-INTERDISCIP RES, V3, P1, DOI 10.1207/s15366359mea0301_1; VANRAAN A, 2008, RES EVALUAT, V8, P81; Weingart P, 2005, SCIENTOMETRICS, V62, P117, DOI 10.1007/s11192-005-0007-7	46	62	65	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17428	10.1371/journal.pone.0017428	http://dx.doi.org/10.1371/journal.pone.0017428			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	730HX	21394198	gold, Green Submitted, Green Published			2022-12-27	WOS:000288025500013
J	Okamoto, H; Teismann, H; Kakigi, R; Pantev, C				Okamoto, Hidehiko; Teismann, Henning; Kakigi, Ryusuke; Pantev, Christo			Broadened Population-Level Frequency Tuning in Human Auditory Cortex of Portable Music Player Users	PLOS ONE			English	Article							RECREATIONAL NOISE EXPOSURE; INDUCED HEARING-LOSS; INFERIOR COLLICULUS; COCHLEAR LESIONS; ADULT CATS; BALANCED INHIBITION; PLASTICITY; DAMAGE; RISK; ORGANIZATION	Nowadays, many people use portable players to enrich their daily life with enjoyable music. However, in noisy environments, the player volume is often set to extremely high levels in order to drown out the intense ambient noise and satisfy the appetite for music. Extensive and inappropriate usage of portable music players might cause subtle damages in the auditory system, which are not behaviorally detectable in an early stage of the hearing impairment progress. Here, by means of magnetoencephalography, we objectively examined detrimental effects of portable music player misusage on the population-level frequency tuning in the human auditory cortex. We compared two groups of young people: one group had listened to music with portable music players intensively for a long period of time, while the other group had not. Both groups performed equally and normally in standard audiological examinations (pure tone audiogram, speech test, and hearing-in-noise test). However, the objective magnetoencephalographic data demonstrated that the population-level frequency tuning in the auditory cortex of the portable music player users was significantly broadened compared to the non-users, when attention was distracted from the auditory modality; this group difference vanished when attention was directed to the auditory modality. Our conclusion is that extensive and inadequate usage of portable music players could cause subtle damages, which standard behavioral audiometric measures fail to detect in an early stage. However, these damages could lead to future irreversible hearing disorders, which would have a huge negative impact on the quality of life of those affected, and the society as a whole.	[Okamoto, Hidehiko; Teismann, Henning; Pantev, Christo] Univ Munster, Inst Biomagnetism & Biosignalanal, D-4400 Munster, Germany; [Okamoto, Hidehiko; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan	University of Munster; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Okamoto, H (corresponding author), Univ Munster, Inst Biomagnetism & Biosignalanal, D-4400 Munster, Germany.	okamotoh@uni-muenster.de	Okamoto, Hidehiko/A-7934-2008	Okamoto, Hidehiko/0000-0003-2799-3340	Deutsche Forschungsgemeinschaft [Pa 392/13-1, Pa 392/10-3]; Tinnitus Research Initiative [BD169968]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tinnitus Research Initiative	This work was supported by the Deutsche Forschungsgemeinschaft, Pa 392/13-1 and Pa 392/10-3, and the Tinnitus Research Initiative, BD169968. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELSSON A, 1994, SCAND AUDIOL, V23, P129, DOI 10.3109/01050399409047497; Biassoni EC, 2005, INT J AUDIOL, V44, P74, DOI 10.1080/14992020500031728; CALFORD MB, 1993, NEUROSCIENCE, V55, P953, DOI 10.1016/0306-4522(93)90310-C; Caspary DM, 2008, J EXP BIOL, V211, P1781, DOI 10.1242/jeb.013581; Clark WW, 1999, JAMA-J AM MED ASSOC, V281, P1658, DOI 10.1001/jama.281.17.1658; Danhauer JL, 2009, J AM ACAD AUDIOL, V20, P5, DOI 10.3766/jaaa.20.1.2; Diesch E, 2010, NEUROSCIENCE, V167, P540, DOI 10.1016/j.neuroscience.2010.02.003; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Fligor BJ, 2004, EAR HEARING, V25, P513, DOI 10.1097/00003446-200412000-00001; Irvine DRF, 2003, J COMP NEUROL, V467, P354, DOI 10.1002/cne.10921; Izquierdo MA, 2008, NEUROSCIENCE, V154, P355, DOI 10.1016/j.neuroscience.2008.01.057; Kamke MR, 2003, J COMP NEUROL, V459, P355, DOI 10.1002/cne.10586; Kauramaki J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000909; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LeBeau FEN, 2001, J NEUROSCI, V21, P7303, DOI 10.1523/JNEUROSCI.21-18-07303.2001; LeBeau FEN, 1996, J NEUROPHYSIOL, V75, P902, DOI 10.1152/jn.1996.75.2.902; MeyerBisch C, 1996, AUDIOLOGY, V35, P121; Milbrandt JC, 2000, HEARING RES, V147, P251, DOI 10.1016/S0378-5955(00)00135-0; MORATA TC, 1993, SCAND J WORK ENV HEA, V19, P245, DOI 10.5271/sjweh.1477; Morata TC, 2007, INT J AUDIOL, V46, P111, DOI 10.1080/14992020601103079; Mossop JE, 2000, HEARING RES, V147, P183, DOI 10.1016/S0378-5955(00)00054-X; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NILSSON M, 1994, J ACOUST SOC AM, V95, P1085, DOI 10.1121/1.408469; Norena AJ, 2003, J NEUROPHYSIOL, V90, P2387, DOI 10.1152/jn.00139.2003; Okamoto H, 2007, J NEUROSCI, V27, P10383, DOI 10.1523/JNEUROSCI.2963-07.2007; Okamoto H, 2010, J NEUROPHYSIOL, V103, P244, DOI 10.1152/jn.00530.2009; Okamoto H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-1; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; Peng JH, 2007, J OTOLARYNGOL, V36, P181, DOI 10.2310/7070.2007.0032; Rabinowitz PM, 2000, AM FAM PHYSICIAN, V61, P2749; Rajan R, 1998, NAT NEUROSCI, V1, P138, DOI 10.1038/388; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; ROSLER G, 1994, SCAND AUDIOL, V23, P13, DOI 10.3109/01050399409047483; SAMS M, 1994, HEARING RES, V75, P67, DOI 10.1016/0378-5955(94)90057-4; Serra MR, 2005, INT J AUDIOL, V44, P65, DOI 10.1080/14992020400030010; Suga N, 1997, J NEUROPHYSIOL, V77, P2098, DOI 10.1152/jn.1997.77.4.2098; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Tucci DL, 2010, OTOL NEUROTOL, V31, P31, DOI 10.1097/MAO.0b013e3181c0eaec; von Bekesy G, 1967, SENSORY INHIBITION; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhao F, 2010, INT J AUDIOL, V49, P54, DOI 10.3109/14992020903202520; Zwicker E., 1999, PSYCHOACOUSTICS FACT	44	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17022	10.1371/journal.pone.0017022	http://dx.doi.org/10.1371/journal.pone.0017022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399676	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300005
J	Herculano-Houzel, S				Herculano-Houzel, Suzana			Scaling of Brain Metabolism with a Fixed Energy Budget per Neuron: Implications for Neuronal Activity, Plasticity and Evolution	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OXIDATIVE-METABOLISM; PRIMATE BRAINS; VISUAL-CORTEX; IN-VIVO; MAMMALS; MATTER; RULES; NEUROSCIENCE; STIMULATION	It is usually considered that larger brains have larger neurons, which consume more energy individually, and are therefore accompanied by a larger number of glial cells per neuron. These notions, however, have never been tested. Based on glucose and oxygen metabolic rates in awake animals and their recently determined numbers of neurons, here I show that, contrary to the expected, the estimated glucose use per neuron is remarkably constant, varying only by 40% across the six species of rodents and primates (including humans). The estimated average glucose use per neuron does not correlate with neuronal density in any structure. This suggests that the energy budget of the whole brain per neuron is fixed across species and brain sizes, such that total glucose use by the brain as a whole, by the cerebral cortex and also by the cerebellum alone are linear functions of the number of neurons in the structures across the species (although the average glucose consumption per neuron is at least 10 x higher in the cerebral cortex than in the cerebellum). These results indicate that the apparently remarkable use in humans of 20% of the whole body energy budget by a brain that represents only 2% of body mass is explained simply by its large number of neurons. Because synaptic activity is considered the major determinant of metabolic cost, a conserved energy budget per neuron has several profound implications for synaptic homeostasis and the regulation of firing rates, synaptic plasticity, brain imaging, pathologies, and for brain scaling in evolution.	[Herculano-Houzel, Suzana] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Herculano-Houzel, Suzana] Ministerio Ciencia & Tecnol, Inst Nacl Neurociencia Translac, Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro	Herculano-Houzel, S (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	suzanahh@gmail.com	Neurociencia, Inct/I-1011-2013		Faperj; CNPq; National Institute for Translational Neuroscience (INNT - MCT); James S. McDonnell Foundation	Faperj(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute for Translational Neuroscience (INNT - MCT); James S. McDonnell Foundation	This work was supported by Faperj, CNPq, the National Institute for Translational Neuroscience (INNT - MCT), and the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Aschoff J, 1971, ENERGIEHAUSHALT TEMP; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; CAMPOS LR, 2008, SOC NEUROSCI; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Clarke Donald D., 1999, P637; CRAGG BG, 1967, J ANAT, V101, P639; d'Avila JC, 2008, CRIT CARE MED, V36, P1925, DOI 10.1097/CCM.0b013e3181760c4b; Finsterer J, 2008, J NEUROL SCI, V272, P20, DOI 10.1016/j.jns.2008.05.011; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gabi M, 2010, BRAIN BEHAV EVOLUT, V76, P32, DOI 10.1159/000319872; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Herculano-Houzel S, 2011, BRAIN BEHAV IN PRESS; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; HOFMAN MA, 1983, Q REV BIOL, V58, P495, DOI 10.1086/413544; HYDER F, 2006, J CEREB BLOOD FLOW M, V26, P856; Karbowski J, 2009, J COMPUT NEUROSCI, V27, P415, DOI 10.1007/s10827-009-0153-7; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kety S.S., 1957, METABOLISM NERVOUS S, P221; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KLEIBER MAX, 1932, HILGARDIA, V6, P315; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; la Fougere C, 2009, EPILEPSY BEHAV, V15, P50, DOI 10.1016/j.yebeh.2009.02.025; Lebon V, 2002, J NEUROSCI, V22, P1523, DOI 10.1523/JNEUROSCI.22-05-01523.2002; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Loaiza A, 2003, J NEUROSCI, V23, P7337; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; MARTIN RD, 1996, NATURE L, V293, P57; MINK JW, 1981, AM J PHYSIOL, V241, pR203, DOI 10.1152/ajpregu.1981.241.3.R203; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Owen-Smith NR, 1988, MEGAHERBIVORES; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PHELPS ME, 1975, J NUCL MED, V16, P210; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR226, DOI 10.1152/ajpregu.1995.269.1.R226; REICHENBACH A, 1989, GLIA, V2, P71, DOI 10.1002/glia.440020202; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sarko DK, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.008.2009; Shen J, 1999, P NATL ACAD SCI USA, V96, P8235, DOI 10.1073/pnas.96.14.8235; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Shulman RG, 2009, P NATL ACAD SCI USA, V106, P11096, DOI 10.1073/pnas.0903941106; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Sokoloff L., 1960, HANDBOOK PHYSIOLOG 1, P1843; TOWER DB, 1954, J COMP NEUROL, V101, P19, DOI 10.1002/cne.901010103; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; Wilson NR, 2007, J NEUROSCI, V27, P13581, DOI 10.1523/JNEUROSCI.3863-07.2007; Wrangham RW, 2009, CATCHING FIRE COOKIN; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com	69	175	175	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e17514	10.1371/journal.pone.0017514	http://dx.doi.org/10.1371/journal.pone.0017514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390261	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100021
J	O'Rourke, SM; Carter, C; Carter, L; Christensen, SN; Jones, MP; Nash, B; Price, MH; Turnbull, DW; Garner, AR; Hamill, DR; Osterberg, VR; Lyczak, R; Madison, EE; Nguyen, MH; Sandberg, NA; Sedghi, N; Willis, JH; Yochem, J; Johnson, EA; Bowerman, B				O'Rourke, Sean M.; Carter, Clayton; Carter, Luke; Christensen, Sara N.; Jones, Minh P.; Nash, Bruce; Price, Meredith H.; Turnbull, Douglas W.; Garner, Aleena R.; Hamill, Danielle R.; Osterberg, Valerie R.; Lyczak, Rebecca; Madison, Erin E.; Nguyen, Michael H.; Sandberg, Nathan A.; Sedghi, Noushin; Willis, John H.; Yochem, John; Johnson, Eric A.; Bowerman, Bruce			A Survey of New Temperature-Sensitive, Embryonic-Lethal Mutations in C. elegans: 24 Alleles of Thirteen Genes	PLOS ONE			English	Article							CELL-DIVISION CYCLE; POLO-LIKE KINASE; CAENORHABDITIS-ELEGANS; DNA-REPLICATION; SCHIZOSACCHAROMYCES-POMBE; CENTRIOLE DUPLICATION; FUNCTIONAL-ANALYSIS; MITOTIC SPINDLE; PHOSPHATASE 2A; SPT-1 MUTATION	To study essential maternal gene requirements in the early C. elegans embryo, we have screened for temperature-sensitive, embryonic lethal mutations in an effort to bypass essential zygotic requirements for such genes during larval and adult germline development. With conditional alleles, multiple essential requirements can be examined by shifting at different times from the permissive temperature of 15 degrees C to the restrictive temperature of 26 degrees C. Here we describe 24 conditional mutations that affect 13 different loci and report the identity of the gene mutations responsible for the conditional lethality in 22 of the mutants. All but four are mis-sense mutations, with two mutations affecting splice sites, another creating an in-frame deletion, and one creating a premature stop codon. Almost all of the mis-sense mutations affect residues conserved in orthologs, and thus may be useful for engineering conditional mutations in other organisms. We find that 62% of the mutants display additional phenotypes when shifted to the restrictive temperature as L1 larvae, in addition to causing embryonic lethality after L4 upshifts. Remarkably, we also found that 13 out of the 24 mutations appear to be fast-acting, making them particularly useful for careful dissection of multiple essential requirements. Our findings highlight the value of C. elegans for identifying useful temperature-sensitive mutations in essential genes, and provide new insights into the requirements for some of the affected loci.	[O'Rourke, Sean M.; Carter, Clayton; Carter, Luke; Christensen, Sara N.; Jones, Minh P.; Nash, Bruce; Price, Meredith H.; Turnbull, Douglas W.; Garner, Aleena R.; Hamill, Danielle R.; Osterberg, Valerie R.; Lyczak, Rebecca; Madison, Erin E.; Nguyen, Michael H.; Sandberg, Nathan A.; Sedghi, Noushin; Willis, John H.; Yochem, John; Johnson, Eric A.; Bowerman, Bruce] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	O'Rourke, SM (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	bbowerman@molbio.uoregon.edu		Garner, Aleena/0000-0002-3488-2959	Leukemia and Lymphoma Society; NIH [GM050817, GM049869]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050817, R01GM049869, R21GM050817] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Leukemia and Lymphoma Society of America fellowship to SOR, and NIH grants GM050817 and GM049869 to BB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBER T, 1987, BIOCHEMISTRY-US, V26, P3754, DOI 10.1021/bi00387a002; Banaszynski LA, 2006, CHEM BIOL, V13, P11, DOI 10.1016/j.chembiol.2005.10.010; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; BONATTI S, 1972, J BACTERIOL, V109, P484, DOI 10.1128/JB.109.2.484-491.1972; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRENNER S, 1974, GENETICS, V77, P71; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; CASSADA R, 1981, DEV BIOL, V84, P193, DOI 10.1016/0012-1606(81)90383-3; Chase D, 2000, GENESIS, V26, P26, DOI 10.1002/(SICI)1526-968X(200001)26:1<26::AID-GENE6>3.0.CO;2-O; Dorfman M, 2009, GENETICS, V182, P1035, DOI 10.1534/genetics.109.104885; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; EKI T, 1990, J BIOL CHEM, V265, P26; Ellis GC, 2004, J CELL SCI, V117, P457, DOI 10.1242/jcs.00869; Encalada SE, 2005, MOL BIOL CELL, V16, P1056, DOI 10.1091/mbc.E04-08-0712; Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Golden A, 2000, J CELL BIOL, V151, P1469, DOI 10.1083/jcb.151.7.1469; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Guedes S, 1997, DEVELOPMENT, V124, P731; HARTWELL LH, 1970, P NATL ACAD SCI USA, V66, P352, DOI 10.1073/pnas.66.2.352; HARTWELL LH, 1967, J BACTERIOL, V93, P1662, DOI 10.1128/JB.93.5.1662-1670.1967; HARTWELL LH, 1973, GENETICS, V74, P267; HERMAN RK, 1984, GENETICS, V108, P165; HILLMAN R, 1962, GENETICS, V47, P11; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; ISNENGHI E, 1983, DEV BIOL, V98, P465, DOI 10.1016/0012-1606(83)90376-7; Kaletta T, 1997, NATURE, V390, P294, DOI 10.1038/36869; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Koushika SP, 2004, J NEUROSCI, V24, P3907, DOI 10.1523/JNEUROSCI.5039-03.2004; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEVITAN DJ, 1994, P NATL ACAD SCI USA, V91, P6108, DOI 10.1073/pnas.91.13.6108; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; MAINS PE, 1990, GENETICS, V125, P351; MAINS PE, 1990, GENETICS, V126, P593; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2006, J CELL BIOL, V175, P881, DOI 10.1083/jcb.200608117; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Nishi Y, 2008, DEVELOPMENT, V135, P687, DOI 10.1242/dev.013425; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Phillips JB, 2004, CELL MOTIL CYTOSKEL, V58, P112, DOI 10.1002/cm.20003; Quintin S, 2003, EMBO REP, V4, P1175, DOI 10.1038/sj.embor.7400029; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schmidt DJ, 2005, MOL BIOL CELL, V16, P1200, DOI 10.1091/mbc.E04-06-0523; Schnabel R, 1996, MECH DEVELOP, V54, P133, DOI 10.1016/0925-4773(95)00466-1; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Shirayama M, 2006, CURR BIOL, V16, P47, DOI 10.1016/j.cub.2005.11.070; Sieburth DS, 1999, GENE DEV, V13, P2562, DOI 10.1101/gad.13.19.2562; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Skop AR, 1998, CURR BIOL, V8, P1110, DOI 10.1016/S0960-9822(98)70465-8; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Srayko M, 2000, GENE DEV, V14, P1072; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579	66	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e16644	10.1371/journal.pone.0016644	http://dx.doi.org/10.1371/journal.pone.0016644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390299	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100002
J	Barry, DP; Asim, M; Leiman, DA; de Sablet, T; Singh, K; Casero, RA; Chaturvedi, R; Wilson, KT				Barry, Daniel P.; Asim, Mohammad; Leiman, David A.; de Sablet, Thibaut; Singh, Kshipra; Casero, Robert A., Jr.; Chaturvedi, Rupesh; Wilson, Keith T.			Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; COMPLETE GENOME SEQUENCE; COCCOID FORMS; ALPHA-DIFLUOROMETHYLORNITHINE; ORNITHINE-DECARBOXYLASE; POLYAMINE-BIOSYNTHESIS; MACROPHAGE APOPTOSIS; CYTOTOXIN ACTIVITY; GENE-EXPRESSION	Helicobacter pylori infects half the world's population, and carriage is lifelong without antibiotic therapy. Current regimens prescribed to prevent infection-associated diseases such as gastroduodenal ulcers and gastric cancer can be thwarted by antibiotic resistance. We reported that administration of 1% D,L-alpha-difluoromethylornithine (DFMO) to mice infected with H. pylori reduces gastritis and colonization, which we attributed to enhanced host immune response due to inhibition of macrophage ornithine decarboxylase (ODC), the rate-limiting enzyme in polyamine biosynthesis. Although no ODC has been identified in any H. pylori genome, we sought to determine if DFMO has direct effects on the bacterium. We found that DFMO significantly reduced the growth rate of H. pylori in a polyamine-independent manner. Two other Gram-negative pathogens possessing ODC, Escherichia coli and Citrobacter rodentium, were resistant to the DFMO effect. The effect of DFMO on H. pylori required continuous exposure to the drug and was reversible when removed, with recovery of growth rate in vitro and the ability to colonize mice. H. pylori exposed to DFMO were significantly shorter in length than those untreated and they contained greater internal levels of ATP, suggesting severe effects on bacterial metabolism. DFMO inhibited expression of the H. pylori virulence factor cytotoxin associated gene A, and its translocation and phosphorylation in gastric epithelial cells, which was associated with a reduction in interleukin-8 expression. These findings suggest that DFMO has effects on H. pylori that may contribute to its effectiveness in reducing gastritis and colonization and may be a useful addition to anti-H. pylori therapies.	[Barry, Daniel P.; Asim, Mohammad; Leiman, David A.; de Sablet, Thibaut; Singh, Kshipra; Chaturvedi, Rupesh; Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA; [Wilson, Keith T.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Barry, Daniel P.; Asim, Mohammad; de Sablet, Thibaut; Singh, Kshipra; Chaturvedi, Rupesh; Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA; [Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Johns Hopkins University; Johns Hopkins Medicine	Barry, DP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Gastroenterol, Nashville, TN 37235 USA.	keith.wilson@vanderbilt.edu	Barry, Daniel P/B-5647-2008; de Sablet, Thibaut/AAI-4513-2020	Barry, Daniel P/0000-0002-3972-3914; Wilson, Keith/0000-0003-4421-1830; Casero, Robert/0000-0001-5653-3306	National Institutes of Health (NIH) [R01DK053620, R01AT004821, 3R01AT004821S1, P01CA028842, P01CA116087, T32DK007673, R01CA051085, R01CA098454, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Office of Medical Research, Department of Veterans Affairs; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485, R01CA098454, R01CA051085, P01CA116087, P01CA028842] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053620, P30DK020593, P60DK020593, P30DK058404, U24DK059637, T32DK007673] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Medical Research, Department of Veterans Affairs(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by National Institutes of Health (NIH) grants R01DK053620, R01AT004821, 3R01AT004821S1, and P01CA028842 (to KTW), P01CA116087 (KTW), T32DK007673 (DPB), R01CA051085 and R01CA098454 (to RAC), the Vanderbilt University Digestive Disease Research Center supported by NIH Grant P30DK058404, and a Merit Review Grant from the Office of Medical Research, Department of Veterans Affairs (to KTW). Electron microscopy was performed with the help of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Andersen LP, 2000, SCAND J GASTROENTERO, V35, P897, DOI 10.1080/003655200750022922; Argent RH, 2004, GASTROENTEROLOGY, V127, P514, DOI 10.1053/j.gastro.2004.06.006; Argent RH, 2008, J MED MICROBIOL, V57, P145, DOI 10.1099/jmm.0.47465-0; Backert S, 2000, CELL MICROBIOL, V2, P155, DOI 10.1046/j.1462-5822.2000.00043.x; BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872; Baltrus DA, 2009, J BACTERIOL, V191, P447, DOI 10.1128/JB.01416-08; Bardhan PK, 1997, CLIN INFECT DIS, V25, P973, DOI 10.1086/516067; Barnard FM, 2004, MOL MICROBIOL, V51, P15, DOI 10.1046/j.1365-2958.2003.03788.x; Bartchewsky W, 2009, SCAND J GASTROENTERO, V44, P153, DOI 10.1080/00365520802530853; Bernstein JA, 2004, P NATL ACAD SCI USA, V101, P2758, DOI 10.1073/pnas.0308747101; BITONTI AJ, 1984, LIFE SCI, V34, P1513, DOI 10.1016/0024-3205(84)90605-2; BITONTI AJ, 1982, BIOCHEM J, V208, P435, DOI 10.1042/bj2080435; BODE G, 1993, EPIDEMIOL INFECT, V111, P483, DOI 10.1017/S0950268800057216; CASERO RA, 1989, CANCER RES, V49, P639; CHAN WY, 1994, AM J CLIN PATHOL, V102, P503, DOI 10.1093/ajcp/102.4.503; Chaturvedi R, 2004, J BIOL CHEM, V279, P40161, DOI 10.1074/jbc.M401370200; Chaturvedi R, 2007, INFECT IMMUN, V75, P4305, DOI 10.1128/IAI.00578-07; Chaturvedi R, 2010, GASTROENTEROLOGY, V139, P1686, DOI 10.1053/j.gastro.2010.06.060; CLARKSON AB, 1984, AM J TROP MED HYG, V33, P1073, DOI 10.4269/ajtmh.1984.33.1073; Cole SP, 1997, INFECT IMMUN, V65, P843, DOI 10.1128/IAI.65.2.843-846.1997; Constanza Camargo M., 2007, Acta Gastroenterologica Latinoamericana, V37, P238; COVER TL, 1990, INFECT IMMUN, V58, P603, DOI 10.1128/IAI.58.3.603-610.1990; DOUA F, 1987, AM J TROP MED HYG, V37, P525, DOI 10.4269/ajtmh.1987.37.525; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; EATON KA, 1995, J INFECT DIS, V171, P459, DOI 10.1093/infdis/171.2.459; Ferlay J, 2010, INT J CANC; Fischbach LA, 2002, INT J EPIDEMIOL, V31, P128, DOI 10.1093/ije/31.1.128; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Fox JG, 2007, J CLIN INVEST, V117, P60, DOI 10.1172/JCI30111; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Gobert AP, 2002, J IMMUNOL, V168, P6002, DOI 10.4049/jimmunol.168.12.6002; Gobert AP, 2002, J IMMUNOL, V168, P4692, DOI 10.4049/jimmunol.168.9.4692; Goodman KJ, 2008, CAN J GASTROENTEROL, V22, P289, DOI 10.1155/2008/258610; Guo YJ, 2005, CANCER RES, V65, P1146, DOI 10.1158/0008-5472.CAN-04-3244; HAEGELE KD, 1981, CLIN PHARMACOL THER, V30, P210, DOI 10.1038/clpt.1981.150; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kim SY, 2006, CELL MICROBIOL, V8, P97, DOI 10.1111/j.1462-5822.2005.00603.x; Kusters JG, 1997, INFECT IMMUN, V65, P3672, DOI 10.1128/IAI.65.9.3672-3679.1997; Lee A, 1997, GASTROENTEROLOGY, V112, P1386, DOI 10.1016/S0016-5085(97)70155-0; Lee MJ, 2005, PROTEIN EXPRES PURIF, V43, P140, DOI 10.1016/j.pep.2005.04.017; Lewis ND, 2010, J IMMUNOL, V184, P2572, DOI 10.4049/jimmunol.0902436; Loh JT, 2008, FEMS MICROBIOL LETT, V289, P53, DOI 10.1111/j.1574-6968.2008.01368.x; MARSHALL BJ, 1984, LANCET, V1, P1311; Mera R, 2005, GUT, V54, P1536, DOI 10.1136/gut.2005.072009; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Michael A. J, 1999, POLYAMINES HLTH NUTR, P55; MOSS SF, 1994, GUT, V35, P1567, DOI 10.1136/gut.35.11.1567; Muller S, 2007, MICROBIOL RES, V162, P1, DOI 10.1016/j.micres.2006.01.003; NAGATA K, 1993, ANTIMICROB AGENTS CH, V37, P769, DOI 10.1128/AAC.37.4.769; Nakachi N, 2000, FEMS IMMUNOL MED MIC, V29, P23, DOI 10.1111/j.1574-695X.2000.tb01500.x; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Osaki T, 2002, J MED MICROBIOL, V51, P295, DOI 10.1099/0022-1317-51-4-295; Papadopulos F, 2007, ULTRASTRUCT PATHOL, V31, P401, DOI 10.1080/01913120701719189; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2010, PHYSIOL REV, V90, P831, DOI 10.1152/physrev.00039.2009; Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001; Perez-Perez GI, 1999, J PHYSIOL PHARMACOL, V50, P833; PEREZPEREZ GI, 1992, INFECT IMMUN, V60, P3658; Philpott DJ, 2002, CELL MICROBIOL, V4, P285, DOI 10.1046/j.1462-5822.2002.00189.x; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Sharma SA, 1998, J IMMUNOL, V160, P2401; She FF, 2003, WORLD J GASTROENTERO, V9, P516, DOI 10.3748/wjg.v9.i3.516; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; TABOR H, 1980, J BACTERIOL, V144, P952, DOI 10.1128/JB.144.3.952-956.1980; Takaji S, 1997, LETT APPL MICROBIOL, V25, P177, DOI 10.1046/j.1472-765X.1997.00198.x; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; Wang X, 1997, J MED MICROBIOL, V46, P657, DOI 10.1099/00222615-46-8-657; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Wilson KT, 1996, GASTROENTEROLOGY, V111, P1524, DOI 10.1016/S0016-5085(96)70014-8; Xu HX, 2004, CANCER RES, V64, P8521, DOI 10.1158/0008-5472.CAN-04-3511; Yerushalmi HF, 2006, MOL CARCINOGEN, V45, P764, DOI 10.1002/mc.20246	80	25	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e17510	10.1371/journal.pone.0017510	http://dx.doi.org/10.1371/journal.pone.0017510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386987	Green Published, gold, Green Submitted			2022-12-27	WOS:000287931400083
J	Mazaheri, A; DiQuattro, NE; Bengson, J; Geng, JJ				Mazaheri, Ali; DiQuattro, Nicholas E.; Bengson, Jesse; Geng, Joy J.			Pre-Stimulus Activity Predicts the Winner of Top-Down vs. Bottom-Up Attentional Selection	PLOS ONE			English	Article							FRONTAL EYE FIELDS; HUMAN VISUAL-CORTEX; OSCILLATIONS PREDICT; ALPHA OSCILLATIONS; OCULOMOTOR CAPTURE; PARIETAL CORTICES; NEURAL MECHANISMS; SPATIAL ATTENTION; BRAIN POTENTIALS; COVERT SHIFTS	Our ability to process visual information is fundamentally limited. This leads to competition between sensory information that is relevant for top-down goals and sensory information that is perceptually salient, but task-irrelevant. The aim of the present study was to identify, from EEG recordings, pre-stimulus and pre-saccadic neural activity that could predict whether top-down or bottom-up processes would win the competition for attention on a trial-by-trial basis. We employed a visual search paradigm in which a lateralized low contrast target appeared alone, or with a low (i.e., non-salient) or high contrast (i.e., salient) distractor. Trials with a salient distractor were of primary interest due to the strong competition between top-down knowledge and bottom-up attentional capture. Our results demonstrated that 1) in the 1-sec pre-stimulus interval, frontal alpha (8-12 Hz) activity was higher on trials where the salient distractor captured attention and the first saccade (bottom-up win); and 2) there was a transient pre-saccadic increase in posterior-parietal alpha (7-8 Hz) activity on trials where the first saccade went to the target (top-down win). We propose that the high frontal alpha reflects a disengagement of attentional control whereas the transient posterior alpha time-locked to the saccade indicates sensory inhibition of the salient distractor and suppression of bottom-up oculomotor capture.	[Mazaheri, Ali; DiQuattro, Nicholas E.; Bengson, Jesse; Geng, Joy J.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Mazaheri, Ali] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Bengson, Jesse; Geng, Joy J.] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA	University of California System; University of California Davis; Radboud University Nijmegen; University of California System; University of California Davis	Mazaheri, A (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.	a.mazaheri@donders.ru.nl	bengson, jesse/L-3470-2019; Geng, Joy/J-6225-2019	Lauwereyns, Jan/0000-0003-0551-2550; Mazaheri, Ali/0000-0001-5732-7555	University of California Davis; Netherlands Organisation for Scientific Research (NWO)	University of California Davis(University of California System); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the University of California Davis. AM was supported by a Rubicon grant from The Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyurek EG, 2010, NEUROPSYCHOLOGIA, V48, P3335, DOI 10.1016/j.neuropsychologia.2010.07.019; Andersen RA, 1997, PHILOS T ROY SOC B, V352, P1421, DOI 10.1098/rstb.1997.0128; Andersen SK, 2008, CURR BIOL, V18, P1006, DOI 10.1016/j.cub.2008.06.030; Baldauf D, 2008, EXP BRAIN RES, V184, P411, DOI 10.1007/s00221-007-1114-x; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bisley James W, 2003, Adv Neurol, V93, P141; Bisley JW, 2006, J NEUROPHYSIOL, V95, P1696, DOI 10.1152/jn.00848.2005; Brooks JL, 2006, J NEUROSCI, V26, P2145, DOI 10.1523/JNEUROSCI.4547-05.2006; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buschman TJ, 2009, NEURON, V63, P386, DOI 10.1016/j.neuron.2009.06.020; Connolly JD, 2002, NAT NEUROSCI, V5, P1345, DOI 10.1038/nn969; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Curtis CE, 2008, J NEUROPHYSIOL, V99, P133, DOI 10.1152/jn.00899.2007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eimer M, 2004, J COGNITIVE NEUROSCI, V16, P272, DOI 10.1162/089892904322984562; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Geng JJ, 2006, J NEUROPHYSIOL, V96, P2601, DOI 10.1152/jn.01245.2005; Geng JJ, 2010, J VISION, V10, DOI 10.1167/10.6.5; Geng JJ, 2009, J COGNITIVE NEUROSCI, V21, P1584, DOI 10.1162/jocn.2009.21103; Gottlieb J, 2007, NEURON, V53, P9, DOI 10.1016/j.neuron.2006.12.009; Grent-'T-Jong T, 2007, PLOS BIOL, V5, P114, DOI 10.1371/journal.pbio.0050012; Hanslmayr S, 2007, NEUROIMAGE, V37, P1465, DOI 10.1016/j.neuroimage.2007.07.011; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Hunt AR, 2007, J EXP PSYCHOL HUMAN, V33, P271, DOI 10.1037/0096-1523.33.2.271; Hunt AR, 2003, COGNITIVE BRAIN RES, V18, P102, DOI 10.1016/j.cogbrainres.2003.08.006; *IFSCN, 1974, ELECTROENCEPHALOGR C, V37, P538; Irwin DE, 2000, VISION RES, V40, P1443, DOI 10.1016/S0042-6989(00)00030-4; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kleiser R, 2004, CURR BIOL, V14, P386, DOI 10.1016/j.cub.2004.02.036; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; MANGUN GRR, 1987, HUM FACTORS, V29, P195, DOI 10.1177/001872088702900207; Mazaheri A, 2005, COGNITIVE BRAIN RES, V24, P81, DOI 10.1016/j.cogbrainres.2004.12.013; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Mazaheri A, 2009, HUM BRAIN MAPP, V30, P1791, DOI 10.1002/hbm.20763; Medendorp WP, 2007, CEREB CORTEX, V17, P2364, DOI 10.1093/cercor/bhl145; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Muggleton NG, 2003, J NEUROPHYSIOL, V89, P3340, DOI 10.1152/jn.01086.2002; Mulckhuyse M, 2008, EXP BRAIN RES, V186, P225, DOI 10.1007/s00221-007-1226-3; Neggers SFW, 2007, J NEUROPHYSIOL, V98, P2765, DOI 10.1152/jn.00357.2007; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osipova D, 2006, J NEUROSCI, V26, P7523, DOI 10.1523/JNEUROSCI.1948-06.2006; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; ROMEI V, 2007, CEREB CORTEX; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Theeuwes J, 1998, J EXP PSYCHOL HUMAN, V24, P1476, DOI 10.1037/0096-1523.24.5.1476; Thut G, 2003, NEUROIMAGE, V18, P334, DOI 10.1016/S1053-8119(02)00048-4; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Yordanova JY, 1998, EVOKED POTENTIAL, V108, P497, DOI 10.1016/S0168-5597(98)00028-8; Zhang Y, 2008, J COGNITIVE NEUROSCI, V20, P1915, DOI 10.1162/jocn.2008.20132	59	44	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e16243	10.1371/journal.pone.0016243	http://dx.doi.org/10.1371/journal.pone.0016243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	729EM	21386896	gold, Green Published			2022-12-27	WOS:000287931400006
J	Zhu, WL; Yang, L; Shan, HL; Zhang, Y; Zhou, R; Su, Z; Du, ZM				Zhu, Wenliang; Yang, Lei; Shan, Hongli; Zhang, Yong; Zhou, Rui; Su, Zhe; Du, Zhimin			MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction	PLOS ONE			English	Article							HEART-DISEASE; MORTALITY; PROTEIN; METOPROLOL	Background: As playing important roles in gene regulation, microRNAs (miRNAs) are believed as indispensable involvers in the pathogenesis of myocardial infarction (MI) that causes significant morbidity and mortality. Working on a hypothesis that modulation of only some key members in the miRNA superfamily could benefit ischemic heart, we proposed a microarray based network biology approach to identify them with the recognized clinical effect of propranolol as a prompt. Methods: A long-term MI model of rat was established in this study. The microarray technology was applied to determine the global miRNA expression change intervened by propranolol. Multiple network analyses were sequentially applied to evaluate the regulatory capacity, efficiency and emphasis of the miRNAs which dysexpression in MI were significantly reversed by propranolol. Results: Microarray data analysis indicated that long-term propranolol administration caused 18 of the 31 dysregulated miRNAs in MI undergoing reversed expression, implying that intentional modulation of miRNA expression might show favorable effects for ischemic heart. Our network analysis identified that, among these miRNAs, the prime players in MI were miR-1, miR-29b and miR-98. Further finding revealed that miR-1 focused on regulation of myocyte growth, yet miR-29b and miR-98 stressed on fibrosis and inflammation, respectively. Conclusion: Our study illustrates how a combination of microarray technology and functional protein network analysis can be used to identify disease-related key miRNAs.	[Zhu, Wenliang; Zhou, Rui; Su, Zhe; Du, Zhimin] Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China; [Yang, Lei] Harbin Med Univ, Affiliated Hosp 1, Harbin, Peoples R China; [Shan, Hongli; Zhang, Yong] Harbin Med Univ, Dept Pharmacol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Du, ZM (corresponding author), Harbin Med Univ, Affiliated Hosp 2, Inst Clin Pharmacol, Harbin, Peoples R China.	dzm1956@126.com			National Natural Science Foundation of China [30873065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (30873065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Asli NS, 2008, CURR MOL MED, V8, P698, DOI 10.2174/156652408786733739; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; da Silva R, 2004, PHYSIOL GENOMICS, V20, P117, DOI 10.1152/physiolgenomics.00166.2004; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; HJALMARSON A, 1983, CIRCULATION, V67, P26; Hu GK, 2009, J IMMUNOL, V183, P1617, DOI 10.4049/jimmunol.0804362; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Larsen JA, 2000, DRUG AGING, V16, P341, DOI 10.2165/00002512-200016050-00004; Li F, 2010, BIOINFORMATICS, V26, P275, DOI 10.1093/bioinformatics/btp634; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lu YJ, 2009, CARDIOVASC RES, V84, P434, DOI 10.1093/cvr/cvp232; Maraziotis IA, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-93; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MICHAEL VGL, 2009, NAT REV CARDIOL, V6, P419; Naeem Haroon, 2010, BMC Bioinformatics, V11, P135, DOI 10.1186/1471-2105-11-135; OLSSON G, 1985, J AM COLL CARDIOL, V5, P1428, DOI 10.1016/S0735-1097(85)80360-0; Pan ZW, 2010, ACTA PHARMACOL SIN, V31, P1, DOI 10.1038/aps.2009.175; PARAS KM, 2009, J CELL MOL MED, V13, P778; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Sam GJ, 2008, NUCLEIC ACIDS RES, V36, P154; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; van Rooij E, 2008, CIRC RES, V103, P919, DOI 10.1161/CIRCRESAHA.108.183426; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Waldo AL, 1996, LANCET, V348, P7, DOI 10.1016/S0140-6736(96)02149-6; Yang BF, 2008, CARDIOVASC RES, V79, P571, DOI 10.1093/cvr/cvn181; Yu W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-528	33	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2011	6	2							e14736	10.1371/journal.pone.0014736	http://dx.doi.org/10.1371/journal.pone.0014736			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729EM	21386882	Green Submitted, Green Published, gold			2022-12-27	WOS:000287931400001
J	Caporaso, JG; Knight, R; Kelley, ST				Caporaso, J. Gregory; Knight, Rob; Kelley, Scott T.			Host-Associated and Free-Living Phage Communities Differ Profoundly in Phylogenetic Composition	PLOS ONE			English	Article								Phylogenetic profiling has been widely used for comparing bacterial communities, but has so far been impossible to apply to viruses because of the lack of a single marker gene analogous to 16S rRNA. Here we developed a reference tree approach for matching viral sequences and applied it to the largest viral datasets available. The resulting technique, Shotgun UniFrac, was used to compare host-associated and non-host-associated phage communities (130 total metagenomes), and revealed a profound split similar to that found with bacterial communities. This new informatics approach complements analysis of bacterial communities and promises to provide new insights into viral community dynamics, such as top-down versus bottom-up control of bacterial communities by viruses in a range of systems.	[Caporaso, J. Gregory; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Kelley, Scott T.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; California State University System; San Diego State University	Caporaso, JG (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	gregcaporaso@gmail.com	Knight, Rob/D-1299-2010	Caporaso, Greg/0000-0002-8865-1670; Knight, Rob/0000-0002-0975-9019	Crohn's and Colitis Foundation of America; National Institutes of Health [HG004872]; Bill and Melinda Gates Foundation; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004872] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded with grants from Crohn's and Colitis Foundation of America (http://www.ccfa.org), National Institutes of Health grant number HG004872 (http://www.nih.gov/), the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/), and the Howard Hughes Medical Institute ( http://www.hhmi.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2010, ENVIRON MICROBIOL, V12, P642, DOI 10.1111/j.1462-2920.2009.02104.x; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; GOWER JC, 1975, PSYCHOMETRIKA, V40, P33, DOI 10.1007/BF02291478; Hamady M, 2009, ISME J; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Sandaa RA, 2009, ENVIRON MICROBIOL, V11, P2585, DOI 10.1111/j.1462-2920.2009.01983.x; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540	16	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e16900	10.1371/journal.pone.0016900	http://dx.doi.org/10.1371/journal.pone.0016900			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21383980	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700016
J	Lagging, M; Askarieh, G; Negro, F; Bibert, S; Soderholm, J; Westin, J; Lindh, M; Romero, A; Missale, G; Ferrari, C; Neumann, AU; Pawlotsky, JM; Haagmans, BL; Zeuzem, S; Bochud, PY; Hellstrand, K				Lagging, Martin; Askarieh, Galia; Negro, Francesco; Bibert, Stephanie; Soderholm, Jonas; Westin, Johan; Lindh, Magnus; Romero, Ana; Missale, Gabriele; Ferrari, Carlo; Neumann, Avidan U.; Pawlotsky, Jean-Michel; Haagmans, Bart L.; Zeuzem, Stefan; Bochud, Pierre-Yves; Hellstrand, Kristoffer		DITTO-HCV Study Grp	Response Prediction in Chronic Hepatitis C by Assessment of IP-10 and IL28B-Related Single Nucleotide Polymorphisms	PLOS ONE			English	Article							GENETIC-VARIATION; VIRUS-INFECTION; PEGINTERFERON ALPHA-2A; PLUS RIBAVIRIN; VIRAL RESPONSE; THERAPY; IL28B; ASSOCIATION; PROTEIN-10	Background: High baseline levels of IP-10 predict a slower first phase decline in HCV RNA and a poor outcome following interferon/ribavirin therapy in patients with chronic hepatitis C. Several recent studies report that single nucleotide polymorphisms (SNPs) adjacent to IL28B predict spontaneous resolution of HCV infection and outcome of treatment among HCV genotype 1 infected patients. Methods and Findings: In the present study, we correlated the occurrence of variants at three such SNPs (rs12979860, rs12980275, and rs8099917) with pretreatment plasma IP-10 and HCV RNA throughout therapy within a phase III treatment trial (HCV-DITTO) involving 253 Caucasian patients. The favorable SNP variants (CC, AA, and TT, respectively) were associated with lower baseline IP-10 (P = 0.02, P = 0.01, P = 0.04) and were less common among HCV genotype 1 infected patients than genotype 2/3 (P<0.0001, P<0.0001, and P = 0.01). Patients carrying favorable SNP genotypes had higher baseline viral load than those carrying unfavorable variants (P = 0.0013, P = 0.029, P = 0.0004 respectively). Among HCV genotype 1 infected carriers of the favorable C, A, or T alleles, IP-10 below 150 pg/mL significantly predicted a more pronounced reduction of HCV RNA from day 0 to 4 (first phase decline), which translated into increased rates of RVR (62%, 53%, and 39%) and SVR (85%, 76%, and 75% respectively) among homozygous carriers with baseline IP-10 below 150 pg/mL. In multivariate analyses of genotype 1-infected patients, baseline IP-10 and C genotype at rs12979860 independently predicted the first phase viral decline and RVR, which in turn independently predicted SVR. Conclusions: Concomitant assessment of pretreatment IP-10 and IL28B-related SNPs augments the prediction of the first phase decline in HCV RNA, RVR, and final therapeutic outcome.	[Lagging, Martin; Askarieh, Galia; Soderholm, Jonas; Westin, Johan; Lindh, Magnus; Romero, Ana; Hellstrand, Kristoffer] Univ Gothenburg, Dept Infect Dis Virol, Gothenburg, Sweden; [Negro, Francesco] Univ Hosp Geneva, Geneva, Switzerland; [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Bibert, Stephanie; Bochud, Pierre-Yves] Univ Lausanne, Lausanne, Switzerland; [Missale, Gabriele; Ferrari, Carlo] Azienda Ospedal Parma, Parma, Italy; [Neumann, Avidan U.] Bar Ilan Univ, Ramat Gan, Israel; [Pawlotsky, Jean-Michel] Univ Paris 12, Hop Henri Mondor, F-94010 Creteil, France; [Haagmans, Bart L.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [Zeuzem, Stefan] JW Goethe Univ Hosp, Dept Med 1, Frankfurt, Germany	University of Gothenburg; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Parma; University Hospital of Parma; Bar Ilan University; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Erasmus University Rotterdam; Erasmus MC; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Lagging, M (corresponding author), Univ Gothenburg, Dept Infect Dis Virol, Gothenburg, Sweden.	martin.lagging@medfak.gu.se	Zeuzem, Stefan/AAE-7435-2019; Missale, Gabriele/J-6083-2016; Negro, Francesco/E-2183-2012; Pawlotsky, Jean-Michel/R-8159-2018; Bochud, Pierre-Yves/ABE-5979-2020; Ferrari, Carlo/D-5663-2017; Lagging, Martin/D-7734-2015; Söderholm, Jonas/U-2091-2019; Haagmans, Bart/E-9791-2015	Missale, Gabriele/0000-0001-6691-8701; Ferrari, Carlo/0000-0002-5461-6842; Lagging, Martin/0000-0002-7995-3626; Söderholm, Jonas/0000-0002-7810-3005; Haagmans, Bart/0000-0001-6221-2015; Bochud, Pierre-Yves/0000-0002-2208-4757; Bibert, Stephanie/0000-0001-5170-7506; Hellstrand, Kristoffer/0000-0002-6617-5976; Ferrari, Carlo/0000-0002-7843-4963; Pawlotsky, Jean-Michel/0000-0003-0745-7559	European Community [QLK2-2000-00836]; Swedish Society Against Cancer (Cancerfonden); Sahlgren's University Hospital; Swedish Society of Medicine; Swedish Research Council; Torsten and Ragnar Soderberg Foundation; Capio Research Foundation; ALF Funds; Swedish Foundation for Strategic Research; VIRGO consortium [BSIK 03012]; Leenaards Foundation; Hoffmann La Roche; Epicept Corporation; Swiss National Science Foundation	European Community(European Commission); Swedish Society Against Cancer (Cancerfonden)(Swedish Cancer Society); Sahlgren's University Hospital; Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten and Ragnar Soderberg Foundation; Capio Research Foundation; ALF Funds; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VIRGO consortium; Leenaards Foundation; Hoffmann La Roche(Hoffmann-La Roche); Epicept Corporation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the European Community (QLK2-2000-00836), the Swedish Society Against Cancer (Cancerfonden), the Sahlgren's University Hospital, the Swedish Society of Medicine, the Swedish Research Council, the Torsten and Ragnar Soderberg Foundation, the Capio Research Foundation, ALF Funds, the Swedish Foundation for Strategic Research, the VIRGO consortium (BSIK 03012), the Leenaards Foundation, Hoffmann La Roche, the Epicept Corporation, and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Montes-Cano MA, 2010, HEPATOLOGY, V52, P33, DOI 10.1002/hep.23624; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI 10.1002/hep.23509; FARCI P, 1992, SCIENCE, V258, P135, DOI 10.1126/science.1279801; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hepatitis C-globalprevalence(update), 1999, WKLY EPIDEMIOL REC, V74, P425; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Lagging M, 2008, HEPATOLOGY, V47, P1837, DOI 10.1002/hep.22253; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lagging M, 2009, SCAND J INFECT DIS, V41, P389, DOI 10.1080/00365540902998271; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Mangia A, 2010, GASTROENTEROLOGY, V139, P821, DOI 10.1053/j.gastro.2010.05.079; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McCarthy JJ, 2010, GASTROENTEROLOGY, V138, P2307, DOI 10.1053/j.gastro.2010.02.009; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; TAUB DD, 1995, J IMMUNOL, V155, P3877; TAUB DD, 1993, J EXP MED, V177, P1809, DOI 10.1084/jem.177.6.1809; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Westin J, 2002, J HEPATOL, V37, P837, DOI 10.1016/S0168-8278(02)00299-4; Zeuzem S, 2005, J HEPATOL, V43, P250, DOI 10.1016/j.jhep.2005.05.016	30	125	132	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2011	6	2							e17232	10.1371/journal.pone.0017232	http://dx.doi.org/10.1371/journal.pone.0017232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726XY	21390311	Green Published, Green Submitted, gold			2022-12-27	WOS:000287761700037
J	Range, F; Viranyi, Z				Range, Friederike; Viranyi, Zsofia			Development of Gaze Following Abilities in Wolves (Canis Lupus)	PLOS ONE			English	Article							PAN-TROGLODYTES; COMMON MARMOSETS; SPECIES FOLLOW; CORVUS-CORAX; CHIMPANZEES; DIRECTION; SENSITIVITY; EVOLUTION; ONTOGENY; HUMANS	The ability to coordinate with others' head and eye orientation to look in the same direction is considered a key step towards an understanding of others mental states like attention and intention. Here, we investigated the ontogeny and habituation patterns of gaze following into distant space and behind barriers in nine hand-raised wolves. We found that these wolves could use conspecific as well as human gaze cues even in the barrier task, which is thought to be more cognitively advanced than gazing into distant space. Moreover, while gaze following into distant space was already present at the age of 14 weeks and subjects did not habituate to repeated cues, gazing around a barrier developed considerably later and animals quickly habituated, supporting the hypothesis that different cognitive mechanisms may underlie the two gaze following modalities. More importantly, this study demonstrated that following another individuals' gaze around a barrier is not restricted to primates and corvids but is also present in canines, with remarkable between-group similarities in the ontogeny of this behaviour. This sheds new light on the evolutionary origins of and selective pressures on gaze following abilities as well as on the sensitivity of domestic dogs towards human communicative cues.	[Range, Friederike; Viranyi, Zsofia] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Range, Friederike; Viranyi, Zsofia] Wolf Sci Ctr, Ernstbrunn, Austria	University of Vienna	Range, F (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	friederike.range@univie.ac.at		Range, Friederike/0000-0003-3127-5536	FWF [P21244]; scientific society the Wolf Science Center; Austrian Science Fund (FWF) [P 21244] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); scientific society the Wolf Science Center; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research has been supported by the FWF (P21244), Royal Canin and the Game Park Ernstbrunn. FWF (http://www.fwf.ac.at/index.asp), Royal Canin (http://www.royal-canin.at/). Moreover, as a scientific society the Wolf Science Center is largely funded through private, anonymous donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici F, 2009, J COMP PSYCHOL, V123, P368, DOI 10.1037/a0017079; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Brooks R, 2002, DEV PSYCHOL, V38, P958, DOI 10.1037//0012-1649.38.6.958; Bugnyar T, 2004, P ROY SOC B-BIOL SCI, V271, P1331, DOI 10.1098/rspb.2004.2738; BURGER J, 1992, J COMP PSYCHOL, V106, P97; Burkart J, 2006, J COMP PSYCHOL, V120, P120, DOI 10.1037/0735-7036.120.2.120; Burkart JM, 2007, ANIM BEHAV, V73, P457, DOI 10.1016/j.anbehav.2006.05.019; BUTTERWORTH G., 1991, NATURAL THEORIES MIN, P223; Call J, 2000, ANIM COGN, V3, P23, DOI 10.1007/s100710050047; Call Josep., 2005, JOINT ATTENTION COMM, P45, DOI [10.1093/acprof:oso/9780199245635.003.0003, DOI 10.1093/ACPROF:OSO/9780199245635.003.0003]; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Fitch WT, 2010, NEURON, V65, P795, DOI 10.1016/j.neuron.2010.03.011; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gomez JC, 2005, TRENDS COGN SCI, V9, P118, DOI 10.1016/j.tics.2005.01.004; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Hare B, 2005, TRENDS COGN SCI, V9, P464, DOI 10.1016/j.tics.2005.08.010; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Loretto MC, 2010, BIOL LETTERS, V6, P14, DOI 10.1098/rsbl.2009.0510; Mech L. David, 1970, WOLF ECOLOGY BEHAV E; MikluEsi A., 2000, ANIM COGN, V3, P159, DOI [DOI 10.1007/S100710000072, 10.1007/s100710000072]; Okamoto S, 2002, ANIM COGN, V5, P107, DOI 10.1007/s10071-002-0133-z; Povinelli DJ, 1997, BRIT J DEV PSYCHOL, V15, P213, DOI 10.1111/j.2044-835X.1997.tb00735.x; Povinelli DJ, 1996, J COMP PSYCHOL, V110, P336, DOI 10.1037/0735-7036.110.4.336; Russell CL, 1997, J COMP PSYCHOL, V111, P185, DOI 10.1037/0735-7036.111.2.185; Schloegl C., 2008, ANIMAL BEHAV NEW RES, P73; Schloegl C, 2007, ANIM BEHAV, V74, P769, DOI 10.1016/j.anbehav.2006.08.017; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Tomasello M, 1999, ANIM BEHAV, V58, P769, DOI 10.1006/anbe.1999.1192; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Tomasello M, 2001, ANIM BEHAV, V61, P335, DOI 10.1006/anbe.2000.1598; Triesch J, 2006, DEVELOPMENTAL SCI, V9, P125, DOI 10.1111/j.1467-7687.2006.00470.x; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Wilkinson A, 2010, ANIM COGN, V13, P765, DOI 10.1007/s10071-010-0320-2	36	62	63	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16888	10.1371/journal.pone.0016888	http://dx.doi.org/10.1371/journal.pone.0016888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373192	Green Published, gold			2022-12-27	WOS:000287657500022
J	Schouten, B; Troje, NF; Vroomen, J; Verfaillie, K				Schouten, Ben; Troje, Nikolaus F.; Vroomen, Jean; Verfaillie, Karl			The Effect of Looming and Receding Sounds on the Perceived In-Depth Orientation of Depth-Ambiguous Biological Motion Figures	PLOS ONE			English	Article							PERCEPTION; INTEGRATION; POINT; GENDER; INFORMATION; JUDGMENTS; NEURONS; SIGHT; BIAS	Background: The focus in the research on biological motion perception traditionally has been restricted to the visual modality. Recent neurophysiological and behavioural evidence, however, supports the idea that actions are not represented merely visually but rather audiovisually. The goal of the present study was to test whether the perceived in-depth orientation of depth-ambiguous point-light walkers (plws) is affected by the presentation of looming or receding sounds synchronized with the footsteps. Methodology/Principal Findings: In Experiment 1 orthographic frontal/back projections of plws were presented either without sound or with sounds of which the intensity level was rising (looming), falling (receding) or stationary. Despite instructions to ignore the sounds and to only report the visually perceived in-depth orientation, plws accompanied with looming sounds were more often judged to be facing the viewer whereas plws paired with receding sounds were more often judged to be facing away from the viewer. To test whether the effects observed in Experiment 1 act at a perceptual level rather than at the decisional level, in Experiment 2 observers perceptually compared orthographic plws without sound or paired with either looming or receding sounds to plws without sound but with perspective cues making them objectively either facing towards or facing away from the viewer. Judging whether either an orthographic plw or a plw with looming (receding) perspective cues is visually most looming becomes harder (easier) when the orthographic plw is paired with looming sounds. Conclusions/Significance: The present results suggest that looming and receding sounds alter the judgements of the in-depth orientation of depth-ambiguous point-light walkers. While looming sounds are demonstrated to act at a perceptual level and make plws look more looming, it remains a challenge for future research to clarify at what level in the processing hierarchy receding sounds affect how observers judge the in-depth perception of plws.	[Schouten, Ben; Verfaillie, Karl] Katholieke Univ Leuven, Expt Psychol Lab, Dept Psychol, Louvain, Belgium; [Troje, Nikolaus F.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Troje, Nikolaus F.] Queens Univ, Sch Comp, Kingston, ON, Canada; [Vroomen, Jean] Tilburg Univ, Dept Psychol, NL-5000 LE Tilburg, Netherlands	KU Leuven; Queens University - Canada; Queens University - Canada; Tilburg University	Schouten, B (corresponding author), Katholieke Univ Leuven, Expt Psychol Lab, Dept Psychol, Louvain, Belgium.	Ben.Schouten@psy.kuleuven.be	Vroomen, Jean/K-1033-2013	Vroomen, Jean/0000-0001-5923-5988; Troje, Niko/0000-0002-1533-2847	Scientific Research Fund Flanders [FWO G.0621.07]	Scientific Research Fund Flanders	This research was supported by the Scientific Research Fund Flanders, FWO G.0621.07: audiovisual perception of biological motion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2009, NEUROPSYCHOLOGIA, V47, P2593, DOI 10.1016/j.neuropsychologia.2009.05.006; Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Arrighi R, 2009, J VISION, V9, DOI 10.1167/9.4.25; Barraclough NE, 2005, J COGNITIVE NEUROSCI, V17, P377, DOI 10.1162/0898929053279586; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Bidet-Caulet A, 2005, NEUROIMAGE, V28, P132, DOI 10.1016/j.neuroimage.2005.06.018; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Brooks A, 2007, NEUROPSYCHOLOGIA, V45, P523, DOI 10.1016/j.neuropsychologia.2005.12.012; Brooks A, 2008, CURR BIOL, V18, pR728, DOI 10.1016/j.cub.2008.06.054; Buccino G, 2004, BRAIN LANG, V89, P370, DOI 10.1016/S0093-934X(03)00356-0; Calvert G., 2004, HDB MULTISENSORY PRO; Calvert GA, 2001, NEUROIMAGE, V14, P427, DOI 10.1006/nimg.2001.0812; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Jackson S, 2010, J NEUROSCI, V30, P838, DOI 10.1523/JNEUROSCI.3116-09.2010; Jackson S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003982; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Kitagawa N, 2002, NATURE, V416, P172, DOI 10.1038/416172a; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Maier JX, 2007, J NEUROSCI, V27, P4093, DOI 10.1523/JNEUROSCI.0330-07.2007; Meyer GF, 2001, NEUROREPORT, V12, P2557, DOI 10.1097/00001756-200108080-00053; Neuhoff JG, 1998, NATURE, V395, P123, DOI 10.1038/25862; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Puce A, 2003, PHILOS T R SOC B, V358, P435, DOI 10.1098/rstb.2002.1221; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; ROSENBLUM LD, 1987, PERCEPTION, V16, P175, DOI 10.1068/p160175; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2008, PSYCHOL SCI, V19, P469, DOI 10.1111/j.1467-9280.2008.02111.x; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schouten B, 2011, ATTEN PERCEPT PSYCHO, V73, P130, DOI 10.3758/s13414-010-0018-1; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Schouten B, 2010, BEHAV RES METHODS, V42, P161, DOI 10.3758/BRM.42.1.161; Stekelenburg JJ, 2007, J COGNITIVE NEUROSCI, V19, P1964, DOI 10.1162/jocn.2007.19.12.1964; Thomas JP, 2010, J VISION, V10, DOI 10.1167/10.12.14; Troje N., 2008, UNDERSTANDING EVENTS, P308, DOI [10.1093/acprof:oso/9780195188370.003.0014, DOI 10.1093/ACPR0T0S0/9780195188370.003.0014]; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Tuomainen J, 2005, COGNITION, V96, pB13, DOI 10.1016/j.cognition.2004.10.004; van der Zwan R, 2009, EXP BRAIN RES, V198, P373, DOI 10.1007/s00221-009-1800-y; van Ee R, 2009, J NEUROSCI, V29, P11641, DOI 10.1523/JNEUROSCI.0873-09.2009; Vanrie J, 2004, PERCEPTION, V33, P547, DOI 10.1068/p5004; Vanrie J, 2008, VIS COGN, V16, P585, DOI 10.1080/13506280701269334; Vanrie J, 2006, PERCEPT PSYCHOPHYS, V68, P601, DOI 10.3758/BF03208762; Verfaillie K, 2000, BRAIN COGNITION, V44, P192, DOI 10.1006/brcg.2000.1228	46	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e14725	10.1371/journal.pone.0014725	http://dx.doi.org/10.1371/journal.pone.0014725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	725PJ	21373181	Green Published, Green Submitted, gold			2022-12-27	WOS:000287657500009
J	Takigawa, I; Tsuda, K; Mamitsuka, H				Takigawa, Ichigaku; Tsuda, Koji; Mamitsuka, Hiroshi			Mining Significant Substructure Pairs for Interpreting Polypharmacology in Drug-Target Network	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; SELECTIVITY	A current key feature in drug-target network is that drugs often bind to multiple targets, known as polypharmacology or drug promiscuity. Recent literature has indicated that relatively small fragments in both drugs and targets are crucial in forming polypharmacology. We hypothesize that principles behind polypharmacology are embedded in paired fragments in molecular graphs and amino acid sequences of drug-target interactions. We developed a fast, scalable algorithm for mining significantly co-occurring subgraph-subsequence pairs from drug-target interactions. A noteworthy feature of our approach is to capture significant paired patterns of subgraph-subsequence, while patterns of either drugs or targets only have been considered in the literature so far. Significant substructure pairs allow the grouping of drug-target interactions into clusters, covering approximately 75% of interactions containing approved drugs. These clusters were highly exclusive to each other, being statistically significant and logically implying that each cluster corresponds to a distinguished type of polypharmacology. These exclusive clusters cannot be easily obtained by using either drug or target information only but are naturally found by highlighting significant substructure pairs in drug-target interactions. These results confirm the effectiveness of our method for interpreting polypharmacology in drug-target network.	[Takigawa, Ichigaku; Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Tsuda, Koji] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo, Japan; [Takigawa, Ichigaku; Tsuda, Koji; Mamitsuka, Hiroshi] Japan Sci & Technol Agcy, Inst Bioinformat Res & Dev, Chiyoda Ku, Tokyo, Japan; [Tsuda, Koji] Japan Sci & Technol Agcy, ERATO Minato Project, Sapporo, Hokkaido, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Takigawa, I (corresponding author), Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan.	mami@kuicr.kyoto-u.ac.jp	Takigawa, Ichigaku/B-3823-2012; Mamitsuka, Hiroshi/R-1110-2016	Takigawa, Ichigaku/0000-0001-5633-995X; Mamitsuka, Hiroshi/0000-0002-6607-5617	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20700134, 21680025]; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work has been supported by Grant-in-Aid for Scientific Research 20700134 and 21680025 from Ministry of Education, Culture, Sports, Science and Technology (MEXT), and "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)'' by the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; Aronov AM, 2004, J MED CHEM, V47, P5616, DOI 10.1021/jm049793g; Batagelj V, 2004, MATH VIS, P77; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Han JW, 2007, DATA MIN KNOWL DISC, V15, P55, DOI 10.1007/s10618-006-0059-1; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Metz JT, 2010, CURR OPIN CHEM BIOL, V14, P498, DOI 10.1016/j.cbpa.2010.06.166; Morphy R, 2007, DRUG DISCOV TODAY, V12, P156, DOI 10.1016/j.drudis.2006.12.006; Murray CW, 2009, NAT CHEM, V1, P187, DOI [10.1038/NCHEM.217, 10.1038/nchem.217]; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	24	28	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2011	6	2							e16999	10.1371/journal.pone.0016999	http://dx.doi.org/10.1371/journal.pone.0016999			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PJ	21373195	Green Submitted, Green Published, gold			2022-12-27	WOS:000287657500026
J	Pietropaolo, S; Guilleminot, A; Martin, B; D'Amato, FR; Crusio, WE				Pietropaolo, Susanna; Guilleminot, Aurelie; Martin, Benoit; D'Amato, Francesca R.; Crusio, Wim E.			Genetic-Background Modulation of Core and Variable Autistic-Like Symptoms in Fmr1 Knock-Out Mice	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; ACOUSTIC STARTLE REFLEX; PERVASIVE DEVELOPMENTAL DISORDERS; MOUSE MODEL; PREPULSE INHIBITION; BEHAVIORAL-PHENOTYPE; AUDIOGENIC-SEIZURES; MENTAL-RETARDATION; SOCIAL-ISOLATION; YOUNG-CHILDREN	Background: No animal models of autism spectrum disorders (ASD) with good construct validity are currently available; using genetic models of pathologies characterized by ASD-like deficits, but with known causes, may be therefore a promising strategy. The Fmr1-KO mouse is an example of this approach, modeling Fragile X syndrome, a well-known genetic disorder presenting ASD symptoms. The Fmr1-KO is available on different genetic backgrounds (FVB versus C57BL/6), which may explain some of the conflicting results that have been obtained with these mutants up till now. Methods: Fmr1 KO and their wild-type littermates on both the FVB and C57BL/6 genetic backgrounds were examined on a battery of tests modeling the clinical symptoms of ASD, including the triad of core symptoms (alterations in social interaction and communication, presence of repetitive behaviors), as well as the secondary symptoms (disturbances in sensori-motor reactivity and in circadian patterns of activity, epileptic events). Results: Fmr1-KO mice displayed autistic-like core symptoms of altered social interaction and occurrence of repetitive behaviors with additional hyperactivity. The genetic background modulated the effects of the Fmr1 deletion and it appears that the C57BL/6 background may be more suitable for further research on core autistic-like symptoms. Conclusions: The Fmr1-mouse line does not recapitulate all of the main core and secondary ASD symptoms, but still can be useful to elucidate the neurobiological mechanisms underlying specific ASD-like endophenotypes.	[Pietropaolo, Susanna; Crusio, Wim E.] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France; [Pietropaolo, Susanna; Crusio, Wim E.] CNRS, UMR 5287, Talence, France; [Guilleminot, Aurelie; Martin, Benoit] INSERM, U642, Lab Traitement Signal & Image, Rennes, France; [Guilleminot, Aurelie; Martin, Benoit] Univ Rennes 1, LTSI, Rennes, France; [D'Amato, Francesca R.] Italian Natl Res Council CNR, Inst Neurosci, Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Pietropaolo, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Talence, France.	wim_crusio@yahoo.com	Crusio, Wim/A-7070-2008; Crusio, Wim/ABD-5214-2021; Crusio, Wim/ABE-1287-2021	Crusio, Wim/0000-0001-6638-202X; Crusio, Wim/0000-0001-6638-202X; pietropaolo, susanna/0000-0002-8993-1922; D'Amato, Francesca/0000-0002-4577-4574	March of Dimes [12-FY05-1198]; Conseil Regional d'Aquitaine, CNRS; University of Bordeaux 1; INSERM; University of Rennes 1; CNRS-CNR [23779]	March of Dimes(March of Dimes); Conseil Regional d'Aquitaine, CNRS; University of Bordeaux 1; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Rennes 1; CNRS-CNR(Consiglio Nazionale delle Ricerche (CNR)Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the March of Dimes (12-FY05-1198), Conseil Regional d'Aquitaine, CNRS, and the University of Bordeaux 1 to Wim E. Crusio. Aurelie Guilleminot and Benoit Martin were supported by grants from INSERM and the University of Rennes 1. Susanna Pietropaolo, Francesca D'Amato, and Wim E. Crusio were supported by the bilateral grant CNRS-CNR 2010 (#23779). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STATMAN MENT D; Bailey DB, 1998, J AUTISM DEV DISORD, V28, P499; Bailey DB, 2001, J AUTISM DEV DISORD, V31, P165; BAKKER CE, 1994, CELL, V78, P23; Baranek GT, 2002, J AUTISM DEV DISORD, V32, P397, DOI 10.1023/A:1020541906063; Belzung C., 2005, DRUG DISC TODAY DIS, V2, P93, DOI DOI 10.1016/J.DDMOD.2005.05.004; Bernardet M, 2006, THESCIENTIFICWORLDJO, V6, P1164, DOI 10.1100/tsw.2006.220; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; Brock M., 2010, J INTELLECT DISABIL; Brodkin ES, 1997, J CHILD ADOL PSYCHOP, V7, P109, DOI 10.1089/cap.1997.7.109; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Crawley JN, 2007, BRAIN PATHOL, V17, P448, DOI 10.1111/j.1750-3639.2007.00096.x; Csomor PA, 2005, BEHAV BRAIN RES, V162, P256, DOI 10.1016/j.bbr.2005.03.020; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; DAmato FR, 1996, NEUROBIOL LEARN MEM, V65, P9, DOI 10.1006/nlme.1996.0002; de Vrij FMS, 2008, NEUROBIOL DIS, V31, P127, DOI 10.1016/j.nbd.2008.04.002; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Dobkin C, 2000, NEUROSCIENCE, V100, P423, DOI 10.1016/S0306-4522(00)00292-X; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Frankland PW, 2004, MOL PSYCHIATR, V9, P417, DOI 10.1038/sj.mp.4001432; GEYER M, 1998, CURRENT PROTOCOLS NE; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Happe F, 2006, NAT NEUROSCI, V9, P1218, DOI 10.1038/nn1770; Hatton DD, 2006, AM J MED GENET A, V140A, P1804, DOI 10.1002/ajmg.a.31286; Horrigan JP, 1997, J AUTISM DEV DISORD, V27, P313, DOI 10.1023/A:1025854532079; Hughes RN, 2004, NEUROSCI BIOBEHAV R, V28, P497, DOI 10.1016/j.neubiorev.2004.06.006; Ivanco TL, 2002, HIPPOCAMPUS, V12, P47, DOI 10.1002/hipo.10004; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; LIU ZH, INT J NEUROPSYCHOPHA, P1; Loesch DZ, 2007, NEUROSCI BIOBEHAV R, V31, P315, DOI 10.1016/j.neubiorev.2006.09.007; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; McNaughton CH, 2008, BEHAV NEUROSCI, V122, P293, DOI 10.1037/0735-7044.122.2.293; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Mineur YS, 2006, BEHAV BRAIN RES, V168, P172, DOI 10.1016/j.bbr.2005.11.004; Mineur YS, 2002, HIPPOCAMPUS, V12, P39, DOI 10.1002/hipo.10005; Moles A, 2000, ANIM BEHAV, V60, P689, DOI 10.1006/anbe.2000.1504; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muris P, 1998, J ANXIETY DISORD, V12, P387, DOI 10.1016/S0887-6185(98)00022-X; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; ORNITZ EM, 1993, J AUTISM DEV DISORD, V23, P619, DOI 10.1007/BF01046105; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Paradee W, 1999, NEUROSCIENCE, V94, P185, DOI 10.1016/S0306-4522(99)00285-7; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; Pietropaolo S, 2008, BEHAV NEUROSCI, V122, P505, DOI 10.1037/0735-7044.122.3.505; Pietropaolo S, 2008, PSYCHOPHARMACOLOGY, V197, P613, DOI 10.1007/s00213-008-1081-3; Pietropaolo S, 2009, BEHAV GENET, V39, P623, DOI 10.1007/s10519-009-9291-y; Polimeni MA, 2005, J INTELL DISABIL RES, V49, P260, DOI 10.1111/j.1365-2788.2005.00642.x; Qin M, 2005, NEUROSCIENCE, V135, P999, DOI 10.1016/j.neuroscience.2005.06.081; Qiu LF, 2009, CEREB CORTEX, V19, P1504, DOI 10.1093/cercor/bhn163; Radde R, 2008, EUR J NUCL MED MOL I, V35, pS70, DOI 10.1007/s00259-007-0704-y; Restivo L, 2005, P NATL ACAD SCI USA, V102, P11557, DOI 10.1073/pnas.0504984102; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Schreier HA, 1998, J CHILD ADOL PSYCHOP, V8, P49, DOI 10.1089/cap.1998.8.49; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spivak B, 2004, NEUROPSYCHOBIOLOGY, V50, P157, DOI 10.1159/000079108; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; Symons FJ, 2003, AM J MED GENET A, V118A, P115, DOI 10.1002/ajmg.a.10078; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Van Dam D, 2000, BEHAV BRAIN RES, V117, P127, DOI 10.1016/S0166-4328(00)00296-5; Ventura R, 2004, BEHAV PHARMACOL, V15, P433, DOI 10.1097/00008877-200409000-00018; VERGNES M, 1982, NEUROSCI LETT, V33, P97, DOI 10.1016/0304-3940(82)90136-7; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Williams PG, 2004, J SLEEP RES, V13, P265; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P240, DOI 10.1038/sj.npp.1300323; YUHAS J, 2010, J AUTISM DEV DISORD; Zhao MG, 2005, J NEUROSCI, V25, P7385, DOI 10.1523/JNEUROSCI.1520-05.2005; Zupan B, 2008, NEUROPSYCHOPHARMACOL, V33, P2667, DOI 10.1038/sj.npp.1301651	80	110	113	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e17073	10.1371/journal.pone.0017073	http://dx.doi.org/10.1371/journal.pone.0017073			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21364941	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600030
J	Ignjatovic, V; Lai, C; Summerhayes, R; Mathesius, U; Tawfilis, S; Perugini, MA; Monagle, P				Ignjatovic, Vera; Lai, Cera; Summerhayes, Robyn; Mathesius, Ulrike; Tawfilis, Sherif; Perugini, Matthew A.; Monagle, Paul			Age-Related Differences in Plasma Proteins: How Plasma Proteins Change from Neonates to Adults	PLOS ONE			English	Article							FIBRINOGEN; PROTEOMICS; EXPRESSION; BIOMARKERS; KININOGEN	The incidence of major diseases such as cardiovascular disease, thrombosis and cancer increases with age and is the major cause of mortality world-wide, with neonates and children somehow protected from such diseases of ageing. We hypothesized that there are major developmental differences in plasma proteins and that these contribute to age-related changes in the incidence of major diseases. We evaluated the human plasma proteome in healthy neonates, children and adults using the 2D-DIGE approach. We demonstrate significant changes in number and abundance of up to 100 protein spots that have marked differences in during the transition of the plasma proteome from neonate and child through to adult. These proteins are known to be involved in numerous physiological processes such as iron transport and homeostasis, immune response, haemostasis and apoptosis, amongst others. Importantly, we determined that the proteins that are differentially expressed with age are not the same proteins that are differentially expressed with gender and that the degree of phosphorylation of plasma proteins also changes with age. Given the multi-functionality of these proteins in human physiology, understanding the differences in the plasma proteome in neonates and children compared to adults will make a major contribution to our understanding of developmental biology in humans.	[Ignjatovic, Vera; Lai, Cera; Summerhayes, Robyn; Monagle, Paul] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Ignjatovic, Vera; Lai, Cera; Summerhayes, Robyn; Monagle, Paul] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Mathesius, Ulrike] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Tawfilis, Sherif] GE Healthcare Life Sci Australia, Bundoora, Vic, Australia; [Perugini, Matthew A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3052, Australia; [Monagle, Paul] Royal Childrens Hosp, Dept Clin Haematol, Parkville, Vic 3052, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Australian National University; University of Melbourne; Royal Children's Hospital Melbourne	Ignjatovic, V (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	verai@unimelb.edu.au	Ignjatovic, Vera/F-8598-2011; Mathesius, Ulrike/C-9767-2009	Ignjatovic, Vera/0000-0002-5548-5813; Mathesius, Ulrike/0000-0002-3557-0105; Perugini, Matthew/0000-0001-8052-5584; Monagle, Paul/0000-0002-3970-8984	GE Healthcare Life Sciences Australia; internal Haematology Research Team	GE Healthcare Life Sciences Australia(General Electric); internal Haematology Research Team	GE Healthcare Life Sciences Australia funded Sherif Tawfilis' time in the initial laboratory aspects of this project, some aspects of data analysis and preparation of the manuscript. This study was funded by internal Haematology Research Team funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1992, BLOOD, V80, P1998, DOI 10.1182/blood.V80.8.1998.1998; Birkenmeier G, 2003, EXP NEUROL, V184, P153, DOI 10.1016/S0014-4886(03)00110-9; Capitanio D, 2009, PROTEOMICS, V9, P2004, DOI 10.1002/pmic.200701162; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Huang SY, 2006, PROTEOMICS, V6, P2217, DOI 10.1002/pmic.200500410; Hurd S, 2000, CHEST, V117, P1; Ignjatovic V, 2010, J THROMB HAEMOST, V8, P1290, DOI 10.1111/j.1538-7836.2010.03847.x; Ishii T, 2000, EUR J CLIN INVEST, V30, P543; Jensen T, 2007, THROMB HAEMOSTASIS, V97, P822, DOI 10.1160/TH07-01-0039; Kakhniashvili DG, 2005, EXP BIOL MED, V230, P787, DOI 10.1177/153537020523001102; Kang UB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-114; LINDMARK BE, 1990, AM REV RESPIR DIS, V141, P884, DOI 10.1164/ajrccm/141.4_Pt_1.884; Liu T, 2006, MOL CELL PROTEOMICS, V5, P1899, DOI 10.1074/mcp.M600068-MCP200; Lull ME, 2006, ASAIO J, V52, P562, DOI 10.1097/01.mat.0000237694.53808.78; Merlo C, 2002, ATHEROSCLEROSIS, V161, P261, DOI 10.1016/S0021-9150(01)00666-9; Michiels JJ, 2006, CLIN APPL THROMB-HEM, V12, P397, DOI 10.1177/1076029606293422; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Omenn GS., 2006, EXPLORING HUMAN PLAS, P1; POLLER W, 1993, GENOMICS, V17, P740, DOI 10.1006/geno.1993.1396; Roxo-Rosa M, 2006, PROTEOMICS, V6, P2314, DOI 10.1002/pmic.200500273; Rubel C, 2002, J IMMUNOL, V168, P3527, DOI 10.4049/jimmunol.168.7.3527; Sagripanti A, 1998, EXP GERONTOL, V33, P891, DOI 10.1016/S0531-5565(98)00047-3; Santilli G, 2003, J BIOL CHEM, V278, P38214, DOI 10.1074/jbc.C300252200; SHARMA JN, 1976, AGENTS ACTIONS, V6, P148; Sitrin RG, 1998, J IMMUNOL, V161, P1462; Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887; Tissot Jean-Daniel, 1993, Applied and Theoretical Electrophoresis, V3, P183; WITT I, 1969, THROMB DIATH HAEMOST, V22, P101; Yocum AK, 2006, J PROTEOME RES, V5, P2743, DOI 10.1021/pr060235v	31	87	90	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 18	2011	6	2							e17213	10.1371/journal.pone.0017213	http://dx.doi.org/10.1371/journal.pone.0017213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723CC	21365000	gold, Green Published			2022-12-27	WOS:000287482800033
J	Ma, C; Yao, Y; Yue, QX; Zhou, XW; Yang, PY; Wu, WY; Guan, SH; Jiang, BH; Yang, M; Liu, XA; Guo, DA				Ma, Chao; Yao, Yan; Yue, Qing-Xi; Zhou, Xin-Wen; Yang, Peng-Yuan; Wu, Wan-Ying; Guan, Shu-Hong; Jiang, Bao-Hong; Yang, Min; Liu, Xuan; Guo, De-An			Differential Proteomic Analysis of Platelets Suggested Possible Signal Cascades Network in Platelets Treated with Salvianolic Acid B	PLOS ONE			English	Article							ALPHA-2-BETA-1 INTEGRIN; INTRACELLULAR CALCIUM; ACTIN CYTOSKELETON; AGGREGATION; MECHANISM; PROTEINS; ADHESION; DANSHEN; FLOW; MEGAKARYOCYTES	Background: Salvianolic acid B (SB) is an active component isolated from Danshen, a traditional Chinese medicine widely used for the treatment of cardiovascular disorders. Previous study suggested that SB might inhibit adhesion as well as aggregation of platelets by a mechanism involving the integrin alpha 2 beta 1. But, the signal cascades in platelets after SB binding are still not clear. Methodology/Principal Findings: In the present study, a differential proteomic analysis (two-dimensional electrophoresis) was conducted to check the protein expression profiles of rat platelets with or without treatment of SB. Proteins altered in level after SB exposure were identified by MALDI-TOF MS/MS. Treatment of SB caused regulation of 20 proteins such as heat shock-related 70 kDa protein 2 (hsp70), LIM domain protein CLP-36, copine I, peroxiredoxin-2, coronin-1 B and cytoplasmic dynein intermediate chain 2C. The regulation of SB on protein levels was confirmed by Western blotting. The signal cascades network induced by SB after its binding with integrin alpha 2 beta 1 was predicted. To certify the predicted network, binding affinity of SB to integrin alpha 2 beta 1 was checked in vitro and ex vivo in platelets. Furthermore, the effects of SB on protein levels of hsp70, coronin-1B and intracellular levels of Ca(2+) and reactive oxygen species (ROS) were checked with or without pre-treatment of platelets using antibody against integrin alpha 2 beta 1. Electron microscopy study confirmed that SB affected cytoskeleton structure of platelets. Conclusions/Significance: Integrin alpha 2 beta 1 might be one of the direct target proteins of SB in platelets. The signal cascades network of SB after binding with integrin alpha 2 beta 1 might include regulation of intracellular Ca(2+) level, cytoskeleton-related proteins such as coronin-1B and cytoskeleton structure of platelets.	[Ma, Chao; Yao, Yan; Yue, Qing-Xi; Wu, Wan-Ying; Guan, Shu-Hong; Jiang, Bao-Hong; Yang, Min; Liu, Xuan; Guo, De-An] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 200031, Peoples R China; [Zhou, Xin-Wen; Yang, Peng-Yuan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Fudan University	Ma, C (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Res Ctr Modernizat Tradit Chinese Med, Shanghai 200031, Peoples R China.	lillianliucn@yahoo.com.cn; daguo@mail.shcnc.ac.cn	ding, zuoqi/C-9271-2013; Liu, Xuan/AAR-5093-2020; zhou, ju/M-3255-2017	Liu, Xuan/0000-0002-7356-7898; Jiang, Baohong/0000-0002-8573-1536	Shanghai Key Laboratory of Complex Prescription (Shanghai University of Traditional Chinese Medicine) [09DZ2270900]; Chinese Academy of Sciences [KSCX2-YW-R-166]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2009ZX09308-005, 2009ZX09311-001, 2009ZX09102-122, 2009ZX09304-002]	Shanghai Key Laboratory of Complex Prescription (Shanghai University of Traditional Chinese Medicine); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China	This research was supported in part by the Opening Project of Shanghai Key Laboratory of Complex Prescription (Shanghai University of Traditional Chinese Medicine) (09DZ2270900), Major Projects of Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-166) and the National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China (2009ZX09308-005, 2009ZX09311-001, 2009ZX09102-122, 2009ZX09304-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bozulic LD, 2007, THROMB HAEMOSTASIS, V97, P587, DOI 10.1160/TH06-08-0438; Briddon SJ, 1999, BLOOD, V93, P3847, DOI 10.1182/blood.V93.11.3847.411k17_3847_3855; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cheng TO, 2006, J AM COLL CARDIOL, V47, P1498, DOI 10.1016/j.jacc.2006.01.001; Cheng TO, 2007, INT J CARDIOL, V121, P9, DOI 10.1016/j.ijcard.2007.01.004; Creutz CE, 1998, J BIOL CHEM, V273, P1393, DOI 10.1074/jbc.273.3.1393; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; HUANG Y S, 1992, Yaoxue Xuebao, V27, P96; Kim SD, 2008, EUR J PHARMACOL, V584, P361, DOI 10.1016/j.ejphar.2008.02.008; LEI XL, 1986, AM J CHINESE MED, V14, P26, DOI 10.1142/S0192415X86000053; Li M, 2004, CLIN HEMORHEOL MICRO, V31, P97; Liu AH, 2007, J CHROMATOGR B, V846, P32, DOI 10.1016/j.jchromb.2006.08.002; Lu ZF, 2010, BIOCHEM BIOPH RES CO, V394, P323, DOI 10.1016/j.bbrc.2010.02.178; Mazzucato M, 2009, BLOOD, V114, P2793, DOI 10.1182/blood-2008-12-193490; Peter K, 2010, BLOOD, V115, P4008, DOI 10.1182/blood-2010-02-270298; Pichard V, 2001, HISTOCHEM CELL BIOL, V116, P337, DOI 10.1007/s004180100324; Qureshi AH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007627; Sabri S, 2004, BLOOD, V104, P3117, DOI 10.1182/blood-2003-12-4398; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; Tomsig JL, 2003, J BIOL CHEM, V278, P10048, DOI 10.1074/jbc.M212632200; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Wu YP, 2008, THROMB RES, V123, P298, DOI 10.1016/j.thromres.2008.05.020; YANG J, 2004, CHIN J EXP TRADIT ME, V10, P21; Yao Y, 2008, AM J CHINESE MED, V36, P313, DOI 10.1142/S0192415X08005795; Yao Y, 2008, PHYTOCHEM LETT, V1, P135, DOI 10.1016/j.phytol.2008.07.003; Ye F, 2006, CHEMBIOCHEM, V7, P74, DOI 10.1002/cbic.200500186; Yue QX, 2008, MOL CELL PROTEOMICS, V7, P949, DOI 10.1074/mcp.M700259-MCP200; Zhao L, 2008, PLATELETS, V19, P24, DOI 10.1080/09537100701286123; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	32	38	49	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e14692	10.1371/journal.pone.0014692	http://dx.doi.org/10.1371/journal.pone.0014692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	723BX	21379382	Green Published, Green Submitted, gold			2022-12-27	WOS:000287482300004
J	Simoes, RD; Emmert-Streib, F				Simoes, Ricardo de Matos; Emmert-Streib, Frank			Influence of Statistical Estimators of Mutual Information and Data Heterogeneity on the Inference of Gene Regulatory Networks	PLOS ONE			English	Article							EXPRESSION DATA; ENTROPY ESTIMATION; NORMALIZATION	The inference of gene regulatory networks from gene expression data is a difficult problem because the performance of the inference algorithms depends on a multitude of different factors. In this paper we study two of these. First, we investigate the influence of discrete mutual information (MI) estimators on the global and local network inference performance of the C3NET algorithm. More precisely, we study 4 different MI estimators (Empirical, Miller-Madow, Shrink and Schurmann-Grassberger) in combination with 3 discretization methods (equal frequency, equal width and global equal width discretization). We observe the best global and local inference performance of C3NET for the Miller-Madow estimator with an equal width discretization. Second, our numerical analysis can be considered as a systems approach because we simulate gene expression data from an underlying gene regulatory network, instead of making a distributional assumption to sample thereof. We demonstrate that despite the popularity of the latter approach, which is the traditional way of studying MI estimators, this is in fact not supported by simulated and biological expression data because of their heterogeneity. Hence, our study provides guidance for an efficient design of a simulation study in the context of network inference, supporting a systems approach.	[Simoes, Ricardo de Matos; Emmert-Streib, Frank] Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Queens University Belfast	Simoes, RD (corresponding author), Queens Univ Belfast, Computat Biol & Machine Learning Lab, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	Engineering and Physical Sciences Research Council (EPSRC); EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work has been supported by the Engineering and Physical Sciences Research Council (EPSRC). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen K, 1955, AM DOCUMENTATION PRE, V6, P93, DOI [10.1002/, DOI 10.1002/ASI.5090060209]; Almudevar Anthony, 2006, NeuroRx, V3, P384, DOI 10.1016/j.nurx.2006.05.037; Alon U, 2007, INTRO SYSTEMS BIOL D; Altay G, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-31; Altay G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-132; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bulashevska S, 2005, BIOINFORMATICS, V21, P2706, DOI 10.1093/bioinformatics/bti388; Butte A J, 2000, Pac Symp Biocomput, P418; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dehmer M, APPL STAT NETWORK BI; Dudoit S, 2008, SPRINGER SER STAT, P1; Emmert-Streib F, 2010, IET SYST BIOL, V4, P277, DOI 10.1049/iet-syb.2010.0028; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; GILBERT EN, 1959, ANN MATH STAT, V30, P1141, DOI 10.1214/aoms/1177706098; Harrell, 2010, HMISC HARRELL MISCEL; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Husmeier D, 2003, BIOINFORMATICS, V19, P2271, DOI 10.1093/bioinformatics/btg313; Irizarry RA, 2006, BIOINFORMATICS, V22, P789, DOI 10.1093/bioinformatics/btk046; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; LI WT, 1990, J STAT PHYS, V60, P823, DOI 10.1007/BF01025996; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Liang S, 1998, Pac Symp Biocomput, P18; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Miller GA., 1955, INF THEORY PSYCHOL P, V2, P95; Nemenman I, 2002, ADV NEURAL INFORM PR, V14, P569; Olsen C, 2009, EURASIP J BIOINFORM, DOI 10.1155/2009/308959; Palsson B O, 2006, SYSTEMS BIOL; Paninski L, 2003, NEURAL COMPUT, V15, P1191, DOI 10.1162/089976603321780272; R Core Team, 2021, R LANGUAGE ENV STAT; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; Steinhoff C, 2006, BRIEF BIOINFORM, V7, P166, DOI 10.1093/bib/bbl002; Stolovitzky G, REVERSE ENG BIOL NET; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Stouffer S. A., 1949, AM SOLDIER, V1; Van den Bulcke T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-43; Verma T, 1990, P 4 WORKSH UNC ART I, P352; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Bertalanffy Ludwig, 1950, BRIT J PHILOS SCI, V1, P134, DOI [DOI 10.1093/BJPS/I.2.134, 10.1093/bjps/I.2.134]; VONBERTALANFFY L, 1950, SCIENCE, V111, P23, DOI 10.1126/science.111.2872.23; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; Xing B, 2005, BIOINFORMATICS, V21, P4007, DOI 10.1093/bioinformatics/bti648; Yang Y, 2001, P EMCL 01 P 12 EUR C	56	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2011	6	12							e29279	10.1371/journal.pone.0029279	http://dx.doi.org/10.1371/journal.pone.0029279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	897SP	22242113	Green Published, gold, Green Submitted			2022-12-27	WOS:000300677000024
J	Simoes, RR; Aires-de-Sousa, M; Conceicao, T; Antunes, F; da Costa, PM; de Lencastre, H				Simoes, Romeo Rocha; Aires-de-Sousa, Marta; Conceicao, Teresa; Antunes, Filipa; da Costa, Paulo Martins; de Lencastre, Herminia			High Prevalence of EMRSA-15 in Portuguese Public Buses: A Worrisome Finding	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PCR STRATEGY; COMMUNITY; STRAINS; CLONE; MRSA; TRANSPORT; INFECTIONS; EMERGENCE	Background: The nosocomial prevalence of methicillin resistant Staphylococcus aureus (MRSA) in Portugal remains one of highest in Europe and is currently around 50%. Transmission of S. aureus, including MRSA, occurs principally by direct human-to-human skin contact. However, S. aureus can survive for long periods on inanimate objects, which may represent an important reservoir for dissemination as well. Methodology/Principal Findings: Between May 2009 and February 2010, handrails of 85 public urban buses circulating in Oporto, Portugal, were screened for the occurrence of MRSA. Twenty-two (26%) buses showed MRSA contamination. The molecular characterization of a total of 55 MRSA, by pulsed-field gel electrophoresis (PFGE), staphylococcal cassette chromosome (SCC) mec typing, spa typing, and multilocus sequence typing (MLST), clustered the isolates into three clonal types. However, the overwhelming majority (n = 50; 91%) of the isolates belonged to a single clone (PFGE A, spa types t747, t032, t025 or t020, ST22, SCCmec type IVh) that exhibits the characteristics of the pandemic EMRSA-15, currently the major lineage circulating in Portuguese hospitals, namely in the Oporto region. Two additional clones were found but in much lower numbers: (i) PFGE B, ST5, spa type t002, SCCmec IVa (n = 3), and (ii) PFGE C, spa type t008, ST8, SCCmec IVa (n = 2). None of the 55 isolates was PVL positive. Conclusions/Significance: Public buses in Oporto seem to be an important reservoir of MRSA of nosocomial origin, providing evidence that the major hospital-associated MRSA clone in Portugal is escaping from the primary ecological niche of hospitals to the community environment. Infection control measures are urgently warranted to limit the spread of EMRSA-15 to the general population and future studies are required to assess the eventual increase of MRSA in the Portuguese community, which so far remains low.	[Simoes, Romeo Rocha; Conceicao, Teresa; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Simoes, Romeo Rocha; Antunes, Filipa; da Costa, Paulo Martins] Univ Porto, Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Aires-de-Sousa, Marta] Escola Super Saude Cruz Vermelha Portuguesa, Lisbon, Portugal; [da Costa, Paulo Martins] CIIMAR Ctr Interdisciplinar Invest Marinha & Ambi, Oporto, Portugal; [de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	Universidade Nova de Lisboa; Universidade do Porto; Universidade do Porto; Rockefeller University	Simoes, RR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal.	lencash@mail.rockefeller.edu	Conceição, Teresa/M-3449-2014; Emmert-Streib, Frank/AAF-2878-2020; da Costa, Paulo Martins/C-3080-2014; Emmert-Streib, Frank/G-8099-2011	Conceição, Teresa/0000-0002-9818-2767; Emmert-Streib, Frank/0000-0003-0745-5641; da Costa, Paulo Martins/0000-0001-6115-8811; Emmert-Streib, Frank/0000-0003-0745-5641; /0000-0001-6816-8932; de Matos Simoes, Ricardo/0000-0002-1700-5276; Antunes, Filipa/0000-0002-8472-078X; Aires-de-Sousa, Marta/0000-0001-5036-2446	European Community [TROCAR-HEALTH-F3-2008-223031, 095/BI-BI/2010]; EPSRC [EP/H048871/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H048871/1] Funding Source: researchfish	European Community(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was partially supported by Project TROCAR (TROCAR-HEALTH-F3-2008-223031) from the European Community to HL and by grant 095/BI-BI/2010 from the same Project to T. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Aires-De-Sousa M, 2007, APPL ENVIRON MICROB, V73, P3845, DOI 10.1128/AEM.00019-07; Allen KD, 1997, J HOSP INFECT, V35, P307, DOI 10.1016/S0195-6701(97)90225-5; Amorim ML, 2007, J CLIN MICROBIOL, V45, P2881, DOI 10.1128/JCM.00603-07; Bocher S, 2010, J ANTIMICROB CHEMOTH, V65, P717, DOI 10.1093/jac/dkq001; Cars O, 2001, LANCET, V357, P1851, DOI 10.1016/S0140-6736(00)04972-2; Chung M, 2000, MICROB DRUG RESIST, V6, P189, DOI 10.1089/mdr.2000.6.189; Clinical and Laboratory Standards Institute, 2018, METHODS DILUTION ANT, VEleventh; Conceicao T, 2011, EUR J CLIN MICROBIOL, V30, P293, DOI 10.1007/s10096-010-1087-8; Conceicao T, 2010, EUR J CLIN MICROBIOL, V29, P543, DOI 10.1007/s10096-010-0892-4; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Gonzalez BE, 2006, INFECT CONT HOSP EP, V27, P1051, DOI 10.1086/507923; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kassem II, 2009, LETT APPL MICROBIOL, V48, P268, DOI 10.1111/j.1472-765X.2008.02518.x; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Manning N, 2004, J HOSP INFECT, V56, P250, DOI 10.1016/j.jhin.2003.12.021; McAdams RM, 2008, PEDIATR INT, V50, P810, DOI 10.1111/j.1442-200X.2008.02646.x; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Mollaghan AM, 2010, EPIDEMIOL INFECT, V138, P673, DOI 10.1017/S0950268810000191; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neely AN, 2000, J CLIN MICROBIOL, V38, P724, DOI 10.1128/JCM.38.2.724-726.2000; O'Brien FG, 2004, J CLIN MICROBIOL, V42, P3185, DOI 10.1128/JCM.42.7.3185-3190.2004; Otter JA, 2009, LETT APPL MICROBIOL, V49, P803, DOI 10.1111/j.1472-765X.2009.02728.x; RAMALHINHO I, EVOLUCAO CONSUMO ANT; Roline CE, 2007, PREHOSP EMERG CARE, V11, P241, DOI 10.1080/10903120701205125; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sa-Leao R, 2001, MICROB DRUG RESIST, V7, P237, DOI 10.1089/10766290152652783; Sexton JD, 2010, AM J INFECT CONTROL, V38, P368, DOI 10.1016/j.ajic.2010.01.004; Stepanovic S, 2008, LETT APPL MICROBIOL, V47, P339, DOI 10.1111/j.1472-765X.2008.02436.x; Tavares DA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-110; Tolba O, 2007, AM J INFECT CONTROL, V35, P342, DOI 10.1016/j.ajic.2006.10.015; Udo EE, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-31	36	74	80	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e17630	10.1371/journal.pone.0017630	http://dx.doi.org/10.1371/journal.pone.0017630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	22242113	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300037
J	Zhou, XH; Wong, LL; Karakoti, AS; Seal, S; McGinnis, JF				Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.			Nanoceria Inhibit the Development and Promote the Regression of Pathologic Retinal Neovascularization in the Vldlr Knockout Mouse	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXIDATIVE STRESS; NADPH OXIDASE; SUBRETINAL NEOVASCULARIZATION; PHOTORECEPTOR DEGENERATION; PIGMENT EPITHELIUM; MODEL; MICE; PROTECTION; INJURY	Many neurodegenerative diseases are known to occur and progress because of oxidative stress, the presence of reactive oxygen species (ROS) in excess of the cellular defensive capabilities. Age related macular degeneration (AMD), diabetic retinopathy (DR) and inherited retinal degeneration share oxidative stress as a common node upstream of the blinding effects of these diseases. Knockout of the Vldlr gene results in a mouse that develops intraretinal and subretinal neovascular lesions within the first month of age and is an excellent model for a form of AMD called retinal angiomatous proliferation (RAP). Cerium oxide nanoparticles (nanoceria) catalytically scavenge ROS by mimicking the activities of superoxide dismutase and catalase. A single intravitreal injection of nanoceria into the Vldlr-/- eye was shown to inhibit: the rise in ROS in the Vldlr-/- retina, increases in vascular endothelial growth factor (VEGF) in the photoreceptor layer, and the formation of intraretinal and subretinal neovascular lesions. Of more therapeutic interest, injection of nanoceria into older mice (postnatal day 28) resulted in the regression of existing vascular lesions indicating that the pathologic neovessels require the continual production of excessive ROS. Our data demonstrate the unique ability of nanoceria to prevent downstream effects of oxidative stress in vivo and support their therapeutic potential for treatment of neurodegenerative diseases such as AMD and DR.	[Zhou, Xiaohong; Wong, Lily L.; Karakoti, Ajay S.; Seal, Sudipta; McGinnis, James F.] Univ Oklahoma, Coll Med, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK 73190 USA; [Karakoti, Ajay S.; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Mech Mat Aerosp Engn Nanosci & Technol Ctr, Orlando, FL 32816 USA; [McGinnis, James F.] Oklahoma Ctr Neurosci, Dept Ophthalmol & Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University System of Florida; University of Central Florida	Zhou, XH (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab, Boston, MA 02115 USA.	lily-wong@ouhsc.edu; james-mcginnis@ouhsc.edu	Karakoti, Ajay/AGI-8160-2022; Wong, Li Lian/AAG-5568-2020; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Seal, Sudipta/A-7698-2012; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; KARAKOTI, AJAY/0000-0001-9081-2325; Na-Nakorn, Uthairat/0000-0002-0804-3561; Wong, Lily/0000-0003-0569-3398	NIH [P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724]; FFB [C-NP-0707-0404-UOK08]; NSF [CBET-0708172]; OCAST [HR06-075]; Presbyterian Health Foundation; Research to Prevent Blindness; RPB; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018724, R21EY018306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FFB; NSF(National Science Foundation (NSF)); OCAST; Presbyterian Health Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); RPB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from: NIH: P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724; FFB (http://www.blindness.org/): C-NP-0707-0404-UOK08; NSF: CBET-0708172; OCAST(http://www.ok.gov/ocast/Programs/Oklahoma_Health_Research_(OHR)/index.html): HR06-075, and unrestricted funds from Presbyterian Health Foundation (http://www.phfokc.com/research.htm) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/) (RPB). JFM is a recipient of an RPB Senior Scientific Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L P, 1997, Curr Opin Ophthalmol, V8, P19; Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; Al-Shabrawey M, 2005, AM J PATHOL, V167, P599, DOI 10.1016/S0002-9440(10)63001-5; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3239, DOI 10.1167/iovs.08-1755; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burn DJ, 2006, CURR OPIN NEUROL, V19, P572, DOI 10.1097/01.wco.0000247607.34697.a2; Butler D, 2006, ANTIOXID REDOX SIGN, V8, P185, DOI 10.1089/ars.2006.8.185; Cao W, 2000, J NEUROSCI RES, V60, P195, DOI 10.1002/(SICI)1097-4547(20000415)60:2<195::AID-JNR8>3.0.CO;2-7; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Chu CT, 2004, EUR J BIOCHEM, V271, P2060, DOI 10.1111/j.1432-1033.2004.04132.x; Cingolani C, 2006, FREE RADICAL BIO MED, V40, P660, DOI 10.1016/j.freeradbiomed.2005.09.032; Dong A, 2006, J CELL PHYSIOL, V208, P516, DOI 10.1002/jcp.20683; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Dorrell MI, 2009, J CLIN INVEST, V119, P611, DOI 10.1172/JCI35977; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; FRIED R, 1975, J NEUROCHEM, V24, P433, DOI 10.1111/j.1471-4159.1975.tb07658.x; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Hardy J, 1998, SCIENCE, V282, P1075, DOI 10.1126/science.282.5391.1075; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heckenlively JR, 2003, RETINA-J RET VIT DIS, V23, P518, DOI 10.1097/00006982-200308000-00012; Hogg R, 2004, CURR EYE RES, V29, P387, DOI 10.1080/02713680490517890; Hollyfield JG, 2010, INVEST OPHTH VIS SCI, V51, P1276, DOI 10.1167/iovs.09-4478; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Kaluzny J J, 1996, Klin Oczna, V98, P145; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Korystov YN, 2007, RADIAT RES, V168, P226, DOI 10.1667/RR0925.1; Li C, 2007, ARCH OPHTHALMOL-CHIC, V125, P795, DOI 10.1001/archopht.125.6.795; Lodi F, 2006, EUR J PHARMACOL, V544, P97, DOI 10.1016/j.ejphar.2006.06.028; Madsen-Bouterse SA, 2010, ANTIOXID REDOX SIGN, V13, P797, DOI 10.1089/ars.2009.2932; Nishiyama A, 2001, IUBMB LIFE, V52, P29, DOI 10.1080/15216540252774739; OLIVEIRA CR, 1994, ANN NY ACAD SCI, V738, P130; Onyango Isaac G., 2006, Current Alzheimer Research, V3, P339, DOI 10.2174/156720506778249489; Platt DH, 2005, FREE RADICAL BIO MED, V39, P1353, DOI 10.1016/j.freeradbiomed.2005.06.015; Poon HF, 2004, J GERONTOL A-BIOL, V59, P478; Sacca SC, 2009, MUTAT RES-FUND MOL M, V667, P98, DOI 10.1016/j.mrfmmm.2008.11.002; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; STERNBERG P, 1993, INVEST OPHTH VIS SCI, V34, P3661; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tobe T, 1998, INVEST OPHTH VIS SCI, V39, P180; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; van Reyk DM, 2003, REDOX REP, V8, P187, DOI 10.1179/135100003225002673; Wu MY, 2008, INVEST OPHTH VIS SCI, V49, P2679, DOI 10.1167/iovs.07-1440; Yannuzzi LA, 2001, RETINA-J RET VIT DIS, V21, P416, DOI 10.1097/00006982-200110000-00003; Yu XR, 2004, J BIOL CHEM, V279, P13086, DOI 10.1074/jbc.M313283200; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zhou XH, 2007, DEV NEUROBIOL, V67, P603, DOI 10.1002/dneu.20373	50	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2011	6	2							e16733	10.1371/journal.pone.0016733	http://dx.doi.org/10.1371/journal.pone.0016733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725PA	21423623	Green Published, Green Submitted, gold			2022-12-27	WOS:000287656600014
J	Wong, LL; Peatman, E; Lu, JG; Kucuktas, H; He, SP; Zhou, CJ; Na-nakorn, U; Liu, ZJ				Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; He, Shunping; Zhou, Chuanjiang; Na-nakorn, Uthairat; Liu, Zhanjiang			DNA Barcoding of Catfish: Species Authentication and Phylogenetic Assessment	PLOS ONE			English	Article							SILURIFORMES; SEQUENCE; TUNA	As the global market for fisheries and aquaculture products expands, mislabeling of these products has become a growing concern in the food safety arena. Molecular species identification techniques hold the potential for rapid, accurate assessment of proper labeling. Here we developed and evaluated DNA barcodes for use in differentiating United States domestic and imported catfish species. First, we sequenced 651 base-pair barcodes from the cytochrome oxidase I (COI) gene from individuals of 9 species (and an Ictalurid hybrid) of domestic and imported catfish in accordance with standard DNA barcoding protocols. These included domestic Ictalurid catfish, and representative imported species from the families of Clariidae and Pangasiidae. Alignment of individual sequences from within a given species revealed highly consistent barcodes (98% similarity on average). These alignments allowed the development and analyses of consensus barcode sequences for each species and comparison with limited sequences in public databases (GenBank and Barcode of Life Data Systems). Validation tests carried out in blinded studies and with commercially purchased catfish samples (both frozen and fresh) revealed the reliability of DNA barcoding for differentiating between these catfish species. The developed protocols and consensus barcodes are valuable resources as increasing market and governmental scrutiny is placed on catfish and other fisheries and aquaculture products labeling in the United States.	[Wong, Li Lian; Peatman, Eric; Lu, Jianguo; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA; [He, Shunping; Zhou, Chuanjiang] Chinese Acad Sci, Inst Hydrobiol, Wuhan, Hubei, Peoples R China; [Zhou, Chuanjiang] Southwest Univ, Sch Life Sci, Chongqing, Peoples R China; [Na-nakorn, Uthairat] Kasetsart Univ, Fac Fisheries, Dept Aquaculture, Bangkok, Thailand	Auburn University System; Auburn University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Southwest University - China; Kasetsart University	Wong, LL (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Karakoti, Ajay/AGI-8160-2022; Wong, Li Lian/AAG-5568-2020; Nanozymes, Nanozymes/D-8197-2019; Karakoti, Ajay/AAY-5886-2020; Liu, Zhanjiang/R-9633-2019; Seal, Sudipta/A-7698-2012; Wong, Lily/D-7737-2011	Wong, Li Lian/0000-0001-9045-4556; KARAKOTI, AJAY/0000-0001-9081-2325; Na-Nakorn, Uthairat/0000-0002-0804-3561; Wong, Lily/0000-0003-0569-3398	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP) [2009-35205-05101]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY018724, R21EY018306] Funding Source: NIH RePORTER	USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP)(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding: This project was supported in part by a grant from USDA NRI Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award # 2009-35205-05101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BOONBRAHM M, 1977, EXPT HYBRIDIZATION F; Botti S, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-60; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; DAWNAY NR, 2007, VALIDATION IN PRESS; DONSAKUL T, 1989, P 27 KAS U C JAN 30, P421; Dugan KA, 2002, J FORENSIC SCI, V47, P811; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferraris Carl J. Jr., 1999, Proceedings of the California Academy of Sciences, V51, P1; *FISH BOL, 2010, FISH BARC LIF IN CAM; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; GARCIAFRANCO M, 1993, THESIS TOKYO U FISHE; HANSON T, CATFISH DATABASE USD; Hardman M, 2005, MOL PHYLOGENET EVOL, V37, P700, DOI 10.1016/j.ympev.2005.04.029; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jondeung A, 2007, GENE, V387, P49, DOI 10.1016/j.gene.2006.08.001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; LEGRANDE WH, 1981, COPEIA, P33; Liu Z, 1998, MOL GEN GENET, V258, P260, DOI 10.1007/s004380050730; Lowenstein JH, 2010, BIOL LETTERS, V6, P692, DOI 10.1098/rsbl.2010.0156; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Na-Nakorn U, 2002, J FISH BIOL, V60, P1051, DOI [10.1111/j.1095-8649.2002.tb02428.x, 10.1006/jfbi.2002.1906]; Nei M, 2000, MOL EVOLUTION PHYLOG; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; SMITH EG, 2002, CAMBODIAN J AGR; Steinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006300; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Teugels GG, 1999, CYBIUM, V23, P285; *USDA, 2002, CATF PROD; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005	35	163	173	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 15	2011	6	3							e17812	10.1371/journal.pone.0017812	http://dx.doi.org/10.1371/journal.pone.0017812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736SH	21423623	Green Submitted, Green Published, gold			2022-12-27	WOS:000288513900034
J	Li, J; Chen, CS; Chen, CH; He, QH; Li, H; Li, J; Moyzis, RK; Xue, G; Dong, Q				Li, Jin; Chen, Chuansheng; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Moyzis, Robert K.; Xue, Gui; Dong, Qi			Neurotensin Receptor 1 Gene (NTSR1) Polymorphism Is Associated with Working Memory	PLOS ONE			English	Article							PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; CORTICAL DOPAMINE; SCHIZOPHRENIA; LOCALIZATION; EXPRESSION; NEURONS; BRAIN; ENDOPHENOTYPE; STIMULATION	Background: Recent molecular genetics studies showed significant associations between dopamine-related genes (including genes for dopamine receptors, transporters, and degradation) and working memory, but little is known about the role of genes for dopamine modulation, such as those related to neurotensin (NT), in working memory. A recent animal study has suggested that NT antagonist administration impaired working memory in a learning task. The current study examined associations between NT genes and working memory among humans. Methods: Four hundred and sixty healthy undergraduate students were assessed with a 2-back working memory paradigm. 5 SNPs in the NTSR1 gene were genotyped. 5 ANOVA tests were conducted to examine whether and how working memory differed by NTSR1 genotype, with each SNP variant as the independent variable and the average accuracy on the working memory task as the dependent variable. Results: ANOVA results suggested that two SNPs in the NTSR1 gene (rs4334545 and rs6090453) were significantly associated with working memory. These results survived corrections for multiple comparisons. Conclusions: Our results demonstrated that NTSR1 SNP polymorphisms were significantly associated with variance in working memory performance among healthy adults. This result extended previous rodent studies showing that the NT deficiency impairs the working memory function. Future research should replicate our findings and extend to an examination of other dopamine modulators.	[Li, Jin; Chen, Chunhui; He, Qinghua; Li, He; Li, Jun; Xue, Gui; Dong, Qi] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jin; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [He, Qinghua; Xue, Gui] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Moyzis, Robert K.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Beijing Normal University; University of California System; University of California Irvine; University of Southern California; University of California System; University of California Irvine	Li, J (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	cschen@uci.edu; dongqi@bnu.edu.cn	Xue, Gui/A-1762-2009; He, Qinghua/B-2573-2008	Xue, Gui/0000-0001-7891-8151; He, Qinghua/0000-0001-6396-6273; li, jin/0000-0002-4413-5746; Chen, Chuansheng/0000-0002-8224-1005	Ministry of Education of China [B07008]	Ministry of Education of China(Ministry of Education, China)	This research was supported by the 111 Project from the Ministry of Education of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MJ, 1998, J COMP NEUROL, V402, P475; Ando J, 2001, BEHAV GENET, V31, P615, DOI 10.1023/A:1013353613591; Austin J, 2000, MOL PSYCHIATR, V5, P552, DOI 10.1038/sj.mp.4000761; Azmi N, 2006, BEHAV PHARMACOL, V17, P357, DOI 10.1097/01.fbp.0000224382.63744.20; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolino A, 2006, J NEUROSCI, V26, P3918, DOI 10.1523/JNEUROSCI.4975-05.2006; Binder EB, 2001, PHARMACOL REV, V53, P453; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Boudin H, 1996, J COMP NEUROL, V373, P76; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Fatigati MD, 2000, BRAIN RES, V876, P196, DOI 10.1016/S0006-8993(00)02654-8; Froehlich TE, 2007, BIOL PSYCHIAT, V62, P243, DOI 10.1016/j.biopsych.2006.09.039; Glahn DC, 2003, BIOL PSYCHIAT, V53, P624, DOI 10.1016/S0006-3223(02)01641-4; Hamid EH, 2002, BIOL PSYCHIAT, V51, P795, DOI 10.1016/S0006-3223(01)01325-7; HETIER E, 1988, N-S ARCH PHARMACOL, V337, P13; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huezo-Diaz P, 2004, SCHIZOPHR RES, V66, P193, DOI 10.1016/S0920-9964(03)00128-2; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Kimberg DY, 2003, NEUROPSYCHOLOGIA, V41, P1020, DOI 10.1016/S0028-3932(02)00317-2; Kondo H, 2004, NEUROIMAGE, V23, P670, DOI 10.1016/j.neuroimage.2004.06.014; Kremen WS, 2007, NEUROPSYCHOLOGY, V21, P569, DOI 10.1037/0894-4105.21.5.569; LAMBERT PD, 1995, ANN NY ACAD SCI, V757, P377, DOI 10.1111/j.1749-6632.1995.tb17496.x; LAURENT P, 1994, MAMM GENOME, V5, P303, DOI 10.1007/BF00389545; Le F, 1997, J BIOL CHEM, V272, P1315, DOI 10.1074/jbc.272.2.1315; Lee YS, 1999, SCHIZOPHR RES, V36, P92; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; MAI JK, 1987, NEUROSCIENCE, V22, P499, DOI 10.1016/0306-4522(87)90349-6; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; McNab F, 2009, SCIENCE, V323, P800, DOI 10.1126/science.1166102; Mizumoto Y, 1997, MOL CELL ENDOCRINOL, V135, P129, DOI 10.1016/S0303-7207(97)00195-0; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Ohinata K, 2007, PEPTIDES, V28, P1470, DOI 10.1016/j.peptides.2007.06.002; Petkova-Kirova P, 2008, NEUROCHEM INT, V53, P355, DOI 10.1016/j.neuint.2008.08.010; Prus AJ, 2007, BRAIN RES, V1184, P354, DOI 10.1016/j.brainres.2007.09.092; QUIRION R, 1983, PEPTIDES, V4, P609, DOI 10.1016/0196-9781(83)90005-0; QUIRION R, 1985, BRAIN RES, V327, P385, DOI 10.1016/0006-8993(85)91542-2; ROMPRE PP, 1992, EUR J PHARMACOL, V211, P295, DOI 10.1016/0014-2999(92)90384-G; Saperstein AM, 2006, SCHIZOPHRENIA BULL, V32, P498, DOI 10.1093/schbul/sbj072; SEROOGY KB, 1987, EXP BRAIN RES, V68, P277; SEUTIN V, 1989, NEUROPHARMACOLOGY, V28, P949, DOI 10.1016/0028-3908(89)90194-9; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; STUDLER JM, 1988, NEUROPEPTIDES, V11, P95, DOI 10.1016/0143-4179(88)90076-5; Tirado-Santiago G, 2006, BEHAV NEUROSCI, V120, P1093, DOI 10.1037/0735-7044.120.5.1093; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wright M, 2001, Twin Res, V4, P48, DOI 10.1375/1369052012146; Xue G, 2004, NEUROIMAGE, V22, P1, DOI 10.1016/j.neuroimage.2004.01.013; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P20552, DOI 10.1073/pnas.0707106104; Zhu B, 2010, MEMORY, V18, P543, DOI 10.1080/09658211.2010.487051	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2011	6	3							e17365	10.1371/journal.pone.0017365	http://dx.doi.org/10.1371/journal.pone.0017365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	730HX	21738684	Green Published, gold			2022-12-27	WOS:000288025500012
J	Campbell, MS; Mullins, JI; Hughes, JP; Celum, C; Wong, KG; Raugi, DN; Sorensen, S; Stoddard, JN; Zhao, H; Deng, WJ; Kahle, E; Panteleeff, D; Baeten, JM; McCutchan, FE; Albert, J; Leitner, T; Wald, A; Corey, L; Lingappa, JR				Campbell, Mary S.; Mullins, James I.; Hughes, James P.; Celum, Connie; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; McCutchan, Francine E.; Albert, Jan; Leitner, Thomas; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.		Partners Prevention HSV HIV	Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HETEROSEXUAL TRANSMISSION; MOLECULAR EPIDEMIOLOGY; INFECTED INDIVIDUALS; SEQUENCE ALIGNMENT; WEB SERVER; VARIANTS; IDENTIFICATION; PROGRESSION; EVOLUTION	Background: Characterization of viruses in HIV-1 transmission pairs will help identify biological determinants of infectiousness and evaluate candidate interventions to reduce transmission. Although HIV-1 sequencing is frequently used to substantiate linkage between newly HIV-1 infected individuals and their sexual partners in epidemiologic and forensic studies, viral sequencing is seldom applied in HIV-1 prevention trials. The Partners in Prevention HSV/HIV Transmission Study (ClinicalTrials.gov #NCT00194519) was a prospective randomized placebo-controlled trial that enrolled serodiscordant heterosexual couples to determine the efficacy of genital herpes suppression in reducing HIV-1 transmission; as part of the study analysis, HIV-1 sequences were examined for genetic linkage between seroconverters and their enrolled partners. Methodology/Principal Findings: We obtained partial consensus HIV-1 env and gag sequences from blood plasma for 151 transmission pairs and performed deep sequencing of env in some cases. We analyzed sequences with phylogenetic techniques and developed a Bayesian algorithm to evaluate the probability of linkage. For linkage, we required monophyletic clustering between enrolled partners' sequences and a Bayesian posterior probability of >= 50%. Adjudicators classified each seroconversion, finding 108 (71.5%) linked, 40 (26.5%) unlinked, and 3 (2.0%) indeterminate transmissions, with linkage determined by consensus env sequencing in 91 (84%). Male seroconverters had a higher frequency of unlinked transmissions than female seroconverters. The likelihood of transmission from the enrolled partner was related to time on study, with increasing numbers of unlinked transmissions occurring after longer observation periods. Finally, baseline viral load was found to be significantly higher among linked transmitters. Conclusions/Significance: In this first use of HIV-1 sequencing to establish endpoints in a large clinical trial, more than one-fourth of transmissions were unlinked to the enrolled partner, illustrating the relevance of these methods in the design of future HIV-1 prevention trials in serodiscordant couples. A hierarchy of sequencing techniques, analysis methods, and expert adjudication contributed to the linkage determination process.	[Campbell, Mary S.; Mullins, James I.; Celum, Connie; Baeten, Jared M.; Wald, Anna; Corey, Lawrence; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Mullins, James I.; Wong, Kim G.; Raugi, Dana N.; Sorensen, Stefanie; Stoddard, Julia N.; Zhao, Hong; Deng, Wenjie] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.; Corey, Lawrence] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Hughes, James P.] Univ Washington, Sch Med, Dept Biostat, Seattle, WA USA; [Celum, Connie; Kahle, Erin; Panteleeff, Dana; Baeten, Jared M.; Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA USA; [McCutchan, Francine E.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Wald, Anna] Univ Washington, Sch Med, Dept Epidemiol, Seattle, WA USA; [Lingappa, Jairam R.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Wald, Anna; Corey, Lawrence] Fred Hutchinson Canc Inst, Vaccine & Infect Dis Div, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Bill & Melinda Gates Foundation; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Campbell, MS (corresponding author), Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.	jmullins@uw.edu	Corey, Lawrence/AAE-1796-2020; Lingappa, Jairam/N-7760-2017; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438; Campbell, Matthew/0000-0002-4469-5209; Were, Edwin/0000-0002-4783-0795; Kapiga, Saidi/0000-0003-1753-4060; , Erin/0000-0001-6060-9852	Bill and Melinda Gates Foundation [26469]; University of Washington Center for AIDS Research (UW CFAR) [AI-27757]; National Institutes of Health [AI029168, AI074424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057005, R01AI029168, P30AI027757, R37AI029168, K08AI074424] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [DP1LM011509] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); University of Washington Center for AIDS Research (UW CFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was part of the Partners in Prevention HSV/HIV Transmission Study funded by the Bill and Melinda Gates Foundation (grant ID #26469). Some computational analyses were also supported by a grant through the University of Washington Center for AIDS Research (UW CFAR, AI-27757) Computational Biology Core. National Institutes of Health grants to JPH (AI029168) and MSC (AI074424) provided additional support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams MR, 2009, J VIROL, V83, P3556, DOI 10.1128/JVI.02132-08; ALBERT J, 1993, NATURE, V361, P595, DOI 10.1038/361595b0; Bull M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007122; Bull ME, 2009, J VIROL, V83, P6020, DOI 10.1128/JVI.02664-08; Celum C, N ENGL J MED, V362, P427; Deng W, 2007, BIOINFORMATICS, V23, P2334, DOI 10.1093/bioinformatics/btm331; Deng WJ, 2010, BIOTECHNIQUES, V48, P405, DOI 10.2144/000113370; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; FISCHER W, PLOS ONE, V5; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Hahn T, 1999, AIDS RES HUM RETROV, V15, P875, DOI 10.1089/088922299310584; HOLMES EC, 1993, J INFECT DIS, V167, P1411, DOI 10.1093/infdis/167.6.1411; HOLMES EC, 1993, NATURE, V364, P766, DOI 10.1038/364766b0; Kearney M, 2009, J VIROL, V83, P2715, DOI 10.1128/JVI.01960-08; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Learn G.H., 2003, HIV SEQUENCE COMPEND, P22; Leitner T, 1996, P NATL ACAD SCI USA, V93, P10864, DOI 10.1073/pnas.93.20.10864; Leitner T., 2000, AIDS REV, V2, P241; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Lingappa JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005272; Lingappa JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001411; Liu SL, 1996, SCIENCE, V273, P415, DOI 10.1126/science.273.5274.415; MADDISON W.P., 2001, MACCLADE ANAL PHYLOG; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rodrigo AG, 1997, AIDS RES HUM RETROV, V13, P737, DOI 10.1089/aid.1997.13.737; Sagar M, 2009, J INFECT DIS, V199, P580, DOI 10.1086/596557; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; STROMBERG M, 2007, MOSAIK IS SUITE COMP; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trask SA, 2002, J VIROL, V76, P397, DOI 10.1128/JVI.76.1.397-405.2002; Truong HHM, 2002, J ACQ IMMUN DEF SYND, V29, P232, DOI 10.1097/00042560-200203010-00003; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006	42	138	140	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 2	2011	6	3							e16986	10.1371/journal.pone.0016986	http://dx.doi.org/10.1371/journal.pone.0016986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729FF	21399681	Green Published, Green Submitted, gold			2022-12-27	WOS:000287933300004
J	Kim, SH; Lu, HF; Alano, CC				Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.			Neuronal Sirt3 Protects against Excitotoxic Injury in Mouse Cortical Neuron Culture	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; POLY(ADP-RIBOSE) PAR POLYMER; APOPTOSIS-INDUCING FACTOR; NMDA RECEPTOR ACTIVATION; CEREVISIAE LIFE-SPAN; INDUCED CELL-DEATH; NAD(+) DEPLETION; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CEREBRAL-ISCHEMIA	Background: Sirtuins (Sirt), a family of nicotinamide adenine nucleotide (NAD) dependent deacetylases, are implicated in energy metabolism and life span. Among the known Sirt isoforms (Sirt1-7), Sirt3 was identified as a stress responsive deacetylase recently shown to play a role in protecting cells under stress conditions. Here, we demonstrated the presence of Sirt3 in neurons, and characterized the role of Sirt3 in neuron survival under NMDA-induced excitotoxicity. Methodology/Principal Findings: To induce excitotoxic injury, we exposed primary cultured mouse cortical neurons to NMDA (30 mu M). NMDA induced a rapid decrease of cytoplasmic NAD (but not mitochondrial NAD) in neurons through poly (ADP-ribose) polymerase-1 (PARP-1) activation. Mitochondrial Sirt3 was increased following PARP-1 mediated NAD depletion, which was reversed by either inhibition of PARP-1 or exogenous NAD. We found that massive reactive oxygen species (ROS) produced under this NAD depleted condition mediated the increase in mitochondrial Sirt3. By transfecting primary neurons with a Sirt3 overexpressing plasmid or Sirt3 siRNA, we showed that Sirt3 is required for neuroprotection against excitotoxicity. Conclusions: This study demonstrated for the first time that mitochondrial Sirt3 acts as a prosurvival factor playing an essential role to protect neurons under excitotoxic injury.	[Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Alano, Conrad C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kim, SH (corresponding author), Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA.	conrad.alano@ucsf.edu	Kim, Sun/GSN-4867-2022; Gaquerel, Emmanuel/I-2503-2014	Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974; Yon, Felipe/0000-0002-5667-873X; Gulati, Jyotasana/0000-0003-0163-1296	Department of Veterans Affairs; American Heart Association	Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association)	This work was supported by the Department of Veterans Affairs (CCA) and the American Heart Association (CCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Ciani E, 1996, BRAIN RES, V728, P1; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaundal RK, 2006, LIFE SCI, V79, P2293, DOI 10.1016/j.lfs.2006.07.034; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TAO R, 2010, J CARDIOVASC PHARM; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; YAN T, 2009, NEUROCHEM INT; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335	71	166	176	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e14731	10.1371/journal.pone.0014731	http://dx.doi.org/10.1371/journal.pone.0014731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390294	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100001
